<SEC-DOCUMENT>0001162194-20-000107.txt : 20201109
<SEC-HEADER>0001162194-20-000107.hdr.sgml : 20201109
<ACCEPTANCE-DATETIME>20201106183046
ACCESSION NUMBER:		0001162194-20-000107
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		95
CONFORMED PERIOD OF REPORT:	20200930
FILED AS OF DATE:		20201109
DATE AS OF CHANGE:		20201106

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FLUIDIGM CORP
		CENTRAL INDEX KEY:			0001162194
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				770513190
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34180
		FILM NUMBER:		201295587

	BUSINESS ADDRESS:	
		STREET 1:		7000 SHORELINE COURT
		STREET 2:		SUITE 100
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		6502666000

	MAIL ADDRESS:	
		STREET 1:		7000 SHORELINE COURT
		STREET 2:		SUITE 100
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>fldm-20200930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:cc860809-a6b3-4939-9e89-fb60809a6371,g:7453d80d-f328-4339-bf18-c087f9945f8a,d:510b60bc5a1a4748b3e64a6ef1966fcd--><html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:fldm="http://fluidigm.com/20200930" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>fldm-20200930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80L2ZyYWc6NTRmMzg0M2E4MDFhNGZlOTk1YTUwZGZiY2IwNzA5ZmUvdGFibGU6NTNjOWY0Yjc0NWM0NDUzNGJjM2I1YTljNGRlYzYwY2YvdGFibGVyYW5nZTo1M2M5ZjRiNzQ1YzQ0NTM0YmMzYjVhOWM0ZGVjNjBjZl8zLTEtMS0xLTA_4ee4539c-3694-4a59-aa75-35675e9ef609">false</ix:nonNumeric><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80L2ZyYWc6NTRmMzg0M2E4MDFhNGZlOTk1YTUwZGZiY2IwNzA5ZmUvdGFibGU6NTNjOWY0Yjc0NWM0NDUzNGJjM2I1YTljNGRlYzYwY2YvdGFibGVyYW5nZTo1M2M5ZjRiNzQ1YzQ0NTM0YmMzYjVhOWM0ZGVjNjBjZl80LTEtMS0xLTA_fc252636-0632-4e5a-8e09-70794dd52c95">2020</ix:nonNumeric><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80L2ZyYWc6NTRmMzg0M2E4MDFhNGZlOTk1YTUwZGZiY2IwNzA5ZmUvdGFibGU6NTNjOWY0Yjc0NWM0NDUzNGJjM2I1YTljNGRlYzYwY2YvdGFibGVyYW5nZTo1M2M5ZjRiNzQ1YzQ0NTM0YmMzYjVhOWM0ZGVjNjBjZl81LTEtMS0xLTA_d30bef38-d30b-472e-8850-1c337364d4fe">Q3</ix:nonNumeric><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80L2ZyYWc6NTRmMzg0M2E4MDFhNGZlOTk1YTUwZGZiY2IwNzA5ZmUvdGFibGU6NTNjOWY0Yjc0NWM0NDUzNGJjM2I1YTljNGRlYzYwY2YvdGFibGVyYW5nZTo1M2M5ZjRiNzQ1YzQ0NTM0YmMzYjVhOWM0ZGVjNjBjZl82LTEtMS0xLTA_da690765-059d-4c64-bc74-0bed7e77bff1">0001162194</ix:nonNumeric><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80L2ZyYWc6NTRmMzg0M2E4MDFhNGZlOTk1YTUwZGZiY2IwNzA5ZmUvdGFibGU6NTNjOWY0Yjc0NWM0NDUzNGJjM2I1YTljNGRlYzYwY2YvdGFibGVyYW5nZTo1M2M5ZjRiNzQ1YzQ0NTM0YmMzYjVhOWM0ZGVjNjBjZl83LTEtMS0xLTA_18333c99-a698-488a-933f-f0b459c31661">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="i903ebee619a74d21ad02859fe06eab6b_D20190101-20191231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNS0wLTEtMS0wL3RleHRyZWdpb246YzE1Y2EwOTY4NmU1NGM2MTg4YzNlY2I4ZmUxN2NiNGJfNTM_94103613-d465-4432-851c-cde5b3c8b940">us-gaap:AccountingStandardsUpdate201613Member</ix:nonNumeric><ix:nonNumeric contextRef="ia193ed94f89f408ab31b7ae2e68ec878_D20200101-20200930" name="fldm:RevenueFromContractWithCustomerPerformanceObligationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfNTUwMg_166c41b6-37fc-4b8a-8206-665c77cdd303">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i57729bb7112d4134be2670ea3e309064_D20200101-20200930" name="fldm:RevenueFromContractWithCustomerPerformanceObligationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfOTE2Nw_1c099c37-d651-4eff-8b5d-06284641991e">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQzNjc_09dd10ab-4bd6-4959-a108-786ca8b4f9e5">us-gaap:AccountingStandardsUpdate201613Member</ix:nonNumeric><ix:nonNumeric contextRef="i5b8ca235d25d4be7b24f48e1d7b063c2_I20200930" format="ixt-sec:durmonth" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80Ni9mcmFnOjRjMDgyZTc3ZmY5ODRmNGQ4ZTQzOTg0ZmJlZjhlYThkL3RhYmxlOmMwNDljM2IyZTE2MTQ5MTJiNDM5N2JmMTQxZjIxMTc2L3RhYmxlcmFuZ2U6YzA0OWMzYjJlMTYxNDkxMmI0Mzk3YmYxNDFmMjExNzZfMS0xLTEtMS0w_d6026a91-897d-41df-bee8-7d32a2915055">3</ix:nonNumeric><ix:nonNumeric contextRef="ibee58402214d46c9b90764b31cb5bb82_I20200930" format="ixt-sec:duryear" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80Ni9mcmFnOjRjMDgyZTc3ZmY5ODRmNGQ4ZTQzOTg0ZmJlZjhlYThkL3RhYmxlOmMwNDljM2IyZTE2MTQ5MTJiNDM5N2JmMTQxZjIxMTc2L3RhYmxlcmFuZ2U6YzA0OWMzYjJlMTYxNDkxMmI0Mzk3YmYxNDFmMjExNzZfMi0xLTEtMS0w_b68ad4ae-3fed-40ba-90e8-5938583ac332">1</ix:nonNumeric><ix:nonNumeric contextRef="ie8df7afdb66042e49508527a5cb31fa1_I20200930" format="ixt-sec:duryear" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80Ni9mcmFnOjRjMDgyZTc3ZmY5ODRmNGQ4ZTQzOTg0ZmJlZjhlYThkL3RhYmxlOmMwNDljM2IyZTE2MTQ5MTJiNDM5N2JmMTQxZjIxMTc2L3RhYmxlcmFuZ2U6YzA0OWMzYjJlMTYxNDkxMmI0Mzk3YmYxNDFmMjExNzZfMy0xLTEtMS0w_16f09007-01eb-49ac-b54f-d9f5d19ccc64">1</ix:nonNumeric><ix:nonNumeric contextRef="i6080b667adf249898c3e460f95952085_I20200930" xsi:nil="true" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80Ni9mcmFnOjRjMDgyZTc3ZmY5ODRmNGQ4ZTQzOTg0ZmJlZjhlYThkL3RhYmxlOmMwNDljM2IyZTE2MTQ5MTJiNDM5N2JmMTQxZjIxMTc2L3RhYmxlcmFuZ2U6YzA0OWMzYjJlMTYxNDkxMmI0Mzk3YmYxNDFmMjExNzZfNC0xLTEtMS0w_05608b36-faeb-40fa-80f0-47275eb32444"></ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="i153e522b034a4cdcbce58b6ee2e543f6_D20180301-20180331" decimals="7" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81OC9mcmFnOjg0YmJjY2IxMmIxZTQ1NTNhYzc5MjZlNThiMGEzNDRkL3RhYmxlOjYwMGFkZmUzYmVlOTQ2ZmVhNDMzNDIzNWVjOTAzY2JjL3RhYmxlcmFuZ2U6NjAwYWRmZTNiZWU5NDZmZWE0MzM0MjM1ZWM5MDNjYmNfMS0yLTEtMS0w_59db6e0b-d30a-4209-be6a-32799c2ece31">0.1269438</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i90329f25a47f4987b6c5028226f49c7f_D20191101-20191130" decimals="7" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81OC9mcmFnOjg0YmJjY2IxMmIxZTQ1NTNhYzc5MjZlNThiMGEzNDRkL3RhYmxlOjYwMGFkZmUzYmVlOTQ2ZmVhNDMzNDIzNWVjOTAzY2JjL3RhYmxlcmFuZ2U6NjAwYWRmZTNiZWU5NDZmZWE0MzM0MjM1ZWM5MDNjYmNfMy0yLTEtMS0w_5b71d29b-32c0-4889-9067-e6b79111cd46">0.3448276</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="fldm-20200930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ie22f33a35cf745b0a81fe1558fdc9dbd_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i63dac85b57b74b8ea053ca16f3171b97_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if32b1e8a019b42fea7b915507e3650c8_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedd975972ec54477b7d1edc9dcd0e9ae_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id978df8be0b2445ca43d804b18f99d88_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea38c8e677cb447a95163f4ee5133194_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38d8014ca50e40ea95a3204f7d46b5a7_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4c104320701492cab8cff2d9393f868_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64595cdf77c94fb899f02002ee32e32b_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied63bbfdfbdd4d17b689fb84bd615a22_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:CollaborationRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33305dd63fcd4c7b827cced58c13da0a_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:CollaborationRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7451c9afcd847cda97b00adbdae3f05_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:CollaborationRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86ecea94f14744c580bbf02abb8493f8_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:CollaborationRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1eb2e1b7d5c4eeaa06d2bbb0f149ea2_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i507e1652ea0c4fb1b2d67aeec5653728_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cb05eac3b154d7798dda674fcc015dd_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6188317019ad466c8b5326b1720b484d_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbea30ceb41f4d23b750317c34a1821d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb6dc60b8a3d4ad7aad987d15b284ba8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacf13335933a47178e0765e3e574fd1e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3689cf18c31b470096fb83d4554d4782_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc0e648162d14d4a989f9ef273403334_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic59bca928d1a49b4afeb85ec17e11c85_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36c4cb3e31604770b06e9f2af6bc483e_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i903ebee619a74d21ad02859fe06eab6b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a2616563d5a4bf89c8fd60f83692c9c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc5ef7f40aa14d038c66e7a001196cf4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i825a8299b5f54c08a2883e0433b958bd_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id422164ca6d94e2e8c2996678b723f51_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d2d48c8e5c3470aab6bb7cb60d28da5_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i670b6d125a2743c08d4f1fb8430f5363_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if10319fa5a0a46069beb6a1617e9f6da_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfb2229b05674790ae2d1f3af5d1a49f_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97dd927c2f794a548af4aa13566b425b_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e3fc5b723344c56acd377344374f431_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9523a3afd1ad4cae8e97ae81c5b0ed5b_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc7d24911d4349cd97850e4e2f548bc4_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa0257e64d8943b3aaf914e3e8b12824_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie18fac1bb2c44c8b98f020e75b62badd_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d8ba5cd36dd447cba44d5143adbb7ff_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9edab7afab564a09b7d72cd4c082b2f5_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc294b4f830b49dd8ecde477cdb866de_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3871bafb7b75405199d644b44fa3429b_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f326510b71a4deaa593f4283e018c5a_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c632cc5576242fab0816f314eb6446f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae5604185464427688d8d6538b0064b8_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95bfaeccfec4464a937794e5c3340391_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i914a38e1ce8241ef9a128a191d3a503c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21d4b3ca64494bd286868cbca12d4736_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d88028473ce421e97253b37a085c9e7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c27fe0a0d9a44659e8415f944fc0c03_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if25548e8d7ec4e77ab7481b4e6c75c64_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15f7cdd5345a4dc1b08684ff2ea04b58_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7e2f1181ae54e4b90452df5f1cf9b06_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4be4fa2cf5014c1bb4baf526bd96dec8_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bd1ce88d5fa454a8d4dad452aa7cf9c_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f51ec45ffb24e5f9fd56e8ed689edf8_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72b360b54d1e4205854b7f3e6a0724de_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i006e76de3dab42169ad0c46b3b037dab_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fa0d20dd1f44516b4524fc6b0a6ad86_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic90d17da59fa4e799e7084567efe5328_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if46fa428977348b594b019217c905309_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67c00423ce714ae287a3c1d8bec497ad_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i762d0930982d49b1b7f455398759b828_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28fa2add73b04911a549411241057bc3_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1627ca022cf54d98a6481fda43a44841_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83369a9b2fda4053aa441b96d2bb50e2_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab67de1396ff47ea8462d8bc17240232_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f25eadecc464dbcaa3a44c5bca043bf_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10aed62e1a344f72932514716243a2f3_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0de2145a374c410095bc37bc5d98afc0_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01c50ded41e34c848e04a247fa124bd3_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia605d1ab95f846f0a9f63de67c948fd4_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3b58d4f02e844cb988b744432f0e0f9_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43b1f7df8afe4a64be00a01331b55b55_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69bd8f22916f463b9f97b4855c9980e9_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i813b7fdc72d64db19cd209236a971747_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i632b1c03d2644d748bb6a03e0f90c982_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d08643e37974cfba86f788447c6f6e2_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf04055382af45aca35807748405a7fa_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab02e207f49f4cb8bf2279f9e687111f_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d98876aa25d4522b3599841a5fc587e_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4c2400e4e364dc9b526d08b10e59300_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14df96aacd544435a5bd5f0a00f0fa84_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id976dd8bd6b34f3b9a6b24612ef2d5bc_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic00370e08713445eacc3076d8d3e2ced_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4101cc4ce01446f6b62b021b3dbb5704_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4329505554d74bb8bd0456959ea7b9d9_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia193ed94f89f408ab31b7ae2e68ec878_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f2c6e8ac0b0407b9dcbc0fb91830d02_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb7c86dd6e67421cbc4e92e76dcf85bd_D20200301-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">fldm:IntellectualPropertyInfringementClaimsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fc39d91e80e413683ccff3b0727279b_D20200301-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51f17d522ac148c68bc6b818c1014f68_D20200301-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57729bb7112d4134be2670ea3e309064_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">fldm:CommissionCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i261b1732f7d64d5ca4da0ff8446c81ce_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">fldm:CommissionCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i4c26186ae0bf4d6799d6b7bcd5a15cd7_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">fldm:OneCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:DevelopmentRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieaa80a8a61d943508698a74efef90b12_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">fldm:OneCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:DevelopmentRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i761f7b389ced4f93be18b27ca86ce004_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">fldm:FiveLargestCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40175ade607f4de5b40b93529bd75aa1_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">fldm:FiveLargestCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9ec2d4a080349c7820e11d6b38ab5d3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">fldm:FiveLargestCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic252519a5f1b45f3853a2e0071c6dcc7_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">fldm:FiveLargestCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ad72ef114054c68ba1d7499333b66b9_I20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa53719e19cc4a179c2e811a860e7411_I20140228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i426efa56430840c1b19eac7bd8d458cc_I20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3111d806397142758e8cb5ee0d0eb9e6_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ac00b245134442884f3defdcfc7fae1_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b34d835daa64fc59dd63f13ee337947_I20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48e1ed537f2e4db1b0713b2e240b93fb_D20191101-20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2019-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23b95cce717045feba062bba6e018b4e_I20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32b55c5ab8514931aa3c38ad7314012a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i522074f70914431c93eb1fb60866c897_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4664c6ae00ef4abf82e3edabaf2c670a_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie36983d4e5c64db793c5d3166fe61fa4_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69ebb284db184ca8bdf4d66d0dff3121_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa27eb06261444ae9b065f2110889263_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ae09a39637843f6a26b4e4e0127ab7d_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i527a5548d615414180d912a5102a2912_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib06456778615411fbbea453bd61bcfdc_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82ce3762aa614b6ebe557f7b073bebe4_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80cf78799b76440ea86f5da1c2493062_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id07a1b059c244e2399380a15a12a57c5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00a783530ec64310a75d4833347282a5_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i377c087ac7164a9897550043dca2a0e6_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83297b8f97a34354a79b62e5e754b631_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59a12e7ed1b243b496ec5f9736293ba2_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76daca0d7ecf4e55b49f9ef61b74d961_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:TwoThousandAndNineteenConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i547f784eb6974c818432924005a65edd_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:TwoThousandAndNineteenConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0007477bb8545a8afa0513c08a9049c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75455403764249069c09679d89b70c29_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i537a3353f9d94a15afb6333fd0f64d0c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:TwoThousandAndFourteenConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i634dc22add2d4eb0a343c30ed934f69b_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:TwoThousandAndFourteenConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibccd6f048dc74a6c953e619b2a9e9ea6_D20200117-20200117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">fldm:InstruNorASMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-17</xbrli:startDate><xbrli:endDate>2020-01-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i879547fef02c413ab97b1073b8418853_I20200117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-01-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic833fc7e7ff14f309dbabe622e99c8de_I20200117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">fldm:InstruNorASMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1f96d93c1f9456eadce09f1a0df997c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc94006eea6b434ca69524643dc9911e_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d0a47c0cefc4e1db4ee8e02eca066a9_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia24e4dab3a1e4846aed1d65d31ca64e9_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i856788a23f0e421e9c4f6bfcd2937c25_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie818350e13f1407c8991ea709abe673f_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36a9b9de3bfd42a795635e6c4734733a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iceddf551be474cbfa9d1febcb7e64631_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c769151da2142868115a7ca0373be74_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c7ed6ed420047e1b49b17f97ea91343_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb3c7d9e2c814e0e8399d92211de70ff_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0b62a4024244e348817dc10a1f4ca62_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9557da47acfa4592bd8a6eb4d01dbcac_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:InstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10f3f219918f49f0a4aaeea16520869b_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:InstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcec3908df424a9b994b171239c3ad23_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:InstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65e54d66980042b78f398dff2722c68c_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:InstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1295e00055ed464589bdacaa5e07480f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3749711354f04142930ba804e3127822_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd2f4f0a6d4b4ccbb836a1200a172bdb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i997fea8ff4474842a30928a2e82a8b6e_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i826fe1457ec74796bbc8e35e49f0de7a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b9fcc905d1e46f5ad329420385ba4f7_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48f7db29c2964b2fab7a487953e7132a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05f132757b684062b8a1afe7a0434252_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27c25df473b54c1d8ffbd994b10b9e7c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0c099e000eb4fe285d40608c7ab5954_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i611ead10ea7746c88a251afc99eef27e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6eb5cddfd9a4a429b59d0409dc55f67_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b8ca235d25d4be7b24f48e1d7b063c2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2020-10-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibee58402214d46c9b90764b31cb5bb82_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2021-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8df7afdb66042e49508527a5cb31fa1_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6080b667adf249898c3e460f95952085_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4597ae00a444403dacaf5086f59bacac_I20140228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">fldm:DVSSciencesInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6b361716cf04338b59854e72cf943b0_D20140201-20140228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">fldm:DVSSciencesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-02-01</xbrli:startDate><xbrli:endDate>2014-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0baca80d39e748b7bcbaf3ac214f583b_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">fldm:InstruNorASMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i62aeb047eea249e8a505e86f7dbd1080_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">fldm:InstruNorASMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id93cbf33dc99482fbdd7c3492d9fd706_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i448598bde68f45d1ba361f740dd9f13e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4d4f73bdbe84c6cb586dc7a3922ccec_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">fldm:PatentsandLicenseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f1a0048873a41439f03f292dfd42431_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">fldm:PatentsandLicenseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a2e644816c049b1a4a674aba901cf89_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb41af4444ce4ac891cf86ca937bc359_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f4c794c8ce04cb098b7c1033bc0c119_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">fldm:PatentsandLicenseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i863d909053654a5097e30eaeb582a60f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">fldm:PatentsandLicenseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bbffea3402e4561b1e8ab6fc7c2bc4d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62ab5d72d0304d8f95c3a6e3503aa15d_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4662072a04b84dfea208dcc931393b9d_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff7244c4435948719187b0a6db553efc_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">fldm:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ecee074f6a34af38aebd80a676157ca_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">fldm:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01205e4ce2b043afa5ff5d22df71e7af_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">fldm:LaboratoryAndManufacturingEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91971e3a302e4ce4a2fa240ccce4fd9f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">fldm:LaboratoryAndManufacturingEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b83a6bdbb5d4e1b9fb3f33d02641612_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i419524240cb046929a4263a9eb516164_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib48332e9db7f4b1cae5ea5950a5b520a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0266b792ecf4882bcc51181909743f4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i266ba35bf50e46ca809c2c0afea3c12e_D20140201-20140228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-02-01</xbrli:startDate><xbrli:endDate>2014-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i901752533bd34a9a91d8a9858d1558a3_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cf57a0407f34c83945d84ded692dd5e_I20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70f4e685daae494d9cca4f8a847b35fe_I20180312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-03-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i153e522b034a4cdcbce58b6ee2e543f6_D20180301-20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-03-01</xbrli:startDate><xbrli:endDate>2018-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e7aaefc048a42149aea7d5215e3344e_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">fldm:TrusteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cad803f6a554d6c9a8a592ef9a317bb_I20190228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">fldm:TrusteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5cf93a475bc40c383848b0c6ddce383_I20190228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9568f571b19e40a9ae266303330ceee6_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd70bc4d28f3483ba710eda050328360_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">fldm:TrusteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c04b2fe57fb44e19f764085727f7dfc_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic24a6649e6b74cc5ac3591a7f4087baa_D20191101-20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2019-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i283104e8693b4a0798cde8043a32a819_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52d079e3857749d3ae194474f9fd3966_I20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i929bb4c9acdd42b2a23fb169207c1a68_D20191101-20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2019-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bc0b6e687014f408106f0f70ddbb047_D20191101-20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2019-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0880c31bdb2349949c55fad2b57d1d5c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id881c17013fa4c2ba5f1f0618b5dcb03_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6106e4be78de4e3d82d9ce346c18dd6d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c17219e8d044f0c861d706caf153722_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c6c4c342964442b8318f2e869e57561_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i989719e68b6f4b5e9cfa93a8c07dd96e_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17eada3644a34f059d1bcbfd779f95b7_D20180801-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-01</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bdc25d355644c6f9172d331aa5efd27_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53d97ec6192a48d09c54804db8566219_D20180801-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-01</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafb598ed96e949659e7f73e00e9c6bbb_D20180801-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-01</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3876be73e4a0486f968bd16f58652b42_D20200421-20200421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-21</xbrli:startDate><xbrli:endDate>2020-04-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ad788af389e495fbf8a9625e4693669_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90329f25a47f4987b6c5028226f49c7f_D20191101-20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2019-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae5da18636984c8688424ae820893260_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b70060a9d624550994ac1dfff5b7ef1_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i151e8307ce6242f184098e1f36b5547f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38ab737fcaf84f2aa05da79a61e26690_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6737de729bd64f70bd4ad7bbc31e49bd_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcdd71a5639445c98dc5fca10293c9ee_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e18a8db5c42483eb2fc3227bf81e1bc_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i280bb003acb74672b814ebca8eb8d86c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6162a93a7603404baafc5676dff7d019_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5eff83c101c4f12b196d0f171c521dc_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fcc88cfdd4a41b8a7adcab32fd08549_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">fldm:RestrictedCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37f15e5bdea442009df048b62f08f96a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29ac583d810f4a91a7b25c3ca9dff3f8_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic036c6e4072e4f078642894c02e6a2b2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i183046f58bdf41d8884897ea6e6cf0af_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">fldm:RestrictedCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f7f6ee0988a4bdba5cf8633c5e65b6e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i681f2afaf9324c6a97f01c2538888b09_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc62fa7bd73e4eae81ee6e9258a1d986_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief09788b1d7b41ddad84a806425db48f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="investment"><xbrli:measure>fldm:investment</xbrli:measure></xbrli:unit><xbrli:context id="ie61b59be16e3451fbb4832bb215eaefa_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34fa6e2b348a44feba0389d8f9e424b4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i807edf5453ef492d89797af2d92ce323_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06f63608f6e14bd49a545fbfd1a0bb51_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84de06c926844e43876c040386be167d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3c3d82adad646dbb37ebc978e243f31_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6b4b841ac1e4d6eb459e46913612d7a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53a339bce2b7419593141ef24bbc8bed_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe0d0e9dffbd495fae18e77547f3d88c_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if34280ce49a6438a9aba047d76278cbc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ef442f5f71545048e77e64914ccc44a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ef4d07044c44fb9900a21ed9c2b3e8a_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fldm:TwoThousandAndTwentyAtTheMarketEquityOfferingProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4d47fe556de4b5a85e774b65e566c18_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fldm:TwoThousandAndTwentyAtTheMarketEquityOfferingProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff9fa89f0d3e4906b1a6686b38fead1e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndNineEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98ff5d8d443c4c78babb4c655a8e6efa_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndNineEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">fldm:RestrictedStockAndPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3da57b8f28d46aa9eb2676696423f21_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndNineEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bd22d380b1a4d6ea4fd44b27e0141f4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndElevenEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i638e57cbaa7d456f8b185da5205acb2f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndElevenEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">fldm:RestrictedStockAndPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ea312f66de54b4e9c6d400430165a3f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndElevenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fabe06699de401a840160fc6badcdb3_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndTenEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id13d013dd44e44adb532dfeeae35dbb5_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndTenEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">fldm:RestrictedStockAndPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafad09c62b1d4a0c9f23fde9d0b1485c_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndTenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0b9e4ec81a9465d991e4f00f8bdb0ce_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndSeventeenInducementAwardPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d7a0bcaab4e48bea67be674fa9e6cdc_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndSeventeenInducementAwardPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">fldm:RestrictedStockAndPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb080589897242f4a5db6a13881cbb4a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndSeventeenInducementAwardPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d050d829f6246668dee88b2edbb05f9_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied741f884347441db18e2bd390ba3411_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">fldm:RestrictedStockAndPerformanceShareUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i241d9546e6e84c83986e1cc5b11f3c0f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7de5c3aaabc04d038a06ae0f7741f31f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefea4fc822cc4bf48772c4ff54bacc58_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">fldm:RestrictedStockAndPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52a11bc3f5e44d13bf15a18be4a29d8f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i263f694376794abc814fc456f821bbd2_I20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b04e9f77df54a0b9e2eb4b34d0fc115_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa1dea2f8c814e519c099b477d05617b_D20200501-20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-01</xbrli:startDate><xbrli:endDate>2020-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibce292aab63145e2bc9d3e50b05a5089_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1284d595ff29438b8ddea2c07841e004_D20200501-20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-01</xbrli:startDate><xbrli:endDate>2020-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfd04ed28b304350bca273167b0b25b1_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8149995fd4334ebd8d795406a38a6aa0_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">fldm:AwardsHeldByOwnersOfMoreThan10OfCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86d0a118c5b6489788d92ddc7d23fbd6_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3e373d05502431a8c7dc9abf1ab0362_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:EquityIncentivePlanTwentyElevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fa5a801a597442f88adb537d10639f1_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:EquityIncentivePlanTwentyElevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a6bf5ef9a12484b86b93a4e3f7508a8_I20170131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:A2017InducementAwardPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3575d83de144e808258ee710b5e28d6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib711ac2faf28446d9e3400f0d3bd6600_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5379688acd14de7b8f11138da8190d7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43caef91ebc84c58affb994dda276bd2_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5115d69f217430288b67bde40c9b1dc_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61c3102478484d46b94add36424eda3f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32afb092bbb44b9b9f083571429c2990_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie07832375f9440358e7271a1d7a2f6c2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icae4702ca6dc445a8b04b4ce1f0e0fd9_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44e0332a734548d5b4a5b0f2a9cd04b5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">fldm:CertainEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76eddca721de44d59d30a86ae6150eae_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">fldm:CertainEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if76795b7980f4cf1b2d2d91e17de5300_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">fldm:CertainEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9dad88f3165a4f0eae5db5d9dc24638f_D20190531-20190531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-05-31</xbrli:startDate><xbrli:endDate>2019-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id735d6be492745c7b536c828704a562f_I20190531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e63e5ad862548fb846d042a7966af01_D20190601-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="offering_period"><xbrli:measure>fldm:offering_period</xbrli:measure></xbrli:unit><xbrli:context id="i5cf64713f36146589fe70c417cb48244_I20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec50ef8ea8764ccc81da85f1d3289c10_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6bc844ecc89460581bfb369e1d5f54c_D20190601-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12094595ba954861a1470caab2024faa_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if87552129e8440cebc8cf50867ede516_D20200601-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28c40c94918f4477a5ef78ff4d1aaa6a_D20200601-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4e3f90a457a4d718ca93f052c881c93_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4856057ff874e7e95190bbf158b2cc5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b89a3284da34463afa07821cc02ca87_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73d9e7c6273e4f8d91c0d44a383a2ca2_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i478d956acce94a509514c698c820bfdc_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ce4b9d2150942418669ac5b5403bf4e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1826be0f06d44338b008edc9592cb9bf_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefccdb36374e4d188b0f54d8e13766ac_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6205bf705fb745b9b232a8a68ddc2049_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>fldm:segment</xbrli:measure></xbrli:unit><xbrli:context id="iaff11e46a2f34810b12b962e4ab4033d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i028e85ad01cf4114b46ee8d96cd7d003_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie397e48475d94899ad01bc3593897a72_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37d450f4eec141f1aa6f1972f269f72d_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9aa3f12a222e452b988bb807b5313e33_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d3e63bab0634cd1b9e1748d9bddf3cb_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_1"></div><div style="min-height:36pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGV4dHJlZ2lvbjphMTM5MTUzZjU3Njc0MjJhOGIwMmU4NGU0NDFhZWNmZF8yMjk2_a09faebc-128d-4b08-aeff-a2bcb6633f0d">10-Q</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGV4dHJlZ2lvbjphMTM5MTUzZjU3Njc0MjJhOGIwMmU4NGU0NDFhZWNmZF8yMjk3_5eae5e00-2183-4f5d-9855-ff0248b073a7">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGV4dHJlZ2lvbjphMTM5MTUzZjU3Njc0MjJhOGIwMmU4NGU0NDFhZWNmZF8yNjA_180257f6-72d6-472c-9f82-ffd065e7a127">September 30, 2020</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">or</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGV4dHJlZ2lvbjphMTM5MTUzZjU3Njc0MjJhOGIwMmU4NGU0NDFhZWNmZF8yMjkx_c37bd71d-0b94-46ff-abbc-e172eda92115">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">_____________________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Commission file number: <ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGV4dHJlZ2lvbjphMTM5MTUzZjU3Njc0MjJhOGIwMmU4NGU0NDFhZWNmZF8yMjky_25bbc18f-04b6-4bfe-a67b-6da88cd85bc5">001-34180</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><img src="fldm-20200930_g1.jpg" alt="fldm-20200930_g1.jpg" style="height:81px;width:250px;"/></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGV4dHJlZ2lvbjphMTM5MTUzZjU3Njc0MjJhOGIwMmU4NGU0NDFhZWNmZF8yMjkz_d2632aff-f0d8-4c53-afd8-8249ab021900">FLUIDIGM CORP</ix:nonNumeric>ORATION </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.759%"><tr><td style="width:1.0%"></td><td style="width:23.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.201%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGFibGU6ZWIxM2M2MjU5OWU5NDU5OTkyZDIyNWNjZTFjMGUxMDQvdGFibGVyYW5nZTplYjEzYzYyNTk5ZTk0NTk5OTJkMjI1Y2NlMWMwZTEwNF8wLTAtMS0xLTA_cf0a68d1-66be-4b43-b09d-711c240ca2d1">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGFibGU6ZWIxM2M2MjU5OWU5NDU5OTkyZDIyNWNjZTFjMGUxMDQvdGFibGVyYW5nZTplYjEzYzYyNTk5ZTk0NTk5OTJkMjI1Y2NlMWMwZTEwNF8wLTQtMS0xLTA_d9d88aac-f81d-44fb-998b-70a00649c01c">77-0513190</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State or other jurisdiction of incorporation or organization</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">I.R.S. Employer Identification No.</span></td></tr><tr style="height:6pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGFibGU6ZWIxM2M2MjU5OWU5NDU5OTkyZDIyNWNjZTFjMGUxMDQvdGFibGVyYW5nZTplYjEzYzYyNTk5ZTk0NTk5OTJkMjI1Y2NlMWMwZTEwNF8zLTAtMS0xLTA_0a0368a6-f216-4513-b60e-0a7a72281f36">2 Tower Place, Ste 2000</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGFibGU6ZWIxM2M2MjU5OWU5NDU5OTkyZDIyNWNjZTFjMGUxMDQvdGFibGVyYW5nZTplYjEzYzYyNTk5ZTk0NTk5OTJkMjI1Y2NlMWMwZTEwNF8zLTEtMS0xLTA_8de501f2-a794-4862-832e-4ed443b621d0">South San Francisco,</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGFibGU6ZWIxM2M2MjU5OWU5NDU5OTkyZDIyNWNjZTFjMGUxMDQvdGFibGVyYW5nZTplYjEzYzYyNTk5ZTk0NTk5OTJkMjI1Y2NlMWMwZTEwNF8zLTItMS0xLTA_033278c4-99d2-4898-bf9e-1c3914af403c">CA</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGFibGU6ZWIxM2M2MjU5OWU5NDU5OTkyZDIyNWNjZTFjMGUxMDQvdGFibGVyYW5nZTplYjEzYzYyNTk5ZTk0NTk5OTJkMjI1Y2NlMWMwZTEwNF8zLTQtMS0xLTA_c748a2fd-02ba-4423-b78e-6d2de5471166">94080</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Address of principal executive offices</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Zip Code</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant&#8217;s telephone number, including area code: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGV4dHJlZ2lvbjphMTM5MTUzZjU3Njc0MjJhOGIwMmU4NGU0NDFhZWNmZF8yMjk0_75a0e412-5086-4e07-97e1-7f17cd7e8cc2">650</ix:nonNumeric>) <ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGV4dHJlZ2lvbjphMTM5MTUzZjU3Njc0MjJhOGIwMmU4NGU0NDFhZWNmZF8yMjk4_ea6c1c75-a68d-4a7d-b8d0-7ec7154bd723">266-6000</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_____________________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.224%"><tr><td style="width:1.0%"></td><td style="width:39.651%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.652%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGFibGU6ZjczYThmNjRlNDIwNDEyZGIxMDA5MGJkNWMyMWE0NGIvdGFibGVyYW5nZTpmNzNhOGY2NGU0MjA0MTJkYjEwMDkwYmQ1YzIxYTQ0Yl8xLTAtMS0xLTA_8fb6a1bc-439c-4f3b-8d02-49ebbed49f03">Common Stock, $0.001 par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGFibGU6ZjczYThmNjRlNDIwNDEyZGIxMDA5MGJkNWMyMWE0NGIvdGFibGVyYW5nZTpmNzNhOGY2NGU0MjA0MTJkYjEwMDkwYmQ1YzIxYTQ0Yl8xLTEtMS0xLTA_e47eed16-9f7a-47cb-9df6-6c30cd2b11d8">FLDM</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGFibGU6ZjczYThmNjRlNDIwNDEyZGIxMDA5MGJkNWMyMWE0NGIvdGFibGVyYW5nZTpmNzNhOGY2NGU0MjA0MTJkYjEwMDkwYmQ1YzIxYTQ0Yl8xLTItMS0xLTA_8ab5580d-815d-4627-b298-59582b9f2463">The Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:2pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:2pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGV4dHJlZ2lvbjphMTM5MTUzZjU3Njc0MjJhOGIwMmU4NGU0NDFhZWNmZF8yMjk5_0509e21c-c77d-49d4-8743-afbd6f0fb01b">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:9pt;margin-top:2pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation S-T (&#167;&#160;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGV4dHJlZ2lvbjphMTM5MTUzZjU3Njc0MjJhOGIwMmU4NGU0NDFhZWNmZF8yMzAw_55d89257-7d42-4c8d-9670-0c38f15eb515">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:9pt;margin-top:2pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ct.           </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:78.825%"><tr><td style="width:1.0%"></td><td style="width:28.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.579%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.950%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.192%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.229%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGFibGU6OGNkYzI4NTM2Nzk1NDU2M2JlNjQzZTUxZGYyMDUwODMvdGFibGVyYW5nZTo4Y2RjMjg1MzY3OTU0NTYzYmU2NDNlNTFkZjIwNTA4M18wLTAtMS0xLTA_5e09b192-9aa2-4077-ae60-19f2e6de237d">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated&#160;filer  </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated&#160;filer  </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company  </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGFibGU6OGNkYzI4NTM2Nzk1NDU2M2JlNjQzZTUxZGYyMDUwODMvdGFibGVyYW5nZTo4Y2RjMjg1MzY3OTU0NTYzYmU2NDNlNTFkZjIwNTA4M18xLTctMS0xLTA_3b35f813-9271-4d66-9138-583ad08725b2">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company  </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGFibGU6OGNkYzI4NTM2Nzk1NDU2M2JlNjQzZTUxZGYyMDUwODMvdGFibGVyYW5nZTo4Y2RjMjg1MzY3OTU0NTYzYmU2NDNlNTFkZjIwNTA4M18yLTctMS0xLTA_9993b8ac-bd9f-413f-a8d6-c4b02cbbd694">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:9pt;margin-top:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGV4dHJlZ2lvbjphMTM5MTUzZjU3Njc0MjJhOGIwMmU4NGU0NDFhZWNmZF8yMjk1_043ef5ae-922b-4fb8-a3da-7a328f324873">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:9pt;margin-top:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 30, 2020, there were <ix:nonFraction unitRef="shares" contextRef="ie22f33a35cf745b0a81fe1558fdc9dbd_I20201030" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGV4dHJlZ2lvbjphMTM5MTUzZjU3Njc0MjJhOGIwMmU4NGU0NDFhZWNmZF8xODE0MTk0MTg2MDgyNQ_eb8e81ce-af82-4db4-8470-4db32cefbe91">74,119,005</ix:nonFraction> shares of the registrant&#8217;s common stock, $0.001 par value per share, outstanding.</span></div><div style="height:22.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FLUIDIGM CORPORATION</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.175%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART&#160;I.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">FINANCIAL INFORMATION</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_13">Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_13">1</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_16">Condensed Consolidated Balance Sheets as of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_16">September </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_16">30, 2020 and December 31, 2019 </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_16">1</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_19">Condensed Consolidated Statements of Operations for the three and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_19">nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_19"> months ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_19">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_19"> 30, 2020 and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_19">2</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_22">Condensed Consolidated Statements of Comprehensive Loss for the three and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_22">nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_22"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_22">months ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_22">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_22"> 30, 2020 and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_22">3</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_25">Condensed Consolidated Statements of Stockholders' Equity for the three and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_25">nine </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_25">months ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_25">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_25"> 30, 2020 and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_25">4</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_28">Condensed Consolidated Statements of Cash Flows for the three and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_28">nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_28"> months ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_28">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_28"> 30, 2020 and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_28">6</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_31">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_31">7</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_88">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_88">30</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_112">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_112">42</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_115">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_115">42</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART&#160;II.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">OTHER INFORMATION</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_121">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_121">44</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_124">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_124">44</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_127">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_127">69</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_1234">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_1234">69</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_1239">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_1239">69</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_130">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_130">69</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_133">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_133">70</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_133">EXHIBIT LIST</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_133">70</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_136">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i510b60bc5a1a4748b3e64a6ef1966fcd_136">71</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_10"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I. FINANCIAL INFORMATION</span></div><div style="text-align:center"><span><br/></span></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_13"></div><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. Financial Statements</span></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FLUIDIGM CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfNC0yLTEtMS0w_3e703f8f-3ed5-4616-a13e-f9d807299684">72,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfNC00LTEtMS0w_0a05644b-ff3b-4e49-bf5c-cb3ad3dc5062">21,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfNS0yLTEtMS0w_b3651c9f-6c99-4304-b309-51b2eb531291">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfNS00LTEtMS0w_95df2f64-f2f5-4419-8752-337dbe40af14">36,978</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable (net of allowances of $<ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfNi0wLTEtMS0wL3RleHRyZWdpb246N2FhNDVkNjJkNDAwNGNjYWEzNjJjZmI5OTAwODQ5OWNfNDY_57173bc7-4c4f-4a38-bad8-506f7df88f9b">324</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfNi0wLTEtMS0wL3RleHRyZWdpb246N2FhNDVkNjJkNDAwNGNjYWEzNjJjZmI5OTAwODQ5OWNfNTM_54aebddc-a120-47ec-9f6c-5ab7d07af3b4">6</ix:nonFraction>, at September 30, 2020 and December&#160;31, 2019, respectively)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfNi0yLTEtMS0w_56c76a00-1326-406d-a341-6a47e4810581">17,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfNi00LTEtMS0w_f3fa093e-8dc9-4abd-87dd-981ca9653291">18,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="fldm:ResearchAndDevelopmentArrangementReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfNy0yLTEtMS0xNTc5_60127cda-a3ad-4e6a-acfb-59e35c9bed70">7,456</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:zerodash" name="fldm:ResearchAndDevelopmentArrangementReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfNy00LTEtMS0xNTc5_c95e0f19-7b03-4177-9894-a8eee60ed817">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfNy0yLTEtMS0w_a4859f24-3a0f-409a-836b-a4d5d14f504d">19,560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfNy00LTEtMS0w_f9db4628-6b10-4d43-b57b-612ed19acf09">13,884</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfOC0yLTEtMS0w_da007e80-5dcf-4f40-8c0f-6420e6a97090">5,689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfOC00LTEtMS0w_96adfc7b-1a76-41a4-9f5a-f6feb261de8b">4,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfOS0yLTEtMS0w_067bdf01-5a8a-486e-b82b-cb35c9c1726f">122,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfOS00LTEtMS0w_ec9546b3-5ce0-471b-b04c-b5fe5273cc2c">96,096</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMTEtMi0xLTEtMA_ed88dd9e-e696-4585-bb4d-e2b2d587ef54">7,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMTEtNC0xLTEtMA_bd048b7d-afdd-4c70-a192-5b7e8d7c7e9c">8,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMTItMi0xLTEtMA_4ff98fad-1d67-4922-804d-76d944622893">38,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMTItNC0xLTEtMA_86cad029-bb63-4cb8-aeaa-d0001dc3099c">4,860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMTMtMi0xLTEtMA_08ecc6ef-f2ea-460f-82e2-d1ab3947f851">4,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMTMtNC0xLTEtMA_166a1840-a396-4e6a-837c-099bed06e160">5,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMTQtMi0xLTEtMA_efe0ebfe-93bc-4c9b-89ea-3fcc20ea3313">42,955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMTQtNC0xLTEtMA_2a3e98c5-c8a0-4c93-b358-b798ed2dd401">46,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMTUtMi0xLTEtMA_7e1c97d3-1d8d-4c98-a79c-b0edadec53c5">106,455</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMTUtNC0xLTEtMA_5811655a-e644-4595-9941-6315e1589234">104,108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMTYtMi0xLTEtMA_c2c90d71-68dd-49fa-8580-ce130e2cf55f">322,977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMTYtNC0xLTEtMA_5c1ff7c5-05cc-4e42-9fcb-87d0f4a37d78">264,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMTktMi0xLTEtMA_0e1682e3-0f29-4f04-bf72-a69cfa77f811">10,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMTktNC0xLTEtMA_9c872ecf-0aec-4a7b-a098-4c3a19a8a359">6,510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and related benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjAtMi0xLTEtMA_45511d8f-1f11-44f2-81b4-fe9e0beb31bc">9,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjAtNC0xLTEtMA_d8bcc6eb-7e45-4253-9952-4884808f1c41">5,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjEtMi0xLTEtMA_e0fc3101-e1b9-4bac-8434-24e41ffb4c0a">2,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjEtNC0xLTEtMA_d1fddfa5-0dd4-418f-88f3-390fdbc5fd1a">1,833</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjItMi0xLTEtMA_bd7e603e-a558-4eec-89fa-e9e488a9d28d">6,565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjItNC0xLTEtMA_9580a3f7-4ac7-452f-ad11-81874552d83d">7,515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjMtMi0xLTEtMA_49fd3277-ee1a-430d-9ba1-0e67d565a4fe">13,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjMtNC0xLTEtMA_ad0e9bf3-45f5-4fab-9dfc-ca60fdfeb98e">11,803</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjQtMi0xLTEtMA_5dcbdeea-45a2-4c91-8eb2-5077fb859722">42,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjQtNC0xLTEtMA_46c17213-2c2c-4010-a9c6-98461cd27692">32,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible notes, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConvertibleLongTermNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjUtMi0xLTEtMA_041eda7a-b7e5-4c82-8fc3-dc8c7fd3f695">54,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConvertibleLongTermNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjUtNC0xLTEtMA_07a2e686-3e64-405c-8eea-2f944f2efa8f">53,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjYtMi0xLTEtMA_c54f6d18-5626-4cff-b64c-f2b0976e633a">9,041</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjYtNC0xLTEtMA_d1a7e6af-e946-4b01-95bb-bb6c3da8305a">11,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, non-current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjctMi0xLTEtMA_0eb3c40a-44ea-429b-b071-e9db587bbf97">38,607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjctNC0xLTEtMA_4748955d-3c65-4d6d-aa1e-c691b8cd8426">4,323</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, non-current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjgtMi0xLTEtMA_a5e17ce4-907b-4ac8-aea0-b3f6eea1552d">7,684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjgtNC0xLTEtMA_2f2a3a73-c13f-4b82-a641-973cc7226a6d">8,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred grant income, non-current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="fldm:DeferredGrantRevenueNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzAtMi0xLTEtMTUwMg_08277549-370f-4ed2-829f-946b8c85e78e">18,224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:zerodash" name="fldm:DeferredGrantRevenueNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzAtNC0xLTEtMTQ5Nw_cd4570ce-c574-4f24-a84e-1d57b463f34f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjktMi0xLTEtMA_52e398a4-cf13-4578-af1a-2960563e55d5">536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjktNC0xLTEtMA_f10104a6-3995-4ee7-bbae-570473ad4d9b">573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzAtMi0xLTEtMA_30ae78f1-23a6-4386-9121-a6fe57cbafe4">171,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzAtNC0xLTEtMA_b14723fc-afe0-4e53-971b-a161e23a1b31">111,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzEtMi0xLTEtMA_76cc9e51-e605-4b91-a443-15269f987dd3"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzEtNC0xLTEtMA_94226603-062e-4c11-a9ac-633366bc10ca"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjQ3NTAwYmYwYjNmMzQ4MjdiNzhjNTI1OGJiYjNjNzMzXzIx_0636529a-9894-4321-bdf4-16bc6e9a6bd2"><ix:nonFraction unitRef="usdPerShare" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjQ3NTAwYmYwYjNmMzQ4MjdiNzhjNTI1OGJiYjNjNzMzXzIx_eac5f643-3718-4f62-9523-22708ccf2b52">0.001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjQ3NTAwYmYwYjNmMzQ4MjdiNzhjNTI1OGJiYjNjNzMzXzM1_96b75cdd-4a70-4cad-9244-9e1a8e735d67"><ix:nonFraction unitRef="shares" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjQ3NTAwYmYwYjNmMzQ4MjdiNzhjNTI1OGJiYjNjNzMzXzM1_ac1e0c2e-a180-4527-884a-ebb3278e5181">10,000</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjQ3NTAwYmYwYjNmMzQ4MjdiNzhjNTI1OGJiYjNjNzMzXzU3_51c750aa-ee00-4336-89a7-ac53c6911097"><ix:nonFraction unitRef="shares" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjQ3NTAwYmYwYjNmMzQ4MjdiNzhjNTI1OGJiYjNjNzMzXzU3_5654cf09-a98e-4edf-a254-72409388effe"><ix:nonFraction unitRef="shares" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjQ3NTAwYmYwYjNmMzQ4MjdiNzhjNTI1OGJiYjNjNzMzXzU3_719c26ad-862b-4345-a355-36a24c7718a9"><ix:nonFraction unitRef="shares" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjQ3NTAwYmYwYjNmMzQ4MjdiNzhjNTI1OGJiYjNjNzMzXzU3_bc0492ad-b6e6-4f8e-a3a7-ed1bc5840368">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding at either September&#160;30, 2020 or December&#160;31, 2019</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzMtMi0xLTEtMA_b46801cb-510d-41af-93ed-d491649994dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzMtNC0xLTEtMA_f8446df5-448f-4837-9334-05b448180a5e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock: $<ix:nonFraction unitRef="usdPerShare" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmI5NTY3YzRiY2JlMzQ2ZDJiZTVjZDkwNmY5MGJiOGIwXzE4_8556c5de-debf-4225-9c04-8b0af47bf6fd"><ix:nonFraction unitRef="usdPerShare" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmI5NTY3YzRiY2JlMzQ2ZDJiZTVjZDkwNmY5MGJiOGIwXzE4_fd510e3f-84e8-426f-ad58-91343dab39dd">0.001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmI5NTY3YzRiY2JlMzQ2ZDJiZTVjZDkwNmY5MGJiOGIwXzMy_ec5db666-2c26-4fb6-8a0a-42023c765fa7"><ix:nonFraction unitRef="shares" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmI5NTY3YzRiY2JlMzQ2ZDJiZTVjZDkwNmY5MGJiOGIwXzMy_f21a58d1-b63b-4463-8df1-2202bb37fed6">200,000</ix:nonFraction></ix:nonFraction> shares authorized at September&#160;30, 2020 and December&#160;31, 2019; <ix:nonFraction unitRef="shares" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmI5NTY3YzRiY2JlMzQ2ZDJiZTVjZDkwNmY5MGJiOGIwXzkz_a879b1de-a656-41cc-8c68-47fb8b7850ff"><ix:nonFraction unitRef="shares" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmI5NTY3YzRiY2JlMzQ2ZDJiZTVjZDkwNmY5MGJiOGIwXzkz_b83fa9df-0814-4d81-91c0-6e35223f0470">74,115</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmI5NTY3YzRiY2JlMzQ2ZDJiZTVjZDkwNmY5MGJiOGIwXzEwMA_7dec243e-069f-46a4-9472-53aa0297262d"><ix:nonFraction unitRef="shares" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmI5NTY3YzRiY2JlMzQ2ZDJiZTVjZDkwNmY5MGJiOGIwXzEwMA_d33b4411-9c6b-4e47-8b11-27c653f3d6d4">69,956</ix:nonFraction></ix:nonFraction> shares issued and outstanding at September&#160;30, 2020 and December&#160;31, 2019, respectively</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzQtMi0xLTEtMA_9aa1b43f-0970-4280-8be7-d308e3ce0ec3">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzQtNC0xLTEtMA_40d4ce61-636c-4567-a114-375a10d1b6a0">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzUtMi0xLTEtMA_7e7392de-7b14-4814-a439-810ddef009ab">810,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzUtNC0xLTEtMA_e153aed2-9f2e-4ec7-a354-aebb78071e08">777,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzYtMi0xLTEtMA_150a35d5-512e-4d33-8a0c-3d89257b5f84">289</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzYtNC0xLTEtMA_0c35a9ce-2237-4af4-afae-b0ab139871f2">582</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzctMi0xLTEtMA_f5ead3b3-6fcd-403d-830e-3a043a5c3ad0">658,735</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzctNC0xLTEtMA_83a79733-343f-48b0-9da3-5d81fbeb5382">623,641</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzgtMi0xLTEtMA_43e18a59-f2b1-4c0f-a018-aa4a13f2aa1b">151,973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzgtNC0xLTEtMA_85385c09-7c81-47b7-8a3e-1a1dac18247b">153,612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzktMi0xLTEtMA_3e06a9db-4bba-4238-b4d6-4fda04a98fe2">322,977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzktNC0xLTEtMA_10e55d42-809b-4b04-84f8-80aef7da2cf0">264,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FLUIDIGM CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:46.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63dac85b57b74b8ea053ca16f3171b97_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMy0yLTEtMS0w_04df5bf3-f03c-429d-82a9-ff9bd1b90fc9">29,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if32b1e8a019b42fea7b915507e3650c8_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMy00LTEtMS0w_b9434857-51ae-4f08-8a98-4b758700b6a9">20,666</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedd975972ec54477b7d1edc9dcd0e9ae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMy02LTEtMS0w_22a52076-27de-44d4-9b05-30e673bad39d">65,596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id978df8be0b2445ca43d804b18f99d88_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMy04LTEtMS0w_b0afbf50-5979-4936-a4e3-1ef160398d18">68,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea38c8e677cb447a95163f4ee5133194_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfNC0yLTEtMS0w_7f7401e4-6312-4fe5-affc-41e1b2ede8d8">6,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38d8014ca50e40ea95a3204f7d46b5a7_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfNC00LTEtMS0w_2612f0de-16ce-42b4-8a79-7939d0b7f9d3">5,630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4c104320701492cab8cff2d9393f868_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfNC02LTEtMS0w_3bc420fb-3cc6-4432-9da7-da79060854ca">16,457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64595cdf77c94fb899f02002ee32e32b_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfNC04LTEtMS0w_c8bb141f-4780-4aab-9f90-d5a673a83c35">15,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Development revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied63bbfdfbdd4d17b689fb84bd615a22_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfNS0yLTEtMS0w_d9ba2b05-8ece-4ffb-8480-b20827e885cf">3,180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33305dd63fcd4c7b827cced58c13da0a_D20190701-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfNS00LTEtMS0w_de5c8caa-0978-4eaa-bdd5-d45accc9ed02">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7451c9afcd847cda97b00adbdae3f05_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfNS02LTEtMS0w_604299e7-85ac-4ee4-b69d-dbf72aa1b973">6,180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86ecea94f14744c580bbf02abb8493f8_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfNS04LTEtMS0w_f7e1322e-8af7-43b1-af97-841c4e2867ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1eb2e1b7d5c4eeaa06d2bbb0f149ea2_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfNi0yLTEtMS0w_0d9dd1f1-210c-421e-ac44-90a8062058bd">1,340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507e1652ea0c4fb1b2d67aeec5653728_D20190701-20190930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfNi00LTEtMS0w_03150dc0-f313-4d00-94a9-15c3922f6630">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cb05eac3b154d7798dda674fcc015dd_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfNi02LTEtMS0w_fd7e6db8-8a59-4120-89db-5450df70d50a">5,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6188317019ad466c8b5326b1720b484d_D20190101-20190930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfNi04LTEtMS0w_b13b49e4-fb32-43ad-abc5-d6986f57bc28">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfNy0yLTEtMS0w_828f9c19-b8ba-46a4-8c1c-e4617483a772">39,861</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfNy00LTEtMS0w_51e57782-5619-4dc5-aa66-3c5edf69ca9e">26,496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfNy02LTEtMS0w_41be0c49-4f28-4c79-9cd1-a980c147120a">93,536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfNy04LTEtMS0w_02dd85f8-9ee8-4af0-9a1d-94ff4bbec46c">84,803</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of product revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63dac85b57b74b8ea053ca16f3171b97_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfOS0yLTEtMS0w_5519c42c-ea51-4db5-bb35-380b66a1cac3">12,773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if32b1e8a019b42fea7b915507e3650c8_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfOS00LTEtMS0w_cc75e57b-b559-4b85-bbb8-d0c83080ffe5">10,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedd975972ec54477b7d1edc9dcd0e9ae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfOS02LTEtMS0w_b6acb7cf-0403-4e33-adcd-4a9cc75d7e5c">31,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id978df8be0b2445ca43d804b18f99d88_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfOS04LTEtMS0w_96ab897f-7a45-47a5-975e-881270f85246">33,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of service revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea38c8e677cb447a95163f4ee5133194_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTAtMi0xLTEtMA_038550f4-bbdc-4c4a-9b48-513bf4bf622f">1,769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38d8014ca50e40ea95a3204f7d46b5a7_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTAtNC0xLTEtMA_cc930b41-4651-4782-b8e2-d510df1be928">1,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4c104320701492cab8cff2d9393f868_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTAtNi0xLTEtMA_5e0490bb-2f7d-4889-821a-870e95f27451">4,531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64595cdf77c94fb899f02002ee32e32b_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTAtOC0xLTEtMA_f3f74869-0ecc-47d8-bc5c-58fca0896960">5,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTEtMi0xLTEtMA_17f646c5-b210-4482-a801-c40ab67ac551">8,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTEtNC0xLTEtMA_0fb26a99-3aed-467e-b01f-3334393debf9">7,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTEtNi0xLTEtMA_28713343-22d8-4b7c-85a2-eae6cbaacca7">25,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTEtOC0xLTEtMA_f7dbb20b-ebd3-45f8-8941-14d5c1bc594f">23,362</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTItMi0xLTEtMA_4d5fe8aa-8897-4e08-9830-365ba8963f23">22,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTItNC0xLTEtMA_64af4d29-b74f-44f5-847b-45591a7a9122">20,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTItNi0xLTEtMA_1b017ae2-0453-4b47-84a0-654952b08e7c">65,966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTItOC0xLTEtMA_06556c39-79d5-4d57-b2e7-73e8e5dc3493">65,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTYtMi0xLTEtMA_423a1ed1-c7bb-49e3-b8b2-bd59820875ea">45,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTYtNC0xLTEtMA_1984e8b1-3e83-4ac5-b387-02947803dcff">40,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTYtNi0xLTEtMA_5a492115-63d5-4210-8524-159972d7d383">127,668</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTYtOC0xLTEtMA_bdf36140-464d-4d08-a645-24e5617ded08">127,461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTctMi0xLTEtMA_e78a2bd3-a1a2-4c13-bbe7-c1d0dfded447">5,464</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTctNC0xLTEtMA_629e0a80-2743-4d19-8b71-67aa4ad9122c">13,816</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTctNi0xLTEtMA_89877270-3786-4d64-973e-d6fc6d89038c">34,132</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTctOC0xLTEtMA_8e3ff703-644c-4011-8ec8-e86eb6b35661">42,658</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTgtMi0xLTEtMA_27ef672b-9180-4996-8443-dbb2f23c2166">885</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTgtNC0xLTEtMA_41f37fc5-55bc-4eef-b8f7-e5c74ba829c0">444</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTgtNi0xLTEtMA_ef6b2890-4ade-423b-9e3c-aedd31931135">2,682</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTgtOC0xLTEtMA_faa90d4a-19f3-475f-8278-c455725e8c3a">3,636</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from extinguishment of debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTktMi0xLTEtMA_4372ce27-2fd8-492e-b792-17524ac56384">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTktNC0xLTEtMA_ff37b67f-2b46-45b3-929b-71f7e519733d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTktNi0xLTEtMA_2a9bf802-0c60-4863-8714-7d1f437a6e52">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTktOC0xLTEtMA_14942160-8df5-4d02-af24-4bb2c9d5de71">9,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjAtMi0xLTEtMA_870b569b-5e20-4641-9ef6-454703f33dc2">107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjAtNC0xLTEtMA_bed83828-9605-4ad4-840a-4094349283f7">205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjAtNi0xLTEtMA_204d5955-4c6e-4a55-961d-e51459d95121">248</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjAtOC0xLTEtMA_1fa042bb-e939-4636-9ced-fae1fa1f2435">920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjEtMi0xLTEtMA_4faf1b20-3dd3-48ec-ba14-2137e2ca295e">6,242</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjEtNC0xLTEtMA_a32996ae-dd33-4917-81bf-c3db3c97324e">14,055</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjEtNi0xLTEtMA_aa239465-4c41-42b8-bee2-d1ec9b392e00">37,062</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjEtOC0xLTEtMA_98a3e8af-6053-42b4-9971-02b4190710c6">54,374</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjItMi0xLTEtMA_c07f5f1f-9773-46cd-a2d2-19d55d63b252">243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjItNC0xLTEtMA_69368de2-598a-494f-91a8-705e86ec9a9b">1,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjItNi0xLTEtMA_edf205cd-0d71-4f44-b566-a394a8f92cc0">2,068</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjItOC0xLTEtMA_8a797e31-cc6d-4635-9fe2-a001a7a515b5">2,269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjMtMi0xLTEtMA_60542476-6ec7-4823-977a-cf8db5034740">5,999</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjMtNC0xLTEtMA_71353883-8225-41d8-8101-fbad1198a3ab">12,887</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjMtNi0xLTEtMA_004a9259-77af-4c31-934e-1f1134767638">34,994</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjMtOC0xLTEtMA_c8b58fc3-6514-485b-b3f3-a571288fe228">52,105</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjQtMi0xLTEtMA_d098b834-fd49-45ad-a863-a25240c1a53d">0.08</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjQtNC0xLTEtMA_fbabd511-df5d-410a-a11a-df8850082e78">0.19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjQtNi0xLTEtMA_ab9b0727-85d1-4e16-bf1a-e4873326befc">0.49</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjQtOC0xLTEtMA_8c4e5b04-53f2-4c9b-b58a-cff2ac3e473c">0.79</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing net loss per share, basic and diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjUtMi0xLTEtMA_65b0ad35-f8b1-4eab-8eb8-16a0147d7a26">72,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjUtNC0xLTEtMA_92e48c9d-d37d-4ece-ba43-c79e30946915">69,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjUtNi0xLTEtMA_0669c046-186c-42ad-b769-53ff8f4d4648">71,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjUtOC0xLTEtMA_f83b2935-bd7e-451b-b66b-685532deaf32">65,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FLUIDIGM CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.187%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfMi0yLTEtMS0w_60542476-6ec7-4823-977a-cf8db5034740">5,999</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfMi00LTEtMS0w_0ee30f21-df76-4c24-ab51-a9a4851ab465">12,887</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfMi02LTEtMS0w_7f2d42d9-bc29-4fc8-b3d6-88723494db9f"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfMi02LTEtMS0w_944f1989-8792-4656-9689-4fabd5f0837f">34,994</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfMi05LTEtMS0w_c8b58fc3-6514-485b-b3f3-a571288fe228">52,105</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfNC0yLTEtMS0w_2d8bd5b4-5a53-4414-ab42-a390e02da086">523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfNC00LTEtMS0w_228d98c5-c655-46cb-a151-14d77741e1b1">121</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfNC02LTEtMS0w_7ef5f3d0-ce94-4e01-9db8-d63128686a41">329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfNC05LTEtMS0w_1bb351b3-2414-4bfe-9995-21525fa2d9eb">122</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized gain (loss) on investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfNS0yLTEtMS0w_2a29002f-9175-4a3f-be47-91766f425f35">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfNS00LTEtMS0w_704b2e33-ecaf-4636-972c-4d2d7d0fb145">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfNS02LTEtMS0w_b224372b-1834-470a-b1b4-a103961fef82">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfNS05LTEtMS0w_bf72656c-e3ff-4b8c-b3a1-2dff9b82f98e">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfNi0yLTEtMS0w_1d9dc43b-57d0-46e1-98a5-2820e4a0fd4d">520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfNi00LTEtMS0w_6b52747e-e6c1-4503-9380-fc849955773f">135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfNi02LTEtMS0w_bd949f94-7851-4cf2-885a-7b28659cd42f">293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfNi05LTEtMS0w_cbde3e25-457d-46c5-8c6b-8a6c8ed50a4a">71</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfNy0yLTEtMS0w_32843186-6a90-42b0-9cfc-4c3d5b0d83d7">5,479</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfNy00LTEtMS0w_f15c54fd-0f82-479b-9409-993133147e03">13,022</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfNy02LTEtMS0w_62fce817-e859-4218-bdb1-dc7c48b88b05">34,701</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfNy05LTEtMS0w_3baafdfe-94b8-4613-a87f-3a4121221da3">52,176</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FLUIDIGM CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.465%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.638%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.638%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.765%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idbea30ceb41f4d23b750317c34a1821d_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMi0yLTEtMS0w_f78ffd4d-f5cc-46e7-a76b-2ae013be5d5e">69,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbea30ceb41f4d23b750317c34a1821d_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMi00LTEtMS0w_92f6bda4-887b-4896-82c5-1436252712ce">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6dc60b8a3d4ad7aad987d15b284ba8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMi02LTEtMS0w_41336a81-ea3a-4207-95f9-76ef08cc402e">777,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iacf13335933a47178e0765e3e574fd1e_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMi04LTEtMS0w_6f98b1b5-f8e3-459c-9967-0790d8ed510d">582</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3689cf18c31b470096fb83d4554d4782_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMi0xMC0xLTEtMA_cea9cc45-b814-44a9-9859-f8775fe82b7e">623,641</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMi0xMi0xLTEtMA_a7c83789-2b5d-4f7c-a711-67fb265f8521">153,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of restricted stock, net of shares withheld for taxes, and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifc0e648162d14d4a989f9ef273403334_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMy0yLTEtMS0w_7f1ecbae-a386-4307-aab8-65f698621bec">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic59bca928d1a49b4afeb85ec17e11c85_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMy02LTEtMS0w_b7e29ad7-9e1f-4277-aca0-b247abdecf69">146</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36c4cb3e31604770b06e9f2af6bc483e_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMy0xMi0xLTEtMA_ee5480af-559b-42f7-8617-9a915fbc2cd3">146</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative-effect of new accounting standard for <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNS0wLTEtMS0wL3RleHRyZWdpb246YzE1Y2EwOTY4NmU1NGM2MTg4YzNlY2I4ZmUxN2NiNGJfNTM_94103613-d465-4432-851c-cde5b3c8b940">Topic 326 Credit Losses</span></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a2616563d5a4bf89c8fd60f83692c9c_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNS0xMC0xLTEtMA_1de0b24e-0859-4f24-a06c-c05d91e56fd7">100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc5ef7f40aa14d038c66e7a001196cf4_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNS0xMi0xLTEtMA_aae285a6-990e-4c63-896b-30c4ae5fca75">100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic59bca928d1a49b4afeb85ec17e11c85_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNi02LTEtMS0w_7193a5f7-f63d-47ef-96a2-25330af3dd8c">2,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36c4cb3e31604770b06e9f2af6bc483e_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNi0xMi0xLTEtMA_bf6445e2-1d93-4faf-a507-293fbab40660">2,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition of InstruNor AS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifc0e648162d14d4a989f9ef273403334_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNy0yLTEtMS0w_66a1e15a-d703-47a8-a1d4-0ba47162f368">485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc0e648162d14d4a989f9ef273403334_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNy00LTEtMS0w_cda4e265-0d67-4a0e-bbd9-c102f9d0da8f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic59bca928d1a49b4afeb85ec17e11c85_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNy02LTEtMS0w_bd4aefb9-cae1-4818-885b-b8fb287e3482">2,048</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36c4cb3e31604770b06e9f2af6bc483e_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNy0xMi0xLTEtMA_91783757-619b-495e-a7df-c587c0a3147a">2,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i825a8299b5f54c08a2883e0433b958bd_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfOC0xMC0xLTEtMA_fde7bed6-2ddf-4619-887c-693fdb117c64">15,980</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36c4cb3e31604770b06e9f2af6bc483e_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfOC0xMi0xLTEtMA_96530458-aeb3-432d-aea5-a40acbc00262">15,980</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id422164ca6d94e2e8c2996678b723f51_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfOS04LTEtMS0w_75a61f61-f27e-4b3f-a178-01c47aa25020">303</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36c4cb3e31604770b06e9f2af6bc483e_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfOS0xMi0xLTEtMA_43760a64-d989-4552-b03e-a71594eae9fb">303</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1d2d48c8e5c3470aab6bb7cb60d28da5_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTAtMi0xLTEtMA_aa094476-ff3e-4097-9cbe-84f342b6f286">70,696</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d2d48c8e5c3470aab6bb7cb60d28da5_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTAtNC0xLTEtMA_5b7b6c88-159d-4fd5-a278-ad77270c1e91">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i670b6d125a2743c08d4f1fb8430f5363_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTAtNi0xLTEtMA_17b2218d-7c0c-4b45-a93d-0d80597ec259">782,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if10319fa5a0a46069beb6a1617e9f6da_I20200331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTAtOC0xLTEtMA_b98de119-cb91-4b04-8981-00f04cf90afb">885</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfb2229b05674790ae2d1f3af5d1a49f_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTAtMTAtMS0xLTA_4ba9f6fc-43b8-49a4-aebf-9b463f6dbff4">639,721</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97dd927c2f794a548af4aa13566b425b_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTAtMTItMS0xLTA_35bd4875-be7e-47df-8b6c-350622fa96fd">141,496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of restricted stock, net of shares withheld for taxes, and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7e3fc5b723344c56acd377344374f431_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTEtMi0xLTEtMA_c3a8e341-3b6b-4f01-a6a0-b96285394652">286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9523a3afd1ad4cae8e97ae81c5b0ed5b_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTEtNi0xLTEtMA_b2d2d8cb-e8e3-48fe-b568-5e1af959c559">116</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc7d24911d4349cd97850e4e2f548bc4_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTEtMTItMS0xLTA_e3304047-1209-48f0-bb62-4c85117a9b8d">116</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock under ESPP</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7e3fc5b723344c56acd377344374f431_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTItMi0xLTEtMA_03468c2d-ebc6-4cab-8bbe-55ede6fc8745">301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9523a3afd1ad4cae8e97ae81c5b0ed5b_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTItNi0xLTEtMA_209bc94b-8366-4b4f-ad09-7961d22c3388">645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc7d24911d4349cd97850e4e2f548bc4_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTItMTItMS0xLTA_6dd71020-4dbb-4d36-92c3-d504a77411f9">645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9523a3afd1ad4cae8e97ae81c5b0ed5b_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTMtNi0xLTEtMA_0fdce3a5-b0bd-4d8b-ac27-24a505df1b3d">3,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc7d24911d4349cd97850e4e2f548bc4_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTMtMTItMS0xLTA_79ae9da2-4496-4150-a199-6a6c0e91c745">3,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa0257e64d8943b3aaf914e3e8b12824_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTUtMTAtMS0xLTA_62823a49-0c10-4b43-887c-ac1013ae03d0">13,015</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc7d24911d4349cd97850e4e2f548bc4_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTUtMTItMS0xLTA_d85b7616-f0bb-477c-aa04-cfd4f5ce2a9d">13,015</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie18fac1bb2c44c8b98f020e75b62badd_D20200401-20200630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTYtOC0xLTEtMA_a6e344dd-ebae-4c89-9401-722b83af44a8">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc7d24911d4349cd97850e4e2f548bc4_D20200401-20200630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTYtMTItMS0xLTA_87582339-5844-4ca8-82ed-dfa43f607f27">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3d8ba5cd36dd447cba44d5143adbb7ff_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTctMi0xLTEtMA_7e449b9b-742a-4681-b38b-25c914da07f1">71,283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d8ba5cd36dd447cba44d5143adbb7ff_I20200630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTctNC0xLTEtMA_7d76c686-b095-4800-83a9-bdab39404285">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9edab7afab564a09b7d72cd4c082b2f5_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTctNi0xLTEtMA_8e163e36-9d8c-4385-8b2f-ac5f39d1cbaa">786,193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc294b4f830b49dd8ecde477cdb866de_I20200630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTctOC0xLTEtMA_d223eeee-9e54-4846-98ed-3aef04e51790">809</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3871bafb7b75405199d644b44fa3429b_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTctMTAtMS0xLTA_ecc730b4-9461-4565-a26b-c019c8119122">652,736</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f326510b71a4deaa593f4283e018c5a_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTctMTItMS0xLTA_52758a83-1be5-45ed-9f03-08e2016d794c">132,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of restricted stock, net of shares withheld for taxes, and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2c632cc5576242fab0816f314eb6446f_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTgtMi0xLTEtMTk1_859faef4-0940-4f00-9fc2-62d5f6b4d420">258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c632cc5576242fab0816f314eb6446f_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTgtNC0xLTEtMjEy_aac222a2-4312-41a8-ba13-33cb4f90e3af">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae5604185464427688d8d6538b0064b8_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTgtNi0xLTEtMTk3_b2df8e63-8084-4277-8175-8a0ce94b46dc">124</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTgtMTItMS0xLTIwMg_d3eecf76-cdfc-4e4c-adc3-273d93f27495">123</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock from option exercises</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2c632cc5576242fab0816f314eb6446f_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTktMi0xLTEtMTk1_5d2124a8-9c75-48dd-8d7d-4a31d2a25ad1">94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae5604185464427688d8d6538b0064b8_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTktNi0xLTEtMTk3_8aea024b-b344-4fb4-8fff-ca54958be896">450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTktMTItMS0xLTIwMg_be5ea545-7ed6-4c58-aee5-c84311f1c194">450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock from at-the-market offering, net of issuance costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2c632cc5576242fab0816f314eb6446f_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjAtMi0xLTEtMjIyNQ_7c3f6e66-6212-4ae8-a618-f19a6293d490">2,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c632cc5576242fab0816f314eb6446f_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjAtNC0xLTEtMjIyNQ_7a34d4f3-4031-475e-91d5-579477c3724b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae5604185464427688d8d6538b0064b8_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjAtNi0xLTEtMjIyNQ_4a46cfc1-311b-4ee7-a948-59bfb2235ea8">20,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjAtMTItMS0xLTIyMjU_17be8b3e-ae41-4e6f-b3be-894b02878573">20,228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae5604185464427688d8d6538b0064b8_D20200701-20200930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjEtNi0xLTEtMzQwNw_85a05ee0-eab9-4baa-9775-1c7c1ceeb5e2">180</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjEtMTItMS0xLTM0MDM_aa69c941-e349-41ff-99f5-b0a44ff38f93">180</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae5604185464427688d8d6538b0064b8_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjAtNi0xLTEtMTk3_04435f5f-5754-4da1-b078-21b14864d9f1">4,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjAtMTItMS0xLTIwMg_a65684aa-d3a3-4f6f-95c6-059ad378337c">4,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95bfaeccfec4464a937794e5c3340391_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjEtMTAtMS0xLTMyOA_1ecbefbc-b5a4-4759-803d-fc19a5129375">5,999</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjEtMTItMS0xLTIwMg_a1cb4131-1756-402a-b674-21d3f0b305f9">5,999</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i914a38e1ce8241ef9a128a191d3a503c_D20200701-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjItOC0xLTEtMjE1_f38fcba7-4f12-4860-9a45-a6ba47abfd22">520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjItMTItMS0xLTIwMg_52e1629f-995e-498c-a2c6-d70b4afc189a">520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i21d4b3ca64494bd286868cbca12d4736_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjQtMi0xLTEtMjA1_225d8160-99b5-411f-ad42-d4c988ce6f78">74,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21d4b3ca64494bd286868cbca12d4736_I20200930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjQtNC0xLTEtMjA1_d198af46-90a7-4a55-9058-adf37c82d2d2">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d88028473ce421e97253b37a085c9e7_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjQtNi0xLTEtMjA1_b8cb673a-ebdb-4758-88a0-3da1204847e3">810,923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c27fe0a0d9a44659e8415f944fc0c03_I20200930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjQtOC0xLTEtMjA1_4cdac42d-cfaa-42b1-868b-6d275d22a3e2">289</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if25548e8d7ec4e77ab7481b4e6c75c64_I20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjQtMTAtMS0xLTIwNQ_ae9312a8-f424-407a-8552-5f9f51ff88e4">658,735</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjQtMTItMS0xLTIwNQ_a8bf6f36-7b3c-481e-a959-0fa2c6a63807">151,973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">See accompanying notes </span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.465%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.638%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.638%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.765%"></td><td style="width:0.1%"></td></tr><tr><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FLUIDIGM CORPORATION</span></td></tr><tr><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></td></tr><tr><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-style:italic;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i15f7cdd5345a4dc1b08684ff2ea04b58_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjEtMi0xLTEtMA_35a9561b-c3c1-4018-94e1-0fe1476c6bc4">49,338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15f7cdd5345a4dc1b08684ff2ea04b58_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjEtNC0xLTEtMA_8af26e8b-9f76-4af3-840a-8320e17615cd">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7e2f1181ae54e4b90452df5f1cf9b06_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjEtNi0xLTEtMA_9a65f5e5-5371-416d-b2c7-56218c531a41">631,605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4be4fa2cf5014c1bb4baf526bd96dec8_I20181231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjEtOC0xLTEtMA_50b5952a-3475-4c4a-96fc-b91e6088a126">687</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bd1ce88d5fa454a8d4dad452aa7cf9c_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjEtMTAtMS0xLTA_93f39301-e8ec-4baa-8109-a04a3b91d3c8">558,851</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f51ec45ffb24e5f9fd56e8ed689edf8_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjEtMTItMS0xLTA_6ea4940b-d5af-489f-98e6-e7edd390af57">72,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock on bond conversion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i72b360b54d1e4205854b7f3e6a0724de_D20190101-20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjItMi0xLTEtMA_fcd71bb0-29e0-4019-9395-ebe21e795f5f">19,460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72b360b54d1e4205854b7f3e6a0724de_D20190101-20190331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjItNC0xLTEtMA_75e64e0d-9a3a-405a-942d-78bf3aa28a9f">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i006e76de3dab42169ad0c46b3b037dab_D20190101-20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjItNi0xLTEtMA_31b741be-5692-4f0b-b03e-d762a6e0fd39">133,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa0d20dd1f44516b4524fc6b0a6ad86_D20190101-20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjItMTItMS0xLTA_9cfcd7a8-98f2-43ff-829a-7a028572ce34">133,298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of restricted stock, net of shares withheld for taxes, and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i72b360b54d1e4205854b7f3e6a0724de_D20190101-20190331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjMtMi0xLTEtMA_0b2dd36b-5d59-4648-87d6-fda644ab417a">140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72b360b54d1e4205854b7f3e6a0724de_D20190101-20190331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjMtNC0xLTEtMA_84a0584b-70dd-4cd0-92f3-b570905c25fe">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i006e76de3dab42169ad0c46b3b037dab_D20190101-20190331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjMtNi0xLTEtMA_553edf76-3ca9-4f37-aaf2-e77b0532a645">177</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa0d20dd1f44516b4524fc6b0a6ad86_D20190101-20190331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjMtMTItMS0xLTA_e943eb88-c6f8-446b-b166-e20e2ca294cd">176</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock from option exercises</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i72b360b54d1e4205854b7f3e6a0724de_D20190101-20190331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjQtMi0xLTEtMA_747f72f9-3cbf-412c-b2dc-b91afd404ec4">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i006e76de3dab42169ad0c46b3b037dab_D20190101-20190331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjQtNi0xLTEtMA_bc7445e5-9f35-4195-8e7c-abb5dbcafc28">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa0d20dd1f44516b4524fc6b0a6ad86_D20190101-20190331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjQtMTItMS0xLTA_385a6880-9f6a-44ab-8f60-169af0daa2a4">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i006e76de3dab42169ad0c46b3b037dab_D20190101-20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjUtNi0xLTEtMA_f14725f3-4016-440d-afb6-2ceaf1bf7f1f">2,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa0d20dd1f44516b4524fc6b0a6ad86_D20190101-20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjUtMTItMS0xLTA_b22ecb35-fc63-4eca-8b2d-bbe43f6843d4">2,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic90d17da59fa4e799e7084567efe5328_D20190101-20190331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjYtMTAtMS0xLTA_382140fd-8b7b-4eb8-8e09-219bd2f8284d">25,465</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa0d20dd1f44516b4524fc6b0a6ad86_D20190101-20190331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjYtMTItMS0xLTA_36a82fa0-e38b-4db1-ac6c-ace761248ef4">25,465</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if46fa428977348b594b019217c905309_D20190101-20190331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjctOC0xLTEtMA_cf7b4eed-9d4d-4e79-8875-3fb4f9580ce9">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa0d20dd1f44516b4524fc6b0a6ad86_D20190101-20190331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjctMTItMS0xLTA_02e6aa18-e0e6-40d0-a0fb-064ebda03572">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i67c00423ce714ae287a3c1d8bec497ad_I20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjgtMi0xLTEtMA_e44d2a49-36e3-42f8-8421-101e16cb8686">68,991</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67c00423ce714ae287a3c1d8bec497ad_I20190331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjgtNC0xLTEtMA_491db82b-c27f-4662-80fb-c8777968092b">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i762d0930982d49b1b7f455398759b828_I20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjgtNi0xLTEtMA_faa9f99c-c02b-4e20-83c9-9fe069e8dea5">767,169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28fa2add73b04911a549411241057bc3_I20190331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjgtOC0xLTEtMA_cdcc3fcb-a109-4f6a-a538-5bfac54ce8ad">677</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1627ca022cf54d98a6481fda43a44841_I20190331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjgtMTAtMS0xLTA_2d3b5eff-91a1-49f1-bfb0-52a9910dc1cd">584,316</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83369a9b2fda4053aa441b96d2bb50e2_I20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjgtMTItMS0xLTA_115c1973-e627-4672-8f4f-21b6ef8259bd">182,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of restricted stock, net of shares withheld for taxes, and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iab67de1396ff47ea8462d8bc17240232_D20190401-20190630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjktMi0xLTEtMA_008bdc1b-d93a-4a87-aad5-8062b7df4f63">183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8f25eadecc464dbcaa3a44c5bca043bf_D20190401-20190630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjktNi0xLTEtMA_779e6b82-c588-49f9-aab1-ff8a350482c3">325</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10aed62e1a344f72932514716243a2f3_D20190401-20190630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjktMTItMS0xLTA_4351adaf-baf5-44df-9aa5-a13fcad8e5c9">325</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock from option exercises</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iab67de1396ff47ea8462d8bc17240232_D20190401-20190630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzAtMi0xLTEtMA_18838cf2-e959-487d-a16f-e42dad9b8456">130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f25eadecc464dbcaa3a44c5bca043bf_D20190401-20190630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzAtNi0xLTEtMA_1cc488bd-573f-48bd-9800-3f1b4a457148">793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10aed62e1a344f72932514716243a2f3_D20190401-20190630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzAtMTItMS0xLTA_19962c90-c232-4fc0-9789-d94b239b0df3">793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock under ESPP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iab67de1396ff47ea8462d8bc17240232_D20190401-20190630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzEtMi0xLTEtMA_b5b6f209-2b0f-4e09-a2d4-fba69b0d7d2c">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f25eadecc464dbcaa3a44c5bca043bf_D20190401-20190630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzEtNi0xLTEtMA_f6ae7a59-0d97-4adf-9003-dcc94bf85d58">641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10aed62e1a344f72932514716243a2f3_D20190401-20190630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzEtMTItMS0xLTA_8ac9b310-012c-42e3-a7d3-3751280dc463">641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f25eadecc464dbcaa3a44c5bca043bf_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzItNi0xLTEtMA_4c5f36bf-faac-4998-8123-b9ccf0a0720e">2,985</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10aed62e1a344f72932514716243a2f3_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzItMTItMS0xLTA_3c8a9e77-1be6-46dc-9739-f90f80e56a36">2,985</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0de2145a374c410095bc37bc5d98afc0_D20190401-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzMtMTAtMS0xLTA_5b3d3b49-5e3f-4bc8-b28a-c9fc50bd0840">13,753</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10aed62e1a344f72932514716243a2f3_D20190401-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzMtMTItMS0xLTA_5bac0ca5-ef11-45de-bfbb-3fb5a52cb0aa">13,753</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01c50ded41e34c848e04a247fa124bd3_D20190401-20190630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzQtOC0xLTEtMA_5d505467-17b0-4a23-80a3-dd2648dcac4c">54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10aed62e1a344f72932514716243a2f3_D20190401-20190630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzQtMTItMS0xLTA_dc95c57a-f47e-419b-99cf-fd0d9375ad23">54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia605d1ab95f846f0a9f63de67c948fd4_I20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzUtMi0xLTEtMA_4d0ebcfb-8134-46c8-9953-6d84a09dd81c">69,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia605d1ab95f846f0a9f63de67c948fd4_I20190630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzUtNC0xLTEtMA_a3373014-ac62-4a36-a5fd-2835497bcc08">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3b58d4f02e844cb988b744432f0e0f9_I20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzUtNi0xLTEtMA_288321c3-db0a-4e42-89c7-3881d28f0068">771,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43b1f7df8afe4a64be00a01331b55b55_I20190630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzUtOC0xLTEtMA_8ad786e1-984d-46e7-9b3f-b8747ea57958">623</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69bd8f22916f463b9f97b4855c9980e9_I20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzUtMTAtMS0xLTA_25b360ea-6989-480d-89dd-d916907caa22">598,069</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i813b7fdc72d64db19cd209236a971747_I20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzUtMTItMS0xLTA_863329e2-bb29-4433-81b1-87ffb30f1f27">172,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of restricted stock, net of shares withheld for taxes, and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i632b1c03d2644d748bb6a03e0f90c982_D20190701-20190930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjItMi0xLTEtMjE4_b4d2cfa0-9612-45cc-b27e-810acf436ab8">149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632b1c03d2644d748bb6a03e0f90c982_D20190701-20190930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjItNC0xLTEtMjE5_16ae2a92-8d87-4cea-97be-dd5fd303ff51">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d08643e37974cfba86f788447c6f6e2_D20190701-20190930" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjItNi0xLTEtMjE5_4ed988a4-ca49-4096-8940-e1e3c4736e15">70</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjItMTItMS0xLTIyNA_6b3b5cc3-23df-436a-b88f-d994f9726254">69</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock from option exercises</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i632b1c03d2644d748bb6a03e0f90c982_D20190701-20190930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjMtMi0xLTEtMjE4_97495a07-d4dd-4bff-bf04-5449b11f9987">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d08643e37974cfba86f788447c6f6e2_D20190701-20190930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjMtNi0xLTEtMjE5_cb306925-c084-4efa-bac3-154e4074d818">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjMtMTItMS0xLTIyNA_ed47eec5-eff1-47f8-9d69-28affbb7f508">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d08643e37974cfba86f788447c6f6e2_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjQtNi0xLTEtMjE5_fd0fbeaf-40c6-4746-91f4-70358e6ed71d">3,055</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjQtMTItMS0xLTIyNA_4a7a3584-1565-4ba8-9d51-78e779268f4e">3,055</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf04055382af45aca35807748405a7fa_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjUtMTAtMS0xLTIyMQ_a7a5e577-a9b2-433e-82dc-c36a5d6dec4b">12,887</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjUtMTItMS0xLTIyNA_c60aaab1-49b6-46e2-be3b-de3b3229b7aa">12,887</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab02e207f49f4cb8bf2279f9e687111f_D20190701-20190930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjYtOC0xLTEtMjIx_e14e177b-0856-495b-abee-5b768612f353">135</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjYtMTItMS0xLTIyNA_3f043e79-6a15-4b0c-af1d-bcb0ff590748">135</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2d98876aa25d4522b3599841a5fc587e_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjctMi0xLTEtMjI5_295e023d-30cb-402e-969e-e02b7ffa6ea3">69,550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d98876aa25d4522b3599841a5fc587e_I20190930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjctNC0xLTEtMjI3_8bac111f-1580-4e83-8cf2-83d62f969775">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4c2400e4e364dc9b526d08b10e59300_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjctNi0xLTEtMjM0_1dc0591a-73df-4ba2-89c9-f460fffb5be6">774,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14df96aacd544435a5bd5f0a00f0fa84_I20190930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjctOC0xLTEtMjIx_3f5d4751-6bab-4235-b34c-caeb9748fd32">758</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id976dd8bd6b34f3b9a6b24612ef2d5bc_I20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjctMTAtMS0xLTIyMQ_fcc4d57f-9de4-4562-b104-3402fe1019f8">610,956</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic00370e08713445eacc3076d8d3e2ced_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjctMTItMS0xLTIyNA_c4a73686-5f30-495c-91cf-e0e7ea850c7b">162,605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FLUIDIGM CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMy0yLTEtMS0w_7f2d42d9-bc29-4fc8-b3d6-88723494db9f"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMy0yLTEtMS0w_944f1989-8792-4656-9689-4fabd5f0837f">34,994</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMy00LTEtMS0w_1c78e136-8d7f-4eaf-b69e-74e250ebef22">52,105</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNS0yLTEtMS0w_c23dbefc-639d-49a6-ac1b-f6c920fc4f60">2,988</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNS00LTEtMS0w_c89d2909-06ec-4903-a8f9-678601cb7c32">3,484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNi0yLTEtMS0w_1dcd3302-db71-464f-9a9d-735b4a7cd60f">10,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNi00LTEtMS0w_b9e41adc-faf8-44a3-ac42-8420d0cca578">8,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNy0yLTEtMS0w_9c8ca640-b0ef-4d83-a3ce-3a2da7927c7e">8,929</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNy00LTEtMS0w_98641d25-310a-47c7-88ce-c91315256979">8,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of debt discounts, premiums and issuance costs </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfOC0yLTEtMS0w_c95c3e10-01fe-4ce4-b438-080552c020c3">415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfOC00LTEtMS0w_32bb2705-0366-4e3e-afee-becf49f49b86">2,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lease amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTAtMi0xLTEtMA_0f941aa4-d429-4d1e-baf5-bb0ab2fea383">1,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" sign="-" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTAtNC0xLTEtMA_c3998f84-01c5-4a00-8b39-b5f4cdf603ef">371</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTEtMi0xLTEtMA_096b8e9a-3f64-4808-bc97-8dd0fbf3f86c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTEtNC0xLTEtMA_316334b9-b3cc-444a-ba10-7d8c53abe3e6">9,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provision for excess and obsolete inventory</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTItMi0xLTEtMA_f8832aec-016d-40fd-be27-edfc38a97199">680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTItNC0xLTEtMA_6167f2e4-5dd2-45ae-baa4-b0d10d8c5f67">1,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss on disposal of property and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTMtMi0xLTEtMA_496e3b2f-a785-4140-a72e-7d8ce9c48102">191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTMtNC0xLTEtMA_c048a36f-9af5-4c7b-9cfd-d58e2abb92bc">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other non-cash items</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTQtMi0xLTEtMA_609ca232-1277-465a-bd7b-074ea3f5eef9">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTQtNC0xLTEtMA_8093a691-40e7-4005-ba26-c8dfc54c01e2">195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTYtMi0xLTEtMA_900ea0c4-af65-48f0-a841-e0dcdfaab1d9">967</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTYtNC0xLTEtMA_c410918a-cdda-4e12-a37c-fe85118e34aa">3,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTctMi0xLTEtMA_e426e31e-cd48-474e-b376-d4aec72879ad">6,773</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTctNC0xLTEtMA_935f3b28-2fe1-4f29-bcd7-436a08fcaed6">3,672</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTgtMi0xLTEtMA_e2146c0d-c128-40ab-b814-cd30e734403a">2,395</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTgtNC0xLTEtMA_11c512cb-2e3b-4dff-a4cb-62176e6220b1">1,338</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTktMi0xLTEtMA_e9991169-042b-4308-b71e-ffc1714c0988">4,996</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTktNC0xLTEtMA_f3490f26-65f0-49b1-87f8-6a9db1db3111">605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjAtMi0xLTEtMA_67ab2ce2-0178-4ed5-863b-e9268851d257">1,258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjAtNC0xLTEtMA_06b61884-137c-4dda-bdce-75861cb378c0">1,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjEtMi0xLTEtMA_4a3f8b11-cfa5-44f4-b5df-216246bf4fd9">180</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjEtNC0xLTEtMA_46cb53b5-666b-48ea-8c77-1fe494288135">10,506</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjItMi0xLTEtMA_e7cff63c-61c6-451c-84f2-1dda1bed2d00">11,684</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjItNC0xLTEtMA_a7633ef2-6db8-4ba9-8bde-799e63a4f6aa">29,691</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition, net of cash acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjQtMi0xLTEtMA_d3c77004-1b3a-4cc1-a6c9-db479a9eeab7">5,154</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjQtNC0xLTEtMA_0033b516-12d7-4570-a48e-d35ab43fb4bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjUtMi0xLTEtMA_1e56ee54-d274-4494-ad22-7d665cf03f7a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjUtNC0xLTEtMA_c63c5ede-1240-4e9a-82c4-17f8691c2061">52,719</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from RADx grant</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="fldm:ProceedsFromResearchAndDevelopmentGrant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjYtMi0xLTEtMzQ3Mg_574d0aba-ee76-49c1-b9d7-bc4be7e0382c">11,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="fldm:ProceedsFromResearchAndDevelopmentGrant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjYtNC0xLTEtMzQ3Mg_d3865658-91d4-47bd-8f90-c8ba517817ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfOtherInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjYtMi0xLTEtMA_b4e35756-ffda-40c5-82bf-44e3ed4ff807">5,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromSaleOfOtherInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjYtNC0xLTEtMA_d1c40705-630e-4c6c-a8a2-b1698b9156ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from maturities of investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjctMi0xLTEtMA_d80b359d-6726-4289-9983-b243fa44dfb8">31,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjctNC0xLTEtMA_1085f281-24bb-41b5-941c-f71322856b46">16,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjktMi0xLTEtMA_c0fef6d5-c0b1-4a52-94b2-0d154b593ba0">2,010</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjktNC0xLTEtMA_c53d4923-95e6-4466-ab60-449fcb7516d6">2,031</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMzAtMi0xLTEtMA_dd588b45-4c9f-4783-b0cb-8d20c787b9e7">40,797</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMzAtNC0xLTEtMA_35123194-0ca7-4133-802c-464fb532f65f">38,750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock from at-the-market offering, net of commissions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMzYtMi0xLTEtMjM0OQ_016d9fef-cfed-42fb-984d-a244091d2852">20,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMzYtNC0xLTEtMjM0OQ_9d26e0a6-7a80-4814-89e6-55f2db9fab1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payment of debt and equity issuance costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" name="us-gaap:PaymentOfFinancingAndStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMzUtMi0xLTEtMA_9a1ab7a0-cbe6-44f1-aa42-f6e2691dd261">509</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" name="us-gaap:PaymentOfFinancingAndStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMzUtNC0xLTEtMA_937f5d90-d52d-4265-863f-5fcc64685ae3">128</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMzYtMi0xLTEtMA_910573b5-9688-4213-a7c4-c45cde715e20">450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMzYtNC0xLTEtMA_3a69fdeb-8035-4ed2-be79-fc62abd16353">1,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from stock issuance from ESPP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMzctMi0xLTEtMA_ac818eb7-87dc-4e8a-8717-6befdd20d53d">645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMzctNC0xLTEtMA_974e81ad-65b2-48e8-9706-b7e20f03bcc2">641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments for taxes related to net share settlement of equity awards and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMzgtMi0xLTEtMA_881b332c-0b58-4bfe-8c54-d687423396d3">387</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMzgtNC0xLTEtMA_bc973d8f-cbe4-4e1e-8b0d-ed03beba3d1b">556</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNDEtMi0xLTEtMA_3ae59e16-db5f-4b3f-9bce-02392ea52e89">20,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNDEtNC0xLTEtMA_a6819b2f-3ad7-4c70-bbc8-f548a9956caa">1,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of foreign exchange rate fluctuations on cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNDItMi0xLTEtMA_a8d2baa1-6d32-42ed-a1b4-42c5b611e2aa">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNDItNC0xLTEtMA_99ff7bb1-73c7-49dd-91b5-4ccef9c4055b">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNDMtMi0xLTEtMA_8708ef1a-5877-4bde-91b6-dba85ea4e208">49,624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNDMtNC0xLTEtMA_c004a943-4e14-4ae6-aac9-f47e337581ce">67,440</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash at beginning of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNDQtMi0xLTEtMA_defe38d0-6e91-4171-9143-2e64cbd23ba2">23,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f51ec45ffb24e5f9fd56e8ed689edf8_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNDQtNC0xLTEtMA_f1d02549-f672-4317-87ef-17419b81e33f">95,401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNDUtMi0xLTEtMA_c8b7cd76-62db-427f-9da2-a6dfcd8f65ef">73,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic00370e08713445eacc3076d8d3e2ced_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNDUtNC0xLTEtMA_b6e75ae5-8191-4847-9868-f0572aeef885">27,961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental disclosures of cash flow information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNDctMi0xLTEtMA_4033449b-53d2-4422-b0ae-eb6c3bc108c9">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNDctNC0xLTEtMA_c955d7bd-8706-49d2-a8aa-107f7a70e17a">3,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for income taxes, net of refunds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNDgtMi0xLTEtMA_21aa24e4-82ba-4988-8d94-ede0a81725bf">386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNDgtNC0xLTEtMA_29a655d3-c624-44f6-ab3a-c18d7d3cd939">128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Asset retirement obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" name="fldm:AssetRetirementObligationsIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNTAtMi0xLTEtMA_38a5951d-4ca7-44b1-a86e-a8da3d08bd61">319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" name="fldm:AssetRetirementObligationsIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNTAtNC0xLTEtMA_7d2dbe86-8f50-44e3-b574-80af3c4b09c5">311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FLUIDIGM CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">September&#160;30, 2020</span></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_34"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNC9mcmFnOmE3Mzg5NGZkMzE4NzQ0NTlhYTA4ZTZlMDU1NWUzYjY2L3RleHRyZWdpb246YTczODk0ZmQzMTg3NDQ1OWFhMDhlNmUwNTU1ZTNiNjZfOTYy_12a9ad5e-fd10-4d57-91da-f7e830983d42" continuedAt="i14de40686b2845578f888767c751a5e0" escape="true">Description of Business</ix:nonNumeric></span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i14de40686b2845578f888767c751a5e0">Fluidigm Corporation (the Company, Fluidigm, we, our or us) creates, manufactures, and markets technologies and tools for life sciences research, including preparatory and analytical instruments for Mass Cytometry, PCR, Library Prep, Single Cell Genomics, and consumables, including integrated fluidic circuits (IFC), assays, and reagents. Our focus is on the most pressing needs in translational and clinical research, including infectious disease, cancer, immunology and immunotherapy. We sell our instruments, consumables and services to academic institutions, clinical laboratories, and contract research organizations, as well as biopharmaceutical, biotechnology, and agricultural biotechnology companies. The Company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was founded in 1999 and is headquartered in South San Francisco, California.</ix:continuation> </span></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_37"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQ0MDY_75f2f5b4-5eb8-40ae-a209-6576188e50bc" continuedAt="i6a71fe21aa7f48d09cb8fe63142e8197" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i6a71fe21aa7f48d09cb8fe63142e8197" continuedAt="ia29efd05554447ff877fc1b1f780c27e"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation and Consolidation</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQzNDg_a3a82197-f067-4c95-92d5-64073827fed6" escape="true">The accompanying consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (U.S. GAAP) and include the accounts of our wholly owned subsidiaries. As of September&#160;30, 2020, we had wholly owned subsidiaries in Singapore, Canada, the Netherlands, Japan, France, the United Kingdom, China, Germany and Norway. All subsidiaries, except for Singapore, use their local currency as their functional currency. The Singapore subsidiary uses the U.S. dollar as its functional currency. All intercompany transactions and balances have been eliminated in consolidation.</ix:nonNumeric></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQzNDk_bbec414f-c659-4757-b19d-eec278a30dc2" escape="true">Certain prior period amounts in the condensed consolidated statements of income and condensed consolidated statements of cash flows were reclassified to conform with the current period presentation. These reclassifications were immaterial and did not affect prior period total assets, total liabilities, stockholders&#8217; equity, total revenue, total costs and expenses, loss from operations or net loss.</ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unaudited Interim Financial Information</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim condensed consolidated financial statements and related disclosures are unaudited, have been prepared on the same basis as the annual financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for a fair statement of the results of operations for the periods presented.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The year-end condensed consolidated balance sheet was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP.  The condensed consolidated results of operations for the nine months ended September 30, 2020 are not necessarily indicative of the results to be expected for the full year or for any other year or interim period. The accompanying condensed consolidated financial statements should be read in conjunction with the audited financial statements and the related notes for the year ended December 31, 2019 included in our annual report on Form 10-K, filed with the SEC on February 27, 2020.</span></div><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQzMjY_92c83558-b7f8-468f-8aa9-edb93178da65" escape="true"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with U.S.&#160;GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions believed to be reasonable, which together form the basis for making judgments about the carrying values of assets and liabilities. The full extent to which the COVID-19 pandemic impacts our business, results of operations and financial condition will depend on numerous evolving factors including, but not limited to, the magnitude and duration of the pandemic, the extent to which it will impact worldwide macroeconomic conditions, including the speed of recovery, and governmental and business reactions to the pandemic. We assessed certain accounting matters that generally require consideration of forecasted financial information in the context of information available to us and the unknown impact of COVID-19 as of September 30, 2020. These accounting matters included, but were not limited to, our allowance for doubtful accounts and credit losses, inventory and related reserves and the carrying value of goodwill and other long-lived assets. Actual results could differ materially from these estimates and could have a material adverse effect on our condensed consolidated financial statements.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia29efd05554447ff877fc1b1f780c27e" continuedAt="i3abf78d7c55f4addb7d5a6158241c42a"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQzNjA_d9871560-21d1-4c71-b019-6319e2839545" continuedAt="ic0676cb946c6433e81cb48e837546350" escape="true">Foreign Currency</ix:nonNumeric></span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic0676cb946c6433e81cb48e837546350">Assets and liabilities of non-U.S. subsidiaries that use the local currency as their functional currency are translated into U.S. dollars at exchange rates in effect on the balance sheet date. The adjustments resulting from the foreign currency translations are recorded in accumulated other comprehensive loss, a separate component of stockholders&#8217; equity. Income and expense accounts are translated at monthly average exchange rates during the year.</ix:continuation> </span></div><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQzNDY_043ccfa5-3269-49d4-978f-f3cf7dff4e65" continuedAt="i5aad988dae85497e8901baa9cf53cb6a" escape="true"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenue primarily from the sale of our products and services. Product revenue is derived from the sale of instruments and consumables, including IFCs, assays and reagents. Service revenue is derived from the sale of instrument service contracts, repairs, installation, training and other specialized product support services. We also generate revenue from development agreements, license and royalty agreements and grants. Revenue is reported net of any sales, use and value-added taxes we collect from customers as required by government authorities. Research and development cost includes costs associated with development and grant revenue. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue based on the amount of consideration we expect to receive in exchange for the goods and services we transfer to the customer. Our commercial arrangements typically include multiple distinct products and services, and we allocate revenue to these performance obligations based on their relative standalone selling prices. Standalone selling prices (SSP) are generally determined using observable data from recent transactions. In cases where sufficient data is not available, we estimate a product&#8217;s SSP using a cost plus a margin approach or by applying a discount to the product&#8217;s list price.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Revenue</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize product revenue at the point in time when control of the goods passes to the customer and we have an enforceable right to payment. This generally occurs either when the product is shipped from one of our facilities or when it arrives at the customer&#8217;s facility, based on the contractual terms. Customers generally do not have a unilateral right to return products after delivery. Invoices are generally issued at shipment and generally become due in <ix:nonNumeric contextRef="i4101cc4ce01446f6b62b021b3dbb5704_D20200101-20200930" format="ixt-sec:durday" name="fldm:RevenueFromContractWithCustomerTermsOfPaymentPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfNDc0Mg_273bcddf-9c5b-49c9-9cb2-06825716f467">30</ix:nonNumeric> to <ix:nonNumeric contextRef="i4329505554d74bb8bd0456959ea7b9d9_D20200101-20200930" format="ixt-sec:durday" name="fldm:RevenueFromContractWithCustomerTermsOfPaymentPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfNDc0OA_df750076-1b23-45f4-b0e8-69b3c9d49e49">60</ix:nonNumeric> days.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sometimes perform shipping and handling activities after control of the product passes to the customer. We have made an accounting policy election to account for these activities as product fulfillment activities rather than as separate performance obligations.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service Revenue</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue from repairs, maintenance, installation, training and other specialized product support services at the point in time the work is completed. Installation and training services are generally billed in advance of service. Repairs and other services are generally billed at the point the work is completed. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue associated with instrument service contracts is recognized on a straight-line basis over the life of the agreement, which is generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfNTUwMg_166c41b6-37fc-4b8a-8206-665c77cdd303">one</span> to <ix:nonNumeric contextRef="i0f2c6e8ac0b0407b9dcbc0fb91830d02_D20200101-20200930" format="ixt-sec:durwordsen" name="fldm:RevenueFromContractWithCustomerPerformanceObligationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfNTUwOA_8e1a7686-f6a4-486e-a955-e90029460ba2">three years</ix:nonNumeric>. We believe this time-elapsed approach is appropriate for service contracts because we provide services on demand throughout the term of the agreement. Invoices are generally issued in advance of service on a monthly, quarterly, annual or multi-year basis. Payments made in advance of service are reported on our condensed consolidated balance sheet as deferred revenue.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Development Revenue</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered and may continue to enter into development agreements with third parties that provide for up-front and periodic milestone payments. Our development agreements may include more than one performance obligation. At the inception of the contract, we assess whether each obligation represents a separate performance obligation or whether such obligations should be combined as a single performance obligation. The transaction price for each development agreement is determined based on the amount of consideration we expect to be entitled to for satisfying all performance obligations within the agreement. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. In arrangements where we satisfy performance obligation(s) over time, we recognize development revenue typically using an input method based on our costs incurred relative to the total expected cost which determines the extent of our progress toward completion. As part of the accounting for these arrangements, we must develop estimates and assumptions that require judgment to determine the transaction price and progress towards completion. We review our estimate of the transaction price and progress toward completion based on the best information available to recognize the cumulative progress toward completion as of the end of each reporting period, and make revisions to such estimates as necessary. </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i3abf78d7c55f4addb7d5a6158241c42a" continuedAt="i5df9328001a34075a62f0a7ce5b7bc1a"><ix:continuation id="i5aad988dae85497e8901baa9cf53cb6a"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also generate revenue from development or collaboration agreements that do not include upfront or milestone-based payments and generally recognize revenue on these types of agreements based on the timing of development activities.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Revenue</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other revenue consists of license and royalty revenue and grant revenue. We recognize revenue from license agreements when the license is transferred to the customer and the customer is able to use and benefit from the license. For contracts that include sales-based royalties, we recognize revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, we entered into an agreement to settle intellectual property infringement claims, in which we received a $<ix:nonFraction unitRef="usd" contextRef="ifb7c86dd6e67421cbc4e92e76dcf85bd_D20200301-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLegalSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfODM0MQ_1fd135e1-1395-47fd-878b-6d9d49e3a69f">3.5</ix:nonFraction> million payment in exchange for a perpetual license under certain Fluidigm intellectual property. The settlement is considered a multiple-element arrangement with each element accounted for individually. Accordingly, $<ix:nonFraction unitRef="usd" contextRef="i7fc39d91e80e413683ccff3b0727279b_D20200301-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfODU1NA_b78672a0-6358-49c2-ba2f-f5ffaa56b090">3.1</ix:nonFraction> million of the proceeds was recognized as license revenue and $<ix:nonFraction unitRef="usd" contextRef="i51f17d522ac148c68bc6b818c1014f68_D20200301-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LegalFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfODYxMQ_818be27e-fc4d-4934-8f94-963b248de434">0.4</ix:nonFraction> million was offset against legal costs.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive grants from various entities to perform research and development activities over contractually defined periods. Revenue is generally recognized provided that the conditions under which the grants were provided have been met and any remaining performance obligations are perfunctory. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Costs</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incremental sales commission costs incurred to obtain instrument service contracts are capitalized and amortized to selling, general and administrative expense over the life of the contract, which is generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfOTE2Nw_1c099c37-d651-4eff-8b5d-06284641991e">one</span> to <ix:nonNumeric contextRef="i261b1732f7d64d5ca4da0ff8446c81ce_D20200101-20200930" format="ixt-sec:durwordsen" name="fldm:RevenueFromContractWithCustomerPerformanceObligationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfOTE3Mw_c178f414-19dc-428c-94bd-44a5c17022f1">three years</ix:nonNumeric>. As a practical expedient, we expense sales commissions associated with product support services that are delivered in less than one year as they are incurred. Sales commissions associated with the sale of products are expensed as they are incurred. To date, capitalized contract costs have been immaterial.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Warranties</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally provide a <ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" format="ixt-sec:durwordsen" name="fldm:ProductWarrantyTerm" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTgxNDE5NDE4ODMwNDk_a7267724-efc2-4f5f-a612-fec8e8b7ee6b">one-year</ix:nonNumeric> warranty on our instruments. We accrue for estimated warranty obligations at the time of product shipment. We periodically review our warranty liability and record adjustments based on the terms of warranties provided to customers, and historical and anticipated warranty claim experience. This expense is recorded as a component of cost of product revenue in the condensed consolidated statements of operations.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Judgments</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Applying the revenue recognition practices discussed above often requires significant judgment. Judgment is required when identifying performance obligations, estimating SSP and allocating purchasing consideration in multi-element arrangements, determining the transaction price and progress towards completion on development arrangements and estimating the future amount of our warranty obligations. Moreover, significant judgment is required when interpreting commercial terms and determining when control of goods and services passes to the customer. Any material changes created by errors in judgment could have a material effect on our operating results and overall financial condition.</span></div></ix:continuation><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQzODI_2a01f6eb-e52f-47ea-804f-4e336c54738b" escape="true"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade accounts receivable are recorded at net invoice value. We review our exposure to accounts receivable and provide allowances of specific amounts if collectability is no longer reasonably assured based on historical experience and specific customer collection issues. We evaluate such allowances on a regular basis and adjust them as needed.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQzNzU_404f7076-daf9-408e-91d4-67b0e5c905bf" continuedAt="i9e5ea5f3a7d949238668d18073ca1a97" escape="true"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentrations of Business and Credit Risk</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to credit risk consist of cash, cash equivalents, investments, and accounts receivable. Our cash, cash equivalents, and investments may consist of deposits held with banks, money market funds, and other highly liquid investments that may at times exceed federally insured limits. Cash equivalents and investments are financial instruments that potentially subject us to concentrations of risk. Under our investment policy, we invest primarily in securities issued by the U.S. government. The goals of our investment policy, in order of priority, are as follows: preserve capital, meet liquidity needs, and optimize returns. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally do not require collateral to support credit sales. To reduce credit risk, we perform credit evaluations of our customers. One customer from whom we derived development revenue exceeded <ix:nonFraction unitRef="number" contextRef="i4c26186ae0bf4d6799d6b7bcd5a15cd7_D20200101-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTY0OTI2NzQ2NjEyOQ_4357c101-ab7c-4e3f-9b6d-8673384997d1"><ix:nonFraction unitRef="number" contextRef="ieaa80a8a61d943508698a74efef90b12_D20200701-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTY0OTI2NzQ2NjEyOQ_6452375f-5e91-4b4c-b0e6-4a4ae19936f5">10</ix:nonFraction></ix:nonFraction>% of revenue for the three and nine months ended September&#160;30, 2020. No other customer represented more than 10% of total revenue for the three and nine months ended September&#160;30, 2020 or 2019. Including the development revenue, revenues from our five largest customers were <ix:nonFraction unitRef="number" contextRef="i761f7b389ced4f93be18b27ca86ce004_D20200701-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTIxNTI_20baa655-409b-400c-9e3a-641aab023cbf">31</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i40175ade607f4de5b40b93529bd75aa1_D20190701-20190930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTIxNTk_43ca4926-4c18-4d33-b7b4-835791d76e28">25</ix:nonFraction>% </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i5df9328001a34075a62f0a7ce5b7bc1a" continuedAt="i331c933aedef4343b5185214894c8bfe"><ix:continuation id="i9e5ea5f3a7d949238668d18073ca1a97"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of total revenue for the three months ended September&#160;30, 2020 and 2019, respectively. Revenues from our five largest customers were <ix:nonFraction unitRef="number" contextRef="ib9ec2d4a080349c7820e11d6b38ab5d3_D20200101-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTIyNjE_7879dbda-2b88-421a-a4e2-9e5ce049b6f6">23</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ic252519a5f1b45f3853a2e0071c6dcc7_D20190101-20190930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTIyNjg_1820e6e0-22df-48eb-b6d9-ac7d059eace8">20</ix:nonFraction>% of total revenue for the nine months ended September&#160;30, 2020 and 2019, respectively. There was no single customer that represented more than 10% of total accounts receivable at September&#160;30, 2020, or December&#160;31, 2019.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products include components that are currently procured from a single source or a limited number of sources. We believe that other vendors would be able to provide similar components; however, the qualification of such vendors may require start-up time. In order to mitigate any adverse impacts from a disruption of supply, we attempt to maintain an adequate supply of critical limited-source components.</span></div></ix:continuation><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQzMTk_9b24637e-ac8e-4f10-b3d8-5063c1cd8a24" continuedAt="ic29cd05731034123bbbf9359c0db8ea4" escape="true"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if an arrangement is a lease, or contains a lease, at inception. Operating leases are included in operating lease right-of-use (ROU) assets and current and non-current operating lease liabilities in our condensed consolidated balance sheets. ROU assets represent our right-to-use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we generally use our incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. Significant judgment is required in determining the incremental collateralized borrowing rate. Lease expense for lease payments is recognized on a straight-line basis over the lease term.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic29cd05731034123bbbf9359c0db8ea4">We elected the short-term lease recognition exemption for all leases that qualify. For those leases that qualify, we will not recognize ROU assets or lease liabilities for leases with an initial lease term of one year or less. We also elected not to separate lease and nonlease components for our building leases. The nonlease components are generally variable in nature and are expected to represent most of our variable lease costs. Variable costs are expensed as incurred. We have taken a portfolio approach for our vehicle leases by country.</ix:continuation> </span></div><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQzOTM_e7708a7d-02f7-4659-8be9-89c5b9a78b45" continuedAt="i21f2fa71d1fa4ce99d1ff5209d69faa3" escape="true"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill, Intangible Assets and Other Long-Lived Assets</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill, which has an indefinite useful life, represents the excess of cost over fair value of net assets acquired. Our intangible assets include developed technology, patents and licenses. The cost of identifiable intangible assets with finite lives is generally amortized on a straight-line basis over the assets&#8217; respective estimated useful lives.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and intangible assets with indefinite lives are not subject to amortization but are tested for impairment on an annual basis during the fourth quarter or whenever events or changes in circumstances indicate the carrying amount of these assets may not be recoverable. Events or changes in circumstances that could affect the likelihood that we will be required to recognize an impairment charge include, but are not limited to, declines in our stock price or market capitalization, economic downturns and other macroeconomic events, including the current COVID-19 pandemic, declines in our market share or revenues, and an increase in our losses, rapid changes in technology, failure to achieve the benefits of capacity increases and utilization, significant litigation arising out of an acquisition, or other matters. Any impairment charges could have a material adverse effect on our operating results and net asset value in the quarter in which we recognize the impairment charge.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In evaluating our goodwill and intangible assets with indefinite lives for indications of impairment, we first conduct an assessment of qualitative factors to determine whether it is more likely than not that the fair value of our reporting unit is less than its carrying amount. If we determine that it is more likely than not that the fair value of our reporting unit is less than its carrying amount, we compare the fair value of our reporting unit to its carrying value. If the fair value of our reporting unit exceeds its carrying value, goodwill is not considered impaired and no further analysis is required. If the carrying value of the reporting unit exceeds its fair value, then an impairment loss equal to the difference would be recorded to goodwill. We did <ix:nonFraction unitRef="usd" contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:GoodwillImpairmentLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTY1NTk_7e82e624-5799-42d9-8cb8-8f197f7c1e39"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:GoodwillImpairmentLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTY1NTk_8f94e07a-9aa2-41dc-9829-f64be6ce579f"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:GoodwillImpairmentLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTY1NTk_d7bf317a-4801-4a54-92a4-49d1e5fcd804"><ix:nonFraction unitRef="usd" contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:GoodwillImpairmentLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTY1NTk_f63ae66e-1a26-43cf-9990-c20fd6aa5ca7">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>t recognize any impairment of goodwill for any of the periods presented herein.</span></div><div style="margin-bottom:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate our long-lived assets, including finite-lived intangibles, for indicators of possible impairment when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. If any indicator of impairment exists, we assess the recoverability of the affected long-lived assets by determining whether the carrying value of the asset can be recovered through undiscounted future operating cash flows. If impairment is indicated, we estimate the asset&#8217;s fair value using future discounted cash flows associated with the use of the asset and adjust the carrying value of the asset accordingly. We did not recognize any impairment of intangibles for any of the periods presented herein.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deferred Grant Income </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, we executed a definitive contract with the National Institutes of Health (NIH) for a project under the NIH Rapid Acceleration of Diagnostics (RADx) program. The definitive contract, which amended the letter contract we entered </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i331c933aedef4343b5185214894c8bfe" continuedAt="i71a4f632f09d44b8be87f81cfb659cc7"><ix:continuation id="i21f2fa71d1fa4ce99d1ff5209d69faa3" continuedAt="id0201e733df84658bbfd94e1d560d2b1"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">into with the NIH in July 2020 (collectively, the NIH Contract), has a total value of up to $<ix:nonFraction unitRef="usd" contextRef="i9ad72ef114054c68ba1d7499333b66b9_I20200928" decimals="-5" format="ixt:numdotdecimal" name="fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTgxNDE5NDE5MDIyODM_a389ee4f-30be-483d-ba1f-7f4111f9a2f2">34.0</ix:nonFraction>&#160;million upon the achievement of certain conditional milestones. Proceeds from the NIH Contract will be used primarily to expand production capacity and product throughput capabilities.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting for the NIH Contract does not fall under ASC 606, Revenue from Contracts with Customers, as the NIH will not benefit directly from our expansion or product development.  As there is no authoritative guidance under U.S. GAAP on accounting for government assistance to for-profit business entities, we applied International Accounting Standards (IAS) 20, Accounting for Government Grants and Disclosure of Government Assistance, by analogy when accounting for the NIH Contract payments to Fluidigm. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The NIH Contract proceeds meet the definition of grants related to assets as the primary condition for the payments is to fund the purchase and construction of longer-term assets to scale up production capacity. Under IAS 20, government grants related to assets are presented in the statement of financial position either by setting up the grant as deferred income or by deducting the grant in arriving at the carrying amount of the asset. Either of these two methods of presentation of grants related to assets in financial statements are regarded as acceptable alternatives under IAS 20. We have elected to record the grants received as deferred income using the first method.</span></div></ix:continuation><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id0201e733df84658bbfd94e1d560d2b1">Under IAS 20, grant proceeds are recognized when there is reasonable assurance the conditions of the grant will be met and the grant will be received.  With the NIH Contract, this occurs when either each milestone has been accepted by NIH or management concludes the conditions of the grant have been substantially met.  We record the NIH Contract proceeds as deferred income.  Proceeds used for capital expenditures will be amortized over the period of depreciation for the assets as a reduction of depreciation expense.  Any portion of the proceeds used to reimburse research and development expense are recorded as a reduction of those expenses incurred to date.</ix:continuation> </span></div><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:DebtPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQ0MDQ_bb93323a-e7a3-49e3-a19f-173c3588f283" escape="true"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Convertible Notes</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2014, we closed an underwritten public offering of $<ix:nonFraction unitRef="usd" contextRef="ifa53719e19cc4a179c2e811a860e7411_I20140228" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTc0NDM_8ff288a5-f56d-451a-bc92-02dbdaeab8f2">201.3</ix:nonFraction> million aggregate principal amount of our <ix:nonFraction unitRef="number" contextRef="ifa53719e19cc4a179c2e811a860e7411_I20140228" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTc0ODA_45e74032-d3c3-4669-bd3e-b494285db957">2.75</ix:nonFraction>% Senior Convertible Notes due 2034 (2014 Notes). In March 2018, we entered into separate privately negotiated transactions with certain holders of our 2014 Notes to exchange $<ix:nonFraction unitRef="usd" contextRef="i426efa56430840c1b19eac7bd8d458cc_I20180331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTc2NTY_db591804-a62f-4790-b886-9a4923a13e80">150.0</ix:nonFraction> million in aggregate principal amount of the 2014 Notes for our <ix:nonFraction unitRef="number" contextRef="i426efa56430840c1b19eac7bd8d458cc_I20180331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTc3MTU_df977f09-19b9-4945-afaa-4002f7b10cba">2.75</ix:nonFraction>% Exchange Convertible Senior Notes due 2034 (2018 Notes). As the 2018 Notes were convertible, at our election, into cash, shares of our common stock, or a combination of cash and shares of our common stock, we accounted for the 2018 Notes under the cash conversion guidance in ASC 470, whereby the embedded conversion option in the 2018 Notes was separated and accounted for in equity. In the first quarter of 2019, the 2018 Notes were converted into <ix:nonFraction unitRef="shares" contextRef="i3111d806397142758e8cb5ee0d0eb9e6_D20190101-20190331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTgxNjg_6a44fc48-f0f4-435d-b6d3-527a0c6c2b5b">19.5</ix:nonFraction> million shares of our common stock and the 2018 Notes were retired. We recorded a loss of $<ix:nonFraction unitRef="usd" contextRef="i3ac00b245134442884f3defdcfc7fae1_D20190101-20190331" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTgyNTM_9e6174ac-b33d-49e1-ac67-9374b0d792bd">9.0</ix:nonFraction> million on the retirement of the 2018 Notes. We determined the fair value of the 2018 Notes&#160;using valuation techniques that required us to make assumptions related to the implied discount rate.&#160;</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, we closed a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of $<ix:nonFraction unitRef="usd" contextRef="i9b34d835daa64fc59dd63f13ee337947_I20191130" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTg1NzU_80fb45b7-8b14-4ae3-ac5d-01a00d826e69">55.0</ix:nonFraction> million aggregate principal amount of our <ix:nonFraction unitRef="number" contextRef="i9b34d835daa64fc59dd63f13ee337947_I20191130" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTg2MTI_3f5ab17b-7654-41ee-8e7d-40e3f2dd60fd">5.25</ix:nonFraction>% Senior Convertible Notes due 2024 (2019 Notes). Most of the issuance proceeds were used to retire approximately $<ix:nonFraction unitRef="usd" contextRef="i48e1ed537f2e4db1b0713b2e240b93fb_D20191101-20191130" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTg3Mjc_d4c22c19-fd3b-4c04-9c9b-4e853fca23b2">50.2</ix:nonFraction> million of aggregate principal amount of our 2014 Notes, leaving approximately $<ix:nonFraction unitRef="usd" contextRef="i23b95cce717045feba062bba6e018b4e_I20191130" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTg4MDE_58f77703-a6b3-4ea4-977e-df4666d08bcd">1.1</ix:nonFraction> million of aggregate principal amount of our 2014 Notes outstanding. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the 2019 Notes do not provide for a cash conversion feature, the 2019 Notes are recorded as debt in their entirety in accordance with ASC 470. For the 2014, 2018 and 2019 Notes, offering-related costs, including underwriting costs, were capitalized as debt issuance costs, recorded as an offset to the carrying value of the related Notes, and are amortized over the expected term of the related Notes using the effective interest method.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 8 for a detailed discussion of the accounting treatment of the transactions and additional information.</span></div><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQ0MTA_2b5c91c3-8cb7-4d26-a922-4c4f4f67f843" escape="true"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comprehensive Loss </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive loss is comprised of net loss and other comprehensive income (loss). Other comprehensive income (loss) consists of unrealized gains and losses on our investments and foreign currency translation adjustments. Total comprehensive loss for all periods presented has been disclosed in the condensed consolidated statements of comprehensive loss.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i71a4f632f09d44b8be87f81cfb659cc7" continuedAt="i5c841e4f7d86464eb06fffd2e7c4384c"><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQzNjE_61918113-31b1-4a83-a84c-15596aed9988" escape="true"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of accumulated other comprehensive loss, net of tax, for the three and nine months ended September&#160;30, 2020 are as follows (in thousands): </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Investments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32b55c5ab8514931aa3c38ad7314012a_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfMS0yLTEtMS0w_185ea4b7-9db2-4267-80d4-d29bcb1dbd8d">618</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i522074f70914431c93eb1fb60866c897_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfMS00LTEtMS0w_b720fad9-48cc-43c3-b7fd-0ab9d79b4bd7">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iacf13335933a47178e0765e3e574fd1e_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfMS02LTEtMS0w_641e50d3-a810-49f4-988c-8c3f9dbc4bcb">582</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4664c6ae00ef4abf82e3edabaf2c670a_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfMi0yLTEtMS0w_7f5110b8-a191-4d87-a6d8-340b1ec38999">303</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36983d4e5c64db793c5d3166fe61fa4_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfMi00LTEtMS0w_b4041d00-6c20-4358-8c90-9a0b11c1924c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36c4cb3e31604770b06e9f2af6bc483e_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfMi02LTEtMS0w_803b9d80-2998-49af-8a0d-dd1faa453178">303</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance at March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69ebb284db184ca8bdf4d66d0dff3121_I20200331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfMy0yLTEtMS0w_47a22e27-dbac-4314-88d3-f13e5252448a">921</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa27eb06261444ae9b065f2110889263_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfMy00LTEtMS0w_3364a100-3e71-4c7a-88d6-3cc650824c98">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if10319fa5a0a46069beb6a1617e9f6da_I20200331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfMy02LTEtMS0w_a98cc016-93e7-4dd3-beae-671538a53ba7">885</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ae09a39637843f6a26b4e4e0127ab7d_D20200401-20200630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfNC0yLTEtMS00MjA_fdee21ba-d90d-4925-813b-450773e1f003">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i527a5548d615414180d912a5102a2912_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfNC00LTEtMS00MjA_a2d49e08-2fe8-42d8-a917-3d93c33ae7b2">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc7d24911d4349cd97850e4e2f548bc4_D20200401-20200630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfNC02LTEtMS00MjA_4cf8e3e9-3abe-489d-96b7-e06372d061de">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance at June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib06456778615411fbbea453bd61bcfdc_I20200630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfNS0yLTEtMS00MjA_78cd0875-609e-4e72-99b9-95c8c4362c19">812</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82ce3762aa614b6ebe557f7b073bebe4_I20200630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfNS00LTEtMS00MjA_62336abe-38ac-4484-b632-24d7114e34e4">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc294b4f830b49dd8ecde477cdb866de_I20200630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfNS02LTEtMS00MjA_965c8fa8-4223-45a2-a2fa-df5f858bb21c">809</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80cf78799b76440ea86f5da1c2493062_D20200701-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfNC0yLTEtMS0w_b2ecea33-63b5-4baa-b036-fe43f855e0c9">523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id07a1b059c244e2399380a15a12a57c5_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfNC00LTEtMS0w_b7e7045a-cd44-45b3-8a01-3a7020cd0dfd">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfNC02LTEtMS0w_75d21101-5942-425d-8fbe-40ac7fd3e531">520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00a783530ec64310a75d4833347282a5_I20200930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfNS0yLTEtMS0w_1e01c4b2-e896-489c-9336-306333436bf5">289</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i377c087ac7164a9897550043dca2a0e6_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfNS00LTEtMS0w_d2ac990f-d1c5-441f-b270-937494b079d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c27fe0a0d9a44659e8415f944fc0c03_I20200930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfNS02LTEtMS0w_3a27a8d3-cedf-45d5-bb8c-114ab4bd41e7">289</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immaterial amounts of unrealized gains and losses have been reclassified into the condensed consolidated statement of operations for the three and nine months ended September&#160;30, 2020 and 2019.</span></div><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQzNTU_267b9941-7ddf-4523-ba73-916aacda809b" escape="true"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Loss per Share </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our basic and diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding for the period. Restricted stock units, performance share units, and stock options to purchase our common stock are considered to be potentially dilutive common shares but have been excluded from the calculation of diluted net loss per share as their effect is anti-dilutive for all periods presented.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQzMTQ_9e3effeb-db96-41ab-bec6-febf2594873c" escape="true"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following potentially dilutive common shares were excluded from the computations of diluted net loss per share for the periods presented because including them would have been anti-dilutive (in thousands):  </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options, restricted stock units and performance awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i83297b8f97a34354a79b62e5e754b631_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOjM5NjM1Njk1MTZkNDQ2Y2Q4ZmIzNDZkYjViNThjMmVjL3RhYmxlcmFuZ2U6Mzk2MzU2OTUxNmQ0NDZjZDhmYjM0NmRiNWI1OGMyZWNfMi0yLTEtMS0w_74227dd7-15ca-458a-8556-3888f46f27c9">7,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i59a12e7ed1b243b496ec5f9736293ba2_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOjM5NjM1Njk1MTZkNDQ2Y2Q4ZmIzNDZkYjViNThjMmVjL3RhYmxlcmFuZ2U6Mzk2MzU2OTUxNmQ0NDZjZDhmYjM0NmRiNWI1OGMyZWNfMi00LTEtMS0w_40887d8d-5645-4fd4-b593-bd135eed6dd0">5,342</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i76daca0d7ecf4e55b49f9ef61b74d961_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOjM5NjM1Njk1MTZkNDQ2Y2Q4ZmIzNDZkYjViNThjMmVjL3RhYmxlcmFuZ2U6Mzk2MzU2OTUxNmQ0NDZjZDhmYjM0NmRiNWI1OGMyZWNfMy0yLTEtMS0w_dde88f98-90b3-4dd5-93db-eb0dee40a2a5">18,966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i547f784eb6974c818432924005a65edd_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOjM5NjM1Njk1MTZkNDQ2Y2Q4ZmIzNDZkYjViNThjMmVjL3RhYmxlcmFuZ2U6Mzk2MzU2OTUxNmQ0NDZjZDhmYjM0NmRiNWI1OGMyZWNfMy00LTEtMS0w_961a612e-d882-4393-b540-fd812f80c802">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Convertible Notes potential make-whole shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if0007477bb8545a8afa0513c08a9049c_D20200101-20200930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOjM5NjM1Njk1MTZkNDQ2Y2Q4ZmIzNDZkYjViNThjMmVjL3RhYmxlcmFuZ2U6Mzk2MzU2OTUxNmQ0NDZjZDhmYjM0NmRiNWI1OGMyZWNfNC0yLTEtMS0w_0e749f06-a14e-4f1a-8157-9ab4104f8df4">826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i75455403764249069c09679d89b70c29_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOjM5NjM1Njk1MTZkNDQ2Y2Q4ZmIzNDZkYjViNThjMmVjL3RhYmxlcmFuZ2U6Mzk2MzU2OTUxNmQ0NDZjZDhmYjM0NmRiNWI1OGMyZWNfNC00LTEtMS0w_1a7863ab-0a1e-4bf8-9f98-1787cc02328f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2014 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i537a3353f9d94a15afb6333fd0f64d0c_D20200101-20200930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOjM5NjM1Njk1MTZkNDQ2Y2Q4ZmIzNDZkYjViNThjMmVjL3RhYmxlcmFuZ2U6Mzk2MzU2OTUxNmQ0NDZjZDhmYjM0NmRiNWI1OGMyZWNfNS0yLTEtMS0w_4ffc18fa-a4b1-4cd4-865e-02efa2792741">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i634dc22add2d4eb0a343c30ed934f69b_D20190101-20190930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOjM5NjM1Njk1MTZkNDQ2Y2Q4ZmIzNDZkYjViNThjMmVjL3RhYmxlcmFuZ2U6Mzk2MzU2OTUxNmQ0NDZjZDhmYjM0NmRiNWI1OGMyZWNfNS00LTEtMS0w_ca11aa39-aaf5-4bf0-ad7b-c8446ef67c9f">916</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOjM5NjM1Njk1MTZkNDQ2Y2Q4ZmIzNDZkYjViNThjMmVjL3RhYmxlcmFuZ2U6Mzk2MzU2OTUxNmQ0NDZjZDhmYjM0NmRiNWI1OGMyZWNfNi0yLTEtMS0w_dff15097-97bd-414d-824b-14f1196a9150">27,463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOjM5NjM1Njk1MTZkNDQ2Y2Q4ZmIzNDZkYjViNThjMmVjL3RhYmxlcmFuZ2U6Mzk2MzU2OTUxNmQ0NDZjZDhmYjM0NmRiNWI1OGMyZWNfNi00LTEtMS0w_4c565870-6559-468c-819a-408622840338">6,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQzNDI_205661ce-f643-4285-a47f-ac3c2ad928c1" continuedAt="ib725f9801ea74e5ca5f74e83439a6137" escape="true"><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Changes and Accounting Pronouncements</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adoption of New Accounting Guidance </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the U.S.-based Financial&#160;Accounting Standards&#160;Board (FASB) issued Accounting Standards Update (ASU) 2018-15-Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40), which establishes new guidance on the accounting for costs incurred to implement a cloud computing arrangement that is considered a service arrangement. The new guidance requires the capitalization of such costs, aligning it with the accounting for costs associated with developing or obtaining internal-use software. The new guidance is effective for fiscal years beginning after December 15, 2019. The adoption of the new guidance did not have a significant impact on our financial results.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2017, the FASB issued ASU 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The ASU eliminates the requirement for an entity to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, an entity performs its annual, or interim, goodwill impairment testing by comparing the fair value of a reporting unit with its carrying amount and recording an impairment charge for the amount by which the carrying amount exceeds the fair value. The ASU is effective for annual and interim goodwill impairment testing performed for our fiscal year beginning January 1, 2020. The adoption of the new guidance did not have a significant impact on our financial results.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FASB issued two ASUs related to financial instruments &#8211; credit losses. The ASUs issued were: (1) in June 2016, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQzNjc_09dd10ab-4bd6-4959-a108-786ca8b4f9e5">ASU 2016-13, Financial Instruments-Credit Losses (Topic 326)</span>: Measurement of Credit Losses on Financial Instruments, and (2) in November 2018, ASU 2018-19-Codification Improvements to Topic 326, Financial Instruments-Credit Losses. ASU 2016-13 is intended to improve financial reporting by requiring more timely recording of credit losses on loans and other financial </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i5c841e4f7d86464eb06fffd2e7c4384c"><ix:continuation id="ib725f9801ea74e5ca5f74e83439a6137"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">instruments held by financial institutions and other organizations. ASU 2018-19 clarifies that receivables arising from operating leases are not within the scope of the credit losses standard, but rather, should be accounted for in accordance with the lease standard. These ASUs are effective for fiscal years beginning after December 15, 2019, and interim periods within those years, with early adoption permitted. The modified retrospective method is required upon adoption. The adoption of the new guidance resulted in an adjustment of approximately $<ix:nonFraction unitRef="usd" contextRef="i8a2616563d5a4bf89c8fd60f83692c9c_I20191231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjMzMTk_c4961740-5cfb-4798-8945-844e445960f0">0.1</ix:nonFraction> million to reduce the accumulated deficit component of stockholders&#8217; equity and decrease current assets by the same amount in our condensed consolidated balance sheet.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06 Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity. The amendment to this ASU reduces the number of accounting models for convertible instruments and allows more contracts to qualify for equity classification, which is expected to result in more convertible instruments being accounted for as a single unit, rather than being bifurcated between debt and equity. The new guidance is effective for fiscal years beginning after December 15, 2021. We are currently evaluating the impact of adoption on our condensed consolidated financial statements.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, the FASB issued ASU 2019-12-Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The amendments in this update improve consistent application of and simplify U.S. GAAP for Topic 740 by clarifying and amending existing guidance for, among other items, intra-period allocation, reporting tax law changes and losses in interim periods, state and local taxes not fully based on income and recognition of deferred tax liability related to certain transactions. There is also new guidance related to consolidated group reporting and tax impacts resulting from business combinations. The new guidance is effective for fiscal years beginning after December 15, 2020. We are currently evaluating the impact of adoption on our condensed consolidated financial statements.</span></div></ix:continuation></ix:continuation><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_40"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RleHRyZWdpb246ZDAyMDAxYzMzZjk0NGIyNmJhN2NkODA4OTVlMzI3YjJfMTI4NA_01109acc-cd68-4618-b2b0-4a6b3bfd0ffe" continuedAt="id1e51d960f144111abd6aeb370df0ffa" escape="true">Business Combination</ix:nonNumeric></span></div><ix:continuation id="id1e51d960f144111abd6aeb370df0ffa" continuedAt="i74ba8b26d5434678800f32a08c1f79f2"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 17, 2020, we completed the acquisition of all of the outstanding shares of InstruNor AS, a privately held Norwegian company (InstruNor). </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">InstruNor is a provider of the only fully integrated sample preparation system for flow and mass cytometry. The acquisition of InstruNor supports our entry into the sample preparation market for cytometry analysis and expands our capabilities to include fully automated sample preparation for flow and mass cytometry. The value of this technology is reflected in the intangible asset for developed technology. The developed technology was valued using a discounted cash flow model for which the most sensitive assumption was revenue growth rate.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purchase price of $<ix:nonFraction unitRef="usd" contextRef="ibccd6f048dc74a6c953e619b2a9e9ea6_D20200117-20200117" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RleHRyZWdpb246ZDAyMDAxYzMzZjk0NGIyNmJhN2NkODA4OTVlMzI3YjJfNzQ2_4fad0d36-d5c0-43b4-99a5-2a689e2e8c46">7.2</ix:nonFraction> million included approximately $<ix:nonFraction unitRef="usd" contextRef="ibccd6f048dc74a6c953e619b2a9e9ea6_D20200117-20200117" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RleHRyZWdpb246ZDAyMDAxYzMzZjk0NGIyNmJhN2NkODA4OTVlMzI3YjJfNzcy_9d4bfe43-ccb6-4b44-972e-f2732a1035a0">5.2</ix:nonFraction> million in cash and <ix:nonFraction unitRef="shares" contextRef="ibccd6f048dc74a6c953e619b2a9e9ea6_D20200117-20200117" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RleHRyZWdpb246ZDAyMDAxYzMzZjk0NGIyNmJhN2NkODA4OTVlMzI3YjJfNzg3_45dace8b-1a27-415a-8901-ee96a88e982a">485,451</ix:nonFraction> shares of our common stock valued at the closing price on the effective date of $<ix:nonFraction unitRef="usdPerShare" contextRef="i879547fef02c413ab97b1073b8418853_I20200117" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RleHRyZWdpb246ZDAyMDAxYzMzZjk0NGIyNmJhN2NkODA4OTVlMzI3YjJfODcw_03a160eb-6fbb-4128-b350-60f0669440b0">4.22</ix:nonFraction>. </span></div><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RleHRyZWdpb246ZDAyMDAxYzMzZjk0NGIyNmJhN2NkODA4OTVlMzI3YjJfMTI4NQ_bc3b5628-cd8a-416d-8825-d7752d1b6693" escape="true"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the net cash flows is summarized below (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:85.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 17, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash consideration paid to former equity holders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibccd6f048dc74a6c953e619b2a9e9ea6_D20200117-20200117" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RhYmxlOmZiNTYzYjk5ZmFhMTQwY2ZhYThjNDFkOTIwOGNmZGRmL3RhYmxlcmFuZ2U6ZmI1NjNiOTlmYWExNDBjZmFhOGM0MWQ5MjA4Y2ZkZGZfMS0yLTEtMS0w_7c71d391-ea15-4033-b06a-a96016500a0f">5,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: cash and cash equivalents acquired</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibccd6f048dc74a6c953e619b2a9e9ea6_D20200117-20200117" decimals="-3" name="us-gaap:CashAcquiredFromAcquisition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RhYmxlOmZiNTYzYjk5ZmFhMTQwY2ZhYThjNDFkOTIwOGNmZGRmL3RhYmxlcmFuZ2U6ZmI1NjNiOTlmYWExNDBjZmFhOGM0MWQ5MjA4Y2ZkZGZfMi0yLTEtMS0w_41f2c685-e04c-48d7-9085-2b80a4aa516e">11</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition of InstruNor, net of cash acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibccd6f048dc74a6c953e619b2a9e9ea6_D20200117-20200117" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RhYmxlOmZiNTYzYjk5ZmFhMTQwY2ZhYThjNDFkOTIwOGNmZGRmL3RhYmxlcmFuZ2U6ZmI1NjNiOTlmYWExNDBjZmFhOGM0MWQ5MjA4Y2ZkZGZfMy0yLTEtMS0w_a6ce0671-16d9-41b2-95ef-92f1ba1d7a3b">5,154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:6pt;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><ix:continuation id="i74ba8b26d5434678800f32a08c1f79f2"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition was accounted for in accordance with ASC 805, Business Combinations. The assets acquired and liabilities assumed were recorded at their estimated fair values at the InstruNor acquisition date. <ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RleHRyZWdpb246ZDAyMDAxYzMzZjk0NGIyNmJhN2NkODA4OTVlMzI3YjJfMTI4Ng_aeadb006-6770-481f-9821-cf4558328e0c" continuedAt="i44ccfc5127d240deaeb969d88ca058de" escape="true">Goodwill of $<ix:nonFraction unitRef="usd" contextRef="ic833fc7e7ff14f309dbabe622e99c8de_I20200117" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RleHRyZWdpb246ZDAyMDAxYzMzZjk0NGIyNmJhN2NkODA4OTVlMzI3YjJfMTE2OA_50b48298-099a-49ae-9296-4a1185270cd6">2.2</ix:nonFraction> million was calculated as the purchase price less the fair value of the net assets acquired as follows (in thousands):</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:14pt;text-align:center"><ix:continuation id="i44ccfc5127d240deaeb969d88ca058de"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:85.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 17, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase price:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash consideration paid on closing to former equity holders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibccd6f048dc74a6c953e619b2a9e9ea6_D20200117-20200117" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RhYmxlOjgyMjYyMDhhYTM4MzQzMjQ4NDU1MmNmZGY4MmQ0OTMzL3RhYmxlcmFuZ2U6ODIyNjIwOGFhMzgzNDMyNDg0NTUyY2ZkZjgyZDQ5MzNfMi0yLTEtMS0w_21ea50fa-64b1-48ba-8329-a4579e1414d0">5,165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash consideration common shares </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibccd6f048dc74a6c953e619b2a9e9ea6_D20200117-20200117" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RhYmxlOjgyMjYyMDhhYTM4MzQzMjQ4NDU1MmNmZGY4MmQ0OTMzL3RhYmxlcmFuZ2U6ODIyNjIwOGFhMzgzNDMyNDg0NTUyY2ZkZjgyZDQ5MzNfMy0yLTEtMS0w_579e216e-a026-4abb-a753-dda218908ceb">2,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibccd6f048dc74a6c953e619b2a9e9ea6_D20200117-20200117" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RhYmxlOjgyMjYyMDhhYTM4MzQzMjQ4NDU1MmNmZGY4MmQ0OTMzL3RhYmxlcmFuZ2U6ODIyNjIwOGFhMzgzNDMyNDg0NTUyY2ZkZjgyZDQ5MzNfNC0yLTEtMS0w_3a04f574-fd89-4495-9e58-b5efe10129ed">7,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets acquired:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic833fc7e7ff14f309dbabe622e99c8de_I20200117" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RhYmxlOjgyMjYyMDhhYTM4MzQzMjQ4NDU1MmNmZGY4MmQ0OTMzL3RhYmxlcmFuZ2U6ODIyNjIwOGFhMzgzNDMyNDg0NTUyY2ZkZjgyZDQ5MzNfNy0yLTEtMS0w_9b1c1df4-0879-4e01-b3d7-05097c21f253">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic833fc7e7ff14f309dbabe622e99c8de_I20200117" decimals="-3" name="fldm:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAccountsReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RhYmxlOjgyMjYyMDhhYTM4MzQzMjQ4NDU1MmNmZGY4MmQ0OTMzL3RhYmxlcmFuZ2U6ODIyNjIwOGFhMzgzNDMyNDg0NTUyY2ZkZjgyZDQ5MzNfOC0yLTEtMS0w_feacc58d-7b37-4cc3-9c9a-4cfde85ebe71">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic833fc7e7ff14f309dbabe622e99c8de_I20200117" decimals="-3" name="fldm:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RhYmxlOjgyMjYyMDhhYTM4MzQzMjQ4NDU1MmNmZGY4MmQ0OTMzL3RhYmxlcmFuZ2U6ODIyNjIwOGFhMzgzNDMyNDg0NTUyY2ZkZjgyZDQ5MzNfOS0yLTEtMS0w_b9d0b12d-eafb-438a-b735-c5ba4f15bcbc">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic833fc7e7ff14f309dbabe622e99c8de_I20200117" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RhYmxlOjgyMjYyMDhhYTM4MzQzMjQ4NDU1MmNmZGY4MmQ0OTMzL3RhYmxlcmFuZ2U6ODIyNjIwOGFhMzgzNDMyNDg0NTUyY2ZkZjgyZDQ5MzNfMTAtMi0xLTEtMA_ba456d18-3014-4dd9-8df0-20f2120d3d54">153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic833fc7e7ff14f309dbabe622e99c8de_I20200117" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RhYmxlOjgyMjYyMDhhYTM4MzQzMjQ4NDU1MmNmZGY4MmQ0OTMzL3RhYmxlcmFuZ2U6ODIyNjIwOGFhMzgzNDMyNDg0NTUyY2ZkZjgyZDQ5MzNfMTEtMi0xLTEtMA_bf56a26e-9ed7-45c1-bd67-c94b90952ce5">5,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic833fc7e7ff14f309dbabe622e99c8de_I20200117" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RhYmxlOjgyMjYyMDhhYTM4MzQzMjQ4NDU1MmNmZGY4MmQ0OTMzL3RhYmxlcmFuZ2U6ODIyNjIwOGFhMzgzNDMyNDg0NTUyY2ZkZjgyZDQ5MzNfMTMtMi0xLTEtMA_50713667-e924-4484-8d8f-d6968535fb8f">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic833fc7e7ff14f309dbabe622e99c8de_I20200117" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RhYmxlOjgyMjYyMDhhYTM4MzQzMjQ4NDU1MmNmZGY4MmQ0OTMzL3RhYmxlcmFuZ2U6ODIyNjIwOGFhMzgzNDMyNDg0NTUyY2ZkZjgyZDQ5MzNfMTQtMi0xLTEtMA_7ff8272c-74f3-40aa-92ac-703ce6c9b4ec">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic833fc7e7ff14f309dbabe622e99c8de_I20200117" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RhYmxlOjgyMjYyMDhhYTM4MzQzMjQ4NDU1MmNmZGY4MmQ0OTMzL3RhYmxlcmFuZ2U6ODIyNjIwOGFhMzgzNDMyNDg0NTUyY2ZkZjgyZDQ5MzNfMTUtMi0xLTEtMA_42ccda72-8747-4beb-b36d-34c7f006e52a">566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of identifiable net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic833fc7e7ff14f309dbabe622e99c8de_I20200117" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RhYmxlOjgyMjYyMDhhYTM4MzQzMjQ4NDU1MmNmZGY4MmQ0OTMzL3RhYmxlcmFuZ2U6ODIyNjIwOGFhMzgzNDMyNDg0NTUyY2ZkZjgyZDQ5MzNfMTYtMi0xLTEtMA_4fad9352-37bf-4254-a822-74531544d8be">4,994</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired on acquisition</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic833fc7e7ff14f309dbabe622e99c8de_I20200117" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RhYmxlOjgyMjYyMDhhYTM4MzQzMjQ4NDU1MmNmZGY4MmQ0OTMzL3RhYmxlcmFuZ2U6ODIyNjIwOGFhMzgzNDMyNDg0NTUyY2ZkZjgyZDQ5MzNfMTctMi0xLTEtMA_5721873a-2854-4b55-9d77-60a75f1fbd2b">2,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_1159"></div><div style="margin-bottom:8pt;text-indent:21.6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xMTU5L2ZyYWc6OTU2NjliMmNjMjdjNGJlMWI0MTA1ZmE3M2QxMjVmMjUvdGV4dHJlZ2lvbjo5NTY2OWIyY2MyN2M0YmUxYjQxMDVmYTczZDEyNWYyNV8xODE0MTk0MTg2MjE1OQ_f453c58a-11df-4595-b1fd-21dc56c2b055" continuedAt="ib8a16abee8cc4e14896301f20398f7b4" escape="true">RADx Program</ix:nonNumeric></span></div><ix:continuation id="ib8a16abee8cc4e14896301f20398f7b4"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">In July 2020, we entered into a letter contract with the National Institutes of Health (NIH) for a project under the NIH Rapid Acceleration of Diagnostics (RADx) program. The RADx program provides grants to support a range of new lab-based and point-of-care tests that could significantly increase the number, type and availability of COVID-19 tests. On September 28, 2020, we executed a definitive contract with the NIH as an amendment to the letter contract (collectively, the NIH Contract). The NIH Contract has a total value of up to $<ix:nonFraction unitRef="usd" contextRef="i9ad72ef114054c68ba1d7499333b66b9_I20200928" decimals="-5" format="ixt:numdotdecimal" name="fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xMTU5L2ZyYWc6OTU2NjliMmNjMjdjNGJlMWI0MTA1ZmE3M2QxMjVmMjUvdGV4dHJlZ2lvbjo5NTY2OWIyY2MyN2M0YmUxYjQxMDVmYTczZDEyNWYyNV8xODE0MTk0MTg4NTg0NQ_0a3745f0-621e-437c-bc62-b402b54cb979">34.0</ix:nonFraction>&#160;million upon the achievement of certain conditional milestones. Proceeds from the NIH Contract will be used primarily to expand production capacity and product throughput capabilities for COVID-19 testing with Fluidigm microfluidics technology. We expect to complete the NIH Contract by the end of 2021.</span></div><div style="margin-bottom:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">The NIH has the right to terminate the NIH Contract for convenience.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">In the event of termination for convenience, Fluidigm will be paid a percentage of the NIH Contract price reflecting the percentage of the work performed prior to the notice of termination, plus reasonable charges. In the event of termination for cause due to our default, NIH is not liable for supplies or services not accepted. </span></div><div style="margin-bottom:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">If we fail to deliver within the time specified in the NIH Contract and the delay is due to Fluidigm&#8217;s fault or negligence, we are required to pay liquidated damages in the amount of <ix:nonFraction unitRef="number" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="2" name="fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xMTU5L2ZyYWc6OTU2NjliMmNjMjdjNGJlMWI0MTA1ZmE3M2QxMjVmMjUvdGV4dHJlZ2lvbjo5NTY2OWIyY2MyN2M0YmUxYjQxMDVmYTczZDEyNWYyNV8xODE0MTk0MTg4NTg2MA_604300a8-2d38-4080-9b4f-d6df9e4cd672">33</ix:nonFraction>% of the amount(s) already disbursed to date under the NIH Contract within <ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" format="ixt-sec:durwordsen" name="fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesTerm" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xMTU5L2ZyYWc6OTU2NjliMmNjMjdjNGJlMWI0MTA1ZmE3M2QxMjVmMjUvdGV4dHJlZ2lvbjo5NTY2OWIyY2MyN2M0YmUxYjQxMDVmYTczZDEyNWYyNV8xODE0MTk0MTg4NTg2NA_5a4246ba-af5c-4ffe-b315-924128aa47a3">six months</ix:nonNumeric> from the date of termination.</span></div><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xMTU5L2ZyYWc6OTU2NjliMmNjMjdjNGJlMWI0MTA1ZmE3M2QxMjVmMjUvdGV4dHJlZ2lvbjo5NTY2OWIyY2MyN2M0YmUxYjQxMDVmYTczZDEyNWYyNV8xNjQ5MjY3NDQyNTYzMQ_f90a9cc9-35c5-40f2-8644-76c09e04acaf" escape="true"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity under the NIH Contract through September&#160;30, 2020 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:15pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.993%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total value of milestones reasonably assured</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xMTU5L2ZyYWc6OTU2NjliMmNjMjdjNGJlMWI0MTA1ZmE3M2QxMjVmMjUvdGFibGU6MzM0NTI3NjgwMDk5NDYzZGE0MDcxODE2ZmU0MzI2N2EvdGFibGVyYW5nZTozMzQ1Mjc2ODAwOTk0NjNkYTQwNzE4MTZmZTQzMjY3YV8yLTItMS0xLTE4MzU_f5f1d3ac-0821-4e3d-a181-dc207971d8ce">18,607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts applied against research and development expenses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" name="fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xMTU5L2ZyYWc6OTU2NjliMmNjMjdjNGJlMWI0MTA1ZmE3M2QxMjVmMjUvdGFibGU6MzM0NTI3NjgwMDk5NDYzZGE0MDcxODE2ZmU0MzI2N2EvdGFibGVyYW5nZTozMzQ1Mjc2ODAwOTk0NjNkYTQwNzE4MTZmZTQzMjY3YV8zLTItMS0xLTE4MzU_c283054a-ccd6-4421-b88c-e0f0ea9aa968">383</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred grant income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="fldm:DeferredGrantRevenueNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xMTU5L2ZyYWc6OTU2NjliMmNjMjdjNGJlMWI0MTA1ZmE3M2QxMjVmMjUvdGFibGU6MzM0NTI3NjgwMDk5NDYzZGE0MDcxODE2ZmU0MzI2N2EvdGFibGVyYW5nZTozMzQ1Mjc2ODAwOTk0NjNkYTQwNzE4MTZmZTQzMjY3YV80LTItMS0xLTE4MzU_f0156ef7-479e-4911-9499-f86d7c838894">18,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total value of milestones reasonably assured </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xMTU5L2ZyYWc6OTU2NjliMmNjMjdjNGJlMWI0MTA1ZmE3M2QxMjVmMjUvdGFibGU6MzM0NTI3NjgwMDk5NDYzZGE0MDcxODE2ZmU0MzI2N2EvdGFibGVyYW5nZTozMzQ1Mjc2ODAwOTk0NjNkYTQwNzE4MTZmZTQzMjY3YV82LTItMS0xLTE4MzU_3ccbb070-b7a1-436e-9c62-949c6f144bc5">18,607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funding received</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersFundingReceived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xMTU5L2ZyYWc6OTU2NjliMmNjMjdjNGJlMWI0MTA1ZmE3M2QxMjVmMjUvdGFibGU6MzM0NTI3NjgwMDk5NDYzZGE0MDcxODE2ZmU0MzI2N2EvdGFibGVyYW5nZTozMzQ1Mjc2ODAwOTk0NjNkYTQwNzE4MTZmZTQzMjY3YV83LTItMS0xLTE4MzU_c76677aa-6170-4c74-998e-d4de8e798d0f">11,151</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant receivable from RADx</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="fldm:ResearchAndDevelopmentArrangementReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xMTU5L2ZyYWc6OTU2NjliMmNjMjdjNGJlMWI0MTA1ZmE3M2QxMjVmMjUvdGFibGU6MzM0NTI3NjgwMDk5NDYzZGE0MDcxODE2ZmU0MzI2N2EvdGFibGVyYW5nZTozMzQ1Mjc2ODAwOTk0NjNkYTQwNzE4MTZmZTQzMjY3YV84LTItMS0xLTE4MzU_815efcb6-6dfa-4b74-9b2c-beb8467cad13">7,456</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:15pt;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_43"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RleHRyZWdpb246MzhkOTM1NDdiYTZhNGNjNDkwMTc1YWYwZTUzYTU5MGNfMTMxNA_a4c7beca-3919-46f8-922f-3515dbad2dc0" continuedAt="i77b72837f094444aa984c53d59c63d54" escape="true">Revenue</ix:nonNumeric></span></div><ix:continuation id="i77b72837f094444aa984c53d59c63d54"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RleHRyZWdpb246MzhkOTM1NDdiYTZhNGNjNDkwMTc1YWYwZTUzYTU5MGNfMTMxNg_73a5b67a-977e-4865-8023-2a9d3ed70e57" escape="true"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our revenue for the three and nine months ended September&#160;30, 2020 and 2019, respectively, based on geographic area and by source (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographic Markets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1f96d93c1f9456eadce09f1a0df997c_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOmFkZGFhMjdkNjVhZjQzN2M4OGIwMGJjY2VjOGQzMDI2L3RhYmxlcmFuZ2U6YWRkYWEyN2Q2NWFmNDM3Yzg4YjAwYmNjZWM4ZDMwMjZfMy0xLTEtMS0w_167ac689-77ed-4900-bf9d-85c8c73c6878">23,653</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc94006eea6b434ca69524643dc9911e_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOmFkZGFhMjdkNjVhZjQzN2M4OGIwMGJjY2VjOGQzMDI2L3RhYmxlcmFuZ2U6YWRkYWEyN2Q2NWFmNDM3Yzg4YjAwYmNjZWM4ZDMwMjZfMy0zLTEtMS0w_5ca73a8a-b93a-493b-8dc0-6e61d6ae9118">11,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d0a47c0cefc4e1db4ee8e02eca066a9_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOmFkZGFhMjdkNjVhZjQzN2M4OGIwMGJjY2VjOGQzMDI2L3RhYmxlcmFuZ2U6YWRkYWEyN2Q2NWFmNDM3Yzg4YjAwYmNjZWM4ZDMwMjZfMy01LTEtMS0w_5644ef19-e0e1-42a2-ac24-6c3a61c1f1ed">52,437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia24e4dab3a1e4846aed1d65d31ca64e9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOmFkZGFhMjdkNjVhZjQzN2M4OGIwMGJjY2VjOGQzMDI2L3RhYmxlcmFuZ2U6YWRkYWEyN2Q2NWFmNDM3Yzg4YjAwYmNjZWM4ZDMwMjZfMy03LTEtMS0w_30b374a9-73d8-458c-be88-5292c8b48934">35,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i856788a23f0e421e9c4f6bfcd2937c25_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOmFkZGFhMjdkNjVhZjQzN2M4OGIwMGJjY2VjOGQzMDI2L3RhYmxlcmFuZ2U6YWRkYWEyN2Q2NWFmNDM3Yzg4YjAwYmNjZWM4ZDMwMjZfNC0xLTEtMS0w_1cc0bf96-5814-4abe-9734-a04a4d1833f4">8,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie818350e13f1407c8991ea709abe673f_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOmFkZGFhMjdkNjVhZjQzN2M4OGIwMGJjY2VjOGQzMDI2L3RhYmxlcmFuZ2U6YWRkYWEyN2Q2NWFmNDM3Yzg4YjAwYmNjZWM4ZDMwMjZfNC0zLTEtMS0w_f70259ce-4df9-46b1-b82a-d5cd1ce09b44">9,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36a9b9de3bfd42a795635e6c4734733a_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOmFkZGFhMjdkNjVhZjQzN2M4OGIwMGJjY2VjOGQzMDI2L3RhYmxlcmFuZ2U6YWRkYWEyN2Q2NWFmNDM3Yzg4YjAwYmNjZWM4ZDMwMjZfNC01LTEtMS0w_c580e6d8-a737-47d0-95f6-27a9d19769e1">23,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iceddf551be474cbfa9d1febcb7e64631_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOmFkZGFhMjdkNjVhZjQzN2M4OGIwMGJjY2VjOGQzMDI2L3RhYmxlcmFuZ2U6YWRkYWEyN2Q2NWFmNDM3Yzg4YjAwYmNjZWM4ZDMwMjZfNC03LTEtMS0w_03100666-191e-4385-a786-b40009885299">28,465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c769151da2142868115a7ca0373be74_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOmFkZGFhMjdkNjVhZjQzN2M4OGIwMGJjY2VjOGQzMDI2L3RhYmxlcmFuZ2U6YWRkYWEyN2Q2NWFmNDM3Yzg4YjAwYmNjZWM4ZDMwMjZfNS0xLTEtMS0w_865118cf-274c-4b2f-a23b-1f1494dfc061">7,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c7ed6ed420047e1b49b17f97ea91343_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOmFkZGFhMjdkNjVhZjQzN2M4OGIwMGJjY2VjOGQzMDI2L3RhYmxlcmFuZ2U6YWRkYWEyN2Q2NWFmNDM3Yzg4YjAwYmNjZWM4ZDMwMjZfNS0zLTEtMS0w_146923d0-5759-4725-85f8-3b45d10974dc">6,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb3c7d9e2c814e0e8399d92211de70ff_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOmFkZGFhMjdkNjVhZjQzN2M4OGIwMGJjY2VjOGQzMDI2L3RhYmxlcmFuZ2U6YWRkYWEyN2Q2NWFmNDM3Yzg4YjAwYmNjZWM4ZDMwMjZfNS01LTEtMS0w_67e13e75-66ca-49d6-b665-c60ba641d44f">17,609</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0b62a4024244e348817dc10a1f4ca62_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOmFkZGFhMjdkNjVhZjQzN2M4OGIwMGJjY2VjOGQzMDI2L3RhYmxlcmFuZ2U6YWRkYWEyN2Q2NWFmNDM3Yzg4YjAwYmNjZWM4ZDMwMjZfNS03LTEtMS0w_d2c7e096-c540-46fb-a270-7b272768a550">21,135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOmFkZGFhMjdkNjVhZjQzN2M4OGIwMGJjY2VjOGQzMDI2L3RhYmxlcmFuZ2U6YWRkYWEyN2Q2NWFmNDM3Yzg4YjAwYmNjZWM4ZDMwMjZfNi0xLTEtMS0w_25b522d2-78f3-4489-aa01-68657fca5a5f">39,861</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOmFkZGFhMjdkNjVhZjQzN2M4OGIwMGJjY2VjOGQzMDI2L3RhYmxlcmFuZ2U6YWRkYWEyN2Q2NWFmNDM3Yzg4YjAwYmNjZWM4ZDMwMjZfNi0zLTEtMS0w_ebac154a-d323-4cdb-ae7e-a91fb3ea06c4">26,496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOmFkZGFhMjdkNjVhZjQzN2M4OGIwMGJjY2VjOGQzMDI2L3RhYmxlcmFuZ2U6YWRkYWEyN2Q2NWFmNDM3Yzg4YjAwYmNjZWM4ZDMwMjZfNi01LTEtMS0w_2d159664-e119-4e78-86f8-16c36b6baecd">93,536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOmFkZGFhMjdkNjVhZjQzN2M4OGIwMGJjY2VjOGQzMDI2L3RhYmxlcmFuZ2U6YWRkYWEyN2Q2NWFmNDM3Yzg4YjAwYmNjZWM4ZDMwMjZfNi03LTEtMS0w_7b936dab-790a-4072-9d1d-9e70cf6c7c09">84,803</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.040%"></td><td style="width:0.1%"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Source:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9557da47acfa4592bd8a6eb4d01dbcac_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfNC0xLTEtMS0w_a3c4730f-89ef-48f0-8ecd-e63d7c2ee175">12,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10f3f219918f49f0a4aaeea16520869b_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfNC0zLTEtMS0w_e7dfe2b0-d0b1-44a8-8122-bebb383eeb7a">9,159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcec3908df424a9b994b171239c3ad23_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfNC01LTEtMS0w_849561d4-8206-4045-9a25-5ee1dacb4ecf">30,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e54d66980042b78f398dff2722c68c_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfNC03LTEtMS0w_a956505e-f483-4973-bd08-2f2b547bb25f">34,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1295e00055ed464589bdacaa5e07480f_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfNS0xLTEtMS0w_ab66c31f-5521-44c1-88b4-43ff22b941df">16,586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3749711354f04142930ba804e3127822_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfNS0zLTEtMS0w_a7601c8d-9b37-447d-a339-64b85a37a6e3">11,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd2f4f0a6d4b4ccbb836a1200a172bdb_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfNS01LTEtMS0w_9429b60e-2ced-4178-8070-e53d86c8709b">34,924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i997fea8ff4474842a30928a2e82a8b6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfNS03LTEtMS0w_d2a048d1-1e96-420b-b720-2ff226f2271f">34,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63dac85b57b74b8ea053ca16f3171b97_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfNi0xLTEtMS0w_b8ded64f-e3bd-4d79-bf0d-7d110248fda5">29,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if32b1e8a019b42fea7b915507e3650c8_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfNi0zLTEtMS0w_dc443e22-fd27-4360-b2b3-b5617067acd7">20,666</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedd975972ec54477b7d1edc9dcd0e9ae_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfNi01LTEtMS0w_a6530c62-95f0-47cb-a55f-4ac9dec5d575">65,596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id978df8be0b2445ca43d804b18f99d88_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfNi03LTEtMS0w_d7621103-5c78-4048-a6d0-875e8a8130a3">68,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea38c8e677cb447a95163f4ee5133194_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfNy0xLTEtMS0w_f49c98e8-9319-415e-8c78-2938f5174b4f">6,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38d8014ca50e40ea95a3204f7d46b5a7_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfNy0zLTEtMS0w_8bb2cfaa-2683-4ea1-91d7-a021ce002190">5,630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4c104320701492cab8cff2d9393f868_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfNy01LTEtMS0w_d997bad2-a624-4b26-9148-c16549d3c7ae">16,457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64595cdf77c94fb899f02002ee32e32b_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfNy03LTEtMS0w_51608bf6-3afe-4095-973c-8dbae3a4ecb8">15,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied63bbfdfbdd4d17b689fb84bd615a22_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfOC0xLTEtMS0w_dc1067e5-c9bd-48e5-83db-5a3c02c02d4c">3,180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33305dd63fcd4c7b827cced58c13da0a_D20190701-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfOC0zLTEtMS0w_7b729491-950f-44ea-8e30-457a80022805">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7451c9afcd847cda97b00adbdae3f05_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfOC01LTEtMS0w_6ef14f46-6410-4d5c-8117-229356a7ca53">6,180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86ecea94f14744c580bbf02abb8493f8_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfOC03LTEtMS0w_142c1b30-d5c8-4909-9d17-dbdd9c225d29">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;License and royalty revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i826fe1457ec74796bbc8e35e49f0de7a_D20200701-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfMTAtMS0xLTEtMA_4d5b0adf-4dca-409e-bafb-df51afdb2ab3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b9fcc905d1e46f5ad329420385ba4f7_D20190701-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfMTAtMy0xLTEtMA_ba90c730-3bfd-41aa-bcfd-bbaff44e6f6f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f7db29c2964b2fab7a487953e7132a_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfMTAtNS0xLTEtMA_0ef1f9d1-0885-4f32-b2ad-2e40d6df45f1">3,163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f132757b684062b8a1afe7a0434252_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfMTAtNy0xLTEtMA_0f38dfc5-f7e9-453f-80b4-8440d124ac31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Grant revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c25df473b54c1d8ffbd994b10b9e7c_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfMTEtMS0xLTEtMA_ce356976-0f43-4171-9dd2-891469b50ae9">1,340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0c099e000eb4fe285d40608c7ab5954_D20190701-20190930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfMTEtMy0xLTEtMA_cabb1bdd-505d-4660-99be-05c7c53ad49e">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611ead10ea7746c88a251afc99eef27e_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfMTEtNS0xLTEtMA_f1f81c1b-1638-4f27-802a-edd2cce491b6">2,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6eb5cddfd9a4a429b59d0409dc55f67_D20190101-20190930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfMTEtNy0xLTEtMA_7ff39215-f608-4c5e-a8c8-325e841e079a">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Total other revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1eb2e1b7d5c4eeaa06d2bbb0f149ea2_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfMTItMS0xLTEtMA_25b164c8-fb09-4f3b-a5d5-177aba507626">1,340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507e1652ea0c4fb1b2d67aeec5653728_D20190701-20190930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfMTItMy0xLTEtMA_f922be90-a5e1-4b40-a088-1548197dd9bf">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cb05eac3b154d7798dda674fcc015dd_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfMTItNS0xLTEtMA_2940631b-9c49-41a9-b137-0e827e6a5004">5,303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6188317019ad466c8b5326b1720b484d_D20190101-20190930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfMTItNy0xLTEtMA_b5cee7b1-2384-4e3c-bd0a-44209aa0ba24">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfMTMtMS0xLTEtMA_13b28616-f69f-4607-ac21-d8ffb064d8b5">39,861</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfMTMtMy0xLTEtMA_ac884f2c-368f-4a58-9ddc-1f4a0207ca73">26,496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfMTMtNS0xLTEtMA_3b792285-df76-4c0e-bdfa-0a6a97d1afe8">93,536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfMTMtNy0xLTEtMA_3c4b64d3-1f68-419b-847c-8e8c3751fa4c">84,803</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Performance Obligations</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We reported $<ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RleHRyZWdpb246MzhkOTM1NDdiYTZhNGNjNDkwMTc1YWYwZTUzYTU5MGNfMjE2_852daf35-678d-4592-ba71-5bbdb5e4347d">20.0</ix:nonFraction> million of deferred revenue in our December&#160;31, 2019 consolidated balance sheet. During the nine months ended September&#160;30, 2020, $<ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RleHRyZWdpb246MzhkOTM1NDdiYTZhNGNjNDkwMTc1YWYwZTUzYTU5MGNfMjk1_e015f844-b65c-4553-a558-a94bc7e696c4">8.8</ix:nonFraction> million of the opening balance was recognized as revenue and $<ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="fldm:ContractWithCustomerLiabilityIncreaseFromCashReceipts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RleHRyZWdpb246MzhkOTM1NDdiYTZhNGNjNDkwMTc1YWYwZTUzYTU5MGNfMzUx_b0ae0383-39ba-4a36-9054-584c0da66f38">9.9</ix:nonFraction> million of net additional advance payments were received from customers, primarily associated with instrument service contracts. At September&#160;30, 2020, we reported $<ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RleHRyZWdpb246MzhkOTM1NDdiYTZhNGNjNDkwMTc1YWYwZTUzYTU5MGNfNDk0_67da0d5d-6998-446b-8f1b-d442ed8fd8a5">21.1</ix:nonFraction> million of deferred revenue. </span></div><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RleHRyZWdpb246MzhkOTM1NDdiYTZhNGNjNDkwMTc1YWYwZTUzYTU5MGNfMTMxMg_c5c7aee7-aead-4ca5-a607-e6e1890a673c" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the expected timing of revenue recognition for unfulfilled performance obligations associated with instrument service contracts that were partially completed at September&#160;30, 2020 (in thousands): </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.798%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.165%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expected Revenue </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 (remainder of the year)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b8ca235d25d4be7b24f48e1d7b063c2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjQ2MzJkYmI2ZTExNjQ5YWRhNTI3OTYxMGE2OWI3NmQ4L3RhYmxlcmFuZ2U6NDYzMmRiYjZlMTE2NDlhZGE1Mjc5NjEwYTY5Yjc2ZDhfMS0yLTEtMS0w_4b9929db-4db2-44c5-ad29-25b2ade38fcc">3,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibee58402214d46c9b90764b31cb5bb82_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjQ2MzJkYmI2ZTExNjQ5YWRhNTI3OTYxMGE2OWI3NmQ4L3RhYmxlcmFuZ2U6NDYzMmRiYjZlMTE2NDlhZGE1Mjc5NjEwYTY5Yjc2ZDhfMi0yLTEtMS0w_c3a32b4c-04b4-40a1-aa2d-3e6f4b53342b">10,385</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8df7afdb66042e49508527a5cb31fa1_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjQ2MzJkYmI2ZTExNjQ5YWRhNTI3OTYxMGE2OWI3NmQ4L3RhYmxlcmFuZ2U6NDYzMmRiYjZlMTE2NDlhZGE1Mjc5NjEwYTY5Yjc2ZDhfMy0yLTEtMS0w_c68f87d7-cf3d-4451-8442-205722d4c5b7">5,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6080b667adf249898c3e460f95952085_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjQ2MzJkYmI2ZTExNjQ5YWRhNTI3OTYxMGE2OWI3NmQ4L3RhYmxlcmFuZ2U6NDYzMmRiYjZlMTE2NDlhZGE1Mjc5NjEwYTY5Yjc2ZDhfNC0yLTEtMS0w_997e98a7-44a7-4292-b5fe-580b1d4956bd">4,079</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjQ2MzJkYmI2ZTExNjQ5YWRhNTI3OTYxMGE2OWI3NmQ4L3RhYmxlcmFuZ2U6NDYzMmRiYjZlMTE2NDlhZGE1Mjc5NjEwYTY5Yjc2ZDhfNS0yLTEtMS0w_c86800d7-95b5-49ac-844c-f231b227c88d">24,112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______</span></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected revenue includes both billed amounts included in deferred revenue and unbilled amounts that are not reflected in our condensed consolidated financial statements and are subject to change if our customers decide to cancel or modify their contracts. Purchase orders for instrument service contracts can generally be canceled before the service period begins without penalty.</span></div></ix:nonNumeric><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply the practical expedient that permits us not to disclose information about unsatisfied performance obligations for service contracts with an expected term of one year or less.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_49"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RleHRyZWdpb246YmI4NWM0ZDFjODFmNDczMDkyNWEzYTY0YzdkNGZmNTNfMjMzOQ_4ed8fdc6-2654-461f-868f-db79bc66b1e4" continuedAt="ief4f53d8fea94c148d28c7c2965f3ab4" escape="true">Goodwill and Intangible Assets, net</ix:nonNumeric></span></div><ix:continuation id="ief4f53d8fea94c148d28c7c2965f3ab4" continuedAt="id723775f54d3427c8f281bf4b2db5cc6"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our acquisition of DVS Sciences, Inc. in February 2014, we recognized goodwill of $<ix:nonFraction unitRef="usd" contextRef="i4597ae00a444403dacaf5086f59bacac_I20140228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RleHRyZWdpb246YmI4NWM0ZDFjODFmNDczMDkyNWEzYTY0YzdkNGZmNTNfMTQ1_07823a71-e7ed-4ed5-9c92-bcf7dae87aec">104.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic6b361716cf04338b59854e72cf943b0_D20140201-20140228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RleHRyZWdpb246YmI4NWM0ZDFjODFmNDczMDkyNWEzYTY0YzdkNGZmNTNfMTUy_e246dda6-e2e3-4236-862d-7013eedda849">112.0</ix:nonFraction> million of developed technology. In the first quarter of 2020, we recognized $<ix:nonFraction unitRef="usd" contextRef="i0baca80d39e748b7bcbaf3ac214f583b_I20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RleHRyZWdpb246YmI4NWM0ZDFjODFmNDczMDkyNWEzYTY0YzdkNGZmNTNfMjI0_5ca0c1cf-423e-4140-8524-11ac5e7e5816">2.2</ix:nonFraction> million (Euro <ix:nonFraction unitRef="eur" contextRef="i0baca80d39e748b7bcbaf3ac214f583b_I20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RleHRyZWdpb246YmI4NWM0ZDFjODFmNDczMDkyNWEzYTY0YzdkNGZmNTNfMTA5OTUxMTYzMDEyMw_30168479-eb13-4ff4-bd64-987e4c858679">2.0</ix:nonFraction> million) of goodwill from the InstruNor acquisition and $<ix:nonFraction unitRef="usd" contextRef="i62aeb047eea249e8a505e86f7dbd1080_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RleHRyZWdpb246YmI4NWM0ZDFjODFmNDczMDkyNWEzYTY0YzdkNGZmNTNfMjc0_96d7559e-e240-4131-92b3-ab752d9967d5">5.4</ix:nonFraction> million (Euro <ix:nonFraction unitRef="eur" contextRef="i62aeb047eea249e8a505e86f7dbd1080_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RleHRyZWdpb246YmI4NWM0ZDFjODFmNDczMDkyNWEzYTY0YzdkNGZmNTNfMTA5OTUxMTYzMDEzNw_641e27a2-88b5-432c-bf62-5e316b590ff7">4.9</ix:nonFraction> million) of developed technology (see Note 3). As the goodwill and developed technology from the InstruNor acquisition are recorded in the functional currency of our European operations, which is the Euro, these balances are revalued each period and the U.S. dollar value of these assets will fluctuate as foreign exchange rates change. We are amortizing InstruNor developed technology over <ix:nonNumeric contextRef="i62aeb047eea249e8a505e86f7dbd1080_D20200101-20200331" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RleHRyZWdpb246YmI4NWM0ZDFjODFmNDczMDkyNWEzYTY0YzdkNGZmNTNfMzY5_cabda0b9-cd3e-4479-a752-9d6b8ae9575f">8.0</ix:nonNumeric> years. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and intangible assets with indefinite lives are not subject to amortization but are tested for impairment on an annual basis during the fourth quarter or whenever events or changes in circumstances indicate the carrying amount of these assets may not be recoverable. Qualitative assessment includes assessing significant events and circumstances such as our current results, assumptions regarding future performance, strategic initiatives and overall economic factors, including the ongoing global COVID-19 pandemic and macroeconomic developments to determine the existence of potential indicators of impairment and assess if it is more likely than not that the fair value of our reporting unit or intangible assets is less than their carrying value. If indicators of impairment are identified, a quantitative impairment test is performed.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of fiscal 2020, the Company assessed whether the current and potential future impact of the COVID-19 pandemic represented an event which necessitated an impairment review.&#160;This assessment included an update of the qualitative and quantitative factors affecting our business. As a result of this assessment, we determined that a triggering event had occurred and a quantitative impairment test was performed. As a result of this quantitative analysis, we determined that the fair values of our goodwill and developed technology intangibles were not less than their carrying values and no impairment was recognized.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets also include other patents and licenses, which are included in other non-current assets. <ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RleHRyZWdpb246YmI4NWM0ZDFjODFmNDczMDkyNWEzYTY0YzdkNGZmNTNfMjMzMw_6d822dee-c1fa-4848-ad4b-58bb3e8ffe9b" continuedAt="i7a593e50a13f444e81147029c138d3b8" escape="true">Intangible assets, net, were as follows (in thousands): </ix:nonNumeric></span></div><ix:continuation id="i7a593e50a13f444e81147029c138d3b8"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.020%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization and Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Amortization Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id93cbf33dc99482fbdd7c3492d9fd706_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjI0MWRlNzY4ODcxNDQwM2I4ODliZmI3NTYxNjE4YjBkL3RhYmxlcmFuZ2U6MjQxZGU3Njg4NzE0NDAzYjg4OWJmYjc1NjE2MThiMGRfMi0yLTEtMS0w_1fbbacd5-8c67-4213-bf09-63db56b4bbaf">117,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id93cbf33dc99482fbdd7c3492d9fd706_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjI0MWRlNzY4ODcxNDQwM2I4ODliZmI3NTYxNjE4YjBkL3RhYmxlcmFuZ2U6MjQxZGU3Njg4NzE0NDAzYjg4OWJmYjc1NjE2MThiMGRfMi00LTEtMS0w_7f17405f-539f-4c3d-8073-6b7d30009d16">74,425</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id93cbf33dc99482fbdd7c3492d9fd706_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjI0MWRlNzY4ODcxNDQwM2I4ODliZmI3NTYxNjE4YjBkL3RhYmxlcmFuZ2U6MjQxZGU3Njg4NzE0NDAzYjg4OWJmYjc1NjE2MThiMGRfMi02LTEtMS0w_4398d779-7c5e-4437-905c-32a3968e222b">42,955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i448598bde68f45d1ba361f740dd9f13e_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjI0MWRlNzY4ODcxNDQwM2I4ODliZmI3NTYxNjE4YjBkL3RhYmxlcmFuZ2U6MjQxZGU3Njg4NzE0NDAzYjg4OWJmYjc1NjE2MThiMGRfMi04LTEtMS0w_28c11635-ed6d-4511-a1b9-e2efb1bc1fc1">9.9</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and licenses</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d4f73bdbe84c6cb586dc7a3922ccec_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjI0MWRlNzY4ODcxNDQwM2I4ODliZmI3NTYxNjE4YjBkL3RhYmxlcmFuZ2U6MjQxZGU3Njg4NzE0NDAzYjg4OWJmYjc1NjE2MThiMGRfMy0yLTEtMS0w_f64414fd-14e3-49a4-935a-c1e5d9928424">11,274</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4d4f73bdbe84c6cb586dc7a3922ccec_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjI0MWRlNzY4ODcxNDQwM2I4ODliZmI3NTYxNjE4YjBkL3RhYmxlcmFuZ2U6MjQxZGU3Njg4NzE0NDAzYjg4OWJmYjc1NjE2MThiMGRfMy00LTEtMS0w_a25a454f-31f1-4b0f-8872-4d5809e190e2">9,030</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d4f73bdbe84c6cb586dc7a3922ccec_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjI0MWRlNzY4ODcxNDQwM2I4ODliZmI3NTYxNjE4YjBkL3RhYmxlcmFuZ2U6MjQxZGU3Njg4NzE0NDAzYjg4OWJmYjc1NjE2MThiMGRfMy02LTEtMS0w_4649a681-fbf2-46f3-b6d3-261f35740caf">2,244</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2f1a0048873a41439f03f292dfd42431_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjI0MWRlNzY4ODcxNDQwM2I4ODliZmI3NTYxNjE4YjBkL3RhYmxlcmFuZ2U6MjQxZGU3Njg4NzE0NDAzYjg4OWJmYjc1NjE2MThiMGRfMy04LTEtMS0w_99c312dd-65b7-4afd-a4a4-e2c676b7a22d">7.8</ix:nonNumeric> years</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.020%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization and Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Amortization Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a2e644816c049b1a4a674aba901cf89_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjRiYmM2YzNkZWRlZTQyMjE5Yjc2MDkzMWM0OGM1MzZjL3RhYmxlcmFuZ2U6NGJiYzZjM2RlZGVlNDIyMTliNzYwOTMxYzQ4YzUzNmNfMy0yLTEtMS0w_ff9617bc-a542-466e-9090-98184a522f2f">112,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a2e644816c049b1a4a674aba901cf89_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjRiYmM2YzNkZWRlZTQyMjE5Yjc2MDkzMWM0OGM1MzZjL3RhYmxlcmFuZ2U6NGJiYzZjM2RlZGVlNDIyMTliNzYwOTMxYzQ4YzUzNmNfMy00LTEtMS0w_65d52e8e-c2cf-420f-87f5-0a12fd63a908">65,800</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a2e644816c049b1a4a674aba901cf89_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjRiYmM2YzNkZWRlZTQyMjE5Yjc2MDkzMWM0OGM1MzZjL3RhYmxlcmFuZ2U6NGJiYzZjM2RlZGVlNDIyMTliNzYwOTMxYzQ4YzUzNmNfMy02LTEtMS0w_76543d5f-5eff-4573-8e98-1cb1f14dd141">46,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifb41af4444ce4ac891cf86ca937bc359_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjRiYmM2YzNkZWRlZTQyMjE5Yjc2MDkzMWM0OGM1MzZjL3RhYmxlcmFuZ2U6NGJiYzZjM2RlZGVlNDIyMTliNzYwOTMxYzQ4YzUzNmNfMy04LTEtMS0w_0a75a44f-f6d3-496b-baec-63abe508737d">10.0</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and licenses</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f4c794c8ce04cb098b7c1033bc0c119_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjRiYmM2YzNkZWRlZTQyMjE5Yjc2MDkzMWM0OGM1MzZjL3RhYmxlcmFuZ2U6NGJiYzZjM2RlZGVlNDIyMTliNzYwOTMxYzQ4YzUzNmNfNC0yLTEtMS0w_bb455575-0a13-4362-8fc1-0c597d0afb72">11,274</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f4c794c8ce04cb098b7c1033bc0c119_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjRiYmM2YzNkZWRlZTQyMjE5Yjc2MDkzMWM0OGM1MzZjL3RhYmxlcmFuZ2U6NGJiYzZjM2RlZGVlNDIyMTliNzYwOTMxYzQ4YzUzNmNfNC00LTEtMS0w_c4642aba-05fd-4ad4-9be4-6d8113697962">8,342</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f4c794c8ce04cb098b7c1033bc0c119_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjRiYmM2YzNkZWRlZTQyMjE5Yjc2MDkzMWM0OGM1MzZjL3RhYmxlcmFuZ2U6NGJiYzZjM2RlZGVlNDIyMTliNzYwOTMxYzQ4YzUzNmNfNC02LTEtMS0w_1d68f3ef-dfc5-444d-8ad8-778e5524e83e">2,932</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i863d909053654a5097e30eaeb582a60f_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjRiYmM2YzNkZWRlZTQyMjE5Yjc2MDkzMWM0OGM1MzZjL3RhYmxlcmFuZ2U6NGJiYzZjM2RlZGVlNDIyMTliNzYwOTMxYzQ4YzUzNmNfNC04LTEtMS0w_1b5e740c-44cb-4fef-ae9b-fcc0c0076200">7.8</ix:nonNumeric> years</span></td></tr></table></div></ix:continuation><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total amortization expense for the three months ended September&#160;30, 2020 and 2019 was $<ix:nonFraction unitRef="usd" contextRef="i8bbffea3402e4561b1e8ab6fc7c2bc4d_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RleHRyZWdpb246YmI4NWM0ZDFjODFmNDczMDkyNWEzYTY0YzdkNGZmNTNfMjA4NQ_6161fd6a-9c19-4c6e-9e75-7046f2f2f7b7">3.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i62ab5d72d0304d8f95c3a6e3503aa15d_D20190701-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RleHRyZWdpb246YmI4NWM0ZDFjODFmNDczMDkyNWEzYTY0YzdkNGZmNTNfMjA5Mg_81ec035b-2bc8-4fa7-80b4-c677be85fb72">3.0</ix:nonFraction> million, respectively. Amortization of intangibles was $<ix:nonFraction unitRef="usd" contextRef="i448598bde68f45d1ba361f740dd9f13e_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RleHRyZWdpb246YmI4NWM0ZDFjODFmNDczMDkyNWEzYTY0YzdkNGZmNTNfMjE0Mg_f2be5d7a-71fb-4cf7-9236-b44cd20a9c5f">9.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4662072a04b84dfea208dcc931393b9d_D20190101-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RleHRyZWdpb246YmI4NWM0ZDFjODFmNDczMDkyNWEzYTY0YzdkNGZmNTNfMjE0OQ_05494c20-0ad1-43f0-870b-554fb34267e9">9.2</ix:nonFraction> million for the nine months ended September&#160;30, 2020 and 2019, respectively.  </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id723775f54d3427c8f281bf4b2db5cc6"><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RleHRyZWdpb246YmI4NWM0ZDFjODFmNDczMDkyNWEzYTY0YzdkNGZmNTNfMjMzNg_ccde4dda-fa44-4e16-9e70-0b2bcb0d2925" escape="true"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the carrying value of intangible assets, net,&#160;as of&#160;September&#160;30, 2020, the amortization expense is expected to be as follows (in thousands): </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:58.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.971%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Technology Amortization Expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Patents and Licenses Amortization Expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 (remainder of the year)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id93cbf33dc99482fbdd7c3492d9fd706_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfMS0xLTEtMS0w_f6c08721-ed24-4b4c-b622-0bb9cd866660">2,978</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d4f73bdbe84c6cb586dc7a3922ccec_I20200930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfMS0zLTEtMS0w_b55cdabf-6148-44c4-a0fa-cf1216f7c70d">229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfMS01LTEtMS0w_d6528f01-76da-4c51-a755-f8a842f60b4c">3,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id93cbf33dc99482fbdd7c3492d9fd706_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfMi0xLTEtMS0w_461489f5-05f8-459a-bc02-57f9c43b6bf2">11,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d4f73bdbe84c6cb586dc7a3922ccec_I20200930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfMi0zLTEtMS0w_da58ecb2-8415-4954-9bb0-c7b76d7feb1d">760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfMi01LTEtMS0w_40553e8e-91e1-4754-ba1a-68bed8dfa1a0">12,671</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id93cbf33dc99482fbdd7c3492d9fd706_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfMy0xLTEtMS0w_0426865c-7f28-40f2-918b-7ee2c1c41c37">11,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d4f73bdbe84c6cb586dc7a3922ccec_I20200930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfMy0zLTEtMS0w_204b21e7-6a01-4e5a-8510-508e9f74e796">677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfMy01LTEtMS0w_5ca8e437-17e6-4108-a716-3e9fedb14ee6">12,588</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id93cbf33dc99482fbdd7c3492d9fd706_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfNC0xLTEtMS0w_738d7063-2ce5-49b5-98ed-4e9c67c8d94d">11,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d4f73bdbe84c6cb586dc7a3922ccec_I20200930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfNC0zLTEtMS0w_928778ef-d9f7-4b09-8fa5-a057d33d4e1f">571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfNC01LTEtMS0w_9d792812-96a4-4cf9-92e6-61cb9d83fb8a">12,482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id93cbf33dc99482fbdd7c3492d9fd706_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfNS0xLTEtMS0w_dd2eb8f4-db28-46ba-ac36-23d66e5ad400">2,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d4f73bdbe84c6cb586dc7a3922ccec_I20200930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfNS0zLTEtMS0w_67d19802-5ed2-410b-b9cb-d9699a17633b">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfNS01LTEtMS0w_c1119f1b-36c5-454b-8364-320f3e51f5b5">2,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id93cbf33dc99482fbdd7c3492d9fd706_I20200930" decimals="-3" format="ixt:numdotdecimal" name="fldm:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfNi0xLTEtMS0w_def7dec5-a4dc-42be-a0ea-8159dc31af61">2,133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d4f73bdbe84c6cb586dc7a3922ccec_I20200930" decimals="-3" format="ixt:zerodash" name="fldm:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfNi0zLTEtMS0w_dd6d3920-cb28-477f-b987-03e00a73db4f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="fldm:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfNi01LTEtMS0w_aebdb540-e1d8-413f-b4fd-7c36d673a764">2,133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id93cbf33dc99482fbdd7c3492d9fd706_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfNy0xLTEtMS0w_1fda8275-27ed-4813-aa1e-1d051fe80c79">42,955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d4f73bdbe84c6cb586dc7a3922ccec_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfNy0zLTEtMS0w_59223eb5-cdf5-41df-ba8c-3d8a4b74fc1d">2,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfNy01LTEtMS0w_15d03388-fff6-415d-a258-94b9b1a9d820">45,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_52"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RleHRyZWdpb246ZjExYjc3MTg4NWFiNDZjZWE4ZWE4YTVlNTVhNGY1NmRfNzkz_c0310ba3-361d-4d14-83b3-f497d8ae9424" continuedAt="i04b433f301a543f5aae03d9e21e4969f" escape="true">Balance Sheet Details</ix:nonNumeric></span></div><ix:continuation id="i04b433f301a543f5aae03d9e21e4969f" continuedAt="ia389334b22f14cdc81528678eb8960a3"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash, Cash Equivalents and Restricted Cash </span></div><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RleHRyZWdpb246ZjExYjc3MTg4NWFiNDZjZWE4ZWE4YTVlNTVhNGY1NmRfNzc1_89830358-c5de-472e-9739-96487950b9ff" escape="true"><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RleHRyZWdpb246ZjExYjc3MTg4NWFiNDZjZWE4ZWE4YTVlNTVhNGY1NmRfNzk2_ece15dd8-e205-453b-b48b-90c76ad037a2" escape="true"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents and restricted cash consisted of the following as of September&#160;30, 2020 and December&#160;31, 2019 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.329%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.973%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.976%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOjRlOTM2NWU4Mzg1ODQwNTc5OGE5OTRmNGExY2FkYjJjL3RhYmxlcmFuZ2U6NGU5MzY1ZTgzODU4NDA1Nzk4YTk5NGY0YTFjYWRiMmNfMS0yLTEtMS0w_13793c5b-5933-482e-bd7c-5e29604924a9">72,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOjRlOTM2NWU4Mzg1ODQwNTc5OGE5OTRmNGExY2FkYjJjL3RhYmxlcmFuZ2U6NGU5MzY1ZTgzODU4NDA1Nzk4YTk5NGY0YTFjYWRiMmNfMS00LTEtMS0w_02e6c295-989b-4931-8446-243e1ce97d15">21,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOjRlOTM2NWU4Mzg1ODQwNTc5OGE5OTRmNGExY2FkYjJjL3RhYmxlcmFuZ2U6NGU5MzY1ZTgzODU4NDA1Nzk4YTk5NGY0YTFjYWRiMmNfMi0yLTEtMS0w_6d260fd9-60b4-43ab-9384-f0623ce02fd2">1,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOjRlOTM2NWU4Mzg1ODQwNTc5OGE5OTRmNGExY2FkYjJjL3RhYmxlcmFuZ2U6NGU5MzY1ZTgzODU4NDA1Nzk4YTk5NGY0YTFjYWRiMmNfMi00LTEtMS0w_9c6e6748-ac6c-4e85-8156-75aea6ea803b">2,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOjRlOTM2NWU4Mzg1ODQwNTc5OGE5OTRmNGExY2FkYjJjL3RhYmxlcmFuZ2U6NGU5MzY1ZTgzODU4NDA1Nzk4YTk5NGY0YTFjYWRiMmNfMy0yLTEtMS0w_c62a2f33-e57f-4bce-9e12-3d96485545bd">73,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOjRlOTM2NWU4Mzg1ODQwNTc5OGE5OTRmNGExY2FkYjJjL3RhYmxlcmFuZ2U6NGU5MzY1ZTgzODU4NDA1Nzk4YTk5NGY0YTFjYWRiMmNfMy00LTEtMS0w_80014639-dfa0-40e1-af92-a3e661d0bc3e">23,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term restricted cash of approximately $<ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RleHRyZWdpb246ZjExYjc3MTg4NWFiNDZjZWE4ZWE4YTVlNTVhNGY1NmRfMjIy_01b67ceb-d386-4ab1-8cc1-be41af0edd4a">15</ix:nonFraction> thousand is included in prepaid expenses and other current assets and $<ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RleHRyZWdpb246ZjExYjc3MTg4NWFiNDZjZWE4ZWE4YTVlNTVhNGY1NmRfMjg2_b6ca6fcb-00d6-4556-a323-9cfead8da771">1.0</ix:nonFraction> million of non-current restricted cash is included in other non-current assets in the condensed consolidated balance sheet as of September&#160;30, 2020. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories</span></div><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RleHRyZWdpb246ZjExYjc3MTg4NWFiNDZjZWE4ZWE4YTVlNTVhNGY1NmRfNzkw_7dc5ebde-bc01-4ad7-9724-c4f6c3358b2c" escape="true"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consisted of the following as of September&#160;30, 2020 and December&#160;31, 2019 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.329%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.973%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.976%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmI5MDk3ZjdjOTE3MjRhNzRiZDdmZmQ3OWUyYmIxYjhhL3RhYmxlcmFuZ2U6YjkwOTdmN2M5MTcyNGE3NGJkN2ZmZDc5ZTJiYjFiOGFfMS0yLTEtMS0w_fa9e4435-09fe-4c00-8f5f-f02afec31178">8,768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmI5MDk3ZjdjOTE3MjRhNzRiZDdmZmQ3OWUyYmIxYjhhL3RhYmxlcmFuZ2U6YjkwOTdmN2M5MTcyNGE3NGJkN2ZmZDc5ZTJiYjFiOGFfMS00LTEtMS0w_75f1cb5c-fcb3-4a69-8713-9239b4d37a3c">6,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmI5MDk3ZjdjOTE3MjRhNzRiZDdmZmQ3OWUyYmIxYjhhL3RhYmxlcmFuZ2U6YjkwOTdmN2M5MTcyNGE3NGJkN2ZmZDc5ZTJiYjFiOGFfMi0yLTEtMS0w_83091e25-f5da-4209-8f59-1bcd04c145da">920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmI5MDk3ZjdjOTE3MjRhNzRiZDdmZmQ3OWUyYmIxYjhhL3RhYmxlcmFuZ2U6YjkwOTdmN2M5MTcyNGE3NGJkN2ZmZDc5ZTJiYjFiOGFfMi00LTEtMS0w_7f06b4ff-72ad-435b-8fa1-b07605df9439">659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmI5MDk3ZjdjOTE3MjRhNzRiZDdmZmQ3OWUyYmIxYjhhL3RhYmxlcmFuZ2U6YjkwOTdmN2M5MTcyNGE3NGJkN2ZmZDc5ZTJiYjFiOGFfMy0yLTEtMS0w_0fa3adaf-9bba-4074-bfbb-c930cfe17e11">9,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmI5MDk3ZjdjOTE3MjRhNzRiZDdmZmQ3OWUyYmIxYjhhL3RhYmxlcmFuZ2U6YjkwOTdmN2M5MTcyNGE3NGJkN2ZmZDc5ZTJiYjFiOGFfMy00LTEtMS0w_51ba002c-2a28-4b92-a600-f2dd10c37493">7,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmI5MDk3ZjdjOTE3MjRhNzRiZDdmZmQ3OWUyYmIxYjhhL3RhYmxlcmFuZ2U6YjkwOTdmN2M5MTcyNGE3NGJkN2ZmZDc5ZTJiYjFiOGFfNC0yLTEtMS0w_ac20cf7d-21ac-4700-939a-535982d82fb3">19,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmI5MDk3ZjdjOTE3MjRhNzRiZDdmZmQ3OWUyYmIxYjhhL3RhYmxlcmFuZ2U6YjkwOTdmN2M5MTcyNGE3NGJkN2ZmZDc5ZTJiYjFiOGFfNC00LTEtMS0w_f18c814a-4973-4f59-b42b-db5d5403d2cc">13,884</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia389334b22f14cdc81528678eb8960a3"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment, net </span></div><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RleHRyZWdpb246ZjExYjc3MTg4NWFiNDZjZWE4ZWE4YTVlNTVhNGY1NmRfNzg4_9759c0d7-cc2a-4d95-a5d9-cd16c1426cbb" escape="true"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following as of September&#160;30, 2020 and December&#160;31, 2019 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.329%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.973%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.976%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff7244c4435948719187b0a6db553efc_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmE2ZDViMWQyZjc3MTQyODRhMDI1MWUyYmMzYTkzYWVkL3RhYmxlcmFuZ2U6YTZkNWIxZDJmNzcxNDI4NGEwMjUxZTJiYzNhOTNhZWRfMS0yLTEtMS0w_4fafbbd6-b481-4974-ac3b-96547ec3bea5">4,363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecee074f6a34af38aebd80a676157ca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmE2ZDViMWQyZjc3MTQyODRhMDI1MWUyYmMzYTkzYWVkL3RhYmxlcmFuZ2U6YTZkNWIxZDJmNzcxNDI4NGEwMjUxZTJiYzNhOTNhZWRfMS00LTEtMS0w_14ae8910-a3c7-49c1-8bdf-12c431d1606d">3,997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory and manufacturing equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01205e4ce2b043afa5ff5d22df71e7af_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmE2ZDViMWQyZjc3MTQyODRhMDI1MWUyYmMzYTkzYWVkL3RhYmxlcmFuZ2U6YTZkNWIxZDJmNzcxNDI4NGEwMjUxZTJiYzNhOTNhZWRfMi0yLTEtMS0w_3eccbe54-adde-4566-9a97-89a1b81aac11">18,988</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91971e3a302e4ce4a2fa240ccce4fd9f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmE2ZDViMWQyZjc3MTQyODRhMDI1MWUyYmMzYTkzYWVkL3RhYmxlcmFuZ2U6YTZkNWIxZDJmNzcxNDI4NGEwMjUxZTJiYzNhOTNhZWRfMi00LTEtMS0w_1d40371e-9ce2-42a2-b46c-77aca8fa5f61">19,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b83a6bdbb5d4e1b9fb3f33d02641612_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmE2ZDViMWQyZjc3MTQyODRhMDI1MWUyYmMzYTkzYWVkL3RhYmxlcmFuZ2U6YTZkNWIxZDJmNzcxNDI4NGEwMjUxZTJiYzNhOTNhZWRfMy0yLTEtMS0w_37c2e06d-898b-4138-9448-21ff3b310010">8,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i419524240cb046929a4263a9eb516164_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmE2ZDViMWQyZjc3MTQyODRhMDI1MWUyYmMzYTkzYWVkL3RhYmxlcmFuZ2U6YTZkNWIxZDJmNzcxNDI4NGEwMjUxZTJiYzNhOTNhZWRfMy00LTEtMS0w_47c92522-c9d3-4433-88c1-74e20ef9cb93">7,788</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib48332e9db7f4b1cae5ea5950a5b520a_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmE2ZDViMWQyZjc3MTQyODRhMDI1MWUyYmMzYTkzYWVkL3RhYmxlcmFuZ2U6YTZkNWIxZDJmNzcxNDI4NGEwMjUxZTJiYzNhOTNhZWRfNC0yLTEtMS0w_af228f05-fc22-47d5-8b60-fca2ca230d5a">2,211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0266b792ecf4882bcc51181909743f4_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmE2ZDViMWQyZjc3MTQyODRhMDI1MWUyYmMzYTkzYWVkL3RhYmxlcmFuZ2U6YTZkNWIxZDJmNzcxNDI4NGEwMjUxZTJiYzNhOTNhZWRfNC00LTEtMS0w_d4633351-9eeb-40ec-8028-949101bb679f">1,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmE2ZDViMWQyZjc3MTQyODRhMDI1MWUyYmMzYTkzYWVkL3RhYmxlcmFuZ2U6YTZkNWIxZDJmNzcxNDI4NGEwMjUxZTJiYzNhOTNhZWRfNS0yLTEtMS0w_42ee16e0-0906-4367-b671-4f8b333adfc6">33,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmE2ZDViMWQyZjc3MTQyODRhMDI1MWUyYmMzYTkzYWVkL3RhYmxlcmFuZ2U6YTZkNWIxZDJmNzcxNDI4NGEwMjUxZTJiYzNhOTNhZWRfNS00LTEtMS0w_699b889e-fbeb-4fea-a67b-3db4750e7280">32,934</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmE2ZDViMWQyZjc3MTQyODRhMDI1MWUyYmMzYTkzYWVkL3RhYmxlcmFuZ2U6YTZkNWIxZDJmNzcxNDI4NGEwMjUxZTJiYzNhOTNhZWRfNi0yLTEtMS0w_16652c19-5977-416b-9395-93cb75b2b0ee">26,262</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmE2ZDViMWQyZjc3MTQyODRhMDI1MWUyYmMzYTkzYWVkL3RhYmxlcmFuZ2U6YTZkNWIxZDJmNzcxNDI4NGEwMjUxZTJiYzNhOTNhZWRfNi00LTEtMS0w_2b768a2f-23fc-44d3-bfbd-6d86382182bb">24,954</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction-in-progress</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" name="us-gaap:ConstructionInProgressGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmE2ZDViMWQyZjc3MTQyODRhMDI1MWUyYmMzYTkzYWVkL3RhYmxlcmFuZ2U6YTZkNWIxZDJmNzcxNDI4NGEwMjUxZTJiYzNhOTNhZWRfNy0yLTEtMS0w_8e172422-aa94-47d1-99c6-ebdcf814fc8d">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" name="us-gaap:ConstructionInProgressGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmE2ZDViMWQyZjc3MTQyODRhMDI1MWUyYmMzYTkzYWVkL3RhYmxlcmFuZ2U6YTZkNWIxZDJmNzcxNDI4NGEwMjUxZTJiYzNhOTNhZWRfNy00LTEtMS0w_3942e8b4-4a7a-41d3-837c-45b4414c9c25">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmE2ZDViMWQyZjc3MTQyODRhMDI1MWUyYmMzYTkzYWVkL3RhYmxlcmFuZ2U6YTZkNWIxZDJmNzcxNDI4NGEwMjUxZTJiYzNhOTNhZWRfOC0yLTEtMS0w_8e5b000f-30cd-4ed3-b4a4-52107f43ee65">7,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmE2ZDViMWQyZjc3MTQyODRhMDI1MWUyYmMzYTkzYWVkL3RhYmxlcmFuZ2U6YTZkNWIxZDJmNzcxNDI4NGEwMjUxZTJiYzNhOTNhZWRfOC00LTEtMS0w_e1a90b4d-4000-4952-bb00-b7c3f606813b">8,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Warranties</span></div><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RleHRyZWdpb246ZjExYjc3MTg4NWFiNDZjZWE4ZWE4YTVlNTVhNGY1NmRfNzcy_32ec292b-84cc-4fb6-9180-6cca992a9b90" escape="true"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity for our warranty accrual for the nine months ended September&#160;30, 2020&#160;and 2019, which is included in other accrued liabilities, is summarized below (in thousands): </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.329%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.973%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.976%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProductWarrantyAccrual" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOjg1ZWQ1MGFiOTQ1YTQ1NTZhM2E3YjE1ZmFhZTljOGRmL3RhYmxlcmFuZ2U6ODVlZDUwYWI5NDVhNDU1NmEzYTdiMTVmYWFlOWM4ZGZfMi0yLTEtMS0w_373afc4e-1df7-4fd8-abe5-0e089edc60fe">1,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f51ec45ffb24e5f9fd56e8ed689edf8_I20181231" decimals="-3" name="us-gaap:ProductWarrantyAccrual" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOjg1ZWQ1MGFiOTQ1YTQ1NTZhM2E3YjE1ZmFhZTljOGRmL3RhYmxlcmFuZ2U6ODVlZDUwYWI5NDVhNDU1NmEzYTdiMTVmYWFlOWM4ZGZfMi00LTEtMS0w_650865ec-8752-4d0b-8b6f-103e41ea052c">863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrual for current period warranties</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" name="us-gaap:ProductWarrantyAccrualWarrantiesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOjg1ZWQ1MGFiOTQ1YTQ1NTZhM2E3YjE1ZmFhZTljOGRmL3RhYmxlcmFuZ2U6ODVlZDUwYWI5NDVhNDU1NmEzYTdiMTVmYWFlOWM4ZGZfMy0yLTEtMS0w_931d1298-af2b-4bf0-b948-de2850876921">677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" name="us-gaap:ProductWarrantyAccrualWarrantiesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOjg1ZWQ1MGFiOTQ1YTQ1NTZhM2E3YjE1ZmFhZTljOGRmL3RhYmxlcmFuZ2U6ODVlZDUwYWI5NDVhNDU1NmEzYTdiMTVmYWFlOWM4ZGZfMy00LTEtMS0w_06bc62a1-960f-407d-ba9c-7531f8811bab">912</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty costs incurred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" name="us-gaap:ProductWarrantyAccrualPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOjg1ZWQ1MGFiOTQ1YTQ1NTZhM2E3YjE1ZmFhZTljOGRmL3RhYmxlcmFuZ2U6ODVlZDUwYWI5NDVhNDU1NmEzYTdiMTVmYWFlOWM4ZGZfNC0yLTEtMS0w_25eb8865-8e11-4ac8-a924-85bcb3a5df1a">387</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" name="us-gaap:ProductWarrantyAccrualPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOjg1ZWQ1MGFiOTQ1YTQ1NTZhM2E3YjE1ZmFhZTljOGRmL3RhYmxlcmFuZ2U6ODVlZDUwYWI5NDVhNDU1NmEzYTdiMTVmYWFlOWM4ZGZfNC00LTEtMS0w_7ed2d209-8bc3-4040-9f05-5b29f167da0f">668</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProductWarrantyAccrual" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOjg1ZWQ1MGFiOTQ1YTQ1NTZhM2E3YjE1ZmFhZTljOGRmL3RhYmxlcmFuZ2U6ODVlZDUwYWI5NDVhNDU1NmEzYTdiMTVmYWFlOWM4ZGZfNS0yLTEtMS0w_b69176cc-5071-4716-88f9-4b84c0bb279f">1,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic00370e08713445eacc3076d8d3e2ced_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProductWarrantyAccrual" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOjg1ZWQ1MGFiOTQ1YTQ1NTZhM2E3YjE1ZmFhZTljOGRmL3RhYmxlcmFuZ2U6ODVlZDUwYWI5NDVhNDU1NmEzYTdiMTVmYWFlOWM4ZGZfNS00LTEtMS0w_16e8c16c-3ee9-4fd0-90a1-4a0b9f94715f">1,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_55"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMTEyODE_8e308591-a544-4d5d-9569-d777c3a23270" continuedAt="ie02ce45d8d60446bb44ed9919ce7ba0d" escape="true">Convertible Notes and Credit Facility</ix:nonNumeric></span></div><ix:continuation id="ie02ce45d8d60446bb44ed9919ce7ba0d" continuedAt="i9017100a09324997963016f5b82e642e"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2014 Senior Convertible Notes (2014 Notes)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2014, we closed an underwritten public offering of $<ix:nonFraction unitRef="usd" contextRef="ifa53719e19cc4a179c2e811a860e7411_I20140228" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMTUy_172134a7-ee0c-40ce-b509-816858fb7445">201.3</ix:nonFraction> million aggregate principal amount of our 2014 Notes. We received $<ix:nonFraction unitRef="usd" contextRef="i266ba35bf50e46ca809c2c0afea3c12e_D20140201-20140228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMjEz_a24e14f2-0eec-4b2a-8fc0-141f57a4f5ef">195.2</ix:nonFraction> million, net of underwriting discounts, from the issuance of the 2014 Notes and incurred approximately $<ix:nonFraction unitRef="usd" contextRef="ifa53719e19cc4a179c2e811a860e7411_I20140228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMzEx_e3d89b4d-887d-451f-b07a-23263e4bd742">1.1</ix:nonFraction> million in offering-related expenses. The underwriting discount and offering-related expenses are being amortized to interest expense using the effective-interest rate method. The effective interest rate on the 2014 Notes, reflecting the impact of debt discounts and issuance costs, is <ix:nonFraction unitRef="number" contextRef="ifa53719e19cc4a179c2e811a860e7411_I20140228" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNzAw_87a1747f-c073-4b21-a8e7-1743f273c632">3.0</ix:nonFraction>%. The 2014 Notes will mature on February 1, 2034, unless earlier converted, redeemed, or repurchased in accordance with the terms of the 2014 Notes. We have retired the majority of the 2014 Notes through the issuance of the 2018 Notes and 2019 Notes, as discussed below. As of September&#160;30, 2020, there is $<ix:nonFraction unitRef="usd" contextRef="i901752533bd34a9a91d8a9858d1558a3_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfOTky_20f50b11-c49a-496b-bc0e-54cceea53efd">1.1</ix:nonFraction> million aggregate principal of the 2014 Notes outstanding. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2018 Senior Convertible Notes (2018 Notes)</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2018, we entered into separate privately negotiated transactions with certain holders of our 2014 Notes to exchange $<ix:nonFraction unitRef="usd" contextRef="i426efa56430840c1b19eac7bd8d458cc_I20180331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMTIxNQ_a2a0dac7-9efd-445e-a97f-3a1d65b200d8">150.0</ix:nonFraction> million in aggregate principal amount of the 2014 Notes for 2018 Notes, leaving $<ix:nonFraction unitRef="usd" contextRef="i7cf57a0407f34c83945d84ded692dd5e_I20180331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMTI5MA_8383a9c6-b5ae-4743-8036-92441b42d329">51.3</ix:nonFraction> million of the aggregate principal amount of the 2014 Notes outstanding. As of the closing of the 2018 Notes on March 12, 2018, the estimated fair value was $<ix:nonFraction unitRef="usd" contextRef="i70f4e685daae494d9cca4f8a847b35fe_I20180312" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMTQzOA_59a1d512-78e5-4297-9983-3a38857b1cef">145.5</ix:nonFraction> million. The difference between the $<ix:nonFraction unitRef="usd" contextRef="i426efa56430840c1b19eac7bd8d458cc_I20180331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMTQ2OQ_2e732fb7-1cdd-409b-9ffc-5fab999705df">150.0</ix:nonFraction> million aggregate principal amount of the 2018 Notes and its fair value was being amortized over the expected term of the 2018 Notes using the effective interest method through the first note holder put date of February 6, 2023. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Notes accrued interest at a rate of <ix:nonFraction unitRef="number" contextRef="i7cf57a0407f34c83945d84ded692dd5e_I20180331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMTczOQ_e3dcd174-8958-4e31-8dbf-341cbcf78f12">2.75</ix:nonFraction>% payable semi-annually in arrears on February 1 and August 1 of each year. The 2018 Notes were set to mature on February 1, 2034, unless earlier converted, redeemed, or repurchased in accordance with the terms of the indenture governing the 2018 Notes. The initial conversion rate of the 2018 Notes was 126.9438 shares of our common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i426efa56430840c1b19eac7bd8d458cc_I20180331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMjA4NQ_7eceb47d-bc9d-4470-8b11-e793106b7d62">0.001</ix:nonFraction> per share, per $1,000 principal amount of the 2018 Notes (which is equivalent to an initial conversion price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="i426efa56430840c1b19eac7bd8d458cc_I20180331" decimals="2" name="fldm:InitialConversionPriceOfStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMjIxNA_e9763867-93b4-4e10-9869-46cd3275a46b">7.88</ix:nonFraction> per share). The conversion rate was subject to adjustment upon the occurrence of certain specified events. Those certain specified events included holders who converted their 2018 Notes voluntarily prior to our exercise of the issuer&#8217;s conversion option described below or in connection with a make-whole fundamental change prior to February 6, 2023, entitling the holders, under certain circumstances, to a make-whole premium in the form of an increase in the conversion rate determined by reference to a make-whole table set forth in the indenture governing the 2018 Notes. Any time </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i9017100a09324997963016f5b82e642e" continuedAt="i71fa887554ac4df3989ca66d3b562d8a"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prior to the maturity of the 2018 Notes, we could convert the 2018 Notes, in whole but not in part, into cash, shares of our common stock, or combination thereof, if the closing price of our common stock equaled or exceeded <ix:nonFraction unitRef="number" contextRef="i153e522b034a4cdcbce58b6ee2e543f6_D20180301-20180331" decimals="INF" name="fldm:DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMzAyNg_2e8c477a-5262-44e9-87ba-287f9f0bffb9">110</ix:nonFraction>% of the conversion price then in effect for a specified number of days. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Offering-related costs for the 2018 Notes were approximately $<ix:nonFraction unitRef="usd" contextRef="i426efa56430840c1b19eac7bd8d458cc_I20180331" decimals="-5" format="ixt:numdotdecimal" name="fldm:DebtAndEquityOfferingCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMzE2Mg_efb72f7a-eba5-4a90-98e8-50a2cb5e1ae8">2.8</ix:nonFraction> million. Offering-related costs of $<ix:nonFraction unitRef="usd" contextRef="i426efa56430840c1b19eac7bd8d458cc_I20180331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMzE5Mg_c4f898fb-7d3c-4721-a5ac-3222977386f8">2.2</ix:nonFraction> million were capitalized as debt issuance costs, recorded as an offset to the carrying value of the 2018 Notes, and were being amortized over the expected term of the 2018 Notes using the effective interest method through the first note holder put date of February 6, 2023. The effective interest rate on the 2018 Notes was <ix:nonFraction unitRef="number" contextRef="i426efa56430840c1b19eac7bd8d458cc_I20180331" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMzUxMQ_08c92323-da06-450a-b1b3-2d656e7c5dff">12.3</ix:nonFraction>%. Offering-related costs of $<ix:nonFraction unitRef="usd" contextRef="i153e522b034a4cdcbce58b6ee2e543f6_D20180301-20180331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMzU0MQ_0ed3fef7-50cb-49b0-9076-0c7d447cf724">0.6</ix:nonFraction> million were accounted for as equity issuance costs, recorded as an offset to additional paid-in capital, and were not subject to amortization. Offering-related costs were allocated between debt and equity in the same proportion as the allocation of the 2018 Notes between debt and equity. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2019, we received notices from holders of the 2018 Notes electing to voluntarily convert approximately $<ix:nonFraction unitRef="usd" contextRef="i4e7aaefc048a42149aea7d5215e3344e_I20190331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMzk1NA_5038ea3e-9ac5-4e14-865c-17e845e5b582">138.1</ix:nonFraction> million in aggregate principal amount of the 2018 Notes. In February 2019, we notified the trustee, U.S. Bank National Association, of our intention to exercise our issuer&#8217;s conversion option with respect to the remaining approximately $<ix:nonFraction unitRef="usd" contextRef="i2cad803f6a554d6c9a8a592ef9a317bb_I20190228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNDE4NQ_d5cc216a-1306-4763-ae5c-423ea51c43b4">11.9</ix:nonFraction> million in aggregate principal amount of the 2018 Notes. In total, $<ix:nonFraction unitRef="usd" contextRef="ib5cf93a475bc40c383848b0c6ddce383_I20190228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNDI0Mw_bc4bbdbb-2932-46ef-baac-5c09ce0c32d6">150.0</ix:nonFraction> million of the 2018 Notes were converted into <ix:nonFraction unitRef="shares" contextRef="i9568f571b19e40a9ae266303330ceee6_D20190101-20190331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNDI4NA_beebafdb-abfb-47cb-bcfc-040cc8f93c53">19.5</ix:nonFraction> million shares of our common stock and the bonds were retired. We recognized a loss of $<ix:nonFraction unitRef="usd" contextRef="icd70bc4d28f3483ba710eda050328360_D20190101-20190331" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNDM2Ng_96a0efa2-9059-48e0-bee0-26ec1710ab18">9.0</ix:nonFraction> million on the retirement of the 2018 Notes, which represented the difference between the fair value of the bonds retired and their carrying costs. The net impact on equity was $<ix:nonFraction unitRef="usd" contextRef="i5c04b2fe57fb44e19f764085727f7dfc_D20190101-20190331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNDUzOA_3fc16d2f-046a-417c-9149-49534fe18203">133.3</ix:nonFraction> million and represented the fair value of the bonds retired.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2019 Senior Convertible Notes (2019 Notes)</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, we issued $<ix:nonFraction unitRef="usd" contextRef="i9b34d835daa64fc59dd63f13ee337947_I20191130" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNDY2NQ_80fb45b7-8b14-4ae3-ac5d-01a00d826e69">55.0</ix:nonFraction> million aggregate principal amount of 2019 Notes. Net proceeds of the offering of the 2019 Notes issuance were $<ix:nonFraction unitRef="usd" contextRef="i48e1ed537f2e4db1b0713b2e240b93fb_D20191101-20191130" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNDc3MQ_0d52a3ed-8c0f-4b35-99a9-4a68d5b1279a">52.7</ix:nonFraction> million, after deductions for commissions and other debt issuance costs of approximately $<ix:nonFraction unitRef="usd" contextRef="i9b34d835daa64fc59dd63f13ee337947_I20191130" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNDg1NQ_f1488900-0979-403c-976f-2548ad90a35c">2.3</ix:nonFraction> million. $<ix:nonFraction unitRef="usd" contextRef="ic24a6649e6b74cc5ac3591a7f4087baa_D20191101-20191130" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNDg1OQ_fd21374e-425b-48a0-9dda-006c0701bfd6">51.8</ix:nonFraction> million of the proceeds of the 2019 Notes were used to retire $<ix:nonFraction unitRef="usd" contextRef="i48e1ed537f2e4db1b0713b2e240b93fb_D20191101-20191130" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNDkxNg_d4c22c19-fd3b-4c04-9c9b-4e853fca23b2">50.2</ix:nonFraction> million aggregate principal amount of our 2014 Notes, leaving $<ix:nonFraction unitRef="usd" contextRef="i901752533bd34a9a91d8a9858d1558a3_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNDk3Mw_20f50b11-c49a-496b-bc0e-54cceea53efd">1.1</ix:nonFraction> million of aggregate principal value of  2014 Notes outstanding. We accounted for the transaction as an extinguishment of debt due to the significance of the change in value of the embedded conversion option, resulting in a $<ix:nonFraction unitRef="usd" contextRef="i283104e8693b4a0798cde8043a32a819_D20191001-20191231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNTE5MQ_15e64182-9ed4-4b77-a027-0e0f4ac2e93d">3.0</ix:nonFraction> million loss in the fourth quarter of 2019. The loss on extinguishment of debt was calculated as the difference between the reacquisition price (i.e., the fair value of the principal amount of 2019 Notes) and the net carrying value of the 2014 Notes exchanged. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2019 Notes bear interest at <ix:nonFraction unitRef="number" contextRef="i9b34d835daa64fc59dd63f13ee337947_I20191130" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNTQ4MA_3f5ab17b-7654-41ee-8e7d-40e3f2dd60fd">5.25</ix:nonFraction>% per annum, payable semiannually in arrears on June 1 and December 1 of each year, beginning on June 1, 2020. The Notes will mature on December 1, 2024, unless earlier repurchased or converted pursuant to their terms. The 2019 Notes will be convertible at the option of the holder at any point prior to the close of business on the second scheduled trading day preceding the maturity date. The initial conversion rate of the Notes is 344.8276 shares of the Company&#8217;s common stock per $1,000 principal amount of 2019 Notes (which is equivalent to an initial conversion price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="i52d079e3857749d3ae194474f9fd3966_I20191130" decimals="2" name="fldm:InitialConversionPriceOfStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNjA2Nw_870be699-172e-4034-bd95-d2bbd159328c">2.90</ix:nonFraction> per share). The conversion rate is subject to adjustment upon the occurrence of certain specified events. Those certain specified events include voluntary conversion of the 2019 Notes prior to our exercise of the Issuer&#8217;s Conversion Option or in connection with a make-whole fundamental change, entitling the holders, under certain circumstances, to a make-whole premium in the form of an increase in the conversion rate determined by reference to a make-whole table set forth in the indenture governing the 2019 Notes. The conversion rate will not be adjusted for any accrued and unpaid interest. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2019 Notes will also be convertible at our option upon certain conditions in accordance with the terms of the indenture governing the 2019 Notes. On or after December 1, 2021 to December 1, 2022, if the price of the Company&#8217;s common stock has equaled or exceeded <ix:nonFraction unitRef="number" contextRef="i929bb4c9acdd42b2a23fb169207c1a68_D20191101-20191130" decimals="INF" name="fldm:DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNjkzNg_2d16f8a7-829a-4169-8a2d-c252e9388c06">150</ix:nonFraction>% of the conversion price then in effect for a specified number of days (Issuer&#8217;s Conversion Option), we may, at our option, elect to convert the 2019 Notes in whole but not in part into shares of the Company, determined in accordance with the terms of the indenture. On or after December 1, 2022, if the price of the Company&#8217;s common stock has equaled or exceeded <ix:nonFraction unitRef="number" contextRef="i9bc0b6e687014f408106f0f70ddbb047_D20191101-20191130" decimals="INF" name="fldm:DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNzMwMg_c4e2237c-cd20-4cfb-bc5a-8d9377ecd91e">130</ix:nonFraction>% of the conversion price then in effect for a specified number of days, we may, at our option, elect to convert the 2019 Notes in whole but not in part into shares of the Company, determined in accordance with the terms of the indenture. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Offering-related costs for the 2019 Notes were capitalized as debt issuance costs and are recorded as an offset to the carrying value of the 2019 Notes. The debt issuance costs are being amortized over the expected term of the 2019 Notes using the effective interest method through the maturity date of December 1, 2024. The effective interest rate on the 2019 Notes is <ix:nonFraction unitRef="number" contextRef="i9b34d835daa64fc59dd63f13ee337947_I20191130" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNzkxMw_53b5ec91-5963-494e-a285-04e2a2022d51">6.2</ix:nonFraction>%.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i71fa887554ac4df3989ca66d3b562d8a"><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMTEyODQ_053a85e4-e954-4b49-a45e-b3c46b18704f" continuedAt="i568a7aeab74e4b99b774dd496e230b9a" escape="true"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of the components of the 2014 Notes and the 2019 Notes are as follows (in thousands): </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.329%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.973%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.976%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;<ix:nonFraction unitRef="number" contextRef="i7cf57a0407f34c83945d84ded692dd5e_I20180331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfMi0wLTEtMS0wL3RleHRyZWdpb246ZjQ0N2I1NmIwMGRmNGU0MDlhNTAwM2M0MTk4Zjk3ZWFfNw_e3dcd174-8958-4e31-8dbf-341cbcf78f12">2.75</ix:nonFraction>% 2014 Notes due 2034   </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i901752533bd34a9a91d8a9858d1558a3_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfMy0yLTEtMS0w_d9022a40-f322-49b1-8637-195437a7c766">1,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0880c31bdb2349949c55fad2b57d1d5c_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfMy00LTEtMS0w_76f08312-750f-411d-9b7f-3236e58559c4">1,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt discount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i901752533bd34a9a91d8a9858d1558a3_I20200930" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfNC0yLTEtMS0w_2b16bfea-efae-4606-b7a0-1a81dede3386">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0880c31bdb2349949c55fad2b57d1d5c_I20191231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfNC00LTEtMS0w_816d47e3-e434-429e-90bb-8de320ed079d">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i901752533bd34a9a91d8a9858d1558a3_I20200930" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfNS0yLTEtMS0w_c84d0cda-01c8-4413-b843-67b35c792d72">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0880c31bdb2349949c55fad2b57d1d5c_I20191231" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfNS00LTEtMS0w_950298fb-844f-43b7-8d48-cd5317970bcc">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i901752533bd34a9a91d8a9858d1558a3_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfNi0yLTEtMS0w_e6abad12-593e-438f-991f-951d0937c7c8">1,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0880c31bdb2349949c55fad2b57d1d5c_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfNi00LTEtMS0w_1fe08753-c31a-47df-98bc-bf563e33e7c9">1,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;<ix:nonFraction unitRef="number" contextRef="i9b34d835daa64fc59dd63f13ee337947_I20191130" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfMTQtMC0xLTEtMC90ZXh0cmVnaW9uOmY3YjQ1MDM2YmI0MzRiYTI4OWI4MmE4ZmYxZDAxN2EzXzg_3f5ab17b-7654-41ee-8e7d-40e3f2dd60fd">5.25</ix:nonFraction>% 2019 Notes due 2024</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id881c17013fa4c2ba5f1f0618b5dcb03_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfMTUtMi0xLTEtMA_be6d7d54-000e-40f0-99f3-087e1602c43f">55,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6106e4be78de4e3d82d9ce346c18dd6d_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfMTUtNC0xLTEtMA_868b3239-81fa-45cf-ac8d-99770bf6e979">55,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id881c17013fa4c2ba5f1f0618b5dcb03_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfMTgtMi0xLTEtMA_1c8403b7-3f41-4b4c-b80a-7212ccb793fd">1,937</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6106e4be78de4e3d82d9ce346c18dd6d_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfMTgtNC0xLTEtMA_f35dfcab-cd52-415a-a1ac-e9e32c009dea">2,236</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id881c17013fa4c2ba5f1f0618b5dcb03_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfMTktMi0xLTEtMA_6ed7c8c1-2b76-4c3f-b5b6-d22c57a363d4">53,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6106e4be78de4e3d82d9ce346c18dd6d_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfMTktNC0xLTEtMA_5afcbb73-e98c-4e9c-a15a-2e4e21233b69">52,764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Net carrying value of all Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c17219e8d044f0c861d706caf153722_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfMjAtMi0xLTEtMA_8028ea3b-c8ca-4a3d-954e-75a930f1d334">54,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c6c4c342964442b8318f2e869e57561_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfMjAtNC0xLTEtMA_9ea054aa-1ffc-45a6-95c7-fcde5c422e89">53,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2018 Revolving Credit Facility </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, we entered into a revolving credit facility with Silicon Valley Bank (as amended, the Revolving Credit Facility) in an aggregate principal amount of up to the lesser of (i) $<ix:nonFraction unitRef="usd" contextRef="i989719e68b6f4b5e9cfa93a8c07dd96e_I20180831" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfODI0OA_a8fcd218-9015-42bb-aeac-4d28b61f0831">15.0</ix:nonFraction> million (Maximum Amount) or (ii) the sum of (a) <ix:nonFraction unitRef="number" contextRef="i17eada3644a34f059d1bcbfd779f95b7_D20180801-20180831" decimals="INF" name="fldm:LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfODI5MQ_cd9aad2a-20ae-4300-8f99-fff83db03a13">85</ix:nonFraction>% of our eligible receivables and (b) <ix:nonFraction unitRef="number" contextRef="i17eada3644a34f059d1bcbfd779f95b7_D20180801-20180831" decimals="INF" name="fldm:LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfODMzMA_5820f24c-be9c-420e-af57-952f2df15c3b">50</ix:nonFraction>% of our eligible inventory, in each case, subject to certain limitations (Borrowing Base), provided that the amount of eligible inventory that may be counted towards the Borrowing Base shall be subject to a cap as set forth in the Revolving Credit Facility. Subject to the level of this Borrowing Base, we may make and repay borrowings from time to time until the maturity of the Revolving Credit Facility. The Borrowing Base as of September&#160;30, 2020 under the Revolving Credit Facility was $<ix:nonFraction unitRef="usd" contextRef="i1bdc25d355644c6f9172d331aa5efd27_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfODgwNw_9573cd09-a75d-45b0-9520-a69f09182d75">15.0</ix:nonFraction> million. There were <ix:nonFraction unitRef="usd" contextRef="i1bdc25d355644c6f9172d331aa5efd27_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LineOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfODgyMg_b2c07d85-3152-4efd-9be6-a960a6b59328">no</ix:nonFraction> borrowings outstanding under the Revolving Credit Facility at September&#160;30, 2020.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Credit Facility is collateralized by substantially all our property, other than intellectual property. Until an amendment in April 2020, the Revolving Credit Facility was set to mature on August 2, 2020. The interest rate on outstanding loans under the Revolving Credit Facility was the greater of (i) prime rate plus <ix:nonFraction unitRef="number" contextRef="i53d97ec6192a48d09c54804db8566219_D20180801-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfOTIyMw_4a7c12c0-f4b1-4757-a753-50a69ea135b7">0.50</ix:nonFraction>% or (ii) <ix:nonFraction unitRef="number" contextRef="iafb598ed96e949659e7f73e00e9c6bbb_D20180801-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfOTIzNA_cf2762ea-5401-4453-99d3-40e99207e68b">5.50</ix:nonFraction>%. Interest on any outstanding loans is due and payable monthly and the principal balance is due at maturity, though loans can be prepaid at any time without penalty. Effective April 21, 2020, the Revolving Credit Facility was amended to extend the maturity date to August 2, 2022. In addition, the interest rate on outstanding loans under the Revolving Credit Facility was reduced by <ix:nonFraction unitRef="number" contextRef="i3876be73e4a0486f968bd16f58652b42_D20200421-20200421" decimals="INF" name="fldm:DebtInstrumentEarlyRedemptionCostPercentOfMaximumBorrowingCapacity" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfOTc3MA_2f06a1f7-89f5-4e64-82b7-2d021a3254bf">0.25</ix:nonFraction>%. The quarterly unused line fee, which was previously based on the Maximum Amount, will now be based on the Borrowing Base. The annual commitment fee of $<ix:nonFraction unitRef="usd" contextRef="i3876be73e4a0486f968bd16f58652b42_D20200421-20200421" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityCommitmentFeeAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfOTkyNQ_2f09cb41-ec2a-4cf7-b356-20800498c87c">112,500</ix:nonFraction> is unchanged.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Credit Facility contains customary affirmative and negative covenants that, unless waived by the bank, limit our ability to, among other things, incur additional indebtedness, grant liens, make investments, repurchase stock, pay dividends, transfer assets, enter into affiliate transactions, undergo a change of control, or engage in merger and acquisition activity, including merging or consolidating with a third party. The Revolving Credit Facility also contains customary events of default, subject to customary cure periods for certain defaults, that include, among other things, non-payment defaults, covenant defaults, material judgment defaults, bankruptcy and insolvency defaults, cross-defaults to certain other material indebtedness, and defaults due to inaccuracy of representation and warranties. Upon an event of default, the lender may declare all or a portion of the outstanding obligations payable by us to be immediately due and payable and exercise other rights and remedies provided for under the Revolving Credit Facility. During the existence of an event of default, interest on the obligations under the Revolving Credit Facility could be increased to&#160;<ix:nonFraction unitRef="number" contextRef="i9ad788af389e495fbf8a9625e4693669_D20200101-20200930" decimals="INF" name="fldm:LineOfCreditFacilityPercentageOfInterestOnObligationUponDefault" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMTExMzE_a3c74cf3-5f8c-4bbd-b565-79f2f6edda5a">5.0</ix:nonFraction>% above the otherwise applicable rate of interest. We were in compliance with all the terms and conditions of the Revolving Credit Facility at September&#160;30, 2020.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_61"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RleHRyZWdpb246N2EzZWFhY2RlOTI3NDQ1M2JjYWJkY2Q0ZTc0ODBjYmNfMTA5Mw_a86e719d-0d45-4b6d-835d-cf99cca98284" continuedAt="id5bfa9770f7d412ea3c9163b27146031" escape="true">Leases</ix:nonNumeric></span></div><ix:continuation id="id5bfa9770f7d412ea3c9163b27146031" continuedAt="ia396ee46284d4e168f7ba76cc708f5ad"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have operating leases for buildings, equipment and vehicles. Existing leases have remaining terms of less than <ix:nonNumeric contextRef="iae5da18636984c8688424ae820893260_D20200101-20200930" format="ixt-sec:durwordsen" name="fldm:LesseeOperatingLeaseRemainingTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RleHRyZWdpb246N2EzZWFhY2RlOTI3NDQ1M2JjYWJkY2Q0ZTc0ODBjYmNfMTI5_cd489d5d-2941-4e30-afab-e54b43a28d8f">one year</ix:nonNumeric> to <ix:nonNumeric contextRef="i2b70060a9d624550994ac1dfff5b7ef1_D20200101-20200930" format="ixt-sec:durwordsen" name="fldm:LesseeOperatingLeaseRemainingTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RleHRyZWdpb246N2EzZWFhY2RlOTI3NDQ1M2JjYWJkY2Q0ZTc0ODBjYmNfMTM1_74637165-5a44-4aaa-88f3-29efef2e3880">ten years</ix:nonNumeric>. Some leases contain options to extend the lease, usually for up to <ix:nonNumeric contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RleHRyZWdpb246N2EzZWFhY2RlOTI3NDQ1M2JjYWJkY2Q0ZTc0ODBjYmNfMjA2_34a767fa-8d27-4a30-a8b9-e86e1505eed8">five years</ix:nonNumeric>, and termination options.</span></div><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="fldm:AssetsAndLiabilitiesLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RleHRyZWdpb246N2EzZWFhY2RlOTI3NDQ1M2JjYWJkY2Q0ZTc0ODBjYmNfMTA5NQ_bb6a0c9e-3587-42e1-a261-1ed3c7bd3329" escape="true"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows as of September&#160;30, 2020 and December&#160;31, 2019 (in thousands, except for discount rate and lease term):</span></div><div style="margin-bottom:5pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use buildings</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i151e8307ce6242f184098e1f36b5547f_I20200930" decimals="-3" format="ixt:numdotdecimal" name="fldm:OperatingLeaseRightOfUseAssetGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfMS0yLTEtMS0w_da7782bb-4b84-4aa2-b675-3407a645c128">40,723</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38ab737fcaf84f2aa05da79a61e26690_I20191231" decimals="-3" format="ixt:numdotdecimal" name="fldm:OperatingLeaseRightOfUseAssetGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfMS00LTEtMS0w_cf8171cc-5316-4ccd-9c6b-555cade1ecf5">6,234</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use equipment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6737de729bd64f70bd4ad7bbc31e49bd_I20200930" decimals="-3" name="fldm:OperatingLeaseRightOfUseAssetGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfMi0yLTEtMS0w_0b530d63-bc91-45d0-a41b-0f3c337c38b9">86</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcdd71a5639445c98dc5fca10293c9ee_I20191231" decimals="-3" name="fldm:OperatingLeaseRightOfUseAssetGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfMi00LTEtMS0w_e36af2be-1ab6-4687-bf9a-42c55724a0b2">69</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use vehicles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18a8db5c42483eb2fc3227bf81e1bc_I20200930" decimals="-3" name="fldm:OperatingLeaseRightOfUseAssetGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfMy0yLTEtMS0w_88f28404-a1e9-4b37-9233-54f639efd22b">583</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i280bb003acb74672b814ebca8eb8d86c_I20191231" decimals="-3" name="fldm:OperatingLeaseRightOfUseAssetGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfMy00LTEtMS0w_40f45cfc-4e50-437b-b802-835f4cb3fd54">355</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease right-of-use assets, gross</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="fldm:OperatingLeaseRightOfUseAssetGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfNC0yLTEtMS0w_f0b5d268-0d7b-4fa7-b6cc-8bf061adcc5a">41,392</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="fldm:OperatingLeaseRightOfUseAssetGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfNC00LTEtMS0w_6b511c68-7023-4632-b053-b804e394b84f">6,658</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="fldm:OperatingLeaseRightOfUseAssetAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfNS0yLTEtMS0w_b325255b-c7ed-4865-8f18-9783112136ab">2,923</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="fldm:OperatingLeaseRightOfUseAssetAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfNS00LTEtMS0w_98ff5be2-1b43-40e9-9a9d-f819deb2f96c">1,798</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease right-of-use assets, net</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfNi0yLTEtMS0w_5faf5c50-7fc2-4e2b-9d88-9b6de5081213">38,469</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfNi00LTEtMS0w_3d41e90f-bc91-4ca6-966b-fdb57307e9f4">4,860</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfOC0yLTEtMS0w_a5ada6f6-d80b-408c-a328-5cd7680959c9">2,697</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfOC00LTEtMS0w_304b78a7-2278-4e46-989e-90daf8190281">1,833</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, non-current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfOS0yLTEtMS0w_053f5d0d-f36a-4bd0-b547-1617935f02e6">38,607</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfOS00LTEtMS0w_1a2c9fdc-5380-4f58-aa7a-d1bf0a883b18">4,323</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfMTAtMi0xLTEtMA_2b9af410-4da2-4c26-89e4-82891c9c5d95">41,304</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfMTAtNC0xLTEtMA_475f3a6f-4a03-4782-bf4b-f02cba091af6">6,156</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfMTItMi0xLTEtMA_49190cd1-699a-415d-a7a7-e7f5508e428d">8.9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfMTItNC0xLTEtMA_0b944d40-10cc-4c31-9168-44d39a2afaca">4.7</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate per annum</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfMTMtMi0xLTEtMA_8d94ff77-0c39-4fc8-9b57-d583dcf07870">11.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfMTMtNC0xLTEtMA_dc7f6d4c-4d0e-44b2-b5cb-d77d8831efb4">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A new operating lease for our corporate headquarters in South San Francisco, California commenced in March 2020.  We recorded a ROU asset of $<ix:nonFraction unitRef="usd" contextRef="i6162a93a7603404baafc5676dff7d019_I20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RleHRyZWdpb246N2EzZWFhY2RlOTI3NDQ1M2JjYWJkY2Q0ZTc0ODBjYmNfNTIz_a34335f1-7931-4815-9a5c-5a18bc825ef2">35.7</ix:nonFraction> million at the inception of the lease and an operating lease liability of $<ix:nonFraction unitRef="usd" contextRef="i6162a93a7603404baafc5676dff7d019_I20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RleHRyZWdpb246N2EzZWFhY2RlOTI3NDQ1M2JjYWJkY2Q0ZTc0ODBjYmNfNTky_7294495c-ff2a-443e-8a72-901905da64ef">35.3</ix:nonFraction> million. The lease term is approximately <ix:nonNumeric contextRef="i6162a93a7603404baafc5676dff7d019_I20200331" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RleHRyZWdpb246N2EzZWFhY2RlOTI3NDQ1M2JjYWJkY2Q0ZTc0ODBjYmNfNjI4_1540f724-9f01-4f08-9d3b-e8c9d86fc776">ten years</ix:nonNumeric>. Future minimum lease payments over the life of the lease were discounted at a rate of <ix:nonFraction unitRef="number" contextRef="i6162a93a7603404baafc5676dff7d019_I20200331" decimals="3" name="us-gaap:LesseeOperatingLeaseDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RleHRyZWdpb246N2EzZWFhY2RlOTI3NDQ1M2JjYWJkY2Q0ZTc0ODBjYmNfNzE4_03f16a85-6318-4ed3-80b1-e49d79e6f09d">12.6</ix:nonFraction>%, which was our estimated incremental collateralized borrowing rate for the term of the lease at the inception of the lease. </span></div><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RleHRyZWdpb246N2EzZWFhY2RlOTI3NDQ1M2JjYWJkY2Q0ZTc0ODBjYmNfMTA4OQ_b35f932c-4fa7-4e9b-abd3-f61c74c2298e" escape="true"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of lease expense for the three and nine months ended September&#160;30, 2020 and 2019, respectively (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost (including variable costs)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjEzYzljMDdlNjJiZTRiNmFhMmVkZmNlMGUxYmI3NjUyL3RhYmxlcmFuZ2U6MTNjOWMwN2U2MmJlNGI2YWEyZWRmY2UwZTFiYjc2NTJfMi0yLTEtMS0w_960ebed8-9770-4fa9-a491-42b4f137de0e">2,501</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjEzYzljMDdlNjJiZTRiNmFhMmVkZmNlMGUxYmI3NjUyL3RhYmxlcmFuZ2U6MTNjOWMwN2U2MmJlNGI2YWEyZWRmY2UwZTFiYjc2NTJfMi00LTEtMS0w_c5bebcb6-de7c-40c9-8110-c35eec5f24af">1,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjEzYzljMDdlNjJiZTRiNmFhMmVkZmNlMGUxYmI3NjUyL3RhYmxlcmFuZ2U6MTNjOWMwN2U2MmJlNGI2YWEyZWRmY2UwZTFiYjc2NTJfMi02LTEtMS0w_8699d84e-0ac8-4e66-8c4f-e2a00ff5e8b2">7,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjEzYzljMDdlNjJiZTRiNmFhMmVkZmNlMGUxYmI3NjUyL3RhYmxlcmFuZ2U6MTNjOWMwN2U2MmJlNGI2YWEyZWRmY2UwZTFiYjc2NTJfMi04LTEtMS0w_5b18952a-13ff-4b2d-be17-03989e5d2d2b">4,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable costs including non-lease component</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjEzYzljMDdlNjJiZTRiNmFhMmVkZmNlMGUxYmI3NjUyL3RhYmxlcmFuZ2U6MTNjOWMwN2U2MmJlNGI2YWEyZWRmY2UwZTFiYjc2NTJfMy0yLTEtMS0w_f802bb12-42f7-4f3b-8133-1f9d5ab7e36d">407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjEzYzljMDdlNjJiZTRiNmFhMmVkZmNlMGUxYmI3NjUyL3RhYmxlcmFuZ2U6MTNjOWMwN2U2MmJlNGI2YWEyZWRmY2UwZTFiYjc2NTJfMy00LTEtMS0w_2a14fd73-f7db-4354-9783-a408ed6aa824">748</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjEzYzljMDdlNjJiZTRiNmFhMmVkZmNlMGUxYmI3NjUyL3RhYmxlcmFuZ2U6MTNjOWMwN2U2MmJlNGI2YWEyZWRmY2UwZTFiYjc2NTJfMy02LTEtMS0w_fefd02bb-b124-4f91-80a9-723463c4e724">1,576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjEzYzljMDdlNjJiZTRiNmFhMmVkZmNlMGUxYmI3NjUyL3RhYmxlcmFuZ2U6MTNjOWMwN2U2MmJlNGI2YWEyZWRmY2UwZTFiYjc2NTJfMy04LTEtMS0w_736b5e92-148d-4c23-9583-e5eab08e00aa">2,051</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental Cash Flow Information:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of operating lease liabilities (included in net cash used in operating activities in thousands):</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 0.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjEzYzljMDdlNjJiZTRiNmFhMmVkZmNlMGUxYmI3NjUyL3RhYmxlcmFuZ2U6MTNjOWMwN2U2MmJlNGI2YWEyZWRmY2UwZTFiYjc2NTJfOS02LTEtMS0w_d5af868d-d2f3-4346-bee3-fd12ce027289">3,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjEzYzljMDdlNjJiZTRiNmFhMmVkZmNlMGUxYmI3NjUyL3RhYmxlcmFuZ2U6MTNjOWMwN2U2MmJlNGI2YWEyZWRmY2UwZTFiYjc2NTJfOS04LTEtMS0w_5375020c-68ec-4716-99a5-6f04424518a0">3,068</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia396ee46284d4e168f7ba76cc708f5ad"><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RleHRyZWdpb246N2EzZWFhY2RlOTI3NDQ1M2JjYWJkY2Q0ZTc0ODBjYmNfMTA5Mg_12caee32-acde-41ea-bb40-14e9e374cd1b" escape="true"><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under commenced non-cancelable operating leases, which are as of September&#160;30, 2020 as follows (in thousands): </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.328%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Minimum Lease Payments for Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 (remainder of year)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjZiNDQyZmIxYjExMDQyYWE5N2E3MDBkZDhlNWM3MTkwL3RhYmxlcmFuZ2U6NmI0NDJmYjFiMTEwNDJhYTk3YTcwMGRkOGU1YzcxOTBfMS0yLTEtMS0w_d5dc74e6-a746-464a-9432-7efc038ff6d8">1,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjZiNDQyZmIxYjExMDQyYWE5N2E3MDBkZDhlNWM3MTkwL3RhYmxlcmFuZ2U6NmI0NDJmYjFiMTEwNDJhYTk3YTcwMGRkOGU1YzcxOTBfMi0yLTEtMS0w_20e21bd3-b28b-4721-b696-f1de7511e450">7,362</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjZiNDQyZmIxYjExMDQyYWE5N2E3MDBkZDhlNWM3MTkwL3RhYmxlcmFuZ2U6NmI0NDJmYjFiMTEwNDJhYTk3YTcwMGRkOGU1YzcxOTBfMy0yLTEtMS0w_9c8fd3ab-99f9-4f0c-bcc7-4b3109c8816f">7,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjZiNDQyZmIxYjExMDQyYWE5N2E3MDBkZDhlNWM3MTkwL3RhYmxlcmFuZ2U6NmI0NDJmYjFiMTEwNDJhYTk3YTcwMGRkOGU1YzcxOTBfNC0yLTEtMS0w_e8720a90-a808-4a75-90f9-8c7db3ef4385">6,950</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjZiNDQyZmIxYjExMDQyYWE5N2E3MDBkZDhlNWM3MTkwL3RhYmxlcmFuZ2U6NmI0NDJmYjFiMTEwNDJhYTk3YTcwMGRkOGU1YzcxOTBfNS0yLTEtMS0w_1f15ecca-76a7-4c77-95a7-a11f0a4be4d6">7,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="fldm:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjZiNDQyZmIxYjExMDQyYWE5N2E3MDBkZDhlNWM3MTkwL3RhYmxlcmFuZ2U6NmI0NDJmYjFiMTEwNDJhYTk3YTcwMGRkOGU1YzcxOTBfNi0yLTEtMS0w_ac42d291-f308-41a3-a1f4-10954b237185">39,254</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum payments </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjZiNDQyZmIxYjExMDQyYWE5N2E3MDBkZDhlNWM3MTkwL3RhYmxlcmFuZ2U6NmI0NDJmYjFiMTEwNDJhYTk3YTcwMGRkOGU1YzcxOTBfNy0yLTEtMS0w_6650265b-049a-411a-b073-2244a82d9512">69,560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjZiNDQyZmIxYjExMDQyYWE5N2E3MDBkZDhlNWM3MTkwL3RhYmxlcmFuZ2U6NmI0NDJmYjFiMTEwNDJhYTk3YTcwMGRkOGU1YzcxOTBfOC0yLTEtMS0w_77041f9a-fb05-4a4b-bf35-b76898232fe6">28,256</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjZiNDQyZmIxYjExMDQyYWE5N2E3MDBkZDhlNWM3MTkwL3RhYmxlcmFuZ2U6NmI0NDJmYjFiMTEwNDJhYTk3YTcwMGRkOGU1YzcxOTBfOS0yLTEtMS0w_d76f649d-ca3f-4dbb-a373-073c8702ef5f">41,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:18pt;text-align:center"><span><br/></span></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_64"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RleHRyZWdpb246MzgwM2U3ZjU4NDA1NGFiYmFiY2YyOWNjN2MzMzExNzdfMTQ2NQ_a9c6c40c-52af-494f-90c8-944233415098" continuedAt="i29f8b2d8c10e43d6a709071543f9335b" escape="true">Fair Value of Financial Instruments</ix:nonNumeric></span></div><ix:continuation id="i29f8b2d8c10e43d6a709071543f9335b" continuedAt="i79f8335393fc4492af74835051f6c6f3"><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RleHRyZWdpb246MzgwM2U3ZjU4NDA1NGFiYmFiY2YyOWNjN2MzMzExNzdfMTQ1NQ_5e44fe45-4326-4714-aef2-85a135568293" escape="true"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize our cash and available-for-sale securities that were measured at fair value by significant investment category within the fair value hierarchy (in thousands): </span></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.828%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gain</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-Term Marketable Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash- Restricted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash-unrestricted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5eff83c101c4f12b196d0f171c521dc_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMy0xLTEtMS0w_a61d3b35-1021-47d4-9d82-2c1860a82c51">49,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5eff83c101c4f12b196d0f171c521dc_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMy03LTEtMS0w_d4a159b2-a06d-44c2-bc4b-ff1aa125c6c0">49,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5eff83c101c4f12b196d0f171c521dc_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMy05LTEtMS0w_742ca9a0-7523-4799-9a80-3d3226c412de">49,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash-restricted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcc88cfdd4a41b8a7adcab32fd08549_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfNC0xLTEtMS0w_7a9149f9-8b09-40ab-9db7-19931e82a4ba">1,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcc88cfdd4a41b8a7adcab32fd08549_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfNC03LTEtMS0w_1b036fd1-ea9b-401e-a11a-7609c8226d93">1,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcc88cfdd4a41b8a7adcab32fd08549_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfNC0xMy0xLTEtMA_95056540-0c24-44da-b377-743f83a8cd25">1,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Total cash</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37f15e5bdea442009df048b62f08f96a_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfNS0xLTEtMS0w_802e8771-f6b8-4f8e-94dd-802370736098">50,159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37f15e5bdea442009df048b62f08f96a_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfNS03LTEtMS0w_6d3fd01f-4c52-4a4e-bbd3-3f958ef7cfca">50,159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37f15e5bdea442009df048b62f08f96a_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfNS05LTEtMS0w_09e2d6b2-3d9a-4a05-9cef-57e30a3bc8b0">49,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37f15e5bdea442009df048b62f08f96a_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfNS0xMy0xLTEtMA_4bde2044-d1ff-4a9b-9781-ff8f3622cb72">1,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Level I:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29ac583d810f4a91a7b25c3ca9dff3f8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfOC0xLTEtMS0w_48b8d761-117e-4732-bab0-b82a7537fb3b">23,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29ac583d810f4a91a7b25c3ca9dff3f8_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfOC0zLTEtMS0w_ddb74ba0-2969-49eb-b617-536a957e46f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29ac583d810f4a91a7b25c3ca9dff3f8_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfOC01LTEtMS0w_02f6057c-7064-4bf7-b2e3-6f8385c2af82">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29ac583d810f4a91a7b25c3ca9dff3f8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfOC03LTEtMS0w_2da96089-905e-4cb3-acc3-3196f29bac52">23,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29ac583d810f4a91a7b25c3ca9dff3f8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfOC05LTEtMS0w_feaa7b46-b301-4584-9b73-8291e17c138c">23,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29ac583d810f4a91a7b25c3ca9dff3f8_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfOC0xMS0xLTEtMA_d90aeaaf-0ad6-45d3-a68a-0cb4cf5754ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29ac583d810f4a91a7b25c3ca9dff3f8_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfOC0xMy0xLTEtMA_3ba30c43-193a-47ad-be2a-0f901b331d01">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="fldm:CashCashEquivalentsAndShortTermInvestmentsAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMTEtMS0xLTEtMA_53de43f9-cd30-408e-8e05-23a98fc1b0f5">73,360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMTEtMy0xLTEtMA_f5f2e8e1-ce05-42c3-9d46-e197515d9972">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMTEtNS0xLTEtMA_c30001a1-91e7-4770-95a4-9b02f99f08b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMTEtNy0xLTEtMA_455e512c-dc9d-413b-8e5b-6b51f68f3da1">73,360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMTEtOS0xLTEtMA_5c0acb31-1bb5-47d9-b0cb-f9e772eaf4fb">72,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMTEtMTEtMS0xLTA_7e79e9a5-ae35-42b7-af0d-b5d521bc9743">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMTEtMTMtMS0xLTA_0c49862a-c9e7-4121-a1a6-dab711aa9d2a">1,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gain</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-Term Marketable Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash- Restricted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash-unrestricted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic036c6e4072e4f078642894c02e6a2b2_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMTYtMS0xLTEtMA_5430842f-762f-4d09-9e63-5146be2aaefb">16,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic036c6e4072e4f078642894c02e6a2b2_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMTYtNy0xLTEtMA_4fbc0611-e093-4ff8-a4db-a4cf711b655d">16,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic036c6e4072e4f078642894c02e6a2b2_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMTYtOS0xLTEtMA_a52383a5-7c38-4ad5-884e-e0f3c6840729">16,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash-restricted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i183046f58bdf41d8884897ea6e6cf0af_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMTctMS0xLTEtMA_84faf1a3-f9f4-455f-8b3a-9de3162cdcf4">2,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i183046f58bdf41d8884897ea6e6cf0af_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMTctNy0xLTEtMA_11a1c5d1-6458-4e7e-b7ec-368e1343c2d6">2,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i183046f58bdf41d8884897ea6e6cf0af_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMTctMTMtMS0xLTA_6c14c31d-4e55-4a97-ba84-be2f05913351">2,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Total cash</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f7f6ee0988a4bdba5cf8633c5e65b6e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMTgtMS0xLTEtMA_5eafaa3e-0fe0-457b-b249-c9b49c06182d">18,689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f7f6ee0988a4bdba5cf8633c5e65b6e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMTgtNy0xLTEtMA_7b26a743-3e45-409d-89bc-4e2e6c6d1763">18,689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f7f6ee0988a4bdba5cf8633c5e65b6e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMTgtOS0xLTEtMA_051ee4d9-ee94-46f2-be22-b2fbe90e27a2">16,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f7f6ee0988a4bdba5cf8633c5e65b6e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMTgtMTMtMS0xLTA_cd7da99c-d50c-4e4a-ac54-37a51f42c108">2,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Level I:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i681f2afaf9324c6a97f01c2538888b09_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjEtMS0xLTEtMA_8a7d0b2d-c5f6-4434-86ef-507064ffe43e">5,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i681f2afaf9324c6a97f01c2538888b09_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjEtMy0xLTEtMA_15c44264-32fa-4822-87b3-edd8bbb96432">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i681f2afaf9324c6a97f01c2538888b09_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjEtNS0xLTEtMA_590d5100-ac3c-461a-90d7-941192052013">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i681f2afaf9324c6a97f01c2538888b09_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjEtNy0xLTEtMA_d5baf33b-7ce8-49e7-9670-f8ef4a853653">5,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i681f2afaf9324c6a97f01c2538888b09_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjEtOS0xLTEtMA_55d5ac4f-c484-455b-88bb-3a8b4f2a44ac">5,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i681f2afaf9324c6a97f01c2538888b09_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ShortTermInvestments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjEtMTEtMS0xLTA_65b0ede0-a0d6-4361-a395-347656d45022">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i681f2afaf9324c6a97f01c2538888b09_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermInvestments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjEtMTMtMS0xLTA_2a09452c-99df-4919-9a4f-7eee2c393e85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;US treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc62fa7bd73e4eae81ee6e9258a1d986_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjItMS0xLTEtMA_71b203bb-b169-4ee9-b0bb-9e0af20c587d">36,942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc62fa7bd73e4eae81ee6e9258a1d986_I20191231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjItMy0xLTEtMA_71aab9af-6b58-46ab-a817-4675b22c145e">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc62fa7bd73e4eae81ee6e9258a1d986_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjItNS0xLTEtMA_86c6c3b6-2ae2-40ee-b7b6-502274a0c222">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc62fa7bd73e4eae81ee6e9258a1d986_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjItNy0xLTEtMA_0a73d3db-b582-424d-8231-818af1a7d1c3">36,978</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc62fa7bd73e4eae81ee6e9258a1d986_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjItOS0xLTEtMA_19cb96de-b0f2-4f4d-a1c1-afe18d5c0016">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc62fa7bd73e4eae81ee6e9258a1d986_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjItMTEtMS0xLTA_a382ad45-2f04-4a68-9226-273e48978367">36,978</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subtotal</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief09788b1d7b41ddad84a806425db48f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjMtMS0xLTEtMA_45dc01e5-10ae-44f1-ac95-5b4959e9ccca">41,989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief09788b1d7b41ddad84a806425db48f_I20191231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjMtMy0xLTEtMA_6bb55f78-1ce6-4b51-a87c-44de2392fadf">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief09788b1d7b41ddad84a806425db48f_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjMtNS0xLTEtMA_d6108bd1-e0ee-4b99-b8a7-561e579cd01e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief09788b1d7b41ddad84a806425db48f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjMtNy0xLTEtMA_83b37b09-5b5d-48c3-9f64-2a6280aebc6d">42,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief09788b1d7b41ddad84a806425db48f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjMtOS0xLTEtMA_232b8822-de96-4deb-b122-709faec6fc88">5,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief09788b1d7b41ddad84a806425db48f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjMtMTEtMS0xLTA_70f24e83-4db7-4a83-9991-21f2231ca3b2">36,978</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="fldm:CashCashEquivalentsAndShortTermInvestmentsAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjQtMS0xLTEtMA_cce6cf86-293b-4292-96bd-c8ed6506ac18">60,678</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjQtMy0xLTEtMA_0d152f1d-0add-4814-9261-d43db4185afa">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjQtNS0xLTEtMA_d2b65213-8644-4df4-9b51-a50e8954db9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjQtNy0xLTEtMA_5d7f5267-4319-4546-bf01-441898288ea1">60,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjQtOS0xLTEtMA_49780a85-704f-4a67-9d8b-5f05422de080">21,661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjQtMTEtMS0xLTA_23cf08af-e347-4166-a014-0e1dc0265595">36,978</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjQtMTMtMS0xLTA_2f54d4a3-72db-4add-8433-c89bc906f774">2,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers between Level I and Level II measurements, and no changes in the valuation techniques used, during the nine months ended&#160;September&#160;30, 2020.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i79f8335393fc4492af74835051f6c6f3"><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on an evaluation of securities that were in a loss position, we did not recognize any other-than-temporary impairment charges for the nine months ended September&#160;30, 2020 and 2019. <ix:nonFraction unitRef="investment" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RleHRyZWdpb246MzgwM2U3ZjU4NDA1NGFiYmFiY2YyOWNjN2MzMzExNzdfNTI2_1d7f46d7-aefb-4f09-a712-625cd2eff12c">None</ix:nonFraction> of our investments have been in a continuous loss position for more than 12 months. We concluded that the declines in market value of our available-for-sale securities investment portfolio were temporary in nature and did not consider any of our investments to be other-than-temporarily impaired. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Notes</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, we significantly reduced the amount of our outstanding debt. As a result, our convertible notes are not regularly traded and it is difficult to estimate a reliable and accurate market price for these securities. The estimated fair values for these securities represent Level III valuations since a fair value for these securities cannot be determined by using readily observable inputs or measures, such as market prices. Fair values were estimated using pricing models and risk-adjusted value ranges. </span></div><ix:continuation id="i568a7aeab74e4b99b774dd496e230b9a"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the par value, carrying value and the estimated fair value of the 2014 and 2019 Notes at September&#160;30, 2020 and December&#160;31, 2019, respectively (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.680%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2014 Notes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i901752533bd34a9a91d8a9858d1558a3_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfMi0xLTEtMS0w_825b786d-218e-43fe-b01a-f01f8bbee5df">1,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie61b59be16e3451fbb4832bb215eaefa_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfMi0zLTEtMS0w_9ad8fbcc-32ec-4b74-844d-281140471fd1">1,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34fa6e2b348a44feba0389d8f9e424b4_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfMi01LTEtMS0w_c9f7f9b0-40b8-40b2-8059-8308aa6163ee">1,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0880c31bdb2349949c55fad2b57d1d5c_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfMi03LTEtMS0w_3c701e7f-25e5-4aa1-9334-e3b70fef14f5">1,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807edf5453ef492d89797af2d92ce323_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfMi05LTEtMS0w_5d19aa60-9b67-45f1-9b4b-b419bce50b8e">1,057</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06f63608f6e14bd49a545fbfd1a0bb51_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfMi0xMS0xLTEtMA_443cbae9-8066-4390-b978-5a7531b272f9">1,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id881c17013fa4c2ba5f1f0618b5dcb03_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfMy0xLTEtMS0w_0f1c2527-f07e-42ec-b0ee-e05b10f146c1">55,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id881c17013fa4c2ba5f1f0618b5dcb03_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfMy0zLTEtMS0w_6ed7c8c1-2b76-4c3f-b5b6-d22c57a363d4">53,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84de06c926844e43876c040386be167d_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfMy01LTEtMS0w_57e82029-07da-4ec4-a1a0-a3231ecca902">143,039</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6106e4be78de4e3d82d9ce346c18dd6d_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfMy03LTEtMS0w_436e2b98-14a1-4dfc-8f8b-93484c90c25f">55,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3c3d82adad646dbb37ebc978e243f31_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfMy05LTEtMS0w_6ca50c30-d767-4c54-b088-19179c7dbf7f">52,764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6b4b841ac1e4d6eb459e46913612d7a_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfMy0xMS0xLTEtMA_25f06345-2944-4c9a-bbc1-136a92865de6">73,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c17219e8d044f0c861d706caf153722_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfNC0xLTEtMS0w_2a2e5de2-247c-402d-9224-698dca67c604">56,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53a339bce2b7419593141ef24bbc8bed_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfNC0zLTEtMS0w_a24182bb-fe10-4a86-aee1-1e337ffd54a8">54,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe0d0e9dffbd495fae18e77547f3d88c_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfNC01LTEtMS0w_379f2d61-7eba-4bf8-92c1-043435cfd3df">144,161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c6c4c342964442b8318f2e869e57561_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfNC03LTEtMS0w_6da95041-62ff-4700-958f-90fd6674d49e">56,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if34280ce49a6438a9aba047d76278cbc_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfNC05LTEtMS0w_ca4dc1a6-eca7-456b-8069-c0ee2ea38857">53,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef442f5f71545048e77e64914ccc44a_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfNC0xMS0xLTEtMA_986bde50-1b44-4b78-a608-e523a631403c">75,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_67"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RleHRyZWdpb246MjY5NDhlYmQ1NGNkNDRkYmI4ODBlNTJiODkzYTU1MWNfNjgx_df1cd33f-2fcb-413d-ad20-863b48e877f8" continuedAt="iee8464bdfeaa49e9934ceb452af25a73" escape="true">Shareholders&#8217; Equity</ix:nonNumeric></span></div><ix:continuation id="iee8464bdfeaa49e9934ceb452af25a73" continuedAt="ie43b89ccf83144d999011e1d9f36e5e9"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2020 At-the-Market Offering </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, we entered into an Open Market Sale Agreement (Sale Agreement) with Jefferies LLC (Jefferies) to sell shares of our common stock having aggregate sales proceeds of up to $<ix:nonFraction unitRef="usd" contextRef="i9ef4d07044c44fb9900a21ed9c2b3e8a_I20200331" decimals="INF" format="ixt:numdotdecimal" name="fldm:SaleOfStockConsiderationReceivableOnTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RleHRyZWdpb246MjY5NDhlYmQ1NGNkNDRkYmI4ODBlNTJiODkzYTU1MWNfMTgxNDE5NDE4NjE5MDQ_8b46653f-e6d1-45b9-bc76-21863e5bce7e">50,000,000</ix:nonFraction>, from time to time, through an &#8220;at-the-market&#8221; equity offering program under which Jefferies acts as sales agent. During the third quarter of 2020, we sold <ix:nonFraction unitRef="shares" contextRef="ic4d47fe556de4b5a85e774b65e566c18_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RleHRyZWdpb246MjY5NDhlYmQ1NGNkNDRkYmI4ODBlNTJiODkzYTU1MWNfMTA5OTUxMTYzMDgwOA_7ea3d9bc-907a-4e05-bf0d-19f8f239c078">2.5</ix:nonFraction> million shares of our common stock pursuant to the Sale Agreement, for aggregate gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="ic4d47fe556de4b5a85e774b65e566c18_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="fldm:ProceedsFromIssuanceOfCommonStockIncludingRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RleHRyZWdpb246MjY5NDhlYmQ1NGNkNDRkYmI4ODBlNTJiODkzYTU1MWNfMTA5OTUxMTYzMDg0Ng_66ad8c73-aab3-4b7a-9cb9-c6aa352afda4">20.9</ix:nonFraction> million. Our net proceeds from the sale of such shares of common stock were approximately $<ix:nonFraction unitRef="usd" contextRef="ic4d47fe556de4b5a85e774b65e566c18_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RleHRyZWdpb246MjY5NDhlYmQ1NGNkNDRkYmI4ODBlNTJiODkzYTU1MWNfMTA5OTUxMTYzMDg2Ng_633c6f9c-9bf2-494a-883d-aef089e5fcbe">20.1</ix:nonFraction> million, after deducting related expenses, including commissions of approximately $<ix:nonFraction unitRef="usd" contextRef="ic4d47fe556de4b5a85e774b65e566c18_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SalesCommissionsAndFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RleHRyZWdpb246MjY5NDhlYmQ1NGNkNDRkYmI4ODBlNTJiODkzYTU1MWNfMTA5OTUxMTYzMDg4NQ_d00c9d69-e804-4cc7-bb65-ce957b99ea9e">0.6</ix:nonFraction> million and issuance costs of approximately $<ix:nonFraction unitRef="usd" contextRef="ic4d47fe556de4b5a85e774b65e566c18_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RleHRyZWdpb246MjY5NDhlYmQ1NGNkNDRkYmI4ODBlNTJiODkzYTU1MWNfMTA5OTUxMTYzMDkwNQ_a3cc4181-186d-4364-ba72-2aabe212baea">0.2</ix:nonFraction> million. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">InstruNor Acquisition</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, we completed the acquisition of all of the outstanding shares of InstruNor (see Note 3). The purchase price was approximately $<ix:nonFraction unitRef="usd" contextRef="ibccd6f048dc74a6c953e619b2a9e9ea6_D20200117-20200117" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RleHRyZWdpb246MjY5NDhlYmQ1NGNkNDRkYmI4ODBlNTJiODkzYTU1MWNfMTk1_4fad0d36-d5c0-43b4-99a5-2a689e2e8c46">7.2</ix:nonFraction> million, consisting of $<ix:nonFraction unitRef="usd" contextRef="ibccd6f048dc74a6c953e619b2a9e9ea6_D20200117-20200117" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RleHRyZWdpb246MjY5NDhlYmQ1NGNkNDRkYmI4ODBlNTJiODkzYTU1MWNfMjEz_9d4bfe43-ccb6-4b44-972e-f2732a1035a0">5.2</ix:nonFraction> million in cash and <ix:nonFraction unitRef="shares" contextRef="ibccd6f048dc74a6c953e619b2a9e9ea6_D20200117-20200117" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RleHRyZWdpb246MjY5NDhlYmQ1NGNkNDRkYmI4ODBlNTJiODkzYTU1MWNfMjI4_45dace8b-1a27-415a-8901-ee96a88e982a">485,451</ix:nonFraction> shares of our common stock.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conversion of 2018 Notes</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2019, we issued <ix:nonFraction unitRef="shares" contextRef="i5c04b2fe57fb44e19f764085727f7dfc_D20190101-20190331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RleHRyZWdpb246MjY5NDhlYmQ1NGNkNDRkYmI4ODBlNTJiODkzYTU1MWNfMzI0_7e09a2e7-41ee-4140-9d60-22d6287215f8">19,460,260</ix:nonFraction> shares of our common stock in connection with the conversion of our 2018 Notes (see Note 8). As a result of this issuance of our common stock, we recorded a total of $<ix:nonFraction unitRef="usd" contextRef="i5c04b2fe57fb44e19f764085727f7dfc_D20190101-20190331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RleHRyZWdpb246MjY5NDhlYmQ1NGNkNDRkYmI4ODBlNTJiODkzYTU1MWNfNDkz_3fc16d2f-046a-417c-9149-49534fe18203">133.3</ix:nonFraction> million of equity, which was equivalent to the fair value of the bonds retired.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie43b89ccf83144d999011e1d9f36e5e9"><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RleHRyZWdpb246MjY5NDhlYmQ1NGNkNDRkYmI4ODBlNTJiODkzYTU1MWNfNjgy_fe58ece4-92fa-4743-ba38-b62acf6b266c" continuedAt="i46b9e111d0014d2d84e18f0dac1f2500" escape="true"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020, we had reserved shares of common stock for future issuance under equity compensation plans as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in 000's)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Securities To Be Issued Upon Exercise Of Options </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number Of Remaining Securities Available For Future Issuance </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2009 Equity Incentive Plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iff9fa89f0d3e4906b1a6686b38fead1e_I20200930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfMS0yLTEtMS0w_b65686a9-52e6-4540-89a7-cf0c9e361169">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i98ff5d8d443c4c78babb4c655a8e6efa_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfMS00LTEtMS0w_955c6bb8-4ca3-429a-8d8f-ca50eae0206d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia3da57b8f28d46aa9eb2676696423f21_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfMS02LTEtMS0w_a3fcb50b-79c9-436e-8886-b58939eb4812">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2011 Equity Incentive Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9bd22d380b1a4d6ea4fd44b27e0141f4_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfMi0yLTEtMS0w_047af4be-b9cf-473b-8aec-4d228a9725e1">1,387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i638e57cbaa7d456f8b185da5205acb2f_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfMi00LTEtMS0w_613cbfcf-de4d-4ed0-9cfd-cc353b282799">5,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4ea312f66de54b4e9c6d400430165a3f_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfMi02LTEtMS0w_1b65f43d-9c6c-4328-90dd-0e3deccdfd5d">3,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DVS Sciences Inc. 2010 Equity Incentive Plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5fabe06699de401a840160fc6badcdb3_I20200930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfMy0yLTEtMS0w_4e1ed34a-aa97-432e-8476-809020cbe92e">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id13d013dd44e44adb532dfeeae35dbb5_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfMy00LTEtMS0w_dffc5497-5db5-455c-ad40-4150ef31b164">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iafad09c62b1d4a0c9f23fde9d0b1485c_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfMy02LTEtMS0w_0546efae-df1f-43e7-8ea2-ba34e136834a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2017 Inducement Award Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib0b9e4ec81a9465d991e4f00f8bdb0ce_I20200930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfNC0yLTEtMS0w_7cee65f9-5091-4f55-939b-cdde1d1fdb77">207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1d7a0bcaab4e48bea67be674fa9e6cdc_I20200930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfNC00LTEtMS0w_d6b4b25e-8280-425e-ab87-2f654742cdca">216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idb080589897242f4a5db6a13881cbb4a_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfNC02LTEtMS0w_ade76e35-a465-4771-8b5b-79c606d80e4f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2017 Employee Stock Purchase Plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8d050d829f6246668dee88b2edbb05f9_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfNS0yLTEtMS0w_2e8c9b3b-f03e-411e-a581-0c4093a1a729">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ied741f884347441db18e2bd390ba3411_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfNS00LTEtMS0w_63cba810-e8e8-45d0-9603-70ebb9e8c457">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i241d9546e6e84c83986e1cc5b11f3c0f_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfNS02LTEtMS0w_83d4aa01-aa04-4b5b-8e51-316e6adaaf82">3,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7de5c3aaabc04d038a06ae0f7741f31f_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfNi0yLTEtMS0w_6515d821-2b97-4afc-8f5f-276a2366f804">1,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iefea4fc822cc4bf48772c4ff54bacc58_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfNi00LTEtMS0w_4e6f7d4b-7826-43e9-99a4-41dbd4dbd05f">6,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfNi02LTEtMS0w_1099c6cd-0313-47c8-af32-60f6cef63893">6,157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_70"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTA5NDA_8b6f488c-9041-4dd0-9026-72a6191cfbd1" continuedAt="icb5db76e6ed84d02ad6fff21bc3053eb" escape="true">Stock-Based Plans</ix:nonNumeric></span></div><ix:continuation id="icb5db76e6ed84d02ad6fff21bc3053eb" continuedAt="i28378c4446e247de90a0fea509c4c4e6"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors sets the terms, conditions, and restrictions related to our 2017 Employee Stock Purchase Plan (ESPP) and the grant of stock options, restricted stock units (RSUs) and performance-based awards under our equity incentive plans. Our board of directors determines the number of awards to grant and also sets vesting criteria. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, RSUs vest on a quarterly basis over a period of <ix:nonNumeric contextRef="i52a11bc3f5e44d13bf15a18be4a29d8f_D20200101-20200930" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNDMz_40aa4e58-69d6-48e6-85d3-91c8c41e266e">four years</ix:nonNumeric> from the date of grant at a rate of either <ix:nonFraction unitRef="number" contextRef="i52a11bc3f5e44d13bf15a18be4a29d8f_D20200101-20200930" decimals="INF" name="fldm:PortionOfStockOptionsVestOnFirstAnniversary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNDc5_5f91ec7a-189b-4a93-9d17-0b001474265f">25</ix:nonFraction>% on the first anniversary of the grant date and ratably each quarter over the remaining 12 quarters, or ratably each quarter over 16 quarters, subject to the employees&#8217; continued employment. In May 2020, we granted <ix:nonFraction unitRef="shares" contextRef="i263f694376794abc814fc456f821bbd2_I20200531" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNjk2_6d43d239-b9a9-44ed-949d-68189629fb8c">1.8</ix:nonFraction> million retention RSUs that vest over <ix:nonNumeric contextRef="i3b04e9f77df54a0b9e2eb4b34d0fc115_D20200101-20200930" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNzI5_9d93c41c-cddd-4d83-800b-c8b1bcafa7e6">three years</ix:nonNumeric>, with <ix:nonFraction unitRef="number" contextRef="ifa1dea2f8c814e519c099b477d05617b_D20200501-20200531" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNzM4_56a156f4-a201-42ae-aca1-35e2c56efa39">50</ix:nonFraction>% of the RSUs vesting after <ix:nonNumeric contextRef="ibce292aab63145e2bc9d3e50b05a5089_D20200101-20200930" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNzY3_2722215b-e34a-454e-ad45-091b250bb51c">one year</ix:nonNumeric> and <ix:nonFraction unitRef="number" contextRef="i1284d595ff29438b8ddea2c07841e004_D20200501-20200531" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNzc0_5eae0c7b-2048-476b-9af3-598add42a5d5">25</ix:nonFraction>% of the RSUs vesting each year thereafter. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incentive stock options and non-statutory stock options granted under our 2011 Equity Incentive Plan (2011 Plan) have a term of no more than <ix:nonNumeric contextRef="ibfd04ed28b304350bca273167b0b25b1_D20200101-20200930" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfOTYx_439ea952-69ed-4c67-9cc9-71041b5875cd">ten years</ix:nonNumeric> from the date of grant and an exercise price of at least <ix:nonFraction unitRef="number" contextRef="ibfd04ed28b304350bca273167b0b25b1_D20200101-20200930" decimals="INF" name="fldm:StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTAyMQ_a2f0030a-c52f-418d-8fc2-a16e28bd5734">100</ix:nonFraction>% of the fair market value of the underlying common stock on the date of grant. If a participant owns stock representing more than <ix:nonFraction unitRef="number" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="INF" name="fldm:SharebasedCompensationArrangementbySharebasedPaymentAwardVestingRestrictionsOwnershipPercentageofVotingStock" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTE1Mw_999a9b11-3b1a-46dd-930e-9bc064c08352">10</ix:nonFraction>% of the voting power of all classes of our stock on the grant date, an incentive stock option awarded to the participant will have a term of no more than <ix:nonNumeric contextRef="i8149995fd4334ebd8d795406a38a6aa0_D20200101-20200930" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTMwOQ_823815fa-49c3-473e-a766-abdc968fc6f6">five years</ix:nonNumeric> from the date of grant and an exercise price of at least <ix:nonFraction unitRef="number" contextRef="i8149995fd4334ebd8d795406a38a6aa0_D20200101-20200930" decimals="INF" name="fldm:StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTM2OQ_209ac1af-ff8b-46b1-846d-ab108a9c74a8">110</ix:nonFraction>% of the fair market value of the underlying common stock on the date of grant. Generally, options vest at a rate of either <ix:nonFraction unitRef="number" contextRef="i86d0a118c5b6489788d92ddc7d23fbd6_D20200101-20200930" decimals="INF" name="fldm:PortionOfStockOptionsVestOnFirstAnniversary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTQ5NA_d783a02f-1ccb-437b-af63-b9ff32512adb">25</ix:nonFraction>% on the first anniversary of the option grant date and ratably each month over the remaining period of <ix:nonNumeric contextRef="i3b04e9f77df54a0b9e2eb4b34d0fc115_D20200101-20200930" format="ixt-sec:durmonth" name="fldm:NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTU5OQ_1c9bab01-dcf0-499d-a091-bd1a38a1f2e6">36</ix:nonNumeric> months, or ratably each month over <ix:nonNumeric contextRef="ibce292aab63145e2bc9d3e50b05a5089_D20200101-20200930" format="ixt-sec:durmonth" name="fldm:NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTYzMA_8125e9ae-35dc-496f-bb0b-aefb7f1f0753">48</ix:nonNumeric> months. We may grant options with different vesting terms from time to time. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For performance-based share awards, our board of directors sets the performance objectives and other vesting provisions in determining the number of shares or value of performance units and performance shares that will be paid out. Such payout will be a function of the extent to which performance objectives or other vesting provisions have been achieved.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2011 Equity Incentive Plan</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January&#160;2011, our board of directors adopted the 2011 Plan under which incentive stock options, non-statutory stock options, RSUs, stock appreciation rights, performance stock units (PSUs), and performance shares may be granted to our employees, directors, and consultants. In April 2019, our board of directors authorized, and in June 2019, our stockholders approved an amendment and restatement of the 2011 Plan to make various changes, including increasing the number of shares reserved for issuance by approximately <ix:nonFraction unitRef="shares" contextRef="ib3e373d05502431a8c7dc9abf1ab0362_I20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMjYxMQ_52667091-0a58-4b7e-89f3-244049d7165c">5.0</ix:nonFraction> million shares and extending the term of the 2011 Plan until April 2029. In May 2020, our board of directors authorized, and in June 2020, our stockholders approved an increase in the number of shares reserved for issuance under the 2011 Plan of <ix:nonFraction unitRef="shares" contextRef="i8fa5a801a597442f88adb537d10639f1_I20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMjg1Mg_0bb70178-8172-42b5-ac6d-4b96598c1c0b">1.4</ix:nonFraction> million shares. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2009 Equity Incentive Plan and 2017 Inducement Award Plan </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our 2009 Equity Incentive Plan (the 2009 Plan) terminated on the date the 2011 Plan was adopted. Options granted, or shares issued under the 2009 Plan that were outstanding on the date the 2011 Plan became effective, remained subject to the terms of the 2009 Plan. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2017, we adopted the Fluidigm Corporation 2017 Inducement Award Plan (Inducement Plan) and reserved <ix:nonFraction unitRef="shares" contextRef="i2a6bf5ef9a12484b86b93a4e3f7508a8_I20170131" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMzMwMQ_2e3af203-e83b-4546-9eb2-553d87ac2024">2</ix:nonFraction> million shares of our common stock for issuance pursuant to equity awards granted under the Inducement Plan. The Inducement Plan provided for the grant of equity-based awards on terms substantially similar to the 2011 Plan. In accordance with Rule 5635(c)(4) of the Nasdaq Listing Rules, awards under the Inducement Plan were only be made to individuals not previously our </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i28378c4446e247de90a0fea509c4c4e6" continuedAt="i86280ad1403d40d2a1d916cbf6a8736a"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">employees or non-employee members of our board of directors (or following such individual&#8217;s bona fide period of non-employment), as an inducement material to the individual&#8217;s entry into employment with us or in connection with a merger or acquisition, to the extent permitted by Rule 5635(c)(3) of the Nasdaq Listing Rules. In June 2019, concurrently with the increase in shares available for grant under the 2011 Plan, the Inducement Plan was terminated such that no further grants could be made thereunder. Options granted and shares issued under the Inducement Plan that were outstanding when the Inducement Plan was terminated remain outstanding subject to their terms and the terms of the Inducement Plan.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Valuation and Expense Information</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the Black-Scholes option-pricing model to estimate the fair value of stock options granted under our equity incentive plans. We grant stock options at exercise prices not less than the fair value of our common stock at the date of grant. The fair value of RSUs granted to employees was estimated on the date of grant by multiplying the number of shares granted by the fair market value of our common stock on the grant date. </span></div><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTA5MzA_2b848e1a-0ab3-487a-9018-706c13222668" escape="true"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity under the various plans was as follows:</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.397%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.423%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Units (in 000s)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant Date Fair Value per Unit</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if3575d83de144e808258ee710b5e28d6_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjdkYmE2ZGJmN2Y0MDRlNDRiNWE2MTJlMzA4MTk5YTdkL3RhYmxlcmFuZ2U6N2RiYTZkYmY3ZjQwNGU0NGI1YTYxMmUzMDgxOTlhN2RfMS0yLTEtMS0w_73dce71a-0df6-4812-88d9-a76868bf558b">2,551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if3575d83de144e808258ee710b5e28d6_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjdkYmE2ZGJmN2Y0MDRlNDRiNWE2MTJlMzA4MTk5YTdkL3RhYmxlcmFuZ2U6N2RiYTZkYmY3ZjQwNGU0NGI1YTYxMmUzMDgxOTlhN2RfMS00LTEtMS0w_b2f873ad-d289-4226-a682-cdb1a7e4a23f">7.43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i52a11bc3f5e44d13bf15a18be4a29d8f_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjdkYmE2ZGJmN2Y0MDRlNDRiNWE2MTJlMzA4MTk5YTdkL3RhYmxlcmFuZ2U6N2RiYTZkYmY3ZjQwNGU0NGI1YTYxMmUzMDgxOTlhN2RfMi0yLTEtMS0w_f5077c71-74a7-4fa2-be49-bcc39dd9f392">3,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i52a11bc3f5e44d13bf15a18be4a29d8f_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjdkYmE2ZGJmN2Y0MDRlNDRiNWE2MTJlMzA4MTk5YTdkL3RhYmxlcmFuZ2U6N2RiYTZkYmY3ZjQwNGU0NGI1YTYxMmUzMDgxOTlhN2RfMi00LTEtMS0w_7ac492c5-b939-4bdd-aa08-7add76553c52">3.95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU released</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i52a11bc3f5e44d13bf15a18be4a29d8f_D20200101-20200930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjdkYmE2ZGJmN2Y0MDRlNDRiNWE2MTJlMzA4MTk5YTdkL3RhYmxlcmFuZ2U6N2RiYTZkYmY3ZjQwNGU0NGI1YTYxMmUzMDgxOTlhN2RfMy0yLTEtMS0w_194a610d-a668-4d2c-a805-dbf2e50513ff">872</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i52a11bc3f5e44d13bf15a18be4a29d8f_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjdkYmE2ZGJmN2Y0MDRlNDRiNWE2MTJlMzA4MTk5YTdkL3RhYmxlcmFuZ2U6N2RiYTZkYmY3ZjQwNGU0NGI1YTYxMmUzMDgxOTlhN2RfMy00LTEtMS0w_4735ac81-1420-4bc6-9632-36c24698e844">7.30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i52a11bc3f5e44d13bf15a18be4a29d8f_D20200101-20200930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjdkYmE2ZGJmN2Y0MDRlNDRiNWE2MTJlMzA4MTk5YTdkL3RhYmxlcmFuZ2U6N2RiYTZkYmY3ZjQwNGU0NGI1YTYxMmUzMDgxOTlhN2RfNC0yLTEtMS0w_81324663-2e61-4ee1-8c68-a387519e8d4c">305</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i52a11bc3f5e44d13bf15a18be4a29d8f_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjdkYmE2ZGJmN2Y0MDRlNDRiNWE2MTJlMzA4MTk5YTdkL3RhYmxlcmFuZ2U6N2RiYTZkYmY3ZjQwNGU0NGI1YTYxMmUzMDgxOTlhN2RfNC00LTEtMS0w_1fb61f93-7ecf-45aa-a5ac-fe29629953cc">6.39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib711ac2faf28446d9e3400f0d3bd6600_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjdkYmE2ZGJmN2Y0MDRlNDRiNWE2MTJlMzA4MTk5YTdkL3RhYmxlcmFuZ2U6N2RiYTZkYmY3ZjQwNGU0NGI1YTYxMmUzMDgxOTlhN2RfNS0yLTEtMS0w_25b8a454-1426-436f-b63c-f6e9cd2e77fa">5,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib711ac2faf28446d9e3400f0d3bd6600_I20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjdkYmE2ZGJmN2Y0MDRlNDRiNWE2MTJlMzA4MTk5YTdkL3RhYmxlcmFuZ2U6N2RiYTZkYmY3ZjQwNGU0NGI1YTYxMmUzMDgxOTlhN2RfNS00LTEtMS0w_439f2673-bbb3-494e-b749-198545ba84aa">4.99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, the unrecognized compensation costs related to outstanding unvested RSUs under our equity incentive plans were $<ix:nonFraction unitRef="usd" contextRef="ib711ac2faf28446d9e3400f0d3bd6600_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNTA4MA_1a657db8-d49e-422f-b054-96bf6f748366">22.0</ix:nonFraction> million. We expect to recognize those costs over a weighted average period of <ix:nonNumeric contextRef="i52a11bc3f5e44d13bf15a18be4a29d8f_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNTE1Mw_8438478b-7450-4a74-bcd9-91d0b53fd754">2.8</ix:nonNumeric> years.</span></div><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTA5Mzc_3c648454-9c1e-4934-92c6-fcba4144dfb5" continuedAt="ie7a889563f264efa9b890d6a46a435a9" escape="true"><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">: </span></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of <br/>Options (000s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Exercise Price<br/>per Option</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average Remaining Contractual Life (in Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intrinsic </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> in (000s)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfMS0yLTEtMS0w_b1644bc1-4bbb-4345-98af-c4a81166a82c">2,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfMS00LTEtMS0w_344061b9-c225-4227-906f-18ed28ac9a10">7.78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i903ebee619a74d21ad02859fe06eab6b_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfMS02LTEtMS0w_850cffa8-7a96-42b4-a708-efde4906a9ac">6.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfMS04LTEtMS0w_ef2bfc16-2269-4023-8f98-585fd4a9a3b7">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfMi0yLTEtMS0w_fa610fc4-211e-4a03-928a-8e92ae59dd07">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfMi00LTEtMS0w_950217e3-438f-454f-b6c4-16fab8871164">3.74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfMy0yLTEtMS0w_b23edcd9-7ebb-48d4-912b-d8d379a4f67b">98</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfMy00LTEtMS0w_a63d3a67-0171-4aaa-99b3-16a0b69e1d0e">4.90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfMy04LTEtMS0w_e994fcf9-c1d2-41bd-8188-6b0c9b119bdd">352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfNC0yLTEtMS0w_11255244-36ea-449f-bef2-ae5574111d78">408</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfNC00LTEtMS0w_a6d9f6e2-c68f-4116-ad09-b7c37957a499">9.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfNS0yLTEtMS0w_75210807-4807-490a-8d79-fee4eb69a498">1,626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfNS00LTEtMS0w_99d20a29-395a-4d1e-8b21-8ea4e55c214e">7.34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfNS02LTEtMS0w_fa439971-6251-4bff-bba0-21dbff5aac7b">6.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfNS04LTEtMS0w_d3fcf0f2-36e5-4b34-8f95-8739f011c05e">2,514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfNi0yLTEtMS0w_7c7e29d2-769d-49cc-b2fd-e09d8e9dfd64">1,259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="2" name="fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfNi00LTEtMS0w_b0828059-2ff2-4c85-994c-b905cd40c7d7">7.86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" format="ixt-sec:duryear" name="fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfNi02LTEtMS0w_51c3ed16-fd76-411a-8e1c-fae8016ee94c">6.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfNi04LTEtMS0w_a4244b94-befd-4f87-bf1a-36d8a9a4e522">1,799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Awards expected to vest at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" name="fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfNy0yLTEtMS0w_534aa547-aa13-4ee5-90b4-cc24fd6117c8">367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="2" name="fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfNy00LTEtMS0w_fcb97fae-1d5c-41c2-b853-7015d3ed5d7e">5.56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" format="ixt-sec:duryear" name="fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfNy02LTEtMS0w_9f6a84b3-e5c0-468e-9076-680da2386c57">7.9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="-3" name="fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfNy04LTEtMS0w_2dbc152a-5dba-4812-9c22-5dd22c321f11">715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______</span></div></ix:nonNumeric><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie7a889563f264efa9b890d6a46a435a9" continuedAt="i895507e618ad49108b897a069fcc66bd">(1)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"><ix:continuation id="i895507e618ad49108b897a069fcc66bd">Aggregate intrinsic value as of September&#160;30, 2020 was calculated as the difference between the closing price per share of our common stock on the last trading day of September&#160;30, 2020, which was $<ix:nonFraction unitRef="usdPerShare" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNTM0Mw_3d175043-4b04-4481-8e4a-0caad87d1e75">7.43</ix:nonFraction>, and the exercise price of the options, multiplied by the number of in-the-money options.</ix:continuation> </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, the unrecognized compensation costs related to outstanding unvested options under our equity incentive plans were $<ix:nonFraction unitRef="usd" contextRef="if5379688acd14de7b8f11138da8190d7_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNTU2MQ_da263161-67cc-4351-b0de-c22fbca0c78e">1.1</ix:nonFraction> million. We expect to recognize those costs over a weighted average period of <ix:nonNumeric contextRef="i43caef91ebc84c58affb994dda276bd2_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNTYzNA_d6160c4f-cada-4fd7-bc7c-3643c89c34a2">1.4</ix:nonNumeric> years. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance-based Awards</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance Stock Units with Market Conditions</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have granted PSU awards to certain executive officers and senior level employees. The number of PSUs ultimately earned under these awards is calculated based on the Total Shareholder Return (TSR) of our common stock as compared to the TSR of a defined group of peer companies during the applicable <ix:nonNumeric contextRef="ic5115d69f217430288b67bde40c9b1dc_D20200101-20200930" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTA5Mzg_963b64ed-a457-4c34-a603-4fd93fca63d5">three-year</ix:nonNumeric> performance period. The percentage of PSUs that vest will depend on our relative position at the end of the performance period and can range from <ix:nonFraction unitRef="number" contextRef="i61c3102478484d46b94add36424eda3f_D20200101-20200930" decimals="INF" name="fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNjE2Ng_96d64ef5-2cc8-4661-8a08-d87fe8da26b7">0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i32afb092bbb44b9b9f083571429c2990_D20200101-20200930" decimals="INF" name="fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNjE3Mg_c09ccea7-0a07-41b7-a05a-7d90d3fd9a2e">200</ix:nonFraction>% of the number of units granted. Under FASB ASC Topic 718, the provisions of the PSU awards related to TSR are considered a market </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i86280ad1403d40d2a1d916cbf6a8736a" continuedAt="i763b7a1865a1456d92f647eaf010a6dd"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">condition, and the effects of that market condition are reflected in the grant date fair value of the awards. We used a Monte Carlo simulation pricing model to incorporate the market condition effects at our grant date. </span></div><ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTA5NDc_24e202b4-4ee2-4abf-8aa9-546b8342f450" continuedAt="i07374251a722435ab05ff9dd057fe2ae" escape="true"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity under the TSR-based PSUs is as follows: </span></div><div style="margin-bottom:5pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.397%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.423%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Units (in 000s)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant Date Fair Value per Unit</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie07832375f9440358e7271a1d7a2f6c2_I20191231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmY4NzRlZDIxMmQwNjQ2NmFhM2VkYmNjOTY0YWY0YjQ3L3RhYmxlcmFuZ2U6Zjg3NGVkMjEyZDA2NDY2YWEzZWRiY2M5NjRhZjRiNDdfMS0yLTEtMS0w_3112c02a-f31b-45dd-aed8-a7d0b58fa521">547</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie07832375f9440358e7271a1d7a2f6c2_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmY4NzRlZDIxMmQwNjQ2NmFhM2VkYmNjOTY0YWY0YjQ3L3RhYmxlcmFuZ2U6Zjg3NGVkMjEyZDA2NDY2YWEzZWRiY2M5NjRhZjRiNDdfMS00LTEtMS0w_5c4d87b8-f7cc-4d66-bff0-37fd430ad3af">15.09</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic5115d69f217430288b67bde40c9b1dc_D20200101-20200930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmY4NzRlZDIxMmQwNjQ2NmFhM2VkYmNjOTY0YWY0YjQ3L3RhYmxlcmFuZ2U6Zjg3NGVkMjEyZDA2NDY2YWEzZWRiY2M5NjRhZjRiNDdfMi0yLTEtMS0w_39ce1fbd-a663-4d48-8005-1c8f37dd62d1">509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic5115d69f217430288b67bde40c9b1dc_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmY4NzRlZDIxMmQwNjQ2NmFhM2VkYmNjOTY0YWY0YjQ3L3RhYmxlcmFuZ2U6Zjg3NGVkMjEyZDA2NDY2YWEzZWRiY2M5NjRhZjRiNDdfMi00LTEtMS0w_83cab8a8-4ecb-403d-bb3c-3c7881266815">4.82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU released</span></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic5115d69f217430288b67bde40c9b1dc_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmY4NzRlZDIxMmQwNjQ2NmFhM2VkYmNjOTY0YWY0YjQ3L3RhYmxlcmFuZ2U6Zjg3NGVkMjEyZDA2NDY2YWEzZWRiY2M5NjRhZjRiNDdfMy0yLTEtMS0w_1be210df-9689-46af-8570-646cd321b3d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bfe4ff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic5115d69f217430288b67bde40c9b1dc_D20200101-20200930" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmY4NzRlZDIxMmQwNjQ2NmFhM2VkYmNjOTY0YWY0YjQ3L3RhYmxlcmFuZ2U6Zjg3NGVkMjEyZDA2NDY2YWEzZWRiY2M5NjRhZjRiNDdfMy00LTEtMS0w_4a0228cd-46ea-46cc-8199-ff1121f45977">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ic5115d69f217430288b67bde40c9b1dc_D20200101-20200930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmY4NzRlZDIxMmQwNjQ2NmFhM2VkYmNjOTY0YWY0YjQ3L3RhYmxlcmFuZ2U6Zjg3NGVkMjEyZDA2NDY2YWEzZWRiY2M5NjRhZjRiNDdfNC0yLTEtMS0w_473d321e-f69a-4f5c-bb92-e5d34f910f96">94</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic5115d69f217430288b67bde40c9b1dc_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmY4NzRlZDIxMmQwNjQ2NmFhM2VkYmNjOTY0YWY0YjQ3L3RhYmxlcmFuZ2U6Zjg3NGVkMjEyZDA2NDY2YWEzZWRiY2M5NjRhZjRiNDdfNC00LTEtMS0w_28341029-cce1-4cc3-94b8-a34f2e24a9b4">14.26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icae4702ca6dc445a8b04b4ce1f0e0fd9_I20200930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmY4NzRlZDIxMmQwNjQ2NmFhM2VkYmNjOTY0YWY0YjQ3L3RhYmxlcmFuZ2U6Zjg3NGVkMjEyZDA2NDY2YWEzZWRiY2M5NjRhZjRiNDdfNS0yLTEtMS0w_aa87f8ef-5c65-4fea-a914-38bf9efd316c">962</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bfe4ff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icae4702ca6dc445a8b04b4ce1f0e0fd9_I20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmY4NzRlZDIxMmQwNjQ2NmFhM2VkYmNjOTY0YWY0YjQ3L3RhYmxlcmFuZ2U6Zjg3NGVkMjEyZDA2NDY2YWEzZWRiY2M5NjRhZjRiNDdfNS00LTEtMS0w_3e6e486f-a163-4c3b-ac0c-e86b91c8ec15">9.74</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of&#160;September&#160;30, 2020, the unrecognized compensation costs related to these awards were $<ix:nonFraction unitRef="usd" contextRef="icae4702ca6dc445a8b04b4ce1f0e0fd9_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNjY1NA_dcf4d28b-8e91-4a4a-9078-249fe6f4fad6">4.6</ix:nonFraction> million. We expect to recognize those costs over a weighted average period of <ix:nonNumeric contextRef="ic5115d69f217430288b67bde40c9b1dc_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNjcyNw_ba7b7633-31fb-45c9-abb2-1d6a505f8bb8">1.7</ix:nonNumeric> years.</span></div><div style="margin-bottom:8pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance Stock Units with Performance Conditions</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2019, we also granted a PSU award under which the number of PSUs that ultimately vest is dependent on achieving certain discrete operational milestones between September 30, 2019 and December 31, 2020. <ix:continuation id="i07374251a722435ab05ff9dd057fe2ae" continuedAt="i9d7298cda62540768d7343556b201ac0">Activity to date under this PSU award is as follows:</ix:continuation></span></div><div style="margin-bottom:5pt;margin-top:11pt;text-align:center"><ix:continuation id="i9d7298cda62540768d7343556b201ac0"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.397%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.423%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Units (in 000s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant Date Fair Value per Unit</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i44e0332a734548d5b4a5b0f2a9cd04b5_I20191231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjU0Mzk5NzQ3NTY0NjRhYzJiZjM5ZDUyMjNiMmUwYjkyL3RhYmxlcmFuZ2U6NTQzOTk3NDc1NjQ2NGFjMmJmMzlkNTIyM2IyZTBiOTJfMS0yLTEtMS0w_5afdedd2-aca4-4184-97ef-af0a56bf4aa9">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i44e0332a734548d5b4a5b0f2a9cd04b5_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjU0Mzk5NzQ3NTY0NjRhYzJiZjM5ZDUyMjNiMmUwYjkyL3RhYmxlcmFuZ2U6NTQzOTk3NDc1NjQ2NGFjMmJmMzlkNTIyM2IyZTBiOTJfMS00LTEtMS0w_3960d1b5-0532-437e-a55d-37a20e248446">7.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i76eddca721de44d59d30a86ae6150eae_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjU0Mzk5NzQ3NTY0NjRhYzJiZjM5ZDUyMjNiMmUwYjkyL3RhYmxlcmFuZ2U6NTQzOTk3NDc1NjQ2NGFjMmJmMzlkNTIyM2IyZTBiOTJfMi0yLTEtMS0w_0909e9c4-ae1a-4d81-ad7a-2b965c9aee1d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i76eddca721de44d59d30a86ae6150eae_D20200101-20200930" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjU0Mzk5NzQ3NTY0NjRhYzJiZjM5ZDUyMjNiMmUwYjkyL3RhYmxlcmFuZ2U6NTQzOTk3NDc1NjQ2NGFjMmJmMzlkNTIyM2IyZTBiOTJfMi00LTEtMS0w_d05648cc-58f8-4b57-997e-d527cfaad13b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU released</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i76eddca721de44d59d30a86ae6150eae_D20200101-20200930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjU0Mzk5NzQ3NTY0NjRhYzJiZjM5ZDUyMjNiMmUwYjkyL3RhYmxlcmFuZ2U6NTQzOTk3NDc1NjQ2NGFjMmJmMzlkNTIyM2IyZTBiOTJfMy0yLTEtMS0w_4906b7df-e22a-4676-a630-3ac2ab13ea85">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i76eddca721de44d59d30a86ae6150eae_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjU0Mzk5NzQ3NTY0NjRhYzJiZjM5ZDUyMjNiMmUwYjkyL3RhYmxlcmFuZ2U6NTQzOTk3NDc1NjQ2NGFjMmJmMzlkNTIyM2IyZTBiOTJfMy00LTEtMS0w_f25e6e4f-10da-4b57-9972-89f9378ee074">7.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i76eddca721de44d59d30a86ae6150eae_D20200101-20200930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjU0Mzk5NzQ3NTY0NjRhYzJiZjM5ZDUyMjNiMmUwYjkyL3RhYmxlcmFuZ2U6NTQzOTk3NDc1NjQ2NGFjMmJmMzlkNTIyM2IyZTBiOTJfNC0yLTEtMS0w_a2eec850-0159-4136-a646-526e29ef1004">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i76eddca721de44d59d30a86ae6150eae_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjU0Mzk5NzQ3NTY0NjRhYzJiZjM5ZDUyMjNiMmUwYjkyL3RhYmxlcmFuZ2U6NTQzOTk3NDc1NjQ2NGFjMmJmMzlkNTIyM2IyZTBiOTJfNC00LTEtMS0w_792c73bb-4bdd-4735-b27d-c6ac8cd5068a">7.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if76795b7980f4cf1b2d2d91e17de5300_I20200930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjU0Mzk5NzQ3NTY0NjRhYzJiZjM5ZDUyMjNiMmUwYjkyL3RhYmxlcmFuZ2U6NTQzOTk3NDc1NjQ2NGFjMmJmMzlkNTIyM2IyZTBiOTJfNS0yLTEtMS0w_a5c51cbc-b06c-45f2-831e-5b641ac93c7e">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if76795b7980f4cf1b2d2d91e17de5300_I20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjU0Mzk5NzQ3NTY0NjRhYzJiZjM5ZDUyMjNiMmUwYjkyL3RhYmxlcmFuZ2U6NTQzOTk3NDc1NjQ2NGFjMmJmMzlkNTIyM2IyZTBiOTJfNS00LTEtMS0w_ba2fb413-9b98-4cec-b939-97559394b4dd">7.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2017 Employee Stock Purchase Plan</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2017, our stockholders approved our ESPP at the annual meeting of stockholders. Our ESPP offers U.S. and some non-U.S. employees the right to purchase shares of our common stock. Our first ESPP offering period began on October 1, 2017 with a shorter offering period ending on November 30, 2017. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to June 2019, our ESPP program had a <ix:nonNumeric contextRef="i9dad88f3165a4f0eae5db5d9dc24638f_D20190531-20190531" format="ixt-sec:durwordsen" name="fldm:EmployeeStockPurchasePlanOfferingPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTA5NDE_46f78a15-fd8a-41b2-b8b4-df357711c995">six-month</ix:nonNumeric> offering period, with a new period commencing on the first trading day on or after May 31 and November 30 of each year. Employees were eligible to participate through payroll deductions of up to <ix:nonFraction unitRef="number" contextRef="id735d6be492745c7b536c828704a562f_I20190531" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNzYzNQ_91d5c760-786d-459e-a1f7-f22dfb0e5ec3">10</ix:nonFraction>% of their compensation. The purchase price at which shares were sold under the ESPP was <ix:nonFraction unitRef="number" contextRef="i9dad88f3165a4f0eae5db5d9dc24638f_D20190531-20190531" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNzcyNQ_e2a21d8f-3917-4c73-8dfb-3b74f2a8d401">85</ix:nonFraction>% of the lower of the fair market value of a share of our common stock on the first day of the offering period or the last day of the offering period. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective in June 2019, our ESPP program was amended to offer a <ix:nonNumeric contextRef="i2e63e5ad862548fb846d042a7966af01_D20190601-20190630" format="ixt-sec:durwordsen" name="fldm:EmployeeStockPurchasePlanOfferingPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTA5NDI_3a3d7494-b921-415b-914a-ecda26cf2a90">twelve-month</ix:nonNumeric> offering period with <ix:nonFraction unitRef="offering_period" contextRef="i5cf64713f36146589fe70c417cb48244_I20200531" decimals="INF" format="ixt-sec:numwordsen" name="fldm:EmployeeStockPurchasePlanNumberOfSixMonthOfferingPeriods" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNzk3Mg_3254ecb2-26c6-4d25-a5e0-ce196adc1723">two</ix:nonFraction> six-month purchase periods beginning on each of May 31 and November 30. Employees were eligible under the amended program to participate through payroll deductions of up to <ix:nonFraction unitRef="number" contextRef="iec50ef8ea8764ccc81da85f1d3289c10_I20190630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfODE0OA_476db68d-4662-4b52-a7bf-14ba7dfb8349">15</ix:nonFraction>% of their compensation. Employees may not purchase more than $<ix:nonFraction unitRef="usd" contextRef="ic6bc844ecc89460581bfb369e1d5f54c_D20190601-20190630" decimals="INF" format="ixt:numdotdecimal" name="fldm:SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfODIxMQ_b589f5f0-248c-4565-a600-95fad93dd207">25</ix:nonFraction> thousand of stock for any calendar year. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the updated ESPP program, the purchase price at which shares are sold for the first purchase period is <ix:nonFraction unitRef="number" contextRef="i9dad88f3165a4f0eae5db5d9dc24638f_D20190531-20190531" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfODM1Ng_e2a21d8f-3917-4c73-8dfb-3b74f2a8d401">85</ix:nonFraction>% of the lower of the fair market value of a share of our common stock on the first day of the offering period or the last day of the first purchase period. For the second purchase period, the purchase price at which shares are sold is <ix:nonFraction unitRef="number" contextRef="i9dad88f3165a4f0eae5db5d9dc24638f_D20190531-20190531" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfODU5Mw_e2a21d8f-3917-4c73-8dfb-3b74f2a8d401">85</ix:nonFraction>% of the lower of the fair market value of the common stock on the first day of the offering period and the last day of the offering period. In the event the fair market value of the common stock at the beginning of the second purchase period is less than the fair market value on the beginning of the offering period, the purchase price for the second offering period is reset to <ix:nonFraction unitRef="number" contextRef="i9dad88f3165a4f0eae5db5d9dc24638f_D20190531-20190531" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfODk3NQ_e2a21d8f-3917-4c73-8dfb-3b74f2a8d401">85</ix:nonFraction>% of the lower of the fair value of the common stock at the beginning of the second purchase period and the last day of the offering period.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The offering period of June 1, 2019 to May 31, 2020 had <ix:nonFraction unitRef="offering_period" contextRef="i5cf64713f36146589fe70c417cb48244_I20200531" decimals="INF" format="ixt-sec:numwordsen" name="fldm:EmployeeStockPurchasePlanNumberOfSixMonthOfferingPeriods" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfOTE3Mw_3254ecb2-26c6-4d25-a5e0-ce196adc1723">two</ix:nonFraction> purchase periods, with one period ending November 30, 2019 and the other period ending May 31, 2020. As the fair market value of the common stock at November 30, 2019 was lower than the fair value of the common stock at the beginning of the offering period, the purchase price for the second purchase period was reset based on the lower of the November 30, 2019 price and the May 31, 2020 price. The resetting of the purchase price is considered to be a modification of the original terms of the award. Under ASC 718, the incremental fair value based on the </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i763b7a1865a1456d92f647eaf010a6dd"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">difference between the fair value of the modified award and the fair value of the original award immediately before it was modified was approximately $<ix:nonFraction unitRef="usd" contextRef="i12094595ba954861a1470caab2024faa_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfOTg4NA_1290cb41-cd8a-4656-a8a1-2c9198a7bc86">0.3</ix:nonFraction> million. This amount was amortized over the remaining offering period which ended May 31, 2020. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, our board of directors authorized, and in June 2020, our stockholders approved, an amendment and restatement of the ESPP that increased the number of shares reserved for issuance by an additional <ix:nonFraction unitRef="shares" contextRef="if87552129e8440cebc8cf50867ede516_D20200601-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTAxODc_4340d34a-f747-4320-a34a-a332d4831caf">3.0</ix:nonFraction> million shares and made various other changes. Effective June 2020, our ESPP program was amended to offer a <ix:nonNumeric contextRef="i28c40c94918f4477a5ef78ff4d1aaa6a_D20200601-20200630" format="ixt-sec:durwordsen" name="fldm:EmployeeStockPurchasePlanOfferingPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTA5MzE_0f0bbaad-ed37-4c00-817a-c30ff8d96ba9">six-month</ix:nonNumeric> offering period, with a new offering and purchase period commencing on the first trading day on or after May 31 and November 30 of each year. Employees are eligible under the amended program to participate through payroll deductions of up to <ix:nonFraction unitRef="number" contextRef="ic4e3f90a457a4d718ca93f052c881c93_I20200630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTA1NDE_a5155984-d4ce-40ca-9983-7476c7588298">10</ix:nonFraction>% of their compensation. Employees may not purchase more than $<ix:nonFraction unitRef="usd" contextRef="ic6bc844ecc89460581bfb369e1d5f54c_D20190601-20190630" decimals="INF" format="ixt:numdotdecimal" name="fldm:SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTA2MDQ_b589f5f0-248c-4565-a600-95fad93dd207">25</ix:nonFraction> thousand of stock for any calendar year. The purchase price of the shares sold under the ESPP is <ix:nonFraction unitRef="number" contextRef="i28c40c94918f4477a5ef78ff4d1aaa6a_D20200601-20200630" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTA2OTU_032b6d4e-ec5d-41ac-b239-d6bddc995cd5">85</ix:nonFraction>% of the lower of fair market value of a share of our common stock on the first day of the offering period or the last day of the offering period.</span></div><ix:continuation id="i46b9e111d0014d2d84e18f0dac1f2500"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense recognized was as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.655%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.202%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units, stock options and performance share units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4856057ff874e7e95190bbf158b2cc5_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjI4M2FjZDU2ZjFiZjQyYzFhZjFkMGFkYzU4ZTM5OTg5L3RhYmxlcmFuZ2U6MjgzYWNkNTZmMWJmNDJjMWFmMWQwYWRjNThlMzk5ODlfMi0yLTEtMS0w_c60293be-0b60-4047-8bc7-68a2039b1820">4,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b89a3284da34463afa07821cc02ca87_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjI4M2FjZDU2ZjFiZjQyYzFhZjFkMGFkYzU4ZTM5OTg5L3RhYmxlcmFuZ2U6MjgzYWNkNTZmMWJmNDJjMWFmMWQwYWRjNThlMzk5ODlfMi00LTEtMS0w_7b93611a-d985-4348-a199-4db6d2424d36">2,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73d9e7c6273e4f8d91c0d44a383a2ca2_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjI4M2FjZDU2ZjFiZjQyYzFhZjFkMGFkYzU4ZTM5OTg5L3RhYmxlcmFuZ2U6MjgzYWNkNTZmMWJmNDJjMWFmMWQwYWRjNThlMzk5ODlfMi02LTEtMS0w_65bc2ce8-e38a-44d6-b360-1bb994ff85b8">9,558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i478d956acce94a509514c698c820bfdc_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjI4M2FjZDU2ZjFiZjQyYzFhZjFkMGFkYzU4ZTM5OTg5L3RhYmxlcmFuZ2U6MjgzYWNkNTZmMWJmNDJjMWFmMWQwYWRjNThlMzk5ODlfMi04LTEtMS0w_8675e1b8-2e8b-4fb6-b9f4-1457b416ddd1">7,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ce4b9d2150942418669ac5b5403bf4e_D20200701-20200930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjI4M2FjZDU2ZjFiZjQyYzFhZjFkMGFkYzU4ZTM5OTg5L3RhYmxlcmFuZ2U6MjgzYWNkNTZmMWJmNDJjMWFmMWQwYWRjNThlMzk5ODlfMy0yLTEtMS0w_142cca3c-1454-49cc-9592-e03c29bc10ae">243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1826be0f06d44338b008edc9592cb9bf_D20190701-20190930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjI4M2FjZDU2ZjFiZjQyYzFhZjFkMGFkYzU4ZTM5OTg5L3RhYmxlcmFuZ2U6MjgzYWNkNTZmMWJmNDJjMWFmMWQwYWRjNThlMzk5ODlfMy00LTEtMS0w_a15eb970-99d3-463d-81f9-d0bdf10e53b4">291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefccdb36374e4d188b0f54d8e13766ac_D20200101-20200930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjI4M2FjZDU2ZjFiZjQyYzFhZjFkMGFkYzU4ZTM5OTg5L3RhYmxlcmFuZ2U6MjgzYWNkNTZmMWJmNDJjMWFmMWQwYWRjNThlMzk5ODlfMy02LTEtMS0w_7b5cd2d7-ac2f-469c-9e94-b7d4940f7338">800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6205bf705fb745b9b232a8a68ddc2049_D20190101-20190930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjI4M2FjZDU2ZjFiZjQyYzFhZjFkMGFkYzU4ZTM5OTg5L3RhYmxlcmFuZ2U6MjgzYWNkNTZmMWJmNDJjMWFmMWQwYWRjNThlMzk5ODlfMy04LTEtMS0w_aa7716ba-99ad-4c25-8eff-772e6b92e068">561</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjI4M2FjZDU2ZjFiZjQyYzFhZjFkMGFkYzU4ZTM5OTg5L3RhYmxlcmFuZ2U6MjgzYWNkNTZmMWJmNDJjMWFmMWQwYWRjNThlMzk5ODlfNC0yLTEtMS0w_1a74b370-0383-42fc-80ff-028a0c4e0f98">4,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjI4M2FjZDU2ZjFiZjQyYzFhZjFkMGFkYzU4ZTM5OTg5L3RhYmxlcmFuZ2U6MjgzYWNkNTZmMWJmNDJjMWFmMWQwYWRjNThlMzk5ODlfNC00LTEtMS0w_d4727a5e-c198-4e5e-b56a-b316a652ab0d">3,029</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjI4M2FjZDU2ZjFiZjQyYzFhZjFkMGFkYzU4ZTM5OTg5L3RhYmxlcmFuZ2U6MjgzYWNkNTZmMWJmNDJjMWFmMWQwYWRjNThlMzk5ODlfNC02LTEtMS0w_f5f3a44e-adaa-4063-8250-f6b72cd3c82f">10,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjI4M2FjZDU2ZjFiZjQyYzFhZjFkMGFkYzU4ZTM5OTg5L3RhYmxlcmFuZ2U6MjgzYWNkNTZmMWJmNDJjMWFmMWQwYWRjNThlMzk5ODlfNC04LTEtMS0w_16743c44-d4a3-494d-adc1-fc9ab0851fff">8,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_73"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13. <ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83My9mcmFnOjk3NjBjYjIwODE5ODQ1ZWRiYjNlZGYyMzg1OTg1YTM0L3RleHRyZWdpb246OTc2MGNiMjA4MTk4NDVlZGJiM2VkZjIzODU5ODVhMzRfMzA4Mw_f36d0e64-fd70-4c20-a1b4-af28406867e4" continuedAt="i85ce229594f74752b61c1657e779c016" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="i85ce229594f74752b61c1657e779c016"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our quarterly provision for income taxes is based on an estimated effective annual income tax rate. Our quarterly provision for income taxes also includes the tax impact of certain unusual or infrequently occurring items, if any, including changes in judgment about valuation allowances and effects of changes in tax laws or rates, in the interim period in which they occur.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded a tax benefit of $<ix:nonFraction unitRef="usd" contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83My9mcmFnOjk3NjBjYjIwODE5ODQ1ZWRiYjNlZGYyMzg1OTg1YTM0L3RleHRyZWdpb246OTc2MGNiMjA4MTk4NDVlZGJiM2VkZjIzODU5ODVhMzRfMTA5OTUxMTYzMTE2Ng_3936d724-5323-4a32-9b99-89df3b1ef0a2">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83My9mcmFnOjk3NjBjYjIwODE5ODQ1ZWRiYjNlZGYyMzg1OTg1YTM0L3RleHRyZWdpb246OTc2MGNiMjA4MTk4NDVlZGJiM2VkZjIzODU5ODVhMzRfMTA5OTUxMTYzMTE3Mg_72ae63fa-22b2-4457-ae99-30ef8ac769d4">2.1</ix:nonFraction> million for the three and nine months ended September&#160;30, 2020, respectively. We recorded a tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83My9mcmFnOjk3NjBjYjIwODE5ODQ1ZWRiYjNlZGYyMzg1OTg1YTM0L3RleHRyZWdpb246OTc2MGNiMjA4MTk4NDVlZGJiM2VkZjIzODU5ODVhMzRfMTA5OTUxMTYzMTE2Mw_110094f5-bbf5-47d8-8243-2605e7b842f4">1.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83My9mcmFnOjk3NjBjYjIwODE5ODQ1ZWRiYjNlZGYyMzg1OTg1YTM0L3RleHRyZWdpb246OTc2MGNiMjA4MTk4NDVlZGJiM2VkZjIzODU5ODVhMzRfMTA5OTUxMTYzMTE3NQ_eb946e20-7e1f-4b19-bdbe-7dd9d4b64d17">2.3</ix:nonFraction> million for the three and nine months ended September&#160;30, 2019, respectively. The benefits for all periods were primarily attributable to the tax benefit from the amortization of our acquisition-related deferred tax liabilities partially offset by tax provisions for our foreign operations and state minimum income taxes. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our tax benefit for income taxes for the periods presented differ from the 21% U.S. Federal statutory rate for the nine months ended September&#160;30, 2020 and 2019, respectively, primarily due to maintaining a valuation allowance for most of our deferred tax assets, which primarily consist of net operating loss carryforwards. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our tax positions are subject to audits by multiple tax jurisdictions. We believe that we have provided adequate reserves for uncertain tax positions for all tax years still open for assessment. For the three and nine months ended September&#160;30, 2020,&#160;and 2019, respectively, we did&#160;not recognize any material interest or penalties related to uncertain tax positions.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recording deferred tax assets is appropriate when realization of these assets is more likely than not. Assessing the realizability of deferred tax assets is dependent upon several factors including historical financial results and future expected financial results. The deferred tax assets have been offset by valuation allowances. In the future we may release valuation allowances and recognize deferred tax assets in certain of our foreign subsidiaries depending on the achievement of future profitability in the relevant jurisdictions. Any release of valuation allowances could have the effect of decreasing the income tax provision in the period the valuation allowance is released. We continue to monitor the likelihood that we will be able to recover our deferred tax assets, including those for which a valuation allowance is recorded. There can be no assurance that we will generate profits in the future periods enabling us to fully realize our deferred tax assets. The timing of recording a valuation allowance or the reversal of such valuation allowance is subject to objective and subjective factors that cannot be readily predicted in advance.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the Coronavirus Aid, Relief and Economic Security (CARES) Act was signed into law. The CARES Act includes provisions relating to refundable payroll tax credits, net operating loss carryback periods, alternative minimum tax credit refunds, modifications to the net interest deduction limitations and technical corrections to the tax deprecation methods for qualified improvement property. We are currently analyzing the impact of these changes and therefore, an estimate of the impact on income taxes, if any, is not yet available.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_76"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14. <ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83Ni9mcmFnOjI0Mjg3MjExYTQ4ZDQ4YmFiNzY2Njg0NGE5ZDYwMjhhL3RleHRyZWdpb246MjQyODcyMTFhNDhkNDhiYWI3NjY2ODQ0YTlkNjAyOGFfMTY4NQ_6d564ceb-aef8-4c5c-8f44-e01ded259ce8" continuedAt="i6dda5c540a2a4a94b57afead66387d2b" escape="true">Information About Geographic Areas</ix:nonNumeric></span></div><ix:continuation id="i6dda5c540a2a4a94b57afead66387d2b"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in <ix:nonFraction unitRef="segment" contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83Ni9mcmFnOjI0Mjg3MjExYTQ4ZDQ4YmFiNzY2Njg0NGE5ZDYwMjhhL3RleHRyZWdpb246MjQyODcyMTFhNDhkNDhiYWI3NjY2ODQ0YTlkNjAyOGFfNTg_d45f1df8-3c6a-44e8-b2ef-1dcf286d4d81">one</ix:nonFraction> reporting segment that develops, manufacturers and commercializes tools for life sciences research. Our chief executive officer manages our operations and evaluates our financial performance on a consolidated basis. For purposes of allocating resources and evaluating regional financial performance, our chief executive officer reviews separate sales information for the different regions of the world. Our general and administrative expenses and our research and development expenses are not allocated to any specific region. Most of our principal operations, other than manufacturing, and our decision-making functions are located at our corporate headquarters in the United States.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary table of our total revenue by geographic areas of our customers and by product and services for the three and nine months ended September&#160;30, 2020 and 2019 is included in Note 5 to the condensed consolidated financial statements. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales to customers in the United States represented $<ix:nonFraction unitRef="usd" contextRef="iaff11e46a2f34810b12b962e4ab4033d_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83Ni9mcmFnOjI0Mjg3MjExYTQ4ZDQ4YmFiNzY2Njg0NGE5ZDYwMjhhL3RleHRyZWdpb246MjQyODcyMTFhNDhkNDhiYWI3NjY2ODQ0YTlkNjAyOGFfOTk3_5fd23c56-d8fa-45dd-9ce4-89e66aaa9829">23.3</ix:nonFraction> million, or <ix:nonFraction unitRef="number" contextRef="iaff11e46a2f34810b12b962e4ab4033d_D20200701-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83Ni9mcmFnOjI0Mjg3MjExYTQ4ZDQ4YmFiNzY2Njg0NGE5ZDYwMjhhL3RleHRyZWdpb246MjQyODcyMTFhNDhkNDhiYWI3NjY2ODQ0YTlkNjAyOGFfMTAwNA_6fc41a51-89f6-4b05-896b-d391537794f6">58</ix:nonFraction>% of total revenues, and $<ix:nonFraction unitRef="usd" contextRef="i028e85ad01cf4114b46ee8d96cd7d003_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83Ni9mcmFnOjI0Mjg3MjExYTQ4ZDQ4YmFiNzY2Njg0NGE5ZDYwMjhhL3RleHRyZWdpb246MjQyODcyMTFhNDhkNDhiYWI3NjY2ODQ0YTlkNjAyOGFfMTAzMA_726a5846-23f9-4f48-b811-5e4d5833a5be">50.7</ix:nonFraction> million, or <ix:nonFraction unitRef="number" contextRef="i028e85ad01cf4114b46ee8d96cd7d003_D20200101-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83Ni9mcmFnOjI0Mjg3MjExYTQ4ZDQ4YmFiNzY2Njg0NGE5ZDYwMjhhL3RleHRyZWdpb246MjQyODcyMTFhNDhkNDhiYWI3NjY2ODQ0YTlkNjAyOGFfMTAzNw_f9ed6067-94b4-4dcd-8e69-51107a7b21d2">54</ix:nonFraction>% of total revenues, for the three and nine months ended September&#160;30, 2020, respectively. Sales to customers in the United States represented $<ix:nonFraction unitRef="usd" contextRef="ie397e48475d94899ad01bc3593897a72_D20190701-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83Ni9mcmFnOjI0Mjg3MjExYTQ4ZDQ4YmFiNzY2Njg0NGE5ZDYwMjhhL3RleHRyZWdpb246MjQyODcyMTFhNDhkNDhiYWI3NjY2ODQ0YTlkNjAyOGFfMTEzOQ_728b8cb4-bec5-4b9b-9b88-45c6e3e996a5">10.5</ix:nonFraction> million, or <ix:nonFraction unitRef="number" contextRef="ie397e48475d94899ad01bc3593897a72_D20190701-20190930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83Ni9mcmFnOjI0Mjg3MjExYTQ4ZDQ4YmFiNzY2Njg0NGE5ZDYwMjhhL3RleHRyZWdpb246MjQyODcyMTFhNDhkNDhiYWI3NjY2ODQ0YTlkNjAyOGFfMTE0Ng_aa1775ef-10ad-403c-9eb3-a27af349eb00">40</ix:nonFraction>% of total revenues, and $<ix:nonFraction unitRef="usd" contextRef="i37d450f4eec141f1aa6f1972f269f72d_D20190101-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83Ni9mcmFnOjI0Mjg3MjExYTQ4ZDQ4YmFiNzY2Njg0NGE5ZDYwMjhhL3RleHRyZWdpb246MjQyODcyMTFhNDhkNDhiYWI3NjY2ODQ0YTlkNjAyOGFfMTE3Mg_3e7b4309-5903-4252-91cc-f8d9fd0c589d">32.9</ix:nonFraction> million, or <ix:nonFraction unitRef="number" contextRef="i37d450f4eec141f1aa6f1972f269f72d_D20190101-20190930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83Ni9mcmFnOjI0Mjg3MjExYTQ4ZDQ4YmFiNzY2Njg0NGE5ZDYwMjhhL3RleHRyZWdpb246MjQyODcyMTFhNDhkNDhiYWI3NjY2ODQ0YTlkNjAyOGFfMTE3OQ_fba683f8-4032-4b76-b99d-f4c1298531f5">39</ix:nonFraction>% of total revenues, for the three and nine months ended September&#160;30, 2019, respectively. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No foreign country or jurisdiction had sales in excess of 10% of total revenues for the three months ended September&#160;30, 2020 and 2019, except for China, which had total revenues of $<ix:nonFraction unitRef="usd" contextRef="i9aa3f12a222e452b988bb807b5313e33_D20190701-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83Ni9mcmFnOjI0Mjg3MjExYTQ4ZDQ4YmFiNzY2Njg0NGE5ZDYwMjhhL3RleHRyZWdpb246MjQyODcyMTFhNDhkNDhiYWI3NjY2ODQ0YTlkNjAyOGFfMTQyMA_6eeda073-0a70-459b-9d80-97f73a63064d">3.9</ix:nonFraction> million, or <ix:nonFraction unitRef="number" contextRef="i9aa3f12a222e452b988bb807b5313e33_D20190701-20190930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83Ni9mcmFnOjI0Mjg3MjExYTQ4ZDQ4YmFiNzY2Njg0NGE5ZDYwMjhhL3RleHRyZWdpb246MjQyODcyMTFhNDhkNDhiYWI3NjY2ODQ0YTlkNjAyOGFfMTQyNw_91bc5917-f2a6-4d87-9ef6-517b3c04b766">15</ix:nonFraction>% of total revenues for the three months ended September&#160;30, 2019. There was no foreign country or jurisdiction with sales in excess of 10% of our total revenues for the nine months ended September&#160;30, 2020 or 2019, except for China, which had sales of $<ix:nonFraction unitRef="usd" contextRef="i3d3e63bab0634cd1b9e1748d9bddf3cb_D20190101-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83Ni9mcmFnOjI0Mjg3MjExYTQ4ZDQ4YmFiNzY2Njg0NGE5ZDYwMjhhL3RleHRyZWdpb246MjQyODcyMTFhNDhkNDhiYWI3NjY2ODQ0YTlkNjAyOGFfMTYxNg_a5014f6c-6ef1-4667-9f82-97a65fd0f47d">11.4</ix:nonFraction> million, or <ix:nonFraction unitRef="number" contextRef="i3d3e63bab0634cd1b9e1748d9bddf3cb_D20190101-20190930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83Ni9mcmFnOjI0Mjg3MjExYTQ4ZDQ4YmFiNzY2Njg0NGE5ZDYwMjhhL3RleHRyZWdpb246MjQyODcyMTFhNDhkNDhiYWI3NjY2ODQ0YTlkNjAyOGFfMTYyMw_151ffc18-4fdd-4480-bfc2-9066a8673235">13</ix:nonFraction>% of total revenues, for the nine months ended September&#160;30, 2019.</span></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_79"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15. <ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83OS9mcmFnOmRkYzcyZThhYjBhMjRhNmM5MWMwMDc3MDEzYjBkYmM5L3RleHRyZWdpb246ZGRjNzJlOGFiMGEyNGE2YzkxYzAwNzcwMTNiMGRiYzlfNTgy_a8179f8c-0481-4ee4-8514-1a4bfa6bd7a1" continuedAt="i01a65cf6b66b4b0889a9706367c6a60b" escape="true">Development Agreement </ix:nonNumeric></span></div><div style="margin-bottom:8pt;text-indent:18pt"><ix:continuation id="i01a65cf6b66b4b0889a9706367c6a60b"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective March 31, 2020, we signed an OEM Supply and Development Agreement (Development Agreement) with a customer. Under the Development Agreement, Fluidigm will develop products based on our microfluidics technology. The Development Agreement provides up-front and periodic milestone payments of up to $<ix:nonFraction unitRef="usd" contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930" decimals="INF" format="ixt:numdotdecimal" name="fldm:UpFrontAndMilestonePaymentsMaximum" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83OS9mcmFnOmRkYzcyZThhYjBhMjRhNmM5MWMwMDc3MDEzYjBkYmM5L3RleHRyZWdpb246ZGRjNzJlOGFiMGEyNGE2YzkxYzAwNzcwMTNiMGRiYzlfMzM3_ca4fe1c0-816e-4fc5-9f09-c185346cadb8">11.7</ix:nonFraction>&#160;million during the development stage. The development stage is expected to last approximately <ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" format="ixt-sec:durwordsen" name="fldm:CollaborativeArrangementTerm" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83OS9mcmFnOmRkYzcyZThhYjBhMjRhNmM5MWMwMDc3MDEzYjBkYmM5L3RleHRyZWdpb246ZGRjNzJlOGFiMGEyNGE2YzkxYzAwNzcwMTNiMGRiYzlfNDI2_375fbaa8-34e7-4a24-8d77-677bc9fe59c8">one year</ix:nonNumeric> from the date of the agreement. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized $<ix:nonFraction unitRef="usd" contextRef="ied63bbfdfbdd4d17b689fb84bd615a22_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83OS9mcmFnOmRkYzcyZThhYjBhMjRhNmM5MWMwMDc3MDEzYjBkYmM5L3RleHRyZWdpb246ZGRjNzJlOGFiMGEyNGE2YzkxYzAwNzcwMTNiMGRiYzlfMTY0OTI2NzQ0MjI1Nw_b07523f0-9efc-45c2-8d72-208528d5a95c">3.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib7451c9afcd847cda97b00adbdae3f05_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83OS9mcmFnOmRkYzcyZThhYjBhMjRhNmM5MWMwMDc3MDEzYjBkYmM5L3RleHRyZWdpb246ZGRjNzJlOGFiMGEyNGE2YzkxYzAwNzcwMTNiMGRiYzlfMTA5OTUxMTYyODYxMA_86c803d0-e108-495c-80e7-1fd3935b86c2">6.2</ix:nonFraction>&#160;million of development revenue from this agreement in the three and nine months ended September&#160;30, 2020, respectively.</span></ix:continuation></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_82"></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16. <ix:nonNumeric contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF84Mi9mcmFnOjBmNmU3NWJmZGZkNjRmZjQ5Y2QwNjE2ZTMxYzk0YjUwL3RleHRyZWdpb246MGY2ZTc1YmZkZmQ2NGZmNDljZDA2MTZlMzFjOTRiNTBfMjE3Mg_8a992f8e-073c-4677-99eb-4d8722ec71de" continuedAt="i39bca10043334e27800633160ace44db" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="i39bca10043334e27800633160ace44db" continuedAt="ia60adc663c564600a06659557191b707"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Indemnification</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we have entered into indemnification provisions under certain of our agreements in the ordinary course of business, typically with business partners, customers, and suppliers. Pursuant to these agreements, we may indemnify, hold harmless, and agree to reimburse the indemnified parties on a case-by-case basis for losses suffered or incurred by the indemnified parties in connection with any patent or other intellectual property infringement claim by any third party with respect to our products. The term of these indemnification provisions is generally perpetual from the time of the execution of the agreement. The maximum potential amount of future payments we could be required to make under these indemnification provisions is typically not limited to a specific amount. In addition, we have entered into indemnification agreements with our officers, directors, and certain other employees. With certain exceptions, these agreements provide for indemnification for related expenses including, among others, attorneys&#8217; fees, judgments, fines and settlement amounts incurred by any of these individuals in any action or proceeding. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, a putative class action complaint alleging violations of the federal securities laws was filed against the Company (also naming our Chief Executive Officer and Chief Financial Officer as defendants) in the U.S. District Court for the Northern District of California. The complaint seeks unspecified damages on behalf of a purported class of persons and entities who acquired our common stock between February 7, 2019 and November 5, 2019. The litigation is in its early stages and the lead plaintiff has not yet been determined. We believe the claims alleged in the complaint lack merit and we intend to defend ourselves vigorously.</span></div></ix:continuation><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia60adc663c564600a06659557191b707">From time to time, we may be subject to various legal proceedings and claims arising in the ordinary course of business. These include disputes and lawsuits related to intellectual property, mergers and acquisitions, licensing, contract law, tax, regulatory, distribution arrangements, employee relations and other matters. Periodically, we review the status of each matter and assess its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and a range of possible losses can be estimated, we accrue a liability for the estimated loss. Legal proceedings are subject to uncertainties, and the outcomes are difficult to predict. Because of such uncertainties, accruals are based only on the best information available at the time. As additional information becomes available, we continue to reassess the potential liability related to pending claims and litigation and may revise estimates.</ix:continuation> </span></div><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_88"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_91"></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis should be read together with our condensed consolidated financial statements and the notes to those statements included elsewhere in this Form&#160;10-Q. This Form&#160;10-Q contains forward-looking statements within the meaning of Section&#160;27A of the Securities Act of 1933, as amended (the Securities Act), and Section&#160;21E of the Securities Exchange Act of 1934, as amended, or Exchange Act, that are based on our management&#8217;s beliefs and assumptions and on information currently available to our management. The forward-looking statements are contained principally in the section entitled &#8220;Risk Factors&#8221; and this Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations. Forward-looking statements include information concerning our possible or assumed future cash flow, revenue, sources of revenue and results of operations, cost of product revenue and product margin, operating and other expenses, unit sales and the selling prices of our products, business strategies, financing plans, expansion of our business, competitive position, industry environment, potential growth opportunities, market growth expectations, and the effects of competition and public health crises (including the COVID-19 pandemic) on our business. Forward-looking statements include statements that are not historical facts and can be identified by terms such as &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;could,&#8221; &#8220;seeks,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;plans,&#8221; &#8220;potential,&#8221; &#8220;predicts,&#8221; &#8220;projects,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; or similar expressions and the negatives of those terms.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. We discuss these risks in greater detail in Part II, Item&#160;1A, &#8220;Risk Factors,&#8221; elsewhere in this quarterly report on Form&#160;10-Q, and in our annual report on Form 10-K filed with the Securities and Exchange Commission (SEC). Given these uncertainties, you should not place undue reliance on these forward-looking statements. Also, forward-looking statements represent our management&#8217;s beliefs and assumptions only as of the date of this Form&#160;10-Q.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Except as required by law, we assume no obligation to update these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. You should read this Form&#160;10-Q completely and with the understanding that our actual future results may be materially different from what we expect.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fluidigm&#174;, the Fluidigm logo, Access Array&#8482;, Advanta&#8482;, Biomark&#8482;, Bringing new insights to life&#8482;, C1&#8482;, Callisto&#8482;, Cell-ID&#8482;, CyTOF&#174;, D3&#8482;, Delta Gene&#8482;, Direct&#8482;, Dynamic Array&#8482;, EP1&#8482;, EQ&#8482;, FC1&#8482;, Flex Six&#8482;, Helios&#8482;, High-Precision 96.96 Genotyping&#8482;, HTI&#8482;, Hyperion&#8482;, IMC&#8482;, Imaging Mass Cytometry&#8482;, Immune Profiling Assay&#8482;, Juno&#8482;, Maxpar&#174;, MCD&#8482;, MSL&#174;, Nanoflex&#8482;, Open App&#8482;, Pathsetter&#8482;, Polaris&#8482;, qdPCR 37K&#8482;, Script Builder&#8482;, Script Hub&#8482;, Singular&#8482;, SNP Trace&#8482;, and SNP Type&#8482; are trademarks or registered trademarks of Fluidigm Corporation. Other service marks, trademarks and trade names referred to in this quarterly report on Form&#160;10-Q are the property of their respective owners.</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">___________________________</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the context requires otherwise, references in this Form&#160;10-Q to &#8220;Fluidigm,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to Fluidigm Corporation and its subsidiaries.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fluidigm is a global company that improves life through comprehensive health insight. Our innovative technologies and multi-omic tools are used by researchers to reveal meaningful insights into health and disease, identify biomarkers to inform decisions, and accelerate the development of more effective therapies. We create, manufacture, and market a range of products and services, including instruments, reagents and software that are used by researchers and clinical labs worldwide. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our focus is on the most pressing needs in translational and clinical research, including infectious disease, cancer, immunology and immunotherapy. We use proprietary CyTOF&#174; and microfluidics technologies to develop innovative end-to-end solutions that have the flexibility required to meet the needs of translational research and the robustness to support high-impact clinical research studies.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell our products to leading academic, government, pharmaceutical, biotechnology, clinical, and plant and animal research laboratories worldwide. We distribute our systems through our direct sales force and support organizations located in North America, Europe, and Asia-Pacific, and through distributors or sales agents in several European, Latin American, Middle Eastern, and Asia-Pacific countries.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our manufacturing operations are located in Singapore and Canada. Our facility in Singapore manufactures our genomics instruments, which are assembled by our contract manufacturer located within our Singapore facility. All of our microfluidics IFCs are fabricated at our Singapore facility. Our mass cytometry instruments, assays and reagents are manufactured at our facility in Canada. We also use U.S.-based third-party contract manufacturers for reagent manufacturing.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="text-indent:27pt"><span><br/></span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total revenue for the nine months ended September&#160;30, 2020 was $93.5 million compared to $84.8 million for the nine months ended September&#160;30, 2019. Our total revenue was $117.2 million in 2019 and $113.0 million in 2018. We have incurred significant net losses since our inception in 1999 and, as of September&#160;30, 2020, our accumulated deficit was $658.7 million.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Developments</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have been responding to the COVID-19 pandemic by taking steps to protect our employees, support our customers, and manage our liquidity. As Fluidigm is a designated essential business, our employees have been working from home offices or our laboratories and offices, and in some cases, at customer sites. We have implemented health and safety practices in accordance with evolving government and public health agency guidelines in all of our facilities around the world, including maintaining social distancing and enhanced cleaning protocols, facilities modifications, temperature checks in some locations, and usage of face masks and other personal protective equipment where appropriate. Other operational adjustments made in response to COVID-19 include increased raw material stocking and proactive supplier management.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have activated our business continuity plans as a result of this pandemic, which include steps taken not only to help keep our workforce healthy and safe, but also to ensure a strong data security and internal control environment. Our controls around financial reporting have been modified slightly as needed to reflect the impact of working remotely. To date we have not needed to take advantage of extended SEC filing deadlines. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While Fluidigm is a designated essential business, widespread global adoption of work-from-home and shelter-in-place orders have resulted in a significant slowdown in customer activities for much of the year. In the first half of 2020, we saw near-term COVID-19-related priorities temporarily displacing longer term projects and research activities. As customers return to work, we have seen some customer ordering recover, but the timing of complete recovery remains uncertain, given additional waves of infection and timing of a vaccine. We estimate that about 10% of our customers are either closed or working at reduced capacity as of the end of September 2020 because of the COVID-19 pandemic, compared to 30-40% in June 2020. We believe the impact of COVID-19 on our customers has resulted in expected sales of our mass cytometry instrument systems to be delayed to future periods. The development of COVID-19-related applications has positively impacted sales of our microfluidics instruments, consumables, and mass cytometry reagents. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the beginning of the COVID-19 pandemic, Fluidigm has been working with a growing body of researchers around the world who are aggressively responding to the pandemic. In June 2020, we submitted an emergency use authorization (EUA) application with the U.S. Food and Drug Administration (FDA) for our saliva-based Advanta Dx SARS-CoV-2 Assay, and the FDA granted the EUA in August 2020. In addition, Fluidigm is actively supporting customers who are developing lab-developed tests, as well as customers who are providing COVID-19 diagnostic tests outside of the U.S.  Fluidigm&#8217;s mass cytometry technology and workflows are also being used by our customers in the U.S. and Europe for multi-site COVID-19 patient immune profiling studies. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our microfluidics and mass cytometry capabilities can play a significant role in virus detection as well as in immune profiling of patients and populations. Furthermore, we believe our technologies and solutions will be important to the durable response from government and medical institutions to be prepared for future outbreaks. Despite these opportunities, there is still uncertainty regarding the impact of COVID-19 on the global economy, our customers, and our business over the near term. Also, though we are now able to sell our Advanta Dx SARS-CoV-2 Assay for diagnostic use and certain clinical laboratory customers are developing lab developed tests using our technology, our experience selling into diagnostic markets is limited and we face significant competition. Many of our target customers in these markets do not have significant prior experience using Fluidigm instruments and consumables, and require validation steps and assistance in establishing, integrating and scaling up testing programs using our technology and products. Also, many such laboratories have experience working with certain of our competitors for diagnostic testing, and we have faced, and expect to continue to face, complex sales processes and competition in the COVID-19 testing market. We expect to seek collaborations with third parties and invest in customer support infrastructure and personnel to meet the challenges associated with penetrating these markets.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have actively sought government funding to support our investment to expand our diagnostics capabilities for microfluidics. In July 2020, we entered into a letter contract with the National Institutes of Health (NIH) for a project under the NIH Rapid Acceleration of Diagnostics (RADx) program. The RADx program provides grants to support a range of new lab-based and point-of-care tests that could significantly increase the number, type and availability of COVID-19 tests. On September 28, 2020, we executed a definitive contract with the NIH as an amendment to the letter contract (collectively, the NIH Contract). The NIH Contract has a total value of up to $34.0 million upon the achievement of certain milestones. Through September&#160;30, 2020, we have achieved milestones with a total value of $18.6 million and have received cash of $11.2 million.  Proceeds from the NIH Contract will be used primarily to expand production capacity and product throughput capabilities for COVID-19 testing with Fluidigm microfluidics technology.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to spend approximately $30.0 million for capital expenditures over the next two quarters for the expansion of our Singapore facility as a result of the NIH Contract.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The NIH has the right to terminate the NIH Contract for convenience.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of termination for convenience, Fluidigm will be paid a percentage of the NIH Contract price reflecting the percentage of the work performed prior to the notice of termination, plus reasonable charges. In the event of termination for cause due to our default, NIH is not liable for supplies or services not accepted. If we fail to deliver within the time specified in the NIH Contract and the delay is due to Fluidigm&#8217;s fault or negligence, we are required to pay liquidated damages in the amount of 33% of the amount(s) already disbursed to date under the NIH Contract within six months from the date of termination.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, we entered into an Open Market Sale Agreement (Sale Agreement) with Jefferies LLC (Jefferies) to sell shares of our common stock having aggregate sales proceeds of up to $50,000,000, from time to time, through an &#8220;at the market&#8221; (ATM) equity offering program under which Jefferies acts as sales agent. During the third quarter of 2020, we sold 2.5 million shares of our common stock, $0.001 par value per share, pursuant to the Sale Agreement, for aggregate gross proceeds of $20.9 million. Our net proceeds were approximately $20.1 million, after deducting related expenses, including commissions of approximately $0.6 million and issuance costs of approximately $0.2 million. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this period of uncertainty, we are actively managing our operating expenses and cash flows in response to the evolving market conditions. In addition, we implemented reductions in our operating expense structure including temporary salary reductions which began in the second quarter and ended in the third quarter of this year and constrained hiring until our business returns to more normal volumes. We have also taken advantage of various government programs available to us. For example, we have applied for or received wage subsidies in certain countries. In the U.S., the Coronavirus Aid, Relief and Economic Security (CARES) Act includes provisions relating to refundable payroll tax credits, deferment of the employer portion of certain payroll taxes, and other tax-related provisions. As a result, we have been preserving cash by deferring payment of U.S. payroll taxes and are currently evaluating the applicability of other provisions in the CARES Act. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are continuing to assess the potential impact of the COVID-19 pandemic on our business and operations. For additional information on the various risks posed by the pandemic, refer to Part II, Item 1A. Risk Factors of this Form 10-Q.</span></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_94"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies, Significant Judgments and Estimates</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our condensed consolidated financial statements and the related notes included elsewhere in this Form 10-Q are prepared in accordance with accounting principles generally accepted in the United States. The preparation of these condensed financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses and related disclosures. We base our estimates on historical experience and on various other assumptions believed to be reasonable, which together form the basis for making judgments about the carrying values of assets and liabilities. The full extent to which the COVID-19 pandemic impacts our business, results of operations and financial condition will depend on numerous evolving factors including, but not limited to, the magnitude and duration of the pandemic, the extent to which it will impact worldwide macroeconomic conditions, including the speed of recovery, and governmental and business reactions to the pandemic. We evaluate our estimates and assumptions on an ongoing basis. To the extent that there are material differences between these estimates and actual results, our future financial statement presentation, financial condition, results of operations, and cash flows will be affected.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have expanded disclosure of our critical accounting policies and estimates in the preparation of our condensed consolidated financial statements during the nine months ended September&#160;30, 2020 compared to those disclosed in our annual report on Form 10-K for the year ended December 31, 2019, as filed with the SEC on February 27, 2020, to reflect the impact of the NIH Contract under the RADx program (see Note 4) and a new development agreement (see Note 15). </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Changes and Accounting Pronouncements</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adoption of New Accounting Guidance</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-15-Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40) which establishes new guidance on the accounting for costs incurred to implement a cloud computing arrangement that is considered a service arrangement. The new guidance requires the capitalization of such costs, aligning it with the accounting for costs associated with developing or obtaining internal-use software. The new guidance is effective for fiscal years beginning after December 15, 2019. The adoption of the new guidance did not have a significant impact on our financial results.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2017, the FASB issued ASU 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The ASU eliminates the requirement for an entity to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, an entity performs its annual, or interim, goodwill impairment testing by comparing the fair value of a reporting unit with its carrying amount and recording an impairment charge for the amount by which the carrying amount exceeds the fair value. The ASU is effective for annual and interim goodwill impairment testing </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">performed for our fiscal year beginning January 1, 2020, with early adoption permitted, which we did not exercise. The adoption of the new guidance did not have a significant impact on our financial results.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FASB issued two ASUs related to financial instruments &#8211; credit losses. The ASUs issued were: (i) in June 2016, ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, and (ii) in November 2018, ASU 2018-19-Codification Improvements to Topic 326, Financial Instruments-Credit Losses. ASU 2016-13 is intended to improve financial reporting by requiring more timely recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. ASU 2018-19 clarifies that receivables arising from operating leases are not within the scope of the credit losses standard, but rather, should be accounted for in accordance with the leasing standard. These ASUs are effective for fiscal years beginning after December 15, 2019, and interim periods within those years, with early adoption permitted. The modified retrospective method is required upon adoption. The adoption of the new guidance resulted in an adjustment of $0.1 million to reduce the accumulated deficit component of stockholders&#8217; equity and decrease current assets by the same amount in the condensed consolidated balance sheet.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06 Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity. The amendment to this ASU reduces the number of accounting models for convertible instruments and allows more contracts to qualify for equity classification, which is expected to result in more convertible instruments being accounted for as a single unit, rather than being bifurcated between debt and equity. The new guidance is effective for fiscal years beginning after December 15, 2021. We are currently evaluating the impact of adoption on our condensed consolidated financial statements.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, the FASB issued ASU 2019-12 Income Taxes (Topic 740)-Simplifying the Accounting for Income Taxes. The amendments in this update improve consistent application of and simplify GAAP for Topic 740 by clarifying and amending existing guidance for, among other items, intra-period allocation, reporting tax law changes and losses in interim periods, state and local taxes not fully based on income and recognition of deferred tax liability related to certain transactions. There is also new guidance related to consolidated group reporting and tax impacts resulting from business combinations. The new guidance is effective for fiscal years beginning after December 15, 2020. We are currently evaluating the impact of adoption on our condensed consolidated financial statements.</span></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_97"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our historical consolidated statements of operations data for the three and nine months ended September&#160;30, 2020 and 2019,&#160;and as a percentage of total revenue for the respective periods (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.781%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,861&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,803&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of product revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,773&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of service revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,769&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,938&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,531&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,966&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,325&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,312&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,668&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,461&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,464)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,816)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,132)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,658)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(885)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(444)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,682)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,636)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from extinguishment of debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(248)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,242)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,055)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,062)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,374)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,999)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,887)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,994)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52,105)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenue primarily from sales of our products and services, and from development agreements, license and royalty agreements, and grants. Our product revenue consists of sales of instruments and consumables. Consumable revenues are largely driven by the size of our installed base of instruments and the annual level of pull-through per instrument. Service revenue is linked to our sales of instruments as our service revenue consists of post-warranty service contracts, preventive maintenance plans, instrument parts, installation and training. We sell our products to leading academic, government, pharmaceutical, biotechnology, clinical, plant and animal research laboratories worldwide. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One customer from which we derived development revenue exceeded 10% of revenue for the three and nine months ended September&#160;30, 2020. No other customer represented more than 10% of total revenue for the three and nine months ended September&#160;30, 2020 or 2019. Revenues from our five largest customers were 31% and 25% of total revenue for the three months ended September&#160;30, 2020 and 2019, respectively. Revenues from our five largest customers were 23% and 20% of total revenue for the nine months ended September&#160;30, 2020 and 2019, respectively. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our revenue by source for the three and nine months ended September&#160;30, 2020 and 2019,&#160;and as a percentage of total revenue for the respective period (in thousands): </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.514%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.785%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year-over-Year Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year-over-Year Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,210&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,666&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,596&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,728&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product and service revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,341&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,296&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,053&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,603&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NA</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">970&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NA</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,861&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,496&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,536&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,803&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our total revenue by geographic area of our customers and as a percentage of total revenue for the three and nine months ended September&#160;30, 2020 and 2019 (in thousands): </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.660%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.785%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year-over-Year Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year-over-Year Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,653&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,112&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,437&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,837&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,490&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,861&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,496&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,536&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,803&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Americas revenue includes revenue generated in the United States of $23.3 million and $50.7 million for the three and nine months ended September&#160;30, 2020, respectively. Sales to customers in the United States represented $10.5 million and $32.9 million for the three and nine months ended September&#160;30, 2019, respectively. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No foreign country or jurisdiction had sales in excess of 10% of total revenues for the three months ended September&#160;30, 2020 and 2019, except for China, which had revenues of $3.9 million, or 15% of total revenues for the three months ended September&#160;30, 2019. There was no foreign country or jurisdiction with sales in excess of 10% of our total revenues for the nine months ended September&#160;30, 2020 or 2019, except for China, which had revenues of $11.4 million, or 13% of total revenues, for the nine months ended September&#160;30, 2019.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_100"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt;text-indent:26.64pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Revenue</span></div><div style="margin-bottom:8pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Three Months ended September&#160;30, 2020</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue increased by $13.4 million or 50%, for the three months ended September&#160;30, 2020 compared to the three months ended September&#160;30, 2019, driven primarily by higher product and service revenue, development revenue, and higher grant revenue. Product revenue increased primarily due to COVID-19-related applications which resulted in higher sales of our microfluidic instruments and consumables and our mass cytometry consumable products.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Americas revenues increased by $12.5 million, or 113%, which includes $8.2 million of higher product and service revenue driven by COVID-19-related opportunities along with $1.1 million of higher grant revenue and $3.2 million of development revenue for the three months ended September&#160;30, 2020 compared to the three months ended September&#160;30, 2019. EMEA revenues fell $0.3 million or 3%. Lower microfluidic consumables and mass cytometry instrument sales were partially offset by increases in microfluidics instrument revenue and service revenue. Favorable foreign exchange rates impacted EMEA revenue by 3%. The $1.1 million, or 17%, increase in Asia-Pacific revenues was driven primarily by higher instrument sales. On a company-wide basis, stronger foreign exchange rates impacted revenues by less than 1% for the three months ended September&#160;30, 2020 compared to the same period in 2019. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nine Months ended September&#160;30, 2020</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue increased by $8.7 million or 10%, for the nine months ended September&#160;30, 2020 compared to the nine months ended September&#160;30, 2019 due to higher development revenue, license revenue, and grant revenue, partially offset by lower product revenue. Lower mass cytometry instrument revenue was partially offset by higher service revenue and microfluidics instrument and consumables sales, driven primarily by COVID-19-related opportunities.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Americas revenues increased by $17.2 million, or 49%, driven by higher development revenue of $6.2 million, higher product and service revenue of $5.9 million, license revenue of $3.1 million, and a $2.1 million increase in grant revenue for the nine months ended September&#160;30, 2020 compared to the nine months ended September&#160;30, 2019. Higher microfluidics revenue was partially offset by decreases in mass cytometry instruments and consumables revenue for the nine months ended September&#160;30, 2020 compared to the nine months ended September&#160;30, 2019. EMEA revenues fell $5.0 million or 17%, for the same period, driven by lower mass cytometry instrument and microfluidics consumables revenue partially offset by higher microfluidics instrument and mass cytometry consumables revenues. A stronger Euro compared to the U.S. dollar favorably impacted EMEA revenues by approximately 1%. The $3.5 million, or 17%, decrease in Asia-Pacific revenues was driven by declines in mass cytometry instrument and microfluidics consumable revenues, partially offset by higher service revenues. On a company-wide basis, foreign exchange rates had a negligible impact for the nine months ended September&#160;30, 2020 compared to the same period in 2019.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Revenue</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product revenue increased by $8.5 million, or 41%, for the three months ended September&#160;30, 2020 compared to the three months ended September 30, 2019. Increases in microfluidic instrument and mass cytometry and microfluidic consumable revenues were partially offset by lower mass cytometry instrument revenue. Higher microfluidics revenue was largely driven by higher unit sales of Biomark and Juno instruments and related consumables, reflecting several COVID-19-related opportunities. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product revenue decreased by $3.1 million, or 5%, for the nine months ended September&#160;30, 2020 compared to the nine months ended September&#160;30, 2019, primarily due to lower sales volumes and lower average selling prices of mass cytometry instruments, partially offset by higher revenue from Biomark and Juno instruments and related consumables. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect the average selling prices of our products to fluctuate over time based on market conditions, product mix, and currency fluctuations. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service Revenue</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service revenue increased by $0.5 million, or 9%, for the three months ended September&#160;30, 2020 compared to the three months ended September&#160;30, 2019. Service plan revenues, which are recognized over the life of the service agreement and are not activity-dependent, drove the majority of the increase in service revenues. As customers have begun to reopen their facilities, we are also seeing increases in training and repair-related revenues. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service revenue increased by $0.6 million, or 4%, for the nine months ended September&#160;30, 2020 compared to the nine months ended September&#160;30, 2019. Service plan revenues drove the majority of the increase, partially offset by lower revenues from training and product maintenance activities. Training and product maintenance revenues declined due primarily to closed customer facilities.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Development Revenue</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective March 31, 2020, we signed an OEM Supply and Development Agreement (Development Agreement) with a customer. Under the Development Agreement, Fluidigm will develop products based on our microfluidics technology. The Development Agreement provides up-front and periodic milestone payments of up to $11.7&#160;million during the development stage. The development stage is expected to last approximately one year from the date of the Development Agreement. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized $3.2 million and $6.2&#160;million of development revenue from this agreement in the three and nine months ended September&#160;30, 2020, respectively.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue under the Development Agreement using an input method based on our costs incurred relative to the total expected cost which determines the extent of our progress toward satisfaction of our obligations under the agreement. Costs associated with the Development Agreement are recorded in research and development expense.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Grant Revenue</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive grants to perform research and development activities over contractually defined periods. Grant revenue in the current quarter is attributable to a grant agreement entered into in the second half of 2019 and which is expected to end in the first half of 2021. Costs associated with grant agreements are recorded in research and development expense.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">License and Royalty Revenue</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, we entered into an agreement to settle intellectual property infringement claims, in which we received a $3.5 million payment in exchange for a perpetual license under certain of our intellectual property. The settlement is considered a multiple-element arrangement with each element accounted for individually. Accordingly, $3.1 million of the proceeds was recognized as license revenue and $0.4 million was offset against legal costs.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product and Service Cost, Product and Service Gross Profit, and Product and Service Margin </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of product revenue includes manufacturing costs incurred in the production process, including component materials, labor and overhead, installation, packaging, and delivery costs. In addition, cost of product revenue includes amortization of developed technology and intangibles,&#160;royalty costs for licensed technologies included in our products, warranty, provisions for slow-moving and obsolete inventory, and stock-based compensation expense. Our cost of product revenue and related product margin may fluctuate depending on the capacity utilization of our manufacturing facilities in response to market conditions and the demand for our products. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of service revenue includes direct labor hours, overhead, and instrument parts. Our cost of service revenue and related service margin may fluctuate depending on the variability in material and labor costs of servicing instruments.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our product and service cost, product and service gross profit and product and service margin for the three and nine months ended September&#160;30, 2020 and 2019 (in thousands): </span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.753%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.847%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.026%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year-over-Year Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year-over-Year Change</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of product revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,773&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,520&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,896</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,009</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of service revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,769&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,531</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,403</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of product and service revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,458&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,427</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,412</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product and service gross profit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,799&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,626</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,191</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product and service margin</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ppts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ppts</span></td></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product and service margin increased by 6.3 percentage points for the three months ended September&#160;30, 2020 compared to the three months ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2019. Fixed depreciation and amortization costs on a higher revenue base positively impacted margins by 3.2 percentage points. Margins were also favorably impacted by COVID-19-related consumable products and lower charges for inventory reserves. This favorability was partially offset by lower average selling prices, lower production volumes of mass cytometry instruments and product mix, which included lower margin microfluidics instruments.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product and service margin increased by 1.0 percentage points for the nine months ended September&#160;30, 2020 compared to the nine months ended September&#160;30, 2019. Fixed depreciation and amortization costs on a higher revenue base contributed 0.2 percentage points to the improvement in the product and service margins. Lower service costs, COVID-19-related consumables products, cost reductions for mass cytometry reagents, and lower charges for inventory reserves also favorably impacted product and service gross margins. This favorability was partially offset by lower average selling prices and production volumes of  mass cytometry instruments and product mix, which included lower margin microfluidics instruments.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our operating expenses for the three and nine months ended September&#160;30, 2020 and 2019 (in thousands): </span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.894%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.779%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year-over-Year Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year-over-Year Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,128&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,125&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,275&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,362&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,783&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,854&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,241&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,049&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense consists primarily of compensation-related costs, product development and material expenses, and other allocated facilities and information technology expenses. Our research and development efforts have focused primarily on enhancing our technologies and supporting development and commercialization of new and existing products and services. Research and development expense also includes costs incurred in conjunction with research grants and development arrangements. We have made substantial investments in research and development since our inception and expect to continue to do so.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense increased by $1.0 million, or 14%, for the three months ended September&#160;30, 2020 compared to the three months ended September&#160;30, 2019. Increases were primarily attributable to higher laboratory supplies and outside service costs related to development and grant projects, partially offset by lower compensation costs. The lower compensation costs reflect temporary salary reductions implemented during the second quarter of 2020, Singapore and Canadian government subsidy programs, and funding from the NIH Contract.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The temporary salary reduction program ended during the third quarter of 2020.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense increased by $1.9 million, or 8%, for the nine months ended September&#160;30, 2020 compared to the nine months ended September&#160;30, 2019. Increases were primarily attributable to higher laboratory supplies and outside service costs related to development and grants projects, partially offset by reduced compensation costs.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our continued investment in research and development is essential to our long-term competitive position and these expenses may increase in future periods.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, General and Administrative</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expense consists primarily of personnel costs for our sales and marketing, business development, finance, legal, human resources, information technology, and general management, as well as professional services, such as legal and accounting services.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expense increased by $1.9 million, or 9%, for the three months ended September&#160;30, 2020 compared to the three months ended September&#160;30, 2019. Facilities cost increased approximately $1.3 million for the three months ended September&#160;30, 2020 compared to the three months ended September&#160;30, 2019, reflecting higher lease costs associated with our new corporate headquarters. Higher legal expenses and an $0.8 million increase in stock-based compensation costs were partially offset by lower travel costs. Travel expense declined $1.4 million in the three months ended September&#160;30, 2020 compared to the three months ended September&#160;30, 2019 due to the COVID-19 pandemic. The remaining increase in selling, general and administrative expense was due to a variety of smaller items.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expense increased by $0.3 million for the nine months ended September&#160;30, 2020 compared to the nine months ended September&#160;30, 2019. Compensation costs fell compared to the prior year period due to the impact of temporary salary reductions implemented in the second quarter of 2020, which salaries were restored to earlier levels in the third quarter of 2020. Travel costs fell $3.0 million compared to the prior period, while costs related to trade shows and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other events fell $1.3 million due to the cancellation of these events in light of the COVID-19 pandemic. Offsetting these declines was $3.4 million of higher facilities costs for the nine months ended September&#160;30, 2020 compared to the nine months ended September&#160;30, 2019, reflecting higher moving and lease costs associated with our new corporate headquarters. In addition, stock-based compensation costs increased by $1.4 million for the nine months ended September&#160;30, 2020 compared to the nine months ended September&#160;30, 2019. The remaining change in selling, general and administrative expense was due to a variety of smaller items. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense, Loss on Extinguishment of Debt and Other Income (Expense), Net </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents these items for the three and nine months ended September&#160;30, 2020 and 2019 (in thousands):</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.894%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.779%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year-over-Year Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year-over-Year Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(885)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(444)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,682)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,636)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from extinguishment of debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NA</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(248)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(778)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(239)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,930)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,716)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, we issued $55.0 million aggregate principal amount of our 5.25% Senior Convertible Notes due 2024 (2019 Notes). Net proceeds of the 2019 Notes issuance were used primarily to retire $50.2 million aggregate principal amount of our Senior Convertible Notes due 2034 (2014 Notes). The 2019 Notes have an effective interest rate of 6.2% compared to the 2014 Notes, which have an effective interest rate 3.0%. The increase in interest expense for the three months ended September&#160;30, 2020 compared to the prior year period reflects the impact of the higher effective interest rate on the 2019 Notes compared to the 2014 Notes.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2014, we closed an underwritten public offering of $201.3 million aggregate principal amount of our 2014 Notes. In March 2018, we entered into separate privately negotiated transactions with certain holders of our 2014 Notes to exchange $150.0 million in aggregate principal amount of the 2014 Notes for our 2.75% Exchange Senior Convertible Notes due 2034 (2018 Notes). The 2018 Notes had an effective interest rate of 12.3%. In the first quarter of 2019, the 2018 Notes were converted into 19.5 million shares of our common stock and the 2018 Notes were retired. We recognized a loss of $9.0 million on the conversion of 2018 Notes, which was included in loss on extinguishment of debt. This amount represents the difference between the fair value of the bonds converted and the carrying value of the bonds at the time of conversion. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense of $2.7 million for the nine months ended September&#160;30, 2020 consists primarily of interest on $55.0 million of 2019 Notes, while interest expense of $3.6 million for the nine months ended September&#160;30, 2019 includes both the interest on $51.3 million of 2014 Notes and a partial quarter of interest expense on $150.0 million of 2018 Notes, which accrued at an effective rate of 12.3%. The higher interest expense for the nine months ended September&#160;30, 2019 compared to the current year-to-date period reflects the impact of higher debt balances and higher interest rates for the first nine months of 2019 compared to the first nine months of 2020.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income of $0.1 million for the three months ended September&#160;30, 2020 is primarily attributable to $0.1 million of foreign exchange gains. Other income of $0.2 million for the three months ended September&#160;30, 2019 includes $0.3 million of interest income, partially offset by $0.1 million of foreign exchange losses. The lower interest income in the current year period is attributable to lower market interest rates. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense of $0.2 million for the nine months ended September&#160;30, 2020 is primarily attributable to $0.5 million of foreign exchange losses, reflecting the impact of a stronger U.S. dollar, partially offset by $0.3 million of interest and other income. Other income of $0.9&#160;million for the nine months ended September&#160;30, 2019 consists primarily of $1.1&#160;million of interest income, offset by $0.2 million of foreign exchange losses.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Benefit</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our tax provision is generally driven by three components: (i) tax provision from our foreign operations, (ii) tax benefits from the amortization of acquisition-related intangible assets, and (iii) discrete items, such as changes in valuation allowances or adjustments upon finalization of tax returns. Depending on the relative value of these components, we can have either a tax benefit or expense for any given period.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded a tax benefit of&#160;$0.2 million, for an effective tax rate of 3.9%, for the three months ended September&#160;30, 2020. For the three months ended September&#160;30, 2019, we recorded a tax benefit of $1.2 million for an effective tax rate of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.3%. For the nine months ended September&#160;30, 2020, we recorded an income tax benefit of $2.1 million for an effective rate of 5.6%. For the nine months ended September&#160;30, 2019, we recorded a tax benefit of $2.3 million, for an effective tax rate of 4.2%. The benefit for all periods was primarily attributable to the tax benefit from the amortization of our acquisition-related deferred tax liabilities partially offset by a provision from our foreign operation and state minimum income taxes.</span></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_103"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources of Liquidity </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, our principal sources of liquidity consisted of $72.3 million of cash and cash equivalents, as well as $1.0 million of restricted cash and $15.0 million of availability under our $15.0 million revolving senior credit facility (Revolving Credit Facility). </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our cash flow summary for the nine months ended September&#160;30, 2020 and 2019 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow summary:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,684)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,691)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,797&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,750)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign exchange rate fluctuations on cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,624&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67,440)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Cash Used in Operating Activities</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive cash flows from operations primarily from cash collected from the sale of our products and services, and license agreements and grants. Our cash flows from operating activities are also significantly influenced by our use of cash for operating expenses and working capital to support our business. We have historically experienced negative cash flows from operating activities as we have expanded our business and built our infrastructure domestically and internationally.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities in the nine months ended September&#160;30, 2020 was $11.7 million and consisted of net loss of $35.0 million, adjusted for non-cash items of $25.4 million, partially offset by a net increase in assets and liabilities of $2.1 million. Non-cash items included amortization of developed technology of $8.9 million, stock-based compensation expense of $10.4 million, depreciation and amortization of $3.0 million, lease amortization of $1.9 million, a provision for excess and obsolete inventory of $0.7 million and a variety of smaller items. The net change in assets and liabilities was primarily due to an increase in inventories of $6.8&#160;million caused by increases in mass cytometry instruments, chips, and reagents, an increase in prepaid expenses and other assets of $2.4 million, primarily comprised of payments to vendors for our Singapore capacity expansion under the NIH Contract and prepaid insurance and a decrease in other liabilities of $0.2 million, partially offset by a decrease in accounts receivable of $1.0 million, an increase in accounts payable of $5.0 million, and an increase in deferred revenue of $1.3 million.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities for the nine months ended September&#160;30, 2019 was $29.7 million and&#160;consisted of net loss of&#160;$52.1 million, adjusted for non-cash items of&#160;$32.5 million, and an increase in the assets and liabilities of $10.1 million. Non-cash items primarily included a $9.0 million loss on extinguishment of debt, amortization of developed technology of $8.4 million, stock-based compensation expense of $8.3 million, amortization of debt discounts, premiums, and issuance costs of $2.1 million, depreciation and amortization of $3.5 million, and a provision for excess and obsolete inventory of $1.4 million. The net change in assets and liabilities included a decrease in other liabilities of $10.5 million, an increase in inventories of $3.7 million, and an increase in prepaid and other assets of $1.3 million, partially offset by a decrease in accounts receivable of $3.2 million, an increase in accounts payable of $0.6 million, and an increase in deferred revenue of $1.6 million.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Cash Provided by (Used in) Investing Activities</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary investing activities consist of purchases, sales, and maturities of our short-term investments and to a much lesser extent, capital expenditures for manufacturing, laboratory, computer equipment and software to support our infrastructure and work force. We expect to continue to incur costs for capital expenditures to expand capacity under the NIH Contract, improve manufacturing efficiencies and strengthen information technology and network security, as well as capital expenditures incurred in moving our corporate headquarters in 2020. However, we may choose to decrease or defer certain capital expenditures and development activities, while further optimizing our organization.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by investing activities in the nine months ended September&#160;30, 2020 was $40.8 million, which was mainly due to proceeds from the NIH Contract of $11.2 million, proceeds from maturities of investments of $31.8 million and proceeds from the sale of investments of $5.0 million, partially offset by the acquisition of InstruNor AS, net of cash acquired, of $5.2 million, and capital expenditures of $2.0&#160;million to support our commercial and manufacturing operations. We expect to spend approximately $30.0 million for capital expenditures over the next two quarters for the expansion of our Singapore facility as a result of the NIH Contract, which will be offset by the proceeds of the NIH Contract.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities in the nine months ended September&#160;30, 2019 was $38.8 million, which consisted of purchases of investments of $52.7 million and capital expenditures of $2.0 million to support our commercial and manufacturing operations, partially offset by $16.0 million of proceeds from maturities of investments.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Cash Provided by Financing Activities</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generated cash from financing activities of $20.4 million during the nine months ended September&#160;30, 2020, which was primarily due to proceeds from our ATM equity offering of $20.2&#160;million, net of commissions, proceeds from stock issuance from the ESPP of $0.6 million, and proceeds from the exercise of stock options of $0.5&#160;million, partially offset by payment of debt and equity issuance costs of $0.5 million, which includes costs from the 2019 Notes offering and the ATM equity offering, and payments for income tax withholding related to net share settlement of equity awards of $0.4 million.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generated cash from financing activities of $1.0 million during the nine months ended September&#160;30, 2019, which included $1.0 million from the exercise of stock options and $0.6 million of ESPP proceeds, partially offset by $0.6 million for income tax withholding related to net share settlement of equity awards, and payment of debt and equity issuance costs of $0.1&#160;million.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capital Resources </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020 and December&#160;31, 2019, our working capital, excluding deferred revenues and restricted cash, was $93.3 million and $74.0 million, respectively, including cash and cash equivalents of $72.3 million and $21.7 million, respectively, and short-term investments of $37.0 million at December&#160;31, 2019. We had no investments outstanding as of September 30, 2020.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2014, we closed an underwritten public offering of $201.3 million in aggregate principal amount of our 2014 Notes. In March 2018, we entered into privately negotiated transactions with certain holders of our 2014 Notes to exchange $150.0 million in aggregate principal amount of the 2014 Notes for $150.0 million in aggregate principal amount of 2018 Notes. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2019, we received notices from holders of the 2018 Notes electing to voluntarily convert $138.1 million in aggregate principal amount of the 2018 Notes. In February 2019, we notified trustee U.S. Bank National Association of our intention to exercise our issuer&#8217;s conversion option with respect to the remaining $11.9 million in aggregate principal amount of 2018 Notes. In total, $150.0 million of the 2018 Notes were converted into 19.5 million shares of our common stock and the 2018 Notes were retired. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, we closed a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of $55.0 million aggregate principal amount of our 2019 Notes. Net proceeds of the 2019 Notes issuance were $52.7 million, after deductions for commissions and other debt issuance costs. $51.8 million of the proceeds was used to retire $50.2 million aggregate principal amount of our 2014 Notes, leaving $1.1 million of aggregate principal amount of our 2014 Notes outstanding. Pursuant to the Indenture governing the 2014 Notes, holders of the 2014 Notes have the right, subject to certain conditions specified in such indenture, to require the Company to purchase their 2014 Notes beginning in February 2021. The private placement of the 2019 Notes, and concurrent repurchase of a portion of the 2014 Notes, had the effect of refinancing a portion of the Company&#8217;s outstanding debt under the 2014 Notes to December 2024.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2019 Notes bear interest at 5.25% per annum, payable semiannually on June 1 and December 1 of each year, beginning on June 1, 2020. The Notes will mature on December 1, 2024, unless earlier repurchased or converted pursuant to their terms. The 2019 Notes will be convertible at the option of the holder at any point prior to close of business on the second scheduled trading day preceding the maturity date. The initial conversion rate of the Notes is 344.8276 shares of the Company&#8217;s common stock per $1,000 principal amount of 2019 Notes (which is equivalent to an initial conversion price of $2.90 per share). The conversion rate will be subject to adjustment upon the occurrence of certain specified events but will not be adjusted for any accrued and unpaid interest. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2019 Notes will also be convertible at our option upon certain conditions in accordance with the terms of the indenture governing the 2019 Notes. On or after December 1, 2021 to December 1, 2022, if the price of the Company&#8217;s common stock has equaled or exceeded 150% of the Conversion Price (as defined in the indenture, currently $2.90, subject to adjustment) for a </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">specified number of days (Issuer&#8217;s Conversion Option), we may, at our option, elect to convert the 2019 Notes in whole but not in part into shares of the Company, determined in accordance with the terms of the indenture. On or after December 1, 2022, if the price of the Company&#8217;s common stock has equaled or exceeded 130% of the Conversion Price then in effect for a specified number of days, we may, at our option, elect to convert the 2019 Notes in whole but not in part into shares of the Company, determined in accordance with the terms of the indenture.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing summaries of the 2014 Notes, the 2018 Notes, the 2019 Notes and the exchange transactions completed in March 2018 and November 2019 are not complete and are qualified in their entirety by the applicable indentures, forms of global notes, and other agreements and documents filed with the SEC.</span></div><div style="margin-bottom:8pt;margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, we entered into the Sale Agreement with Jefferies to sell shares of our common stock having aggregate sales proceeds of up to $50,000,000, from time to time, through the ATM equity offering program under which Jefferies acts as sales agent. During the third quarter of 2020, we sold 2.5 million shares of our common stock, pursuant to the Sale Agreement, for aggregate gross proceeds of $20.9 million. Our net proceeds were approximately $20.1 million, after deducting related expenses, including commissions of approximately $0.6 million and issuance costs of approximately $0.2 million. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 2, 2018, we entered into our Revolving&#160;Credit Facility&#160;with&#160;Silicon Valley Bank (SVB), with a </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">maturity date of August 2, 2020.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Revolving Credit Facility is collateralized by substantially all our property, other than intellectual property. Outstanding loans under the Revolving Credit Facility bear interest, at the greater of (i) prime rate plus 0.50% or (ii) 5.50%. Amounts drawn under the Revolving&#160;Credit Facility&#160;will be used for working capital and general corporate purposes. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 21, 2020, we entered into the Third Amendment to Loan and Security Agreement with SVB (the Amendment), which amends the Loan and Security Agreement dated as of August 2, 2018, between the Company and SVB (as amended by the Default Waiver and First Amendment to Loan and Security Agreement dated September 7, 2018, and the Second Amendment to Loan and Security Agreement dated November 20, 2019, the Revolving Credit Agreement). The Amendment extends the maturity date by two years, to August 2, 2022. We also amended the interest rate to be the greater of (i) prime rate (as customarily defined), plus 0.50%, floating, and (ii) 5.25%. Interest on any outstanding loans continues to be due and payable monthly and the principal balance is due at maturity though loans can be prepaid at any time without penalty. Annual administration fees are unchanged. The Amendment also includes various administrative changes. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, total availability under the Revolving Credit Facility was $15.0 million. We currently have no outstanding debt under the Revolving Credit Facility, and we are in compliance with all the terms and conditions of the Revolving Credit Agreement governing the Revolving Credit Facility. See Note 8 to our consolidated financial statements for more information about the Revolving Credit Facility.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our existing cash, cash equivalents, and investments will be sufficient to meet our working capital and capital expenditure needs for at least the next 18 months. However, we may experience lower than expected cash generated from operating activities or greater than expected capital expenditures, cost of revenue, or operating expenses, and we may need to raise additional capital to fund our operations, further our research and development activities, or acquire or invest in a business. Our future funding requirements will depend on many factors, including market acceptance of our products, the cost of our research and development activities, the cost of filing and prosecuting patent applications, the cost associated with litigation or disputes relating to intellectual property rights or otherwise, the cost and timing of regulatory clearances or approvals, if any, the cost and timing of establishing additional sales, marketing, and distribution capabilities, the cost and timing of establishing additional technical support capabilities, and the effect of competing technological and market developments. In the future, we may acquire businesses or technologies from third parties, and we may decide to raise additional capital through debt or equity financing to the extent we believe this is necessary to successfully complete these acquisitions. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we require additional funds in the future, we may not be able to obtain such funds on acceptable terms, or at all, and our ability to raise additional capital may be adversely impacted by potential worsening global economic conditions and the recent disruptions to and volatility in the credit and financial markets in the United States and worldwide resulting from the COVID-19 pandemic. If we raise additional funds by issuing equity securities, our stockholders could experience dilution. Debt financing, if available, may involve covenants restricting our operations or our ability to incur additional debt. Any additional debt or equity financing that we raise may contain terms that are not favorable to us or our stockholders. If we do not have, or are not able to obtain, sufficient funds, we may have to delay development or commercialization of our products or license to third parties the rights to commercialize products or technologies that we would otherwise seek to commercialize. We also may have to reduce marketing, customer support, research and development, or other resources devoted to our products. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual Obligations and Commitments</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating lease obligations relate to leases for our current corporate headquarters and leases for manufacturing and office space for our foreign subsidiaries. Please see Note 9 to our condensed consolidated financial statements for a discussion of our lease obligations. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than as disclosed above, there have been no material changes during the nine months ended September&#160;30, 2020 to our contractual obligations disclosed in our &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in our annual report on Form 10-K for the year ended December&#160;31, 2019.</span></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_106"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception, we have not had any off-balance sheet arrangements as defined in Item&#160;303(a)(4) of the SEC&#8217;s Regulation&#160;S-K.</span></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_112"></div><div style="margin-bottom:8pt;margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3. Quantitative and Qualitative Disclosures about Market Risk </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily a result of fluctuations in foreign currency exchange rates and interest rates. We do not hold or issue financial instruments for trading purposes.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Exchange Risk</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we expand internationally our results of operations and cash flows will become increasingly subject to fluctuations due to changes in foreign currency exchange rates. Our revenue is generally denominated in the local currency of the contracting party. Historically, the majority of our revenue has been denominated in U.S. dollars. Our expenses are generally denominated in the currencies in which our operations are located, which is primarily in the United States, with a portion of expenses incurred in Singapore and Canada where our manufacturing facilities are located. Our results of operations and cash flows are, therefore, subject to fluctuations due to changes in foreign currency exchange rates. The volatility of exchange rates depends on many factors that we cannot forecast with reliable accuracy. We have experienced and will continue to experience fluctuations in our net income or loss as a result of transaction gains or losses related to revaluing certain current asset and current liability balances that are denominated in currencies other than the functional currency of the entities in which they are recorded. For the nine months ended September&#160;30, 2020, we had a foreign currency loss of $0.5 million compared to a foreign currency loss of $0.2 million in the prior year for the same period. To date, we have not entered into any foreign currency hedging contracts although we may do so in the future. As our international operations grow, we will continue to reassess our approach to manage our risk relating to fluctuations in currency rates. If foreign currency exchange rates had changed by 10% during the periods presented, it would not have had a material impact on our financial position or results of operations.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Sensitivity</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had cash and cash equivalents of $72.3 million as of September&#160;30, 2020. These amounts were held primarily in cash on deposit with banks and money market funds which are short-term. We held no investments in treasury securities at September&#160;30, 2020. Cash, cash equivalents and investments are held for working capital purposes. We believe that we do not have any material exposure to changes in the fair value of our money market portfolio as a result of changes in interest rates. Declines in interest rates, however, will reduce future investment income. If overall interest rates had decreased by 10% during the periods presented, our interest income would not have been materially affected.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not have material exposure to market risk with respect to investments. We do not use derivative financial instruments for speculative or trading purposes. We may adopt specific hedging strategies in the future.</span></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_115"></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4. Controls and Procedures</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of September&#160;30, 2020. The term &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company&#8217;s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of September&#160;30, 2020, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting that occurred during the three months ended September&#160;30, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Limitations on the Effectiveness of Controls</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Control systems, no matter how well conceived and operated, are designed to provide a reasonable, but not an absolute, level of assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. Because of the inherent limitations in any control system, misstatements due to error or fraud may occur and not be detected.</span></div><div style="margin-top:9pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_118"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;II.  OTHER INFORMATION</span></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_121"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. Legal Proceedings</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, a putative class action complaint alleging violations of the federal securities laws was filed against the Company (also naming our Chief Executive Officer and Chief Financial Officer as defendants) in the U.S. District Court for the Northern District of California. The complaint seeks unspecified damages on behalf of a purported class of persons and entities who acquired our common stock between February 7, 2019 and November 5, 2019. The litigation is in its early stages and the lead plaintiff has not yet been determined. We believe the claims alleged in the complaint lack merit and we intend to defend ourselves vigorously.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we are from time to time involved in legal proceedings or potential legal proceedings, including matters involving employment, intellectual property, or others. Although the results of litigation and claims cannot be predicted with certainty, we currently believe that the final outcome of any currently pending matters would not have a material adverse effect on our business, operating results, financial condition, or cash flows. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources, and other factors.</span></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_124"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1A. Risk Factors</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> operate in a rapidly changing environment that involves numerous uncertainties and risks. The following risks and uncertainties may have a material and adverse effect on our business, financial condition, or results of operations. You should consider these risks and uncertainties carefully, together with all of the other information included or incorporated by reference in this Form 10-Q. The risks described below are not the only ones we face. Our business is also subject to the risks that affect many other companies, such as employment relations, general economic conditions, global sociopolitical events, and international operations. Further, additional risks not currently known to us or that we currently believe are immaterial may in the future materially and adversely affect our business, operations, liquidity and stock price. If any of these risks occur, our business, results of operations, or financial condition could suffer, the trading price of our securities could decline, and you may lose all or part of your investment.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Fluidigm&#8217;s Business and Strategy</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The global COVID-19 pandemic has significantly affected our business operations and could adversely impact our financial position and cash flows to an extent that is unknown and difficult to predict. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pandemic and international public health emergency caused by SARS-CoV-2, the novel strain of coronavirus that causes the disease commonly known as COVID-19, has spread throughout all the countries in which we and our customers, suppliers, and other business partners operate, causing significant disruption and volatility in global financial markets and raising the prospect of an extended global recession. Public health problems resulting from COVID-19 and precautionary measures instituted by governments and businesses to mitigate its spread, including travel restrictions and quarantines, could continue to contribute to a general slowdown in the global economy, cause increasingly adverse impacts on our customers, suppliers, and other business partners, and further disrupt our operations. Changes in our operations as a result of the COVID-19 pandemic have resulted in inefficiencies and delays, including in sales and product development efforts, and additional costs related to business continuity initiatives that cannot be fully mitigated through succession planning, employees working remotely, or teleconferencing technologies. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic and related governmental reactions have had, and may continue to have, a negative impact on our business, liquidity, results of operations, and stock price due to the occurrence of some or all of the following events or circumstances among others:</span></div><div style="margin-bottom:6pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reduced demand for some of our products and services due to the impact of COVID-19 on our customers, particularly in the global academic research community;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">diminished business productivity due to inefficiencies in employees working from home or increasing physical distancing and other pandemic response protocols in our production facilities;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased susceptibility to the risk of information technology security breaches and other disruptions due to increased volumes of remote access to our information systems from our employees working at home;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the negative impact of travel restrictions and social distancing policies on our sales operations, marketing efforts, and customer field support;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">impaired ability to hire and effectively train new personnel due to travel restrictions and physical distancing protocols; </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased operating costs if one of our facilities were to experience a COVID-19 outbreak;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disruption of the operations of our contract manufacturers, suppliers, and other business partners; and</span></div><div style="margin-bottom:8pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased volatility in our stock price due to financial market instability.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The extent to which the COVID-19 pandemic will continue to adversely impact our business and financial results will depend on future developments, which are highly uncertain and cannot be predicted with confidence, such as the continued spread of the disease, the duration of the public health emergency, and actions taken in the United States and elsewhere to contain the virus and prevent new outbreaks, such as social distancing and quarantines, business closures or business disruptions.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because the severity, magnitude, and duration of the COVID-19 pandemic and its economic consequences are uncertain and rapidly changing, we are unable to predict the impact of COVID-19 on our operations, our financial performance, and our ability to successfully execute our business strategies and initiatives. The ultimate impact of the COVID-19 pandemic on our operations and financial performance depends on many factors that are not within our control, including, but not limited, to: governmental, business, and individual actions that have been and continue to be taken in response to the pandemic (including restrictions on travel, transport and workforce pressures); the impact of the pandemic and actions taken in response on global and regional economies, travel, and economic activity; the availability of federal, state, local or non-U.S. funding programs; general economic uncertainty in key global markets and financial market volatility; global economic conditions and levels of economic growth; and the pace of recovery when the COVID-19 pandemic subsides.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the COVID-19 crisis continues to adversely affect our operating and financial results, it may also have the effect of heightening many of the other risks described in our other risk factors below. COVID-19 may also affect our operating and financial results in a manner that is not presently known to us or that we currently do not expect to present significant risks to our operations or financial results, particularly if the pandemic and its associated impacts reoccur in the coming months. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our financial results and revenue growth rates have varied significantly from quarter-to-quarter and year-to-year due to a number of factors, and a significant variance in our operating results or rates of growth, if any, could lead to substantial volatility in our stock price.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue, results of operations, and revenue growth rates have varied in the past and may continue to vary significantly from quarter-to-quarter or year-to-year. We may experience substantial variability in our product mix from period-to-period as revenue from sales of our instruments relative to sales of our consumables may fluctuate or deviate significantly from expectations. For example, our revenue declined year-over-year in 2017 compared to 2016, but increased year-over-year in 2018 compared to 2017. Our revenue continued to increase year-over-year in 2019 compared to 2018, but we may not be able to achieve similar revenue growth in future periods. We are also increasingly dependent on our mass cytometry business, which is very capital intensive. Variability in our quarterly or annual results of operations, mix of product revenue, including any decline in our mass cytometry revenue, or variability in rates of revenue growth, if any, may lead to volatility in our stock price as research analysts and investors respond to these fluctuations. These fluctuations are due to numerous factors that are difficult to forecast, including: fluctuations in demand for our products; changes in customer budget cycles and capital spending; seasonal variations in customer operations; tendencies among some customers to defer purchase decisions to the end of the quarter; the large unit value of our systems, particularly our proteomics systems; changes in our pricing and sales policies or the pricing and sales policies of our competitors; our ability to design, manufacture, market, sell, and deliver products to our customers in a timely and cost-effective manner; fluctuations or reductions in revenue from sales of legacy instruments that may have contributed significant revenue in prior periods; quality control or yield problems in our manufacturing operations; our ability to timely obtain adequate quantities of the materials or components used in our products, which in certain cases are purchased through sole and single source suppliers; new product introductions and enhancements by us and our competitors; unanticipated increases in costs or expenses; our complex, variable and, at times, lengthy sales cycle; global economic conditions; and fluctuations in foreign currency exchange rates. Additionally, we have certain customers who have historically placed large orders in multiple quarters during a calendar year. A significant reduction in orders from one or more of these customers could adversely affect our revenue and operating results, and if these customers defer or cancel purchases or otherwise alter their purchasing patterns, our financial results and actual results of operations could be significantly impacted. Other unknown or unpredictable factors also could harm our results.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing factors, as well as other factors, could materially and adversely affect our quarterly and annual results of operations and rates of revenue growth, if any. We have experienced significant revenue growth in the past but we may not achieve similar growth rates in future periods. You should not rely on our operating results for any prior quarterly or annual period as an indication of our future operating performance. If we are unable to achieve adequate revenue growth, our operating results could suffer and our stock price could decline. In addition, a significant amount of our operating expenses are relatively fixed due to our manufacturing, research and development, and sales and general administrative efforts. Any failure to adjust </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">spending quickly enough to compensate for a shortfall relative to our anticipated revenue could magnify the adverse impact of such shortfalls on our results of operations. We expect that our sales will continue to fluctuate on an annual and quarterly basis and that our financial results for some periods may be below those projected by securities analysts, which could significantly decrease the price of our common stock.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We have incurred losses since inception, and we may continue to incur substantial losses for the foreseeable future.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred significant losses in each fiscal year since our inception, including net losses of $64.8 million, $59.0 million, and $60.5 million during the years 2019, 2018, and 2017, respectively. As of September 30, 2020, we had an accumulated deficit of $658.7 million. These losses have resulted principally from costs incurred in our research and development programs, and from our manufacturing costs and selling, general, and administrative expenses. To date, we have funded our operations primarily through equity offerings, the issuance of debt instruments, and from sales of our products. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until we are able to generate additional revenue to support our level of operating expenses, we will continue to incur operating and net losses and negative cash flow from operations.  We believe that our continued investment in research and development, sales, and marketing is essential to our long-term competitive position and future revenue growth and, as a result, we may incur operating losses for the foreseeable future and may never achieve profitability.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The life science markets are highly competitive and subject to rapid technological change, and we may not be able to successfully compete.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The markets for our products are characterized by rapidly changing technology, evolving industry standards, changes in customer needs, emerging competition, new product introductions, and strong price competition. We compete with both established and development stage life science research companies that design, manufacture, and market instruments and consumables for gene expression analysis, single-cell targeted gene expression and protein expression analysis, SNP genotyping, quantitative polymerase chain reaction (qPCR), digital PCR, flow cytometry, cell imaging, and additional applications using well established laboratory techniques, as well as newer technologies such as bead encoded arrays, microfluidics, next generation DNA sequencing, microdroplets, spatial protein expression, and photolithographic arrays. Most of our current competitors have significantly greater name recognition, greater financial and human resources, broader product lines and product packages, larger sales forces, larger existing installed bases, larger intellectual property portfolios, and greater experience and scale in research and development, manufacturing, and marketing than we do. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider Agilent Technologies, Inc., Thermo Fisher Scientific Inc. (Thermo), Bio-Rad Laboratories, Inc., NanoString Technologies, Inc. (NanoString), and Agena Bioscience, Inc. to be our principal competitors in the microfluidics space.  We believe that Cytek Biosciences, Inc. and Becton, Dickinson and Company are currently our principal competitors for our mass cytometry market share, and that IonPath Inc., Akoya Biosciences, Inc., and NanoString are our principal competitors for our Imaging Mass Cytometry&#8482; market share. While the aforementioned principal competitors are the largest and most prevalent in their representative technology areas, the combined markets in which we compete have an additional 10 to 20 smaller competitors with competing approaches and technologies that we routinely face in selling situations.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competitors may be able to respond more quickly and effectively than we can to new or changing opportunities, technologies, standards, or customer requirements. In light of these advantages, even if our technology is more effective than the product or service offerings of our competitors, current or potential customers might accept competitive products and services in lieu of purchasing our technology. We anticipate that we will continue to face increased competition in the future as existing companies and competitors develop new or improved products and as new companies enter the market with new technologies. Increased competition is likely to result in pricing pressures, which could reduce our profit margins and increase our sales and marketing expenses. In addition, mergers, consolidations, or other strategic transactions between two or more of our competitors, or between our competitor and one of our key customers, could change the competitive landscape and weaken our competitive position, adversely affecting our business.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market opportunities may not develop as quickly as we expect, limiting our ability to successfully sell our products, or our product development and strategic plans may change and our entry into certain markets may be delayed, if it occurs at all. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The application of our technologies to high-throughput genomics, single-cell genomics and, particularly, mass cytometry applications are in many cases emerging market opportunities. We believe these opportunities will take several years to develop or mature and we cannot be certain that these market opportunities will develop as we expect. The future growth of our markets and the success of our products depend on many factors beyond our control, including recognition and acceptance by the scientific community, and the growth, prevalence, and costs of competing methods of genetic and protein analysis. Additionally, our success depends on the ability of our sales organization to successfully sell our products into these new markets. If we are not able to successfully market and sell our products, or to achieve the revenue or margins we expect, our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">operating results may be harmed and we may not recover our product development and marketing expenditures. In addition, our product development and strategic plans may change, which could delay or impede our entry into these markets.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If our products fail to achieve and sustain sufficient market acceptance, our revenue will be adversely affected.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends on our ability to develop and market products that are recognized and accepted as reliable, enabling and cost-effective. Most of our potential customers already use expensive research systems in their laboratories and may be reluctant to replace those systems. Market acceptance of our systems will depend on many factors, including our ability to convince potential customers that our systems are an attractive alternative to existing technologies. Compared to some competing technologies, our technology is relatively new, and most potential customers have limited knowledge of, or experience with, our products. Prior to adopting our systems, some potential customers may need to devote time and effort to testing and validating our systems. Any failure of our systems to meet these customer benchmarks could result in customers choosing to retain their existing systems or to purchase systems other than ours, and revenue from the sale of legacy instruments that may have contributed significant revenue in prior periods may decrease.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, it is important that our systems be perceived as accurate and reliable by the scientific and medical research community as a whole. Historically, a significant part of our sales and marketing efforts has been directed at convincing industry leaders of the advantages of our systems and encouraging such leaders to publish or present the results of their evaluation of our system. If we are unable to continue to induce leading researchers to use our systems, or if such researchers are unable to achieve and publish or present significant experimental results using our systems, acceptance and adoption of our systems will be slowed and our ability to increase our revenue would be adversely affected.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may experience development or manufacturing problems or delays that could limit the potential growth of our revenue or increase our losses. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may encounter unforeseen situations in the manufacturing and assembly of our products that would result in delays or shortfalls in our production. For example, our production processes and assembly methods may have to change to accommodate any significant future expansion of our manufacturing capacity, which may increase our manufacturing costs, delay production of our products, reduce our product margin, and adversely impact our business. Conversely, if demand for our products shifts such that a manufacturing facility is operated below its capacity for an extended period, we may adjust our manufacturing operations to reduce fixed costs, which could lead to uncertainty and delays in manufacturing times and quality during any transition period.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, all of our integrated fluidic circuits (IFCs) for commercial sale are manufactured at our facility in Singapore. Production of the elastomeric block that is at the core of our IFCs is a complex process requiring advanced clean rooms, sophisticated equipment, and strict adherence to procedures. Any contamination of the clean room, equipment malfunction, or failure to strictly follow procedures can significantly reduce our yield in one or more batches. We have in the past experienced variations in yields due to such factors. A drop in yield can increase our cost to manufacture our IFCs or, in more severe cases, require us to halt the manufacture of our IFCs until the problem is resolved. Identifying and resolving the cause of a drop in yield can require substantial time and resources. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, developing an IFC for a new application may require developing a specific production process for that type of IFC. While all of our IFCs are produced using the same basic processes, significant variations may be required to ensure adequate yield of any particular type of IFC. Developing such a process can be very time consuming, and any unexpected difficulty in doing so can delay the introduction of a product.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our manufacturing activities are adversely impacted, or if we are otherwise unable to keep up with demand for our products by successfully manufacturing, assembling, testing, and shipping our products in a timely manner, our revenue could be impaired, market acceptance for our products could be adversely affected and our customers might instead purchase our competitors&#8217; products.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If our research and product development efforts do not result in commercially viable products within anticipated timelines, if at all, our business and results of operations will be adversely affected.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is dependent on the improvement of our existing products, our development of new products to serve existing markets, and our development of new products to create new markets and applications that were previously not practical with existing systems. We intend to devote significant personnel and financial resources to research and development activities designed to advance the capabilities of our technology. We have developed design rules for the implementation of our technology that are frequently revised to reflect new insights we have gained about the technology. In addition, we have discovered that biological or chemical reactions sometimes behave differently when implemented on our systems rather than in a standard laboratory environment. Furthermore, many such reactions take place within the confines of single cells, which have </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">also demonstrated unexpected behavior when grown and manipulated within microfluidic environments. As a result, research and development efforts may be required to transfer certain reactions and cell handling techniques to our systems. In the past, product development projects have been significantly delayed when we encountered unanticipated difficulties in implementing a process on our systems. We may have similar delays in the future, and we may not obtain any benefits from our research and development activities. Any delay or failure by us to develop and release new products or product enhancements would have a substantial adverse effect on our business and results of operations. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our products could have defects or errors, which may give rise to claims against us, adversely affect market adoption of our systems, and adversely affect our business, financial condition, and results of operations.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our systems utilize novel and complex technology and such systems may develop or contain undetected defects or errors. We cannot assure you that material performance problems, defects, or errors will not arise, and as we increase the density and integration of our systems, these risks may increase. We generally provide warranties that our systems will meet performance expectations and will be free from defects. The costs incurred in correcting any defects or errors may be substantial and could adversely affect our operating margins.  For example, we have experienced a performance issue with respect to certain IFCs used in our C1 systems due to the presence of more than one cell in an IFC chamber.  Although we have redesigned such C1 IFCs, we may experience additional unexpected product defects or errors that could affect our ability to adequately address these performance issues.  </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In manufacturing our products, including our systems, IFCs, and assays, we depend upon third parties for the supply of various components, many of which require a significant degree of technical expertise to produce. In addition, we purchase certain products from third-party suppliers for resale. If our suppliers fail to produce components to specification or provide defective products to us for resale and our quality control tests and procedures fail to detect such errors or defects, or if we or our suppliers use defective materials or workmanship in the manufacturing process, the reliability and performance of our products will be compromised.</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our products contain defects, we may experience:</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a failure to achieve market acceptance or expansion of our product sales;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">loss of customer orders and delay in order fulfillment;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">damage to our brand reputation;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased cost of our warranty program due to product repair or replacement;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">product recalls or replacements;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">inability to attract new customers;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">diversion of resources from our manufacturing and research and development departments into our service department; and</span></div><div style="margin-bottom:8pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">legal claims against us, including product liability claims, which could be costly and time consuming to defend and result in substantial damages.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, certain of our products are marketed for use with products sold by third parties. For example, certain of our systems are marketed as compatible with major next-generation DNA sequencing instruments. If such third-party products are not produced to specification, are produced in accordance with modified specifications, or are defective, they may not be compatible with our products. In such case, the reliability and performance of our products may be compromised.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The occurrence of any one or more of the foregoing could negatively affect our business, financial condition, and results of operations.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our business depends on research and development spending levels of our customers, a reduction in which could limit our ability to sell our products and adversely affect our business.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that our revenue in the foreseeable future will continue to be derived primarily from sales of our systems, IFCs, assays, and reagents to academic research institutions, translational research and medicine centers, cancer centers, clinical research laboratories biopharmaceutical, biotechnology, and plant and animal research companies, and contract research organizations worldwide. Our success will depend upon their demand for and use of our products. Accordingly, the spending policies and practices of these customers&#8212;which have been impacted by the COVID-19 pandemic and may additionally be impacted by other factors&#8212;could have a significant effect on the demand for our technology. These policies may be based on a wide variety of factors, including concerns regarding any future federal government budget sequestrations, the availability of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">resources to make purchases, the spending priorities among various types of equipment, policies regarding spending during recessionary periods, and changes in the political climate. In addition, academic, governmental, and other research institutions that fund research and development activities may be subject to stringent budgetary constraints that could result in spending reductions, reduced allocations, or budget cutbacks, which could jeopardize the ability of these customers to purchase our products. Our operating results may fluctuate substantially due to reductions and delays in research and development expenditures by our customers. For example, reductions in operating expenditures by global academic research facilities because of the COVID-19 pandemic have resulted in lower than expected sales of our mass cytometry instruments. Similar reductions and delays in customer spending may result from other factors that are not within our control, such as:</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in economic conditions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">natural disasters or public health crises;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in government programs that provide funding to research institutions and companies;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the regulatory environment affecting life science and plant and animal research companies engaged in research and commercial activities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">differences in budget cycles across various geographies and industries;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">market-driven pressures on companies to consolidate operations and reduce costs;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">mergers and acquisitions in the life science and plant and animal research industries; and</span></div><div style="margin-bottom:8pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other factors affecting research and development spending.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any decrease in our customers&#8217; budgets or expenditures, or in the size, scope, or frequency of capital or operating expenditures, could materially and adversely affect our operations or financial condition.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If one or more of our manufacturing facilities become unavailable or inoperable, we will be unable to continue manufacturing our instruments, IFCs, assays and/or reagents and, as a result, our business will be harmed until we are able to secure a new facility.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manufacture our genomics analytical and preparatory instruments and IFCs for commercial sale at our facility in Singapore and our mass cytometry instruments, assays, and reagents for commercial sale at our facility in Canada. No other manufacturing facilities are currently available to us, particularly facilities of the size and scope of our Singapore and Canada operations. Our facilities and the equipment we use to manufacture our instruments, IFCs, assays, and reagents would be costly to replace and could require substantial lead times to repair or replace. Our facilities may be harmed or rendered inoperable by natural or man-made disasters, which may render it difficult or impossible for us to manufacture our products for some period of time. If any of our facilities become unavailable to us, we cannot provide assurances that we will be able to secure a new manufacturing facility on acceptable terms, if at all. The inability to manufacture our products, combined with our limited inventory of manufactured supplies, may result in the loss of customers or harm our reputation, and we may be unable to reestablish relationships with those customers in the future. Although we possess insurance for damage to our property and the disruption of our business, this insurance may not be sufficient to cover all of our potential losses and may not continue to be available to us on acceptable terms, or at all. If our manufacturing capabilities are impaired, we may not be able to manufacture and ship our products in a timely manner, which would adversely impact our business. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disruption of our manufacturing facilities or other operations, or in the operations of our customers or business partners, due to earthquake, flood, other natural catastrophic events, public health crises, or terrorism could result in cancellation of orders, delays in deliveries or other business activities, or loss of customers and could seriously harm our business.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have significant manufacturing operations in Singapore and Canada and operations in the United States. In addition, our business is international in nature, with our sales, service and administrative personnel and our customers located in numerous countries throughout the world. Operations at our manufacturing facilities and our subcontractors, as well as our other operations and those of our customers, are subject to disruption for a variety of reasons, including work stoppages, acts of war, terrorism, public health crises (including the ongoing COVID-19 pandemic), fire, earthquake, volcanic eruptions, energy shortages, flooding, or other natural disasters. Such disruption could cause delays in, among other things, shipments of products to our customers, our ability to perform services requested by our customers, or the installation of our products at customer sites. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot provide any assurance that alternate means of conducting our operations (whether through alternate production capacity or service providers or otherwise) would be available if a major disruption were to occur or that, if such alternate means were available, they could be obtained on favorable terms.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We generate a substantial portion of our revenue internationally and our international business exposes us to business, regulatory, political, operational, financial, and economic risks associated with doing business outside of the United States.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years 2019, 2018, and 2017, approximately 63%, 57%, and 55%, respectively, of our product and service revenue was generated from sales to customers located outside of the United States. We believe that a significant percentage of our future revenue will continue to come from international sources as we expand our international operations and develop opportunities in other countries. Engaging in international business inherently involves a number of difficulties and risks, including:</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">required compliance with existing and changing foreign regulatory requirements and laws that are or may be applicable to our business in the future, such as the European Union&#8217;s General Data Protection Regulation and other data privacy requirements, labor and employment regulations, anticompetition regulations, the U.K. Bribery Act of 2010 and other anticorruption laws, and the RoHS and WEEE directives, which regulate the use of certain hazardous substances in, and require the collection, reuse, and recycling of waste from, products we manufacture;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">required compliance with U.S. laws such as the Foreign Corrupt Practices Act, and other U.S. federal laws and regulations established by the office of Foreign Asset Control;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">export requirements and import or trade restrictions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">laws and business practices favoring local companies;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">longer payment cycles and difficulties in enforcing agreements and collecting receivables through certain foreign legal systems;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in social, economic, and political conditions or in laws, regulations and policies governing foreign trade, manufacturing, development, and investment both domestically as well as in the other countries and jurisdictions in which we operate and into which we sell our products, including as a result of the separation of the United Kingdom from the European Union (Brexit);</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">business interruptions resulting from global sociopolitical events, including war and terrorism, public health crises such as the COVID-19 pandemic, and natural disasters including earthquakes, typhoons, floods and fires;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potentially adverse tax consequences, tariffs, customs charges, bureaucratic requirements, and other trade barriers;</span></div><div style="margin-bottom:8pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties and costs of staffing and managing foreign operations; and</span></div><div style="margin-bottom:8pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties protecting or procuring intellectual property rights.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If one or more of these risks occurs, it could require us to dedicate significant resources to remedy, and if we are unsuccessful in finding a solution, our financial results will suffer.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are subject to fluctuations in the exchange rate of the U.S. dollar and foreign currencies. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A majority of our product sales are currently denominated in U.S. dollars and fluctuations in the value of the U.S. dollar relative to foreign currencies could decrease demand for our products and adversely impact our financial performance. For example, if the value of the U.S. dollar increases relative to foreign currencies, our products could become more costly to the international consumer and therefore less competitive in international markets, or if the value of the U.S. dollar decreases relative to the Singapore dollar or the Canadian dollar, it would become more costly in U.S. dollars for us to manufacture our products in Singapore and/or in Canada. Additionally, our expenses are generally denominated in the currencies of the countries in which our operations are located, which is primarily in the United States, with a portion of expenses incurred in Singapore and Canada where a significant portion of our manufacturing operations are located. Our results of operations and cash flows are, therefore, subject to fluctuations due to changes in foreign currency exchange rates. The volatility of exchange rates depends on many factors that we cannot forecast with reliable accuracy. We have experienced and will continue to experience fluctuations in our net income or loss as a result of transaction gains or losses related to revaluing certain current asset and current liability balances that are denominated in currencies other than the functional currency of the entities in which they are recorded. Fluctuations in currency exchange rates could have an adverse impact on our financial results in the future. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Any disruption or delay in the shipping or off-loading of our products, whether domestically or internationally, may have an adverse effect on our financial condition and results of operations.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on shipping providers to deliver products to our customers globally. Labor, tariff, or World Trade Organization-related disputes, piracy, physical damage to shipping facilities or equipment caused by severe weather or terrorist incidents, congestion at shipping facilities, complications related to public health crises, inadequate equipment to load, dock, and offload </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our products, energy-related tie-ups, or other factors could disrupt or delay shipping or off-loading of our products domestically and internationally. Such disruptions or delays may have an adverse effect on our financial condition and results of operations.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are dependent on single and sole source suppliers for some of the components and materials used in our products, and the loss of any of these suppliers could harm our business.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on single and sole source suppliers for certain components and materials used in our products. Additionally, several of our instruments are assembled at the facilities of contract manufacturers in Singapore. We do not have long term contracts with our suppliers of these components and materials or our assembly service providers. The loss of a single or sole source supplier of any of the following components and/or materials would require significant time and effort to locate and qualify an alternative source of supply, if at all: </span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The IFCs used in our microfluidic systems are fabricated using a specialized polymer, and other specialized materials, that are available from a limited number of sources. In the past, we have encountered quality issues that have reduced our manufacturing yield or required the use of additional manufacturing processes.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The electron multiplier detector included in the Hyperion/Helios systems and certain metal isotopes used with the Hyperion/Helios systems are purchased from sole source suppliers.</span></div><div style="margin-bottom:8pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The raw materials for our Delta Gene and SNP Type assays and Access Array target-specific primers are available from a limited number of sources.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reliance on single and sole source suppliers and assembly service providers also subjects us to other risks that could harm our business, including the following: </span></div><div style="margin-bottom:6pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may be subject to increased component or assembly costs and</span></div><div style="margin-bottom:8pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may not be able to obtain adequate supply or services in a timely manner or on commercially reasonable terms.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have in the past experienced quality control and supply problems with some of our suppliers, such as manufacturing errors, and may again experience problems in the future. We may not be able to quickly establish additional or replacement suppliers, particularly for our single source components, or assembly service providers. Any interruption or delay in the supply of components or materials or assembly of our instruments, or our inability to obtain components, materials, or assembly services from alternate sources at acceptable prices in a timely manner, could impair our ability to meet the demand of our customers and cause them to cancel orders or switch to competitive products. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our future success is dependent upon our ability to expand our customer base and introduce new applications. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our customer base is primarily composed of academic research institutions, translational research and medicine centers, cancer centers, clinical research laboratories, biopharmaceutical, biotechnology, and plant and animal research companies, and contract research organizations that perform analyses for research and commercial purposes. Our success will depend, in part, upon our ability to increase our market share among these customers, attract additional customers outside of these markets, and market new applications to existing and new customers as we develop such applications. Attracting new customers and introducing new applications require substantial time and expense. For example, it may be difficult to identify, engage, and market to customers who are unfamiliar with the current applications of our systems. Any failure to expand our existing customer base or launch new applications would adversely affect our ability to increase our revenue.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may not be able to develop new products or enhance the capabilities of our existing systems to keep pace with rapidly changing technology and customer requirements, which could have a material adverse effect on our business, revenue, financial condition, and operating results.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends on our ability to develop new products and applications for our technology in existing and new markets, while improving the performance and cost-effectiveness of our systems. New technologies, techniques, or products could emerge that might offer better combinations of price and performance than our current or future product lines and systems. Existing markets for our products, including high-throughput genomics, single-cell genomics and mass cytometry, as well as potential markets for our products such as high-throughput DNA sequencing and molecular applications, are characterized by rapid technological change and innovation. It is critical to our success for us to anticipate changes in technology and customer requirements and to successfully introduce new, enhanced, and competitive technology to meet our customers&#8217; and prospective customers&#8217; needs on a timely and cost-effective basis. Developing and implementing new technologies will require us to incur substantial development costs and we may not have adequate resources available to be able to successfully introduce new applications of, or enhancements to, our systems. We cannot guarantee that we will be able to maintain technological advantages over emerging technologies in the future. While we typically plan improvements to our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">systems, we may not be able to successfully implement these improvements. If we fail to keep pace with emerging technologies, demand for our systems will not grow and may decline, and our business, revenue, financial condition, and operating results could suffer materially. In addition, if we introduce enhanced systems but fail to manage product transitions effectively, customers may delay or forgo purchases of our systems and our operating results may be adversely affected by product obsolescence and excess inventory. Even if we successfully implement some or all of these planned improvements, we cannot guarantee that our current and potential customers will find our enhanced systems to be an attractive alternative to existing technologies, including our current products.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our business operations depend upon the continuing efforts of our management team and other skilled and experienced personnel, and if we are unable to retain them or to recruit and train new key executives, scientists, and technical support personnel, we may be unable to achieve our goals.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends largely on the skills, experience, and performance of our management team and scientific and technical support personnel.  The loss of the services of any key member of our management team or our scientific or technical support staff might significantly delay or prevent the development of our products or achievement of other business objectives by diverting management&#8217;s attention to transition matters and identification of suitable replacements, if any, and could have a material adverse effect on our business. Our research and product development efforts could also be delayed or curtailed if we are unable to attract, train, and retain highly skilled employees, particularly, senior scientists and engineers. For example, as part of our cost reduction program to manage the impact of the COVID-19 pandemic, we implemented temporary enterprise-wide salary reductions and delayed implementation of 2020 merit-based salary increases. Although all salaries have been restored as of the date of this filing, any reinstatement of salary reductions or any other failure to maintain competitive levels of compensation may negatively impact our ability to retain the personnel necessary to achieve our goals. We do not maintain fixed term employment contracts or significant key person life insurance with any of our employees.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, to expand our research and product development efforts, we need to retain and recruit scientists skilled in areas such as molecular and cellular biology, assay development, and manufacturing. We also need highly trained technical support personnel with the necessary scientific background and ability to understand our systems at a technical level to effectively support potential new customers and the expanding needs of current customers. Competition for these people is intense and we may face challenges in retaining and recruiting such individuals if, for example, our stock price declines, reducing the retention value of equity awards, or our business or technology is no longer perceived as leading in our field. Because of the complex and technical nature of our systems and the dynamic market in which we compete, any failure to attract and retain a sufficient number of qualified employees could materially harm our ability to develop and commercialize our technology.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our business growth strategy involves the potential for significant acquisitions, and our operating results and prospects could be harmed if we are unable to integrate future acquisitions successfully.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may acquire other businesses to improve our product offerings or expand into new markets. Our future acquisition strategy will depend on our ability to identify, negotiate, complete, and integrate acquisitions and, if necessary, to obtain satisfactory debt or equity financing to fund those acquisitions. Mergers and acquisitions are inherently risky, and any transaction we complete may not be successful. Any merger or acquisition we may pursue would involve numerous risks, including but not limited to the following:</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties in integrating and managing the operations, technologies, and products of the companies we acquire;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">diversion of our management&#8217;s attention from normal daily operation of our business;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our inability to maintain the key business relationships and the reputations of the businesses we acquire;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our inability to retain key personnel of the acquired company;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">uncertainty of entry into markets in which we have limited or no prior experience and in which competitors have stronger market positions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our dependence on unfamiliar affiliates and customers of the companies we acquire;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">insufficient revenue to offset our increased expenses associated with acquisitions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our responsibility for the liabilities of the businesses we acquire, including those which we may not anticipate; and</span></div><div style="margin-bottom:8pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our inability to maintain internal standards, controls, procedures, and policies.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be unable to secure the equity or debt funding necessary to finance future acquisitions on terms that are acceptable to us. If we finance acquisitions by issuing equity or convertible debt securities, our existing stockholders will likely experience </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">dilution, and if we finance future acquisitions with debt funding, we will incur interest expense and may have to comply with financial covenants and secure that debt obligation with our assets.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Security breaches, loss of data, cyberattacks, and other information technology failures could disrupt our operations, damage our reputation, and adversely affect our business, operations, and financial results.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are dependent upon our data and information technology systems for the effective operation of our business and for the secure maintenance and storage of confidential data relating to our business and third-party businesses. Our information technology systems may be damaged, disrupted or shut down due to attacks by experienced programmers or hackers who may be able to penetrate our security controls and deploy computer viruses, cyberattacks, phishing schemes, or other malicious software programs, or due to employee error or malfeasance, power outages, hardware failures, telecommunication or utility failures, catastrophes or other unforeseen events, and our system redundancy and other disaster recovery planning may be ineffective or inadequate in preventing or responding to any of these circumstances. Any such compromise of our information technology systems could result in the unauthorized publication of our confidential business or proprietary information and unauthorized release of customer, supplier or employee data, any of which could expose us to a risk of legal claims or proceedings, liability under privacy or other laws, disruption of our operations and damage to our reputation, which could divert our management&#8217;s attention from the operation of our business and materially and adversely affect our business, revenues and competitive position. In addition, our liability insurance may not be sufficient in type or amount to cover us against claims related to security breaches, cyberattacks and other related breaches. The cost and operational consequences of implementing further data protection measures, either as a response to specific breaches or as a result of evolving risks, could be significant. In addition, our inability to use or access our information systems at critical points in time could adversely affect the timely and efficient operation of our business. Any delayed sales, significant costs or lost customers resulting from these technology failures could adversely affect our business, operations, and financial results. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have implemented security controls to protect our information technology infrastructure but, despite our efforts, we are not fully insulated from technology disruptions that could adversely impact us.  For example, in March 2019, we experienced a ransomware attack that infiltrated and encrypted certain of our information technology systems, including systems containing critical business data. Immediately following the attack, actions were taken to recover the compromised systems and we believe we were able to restore their operation without significant loss of business data. Based on the nature of the attack and its impact on our systems, we do not believe confidential data was lost or disclosed. If, however, confidential data is later determined to have been released in the course of this or any future event, it is possible that we could be the subject of actions by governmental authorities or claims from persons alleging they suffered damages from such a release. Although we believe we have contained the disruption from the March 2019 attack, we anticipate additional work and expense in the future as we continue to enhance our security processes and initiatives in response to ever-evolving information security threats.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to risks affecting our own systems, we could also be negatively impacted by a data breach or cyber incident happening to a third party&#8217;s network and affecting us. Third parties with which we conduct business have access to certain portions of our sensitive data, including information pertaining to our customers and employees. In the event that these third parties do not adequately safeguard our data, security breaches could result and negatively impact our business, operations, and financial results.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the COVID-19 pandemic, we have an increased number of employees working remotely. As a result, we may have increased cyber security and data security risks, due to increased use of home wi-fi networks and virtual private networks, as well as increased disbursement of physical machines.  While we have implemented security controls to reduce the risk of cyberattacks and security breaches, there is no guarantee that these measures will be adequate to safeguard all systems with the increased number of employees working remotely.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our efficiency and cost-savings initiatives could be disruptive to our operations and adversely affect our results of operations and financial condition, and we may not realize some or all of the anticipated benefits of these initiatives in the time frame anticipated or at all.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since 2017, we have implemented efficiency and cost-savings initiatives intended to stabilize our business operations and return to growth. These efficiency initiatives have included targeted workforce reductions, optimizing our facilities, and reducing excess space. In response to the COVID-19 pandemic, we initiated a range of additional actions aimed at temporarily reducing our operating expenses and preserving liquidity.  These actions included implementing temporary enterprise-wide salary reductions of 20% for employees at or above the &#8216;director&#8217; level and 10% for all others, temporarily reducing our board members&#8217; cash retainers by 20%, and constraining hiring. Further actions such as these may be required on an ongoing basis to preserve liquidity and optimize our organization. For example, we may need to decrease or defer capital expenditures and development activities or implement further operating expense reduction measures. The implementation of these further efficiency and cost-savings initiatives could impair our ability to invest in developing, marketing and selling new and existing products, be disruptive to our operations, make it difficult to attract or retain employees, result in higher than anticipated </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">charges, divert the attention of management, result in a loss of accumulated knowledge, impact our customer and supplier relationships, and otherwise adversely affect our results of operations and financial condition. In addition, our ability to complete our efficiency and cost-savings initiatives and achieve the anticipated benefits within the expected time frame is subject to estimates and assumptions and may vary materially from our expectations, including as a result of factors that are beyond our control. Furthermore, our efforts to grow our business and become profitable may not be successful.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">To use our products, our Biomark, EP1, Helios/CyTOF 2, and Hyperion systems in particular, customers typically need to purchase specialized reagents. Any interruption in the availability of these reagents for use in our products could limit our ability to market our products.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products, our Biomark, EP1, Helios, and Hyperion systems in particular, must be used in conjunction with one or more reagents designed to produce or facilitate the particular biological or chemical reaction desired by the user. Many of these reagents are highly specialized and available to the user only from a single supplier or a limited number of suppliers. Although we sell reagents for use with certain of our products, our customers may purchase these reagents directly from third-party suppliers, and we have no control over the supply of those materials. In addition, our products are designed to work with these reagents as they are currently formulated. We have no control over the formulation of reagents sold by third-party suppliers, and the performance of our products might be adversely affected if the formulation of these reagents is changed. If one or more of these reagents were to become unavailable or were reformulated, our ability to market and sell our products could be materially and adversely affected.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the use of a reagent for a particular process may be covered by one or more patents relating to the reagent itself, the use of the reagent for the particular process, the performance of that process, or the equipment required to perform the process. Typically, reagent suppliers, who are either the patent holders or their authorized licensees, sell the reagents along with a license or covenant not to sue with respect to such patents. The license accompanying the sale of a reagent often purports to restrict the purposes for which the reagent may be used. If a patent holder or authorized licensee were to assert against us or our customers that the license or covenant relating to a reagent precluded its use with our systems, our ability to sell and market our products could be materially and adversely affected. For example, our Biomark system involves real-time quantitative polymerase chain reaction (qPCR) technology. Leading suppliers of reagents for real-time qPCR reactions include Life Technologies Corporation (now part of Thermo) and Roche Diagnostics Corporation, who are our direct competitors, and their licensees. These real-time qPCR reagents are typically sold pursuant to limited licenses or covenants not to sue with respect to patents held by these companies. We do not have any contractual supply agreements for these real-time qPCR reagents, and we cannot assure you that these reagents will continue to be available to our customers for use with our systems, or that these patent holders will not seek to enforce their patents against us, our customers, or suppliers.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Although the FDA granted Emergency Use Authorization (EUA) for our Advanta Dx SARS-CoV-2 RT-PCR Assay in August 2020, this approval is only valid during the COVID-19 pandemic, and when the federally declared public health emergency ends, we will be required to stop commercial distribution of our test immediately unless we can obtain FDA clearance or approval for our test under a traditional regulatory pathway for in vitro diagnostics, which is lengthy and expensive.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under section 564 of the Federal Food, Drug, and Cosmetic Act (FD&amp;C Act), the FDA has authority to allow certain unapproved medical products or unapproved uses of approved medical products to be used during a public health emergency. In issuing an EUA, the FDA will consider the totality of scientific evidence available to the FDA regarding safety, efficacy and known and potential risks of such products and availability of alternatives to the emergency use products, among others. EUAs issued by the FDA will specify the scope of authorization and conditions of authorization, including limitations on distribution and conditions related to product advertising and promotion. Once granted, an EUA is effective until the declaration that circumstances exist justifying the authorization of the emergency use is terminated under Section 564(b)(2) of the Act or the EUA is revoked under Section 564(g) of the Act, after which the product must be cleared or approved by the FDA under a traditional pathway in order to remain on the market or to continue commercialization of the product. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FDA granted EUA for our Advanta Dx SARS-CoV-2 RT-PCR Assay for qualitative detection of nucleic acid from SARS-CoV-2 in saliva specimens from individuals suspected by their healthcare providers of having COVID-19. As set forth in the EUA, we are required to comply with the conditions of authorization, including certain requirements pertaining to FDA notification, distribution, printed materials, advertising and promotion. If we, our distributors, or authorized laboratories do not comply with the EUA requirements, our business, financial condition and results of operations may be adversely impacted, and we may be subject to regulatory or enforcement actions, including the issuance of an untitled letter, a warning letter, penalties, or fines, among other adverse actions.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If the FDA&#8217;s policies and guidance change unexpectedly and/or materially or if we misinterpret them, potential sales of Advanta Dx SARS-CoV-2 RT-PCR could be adversely impacted. In addition, the FDA will revoke an EUA where it is </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">determined that the underlying public health emergency no longer exists or warrants such authorization, or if new evidence becomes available that indicates the test does not meet the conditions of authorization or perform as provided in the EUA application. We cannot predict how long this EUA will remain effective. The termination or revocation of the EUA and changing policies and regulatory requirements could adversely impact our business, financial condition and results of operations. Given the uncertain nature of the COVID-19 pandemic and future legislation and regulation in this space, we can provide no assurance with respect to our ability to achieve or sustain profitability on a quarterly or annual basis.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our contract with the National Institutes of Health (NIH) could expose us to unique risks and costs as an entity contracting with the federal government.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The NIH launched the Rapid Acceleration of Diagnostics (RADx) program to expedite development, commercialization, and implementation of technologies for COVID-19 testing to help increase testing in the United States. In July 2020, we entered into a letter contract with the NIH for a project under the RADx program. The letter contract provided access to approximately $12.2 million of the total proposed funding for the project prior to execution of a further definitive contract for the project. In September 2020, we executed a definitive contract with the NIH as an amendment to the letter contract (collectively, the NIH Contract) to expand production capacity and throughput capabilities for COVID-19 testing with our microfluidics technology. Pursuant to the terms of the NIH Contract, the funding for the project was increased by approximately $22.0 million, for a total contract value of up to approximately $34.0 million. Release of funding under the NIH Contract is based on the achievement of milestones, including expansion of our manufacturing facilities, addition of production lines, and achieving full production capacity.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is significant competition among RADx projects, which are evaluated by experts on a rolling basis. Projects with the most potential for success are advanced to the next stage. There is no certainty that we can meet all the milestones in our NIH Contract on a timely basis, if at all. If we do not meet all the milestones, we will not be able access all $34.0 million in funding under the NIH Contract. We cannot guarantee that we will be able to access all the available funding under the NIH Contract in a timely manner, or at all.  We must prioritize among many different opportunities, and we may expend our limited resources on programs that do not yield a successful or profitable product candidate and may forego other more profitable opportunities.  Further, the Bayh-Dole Act applies to all NIH research and development funding granted to for-profit organizations, which requires the government to be provided a nonexclusive, nontransferable, irrevocable, paid-up license to practice or have practiced for or on behalf of the United States any subject invention throughout the world. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Factors that could materially adversely affect our revenue stemming from the NIH Contract include:</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">budgetary constraints affecting U.S. government spending generally, or NIH in particular;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in U.S. government or NIH fiscal policies or available funding, including due to changes in Congressional appropriations;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in U.S. government or NIH programs, requirements or priorities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adoption of new laws or regulations;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">technological developments;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. government shutdowns, threatened shutdowns or budget delays;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competition and consolidation in our industry; and</span></div><div style="margin-bottom:8pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic conditions.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These or other factors could cause NIH to reduce its funding or future activities under the NIH Contract, or to exercise its right to terminate the NIH Contract for convenience, either of which could have a material adverse effect on the revenue generated by the NIH Contract.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The NIH Contract includes certain provisions from the Federal Acquisition Regulations (FAR), some of which are customary or legally required, that give the U.S. government substantial rights and remedies, many of which are not typically found in commercial contracts.  For example, the NIH Contract contains provisions permitting unilateral termination or modification, in whole or in part, at the convenience of the U.S. government. Under general principles of government contracting law, if the U.S. government terminates a contract for convenience, the government contractor may recover only its incurred or committed costs, settlement expenses and profit on work completed prior to the termination. If the U.S. government terminates a contract for default, the government contractor is entitled to recover costs incurred and associated profits on accepted items only and may be liable for excess costs incurred by the government in procuring undelivered items from another source. In addition, government contracts normally contain additional requirements that may increase our costs of doing business, reduce our profits, and expose us to liability for failure to comply with these terms and conditions. These requirements </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">include, for example, mandatory internal control systems and policies, mandatory socioeconomic compliance requirements, including labor standards, non-discrimination and affirmative action programs and environmental compliance requirements and public disclosures of certain contract information, which may enable competitors to gain insights into our research program.  If we fail to maintain compliance with these requirements, we may be subject to potential contract or False Claims Act liability and to termination of our NIH Contract:</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other examples of rights and remedies under the NIH Contract include provisions that allow NIH to:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">terminate the NIH Contract, in whole or in part, for any reason or no reason;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unilaterally reduce or modify the government&#8217;s obligations under the NIH Contract, without our consent, including by imposing price adjustments;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">claim rights, including intellectual property rights, in or to (i) products, (ii) data, and (iii) facilities, in each case developed under the NIH Contract;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">under certain circumstances involving public health and safety, license inventions made under such agreements to third parties;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">suspend us from receiving new contracts pending resolution of alleged violations of procurement laws or regulations;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">impose U.S. manufacturing requirements for products that embody inventions conceived or first reduced to practice under the NIH Contract;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">suspend or debar us from doing future business with the government;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">change the course of a development program in a manner that differs from the NIH Contract&#8217;s original terms or from our desired development plan, including decisions regarding our partners in the program;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pursue civil or criminal remedies under the False Claims Act and False Statements Act; and</span></div><div style="margin-bottom:8pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">control or prohibit the export of products.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, we may be required to enter into agreements and subcontracts with third parties, including suppliers, consultants and other third-party contractors in order to satisfy our contractual obligations pursuant to our agreements with the United States government. Negotiating and entering into such arrangements can be time-consuming and we may not be able to reach agreement with such third parties. Any such agreement must also be compliant with the terms of the NIH Contract. Any delay or inability to enter into such arrangements or entering into such arrangements in a manner that is non-compliant with the terms of our contract, may result in violations of our contract.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agencies routinely audit and investigate government contractors and recipients of federal grants and contracts. These agencies review a contractor&#8217;s performance under its contracts, cost structure and compliance with applicable laws, regulations and standards.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The audit may also include review of the adequacy of, and a contractor&#8217;s compliance with, its internal control systems and policies, including the contractor&#8217;s accounting, purchasing, property, estimating, compensation and management information systems. If an audit uncovers improper or illegal activities, we may be subject to civil and criminal penalties and administrative sanctions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we could suffer serious reputational harm if allegations of impropriety were made against us, which could cause our stock price to decrease.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we elect to label and promote any of our non-EUA products as medical devices, we would be required to obtain prior approval or clearance by the FDA, which would take significant time and expense and could fail to result in FDA clearance or approval for the intended uses we believe are commercially attractive. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except for the Advanta Dx SARS-CoV-2 Assay authorized by the FDA under an EUA granted in August 2020, our other products are currently labeled, promoted and sold to academic research institutions, translational research and medicine centers, cancer centers, clinical research laboratories, contract research organizations, and biopharmaceutical, biotechnology, and plant and animal research companies as &#8220;research use only&#8221; (RUO), and are not designed, or intended to be used, for clinical diagnostic tests or as medical devices as currently marketed. If we elect to label and market our products for use as, or in the performance of, clinical diagnostics in the United States, thereby subjecting them to FDA regulation as medical devices, we would be required to obtain premarket 510(k) clearance or premarket approval from the FDA, unless an exception applies. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently registered with the FDA as a medical device manufacturer, with the reagents for the Advanta Dx SARS-CoV-2 Assay listed as our sole medical device product. As noted in the issued EUA for the Advanta Dx SARS-CoV-2 Assay, the FDA has waived certain quality system requirements under 21 CFR Part 820 for the duration of the EUA. We may in the future list some of our other products with the FDA pursuant to an FDA Class I listing for general purpose laboratory equipment if we pursue clinical applications for such equipment. While this regulatory classification is generally exempt from </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">certain FDA requirements, such as the need to submit a premarket notification commonly known as a 510(k), and some of the requirements of the FDA&#8217;s Quality System Regulations (QSRs), we would be subject to ongoing FDA &#8220;general controls,&#8221; which include compliance with FDA regulations for labeling, inspections by the FDA, complaint evaluation, corrections and removals reporting, promotional restrictions, reporting adverse events or malfunctions for our products, and general prohibitions against misbranding and adulteration. If we do not comply with all the requirements of the EUA or the normal regulatory requirements for any of our medical device products, including additional regulatory requirements that would apply to the Advanta Dx SARS-CoV-2 Assay after the expiration or termination of the EUA, we may be subject to regulatory or enforcement actions, including the issuance of an untitled letter, a warning letter, penalties, or fines, among other adverse actions, any of which may adversely impact our business, financial condition and results of operations. Compliance with additional or changing regulatory requirements can be time-consuming and costly.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may in the future submit 510(k) premarket notifications to the FDA to obtain FDA clearance of certain of our products on a selected basis.  It is possible, in the event we elect to submit 510(k) applications for certain of our products, that the FDA would take the position that a more burdensome premarket application, such as a premarket approval application or a de novo application is required for some of our products.  If such applications were required, greater time and investment would be required to obtain FDA approval.  Even if the FDA agreed that a 510(k) was appropriate, FDA clearance can be expensive and time consuming.  It generally takes a significant amount of time to prepare a 510(k), including conducting appropriate testing on our products, and several months to years for the FDA to review a submission.  Notwithstanding the effort and expense, FDA clearance or approval could be denied for some or all of our products. Even if we were to seek and obtain regulatory approval or clearance, it may not be for the intended uses we believe are important or commercially attractive.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we sought and received regulatory clearance or approval for certain of our products, we would be subject to ongoing FDA obligations and continued regulatory oversight and review, including the general controls listed above and the FDA&#8217;s QSRs for our development and manufacturing operations. In addition, we would be required to obtain a new 510(k) clearance before we could introduce subsequent modifications or improvements to such products.  We could also be subject to additional FDA post-marketing obligations for such products, any or all of which would increase our costs and divert resources away from other projects.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we sought and received regulatory clearance or approval and are not able to maintain regulatory compliance with applicable laws, we could be prohibited from marketing our products for use as, or in the performance of, clinical diagnostics and/or could be subject to enforcement actions, including warning letters and adverse publicity, fines, injunctions, and civil penalties; recall or seizure of products; operating restrictions; and criminal prosecution.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we could decide to seek regulatory clearance or approval for certain of our products in countries outside of the United States. Sales of such products outside the United States will likely be subject to foreign regulatory requirements, which can vary greatly from country to country. As a result, the time required to obtain clearances or approvals outside the United States may differ from that required to obtain FDA clearance or approval and we may not be able to obtain foreign regulatory approvals on a timely basis or at all.  In Europe, we need to comply with the In Vitro Diagnostic Directive 98/79/EC and transition to the In Vitro Diagnostic Regulation 2017/746, which became effective May 26, 2017, with an application date of May 26, 2022. This will increase the difficulty of regulatory approvals in Europe in the future. In addition, the FDA regulates exports of medical devices. Failure to comply with these regulatory requirements or obtain and maintain required approvals, clearances and certifications could impair our ability to commercialize our products for diagnostic use outside of the United States.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our products could become subject to regulation as medical devices by the FDA or other regulatory agencies even if we do not elect to seek regulatory clearance or approval to market our products for diagnostic purposes, which would adversely impact our ability to market and sell our products and harm our business.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As products that are currently labeled, promoted and intended as RUO, our products are not currently subject to regulation as medical devices by the FDA or comparable agencies of other countries.  However, the FDA or comparable agencies of other countries could disagree with our conclusion that our products are currently intended for research use only or deem our current sales, marketing and promotional efforts as being inconsistent with research use only products.  For example, our customers may independently elect to use our research use only labeled products in their own laboratory developed tests (LDTs) for clinical diagnostic use. The FDA has historically exercised enforcement discretion in not enforcing the medical device regulations against laboratories offering LDTs. However, on October 3, 2014, the FDA issued two draft guidance documents that set forth the FDA&#8217;s proposed risk-based framework for regulating LDTs, which are designed, manufactured, and used within a single laboratory. The draft guidance documents provide the anticipated details through which the FDA would propose to establish an LDT oversight framework, including premarket review for higher-risk LDTs, such as those that have the same intended use as FDA-approved or cleared companion diagnostic tests currently on the market. In January 2017, the FDA announced that it would not issue final guidance on the oversight of LDTs and manufacturers of products used for LDTs, but would seek further public discussion on an appropriate oversight approach, and give Congress an opportunity to develop a legislative solution. More recently, the FDA has issued warning letters to certain genomics labs for illegally marketing genetic </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tests that claim to predict patients&#8217; responses to specific medications, noting that the FDA has not created a legal &#8220;carve-out&#8221; for LDTs and retains discretion to take action when appropriate, such as when certain genomic tests raise significant public health concerns. As manufacturers develop more complex genetic tests and diagnostic software, the FDA may increase its regulation of LDTs. Any future legislative or administrative rule making or oversight of LDTs, if and when finalized, may impact the sales of our products and how customers use our products, and may require us to change our business model in order to maintain compliance with these laws.  We cannot predict how these various efforts will be resolved, how Congress or the FDA will regulate LDTs in the future, or how that regulatory system will impact our business.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, on November&#160;25, 2013, the FDA issued Final Guidance &#8220;Distribution of In Vitro Diagnostic Products Labeled for Research Use Only.&#8221; The guidance emphasizes that the FDA will review the totality of the circumstances when it comes to evaluating whether equipment and testing components are properly labeled as RUO. The final guidance states that merely including a labeling statement that the product is for research purposes only will not necessarily render the device exempt from the FDA&#8217;s clearance, approval, and other regulatory requirements if the circumstances surrounding the distribution, marketing and promotional practices indicate that the manufacturer knows its products are, or intends for its products to be, used for clinical diagnostic purposes. These circumstances may include written or verbal sales and marketing claims or links to articles regarding a product&#8217;s performance in clinical applications and a manufacturer&#8217;s provision of technical support for clinical applications. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recently, as part of the Trump Administration&#8217;s efforts to combat COVID-19 and consistent with the President&#8217;s direction in Executive Orders 13771 and 13924, the Department of Health and Human Services (HHS) announced rescission of guidances and other informal issuances of the FDA regarding premarket review of LDTs absent notice-and-comment rulemaking, stating that, absent notice-and-comment rulemaking, those seeking approval or clearance of, or an emergency use authorization, for an LDT may nonetheless voluntarily submit a premarket approval application, premarket notification or an EUA request, respectively, but are not required to do so. However, laboratories opting to use LDTs without FDA premarket review or authorization would not be eligible for liability protection under the Public Readiness and Emergency Preparedness Act, or the PREP Act. Following this HHS announcement, the FDA announced in October 2020 that it will no longer review EUA requests for COVID-19 LDTs at this time and will continue to prioritize review of EUA requests for point-of-care tests, home collection tests, at-home tests, tests that reduce reliance on test supplies, and high-throughput tests that are widely distributed. While these actions by HHS and the FDA are expected to reduce the regulatory burden on clinical laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) that develop LDTs, it is unclear how this action as well as future legislation by federal and state governments and FDA regulation will impact the industry, including our business and that of our customers. Such measures may compel the FDA to formalize earlier enforcement discretionary policies and informal guidances through notice-and-comment rulemaking.  HHS&#8217;s rescission policy and the FDA&#8217;s position with respect to EUAs in the short-term or LDTs in general in the long-term may also change over time. Congress could also enact legislation restricting LDTs. Any restrictions on LDTs by the FDA, HHS, Congress, or state regulatory authorities may decrease the demand for our products. The adoption of new restrictions on RUOs, whether by the FDA or Congress, could adversely affect demand for our specialized reagents and instruments. Further, we could be required to obtain premarket clearance or approval from the FDA before we can sell our products to certain customers.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the FDA determines our products or related applications should be subject to additional regulation as in vitro diagnostic devices based upon customers&#8217; use of our products for clinical diagnostic or therapeutic purposes, our ability to market and sell our products could be impeded and our business, prospects, results of operations and financial condition may be adversely affected. In addition, the FDA could consider our products to be misbranded or adulterated under the Federal Food, Drug, and Cosmetic Act and subject to recall and/or other enforcement action.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compliance or the failure to comply with current and future regulations affecting our products and business operations worldwide, such as environmental regulations enacted in the European Union, could cause us significant expense and adversely impact our business. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to many federal, state, local, and foreign regulations relating to various aspects of our business operations. Governmental entities at all levels are continuously enacting new regulations, and it is difficult to identify all applicable regulations and anticipate how such regulations will be implemented and enforced. We continue to evaluate the necessary steps for compliance with applicable regulations. To comply with applicable regulations, we have and will continue to incur significant expense and allocate valuable internal resources to manage compliance-related issues. In addition, such regulations could restrict our ability to expand or equip our facilities, or could require us to acquire costly equipment or to incur other significant expenses to comply with the regulations. For example, the Restriction on the Use of Certain Hazardous Substances in Electrical and Electronic Equipment Directive (RoHS) and the Waste Electrical and Electronic Equipment Directive (WEEE), both enacted in the European Union, regulate the use of certain hazardous substances in, and require the collection, reuse, and recycling of waste from, products we manufacture. Certain of our products sold in these countries are subject to WEEE and RoHS. These and similar regulations that have been or are in the process of being enacted in other countries may </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">require us to redesign our products, use different types of materials in certain components, or source alternative components to ensure compliance with applicable standards, and may reduce the availability of parts and components used in our products by negatively impacting our suppliers&#8217; ability to source parts and components in a timely and cost-effective manner.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) regulation (EC) No. 1907/206 is the European Union&#8217;s regulation on chemicals and their safe use.  The list of chemicals has been updated and some of the updates affect chemicals used in our products.  We will request a research exception, but if not granted, we will need to reduce the concentration of some of the chemicals in our products, which will require significant research and development and operations efforts. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any such redesigns, required use of alternative materials, or limited availability of parts and components used in our products may detrimentally impact the performance of our products, add greater testing lead times for product introductions, reduce our product margins, or limit the markets for our products, and if we fail to comply with any present and future regulations, we could be subject to future fines, penalties, and restrictions, such as the suspension of manufacturing of our products or a prohibition on the sale of products we manufacture. Any of the foregoing could adversely affect our business, financial condition, or results of operations. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we fail to maintain effective internal control over financial reporting in the future, the accuracy and timing of our financial reporting may be impaired, which could adversely affect our business and our stock price.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sarbanes-Oxley Act requires, among other things, that we maintain effective internal control over financial reporting and disclosure controls and procedures. In particular, we must perform system and process evaluation and testing of our internal control over financial reporting to allow management to report on the effectiveness of our internal control over financial reporting, as required by Section&#160;404 of the Sarbanes-Oxley Act. Our testing may reveal deficiencies in our internal control over financial reporting that are deemed to be material weaknesses. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our compliance with Section&#160;404 requires that we incur substantial accounting expense and expend significant management time on compliance-related issues. We currently do not have an internal audit group, and we continue to evaluate our need for additional accounting and financial staff with appropriate public company experience and technical accounting knowledge. Moreover, if we do not comply with the requirements of Section&#160;404, or if we or our independent registered public accounting firm identify deficiencies in our internal control over financial reporting that are deemed to be material weaknesses, the market price of our stock could decline and we could be subject to sanctions or investigations by The Nasdaq Stock Market LLC, the SEC, or other regulatory authorities, which would require additional financial and management resources.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of our goodwill or other intangible assets could materially and adversely affect our business, operating results, and financial condition.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, we had approximately $151.5 million of goodwill and net intangible assets, including approximately $106.5&#160;million of goodwill and $45.2 million of net intangible assets. These assets represent a significant portion of the assets recorded on our consolidated balance sheet and relate primarily to our acquisition of DVS Sciences, Inc. (DVS) in February 2014. In addition, if in the future we acquire additional businesses, technologies, or other intangible assets, a substantial portion of the value of such assets may be recorded as goodwill or intangible assets. In the fourth quarter of 2019, we concluded that certain of our patents and licenses were impaired and reduced the applicable carrying value to zero, recognizing a charge of $0.4 million, which is reflected in accumulated amortization.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of goodwill and intangible assets are affected whenever events or changes in circumstances indicate that their carrying amounts may not be recoverable. We review goodwill and indefinite lived intangible assets for impairment at least annually and more frequently under certain circumstances. Other intangible assets that are deemed to have finite useful lives will continue to be amortized over their useful lives but must be reviewed for impairment when events or changes in circumstances indicate that the carrying amount of these assets may not be recoverable. Events or changes in circumstances that could affect the likelihood that we will be required to recognize an impairment charge include declines in our stock price or market capitalization, declines in our market share or revenues, an increase in our losses, rapid changes in technology, failure to achieve the benefits of capacity increases and utilization, significant litigation arising out of an acquisition, or other matters. In particular, these or other adverse events or changes in circumstances may affect the estimated undiscounted future operating cash flows expected to be derived from our goodwill and intangible assets.  Any impairment charges could have a material adverse effect on our operating results and net asset value in the quarter in which we recognize the impairment charge.  We cannot provide assurances that we will not in the future be required to recognize impairment charges.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our future capital needs are uncertain and we may need to raise additional funds in the future, which may cause dilution to stockholders or may be upon terms that are not favorable to us.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have continued to experience losses and, if that trend continues, we may need to seek additional sources of financing.  In addition, we may need to raise substantial additional capital for various purposes, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expanding the commercialization of our products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">funding our operations;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">furthering our research and development; and</span></div><div style="margin-bottom:8pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">acquiring other businesses or assets and licensing technologies.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future funding requirements will depend on many factors, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">market acceptance of our products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost of our research and development activities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost of filing and prosecuting patent applications;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost of defending any litigation including intellectual property, employment, contractual or other litigation;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and timing of regulatory clearances or approvals, if any;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and timing of establishing additional sales, marketing, and distribution capabilities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and timing of establishing additional technical support capabilities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fluctuations in cash demands (e.g., due to interest or principal payments or payouts under existing cash compensation plans);</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">variability in sales and timing of related cash collections;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effectiveness of our efficiency and cost-savings initiatives; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of any natural disasters or public health crises, such as the COVID-19 pandemic;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effect of competing technological and market developments; and</span></div><div style="margin-bottom:8pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which we acquire or invest in businesses, products, and technologies, although we currently have no commitments or agreements relating to any of these types of transactions.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent we draw on our Revolving Credit Facility or otherwise incur additional indebtedness, the risks described above could increase. Further, if we increase our indebtedness, our actual cash requirements in the future may be greater than expected. Our cash flow from operations may not be sufficient to repay all of the outstanding debt as it becomes due, and we cannot assure you that we will be able to obtain additional funds on acceptable terms, or at all. The ongoing COVID-19 pandemic has led to significant disruption and volatility in the global capital markets, increasing the cost of&#8212;and adversely impacting access to&#8212;capital. We have a Sale Agreement with Jefferies to sell shares of our common stock having aggregate sales proceeds of up to $50,000,000, from time to time, through an ATM equity offering program under which Jefferies acts as sales agent. During the third quarter of 2020, we sold approximately 2.5 million shares of our common stock pursuant to the Sale Agreement, for aggregate gross proceeds of $20.9 million. Our net proceeds were approximately $20.1 million, after deducting related expenses, including commissions of approximately $0.6 million and issuance costs of approximately $0.2 million. If we raise additional funds by issuing equity securities, either under the ATM program or otherwise, our stockholders may experience dilution. Debt financing in addition to the Revolving Credit Facility, if available, may involve covenants restricting our operations or our ability to incur additional debt. Any additional debt or equity financing that we raise may contain terms that are not favorable to us or our stockholders, and our ability to raise additional capital may be adversely impacted by the impact of the COVID-19 pandemic on the economy. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we raise additional funds through collaboration and licensing arrangements with third parties, it may be necessary to relinquish some rights to our technologies or our products, or grant licenses on terms that are not favorable to us. If we do not have or are unable to raise adequate funds, we may have to liquidate some or all of our assets, delay development or commercialization of our products, or license to third parties the rights to commercialize products or technologies that we would otherwise seek to commercialize. We also may have to reduce marketing, customer support, research and development, or other resources devoted to our products, or cease operations. Any of these factors could harm our operating results.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we fail to comply with the covenants and other obligations under our Revolving Credit Facility, the lenders may be able to accelerate amounts owed under the facilities and may foreclose upon the assets securing our obligations.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, we amended our Revolving Credit Facility, which provides for secured revolving loans in an aggregate amount of up to $15.0 million, to extend the maturity date to August 2, 2022. The Revolving Credit Facility is secured by substantially all of our assets, other than intellectual property. The Revolving Credit Facility contains customary affirmative and negative covenants which, unless waived by the bank, limit our ability to, among other things, incur additional indebtedness, grant liens, make investments, repurchase stock, pay dividends, transfer assets, enter into affiliate transactions, undergo a change of control, or engage in merger and acquisition activity, including merging or consolidating with a third party.  If we fail to comply with the covenants and our other obligations under the Revolving Credit Facility, the lenders would be able to accelerate the required repayment of amounts due under the Revolving Credit Agreement and, if they are not repaid, could foreclose upon the assets securing our obligations under the Revolving Credit Facility.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are subject to risks related to taxation in multiple jurisdictions and if taxing authorities disagree with our interpretations of existing tax laws or regulations, our effective income tax rate could be adversely affected and we could have additional tax liability. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to income taxes in both the United States and certain foreign jurisdictions. Significant judgments based on interpretations of existing tax laws or regulations are required in determining the provision for income taxes.  For example, we have made certain interpretations of existing tax laws or regulations based upon the operations of our business internationally and we have implemented intercompany agreements based upon these interpretations and related transfer pricing analyses.  If the U.S. Internal Revenue Service or other taxing authorities disagree with the positions, our effective income tax rate could be adversely affected and we could have additional tax liability, including interest and penalties. From time to time, we may review our corporate structure and tax positions in the various international jurisdictions in which we operate and such review may result in changes to how we structure our international business operations, which may adversely impact our effective income tax rate. Our effective income tax rate could also be adversely affected by changes in the mix of earnings in tax jurisdictions with different statutory tax rates, changes in the valuation of deferred tax assets and liabilities, changes in existing tax laws or tax rates, changes in the level of non-deductible expenses (including share-based compensation), changes in our future levels of research and development spending, mergers and acquisitions, or the result of examinations by various tax authorities. Payment of additional amounts as a result of changes in applicable tax law or upon final adjudication of any disputes could have a material impact on our results of operations and financial position.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our ability to use net operating loss carryforwards to offset future taxable income for U.S. federal income tax purposes and other tax benefits may be limited.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 382 of the Internal Revenue Code of 1986, as amended (the Code), imposes an annual limitation on the amount of taxable income that may be offset by net operating loss carryforwards (NOLs) if a corporation experiences an &#8220;ownership change.&#8221; As provided in Section 382 of the Code, an &#8220;ownership change&#8221; occurs when a company&#8217;s &#8220;five-percent shareholders&#8221; collectively increase their ownership in the company by more than 50 percentage points (by value) over a rolling three-year period. Various states also have limitations on the use of state NOLs following an ownership change.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future changes in our stock ownership, some of which are outside our control, could result in an ownership change under Section 382 of the Code. If we experience an ownership change, our ability to use our NOLs or other tax benefits could be substantially limited, which could significantly impair their value.&#160; There is no assurance that we will be able to fully utilize our NOLs or other tax benefits, which could adversely impact our results of operations.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that these tax benefits are a valuable asset for us and we monitor our stock ownership to determine whether our NOLs are at material risk of limitation based on an ownership change pursuant to Section 382.  If our board of directors determines a potential risk exists that our NOLs could be limited, it could elect to adopt a tax benefit preservation plan in an effort to protect our tax benefits. Adoption of a tax benefit preservation plan could make it more difficult for a third party to acquire, or could discourage a third party from acquiring, us or a large block of our common stock.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adverse conditions in the global economy and disruption of financial markets may significantly harm our revenue, profitability, and results of operations.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adverse economic conditions in the U.S. and international markets, including the worldwide economic disruption related to the COVID-19 pandemic, have negatively affected our revenues and operating results and may continue to do so. Even before the current public health crisis took hold, the global credit and financial markets had been experiencing volatility and disruptions, including diminished liquidity and credit availability, increased concerns about inflation and deflation, and the downgrade of U.S. debt and exposure risks on other sovereign debts, decreased consumer confidence, lower economic growth, volatile energy costs, increased unemployment rates, and uncertainty about economic stability. Geopolitical events including </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the COVID-19 pandemic, the United States government&#8217;s adoption and expansion of trade restrictions, and the United Kingdom&#8217;s withdrawal from the European Union have caused significant economic, market, political and regulatory uncertainty in some of our markets. Volatility and disruption of financial markets could limit our customers&#8217; ability to obtain adequate financing or credit to purchase and pay for our products in a timely manner or to maintain operations, which could result in a decrease in sales volume that could harm our results of operations. General concerns about the fundamental soundness of domestic and international economies may also cause our customers to reduce their purchases. Changes in governmental banking, monetary, and fiscal policies to address liquidity and increase credit availability may not be effective. Significant government investment and allocation of resources to assist the economic recovery of sectors that do not include our customers may reduce the resources available for government grants and related funding for life science, plant and animal research, and clinical research and development. Continuation or further deterioration of these financial and macroeconomic conditions could significantly harm our sales, profitability, and results of operations.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we are unable to expand our direct sales and marketing force or distribution capabilities to adequately address our customers&#8217; needs, our business may be adversely affected.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not be able to market, sell, and, distribute our products effectively enough to support our planned growth. We sell our products primarily through our own sales force and through distributors in certain territories. Our future sales will depend in large part on our ability to continue to develop and substantially expand our direct sales force and to increase the scope of our marketing efforts. Our products are technically complex and used for highly specialized applications. As a result, we believe it is necessary to continue to develop a direct sales force that includes people with specific scientific backgrounds and expertise, and a marketing group with technical sophistication. We have experienced significant changes in our sales organization in the past year due to reorganizations and changes in leadership. In addition, as part of our cost reduction program to manage the impact of the COVID-19 pandemic, we implemented temporary enterprise-wide salary reductions, including with respect to our sales and marketing employees. Although all salaries have been restored to prior levels as of the date of this filing, any reinstatement of salary reductions or any other failure to maintain competitive levels of compensation may negatively impact our ability to maintain the skilled sales and marketing force necessary to support our business activities. As a result, our future success will depend largely on our ability to retain and motivate such personnel. Because competition for such employees is intense, we can provide no assurance that we will be able to retain them on favorable or commercially reasonable terms, if at all. Failure to attract and retain our current personnel or to build an efficient and effective sales and marketing force would negatively impact sales of our products and reduce our revenue and profitability.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may continue to enlist one or more sales representatives and distributors to assist with sales, distribution, and customer support globally or in certain regions of the world. If we do seek to enter into such arrangements, we may not be successful in attracting desirable sales representatives and distributors, or we may not be able to enter into such arrangements on favorable terms. If our sales and marketing efforts, or those of any third-party sales representatives and distributors, are not successful, our technologies and products may not gain market acceptance, which would materially and adversely impact our business operations.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we seek to implement a company-wide enterprise resource planning (ERP) system, such implementation could adversely affect our business and results of operations or the effectiveness of internal control over financial reporting.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have considered implementing a company-wide ERP system to handle the business and financial processes within our operations and corporate functions. ERP implementations are complex and time-consuming projects that involve substantial expenditures on system software and implementation activities that can continue for several years. ERP implementations also require transformation of business and financial processes in order to reap the benefits of the ERP system. If we decide to implement a company-wide ERP system, our business and results of operations could be adversely affected if we experience operating problems and/or cost overruns during the ERP implementation process, or if the ERP system and the associated process changes do not give rise to the benefits that we expect. If we do not effectively implement the ERP system as planned or if the system does not operate as intended, our business, results of operations, and internal controls over financial reporting could be adversely affected. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in accounting principles, or interpretations thereof, could have a significant impact on our financial position and results of operations. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We prepare our consolidated financial statements in accordance with U.S. GAAP. These principles are subject to interpretation by the SEC and various bodies formed to interpret and create appropriate accounting principles. A change in these principles can have a significant effect on our reported results and may even retroactively affect previously reported transactions. Additionally, the adoption of new or revised accounting principles may require that we make significant&#160;changes&#160;to our systems, processes and controls.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, the U.S.-based Financial&#160;Accounting Standards&#160;Board (FASB) is currently working together with the International Accounting Standards Board (IASB), on several projects to further align accounting principles and facilitate more comparable financial reporting between companies who are required to follow U.S. GAAP under SEC regulations and those who are required to follow International Financial Reporting Standards outside of the United States. These efforts by the FASB and IASB may result in different accounting principles under U.S. GAAP that may result in materially different financial results for us in areas including, but not limited to, principles for recognizing revenue and lease accounting. Additionally, significant changes to U.S. GAAP resulting from the FASB&#8217;s and IASB&#8217;s efforts may require that we change how we process, analyze and report financial information and that we change financial reporting controls. Additionally, the FASB issued new guidance (ASU 2014-09) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers (Topic 606)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which supersedes nearly all existing U.S. GAAP revenue recognition guidance. The new guidance was effective for our fiscal year 2018. We adopted ASU 2014-09 in the first quarter of 2018 using the modified retrospective method. Under the modified retrospective method, periods prior to the adoption of ASU 2014-09 are not restated and the cumulative effect of initially applying the new standard is reflected in the opening balance of accumulated deficit as of January 1, 2018. To date, the adoption has not had a material impact on our consolidated financial statements. Additional disclosures are required for significant differences between the reported results under the new standard and those that would have been reported under the legacy standard, which required us to make certain changes to our business processes and controls to support revenue recognition and disclosure under the new standard. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FASB also issued Accounting Standards Update (ASU) 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ASU 2016-02). The core principle is that lessees should recognize the assets and liabilities arising from leases on the balance sheet. Under the new standard, lessees will be required to recognize lease assets and liabilities for all leases, with certain exceptions, on their balance sheets. We adopted ASU 2016-02 as of January 1, 2019. The adoption of this standard had a material impact on our consolidated financial statements. We continue to identify the appropriate changes to our business processes, systems, and controls to support the new lease standard and the required disclosures under the new standard. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is not clear if or when potential changes in accounting principles may become effective, whether we have the proper systems and controls in place to accommodate such changes and the impact that any such changes may have on our financial position and results of operations.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We have a significant amount of outstanding indebtedness, and our financial condition and results of operations could be adversely affected if we do not efficiently manage our liabilities.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have significant outstanding convertible debt. As of September 30, 2020, we had outstanding $1.1 million aggregate principal amount of our 2.75% Senior Convertible Notes due 2034 (2014 Notes) and $55.0 million aggregate principal amount of our 5.25% convertible senior notes due 2024 (2019 Notes).&#160;The 2014 Notes will mature on February 1, 2034, unless earlier converted, redeemed, or repurchased in accordance with the terms of the 2014 Notes. Holders of the 2014 Notes may require us to repurchase all or a portion of their 2014 Notes on each of February 6, 2021, February 6, 2024, and February 6, 2029 at a repurchase price in cash equal to 100% of the principal amount of the Notes plus accrued and unpaid interest.  The 2019 Notes will mature on December 1, 2024, unless earlier converted, or repurchased in accordance with the terms of the 2019 Notes. If we undergo a fundamental change (as defined in the terms of the indenture governing either the 2014 Notes or the 2019 Notes (collectively, the Convertible Notes)), holders of the applicable series of Convertible Notes may require us to repurchase such Convertible Notes in whole or in part for cash at a repurchase price equal to 100% of the principal amount of the applicable series of Convertible Notes plus accrued and unpaid interest. If we refinance the debt owed under the 2014 Notes or 2019 Notes, we may issue additional convertible notes or other debt, which could include additional company obligations and represent more dilution to existing stockholders and noteholders.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This significant amount of debt has important risks to us and our investors, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">requiring a portion of our cash flow from operations to make interest payments on this debt;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increasing our vulnerability to general adverse economic and industry conditions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reducing the cash flow available to fund capital expenditures and other corporate purposes and to grow our business;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limiting our flexibility in planning for, or reacting to, changes in our business and the industry; and</span></div><div style="margin-bottom:8pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limiting our ability to borrow additional funds as needed or take advantage of business opportunities as they arise.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, to the extent we draw on our Revolving Credit Facility or otherwise incur additional indebtedness, the risks described above could increase. Further, if we increase our indebtedness, our actual cash requirements in the future may be greater than expected. Our cash flow from operations may not be sufficient to repay all of the outstanding debt as it becomes due, and we may not be able to borrow money, sell assets or otherwise raise funds on acceptable terms, or at all, to refinance our debt.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Intellectual Property</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our ability to protect our intellectual property and proprietary technology through patents and other means is uncertain.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial success depends in part on our ability to protect our intellectual property and proprietary technologies. We rely on patent protection, where appropriate and available, as well as a combination of copyright, trade secret, and trademark laws, and nondisclosure, confidentiality, and other contractual restrictions to protect our proprietary technology. However, these legal means afford only limited protection and may not adequately protect our rights or permit us to gain or keep any competitive advantage. We apply for patents covering our products and technologies and uses thereof, as we deem appropriate. However, we may fail to apply for patents on important products and technologies in a timely fashion or at all. Our pending U.S. and foreign patent applications may not issue as patents or may not issue in a form that will be sufficient to protect our proprietary technology and gain or keep our competitive advantage. Any patents we have obtained or do obtain may be subject to re-examination, reissue, opposition, or other administrative proceeding, or may be challenged in litigation, and such challenges could result in a determination that the patent is invalid or unenforceable. In addition, competitors may be able to design alternative methods or devices that avoid infringement of our patents. Both the patent application process and the process of managing patent disputes can be time consuming and expensive.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, the laws of some foreign countries may not protect our intellectual property rights to the same extent as do the laws of the United States, and many companies have encountered significant problems in protecting and defending such rights in foreign jurisdictions. Proceedings to enforce our patent rights in foreign jurisdictions could result in substantial cost and divert our efforts and attention from other aspects of our business. Changes in either the patent laws or in interpretations of patent laws in the United States or other countries may diminish the value of our intellectual property. We cannot predict the breadth of claims that may be allowed or enforced in our patents or in third-party patents. For example:</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we might not have been the first to make the inventions covered by each of our pending patent applications;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we might not have been the first to file patent applications for these inventions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the patents of others may have an adverse effect on our business; and</span></div><div style="margin-bottom:8pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">others may independently develop similar or alternative products and technologies or duplicate any of our products and technologies.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent our intellectual property, including licensed intellectual property, offers inadequate protection, or is found to be invalid or unenforceable, our competitive position and our business could be adversely affected.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may be involved in lawsuits to protect or enforce our patents and proprietary rights, to determine the scope, coverage and validity of others&#8217; proprietary rights, or to defend against third-party claims of intellectual property infringement, any of which could be time-intensive and costly and may adversely impact our business or stock price.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litigation may be necessary for us to enforce our patent and proprietary rights, determine the scope, coverage, and validity of others&#8217; proprietary rights, and/or defend against third-party claims of intellectual property infringement against us as well as against our suppliers, distributors, customers, and other entities with which we do business. Litigation could result in substantial legal fees and could adversely affect the scope of our patent protection. The outcome of any litigation or other proceeding is inherently uncertain and might not be favorable to us, and we might not be able to obtain licenses to technology that we require. Even if such licenses are obtainable, they may not be available at a reasonable cost. We could therefore incur substantial costs related to royalty payments for licenses obtained from third parties, which could negatively affect our product margins or financial position. Further, we could encounter delays in product introductions, or interruptions in product sales, as we develop alternative methods or products. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we move into new markets and applications for our products, incumbent participants in such markets may assert their patents and other proprietary rights against us as a means of impeding our entry into such markets or as a means to extract substantial license and royalty payments from us. Our commercial success may depend in part on our non-infringement of the patents or proprietary rights of third parties. Numerous significant intellectual property issues have been litigated, and will likely continue to be litigated, between existing and new participants in our existing and targeted markets. For example, some of our products provide for the testing and analysis of genetic material, and patent rights relating to genetic materials remain a developing area of patent law. A recent U.S. Supreme Court decision held, among other things, that claims to isolated genomic DNA occurring in nature are not patent eligible, while claims relating to synthetic DNA may be patent eligible. We expect the ruling will result in additional litigation in our industry. In addition, third parties may assert that we are employing their proprietary technology without authorization, and if they are successful in making such claims, we may be forced to enter into </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">license agreements, pay additional royalties or license fees, or enter into settlements that include monetary obligations or restrictions on our business.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our customers have been sued for various claims of intellectual property infringement in the past, and we expect that our customers will be involved in additional litigation in the future. In particular, our customers may become subject to lawsuits claiming that their use of our products infringes third-party patent rights, and we could become subject to claims that we contributed to or induced our customer&#8217;s infringement. In addition, our agreements with some of our suppliers, distributors, customers, and other entities with which we do business may require us to defend or indemnify these parties to the extent they become involved in infringement claims against us, including the claims described above. We could also voluntarily agree to defend or indemnify third parties in instances where we are not obligated to do so if we determine it would be important to our business relationships. If we are required or agree to defend or indemnify any of these third parties in connection with any infringement claims, we could incur significant costs and expenses that could adversely affect our business, operating results, or financial condition.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may be subject to damages resulting from claims that we or our employees have wrongfully used or disclosed alleged trade secrets of our employees&#8217; former employers or other institutions or third parties with which such employees may have been previously affiliated.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our employees were previously employed at universities or other life science or plant and animal research companies, including our competitors or potential competitors. In the future, we may become subject to claims that our employees, or we, have inadvertently or otherwise used or disclosed trade secrets or other proprietary information of their former employers or other third parties or institutions with which our employees may have been previously affiliated. Litigation may be necessary to defend against these claims. For example, we were a defendant in litigation brought against us and one of our non-executive employees by Thermo alleging, among other claims, misappropriation of proprietary information and breach of contractual and fiduciary obligations. While we resolved our dispute with Thermo in July 2017, if we fail in defending against similar claims brought in the future, we could be subject to injunctive relief against us.  A loss of key research personnel work product could hamper or prevent our ability to commercialize certain potential products or a loss of or inability to hire key marketing, sales or research and development personnel could adversely affect our future product development, sales and revenues, any of which could severely harm our business. Even if we are successful in defending against any similar claims brought in the future, litigation could result in substantial costs and be a distraction to management.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We depend on certain technologies that are licensed to us. We do not control these technologies and any loss of our rights to them could prevent us from selling our products, which would have an adverse effect on our business.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on licenses in order to be able to use various proprietary technologies that are material to our business, including our core IFC, multi-layer soft lithography, and mass cytometry technologies. In some cases, we do not control the prosecution, maintenance, or filing of the patents to which we hold licenses, or the enforcement of these patents against third parties.  Additionally, our business and product development plans anticipate and may substantially depend on future in-license agreements with additional third parties, some of which are currently in the early discussion phase.  For example, Fluidigm Canada Inc., or Fluidigm Canada, an Ontario corporation and wholly owned subsidiary of Fluidigm Sciences, was party to an interim license agreement, now expired, with Nodality, Inc., or Nodality, under which Nodality granted Fluidigm Canada a worldwide, non-exclusive, research use only, royalty bearing license to certain cytometric reagents, instruments, and other products. While we were able to secure a license under a new license agreement with Nodality, we cannot provide assurances that we will always be able to obtain suitable license rights to technologies or intellectual property of other third parties on acceptable terms, if at all.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In-licensed intellectual property rights that are fundamental to our business being operated present numerous risks and limitations.  For example, all or a portion of the license rights granted may be limited for research use only, and in the event we attempt to expand into diagnostic applications, we would be required to negotiate additional rights, which may not be available to us on commercially reasonable terms, if at all.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our rights to use the technology we license are also subject to the negotiation and continuation of those licenses. Certain of our licenses contain provisions that allow the licensor to terminate the license upon specific conditions. Our rights under the licenses are subject to our continued compliance with the terms of the license, including the payment of royalties due under the license. Because of the complexity of our products and the patents we have licensed, determining the scope of the license and related royalty obligation can be difficult and can lead to disputes between us and the licensor. An unfavorable resolution of such a dispute could lead to an increase in the royalties payable pursuant to the license. If a licensor believed we were not paying the royalties due under the license or were otherwise not in compliance with the terms of the license, the licensor might attempt to revoke the license. If such an attempt were successful and the license is terminated, we might be barred from marketing, producing, and selling some or all of our products, which would have an adverse effect on our business. Potential </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">disputes between us and one of our existing licensors concerning the terms or conditions of the applicable license agreement could result, among other risks, in substantial management distraction; increased expenses associated with litigation or efforts to resolve disputes; substantial customer uncertainty concerning the direction of our product lines; potential infringement claims against us and/or our customers, which could include efforts by a licensor to enjoin sales of our products; customer requests for indemnification by us; and, in the event of an adverse determination, our inability to operate our business as currently operated. Termination of material license agreements could prevent us from manufacturing and selling our products unless we can negotiate new license terms or develop or acquire alternative intellectual property rights that cover or enable similar functionality. Any of these factors would be expected to have a material adverse effect on our business, operating results, and financial condition and could result in a substantial decline in our stock price.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are subject to certain manufacturing restrictions related to licensed technologies that were developed with the financial assistance of U.S. governmental grants.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to certain U.S. government regulations because we have licensed technologies that were developed with U.S. government grants. In accordance with these regulations, these licenses provide that products embodying the technologies are subject to domestic manufacturing requirements. If this domestic manufacturing requirement is not met, the government agency that funded the relevant grant is entitled to exercise specified rights, referred to as &#8220;march-in rights,&#8221; which if exercised would allow the government agency to require the licensors or us to grant a non-exclusive, partially exclusive, or exclusive license in any field of use to a third party designated by such agency. All of our microfluidic systems revenue is dependent upon the availability of our IFCs, which incorporate technology developed with U.S. government grants. Our genomics instruments, including microfluidic systems, and IFCs are manufactured at our facility in Singapore. The federal regulations allow the funding government agency to grant, at the request of the licensors of such technology, a waiver of the domestic manufacturing requirement. Waivers may be requested prior to any government notification. We have assisted the licensors of these technologies with the analysis of the domestic manufacturing requirement, and, in December 2008, the sole licensor subject to the requirement applied for a waiver of the domestic manufacturing requirement with respect to the relevant patents licensed to us by this licensor. In July 2009, the funding government agency granted the requested waiver of the domestic manufacturing requirement for a three-year period commencing in July 2009. In June 2012, the licensor requested a continued waiver of the domestic manufacturing requirement with respect to the relevant patents, but the government agency has not yet taken any action in response to this request. If the government agency does not grant the requested waiver or the government fails to grant additional waivers of such requirement that may be sought in the future, then the U.S. government could exercise its march-in rights with respect to the relevant patents licensed to us. In addition, the license agreement under which the relevant patents are licensed to us contains provisions that obligate us to comply with this domestic manufacturing requirement. We are not currently manufacturing instruments and IFCs in the United States that incorporate the relevant licensed technology. If our lack of compliance with this provision constituted a material breach of the license agreement, the license of the relevant patents could be terminated or we could be compelled to relocate our manufacturing of microfluidic systems and IFCs to the United States to avoid or cure a material breach of the license agreement. Any of the exercise of march-in rights, the termination of our license of the relevant patents or the relocation of our manufacturing of microfluidic systems and IFCs to the United States could materially adversely affect our business, operations and financial condition.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are subject to certain obligations and restrictions relating to technologies developed in cooperation with Canadian government agencies. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our Canadian research and development is funded in part through government grants and by government agencies. The intellectual property developed through these projects is subject to rights and restrictions in favor of government agencies and Canadians generally. In most cases the government agency retains the right to use intellectual property developed through the project for non-commercial purposes and to publish the results of research conducted in connection with the project. This may increase the risk of public disclosure of information relating to our intellectual property, including confidential information, and may reduce its competitive advantage in commercializing intellectual property developed through these projects. In certain projects, we have also agreed to use commercially reasonable efforts to commercialize intellectual property in Canada, or more specifically in the province of Ontario, for the economic benefit of Canada and the province of Ontario. These restrictions will limit our choice of business and manufacturing locations, business partners and corporate structure and may, in certain circumstances, restrict our ability to achieve maximum profitability and cost efficiency from the intellectual property generated by these projects. In one instance, a dispute with the applicable government funded entity may require mediation, which could lead to unanticipated delays in our commercialization efforts to that project. One of our Canadian government funded projects is also subject to certain limited &#8220;march-in&#8221; rights in favor of the government of the Province of Ontario, under which we may be required to grant a license to our intellectual property, including background intellectual property developed outside the scope of the project, to a responsible applicant on reasonable terms in circumstances where the government determines that such a license is necessary in order to alleviate emergency or extraordinary health or safety needs or for public use. In addition, we must provide reasonable assistance to the government in obtaining similar licenses from third </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">parties required in connection with the use of its intellectual property. Instances in which the government of the Province of Ontario has exercised similar &#8220;march-in&#8221; rights are rare; however, the exercise of such rights could materially adversely affect our business, operations and financial condition. </span></div><div style="margin-bottom:8pt;margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Common Stock</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our stock price may fluctuate significantly, particularly if holders of substantial amounts of our stock attempt to sell, and holders may have difficulty selling their shares based on current trading volumes of our stock.&#160;In addition, numerous other factors could result in substantial volatility in the trading price of our stock. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our stock is currently traded on the Nasdaq Global Select Market (Nasdaq), but we can provide no assurance that we will be able to maintain an active trading market on Nasdaq or any other exchange in the future.&#160;The trading volume of our stock tends to be low relative to our total outstanding shares, and we have several stockholders who hold substantial blocks of our stock.&#160;As of December&#160;31, 2019, we had 69,956,397 shares of common stock outstanding, and stockholders holding at least 5% of our stock, individually or with affiliated persons or entities, collectively beneficially owned or controlled approximately 46.3% of such shares and one stockholder beneficially owned approximately 9.8% of our outstanding common stock.&#160;Sales of large numbers of shares by any of our large stockholders could adversely affect our trading price, particularly given our relatively small historic trading volumes.&#160;If stockholders holding shares of our common stock sell, indicate an intention to sell, or if it is perceived that they will sell, substantial amounts of their common stock in the public market, the trading price of our common stock could decline. Moreover, if there is no active trading market or if the volume of trading is limited, holders of our common stock may have difficulty selling their shares.  In addition, the concentration of ownership of our outstanding common stock (approximately 46.3% held by our top six stockholders) means that a relatively small number of stockholders have significant control over the outcomes of stockholder voting. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the trading price of our common stock may be highly volatile and could be subject to wide fluctuations in response to various factors, some of which are beyond our control. These factors include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of public health crises, including the COVID-19 pandemic, on global financial markets;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actual or anticipated quarterly variation in our results of operations or the results of our competitors;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements or communications by us or our competitors relating to, among other things, new commercial products, technological advances, significant contracts, commercial relationships, capital commitments, acquisitions or sales of businesses, and/or misperceptions in or speculation by the market regarding such announcements or communications;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">issuance of new or changed securities analysts&#8217; reports or recommendations for our stock;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments or disputes concerning our intellectual property or other proprietary rights;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">commencement of, or our involvement in, litigation;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">market conditions in the life science, plant and animal research, and contract research organization sectors;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to complete significant sales;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">manufacturing disruptions that could occur if we are unable to successfully expand our production in our current or an alternative facility;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any future sales of our common stock or other securities in connection with raising additional capital or otherwise;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any major change to the composition of our board of directors or management; and</span></div><div style="margin-bottom:8pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic conditions and slow or negative growth of our markets.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The stock market in general, and market prices for the securities of technology-based companies like ours in particular, have from time to time experienced volatility that often has been unrelated to the operating performance of the underlying companies. These broad market and industry fluctuations may adversely affect the market price of our common stock regardless of our operating performance. In several recent situations where the market price of a stock has been volatile, holders of that stock have instituted securities class action litigation against the company that issued the stock. As discussed in the &#8220;Legal Proceedings&#8221; section of this Quarterly Report on Form 10-Q, a class action securities lawsuit against us is currently pending. While we are continuing to defend such action vigorously, the defense of this action and any additional actions can be costly, divert the time and attention of our management, and harm our operating results, and any judgment against us or any future stockholder litigation could result in substantial costs.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Future sales of our common stock in the public market could cause our stock price to fall.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our stock price could decline as a result of sales of a large number of shares of our common stock or the perception that these sales could occur. These sales, or the possibility that these sales may occur, also might make it more difficult for us to sell equity securities in the future at a time and at a price that we deem appropriate.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in the future, we may issue additional shares of common stock or other equity or debt securities convertible into common stock in connection with a financing, acquisition, litigation settlement, employee arrangements or otherwise. Any such future issuance, including any issuances pursuant to our ATM equity offering program under our Sale Agreement with Jefferies, could result in substantial dilution to our existing stockholders and could cause our stock price to decline.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We will have broad discretion over the use of the proceeds to us from our ATM equity offering program and may apply the proceeds to uses that do not improve our operating results or the value of your securities.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will have broad discretion to use the net proceeds to us from our ATM equity offering program, and investors will be relying solely on the judgment of our board of directors and management regarding the application of these proceeds. Investors will not have the opportunity, as part of their investment decision, to assess whether the proceeds are being used appropriately. Our use of the proceeds may not improve our operating results or increase the value of the securities offered pursuant to the ATM equity offering program.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If securities or industry analysts publish unfavorable research about our business or cease to cover our business, our stock price and/or trading volume could decline.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading market for our common stock may rely, in part, on the research and reports that equity research analysts publish about us and our business. We do not have any control of the analysts or the content and opinions included in their reports. The price of our stock could decline if one or more equity research analysts downgrade our stock or issue other unfavorable commentary or research. If one or more equity research analysts ceases coverage of our company or fails to publish reports on us regularly, demand for our stock could decrease, which in turn could cause our stock price or trading volume to decline.</span></div><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-takeover provisions in our charter documents and under Delaware law could make an acquisition of us, which may be beneficial to our stockholders, more difficult and may prevent attempts by our stockholders to replace or remove our current management and limit the market price of our common stock.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provisions in our certificate of incorporation and bylaws may have the effect of delaying or preventing a change of control or changes in our management, including provisions that:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">authorize our board of directors to issue, without further action by the stockholders, up to 10,000,000 shares of undesignated preferred stock;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">require that any action to be taken by our stockholders be effected at a duly called annual or special meeting and not by written consent;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">specify that special meetings of our stockholders can be called only by our board of directors, the chairman of the board, the chief executive officer or the president;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establish an advance notice procedure for stockholder approvals to be brought before an annual meeting of our stockholders, including proposed nominations of persons for election to our board of directors;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establish that our board of directors is divided into three classes, Class I, Class II, and Class III, with each class serving staggered three-year terms;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide that our directors may be removed only for cause;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide that vacancies on our board of directors may be filled only by a majority of directors then in office, even though less than a quorum;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">specify that no stockholder is permitted to cumulate votes at any election of directors; and</span></div><div style="margin-bottom:8pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">require a super-majority of votes to amend certain of the above-mentioned provisions.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our board of directors, which is responsible for appointing the members of our management. In addition, because we are incorporated in Delaware, we are governed by the provisions of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;203 of the Delaware General Corporation Law, which limits the ability of stockholders owning in excess of 15% of our outstanding voting stock to merge or combine with us.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We have never paid cash dividends on our capital stock, and we do not anticipate paying any cash dividends in the foreseeable future.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have paid no cash dividends on any of our classes of capital stock to date and currently intend to retain our future earnings to fund the development and growth of our business. In addition, we cannot pay any cash dividends on any of our classes of common stock without approval from the lender under our Revolving Credit Facility, and may become subject to covenants under future debt arrangements that place restrictions on our ability to pay dividends. As a result, capital appreciation, if any, of our common stock will be stockholders&#8217; sole source of gain for the foreseeable future.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Any conversions of the 2014 Notes or 2019 Notes will dilute the ownership interest of our existing stockholders and may otherwise depress the price of our common stock.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any conversion of some or all of the 2014 Notes or 2019 Notes will dilute the ownership interests of our existing stockholders. Any sales in the public market of our common stock issuable upon such conversion could also adversely affect prevailing market prices of our common stock.  In addition, holders of the 2014 Notes or 2019 Notes may hedge their position in such Convertible Notes by entering into short positions with respect to the underlying common stock. As a result, any anticipated conversion of the 2014 Notes or 2019 Notes could depress the market price of our common stock and impair our ability to raise capital through the sale of additional equity securities. </span></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_127"></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_1234"></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Defaults Upon Senior Securities</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_1239"></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Mine Safety Disclosures</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_130"></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Other Information</span></div><div style="margin-bottom:8pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_133"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;6. Exhibits</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The documents listed in the Exhibit List, which follows below, are incorporated by reference or are filed with this quarterly report on Form 10-Q, in each case as indicated therein (numbered in accordance with Item 601 of Regulation S-K).</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT LIST</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.198%"><tr><td style="width:1.0%"></td><td style="width:9.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.121%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.690%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated<br/>by&#160;Reference<br/>From Form</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated<br/>by&#160;Reference<br/>From&#160;Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date&#160;Filed</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit101to3q20orm.htm">Contract by and between the National Institutes of Health and the </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit101to3q20orm.htm">r</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit101to3q20orm.htm">egistrant effective as of July 30, 2020, as amended September 28, 2020.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit10210q3q2020.htm">Second Amended and Restated License Agreement between California Institute of Technology and the registrant effective as of May 1, 2004.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2A*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit102a10q3q2020.htm">First Addendum, effective as of March 29, 2007, to Second Amended and Restated License Agreement between California Institute of Technology and the registrant effective as of May 1, 2004.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit10310q3q2020.htm">Co-Exclusive License Agreement between President and Fellows of Harvard College and the registrant effective as of October 15, 2000.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3A*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit103a10q3q2020.htm">First Amendment to Co-Exclusive License Agreement between President and Fellows of Harvard College and the registrant effective as of October 15, 2000.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit10410q3q2020.htm">Co-Exclusive License Agreement between President and Fellows of Harvard College and the registrant effective as of October 15, 2000.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit10510q3q2020.htm">Co-Exclusive License Agreement between President and Fellows of Harvard College and the registrant effective as of October 15, 2000.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit10610q3q2020.htm">Letter Agreement between President and Fellows of Harvard College and the registrant dated December 22, 2004.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit31110q3q2020ng.htm">Certification Pursuant to 18 U.S.C. Section&#160;1350, as Adopted Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002 of Chief Executive Officer.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit31210q3q2020ng.htm">Certification Pursuant to 18 U.S.C. Section&#160;1350, as Adopted Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002 of Chief Financial Officer.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit32110q3q2020ng.htm">Certification Pursuant to 18 U.S.C. Section&#160;1350, as Adopted Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 of Chief Executive Officer.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit32210q3q2020ng.htm">Certification Pursuant to 18 U.S.C. Section&#160;1350, as Adopted Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 of Chief Executive Officer.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document&#160;- the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)  In accordance with Item&#160;601(b)(32)(ii) of Regulation&#160;S-K and SEC Release No.&#160;33-8238 and 34-47986, Final Rule: Management&#8217;s Reports on Internal Control Over Financial Reporting and Certification of Disclosure in Exchange Act Periodic Reports, the certifications furnished in Exhibits 32.1 and 32.2 hereto are deemed to accompany this Form&#160;10-Q and will not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Exchange Act. Such certifications will not be deemed to be incorporated by reference into any filings under the Securities Act or the Exchange Act, except to the extent that the registrant specifically incorporates it by reference.</span></div><div style="margin-top:6pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">*  Portions of this exhibit have been redacted in compliance with Regulation S-K Item 601(b)(10)(iv).</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><div id="i510b60bc5a1a4748b3e64a6ef1966fcd_136"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:9pt;text-indent:27pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:15pt;margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.794%"><tr><td style="width:1.0%"></td><td style="width:30.025%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.290%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.627%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.095%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FLUIDIGM CORPORATION</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated:  November 6, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Stephen Christopher Linthwaite</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stephen Christopher Linthwaite</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated:  November 6, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Vikram Jog</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vikram Jog</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>exhibit101to3q20orm.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="ice27bba39ac84ed2a40a7c842e33b4c4_84"></div><div style="min-height:40.3pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:17.248%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.054%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.896%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.203%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:115%">SOLICITATION&#47;CONTRACT&#47;ORDER </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:115%">FOR </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:115%">COMMERCIAL</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:115%">ITEMS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:115%">OFFEROR TO COMPLETE BLOCKS 12, 17, 23, 24, &#38; 30</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:115%">O</font></div></td><td colspan="6" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1. REQUISITION NUMBER</font></div><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">5763920</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:4.5pt;text-align:center;text-indent:22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:111%">PAGE OF </font></div><div style="margin-top:4.65pt;padding-left:8.75pt;padding-right:4.5pt;text-align:center;text-indent:22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:111%">1    &#47;  </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:111%">34</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.6pt;text-indent:-3.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:111%">2. CONTRACT NO.</font></div><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">75N92020C00009</font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.6pt;text-indent:-1.15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:111%">3. AWARD&#47; </font></div><div style="padding-left:3.6pt;text-indent:-1.15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:111%">EFFECTIVE DATE</font></div><div style="margin-bottom:0.9pt;margin-top:6.45pt;padding-left:3.6pt"><font><br></font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">4. ORDER NUMBER.</font></div><div style="margin-bottom:4pt;margin-top:3.3pt"><font><br></font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:113%">1 5. SOLICITATION NUMBER </font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:113%">&#160;6 . SOLICITATION<br>ISSUE DATE</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:115%">7.  FOR SOLICITATION INFORMATION CALL&#58;</font></div><div><font><br></font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">a. NAME</font></div><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">LINDA SMITH</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">b. TELEPHONE NUMBERT             </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(No collect calls)</font></div><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">+1 301 827-7741</font></div></td><td colspan="6" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:113%">8. OFFER DUE DATE&#47;LOCAL TIME                                                   </font></td></tr><tr style="height:14pt"><td colspan="6" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:111%">9. ISSUED BY&#160;&#160;&#160;&#160;CODE</font></div><div style="margin-top:6.1pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:109%">National Institutes of Health National Heart, Lung, and Blood Institute</font></div><div style="margin-bottom:22.45pt;margin-top:2.95pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:92%">Bethesda, MD 20892</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:5.85pt;font-weight:400;line-height:92%;position:relative;top:-3.15pt;vertical-align:baseline">-</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:92%">7511</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9.5pt;font-weight:400;line-height:120%">NHLBI</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" rowspan="2" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:3.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10. THIS ACQUISITION IS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">       </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:6.5pt;font-weight:400;line-height:120%">x</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:6pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">UNRESTRICTED OR</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">      </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">SET ASIDE&#58;                          % FOR&#58;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#9744;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">  SMALL BUSINESS                </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#9744;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> WOMEN-OWNED SMALL BUSINESS </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(WOSB) ELIGIBLE UNDER THE WOMEN-OWNED</font></div><div style="text-indent:12.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:115%">&#160;&#9744;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">  HUBZONE SMALL                    SMALL BUSINESS  PROGRAM                                  NAICS&#58;</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:115%">334516 </font></div><div style="text-indent:12.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;BUSINESS                           </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:115%">&#9744; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">EDWOSB</font></div><div><font><br></font></div><div style="text-indent:12.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:115%">&#160;&#9744;  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">SERVICE-DISABLED            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:115%">&#9744;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%"> 8(A)</font></div><div style="text-indent:12.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;&#160;&#160;VETERAN-OWNED                                                                                                         SIZE STANDARD&#58;  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:115%">1,000</font></div><div style="text-indent:12.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">&#160;SMALL BUSINESS</font></div></td></tr><tr style="height:74pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="6" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:126%">11.    DELIVERY FOR FOB DESTINA- </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:126%">TION UNLESS BLOCK IS MARKED</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">x </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">SEE SCHEDULE</font></div></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.5pt;font-weight:400;line-height:115%">12.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.5pt;font-weight:400;line-height:115%">DISCOUNT</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.5pt;font-weight:400;line-height:115%">TERMS</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#9744;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> 13a.  THIS CONTRACT IS A </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;RATED  ORDER  UNDER</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;DPAS (15 CFR 700)</font></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">13b.RATING</font></div></td></tr><tr style="height:21pt"><td colspan="3" style="border-right:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">14. METHOD OF SOLICITATION</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;&#160;&#9744;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">RFQ                </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">  &#9744;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">  IFB             </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> &#9744;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">RFP</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:116%">15 DELIVER TO</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">CODE</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">TDP,</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">BTHOFF</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">TDP,</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">BTHOFF</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">CODE</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">NIBIB</font></div></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">Two</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">Democracy</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">Plaza,</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">Bethesda</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">Off</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">C</font></div><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">2</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">Democracy</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">Plaza</font></div><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">6707</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">Democracy</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">Blvd</font></div><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">Bethesda</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">MD</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">20817</font></div></td><td colspan="15" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">National</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">Institutes</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">of</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">Health</font></div><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">National</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">Institute</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">of</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">Biomedical</font></div><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">Imaging</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">and</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">Bioengineering</font></div><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">Bethesda,</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">MD</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">20892-7511</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">17a. CONTRACTOR&#47;               CODE</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;OFFEROR</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5pt;font-weight:400;line-height:115%">FACILITY</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.5pt;font-weight:400;line-height:115%">CODE</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">18a. PAYMENT WILL BE MADE BY&#160;&#160;&#160;&#160;                                                                     CODE</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">NHLBI</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">INV-BR-A</font></div></td></tr><tr style="height:21pt"><td colspan="9" rowspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><font><br></font></div><div style="margin-top:11.5pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:86%">FLUIDIGM CORPORATION&#58;1157584</font></div><div style="margin-top:2.9pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:86%">2 TOWER PLACE SUITE 2000</font></div><div style="margin-bottom:4.2pt;margin-top:3.45pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:86%">SOUTH SAN FRANCISCO CA 940801826</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">TELEPHONE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">NO.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">    -                  </font></div><div><font><br></font></div></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.45pt"><font><br></font></div><div style="padding-left:1.45pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:108%">Approved</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:108%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:108%">By,</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:108%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:108%">NHLBI</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:108%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:108%">Branch</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:108%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:108%">A</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:108%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:108%">Invoice Paid</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:108%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:108%">By&#58;</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:108%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:108%">NIH</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:108%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:108%">Commercial</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:108%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:108%">Accounts</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:108%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:108%">Br 2115</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:108%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:108%">East</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:108%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:108%">Jefferson</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:108%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:108%">St,</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:108%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:108%">MSC</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:108%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:108%">8500 Room</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:108%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:108%">4B-432</font></div><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">Bethesda,</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">MD</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">20892-8500</font></div></td></tr><tr style="height:21pt"><td colspan="27" style="display:none"></td></tr><tr style="height:30pt"><td colspan="27" style="display:none"></td></tr><tr><td colspan="12" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">17b. CHECK IF REMITTANCE IS DIFFERENT AND PUT SUCH ADDRESS IN OFFER</font></div></td><td colspan="15" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">18b. SUBMIT INVOICES TO ADDRESS SHOWN IN BLOCK 18a UNLESS BLOCK  BELOW</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;IS CHECKED&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> &#9744; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">SEE ADDENDUM</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.710%"><tr><td style="width:1.0%"></td><td style="width:6.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.488%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.342%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">19.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">ITEM NO.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">20.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">SCHEDULE OF SUPPLIES&#47;SERVICES</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">21<br>QUANTITY</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">22. UNIT</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.5pt;font-weight:400;line-height:115%">23.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.5pt;font-weight:400;line-height:115%">UNIT</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.5pt;font-weight:400;line-height:115%">PRICE</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.5pt;font-weight:400;line-height:115%">24.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.5pt;font-weight:400;line-height:115%">AMOUNT</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">1</font></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">NIBID&#58; 75N92020C00009 Rapid Acceleration of <br>Diagnostics ( RADx) Program&#58; Tech Project # 6114 <br>Fluidigm - Advanta Dx SARS-CoV-2 RT-PCR Assay for <br>Saliva<br>Period of Performance&#58; 07&#47;30&#47;2020 to 07&#47;29&#47;2021<br><br>Stage 1 - Test Verification<br>Obligated Amount&#58; &#91;***&#93;<br>Delivery To&#58; Bldg.31&#47;RM 1C31 <br>Continued ...<br>(Use Reverse and!or Attach Additional Sheets as Necessary)<br></font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">25.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">ACCOUNTING</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">AND</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">APPROPRIATION DATA</font></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">26. TOTAL AWARD AMOUNT </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:115%">(For Govt. Use Only)</font></div><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:115%">$12,151,000.00</font></div></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9744; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">27a. SOLICITATION INCORPORATES BY REFERENCE FAR 52.212-1, 52.212-4. FAR 52.212-3 AND 52.212-5 ARE ATTACHED.  ADDENDA&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9744;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">ARE </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9744;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">ARE NOT ATTACHED</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">x </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">27b. CONTRACT&#47;PURCHASE ORDER INCORPORATES BY REFERENCE FAR 52.212-4. FAR 52.212-5 IS ATTACHED.             ADDENDA&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">x</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">ARE </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">x</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">ARE NOT ATTACHED</font></div><div style="margin-bottom:0.75pt;margin-top:4.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:111%">Except as provided herein, all terms and conditions of the document referenced in Item 9 A or 10A, as heretofore changed, remains unchanged and in full force and effect.</font></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.982%"><tr><td style="width:1.0%"></td><td style="width:18.271%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.271%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.418%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.470%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.207%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9744; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">28. CONTRACTOR IS REQUIRED TO SIGN THIS DOCUMENT AND RETURN     </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:115%;text-decoration:underline">       </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:6pt;font-weight:400;line-height:115%;text-decoration:underline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:115%;text-decoration:underline">               </font></div><div style="text-indent:9.89pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">COPIES TO ISSUING OFFICE. CONTRACTOR AGREES TO FURNISH AND DELIVER</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;&#160;&#160;ALL ITEMS SET FORTH OR OTHERWISE IDENTIFIED ABOVE AND ON ANY ADDITIONAL</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;&#160;SHEETS SUBJECT TO THE TERMS AND CONDITIONS SPECIFIED.</font></div></td><td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">29. AWARD OF CONTRACT&#58;                  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;text-decoration:underline">                                                             </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">OFFER       DATED       . YOUR OFFER ON SOLICITATION (BLOCK 5),</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">&#160;INCLUDING ANY ADDITIONS OR CHANGES WHICH ARE SET FORTH</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">&#160;HEREIN, IS ACCEPTED AS TO ITEMS&#58;</font></div></td></tr><tr><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">30a. SIGNATURE OF OFFEROR&#47;CONTRACTOR</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#47;s&#47; S. Christopher Linthwaite</font></div></td><td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1        16B. UNITED STATES OF AMERICA (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">SIGNATURE OFCONTRACTING OFFICER)</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#47;s&#47; Roxane S. Burkett -S       Digitally signed by Roxane S. Burkett -S</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Date&#58; 2020.07.30 077&#58;36&#58;45 -04'00'</font></div></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">30b. NAME AND TITLE OF SIGNER </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:115%">(Type or print)</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6pt;font-weight:400;line-height:115%">S. Christopher Linthwaite, President and CEO</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">)</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">30C. DATE SIGNED<br>7&#47;29&#47;2020</font></td><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">31b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">NAME</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">OF</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">CONTRACTING</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">OFFICER</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:115%">(Type or print)</font></div><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:6pt;font-weight:400;line-height:115%">ROxANE S. BURKETT</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">31c. DATE SIGNED</font></div></td></tr></table></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">AUTHORIZED FOR LOCAL REPRODUCTION&#160;&#160;&#160;&#160;STANDARD FORM</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">1449 (REV. 2&#47;2012)3)</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">PREVIOUS EDITION IS NOT USABLE&#160;&#160;&#160;&#160;Prescribed by GSA - FAR (48 CFR) 53.212</font></div><div style="margin-top:1.5pt;padding-left:414pt"><font><br></font></div><div style="height:0pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:40.3pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="margin-top:1.5pt;padding-left:414pt"><font><br></font></div><div style="margin-bottom:1.65pt;margin-top:1.05pt;padding-left:3.6pt;text-align:right;text-indent:-3.6pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:113%">2 of 20</font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.150%"><tr><td style="width:1.0%"></td><td style="width:6.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.033%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.166%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:9.8pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:204%">19.</font></div><div style="padding-right:9.8pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:204%">ITEM NO.</font></div><div style="margin-bottom:4.35pt;margin-top:3.2pt;padding-right:18.8pt;text-align:right"><font><br></font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:106.95pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:206%">20.</font></div><div style="padding-right:106.95pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:206%">SCHEDULE OF SUPPLIES&#47;SERVICES</font></div><div style="margin-top:3.2pt;padding-right:18.8pt;text-align:center"><font><br></font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:203%">21.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:203%">QUANTITY</font></div><div style="margin-bottom:4.35pt;margin-top:3.25pt;padding-right:6.6pt;text-align:center"><font><br></font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:204%">22.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:204%">UNIT</font></div><div style="margin-bottom:4.35pt;margin-top:3.2pt;text-align:center"><font><br></font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:7.9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:204%">23.</font></div><div style="padding-right:7.9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:204%">UNIT PRICE</font></div><div style="margin-bottom:4.35pt;margin-top:3.2pt;padding-right:16.9pt;text-align:center"><font><br></font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:24.4pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:204%">24.</font></div><div style="padding-right:24.4pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:204%">AMOUNT</font></div><div style="margin-bottom:4.35pt;margin-top:3.2pt;padding-right:28.9pt;text-align:center"><font><br></font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">Product&#47;Service</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">Code&#58;</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%">  </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">Q301</font></div><div style="text-indent:1.6pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">Product&#47;Service</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">Description&#58;</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">MEDICAL- LABORATORY</font></div><div style="text-indent:2.4pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">TESTING</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:1.6pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">Delivery&#58;</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">08&#47;08&#47;2020</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:120%">2</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:147%">Stage</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:147%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:147%">1A</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:147%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:147%">-</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:147%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:147%">Design</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:147%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:147%">Review</font></div><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:147%">Obligated</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:147%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:147%">Amount&#58;</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:147%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:147%">&#91;***&#93; </font></div><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:147%">Delivery</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:147%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:147%">To&#58;</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:147%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:147%">Bldg.31&#47;RM</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:147%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:147%">1C31 </font></div><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:147%">Product&#47;Service</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:147%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:147%">Code&#58;</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:147%">                       </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:147%">Q301</font></div><div style="text-indent:1.6pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:147%">Product&#47;Service</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:147%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:147%">Description&#58;</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:147%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:147%">MEDICAL-</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:147%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:147%">LABORATORY TESTING</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">Delivery&#58;</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:115%">09&#47;12&#47;2020</font></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td></tr></table></div><div style="margin-top:3.85pt;padding-left:3.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:110%">  32a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:110%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:110%">QUANTITY IN COLUMN 21 HAS BEEN</font></div><div><font><br></font></div><div style="text-indent:26.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9744;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">RECEIVED                          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9744;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">   INSPECTED       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9744;   </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">ACCEPTED, AND CONFORMS TO THE CONTRACT, EXCEPT AS NOTED&#58;                  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:115%;text-decoration:underline">                                                                                                          </font></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.328%"><tr><td style="width:1.0%"></td><td style="width:9.308%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.308%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.308%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.308%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.308%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.889%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.889%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.889%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.893%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">32b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">SIGNATURE OF AUTHORIZED GOVERNMENT REPRESENTATIVE</font></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:2.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">32c. DAT</font></div></td><td colspan="12" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:1.65pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">32d. PRINTED NAME AND TITLE OF AUTHORIZED GOVERNMENT REPRESENTATIVE</font></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:25pt"><td colspan="15" rowspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:1.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">2e. MAILING ADDRESS OF AUTHORIZED GOVERNMENT  REPRESENTATIVE</font></div></td><td colspan="12" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:1.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">32f. TELEPHONE NUMBER OF AUTHORIZED GOVERNMENT  REPRESENTATIVE</font></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:28pt"><td colspan="12" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:1.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">32g. E-MAIL OF AUTHORIZED GOVERNMENT  REPRESENTATIVE</font></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:30pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">33. SHIP NUMB</font></div></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:0.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">34. VOUCHER NUMBER</font></div></td><td colspan="9" rowspan="2" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:0.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:130%">35. AMOUNT VERIFIED CORRECT</font></div></td><td colspan="9" rowspan="2" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:2.15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">36.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">PAYMENT</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:16.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">COMPLETE PARTIAL FINAL</font></div></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:2.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">37. CHECK NUMBER</font></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:26pt"><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:14.8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">PARTIAL FINAL</font></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">38. S&#47;R ACCOUNT NUMBER</font></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:0.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">39. S&#47;R VOUCHER NUMBER</font></div></td><td colspan="21" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:0.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">40.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">PAID BY</font></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="18" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">41a. I CERTIFY THIS ACCOUNT IS CORRECT AND PROPER FOR PAYMENT</font></div></td><td colspan="9" rowspan="2" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:1.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">42a. RECEIVED </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:115%">BY (Print)</font></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:9pt"><td colspan="9" rowspan="3" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">41b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">SIGNATURE AND TITLE OF CERTIFYING OFFICERFFI</font></div></td><td colspan="9" rowspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:5.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">41c. DATE</font></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:22pt"><td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:1.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">42b. RECEIVED </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:115%">AT (Locatiion)</font></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:27pt"><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:0.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">42c.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">DATE REC</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:115%">'D (YY!MM!&#47;DD)</font></div></td><td colspan="6" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:1.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%">42d. TOTAL CONTAINEERS</font></div></td><td colspan="3" style="display:none"></td></tr></table></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">STANDARD FORM1449 (REV. 2&#47;2012)BACK</font></div><div style="height:0pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:1pt"><font><br></font></div></div></div><div id="ice27bba39ac84ed2a40a7c842e33b4c4_101"></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div><font><br></font></div><div><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION B - SUPPLIES OR SERVICES AND PRICES&#47;COSTS </font></div><div><font><br></font></div><div><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE B.1. BRIEF DESCRIPTION OF SERVICES</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Letter Contract forms a preliminary understanding between Fluidigm Corporation and the National Institutes of Health (NIH) and is issued as a result of the Rapid Acceleration of Diagnostics Advanced Technology Platforms (RADx-ATP) to increase the testing capacity of high throughput labs by scaling up late stage testing platforms for detecting SARS-CoV-2, the virus that causes COVID-19. Issuance of this Letter Contract authorizes the Contractor to immediately begin the activities necessary to perform the requirements as identified in the Statement of Objectives covering the full range of activities needed to increase capacity and optimize throughput necessary to distribute a viable product to the public.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The scope of work executed under this contract, includes completing the validation, approval, and production processes in order to deliver a viable product in a scaled up capacity to the U.S. public. Fluidigm technology to support this effort will be to scale up the Integrated Fluidic Circuit (IFC) and completion of the multiplex assay development system for rapid acceleration of testing.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Letter Contract has been issued based on the application and preliminary work file submitted by the contractor and subsequent documentation submitted during the Point of Care Teachnology Research Network (POCTRN) application review process.  The Contractor&#8217;s inability to meet the requirements as defined within this Letter Contract and proposed within the POCTRN application process may result in the termination of the Letter Contract in accordance with the termination clauses contained herein.</font></div><div><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE B.2. PRICES</font></div><div style="margin-top:0.5pt;padding-left:36pt"><font><br></font></div><div style="margin-top:0.5pt;padding-left:36pt;text-indent:-18.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:10.02pt">The total Firm Fixed Price (FFP) amount for this Letter Contract </font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">is </font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">$12,151,000</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.5pt;padding-left:36pt"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:73.214%"><tr><td style="width:1.0%"></td><td style="width:51.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.852%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.15pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Payment Schedule</font></div><div style="padding-right:2.15pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#91;See complete breakdown in Deliverable Schedule&#93;</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Milestone</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Amount</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Stage 1 &#8211; Test Verification</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Stage 1A &#8211; Design Review</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Total</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">$12,151,000</font></td></tr></table></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:2.8pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE B.3. ADVANCE UNDERSTANDINGS</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:10.02pt">The parties acknowledge and agree that the situation around COVID-19 is highly dynamic, evolving rapidly, and subject to significant uncertainty. The Letter Contract is being executed on an expedited timeline to meet an urgent and compelling government need without the benefit of prior negotiation. Thus, the parties will negotiate in good faith to ensure that the definitized contract reflects an appropriate allocation of risk and responsibility and that it is consistent with the application and preliminary work file submitted by the contractor and subsequent documentation submitted during the application review process and the discussions between the parties that have taken place between date of application submission through Letter Contract issuance. Until the Performance Work Statement (PWS) is finalized the Statement of Objective (SOO) will govern.</font></div><div style="margin-top:0.5pt;padding-left:36pt"><font><br></font></div><div style="margin-top:0.5pt;padding-left:36pt;text-indent:-18.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.51pt">The parties anticipate that the definitive contract resulting from this Letter Contract will include a </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">Contract number&#58; </font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="margin-top:0.5pt;padding-left:36pt;text-indent:-0.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">negotiated firm fixed price not to exceed </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$36,834,000.  The amount of funding provided for this Letter Contract is stated in Article B.2 avove, the contractor shall not incur costs in excess of this amount.</font></div><div style="margin-top:0.5pt;padding-left:17.95pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:10.63pt">Commercial Item Status&#58; The services provided by the Contractor under the Letter Contract and any definitized contract constitute commercial item services, and the terms of any definitized contract will reflect that understanding.</font></div><div style="padding-left:36pt;text-indent:-18.05pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">d.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.51pt">Performance Work Statement&#58; The parties will negotiate the Performance Work Statement in the process of contract definitization to fairly reflect the application and preliminary work file submitted by the contractor and subsequent documentation submitted during the application review process and the discussions between the parties that have taken place between application submission through letter contract issuance.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">e.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.81pt">HHS reserves the right to exercise priorities and allocations authority with respect to this contract, to include rating this order in accordance with 45 CFR Part 101, Subpart A&#8212;Health Resources Priorities and Allocations System.</font></div><div style="padding-left:95pt;text-indent:-18.05pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">f.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:11.93pt">The parties agree prior to negotiate further the terms of milestone payments to include in the definitized contract.  In the negotiation, the parties will consider terms addressing liquidation of milestone payments.</font></div><div style="padding-left:95pt;text-indent:-18.05pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">g.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:10.11pt">Successful performance under this contract requires the Contractor obtain and maintain an Emergency Use Authorization (EUA) from the Food and Drug Administration (FDA)&#59; the Contractor shall copy us on all FDA correspondence related to the project, including email communications to and from the FDA. The FDA EUA services provided under this Letter Contract constitute a commercial service to detect SARS-CoV-2.            </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">h.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.51pt">Fair Pricing&#58; The Rapid Acceleration of Diagnostics (RADx) application review process determined the cost per test is competitive with the current market price. The Contractor must comply with applicable federal law to ensure that prices to consumers are offered at fair market rate and at a rate consistent with the objective to increase and improve testing in the United States and its territories. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">i.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.76pt">In accordance with the goals of the RADx program, the tests produced under this contract are to be sold within the U.S. and its territories&#59; provided, however, that, to the extent there is insufficient demand within the U.S. and its territories for the tests produced up to the additional manufacturing capacity funded by NIH and then available (as described in the Schedule of Deliverables), contractor will be permitted to sell such tests outside the U.S. and its territories.  The factors, process and mechanism to determine whether contractor has insufficient demand for the tests up to the then-available capacity will be determined in the definitive contract.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">j.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.65pt">Sharing Data and Reports&#58;  The Contractor will be required to provide data and reports (e.g., manufacturing, supply chain, production rates), which NIH will use to evaluate completion or achievement of milestones, progress toward deliverables, and compliance with the requirements of this Letter Contract.  NIH may use the data to coordinate with other U.S. Government Agencies to accelerate development and deployment of innovative COVID-19 diagnostic tests, and ensure effective stewardship of federal funds.  Sharing data within the federal government enables NIH to discuss the project&#8217;s challenges and progress with federal agencies offering scientific, manufacturing, and logistics expertise.  To ensure that innovations are available to the public as quickly as possible, NIH will leverage </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">Contract number&#58; </font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="padding-left:36pt;text-indent:-0.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">established partnerships with federal agencies, such as FDA, CDC, CMS, ASPR&#47;BARDA, and the Department of Defense, and partnerships with State agencies to propel technologies developed by RADx into widespread use.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">k.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:10.28pt">Contractor Facilities&#58; The contractor shall certify that they will maintain their Facility and Equipment in satisfactory operating condition, as required to enable the contractor to perform the deliverables and achieve the milestones in accordance with the Statement of Objectives and all other applicable laws, regulations, rules or orders. Routine repairs, preventive maintenance, and service contracts for the Facility and Equipment shall be arranged by contractor at no additional cost to the Government.   </font></div><div style="padding-left:95pt;text-indent:-18.05pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">l.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.76pt">FAR 52.212-4 (l), the Government reserves the right to terminate this contract, or any part hereof, for its sole convenience. In the event of such termination, the Contractor shall immediately stop all work hereunder and shall immediately cause any and all of its suppliers and subcontractors to cease work. Subject to the terms of this contract, the Contractor shall be paid a percentage of the contract price reflecting the percentage of the work performed prior to the notice of termination, plus reasonable charges the Contractor can demonstrate to the satisfaction of the Government using its standard record keeping system, have resulted from the termination. The Contractor shall not be required to comply with the cost accounting standards or contract cost principles for this purpose. This paragraph does not give the Government any right to audit the Contractor&#8217;s records. The Contractor shall not be paid for any work performed or costs incurred which reasonably could have been avoided.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">m.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:6.5pt">Letter Contract Termination&#58; In accordance with FAR 52.212-4(m), the Government may terminate this contract, or any part hereof, for cause in the event of any default by the Contractor, or if the Contractor fails to comply with any contract terms and conditions, or fails to provide the Government, upon request, with adequate assurances of future performance. In the event of termination for cause, the Government shall not be liable to the Contractor for any amount for supplies or services not accepted, and the Contractor shall be liable to the Government for any and all rights and remedies provided by law. If it is determined that the Government improperly terminated this contract for default, such termination shall be deemed a termination for convenience.</font></div><div style="padding-left:95pt;text-indent:-18.05pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">n.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.51pt">Security and Privacy of Protected Health Information (PHI) processed under this contract&#58;  The Contractor , shall meet the definition of either a Covered Entity or Business Associate under the Health Insurance Portability and Accountability Act of 1996 (HIPAA).  The contractor shall therefore comply with the HIPAA regulatory standards set forth in the Code of Federal Regulations (CFR) 45 C.F.R. Part 160, Part 162, and Part 164.  To the extent that the Contractor engages subcontractors or other Business Associates to provide services under this Contract, and such Subcontractors or Business Associates will receive or create protected health information (PHI) on behalf of the contractor, the contractor shall obtain satisfactory assurances from its business associate that the business associate will appropriately safeguard the protected health information. The satisfactory assurances must be in writing, whether in the form of a contract or other agreement between the Contractor and the business associate.  In the event of a suspected or known security or privacy breach, in addition to following the procedures set forth in 45 C.F.R. Part 164, the contractor shall also immediately notify the NIH via the Contracting Officer (CO)and the Contracting Officer&#8217;s Representative (COR).</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">o.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.48pt">The parties agree to address HHS Information Security and Privacy Requirements, as applicable, during definitization of the contract.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">Contract number&#58; </font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="padding-left:36pt"><font><br></font></div><div><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION C - DESCRIPTION&#47;SPECIFICATIONS&#47;WORK STATEMENT </font></div><div><font><br></font></div><div style="margin-top:2.8pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE C.1. STATEMENT OF OBJECTIVES</font></div><div style="padding-right:26.9pt"><font><br></font></div><div style="margin-top:0.55pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Independently and not as an agent of the Government, the Contractor shall furnish all the necessary services, qualified personnel, material, equipment, and facilities, not otherwise provided by the Government as needed to perform the Statement of Objectives, dated July 27, 2020, set forth in SECTION J &#8211; List of Attachments, attached hereto and made a part of this Leter Contract. Work to be performed shall be consistent with the application and preliminary work file submitted by the Contractor and subsequent documentation submitted during the application review process and the discussions between the parties that have taken place between date of application submission through Letter Contract issuance.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE C.2. REPORTING REQUIREMENTS</font></div><div><font><br></font></div><div><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">All reports required herein shall be submitted in electronic format only. All electronic reports submitted shall be compliant with Section 508 of the Rehabilitation Act of 1973. Additional information about testing documents for Section 508 compliance, including guidance and specific checklists, by application, can be found at&#58; </font><font style="color:#3953a4;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">http&#58;&#47;&#47;www.hhs.gov&#47;web&#47;508&#47;index.html</font><font style="color:#3953a4;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">under &#34;Making Files Accessible.&#34;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:2.8pt;padding-left:36pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Reporting requirements TBD.</font></div><div style="margin-top:2.8pt;padding-left:36pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Placeholder&#58; De-identified data for NIH research database</font></div><div style="margin-top:0.1pt"><font><br></font></div><div><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION D &#8211; PACKAGING, MARKING, AND SHIPPING</font></div><div><font><br></font></div><div><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">There are no additional instructions or specifications applicable to this contract other than the delivery instructions contained herein.</font></div><div><font><br></font></div><div><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION E - INSPECTION AND ACCEPTANCE</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:10.02pt">The Contracting Officer or the duly authorized Contracting Officer&#8217;s Representative (COR) will perform inspection and acceptance of deliverables to be performed and the milestones to be achieved.</font></div><div style="padding-left:36pt;text-indent:-18.55pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:10.01pt">Inspection and acceptance will be performed as identified in the contract requirements.</font></div><div style="padding-left:36pt"><font><br></font></div><div><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION F - DELIVERIES OR PERFORMANCE ARTICLE F.1. PERIOD OF PERFORMANCE</font></div><div><font><br></font></div><div><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:122%">The period of performance of the contract is anticipated to be </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:122%">July 30, 2020 through July 29, 2021.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE F.2. DELIVERIES</font></div><div><font><br></font></div><div style="margin-bottom:0.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Satisfactory performance shall be deemed to occur upon performance of the work described in the Statement of Objectives Article in SECTION C of this Letter Contract and upon notice and acceptance by the Contracting Officer, or the duly authorized representative, in accordance with the stated deliverables schedule.</font></div><div style="margin-bottom:0.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">         </font></div><div style="margin-bottom:0.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The deliverables or documentation there of shall be submitted to the Contracting Officer or designated Contracting Officer Representative (COR).</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">Contract number&#58; </font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION G - CONTRACT ADMINISTRATION DATA</font></div><div style="padding-right:26.9pt"><font><br></font></div><div><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE G.1. CONTRACTING OFFICER (CO)</font></div><div style="padding-right:26.9pt"><font><br></font></div><div style="padding-right:26.9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following Contracting Officer (CO) will represent the Government for the purpose of this contract&#58;</font></div><div style="padding-left:36pt;padding-right:26.9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; Roxane Burkett&#160;&#160;&#160;&#160;</font></div><div style="padding-left:36pt;padding-right:26.9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Telephone&#58; 301-827-7535</font></div><div style="padding-left:36pt;padding-right:26.9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Email&#58; </font><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">burkettr&#64;nih.nhlbi.gov</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="padding-right:26.9pt"><font><br></font></div><div style="padding-right:26.9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Contracting Officer is the only person with authority to act as agent of the Government</font></div><div style="padding-right:26.9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">under this task order. Only the Contracting Officer has authority to&#58;</font></div><div style="padding-left:45pt;padding-right:26.9pt;text-indent:-9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1) direct or negotiate any changes in the statement of work&#59;</font></div><div style="padding-left:45pt;padding-right:26.9pt;text-indent:-9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2) modify or extend the period of performance&#59;</font></div><div style="padding-left:45pt;padding-right:26.9pt;text-indent:-9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3) change the delivery schedule&#59;</font></div><div style="padding-left:45pt;text-indent:-9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4) authorize reimbursement to the Contractor for any costs incurred during the performance of this contract&#59; </font></div><div style="padding-left:45pt;padding-right:26.9pt;text-indent:-9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5) otherwise change any terms and conditions of this contract&#59; or</font></div><div style="padding-left:45pt;padding-right:26.9pt;text-indent:-9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6) sign written licensing agreements. Any signed agreement shall be incorporated by reference in Section K of the contract.</font></div><div style="padding-right:26.9pt"><font><br></font></div><div style="padding-right:4.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">All correspondence (including invoices) that proposes or otherwise involves waivers, deviations, or modifications to requirement shall be provided to the CO issuing the task order and the COR supporting the CO.</font></div><div><font><br></font></div><div><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE G.2. CONTRACTING OFFICER'S REPRESENTATIVE (COR)</font></div><div style="padding-right:26.9pt"><font><br></font></div><div style="margin-top:0.25pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following Contracting Officer's Representative (COR) is anticipated to represent the Government for the purpose of this contract&#58;</font></div><div style="margin-top:0.25pt;padding-left:36pt"><font><br></font></div><div style="margin-top:0.25pt;padding-left:36pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Olga Hartman, PhD</font></div><div style="margin-top:0.25pt;padding-left:36pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Telephone&#58; 443-350-7696</font></div><div style="margin-top:0.25pt;padding-left:36pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Email&#58; </font><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">olga.hartman.civ&#64;mail.mil</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:0.25pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The COR is responsible for&#58; </font></div><div style="margin-top:0.25pt;padding-left:36pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1) monitoring the Contractor's technical progress, including the surveillance and assessment of performance and recommending to the Contracting Officer changes in requirements&#59; </font></div><div style="margin-top:0.25pt;padding-left:36pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2) interpreting the Statement of Objectives and any other technical performance requirements&#59; </font></div><div style="margin-top:0.25pt;padding-left:36pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3) performing technical evaluation as required&#59; </font></div><div style="margin-top:0.25pt;padding-left:36pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(4) performing technical inspections and acceptances required by this Letter Contract&#59; and </font></div><div style="margin-top:0.25pt;padding-left:36pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(5) assisting in the resolution of technical problems encountered during performance.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:0.25pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Government may unilaterally change the COR designation.</font></div><div><font><br></font></div><div><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE G.3. PRIMARY PROGRAM MANAGER</font></div><div style="padding-right:26.9pt"><font><br></font></div><div style="padding-right:26.9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Primary Program Manager specified in this task order is considered to be essential to work performance. At least 30 days prior to any changes to the individual listed below to other programs or task orders (or as soon as reasonably possible, if an individual must be replaced, for example, as a result of </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">Contract number&#58; </font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="padding-right:26.9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">leaving the employ of the Contractor), the Contractor shall notify the Contracting Officer and shall submit comprehensive justification for the change request (including proposed substitutions for primary program manager) to permit evaluation by the Government of the impact on performance under this task order. The Contractor shall not replace any primary program manager without the written consent of the Contracting Officer. The Government may modify the task order to add or delete primary program manager at the request of the contractor or Government. In no case shall the individual&#8217;s effort exceed 100% across all task orders.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93; </font></div><div style="margin-top:0.5pt"><font><br></font></div><div><font><br></font></div><div><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE G.4. INVOICE SUBMISSION</font></div><div style="padding-right:26.9pt"><font><br></font></div><div style="padding-right:26.9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition to the requirements specified in FAR 32.905 for a proper invoice, the Contractor shall include the following information on the face page of all task order payment requests&#58;</font></div><div style="padding-left:36pt;text-indent:-18.1pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:10.07pt">The Contract </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title is&#58;  &#8220;Rapid Acceleration of Diagnostics ( RADx) Program&#58; Tech Project # 6114 Fluidigm &#8211; Advanta Dx SARS-CoV-2 RT-PCR Assay for Saliva&#8221; </font></div><div style="margin-top:2.05pt;padding-left:36pt;text-indent:-17.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:8.96pt">The Contract Line Items are defined within the Section 20. Schedule of Supplies&#47;Services of the Standard Form 1449.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:10.58pt">Invoice Instructions are attached and made part of this task order. The Contractor shall follow the attached instructions and submission procedures specified below to meet the requirements of a &#34;proper invoice&#34; pursuant to FAR Subpart 32.9, Prompt Payment. </font></div><div style="margin-bottom:6pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.66pt">Payment requests shall be submitted to the offices identified below. Do not submit supporting documentation (e.g., receipts, time sheets, vendor invoices, etc.) with your payment request unless specified elsewhere in the contract or requested by the Contracting Officer.</font></div><div style="margin-bottom:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.97pt">One&#160;copy of the invoice shall be submitted to the approving official at the following email addresses&#58;</font></div><div style="margin-bottom:6pt;padding-left:81pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NHLBI Branch B Central Mailbox (</font><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">NHLBIContractsBranchB&#64;mail.nih.gov</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) </font></div><div><font><br></font></div><div style="margin-bottom:6pt;padding-left:81pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NIH centralized invoice email box&#58; </font><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">invoicing&#64;nih.gov</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:6pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.    E-Mail&#58; The Contractor shall submit an electronic copy of the payment request to the approving official instead of a paper copy. The payment request shall be transmitted as an attachment via e-mail to the address listed above in one of the following formats&#58;&#160; MSWord, MS Excel, or Adobe Portable Document Format (PDF).&#160; Only one payment request shall be submitted per e-mail and the subject line of the e-mail shall include the Contractor's name, contract number, and unique invoice number.&#160;   </font></div><div style="margin-bottom:6pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.    In addition to the requirements specified in FAR&#160;32.905 for a proper invoice, the Contractor shall include the following information on the face page of all payment requests (invoices)&#58;</font></div><div style="margin-bottom:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.97pt">Name of the Office of Acquisitions. The Office of Acquisitions for this task order is </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NHLBI</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.&#160;</font></div><div style="margin-bottom:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.46pt">Central Point of Distribution. For the purpose of this Task Order, the Central Point of Distribution is </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NHLBI Branch B Invoices</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:10.58pt">Federal Taxpayer&#160;Identification Number (TIN).&#160; If the Contractor does not have a valid TIN, it shall identify the Vendor Identification Number (VIN) on the payment request.&#160; The VIN is the number that appears after the Contractor's name on the face page of the contract.&#160; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#91;Note&#58;&#160; A VIN is </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">Contract number&#58; </font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="margin-bottom:6pt;padding-left:63pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">assigned to new contracts awarded on or after June 4, 2007, and any existing contract modified to include the VIN number.&#93;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160; If the Contractor has neither a TIN, DUNS, or VIN, contact the Contracting Officer.  </font></div><div style="margin-bottom:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.46pt">DUNS&#160;or DUNS+4 Number.&#160; The DUNS number must identify the&#160;Contractor's name and address exactly as stated in the&#160;contract and as registered in the Central Contractor Registration (CCR) database.&#160; If the Contractor does not have a valid DUNS number, it shall identify the Vendor Identification Number (VIN) on the payment request.&#160; The VIN is the number that appears after the Contractor's name on the face page of the contract.&#160; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#91;Note&#58; A VIN is assigned to new contracts awarded on or after June 4, 2007, and any existing contract modified to include the VIN number.&#93;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160; If the Contractor has neither a TIN, DUNS, or VIN, contact the Contracting Officer.</font></div><div style="margin-bottom:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.76pt">Invoice Matching Option.&#160;&#160;This Task Order requires a </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">two-way </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">match.</font></div><div style="margin-bottom:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:11.88pt">Unique Invoice Number.&#160; Each payment request must be identified by a unique invoice number, which can only be used one time regardless of the number of contracts or orders held by an organization.</font></div><div style="margin-bottom:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">g.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:10.06pt">PRISM&#47;NBS Line Item Number and associated PRISM&#47;NBS Line Item Period of Performance (see SF 1449, Attachment #2).</font></div><div style="margin-top:2.05pt;padding-left:36pt;text-indent:-17.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)  Inquiries regarding payment of invoices shall be directed to the designated billing office, (301) 496-6088.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION H - ADDITONAL CONTRACT CLAUSES&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE H.1. CONFIDENTIALITY OF INFORMATION</font></div><div style="padding-left:54pt;padding-right:46.7pt"><font><br></font></div><div style="padding-left:54pt;padding-right:46.7pt;text-indent:-14.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:6.02pt">Confidential information, as used in this article, means information or data of a personal nature about an individual, or proprietary information or data submitted by or pertaining to an institution or organization.</font></div><div style="padding-left:54pt;padding-right:46.7pt"><font><br></font></div><div style="padding-left:54pt;padding-right:19.55pt;text-indent:-14.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:6.02pt">The Contracting Officer and the Contractor may, by mutual consent, identify elsewhere in this contract specific information and&#47;or categories of information which the Government will furnish to the Contractor or that the Contractor is expected to generate which is confidential. Similarly, the Contracting Officer and the Contractor may, by mutual consent, identify such confidential information from time to time during the performance of the contract. Failure to agree will be settled pursuant to the &#34;Disputes&#34; clause.</font></div><div style="padding-right:19.55pt"><font><br></font></div><div style="padding-left:54pt;padding-right:11.75pt;text-indent:-13.8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:6.03pt">If it is established elsewhere in this contract that information to be utilized under this contract, or a portion thereof, is subject to the Privacy Act, the Contractor will follow the rules and procedures of disclosure set forth in the Privacy Act of 1974, 5 U.S.C. 552a, and implementing regulations and policies, with respect to systems of records determined to be subject to the Privacy Act.</font></div><div style="padding-right:11.75pt"><font><br></font></div><div style="padding-left:54pt;padding-right:8.95pt;text-indent:-14.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:6.02pt">Confidential information, as defined in paragraph (a) of this article, shall not be disclosed without the prior written consent of the individual, institution, or organization.</font></div><div style="padding-right:8.95pt"><font><br></font></div><div style="padding-left:54pt;padding-right:16.15pt;text-indent:-14.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:6.02pt">Whenever the Contractor is uncertain with regard to the proper handling of material under the contract, or if the material in question is subject to the Privacy Act or is confidential information subject to the provisions of this article, the Contractor should obtain a written determination</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">Contract number&#58; </font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="padding-left:54pt;padding-right:16.15pt;text-indent:3.65pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> from the Contracting Officer prior to any release, disclosure, dissemination, or publication.</font></div><div style="padding-right:16.15pt"><font><br></font></div><div style="padding-left:54pt;padding-right:26.2pt;text-indent:-11.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:6.06pt">Contracting Officer determinations will reflect the result of internal coordination with appropriate program and legal officials.</font></div><div style="padding-right:26.2pt"><font><br></font></div><div style="padding-left:54pt;padding-right:32.3pt;text-indent:-14.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:6.02pt">The provisions of paragraph (d) of this article shall not apply to conflicting or overlapping provisions in other Federal, State or local laws.</font></div><div><font><br></font></div><div><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE H.2. PUBLICATION AND PUBLICITY</font></div><div style="padding-left:40.5pt;padding-right:14.25pt"><font><br></font></div><div style="padding-left:40.5pt;padding-right:14.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition to the requirements set forth in HHSAR Clause </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">352.227-70, Publications and Publicity </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">incorporated by reference in SECTION I of this contract, the Contractor shall acknowledge the support of the National Institutes of Health whenever publicizing the work under this contract in any media by including an acknowledgment substantially as follows&#58;</font></div><div style="padding-left:40.5pt"><font><br></font></div><div style="padding-left:40.5pt;padding-right:25.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#34;This project has been funded in whole or in part with Federal funds from the National Institutes of Health, Department of Health and Human Services, under Contract No&#58; 75N92020C00009.&#8221;</font></div><div><font><br></font></div><div><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE H.3. REPORTING MATTERS INVOLVING FRAUD, WASTE AND ABUSE</font></div><div style="padding-left:40.5pt;padding-right:22.95pt"><font><br></font></div><div style="padding-left:40.5pt;padding-right:22.95pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Anyone who becomes aware of the existence or apparent existence of fraud, waste and abuse in NIH funded programs is encouraged to report such matters to the HHS Inspector General's Office in writing or on the Inspector General's Hotline. The toll free number is </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1-800-HHS-TIPS (1-800-447-8477). </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">All telephone calls will be handled confidentially. The website to file a complaint on-line is&#58; </font><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">http&#58;&#47;&#47;oig.hhs.gov&#47;fraud&#47;hotline&#47; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and the mailing address is&#58;</font></div><div style="padding-left:72pt;padding-right:125.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:124%">US Department of Health and Human Services Office of Inspector General</font></div><div style="padding-left:72pt;padding-right:125.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ATTN&#58; OIG HOTLINE OPERATIONS</font></div><div style="padding-left:72pt;padding-right:125.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:124%">P.O. Box 23489 Washington, D.C. 20026</font></div><div><font><br></font></div><div><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PART II - CONTRACT CLAUSES SECTION I - CONTRACT CLAUSES</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Selections will be made by the Contracting Officer during definitization</font></div><div><font><br></font></div><div><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE I.1. ADDITIONAL CONTRACT CLAUSES</font></div><div><font><br></font></div><div><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">This contract incorporates the following clauses by reference, (unless otherwise noted), with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">a.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:9.97pt">FAR Clause 52.212-3 Offeror Representations and Certifications &#8211; Commercial Items (Jun 2020)</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">a.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:9.97pt">FAR Clause 52.212-4 Contract Terms and Conditions &#8211; Commercial Items (Oct 2018)</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">b.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:9.46pt">FAR Clause 52.203-13, Contractor Code of Business Ethics and Conduct (October 2015)</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">c.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:10.58pt">FAR Clause 52.204-2, Security Requirements (August 1996).</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">d.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:9.46pt">FAR Clause 52.204-9, Personal Identity Verification of Contractor Personnel (January 2011).</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">e.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:9.76pt">FAR Clause 52.204-13, System for Award Management Maintenance</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">f.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:11.88pt">FAR Clause 52.204-18 Commercial and Government Entity Code Maintenance (July 2016)</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">g.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:10.06pt">FAR Clause 52.204-23 Prohibition on Contracting for Hardware, Software, and Services Developed or Provided by Kaspersky Lab and Other Covered Entities</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">Contract number&#58; </font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">h.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:9.46pt">FAR Clause 52.209-10, Prohibition on Contracting With Inverted Domestic Corporations(November 2015).</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">i.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:12.71pt">FAR Clause 52.222-4, Contract Work Hours and Safety Standards - Overtime Compensation -General (May 2014).</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">j.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:12.6pt">FAR Clause 52.222-29, Notification of Visa Denial (April 2015).</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">k.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:10.23pt">FAR Clause 52.223-15, Energy Efficiency in Energy-Consuming Products (December 2007).</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">l.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:12.71pt">FAR Clause 52.224-1, Privacy Act Notification (April 1984).</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">m.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:6.45pt">FAR Clause 52.224-2, Privacy Act (April 1984).</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">n.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:9.46pt">FAR Clause 52.227-1, Aughorization and Consent (Jun 2020).</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">o.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:9.43pt">FAR Clause 52.227-3 Patent Indemnity (Apr 1984).</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">p.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:9.46pt">FAR Claus 52.227-11 Patent Rights-Ownership by the Contractor (May 2014).</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">q.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:9.46pt">FAR Clause 52.227-14, Rights in Data - General (May 2014).</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">r.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:11.4pt">FAR Clause 52.227-14, Rights in Data - General (May 2014) Alternate II (Dec 2007).</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">s.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:10.93pt">FAR Clause 52.232-40, Providing Accelerated Payments to Small Business Subcontractors (Dec 2013)</font></div><div style="margin-top:0.45pt"><font><br></font></div><div><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE I.3. ADDITIONAL FAR CONTRACT CLAUSES INCLUDED IN FULL TEXT</font></div><div style="margin-top:0.45pt;padding-left:36pt;text-indent:-18.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">a.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:9.69pt">FEDERAL ACQUISITION REGULATION (FAR) (48 CFR CHAPTER 1) CLAUSES</font></div><div style="margin-top:0.05pt;padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Additional clauses other than those listed below which are based on the type of contract&#47;Contractor shall be determined during definitization. This contract incorporates the following clauses in full text.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:49.5pt;text-indent:-18.1pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:9.6pt">FAR 52.216-23 - EXECUTION AND COMMENCMENT OF WORK (APR 1984)</font></div><div style="margin-top:2pt;padding-left:49.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">The Contractor shall indicate acceptance of this </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">letter contract by signing </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">One Copy</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> of the contract and returning them to the Contracting Officer not later than July 29, 2020 at 4&#58;00 p.m. Eastern</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">. Upon acceptance by both parties, the Contractor shall proceed with performance of the work, including purchase of necessary materials.</font></div><div style="margin-top:0.2pt;padding-left:49.5pt"><font><br></font></div><div style="margin-top:2.75pt;padding-left:49.5pt;text-indent:-18.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:9.55pt">FAR 52.216-24 - LIMITATION OF GOVERNMENT LIABILITY (APR 1984)</font></div><div style="margin-top:0.45pt;padding-left:49.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(a)</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:6.08pt">In performing this contract, the Contractor is not authorized to make expenditures or incur obligations exceeding $12,151,000 dollars.</font></div><div style="padding-left:27pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(b)</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:5.57pt">The maximum amount for which the Government shall be liable if this contract is  terminated is $12,151,000 dollars.</font></div><div style="margin-top:0.3pt;padding-left:49.5pt"><font><br></font></div><div style="padding-left:49.5pt;text-indent:-18.1pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:9.6pt">FAR 52.216-25 - CONTRACT DEFINITIZATION (OCT 2010)</font></div><div style="margin-top:0.5pt;padding-left:45pt"><font><br></font></div><div style="margin-top:0.5pt;padding-left:45pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) A </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Firm Fixed Price (FFP)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> definitive contract is contemplated. The Contractor agrees to begin promptly negotiating with the Contracting Officer the terms of a definitive contract that will include (1) all clauses required by the Federal Acquisition Regulation (FAR) on the date of execution of the letter contract, (2) all clauses required by law on the date of execution of the definitive contract, and (3) any other mutually agreeable clauses, terms, and conditions. The Contractor agrees to submit a </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Firm Fixed Price</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> proposal, including data other than certified cost or pricing data, and certified cost or pricing data, in accordance with FAR 15.408, Table  15-2, supporting its proposal.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:58.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(b)</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:1.07pt">The schedule for definitizing this contract is as follows&#58; </font></div><div style="padding-left:81pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Estimated date for start of negotiations&#58;   8&#47;3&#47;2020</font></div><div style="padding-left:81pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Target date for definitization&#58;  9&#47;25&#47;2020</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:67.857%"><tr><td style="width:1.0%"></td><td style="width:67.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.479%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Definitization Schedule</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Date</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Statement of Work Review</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7&#47;27&#47;2020</font></td></tr></table></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">Contract number&#58; </font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:67.857%"><tr><td style="width:1.0%"></td><td style="width:67.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.479%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Issuance of Letter Contract</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7&#47;30&#47;2020</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Letter Contract Post Award Kick Off meeting</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7&#47;31&#47;2020</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Contractor Price Proposal Submittal</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8&#47;5&#47;2020</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Business and Technical Review</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8&#47;12&#47;2020</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Negotiations Start</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8&#47;13&#47;2020</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Request Budget and Price Breakdown</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9&#47;7&#47;2020</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Definitization of Letter Contract</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9&#47;25&#47;2020</font></td></tr></table></div><div style="margin-top:0.05pt;padding-right:-4.5pt"><font><br></font></div><div style="padding-left:58.5pt;text-indent:-14.45pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(c)</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:3.14pt">If agreement on a definitive contract to supersede this letter contract is not reached by the target date in paragraph (b) of this section, or within any extension of it granted by the Contracting Officer, the Contracting Officer may, with the approval of the head of the contracting activity, determine a reasonable price or fee in accordance with subpart 15.4 and part 31 of the FAR, subject to Contractor appeal as provided in the Disputes clause. In any event, the Contractor shall proceed with completion of the contract, subject only to the Limitation of Government Liability clause.</font></div><div style="padding-left:95pt;text-indent:-23pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(1)</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:10.77pt">After the Contracting Officer&#8217;s determination of price or fee, the contract shall be governed by-</font></div><div style="margin-top:0.05pt;padding-left:153pt;text-indent:-14.2pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:5.02pt">All clauses required by the FAR on the date of execution of this letter contract for either fixed-price or cost-reimbursement contracts, as determined by the Contracting Officer under this paragraph (c)&#59;</font></div><div style="margin-top:0.05pt;padding-left:153pt;text-indent:-14.2pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:2.5pt">All clauses required by law as of the date of the Contracting Officer&#8217;s determination&#59; and</font></div><div style="margin-top:0.05pt;padding-left:153pt;text-indent:-14.2pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:26.98pt"> Any other clauses, terms, and conditions mutually agreed upon.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:23pt;text-indent:-5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(2)   To the extent consistent with paragraph (c)(1) of this section, all clauses, terms, and conditions included in this letter contract shall continue in effect, except those that by their nature apply only to a letter contract.</font></div><div><font><br></font></div><div style="padding-left:49.5pt;text-indent:-18.1pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:9.6pt">FAR Clause 52.204-21, </font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Basic Safeguarding of Covered Contractor Information</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Systems</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> (Jun 2016)</font></div><div style="padding-left:62.55pt"><font><br></font></div><div style="padding-left:77pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">      (a) Definitions. As used in this clause&#8211;</font></div><div style="padding-left:77pt"><font><br></font></div><div style="padding-left:103.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Covered contractor information system means an information system that is owned or operated by a contractor that processes, stores, or transmits Federal contract information.</font></div><div style="padding-left:103.5pt"><font><br></font></div><div style="padding-left:103.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Federal contract information means information, not intended for public release, that is provided by or generated for the Government under a contract to develop or deliver a product or service to the Government, but not including information provided by the Government to the public (such as on public websites) or simple transactional information, such as necessary to process payments.</font></div><div style="padding-left:103.5pt"><font><br></font></div><div style="padding-left:103.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Information means any communication or representation of knowledge such as facts, data, or opinions, in any medium or form, including textual, numerical, graphic, cartographic, narrative, or audiovisual (Committee on National Security Systems Instruction (CNSSI) 4009).</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">Contract number&#58; </font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="padding-left:103.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Information system means a discrete set of information resources organized for the collection, processing, maintenance, use, sharing, dissemination, or disposition of information (44 U.S.C. 3502).</font></div><div style="padding-left:103.5pt"><font><br></font></div><div style="padding-left:103.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Safeguarding means measures or controls that are prescribed to protect information systems.</font></div><div style="padding-left:77pt"><font><br></font></div><div style="padding-left:77pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">      (b) Safeguarding requirements and procedures.</font></div><div style="padding-left:77pt"><font><br></font></div><div style="padding-left:108pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(1) The Contractor shall apply the following basic safeguarding requirements and procedures to protect covered contractor information systems. Requirements and procedures for basic safeguarding of covered contractor information systems shall include, at a minimum, the following security controls&#58;</font></div><div style="padding-left:77pt"><font><br></font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(i) Limit information system access to authorized users, processes acting on behalf of authorized users, or devices (including other information systems).</font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font><br></font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(ii) Limit information system access to the types of transactions and functions that authorized users are permitted to execute.</font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font><br></font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(iii) Verify and control&#47;limit connections to and use of external information systems.</font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font><br></font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(iv) Control information posted or processed on publicly accessible information systems.</font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font><br></font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(v) Identify information system users, processes acting on behalf of users, or devices.</font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font><br></font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(vi) Authenticate (or verify) the identities of those users, processes, or devices, as a prerequisite to allowing access to organizational information systems.</font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font><br></font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(vii) Sanitize or destroy information system media containing Federal Contract Information before disposal or release for reuse.</font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font><br></font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(viii) Limit physical access to organizational information systems, equipment, and the respective operating environments to authorized individuals.</font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font><br></font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(ix) Escort visitors and monitor visitor activity&#59; maintain audit logs of physical access&#59; and control and manage physical access devices.</font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(x) Monitor, control, and protect organizational communications (i.e., information transmitted or received by organizational information systems) at the external boundaries and key internal boundaries of the information systems.</font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font><br></font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(xi) Implement subnetworks for publicly accessible system components that are physically or logically separated from internal networks.</font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font><br></font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(xii) Identify, report, and correct information and information system flaws in a timely manner.</font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">Contract number&#58; </font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="padding-left:126pt;text-indent:-13.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(xiii) Provide protection from malicious code at appropriate locations within organizational information systems.</font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font><br></font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(xiv) Update malicious code protection mechanisms when new releases are available.</font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font><br></font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(xv) Perform periodic scans of the information system and real-time scans of files from external sources as files are downloaded, opened, or executed.</font></div><div style="padding-left:77pt"><font><br></font></div><div style="padding-left:108pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(2) Other requirements. This clause does not relieve the Contractor of any other specific safeguarding requirements specified by Federal agencies and departments relating to covered contractor information systems generally or other Federal safeguarding requirements for controlled unclassified information (CUI) as established by Executive Order 13556.</font></div><div style="padding-left:62.55pt"><font><br></font></div><div style="padding-left:94.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(c) Subcontracts. The Contractor shall include the substance of this clause, including this paragraph (c), in subcontracts under this contract (including subcontracts for the acquisition of commercial items, other than commercially available off-the-shelf items), in which the subcontractor may have Federal contract information residing in or transiting through its information system.    </font></div><div style="padding-left:77pt"><font><br></font></div><div style="padding-left:77pt;text-align:center"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(End of clause)</font></div><div style="padding-left:77pt;text-align:center"><font><br></font></div><div style="padding-left:49.5pt;text-indent:-18.1pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:9.6pt">FAR 52.214-5 </font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> (Jul 2020)</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;The Contractor shall comply with the following Federal Acquisition Regulation (FAR) clauses, which are incorporated in this contract by reference, to implement provisions of law or Executive orders applicable to acquisitions of commercial items&#58;</font></div><div style="margin-bottom:12pt;padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)&#160;52.203-19, Prohibition on Requiring Certain Internal Confidentiality Agreements or Statements&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Jan 2017)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;(section 743 of Division E, Title VII, of the Consolidated and Further Continuing Appropriations Act, 2015 (Pub. L. 113-235) and its successor provisions in subsequent appropriations acts (and as extended in continuing resolutions)).</font></div><div style="margin-bottom:12pt;padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2)&#160;52.204-23, Prohibition on Contracting for Hardware, Software, and Services Developed or Provided by Kaspersky Lab and Other Covered Entities&#160;(Jul 2018)&#160;(Section 1634 of Pub. L. 115-91).&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)&#160;52.204-25, Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment.&#160;(Aug 2019)&#160;(Section 889(a)(1)(A) of Pub. L. 115-232).&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(4)&#160;52.209-10, Prohibition on Contracting with Inverted Domestic Corporations&#160;(Nov 2015).&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(5)&#160;52.233-3, Protest After Award&#160;(Aug 1996)&#160;(31&#160;U.S.C.&#160;3553).</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(6)&#160;52.233-4, Applicable Law for Breach of Contract Claim&#160;(Oct 2004)&#160;(Public Laws 108-77 and 108-78 (&#160;19&#160;U.S.C.&#160;3805&#160;note)).</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">Contract number&#58; </font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 12</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;The Contractor shall comply with the FAR clauses in this paragraph (b) that the Contracting Officer has indicated as being incorporated in this contract by reference to implement provisions of law or Executive orders applicable to acquisitions of commercial items. Selections will be made by the Contracting Officer during definitization&#58;</font></div><div style="padding-left:36pt;text-indent:36pt"><font><br></font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(1)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.203-6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Restrictions on Subcontractor Sales to the Government&#160;(June 2020), with&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Alternate I</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;(Oct 1995)&#160;(&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">41U.S.C.4704</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;and&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">10&#160;U.S.C.&#160;2402</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(2)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.203-13</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Contractor Code of Business Ethics and Conduct&#160;(Jun 2020)&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">41&#160;U.S.C.&#160;3509</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">)).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(3)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.203-15</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Whistleblower Protections under the American Recovery and Reinvestment Act of 2009&#160;(Jun 2010)&#160;(Section 1553 of Pub. L. 111-5). (Applies to contracts funded by the American Recovery and Reinvestment Act of 2009.)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(4)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.204-10</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Reporting Executive Compensation and First-Tier Subcontract Awards&#160;(Jun 2020)&#160;(Pub. L. 109-282) (&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">31&#160;U.S.C.&#160;6101&#160;note</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(5)&#160;&#91;Reserved&#93;.</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(6)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.204-14</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Service Contract Reporting Requirements&#160;(Oct 2016)&#160;(Pub. L. 111-117, section 743 of Div. C).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(7)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.204-15</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Service Contract Reporting Requirements for Indefinite-Delivery Contracts&#160;(Oct 2016)&#160;(Pub. L. 111-117, section 743 of Div. C).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(8)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.209-6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Protecting the Government&#8217;s Interest When Subcontracting with Contractors Debarred, Suspended, or Proposed for Debarment.&#160;(Jun 2020)&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">31&#160;U.S.C.&#160;6101&#160;note</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(9)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.209-9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Updates of Publicly Available Information Regarding Responsibility Matters&#160;(Oct 2018)&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">41&#160;U.S.C.&#160;2313</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(10)&#160;&#91;Reserved&#93;.</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(11)&#160;(i)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.219-3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Notice of HUBZone Set-Aside or Sole-Source Award&#160;(Mar 2020)&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">15&#160;U.S.C.&#160;657a</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(ii)&#160;Alternate I&#160;(Mar 2020)&#160;of&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.219-3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(12)&#160;(i)&#160;52.219-4, Notice of Price Evaluation Preference for HUBZone Small Business Concerns&#160;(Mar 2020)&#160;(if the offeror elects to waive the preference, it shall so indicate in its offer) (15&#160;U.S.C.&#160;657a).</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(ii)&#160;Alternate I&#160;(Mar 2020)&#160;of&#160;52.219-4.</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(13)&#160;&#91;Reserved&#93;</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(14)&#160;(i)&#160;52.219-6, Notice of Total Small Business Set-Aside&#160;(Mar 2020)&#160;of&#160;52.219-6&#160;(15&#160;U.S.C.&#160;644).</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(ii)&#160;Alternate I&#160;(Mar 2020)&#160;of&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.219-6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;.</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(15)&#160;(i)&#160;52.219-7, Notice of Partial Small Business Set-Aside&#160;(Mar 2020)&#160;(15&#160;U.S.C.&#160;644).</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(ii)&#160;Alternate I&#160;(Mar 2020)&#160;of&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.219-7</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(16)&#160;52.219-8, Utilization of Small Business Concerns&#160;(Oct 2018)&#160;(15&#160;U.S.C.&#160;637(d)(2)&#160;and (3)).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(17)&#160;(i)&#160;52.219-9, Small Business Subcontracting Plan&#160;(Jun 2020)&#160;(15&#160;U.S.C.&#160;637(d)(4)).</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(ii)&#160;Alternate I&#160;(Nov 2016)&#160;of&#160;52.219-9.</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(iii)&#160;Alternate II&#160;(Nov 2016)&#160;of&#160;52.219-9.</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(iv)Alternate III&#160;(Jun 2020)&#160;of&#160;52.219-9.</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(v)Alternate IV&#160;(Jun 2020)&#160;of&#160;52.219-9</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(18)&#160;(i)&#160;52.219-13, Notice of Set-Aside of Orders&#160;(Mar 2020)&#160;(15&#160;U.S.C.&#160;644(r)).</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__ (ii)&#160;Alternate I&#160;(Mar 2020)&#160;of&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.219-13</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(19)&#160;52.219-14, Limitations on Subcontracting&#160;(Mar 2020)&#160;(15&#160;U.S.C.&#160;637(a)(14)).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(20)&#160;52.219-16, Liquidated Damages-Subcontracting Plan&#160;(Jan 1999)&#160;(15&#160;U.S.C.&#160;637(d)(4)(F)(i)).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(21)&#160;52.219-27, Notice of Service-Disabled Veteran-Owned Small Business Set-Aside&#160;(Mar </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">Contract number&#58; </font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 13</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">                                   2020)&#160;(15&#160;U.S.C.&#160;657f).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(22)&#160;(i)&#160;52.219-28, Post Award Small Business Program Rerepresentation&#160;(May 2020)&#160;(15&#160;U.S.C.&#160;632(a)(2)).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__ (ii)&#160;Alternate I (MAR 2020) of&#160;52.219-28.</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(23)&#160;52.219-29, Notice of Set-Aside for, or Sole Source Award to, Economically Disadvantaged Women-Owned Small Business Concerns&#160;(Mar 2020)&#160;(15&#160;U.S.C.&#160;637(m)).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(24)&#160;52.219-30, Notice of Set-Aside for, or Sole Source Award to, Women-Owned Small Business Concerns Eligible Under the Women-Owned Small Business Program (Mar2020) (15&#160;U.S.C.&#160;637(m)).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__ (25) &#160;52.219-32, Orders Issued Directly Under Small Business Reserves (Mar 2020)(15 U.S.C. 644(r)). </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(26)&#160;52.219-33, Nonmanufacturer Rule&#160;(Mar 2020)&#160;(15U.S.C. 637(a)(17)).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(27)&#160;52.222-3, Convict Labor&#160;(Jun 2003)&#160;(E.O.11755).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__ (28) 52.222-19, Child Labor- Cooperation with Authorities and Remedies (Jan2020) (E.O.13126) &#160;</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(29)&#160;52.222-21, Prohibition of Segregated Facilities&#160;(Apr 2015).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(30)&#160;(i)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-26</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Equal Opportunity&#160;(Sep 2016)&#160;(E.O.11246).</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(ii)&#160;Alternate I&#160;(Feb 1999)&#160;of&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-26</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(31)&#160;(i)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-35</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Equal Opportunity for Veterans&#160;(Jun 2020)&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">38&#160;U.S.C.&#160;4212</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(ii)&#160;Alternate I&#160;(Jul 2014)&#160;of&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-35</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(32)&#160;(i)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-36</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Equal Opportunity for Workers with Disabilities&#160;(Jun 2020)&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">29&#160;U.S.C.&#160;793</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(ii)&#160;Alternate I&#160;(Jul 2014)&#160;of&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-36</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(33)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-37</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Employment Reports on Veterans (Jun 2020) (38&#160;U.S.C.&#160;4212).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(34)&#160;52.222-40, Notification of Employee Rights Under the National Labor Relations Act&#160;(Dec 2010)&#160;(E.O. 13496).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(35)&#160;(i)&#160;52.222-50, Combating Trafficking in Persons&#160;(Jan 2019)&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">22&#160;U.S.C.&#160;chapter&#160;78</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;and E.O. 13627).</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(ii)&#160;Alternate I&#160;(Mar 2015)&#160;of&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-50</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">22&#160;U.S.C.&#160;chapter&#160;78</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;and E.O. 13627).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(36)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-54</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Employment Eligibility Verification (Oct 2015). (Executive Order 12989). (Not applicable to the acquisition of commercially available off-the-shelf items or certain other types of commercial items as prescribed in&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">22.1803</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(37)&#160;(i)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.223-9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Estimate of Percentage of Recovered Material Content for EPA&#8211;Designated Items (May 2008) (&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">42&#160;U.S.C.&#160;6962(c)(3)(A)(ii)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">). (Not applicable to the acquisition of commercially available off-the-shelf items.)</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(ii)&#160;Alternate I&#160;(May 2008)&#160;of&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.223-9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">42&#160;U.S.C.&#160;6962(i)(2)(C)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">). (Not applicable to the acquisition of commercially available off-the-shelf items.)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(38)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.223-11</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Ozone-Depleting Substances and High Global Warming Potential Hydrofluorocarbons (Jun 2016) (E.O. 13693).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(39)&#160;52.223-12, Maintenance, Service, Repair, or Disposal of Refrigeration Equipment and Air Conditioners&#160;(Jun 2016)&#160;(E.O. 13693).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(40)&#160;(i)&#160;52.223-13, Acquisition of EPEAT&#174;-Registered Imaging Equipment&#160;(Jun 2014)&#160;(E.O.s 13423 and 13514).</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(ii)&#160;Alternate I&#160;(Oct 2015)&#160;of&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.223-13</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(41)&#160;(i)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.223-14</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Acquisition of EPEAT&#174;-Registered Televisions&#160;(Jun 2014)&#160;(E.O.s 13423 and 13514).</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(ii)&#160;Alternate I (Jun2014) of&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.223-14</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(42)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.223-15</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Energy Efficiency in Energy-Consuming Products&#160;(May 2020)&#160;(42&#160;U.S.C.&#160;8259b).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">Contract number&#58; </font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 14</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(43)&#160;(i)&#160;52.223-16, Acquisition of EPEAT&#174;-Registered Personal Computer Products&#160;(Oct 2015)&#160;(E.O.s 13423 and 13514).</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(ii)&#160;Alternate I&#160;(Jun 2014)&#160;of&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.223-16</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_&#160;(44)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.223-18</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Encouraging Contractor Policies to Ban Text Messaging While Driving&#160;(Jun 2020)&#160;(E.O. 13513).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(45)&#160;52.223-20, Aerosols&#160;(Jun 2016)&#160;(E.O. 13693).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(46)&#160;52.223-21, Foams (Jun2016) (E.O. 13693).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(47)&#160;(i)&#160;52.224-3&#160;Privacy Training&#160;(Jan 2017)&#160;(5 U.S.C. 552 a).</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(ii)&#160;Alternate I&#160;(Jan 2017)&#160;of&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.224-3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(48)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.225-1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Buy American-Supplies (May 2014) (41&#160;U.S.C.&#160;chapter&#160;83).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(49)&#160;(i)&#160;52.225-3, Buy American-Free Trade Agreements-Israeli Trade Act&#160;(May 2014)&#160;(41&#160;U.S.C.chapter83,&#160;19&#160;U.S.C.&#160;3301&#160;note,&#160;19&#160;U.S.C.&#160;2112&#160;note,&#160;19&#160;U.S.C.&#160;3805&#160;note,&#160;19&#160;U.S.C.&#160;4001&#160;note, Pub. L. 103-182, 108-77, 108-78, 108-286, 108-302, 109-53, 109-169, 109-283, 110-138, 112-41, 112-42, and 112-43.</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(ii)&#160;Alternate I&#160;(May 2014)&#160;of&#160;52.225-3.</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(iii)&#160;Alternate II&#160;(May 2014)&#160;of&#160;52.225-3.</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(iv)&#160;Alternate III&#160;(May 2014)&#160;of&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.225-3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(50)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.225-5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Trade Agreements&#160;(Oct 2019)&#160;(19&#160;U.S.C.&#160;2501,&#160;et seq.,&#160;19&#160;U.S.C.&#160;3301&#160;note).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(51)&#160;52.225-13, Restrictions on Certain Foreign Purchases&#160;(Jun 2008)&#160;(E.O.&#8217;s, proclamations, and statutes administered by the Office of Foreign Assets Control of the Department of the Treasury).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(52)&#160;52.225-26, Contractors Performing Private Security Functions Outside the United States (Oct 2016) (Section 862, as amended, of the National Defense Authorization Act for Fiscal Year 2008&#59;&#160;10&#160;U.S.C. 2302Note).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(53)&#160;52.226-4, Notice of Disaster or Emergency Area Set-Aside (Nov2007) (42&#160;U.S.C.&#160;5150).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(54)&#160;52.226-5, Restrictions on Subcontracting Outside Disaster or Emergency Area (Nov2007) (42&#160;U.S.C.&#160;5150).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(55)&#160;52.229-12, Tax on Certain Foreign Procurements&#160;(Jun 2020).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(56)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.232-29</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Terms for Financing of Purchases of Commercial Items&#160;(Feb 2002)&#160;(41&#160;U.S.C.&#160;4505,&#160;10&#160;U.S.C.&#160;2307(f)).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(57)&#160;52.232-30, Installment Payments for Commercial Items (Jan2017) (41&#160;U.S.C.&#160;4505,&#160;10&#160;U.S.C.&#160;2307(f)_&#160;(58)&#160;52.232-33, Payment by Electronic Funds Transfer-System for Award Management&#160;(Oct2018)&#160;(31&#160;U.S.C.&#160;3332).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(59)&#160;52.232-34, Payment by Electronic Funds Transfer-Other than System for Award Management (Jul 2013) (31&#160;U.S.C.&#160;3332).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(60)&#160;52.232-36, Payment by Third Party&#160;(May 2014)&#160;(31&#160;U.S.C.&#160;3332).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(61)&#160;52.239-1, Privacy or Security Safeguards&#160;(Aug 1996)&#160;(5&#160;U.S.C.&#160;552a).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(62)&#160;52.242-5, Payments to Small Business Subcontractors&#160;(Jan 2017)&#160;(15&#160;U.S.C.&#160;637(d)(13)).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(63)&#160;(i)&#160;52.247-64, Preference for Privately Owned U.S.-Flag Commercial Vessels&#160;(Feb 2006)&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">46&#160;U.S.C.&#160;Appx.&#160;1241(b)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;and&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">10&#160;U.S.C.&#160;2631</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(ii)&#160;Alternate I&#160;(Apr 2003)&#160;of&#160;52.247-64.</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(iii)&#160;Alternate II&#160;(Feb 2006)&#160;of&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.247-64</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (c)&#160;The Contractor shall comply with the FAR clauses in this paragraph (c), applicable to commercial services, that the Contracting Officer has indicated as being incorporated in this contract by reference to implement provisions of law or Executive orders applicable to acquisitions of commercial items&#58;</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(1)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-41</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Service Contract Labor Standards&#160;(Aug 2018)&#160;(41&#160;U.S.C.&#160;chapter67).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(2)&#160;52.222-42, Statement of Equivalent Rates for Federal Hires&#160;(May </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">Contract number&#58; </font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 15</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">       2014)&#160;(29&#160;U.S.C.&#160;206&#160;and&#160;41&#160;U.S.C.&#160;chapter&#160;67).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(3)&#160;52.222-43, Fair Labor Standards Act and Service Contract Labor Standards-Price Adjustment (Multiple Year and Option Contracts)&#160;(Aug 2018)&#160;(29&#160;U.S.C.&#160;206&#160;and&#160;41&#160;U.S.C.&#160;chapter&#160;67).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(4)&#160;52.222-44, Fair Labor Standards Act and Service Contract Labor Standards-Price Adjustment (May 2014) (&#160;29U.S.C.206&#160;and&#160;41&#160;U.S.C.&#160;chapter&#160;67).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(5)&#160;52.222-51, Exemption from Application of the Service Contract Labor Standards to Contracts for Maintenance, Calibration, or Repair of Certain Equipment-Requirements (May 2014) (41&#160;U.S.C.&#160;chapter&#160;67).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(6)&#160;52.222-53, Exemption from Application of the Service Contract Labor Standards to Contracts for Certain Services-Requirements&#160;(May 2014)&#160;(41&#160;U.S.C.&#160;chapter&#160;67).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(7)&#160;52.222-55, Minimum Wages Under Executive Order 13658&#160;(Dec 2015).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(8)&#160;52.222-62, Paid Sick Leave Under Executive Order 13706&#160;(Jan 2017)&#160;(E.O. 13706).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(9)&#160;52.226-6, Promoting Excess Food Donation to Nonprofit Organizations (Jun 2020) (</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">42&#160;U.S.C.&#160;1792</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (d)&#160;Comptroller General Examination of Record. The Contractor shall comply with the provisions of this paragraph (d) if this contract was awarded using other than sealed bid, is in excess of the simplified acquisition threshold, as defined in FAR&#160;2.101, on the date of award of this contract, and does not contain the clause at&#160;52.215-2, Audit and Records-Negotiation.</font></div><div style="margin-bottom:12pt;padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (1)&#160;The Comptroller General of the United States, or an authorized representative of the Comptroller General, shall have access to and right to examine any of the Contractor&#8217;s directly pertinent records involving transactions related to this contract.</font></div><div style="margin-bottom:12pt;padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (2)&#160;The Contractor shall make available at its offices at all reasonable times the records, materials, and other evidence for examination, audit, or reproduction, until 3 years after final payment under this contract or for any shorter period specified in FAR&#160;subpart 4.7, Contractor Records Retention, of the other clauses of this contract. If this contract is completely or partially terminated, the records relating to the work terminated shall be made available for 3 years after any resulting final termination settlement. Records relating to appeals under the disputes clause or to litigation or the settlement of claims arising under or relating to this contract shall be made available until such appeals, litigation, or claims are finally resolved.</font></div><div style="margin-bottom:12pt;padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (3)&#160;As used in this clause, records include books, documents, accounting procedures and practices, and other data, regardless of type and regardless of form. This does not require the Contractor to create or maintain any record that the Contractor does not maintain in the ordinary course of business or pursuant to a provision of law.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (e)(1)&#160;Notwithstanding the requirements of the clauses in paragraphs (a), (b), (c), and (d) of this clause, the Contractor is not required to flow down any FAR clause, other than those in this paragraph (e)(1) in a subcontract for commercial items. Unless otherwise indicated below, the extent of the flow down shall be as required by the clause-</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (i)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.203-13</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Contractor Code of Business Ethics and Conduct&#160;(Jun 2020)&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">41&#160;U.S.C.&#160;3509</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (ii)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.203-19</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Prohibition on Requiring Certain Internal Confidentiality Agreements or Statements (Jan 2017) (section 743 of Division E, Title VII, of the Consolidated and Further Continuing Appropriations Act, 2015 (Pub. L. 113-235) and its successor provisions in subsequent appropriations acts (and as extended in continuing resolutions)).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">Contract number&#58; </font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 16</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (iii)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.204-23</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Prohibition on Contracting for Hardware, Software, and Services Developed or Provided by Kaspersky Lab and Other Covered Entities&#160;(Jul 2018)&#160;(Section 1634 of Pub. L. 115-91).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (iv)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.204-25</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment.&#160;(Aug 2019)&#160;(Section 889(a)(1)(A) of Pub. L. 115-232).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (v)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.219-8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Utilization of Small Business Concerns&#160;(Oct 2018)&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">15&#160;U.S.C.&#160;637(d)(2)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;and (3)), in all subcontracts that offer further subcontracting opportunities. If the subcontract (except subcontracts to small business concerns) exceeds the applicable threshold specified in FAR&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">19.702</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a) on the date of subcontract award, the subcontractor must include&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.219-8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;in lower tier subcontracts that offer subcontracting opportunities.</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (vi)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-21</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Prohibition of Segregated Facilities&#160;(Apr 2015).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (vii)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-26</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Equal Opportunity&#160;(Sep 2015)&#160;(E.O.11246).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (viii)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-35</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Equal Opportunity for Veterans&#160;(Jun 2020)&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">38&#160;U.S.C.&#160;4212</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (ix)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-36</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Equal Opportunity for Workers with Disabilities&#160;(Jun 2020)&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">29&#160;U.S.C.&#160;793</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (x)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-37</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Employment Reports on Veterans&#160;(Jun 2020)&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">38&#160;U.S.C.&#160;4212</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (xi)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-40</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Notification of Employee Rights Under the National Labor Relations Act&#160;(Dec 2010)&#160;(E.O. 13496). Flow down required in accordance with paragraph (f) of FAR clause&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-40</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (xii)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-41</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Service Contract Labor Standards (Aug2018) (</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">41&#160;U.S.C.&#160;chapter&#160;67</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (xiii)&#160;(A)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-50</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Combating Trafficking in Persons&#160;(Jan 2019)&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">22&#160;U.S.C.&#160;chapter&#160;78</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;and E.O 13627).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (B)&#160;Alternate I (Mar2015) of&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-50</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">22&#160;U.S.C.&#160;chapter&#160;78&#160;and&#160;E.O.&#160;13627</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (xiv)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-51</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Exemption from Application of the Service Contract Labor Standards to Contracts for Maintenance, Calibration, or Repair of Certain Equipment-Requirements (May2014) (</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">41&#160;U.S.C.&#160;chapter&#160;67</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (xv)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-53</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Exemption from Application of the Service Contract Labor Standards to Contracts for Certain Services-Requirements&#160;(May2014)&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">41&#160;U.S.C.&#160;chapter&#160;67</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (xvi)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-54</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Employment Eligibility Verification&#160;(Oct 2015)&#160;(E.O. 12989).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (xvii)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-55</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Minimum Wages Under Executive Order 13658&#160;(Dec 2015).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (xviii)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-62</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Paid Sick Leave Under Executive Order 13706&#160;(Jan 2017)&#160;(E.O. 13706).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (xix)&#160;(A)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.224-3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Privacy Training (Jan 2017) (</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">5&#160;U.S.C.&#160;552a</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (B)&#160;Alternate I&#160;(Jan 2017)&#160;of&#160;52.224-3.</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (xx)&#160;52.225-26, Contractors Performing Private Security Functions Outside the United States&#160;(Oct 2016)&#160;(Section 862, as amended, of the National Defense Authorization Act for Fiscal Year 2008&#59;&#160;10&#160;U.S.C.&#160;2302&#160;Note).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (xxi)&#160;52.226-6, Promoting Excess Food Donation to Nonprofit Organizations&#160;(Jun 2020)&#160;(42&#160;U.S.C.&#160;1792). Flow down required in accordance with paragraph (e) of FAR clause&#160;52.226-6.</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (xxii)&#160;52.247-64, Preference for Privately Owned U.S.-Flag Commercial Vessels&#160;(Feb 2006)&#160;(46&#160;U.S.C.&#160;Appx.&#160;1241(b)&#160;and&#160;10&#160;U.S.C.&#160;2631). Flow down required in accordance with paragraph (d) of FAR clause&#160;52.247-64.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (2)&#160;While not required, the Contractor may include in its subcontracts for commercial items a minimal number of additional clauses necessary to satisfy its contractual obligations.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(End of clause)</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">Contract number&#58; </font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 17</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PART III - LIST OF DOCUMENTS, EXHIBITS AND OTHER ATTACHMENTS </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION J LIST OF ATTACHMENTS</font></div><div style="margin-top:0.1pt;padding-left:72pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.66pt">Statement of Objectives</font></div><div style="margin-top:0.1pt;padding-left:108pt;text-indent:-9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">i.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:3.71pt"> Appendix 1&#58; Contract Deliverables</font></div><div style="margin-top:0.1pt;padding-left:54pt"><font><br></font></div><div style="margin-top:0.1pt;padding-left:72pt"><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">Contract number&#58; </font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 18</font></div><div><font><br></font></div></div></div><div id="ice27bba39ac84ed2a40a7c842e33b4c4_148"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed.</font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attachment 1 &#8211; Statement of Objectives</font></div></div><div style="margin-top:3pt;padding-left:7.25pt"><font style="color:#232323;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Statement of Objectives</font></div><div style="padding-left:5.35pt"><font><br></font></div><div style="padding-left:7.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Program Title&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Rapid Acceleration of Diagnostics (RADx) &#8211; Tech</font></div><div style="margin-top:0.05pt;padding-left:7.2pt;padding-right:10.8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Project Title</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; Rapid Acceleration of Diagnostics ( RADx) Program&#58; Tech Project # 6114 Fluidigm &#8211; Advanta Dx SARS-CoV-2RT-PCR Assay for Saliva</font></div><div style="padding-left:7.2pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:117%">Agency&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:117%">National Institute of Biomedical Imaging and Bioengineering (NIBIB) &#47; National Institutes of Health (NIH)</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.75pt"><font style="color:#232323;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> 1.   Background&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:2.95pt;padding-left:7.25pt;padding-right:6.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The National Institute of Biomedical Imaging and Bioengineering (NIBIB) has a requirement for proposals to provide up to $500 million  across  multiple projects to rapidly  produce innovative SARS-CoV-2 diagnostic tests that will assist the public&#8217;s safe return to normal activities. Rapid Acceleration of Diagnostics  (RADx), is a fast-track technology development program that leverages the National Institutes of Health (NIH) Point-of- Care Technology Research Network (POCTRN). RADx will support novel solutions that build the U.S. capacity for SARS-CoV-2 testing up to 100-fold above what is  achievable with standard approaches. RADx is structured to deliver innovative testing strategies to the public as soon as late summer 2020 and is an accelerated and comprehensive multi-pronged effort by NIH to make SARS-CoV-2 testing readily available to every American.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-bottom:0.5pt;padding-left:7.25pt"><font style="color:#232323;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2. Purpose and Objectives</font></div><div style="padding-left:5.35pt"><font><br></font></div><div style="margin-top:2.95pt;padding-left:7.2pt;padding-right:6.95pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NIBIB is providing substantial support to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19. NIBIB will support the full range of product development including commercialization and product distribution. The ultimate goal of the RADx program</font></div><div style="margin-top:0.5pt;padding-left:7.2pt;padding-right:10.65pt;text-align:justify;text-indent:0.05pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">&#8211;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%;padding-left:23.28pt">across multiple projects&#47;contracts &#8211; is to make millions of tests per week available to the American public, particularly those most vulnerable to and&#47;or disproportionately impacted by COVID-19, in the late summer of 2020, and having even more tests available in time for the 2020&#8211;2021 flu season.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:7.2pt;padding-right:10.8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To meet the accelerated timelines, RADx has assembled a national network of expert technical, clinical, manufacturing, and regulatory advisors who will provide individualized assistance for project development and commercialization. Funding for projects selected for this program will be dependent on successfully meeting aggressive project milestones. Through the POCTRN grants, NIBIB provides financial and in-kind support to accelerate the entire product life-cycle, from design to market, for projects that meet milestones successfully. To ensure that innovations are available to the public as quickly as possible, NIH will leverage established partnerships with federal agencies, such as FDA, CDC, CMS, ASPR&#47;BARDA, the Department of Defense, as well as commercial and private entities to propel technologies developed by RADx into widespread use.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:7.2pt;padding-right:21.2pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The RADx program will consider innovations at all stages of readiness to circumvent current limitations to SARS-CoV-2 testing capacity, including&#58;</font></div><div style="margin-top:0.3pt;padding-left:43.2pt;padding-right:27.7pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.11pt">Early stage&#58; transformative innovations based on novel testing strategies that have potential for major scale up</font></div><div style="padding-left:43.15pt;padding-right:17.35pt;text-indent:-17.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:117%;padding-left:14.06pt">Mid stage&#58; technologies using novel testing strategies that have demonstrated capability but need further validation, regulatory approval, and scale up</font></div><div style="padding-left:43.15pt;padding-right:9.85pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.11pt">Advanced stage (RADx ATP)&#58; modification and optimization of existing SARS-CoV-2 testing approaches, including clinical laboratory tests, that can dramatically increase testing capacity. Note&#58; This arm of the RADx program is addressed under separate Acquisition Plan.</font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">Page 1 of 3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed.</font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attachment 1 &#8211; Statement of Objectives</font></div></div><div style="margin-top:2.45pt;padding-left:7.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Design features might include technical innovations that&#58;</font></div><div style="margin-top:0.25pt;padding-left:43.25pt;padding-right:35.4pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.11pt">Improve analytical performance, e.g., sensitivity, specificity, dynamic range, limit of detection, reliability, accuracy, speed (time to test result) and throughput</font></div><div style="margin-top:0.5pt;padding-left:43.2pt;padding-right:6.3pt;text-align:justify;text-indent:-17.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%;padding-left:14.06pt">Enhance operational performance through, e.g., development of a patient- and user-friendly design, use of alternative sampling strategies (e.g., saliva, exhaled breath), integration with mobile-devices, designs for home-based use or strategies to overcome bottlenecks with current testing approaches</font></div><div style="margin-top:0.25pt;padding-left:43.2pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.11pt">Improve access and reduce the cost of testing.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5.75pt"><font style="color:#232323;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> 3.   Scope&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:2.95pt;padding-left:7.2pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">RADx-Tech is a two-phase program. All applications undergo an intensive week-long risk assessment by a panel of expert technical, clinical, manufacturing, and regulatory advisors. If the proposed technology meets viability metrics, projects may be selected to enter phase one.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:7.2pt;padding-right:11.2pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Phase one, performed under separate funding mechanism, consists of an accelerated research and development program in which the awardee receives both financial support and in-kind services through RADx grant funding. This outcome of this work is a fully instantiated technology ready for clinical validation, regulatory authorization, production and commercialization.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:7.2pt;padding-right:10.8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Phase two, or Work Package 2, of the program, executed under this contract, includes completing the validation, approval, and production processes in order to deliver a viable product in a scaled up capacity to the U.S. public.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-bottom:0.5pt;padding-left:7.25pt"><font style="color:#232323;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4. Performance Objectives (Required Results)</font></div><div style="padding-left:5.35pt"><font><br></font></div><div style="margin-top:2.95pt;padding-left:25.2pt;padding-right:16.95pt;text-indent:-17.95pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:8.82pt">Contract recipients have completed major research and development efforts and are focused in phase two on completion of required clinical validation, preparation of regulatory submissions, scale-up of production capabilities, and preparation for full commercialization of their product &#8211; a testing technology. Every contract will encompass similar expectations and milestones concerned with&#58;</font></div><div style="margin-top:0.3pt;padding-left:43.2pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.66pt">meeting regulatory requirements, resulting in regulatory authorization for sale and use of the test&#59;</font></div><div style="margin-top:0.05pt;padding-left:43.2pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.66pt">instantiation of agreed-upon production capacity&#59;</font></div><div style="margin-top:0.1pt;padding-left:43.2pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.66pt">meeting agreed-upon production goals&#59; and</font></div><div style="margin-top:0.05pt;padding-left:43.2pt;padding-right:15.35pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.66pt">implementation of an agreed-upon commercial strategy to bring the test to market in a timeframe that will impact the COVID-19 pandemic as soon as possible.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:25.2pt;padding-right:6.9pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">B.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.25pt">Contract funding in phase two is structured in order to reduce risk to the Government, and is dependent on achievement of specific milestones in the Schedule of Deliverables, according to the Payment Schedule.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:25.2pt;padding-right:28.6pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">C.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.37pt">The contractor must use a SARS-Cov-2 test with FDA EUA (or will have EUA near the time of award), indicating a combination of sensitivity, specificity, and usability appropriate to the intended use according to FDA and&#47;or CDC guidance, as applicable.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:25.15pt;padding-right:21.2pt;text-indent:-17.95pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">D.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%;padding-left:8.42pt">The contractor must make the product available for a confidential independent regulatory&#47;validation assessment. The independent assessor will be selected by the Government and specified in the contract.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:43.15pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">E.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.86pt">The contractor must provide a risk mitigation plan for each identified risk and update and inform</font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">Page 2 of 3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed.</font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attachment 1 &#8211; Statement of Objectives</font></div></div><div style="margin-top:2.45pt;padding-left:43.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NIH on any changes&#47;newly identified risks in an ongoing manner.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5.75pt"><font style="color:#232323;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> 5.   Contract Type&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.55pt;padding-left:7.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The contract type is Firm Fixed Price.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.75pt"><font style="color:#232323;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> 6.   Place of Performance&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.55pt;padding-left:7.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Place of Performance will be at the contractor&#8217;s site(s).</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5.75pt"><font style="color:#232323;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> 7.   Period of Performance&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.55pt;padding-left:7.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The period of performance of the contract is anticipated to be July 30, 2020 through July 29, 2021.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5.75pt"><font style="color:#232323;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> 8.    Deliverables&#47;Delivery Schedule&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.55pt;padding-left:7.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">See the attached Appendix 1&#58; Schedule of Deliverables.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5.75pt"><font style="color:#232323;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> 9.    Other Requirements&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:3pt;padding-left:25.2pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">A. The contractor must meet regularly (at least weekly) with NIH officials to update on progress toward deliverables&#59; anticipated and ongoing issues and problems&#59; and timelines for deliverable completion. When guided by NIH officials, the contractor must be willing to collaborate and cooperate under reasonable confidentiality terms with external organizations as needed to meet the contract goals in a manner which will not infringe contractor commercial or intellectual property rights.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:7%">Page 3 of 3</font></div><div><font><br></font></div></div></div><div id="ice27bba39ac84ed2a40a7c842e33b4c4_161"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed.</font></div></div><div style="margin-top:3.8pt;padding-right:17.9pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Appendix 1 - Deliverables</font></div><div><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.481%"><tr><td style="width:1.0%"></td><td style="width:4.740%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.269%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.863%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.649%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:120%">No.</font></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.05pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:118%">Objective</font></div><div style="margin-top:0.85pt;padding-left:9.55pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:102%">Defined</font></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Milestone Defined</font></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Deliverable</font></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Success Criteria</font></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.1pt;padding-right:0.35pt;text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:118%">Est. Deliverable</font></div><div style="margin-top:0.85pt;padding-left:0.85pt;padding-right:0.35pt;text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:102%">Due Date</font></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Stage</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:1.1pt;text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:116%">1</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:1.1pt;text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:116%">2</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:1.1pt;text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:116%">3</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:1.1pt;text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:116%">4</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:0.85pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:120%">3</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:1.1pt;text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:116%">5</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:0.85pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:120%">4</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:1.1pt;text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:116%">6</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:1.1pt;text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:116%">7</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:0.85pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:120%">5</font></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:1.1pt;text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:116%">8</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:0.85pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:120%">5</font></div></td></tr></table></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-bottom:0.15pt;margin-top:0.05pt;padding-left:6.8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SubTasks</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.481%"><tr><td style="width:1.0%"></td><td style="width:4.740%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.863%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.176%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:120%">No.</font></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.05pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:118%">Objective</font></div><div style="margin-top:0.85pt;padding-left:9.55pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:102%">Defined</font></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Milestone Defined</font></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Deliverable</font></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Success Criteria</font></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.1pt;padding-right:0.35pt;text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:118%">Est. Deliverable</font></div><div style="margin-top:0.85pt;padding-left:0.85pt;padding-right:0.35pt;text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:102%">Due Date</font></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Stage</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:1.2pt;text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:116%">A</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1A</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-right:11.15pt;text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:116%">B **</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1A</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:1.05pt;text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:116%">C</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2A</font></td></tr></table></div><div><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ice27bba39ac84ed2a40a7c842e33b4c4_1"></div><hr style="page-break-after:always"><div style="min-height:40.3pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed.</font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.459%"><tr><td style="width:1.0%"></td><td style="width:17.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.189%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.873%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.084%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.508%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">AMENDMENT OF SOLICITATION&#47;MODIFICATION OF CONTRACT</font></td><td colspan="6" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">1. CONTRACT ID CODE</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:4.5pt;text-align:right;text-indent:22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:111%">PAGE OF PAGES</font></div><div style="margin-top:4.65pt;padding-left:8.75pt;padding-right:4.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:111%">1    &#47;  </font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:111%">34</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.6pt;text-indent:-3.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:111%">2. AMENDMENT&#47;MODIFICATION NO.</font></div><div style="margin-bottom:1.1pt;margin-top:6.3pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:86%">P00001</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.6pt;text-indent:-1.15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:111%">3. EFFECTIVE DATE</font></div><div style="margin-bottom:0.9pt;margin-top:6.45pt;padding-left:3.6pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:86%">09&#47;25&#47;2020</font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:111%">4. REQUISITION&#47;PURCHASE REQ. NO.</font></div><div style="margin-bottom:4pt;margin-top:3.3pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:86%">5830960</font></div></td><td colspan="6" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:15.05pt;padding-right:84.9pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:113%">5. PROJECT NO. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:113%">(If applicable)</font></div></td></tr><tr style="height:14pt"><td colspan="6" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:111%">6. ISSUED BY&#160;&#160;&#160;&#160;CODE</font></div><div style="margin-top:6.1pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:109%">National Institutes of Health National Heart, Lung, and Blood Institute</font></div><div style="margin-bottom:22.45pt;margin-top:2.95pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:92%">Bethesda, MD 20892</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:5.85pt;font-weight:400;line-height:92%;position:relative;top:-3.15pt;vertical-align:baseline">-</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:92%">7511</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9.5pt;font-weight:400;line-height:120%">NHLBI</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="12" rowspan="2" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:3.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:113%">7. ADMINISTERED BY </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:113%">(If other than item 6)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:113%">CODE</font></div><div style="margin-bottom:1.45pt;margin-top:6.45pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:112%">&#160;National Institutes of Health </font></div><div style="padding-left:4.5pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:120%">&#160;National Institute of Biomedical </font></div><div style="padding-left:4.5pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:120%">&#160;Imaging and Bioengineering </font></div><div style="padding-left:4.5pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:120%">&#160;Bethesda, MD 20892-7511</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9.5pt;font-weight:400;line-height:120%">NIBIB</font></td></tr><tr style="height:53pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="9" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:116%">8. NAME AND ADDRESS OF CONTRACTOR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:116%">(No., street, county, State and ZIP Code)</font></div><div style="margin-top:11.5pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:86%">FLUIDIGM CORPORATION&#58;1157584</font></div><div style="margin-top:2.9pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:86%">2 TOWER PLACE SUITE 2000</font></div><div style="margin-bottom:49.2pt;margin-top:3.45pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:86%">SOUTH SAN FRANCISCO CA 940801826</font></div></td><td colspan="3" rowspan="4" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:44.85pt;padding-left:1.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:164%">(x) </font></div></td><td colspan="12" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">9A. AMENDMENT OF SOLICITATION NO.</font></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="12" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:19.5pt;margin-top:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:113%">9B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:113%;padding-left:27.5pt">DATED </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:113%">(SEE ITEM 11)</font></div></td></tr><tr style="height:29pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Courier New',monospace;font-size:8pt;font-weight:400;line-height:120%">x</font></td><td colspan="12" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:104%">10A.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:104%;padding-left:23.68pt">MODIFICATION OF CONTRACT&#47;ORDER NO.</font></div><div style="margin-bottom:14.1pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:81%">75N92020C00009</font></div></td></tr><tr style="height:12pt"><td colspan="12" rowspan="2" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:113%">10B.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:113%;padding-left:23.68pt">&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:113%">(SEE ITEM 13</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:113%">)</font></div><div style="margin-bottom:5.95pt;margin-top:6.1pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:86%">07&#47;30&#47;2020</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">CODE</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">FACILITY CODE</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="27" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:98%">11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS</font></div></td></tr></table></div><div style="text-indent:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">is extended. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">is not extended. </font></div><div style="padding-left:10.8pt;padding-right:54pt;text-indent:7.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended , by one of the following methods&#58; (a) By completing</font></div><div style="padding-left:10.8pt;padding-right:54pt;text-indent:7.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Items 8 and 15, and returning ____________  copies of the amendment&#59; (b) By acknowledging receipt of this amendment on each copy of the offer submitted &#59; or (c) By</font></div><div style="padding-left:10.8pt;padding-right:54pt;text-indent:7.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">separate letter or telegram which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGEMENT TO BE RECEIVED AT</font></div><div style="padding-left:10.8pt;text-indent:7.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER If by </font></div><div style="padding-left:10.8pt;text-indent:7.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">virtue of this amendment you desire to change an offer already submitted , such change may be made by telegram or letter, provided each telegram or letter makes</font></div><div style="padding-left:10.8pt;text-indent:7.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%;text-decoration:underline"> </font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.459%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:123%">12. ACCOUNTING AND APPROPRIATION DATA </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:123%">(If required)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:123%">Net Increase&#58;&#160;&#160;&#160;&#160;$21,865,056.00</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.459%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6.55pt;margin-top:3.45pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:113%">13.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:113%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:113%">THIS ITEM ONLY APPLIES TO MODIFICATION OF CONTRACTS&#47;ORDERS. IT MODIFIES THE CONTRACT&#47;ORDER NO. AS DESCRIBED IN ITEM 14.</font></div><div style="margin-top:7.3pt;padding-right:82.8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.720%"><tr><td style="width:1.0%"></td><td style="width:6.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.158%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">CHECK ONE</font></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">A. THIS CHANGE ORDER IS ISSUED PURSUANT TO&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(Specify authority)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;ORDER NO. IN ITEM 10A.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">B. THE ABOVE NUMBERED CONTRACT&#47;ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(such as changes in paying office, </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">appropriation date, etc.)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF&#58;</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">OTHER </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(Specify type of modification and authority)</font></div><div style="margin-top:4.75pt;padding-left:10.8pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:104%">FAR 52.216-25 &#8212; Contract Definitization</font></div></td></tr></table></div><div style="padding-right:82.8pt;text-align:justify"><font><br></font></div><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:121%">E. IMPORTANT&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:121%">Contractor&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:121%">&#9744;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:121%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:121%">is not.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:121%">&#9746;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:121%"> is required to sign this document and return </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:121%;text-decoration:underline">&#160;&#160;&#160;&#160;1 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:121%">copies to the issuing office.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.459%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:2.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:113%">14. DESCRIPTION OF AMENDMENT&#47;MODIFICATION </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:113%">(Organized by UCF section headings, including solicitation&#47;contract subject matter where feasible.)</font></div><div style="padding-right:54pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:125%">TITLE&#58; RADx Tech Project # 6114 Fluidigm Corporation, Inc. &#34;Advanta Dx SARS&#8212;CoV-2 RT&#8212;PCR </font></div><div style="margin-bottom:8pt;padding-right:54pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:120%">Assay for Saliva&#34;</font></div><div style="padding-right:54pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:125%">PURPOSE&#58; To definitize the letter contract.</font></div><div style="padding-right:54pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:125%">Delivery Location Code&#58; TDP, BTHOFF</font></div><div style="padding-right:54pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:125%">Two Democracy Plaza, Bethesda Off C</font></div><div style="padding-right:54pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:125%">2 Democracy Plaza</font></div><div style="padding-right:54pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:125%">6707 Democracy Blvd</font></div><div style="padding-right:54pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:125%">Bethesda MD 20817 US</font></div><div style="margin-top:24pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:120%">Continued </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">...</font></div><div style="margin-bottom:0.75pt;margin-top:4.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:111%">Except as provided herein, all terms and conditions of the document referenced in Item 9 A or 10A, as heretofore changed, remains unchanged and in full force and effect.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.982%"><tr><td style="width:1.0%"></td><td style="width:18.795%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.470%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.690%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.207%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.6pt;text-indent:-3.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:113%">15A. NAME AND TITLE OF SIGNER </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:113%">(Type or print)</font></div><div style="margin-bottom:1.85pt;margin-top:7.3pt;padding-left:3.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:123%">Andrew Quong, Chief Science Officer</font></div></td><td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.7pt;padding-left:3.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:113%">16A. NAME AND TITLE OF CONTRACTING OFFICER </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:113%">(Type or print)</font></div><div style="margin-bottom:4.95pt;margin-top:8.1pt;padding-left:3.6pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:86%">ROXANE S. BURKETT</font></div></td></tr><tr style="height:38pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:17pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:111%">15B. CONTRACTOR&#47;OFFEROR</font></div><div style="margin-bottom:17pt;padding-left:2.85pt;text-indent:-2.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; Andrew Quong</font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:80%">Digitally signed by Andrew Quong</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:80%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:80%">Date&#58; 2020.09.28 13&#58;10&#58;54 -07'00'</font></div></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">15C. DATE SIGNED<br><br></font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:16.75pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:111%">1        16B. UNITED STATES OF AMERICA</font></div><div style="margin-bottom:17pt;padding-left:2.85pt;text-indent:-2.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">&#47;s&#47; Roxane S. Burkett -S </font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:80%">Digitally signed by Roxane S. Burkett -S</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:80%">Date&#58; 2020.09.28 17&#58;34&#58;18 -04'00'</font></div></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">16C. DATE SIGNED<br><br></font></td></tr><tr style="height:11pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(Signature of person authorized to sign)</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">(Signature of Contracting Office!)</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:0.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:111%">NSN 7540-01-152-8070&#160;&#160;&#160;&#160;STANDARD FORM 30 (REV. 10-83)</font></div><div style="margin-top:1.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:111%">Previous edition unusable&#160;&#160;&#160;&#160;Prescribed by GSA</font></div><div style="margin-top:1.5pt;padding-left:414pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:109%">FAR (48 CFR) 53.243</font></div><div style="height:0pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ice27bba39ac84ed2a40a7c842e33b4c4_4"></div><hr style="page-break-after:always"><div style="min-height:13pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed.</font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.991%"><tr><td style="width:1.0%"></td><td style="width:17.833%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:58.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">CONTINUATION SHEET</font></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;padding-left:6.5pt;text-indent:-6.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">REFERENCE NO. OF DOCUMENT BEING CONTINUED</font></div><div style="margin-top:2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">75N92020C00009&#47;P00001</font></div><div style="padding-right:390.95pt"><font><br></font></div></td><td colspan="6" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">PAGE       OF</font></div><div style="margin-top:2pt;padding-right:7.2pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;2     &#47;    34</font></div></td></tr><tr style="height:1pt"><td colspan="6" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="padding-left:3.6pt;text-indent:-3.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:155%">NAME OF OFFEROR OR CONTRACTOR</font></div><div style="margin-bottom:1.65pt;margin-top:1.05pt;padding-left:3.6pt;text-indent:-3.6pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:113%">FLUIDIGM CORPORATION&#58;1157584</font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.991%"><tr><td style="width:1.0%"></td><td style="width:6.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.033%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.166%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:9.8pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:204%">ITEM NO.</font></div><div style="margin-bottom:4.35pt;margin-top:3.2pt;padding-right:18.8pt;text-align:right"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:113%">(A)</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:106.95pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:206%">SUPPLIES&#47;SERVICES</font></div><div style="margin-top:3.2pt;padding-right:18.8pt;text-align:center"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:113%">(B)</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:203%">QUANTITY</font></div><div style="margin-bottom:4.35pt;margin-top:3.25pt;padding-right:6.6pt;text-align:center"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:113%">(C)</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:204%">UNIT</font></div><div style="margin-bottom:4.35pt;margin-top:3.2pt;text-align:center"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:113%">(D)</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:7.9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:204%">UNIT PRICE</font></div><div style="margin-bottom:4.35pt;margin-top:3.2pt;padding-right:16.9pt;text-align:center"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:113%">(E)</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:24.4pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:204%">AMOUNT</font></div><div style="margin-bottom:4.35pt;margin-top:3.2pt;padding-right:28.9pt;text-align:center"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:113%">(F)</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:120%">Payment&#58;<br>Approved By, NHLBI Branch A Invoice Paid By&#58; NIH Commercial Accounts Br 2115 East Jefferson St, MSC 8500 Room 4B-432<br>Bethesda, MD 20892-8500<br>Period of Performance&#58; &#91;***&#93;<br>Add Item 3 as follows&#58;</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:120%">3</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:120%">Operation established - Phase I<br>Obligated Amount&#58;&#160;&#160;&#160;&#160;&#91;***&#93;<br> Delivery To&#58; Bldg.31&#47;RM 1C31<br>Product&#47;Service Code&#58;&#160;&#160;&#160;&#160;Q301<br>Product&#47;Service Description&#58; MEDICAL- LABORATORY<br>TESTING<br>Delivery&#58;&#160;&#160;&#160;&#160; &#91;***&#93;<br>Add Item 4 as follows&#58;</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:120%">4</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:120%">Submit FDA EUA<br>Obligated Amount&#58;&#160;&#160;&#160;&#160;&#91;***&#93;<br>Delivery To&#58; Bldg.31&#47;RM 1C31<br>Product&#47;Service Code&#58;&#160;&#160;&#160;&#160;Q301<br>Product&#47;Service Description&#58; MEDICAL- LABORATORY<br>TESTING<br>Delivery&#58;&#160;&#160;&#160;&#160;&#91;***&#93;<br>Add Item 5 as follows&#58;</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:120%">5</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:120%">Clinical Samples<br>Obligated Amount&#58;&#160;&#160;&#160;&#160;&#91;***&#93;<br>Product&#47;Service Code&#58;&#160;&#160;&#160;&#160;Q301<br>Product&#47;Service Description&#58; MEDICAL- LABORATORY<br>TESTING<br>Delivery&#58;&#160;&#160;&#160;&#160;&#91;***&#93; <br> Add Item 6 as follows&#58;</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:120%">6</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:120%">Facility Construction Initiated<br>Obligated Amount&#58;&#160;&#160;&#160;&#160;&#91;***&#93; <br>Delivery To&#58; Bldg.31&#47;RM 1C31 <br> Continued ...</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td></tr></table></div><div style="margin-top:3.85pt;padding-left:3.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:110%">NSN 7540-01-152-8067&#160;&#160;&#160;&#160;OPTIONAL FORM 336 (4-86)</font></div><div style="margin-top:1.6pt;padding-left:460.8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:110%">Sponsored by GSA</font></div><div style="margin-top:0.6pt;padding-left:460.8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:105%">FAR (48 CFR) 53.110</font></div><div><font><br></font></div><div style="height:4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ice27bba39ac84ed2a40a7c842e33b4c4_7"></div><hr style="page-break-after:always"><div style="min-height:13pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed.</font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.991%"><tr><td style="width:1.0%"></td><td style="width:17.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:58.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.968%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:9.35pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">CONTINUATION SHEET<br></font></td><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;padding-left:6.5pt;text-indent:-6.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">REFERENCE NO. OF DOCUMENT BEING CONTINUED</font></div><div style="margin-top:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">75N92020C00009&#47;P00001</font></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;padding-right:2.9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">PAGE      OF</font></div><div style="margin-top:2pt;padding-right:2.9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3      &#47;     </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">34</font></div></td></tr></table></div><div style="padding-left:3.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:155%">NAME OF OFFEROR OR CONTRACTOR</font></div><div style="margin-top:1.05pt;padding-left:3.6pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:113%">FLUIDIGM CORPORATION&#58;1157584</font></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.991%"><tr><td style="width:1.0%"></td><td style="width:6.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.033%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.166%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:9.8pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:204%">ITEM NO.</font></div><div style="margin-bottom:4.35pt;margin-top:3.2pt;padding-right:18.8pt;text-align:right"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:113%">(A)</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:106.95pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:206%">SUPPLIES&#47;SERVICES</font></div><div style="margin-top:3.2pt;padding-right:18.8pt;text-align:center"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:113%">(B)</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:203%">QUANTITY</font></div><div style="margin-bottom:4.35pt;margin-top:3.25pt;padding-right:6.6pt;text-align:center"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:113%">(C)</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:204%">UNIT</font></div><div style="margin-bottom:4.35pt;margin-top:3.2pt;text-align:center"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:113%">(D)</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:7.9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:204%">UNIT PRICE</font></div><div style="margin-bottom:4.35pt;margin-top:3.2pt;padding-right:16.9pt;text-align:center"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:113%">(E)</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:24.4pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:204%">AMOUNT</font></div><div style="margin-bottom:4.35pt;margin-top:3.2pt;padding-right:28.9pt;text-align:center"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:113%">(F)</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.6pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:113%">Product&#47;Service Code&#58;&#160;&#160;&#160;&#160;Q301</font></div><div style="margin-top:1.15pt;padding-left:3.6pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:113%">Product&#47;Service Description&#58; MEDICAL- LABORATORY</font></div><div style="margin-top:1.2pt;padding-left:3.6pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:113%">TESTING</font></div><div style="margin-top:1.2pt;padding-left:3.6pt"><font><br></font></div><div style="margin-top:12.95pt;padding-left:3.6pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:113%">Delivery&#58;&#160;&#160;&#160;&#160; &#91;***&#93;</font></div><div style="margin-top:24.2pt;padding-left:3.6pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:113%">Add Item 7 as follows&#58;</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:120%">7</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:24.05pt;padding-left:3.6pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:113%">Additional Production Lines Initiated</font></div><div style="margin-top:0.35pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:124%">&#160;Obligated Amount&#58;&#160;&#160;&#160;&#160;&#91;***&#93; </font></div><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:120%">&#160;Delivery To&#58; Bldg.31&#47;RM 1C31</font></div><div style="margin-top:1.55pt;padding-left:3.6pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:113%">Product&#47;Service Code&#58;&#160;&#160;&#160;&#160;Q301</font></div><div style="margin-top:1.15pt;padding-left:3.6pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:113%">Product&#47;Service Description&#58; MEDICAL- LABORATORY</font></div><div style="margin-top:1.2pt;padding-left:3.6pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:113%">TESTING</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:120%">Delivery&#58;&#160;&#160;&#160;&#160;&#91;***&#93;</font></div><div style="margin-top:24.3pt;padding-left:3.6pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:113%">Add Item 8 as follows&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:120%">8</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:120%">Full production capacity on all 3 lines.</font></div><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:120%">Obligated Amount&#58;&#160;&#160;&#160;&#160;&#91;***&#93; </font></div><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:120%">Delivery To&#58; Bldg.31&#47;RM 1C31</font></div><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:120%">Product&#47;Service Code&#58;&#160;&#160;&#160;&#160;Q301</font></div><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:120%">Product&#47;Service Description&#58; MEDICAL- LABORATORY</font></div><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:120%">TESTING</font></div><div style="margin-bottom:295.2pt;margin-top:12.85pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:113%">Delivery&#58;&#160;&#160;&#160;&#160; &#91;***&#93;</font></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Courier New',monospace;font-size:9pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td></tr></table></div><div style="margin-top:3pt;padding-left:3.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:110%">NSN 7540-01-152-8067&#160;&#160;&#160;&#160;OPTIONAL FORM 336 (4-86)</font></div><div style="margin-top:3pt;padding-left:460.8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:110%">Sponsored by GSA</font></div><div style="margin-top:0.6pt;padding-left:460.8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:105%">FAR (48 CFR) 53.110</font></div><div><font><br></font></div><div style="height:4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ice27bba39ac84ed2a40a7c842e33b4c4_90"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed.</font></div></div><div><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PART I &#8211; THE SCHEDULE </font></div><div><font><br></font></div><div><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION B - SUPPLIES OR SERVICES AND PRICES&#47;COSTS </font></div><div><font><br></font></div><div><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE B.1. BRIEF DESCRIPTION OF SERVICES</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This contract is part of the Rapid Acceleration of Diagnostics (RADx) Tech program which is structured to deliver innovative testing strategies to the public and is an accelerated and comprehensive multi-pronged effort by NIH to make SARS-CoV-2 testing readily available to every American. The scope of work executed under this contract includes completing the validation, approval, and production processes in order to deliver a viable product in a scaled-up capacity to the U.S. public. Fluidigm technology to support this effort will be to scale up the Integrated Fluidic Circuit (IFC) and completion of the multiplex assay development system for rapid acceleration of testing.</font></div><div><font><br></font></div><div style="margin-top:2pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE B.2. PRICES</font></div><div style="margin-top:0.5pt;padding-left:36pt"><font><br></font></div><div style="margin-top:0.5pt;padding-left:36pt;text-indent:-18.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:10.02pt">The total Firm Fixed Price (FFP) amount for this contract </font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">is $34,016,056.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:8.377%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.318%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.599%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Prism Line Item</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Milestone</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Description</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Date</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Amount</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Stage 1 Test Verification - &#91;***&#93;</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A1</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Stage 1A- Design Review - &#91;***&#93;</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Operation established - Phase I - &#91;***&#93;</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A2</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Submit FDA EUA -</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#91;***&#93;</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A3</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Clinical samples &#8211; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Facility Construction Initiated - </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Additional Production Lines Initiated</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> - &#91;***&#93;</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:111%">Contract number 75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed.</font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:8.377%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.318%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.599%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.882%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Full production capacity on all 3 lines - &#91;***&#93;</font></div><div style="margin-top:0.5pt"><font><br></font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Total</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">$34,016,056</font></div></td></tr></table></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.5pt;padding-left:36pt"><font><br></font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:2pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE B.3. ADVANCE UNDERSTANDINGS</font></div><div style="margin-top:0.5pt;padding-left:36pt"><font><br></font></div><div style="margin-top:0.5pt;padding-left:36pt;text-indent:-18.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:10.02pt">Commercial Item Status&#58; The services provided by the Contractor under this definitized contract constitutes commercial item services.</font></div><div style="margin-top:0.5pt;padding-left:36pt"><font><br></font></div><div style="margin-top:0.5pt;padding-left:36pt;text-indent:-18.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.51pt">HHS reserves the right to exercise priorities and allocations authority with respect to this contract, to include rating this order in accordance with 45 CFR Part 101, Subpart A&#8212;Health Resources Priorities and Allocations System.</font></div><div style="padding-left:36pt;text-indent:-18.05pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:10.63pt">Liquidated Damages &#8211; Milestone-Based Payments</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If the Contractor fails to deliver the supplies or perform the services within the time specified in this contract, and fails to cure within the time specified by the Government and the Government terminates this contract in whole or in part for cause, the Contractor shall, in place of actual damages, pay to the Government liquidated damages in the amount of 33% of the amount(s) already disbursed to date under the contract.  Any liquidated damaged owed by the Contractor shall be paid to the Government no later than 6 months from the date of termination.  </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Contractor will not be charged with liquidated damages when the delay in delivery or performance is beyond the control and without the fault or negligence of the Contractor as defined in FAR Clause 52.212-4, Contract Terms and Conditions-Commercial Items, incorporated in this contract.</font></div><div style="padding-left:95pt;text-indent:-18.05pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">d.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.51pt">Successful performance under this contract requires&#160;the&#160;Contractor&#160;obtain&#160;and maintain an&#160;Emergency Use Authorization (EUA)&#160;from the&#160;Food and&#160;Drug&#160;Administration&#160;(FDA)&#59; the Contractor shall</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;copy us on all FDA correspondence related to the project, including&#160;email&#160;communications to and from the FDA. The</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;FDA&#160;EUA&#160;services&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">provided under this&#160;Contract constitute a commercial service to detect SARS-CoV-2.&#160;</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;</font></div><div style="padding-left:36pt;text-indent:-18.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.81pt">Fair Pricing&#58; The Rapid Acceleration of Diagnostics (RADx) application review process determined the cost per test is competitive with the current market price. The Contractor must comply with applicable federal law to ensure that prices to consumers are offered at fair market rate and at a rate consistent with the objective to increase and improve testing in the United States. </font></div><div style="padding-left:36pt;text-indent:-18.05pt"><font><br></font></div><div style="text-indent:-0.05pt"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:111%">Contract number 75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed.</font></div></div><div style="padding-left:36pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:11.93pt">Security and Privacy of Protected Health Information (PHI) processed under this contract&#58;  In the event the Contractor meets the definition of either a Covered Entity or Business Associate under the Health Insurance Portability and Accountability Act of 1996 (HIPAA), the Contractor shall comply with the HIPAA regulatory standards set forth in the Code of Federal Regulations (CFR) 45 C.F.R. Part 160, Part 162, and Part 164.  To the extent that the Contractor engages subcontractors or other Business Associates to provide services under this Contract, and such Subcontractors or Business Associates will receive or create protected health information (PHI) on behalf of the contractor, the contractor shall obtain satisfactory assurances from its business associate that the business associate will appropriately safeguard the protected health information. The satisfactory assurances must be in writing, whether in the form of a contract or other agreement between the Contractor and the business associate.  In the event of a suspected or known security or privacy breach, in addition to following the procedures set forth in 45 C.F.R. Part 164, the contractor shall also immediately notify the NIH via the Contracting Officer (CO)and the Contracting Officer&#8217;s Representative (COR).</font></div><div style="padding-left:36pt"><font><br></font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">g.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:10.11pt">Sharing Data and Reports&#58;  The Contractor will be required to provide data and reports (e.g., manufacturing, supply chain, production rates), which NIH will use to evaluate completion or achievement of milestones, progress toward deliverables, and compliance with the requirements of this contract.  NIH may use the data to coordinate with other U.S. Government Agencies to accelerate development and deployment of innovative COVID-19 diagnostic tests, and ensure effective stewardship of federal funds.  The reports and data shall not be disclosed outside of the U.S. Government. Sharing data within the federal government enables NIH to discuss the project&#8217;s challenges and progress with federal agencies offering scientific, manufacturing, and logistics expertise.  To ensure that innovations are available to the public as quickly as possible, NIH will leverage established partnerships with federal agencies, such as FDA, CDC, CMS, ASPR&#47;BARDA, and the Department of Defense, and partnerships with State agencies to propel technologies developed by RADx into widespread use.</font></div><div style="padding-left:36pt;text-indent:-18.05pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">h.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.51pt">Contractor Facilities&#58; The contractor shall certify that they will maintain their Facility and Equipment in satisfactory operating condition, as required to enable the contractor to perform the deliverables and achieve the milestones in accordance with the Statement of Objectives and all other applicable laws, regulations, rules or orders. Routine repairs, preventive maintenance, and service contracts for the Facility and Equipment beyond that accounted for in the contract shall be arranged by contractor at no additional cost to the Government.   </font></div><div style="padding-left:36pt;text-indent:-18.05pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.76pt">The novel coronavirus (COVID-19) pandemic has introduced new cybersecurity risks both at the NIH and across the globe. NIH and NIBIB recognize that that the high profile nature of the RADx response may attract the attention of highly motivated malicious actors and want vendors to understand that the risks are real and there is a strong interest in protecting the valued work being conducted through these contracts. NIH and NIBIB are asking vendors to consider their current security posture and to make all reasonable efforts to protect their environment, Information technology, and the products that are being produced.  NIST Special Publication 800-171 can be a useful tool or measuring stick to understand your current security posture as it relates to government computer security standards.  Templates can be found at </font><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;csrc.nist.gov&#47;publications&#47;detail&#47;sp&#47;800-171&#47;rev-2&#47;final</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> .</font></div><div style="padding-left:95pt;text-indent:-18.05pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">j.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.65pt">Contract Termination&#58; In accordance with FAR 52.212-4 (l) Termination for the Government&#8217;s convenience. The Government reserves the right to terminate this contract, or any part hereof, for its sole convenience. In the event of such termination, the Contractor shall immediately stop all work hereunder and shall immediately cause any and all of its suppliers and subcontractors to cease work. </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:111%">Contract number 75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed.</font></div></div><div style="padding-left:36pt;text-indent:-0.05pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Subject to the terms of this contract, the Contractor shall be paid a percentage of the contract price reflecting the percentage of the work performed prior to the notice of termination, plus reasonable charges the Contractor can demonstrate to the satisfaction of the Government using its standard record keeping system, have resulted from the termination. The Contractor shall not be required to comply with the cost accounting standards or contract cost principles for this purpose. This paragraph does not give the Government any right to audit the Contractor&#8217;s records. The Contractor shall not be paid for any work performed or costs incurred which reasonably could have been avoided.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">k.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:10.28pt">Contract Termination&#58; In accordance with FAR 52.212-4(m), the Government may terminate this contract, or any part hereof, for cause in the event of any default by the Contractor, or if the Contractor fails to comply with any contract terms and conditions, or fails to provide the Government, upon request, with adequate assurances of future performance. In the event of termination for cause, the Government shall not be liable to the Contractor for any amount for supplies or services not accepted, and the Contractor shall be liable to the Government for any and all rights and remedies provided by law. If it is determined that the Government improperly terminated this contract for default, such termination shall be deemed a termination for convenience.</font></div><div style="padding-left:95pt;text-indent:-18.05pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">l.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.76pt">Any imported materials must be FDA-approved for use in the U.S.</font></div><div style="padding-left:95pt;text-indent:-18.05pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">m.</font><font style="color:#252525;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:6.45pt">In accordance with the goals of the RADx program, during the Period of Performance (as defined below) the tests manufactured under this contract are to be sold within the U.S. and its territories&#59; provided, however, that, to the extent there is insufficient demand within the U.S. and its territories for the tests produced up to the additional manufacturing capacity funded by NIH and then available (as described in the Schedule of Deliverables), contractor will be permitted to sell such tests outside the U.S. and its territories. The factors, process and mechanism to determine whether contractor has insufficient demand for the tests up to the then-available capacity will be determined on a case by case basis and with approval of the Contracting Officer.</font></div><div style="padding-left:95pt;text-indent:-18.05pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">n.</font><font style="color:#252525;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.46pt">Purchase of clinical samples is permited under this contract and identified as a separate line item.  If samples are not purchased this line item will not be billed against and therefore deobligated from the contract.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:2.8pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION C - DESCRIPTION&#47;SPECIFICATIONS&#47;WORK STATEMENT </font></div><div><font><br></font></div><div style="margin-top:2pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE C.1. STATEMENT OF OBJECTIVES</font></div><div style="padding-right:26.9pt"><font><br></font></div><div style="padding-right:26.9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Independently and not as an agent of the Government, the Contractor shall furnish all the necessary services, qualified personnel, material, equipment, and facilities, not otherwise provided by the Government as needed to perform the Statement of Objectives</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, dated July 27, 2020 and the Performance Work Statement (PWS) dated August 31, 2020, </font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">set forth in SECTION J &#8211; List of Attachments, attached hereto and made a part of this Contract. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Work to be performed shall be consistent with the application and preliminary work file submitted by the Contractor and subsequent documentation submitted during the application review process and the discussions between the parties that have taken place between date of application submission through contract award. </font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:2pt"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:111%">Contract number 75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed.</font></div></div><div style="margin-top:2pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE C.2. REPORTING REQUIREMENTS</font></div><div><font><br></font></div><div><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">All reports required herein shall be submitted in electronic format only. All electronic reports submitted shall be compliant with Section 508 of the Rehabilitation Act of 1973. Additional information about testing documents for Section 508 compliance, including guidance and specific checklists, by application, can be found at&#58; </font><font style="color:#3953a4;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">http&#58;&#47;&#47;www.hhs.gov&#47;web&#47;508&#47;index.html</font><font style="color:#3953a4;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">under &#34;Making Files Accessible.&#34;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following reporting requirements shall be submitted electronically to the Contracting Officer and Contracting Officer&#8217;s Representative in accordance with the due dates specified below&#58; </font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.977%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.286%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.437%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#4f81bd;border-left:1pt solid #4f81bd;border-top:1pt solid #4f81bd;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item No.</font></td><td colspan="3" style="background-color:#4f81bd;border-top:1pt solid #4f81bd;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Reporting Requirements</font></td><td colspan="3" style="background-color:#4f81bd;border-right:1pt solid #4f81bd;border-top:1pt solid #4f81bd;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#ffffff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Due Date</font></td></tr><tr><td colspan="3" style="background-color:#dbe5f1;border-left:1pt solid #95b3d7;border-top:1pt solid #95b3d7;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1</font></td><td colspan="3" style="background-color:#dbe5f1;border-left:1pt solid #95b3d7;border-top:1pt solid #95b3d7;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Bi-weekly Production Status Report &#8211; to include the following&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">current plant production capacity and output on a per-week basis, </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">a breakdown of capacity and output on a per-line&#47;per week basis, </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">a description of any issues&#47;problems encountered with plans for solution&#47;mitigation (e.g., delays in meeting deliverables, supply chain issues, design&#47;validation issues, etc.)</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">sales reporting to include the name and kind of organization, as well as the number of IFCs sold to that organization during the reporting period.  Sales reports may be submitted in every other bi-weekly report (i.e. monthly).</font></div><div><font><br></font></div></td><td colspan="3" style="background-color:#dbe5f1;border-left:1pt solid #95b3d7;border-right:1pt solid #95b3d7;border-top:1pt solid #95b3d7;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #95b3d7;border-left:1pt solid #95b3d7;border-top:1pt solid #95b3d7;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2</font></td><td colspan="3" style="border-bottom:1pt solid #95b3d7;border-left:1pt solid #95b3d7;border-top:1pt solid #95b3d7;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Final Report  - Summary of salient results of the entire contract period, including number of lines built, production capacity over time, production output over time, and a summary of the sales reports. It shall include evidence of sustained production at capacity levels or higher assuming demand has not decreased.</font></td><td colspan="3" style="border-bottom:1pt solid #95b3d7;border-left:1pt solid #95b3d7;border-right:1pt solid #95b3d7;border-top:1pt solid #95b3d7;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div></td></tr></table></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:2.8pt;padding-left:36pt"><font><br></font></div><div style="margin-top:2.8pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION D &#8211; PACKAGING, MARKING, AND SHIPPING</font></div><div><font><br></font></div><div><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">There are no additional instructions or specifications applicable to this contract other than the delivery instructions contained herein.</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:2.8pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION E - INSPECTION AND ACCEPTANCE</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:10.02pt">The Contracting Officer or the duly authorized Contracting Officer&#8217;s Representative (COR) will perform inspection and acceptance of deliverables to be performed and the milestones to be achieved.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:111%">Contract number 75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed.</font></div></div><div style="padding-left:36pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.51pt">Inspection and acceptance will be performed utilizing the success criteria outlined in the deliverable schedule.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="margin-top:2.8pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION F - DELIVERIES OR PERFORMANCE </font></div><div><font><br></font></div><div style="margin-top:2pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE F.1. PERIOD OF PERFORMANCE</font></div><div><font><br></font></div><div><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:122%">The period of performance of the contract is </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:122%">&#91;***&#93;</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:122%">.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:2pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE F.2. DELIVERIES</font></div><div><font><br></font></div><div><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:122%">Satisfactory performance shall be deemed to occur upon performance of the work described in the Statement of Objectives Article in SECTION C of this Contract and upon notice and acceptance by the Contracting Officer, or the duly authorized representative, in accordance with the stated deliverables schedule  as listed in the Performance Work Statement (PWS) (See Attachment 2).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The deliverables or documentation shall be submitted to the Contracting Officer and designated Contracting Officer Representative (COR) by email.</font></div><div><font><br></font></div><div style="margin-top:2.8pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION G - CONTRACT ADMINISTRATION DATA</font></div><div style="padding-right:26.9pt"><font><br></font></div><div style="margin-top:2pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE G.1. CONTRACTING OFFICER (CO)</font></div><div style="padding-right:26.9pt"><font><br></font></div><div style="padding-right:26.9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following Contracting Officer (CO) will represent the Government for the purpose of</font></div><div style="padding-right:26.9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">this contract&#58;</font></div><div style="padding-right:26.9pt"><font><br></font></div><div style="padding-left:36pt;padding-right:26.9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; Roxane Burkett</font></div><div style="padding-left:36pt;padding-right:26.9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Telephone&#58; 301.827.7535</font></div><div style="padding-left:36pt;padding-right:26.9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Email&#58; </font><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">burkettr&#64;nhlbi.nih.gov</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">   </font></div><div style="padding-left:36pt;padding-right:26.9pt"><font><br></font></div><div style="padding-right:26.9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Contracting Officer is the only person with authority to act as agent of the Government</font></div><div style="padding-right:26.9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">under this contract. Only the Contracting Officer has authority to&#58;</font></div><div style="padding-left:45pt;padding-right:26.9pt;text-indent:-9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1) direct or negotiate any changes in the Statement of Objectives or Performance Work Statement&#59;</font></div><div style="padding-left:45pt;padding-right:26.9pt;text-indent:-9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2) modify or extend the period of performance&#59;</font></div><div style="padding-left:45pt;padding-right:26.9pt;text-indent:-9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3) change the deliverables or milestones schedule&#59;</font></div><div style="padding-left:45pt;text-indent:-9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4) authorize reimbursement to the Contractor for any costs incurred during the performance of this Contract&#59; </font></div><div style="padding-left:45pt;padding-right:26.9pt;text-indent:-9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5) otherwise change any terms and conditions of this Contract&#59; </font></div><div style="padding-right:26.9pt"><font><br></font></div><div><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">All correspondence (including invoices) that proposes or otherwise involves waivers, deviations, or modifications to requirement shall be provided to the CO issuing this Contract and the COR supporting the CO.</font></div><div><font><br></font></div><div style="margin-top:2pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE G.2. CONTRACTING OFFICER'S REPRESENTATIVE (COR)</font></div><div style="padding-right:26.9pt"><font><br></font></div><div style="padding-right:26.9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following Contracting Officer's Representative (COR) is anticipated to represent the Government for the purpose of this contract&#58;</font></div><div style="padding-right:26.9pt"><font><br></font></div><div style="text-indent:36pt"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:111%">Contract number 75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed.</font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Olga Hartman, PhD</font></div><div style="padding-left:36pt;padding-right:26.9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Telephone&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">443-350-7696</font></div><div style="padding-left:36pt;padding-right:26.9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Email&#58; </font><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">olga.hartman.civ&#64;mail.mil</font></div><div style="padding-right:26.9pt"><font><br></font></div><div style="padding-right:26.9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The COR is responsible for&#58; </font></div><div style="padding-left:45pt;padding-right:26.9pt;text-indent:-9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1) monitoring the Contractor's technical progress, including the surveillance and assessment of performance and recommending to the Contracting Officer changes in requirements&#59; </font></div><div style="padding-left:45pt;padding-right:26.9pt;text-indent:-9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2) interpreting the Statement of Objectives and any other technical performance requirements&#59; </font></div><div style="padding-left:45pt;padding-right:26.9pt;text-indent:-9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3) performing technical evaluation as required&#59; </font></div><div style="padding-left:45pt;padding-right:26.9pt;text-indent:-9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(4) performing technical inspections and acceptances required by this Contract&#59; and </font></div><div style="padding-left:45pt;padding-right:26.9pt;text-indent:-9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(5) assisting in the resolution of technical problems encountered during performance.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:0.25pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Government may unilaterally change the COR designation.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:2pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE G.3. PRIMARY PROGRAM MANAGER</font></div><div style="padding-right:26.9pt"><font><br></font></div><div style="padding-right:26.9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Primary Program Manager specified in this contract is considered to be essential to work performance. At least 30 days prior to any changes to the individual listed below to other programs or contracts (or as soon as reasonably possible, if an individual must be replaced, for example, as a result of leaving the employ of the Contractor), the Contractor shall notify the Contracting Officer and shall submit comprehensive justification for the change request (including proposed substitutions for primary program manager) to permit evaluation by the Government of the impact on performance under this contract. The Contractor shall not replace any primary program manager without the written consent of the Contracting Officer. The Government may modify the contract to add or delete primary program manager at the request of the Contractor or Government. In no case shall the individual&#8217;s effort exceed 100% across all contracts.</font></div><div style="padding-right:26.9pt;text-align:center"><font><br></font></div><div style="padding-right:26.9pt;text-align:center"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div style="padding-right:26.9pt;text-align:center"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div style="padding-right:26.9pt;text-align:center"><font><br></font></div><div style="margin-top:2pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE G.4. INVOICE SUBMISSION</font></div><div style="padding-right:26.9pt"><font><br></font></div><div style="padding-right:26.9pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition to the requirements specified in FAR 32.905 for a proper invoice, the Contractor shall include the following information on the face page of all contract payment requests&#58;</font></div><div style="padding-left:36pt;text-indent:-18.1pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:10.07pt">The Contract Title is&#58; RADx Tech Fluidigm  6114 &#8211; &#8220;Advanta Dx SARS-CoV-2 RT-PCR Assay for Saliva&#8221;  </font></div><div style="margin-top:2.05pt;padding-left:36pt;text-indent:-17.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:8.96pt">The Contract Line Items are defined within the Section 20. Schedule of Supplies&#47;Services of the Standard Form 1449.</font></div><div style="padding-left:36pt;text-indent:-17.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">c.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:10.08pt">Invoice Instructions are attached and made part of this Contract. The Contractor shall follow the attached instructions and submission procedures specified below to meet the requirements of a &#34;proper invoice&#34; pursuant to FAR Subpart 32.9, Prompt Payment. </font></div><div style="margin-bottom:6pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.66pt">Payment requests shall be submitted to the offices identified below. Do not submit supporting documentation (e.g., receipts, time sheets, vendor invoices, etc.) with your payment request unless specified elsewhere in this Contract or requested by the Contracting Officer.</font></div><div style="margin-bottom:6pt;padding-left:27pt"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:111%">Contract number 75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed.</font></div></div><div style="margin-bottom:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.97pt">One&#160;copy of the invoice shall be submitted to the approving official at the following email addresses&#58;</font></div><div style="margin-bottom:6pt;padding-left:81pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NHLBI Branch B Central Mailbox (</font><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">NHLBIContractsBranchB&#64;mail.nih.gov</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) </font></div><div><font><br></font></div><div style="margin-bottom:6pt;padding-left:81pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NIH centralized invoice email box&#58; </font><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">invoicing&#64;nih.gov</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:6pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.66pt">E-Mail&#58; The Contractor shall submit an electronic copy of the payment request to the approving official. The payment request shall be transmitted as an attachment via e-mail to the address listed above in one of the following formats&#58;&#160; MSWord, MS Excel, or Adobe Portable Document Format (PDF).&#160; Only one payment request shall be submitted per e-mail and the subject line of the e-mail shall include the Contractor's name, contract number, and unique invoice number.&#160;   </font></div><div style="margin-bottom:6pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.66pt">In addition to the requirements specified in FAR&#160;32.905 for a proper invoice, the Contractor shall include the following information on the face page of all payment requests (invoices)&#58;</font></div><div style="margin-bottom:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.97pt">Name of the Office of Acquisitions. The Office of Acquisitions for this contract is </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NHLBI</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.&#160;</font></div><div style="margin-bottom:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.46pt">Central Point of Distribution. For the purpose of this contract, the Central Point of Distribution is </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NHLBI Branch B Invoices</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:10.58pt">Federal Taxpayer&#160;Identification Number (TIN).&#160; If the Contractor does not have a valid TIN, it shall identify the Vendor Identification Number (VIN) on the payment request.&#160; The VIN is the number that appears after the Contractor's name on the face page of the contract.&#160; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#91;Note&#58;&#160; A VIN is assigned to new contracts awarded on or after June 4, 2007, and any existing contract modified to include the VIN number.&#93;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160; If the Contractor has neither a TIN, DUNS, or VIN, contact the Contracting Officer.  </font></div><div style="margin-bottom:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.46pt">DUNS&#160;or DUNS+4 Number.&#160; The DUNS number must identify the&#160;Contractor's name and address exactly as stated in the&#160;contract and as registered in the Central Contractor Registration (CCR) database.&#160; If the Contractor does not have a valid DUNS number, it shall identify the Vendor Identification Number (VIN) on the payment request.&#160; The VIN is the number that appears after the Contractor's name on the face page of the contract.&#160; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#91;Note&#58; A VIN is assigned to new contracts awarded on or after June 4, 2007, and any existing contract modified to include the VIN number.&#93;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160; If the Contractor has neither a TIN, DUNS, or VIN, contact the Contracting Officer.</font></div><div style="margin-bottom:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.76pt">Invoice Matching Option.&#160;&#160;This Contract requires a </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">two-way </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">match.</font></div><div style="margin-bottom:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:11.88pt">Unique Invoice Number.&#160; Each payment request must be identified by a unique invoice number, which can only be used one time regardless of the number of contracts or orders held by an organization.</font></div><div style="margin-bottom:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">g.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:10.06pt">PRISM&#47;NBS Line Item Number and associated PRISM&#47;NBS Line Item Period of Performance (see Section B &#8211; PRICES&#47;OPTION).</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">       d.   Inquiries regarding payment of invoices shall be directed to the designated billing office, (301) 496-6088.</font></div><div style="margin-top:2.8pt"><font><br></font></div><div style="margin-top:2.8pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION H - ADDITONAL CONTRACT CLAUSES&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="margin-top:2pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE H.1. CONFIDENTIALITY OF INFORMATION</font></div><div style="padding-left:54pt;padding-right:46.7pt"><font><br></font></div><div style="padding-left:54pt;padding-right:46.7pt;text-indent:-14.35pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:6.32pt">Confidential information, as used in this article, means information or data of a personal </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:111%">Contract number 75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed.</font></div></div><div style="padding-left:54pt;padding-right:46.7pt;text-indent:3.65pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">nature about an individual, or proprietary information or data submitted by or pertaining to an institution or organization.</font></div><div style="padding-left:54pt;padding-right:46.7pt"><font><br></font></div><div style="padding-left:54pt;padding-right:19.55pt;text-indent:-14.35pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:5.81pt">The Contracting Officer and the Contractor may, by mutual consent, identify elsewhere in this  Contract specific information and&#47;or categories of information which the Government will furnish to the Contractor or that the Contractor is expected to generate which is confidential. Similarly, the Contracting Officer and the Contractor may, by mutual consent, identify such confidential information from time to time during the performance of the Contract. Failure to agree will be settled pursuant to the &#34;Disputes&#34; clause.</font></div><div style="padding-right:19.55pt"><font><br></font></div><div style="padding-left:54pt;padding-right:11.75pt;text-indent:-13.8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:6.38pt">If it is established elsewhere in this Contract that information to be utilized under this contract, or a portion thereof, is subject to the Privacy Act, the Contractor will follow the rules and procedures of disclosure set forth in the Privacy Act of 1974, 5 U.S.C. 552a, and implementing regulations and policies, with respect to systems of records determined to be subject to the Privacy Act.</font></div><div style="padding-right:11.75pt"><font><br></font></div><div style="padding-left:54pt;padding-right:8.95pt;text-indent:-14.35pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:5.81pt">Confidential information, as defined in paragraph (a) of this article, shall not be disclosed without the prior written consent of the individual, institution, or organization.</font></div><div style="padding-right:8.95pt"><font><br></font></div><div style="padding-left:54pt;padding-right:16.15pt;text-indent:-14.35pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:6.11pt">Whenever the Contractor is uncertain with regard to the proper handling of material under the contract, or if the material in question is subject to the Privacy Act or is confidential information subject to the provisions of this article, the Contractor should obtain a written determination from the Contracting Officer prior to any release, disclosure, dissemination, or publication.</font></div><div style="padding-right:16.15pt"><font><br></font></div><div style="padding-left:54pt;padding-right:26.2pt;text-indent:-11.6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:5.48pt">Contracting Officer determinations will reflect the result of internal coordination with appropriate program and legal officials.</font></div><div style="padding-right:26.2pt"><font><br></font></div><div style="padding-left:54pt;padding-right:32.3pt;text-indent:-14.35pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">g.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:6.41pt">The provisions of paragraph (d) of this article shall not apply to conflicting or overlapping provisions in other Federal, State or local laws.</font></div><div><font><br></font></div><div style="margin-top:2pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE H.2. PUBLICATION AND PUBLICITY</font></div><div style="padding-left:40.5pt;padding-right:14.25pt"><font><br></font></div><div style="padding-left:40.5pt;padding-right:14.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition to the requirements set forth in HHSAR Clause </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">352.227-70, Publications and Publicity </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">incorporated by reference in SECTION I of this contract, the Contractor shall acknowledge the support of the National Institutes of Health whenever publicizing the work under this Contract in any media by including an acknowledgment substantially as follows&#58;</font></div><div style="padding-left:40.5pt"><font><br></font></div><div style="padding-left:40.5pt;padding-right:25.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#34;This project has been funded in whole or in part with Federal funds from the National Institute</font></div><div style="padding-left:40.5pt;padding-right:25.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of Biomedical Imaging and Bioengineering, National Institutes of Health, Department of Health</font></div><div style="padding-left:40.5pt;padding-right:25.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and Human Services, under Contract No. 75N92020C0009.&#34;</font></div><div style="padding-left:40.5pt;padding-right:25.4pt"><font><br></font></div><div style="padding-left:40.5pt;padding-right:25.4pt"><font><br></font></div><div style="padding-left:40.5pt;padding-right:25.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition to acknowledging NIH funding, the Contractor shall refer any media inquiries relating to the role of the US Government in their contract to the COR within one day for a response.</font></div><div><font><br></font></div><div style="margin-top:2pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE H.3. REPORTING MATTERS INVOLVING FRAUD, WASTE AND ABUSE</font></div><div style="padding-left:40.5pt;padding-right:22.95pt"><font><br></font></div><div style="padding-left:40.5pt;padding-right:22.95pt"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:111%">Contract number 75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed.</font></div></div><div style="padding-left:40.5pt;padding-right:22.95pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Anyone who becomes aware of the existence or apparent existence of fraud, waste and abuse in NIH funded programs is encouraged to report such matters to the HHS Inspector General's Office in writing or on the Inspector General's Hotline. The toll free number is </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1-800-HHS-TIPS (1-800-447-8477). </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">All telephone calls will be handled confidentially. The website to file a complaint on-line is&#58; </font><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">http&#58;&#47;&#47;oig.hhs.gov&#47;fraud&#47;hotline&#47; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and the mailing address is&#58;</font></div><div style="padding-left:72pt;padding-right:125.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:124%">US Department of Health and Human Services Office of Inspector General</font></div><div style="padding-left:72pt;padding-right:125.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ATTN&#58; OIG HOTLINE OPERATIONS</font></div><div style="padding-left:72pt;padding-right:125.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:124%">P.O. Box 23489 Washington, D.C. 20026</font></div><div style="padding-left:72pt;padding-right:125.5pt"><font><br></font></div><div style="padding-right:5.75pt;text-align:justify"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE H.4. ELECTRONIC AND INFORMATION TECHNOLOGY ACCESSIBILITY, HHSAR 352.239-74 (December 2015)  </font></div><div style="padding-left:36pt;padding-right:5.75pt;text-align:justify;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.97pt">Pursuant to Section 508 of the Rehabilitation Act of 1973(29 U.S.C. 794d), as amended by the Workforce Investment Act of 1998, all electronic and information technology (EIT) supplies and services developed, acquired, or maintained under this contract or order must comply with the &#34;Architectural and Transportation Barriers Compliance Board Electronic and Information Technology (EIT) Accessibility Standards'' set forth by the Architectural and Transportation Barriers Compliance Board (also referred to as the &#34;Access Board'') in 36 CFR part 1194. Information about Section 508 is available at</font><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline"> http&#58;&#47;&#47;www.hhs.gov&#47;web&#47;508 </font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The complete text of Section 508 Final Provisions can be accessed at</font><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline"> http&#58;&#47;&#47;www.access-board.gov&#47;guidelines-and-standards&#47;communications-and-it&#47;about-the-section-508-standards </font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:36pt;padding-right:5.75pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;padding-right:5.75pt;text-align:justify;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.46pt">The Section 508 accessibility standards applicable to this contract or order are identified below. The contractor must provide any necessary updates to the submitted HHS Product Assessment Template(s) at the end of each contract or order exceeding the simplified acquisition threshold (see FAR 2.101) when the contract or order duration is one year or less. If it is determined by the Government that EIT supplies and services provided by the Contractor do not conform to the described accessibility standards in the contract, remediation of the supplies or services to the level of conformance specified in the contract will be the responsibility of the Contractor at its own expense.</font></div><div style="padding-right:5.75pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;padding-right:5.75pt;text-align:justify;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">c.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:10.58pt">The Section 508 accessibility standards applicable to this contract are&#58;</font></div><div style="padding-left:72pt;padding-right:5.75pt;text-align:justify;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">300 &#8211; Functional Performance Requirements </font></div><div style="padding-left:72pt;padding-right:5.75pt;text-align:justify;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">500 &#8211; Software Standards General</font></div><div style="padding-left:72pt;padding-right:5.75pt;text-align:justify;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">600 &#8211; Support Services &#38; Documentation Standards</font></div><div style="padding-left:72pt;padding-right:5.75pt;text-align:justify;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">WCAG Level A Requirements</font></div><div style="padding-left:72pt;padding-right:5.75pt;text-align:justify;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.53pt">WCAG Level AA Requirements</font></div><div style="padding-left:72pt;padding-right:5.75pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;padding-right:5.75pt;text-align:justify;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">d.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.46pt">In the event of a modification(s) to this contract or order, which adds new EIT supplies or services or revises the type of, or specifications for, supplies or services, the Contracting Officer may require that the contractor submit a completed HHS Section 508 Product Assessment Template and any other additional information necessary to assist the Government in determining that the EIT supplies or services conform to Section 508 accessibility standards. Instructions for documenting accessibility via the HHS Section 508 Product Assessment Template may be found under Section 508 policy on the HHS Web site&#58; (</font><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline"> http&#58;&#47;&#47;www.hhs.gov&#47;web&#47;508 </font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">). If it is determined by the Government that EIT supplies and services provided by the Contractor do not conform to the described accessibility standards in the contract, remediation of the supplies or services to the level of conformance specified in the contract will be the responsibility of the Contractor at its own expense.</font></div><div style="padding-left:36pt;padding-right:5.75pt;text-align:justify"><font><br></font></div><div style="padding-right:5.75pt;text-align:justify"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:111%">Contract number 75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed.</font></div></div><div style="padding-left:36pt;padding-right:5.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">e.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.76pt">If this is an Indefinite Delivery contract, a Blanket Purchase Agreement or a Basic Ordering Agreement, the task&#47;delivery order requests that include EIT supplies or services will define the specifications and accessibility standards for the order. In those cases, the Contractor may be required to provide a completed HHS Section 508 Product Assessment Template and any other additional information necessary to assist the Government in determining that the EIT supplies or services conform to Section 508 accessibility standards. Instructions for documenting accessibility via the HHS Section 508 Product Assessment Template may be found at</font><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline"> http&#58;&#47;&#47;www.hhs.gov&#47;web&#47;508 </font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If it is determined by the Government that EIT supplies and services provided by the Contractor do not conform to the described accessibility standards in the provided documentation, remediation of the supplies or services to the level of conformance specified in the contract will be the responsibility of the Contractor at its own expense.</font></div><div style="padding-right:5.75pt;text-align:justify"><font><br></font></div><div style="padding-right:5.75pt;text-align:justify"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(End of clause)</font></div><div style="padding-right:5.75pt;text-align:justify"><font><br></font></div><div style="padding-right:125.5pt"><font><br></font></div><div style="padding-left:40.3pt;padding-right:14.4pt"><font><br></font></div><div style="padding-right:14.4pt"><font><br></font></div><div style="margin-top:4pt;padding-left:137.3pt;padding-right:119.45pt;text-align:center"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">PART II - CONTRACT CLAUSES </font></div><div><font><br></font></div><div style="margin-top:2.8pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION I - CONTRACT CLAUSES</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:2pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE I.1. ADDITIONAL CONTRACT CLAUSES</font></div><div><font><br></font></div><div><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">This contract incorporates the following clauses by reference, (unless otherwise noted), with the same force and effect as if they were given in full text. </font></div><div><font><br></font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:9.5pt">    FEDERAL ACQUISITION REGULATION (FAR) (48 CFR CHAPTER 1) CLAUSES</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">a.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:9.97pt">FAR Clause 52.202-1 Definitions </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">b.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:9.46pt">FAR Clause 52.203-6 Restrictions on Subcontractor Sales to the Government.</font></div><div style="padding-left:72pt;text-indent:-23.29pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">i.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:18pt">Alternate I 52.203-6</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">c.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:10.58pt">FAR Clause 52.203-13, Contractor Code of Business Ethics and Conduct (October 2015)</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">d.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:9.46pt">FAR Clause 52.203-17 Contractor Employee Whistleblower Rights and Requirement To Inform Employees of Whistleblower Rights.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">e.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:9.76pt">FAR Clause 52.204-9, Personal Identity Verification of Contractor Personnel (January 2011).</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">f.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:11.88pt">FAR Clause 52.204-13, System for Award Management Maintenance</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">g.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:10.06pt">FAR Clause 52.204-18 Commercial and Government Entity Code Maintenance (July 2016)</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">h.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:9.46pt">FAR Clause 52.204-23 Prohibition on Contracting for Hardware, Software, and Services Developed or Provided by Kaspersky Lab and Other Covered Entities</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">i.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:12.71pt">FAR Clause 52.204-25 Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services of Equipment (Aug 2020)</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">j.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:12.6pt">FAR Clause 52.209-10, Prohibition on Contracting With Inverted Domestic Corporations(November 2015).</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">k.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:10.23pt">FAR Provision 52.212-3, Offeror Representations and Certifications &#8211; Commercial Items (Jun 2020) </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">l.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:12.71pt">FAR Clause 52.212-4 Contract Terms and Conditions &#8211; Commercial Items (Oct 2018)</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">m.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:6.45pt">FAR Clause 52.222-4, Contract Work Hours and Safety Standards - Overtime Compensation -General (May 2014).</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">n.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:9.46pt">FAR Clause 52.222-29, Notification of Visa Denial (April 2015).</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">o.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:9.43pt">FAR Clause 52.223-15, Energy Efficiency in Energy-Consuming Products (December 2007).</font></div><div><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:111%">Contract number 75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed.</font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">p.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:9.46pt">FAR Clause 52.227-11 Patent Rights-Ownership by the Contractor</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">q.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:9.46pt">FAR Clause 52.227-14, Rights in Data - General (May 2014).</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">r.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:11.4pt">FAR Clause 52.227-14, Rights in Data - General (May 2014) Alternate II (Dec 2007).</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">s.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:10.93pt">FAR Clause 52.232-40, Providing Accelerated Payments to Small Business Subcontractors</font></div><div style="padding-left:36pt"><font><br></font></div><div style="margin-bottom:6pt;padding-left:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">    </font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:9.5pt"> DEPARTMENT OF HEALTH AND HUMAN SERVICES ACQUISITION REGULATION (HHSAR) (48 CHAPTER CLAUSES&#58;</font></div><div style="margin-top:0.45pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.97pt">HHSAR Clause 352.227-70, Publications and Publicity</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:2pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE I.2. ADDITIONAL FAR CONTRACT CLAUSES INCLUDED IN FULL TEXT</font></div><div style="margin-top:0.45pt;padding-left:36pt;text-indent:-18.05pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">a.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:9.69pt">FEDERAL ACQUISITION REGULATION (FAR) (48 CFR CHAPTER 1) CLAUSES</font></div><div style="margin-top:0.05pt;padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This contract incorporates the following clauses in full text.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:95pt;text-indent:-23.68pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">i.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:18.05pt">FAR Clause 52.204-21, Basic Safeguarding of Covered Contractor Information Systems (Jun 2016)</font></div><div style="padding-left:62.55pt"><font><br></font></div><div style="padding-left:77pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">      (a) Definitions. As used in this clause&#8211;</font></div><div style="padding-left:77pt"><font><br></font></div><div style="padding-left:103.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Covered contractor information system means an information system that is owned or operated by a contractor that processes, stores, or transmits Federal contract information.</font></div><div style="padding-left:103.5pt"><font><br></font></div><div style="padding-left:103.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Federal contract information means information, not intended for public release, that is provided by or generated for the Government under a contract to develop or deliver a product or service to the Government, but not including information provided by the Government to the public (such as on public websites) or simple transactional information, such as necessary to process payments.</font></div><div style="padding-left:103.5pt"><font><br></font></div><div style="padding-left:103.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Information means any communication or representation of knowledge such as facts, data, or opinions, in any medium or form, including textual, numerical, graphic, cartographic, narrative, or audiovisual (Committee on National Security Systems Instruction (CNSSI) 4009).</font></div><div style="padding-left:103.5pt"><font><br></font></div><div style="padding-left:103.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Information system means a discrete set of information resources organized for the collection, processing, maintenance, use, sharing, dissemination, or disposition of information (44 U.S.C. 3502).</font></div><div style="padding-left:103.5pt"><font><br></font></div><div style="padding-left:103.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Safeguarding means measures or controls that are prescribed to protect information systems.</font></div><div style="padding-left:77pt"><font><br></font></div><div style="padding-left:77pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">      (b) Safeguarding requirements and procedures.</font></div><div style="padding-left:77pt"><font><br></font></div><div style="padding-left:108pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(1) The Contractor shall apply the following basic safeguarding requirements and procedures to protect covered contractor information systems. Requirements and procedures for basic safeguarding of covered contractor information systems shall </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:111%">Contract number 75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed.</font></div></div><div style="padding-left:108pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">include, at a minimum, the following security controls&#58;</font></div><div style="padding-left:77pt"><font><br></font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(i) Limit information system access to authorized users, processes acting on behalf of authorized users, or devices (including other information systems).</font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font><br></font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(ii) Limit information system access to the types of transactions and functions that authorized users are permitted to execute.</font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font><br></font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(iii) Verify and control&#47;limit connections to and use of external information systems.</font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font><br></font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(iv) Control information posted or processed on publicly accessible information systems.</font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font><br></font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(v) Identify information system users, processes acting on behalf of users, or devices.</font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font><br></font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(vi) Authenticate (or verify) the identities of those users, processes, or devices, as a prerequisite to allowing access to organizational information systems.</font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font><br></font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(vii) Sanitize or destroy information system media containing Federal Contract Information before disposal or release for reuse.</font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font><br></font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(viii) Limit physical access to organizational information systems, equipment, and the respective operating environments to authorized individuals.</font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font><br></font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(ix) Escort visitors and monitor visitor activity&#59; maintain audit logs of physical access&#59; and control and manage physical access devices.</font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(x) Monitor, control, and protect organizational communications (i.e., information transmitted or received by organizational information systems) at the external boundaries and key internal boundaries of the information systems.</font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font><br></font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(xi) Implement subnetworks for publicly accessible system components that are physically or logically separated from internal networks.</font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font><br></font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(xii) Identify, report, and correct information and information system flaws in a timely manner.</font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font><br></font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(xiii) Provide protection from malicious code at appropriate locations within organizational information systems.</font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font><br></font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(xiv) Update malicious code protection mechanisms when new releases are available.</font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font><br></font></div><div style="padding-left:126pt;text-indent:-13.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(xv) Perform periodic scans of the information system and real-time scans of files from external sources as files are downloaded, opened, or executed.</font></div><div style="padding-left:77pt"><font><br></font></div><div style="padding-left:108pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(2) Other requirements. This clause does not relieve the Contractor of any other specific safeguarding requirements specified by Federal agencies and departments relating to covered contractor information systems generally or other Federal safeguarding requirements for controlled unclassified information (CUI) as established by Executive </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:111%">Contract number 75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed.</font></div></div><div style="padding-left:108pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Order 13556.</font></div><div style="padding-left:62.55pt"><font><br></font></div><div style="padding-left:94.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(c) Subcontracts. The Contractor shall include the substance of this clause, including this paragraph (c), in subcontracts under this contract (including subcontracts for the acquisition of commercial items, other than commercially available off-the-shelf items), in which the subcontractor may have Federal contract information residing in or transiting through its information system.    </font></div><div style="padding-left:77pt"><font><br></font></div><div style="padding-left:77pt;text-align:center"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(End of clause)</font></div><div style="padding-left:77pt;text-align:center"><font><br></font></div><div style="padding-left:95pt;text-indent:-26.38pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ii.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:18.05pt">FAR 52.212-5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items (Aug 2020)</font></div><div style="padding-left:95pt"><font><br></font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;The Contractor shall comply with the following Federal Acquisition Regulation (FAR) clauses, which are incorporated in this contract by reference, to implement provisions of law or Executive orders applicable to acquisitions of commercial items&#58;</font></div><div style="margin-bottom:12pt;padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)&#160;52.203-19, Prohibition on Requiring Certain Internal Confidentiality Agreements or Statements&#160;(Jan 2017)&#160;(section 743 of Division E, Title VII, of the Consolidated and Further Continuing Appropriations Act, 2015 (Pub. L. 113-235) and its successor provisions in subsequent appropriations acts (and as extended in continuing resolutions)).</font></div><div style="margin-bottom:12pt;padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)&#160;52.204-23, Prohibition on Contracting for Hardware, Software, and Services Developed or Provided by Kaspersky Lab and Other Covered Entities&#160;(Jul 2018)&#160;(Section 1634 of Pub. L. 115-91).&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)&#160;52.204-25, Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment.&#160;(Aug 2020)&#160;(Section 889(a)(1)(A) of Pub. L. 115-232).&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(4)&#160;52.209-10, Prohibition on Contracting with Inverted Domestic Corporations&#160;(Nov 2015).&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(5)&#160;52.233-3, Protest After Award&#160;(Aug 1996)&#160;(31&#160;U.S.C.&#160;3553).&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(6)&#160;52.233-4, Applicable Law for Breach of Contract Claim&#160;(Oct 2004)&#160;(Public Laws 108-77 and 108-78 (&#160;19&#160;U.S.C.&#160;3805&#160;note)).</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;The Contractor shall comply with the FAR clauses in this paragraph (b) that the Contracting Officer has indicated as being incorporated in this contract by reference to implement provisions of law or Executive orders applicable to acquisitions of commercial items&#58;</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Contracting Officer check as appropriate</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.&#93; &#8211; </font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_X_&#160;(1)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.203-6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Restrictions on Subcontractor Sales to the Government&#160;(June 2020), with&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Alternate I</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;(Oct 1995)&#160;(&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">41U.S.C.4704</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;and&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">10&#160;U.S.C.&#160;2402</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_X_&#160;(2)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.203-13</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Contractor Code of Business Ethics and Conduct&#160;(Jun 2020)&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">41&#160;U.S.C.&#160;3509</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">)).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(3)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.203-15</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Whistleblower Protections under the American Recovery and Reinvestment Act of 2009&#160;(Jun 2010)&#160;(Section 1553 of Pub. L. 111-5). (Applies to contracts funded by the American Recovery and Reinvestment Act of 2009.)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:111%">Contract number 75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed.</font></div></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_X_&#160;(4)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.204-10</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Reporting Executive Compensation and First-Tier Subcontract Awards&#160;(Jun 2020)&#160;(Pub. L. 109-282) (&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">31&#160;U.S.C.&#160;6101&#160;note</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(5)&#160;&#91;Reserved&#93;.</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_X_&#160;(6)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.204-14</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Service Contract Reporting Requirements&#160;(Oct 2016)&#160;(Pub. L. 111-117, section 743 of Div. C).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(7)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.204-15</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Service Contract Reporting Requirements for Indefinite-Delivery Contracts&#160;(Oct 2016)&#160;(Pub. L. 111-117, section 743 of Div. C).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_X_&#160;(8)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.209-6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Protecting the Government&#8217;s Interest When Subcontracting with Contractors Debarred, Suspended, or Proposed for Debarment.&#160;(Jun 2020)&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">31&#160;U.S.C.&#160;6101&#160;note</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_X_&#160;(9)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.209-9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Updates of Publicly Available Information Regarding Responsibility Matters&#160;(Oct 2018)&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">41&#160;U.S.C.&#160;2313</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(10)&#160;&#91;Reserved&#93;.</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(11)&#160;(i)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.219-3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Notice of HUBZone Set-Aside or Sole-Source Award&#160;(Mar 2020)&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">15&#160;U.S.C.&#160;657a</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(ii)&#160;Alternate I&#160;(Mar 2020)&#160;of&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.219-3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(12)&#160;(i)&#160;52.219-4, Notice of Price Evaluation Preference for HUBZone Small Business Concerns&#160;(Mar 2020)&#160;(if the offeror elects to waive the preference, it shall so indicate in its offer) (15&#160;U.S.C.&#160;657a).</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(ii)&#160;Alternate I&#160;(Mar 2020)&#160;of&#160;52.219-4.</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(13)&#160;&#91;Reserved&#93;</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(14)&#160;(i)&#160;52.219-6, Notice of Total Small Business Set-Aside&#160;(Mar 2020)&#160;of&#160;52.219-6&#160;(15&#160;U.S.C.&#160;644).</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(ii)&#160;Alternate I&#160;(Mar 2020)&#160;of&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.219-6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;.</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(15)&#160;(i)&#160;52.219-7, Notice of Partial Small Business Set-Aside&#160;(Mar 2020)&#160;(15&#160;U.S.C.&#160;644).</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(ii)&#160;Alternate I&#160;(Mar 2020)&#160;of&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.219-7</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_X_&#160;(16)&#160;52.219-8, Utilization of Small Business Concerns&#160;(Oct 2018)&#160;(15&#160;U.S.C.&#160;637(d)(2)&#160;and (3)).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(17)&#160;(i)&#160;52.219-9, Small Business Subcontracting Plan&#160;(Jun 2020)&#160;(15&#160;U.S.C.&#160;637(d)(4)).</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__    (ii)&#160;Alternate I&#160;(Nov 2016)&#160;of&#160;52.219-9.</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;  (iii)&#160;Alternate II&#160;(Nov 2016)&#160;of&#160;52.219-9.</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;  (iv)Alternate III&#160;(Jun 2020)&#160;of&#160;52.219-9.</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;  (v)Alternate IV&#160;(Jun 2020)&#160;of&#160;52.219-9</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(18)&#160;(i)&#160;52.219-13, Notice of Set-Aside of Orders&#160;(Mar 2020)&#160;(15&#160;U.S.C.&#160;644(r)).</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__ (ii)&#160;Alternate I&#160;(Mar 2020)&#160;of&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.219-13</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(19)&#160;52.219-14, Limitations on Subcontracting&#160;(Mar 2020)&#160;(15&#160;U.S.C.&#160;637(a)(14)).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(20)&#160;52.219-16, Liquidated Damages-Subcontracting Plan&#160;(Jan 1999)&#160;(15&#160;U.S.C.&#160;637(d)(4)(F)(i)).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(21)&#160;52.219-27, Notice of Service-Disabled Veteran-Owned Small Business Set-Aside&#160;(Mar 2020)&#160;(15&#160;U.S.C.&#160;657f).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(22)&#160;(i)&#160;52.219-28, Post Award Small Business Program Rerepresentation&#160;(May 2020)&#160;(15&#160;U.S.C.&#160;632(a)(2)).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__ (ii)&#160;Alternate I (MAR 2020) of&#160;52.219-28.</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(23)&#160;52.219-29, Notice of Set-Aside for, or Sole Source Award to, Economically Disadvantaged Women-Owned Small Business Concerns&#160;(Mar 2020)&#160;(15&#160;U.S.C.&#160;637(m)).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(24)&#160;52.219-30, Notice of Set-Aside for, or Sole Source Award to, Women-Owned Small Business Concerns Eligible Under the Women-Owned Small Business Program (Mar2020) (15&#160;U.S.C.&#160;637(m)).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__ (25) &#160;52.219-32, Orders Issued Directly Under Small Business Reserves (Mar 2020)(15 U.S.C. </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:111%">Contract number 75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed.</font></div></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">       644(r)). </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(26)&#160;52.219-33, Nonmanufacturer Rule&#160;(Mar 2020)&#160;(15U.S.C. 637(a)(17)).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_X_&#160;(27)&#160;52.222-3, Convict Labor&#160;(Jun 2003)&#160;(E.O.11755).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_X_ (28) 52.222-19, Child Labor- Cooperation with Authorities and Remedies (Jan2020) (E.O.13126) &#160;</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_X_&#160;(29)&#160;52.222-21, Prohibition of Segregated Facilities&#160;(Apr 2015).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_X_&#160;(30)&#160;(i)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-26</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Equal Opportunity&#160;(Sep 2016)&#160;(E.O.11246).</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(ii)&#160;Alternate I&#160;(Feb 1999)&#160;of&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-26</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(31)&#160;(i)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-35</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Equal Opportunity for Veterans&#160;(Jun 2020)&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">38&#160;U.S.C.&#160;4212</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(ii)&#160;Alternate I&#160;(Jul 2014)&#160;of&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-35</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(32)&#160;(i)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-36</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Equal Opportunity for Workers with Disabilities&#160;(Jun 2020)&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">29&#160;U.S.C.&#160;793</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(ii)&#160;Alternate I&#160;(Jul 2014)&#160;of&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-36</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(33)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-37</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Employment Reports on Veterans (Jun 2020) (38&#160;U.S.C.&#160;4212).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_X_&#160;(34)&#160;52.222-40, Notification of Employee Rights Under the National Labor Relations Act&#160;(Dec 2010)&#160;(E.O. 13496).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_X_&#160;(35)&#160;(i)&#160;52.222-50, Combating Trafficking in Persons&#160;(Jan 2019)&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">22&#160;U.S.C.&#160;chapter&#160;78</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;and E.O. 13627).</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(ii)&#160;Alternate I&#160;(Mar 2015)&#160;of&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-50</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">22&#160;U.S.C.&#160;chapter&#160;78</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;and E.O. 13627).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(36)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-54</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Employment Eligibility Verification (Oct 2015). (Executive Order 12989). (Not applicable to the acquisition of commercially available off-the-shelf items or certain other types of commercial items as prescribed in&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">22.1803</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(37)&#160;(i)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.223-9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Estimate of Percentage of Recovered Material Content for EPA&#8211;Designated Items (May 2008) (&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">42&#160;U.S.C.&#160;6962(c)(3)(A)(ii)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">). (Not applicable to the acquisition of commercially available off-the-shelf items.)</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(ii)&#160;Alternate I&#160;(May 2008)&#160;of&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.223-9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">42&#160;U.S.C.&#160;6962(i)(2)(C)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">). (Not applicable to the acquisition of commercially available off-the-shelf items.)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(38)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.223-11</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Ozone-Depleting Substances and High Global Warming Potential Hydrofluorocarbons (Jun 2016) (E.O. 13693).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(39)&#160;52.223-12, Maintenance, Service, Repair, or Disposal of Refrigeration Equipment and Air Conditioners&#160;(Jun 2016)&#160;(E.O. 13693).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(40)&#160;(i)&#160;52.223-13, Acquisition of EPEAT&#174;-Registered Imaging Equipment&#160;(Jun 2014)&#160;(E.O.s 13423 and 13514).</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(ii)&#160;Alternate I&#160;(Oct 2015)&#160;of&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.223-13</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(41)&#160;(i)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.223-14</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Acquisition of EPEAT&#174;-Registered Televisions&#160;(Jun 2014)&#160;(E.O.s 13423 and 13514).</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(ii)&#160;Alternate I (Jun2014) of&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.223-14</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(42)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.223-15</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Energy Efficiency in Energy-Consuming Products&#160;(May 2020)&#160;(42&#160;U.S.C.&#160;8259b).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(43)&#160;(i)&#160;52.223-16, Acquisition of EPEAT&#174;-Registered Personal Computer Products&#160;(Oct 2015)&#160;(E.O.s 13423 and 13514).</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(ii)&#160;Alternate I&#160;(Jun 2014)&#160;of&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.223-16</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_X_&#160;(44)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.223-18</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Encouraging Contractor Policies to Ban Text Messaging While Driving&#160;(Jun 2020)&#160;(E.O. 13513).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(45)&#160;52.223-20, Aerosols&#160;(Jun 2016)&#160;(E.O. 13693).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(46)&#160;52.223-21, Foams (Jun2016) (E.O. 13693).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_&#160;(47)&#160;(i)&#160;52.224-3&#160;Privacy Training&#160;(Jan 2017)&#160;(5 U.S.C. 552 a).</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(ii)&#160;Alternate I&#160;(Jan 2017)&#160;of&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.224-3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(48)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.225-1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Buy American-Supplies (May 2014) (41&#160;U.S.C.&#160;chapter&#160;83).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:111%">Contract number 75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 22</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed.</font></div></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(49)&#160;(i)&#160;52.225-3, Buy American-Free Trade Agreements-Israeli Trade Act&#160;(May 2014)&#160;(41&#160;U.S.C.chapter83,&#160;19&#160;U.S.C.&#160;3301&#160;note,&#160;19&#160;U.S.C.&#160;2112&#160;note,&#160;19&#160;U.S.C.&#160;3805&#160;note,&#160;19&#160;U.S.C.&#160;4001&#160;note, Pub. L. 103-182, 108-77, 108-78, 108-286, 108-302, 109-53, 109-169, 109-283, 110-138, 112-41, 112-42, and 112-43.</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(ii)&#160;Alternate I&#160;(May 2014)&#160;of&#160;52.225-3.</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(iii)&#160;Alternate II&#160;(May 2014)&#160;of&#160;52.225-3.</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(iv)&#160;Alternate III&#160;(May 2014)&#160;of&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.225-3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(50)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.225-5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Trade Agreements&#160;(Oct 2019)&#160;(19&#160;U.S.C.&#160;2501,&#160;et seq.,&#160;19&#160;U.S.C.&#160;3301&#160;note).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_X_&#160;(51)&#160;52.225-13, Restrictions on Certain Foreign Purchases&#160;(Jun 2008)&#160;(E.O.&#8217;s, proclamations, and statutes administered by the Office of Foreign Assets Control of the Department of the Treasury).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(52)&#160;52.225-26, Contractors Performing Private Security Functions Outside the United States (Oct 2016) (Section 862, as amended, of the National Defense Authorization Act for Fiscal Year 2008&#59;&#160;10&#160;U.S.C. 2302Note).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(53)&#160;52.226-4, Notice of Disaster or Emergency Area Set-Aside (Nov2007) (42&#160;U.S.C.&#160;5150).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(54)&#160;52.226-5, Restrictions on Subcontracting Outside Disaster or Emergency Area (Nov2007) (42&#160;U.S.C.&#160;5150).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(55)&#160;52.229-12, Tax on Certain Foreign Procurements&#160;(Jun 2020).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(56)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.232-29</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Terms for Financing of Purchases of Commercial Items&#160;(Feb 2002)&#160;(41&#160;U.S.C.&#160;4505,&#160;10&#160;U.S.C.&#160;2307(f)).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(57)&#160;52.232-30, Installment Payments for Commercial Items (Jan2017) (41&#160;U.S.C.&#160;4505,&#160;10&#160;U.S.C.&#160;2307(f)).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_X_&#160;(58)&#160;52.232-33, Payment by Electronic Funds Transfer-System for Award Management&#160;(Oct2018)&#160;(31&#160;U.S.C.&#160;3332).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(59)&#160;52.232-34, Payment by Electronic Funds Transfer-Other than System for Award Management (Jul 2013) (31&#160;U.S.C.&#160;3332).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(60)&#160;52.232-36, Payment by Third Party&#160;(May 2014)&#160;(31&#160;U.S.C.&#160;3332).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(61)&#160;52.239-1, Privacy or Security Safeguards&#160;(Aug 1996)&#160;(5&#160;U.S.C.&#160;552a).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_X_&#160;(62)&#160;52.242-5, Payments to Small Business Subcontractors&#160;(Jan 2017)&#160;(15&#160;U.S.C.&#160;637(d)(13)).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(63)&#160;(i)&#160;52.247-64, Preference for Privately Owned U.S.-Flag Commercial Vessels&#160;(Feb 2006)&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">46&#160;U.S.C.&#160;Appx.&#160;1241(b)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;and&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">10&#160;U.S.C.&#160;2631</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(ii)&#160;Alternate I&#160;(Apr 2003)&#160;of&#160;52.247-64.</font></div><div style="padding-left:117pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(iii)&#160;Alternate II&#160;(Feb 2006)&#160;of&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.247-64</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (c)&#160;The Contractor shall comply with the FAR clauses in this paragraph (c), applicable to commercial services, that the Contracting Officer has indicated as being incorporated in this contract by reference to implement provisions of law or Executive orders applicable to acquisitions of commercial items&#58;</font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#91;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Contracting Officer check as appropriate.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#93;</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(1)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-41</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Service Contract Labor Standards&#160;(Aug 2018)&#160;(41&#160;U.S.C.&#160;chapter67).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(2)&#160;52.222-42, Statement of Equivalent Rates for Federal Hires&#160;(May 2014)&#160;(29&#160;U.S.C.&#160;206&#160;and&#160;41&#160;U.S.C.&#160;chapter&#160;67).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(3)&#160;52.222-43, Fair Labor Standards Act and Service Contract Labor Standards-Price Adjustment (Multiple Year and Option Contracts)&#160;(Aug 2018)&#160;(29&#160;U.S.C.&#160;206&#160;and&#160;41&#160;U.S.C.&#160;chapter&#160;67).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(4)&#160;52.222-44, Fair Labor Standards Act and Service Contract Labor Standards-Price Adjustment (May 2014) (&#160;29U.S.C.206&#160;and&#160;41&#160;U.S.C.&#160;chapter&#160;67).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(5)&#160;52.222-51, Exemption from Application of the Service Contract Labor Standards to Contracts for Maintenance, Calibration, or Repair of Certain Equipment-Requirements (May </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:111%">Contract number 75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 23</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed.</font></div></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">        2014) (41&#160;U.S.C.&#160;chapter&#160;67).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(6)&#160;52.222-53, Exemption from Application of the Service Contract Labor Standards to Contracts for Certain Services-Requirements&#160;(May 2014)&#160;(41&#160;U.S.C.&#160;chapter&#160;67).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(7)&#160;52.222-55, Minimum Wages Under Executive Order 13658&#160;(Dec 2015).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(8)&#160;52.222-62, Paid Sick Leave Under Executive Order 13706&#160;(Jan 2017)&#160;(E.O. 13706).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__&#160;(9)&#160;52.226-6, Promoting Excess Food Donation to Nonprofit Organizations (Jun 2020) (</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">42&#160;U.S.C.&#160;1792</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:90pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (d)&#160;Comptroller General Examination of Record. The Contractor shall comply with the provisions of this paragraph (d) if this contract was awarded using other than sealed bid, is in excess of the simplified acquisition threshold, as defined in FAR&#160;2.101, on the date of award of this contract, and does not contain the clause at&#160;52.215-2, Audit and Records-Negotiation.</font></div><div style="margin-bottom:12pt;padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (1)&#160;The Comptroller General of the United States, or an authorized representative of the Comptroller General, shall have access to and right to examine any of the Contractor&#8217;s directly pertinent records involving transactions related to this contract.</font></div><div style="margin-bottom:12pt;padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (2)&#160;The Contractor shall make available at its offices at all reasonable times the records, materials, and other evidence for examination, audit, or reproduction, until 3 years after final payment under this contract or for any shorter period specified in FAR&#160;subpart 4.7, Contractor Records Retention, of the other clauses of this contract. If this contract is completely or partially terminated, the records relating to the work terminated shall be made available for 3 years after any resulting final termination settlement. Records relating to appeals under the disputes clause or to litigation or the settlement of claims arising under or relating to this contract shall be made available until such appeals, litigation, or claims are finally resolved.</font></div><div style="margin-bottom:12pt;padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (3)&#160;As used in this clause, records include books, documents, accounting procedures and practices, and other data, regardless of type and regardless of form. This does not require the Contractor to create or maintain any record that the Contractor does not maintain in the ordinary course of business or pursuant to a provision of law.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (e)(1)&#160;Notwithstanding the requirements of the clauses in paragraphs (a), (b), (c), and (d) of this clause, the Contractor is not required to flow down any FAR clause, other than those in this paragraph (e)(1) in a subcontract for commercial items. Unless otherwise indicated below, the extent of the flow down shall be as required by the clause-</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (i)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.203-13</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Contractor Code of Business Ethics and Conduct&#160;(Jun 2020)&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">41&#160;U.S.C.&#160;3509</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (ii)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.203-19</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Prohibition on Requiring Certain Internal Confidentiality Agreements or Statements (Jan 2017) (section 743 of Division E, Title VII, of the Consolidated and Further Continuing Appropriations Act, 2015 (Pub. L. 113-235) and its successor provisions in subsequent appropriations acts (and as extended in continuing resolutions)).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (iii)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.204-23</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Prohibition on Contracting for Hardware, Software, and Services Developed or Provided by Kaspersky Lab and Other Covered Entities&#160;(Jul 2018)&#160;(Section 1634 of Pub. L. 115-91).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (iv)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.204-25</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment.&#160;(Aug 2020)&#160;(Section 889(a)(1)(A) of Pub. L. 115-232).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (v)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.219-8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Utilization of Small Business Concerns&#160;(Oct 2018)&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">15&#160;U.S.C.&#160;637(d)(2)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;and (3)), in all subcontracts that offer further subcontracting opportunities. If the subcontract (except subcontracts to small business concerns) exceeds the applicable threshold specified in </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:111%">Contract number 75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 24</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed.</font></div></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">       FAR&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">19.702</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a) on the date of subcontract award, the subcontractor must include&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.219-8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;in lower tier subcontracts that offer subcontracting opportunities.</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (vi)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-21</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Prohibition of Segregated Facilities&#160;(Apr 2015).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (vii)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-26</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Equal Opportunity&#160;(Sep 2015)&#160;(E.O.11246).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (viii)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-35</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Equal Opportunity for Veterans&#160;(Jun 2020)&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">38&#160;U.S.C.&#160;4212</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (ix)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-36</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Equal Opportunity for Workers with Disabilities&#160;(Jun 2020)&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">29&#160;U.S.C.&#160;793</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (x)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-37</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Employment Reports on Veterans&#160;(Jun 2020)&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">38&#160;U.S.C.&#160;4212</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (xi)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-40</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Notification of Employee Rights Under the National Labor Relations Act&#160;(Dec 2010)&#160;(E.O. 13496). Flow down required in accordance with paragraph (f) of FAR clause&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-40</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (xii)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-41</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Service Contract Labor Standards (Aug2018) (</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">41&#160;U.S.C.&#160;chapter&#160;67</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (xiii)&#160;(A)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-50</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Combating Trafficking in Persons&#160;(Jan 2019)&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">22&#160;U.S.C.&#160;chapter&#160;78</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;and E.O 13627).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (B)&#160;Alternate I (Mar2015) of&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-50</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">22&#160;U.S.C.&#160;chapter&#160;78&#160;and&#160;E.O.&#160;13627</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (xiv)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-51</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Exemption from Application of the Service Contract Labor Standards to Contracts for Maintenance, Calibration, or Repair of Certain Equipment-Requirements (May2014) (</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">41&#160;U.S.C.&#160;chapter&#160;67</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (xv)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-53</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Exemption from Application of the Service Contract Labor Standards to Contracts for Certain Services-Requirements&#160;(May2014)&#160;(</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">41&#160;U.S.C.&#160;chapter&#160;67</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (xvi)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-54</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Employment Eligibility Verification&#160;(Oct 2015)&#160;(E.O. 12989).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (xvii)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-55</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Minimum Wages Under Executive Order 13658&#160;(Dec 2015).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (xviii)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.222-62</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Paid Sick Leave Under Executive Order 13706&#160;(Jan 2017)&#160;(E.O. 13706).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (xix)&#160;(A)&#160;</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">52.224-3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Privacy Training (Jan 2017) (</font><font style="color:#1062ae;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">5&#160;U.S.C.&#160;552a</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (B)&#160;Alternate I&#160;(Jan 2017)&#160;of&#160;52.224-3.</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (xx)&#160;52.225-26, Contractors Performing Private Security Functions Outside the United States&#160;(Oct 2016)&#160;(Section 862, as amended, of the National Defense Authorization Act for Fiscal Year 2008&#59;&#160;10&#160;U.S.C.&#160;2302&#160;Note).</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (xxi)&#160;52.226-6, Promoting Excess Food Donation to Nonprofit Organizations&#160;(Jun 2020)&#160;(42&#160;U.S.C.&#160;1792). Flow down required in accordance with paragraph (e) of FAR clause&#160;52.226-6.</font></div><div style="padding-left:99pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (xxii)&#160;52.247-64, Preference for Privately Owned U.S.-Flag Commercial Vessels&#160;(Feb 2006)&#160;(46&#160;U.S.C.&#160;Appx.&#160;1241(b)&#160;and&#160;10&#160;U.S.C.&#160;2631). Flow down required in accordance with paragraph (d) of FAR clause&#160;52.247-64.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (2)&#160;While not required, the Contractor may include in its subcontracts for commercial items a minimal number of additional clauses necessary to satisfy its contractual obligations.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(End of clause)</font></div><div><font><br></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-right:4.5pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PART III - LIST OF DOCUMENTS, EXHIBITS AND OTHER ATTACHMENTS </font></div><div><font><br></font></div><div style="margin-top:2.8pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION J  - LIST OF ATTACHMENTS</font></div><div><font><br></font></div><div style="margin-top:0.1pt;padding-left:36pt;text-indent:-18pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.97pt">Statement of Objectives</font></div><div style="margin-top:0.1pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b.</font><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.46pt">Performance Work Statement</font></div><div style="margin-top:0.1pt;padding-left:36pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Appendix 1&#58; Cost-Price Quote</font></div><div style="margin-top:0.1pt;padding-left:36pt"><font style="color:#231f20;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Appendix 2&#58; Quality Assurance Surveillance Plan (QASP)</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:111%">Contract number 75N92020C00009&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Page 25</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>exhibit10210q3q2020.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="idee3b0553e3b4a6b9c14548ba27069be_1"></div><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.2</font></div><div style="margin-top:9pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2020.LICI.001.B </font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">California Institute of Technology</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECOND AMENDED AND RESTATED LICENSE AGREEMENT</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">THIS SECOND AMENDED AND RESTATED LICENSE AGREEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (&#8220;Agreement&#8221;), effective May 1, 2000 (the &#8220;Effective Date&#8221;) with a second restatement date as of May 1, 2004 (the &#8220;Second Restatement Date&#8221;), between</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> CALIFORNIA INSTITUTE OF TECHNOLOGY</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, 1200 East California Boulevard, Pasadena, California 91125 (&#8220;Caltech&#8221;) and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> FLUIDIGM CORPORATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, 7100 Shoreline Court, South San Francisco, California 94080 (formerly Mycometrix Corporation) (&#8220;Licensee&#8221;).</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, Caltech has been engaged in basic research in the field of microfluidics&#59;</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that research led to the United States patents, patent applications and other inventions listed in Exhibit A, which are owned, solely or jointly, by Caltech&#59;</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, Licensee is desirous of obtaining, and Caltech wishes to grant to Licensee, an exclusive license (or the maximum rights Caltech can grant) to the Licensed Patents (as defined in Section 1.5) and Improvements thereof in the Field (as defined in Sections 1.4 and 1.3, respectively) and an exclusive license to the Technology (as defined in Section 1.9)&#59;</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Caltech and Licensee have entered into a prior License Agreement made as of May 1, 2000, and an Amended and Restated License Agreement made as of June 1, 2002, which the parties now wish to further amend and restate as set forth herein.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NOW, THEREFORE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the parties agree as follows&#58;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 1 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 1</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DEFINITIONS</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Affiliate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean, with respect to Licensee, any entity which controls, is controlled by or is under common control with Licensee. An entity shall be regarded as in control of another entity for purposes of this definition if it owns or controls fifty percent (50%) or more of the shares of the subject entity entitled to vote in the election of directors (or, in the case of an entity that is not a corporation, for the election of the corresponding managing authority). &#8220;Affiliate&#8221; shall mean, with respect to Caltech, any research entity which is operated or managed as a facility under Caltech.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.2 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Deductible Expenses&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means (i) all trade, cash and quantity credits, discounts, refunds or government rebates&#59; (ii) amounts for claims, allowances or credits for returns, retroactive price reductions, or chargebacks&#59; (iii) packaging, handling fees and prepaid freight, sales taxes, duties and other governmental charges (including value added tax)&#59; and (iv) provisions for uncollectible accounts determined in accordance with reasonable accounting practices, consistently applied to all products of the selling party. For the removal of doubt, Net Sales shall not include sales by Licensee to its Affiliates for resale, provided that if Licensee sells a Licensed Product to an Affiliate for resale, Net Sales shall include the amounts invoiced by such Affiliate to third parties on the resale of such Licensed Product. In the event that Licensee grants a sublicense hereunder, and receives payments based upon the Sublicensee&#8217;s sales of Licensed Products, Licensee may upon notice to Caltech modify this definition of &#8220;Net Sales&#8221; for purposes of calculating royalties payable to Caltech on such Sublicensee&#8217;s sales to be the same as the definition of &#8220;Net Sales&#8221; on which such royalties to Licensee are calculated.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.3 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Field&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means &#91;***&#93;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 2 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.4 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Improvements&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean all Caltech rights (whether or not Caltech has sole or joint rights) in any improvement or invention conceived and reduced to practice or otherwise developed in or arising from research in the Field as conducted by Dr. Stephen Quake, researchers of the Quake laboratory, or in collaboration with members of the Frances Arnold or Axel Scherer laboratories, whether invented solely by Caltech researchers or jointly with (i) Licensee or (ii) other researchers without an obligation of assignment to Caltech.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.5 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Licensed Patents&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the patent applications listed in Exhibit A hereto&#59; any patents issuing on such patent applications, all divisionals, continuations, continuations-in-part, patents of addition, substitutions, registrations, reissues, reexaminations or extensions of any kind with respect to any of the existing patents and any foreign counterparts of such patent applications and patents, and Improvements.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.6 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Licensed Product&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means products covered by a Valid Claim of a Licensed Patent in the country in which such product is sold or products in which the Technology is utilized.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.7 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Net Sales&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the total amount invoiced to third parties on sales of Licensed Products for which royalties are due under Article 4 below, less, to the extent allocable to such invoiced amounts, Deductible Expenses.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.8 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Sublicensee&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean any non-Affiliate third party to whom Licensee has granted the right under the Licensed Patents and Technology to manufacture and sell Licensed Products, with respect to Licensed Products made and sold by such third party.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 3 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.9 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Technology&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means all proprietary information, know-how, procedures, methods, prototypes, designs, technical data, reports, and data owned by Caltech that are necessary or useful in the development of products in the Field covered by any issued patent or pending patent application within the Licensed Patents, and which relate to such products.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.10 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Valid Claim&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means a claim of an issued and unexpired patent or a claim of a pending patent application within the Licensed Patents which has not been held unpatentable, invalid or unenforceable by a court or other government agency of competent jurisdiction and has not been admitted to be invalid or unenforceable through reissue, re-examination, disclaimer or otherwise&#59; provided, however, that if the holding of such court or agency is later reversed by a court or agency with overriding authority, the claim shall be reinstated as a Valid Claim with respect to Net Sales made after the date of such reversal. Notwithstanding the foregoing provisions of this Section 1.10, if a claim of a pending patent application within the Licensed Patents has not issued as a claim of an issued patent within the Licensed Patents, within five (5) years after the filing date from which such claim takes priority, such pending claim shall not be a Valid Claim for purposes of this Agreement.</font></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 2</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PATENT LICENSE GRANT</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1 Caltech hereby grants to Licensee an exclusive, royalty-bearing, worldwide license, with the right to grant and authorize sublicenses, under the Licensed Patents and Technology to make, have made, use, import, offer for sale and sell Licensed Products, practice any method or procedure and otherwise exploit the Licensed Patents and Technology.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.2 These licenses are subject to&#58; (a) the reservation of Caltech&#8217;s right to make, have made, and use Licensed Products for noncommercial educational and research purposes, but not for sale or other distribution to third parties&#59; and (b) the rights of the U.S. Government under Title 35, United States Code, Section 200 et seq., including but not limited to the grant to the U.S. government of a nonexclusive, nontransferrable, irrevocable, paid-up license to practice or have practiced any invention conceived or first actually reduced to practice in the performance of work for or on behalf of the U.S. Government throughout the world. These licenses are not</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 4 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">transferable by Licensee except as provided in Section 16.4, but Licensee shall have the right to grant non-exclusive or exclusive sublicenses hereunder, provided that&#58;</font></div><div style="margin-top:9pt;text-indent:30.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a) License shall include all its sublicensing income in Licensee&#8217;s reports to Caltech, as provided in Section 9.2, and Licensee shall pay royalties thereon to Caltech pursuant to Section 4.2 and 4.4&#59;</font></div><div style="margin-top:9pt;text-indent:30.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b) Licensee shall furnish Caltech within thirty (30) days of the execution thereof, a true and complete copy of each sublicense and any changes or additions thereto&#59;</font></div><div style="margin-top:9pt;text-indent:30.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c) License may grant sublicenses of no greater scope than the license granted under Section 2.1&#59; and</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Each sublicense granted by Licensee shall include provisions similar in all material respects to those of Articles 6, 12, 15, 16 and Section 2.2.</font></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 3</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">IMPROVEMENTS</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.1 The parties acknowledge that Exhibit A includes all Improvements disclosed by Caltech to Licensee between May 1, 2000 and the Second Restatement Date, and elected by Licensee as of the Second Restatement Date. Caltech shall notify Licensee in writing of Improvements made after the Second Restatement Date and during the term of the Agreement. Upon receipt of an invention disclosure constituting an Improvement, Licensee can elect to add such Improvement and any related patent filings to Exhibit A hereof to be within the Licensed Patents. Thereafter, Licensee shall be responsible for patent prosecution and costs associated with such elected Improvement in accordance with Article 11 herein, as well as to issue additional stock pursuant to Section 5.3. No less than at each anniversary of the Second Restatement Date, Exhibit A shall be updated by the parties to reflect the inclusion of all Improvements so elected, as well as updates on all Licensed Patents.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 5 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 4</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ROYALTIES</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.1 With respect to Licensed Products manufactured or sold by Licensee in a country in which such manufacture or sale is covered by a Valid Claim of a Licensed Patent, Licensee agrees to pay Caltech &#91;***&#93; of Net Sales of such Licensed Products wherein the Licensed Products are instruments or apparatus directly used for the reading and&#47;or analysis of data from other Licensed Products, including microfluidic chips that are Licensed Products, and &#91;***&#93; of Net Sales of Licensed Products by Licensee for all such other Licensed Products, including microfluidic chips that are Licensed Products, Royalties due under this Section 4.1 shall be payable on a country-by-country and Licensed Product-by-Licensed Product basis until the expiration of the last-to-expire issued Valid Claim covering such Licensed Product in such country.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.2 With respect to Licensed Products manufactured or sold by Sublicensees in a country in which such manufacture or sale is covered by a Valid Claim of a Licensed Patent, Licensee agrees to pay Caltech &#91;***&#93; of the revenues received by Licensee from Sublicensees&#8217; Net Sales of such Licensed Products wherein the Licensed Products are instruments or apparatus directly used for the reading and&#47;or analysis of data from other Licensed Products, including microfluidic chips that are Licensed Products, and &#91;***&#93; of the revenues received by Licensee from Sublicensees&#8217; Net Sales of Licensed Products for all such other Licensed Products, including microfluidic chips that are Licensed Products. Royalties due under this Section 4.2 shall be payable on a country-by-country and Licensed Product-by-Licensed Product basis until the expiration of the last-to-expire issued Valid Claim covering such Licensed Product in such country.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.3 With respect to Licensed Products manufactured or sold by Licensee in a country in which such manufacture or sale is not covered by Valid Claim of a Licensed Patent but the Technology is utilized, Licensee agrees to pay Caltech &#91;***&#93; of Net Sales of such Licensed Products by Licensee, wherein the Licensed Products are instruments or</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 6 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">apparatus directly used for the reading and&#47;or analysis of data from other Licensed Products, including microfluidic chips that are Licensed Products, and &#91;***&#93; of Net Sales of Licensed Products by Licensee for all such other Licensed Products, including microfluidic chips that are Licensed Products. Royalties due under this Section 4.3 shall be payable on a country-by-country and Licensed Product-by-Licensed Product basis for a period of &#91;***&#93; years from the Effective Date or the issuance of a U.S. patent that covers the Licensed Product, whichever first occurs.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.4 With respect to Licensed Products manufactured or sold by Sublicensees in a country in which such manufacture or sale is not covered by a Valid Claim of a Licensed Patent but the Technology is utilized, Licensee agrees to pay Caltech &#91;***&#93; of the revenues received by Licensee from Sublicensees&#8217; Net Sales of such Licensed Products wherein the Licensed Products are instruments or apparatus directly used for the reading and&#47;or analysis of data from other Licensed Products, including microfluidic chips that are Licensed Products, and &#91;***&#93; of the revenues received by Licensee from Sublicensees&#8217; Net Sales of Licensed Products for all such other Licensed Products, including microfluidic chips that are Licensed Products. Royalties due under this Section 4.4 shall be payable on a country-by-country and Licensed Product-by-Licensed Product basis for a period of &#91;***&#93; years from the Effective Date or the issuance of a U.S. patent that covers the Licensed Product, whichever first occurs.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.5 Notwithstanding the above, it is understood and agreed that Caltech shall not be entitled to any share of amounts received by Licensee for equity, debt, pilot studies, to support research or development activities to be undertaken by Licensee, research and development or other performance based milestones, the achievement by Licensee or Sublicensee of specified milestones or benchmarks relating to the development of Licensed Products, the license or sublicense of any intellectual property other than the Licensed Patents, reimbursement for patent or other expenses, or with respect to products other than Licensed Products.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.6 In the event that a Licensed Product is sold in combination with one or more other products or other items that are not Licensed Products, Net Sales for such combination products will be reasonably calculated on a country-by-country and Licensed Product-by-Licensed</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 7 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Product basis by Licensee by multiplying the Net Sales of that combination by a fraction equal to the relative value of the combination attributable to the Licensed Product, in relation to the relative value of the combination, as reasonably determined by Licensee in good faith. In addition, in the event that a Licensed Product is not sold in combination with one or more other products or other items that are not Licensed Products, but instead comprises multiple components, some of which would constitute a Licensed Product if sold separately (each, a &#8220;Licensed Component&#8221;), and the others would not constitute a Licensed Product if sold separately, then Net Sales for such Licensed Product will be calculated by multiplying the Net Sales of such Licensed Product by the fraction A&#47;B, where A is the gross selling price of the Licensed Component sold separately and B is the gross selling price of such Licensed Product. If no such separate sales are made by Licensee, its Affiliate or Sublicensee, Net Sales for such Licensed Product shall be calculated by multiplying Net Sales of such Licensed Product by the fraction C&#47;(C+D), where C is the fully allocated cost of the Licensed Component and D is the fully allocated cost of the other components.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.7 Commencing on January 1, 2004, and continuing for each anniversary thereof during the term of this Agreement, if Licensee has not paid, during the preceding calendar year, a minimum of &#91;***&#93; in royalties under Sections 4.1, 4.2, 4.3, and 4.4, Licensee agrees to pay, on or before March 1 of that calendar year, an additional royalty for the prior calendar year equal to the difference between &#91;***&#93; and any lower amount paid under Sections 4.1, 4.2, 4.3, and 4.4 for the prior calendar year.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.8 In the event Licensee or Sublicensee becomes obligated to pay amounts to a third party with respect to a Licensed Product for patent rights of a third party, Licensee may deduct &#91;***&#93; of the amounts owing to such third party (prior to reductions) from the amount owing to Caltech for such Licensed Product&#59; provided, however, the amounts otherwise due to Caltech shall not be so reduced by more than &#91;***&#93;.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.9 For the purpose of determining royalties payable under this Agreement, any royalties or other revenues Licensee receives from Sublicensees in currencies other than U.S. dollars and any Net Sales denominated in currencies other than U.S. dollars shall be converted</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 8 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">into U.S. dollars according to Licensee&#8217;s reasonable standard internal conversion procedures, including Licensee&#8217;s standard internal rates and conversion schedule.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.10 No more than one royalty payment shall be due with respect to a sale of a particular Licensed Product. No multiple royalties shall be payable because any Licensed Product, or its manufacture, sale or use is covered by more than one Valid Claim in a given country. No royalty shall be payable under this Article 4 with respect to Licensed Products distributed for use in research and&#47;or development or as promotional samples or otherwise distributed without charge to third parties.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.11 Any sublicenses granted by Licensee, including, without limitation, any nonexclusive sublicenses, shall remain in effect in the event this license terminates pursuant to Article 12&#59; provided, the financial obligations of each Sublicensee to Caltech shall be limited to the amounts Licensee shall be obligated to pay Caltech for the activities of such Sublicensee pursuant to this Agreement.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.12 Royalties due under this Article 4 shall be payable on a country-by-country and Licensed Product-by-Licensed Product basis until the expiration of the last-to-expire issued Valid Claim covering such Licensed Product in such country, if the manufacture or sale of such Licensed Product was at the time of the first commercial sale in such country covered by a Valid Claim. Otherwise, royalties due under this Article 4 shall be payable on a country-by-country and Licensed Product-by-Licensed Product basis until &#91;***&#93; whichever first occurs.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.13 Notwithstanding the provisions of this Article 4, no royalty shall be payable to Caltech with respect to any sales of Licensed Products to the U.S. Government on sales made solely to permit the U.S. Government to practice or have practiced or have practiced or sue on its behalf any invention or process covered by the Licensed Patents.</font></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 5</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">LICENSEE EQUITY INTEREST</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.1 In accordance with the License Agreement of May 1, 2000, Licensee issued to Caltech, in consideration of Licensee&#8217;s receipt of the intangible property rights granted under</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 9 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">that License Agreement (which rights are carried forward herein), &#91;***&#93; shares of common stock of Licensee, pursuant to the terms of a reasonable and customary stock issuance agreement. Further, it is acknowledged that, as partial consideration for entering into the first Amended and Restated License Agreement of June 1, 2002, with the reformation of the initial License Agreement of May 1, 2000 and the associated restatements and amendments (including, but not limited to, an updated Exhibit A), Licensee issued to Caltech &#91;***&#93; shares of common stock of Licensee.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.2 Caltech agrees that, in the event of any underwritten or public offering of securities of Licensee or a Affiliate, Caltech shall comply with and agree to any reasonable restriction on the transfer of equity interest, or any part thereof, imposed by an underwriter, and shall perform all acts and sign all necessary documents required with respect thereto.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.3 If Licensee wishes at its sole discretion to license hereunder any Improvements disclosed by Caltech to Licensee during a twelve (12) month period beginning with June 1, 2003, and for each anniversary thereafter (each twelve month period will be referred to as an &#8220;Improvement Period&#8221;), Licensee shall notify Caltech in writing accordingly within thirty (30) days after the end of each Improvement Period. For the first two (2) Improvement Periods, Licensee agrees to issue to Caltech, in consideration of Licensee&#8217;s election to receive additional intangible property rights to all Improvements disclosed to Licensee during an Improvement Period, &#91;***&#93; shares of common stock of Licensee, pursuant to the terms of a reasonable and customary stock issuance agreement. Thereafter, Licensee is hereby granted an option by Caltech that Licensee can exercise during the final year of the first two (2) Improvement Period on an annual basis on the same terms and conditions. The consideration of this option was partially paid by the &#91;***&#93; shares granted by Licensee to Caltech as referenced in Section 5.1 of this Agreement. Further, it is acknowledged that pursuant to the initial License Agreement of May 1, 2000 and the first Amended and Restated License Agreement of June 1, 2002, Licensee elected to receive additional intangible property rights to Improvements disclosed to Licensee by Caltech during May 1, 2000 through May 31, 2003, in consideration of the issuance to Caltech by Licensee of &#91;***&#93; shares of common stock of Licensee (which represents the &#91;***&#93; share grant under Section 5.1 above and &#91;***&#93; shares pursuant to the parties&#8217;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 10 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Letter Agreement dated June 19, 2003, paragraph #3), receipt of which shares Caltech hereby acknowledges.</font></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 6</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DUE DILIGENCE</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.1 Licensee agrees to use commercially reasonable efforts to introduce commercial Licensed Product(s) as soon as practical, consistent with sound and reasonable business practices and judgments. Licensee shall be deemed to have satisfied its obligations under this Section if Licensee has an ongoing and active research program or marketing program, as appropriate, directed toward production and use of one or more Licensed Products. Any efforts of Licensee&#8217;s Sublicensees shall be considered efforts of Licensee for the sole purpose of determining Licensee&#8217;s compliance with its obligation under this Section.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.2 After the first year from the Effective Date, Caltech shall have the right, no more often than once each year, to require Licensee to report to Caltech in writing on its progress in introducing commercial Licensed Product(s) in the United States.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.3 If Licensee is not fulfilling its obligations under Section 6.1 with respect to the Field and Caltech so notifies Licensee in writing, Caltech and Licensee shall negotiate in good faith any additional efforts to be taken by Licensee. If the parties do not reach agreement within ninety (90) days, the parties shall submit the issue to arbitration as provided in Article 14 to determine whether any additional efforts shall be required of Licensee. If subsequent to the conclusion of such arbitration proceedings Licensee then fails to make any required efforts, and does not remedy that failure within sixty (60) days after further written notice to Licensee, Caltech may convert the license granted in Section 2.1 to a nonexclusive license in any part of the Field in which Licensee is not fulfilling its obligations under Section 6.1, and the royalties payable under this Agreement shall be reduced by &#91;***&#93; for Licensed Products in the Field sold under such a nonexclusive license.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 11 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 7</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">INFRINGEMENT BY THIRD PARTY</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.1 Both Caltech and Licensee agree to notify the other in writing should either party become aware of infringement of the Licensed Patents. Licensee, upon notice to Caltech, shall have the sole right to initiate an action against the infringer at Licensee&#8217;s expense, either in Licensee&#8217;s name or in Caltech&#8217;s name if so required by law, Licensee shall have sole control of the action.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.2 If Licensee, its Affiliate or Sublicensee, distributor or other customer is sued by a third party charging infringement of patent rights that dominate a claim of the Licensed Patents or that cover the development, manufacture, use, distribution or sale of a Licensed Product, Licensee will promptly notify Caltech. As between the parties to this Agreement, Licensee shall have sole control of the defense in any such action(s).</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.3 If a declaratory judgment action alleging invalidity unenforceability or noninfringement of any of the Licensed Patents is brought against Licensee and&#47;or Caltech, Licensee may elect to have sole control of the action, and if Licensee so elects it shall bear all the costs of the action. Licensee also may elect to undertake and have sole control of the defense of any interference, opposition or similar action with respect to the Licensed Patents providing it bears all the costs of such action.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.4 In the event Licensee institutes a legal action pursuant to Section 7.1, within thirty (30) days after receipt of notice of Licensee&#8217;s intent to institute such legal action, Caltech shall have the right to jointly prosecute such action and to fund up to one-half (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) the costs of such action. Caltech shall fully cooperate with and supply all assistance reasonably requested by Licensee, including by using commercially reasonable efforts to have its employees testify when requested and to make available relevant records, papers, information, samples, specimens, and the like. Licensee shall bear the reasonable expenses incurred by Caltech in providing such assistance and cooperation as is requested pursuant to this Section 7.4. Licensee shall keep Caltech reasonably informed of the progress of the legal action, and Caltech shall be entitled to be represented by counsel in connection with such legal action at its own expense. Licensee&#8217;s</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 12 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">reasonable and customary expenses for such action (including attorneys&#8217; fees and expert fees) shall be fully creditable against royalties owed to Caltech hereunder, provided that in no one year shall such expenses to be credited against more than &#91;***&#93; of royalty payments to Caltech. Any remaining expenses may be carried over and credited against royalties owed in future years.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.5 Licensee shall have the light to settle any claims, but only upon terms and conditions that are reasonably acceptable to Caltech. Should Licensee elect to abandon such an action other than pursuant to a settlement with the alleged infringer that is reasonably acceptable to Caltech, Licensee shall give timely notice to Caltech who, if it so desires, may continue the action&#59; provided, however, that the sharing of expenses and any recovery in such suit shall be as agreed upon between the parties.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.6 Any amounts paid to Licensee by third parties as the result of an action pursuant to this Article 7 (such as in satisfaction of a judgment or pursuant to a settlement) shall first be applied to reimbursement of the unreimbursed expenses (including attorneys&#8217; fees and expert fees) incurred by Licensee and then to the payment to Caltech of any royalties against which were credited expenses of the action in accordance with Section 7.4. Any remainder shall be divided between the parties as follows&#58;</font></div><div style="margin-top:9pt;text-indent:30.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a) To the extent the amount recovered reflects lost profits, Licensee shall retain the remainder, less the amount of any royalties that would have been due Caltech on sales of Licensed Product lost by Licensee as a result of the infringement had Licensee made such sales, provided that (i) Licensee shall in any event retain at least &#91;***&#93; of the remainder&#59; and (ii) Caltech shall receive an amount equal to the royalties it would have received if such sales had been made by Licensee, provided such amount shall in no event exceed &#91;***&#93; of the remainder&#59; or</font></div><div style="margin-top:9pt;text-indent:30.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b) To the extent the amount recovered does not reflect lost profits, such amount shall be shared by Caltech and Licensee pro rata according to the respective percentages of costs borne by each in such action&#59; provided, however, that in no event shall Caltech receive less than twenty-five percent (25%) of such amount.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 13 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 8</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">BENEFITS OF LITIGATION,</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EXPIRATION OR ABANDONMENT</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.1 In a case where one or more patents or particular claims thereof within the Licensed Patents expire, or are abandoned, or are declared invalid or unenforceable or otherwise construed by a court of last resort or by a lower court from whose decree no appeal is taken, or certiorari is not granted within the period allowed therefor, then the effect thereof hereunder shall be&#58;</font></div><div style="margin-top:9pt;text-indent:30.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a) that such patents or particular claims shall, as of the date of expiration or abandonment or final decision as the case may be, cease to be included within the Licensed Patents for the purpose of this Agreement&#59;</font></div><div style="margin-top:9pt;text-indent:30.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b) that such construction so placed upon the Licensed Patents by the court shall be followed from and after the date of entry of the decision, and royalties shall thereafter be payable by Licensee only in accordance with such construction&#59; and</font></div><div style="margin-top:9pt;text-indent:30.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c) In the event that Licensee challenges the validity of Licensed Patents, Licensee may not cease paying royalties as of the date validity of the claims in issue are challenged, but rather may cease paying royalties as to those claims only after a final adjudication of invalidity of those claims.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.2 In the event that any of the contingencies provided for in Section 8.1 occurs, Caltech agrees to renegotiate in good faith with Licensee a reasonable royalty rate under the remaining Licensed Patents which are unexpired and in effect and under which Licensee desires to retain a License.</font></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 9</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">RECORDS, REPORTS AND PAYMENTS</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.1 Licensee shall keep records and books of account in respect of all Licensed Products made and sold by Licensee or its Affiliates under this Agreement and of royalties or other revenues Licensee receives from Sublicensees other than Licensee&#8217;s Affiliates for the sale</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 14 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">of Licensed Products. Caltech shall have the right at its own cost, during Licensee&#8217;s business hours, no more often than annually, to have an independent certified public accounting firm of nationally recognized standing to examine such records and books. Licensee shall keep the same for at least three (3) years after it pays Caltech the royalties due for such Licensed Products and require Licensee&#8217;s Affiliates to do the same. The accounting firm shall disclose to Caltech only whether or not the reports are correct and the amount of any discrepancies. Caltech shall, and shall cause its accounting firm to, not disclose to any third party any confidential information learned through an examination of such records and books.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.2 Following the first commercial sale of a Licensed Product, on or before the last day of each February, May, August and November for so long as royalties are payable under this Agreement, Licensee shall render to Caltech a report in writing, setting forth Net Sales and the number of units of Licensed Products sold during the preceding calendar quarter by Licensee and its Affiliates, and the royalties or other revenues received by Licensee from Net Sales of Licensed Products made by Licensee&#8217;s Sublicensees other than Affiliates during the preceding calendar quarter. Each such report shall also set forth an explanation of the calculation of the royalties payable hereunder and be accompanied by payment of the royalties shown by said report to be due Caltech. Notwithstanding foregoing, if (i) Caltech materially breaches this Agreement, (ii) Licensee gives Caltech written notice of the breach, and (iii) Caltech has not cured the breach by the time a payment is due under this Section, then Licensee may make the required payment into an interest bearing escrow account to be released when the breach is cured, less any damages that may be payable to License by virtue or Caltech&#8217;s breach. Royalty reports which are not challenged by Caltech or amended by Licensee within thirty-six (36) months after receipt by Caltech shall be conclusively presumed correct and not subject to challenge, audit, or amendment.</font></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 10</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CONFIDENTIALITY</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.1 Except as provided herein, each party shall maintain in confidence, and shall not use for any purpose or disclose to any third party, information disclosed by the other party in writing and marked &#8220;Confidential&#8221; or that is disclosed orally and confirmed in writing as</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 15 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">confidential within forty-five (45) days following such disclosure (collectively, &#8220;Confidential Information&#8221;). Confidential Information shall not include any information that is&#59; (i) already known to the receiving party at the time of disclosure hereunder, (ii) now or hereafter becomes publicly known other than through acts or omissions of the receiving party, (iii) disclosed to the receiving party by a third party under no obligation of confidentiality to the disclosing party, (iv) disclosed as required by securities or other applicable laws or pursuant to legal requirement, or (v) disclosed to actual or prospective investors or corporate partners, or to a party&#8217;s accountants, attorneys, and other professional advisors. All reports provided to Caltech by Licensee pursuant to this Agreement shall be treated as confidential information of Licensee, pursuant to this Section 10.1. The terms of this Agreement shall be treated as confidential information of Licensee, pursuant to this Section 10.1.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.2 Notwithstanding the provisions of Section 10.1 above, Licensee may use or disclose confidential information comprising the Licensed Patents and Technology to the extent necessary to exercise its rights hereunder (including commercialization and&#47;or sublicensing of the Licensed Patents and Technology) or fulfill its obligations and&#47;or duties hereunder and in filing for, prosecuting or maintaining any proprietary rights, prosecuting or defending litigation, complying with applicable governmental regulations and&#47;or submitting information to tax or other governmental authorities.</font></div><div style="margin-top:13.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 11</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PATENT PROSECUTION AND PATENT COSTS</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.1 Licensee shall have the right to apply for, prosecute and maintain during the term of this Agreement, the Licensed Patents. Caltech shall provide Licensee with timely disclosures regarding Improvements and potential Improvements. The application filings, prosecution, maintenance and payment of all fees and expenses, including legal fees, relating to such Licensed Patents shall be the responsibility of Licensee, provided that Licensee shall pay for all reasonable fees and expenses, including reasonable legal fees, incurred in such application filings, prosecution and maintenance. Caltech shall provide Licensee with all information necessary or useful for the filing and prosecution of such Licensed Patents and shall cooperate fully with Licensee so that Licensee may establish and maintain such rights. Patent attorneys</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 16 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">chosen by Licensee shall handle all patent filings and prosecutions, on behalf of Caltech, provided, however, Caltech shall be entitled to review and comment upon and approve all actions undertaken in the prosecution of all patents and applications. Caltech shall provide any comments or approvals hereunder promptly.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.2 In the event Licensee declines to apply for, prosecute or maintain any Licensed Patents, Caltech shall have the right to pursue the same at Caltech&#8217;s expense and Licensee shall have no rights under Caltech&#8217;s interest therein. If Licensee decides not to apply for, prosecute or maintain any Licensed Patents, Licensee shall give sufficient and timely notice to Caltech so as to permit Caltech to apply for, prosecute and maintain such Licensed Patents. In such event, Licensee shall provide Caltech with all information necessary or useful for the filing and prosecution of such Licensed Patents and shall cooperate fully with Caltech so that Caltech may establish and maintain such rights.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.3 Licensee shall reimburse Caltech for all reasonable out-of-pocket expenses incurred by Caltech for the filing for, prosecution and maintenance of the Licensed Patents Rights. Such expenses shall be reimbursed following receipt by Licensee from Caltech of (i) an invoice covering such fees (including copies of invoices for legal fees describing the legal services performed in reasonable detail) and (ii) reasonably satisfactory evidence that such fees were paid. Initially, payments shall be made in six (6) equal quarterly installments due within ten days after the end of the first six (6) full calendar quarters, effective twenty-four (24) months from the Effective Date of this Agreement. Subsequent payments under this Section 11.3 shall be made to Caltech within sixty (60) days following receipt by Licensee from Caltech of (i) an invoice covering such fees (including copies of invoices for legal fees describing the legal services performed in reasonable detail) and (ii) reasonably satisfactory evidence that such fees were paid. If Licensee elects to no longer pay the expenses of a patent or patent application within the Licensed Patents in any country, Licensee shall notify Caltech not less than thirty (30) days prior to such action. In the event that Licensee elects not to pay such expenses the license granted to Licensee hereunder shall terminate. &#91;***&#93; of patent expenses paid by Licensee in conjunction with foreign patent costs shall be creditable against earned royalties due Caltech in the respective territory covered by the patent or patents that are foreign filed.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 17 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 12</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">TERMINATION</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.1 The term of this Agreement shall commence upon the Effective Date and shall terminate on a country-by-country and Licensed Product by Licensed Product basis upon the expiration of the last to expire Licensed Patent in such country. Caltech shall have the right to terminate this Agreement, subsequent to and subject to the outcome of arbitration proceedings pursuant to Article 14, prior to the date it would otherwise expire pursuant to this Section 12.1 if Licensee fails to make any payment due hereunder and Licensee continues to fail to make the payment, either to Caltech directly or by placing any disputed amount into an interest bearing escrow account to be released when the dispute is resolved, for a period of sixty (60) days after receiving written notice from Caltech specifying Licensee&#8217;s failure. If this Agreement expires pursuant to the first sentence of this Section 12.1, Licensee shall retain a nonexclusive, perpetual, royalty-free, worldwide license, with the right to sublicense, under the Licensed Patents and Technology, to research, develop, make, use, sell, offer for sale and import Licensed Products.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.2 If either party materially breaches this Agreement, the other party may elect to give the bleaching party written notice describing the alleged breach. If the breaching party has not cured such breach within sixty (60) days after receipt of such notice, the notifying party will be entitled, in addition to any other rights it may have under this Agreement, to terminate this Agreement effective immediately&#59; provided, however, that if either party receives notification from the other of a material breach and if the party alleged to be in default notifies the other party in writing within thirty (30) days of receipt of such default notice that it disputes the asserted default, the matter will be submitted to arbitration as provided in Article 14 of this Agreement. In such event, the nonbreaching party shall not have the right to terminate this Agreement until it has been determined in such arbitration proceeding that the other party materially breached this Agreement, and the breaching party fails to cure such breach within ninety (90) days after the conclusion of such arbitration proceeding.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.3 Licensee shall have the right to terminate this Agreement either in its entirety or as to any jurisdiction or any part of the Licensed Patents or Technology upon thirty (30) days</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 18 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">written notice. If Licensee does so, it shall submit all required reports and make all required payments in accordance with Section 9.2</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.4 In the event of any termination or expiration of the term of this Agreement, Licensee shall have the right to use or sell Licensed Products on hand on the date of such termination or expiration and to complete Licensed Products in the process of manufacture at the time of such termination or expiration and use or sell the same, provided that Licensee shall submit the applicable royalty report described in Section 9.2, along with the royalty payments required above in accordance with Section 4.1 for sale of such Licensed Products, provided that the Licensed Products are still covered by a Valid Claim following such termination or expiration.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.5 Termination of this Agreement for any reason shall not release any party hereto from any liability which, at the time of such termination, has already accrued to the other party or which is attributable to a period prior to such termination, nor preclude either party from pursuing any rights and remedies it may have hereunder or at law or in equity which accrued or are based upon any event occurring prior to such termination.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.6 Section 5.2 and Articles 10, 12, 14, and 16 of this Agreement shall survive termination of this Agreement for any reason.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.7 If Licensee is acquired by or merges into a third party (i.e., Licensee is not a surviving company in the merger), then Caltech may terminate its obligations to disclose and grant licenses to Improvements by providing notice to Licensee of that termination. The remainder of the Agreement and the licenses granted hereunder (including prior licenses granted to Improvements) continues.</font></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 13</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WARRANTIES AND NEGATION OF</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WARRANTIES, IMPLIED LICENSES AND AGENCY</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.1 Caltech represents and warrants that (i) it owns all right, title and interest in and to the Licensed Patents and Technology, (ii) it has the right to enter into this Agreement, (iii) it has not granted and will not grant during the term of this Agreement rights in or to any Licensed</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 19 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Patents or Technology that are inconsistent with the rights granted to Licensee herein, (iv) to Caltech&#8217;s knowledge, there are no claims of third parties that would call into question the rights of Caltech to grant to Licensee the rights contemplated hereunder&#59; (v) to Caltech&#8217;s knowledge, practice of the Licensed Patents will not infringe intellectual property rights of third parties&#59; (vi) except for the Licensed Patents, as of the effective date of the Agreement, to Caltech&#8217;s belief and knowledge, Caltech does not own or control any patents or patent applications that would dominate any practice of the Licensed Patents or Technology, and (vii) there are no threatened or pending actions, suits, investigations, claims, or proceedings in any way relating to the Licensed Patents or Technology.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.2 Nothing in this Agreement shall be construed as&#58;</font></div><div style="margin-top:9pt;text-indent:30.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a) a representation or warranty of Caltech as to the validity or scope of Licensed Patents or any claim thereof&#59; or</font></div><div style="margin-top:9pt;text-indent:30.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b) an obligation to bring or prosecute actions or suits against third parties for infringement.</font></div><div style="margin-top:9pt;text-indent:30.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c) conferring by implication, estoppel or otherwise, any license or rights under any existing patents of Caltech other than Licensed Patents, regardless of whether such other patents are dominant or subordinate to Licensed Patents. Notwithstanding the foregoing, and to the extent legally permissible, Caltech hereby grants Licensee a right of first refusal as to such dominant or subordinate patents, providing that a Caltech faculty member does not wish to personally commercialize the technology embodied in such patents.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.3 CALTECH MAKES NO EXPRESS OR IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, AND ASSUMES NO RESPONSIBILITIES WHATEVER WITH RESPECT TO THE USE, SALE, OR OTHER DISPOSITION BY LICENSEE OF LICENSED PRODUCT(S).</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.4 Caltech shall indemnify, defend and hold harmless Licensee from and against any and all losses, damages, costs and expenses (including attorneys&#8217; fees) arising out of a material breach by Caltech of its representations and warranties (&#8220;Claims&#8221;), provided that (i) Caltech is notified promptly of any Claims, (ii) Licensee has the sole right to control and defend or settle</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 20 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any litigation within the scope of this indemnity, and (iii) all indemnified parties cooperate to the extent necessary in the defense of any Claims.</font></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 14</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARBITRATION</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.1 Any dispute under this Agreement which is not settled by mutual consent shall be finally settled by binding arbitration, conducted in accordance with the Commercial Arbitration Rules of the American Arbitration Association by one (1) independent, neutral arbitrator appointed in accordance with said rules. The arbitration shall be held in San Francisco, California. The arbitrators shall determine what discovery shall be permitted, consistent with the goal of limiting the cost and time that the parties must expend for discovery&#59; provided the arbitrators shall permit such discovery as they deem necessary to permit an equitable resolution of the dispute. Any written evidence originally in a language other than English shall be submitted in English translation accompanied by the original or a true copy thereof. Except as otherwise expressly provided in this Agreement, the costs of the arbitration, including administrative and arbitrator(s)&#8217; fees, shall be shared equally by the parties and each party shall bear its own costs and attorneys&#8217; and witness&#8217; fees incurred in connection with the arbitration. A disputed performance or suspended performances pending the resolution of the arbitration must be completed within a reasonable time period following the final decision of the arbitrator(s). Any arbitration subject to this Article shall be completed within one (1) year from the filing of notice of a request for such arbitration. The arbitration proceedings and the decision shall not be made public without the joint consent of the parties and each party shall maintain the confidentiality of such proceedings and decision unless otherwise permitted by the other party. Any decision which requires a monetary payment shall require such payment to be payable in United States dollars, free of any tax or other deduction. The parties agree that the decision shall be the sole, exclusive and binding remedy between them regarding any and all disputes, controversies, claims and counterclaims presented to the arbitrators. Any award may be entered in a court of competent jurisdiction for a judicial recognition of the decision and an order of enforcement.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 21 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 15</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PRODUCT LIABILITY</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.1 Licensee agrees that Caltech shall have no liability to Licensee or to any purchasers or users of Licensed Products made or sold by Licensee for any claims, demands, losses, costs, or damages suffered by Licensee, or purchasers or users of such Licensed Products, or any other party, which may result from personal injury, death, or property damage related to the manufacture, use, or sale of such Licensed Products (&#8220;Product Claims&#8221;). Licensee agrees to defend, indemnify, and hold harmless Caltech, its trustees, officers, agents, and employees from any such Product Claims, provided that (i) Licensee is notified promptly of any Product Claims, (ii) Licensee has the sole right to control and defend or settle any litigation within the scope of this indemnity, (iii) all indemnified parties cooperate in the defense of any Product Claims, and (iv) the Product Claims do not involve or relate to a material breach by Caltech of its representations and warranties.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.2 At such time as Licensee begins to sell or distribute Licensed Products (other than for the purpose of obtaining regulatory approvals), Licensee shall at its sole expense, procure and maintain policies of comprehensive general liability insurance in amounts not less than &#91;***&#93; in annual aggregate and naming those indemnified under Section 15.1 as additional insureds. Such comprehensive general liability insurance shall provide (i) product liability coverage and (ii) broad form contractual liability coverage for Licensee&#8217;s indemnification under Section 15.1. In the event the aforesaid product liability coverage does not provide for occurrence liability, Licensee shall maintain such comprehensive general liability insurance for a reasonable period of not less than five (5) years after it has ceased commercial distribution or use of any Licensed Product.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.3 Licensee shall provide Caltech with written evidence of Such insurance upon request of Caltech. Licensee shall provide Caltech with notice at least fifteen (15) days prior to any cancellation, non-renewal or material change in such insurance, to the extent Licensee receives advance notice of such matters from its insurer. If Licensee does not obtain replacement insurance providing comparable coverage within ninety (90) days following the date of such cancellation, non-renewal or material change, Caltech shall have the right to terminate this</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 22 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Agreement effective at the end of such ninety (90) day period without any additional waiting period&#59; provided that if Licensee uses reasonable efforts but is unable to obtain the required insurance at commercially reasonable rates, Caltech shall not have the right to terminate this Agreement, and Caltech instead shall cooperate with Licensee to either grant a waiver of Licensee&#8217;s obligations under this Article or assist Licensee in identifying a carrier to provide such insurance or in developing a program for self-insurance or other alternative measures.</font></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE 16</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">MISCELLANEOUS</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.1 Licensee agrees that it shall not use the name of Caltech, or California Institute of Technology, in any advertising or publicity material, or make any form of representation or statement which would constitute an express or implied endorsement by Caltech of any Licensed Product, and that it shall not authorize others to do so, without first having obtained written approval from Caltech, except as may be required by governmental law, rule or regulation.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.2 Licensee agrees to mark the appropriate U.S. patent number or numbers on all Licensed Products made or sold in the United States in accordance with all applicable governmental laws, rules and regulations, and to require its Sublicensees to do the same.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.3 This Agreement sets forth the complete agreement of the parties concerning the subject matter hereof. No claimed oral agreement in respect thereto shall be considered as any part hereof. No waiver of or change in any of the terms hereof subsequent to the execution hereof claimed to have been made by any representative of either party shall have any force or effect unless in writing, signed by duly authorized representatives of the parties.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.4 This Agreement shall be binding upon and inure to the benefit of any successor or assignee of Caltech. This Agreement is not assignable by Licensee without the prior written consent of Caltech, except that Licensee may assign this Agreement without the prior written consent of Caltech, to any Affiliate, or in connection with the sale or transfer of all or substantially all the assets of Licensee relating to the Licensed Products or services utilizing the methods within the Licensed Patents. Any permitted assignee shall succeed to all of the rights and obligations of Licensee under this Agreement.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 23 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.5 This Agreement is subject in all respects to the laws and regulations of the United States of America, including the Export Administration Act of 1979, as amended, and any regulations thereunder.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.6 This Agreement shall be deemed to have been entered into in California and shall be construed and enforced in accordance with California law.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.7 Any notice or communication required or permitted to be given or made under this Agreement shall be addressed as follows&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.955%"><tr><td style="width:1.0%"></td><td style="width:8.982%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.827%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Caltech&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Office of Technology Transfer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">California Institute of Technology</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">1200 East California Boulevard (MC 210-85)</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Pasadena, CA 91125</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Fax No.&#58; (626) 356-2486</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Licensee&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Fluidigm Corporation</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">7100 Shoreline Court</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">South San Francisco, CA 94080</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Attn&#58; President</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Fax No&#58; (650) 871-7195</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Phone&#58; (650) 266-6000</font></td></tr></table></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Either party may notify the other in writing of a change of address or fax number, in which event any subsequent communication relative to this Agreement shall be sent to the last said notified address or number, provided, however, that the parties shall deliver all material notices under this Agreement by registered mail or overnight delivery service. All notices and communications relating to this Agreement shall be deemed to have been given when received.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.8 Nothing in this Agreement will impair Licensee&#8217;s right to independently acquire, license, develop for itself, or have others develop for it, intellectual property and technology performing similar functions as the Licensed Patents and Technology or to market and distribute products other than Licensed Products based on such other intellectual property and technology.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.9 NEITHER PARTY SHALL BE LIABLE TO THE OTHER FOR ANY SPECIAL, CONSEQUENTIAL, INCIDENTAL, OR INDIRECT DAMAGES ARISING OUT OF THIS AGREEMENT, HOWEVER CAUSED, UNDER ANY THEORY OF LIABILITY.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 24 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.10 The relationship of Licensee and Caltech established by this Agreement is that of independent contractors, Nothing in this Agreement shall be construed to create any other relationship between Licensee and Caltech. Neither party shall have any right, power or authority to assume, create or incur any expense, liability or obligation, express or implied, on behalf of the other.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.11 Licensee agrees that a Licensed Product which embodies a patented invention or is produced through the use thereof for sale in the United States shall be manufactured substantially in the United States to the extent required by 35 U.S.C. Section 204.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.12 Neither party shall lose any rights hereunder or be liable to the other party for damages or losses (except for payment obligations) on account of failure of performance by the defaulting party if the failure is occasioned by war, strike, fire, Act of God, earthquake, flood, lockout, embargo, governmental acts or orders or restrictions, failure of suppliers, or any other reason where failure to perform is beyond reasonable control and not caused by the negligence or intentional conduct or misconduct of the nonperforming party, and such party has exerted all reasonable efforts to avoid or remedy such force majeure&#59; provided, however, that in no event shall a party be required to settle any labor dispute or disturbance.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.13 In the event that any provisions of this Agreement are determined to be invalid or unenforceable by a court of competent jurisdiction, the remainder of the Agreement shall remain in full force and effect without said provision. The parties shall in good faith negotiate a substitute clause for any provision declared invalid or unenforceable, which shall most nearly approximate the intent of the parties in entering this Agreement.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.14 This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.15 The headings of the several Sections are inserted for convenience of reference only and are not intended to be a part of or to affect the meaning or interpretation of this Agreement.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 25 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.16 Whenever provision is made in this Agreement for either party to secure the consent or approval of the other, that consent or approval shall not unreasonably be withheld or delayed, and whenever in this Agreement provisions are made for one party to object to or disapprove a matter, such objection or disapproval shall not unreasonably be exercised.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the parties have caused this Agreement to be executed&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:44.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.290%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.762%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.290%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.470%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Date&#58; 4&#47;29&#47;04</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">CALIFORNIA INSTITUTE OF TECHNOLOGY</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(Caltech)</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#47;s&#47; Lawrence Gilbert</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Lawrence Gilbert</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Senior Director</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Office of Technology Transfer</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Date&#58; April 28, 2004</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">FLUIDIGM CORPORATION</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(Licensee)</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#47;s&#47; Gajus Worthington</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Gajus Worthington</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">President and CEO</font></td></tr></table></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 26 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit A</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Licensed Patents</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:49.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.760%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.960%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Date&#58; April 22, 2004</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Confidential</font></td></tr></table></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 27 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit A</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Licensed Patents</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 28 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit A</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Licensed Patents</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 29 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit A</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Licensed Patents</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 30 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit A</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Licensed Patents</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 31 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit A</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Licensed Patents</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 32 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit A</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Licensed Patents</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 33 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit A</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Licensed Patents</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 34 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit A</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Licensed Patents</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 35 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit A</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Licensed Patents</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#91;***&#93;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 36 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit A</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Licensed Patents</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#91;***&#93;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 37 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit A</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Licensed Patents</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#91;***&#93;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 38 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit A</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Licensed Patents</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#91;***&#93;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 39 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit A</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Licensed Patents</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#91;***&#93;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 40 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit A</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Licensed Patents</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#91;***&#93;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 41 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit A</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Licensed Patents</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#91;***&#93;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 42 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit A</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Licensed Patents</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#91;***&#93;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 43 -</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit A</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Licensed Patents</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#91;***&#93;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 44 -</font></div><div><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2A
<SEQUENCE>4
<FILENAME>exhibit102a10q3q2020.htm
<DESCRIPTION>EX-10.2A
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="icc7d8f4035014e5bb44e4ad48904c336_1"></div><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit&#160;10.2A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">&#160;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">2020.LICI.001.C</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">California&#160;Institute&#160;of Technology</font></div></td></tr></table></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ADDENDUM TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECOND AMENDED AND RESTATED LICENSE AGREEMENT</font></div><div style="margin-top:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">THIS ADDENDUM TO SECOND AMENDED AND RESTATED LICENSE AGREEMENT (this &#8220;Addendum&#8221;) dated as of March&#160;29, 2007 (the &#8220;Addendum Date&#8221;), is entered into between CALIFORNIA INSTITUTE OF TECHNOLOGY (&#8220;Caltech&#8221;), having an address at 1200 East California Boulevard, Pasadena, California 91125, and FLUIDIGM CORPORATION (&#8220;Licensee&#8221;), having a principal place of business at 7100 Shoreline Court, South San Francisco, California 94080, with respect to the following facts&#58;</font></div><div style="margin-top:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A. &#160;&#160;&#160;&#160;The parties entered into the Second Amended and Restated License Agreement (the &#8220;Agreement&#8221;) effective May&#160;1, 2000, with a second restatement date as of May&#160;1, 2004. All terms used, but not defined herein, shall have the respective meanings set forth in the Agreement.</font></div><div style="margin-top:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">B.&#160;&#160;&#160;&#160;&#160;On the terms and conditions of this Addendum, the parties desire to clarify and modify certain provisions to the Agreement.</font></div><div style="margin-top:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">NOW, THEREFORE, in consideration of the foregoing premises and the mutual covenants set forth below, the parties agree as follows&#58;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Licensed Patents and Improvements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1 &#160;&#160;&#160;&#160;The Agreement is amended by deleting Exhibit&#160;A to the Agreement and by replacing it with Exhibit&#160;A to this Addendum.</font></div><div style="margin-top:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.2 &#160;&#160;&#160;&#160;Caltech represents that it has disclosed to Licensee all Improvements arising prior to the Addendum Date.</font></div><div style="margin-top:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.3 &#160;&#160;&#160;&#160;The parties acknowledge that Exhibit&#160;A to this Addendum includes (a)&#160;all Improvements disclosed by Caltech to Licensee prior to the Addendum Date, and elected by Licensee to be included in the scope of the license grant by Caltech to Licensee under the Agreement, and (b)&#160;all updates on all Licensed Patents as of the Addendum Date. Caltech confirms that Licensee has taken all action on its part that is necessary for all subject matter included in Exhibit&#160;A to this Addendum to be included in the scope of the license grant by Caltech to Licensee under the Agreement.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Licensee Equity Interest and Improvement Periods</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1 &#160;&#160;&#160;&#160;Notwithstanding anything to the contrary in Article&#160;5 of the Agreement, the Improvement Periods shall be those periods from June&#160;1, 2003 through May&#160;31, 2004, from June&#160;1, 2004 through May&#160;31, 2005, from &#91;***&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="margin-top:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.2 &#160;&#160;&#160;&#160;Notwithstanding anything to the contrary in Article&#160;5 of the Agreement, (a)&#160;Licensee shall issue to Caltech &#91;***&#93; &#91;***&#93; shares of common stock of Licensee, pursuant to the terms of a reasonable and customary stock issuance agreement, and (b)&#160;the parties acknowledge that the issuance of such shares (in addition to the shares issued by Licensee to Caltech prior to the Second Restatement Date) shall be in full satisfaction of Licensee&#8217;s obligations to issue shares or otherwise make payments to Caltech pursuant to the Agreement.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Royalty Reports</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The parties acknowledge (a)&#160;that the royalty reports received by Caltech under Section&#160;9.2 of the Agreement prior to the Addendum Date are presumed correct and not subject to challenge, audit or amendment, and (b)&#160;that the format of, and the methodology used by Licensee in preparing, the royalty reports under Section&#160;9.2 of the Agreement are mutually acceptable and in compliance with the terms and conditions of the Agreement.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Patent Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding anything to the contrary in Article&#160;11 of the Agreement, Licensee shall have no obligation to reimburse Caltech for any costs or expenses incurred by Caltech in connection with the Licensed Patents that have not been reimbursed by Licensee prior to the Addendum Date.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Further Assurances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:9pt;text-indent:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Each party shall take such further actions, and execute such further documents and instruments, as reasonably requested by the other party to effectuate the grant of licenses and rights from Caltech to Licensee under the Agreement and otherwise to enable Licensee to enjoy the full benefit thereof.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.1 &#160;&#160;&#160;&#160;This Addendum shall be effective for all purposes as of the Addendum Date. Except as otherwise expressly modified by this Addendum, the Agreement shall remain in full force and effect in accordance with its terms.</font></div><div style="margin-top:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.2 &#160;&#160;&#160;&#160;This Addendum shall be governed by, interpreted and construed in accordance with the laws of the State of California, without regard to conflicts of law principles.</font></div><div style="margin-top:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.3 &#160;&#160;&#160;&#160;This Addendum may be executed in counterparts, each of which shall be deemed to be an original and together shall be deemed to be one and the same document.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div style="text-indent:30.6pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-indent:30.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the parties have caused this Addendum to be duly executed and delivered effective as of the Addendum Date.</font></div><div style="margin-bottom:0.1pt"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.147%"><tr><td style="width:1.0%"></td><td style="width:61.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.334%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.294%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">CALIFORNIA INSTITUTE OF TECHNOLOGY</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#47;s&#47; Lawrence Gilbert</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(Signature)</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Lawrence Gilbert</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(Printed Name)</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">SR DR Tech Transfer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(Title)</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:0 1pt"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;FLUIDIGM CORPORATION</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#47;s&#47; Gajus V. Worthington</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(Signature)</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Gajus V. Worthington</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(Printed Name)</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">CEO</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(Title)</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">EXHIBIT A</font></div><div style="margin-top:4.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;TO BE ATTACHED&#93;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Appendix&#160;1.7 Fluidigm Patent Family</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">US Cases</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 1</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Appendix&#160;1.7 Fluidigm Patent Family</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">US Cases</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 2</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Appendix&#160;1.7 Fluidigm Patent Family</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">US Cases</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 3</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Appendix&#160;1.7 Fluidigm Patent Family</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">US Cases</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 4</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Appendix&#160;1.7 Fluidigm Patent Family</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">US Cases</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 5</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Appendix&#160;1.7 Fluidigm Patent Family</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">US Cases</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 6</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Appendix&#160;1.7 Fluidigm Patent Family</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">US Cases</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 7</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Appendix&#160;1.7 Fluidigm Patent Family</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">US Cases</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 8</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Appendix&#160;1.7 Fluidigm Patent Family</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">US Cases</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 9</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Appendix&#160;1.7 Fluidigm Patent Family</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">US Cases</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 10</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Appendix&#160;1.7 Fluidigm Patent Family</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">US Cases</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 11</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Appendix&#160;1.7 Fluidigm Patent Family</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">International Cases</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 1</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Appendix&#160;1.7 Fluidigm Patent Family</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">International Cases</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 2</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Appendix&#160;1.7 Fluidigm Patent Family</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">International Cases</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 3</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Appendix&#160;1.7 Fluidigm Patent Family</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">International Cases</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 4</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Appendix&#160;1.7 Fluidigm Patent Family</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">International Cases</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 5</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Appendix&#160;1.7 Fluidigm Patent Family</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">International Cases</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 6</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Appendix&#160;1.7 Fluidigm Patent Family</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">International Cases</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 7</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Appendix&#160;1.7 Fluidigm Patent Family</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">International Cases</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 8</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Appendix&#160;1.7 Fluidigm Patent Family</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">International Cases</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 9</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Appendix&#160;1.7 Fluidigm Patent Family</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">International Cases</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 10</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>5
<FILENAME>exhibit10310q3q2020.htm
<DESCRIPTION>EX-10.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i78b754e7ba8f4cb98ca266c8b1871536_1"></div><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;10.3</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4060.LICI.006 Harvard</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CO-EXCLUSIVE LICENSE AGREEMENT</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Between</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">President and Fellows of Harvard College</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">And</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mycometrix Corporation</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective as of October&#160;15, 2000</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Re&#58; Harvard Case &#91;***&#93;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In consideration of the mutual promises and covenants set forth below, the parties hereto agree as follows&#58;</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE I</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DEFINITIONS</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As used in this Agreement, the following terms shall have the following meanings&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">ACADEMIC RESEARCH PURPOSES&#58; use of PATENT RIGHTS for academic research or other not-for-profit scholarly purposes which are undertaken at a non-profit or governmental institution that does not use the PATENT RIGHTS in the production or manufacture of products for sale or the performance of services for a fee.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">AFFILIATE&#58; any entity which controls, is controlled by, or is under common control with a party by ownership or control of at least fifty percent (50%)&#160;of the voting stock or other ownership. Unless otherwise specified, the term LICENSEE includes AFFILIATES.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">FIELD&#58; use of PATENT RIGHTS to develop, manufacture, use, offer for sale, sell, or import components and products in FIELD I and&#47;or FIELD II&#58;</font></td></tr></table></div><div style="margin-top:10pt;padding-left:56.6pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FIELD I&#58; &#91;***&#93;</font></div><div style="margin-top:10pt;padding-left:56.6pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FIELD II&#58; &#91;***&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD&#58; President and Fellows of Harvard College, a nonprofit Massachusetts educational corporation having offices at the Office for Technology and Trademark Licensing, Holyoke Center, Suite&#160;727, 1350 Massachusetts Avenue, Cambridge, Massachusetts 02138.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSED PROCESSES&#58; the processes covered by at least one VALID CLAIM included within the PATENT RIGHTS.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSED PRODUCTS&#58; products covered by at least one VALID CLAIM included within the PATENT RIGHTS or products made or services provided in accordance with or by means of LICENSED PROCESSES.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE&#58; Mycometrix Corporation, a corporation organized under the laws of Califonia having its principal offices at 213 East Grand Avenue, South San Francisco, CA 94080.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">NET SERVICE INCOME&#58; SERVICE INCOME less LICENSEE&#8217;s actual direct and indirect cost for research, development and&#47;or services provided.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">NET SALES&#58; the amount actually received for sales, leases, or other transfers of LICENSED PRODUCTS, less&#58;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.590%"><tr><td style="width:1.0%"></td><td style="width:6.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.829%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(i)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">customary trade, quantity or cash discounts and non-affiliated brokers&#8217; or agents&#8217; commissions actually allowed and taken&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.590%"><tr><td style="width:1.0%"></td><td style="width:6.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.829%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(ii)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">amounts repaid or credited by reason of rejection or return&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.590%"><tr><td style="width:1.0%"></td><td style="width:6.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.829%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(iii)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">to the extent separately stated on purchase orders, invoices, or other documents of sale, taxes levied on and&#47;or other governmental charges made as to production, sale, transportation, delivery or use and paid by or on behalf of LICENSEE&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.590%"><tr><td style="width:1.0%"></td><td style="width:6.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.829%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(iv)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">reasonable charges for delivery or transportation provided by third parties and cost of insurance in transit, if separately stated.</font></td></tr></table></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:27pt;text-indent:-0.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NET SALES also includes the fair market value of any non-cash consideration received by LICENSEE for the sale, lease, or transfer of LICENSED PRODUCTS.</font></div><div style="margin-top:4.5pt;padding-left:27pt;text-indent:-0.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a LICENSED PRODUCT is sold as a combination product containing the LICENSED PRODUCT and one or more other components, NET SALES shall be calculated by multiplying the gross amount invoiced for the sale of the combination product by the fraction A&#47;A+B where A is the average gross selling price of the LICENSED PRODUCT sold separately by LICENSEE and B is the average gross selling price of such other components of the combination products sold separately by LICENSEE during the relevant royalty payment period.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="margin-top:4.5pt;padding-left:27pt;text-indent:-0.01pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:27pt;text-indent:-0.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that LICENSEE grants a sublicensee hereunder, and receives payments based upon SUBLICENSEE&#8217;s sales of LICENSED PRODUCTS, LICENSEE may upon approval from HARVARD (which shall not be unreasonably withheld) modify the definition of NET SALES for the purposes of calculating royalties payable to HARVARD on such SUBLICENSEE&#8217;s sales to be the same as the definition of NET SALES on which such royalties to LICENSEE are calculated.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">SERVICE INCOME&#58; the total financial consideration received by LICENSEE for commercial services performed on a fee-for-service basis using the LICENSED PRODUCTS or LICENSED PROCESSES by LICENSEE under a contract with a third party, where such services are based primarily on the use of fully functional LICENSED PRODUCTS or LICENSED PROCESSES (as applicable) for their intended commercial use (such as, for example, where LICENSEE performs commercial-scale genotyping services for a pharmaceutical company on a fee-for-service basis using fully developed microfluidics chips comprising LICENSED PRODUCTS). SERVICE INCOME shall not include amounts received in connection with research and&#47;or development of LICENSED PRODUCTS or LICENSED PROCESSES themselves.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">PATENT RIGHTS&#58; The applications and patents as listed in Appendix&#160;A of this Agreement, the allowed claims of such applications, the inventions described and claimed therein, and any divisions or continuations of the applications and patents as listed in Appendix&#160;A, and specific claims of any continuations-in-part of such applications to the extent the specific claims are directed to subject matter described in the applications and patents listed in Appendix&#160;A in a manner sufficient to support such specific claims under 35 U.S.C., patents issuing thereon or reissues thereof, and any and all foreign patents and patent applications corresponding thereto, all to the extent owned or controlled by HARVARD.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.12</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">SUBLICENSE INCOME&#58; the amount paid to LICENSEE by a third party (other than an AFFILIATE of LICENSEE) (a)&#160;for the sublicening of PATENT RIGHTS to a third party as well as (b)&#160;for the related licensing of LICENSEE&#8217;s own patent rights or know-how or LICENSEE&#8217;s in-licensed non-HARVARD technologies, including but not limited to (i)&#160;license fees, (ii)&#160;milestone payments, (iii)&#160;royalties, (iv)&#160;the fair market value in cash of any non-cash consideration for such sublicense, and (v)&#160;in the event that LICENSEE receives any payment for equity in consideration for the grant of sublicense rights that included a premium over the fair market value of such equity, the amount of such premium. LICENSEE shall be responsible for determining such fair market value with reasonable business judgment.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.13</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">SUBLICENSEE&#58; any non-AFFILIATE granted a sublicense of any of the rights HARVARD has granted to LICENSEE under Section&#160;3.1.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.14</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">TERRITORY&#58; Worldwide.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.15</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">VALID CLAIM&#58; either (i)&#160;a claim of an issued patent that has not been held unenforceable or invalid by an agency or a court of competent jurisdiction in any unappealable or unappealed decision or (ii)&#160;a claim of a published, pending patent application, which claim is substantially identical to a corresponding claim in a subsequently issued patent having priority to the patent application.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.16</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The terms &#8220;Public Law 96-517&#8221; and &#8220;Public Law 98-620&#8221; include all amendments to those statutes.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.17</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The terms &#8220;sold&#8221; and &#8220;sell&#8221; include, without limitation, leases and other transfers and similar transactions.</font></td></tr></table></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE II</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REPRESENTATIONS</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD is owner by assignment from &#91;***&#93;, in the US and foreign patent applications corresponding thereto, and in the inventions described and claimed therein. Inventorship will be finalized in the near future.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD has authority to issue licenses under PATENT RIGHTS.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD is committed to the policy that ideas or creative works produced at HARVARD should be used for the greatest possible public benefit, and believes that every reasonable incentive should be provided for the prompt introduction of such ideas into public use, all in a manner consistent with the public interest.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE is prepared and intends to diligently develop the invention and to bring products to market which are subject to this Agreement, specifically including one or more products in the FIELD selected from a &#91;***&#93;.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE is desirous of obtaining a co-exclusive license in the FIELD and in the TERRITORY in order to practice the PATENT RIGHTS in the United States and in certain foreign countries, and to manufacture, use and sell in the commercial market the products made in accordance therewith, and HARVARD is desirous of granting such a license to LICENSEE in accordance with the terms of this Agreement.</font></td></tr></table></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE&#160;III</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GRANT OF RIGHTS</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD hereby grants to LICENSEE and LICENSEE accepts, subject to the terms and conditions hereof, in the TERRITORY a co-exclusive commercial license under PATENT</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">RIGHTS in FIELD I and in FIELD II to make and have made, to use and have used, to sell and have sold, and to offer for sale and have offered for sale the LICENSED PRODUCTS, and to practice the LICENSED PROCESSES, for the life of the PATENT RIGHTS. HARVARD will grant no more than two commercial licenses in FIELD I at any time and will grant no more than two commercial licenses in FIELD II at any time and HARVARD will not grant other licenses in the FIELD except as required by HARVARD&#8217;s obligations in Section&#160;3.2(a) or as permitted Section&#160;3.2(b). Such co-exclusive license shall include the right to grant sublicenses under the following circumstances&#58; (i)&#160;LICENSEE can demonstrate that it has added significant value to the PATENT RIGHTS to be sublicensed, and that such a sublicense also contains a substantial and essentially simultaneous license of LICENSEE owned intellectual property, or (ii)&#160;LICENSEE grants a sublicense under other HARVARD patent rights licensed exclusively to LICENSEE which are dominated by PATENT RIGHTS, and such sublicense under PATENT RIGHTS is necessary to practice such other HARVARD patent rights.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The granting and exercise of this license is subject to the following conditions&#58;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.537%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD&#8217;s &#8220;Statement of Policy in Regard to Inventions, Patents and Copyrights,&#8221; dated August&#160;10, 1998, Public Law 96-517, Public Law 98-620. In addition, this Agreement is subject to HARVARD&#8217;s obligations under agreements with other sponsors of research, provided that such obligations are not in conflict with the rights granted hereunder. Any right granted in this Agreement greater than that permitted under Public Law 96-517, or Public Law 98-620, shall be subject to modification as may be required to conform to the provisions of those statutes.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.537%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD reserves the right to make and use, and grant to others non-exclusive licenses to make and use solely for ACADEMIC RESEARCH PURPOSES the subject matter described and claimed in PATENT RIGHTS.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.537%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(c)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall use commercially reasonable efforts to effect introduction of the LICENSED PRODUCTS into the commercial market as soon as practicable, consistent with sound and reasonable business practice and judgment&#59; thereafter, until the expiration of this Agreement, LICENSEE shall endeavor to keep LICENSED PRODUCTS reasonably available to the public.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.537%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(d)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">At any time after three years from the effective date of this Agreement and as HARVARD&#8217;s sole remedy for such non-performance, HARVARD may increase the license maintenance royalty under Section&#160;4.4 to &#91;***&#93; ($&#91;***&#93;) dollars each in FIELD I and in FIELD II in year 2004 and &#91;***&#93; ($&#91;***&#93;) dollars each in FIELD I and FIELD II per year each year beginning in 2005, if in HARVARD&#8217;s reasonable judgment, the Progress Reports furnished by LICENSEE do not demonstrate that LICENSEE has satisfied at least one of the following conditions, which non-performance is not cured within ninety (90)&#160;days following the written notification of such by HARVARD to LICENSEE&#58;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.906%"><tr><td style="width:1.0%"></td><td style="width:7.857%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(i)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">has put the licensed subject matter into commercial use in at least one of the countries hereby licensed, directly or through a sublicense, and is keeping the licensed subject matter reasonably available to the public&#59; or</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.906%"><tr><td style="width:1.0%"></td><td style="width:7.857%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(ii)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">is engaged in research, development, manufacturing, marketing or sublicensing activity appropriate to achieving 3.2(d)(i).</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.537%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(e)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In all sublicenses granted by LICENSEE hereunder, LICENSEE shall include a requirement that the SUBLICENSEE use commercially reasonable efforts to bring the subject matter of the sublicense into commercial use. LICENSEE shall further provide in such sublicenses that such sublicenses are subject and subordinate to the terms and conditions of this Agreement, except&#58; (i)&#160;the SUBLICENSEE may not further sublicense&#59; and (ii)&#160;the rate of royalty on NET SALES paid by the SUBLICENSEE to the LICENSEE. Copies of the relevant provisions of all sublicense agreements shall be provided promptly to HARVARD. HARVARD agrees to maintain any information contained in such provisions in confidence, except as otherwise required by law, however, HARVARD may include in its usual reports annual amounts of royalties paid.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.537%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(f)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">A license in any other field of use in addition to the FIELD shall be the subject of a separate agreement and shall require LICENSEE&#8217;s submission of evidence, satisfactory to HARVARD, demonstrating LICENSEE&#8217;s willingness and ability to develop and commercialize in such other field of use the kinds of products or processes likely to be encompassed in such other fields.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.537%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(g)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">To the extent that federal funds are used to support research leading to a patent or patent application in the PATENT RIGHTS, LICENSEE shall cause any LICENSED PRODUCT produced for sale by LICENSEE or SUBLICENSEES in the United States to be manufactured substantially in the United States during the period of exclusivity of this license in the United States.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">All rights reserved to the United States Government and others under Public Law 96-517, and Public Law 98-620, shall remain and shall in no way be affected by this Agreement.</font></td></tr></table></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE IV</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ROYALTIES</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall pay to HARVARD a non-refundable license royalty fee in the sum of &#91;***&#93; dollars ($&#91;***&#93;) payable within thirty (30)&#160;days of the execution date of this Agreement.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(a)&#160;In consideration of the right and license granted herein, LICENSEE shall pay to HARVARD during the term of this Agreement a royalty of &#91;***&#93; percent (&#91;***&#93;) on NET SALES of LICENSED PRODUCTS sold by LICENSEE.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;In the event that a single LICENSED PRODUCT or LICENSED PROCESS is covered by HARVARD intellectual property in addition to PATENT RIGHTS, which is licensed to LICENSEE under other agreements as of the date of this Agreement, then the total royalty payment due HARVARD under all such agreements including this Agreement shall be &#91;***&#93; percent (&#91;***&#93;) of NET SALES. LICENSEE shall notify HARVARD of the identity of each license agreement that includes patent rights covering the product or process, and HARVARD shall distribute the royalties evenly among such agreements.</font></div><div style="margin-top:4.5pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;As consideration for the rights granted hereunder, LICENSEE shall pay to HARVARD during the term of this Agreement a royalty in the form of stock of LICENSEE as follows&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.590%"><tr><td style="width:1.0%"></td><td style="width:6.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.829%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(i)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall issue to HARVARD &#91;***&#93; shares of the Common Stock of LICENSEE (&#8220;Shares&#8221;) pursuant to the terms of a mutually acceptable Stock Subscription Agreement, provided, however, that HARVARD shall be subject to and enter into appropriate agreements and related documents as required of other stockholders of LICENSEE.</font></td></tr></table></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;&#160;HARVARD represents and warrants to LICENSEE that&#58;</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;&#160;HARVARD is acquiring the Shares for its own account for investment and not with a view to, or for sale in connection with any distribution thereof, nor with any present intention of distributing or selling the same&#59; and HARVARD has no present or contemplated agreement, undertaking, arrangement, obligation, indebtedness or commitment providing for the disposition thereof.</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;&#160;HARVARD has full power and authority to enter into and to perform this Agreement in accordance with its terms.</font></div><div style="margin-bottom:10pt;padding-left:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;&#160;HARVARD has sufficient knowledge and experience in investing in companies similar to LICENSEE so as to be able to evaluate the risks and merits of its investment in LICENSEE and is able financially to bear the risks thereof.</font></div><div style="margin-bottom:0.1pt;padding-left:45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;Each certificate representing the Shares shall bear a legend substantially in the following form&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:10pt;padding-left:56.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;The shares represented by this certificate have not been registered under the Securities Act of 1933 or any state securities law and they may not be sold or otherwise transferred by any person, including a pledgee, unless (1)&#160;either (a)&#160;a registration statement with respect to such shares shall be effective under the Securities Act of 1933, as amended, or (b)&#160;the Corporation shall have received an opinion of counsel satisfactory to the Corporation that an exemption from registration under such Act is then available, and (2)&#160;there shall have been compliance with all applicable securities laws.&#8221;</font></div><div style="margin-bottom:10pt;margin-top:4.5pt;padding-left:56.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;The shares represented by this certificate are subject to a mutually agree-upon Stock Purchase and Right of First Refusal Agreement with this Corporation, a copy of which Stock Purchase and Right of First Refusal Agreement is available for inspection at the offices of the Corporation or may be made available upon request.&#8221;</font></div><div style="margin-bottom:10pt;margin-top:4.5pt;padding-left:56.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing legend shall be removed from the certificates representing any Shares, at the request of the holder thereof, at such time as they become eligible for resale pursuant to the Securities Act of 1933, as amended.</font></div><div style="margin-bottom:10pt;margin-top:4.5pt;padding-left:56.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If at any time prior to the time the Shares are eligible for resale pursuant to an exemption from registration under the Securities Act of 1933, as amended, LICENSEE proposes to register any of its Common Stock, under the Securities Act of 1933, except at LICENSEE&#8217;s initial public offering or any offering pursuant to Forms S-4 or S-8, LICENSEE shall offer HARVARD the opportunity to have its Shares registered under the registration statement to be filed at such time. HARVARD will be offered the right to register its Shares under the same terms, conditions and restrictions as other shareholders with piggyback registration rights and the inclusion of any Shares in such registration statement shall be subject to the approval of the underwriters of such offering</font></div><div style="margin-bottom:10pt;margin-top:4.5pt;padding-left:56.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;&#160;HARVARD&#8217;s ownership rights to Shares shall not be affected should the license pursuant to this Agreement be converted to a non-exclusive one.</font></div><div style="margin-bottom:0.1pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;In the case of sublicenses, LICENSEE shall also pay to HARVARD a royalty of &#91;***&#93; of SUBLICENSE INCOME. If compensation for such a sublicense of PATENT RIGHTS is bundled with compensation received for the sublicensing of the other HARVARD patent rights licensed to LICENSEE under other agreements as of the date of this Agreement, LICENSEE shall pay HARVARD only &#91;***&#93; of the total compensation received no matter how many license agreements from HARVARD are involved. In such a case, LICENSEE shall notify HARVARD of the identity of each license agreement involved and HARVARD shall distribute its &#91;***&#93; of</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">compensation equally among those license agreements, including this Agreement.</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;LICENSEE shall pay HARVARD &#91;***&#93; of NET SERVICE INCOME. If SERVICE INCOME is bundled with service income under another license to LICENSEE as of the date of this Agreement, LICENSEE shall pay a royalty of &#91;***&#93; of NET SERVICE INCOME received from each and every third party (&#8220;Third Party&#8221;) to which services are provided. LICENSEE shall notify HARVARD of the identity of each license agreement involved in the services and HARVARD shall distribute its &#91;***&#93; of compensation equally among those license agreements, including this Agreement.</font></div><div style="margin-bottom:0.1pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;If other co-exclusive licenses in the same FIELD and TERRITORY are granted after the date this Agreement is executed, the above financial compensation shall not exceed the financial compensation to be paid by other licensees in the same FIELD and TERRITORY during the term of the co-exclusive license provided LICENSEE accepts any less favorable terms included in such other license.</font></div><div style="margin-bottom:0.1pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If stock is part of the financial compensation to be paid by other licensees in the same FIELD and TERITORY, the fair market value of the stock shall be the same as the price per share which other investors paid in the last round of financing unless the stock is publicly traded.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.750%"><tr><td style="width:1.0%"></td><td style="width:4.118%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.682%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On sales between LICENSEE and its AFFILIATES for resale or incorporation into products, the royalty shall be paid on the NET SALES of the AFFILIATE. On sales between LICENSEE and sublicensees for resale, the royalty shall be paid on the SUBLICENSE INCOME.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.750%"><tr><td style="width:1.0%"></td><td style="width:4.118%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.682%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">No later than January&#160;1 of each calendar year indicated below, LICENSEE shall pay to HARVARD the following non-refundable license maintenance royalty and&#47;or advance on royalties. Such payments shall be credited against running royalties due for that calendar year and Royalty Reports shall reflect such a credit. Such payments shall not be credited against milestone payments (if any) nor against royalties due for any subsequent calendar year nor against such payments due under any other agreements with HARVARD.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:76.862%"><tr><td style="width:1.0%"></td><td style="width:33.191%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.460%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.460%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.826%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.463%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">FIELD&#160;I</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">FIELD&#160;II</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">January&#160;1, 2002</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#91;***&#93;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#91;***&#93;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">January&#160;1, 2003</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#91;***&#93;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#91;***&#93;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">January&#160;1, 2004</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#91;***&#93;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#91;***&#93;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">each year thereafter</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#91;***&#93;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#91;***&#93;</font></td></tr></table></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE V</font></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REPORTING</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.750%"><tr><td style="width:1.0%"></td><td style="width:4.118%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.682%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Prior to signing this Agreement, LICENSEE has provided to HARVARD a written business plan under which LICENSEE intends to bring the subject matter of the licenses</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">granted hereunder into commercial use upon execution of this Agreement. Such plan includes proposed marketing efforts.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">No later than sixty (60)&#160;days after June&#160;30 of each calendar year, LICENSEE shall provide to HARVARD a written annual Progress Report describing progress on research and development, regulatory approvals, manufacturing, sublicensing, marketing and sales during the most recent twelve (12)&#160;month period ending June&#160;30 and plans for the forthcoming year. If multiple technologies are covered by the license granted hereunder, the Progress Report shall provide the information set forth above for each technology. If progress differs from that anticipated in the plan required under Section&#160;5.1, LICENSEE shall explain the reasons for the difference and propose a modified plan for HARVARD&#8217;s review. LICENSEE shall also provide any reasonable additional data HARVARD requires to evaluate LICENSEE&#8217;s performance.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall report to HARVARD the date of first sale of LICENSED PRODUCTS (or results of LICENSED PROCESSES) in each country within thirty (30)&#160;days of occurrence.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.800%"><tr><td style="width:1.0%"></td><td style="width:3.852%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.115%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall submit to HARVARD within sixty (60)&#160;days after each calendar half year ending June&#160;30 and December&#160;31, a Royalty Report setting forth for such half year at least the following information&#58;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.537%"><tr><td style="width:1.0%"></td><td style="width:7.799%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(i)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">the number of LICENSED PRODUCTS sold by LICENSEE in each country&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.537%"><tr><td style="width:1.0%"></td><td style="width:7.799%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(ii)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">total billings and amounts actually received for such LICENSED PRODUCTS&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.537%"><tr><td style="width:1.0%"></td><td style="width:7.799%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(iii)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">an accounting for all LICENSED PROCESSES used or sold&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.537%"><tr><td style="width:1.0%"></td><td style="width:7.799%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(iv)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">deductions applicable to determine the NET SALES thereof&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.537%"><tr><td style="width:1.0%"></td><td style="width:7.799%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(v)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">the amount of SERVICE INCOME received by LICENSEE and an accounting of all deductions to yield NET SERVICE INCOME&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.537%"><tr><td style="width:1.0%"></td><td style="width:7.799%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(vi)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">the amount of SUBLICENSE INCOME received by LICENSEE&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.537%"><tr><td style="width:1.0%"></td><td style="width:7.799%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(vii)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">the amount of royalty due thereon, or, if no royalties are due to HARVARD for any reporting period, the statement that no royalties are due.</font></td></tr></table></div><div style="margin-top:10pt;padding-left:45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Such report shall be certified as correct by an officer of LICENSEE and shall include a detailed listing of all deductions from royalties.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.537%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall pay to HARVARD with each such Royalty Report the amount of royalty due with respect to such half year. If multiple technologies are covered by the license granted hereunder, LICENSEE shall specify which PATENT RIGHTS are utilized for each LICENSED PRODUCT and LICENSED PROCESS included in the Royalty Report.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.537%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(c)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">All payments due hereunder shall be deemed received when funds are credited to HARVARD&#8217;s bank account and shall be payable by check or wire transfer in United States dollars. Conversion of foreign currency to U.S. dollars shall be made at the conversion rate existing in the United States (as reported in the New York Times or the Wall Street Journal) on the last working day of each royalty period. No transfer, exchange, collection or other charges shall be deducted from such payments.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.537%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(d)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">All such reports shall be maintained in confidence by HARVARD except as required by law&#59; however, HARVARD may include in its usual reports annual amounts of royalties paid.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.537%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(e)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Late payments shall be subject to a charge of one and one-half percent (1.5%)&#160;per month, or $250, whichever is greater.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In the event of acquisition, merger, change of corporate name or change in make-up, organization, or identity, LICENSEE shall notify HARVARD in writing within thirty (30)&#160;days of such event.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If by law, regulation or fiscal policy of a particular country, conversion into United States dollars or transfer of funds of a convertible currency to the United States is restricted or forbidden, LICENSEE shall give HARVARD prompt notice in writing and shall pay the royalty and other amounts due through such means or methods as are lawful in such country as HARVARD may reasonably designate. Failing the designation by HARVARD of such lawful means or methods within thirty (30)&#160;days after such notice is given to HARVARD, LICENSEE shall deposit such royalty or other payment in local currency to the credit of HARVARD in a recognized banking institution designated by HARVARD, or if none is designated by HARVARD within the thirty (30)&#160;day period described above, in a recognized banking institution selected by LICENSEE and identified in a written notice to HARVARD by LICENSEE, and such deposit shall fulfill all obligations of LICENSEE to HARVARD with respect to such royalties. When in any country in which the law or regulations prohibit both the transmittal and deposit of royalties on sales in such country, royalty payments shall be suspended for as long as such prohibition is in effect, and as soon as such prohibition ceases to be in effect, all royalties which LICENSEE would have been under obligation to transmit or deposit, but for the prohibition, shall be deposited or transmitted promptly to the extent allowable.</font></td></tr></table></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE VI</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RECORD KEEPING</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">6.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall keep, and shall require its SUBLICENSEES to keep, accurate records (together with supporting documentation) of LICENSED PRODUCTS made, used or sold under this Agreement, and SERVICE INCOME and SUBLICENSE INCOME received by LICENSEE under this Agreement, appropriate to determine the amount of royalties due to HARVARD hereunder. Such records shall be retained for three (3)&#160;years following the end of the reporting period to which they relate. For such three year period, they shall be</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">available during normal business hours upon reasonable advance notice for examination by a certified public accountant selected by HARVARD, and reasonably acceptable to LICENSEE, for the sole purpose of verifying reports and payments hereunder. In conducting examinations pursuant to this Section&#160;6.1, HARVARD&#8217;s accountant shall have access to all records which HARVARD reasonably believes to be relevant to the calculation of royalties under Article&#160;IV. HARVARD agrees to maintain any information contained in such records in confidence, except as otherwise required by law and except information in regarding the amount of royalties due.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">6.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD&#8217;s accountant shall not disclose to HARVARD any information other than information relating to the accuracy of reports and payments made hereunder.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">6.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Such examination by HARVARD&#8217;s accountant shall be at HARVARD&#8217;s expense, except that if such examination shows an underreporting or underpayment in excess of five percent (5%)&#160;for any twelve (12)&#160;month period, then LICENSEE shall pay the cost of such examination as well as any additional sum that would have been payable to HARVARD had the LICENSEE reported correctly, plus interest on said sum at the rate of one and one-half percent (1.5%)&#160;per month.</font></td></tr></table></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE VII</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DOMESTIC AND FOREIGN PATENT FILING AND MAINTENANCE</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Upon execution of this Agreement, LICENSEE shall reimburse HARVARD for fifty percent (50%)&#160;of all reasonable expenses HARVARD has incurred for the preparation, filing, prosecution, maintenance and counseling with respect to PATENT RIGHTS. Such expenses total &#91;***&#125; as of October&#160;1, 2000. Thereafter, LICENSEE shall reimburse HARVARD for &#91;***&#125; of all such future reasonable expenses prior to termination of this Agreement upon receipt of invoices from HARVARD.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD shall be responsible for the preparation, filing, prosecution and maintenance of any and all patent applications and patents included in PATENT RIGHTS. HARVARD will instruct counsel to directly notify HARVARD and LICENSEE and provide them copies of any official communications from the United States and foreign patent offices relating to said prosecution, and to provide LICENSEE with advance draft copies of all relevant communications to the various patent offices, so that LICENSEE may be informed and apprised of the continuing prosecution of patent applications in PATENT RIGHTS. LICENSEE shall have reasonable opportunities to participate in decision making on all key decisions affecting filing, prosecution and maintenance of patents and patent applications in PATENT RIGHTS. HARVARD will use reasonable efforts to incorporate LICENSEE&#8217;s reasonable suggestions regarding said prosecution. HARVARD shall use all reasonable efforts to amend any patent application to include claims reasonably requested by LICENSEE to protect LICENSED PRODUCTS.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD and LICENSEE shall cooperate fully in the preparation, filing, prosecution and maintenance of PATENT RIGHTS and of all patents and patent applications licensed to LICENSEE hereunder, executing all papers and instruments or requiring members of</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD to execute such papers and instruments so as to enable HARVARD to apply for, to prosecute and to maintain patent applications and patents in HARVARD&#8217;s name in any country. Each party shall provide to the other prompt notice as to all matters which come to its attention and which may affect the preparation, filing, prosecution or maintenance of any such patent applications or patents.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE may elect to surrender its PATENT RIGHTS in any country upon sixty (60)&#160;days written notice to HARVARD. Such notice shall not relieve LICENSEE from responsibility to reimburse HARVARD for patent-related expenses incurred prior to the expiration of the (60)&#160;day notice period.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If HARVARD elects not to prosecute or maintain any of the patents or patent applications relating to PATENT RIGHTS or any portion thereof in any country, LICENSEE shall be given sufficient notice of HARVARD&#8217;s decision so that LICENSEE may request that HARVARD continue prosecuting or maintaining such patents or patent applications, at LICENSEE&#8217;s expense. If HARVARD elects not to prosecute or maintain such patents or patent applications after such request by LICENSEE, then LICENSEE shall have the right, but not the obligation, at its own expense to prosecute and maintain such patents and patent applications or portion thereof in such country and in HARVARD&#8217;s name. If LICENSEE assumes 100% of the costs to file, prosecute, and maintain certain patents and patent applications relating to the PATENT RIGHTS pursuant to this Section&#160;7.5, and, if HARVARD licenses the PATENT RIGHTS to one or more co-exclusive licensees designated in Section&#160;3.1 after such time, then HARVARD will credit LICENSEE with the costs LICENSEE has paid in excess of &#91;***&#125; if one other licensee, due for the preparation, filing, prosecution and maintenance of patents and patent applications relating to PATENT RIGHTS pursuant to Section&#160;7.1 above.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If LICENSEE can demonstrate that it is not being adequately informed or apprised of the continuing prosecution of patents or patent applications in PATENT RIGHTS, or that it is not being provided with reasonable opportunities to participate in decision making or that its interests are not being adequately protected, LICENSEE shall be entitled to engage, at LICENSEE&#8217;s expense, independent patent counsel to review and evaluate patent prosecution and filing of patents and patent applications included in PATENT RIGHTS.</font></td></tr></table></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE VIII</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INFRINGEMENT</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">With respect to any PATENT RIGHTS that are licensed to LICENSEE pursuant to this Agreement, LICENSEE shall have the right to prosecute in its own name and at its own expense any infringement of such patent. HARVARD agrees to notify LICENSEE promptly of each infringement of such patents of which HARVARD, as applicable, is or becomes aware. Before LICENSEE commences an action with respect to any infringement of such patents, LICENSEE shall give careful consideration to the views of HARVARD and to potential effects on the public interest in making its decision whether or not to sue.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE acknowledges that other co-exclusive licensees of PATENT RIGHTS designated in Section&#160;3.1 shall have rights identical to LICENSEE to prosecute infringers and that co- exclusive licensees will be bound by the identical terms of this Section&#160;8.2. In any prosecution instigated by LICENSEE and in which HARVARD, as necessary, is also named plaintiff as owner of the PATENT RIGHTS, LICENSEE must notify other co-exclusive licensees of the existence of such legal action and allow other co-exclusive licensees to join as a plaintiff upon co-exclusive licensees&#8217; request. In addition, in the event other co- exclusive licensees instigate an infringement prosecution, LICENSEE hereby consents to being joined as a plaintiff in such suit solely for the purpose of procuring standing to bring the action and at the sole expense of the instigating co-exclusive licensee. To the extent that LICENSEE desires to participate in any strategic decisions affecting the prosecution of the action brought by other co-exclusive licensees, LICENSEE acknowledges that it and co- exclusive licensees will necessarily have to reach a mutual agreement concerning litigation expenses and strategy. In no event shall HARVARD incur any liability or expense in connection with any action of co-exclusive licensees, joint or otherwise.</font></td></tr></table></div><div style="margin-top:4.5pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During any such litigation, HARVARD will agree to not license any defendant or accused infringer of the PATENT RIGHTS in the litigation, without LICENSEE&#8217;s prior written consent.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.116%"><tr><td style="width:1.0%"></td><td style="width:3.836%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.721%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.347%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If LICENSEE elects to commence an action as described above, HARVARD may, to the extent permitted by law, elect to join as parties in that action. Regardless of whether HARVARD elects to join as parties, HARVARD shall cooperate fully with LICENSEE in connection with any such action.</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD agrees to join as a party in any action if required by law to do so in order to bring an action under the PATENT RIGHTS.</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(c)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall reimburse HARVARD for any costs incurs with LICENSEE&#8217;s approval, including reasonable attorneys&#8217; fees, as part of an action brought by LICENSEE, irrespective of whether HARVARD becomes a co-plaintiff.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If LICENSEE elects to commence an action as described above, LICENSEE may deduct from its royalty payments to HARVARD with respect to the patent(s) subject to suit an amount not exceeding &#91;***&#125; of LICENSEE&#8217;s expenses and costs of such action, including reasonable attorneys&#8217; fees&#59; provided, however, that such reduction shall not exceed &#91;***&#125; of the total royalty due to HARVARD with respect to the patent(s) subject to suit for each calendar year. If such &#91;***&#125; of LICENSEE&#8217;s expenses and costs exceeds the amount of royalties deducted by LICENSEE for any calendar year, LICENSEE may to that extent reduce the royalties due to HARVARD from LICENSEE in succeeding calendar years, but never by more than &#91;***&#125; of the total royalty due in any one year with respect to the patent(s) subject to suit.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">No settlement, consent judgment or other voluntary final disposition of the suit may be entered into without the prior written consent of HARVARD which consent shall not be unreasonably withheld.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Recoveries or reimbursements from actions commenced by LICENSEE pursuant to this Article shall first be applied to reimburse LICENSEE, HARVARD for litigation costs not paid from royalties and then to reimburse HARVARD for royalties deducted by LICENSEE pursuant to Section&#160;8.4. Any remaining recoveries or reimbursements shall be shared as follows&#58;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.537%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If the amount is lost profits or lost royalties, LICENSEE shall receive an amount equal to the damages the court determines LICENSEE has suffered as a result of the infringement less the amount of any royalties that would have been due HARVARD on sales of LICENSED PRODUCTS lost by LICENSEE as a result of the infringement had LICENSEE made such sales, and HARVARD shall receive an amount equal to the royalties it would have received if such sales had been made by LICENSEE, and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.537%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">As to awards other than lost profits or lost royalties, &#91;***&#125; to LICENSEE and fifty percent (50%)&#160;to HARVARD.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.537%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(c)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If two or more co-exclusive licensees undertake the suit, the provision of this Section&#160;8.6 will be modified to take into account each co-exclusive licensee&#8217;s expenses and lost profits.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If LICENSEE elects not to exercise its right to prosecute an infringement of the PATENT RIGHTS pursuant to this Article, HARVARD may do so at its own expense, controlling such action and retaining all recoveries therefrom. LICENSEE shall cooperate fully with HARVARD in connection with any such action.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If a declaratory judgment action is brought naming LICENSEE as a defendant and alleging invalidity of any of the PATENT RIGHTS, HARVARD may elect to take over the sole defense of the action at its own expense. LICENSEE shall cooperate fully with HARVARD in connection with any such action. HARVARD shall consult with LICENSEE regarding such defense.</font></td></tr></table></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE IX</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TERMINATION OF AGREEMENT</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">9.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">This Agreement, unless terminated as provided herein, shall remain in effect until the last patent or patent application in PATENT RIGHTS has expired or been abandoned.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">9.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD may terminate this Agreement as follows&#58;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.537%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If LICENSEE does not make a payment due hereunder and fails to cure such non-payment (including the payment of interest in accordance with Section&#160;5.4(e)) within</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.590%"><tr><td style="width:1.0%"></td><td style="width:6.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.894%"></td><td style="width:0.1%"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">thirty (30)&#160;days after the date of notice in writing of such non-payment by HARVARD.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.537%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If LICENSEE defaults in its obligations under Sections&#160;10.3(c) and 10.3(d) to procure and maintain insurance.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.537%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(c)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If LICENSEE shall become insolvent, shall make an assignment for the benefit of creditors, or shall have a petition in bankruptcy filed for or against it. Such termination shall be effective immediately upon HARVARD giving written notice to LICENSEE.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.537%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(d)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If an examination by HARVARD&#8217;s accountant pursuant to Article&#160;V shows an underreporting or underpayment by LICENSEE in excess of twenty percent (20%)&#160;for any twelve (12)&#160;month period, provided that such underreporting or underpayment is not determined to be inadvertent or the result of an honest mistake.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.537%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(e)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If LICENSEE is convicted of a felony relating to the manufacture, use, or sale of LICENSED PRODUCTS.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.537%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(f)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Except as provided in Subsections (a), (b), and (c)&#160;above, if LICENSEE defaults in the performance of any material obligations under this Agreement and the default has not been remedied within forty-five (45)&#160;days after the date of notice in writing of such default by HARVARD.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">9.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall provide, in all sublicenses granted by it under this Agreement, that LICENSEE&#8217;s interest in such sublicenses shall at HARVARD&#8217;s option terminate or be assigned to HARVARD upon termination of this Agreement&#59; however, LICENSEE shall have the option to nominate one of its sublicensees as a substitute for LICENSEE. The proposed substitute must (i)&#160;have a net worth of at least equivalent to the net worth LICENSEE had as of the date of this Agreement and (ii)&#160;have available resources and sufficient scientific, business and other expertise comparable to LICENSEE in order to satisfy its obligations under this Agreement. At least sixty (60)&#160;days prior to termination of this Agreement, LICENSEE shall provide HARVARD with written notice of LICENSEE&#8217;s nominee together with documentation sufficient to demonstrate the requirements set forth in subparagraphs (i)&#160;and (ii)&#160;above for HARVARD&#8217;s approval, which shall not be unreasonably withheld. HARVARD shall notify LICENSEE in writing of its decision prior to termination of this Agreement. If HARVARD approves LICENSEE&#8217;s nominee, LICENSEE shall assign this Agreement to its nominee and its nominee shall accept the assignment no later than thirty (30)&#160;days after the termination date of this Agreement.</font></td></tr></table></div><div style="margin-top:4.5pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that HARVARD disapproved LICENSEE&#8217;s first nominee, prior to the termination date of this Agreement, LICENSEE shall have the option to nominate one of its other sublicensees for HARVARD&#8217;s approval which shall not be unreasonably withheld.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">9.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE may terminate this Agreement by giving ninety (90)&#160;days advance written notice of termination to HARVARD. Upon termination, LICENSEE shall submit a final Royalty Report to HARVARD and any royalty payments and unreimbursed patent expenses invoiced by HARVARD shall become immediately payable.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">9.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Sections&#160;6.1, 6.2, 6.3, 7.1, 9.4, 9.5, 10.2, 10.3, 10.4, and 10.7 of this Agreement shall survive termination.</font></td></tr></table></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE X</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GENERAL</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD does not warrant the validity of the PATENT RIGHTS licensed hereunder and make no representations whatsoever with regard to the scope of the licensed PATENT RIGHTS or that such PATENT RIGHTS may be exploited by LICENSEE, an AFFILIATE, or SUBLICENSEE without infringing other patents, provided, however, HARVARD represents that it has no knowledge of any facts or circumstances as of the execution date of this Agreement that would render any of the PATENT RIGHTS invalid or unenforceable. HARVARD represents and warrants, to the best of its knowledge, that HARVARD owns all right, title and interest in and to the PATENT RIGHTS.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD EXPRESSLY DISCLAIMS ANY AND ALL IMPLIED WARRANTIES AND MAKES NO EXPRESS OR IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE OF THE PATENT RIGHTS OR INFORMATION SUPPLIED BY HARVARD, LICENSED PROCESSES OR LICENSED PRODUCTS CONTEMPLATED BY THIS AGREEMENT.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.015%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall indemnify, defend and hold harmless HARVARD and its current or former directors, governing board members, trustees, officers, faculty, medical and professional staff, employees, students, and agents and their respective successors, heirs and assigns (collectively, the &#8220;INDEMNITEES&#8221;), from and against any claim, liability, cost, expense, damage, deficiency, loss or obligation of any kind or nature (including, without limitation, reasonable attorney&#8217;s fees and other costs and expenses of litigation) (collectively, &#8220;Claims&#8221;), based upon, arising out of, or otherwise relating to this Agreement, including without limitation any cause of action relating to product liability concerning any product, process, or service made, used or sold pursuant to any right or license granted under this Agreement, provided, however, that such indemnification shall not apply to any liability, damage, loss, or expense to the extent directly attributable to the negligent activities, reckless misconduct or intentional misconduct of Indemnitees.</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Each Indemnitee that intends to claim indemnification under Section&#160;10.3(a) shall promptly notify LICENSEE of any claim or action in respect of which the Indemnitee intends to claim such indemnification, and LICENSEE shall assume the defense thereof with counsel mutually satisfactory to LICENSEE and HARVARD. The failure to deliver notice to LICENSEE within a reasonable time after the</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.327%"><tr><td style="width:1.0%"></td><td style="width:3.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.073%"></td><td style="width:0.1%"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">commencement of any such claim or action, if materially prejudicial to its ability to defend such action, shall relieve LICENSEE of any liability to the Indemnitee under Section&#160;10.3(a) with respect to such action, but the omission so to deliver notice to LICENSEE will not relieve it of any liability that it may have to any Indemnitee otherwise than under Section&#160;10.3(a). HARVARD and any other Indemnitee, and their respective employees and agents, shall cooperate fully with LICENSEE and its legal representatives in the investigation of any claim or action covered by the indemnification under Section&#160;10.3(a).</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(c)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Beginning at the time any such product, process or service is being commercially distributed or sold (other than for the purpose of obtaining regulatory approvals) by LICENSEE or by a SUBLICENSEE, AFFILIATE or agent of LICENSEE, LICENSEE shall, at its sole cost and expense, procure and maintain commercial general liability insurance in amounts not less than &#91;***&#125; per incident and &#91;***&#125; annual aggregate and naming the Indemnitees as additional insureds. During clinical trials of any such product, process or service, LICENSEE shall, at its sole cost and expense, procure and maintain commercial general liability insurance in such equal or lesser amount as HARVARD shall require, naming the Indemnitees as additional insureds. Such commercial general liability insurance shall provide&#58; (i)&#160;product liability coverage&#59; and (ii)&#160;broad form contractual liability coverage for LICENSEE&#8217;s indemnification under this Agreement. If LICENSEE elects to self-insure all or part of the limits described above (including deductibles or retentions which are in excess of &#91;***&#125; annual aggregate) such self-insurance program must be acceptable to HARVARD and the Risk Management Foundation of the Harvard Medical Institutions, Inc. in their sole discretion. The minimum amounts of insurance coverage required shall not be construed to create a limit of LICENSEE&#8217;s liability with respect to its indemnification under this Agreement.</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(d)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall provide HARVARD with written evidence of such insurance upon request of HARVARD. LICENSEE shall provide HARVARD with written notice at least fifteen (15)&#160;days prior to the cancellation, non-renewal or material change in such insurance&#59; if LICENSEE does not obtain replacement insurance providing comparable coverage within such fifteen (15)&#160;day period, HARVARD shall have the right to terminate this Agreement effective at the end of such fifteen (15)&#160;day period without notice or any additional waiting periods.</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(e)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall maintain such commercial general liability insurance beyond the expiration or termination of this Agreement during&#58; (i)&#160;the period that any product, process, or service, relating to, or developed pursuant to, this Agreement is being commercially distributed or sold by LICENSEE or by a SUBLICENSEE, AFFILIATE or agent of LICENSEE&#59; and (ii)&#160;a reasonable period after the period referred to in Subsection (e)(i) above which in no event shall be less than fifteen (15)&#160;years.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.327%"><tr><td style="width:1.0%"></td><td style="width:4.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.283%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall not use HARVARD&#8217;s name or insignia, or any adaptation of them, or the name of any of HARVARD&#8217;s inventors in any advertising, promotional or sales literature without the prior written approval of HARVARD.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Without the prior written approval of HARVARD in each instance, neither this Agreement nor the rights granted hereunder shall be transferred or assigned in whole or in part by LICENSEE to any person whether voluntarily or involuntarily, by operation of law or otherwise, except that each of LICENSEE and its AFFILIATES may assign this Agreement in connection with a merger, consolidation or sale or transfer of all or substantially all of its assets. This Agreement shall be binding upon the respective successors, legal representatives and assignees of HARVARD and LICENSEE.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The interpretation and application of the provisions of this Agreement shall be governed by the laws of the Commonwealth of Massachusetts.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall comply with all applicable laws and regulations. In particular, it is understood and acknowledged that the transfer of certain commodities and technical data is subject to United States laws and regulations controlling the export of such commodities and technical data, including all Export Administration Regulations of the United States Department of Commerce. These laws and regulations among other things, prohibit or require a license for the export of certain types of technical data to certain specified countries. LICENSEE hereby agrees and gives written assurance that it will comply with all United States laws and regulations controlling the export of commodities and technical data, that it will be solely responsible for any violation of such by LICENSEE or its AFFILIATES or SUBLICENSEES, and that it will defend and hold HARVARD, CHILDREN, and MIT harmless in the event of any legal action of any nature occasioned by such violation.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE agrees&#58; (i)&#160;to obtain all regulatory approvals required for the manufacture and sale of LICENSED PRODUCTS and LICENSED PROCESSES&#59; and (ii)&#160;to utilize appropriate patent marking on such LICENSED PRODUCTS. LICENSEE also agrees to register or record this Agreement as is required by law or regulation in any country where the license is in effect.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.695%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Any notices to be given hereunder shall be sufficient if signed by the party (or party&#8217;s attorney) giving same and either&#58; (i)&#160;delivered in person&#59; (ii)&#160;mailed certified mail return receipt requested&#59; or (iii)&#160;faxed to other party if the sender has evidence of successful transmission and if the sender promptly sends the original by ordinary mail, in any event to the following addresses&#58;</font></td></tr></table></div><div style="margin-top:10pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If to LICENSEE&#58;</font></div><div style="margin-top:4.5pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mycometrix Corporation</font></div><div style="padding-left:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">213 E. Grand Ave.</font></div><div style="padding-left:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">South San Francisco, CA 94080</font></div><div style="padding-left:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attention&#58;</font></div><div style="padding-left:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fax&#58; (650)-</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="margin-top:10pt;text-indent:31.5pt"><font><br></font></div><div style="text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If to HARVARD&#58;</font></div><div style="margin-top:4.5pt;padding-left:49.5pt;text-indent:-0.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Office for Technology and Trademark Licensing</font></div><div style="padding-left:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Harvard University</font></div><div style="padding-left:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holyoke Center, Suite&#160;727</font></div><div style="padding-left:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1350 Massachusetts Avenue</font></div><div style="padding-left:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cambridge, MA 02138</font></div><div style="margin-bottom:18pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fax&#58; (617)&#160;495-9568</font></div><div style="margin-bottom:10pt;margin-top:4.5pt;padding-left:31.5pt;text-indent:-0.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By such notice either party may change their address for future notices.</font></div><div style="margin-top:4.5pt;padding-left:31.5pt;text-indent:-0.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notices delivered in person shall be deemed given on the date delivered. Notices sent by fax shall be deemed given on the date faxed. Notices mailed shall be deemed given on the date postmarked on the envelope.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.853%"><tr><td style="width:1.0%"></td><td style="width:5.190%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.610%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Should a court of competent jurisdiction later hold any provision of this Agreement to be invalid, illegal, or unenforceable, and such holding is not reversed on appeal, it shall be considered severed from this Agreement. All other provisions, rights and obligations shall continue without regard to the severed provision, provided that the remaining provisions of this Agreement are in accordance with the intention of the parties.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.853%"><tr><td style="width:1.0%"></td><td style="width:5.190%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.610%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In the event of any controversy or claim arising out of or relating to any provision of this Agreement or the breach thereof, the parties shall try to settle such conflict amicably between themselves. Subject to the limitation stated in the final sentence of this Section&#160;10.11, any such conflict which the parties are unable to resolve promptly shall be settled through arbitration conducted in accordance with the rules of the American Arbitration Association. The demand for arbitration shall be filed within a reasonable time after the controversy or claim has arisen, and in no event after the date upon which institution of legal proceedings based on such controversy or claim would be barred by the applicable statute of limitation. Such arbitration shall be held in Boston, Massachusetts. The award through arbitration shall be final and binding. Either party may enter any such award in a court having jurisdiction or may make application to such court for judicial acceptance of the award and an order of enforcement, as the case may be. Notwithstanding the foregoing, either party may, without recourse to arbitration, assert against the other party a third-party claim or cross-claim in any action brought by a third party, to which the subject matter of this Agreement may be relevant.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.853%"><tr><td style="width:1.0%"></td><td style="width:5.190%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.610%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.12</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">This Agreement constitutes the entire understanding between the parties and neither party shall be obligated by any condition or representation other than those expressly stated herein or as may be subsequently agreed to by the parties hereto in writing.</font></td></tr></table></div><div style="margin-top:20pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;The remainder of this page is intentionally blank.&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed by their duly authorized representatives.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.486%"><tr><td style="width:1.0%"></td><td style="width:30.800%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.800%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.118%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">PRESIDENT AND FELLOWS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">MYCOMETRIX CORPORATION</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">OF HARVARD COLLEGE</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#47;s&#47; Joyce Brinton</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#47;s&#47; Gajus Worthington</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Joyce Brinton, Director</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Office for Technology and</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">President</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Trademark Licensing</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">12&#47;7&#47;00</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">12&#47;10&#47;00</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Date</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Date</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">APPENDIX A</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following comprise PATENT RIGHTS&#58;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#91;***&#125;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;***&#125;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3A
<SEQUENCE>6
<FILENAME>exhibit103a10q3q2020.htm
<DESCRIPTION>EX-10.3A
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="ib625ecf619354c5cbdb603fc009d361a_1"></div><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;10.3A</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">First Amendment</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">To</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Co-Exclusive License Agreement</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Between</font></div><div style="margin-top:4.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PRESIDENT AND FELLOWS OF HARVARD COLLEGE</font></div><div style="margin-top:4.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">And</font></div><div style="margin-top:4.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">MYCOMETRIX CORPORATION (now Fluidigm Corporation)</font></div><div style="margin-top:4.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Re&#58; Harvard Case #&#91;***&#93;</font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This is the first amendment to a co-exclusive license agreement effective October&#160;15, 2000, by and between the President and Fellows of Harvard College, with offices at 1350 Massachusetts Avenue, Suite&#160;727, Cambridge, MA 02138 (&#8220;Harvard&#8221;) and Mycometrix Corporation, a California Corporation, with offices at 213 East Grand Avenue, South San Francisco, CA 94080 (&#8220;Licensee&#8221;).</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, Licensee has changed its name to Fluidigm Corporation, and moved to a new address at 7100 Shoreline Court, South San Francisco, California 94080&#59; and</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, both parties desire to clarify the definition of NET SALES and to make various minor changes to the Agreement.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NOW THEREFORE, Harvard and Licensee agree as follows&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.827%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">1.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Change Paragraph&#160;1.5 to&#58;</font></td></tr></table></div><div style="margin-bottom:8pt;margin-top:10pt;padding-left:45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">LICENSED PROCESSES&#58; the processes claimed, in whole or in part, by at least one VALID CLAIM included within PATENT RIGHTS.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.827%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">2.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Change Paragraph&#160;1.6 to&#58;</font></td></tr></table></div><div style="margin-top:10pt;padding-left:45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">LICENSED PRODUCTS&#58; the products which are claimed, or the use of which is claimed, by at least one VALID CLAIM included within</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed.</font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:8pt;padding-left:45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">PATENT RIGHTS or products made or services provided in accordance with or by means of LICENSED PROCESSES.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.827%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">3.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Change Paragraph&#160;1.7 to&#58;</font></td></tr></table></div><div style="margin-bottom:8pt;margin-top:10pt;padding-left:45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">LICENSEE&#58; Fluidigm Corporation, a corporation organized under the laws of California, having its principal offices at 7100 Shoreline Court, South San Francisco, California 94080.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.827%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">4.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Change the second full paragraph of Paragraph&#160;1.9 to&#58;</font></td></tr></table></div><div style="margin-bottom:8pt;margin-top:10pt;padding-left:45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the event that a LICENSED PRODUCT is sold or leased as a combination product containing the LICENSED PRODUCT and one or more other components, NET SALES shall be calculated by multiplying the gross amount invoiced for the sale of the combination product by the fraction A&#47;A+B, where A is the average gross selling price of the LICENSED PRODUCT sold separately by LICENSEE, and B is the average gross selling price of such other components of the combination products sold separately by LICENSEE during the relevant royalty payment period. In the event a substantial number of such separate sales were not made during the relevant royalty period, then NET SALES shall be reasonably allocated by LICENSEE between such LICENSED PRODUCT and such other components of the combination based on their relative importance or value. If LICENSEE does so allocate, LICENSEE shall promptly deliver to HARVARD a written report providing a detailed explanation of how LICENSEE determined said relative importance or value. In the event that HARVARD disagrees with the determination made by LICENSEE of said allocation of importance or value, HARVARD shall so notify LICENSEE in writing, and a representative of LICENSEE and a representative of HARVARD shall meet in order to discuss and resolve such disagreement. If such disagreement cannot be resolved within sixty (60)&#160;days, such disagreement shall be subject to resolution in accordance with Section&#160;10.11.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.827%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">5.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Add the following sentence to the end of Paragraph&#160;1.10&#58;</font></td></tr></table></div><div style="margin-top:10pt;padding-left:45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, SERVICE INCOME shall be subject to the following deductions&#58;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.734%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">i)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">customary trade, quantity or cash discounts and non-affiliated broker&#8217;s or agents&#8217; commissions actually allowed and taken&#59;</font></td></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.717%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.673%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.673%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">ii)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">amounts repaid or credited by reason of rejection&#59; and</font></td></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.717%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.673%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.673%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">iii)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">to the extent separately stated on purchase orders, invoices, or other documents of sale, taxes levied on and&#47;or other governmental</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed.</font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.802%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">charges made as to performance, production, sale or use and paid by or on behalf of LICENSE.</font></td></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.827%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">6.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Change Paragraph&#160;1.15 to&#58;</font></td></tr></table></div><div style="margin-bottom:8pt;margin-top:10pt;padding-left:45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">VALID CLAIM&#58; either (i)&#160;a claim of an issued patent that has not been held unenforceable or invalid by an agency or a court of competent jurisdiction in any unappealable or unappealed decision or (ii)&#160;a claim of a pending patent application that has not been abandoned or finally rejected without the possibility of appeal or refiling and that has been pending for less than six (6)&#160;years from the earlier of a) the first priority date of such patent application or b) the effective date of this Agreement.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.827%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">7.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Change Paragraph&#160;3.2(c) to&#58;</font></td></tr></table></div><div style="margin-bottom:8pt;margin-top:10pt;padding-left:45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">LICENSEE shall use commercially reasonable efforts to effect introduction of the LICENSED PRODUCTS into the commercial market as soon as practicable, consistent with sound and reasonable business practice and judgment&#59; thereafter, until the expiration of this Agreement, LICENSEE shall endeavor to keep LICENSED PRODUCTS reasonably available to the public, in each case consistent with industry practices for similar companies and similar products.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.827%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">8.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Replace the last two sentences of Paragraph&#160;3.2(e) with&#58;</font></td></tr></table></div><div style="margin-bottom:8pt;margin-top:10pt;padding-left:45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;Copies of all sublicense agreements shall be promptly provided to HARVARD. If a sublicense agreement is part of a larger agreement (i.e., one that includes a business relationship in addition to a sublicense agreement), LICENSEE need only send the part of said larger agreement that is the sublicense agreement. HARVARD agrees to maintain any information contained in such sublicensing agreements in confidence, except as otherwise required by law, however, HARVARD may include in its usual reports annual amounts of royalties paid.&#8221;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.827%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">9.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">In Paragraph&#160;5.3 delete &#8220;in each country&#8221;, so LICENSEE needs to report the date of first sale in the first country to have a sale, but LICENSEE still needs to report the date of first sale for each LICENSED PRODUCT.</font></td></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.827%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">10.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Replace Paragraph&#160;6.2 with&#58;</font></td></tr></table></div><div style="margin-bottom:8pt;margin-top:10pt;padding-left:45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;HARVARD&#8217;s accountant shall not disclose to HARVARD any information other than whether the reports are correct or not, the reasons for any incorrectness and the amount of any discrepancies.&#8221;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed.</font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.827%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">11.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Add new Paragraph&#160;6.4&#58;</font></td></tr></table></div><div style="margin-bottom:8pt;margin-top:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;Such examination by HARVARD&#8217;s accountant shall take place not more than once in each calendar year.&#8221;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.827%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">12.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Change Paragraph&#160;9.2(d) to&#58;</font></td></tr></table></div><div style="margin-bottom:8pt;margin-top:10pt;text-indent:36.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;If an examination by HARVARD&#8217;s accountant pursuant to Article&#160;V shows an underreporting or underpayment by LICENSEE in excess of twenty (20%)&#160;percent for any twelve (12)&#160;month period and HARVARD&#8217;s accountant determines said underreporting or underpayment was not inadvertent or not the result of an honest mistake on LICENSEE&#8217;s part. In that event, LICENSEE may promptly request HARVARD to have its accountant&#8217;s findings reviewed by another independent certified public accounting firm of nationally recognized standing reasonably acceptable to LICENSEE, the total cost of which will be invoiced to LICENSEE and paid within thirty (30)&#160;days. If said review indicates said underreporting or underpayment by LICENSEE was inadvertent or the result of an honest mistake then HARVARD will not terminate this Agreement.&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.827%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">13.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">In Paragraph&#160;10.9, change lines 6-11 to&#58;</font></td></tr></table></div><div style="margin-bottom:8pt;margin-top:10pt;padding-left:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If to LICENSEE&#58;</font></div><div style="margin-top:9pt;padding-left:45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Fluidigm Corporation</font></div><div style="padding-left:45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7100 Shoreline Court</font></div><div style="padding-left:45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">South San Francisco, CA 94080</font></div><div style="padding-left:45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attention&#58; General Counsel</font></div><div style="padding-left:45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Fax&#58; 650-871-7195</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In all other respects the co-exclusive License Agreement, effective October&#160;15, 2000, shall remain the same. This amendment shall become effective upon both parties signing below, and have an effective date of January&#160;1, 2005.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the parties hereto have caused this second amendment to be executed by their duly authorized representatives.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.108%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.973%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">PRESIDENT AND FELLOWS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">FLUIDIGM</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">OF HARVARD COLLEGE&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">CORPORATION&#58;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="12" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#47;s&#47; Joyce Brinton</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#47;s&#47; Gajus Worthington</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Joyce Brinton</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Director</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Printed&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Gajus Worthington</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Office for Technology and</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Trademark Licensing</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">President &#38; CEO</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Date&#58; 12&#47;22&#47;04</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">12&#47;23&#47;04</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>7
<FILENAME>exhibit10410q3q2020.htm
<DESCRIPTION>EX-10.4
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i3555c4180e444511aca4116f9571cd13_1"></div><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;10.4</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4060.LICI.008 Harvard</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CO-EXCLUSIVE LICENSE AGREEMENT</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Between</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">President and Fellows of Harvard College</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">And</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mycometrix Corporation</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective as of October&#160;15, 2000</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Re&#58; Harvard Case #&#91;***&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In consideration of the mutual promises and covenants set forth below, the parties hereto agree as follows&#58;</font></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE I</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DEFINITIONS</font></div><div style="margin-top:9pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As used in this Agreement, the following terms shall have the following meanings&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">ACADEMIC RESEARCH PURPOSES&#58; use of PATENT RIGHTS for academic research or other not-for-profit scholarly purposes which are undertaken at a non-profit or governmental institution that does not use the PATENT RIGHTS in the production or manufacture of products for sale or the performance of services for a fee.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">AFFILIATE&#58; any entity which controls, is controlled by, or is under common control with a party by ownership or control of at least fifty percent (50%)&#160;of the voting stock or other ownership. Unless otherwise specified, the term LICENSEE includes AFFILIATES.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">FIELD&#58; use of PATENT RIGHTS to develop, manufacture, use, offer for sale, sell, or import components and products in FIELD I and&#47;or FIELD II&#58;</font></td></tr></table></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FIELD I&#58; &#91;***&#93;</font></div><div style="margin-top:4.5pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FIELD II&#58; &#91;***&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD&#58; President and Fellows of Harvard College, a nonprofit Massachusetts educational corporation having offices at the Office for Technology and Trademark Licensing, Holyoke Center, Suite&#160;727, 1350 Massachusetts Avenue, Cambridge, Massachusetts 02138.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSED PROCESSES&#58; the processes covered by at least one VALID CLAIM included within the PATENT RIGHTS.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSED PRODUCTS&#58; products covered by at least one VALID CLAIM included within the PATENT RIGHTS or products made or services provided in accordance with or by means of LICENSED PROCESSES.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE&#58; Mycometrix Corporation, a corporation organized under the laws of Califonia having its principal offices at 213 East Grand Avenue, South San Francisco, CA 94080.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">NET SERVICE INCOME&#58; SERVICE INCOME less LICENSEE&#8217;S actual direct and indirect cost for research, development and&#47;or services provided.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">NET SALES&#58; the amount actually received for sales, leases, or other transfers of LICENSED PRODUCTS, less&#58;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.756%"><tr><td style="width:1.0%"></td><td style="width:3.981%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.768%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.951%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(i)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">customary trade, quantity or cash discounts and non-affiliated brokers&#8217; or agents&#8217; commissions actually allowed and taken&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:79.807%"><tr><td style="width:1.0%"></td><td style="width:5.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.038%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(ii)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">amounts repaid or credited by reason of rejection or return&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.916%"><tr><td style="width:1.0%"></td><td style="width:3.973%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.755%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.972%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(iii)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">to the extent separately stated on purchase orders, invoices, or other documents of sale, taxes levied on and&#47;or other governmental charges made as to production, sale, transportation, delivery or use and paid by or on behalf of LICENSEE&#59; and</font></td></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.538%"><tr><td style="width:1.0%"></td><td style="width:4.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.272%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(iv)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">reasonable charges for delivery or transportation provided by third parties and cost of insurance in transit, if separately stated.</font></td></tr></table></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NET SALES also includes the fair market value of any non-cash consideration received by LICENSEE for the sale, lease, or transfer of LICENSED PRODUCTS.</font></div><div style="margin-top:4.5pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a LICENSED PRODUCT is sold as a combination product containing the LICENSED PRODUCT and one or more other components, NET SALES shall be calculated by multiplying the gross amount invoiced for the sale of the combination product by the fraction A&#47;A+B where A is the average gross selling price of the LICENSED PRODUCT sold separately by LICENSEE and B is the average gross selling price of such other components of the combination products sold separately by LICENSEE during the relevant royalty payment period.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that LICENSEE grants a sublicensee hereunder, and receives payments based upon SUBLICENSEE&#8217;s sales of LICENSED PRODUCTS, LICENSEE may upon approval from HARVARD (which shall not be unreasonably withheld) modify the definition of NET SALES for the purposes of calculating royalties payable to HARVARD on such SUBLICENSEE&#8217;s sales to be the same as the definition of NET SALES on which such royalties to LICENSEE are calculated.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">SERVICE INCOME&#58; the total financial consideration received by LICENSEE for commercial services performed on a fee-for-service basis using the LICENSED PRODUCTS or LICENSED PROCESSES by LICENSEE under a contract with a third party, where such services are based primarily on the use of fully functional LICENSED PRODUCTS or LICENSED PROCESSES (as applicable) for their intended commercial use (such as, for example, where LICENSEE performs commercial-scale genotyping services for a pharmaceutical company on a fee-for-service basis using fully developed microfluidics chips comprising LICENSED PRODUCTS). SERVICE INCOME shall not include amounts received in connection with research and&#47;or development of LICENSED PRODUCTS or LICENSED PROCESSES themselves.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">PATENT RIGHTS&#58; The applications and patents filed on the basis of the disclosure attached in Appendix&#160;A of this Agreement, the allowed claims of such applications, the inventions described and claimed therein, and any divisions or continuations of the applications and patents, and specific claims of any continuations-in-part of such applications to the extent the specific claims are directed to subject matter described in the applications and patents in a manner sufficient to support such specific claims under 35 U.S.C., patents issuing thereon or reissues thereof, and any and all foreign patents and patent applications corresponding thereto, all to the extent owned or controlled by HARVARD.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.12</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">SUBLICENSE INCOME&#58; the amount paid to LICENSEE by a third party (other than an AFFILIATE of LICENSEE) (a)&#160;for the sublicening of PATENT RIGHTS to a third party as well as (b)&#160;for the related licensing of LICENSEE&#8217;s own patent rights or know-how or LICENSEE&#8217;s in-licensed non-HARVARD technologies, including but not limited to (i)&#160;license fees, (ii)&#160;milestone payments, (iii)&#160;royalties, (iv)&#160;the fair market value in cash of any non-cash consideration for such sublicense, and (v)&#160;in the event that LICENSEE receives any payment for equity in consideration for the grant of sublicense rights that included a premium over the fair market value of such equity, the amount of such premium. LICENSEE shall be responsible for determining such fair market value with reasonable business judgment.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.13</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">SUBLICENSEE&#58; any non-AFFILIATE granted a sublicense of any of the rights HARVARD has granted to LICENSEE under Section&#160;3.1.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.14</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">TERRITORY&#58; Worldwide.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.15</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">VALID CLAIM&#58; either (i)&#160;a claim of an issued patent that has not been held unenforceable or invalid by an agency or a court of competent jurisdiction in any unappealable or unappealed decision or (ii)&#160;a claim of a published, pending patent application, which claim is substantially identical to a corresponding claim in a subsequently issued patent having priority to the patent application.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.16</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The terms &#8220;Public Law 96-517&#8221; and &#8220;Public Law 98-620&#8221; include all amendments to those statutes.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.17</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The terms &#8220;sold&#8221; and &#8220;sell&#8221; include, without limitation, leases and other transfers and similar transactions.</font></td></tr></table></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE II</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REPRESENTATIONS</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD is or will be owner by assignment from &#91;***&#93; in the US and foreign patent applications corresponding thereto, and in the inventions described and claimed therein. Inventorship will be finalized at the time of the US utility filing or in the near future when it is necessary.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD has authority to issue licenses under PATENT RIGHTS.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD is committed to the policy that ideas or creative works produced at HARVARD should be used for the greatest possible public benefit, and believes that every reasonable incentive should be provided for the prompt introduction of such ideas into public use, all in a manner consistent with the public interest.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE is prepared and intends to diligently develop the invention and to bring products to market which are subject to this Agreement, specifically including one or more products in the FIELD selected from a &#91;***&#93;.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE is desirous of obtaining a co-exclusive license in the FIELD and in the TERRITORY in order to practice the PATENT RIGHTS in the United States and in certain foreign countries, and to manufacture, use and sell in the commercial market the products made in accordance therewith, and HARVARD is desirous of granting such a license to LICENSEE in accordance with the terms of this Agreement.</font></td></tr></table></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE III</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GRANT OF RIGHTS</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD hereby grants to LICENSEE and LICENSEE accepts, subject to the terms and conditions hereof, in the TERRITORY a co-exclusive commercial license under PATENT</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RIGHTS in FIELD I and in FIELD II to make and have made, to use and have used, to sell and have sold, and to offer for sale and have offered for sale the LICENSED PRODUCTS, and to practice the LICENSED PROCESSES, for the life of the PATENT RIGHTS. HARVARD will grant no more than two commercial licenses in FIELD I at any time and will grant no more than two commercial licenses in FIELD II at any time and HARVARD will not grant other licenses in the FIELD except as required by HARVARD&#8217;s obligations in Section&#160;3.2(a) or as permitted Section&#160;3.2(b). Such co-exclusive license shall include the right to grant sublicenses under the following circumstances&#58; (i)&#160;LICENSEE can demonstrate that it has added significant value to the PATENT RIGHTS to be sublicensed, and that such a sublicense also contains a substantial and essentially simultaneous license of LICENSEE owned intellectual property, or (ii)&#160;LICENSEE grants a sublicense under other HARVARD patent rights licensed exclusively to LICENSEE which are dominated by PATENT RIGHTS, and such sublicense under PATENT RIGHTS is necessary to practice such other HARVARD patent rights.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The granting and exercise of this license is subject to the following conditions&#58;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD&#8217;s &#8220;Statement of Policy in Regard to Inventions, Patents and Copyrights,&#8221; dated August&#160;10, 1998, Public Law 96-517, Public Law 98-620. In addition, this Agreement is subject to HARVARD&#8217;s obligations under agreements with other sponsors of research, provided that such obligations are not in conflict with the rights granted hereunder. Any right granted in this Agreement greater than that permitted under Public Law 96-517, or Public Law 98-620, shall be subject to modification as may be required to conform to the provisions of those statutes.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD reserves the right to make and use, and grant to others non-exclusive licenses to make and use solely for ACADEMIC RESEARCH PURPOSES the subject matter described and claimed in PATENT RIGHTS.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(c)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall use commercially reasonable efforts to effect introduction of the LICENSED PRODUCTS into the commercial market as soon as practicable, consistent with sound and reasonable business practice and judgment&#59; thereafter, until the expiration of this Agreement, LICENSEE shall endeavor to keep LICENSED PRODUCTS reasonably available to the public.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(d)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">At any time after three years from the effective date of this Agreement and as HARVARD&#8217;s sole remedy for such non-performance, HARVARD may increase the license maintenance royalty under Section&#160;4.4 to &#91;***&#93; dollars each in FIELD I and in FIELD II in year 2004 and &#91;***&#93; dollars each in FIELD I and in FIELD II per year each year beginning in 2005, if in HARVARD&#8217;s reasonable judgment, the Progress Reports furnished by LICENSEE do not demonstrate that LICENSEE has satisfied at least one of the following conditions, which non-performance is not cured within ninety (90)&#160;days following the written notification of such by HARVARD to LICENSEE&#58;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:7.799%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(i)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">has put the licensed subject matter into commercial use in at least one of the countries hereby licensed, directly or through a sublicense, and is keeping the licensed subject matter reasonably available to the public&#59; or</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:7.799%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(ii)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">is engaged in research, development, manufacturing, marketing or sublicensing activity appropriate to achieving 3.2(d)(i).</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(e)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In all sublicenses granted by LICENSEE hereunder, LICENSEE shall include a requirement that the SUBLICENSEE use commercially reasonable efforts to bring the subject matter of the sublicense into commercial use. LICENSEE shall further provide in such sublicenses that such sublicenses are subject and subordinate to the terms and conditions of this Agreement, except&#58; (i)&#160;the SUBLICENSEE may not further sublicense&#59; and (ii)&#160;the rate of royalty on NET SALES paid by the SUBLICENSEE to the LICENSEE. Copies of the relevant provisions of all sublicense agreements shall be provided promptly to HARVARD. HARVARD agrees to maintain any information contained in such provisions in confidence, except as otherwise required by law, however, HARVARD may include in its usual reports annual amounts of royalties paid.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(f)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">A license in any other field of use in addition to the FIELD shall be the subject of a separate agreement and shall require LICENSEE&#8217;s submission of evidence, satisfactory to HARVARD, demonstrating LICENSEE&#8217;s willingness and ability to develop and commercialize in such other field of use the kinds of products or processes likely to be encompassed in such other fields.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(g)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">To the extent that federal funds are used to support research leading to a patent or patent application in the PATENT RIGHTS, LICENSEE shall cause any LICENSED PRODUCT produced for sale by LICENSEE or SUBLICENSEES in the United States to be manufactured substantially in the United States during the period of exclusivity of this license in the United States.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">All rights reserved to the United States Government and others under Public Law 96-517, and Public Law 98-620, shall remain and shall in no way be affected by this Agreement.</font></td></tr></table></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE IV</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ROYALTIES</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall pay to HARVARD a non-refundable license royalty fee in the sum of &#91;***&#93; payable within thirty (30)&#160;days of the execution date of this Agreement.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(a)&#160;In consideration of the right and license granted herein, LICENSEE shall pay to HARVARD during the term of this Agreement a royalty of &#91;***&#93; on NET SALES of LICENSED PRODUCTS sold by LICENSEE.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;In the event that a single LICENSED PRODUCT or LICENSED PROCESS is covered by HARVARD intellectual property in addition to PATENT RIGHTS, which is licensed to LICENSEE under other agreements as of the date of this Agreement, then the total royalty payment due HARVARD under all such agreements including this Agreement shall be &#91;***&#93; of NET SALES. LICENSEE shall notify HARVARD of the identity of each license agreement that includes patent rights covering the product or process, and HARVARD shall distribute the royalties evenly among such agreements.</font></div><div style="margin-top:4.5pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;As consideration for the rights granted hereunder, LICENSEE shall pay to HARVARD during the term of this Agreement a royalty in the form of stock of LICENSEE as follows&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:6.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.829%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(i)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall issue to HARVARD &#91;***&#93; shares of the Common Stock of LICENSEE (&#8220;Shares&#8221;) pursuant to the terms of a mutually acceptable Stock Subscription Agreement, provided, however, that HARVARD shall be subject to and enter into appropriate agreements and related documents as required of other stockholders of LICENSEE.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:6.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.829%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(ii)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD represents and warrants to LICENSEE that&#58;</font></td></tr></table></div><div style="margin-top:4.5pt;padding-left:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;HARVARD is acquiring the Shares for its own account for investment and not with a view to, or for sale in connection with any distribution thereof, nor with any present intention of distributing or selling the same&#59; and HARVARD has no present or contemplated agreement, undertaking, arrangement, obligation, indebtedness or commitment providing for the disposition thereof.</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;HARVARD has full power and authority to enter into and to perform this Agreement in accordance with its terms.</font></div><div style="margin-top:4.5pt;padding-left:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)&#160;HARVARD has sufficient knowledge and experience in investing in companies similar to LICENSEE so as to be able to evaluate the risks and merits of its investment in LICENSEE and is able financially to bear the risks thereof.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:6.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.829%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(iii)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Each certificate representing the Shares shall bear a legend substantially in the following form&#58;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="padding-left:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;The shares represented by this certificate have not been registered under the Securities Act of 1933 or any state securities law and they may not be sold or otherwise transferred by any person, including a pledgee, unless (1)&#160;either (a)&#160;a registration statement with respect to such shares shall be effective under the Securities Act of 1933, as amended, or (b)&#160;the Corporation shall have received an opinion of counsel satisfactory to the Corporation that an exemption from registration under such Act is then available, and (2)&#160;there shall have been compliance with all applicable securities laws.&#8221;</font></div><div style="margin-top:4.5pt;padding-left:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;The shares represented by this certificate are subject to a mutually agree-upon Stock Purchase and Right of First Refusal Agreement with this Corporation, a copy of which Stock Purchase and Right of First Refusal Agreement is available for inspection at the offices of the Corporation or may be made available upon request.&#8221;</font></div><div style="margin-top:4.5pt;padding-left:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing legend shall be removed from the certificates representing any Shares, at the request of the holder thereof, at such time as they become eligible for resale pursuant to the Securities Act of 1933, as amended.</font></div><div style="margin-top:4.5pt;padding-left:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If at any time prior to the time the Shares are eligible for resale pursuant to an exemption from registration under the Securities Act of 1933, as amended, LICENSEE proposes to register any of its Common Stock, under the Securities Act of 1933, except at LICENSEE&#8217;s initial public offering or any offering pursuant to Forms S-4 or S-8, LICENSEE shall offer HARVARD the opportunity to have its Shares registered under the registration statement to be filed at such time. HARVARD will be offered the right to register its Shares under the same terms, conditions and restrictions as other shareholders with piggyback registration rights and the inclusion of any Shares in such registration statement shall be subject to the approval of the underwriters of such offering</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)&#160;HARVARD&#8217;s ownership rights to Shares shall not be affected should the license pursuant to this Agreement be converted to a nonexclusive one.</font></div><div style="margin-top:4.5pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;In the case of sublicenses, LICENSEE shall also pay to HARVARD a royalty of &#91;***&#93; of SUBLICENSE INCOME. If compensation for such a sublicense of PATENT RIGHTS is bundled with compensation received for the sublicensing of the other HARVARD patent rights licensed to LICENSEE under other agreements as of the date of this Agreement, LICENSEE shall pay HARVARD only &#91;***&#93; of the total compensation received no matter how many license agreements from HARVARD are involved. In such a case, LICENSEE shall notify HARVARD of the identity of each license agreement involved and HARVARD shall distribute its &#91;***&#93; of</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">compensation equally among those license agreements, including this Agreement.</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;LICENSEE shall pay HARVARD &#91;***&#93; of NET SERVICE INCOME. If SERVICE INCOME is bundled with service income under another license to LICENSEE as of the date of this Agreement, LICENSEE shall pay a royalty of &#91;***&#93; of NET SERVICE INCOME received from each and every third party (&#8220;Third Party&#8221;) to which services are provided. LICENSEE shall notify HARVARD of the identity of each license agreement involved in the services and HARVARD shall distribute its &#91;***&#93; of compensation equally among those license agreements, including this Agreement.</font></div><div style="margin-top:4.5pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;If other co-exclusive licenses in the same FIELD and TERRITORY are granted after the date this Agreement is executed, the above financial compensation shall not exceed the financial compensation to be paid by other licensees in the same FIELD and TERRITORY during the term of the co-exclusive license provided LICENSEE accepts any less favorable terms included in such other license.</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If stock is part of the financial compensation to be paid by other licensees in the same FIELD and TERITORY, the fair market value of the stock shall be the same as the price per share which other investors paid in the last round of financing unless the stock is publicly traded.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On sales between LICENSEE and its AFFILIATES for resale or incorporation into products, the royalty shall be paid on the NET SALES of the AFFILIATE. On sales between LICENSEE and sublicensees for resale, the royalty shall be paid on the SUBLICENSE INCOME.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">No later than January&#160;1 of each calendar year indicated below, LICENSEE shall pay to HARVARD the following non-refundable license maintenance royalty and&#47;or advance on royalties. Such payments shall be credited against running royalties due for that calendar year and Royalty Reports shall reflect such a credit. Such payments shall not be credited against milestone payments (if any) nor against royalties due for any subsequent calendar year nor against such payments due under any other agreements with HARVARD.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.916%"><tr><td style="width:1.0%"></td><td style="width:69.931%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.600%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.600%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.995%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">FIELD&#160;I</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">FIELD&#160;II</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">January&#160;1, 2002</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#91;***&#93;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#91;***&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">January&#160;1, 2003</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#91;***&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#91;***&#93;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">January&#160;1, 2004</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#91;***&#93;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#91;***&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">each year thereafter</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#91;***&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#91;***&#93;</font></td></tr></table></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE V</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REPORTING</font></div><div style="margin-top:9pt;padding-left:27pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt"> Prior to signing this Agreement, LICENSEE has provided to HARVARD a written business plan under which LICENSEE intends to bring the subject matter of the licenses</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.993%"><tr><td style="width:1.0%"></td><td style="width:4.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.725%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">granted hereunder into commercial use upon execution of this Agreement. Such plan includes proposed marketing efforts.</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">No later than sixty (60)&#160;days after June&#160;30 of each calendar year, LICENSEE shall provide to HARVARD a written annual Progress Report describing progress on research and development, regulatory approvals, manufacturing, sublicensing, marketing and sales during the most recent twelve (12)&#160;month period ending June&#160;30 and plans for the forthcoming year. If multiple technologies are covered by the license granted hereunder, the Progress Report shall provide the information set forth above for each technology. If progress differs from that anticipated in the plan required under Section&#160;5.1, LICENSEE shall explain the reasons for the difference and propose a modified plan for HARVARD&#8217;s review. LICENSEE shall also provide any reasonable additional data HARVARD requires to evaluate LICENSEE&#8217;s performance.</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall report to HARVARD the date of first sale of LICENSED PRODUCTS (or results of LICENSED PROCESSES) in each country within thirty (30)&#160;days of occurrence.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(a)&#160;&#160;&#160;&#160;LICENSEE shall submit to HARVARD within sixty (60)&#160;days after each calendar half year ending June&#160;30 and December&#160;31, a Royalty Report setting forth for such half year at least the following information&#58;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.358%"><tr><td style="width:1.0%"></td><td style="width:8.093%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.707%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(i)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">the number of LICENSED PRODUCTS sold by LICENSEE in each country&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:7.799%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(ii)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">total billings and amounts actually received for such LICENSED PRODUCTS&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:7.799%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(iii)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">an accounting for all LICENSED PROCESSES used or sold&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:7.799%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(iv)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">deductions applicable to determine the NET SALES thereof&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:7.799%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(v)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">the amount of SERVICE INCOME received by LICENSEE and an accounting of all deductions to yield NET SERVICE INCOME&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:7.799%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(vi)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">the amount of SUBLICENSE INCOME received by LICENSEE&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:7.799%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(vii)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">the amount of royalty due thereon, or, if no royalties are due to HARVARD for any reporting period, the statement that no royalties are due.</font></td></tr></table></div><div style="margin-top:10pt;padding-left:45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Such report shall be certified as correct by an officer of LICENSEE and shall include a detailed listing of all deductions from royalties.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall pay to HARVARD with each such Royalty Report the amount of royalty due with respect to such half year. If multiple technologies are covered by the license granted hereunder, LICENSEE shall specify which PATENT RIGHTS are utilized for each LICENSED PRODUCT and LICENSED PROCESS included in the Royalty Report.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(c)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">All payments due hereunder shall be deemed received when funds are credited to HARVARD&#8217;s bank account and shall be payable by check or wire transfer in United States dollars. Conversion of foreign currency to U.S. dollars shall be made at the conversion rate existing in the United States (as reported in the New York Times or the Wall Street Journal) on the last working day of each royalty period. No transfer, exchange, collection or other charges shall be deducted from such payments.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(d)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">All such reports shall be maintained in confidence by HARVARD except as required by law&#59; however, HARVARD may include in its usual reports annual amounts of royalties paid.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(e)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Late payments shall be subject to a charge of one and one-half percent (1.5%)&#160;per month, or $250, whichever is greater.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In the event of acquisition, merger, change of corporate name or change in make-up, organization, or identity, LICENSEE shall notify HARVARD in writing within thirty (30)&#160;days of such event.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If by law, regulation or fiscal policy of a particular country, conversion into United States dollars or transfer of funds of a convertible currency to the United States is restricted or forbidden, LICENSEE shall give HARVARD prompt notice in writing and shall pay the royalty and other amounts due through such means or methods as are lawful in such country as HARVARD may reasonably designate. Failing the designation by HARVARD of such lawful means or methods within thirty (30)&#160;days after such notice is given to HARVARD, LICENSEE shall deposit such royalty or other payment in local currency to the credit of HARVARD in a recognized banking institution designated by HARVARD, or if none is designated by HARVARD within the thirty (30)&#160;day period described above, in a recognized banking institution selected by LICENSEE and identified in a written notice to HARVARD by LICENSEE, and such deposit shall fulfill all obligations of LICENSEE to HARVARD with respect to such royalties. When in any country in which the law or regulations prohibit both the transmittal and deposit of royalties on sales in such country, royalty payments shall be suspended for as long as such prohibition is in effect, and as soon as such prohibition ceases to be in effect, all royalties which LICENSEE would have been under obligation to transmit or deposit, but for the prohibition, shall be deposited or transmitted promptly to the extent allowable.</font></td></tr></table></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE VI</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RECORD KEEPING</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">6.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall keep, and shall require its SUBLICENSEES to keep, accurate records (together with supporting documentation) of LICENSED PRODUCTS made, used or sold under this Agreement, and SERVICE INCOME and SUBLICENSE INCOME received by LICENSEE under this Agreement, appropriate to determine the amount of royalties due to HARVARD hereunder. Such records shall be retained for three (3)&#160;years following the end of the reporting period to which they relate. For such three year period, they shall be</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">available during normal business hours upon reasonable advance notice for examination by a certified public accountant selected by HARVARD, and reasonably acceptable to LICENSEE, for the sole purpose of verifying reports and payments hereunder. In conducting examinations pursuant to this Section&#160;6.1, HARVARD&#8217;s accountant shall have access to all records which HARVARD reasonably believes to be relevant to the calculation of royalties under Article&#160;IV. HARVARD agrees to maintain any information contained in such records in confidence, except as otherwise required by law and except information in regarding the amount of royalties due.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">6.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD&#8217;s accountant shall not disclose to HARVARD any information other than information relating to the accuracy of reports and payments made hereunder.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">6.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Such examination by HARVARD&#8217;s accountant shall be at HARVARD&#8217;s expense, except that if such examination shows an underreporting or underpayment in excess of five percent (5%)&#160;for any twelve (12)&#160;month period, then LICENSEE shall pay the cost of such examination as well as any additional sum that would have been payable to HARVARD had the LICENSEE reported correctly, plus interest on said sum at the rate of one and one-half percent (1.5%)&#160;per month.</font></td></tr></table></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE VII</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DOMESTIC AND FOREIGN PATENT FILING AND MAINTENANCE</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Upon execution of this Agreement, LICENSEE shall reimburse HARVARD for fifty percent (50%)&#160;of all reasonable expenses HARVARD has incurred for the preparation, filing, prosecution, maintenance and counseling with respect to PATENT RIGHTS. Such expenses total &#91;***&#93; as of October&#160;1, 2000. Thereafter, LICENSEE shall reimburse HARVARD for fifty percent (50%)&#160;of all such future reasonable expenses prior to the termination of this Agreement upon receipt of invoices from HARVARD.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD shall be responsible for the preparation, filing, prosecution and maintenance of any and all patent applications and patents included in PATENT RIGHTS. HARVARD will instruct counsel to directly notify HARVARD and LICENSEE and provide them copies of any official communications from the United States and foreign patent offices relating to said prosecution, and to provide LICENSEE with advance draft copies of all relevant communications to the various patent offices, so that LICENSEE may be informed and apprised of the continuing prosecution of patent applications in PATENT RIGHTS. LICENSEE shall have reasonable opportunities to participate in decision making on all key decisions affecting filing, prosecution and maintenance of patents and patent applications in PATENT RIGHTS. HARVARD will use reasonable efforts to incorporate LICENSEE&#8217;s reasonable suggestions regarding said prosecution. HARVARD shall use all reasonable efforts to amend any patent application to include claims reasonably requested by LICENSEE to protect LICENSED PRODUCTS.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD and LICENSEE shall cooperate fully in the preparation, filing, prosecution and maintenance of PATENT RIGHTS and of all patents and patent applications licensed to LICENSEE hereunder, executing all papers and instruments or requiring members of</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD to execute such papers and instruments so as to enable HARVARD to apply for, to prosecute and to maintain patent applications and patents in HARVARD&#8217;s name in any country. Each party shall provide to the other prompt notice as to all matters which come to its attention and which may affect the preparation, filing, prosecution or maintenance of any such patent applications or patents.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE may elect to surrender its PATENT RIGHTS in any country upon sixty (60)&#160;days written notice to HARVARD. Such notice shall not relieve LICENSEE from responsibility to reimburse HARVARD for patent-related expenses incurred prior to the expiration of the (60)&#160;day notice period.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If HARVARD elects not to prosecute or maintain any of the patents or patent applications relating to PATENT RIGHTS or any portion thereof in any country, LICENSEE shall be given sufficient notice of HARVARD&#8217;s decision so that LICENSEE may request that HARVARD continue prosecuting or maintaining such patents or patent applications, at LICENSEE&#8217;s expense. If HARVARD elects not to prosecute or maintain such patents or patent applications after such request by LICENSEE, then LICENSEE shall have the right, but not the obligation, at its own expense to prosecute and maintain such patents and patent applications or portion thereof in such country and in HARVARD&#8217;s name. If LICENSEE assumes 100% of the costs to file, prosecute, and maintain certain patents and patent applications relating to the PATENT RIGHTS pursuant to this Section&#160;7.5, and, if HARVARD licenses the PATENT RIGHTS to one or more co-exclusive licensees designated in Section&#160;3.1 after such time, then HARVARD will credit LICENSEE with the costs LICENSEE has paid in excess of 50% if one other licensee, due for the preparation, filing, prosecution and maintenance of patents and patent applications relating to PATENT RIGHTS pursuant to Section&#160;7.1 above.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If LICENSEE can demonstrate that it is not being adequately informed or apprised of the continuing prosecution of patents or patent applications in PATENT RIGHTS, or that it is not being provided with reasonable opportunities to participate in decision making or that its interests are not being adequately protected, LICENSEE shall be entitled to engage, at LICENSEE&#8217;s expense, independent patent counsel to review and evaluate patent prosecution and filing of patents and patent applications included in PATENT RIGHTS.</font></td></tr></table></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE VIII</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INFRINGEMENT</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">With respect to any PATENT RIGHTS that are licensed to LICENSEE pursuant to this Agreement, LICENSEE shall have the right to prosecute in its own name and at its own expense any infringement of such patent. HARVARD agrees to notify LICENSEE promptly of each infringement of such patents of which HARVARD, as applicable, is or becomes aware. Before LICENSEE commences an action with respect to any infringement of such patents, LICENSEE shall give careful consideration to the views of HARVARD and to potential effects on the public interest in making its decision whether or not to sue.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.087%"></td><td style="width:0.1%"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8.2</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE acknowledges that other co-exclusive licensees of PATENT RIGHTS designated in Section&#160;3.1 shall have rights identical to LICENSEE to prosecute infringers and that co-exclusive licensees will be bound by the identical terms of this Section&#160;8.2. In any prosecution instigated by LICENSEE and in which HARVARD, as necessary, is also named plaintiff as owner of the PATENT RIGHTS, LICENSEE must notify other co-exclusive licensees of the existence of such legal action and allow other co-exclusive licensees to join as a plaintiff upon co-exclusive licensees&#8217; request. In addition, in the event other co-exclusive licensees instigate an infringement prosecution, LICENSEE hereby consents to being joined as a plaintiff in such suit solely for the purpose of procuring standing to bring the action and at the sole expense of the instigating co-exclusive licensee. To the extent that LICENSEE desires to participate in any strategic decisions affecting the prosecution of the action brought by other co-exclusive licensees, LICENSEE acknowledges that it and co-exclusive licensees will necessarily have to reach a mutual agreement concerning litigation expenses and strategy. In no event shall HARVARD incur any liability or expense in connection with any action of co-exclusive licensees, joint or otherwise.</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">During any such litigation, HARVARD will agree to not license any defendant or accused infringer of the PATENT RIGHTS in the litigation, without LICENSEE&#8217;S prior written consent.</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If LICENSEE elects to commence an action as described above, HARVARD may, to the extent permitted by law, elect to join as parties in that action. Regardless of whether HARVARD elects to join as parties, HARVARD shall cooperate fully with LICENSEE in connection with any such action.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:2.984%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.895%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD agrees to join as a party in any action if required by law to do so in order to bring an action under the PATENT RIGHTS.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:2.984%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.895%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(c)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall reimburse HARVARD for any costs incurs with LICENSEE&#8217;s approval, including reasonable attorneys&#8217; fees, as part of an action brought by LICENSEE, irrespective of whether HARVARD becomes a co-plaintiff.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If LICENSEE elects to commence an action as described above, LICENSEE may deduct from its royalty payments to HARVARD with respect to the patent(s) subject to suit an amount not exceeding fifty percent (50%)&#160;of LICENSEE&#8217;s expenses and costs of such action, including reasonable attorneys&#8217; fees&#59; provided, however, that such reduction shall not exceed fifty percent (50%)&#160;of the total royalty due to HARVARD with respect to the patent(s) subject to suit for each calendar year. If such fifty percent (50%)&#160;of LICENSEE&#8217;s expenses and costs exceeds the amount of royalties deducted by LICENSEE for any calendar year, LICENSEE may to that extent reduce the royalties due to HARVARD from LICENSEE in succeeding calendar years, but never by more than fifty percent (50%)&#160;of the total royalty due in any one year with respect to the patent(s) subject to suit.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">No settlement, consent judgment or other voluntary final disposition of the suit may be entered into without the prior written consent of HARVARD which consent shall not be unreasonably withheld.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Recoveries or reimbursements from actions commenced by LICENSEE pursuant to this Article shall first be applied to reimburse LICENSEE, HARVARD for litigation costs not paid from royalties and then to reimburse HARVARD for royalties deducted by LICENSEE pursuant to Section&#160;8.4. Any remaining recoveries or reimbursements shall be shared as follows&#58;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If the amount is lost profits or lost royalties, LICENSEE shall receive an amount equal to the damages the court determines LICENSEE has suffered as a result of the infringement less the amount of any royalties that would have been due HARVARD on sales of LICENSED PRODUCTS lost by LICENSEE as a result of the infringement had LICENSEE made such sales, and HARVARD shall receive an amount equal to the royalties it would have received if such sales had been made by LICENSEE, and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">As to awards other than lost profits or lost royalties, fifty percent (50%)&#160;to LICENSEE and fifty percent (50%)&#160;to HARVARD.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(c)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If two or more co-exclusive licensees undertake the suit, the provision of this Section&#160;8.6 will be modified to take into account each co-exclusive licensee&#8217;s expenses and lost profits.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If LICENSEE elects not to exercise its right to prosecute an infringement of the PATENT RIGHTS pursuant to this Article, HARVARD may do so at its own expense, controlling such action and retaining all recoveries therefrom. LICENSEE shall cooperate fully with HARVARD in connection with any such action.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If a declaratory judgment action is brought naming LICENSEE as a defendant and alleging invalidity of any of the PATENT RIGHTS, HARVARD may elect to take over the sole defense of the action at its own expense. LICENSEE shall cooperate fully with HARVARD in connection with any such action. HARVARD shall consult with LICENSEE regarding such defense.</font></td></tr></table></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE IX</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TERMINATION OF AGREEMENT</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">9.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">This Agreement, unless terminated as provided herein, shall remain in effect until the last patent or patent application in PATENT RIGHTS has expired or been abandoned.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">9.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD may terminate this Agreement as follows&#58;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:2.984%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.895%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If LICENSEE does not make a payment due hereunder and fails to cure such non-payment (including the payment of interest in accordance with Section&#160;5.4(e)) within</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.192%"><tr><td style="width:1.0%"></td><td style="width:4.118%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.682%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">thirty (30)&#160;days after the date of notice in writing of such non-payment by HARVARD.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If LICENSEE defaults in its obligations under Sections&#160;10.3(c) and 10.3(d) to procure and maintain insurance.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(c)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If LICENSEE shall become insolvent, shall make an assignment for the benefit of creditors, or shall have a petition in bankruptcy filed for or against it. Such termination shall be effective immediately upon HARVARD giving written notice to LICENSEE.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(d)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If an examination by HARVARD&#8217;s accountant pursuant to Article&#160;V shows an underreporting or underpayment by LICENSEE in excess of twenty percent (20%)&#160;for any twelve (12)&#160;month period, provided that such underreporting or underpayment is not determined to be inadvertent or the result of an honest mistake.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(e)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If LICENSEE is convicted of a felony relating to the manufacture, use, or sale of LICENSED PRODUCTS.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(f)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Except as provided in Subsections (a), (b), and (c)&#160;above, if LICENSEE defaults in the performance of any material obligations under this Agreement and the default has not been remedied within forty-five (45)&#160;days after the date of notice in writing of such default by HARVARD.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">9.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall provide, in all sublicenses granted by it under this Agreement, that LICENSEE&#8217;s interest in such sublicenses shall at HARVARD&#8217;s option terminate or be assigned to HARVARD upon termination of this Agreement&#59; however, LICENSEE shall have the option to nominate one of its sublicensees as a substitute for LICENSEE. The proposed substitute must (i)&#160;have a net worth of at least equivalent to the net worth LICENSEE had as of the date of this Agreement and (ii)&#160;have available resources and sufficient scientific, business and other expertise comparable to LICENSEE in order to satisfy its obligations under this Agreement. At least sixty (60)&#160;days prior to termination of this Agreement, LICENSEE shall provide HARVARD with written notice of LICENSEE&#8217;s nominee together with documentation sufficient to demonstrate the requirements set forth in subparagraphs (i)&#160;and (ii)&#160;above for HARVARD&#8217;s approval, which shall not be unreasonably withheld. HARVARD shall notify LICENSEE in writing of its decision prior to termination of this Agreement. If HARVARD approves LICENSEE&#8217;s nominee, LICENSEE shall assign this Agreement to its nominee and its nominee shall accept the assignment no later than thirty (30)&#160;days after the termination date of this Agreement.</font></td></tr></table></div><div style="margin-top:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that HARVARD disapproved LICENSEE&#8217;s first nominee, prior to the termination date of this Agreement, LICENSEE shall have the option to nominate one of its other sublicensees for HARVARD&#8217;s approval which shall not be unreasonably withheld.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">9.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE may terminate this Agreement by giving ninety (90)&#160;days advance written notice of termination to HARVARD. Upon termination, LICENSEE shall submit a final Royalty Report to HARVARD and any royalty payments and unreimbursed patent expenses invoiced by HARVARD shall become immediately payable.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">9.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Sections&#160;6.1, 6.2, 6.3, 7.1, 9.4, 9.5, 10.2, 10.3, 10.4, and 10.7 of this Agreement shall survive termination.</font></td></tr></table></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE X</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GENERAL</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD does not warrant the validity of the PATENT RIGHTS licensed hereunder and make no representations whatsoever with regard to the scope of the licensed PATENT RIGHTS or that such PATENT RIGHTS may be exploited by LICENSEE, an AFFILIATE, or SUBLICENSEE without infringing other patents, provided, however, HARVARD represents that it has no knowledge of any facts or circumstances as of the execution date of this Agreement that would render any of the PATENT RIGHTS invalid or unenforceable. HARVARD represents and warrants, to the best of its knowledge, that HARVARD will own all right, title and interest in and to the PATENT RIGHTS.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD EXPRESSLY DISCLAIMS ANY AND ALL IMPLIED WARRANTIES AND MAKES NO EXPRESS OR IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE OF THE PATENT RIGHTS OR INFORMATION SUPPLIED BY HARVARD, LICENSED PROCESSES OR LICENSED PRODUCTS CONTEMPLATED BY THIS AGREEMENT.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.551%"><tr><td style="width:1.0%"></td><td style="width:4.154%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.646%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(a)&#160;&#160;LICENSEE shall indemnify, defend and hold harmless HARVARD and its current or former directors, governing board members, trustees, officers, faculty, medical and professional staff, employees, students, and agents and their respective successors, heirs and assigns (collectively, the &#8220;INDEMNITEES&#8221;), from and against any claim, liability, cost, expense, damage, deficiency, loss or obligation of any kind or nature (including, without limitation, reasonable attorney&#8217;s fees and other costs and expenses of litigation) (collectively, &#8220;Claims&#8221;), based upon, arising out of, or otherwise relating to this Agreement, including without limitation any cause of action relating to product liability concerning any product, process, or service made, used or sold pursuant to any right or license granted under this Agreement, provided, however, that such indemnification shall not apply to any liability, damage, loss, or expense to the extent directly attributable to the negligent activities, reckless misconduct or intentional misconduct of Indemnitees.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.938%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.854%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Each Indemnitee that intends to claim indemnification under Section&#160;10.3(a) shall promptly notify LICENSEE of any claim or action in respect of which the Indemnitee intends to claim such indemnification, and LICENSEE shall assume the defense thereof with counsel mutually satisfactory to LICENSEE and HARVARD. The failure to deliver notice to LICENSEE within a reasonable time after the commencement of any such claim or action, if materially prejudicial to its ability to</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:7.799%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">defend such action, shall relieve LICENSEE of any liability to the Indemnitee under Section&#160;10.3(a) with respect to such action, but the omission so to deliver notice to LICENSEE will not relieve it of any liability that it may have to any Indemnitee otherwise than under Section&#160;10.3(a). HARVARD and any other Indemnitee, and their respective employees and agents, shall cooperate fully with LICENSEE and its legal representatives in the investigation of any claim or action covered by the indemnification under Section&#160;10.3(a).</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(c)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Beginning at the time any such product, process or service is being commercially distributed or sold (other than for the purpose of obtaining regulatory approvals) by LICENSEE or by a SUBLICENSEE, AFFILIATE or agent of LICENSEE, LICENSEE shall, at its sole cost and expense, procure and maintain commercial general liability insurance in amounts not less than $2,000,000 per incident and $2,000,000 annual aggregate and naming the Indemnitees as additional insureds. During clinical trials of any such product, process or service, LICENSEE shall, at its sole cost and expense, procure and maintain commercial general liability insurance in such equal or lesser amount as HARVARD shall require, naming the Indemnitees as additional insureds. Such commercial general liability insurance shall provide&#58; (i)&#160;product liability coverage&#59; and (ii)&#160;broad form contractual liability coverage for LICENSEE&#8217;s indemnification under this Agreement. If LICENSEE elects to self-insure all or part of the limits described above (including deductibles or retentions which are in excess of $250,000 annual aggregate) such self-insurance program must be acceptable to HARVARD and the Risk Management Foundation of the Harvard Medical Institutions, Inc. in their sole discretion. The minimum amounts of insurance coverage required shall not be construed to create a limit of LICENSEE&#8217;s liability with respect to its indemnification under this Agreement.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(d)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall provide HARVARD with written evidence of such insurance upon request of HARVARD. LICENSEE shall provide HARVARD with written notice at least fifteen (15)&#160;days prior to the cancellation, non-renewal or material change in such insurance&#59; if LICENSEE does not obtain replacement insurance providing comparable coverage within such fifteen (15)&#160;day period, HARVARD shall have the right to terminate this Agreement effective at the end of such fifteen (15)&#160;day period without notice or any additional waiting periods.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:3.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(e)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall maintain such commercial general liability insurance beyond the expiration or termination of this Agreement during&#58; (i)&#160;the period that any product, process, or service, relating to, or developed pursuant to, this Agreement is being commercially distributed or sold by LICENSEE or by a SUBLICENSEE, AFFILIATE or agent of LICENSEE&#59; and (ii)&#160;a reasonable period after the period referred to in Subsection (e)(i) above which in no event shall be less than fifteen (15)&#160;years.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall not use HARVARD&#8217;s name or insignia, or any adaptation of them, or the name of any of HARVARD&#8217;s inventors in any advertising, promotional or sales literature without the prior written approval of HARVARD.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Without the prior written approval of HARVARD in each instance, neither this Agreement nor the rights granted hereunder shall be transferred or assigned in whole or in part by LICENSEE to any person whether voluntarily or involuntarily, by operation of law or otherwise, except that each of LICENSEE and its AFFILIATES may assign this Agreement in connection with a merger, consolidation or sale or transfer of all or substantially all of its assets. This Agreement shall be binding upon the respective successors, legal representatives and assignees of HARVARD and LICENSEE.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The interpretation and application of the provisions of this Agreement shall be governed by the laws of the Commonwealth of Massachusetts.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall comply with all applicable laws and regulations. In particular, it is understood and acknowledged that the transfer of certain commodities and technical data is subject to United States laws and regulations controlling the export of such commodities and technical data, including all Export Administration Regulations of the United States Department of Commerce. These laws and regulations among other things, prohibit or require a license for the export of certain types of technical data to certain specified countries. LICENSEE hereby agrees and gives written assurance that it will comply with all United States laws and regulations controlling the export of commodities and technical data, that it will be solely responsible for any violation of such by LICENSEE or its AFFILIATES or SUBLICENSEES, and that it will defend and hold HARVARD, CHILDREN, and MIT harmless in the event of any legal action of any nature occasioned by such violation.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE agrees&#58; (i)&#160;to obtain all regulatory approvals required for the manufacture and sale of LICENSED PRODUCTS and LICENSED PROCESSES&#59; and (ii)&#160;to utilize appropriate patent marking on such LICENSED PRODUCTS. LICENSEE also agrees to register or record this Agreement as is required by law or regulation in any country where the license is in effect.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Any notices to be given hereunder shall be sufficient if signed by the party (or party&#8217;s attorney) giving same and either&#58; (i)&#160;delivered in person&#59; (ii)&#160;mailed certified mail return receipt requested&#59; or (iii)&#160;faxed to other party if the sender has evidence of successful transmission and if the sender promptly sends the original by ordinary mail, in any event to the following addresses&#58;</font></td></tr></table></div><div style="margin-top:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If to LICENSEE&#58;</font></div><div style="padding-left:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mycometrix Corporation</font></div><div style="padding-left:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">213 E. Grand Ave.</font></div><div style="padding-left:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">South San Francisco, CA 94080</font></div><div style="padding-left:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attention&#58;</font></div><div style="padding-left:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fax&#58; (650)-</font></div><div style="margin-bottom:0.1pt;margin-top:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If to HARVARD&#58;</font></div><div style="padding-left:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Office for Technology and Trademark Licensing</font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-top:4.5pt;padding-left:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Harvard University</font></div><div style="padding-left:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holyoke Center, Suite&#160;727</font></div><div style="padding-left:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1350 Massachusetts Avenue</font></div><div style="padding-left:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cambridge, MA 02138</font></div><div style="margin-bottom:10pt;padding-left:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fax&#58; (617)&#160;495-9568</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By such notice either party may change their address for future notices.</font></div><div style="margin-bottom:10pt;margin-top:4.5pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notices delivered in person shall be deemed given on the date delivered. Notices sent by fax shall be deemed given on the date faxed. Notices mailed shall be deemed given on the date postmarked on the envelope.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.849%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Should a court of competent jurisdiction later hold any provision of this Agreement to be invalid, illegal, or unenforceable, and such holding is not reversed on appeal, it shall be considered severed from this Agreement. All other provisions, rights and obligations shall continue without regard to the severed provision, provided that the remaining provisions of this Agreement are in accordance with the intention of the parties.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.849%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In the event of any controversy or claim arising out of or relating to any provision of this Agreement or the breach thereof, the parties shall try to settle such conflict amicably between themselves. Subject to the limitation stated in the final sentence of this Section&#160;10.11, any such conflict which the parties are unable to resolve promptly shall be settled through arbitration conducted in accordance with the rules of the American Arbitration Association. The demand for arbitration shall be filed within a reasonable time after the controversy or claim has arisen, and in no event after the date upon which institution of legal proceedings based on such controversy or claim would be barred by the applicable statute of limitation. Such arbitration shall be held in Boston, Massachusetts. The award through arbitration shall be final and binding. Either party may enter any such award in a court having jurisdiction or may make application to such court for judicial acceptance of the award and an order of enforcement, as the case may be. Notwithstanding the foregoing, either party may, without recourse to arbitration, assert against the other party a third-party claim or cross-claim in any action brought by a third party, to which the subject matter of this Agreement may be relevant.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.009%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.12</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">This Agreement constitutes the entire understanding between the parties and neither party shall be obligated by any condition or representation other than those expressly stated herein or as may be subsequently agreed to by the parties hereto in writing.</font></td></tr></table></div><div style="margin-top:9pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;The remainder of this page is intentionally blank.&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed by their duly authorized representatives.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:31.906%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.886%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.948%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PRESIDENT AND FELLOWS</font></div><div style="margin-bottom:0.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OF HARVARD COLLEGE</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">MYCOMETRIX CORPORATION</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#47;s&#47; Joyce Brinton</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#47;s&#47; Gajus Worthington</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Joyce Brinton, Director</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Office for Technology and</font></div><div style="margin-bottom:0.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademark Licensing</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">President</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">12&#47;7&#47;00</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">12&#47;18&#47;00</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Date</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Date</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">APPENDIX A</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following comprise PATENT RIGHTS&#58;</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>8
<FILENAME>exhibit10510q3q2020.htm
<DESCRIPTION>EX-10.5
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="icf3e79bce1244e3cacfd0b271282b1f3_1"></div><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;10.5</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4060.LICI.010 Harvard</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CO-EXCLUSIVE LICENSE AGREEMENT</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Between</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">President and Fellows of Harvard College</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">And</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Mycometrix Corporation</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective as of October&#160;15, 2000</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Re&#58; Harvard Case #&#91;***&#93;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In consideration of the mutual promises and covenants set forth below, the parties hereto agree as follows&#58;</font></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE I</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DEFINITIONS</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As used in this Agreement, the following terms shall have the following meanings&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">ACADEMIC RESEARCH PURPOSES&#58; use of PATENT RIGHTS for academic research or other not-for-profit scholarly purposes which are undertaken at a non-profit or governmental institution that does not use the PATENT RIGHTS in the production or manufacture of products for sale or the performance of services for a fee.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">AFFILIATE&#58; any entity which controls, is controlled by, or is under common control with a party by ownership or control of at least fifty percent (50%)&#160;of the voting stock or other ownership. Unless otherwise specified, the term LICENSEE includes AFFILIATES.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">FIELD &#58; use of PATENT RIGHTS to develop, manufacture, use, offer for sale, sell, or import components and products in FIELD I and&#47;or FIELD II&#58;</font></td></tr></table></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FIELD I&#58; &#91;***&#93;</font></div><div style="margin-top:4.5pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FIELD II&#58; &#91;***&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD&#58; President and Fellows of Harvard College, a nonprofit Massachusetts educational corporation having offices at the Office for Technology and Trademark Licensing, Holyoke Center, Suite&#160;727, 1350 Massachusetts Avenue, Cambridge, Massachusetts 02138.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSED PROCESSES&#58; the processes covered by at least one VALID CLAIM included within the PATENT RIGHTS.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSED PRODUCTS&#58; products covered by at least one VALID CLAIM included within the PATENT RIGHTS or products made or services provided in accordance with or by means of LICENSED PROCESSES.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE&#58; Mycometrix Corporation, a corporation organized under the laws of California having its principal offices at 213 East Grand Avenue, South San Francisco, CA 94080.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">NET SERVICE INCOME&#58; SERVICE INCOME less LICENSEE&#8217;s actual direct and indirect cost for research, development and&#47;or services provided.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">NET SALES&#58; the amount actually received for sales, leases, or other transfers of LICENSED PRODUCTS, less&#58;</font></td></tr></table></div><div style="margin-top:4.5pt;padding-left:85.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.07pt">customary trade, quantity or cash discounts and non-affiliated brokers&#8217; or agents&#8217; commissions actually allowed and taken&#59;</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:85.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.3pt">amounts repaid or credited by reason of rejection or return&#59;</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)   to the extent separately stated on purchase orders, invoices, or other documents of sale, taxes levied on and&#47;or other governmental charges made as to production, sale, transportation, delivery or use and paid by or on behalf of LICENSEE&#59; and</font></div><div style="margin-bottom:10pt;margin-top:4.5pt;padding-left:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)   reasonable charges for delivery or transportation provided by third parties and cost of insurance in transit, if separately stated.</font></div><div style="margin-bottom:10pt;margin-top:4.5pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NET SALES also includes the fair market value of any non-cash consideration received by LICENSEE for the sale, lease, or transfer of LICENSED PRODUCTS.</font></div><div style="margin-bottom:10pt;margin-top:4.5pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a LICENSED PRODUCT is sold as a combination product containing the LICENSED PRODUCT and one or more other components, NET SALES shall be calculated by multiplying the gross amount invoiced for the sale of the combination product by the fraction A&#47;A+B where A is the average gross selling price of the LICENSED PRODUCT sold separately by LICENSEE and B is the average gross selling price of such other components of the combination products sold separately by LICENSEE during the relevant royalty payment period.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:72pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:10pt;margin-top:4.5pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that LICENSEE grants a sublicensee hereunder, and receives payments based upon SUBLICENSEE&#8217;s sales of LICENSED PRODUCTS, LICENSEE may upon approval from HARVARD (which shall not be unreasonably withheld) modify the definition of NET SALES for the purposes of calculating royalties payable to HARVARD on such SUBLICENSEE&#8217;s sales to be the same as the definition of NET SALES on which such royalties to LICENSEE are calculated.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">SERVICE INCOME&#58; the total financial consideration received by LICENSEE for commercial services performed on a fee-for-service basis using the LICENSED PRODUCTS or LICENSED PROCESSES by LICENSEE under a contract with a third party, where such services are based primarily on the use of fully functional LICENSED PRODUCTS or LICENSED PROCESSES (as applicable) for their intended commercial use (such as, for example, where LICENSEE performs commercial-scale genotyping services for a pharmaceutical company on a fee-for-service basis using fully developed microfluidics chips comprising LICENSED PRODUCTS). SERVICE INCOME shall not include amounts received in connection with research and&#47;or development of LICENSED PRODUCTS or LICENSED PROCESSES themselves.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">PATENT RIGHTS&#58; The applications and patents as listed in Appendix&#160;A of this Agreement, the allowed claims of such applications, the inventions described and claimed therein, and any divisions or continuations of the applications and patents as listed in Appendix&#160;A, and specific claims of any continuations-in-part of such applications to the extent the specific claims are directed to subject matter described in the applications and patents listed in Appendix&#160;A in a manner sufficient to support such specific claims under 35 U.S.C., patents issuing thereon or reissues thereof, and any and all foreign patents and patent applications corresponding thereto, all to the extent owned or controlled by HARVARD.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.12</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">SUBLICENSE INCOME&#58; the amount paid to LICENSEE by a third party (other than an AFFILIATE of LICENSEE) (a)&#160;for the sublicening of PATENT RIGHTS to a third party as well as (b)&#160;for the related licensing of LICENSEE&#8217;s own patent rights or know-how or LICENSEE&#8217;s in-licensed non-HARVARD technologies, including but not limited to (i)&#160;license fees, (ii)&#160;milestone payments, (iii)&#160;royalties, (iv)&#160;the fair market value in cash of any non-cash consideration for such sublicense, and (v)&#160;in the event that LICENSEE receives any payment for equity in consideration for the grant of sublicense rights that included a premium over the fair market value of such equity, the amount of such premium. LICENSEE shall be responsible for determining such fair market value with reasonable business judgment.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.13</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">SUBLICENSEE&#58; any non-AFFILIATE granted a sublicense of any of the rights HARVARD has granted to LICENSEE under Section&#160;3.1.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.14</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">TERRITORY&#58; Worldwide.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.15</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">VALID CLAIM&#58; either (i)&#160;a claim of an issued patent that has not been held unenforceable or invalid by an agency or a court of competent jurisdiction in any</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:72pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">unappealable or unappealed decision or (ii)&#160;a claim of a published, pending patent application, which claim is substantially identical to a corresponding claim in a subsequently issued patent having priority to the patent application.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.16</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The terms &#8220;Public Law 96-517&#8221; and &#8220;Public Law 98-620&#8221; include all amendments to those statutes.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1.17</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The terms &#8220;sold&#8221; and &#8220;sell&#8221; include, without limitation, leases and other transfers and similar transactions.</font></td></tr></table></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE II</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REPRESENTATIONS</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD is owner by assignment from &#91;***&#93;, in the foreign patent applications corresponding thereto, and in the inventions described and claimed therein.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD has authority to issue licenses under PATENT RIGHTS.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD is committed to the policy that ideas or creative works produced at HARVARD should be used for the greatest possible public benefit, and believes that every reasonable incentive should be provided for the prompt introduction of such ideas into public use, all in a manner consistent with the public interest.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE is prepared and intends to diligently develop the invention and to bring products to market which are subject to this Agreement, specifically including one or more products in the FIELD selected from a &#91;***&#93;.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE is desirous of obtaining a co-exclusive license in the FIELD and in the TERRITORY in order to practice the PATENT RIGHTS in the United States and in certain foreign countries, and to manufacture, use and sell in the commercial market the products made in accordance therewith, and HARVARD is desirous of granting such a license to LICENSEE in accordance with the terms of this Agreement.</font></td></tr></table></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE III</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GRANT OF RIGHTS</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD hereby grants to LICENSEE and LICENSEE accepts, subject to the terms and conditions hereof, in the TERRITORY a co-exclusive commercial license under PATENT RIGHTS in FIELD I and in FIELD II to make and have made, to use and have used, to sell</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:72pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">and have sold, and to offer for sale and have offered for sale the LICENSED PRODUCTS, and to practice the LICENSED PROCESSES, for the life of the PATENT RIGHTS. HARVARD will grant no more than two commercial licenses in FIELD I at any time and will grant no more than two commercial licenses in FIELD II at any time and HARVARD will not grant other licenses in the FIELD except as required by HARVARD&#8217;s obligations in Section&#160;3.2(a) or as permitted Section&#160;3.2(b). Such co-exclusive license shall include the right to grant sublicenses under the following circumstances&#58; (i)&#160;LICENSEE can demonstrate that it has added significant value to the PATENT RIGHTS to be sublicensed, and that such a sublicense also contains a substantial and essentially simultaneous license of LICENSEE owned intellectual property, or (ii)&#160;LICENSEE grants a sublicense under other HARVARD patent rights licensed exclusively to LICENSEE which are dominated by PATENT RIGHTS, and such sublicense under PATENT RIGHTS is necessary to practice such other HARVARD patent rights.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The granting and exercise of this license is subject to the following conditions&#58;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD&#8217;s &#8220;Statement of Policy in Regard to Inventions, Patents and Copyrights,&#8221; dated August&#160;10, 1998, Public Law 96-517, Public Law 98-620. In addition, this Agreement is subject to HARVARD&#8217;s obligations under agreements with other sponsors of research, provided that such obligations are not in conflict with the rights granted hereunder. Any right granted in this Agreement greater than that permitted under Public Law 96-517, or Public Law 98-620, shall be subject to modification as may be required to conform to the provisions of those statutes.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD reserves the right to make and use, and grant to others non-exclusive licenses to make and use solely for ACADEMIC RESEARCH PURPOSES the subject matter described and claimed in PATENT RIGHTS.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(c)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall use commercially reasonable efforts to effect introduction of the LICENSED PRODUCTS into the commercial market as soon as practicable, consistent with sound and reasonable business practice and judgment&#59; thereafter, until the expiration of this Agreement, LICENSEE shall endeavor to keep LICENSED PRODUCTS reasonably available to the public.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(d)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">At any time after three years from the effective date of this Agreement and as HARVARD&#8217;s sole remedy for such non-performance, HARVARD may increase the license maintenance royalty under Section&#160;4.4 to &#91;***&#93; dollars each in FIELD I and in FIELD II in year 2004 and &#91;***&#93; dollars each in FIELD I and in FIELD II per year each year beginning in 2005, if in HARVARD&#8217;s reasonable judgment, the Progress Reports furnished by LICENSEE do not demonstrate that LICENSEE has satisfied at least one of the following conditions, which non-performance is not cured within ninety (90)&#160;days following the written notification of such by HARVARD to LICENSEE&#58;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:72pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.868%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(i)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">has put the licensed subject matter into commercial use in at least one of the countries hereby licensed, directly or through a sublicense, and is keeping the licensed subject matter reasonably available to the public&#59; or</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.868%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(ii)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">is engaged in research, development, manufacturing, marketing or sublicensing activity appropriate to achieving 3.2(d)(i).</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(e)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In all sublicenses granted by LICENSEE hereunder, LICENSEE shall include a requirement that the SUBLICENSEE use commercially reasonable efforts to bring the subject matter of the sublicense into commercial use. LICENSEE shall further provide in such sublicenses that such sublicenses are subject and subordinate to the terms and conditions of this Agreement, except&#58; (i)&#160;the SUBLICENSEE may not further sublicense&#59; and (ii)&#160;the rate of royalty on NET SALES paid by the SUBLICENSEE to the LICENSEE. Copies of the relevant provisions of all sublicense agreements shall be provided promptly to HARVARD. HARVARD agrees to maintain any information contained in such provisions in confidence, except as otherwise required by law, however, HARVARD may include in its usual reports annual amounts of royalties paid.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(f)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">A license in any other field of use in addition to the FIELD shall be the subject of a separate agreement and shall require LICENSEE&#8217;s submission of evidence, satisfactory to HARVARD, demonstrating LICENSEE&#8217;s willingness and ability to develop and commercialize in such other field of use the kinds of products or processes likely to be encompassed in such other fields.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(g)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">To the extent that federal funds are used to support research leading to a patent or patent application in the PATENT RIGHTS, LICENSEE shall cause any LICENSED PRODUCT produced for sale by LICENSEE or SUBLICENSEES in the United States to be manufactured substantially in the United States during the period of exclusivity of this license in the United States.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">All rights reserved to the United States Government and others under Public Law 96-517, and Public Law 98-620, shall remain and shall in no way be affected by this Agreement.</font></td></tr></table></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE IV</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ROYALTIES</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall pay to HARVARD a non-refundable license royalty fee in the sum of &#91;***&#93; payable within thirty (30)&#160;days of the execution date of this Agreement.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(a)&#160;In consideration of the right and license granted herein, LICENSEE shall pay to HARVARD during the term of this Agreement a royalty of &#91;***&#93; on NET SALES of LICENSED PRODUCTS sold by LICENSEE.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:72pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;In the event that a single LICENSED PRODUCT or LICENSED PROCESS is covered by HARVARD intellectual property in addition to PATENT RIGHTS, which is licensed to LICENSEE under other agreements as of the date of this Agreement, then the total royalty payment due HARVARD under all such agreements including this Agreement shall be &#91;***&#93; of NET SALES. LICENSEE shall notify HARVARD of the identity of each license agreement that includes patent rights covering the product or process, and HARVARD shall distribute the royalties evenly among such agreements.</font></div><div style="margin-top:9pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;As consideration for the rights granted hereunder, LICENSEE shall pay to HARVARD during the term of this Agreement a royalty in the form of stock of LICENSEE as follows&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.075%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(i)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall issue to HARVARD &#91;***&#93; shares of the Common Stock of LICENSEE (&#8220;Shares&#8221;) pursuant to the terms of a mutually acceptable Stock Subscription Agreement, provided, however, that HARVARD shall be subject to and enter into appropriate agreements and related documents as required of other stockholders of LICENSEE.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.452%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.092%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.156%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(ii)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD represents and warrants to LICENSEE that&#58;</font></td></tr></table></div><div style="margin-top:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;HARVARD is acquiring the Shares for its own account for investment and not with a view to, or for sale in connection with any distribution thereof, nor with any present intention of distributing or selling the same&#59; and HARVARD has no present or contemplated agreement, undertaking, arrangement, obligation, indebtedness or commitment providing for the disposition thereof.</font></div><div style="margin-top:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;HARVARD has full power and authority to enter into and to perform this Agreement in accordance with its terms.</font></div><div style="margin-top:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)&#160;HARVARD has sufficient knowledge and experience in investing in companies similar to LICENSEE so as to be able to evaluate the risks and merits of its investment in LICENSEE and is able financially to bear the risks thereof.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.666%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(iii)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Each certificate representing the Shares shall bear a legend substantially in the following form&#58;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:72pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-left:67.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;The shares represented by this certificate have not been registered under the Securities Act of 1933 or any state securities law and they may not be sold or otherwise transferred by any person, including a pledgee, unless (1)&#160;either (a)&#160;a registration statement with respect to such shares shall be effective under the Securities Act of 1933, as amended, or (b)&#160;the Corporation shall have received an opinion of counsel satisfactory to the Corporation that an exemption from registration under such Act is then available, and (2)&#160;there shall have been compliance with all applicable securities laws.&#8221;</font></div><div style="margin-bottom:10pt;padding-left:67.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;The shares represented by this certificate are subject to a mutually agree-upon Stock Purchase and Right of First Refusal Agreement with this Corporation, a copy of which Stock Purchase and Right of First Refusal Agreement is available for inspection at the offices of the Corporation or may be made available upon request.&#8221;</font></div><div style="margin-bottom:10pt;padding-left:67.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing legend shall be removed from the certificates representing any Shares, at the request of the holder thereof, at such time as they become eligible for resale pursuant to the Securities Act of 1933, as amended.</font></div><div style="padding-left:67.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If at any time prior to the time the Shares are eligible for resale pursuant to an exemption from registration under the Securities Act of 1933, as amended, LICENSEE proposes to register any of its Common Stock, under the Securities Act of 1933, except at LICENSEE&#8217;s initial public offering or any offering pursuant to Forms S-4 or S-8, LICENSEE shall offer HARVARD the opportunity to have its Shares registered under the registration statement to be filed at such time. HARVARD will be offered the right to register its Shares under the same terms, conditions and restrictions as other shareholders with piggyback registration rights and the inclusion of any Shares in such registration statement shall be subject to the approval of the underwriters of such offering</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.799%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(iv)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD&#8217;s ownership rights to Shares shall not be affected should the license pursuant to this Agreement be converted to a nonexclusive one.</font></td></tr></table></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;In the case of sublicenses, LICENSEE shall also pay to HARVARD a royalty of &#91;***&#93; of SUBLICENSE INCOME. If compensation for such a sublicense of PATENT RIGHTS is bundled with compensation received for the sublicensing of the other HARVARD patent rights licensed to LICENSEE under other agreements as of the date of this Agreement, LICENSEE shall pay HARVARD only &#91;***&#93; of the total compensation received no matter how many license agreements from HARVARD are involved. In such a case, LICENSEE shall notify HARVARD of the identity of each license agreement involved and HARVARD shall distribute its &#91;***&#93; of</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:72pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">compensation equally among those license agreements, including this Agreement.</font></div><div style="margin-top:9pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;LICENSEE shall pay HARVARD &#91;***&#93; of NET SERVICE INCOME. If SERVICE INCOME is bundled with service income under another license to LICENSEE as of the date of this Agreement, LICENSEE shall pay a royalty of &#91;***&#93; of NET SERVICE INCOME received from each and every third party (&#8220;Third Party&#8221;) to which services are provided. LICENSEE shall notify HARVARD of the identity of each license agreement involved in the services and HARVARD shall distribute its &#91;***&#93; of compensation equally among those license agreements, including this Agreement.</font></div><div style="margin-top:9pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;If other co-exclusive licenses in the same FIELD and TERRITORY are granted after the date this Agreement is executed, the above financial compensation shall not exceed the financial compensation to be paid by other licensees in the same FIELD and TERRITORY during the term of the co-exclusive license provided LICENSEE accepts any less favorable terms included in such other license.</font></div><div style="margin-top:9pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If stock is part of the financial compensation to be paid by other licensees in the same FIELD and TERITORY, the fair market value of the stock shall be the same as the price per share which other investors paid in the last round of financing unless the stock is publicly traded.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On sales between LICENSEE and its AFFILIATES for resale or incorporation into products, the royalty shall be paid on the NET SALES of the AFFILIATE. On sales between LICENSEE and sublicensees for resale, the royalty shall be paid on the SUBLICENSE INCOME.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">No later than January&#160;1 of each calendar year indicated below, LICENSEE shall pay to HARVARD the following non-refundable license maintenance royalty and&#47;or advance on royalties. Such payments shall be credited against running royalties due for that calendar year and Royalty Reports shall reflect such a credit. Such payments shall not be credited against milestone payments (if any) nor against royalties due for any subsequent calendar year nor against such payments due under any other agreements with HARVARD.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.452%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.941%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.751%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.947%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">FIELD&#160;I</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">FIELD&#160;II&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">January&#160;1, 2002</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#91;***&#93;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#91;***&#93;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">January&#160;1, 2003</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#91;***&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#91;***&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">January&#160;1, 2004</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#91;***&#93;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#91;***&#93;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">each year thereafter</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#91;***&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#91;***&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;&#160;</font></td></tr></table></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE V</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REPORTING</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Prior to signing this Agreement, LICENSEE has provided to HARVARD a written business plan under which LICENSEE intends to bring the subject matter of the licenses</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:72pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.989%"><tr><td style="width:1.0%"></td><td style="width:4.172%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.628%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">granted hereunder into commercial use upon execution of this Agreement. Such plan includes proposed marketing efforts.</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">No later than sixty (60)&#160;days after June&#160;30 of each calendar year, LICENSEE shall provide to HARVARD a written annual Progress Report describing progress on research and development, regulatory approvals, manufacturing, sublicensing, marketing and sales during the most recent twelve (12)&#160;month period ending June&#160;30 and plans for the forthcoming year. If multiple technologies are covered by the license granted hereunder, the Progress Report shall provide the information set forth above for each technology. If progress differs from that anticipated in the plan required under Section&#160;5.1, LICENSEE shall explain the reasons for the difference and propose a modified plan for HARVARD&#8217;s review. LICENSEE shall also provide any reasonable additional data HARVARD requires to evaluate LICENSEE&#8217;s performance.</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall report to HARVARD the date of first sale of LICENSED PRODUCTS (or results of LICENSED PROCESSES) in each country within thirty (30)&#160;days of occurrence.</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;padding-left:6.91pt">LICENSEE shall submit to HARVARD within sixty (60)&#160;days after each calendar half year ending June&#160;30 and December&#160;31, a Royalty Report setting forth for such half year at least the following information&#58;</font></div></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.868%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(i)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">the number of LICENSED PRODUCTS sold by LICENSEE in each country&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.868%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(ii)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">total billings and amounts actually received for such LICENSED PRODUCTS&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.868%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(iii)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">an accounting for all LICENSED PROCESSES used or sold&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.868%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(iv)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">deductions applicable to determine the NET SALES thereof&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.868%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(v)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">the amount of SERVICE INCOME received by LICENSEE and an accounting of all deductions to yield NET SERVICE INCOME&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.868%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(vi)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">the amount of SUBLICENSE INCOME received by LICENSEE&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.868%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(vii)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">the amount of royalty due thereon, or, if no royalties are due to HARVARD for any reporting period, the statement that no royalties are due.</font></td></tr></table></div><div style="margin-top:10pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Such report shall be certified as correct by an officer of LICENSEE and shall include a detailed listing of all deductions from royalties.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall pay to HARVARD with each such Royalty Report the amount of royalty due with respect to such half year. If multiple technologies are covered by the license granted hereunder, LICENSEE shall specify which PATENT RIGHTS are utilized for each LICENSED PRODUCT and LICENSED PROCESS included in the Royalty Report.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:72pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(c)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">All payments due hereunder shall be deemed received when funds are credited to HARVARD&#8217;s bank account and shall be payable by check or wire transfer in United States dollars. Conversion of foreign currency to U.S. dollars shall be made at the conversion rate existing in the United States (as reported in the New York Times or the Wall Street Journal) on the last working day of each royalty period. No transfer, exchange, collection or other charges shall be deducted from such payments.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(d)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">All such reports shall be maintained in confidence by HARVARD except as required by law&#59; however, HARVARD may include in its usual reports annual amounts of royalties paid.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(e)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Late payments shall be subject to a charge of one and one-half percent (1.5%)&#160;per month, or $250, whichever is greater.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In the event of acquisition, merger, change of corporate name or change in make-up, organization, or identity, LICENSEE shall notify HARVARD in writing within thirty (30)&#160;days of such event.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If by law, regulation or fiscal policy of a particular country, conversion into United States dollars or transfer of funds of a convertible currency to the United States is restricted or forbidden, LICENSEE shall give HARVARD prompt notice in writing and shall pay the royalty and other amounts due through such means or methods as are lawful in such country as HARVARD may reasonably designate. Failing the designation by HARVARD of such lawful means or methods within thirty (30)&#160;days after such notice is given to HARVARD, LICENSEE shall deposit such royalty or other payment in local currency to the credit of HARVARD in a recognized banking institution designated by HARVARD, or if none is designated by HARVARD within the thirty (30)&#160;day period described above, in a recognized banking institution selected by LICENSEE and identified in a written notice to HARVARD by LICENSEE, and such deposit shall fulfill all obligations of LICENSEE to HARVARD with respect to such royalties. When in any country in which the law or regulations prohibit both the transmittal and deposit of royalties on sales in such country, royalty payments shall be suspended for as long as such prohibition is in effect, and as soon as such prohibition ceases to be in effect, all royalties which LICENSEE would have been under obligation to transmit or deposit, but for the prohibition, shall be deposited or transmitted promptly to the extent allowable.</font></td></tr></table></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE VI</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RECORD KEEPING</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">6.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall keep, and shall require its SUBLICENSEES to keep, accurate records (together with supporting documentation) of LICENSED PRODUCTS made, used or sold under this Agreement, and SERVICE INCOME and SUBLICENSE INCOME received by LICENSEE under this Agreement, appropriate to determine the amount of royalties due to HARVARD hereunder. Such records shall be retained for three (3)&#160;years following the end of the reporting period to which they relate. For such three year period, they shall be</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:72pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">available during normal business hours upon reasonable advance notice for examination by a certified public accountant selected by HARVARD, and reasonably acceptable to LICENSEE, for the sole purpose of verifying reports and payments hereunder. In conducting examinations pursuant to this Section&#160;6.1, HARVARD&#8217;s accountant shall have access to all records which HARVARD reasonably believes to be relevant to the calculation of royalties under Article&#160;IV. HARVARD agrees to maintain any information contained in such records in confidence, except as otherwise required by law and except information in regarding the amount of royalties due.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">6.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD&#8217;s accountant shall not disclose to HARVARD any information other than information relating to the accuracy of reports and payments made hereunder.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">6.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Such examination by HARVARD&#8217;s accountant shall be at HARVARD&#8217;s expense, except that if such examination shows an underreporting or underpayment in excess of five percent (5%)&#160;for any twelve (12)&#160;month period, then LICENSEE shall pay the cost of such examination as well as any additional sum that would have been payable to HARVARD had the LICENSEE reported correctly, plus interest on said sum at the rate of one and one-half percent (1.5%)&#160;per month.</font></td></tr></table></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE VII</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DOMESTIC AND FOREIGN PATENT FILING AND MAINTENANCE</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Upon execution of this Agreement, LICENSEE shall reimburse HARVARD for fifty percent (50%)&#160;of all reasonable expenses HARVARD has incurred for the preparation, filing, prosecution, maintenance and counseling with respect to PATENT RIGHTS. Such expenses total &#91;***&#93; as of October&#160;1, 2000. Thereafter, LICENSEE shall reimburse HARVARD for fifty percent (50%)&#160;of all such future reasonable expenses prior to the termination of this Agreement upon receipt of invoices from HARVARD.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD shall be responsible for the preparation, filing, prosecution and maintenance of any and all patent applications and patents included in PATENT RIGHTS. HARVARD will instruct counsel to directly notify HARVARD and LICENSEE and provide them copies of any official communications from the United States and foreign patent offices relating to said prosecution, and to provide LICENSEE with advance draft copies of all relevant communications to the various patent offices, so that LICENSEE may be informed and apprised of the continuing prosecution of patent applications in PATENT RIGHTS. LICENSEE shall have reasonable opportunities to participate in decision making on all key decisions affecting filing, prosecution and maintenance of patents and patent applications in PATENT RIGHTS. HARVARD will use reasonable efforts to incorporate LICENSEE&#8217;s reasonable suggestions regarding said prosecution. HARVARD shall use all reasonable efforts to amend any patent application to include claims reasonably requested by LICENSEE to protect LICENSED PRODUCTS.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD and LICENSEE shall cooperate fully in the preparation, filing, prosecution and maintenance of PATENT RIGHTS and of all patents and patent applications licensed to LICENSEE hereunder, executing all papers and instruments or requiring members of</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:72pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD to execute such papers and instruments so as to enable HARVARD to apply for, to prosecute and to maintain patent applications and patents in HARVARD&#8217;s name in any country. Each party shall provide to the other prompt notice as to all matters which come to its attention and which may affect the preparation, filing, prosecution or maintenance of any such patent applications or patents.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE may elect to surrender its PATENT RIGHTS in any country upon sixty (60)&#160;days written notice to HARVARD. Such notice shall not relieve LICENSEE from responsibility to reimburse HARVARD for patent-related expenses incurred prior to the expiration of the (60)&#160;day notice period.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If HARVARD elects not to prosecute or maintain any of the patents or patent applications relating to PATENT RIGHTS or any portion thereof in any country, LICENSEE shall be given sufficient notice of HARVARD&#8217;s decision so that LICENSEE may request that HARVARD continue prosecuting or maintaining such patents or patent applications, at LICENSEE&#8217;s expense. If HARVARD elects not to prosecute or maintain such patents or patent applications after such request by LICENSEE, then LICENSEE shall have the right, but not the obligation, at its own expense to prosecute and maintain such patents and patent applications or portion thereof in such country and in HARVARD&#8217;s name. If LICENSEE assumes 100% of the costs to file, prosecute, and maintain certain patents and patent applications relating to the PATENT RIGHTS pursuant to this Section&#160;7.5, and, if HARVARD licenses the PATENT RIGHTS to one or more co-exclusive licensees designated in Section&#160;3.1 after such time, then HARVARD will credit LICENSEE with the costs LICENSEE has paid in excess of 50% if one other licensee, due for the preparation, filing, prosecution and maintenance of patents and patent applications relating to PATENT RIGHTS pursuant to Section&#160;7.1 above.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If LICENSEE can demonstrate that it is not being adequately informed or apprised of the continuing prosecution of patents or patent applications in PATENT RIGHTS, or that it is not being provided with reasonable opportunities to participate in decision making or that its interests are not being adequately protected, LICENSEE shall be entitled to engage, at LICENSEE&#8217;s expense, independent patent counsel to review and evaluate patent prosecution and filing of patents and patent applications included in PATENT RIGHTS.</font></td></tr></table></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE VIII</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INFRINGEMENT</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">With respect to any PATENT RIGHTS that are licensed to LICENSEE pursuant to this Agreement, LICENSEE shall have the right to prosecute in its own name and at its own expense any infringement of such patent. HARVARD agrees to notify LICENSEE promptly of each infringement of such patents of which HARVARD, as applicable, is or becomes aware. Before LICENSEE commences an action with respect to any infringement of such patents, LICENSEE shall give careful consideration to the views of HARVARD and to potential effects on the public interest in making its decision whether or not to sue.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:72pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE acknowledges that other co-exclusive licensees of PATENT RIGHTS designated in Section&#160;3.1 shall have rights identical to LICENSEE to prosecute infringers and that co-exclusive licensees will be bound by the identical terms of this Section&#160;8.2. In any prosecution instigated by LICENSEE and in which HARVARD, as necessary, is also named plaintiff as owner of the PATENT RIGHTS, LICENSEE must notify other co-exclusive licensees of the existence of such legal action and allow other co-exclusive licensees to join as a plaintiff upon co-exclusive licensees&#8217; request. In addition, in the event other co-exclusive licensees instigate an infringement prosecution, LICENSEE hereby consents to being joined as a plaintiff in such suit solely for the purpose of procuring standing to bring the action and at the sole expense of the instigating co-exclusive licensee. To the extent that LICENSEE desires to participate in any strategic decisions affecting the prosecution of the action brought by other co-exclusive licensees, LICENSEE acknowledges that it and co-exclusive licensees will necessarily have to reach a mutual agreement concerning litigation expenses and strategy. In no event shall HARVARD incur any liability or expense in connection with any action of co-exclusive licensees, joint or otherwise.</font></td></tr></table></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During any such litigation, HARVARD will agree to not license any defendant or accused infringer of the PATENT RIGHTS in the litigation, without LICENSEE&#8217;s prior written consent.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.913%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.468%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.468%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.308%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.910%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.033%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8.3</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If LICENSEE elects to commence an action as described above, HARVARD may, to the extent permitted by law, elect to join as parties in that action. Regardless of whether HARVARD elects to join as parties, HARVARD shall cooperate fully with LICENSEE in connection with any such action.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD agrees to join as a party in any action if required by law to do so in order to bring an action under the PATENT RIGHTS.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(c)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall reimburse HARVARD for any costs incurs with LICENSEE&#8217;s approval, including reasonable attorneys&#8217; fees, as part of an action brought by LICENSEE, irrespective of whether HARVARD becomes a co-plaintiff.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If LICENSEE elects to commence an action as described above, LICENSEE may deduct from its royalty payments to HARVARD with respect to the patent(s) subject to suit an amount not exceeding fifty percent (50%)&#160;of LICENSEE&#8217;s expenses and costs of such action, including reasonable attorneys&#8217; fees&#59; provided, however, that such reduction shall not exceed fifty percent (50%)&#160;of the total royalty due to HARVARD with respect to the patent(s) subject to suit for each calendar year. If such fifty percent (50%)&#160;of LICENSEE&#8217;s expenses and costs exceeds the amount of royalties deducted by LICENSEE for any calendar year, LICENSEE may to that extent reduce the royalties due to HARVARD from LICENSEE in succeeding calendar years, but never by more than fifty percent (50%)&#160;of the total royalty due in any one year with respect to the patent(s) subject to suit.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:72pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">No settlement, consent judgment or other voluntary final disposition of the suit may be entered into without the prior written consent of HARVARD which consent shall not be unreasonably withheld.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Recoveries or reimbursements from actions commenced by LICENSEE pursuant to this Article shall first be applied to reimburse LICENSEE, HARVARD for litigation costs not paid from royalties and then to reimburse HARVARD for royalties deducted by LICENSEE pursuant to Section&#160;8.4. Any remaining recoveries or reimbursements shall be shared as follows&#58;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If the amount is lost profits or lost royalties, LICENSEE shall receive an amount equal to the damages the court determines LICENSEE has suffered as a result of the infringement less the amount of any royalties that would have been due HARVARD on sales of LICENSED PRODUCTS lost by LICENSEE as a result of the infringement had LICENSEE made such sales, and HARVARD shall receive an amount equal to the royalties it would have received if such sales had been made by LICENSEE, and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">As to awards other than lost profits or lost royalties, fifty percent (50%)&#160;to LICENSEE and fifty percent (50%)&#160;to HARVARD.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(c)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If two or more co-exclusive licensees undertake the suit, the provision of this Section&#160;8.6 will be modified to take into account each co-exclusive licensee&#8217;s expenses and lost profits.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If LICENSEE elects not to exercise its right to prosecute an infringement of the PATENT RIGHTS pursuant to this Article, HARVARD may do so at its own expense, controlling such action and retaining all recoveries therefrom. LICENSEE shall cooperate fully with HARVARD in connection with any such action.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If a declaratory judgment action is brought naming LICENSEE as a defendant and alleging invalidity of any of the PATENT RIGHTS, HARVARD may elect to take over the sole defense of the action at its own expense. LICENSEE shall cooperate fully with HARVARD in connection with any such action. HARVARD shall consult with LICENSEE regarding such defense.</font></td></tr></table></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE IX</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TERMINATION OF AGREEMENT</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">9.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">This Agreement, unless terminated as provided herein, shall remain in effect until the last patent or patent application in PATENT RIGHTS has expired or been abandoned.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">9.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD may terminate this Agreement as follows&#58;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If LICENSEE does not make a payment due hereunder and fails to cure such non-payment (including the payment of interest in accordance with Section&#160;5.4(e)) within</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:72pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.933%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">thirty (30)&#160;days after the date of notice in writing of such non-payment by HARVARD.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If LICENSEE defaults in its obligations under Sections&#160;10.3(c) and 10.3(d) to procure and maintain insurance.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(c)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If LICENSEE shall become insolvent, shall make an assignment for the benefit of creditors, or shall have a petition in bankruptcy filed for or against it. Such termination shall be effective immediately upon HARVARD giving written notice to LICENSEE.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(d)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If an examination by HARVARD&#8217;s accountant pursuant to Article&#160;V shows an underreporting or underpayment by LICENSEE in excess of twenty percent (20%)&#160;for any twelve (12)&#160;month period, provided that such underreporting or underpayment is not determined to be inadvertent or the result of an honest mistake.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(e)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">If LICENSEE is convicted of a felony relating to the manufacture, use, or sale of LICENSED PRODUCTS.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(f)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Except as provided in Subsections (a), (b), and (c)&#160;above, if LICENSEE defaults in the performance of any material obligations under this Agreement and the default has not been remedied within forty-five (45)&#160;days after the date of notice in writing of such default by HARVARD.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">9.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall provide, in all sublicenses granted by it under this Agreement, that LICENSEE&#8217;s interest in such sublicenses shall at HARVARD&#8217;s option terminate or be assigned to HARVARD upon termination of this Agreement&#59; however, LICENSEE shall have the option to nominate one of its sublicensees as a substitute for LICENSEE. The proposed substitute must (i)&#160;have a net worth of at least equivalent to the net worth LICENSEE had as of the date of this Agreement and (ii)&#160;have available resources and sufficient scientific, business and other expertise comparable to LICENSEE in order to satisfy its obligations under this Agreement. At least sixty (60)&#160;days prior to termination of this Agreement, LICENSEE shall provide HARVARD with written notice of LICENSEE&#8217;s nominee together with documentation sufficient to demonstrate the requirements set forth in subparagraphs (i)&#160;and (ii)&#160;above for HARVARD&#8217;s approval, which shall not be unreasonably withheld. HARVARD shall notify LICENSEE in writing of its decision prior to termination of this Agreement. If HARVARD approves LICENSEE&#8217;s nominee, LICENSEE shall assign this Agreement to its nominee and its nominee shall accept the assignment no later than thirty (30)&#160;days after the termination date of this Agreement.</font></td></tr></table></div><div style="margin-top:4.5pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that HARVARD disapproved LICENSEE&#8217;s first nominee, prior to the termination date of this Agreement, LICENSEE shall have the option to nominate one of its other sublicensees for HARVARD&#8217;s approval which shall not be unreasonably withheld.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:72pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">9.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE may terminate this Agreement by giving ninety (90)&#160;days advance written notice of termination to HARVARD. Upon termination, LICENSEE shall submit a final Royalty Report to HARVARD and any royalty payments and unreimbursed patent expenses invoiced by HARVARD shall become immediately payable.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">9.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Sections&#160;6.1, 6.2, 6.3, 7.1, 9.4, 9.5, 10.2, 10.3, 10.4, and 10.7 of this Agreement shall survive termination.</font></td></tr></table></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARTICLE X</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GENERAL</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD does not warrant the validity of the PATENT RIGHTS licensed hereunder and make no representations whatsoever with regard to the scope of the licensed PATENT RIGHTS or that such PATENT RIGHTS may be exploited by LICENSEE, an AFFILIATE, or SUBLICENSEE without infringing other patents, provided, however, HARVARD represents that it has no knowledge of any facts or circumstances as of the execution date of this Agreement that would render any of the PATENT RIGHTS invalid or unenforceable. HARVARD represents and warrants, to the best of its knowledge, that HARVARD owns all right, title and interest in and to the PATENT RIGHTS.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HARVARD EXPRESSLY DISCLAIMS ANY AND ALL IMPLIED WARRANTIES AND MAKES NO EXPRESS OR IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE OF THE PATENT RIGHTS OR INFORMATION SUPPLIED BY HARVARD, LICENSED PROCESSES OR LICENSED PRODUCTS CONTEMPLATED BY THIS AGREEMENT.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.769%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.915%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall indemnify, defend and hold harmless HARVARD and its current or former directors, governing board members, trustees, officers, faculty, medical and professional staff, employees, students, and agents and their respective successors, heirs and assigns (collectively, the &#8220;INDEMNITEES&#8221;), from and against any claim, liability, cost, expense, damage, deficiency, loss or obligation of any kind or nature (including, without limitation, reasonable attorney&#8217;s fees and other costs and expenses of litigation) (collectively, &#8220;Claims&#8221;), based upon, arising out of, or otherwise relating to this Agreement, including without limitation any cause of action relating to product liability concerning any product, process, or service made, used or sold pursuant to any right or license granted under this Agreement, provided, however, that such indemnification shall not apply to any liability, damage, loss, or expense to the extent directly attributable to the negligent activities, reckless misconduct or intentional misconduct of Indemnitees.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Each Indemnitee that intends to claim indemnification under Section&#160;10.3(a) shall promptly notify LICENSEE of any claim or action in respect of which the Indemnitee intends to claim such indemnification, and LICENSEE shall assume the defense thereof with counsel mutually satisfactory to LICENSEE and HARVARD. The failure to deliver notice to LICENSEE within a reasonable time after the</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:72pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.933%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">commencement of any such claim or action, if materially prejudicial to its ability to defend such action, shall relieve LICENSEE of any liability to the Indemnitee under Section&#160;10.3(a) with respect to such action, but the omission so to deliver notice to LICENSEE will not relieve it of any liability that it may have to any Indemnitee otherwise than under Section&#160;10.3(a). HARVARD and any other Indemnitee, and their respective employees and agents, shall cooperate fully with LICENSEE and its legal representatives in the investigation of any claim or action covered by the indemnification under Section&#160;10.3(a).</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(c)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Beginning at the time any such product, process or service is being commercially distributed or sold (other than for the purpose of obtaining regulatory approvals) by LICENSEE or by a SUBLICENSEE, AFFILIATE or agent of LICENSEE, LICENSEE shall, at its sole cost and expense, procure and maintain commercial general liability insurance in amounts not less than $2,000,000 per incident and $2,000,000 annual aggregate and naming the Indemnitees as additional insureds. During clinical trials of any such product, process or service, LICENSEE shall, at its sole cost and expense, procure and maintain commercial general liability insurance in such equal or lesser amount as HARVARD shall require, naming the Indemnitees as additional insureds. Such commercial general liability insurance shall provide&#58; (i)&#160;product liability coverage&#59; and (ii)&#160;broad form contractual liability coverage for LICENSEE&#8217;s indemnification under this Agreement. If LICENSEE elects to self-insure all or part of the limits described above (including deductibles or retentions which are in excess of $250,000 annual aggregate) such self-insurance program must be acceptable to HARVARD and the Risk Management Foundation of the Harvard Medical Institutions, Inc. in their sole discretion. The minimum amounts of insurance coverage required shall not be construed to create a limit of LICENSEE&#8217;s liability with respect to its indemnification under this Agreement.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(d)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall provide HARVARD with written evidence of such insurance upon request of HARVARD. LICENSEE shall provide HARVARD with written notice at least fifteen (15)&#160;days prior to the cancellation, non-renewal or material change in such insurance&#59; if LICENSEE does not obtain replacement insurance providing comparable coverage within such fifteen (15)&#160;day period, HARVARD shall have the right to terminate this Agreement effective at the end of such fifteen (15)&#160;day period without notice or any additional waiting periods.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(e)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall maintain such commercial general liability insurance beyond the expiration or termination of this Agreement during&#58; (i)&#160;the period that any product, process, or service, relating to, or developed pursuant to, this Agreement is being commercially distributed or sold by LICENSEE or by a SUBLICENSEE, AFFILIATE or agent of LICENSEE&#59; and (ii)&#160;a reasonable period after the period referred to in Subsection (e)(i) above which in no event shall be less than fifteen (15)&#160;years.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:72pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall not use HARVARD&#8217;s name or insignia, or any adaptation of them, or the name of any of HARVARD&#8217;s inventors in any advertising, promotional or sales literature without the prior written approval of HARVARD.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Without the prior written approval of HARVARD in each instance, neither this Agreement nor the rights granted hereunder shall be transferred or assigned in whole or in part by LICENSEE to any person whether voluntarily or involuntarily, by operation of law or otherwise, except that each of LICENSEE and its AFFILIATES may assign this Agreement in connection with a merger, consolidation or sale or transfer of all or substantially all of its assets. This Agreement shall be binding upon the respective successors, legal representatives and assignees of HARVARD and LICENSEE.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The interpretation and application of the provisions of this Agreement shall be governed by the laws of the Commonwealth of Massachusetts.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE shall comply with all applicable laws and regulations. In particular, it is understood and acknowledged that the transfer of certain commodities and technical data is subject to United States laws and regulations controlling the export of such commodities and technical data, including all Export Administration Regulations of the United States Department of Commerce. These laws and regulations among other things, prohibit or require a license for the export of certain types of technical data to certain specified countries. LICENSEE hereby agrees and gives written assurance that it will comply with all United States laws and regulations controlling the export of commodities and technical data, that it will be solely responsible for any violation of such by LICENSEE or its AFFILIATES or SUBLICENSEES, and that it will defend and hold HARVARD, CHILDREN, and MIT harmless in the event of any legal action of any nature occasioned by such violation.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LICENSEE agrees&#58; (i)&#160;to obtain all regulatory approvals required for the manufacture and sale of LICENSED PRODUCTS and LICENSED PROCESSES&#59; and (ii)&#160;to utilize appropriate patent marking on such LICENSED PRODUCTS. LICENSEE also agrees to register or record this Agreement as is required by law or regulation in any country where the license is in effect.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.835%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Any notices to be given hereunder shall be sufficient if signed by the party (or party&#8217;s attorney) giving same and either&#58; (i)&#160;delivered in person&#59; (ii)&#160;mailed certified mail return receipt requested&#59; or (iii)&#160;faxed to other party if the sender has evidence of successful transmission and if the sender promptly sends the original by ordinary mail, in any event to the following addresses&#58;</font></td></tr></table></div><div style="margin-top:10pt;padding-left:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If to LICENSEE&#58;</font></div><div style="margin-top:4.5pt;padding-left:67.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;Mycometrix Corporation</font></div><div style="padding-left:67.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;213 E. Grand Ave.</font></div><div style="padding-left:67.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;South San Francisco, CA 94080</font></div><div style="padding-left:67.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;Attention&#58;</font></div><div style="padding-left:67.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;Fax&#58; (650)-</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:72pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:10pt;padding-left:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If to HARVARD&#58;</font></div><div style="margin-top:4.5pt;padding-left:67.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;Office for Technology and Trademark Licensing</font></div><div style="padding-left:67.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;Harvard University</font></div><div style="padding-left:67.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;Holyoke Center, Suite&#160;727</font></div><div style="padding-left:67.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;1350 Massachusetts Avenue</font></div><div style="padding-left:67.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;Cambridge, MA 02138</font></div><div style="padding-left:67.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;Fax&#58; (617)&#160;495-9568</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By such notice either party may change their address for future notices.</font></div><div style="margin-top:4.5pt;padding-left:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notices delivered in person shall be deemed given on the date delivered. Notices sent by fax shall be deemed given on the date faxed. Notices mailed shall be deemed given on the date postmarked on the envelope.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.989%"><tr><td style="width:1.0%"></td><td style="width:5.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.268%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Should a court of competent jurisdiction later hold any provision of this Agreement to be invalid, illegal, or unenforceable, and such holding is not reversed on appeal, it shall be considered severed from this Agreement. All other provisions, rights and obligations shall continue without regard to the severed provision, provided that the remaining provisions of this Agreement are in accordance with the intention of the parties.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:87.542%"><tr><td style="width:1.0%"></td><td style="width:6.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In the event of any controversy or claim arising out of or relating to any provision of this Agreement or the breach thereof, the parties shall try to settle such conflict amicably between themselves. Subject to the limitation stated in the final sentence of this Section&#160;10.11, any such conflict which the parties are unable to resolve promptly shall be settled through arbitration conducted in accordance with the rules of the American Arbitration Association. The demand for arbitration shall be filed within a reasonable time after the controversy or claim has arisen, and in no event after the date upon which institution of legal proceedings based on such controversy or claim would be barred by the applicable statute of limitation. Such arbitration shall be held in Boston, Massachusetts. The award through arbitration shall be final and binding. Either party may enter any such award in a court having jurisdiction or may make application to such court for judicial acceptance of the award and an order of enforcement, as the case may be. Notwithstanding the foregoing, either party may, without recourse to arbitration, assert against the other party a third-party claim or cross-claim in any action brought by a third party, to which the subject matter of this Agreement may be relevant.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.592%"><tr><td style="width:1.0%"></td><td style="width:5.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.12</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">This Agreement constitutes the entire understanding between the parties and neither party shall be obligated by any condition or representation other than those expressly stated herein or as may be subsequently agreed to by the parties hereto in writing.</font></td></tr></table></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;The remainder of this page is intentionally blank.&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:72pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed by their duly authorized representatives.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.926%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.781%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.901%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.781%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.911%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">PRESIDENT AND FELLOWS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">MYCOMETRIX CORPORATION</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">OF HARVARD COLLEGE</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#47;s&#47; Joyce Brinton</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#47;s&#47; Gajus Worthington</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Joyce Brinton, Director</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Office for Technology and</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">President</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Trademark Licensing</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">12&#47;20&#47;00</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">12&#47;21&#47;00</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Date</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Date</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:72pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">APPENDIX A</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following comprise PATENT RIGHTS&#58;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#91;***&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:72pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>9
<FILENAME>exhibit10610q3q2020.htm
<DESCRIPTION>EX-10.6
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i3e4ecd0d0dc9432cbfb0aec1a00e67ec_1"></div><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:4.5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;10.6</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HARVARD UNIVERSITY</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Office for Technology and Trademark Licensing</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:66.155%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.565%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.281%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.399%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holyoke Center, Suite&#160;727</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1350 Massachusetts Avenue</font></div><div style="margin-bottom:0.75pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cambridge, MA 02138 USA</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:0.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">t. 617.495.3067</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f. 617.495.9568</font></div><div style="margin-bottom:0.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">www.techtransfer.harvard.edu</font></div></td></tr></table></div><div style="margin-top:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;22, 2004</font></div><div style="margin-top:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">William M. Smith</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vice President, Legal Affairs</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fluidigm Corporation</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7100 Shoreline Court</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">South San Francisco, CA 94080</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject&#58; Letter Agreement between Fluidigm and Harvard Concerning Harvard Case Numbers &#91;***&#93;</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dear Bill,</font></div><div style="margin-top:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Fluidigm Corporation (Fluidigm) has licensed a number of Harvard University (Harvard) owned patents and patent applications in the area of &#91;***&#93;. In particular, on October&#160;15, 2000, Fluidigm (then known as Mycometrix Corporation) licensed Harvard Case Numbers &#91;***&#93;, all exclusively or co- exclusively. Fluidigm has since terminated the license to Case Numbers &#91;***&#93;, and the parties have mutually agreed in this letter to hereby terminate Fluidigm&#8217;s licenses to Case Numbers &#91;***&#93;. Fluidigm is retaining its licenses to Case Numbers &#91;***&#93;.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Fluidigm is concerned that Harvard or a licensee of Harvard may file claims in the previously or hereby terminated Case Numbers &#91;***&#93; or &#91;***&#93; that cover inventions that are not separately patentable (as described in 37 CFR 1.601(n)) from inventions covered, as of the date of this letter, by the pending or issued claims in Case Numbers &#91;***&#93;. Fluidigm further is concerned that Harvard or a licensee of Harvard may file claims in the previously or hereby terminated Case Numbers &#91;***&#93; that (a)&#160;cover inventions that (i)&#160;are separately patentable (as described in 37 CFR 1.601(n)) from inventions covered, as of the date of this letter, by the pending or issued claims in Case Numbers &#91;***&#93;, and (ii)&#160;would meet the criteria of 35 USC &#167;&#167;102, 103 and 112 for patentability in Case Numbers &#91;***&#93;, and (b)&#160;are not now pending in any of Case Numbers &#91;***&#93;. Fluidigm believes it has rights (through its co-exclusive license agreements to Case Numbers &#91;***&#93;,)) to the not separately patentable inventions and the separately patentable inventions, each as described above. Harvard is willing to address Fluidigm&#8217;s concerns through this letter agreement.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Therefore, Harvard and Fluidigm agree as follows&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.979%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">A)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Harvard agrees not to file, or to permit any other to file, claims in the previously or hereby terminated Case Numbers &#91;***&#93;, that cover inventions that are not</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.979%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">separately patentable (as described in 37 CFR 1.601(n)) from inventions covered, as of the date of this letter, by the pending or issued claims in Case Numbers &#91;***&#93;, without the prior express written consent of Fluidigm given after the date of this letter.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.979%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">B)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Harvard agrees to first offer to Fluidigm for licensing any claims, filed after the date of this letter, in Case Number &#91;***&#93; that (a)&#160;cover inventions that (i)&#160;are separately patentable (as described in 37 CFR 1.601(n)) from inventions covered, as of the date of this letter, by the pending or issued claims in Case Numbers &#91;***&#93;, and (ii)&#160;would meet the criteria of 35 USC &#167;&#167;102, 103 and 112 for patentability in Case Numbers &#91;***&#93;, and (b)&#160;are not now pending in any of Case Numbers &#91;***&#93;. Fluidigm agrees to inform Harvard within one month after Fluidigm receives express written notice form Harvard of the existence of said claims (together with a copy of such claims) whether it desires a license to said claims, or else Harvard shall be free to license them to other parties. Any license agreement between Fluidigm and Harvard for said claims shall be negotiated in good faith by the parties, have a field no broader than that now pending in Fluidigm&#8217;s license to Case &#91;***&#93;, have commercially reasonably royalties and be substantially like Harvard&#8217;s then current license agreement with diligence requirements based on an acceptable development plan provided by Fluidigm&#59; provided, however, if the parties have not entered into such license agreement within &#91;***&#93; after Fluidigm receives express written notice from Harvard of the existence of the applicable claims (together with a copy of such claims), then any license agreement between Fluidigm and Harvard for said claims shall be on the same terms and conditions, and in the same form, as the parties&#8217; license agreements with respect to Case Numbers &#91;***&#93;, (as in effect as of the date of this letter), except that the license will be a non-exclusive license.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.979%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">C)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Harvard represents that all patent applications in Case Numbers &#91;***&#93; have been abandoned as of the date of this letter. Harvard agrees not to revive any such patent application or to file any other patent application under Case Number &#91;***&#93;.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.979%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">D)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Fluidigm agrees to pay &#91;***&#93; of Harvard&#8217;s reasonable out-of-pocket patent expenses, incurred after the date of this letter agreement, in Case Number &#91;***&#93;, and within &#91;***&#93; of receiving an invoice from Harvard, up to a maximum aggregate amount of &#91;***&#93;. Harvard agrees to inform Fluidigm if any US patent or patent application in Case Number &#91;***&#93; becomes involved in an interference proceeding in the US Patent and Trademark Office before Harvard has incurred any expense to allow Fluidigm to terminate this letter agreement.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.979%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">E)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The parties mutually agree that the license to Case Numbers &#91;***&#93; hereby are terminated, and in connection therewith, promptly following the first meeting of the Board of Directors of Fluidigm after such date, Fluidigm shall issue to Harvard &#91;***&#93; of Common Stock of Fluidigm. Fluidigm represents that, in its last institutional round of financing, Fluidigm sold shares of its Series&#160;D Preferred Stock at a price of $2.80 per share. Harvard makes to Fluidigm, as of the date of the issuance of such &#91;***&#93;, the same representations and warranties with respect to such shares as those representations and warranties set forth in Paragraph&#160;4.2(c)(ii)(1), (2)&#160;and (3)&#160;of the</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Certain identified information marked with &#91;***&#93; has been excluded from this exhibit because it is not material and would be competitively harmful if publicly disclosed. </font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.979%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">license for Case Number &#91;***&#93; regarding the Shares. Paragraphs 4.2(c)(iii) and (iv)&#160;of the license for Case Number &#91;***&#93; shall apply as well to such &#91;***&#93;.</font></td></tr></table></div><div style="margin-top:10pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fluidigm may terminate this Letter Agreement in writing with thirty (30)&#160;days written notice to Harvard and owe no patent expenses incurred by Harvard in Case Number &#91;***&#93; after said thirty day notice period.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.979%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">F)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Harvard may terminate this Letter Agreement for any material breach by Fluidigm of its obligations under Paragraphs (D)&#160;or (E)&#160;of this letter if Harvard gives express written notice to Fluidigm of such breach and such breach is not cured within thirty (30)&#160;days after Fluidigm&#8217;s receipt of such notice.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.979%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">G)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Any disputes between the parties regarding this letter shall be resolved in the same manner as disputes are resolved under Fluidigm&#8217;s licenses to Case Numbers &#91;***&#93;.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.979%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">H)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The parties acknowledge that each party may currently have a different interpretation of certain aspects of the three remaining license agreements. With respect to the three remaining license agreements, the provisions of this letter are intended by the parties solely to provide specific protective mechanisms regarding the subject matter licensed by Harvard to Fluidigm. This letter shall not prejudice either parties&#8217; interpretation or intent of the three remaining license agreements, and is not intended to constitute the parties&#8217; interpretation of the three remaining license agreements (including the original intent thereof).</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.920%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Sincerely,</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#47;s&#47; Robert Benson</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Robert Benson, PhD</font></div><div style="margin-bottom:0.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Associate Director</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Agreed to&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">PRESIDENT AND FELLOWS</font></div><div style="margin-bottom:0.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">OF HARVARD COLLEGE&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Fluidigm Corporation&#58;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#47;s&#47; Robert Benson for</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#47;s&#47; Gajus Worthington</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Joyce Brinton</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Signature</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Director</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Office for Technology and Trademark</font></div><div style="margin-bottom:0.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Licensing</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">President and CEO</font></div><div style="margin-bottom:0.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Date&#58; Dec. 23, 2004</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Date&#58; 12&#47;23&#47;04</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>10
<FILENAME>exhibit31110q3q2020ng.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="iace25b9c1a7f45b0b052aaf62a5cad27_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.1</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF THE PRESIDENT AND CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECURITIES EXCHANGE ACT RULES 13a-14(a)&#160;AND 15d-14(a),</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION&#160;302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Stephen Christopher Linthwaite, certify that&#58;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this quarterly report on Form 10-Q of Fluidigm Corporation&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:9pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:9pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:9pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:9pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:9pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:9pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:37.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.447%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; November 6, 2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Stephen Christopher Linthwaite</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stephen Christopher Linthwaite</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>11
<FILENAME>exhibit31210q3q2020ng.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i2204a5324f6f4783a4568473d6162ad4_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.2</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF THE CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECURITIES EXCHANGE ACT RULES 13a-14(a)&#160;AND 15d-14(a),</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION&#160;302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Vikram Jog, certify that&#58;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this quarterly report on Form 10-Q of Fluidigm Corporation&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:9pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:9pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:9pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:9pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:9pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:9pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:37.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.447%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; November 6, 2020</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Vikram Jog</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vikram Jog</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>12
<FILENAME>exhibit32110q3q2020ng.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="if4c6e38eaca043a9b118613c3ce6ad35_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.1</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 18 U.S.C. SECTION 1350, </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION&#160;906</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Stephen Christopher Linthwaite, the chief executive officer of Fluidigm Corporation (the &#8220;Company&#8221;), certify for the purposes of 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge,</font></div><div style="margin-top:9pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6pt">the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2020 (the &#8220;Report&#8221;), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-bottom:3pt;margin-top:9pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.766%"><tr><td style="width:1.0%"></td><td style="width:57.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.460%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.197%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; November 6, 2020</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Stephen Christopher Linthwaite</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stephen Christopher Linthwaite</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-top:9pt;text-indent:24.75pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>13
<FILENAME>exhibit32210q3q2020ng.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="if8765aee984f4d17b9867881b035dba1_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.2</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 18 U.S.C. SECTION 1350, </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION&#160;906</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Vikram Jog, the chief financial officer of Fluidigm Corporation (the &#8220;Company&#8221;), certify for the purposes of 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge,</font></div><div style="margin-top:9pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6pt">the Company&#8217;s Quarterly Report on Form 10-Q for the quarter year ended September 30, 2020 (the &#8220;Report&#8221;), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-bottom:3pt;margin-top:9pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.619%"><tr><td style="width:1.0%"></td><td style="width:57.138%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.095%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; November 6, 2020</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Vikram Jog</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vikram Jog</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>14
<FILENAME>fldm-20200930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:cc860809-a6b3-4939-9e89-fb60809a6371,g:7453d80d-f328-4339-bf18-c087f9945f8a-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:fldm="http://fluidigm.com/20200930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://fluidigm.com/20200930">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="fldm-20200930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="fldm-20200930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="fldm-20200930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="fldm-20200930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://fluidigm.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://fluidigm.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>1001002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperations" roleURI="http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations">
        <link:definition>1003004 - Statement - Condensed Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveLoss" roleURI="http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss">
        <link:definition>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquity" roleURI="http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>1006007 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionofBusiness" roleURI="http://fluidigm.com/role/DescriptionofBusiness">
        <link:definition>2101101 - Disclosure - Description of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>2102102 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>2203201 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>2304301 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2405401 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails" roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails">
        <link:definition>2406402 - Disclosure - Summary of Significant Accounting Policies - Accumulated Other Comprehensive Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails" roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails">
        <link:definition>2407403 - Disclosure - Summary of Significant Accounting Policies - Potential Common Shares Excluded from Computations of Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombination" roleURI="http://fluidigm.com/role/BusinessCombination">
        <link:definition>2108103 - Disclosure - Business Combination</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationTables" roleURI="http://fluidigm.com/role/BusinessCombinationTables">
        <link:definition>2309302 - Disclosure - Business Combination (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationNarrativeDetails" roleURI="http://fluidigm.com/role/BusinessCombinationNarrativeDetails">
        <link:definition>2410404 - Disclosure - Business Combination - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationNetCashFlowsDetails" roleURI="http://fluidigm.com/role/BusinessCombinationNetCashFlowsDetails">
        <link:definition>2411405 - Disclosure - Business Combination - Net Cash Flows (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails" roleURI="http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails">
        <link:definition>2412406 - Disclosure - Business Combination - Schedule of Consideration Transferred and Identifiable Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RADxProgram" roleURI="http://fluidigm.com/role/RADxProgram">
        <link:definition>2113104 - Disclosure - RADx Program</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RADxProgramTables" roleURI="http://fluidigm.com/role/RADxProgramTables">
        <link:definition>2314303 - Disclosure - RADx Program (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RADxProgramDetails" roleURI="http://fluidigm.com/role/RADxProgramDetails">
        <link:definition>2415407 - Disclosure - RADx Program (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenue" roleURI="http://fluidigm.com/role/Revenue">
        <link:definition>2116105 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://fluidigm.com/role/RevenueTables">
        <link:definition>2317304 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueScheduleofDisaggregationofRevenueDetails" roleURI="http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails">
        <link:definition>2418408 - Disclosure - Revenue - Schedule of Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueNarrativeDetails" roleURI="http://fluidigm.com/role/RevenueNarrativeDetails">
        <link:definition>2419409 - Disclosure - Revenue - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuePerformanceObligationsDetails" roleURI="http://fluidigm.com/role/RevenuePerformanceObligationsDetails">
        <link:definition>2420410 - Disclosure - Revenue - Performance Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuePerformanceObligationsDetails_1" roleURI="http://fluidigm.com/role/RevenuePerformanceObligationsDetails_1">
        <link:definition>2420410 - Disclosure - Revenue - Performance Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsnet" roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnet">
        <link:definition>2121106 - Disclosure - Goodwill and Intangible Assets, net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsnetTables" roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetTables">
        <link:definition>2322305 - Disclosure - Goodwill and Intangible Assets, net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsnetNarrativeDetails" roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails">
        <link:definition>2423411 - Disclosure - Goodwill and Intangible Assets, net - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails" roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails">
        <link:definition>2424412 - Disclosure - Goodwill and Intangible Assets, net - Schedule of Finite-lived Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails" roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails">
        <link:definition>2425413 - Disclosure - Goodwill and Intangible Assets, net - Future Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetails" roleURI="http://fluidigm.com/role/BalanceSheetDetails">
        <link:definition>2126107 - Disclosure - Balance Sheet Details</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsTables" roleURI="http://fluidigm.com/role/BalanceSheetDetailsTables">
        <link:definition>2327306 - Disclosure - Balance Sheet Details (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails" roleURI="http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails">
        <link:definition>2428414 - Disclosure - Balance Sheet Details - Summary of Cash and Cash Equivalents (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsInventoriesDetails" roleURI="http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails">
        <link:definition>2429415 - Disclosure - Balance Sheet Details - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsPropertyandEquipmentDetails" roleURI="http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails">
        <link:definition>2430416 - Disclosure - Balance Sheet Details - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsWarrantyAccrualDetails" roleURI="http://fluidigm.com/role/BalanceSheetDetailsWarrantyAccrualDetails">
        <link:definition>2431417 - Disclosure - Balance Sheet Details - Warranty Accrual (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleNotesandCreditFacility" roleURI="http://fluidigm.com/role/ConvertibleNotesandCreditFacility">
        <link:definition>2132108 - Disclosure - Convertible Notes and Credit Facility</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleNotesandCreditFacilityTables" roleURI="http://fluidigm.com/role/ConvertibleNotesandCreditFacilityTables">
        <link:definition>2333307 - Disclosure - Convertible Notes and Credit Facility (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleNotesandCreditFacilityNarrativeDetails" roleURI="http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails">
        <link:definition>2434418 - Disclosure - Convertible Notes and Credit Facility - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleNotesandCreditFacilityScheduleofDebtDetails" roleURI="http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails">
        <link:definition>2435419 - Disclosure - Convertible Notes and Credit Facility - Schedule of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://fluidigm.com/role/Leases">
        <link:definition>2136109 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://fluidigm.com/role/LeasesTables">
        <link:definition>2337308 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://fluidigm.com/role/LeasesNarrativeDetails">
        <link:definition>2438420 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalBalancesheetDetails" roleURI="http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails">
        <link:definition>2439421 - Disclosure - Leases - Supplemental Balance sheet (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofOperatingLeaseCostDetails" roleURI="http://fluidigm.com/role/LeasesScheduleofOperatingLeaseCostDetails">
        <link:definition>2440422 - Disclosure - Leases - Schedule of Operating Lease Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesOperatingLeaseMaturityDetails" roleURI="http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails">
        <link:definition>2441423 - Disclosure - Leases - Operating Lease Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesOperatingLeaseMaturityDetails_1" roleURI="http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails_1">
        <link:definition>2441423 - Disclosure - Leases - Operating Lease Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstruments" roleURI="http://fluidigm.com/role/FairValueofFinancialInstruments">
        <link:definition>2142110 - Disclosure - Fair Value of Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstrumentsTables" roleURI="http://fluidigm.com/role/FairValueofFinancialInstrumentsTables">
        <link:definition>2343309 - Disclosure - Fair Value of Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" roleURI="http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails">
        <link:definition>2444424 - Disclosure - Fair Value of Financial Instruments - Summary of Investments and Cash Equivalents (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstrumentsScheduleofDebtDetails" roleURI="http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails">
        <link:definition>2445425 - Disclosure - Fair Value of Financial Instruments - Schedule of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquity" roleURI="http://fluidigm.com/role/ShareholdersEquity">
        <link:definition>2146111 - Disclosure - Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityTables" roleURI="http://fluidigm.com/role/ShareholdersEquityTables">
        <link:definition>2347310 - Disclosure - Shareholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityNarrativeDetails" roleURI="http://fluidigm.com/role/ShareholdersEquityNarrativeDetails">
        <link:definition>2448426 - Disclosure - Shareholders' Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityScheduleofStockOptionsDetails" roleURI="http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails">
        <link:definition>2449427 - Disclosure - Shareholders' Equity - Schedule of Stock Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedPlans" roleURI="http://fluidigm.com/role/StockBasedPlans">
        <link:definition>2150112 - Disclosure - Stock-Based Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedPlansTables" roleURI="http://fluidigm.com/role/StockBasedPlansTables">
        <link:definition>2351311 - Disclosure - Stock-Based Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedPlansNarrativeDetails" roleURI="http://fluidigm.com/role/StockBasedPlansNarrativeDetails">
        <link:definition>2452428 - Disclosure - Stock-Based Plans - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedPlansRestrictedandPerformanceStockUnitsDetails" roleURI="http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails">
        <link:definition>2453429 - Disclosure - Stock-Based Plans - Restricted and Performance Stock Units (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedPlansStockOptionActivityDetails" roleURI="http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails">
        <link:definition>2454430 - Disclosure - Stock-Based Plans - Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedPlansStockBasedCompensationExpenseDetails" roleURI="http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails">
        <link:definition>2455431 - Disclosure - Stock-Based Plans - Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://fluidigm.com/role/IncomeTaxes">
        <link:definition>2156113 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://fluidigm.com/role/IncomeTaxesDetails">
        <link:definition>2457432 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InformationAboutGeographicAreas" roleURI="http://fluidigm.com/role/InformationAboutGeographicAreas">
        <link:definition>2158114 - Disclosure - Information About Geographic Areas</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InformationAboutGeographicAreasDetails" roleURI="http://fluidigm.com/role/InformationAboutGeographicAreasDetails">
        <link:definition>2459433 - Disclosure - Information About Geographic Areas (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DevelopmentAgreement" roleURI="http://fluidigm.com/role/DevelopmentAgreement">
        <link:definition>2160115 - Disclosure - Development Agreement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DevelopmentAgreementDetails" roleURI="http://fluidigm.com/role/DevelopmentAgreementDetails">
        <link:definition>2461434 - Disclosure - Development Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://fluidigm.com/role/CommitmentsandContingencies">
        <link:definition>2162116 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="fldm_PortionOfStockOptionsVestOnFirstAnniversary" abstract="false" name="PortionOfStockOptionsVestOnFirstAnniversary" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherReceivables" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherReceivables" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember" abstract="true" name="TwoThousandSeventeenEmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables" abstract="false" name="LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="fldm_RevenueFromContractWithCustomerTermsOfPaymentPeriod" abstract="false" name="RevenueFromContractWithCustomerTermsOfPaymentPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="fldm_DVSSciencesInc.Member" abstract="true" name="DVSSciencesInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="fldm_ScheduleOfSignificantAccountingPoliciesTable" abstract="true" name="ScheduleOfSignificantAccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="fldm_ExchangeConvertibleSeniorNotesDue2034Member" abstract="true" name="ExchangeConvertibleSeniorNotesDue2034Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="fldm_CertainEmployeeMember" abstract="true" name="CertainEmployeeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="fldm_DeferredGrantRevenueNoncurrent" abstract="false" name="DeferredGrantRevenueNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice" abstract="false" name="DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="fldm_TwoThousandAndTenEquityIncentivePlanMember" abstract="true" name="TwoThousandAndTenEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="fldm_TwoThousandAndElevenEquityIncentivePlanMember" abstract="true" name="TwoThousandAndElevenEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue" abstract="false" name="StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="fldm_TwoThousandAndNineEquityIncentivePlanMember" abstract="true" name="TwoThousandAndNineEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="fldm_A2017InducementAwardPlanMember" abstract="true" name="A2017InducementAwardPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="fldm_SeniorConvertibleNotesdue2034Member" abstract="true" name="SeniorConvertibleNotesdue2034Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="fldm_EquityIncentivePlanMember" abstract="true" name="EquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAccountsReceivables" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAccountsReceivables" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_TwoThousandAndFourteenConvertibleNotesMember" abstract="true" name="TwoThousandAndFourteenConvertibleNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="fldm_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" abstract="false" name="LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesPercentage" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="fldm_SharebasedCompensationArrangementbySharebasedPaymentAwardVestingRestrictionsOwnershipPercentageofVotingStock" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardVestingRestrictionsOwnershipPercentageofVotingStock" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="fldm_ComputerEquipmentAndSoftwareMember" abstract="true" name="ComputerEquipmentAndSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="fldm_DevelopmentRevenueMember" abstract="true" name="DevelopmentRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="fldm_SaleOfStockConsiderationReceivableOnTransaction" abstract="false" name="SaleOfStockConsiderationReceivableOnTransaction" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_ConsumablesMember" abstract="true" name="ConsumablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="fldm_CashCashEquivalentsAndShortTermInvestmentsAmortizedCost" abstract="false" name="CashCashEquivalentsAndShortTermInvestmentsAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_InstruNorASMember" abstract="true" name="InstruNorASMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount" abstract="false" name="SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_DebtInstrumentEarlyRedemptionCostPercentOfMaximumBorrowingCapacity" abstract="false" name="DebtInstrumentEarlyRedemptionCostPercentOfMaximumBorrowingCapacity" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="fldm_RevenueFromContractWithCustomerPerformanceObligationPeriod" abstract="false" name="RevenueFromContractWithCustomerPerformanceObligationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="fldm_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="fldm_OperatingLeaseRightOfUseAssetGross" abstract="false" name="OperatingLeaseRightOfUseAssetGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_OneCustomerMember" abstract="true" name="OneCustomerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="fldm_LesseeOperatingLeaseRemainingTermOfContract" abstract="false" name="LesseeOperatingLeaseRemainingTermOfContract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="fldm_TwoThousandAndSeventeenInducementAwardPlanMember" abstract="true" name="TwoThousandAndSeventeenInducementAwardPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember" abstract="true" name="OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="fldm_ProceedsFromIssuanceOfCommonStockIncludingRelatedExpenses" abstract="false" name="ProceedsFromIssuanceOfCommonStockIncludingRelatedExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_EmployeeStockPurchasePlanNumberOfSixMonthOfferingPeriods" abstract="false" name="EmployeeStockPurchasePlanNumberOfSixMonthOfferingPeriods" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="fldm_RestrictedCashAndCashEquivalentsMember" abstract="true" name="RestrictedCashAndCashEquivalentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_TwoThousandAndTwentyAtTheMarketEquityOfferingProgramMember" abstract="true" name="TwoThousandAndTwentyAtTheMarketEquityOfferingProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="fldm_RestrictedStockAndPerformanceShareUnitsMember" abstract="true" name="RestrictedStockAndPerformanceShareUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" abstract="false" name="FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_DebtAndEquityOfferingCosts" abstract="false" name="DebtAndEquityOfferingCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization" abstract="false" name="OperatingLeaseRightOfUseAssetAccumulatedAmortization" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="fldm_TwoThousandAndNineteenConvertibleNotesMember" abstract="true" name="TwoThousandAndNineteenConvertibleNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts" abstract="false" name="ContractWithCustomerLiabilityIncreaseFromCashReceipts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_UpFrontAndMilestonePaymentsMaximum" abstract="false" name="UpFrontAndMilestonePaymentsMaximum" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember" abstract="true" name="TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="fldm_AssetRetirementObligationsIncurredButNotYetPaid" abstract="false" name="AssetRetirementObligationsIncurredButNotYetPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersFundingReceived" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersFundingReceived" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_IntellectualPropertyInfringementClaimsMember" abstract="true" name="IntellectualPropertyInfringementClaimsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="fldm_ShareholdersEquityLineItems" abstract="true" name="ShareholdersEquityLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_ProceedsFromResearchAndDevelopmentGrant" abstract="false" name="ProceedsFromResearchAndDevelopmentGrant" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_AwardsHeldByOwnersOfMoreThan10OfCommonStockMember" abstract="true" name="AwardsHeldByOwnersOfMoreThan10OfCommonStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="fldm_PatentsandLicenseAgreementsMember" abstract="true" name="PatentsandLicenseAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="fldm_ShareholdersEquityTable" abstract="true" name="ShareholdersEquityTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="fldm_SeniorConvertibleNotesDue2024Member" abstract="true" name="SeniorConvertibleNotesDue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_InitialConversionPriceOfStock" abstract="false" name="InitialConversionPriceOfStock" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="fldm_ResearchAndDevelopmentArrangementReceivables" abstract="false" name="ResearchAndDevelopmentArrangementReceivables" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory" abstract="false" name="LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="fldm_LineOfCreditFacilityPercentageOfInterestOnObligationUponDefault" abstract="false" name="LineOfCreditFacilityPercentageOfInterestOnObligationUponDefault" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="fldm_ProductWarrantyTerm" abstract="false" name="ProductWarrantyTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="fldm_ScheduleOfSignificantAccountingPoliciesLineItems" abstract="true" name="ScheduleOfSignificantAccountingPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="fldm_FiveLargestCustomersMember" abstract="true" name="FiveLargestCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="fldm_InstrumentsMember" abstract="true" name="InstrumentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="fldm_CollaborationRevenueMember" abstract="true" name="CollaborationRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="fldm_CollaborativeArrangementTerm" abstract="false" name="CollaborativeArrangementTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="fldm_TrusteeMember" abstract="true" name="TrusteeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="fldm_LaboratoryAndManufacturingEquipmentMember" abstract="true" name="LaboratoryAndManufacturingEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="fldm_CashPaidForOperatingLeaseLiabilitiesAbstract" abstract="true" name="CashPaidForOperatingLeaseLiabilitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement" abstract="false" name="NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesTerm" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="fldm_CommissionCostsMember" abstract="true" name="CommissionCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="fldm_EmployeeStockPurchasePlanOfferingPeriod" abstract="false" name="EmployeeStockPurchasePlanOfferingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="fldm_EquityIncentivePlanTwentyElevenMember" abstract="true" name="EquityIncentivePlanTwentyElevenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>15
<FILENAME>fldm-20200930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:cc860809-a6b3-4939-9e89-fb60809a6371,g:7453d80d-f328-4339-bf18-c087f9945f8a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://fluidigm.com/role/Cover" xlink:type="simple" xlink:href="fldm-20200930.xsd#Cover"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/Cover" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="fldm-20200930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_81b83608-9633-404a-8629-f5925df7f7c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_b88d3337-87ed-408e-8887-6e677a90d720" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_81b83608-9633-404a-8629-f5925df7f7c7" xlink:to="loc_us-gaap_Liabilities_b88d3337-87ed-408e-8887-6e677a90d720" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e233af31-be41-451d-9572-20fa992431f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_81b83608-9633-404a-8629-f5925df7f7c7" xlink:to="loc_us-gaap_StockholdersEquity_e233af31-be41-451d-9572-20fa992431f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_5e60375e-29e4-456f-8807-bd5f44e5d55b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_81b83608-9633-404a-8629-f5925df7f7c7" xlink:to="loc_us-gaap_CommitmentsAndContingencies_5e60375e-29e4-456f-8807-bd5f44e5d55b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_7be4be1d-e3a2-4d70-956e-8a684430c8fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_14b3ded5-d9d4-4367-96f7-8ead3690444b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7be4be1d-e3a2-4d70-956e-8a684430c8fd" xlink:to="loc_us-gaap_AssetsCurrent_14b3ded5-d9d4-4367-96f7-8ead3690444b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_b301dbcd-3341-4685-8235-7afe4602bd7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7be4be1d-e3a2-4d70-956e-8a684430c8fd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_b301dbcd-3341-4685-8235-7afe4602bd7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_c3e5f9ca-7963-4c56-8c3f-52519a8f78b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7be4be1d-e3a2-4d70-956e-8a684430c8fd" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_c3e5f9ca-7963-4c56-8c3f-52519a8f78b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_a8ddfe67-55bc-4659-a626-9e2fb54ba7d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7be4be1d-e3a2-4d70-956e-8a684430c8fd" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_a8ddfe67-55bc-4659-a626-9e2fb54ba7d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_adb346ee-737d-41bc-9cac-26427c491748" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7be4be1d-e3a2-4d70-956e-8a684430c8fd" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_adb346ee-737d-41bc-9cac-26427c491748" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f1bffda1-0e07-4c23-a63d-e39934df032b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7be4be1d-e3a2-4d70-956e-8a684430c8fd" xlink:to="loc_us-gaap_Goodwill_f1bffda1-0e07-4c23-a63d-e39934df032b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_df033b21-cefd-4cd8-9ad6-aef534bd0170" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_0faf005b-0574-4a76-92f7-7d7a64200b20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_df033b21-cefd-4cd8-9ad6-aef534bd0170" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_0faf005b-0574-4a76-92f7-7d7a64200b20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_4793d35d-34c5-435f-bf12-3298cd6b9fda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_df033b21-cefd-4cd8-9ad6-aef534bd0170" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_4793d35d-34c5-435f-bf12-3298cd6b9fda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2c2b441c-7463-450a-849d-1075cc690e85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_df033b21-cefd-4cd8-9ad6-aef534bd0170" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2c2b441c-7463-450a-849d-1075cc690e85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable_d385136b-d7f6-43e7-be2c-380f680dc3b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_df033b21-cefd-4cd8-9ad6-aef534bd0170" xlink:to="loc_us-gaap_ConvertibleLongTermNotesPayable_d385136b-d7f6-43e7-be2c-380f680dc3b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_775a7826-e22f-47d3-870a-de38595fe9bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_df033b21-cefd-4cd8-9ad6-aef534bd0170" xlink:to="loc_us-gaap_LiabilitiesCurrent_775a7826-e22f-47d3-870a-de38595fe9bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DeferredGrantRevenueNoncurrent_cf48e88e-4e7f-4cb2-8e04-25850e7abc15" xlink:href="fldm-20200930.xsd#fldm_DeferredGrantRevenueNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_df033b21-cefd-4cd8-9ad6-aef534bd0170" xlink:to="loc_fldm_DeferredGrantRevenueNoncurrent_cf48e88e-4e7f-4cb2-8e04-25850e7abc15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_81061482-17ad-4562-86f4-5d2affa4317b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_df033b21-cefd-4cd8-9ad6-aef534bd0170" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_81061482-17ad-4562-86f4-5d2affa4317b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_29a919ec-dace-4a18-bc04-4e8b34921656" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_d73ac6dd-b43f-4951-881c-34c737830836" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_29a919ec-dace-4a18-bc04-4e8b34921656" xlink:to="loc_us-gaap_AccountsPayableCurrent_d73ac6dd-b43f-4951-881c-34c737830836" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_36b84f37-53b4-4a0c-befd-05185634ad8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_29a919ec-dace-4a18-bc04-4e8b34921656" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_36b84f37-53b4-4a0c-befd-05185634ad8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_56c1ce4d-f4ec-4659-89fd-a7a5c6caf063" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_29a919ec-dace-4a18-bc04-4e8b34921656" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_56c1ce4d-f4ec-4659-89fd-a7a5c6caf063" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_627cebec-c54a-4916-8ec2-826e2caa868e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_29a919ec-dace-4a18-bc04-4e8b34921656" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_627cebec-c54a-4916-8ec2-826e2caa868e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_de89d11d-e6a2-4f46-a509-ec630585da40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_29a919ec-dace-4a18-bc04-4e8b34921656" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_de89d11d-e6a2-4f46-a509-ec630585da40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a15e9610-671d-4b4a-93ad-31a153627ee8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_f98e5cbf-4192-446a-95f0-3ff9af7b3b24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a15e9610-671d-4b4a-93ad-31a153627ee8" xlink:to="loc_us-gaap_PreferredStockValue_f98e5cbf-4192-446a-95f0-3ff9af7b3b24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_4232c5aa-8ce3-4db7-a4ab-9cda1aa31d69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a15e9610-671d-4b4a-93ad-31a153627ee8" xlink:to="loc_us-gaap_CommonStockValue_4232c5aa-8ce3-4db7-a4ab-9cda1aa31d69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_968d871a-2b3a-4f34-8fdf-91392de3e2c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a15e9610-671d-4b4a-93ad-31a153627ee8" xlink:to="loc_us-gaap_AdditionalPaidInCapital_968d871a-2b3a-4f34-8fdf-91392de3e2c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d010c39b-4c11-4c1f-b671-dbed285c0fa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a15e9610-671d-4b4a-93ad-31a153627ee8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d010c39b-4c11-4c1f-b671-dbed285c0fa7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_785c69d7-d0da-4266-8047-20a60763c252" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a15e9610-671d-4b4a-93ad-31a153627ee8" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_785c69d7-d0da-4266-8047-20a60763c252" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_55fa4527-1ad5-4799-9773-008d9333f961" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b4c6c3c4-ea49-49a6-823b-d57f8b48d2d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_55fa4527-1ad5-4799-9773-008d9333f961" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b4c6c3c4-ea49-49a6-823b-d57f8b48d2d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_8d1c8bf0-e7f5-4576-9e8b-620093719d17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_55fa4527-1ad5-4799-9773-008d9333f961" xlink:to="loc_us-gaap_ShortTermInvestments_8d1c8bf0-e7f5-4576-9e8b-620093719d17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_2f7bcdd6-9a5f-4269-96b9-d9242754fc0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_55fa4527-1ad5-4799-9773-008d9333f961" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_2f7bcdd6-9a5f-4269-96b9-d9242754fc0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_0557f19f-a1ab-4329-9547-1f9af9d78c16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_55fa4527-1ad5-4799-9773-008d9333f961" xlink:to="loc_us-gaap_InventoryNet_0557f19f-a1ab-4329-9547-1f9af9d78c16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5884697a-f6d0-497b-9ec8-26146ee14715" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_55fa4527-1ad5-4799-9773-008d9333f961" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5884697a-f6d0-497b-9ec8-26146ee14715" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementReceivables_e54d2f4b-682e-4c06-b2d9-fd22de5eacf2" xlink:href="fldm-20200930.xsd#fldm_ResearchAndDevelopmentArrangementReceivables"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_55fa4527-1ad5-4799-9773-008d9333f961" xlink:to="loc_fldm_ResearchAndDevelopmentArrangementReceivables_e54d2f4b-682e-4c06-b2d9-fd22de5eacf2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="fldm-20200930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="fldm-20200930.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_2c1e80fe-8315-4767-b8b3-a5adf914d7f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_c40c934e-5d40-4cde-bf61-cfdf9e0bce32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_2c1e80fe-8315-4767-b8b3-a5adf914d7f6" xlink:to="loc_us-gaap_OperatingExpenses_c40c934e-5d40-4cde-bf61-cfdf9e0bce32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_69fcbb0b-17ee-495f-981b-61aaf307a16d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_2c1e80fe-8315-4767-b8b3-a5adf914d7f6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_69fcbb0b-17ee-495f-981b-61aaf307a16d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c8d06c35-7b97-4332-aa63-d1536bb4b95f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0fc31211-bfba-4710-b39d-884247f19aa5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_c8d06c35-7b97-4332-aa63-d1536bb4b95f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0fc31211-bfba-4710-b39d-884247f19aa5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_47ca0150-96cf-4e99-9160-9942140ccf1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_c8d06c35-7b97-4332-aa63-d1536bb4b95f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_47ca0150-96cf-4e99-9160-9942140ccf1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_fe0364d8-9484-49c5-855a-a0603f08e686" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_e54b686f-feb2-4765-86ea-b6677b835b36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_fe0364d8-9484-49c5-855a-a0603f08e686" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_e54b686f-feb2-4765-86ea-b6677b835b36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_982344b5-0641-47bc-b861-8af98cac8ab5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_fe0364d8-9484-49c5-855a-a0603f08e686" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_982344b5-0641-47bc-b861-8af98cac8ab5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_2418b9b9-4e97-4387-a96e-a9c592e4c2ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_fe0364d8-9484-49c5-855a-a0603f08e686" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_2418b9b9-4e97-4387-a96e-a9c592e4c2ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_8f08273a-fe28-4aa8-a712-31910a28f892" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d616bbe9-e7e8-4074-835e-f0f955fe6cd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_8f08273a-fe28-4aa8-a712-31910a28f892" xlink:to="loc_us-gaap_OperatingIncomeLoss_d616bbe9-e7e8-4074-835e-f0f955fe6cd9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_d737c914-72f2-4ff4-9f05-dcdebcabefca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_8f08273a-fe28-4aa8-a712-31910a28f892" xlink:to="loc_us-gaap_InterestExpense_d737c914-72f2-4ff4-9f05-dcdebcabefca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_429744ee-902d-457e-a455-fa92de84b0a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_8f08273a-fe28-4aa8-a712-31910a28f892" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_429744ee-902d-457e-a455-fa92de84b0a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_5da53ffe-bc11-40f7-9501-c623b7814cab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_8f08273a-fe28-4aa8-a712-31910a28f892" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_5da53ffe-bc11-40f7-9501-c623b7814cab" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="fldm-20200930.xsd#CondensedConsolidatedStatementsofComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_3ae8e623-a666-4d1b-907f-63711cf0ce4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_73bb5e66-116a-492b-b61e-a1e6ac452686" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_3ae8e623-a666-4d1b-907f-63711cf0ce4b" xlink:to="loc_us-gaap_NetIncomeLoss_73bb5e66-116a-492b-b61e-a1e6ac452686" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_447a13f9-5802-4b17-90c9-749ae89c37e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_3ae8e623-a666-4d1b-907f-63711cf0ce4b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_447a13f9-5802-4b17-90c9-749ae89c37e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_be0a61f4-f288-4d8e-ba5e-b94109e37b7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3bd95286-8783-4579-b5b6-876728c5cb67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_be0a61f4-f288-4d8e-ba5e-b94109e37b7e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3bd95286-8783-4579-b5b6-876728c5cb67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_f6180fd5-5dcb-49a5-a538-648dab4655c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_be0a61f4-f288-4d8e-ba5e-b94109e37b7e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_f6180fd5-5dcb-49a5-a538-648dab4655c9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="fldm-20200930.xsd#CondensedConsolidatedStatementsofStockholdersEquity"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="fldm-20200930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_188fa096-8c2e-4e22-ad5d-c17da111ecf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ProceedsFromResearchAndDevelopmentGrant_cb2cb348-9760-42d7-866c-628f17372ec0" xlink:href="fldm-20200930.xsd#fldm_ProceedsFromResearchAndDevelopmentGrant"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_188fa096-8c2e-4e22-ad5d-c17da111ecf0" xlink:to="loc_fldm_ProceedsFromResearchAndDevelopmentGrant_cb2cb348-9760-42d7-866c-628f17372ec0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments_335e8950-9244-4846-88b5-e42d365debe9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_188fa096-8c2e-4e22-ad5d-c17da111ecf0" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments_335e8950-9244-4846-88b5-e42d365debe9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_917bb4a1-c460-47e1-985a-dd815ae78911" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_188fa096-8c2e-4e22-ad5d-c17da111ecf0" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_917bb4a1-c460-47e1-985a-dd815ae78911" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_100040a5-5775-4ff7-a459-e275103a482c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_188fa096-8c2e-4e22-ad5d-c17da111ecf0" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_100040a5-5775-4ff7-a459-e275103a482c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfOtherInvestments_78669b91-3ec8-4eb8-8f22-36a13d6e2097" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfOtherInvestments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_188fa096-8c2e-4e22-ad5d-c17da111ecf0" xlink:to="loc_us-gaap_ProceedsFromSaleOfOtherInvestments_78669b91-3ec8-4eb8-8f22-36a13d6e2097" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_bbd7bb29-28fe-4fa6-a7bb-feeba71dfd7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_188fa096-8c2e-4e22-ad5d-c17da111ecf0" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_bbd7bb29-28fe-4fa6-a7bb-feeba71dfd7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_00d99246-09d0-40f1-b2f7-57088b5c7498" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_ace3ef8e-2521-439e-b659-4e366d5b2062" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_00d99246-09d0-40f1-b2f7-57088b5c7498" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_ace3ef8e-2521-439e-b659-4e366d5b2062" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_b2a491dd-e290-4f34-a96f-8d8110d1aece" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_00d99246-09d0-40f1-b2f7-57088b5c7498" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_b2a491dd-e290-4f34-a96f-8d8110d1aece" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_c9a6362d-8877-404b-94c7-14d489702213" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_00d99246-09d0-40f1-b2f7-57088b5c7498" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_c9a6362d-8877-404b-94c7-14d489702213" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentOfFinancingAndStockIssuanceCosts_6276e651-08b9-42dd-9779-81a98b4dce83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentOfFinancingAndStockIssuanceCosts"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_00d99246-09d0-40f1-b2f7-57088b5c7498" xlink:to="loc_us-gaap_PaymentOfFinancingAndStockIssuanceCosts_6276e651-08b9-42dd-9779-81a98b4dce83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_1aaea681-72da-498e-bbfc-90a3c7011624" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_00d99246-09d0-40f1-b2f7-57088b5c7498" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_1aaea681-72da-498e-bbfc-90a3c7011624" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_adbc2d6d-836d-4e3a-af03-c93855d92132" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_485a9023-d7e7-4449-99c1-5167d14f26ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_adbc2d6d-836d-4e3a-af03-c93855d92132" xlink:to="loc_us-gaap_NetIncomeLoss_485a9023-d7e7-4449-99c1-5167d14f26ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_35a4178a-1de1-4380-bce6-301e3c1b7b69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_adbc2d6d-836d-4e3a-af03-c93855d92132" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_35a4178a-1de1-4380-bce6-301e3c1b7b69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_d1da45a8-a05b-4787-ad21-0b548249faec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_adbc2d6d-836d-4e3a-af03-c93855d92132" xlink:to="loc_us-gaap_ShareBasedCompensation_d1da45a8-a05b-4787-ad21-0b548249faec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_c91422e0-4b97-4983-b5c2-7268d7d84e57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_adbc2d6d-836d-4e3a-af03-c93855d92132" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_c91422e0-4b97-4983-b5c2-7268d7d84e57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_7c608363-23fa-4927-9896-400022023c5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_adbc2d6d-836d-4e3a-af03-c93855d92132" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_7c608363-23fa-4927-9896-400022023c5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_e6738336-75db-423e-b7a1-389385b5eb80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_adbc2d6d-836d-4e3a-af03-c93855d92132" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_e6738336-75db-423e-b7a1-389385b5eb80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_00f3b08e-e8d0-4a3e-ac99-7b09cffbb570" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_adbc2d6d-836d-4e3a-af03-c93855d92132" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_00f3b08e-e8d0-4a3e-ac99-7b09cffbb570" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1e110808-5086-4031-8ee9-efdfe0ca3aca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_adbc2d6d-836d-4e3a-af03-c93855d92132" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1e110808-5086-4031-8ee9-efdfe0ca3aca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_6bb5944c-1bd9-4451-b0d4-37e8742af74f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_adbc2d6d-836d-4e3a-af03-c93855d92132" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_6bb5944c-1bd9-4451-b0d4-37e8742af74f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_30ae7987-c235-450f-9930-0e6694321a8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_adbc2d6d-836d-4e3a-af03-c93855d92132" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_30ae7987-c235-450f-9930-0e6694321a8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_3a5af918-edb3-4cf2-bf2f-cc01b59244a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_adbc2d6d-836d-4e3a-af03-c93855d92132" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_3a5af918-edb3-4cf2-bf2f-cc01b59244a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_a1cd4119-9bc5-4578-a1ed-7783ed9d120a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_adbc2d6d-836d-4e3a-af03-c93855d92132" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_a1cd4119-9bc5-4578-a1ed-7783ed9d120a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_71ff59b6-8e82-45b0-8b83-89cf259ba44f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_adbc2d6d-836d-4e3a-af03-c93855d92132" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_71ff59b6-8e82-45b0-8b83-89cf259ba44f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_83f8f0f2-0787-4130-ba9d-bb53d9273fbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_adbc2d6d-836d-4e3a-af03-c93855d92132" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_83f8f0f2-0787-4130-ba9d-bb53d9273fbf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_621f5014-91de-4355-bbb2-d00672e7af38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_adbc2d6d-836d-4e3a-af03-c93855d92132" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_621f5014-91de-4355-bbb2-d00672e7af38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_e25074dc-c744-45d2-92bb-877f6a74480b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_adbc2d6d-836d-4e3a-af03-c93855d92132" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_e25074dc-c744-45d2-92bb-877f6a74480b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7782080c-e580-461a-88bd-209b445914a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_814c37af-9c38-43b1-9c0b-51cc4e0fe745" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7782080c-e580-461a-88bd-209b445914a6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_814c37af-9c38-43b1-9c0b-51cc4e0fe745" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3edfe96a-c82f-4dde-a741-fda5134aa2e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7782080c-e580-461a-88bd-209b445914a6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3edfe96a-c82f-4dde-a741-fda5134aa2e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_91baad8a-e3ec-4222-9178-b39222e98741" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7782080c-e580-461a-88bd-209b445914a6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_91baad8a-e3ec-4222-9178-b39222e98741" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e14e5c89-5383-4df7-81ce-1a86dfdbd76d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7782080c-e580-461a-88bd-209b445914a6" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e14e5c89-5383-4df7-81ce-1a86dfdbd76d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/DescriptionofBusiness" xlink:type="simple" xlink:href="fldm-20200930.xsd#DescriptionofBusiness"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/DescriptionofBusiness" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="fldm-20200930.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="fldm-20200930.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="fldm-20200930.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/BusinessCombination" xlink:type="simple" xlink:href="fldm-20200930.xsd#BusinessCombination"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/BusinessCombination" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/BusinessCombinationTables" xlink:type="simple" xlink:href="fldm-20200930.xsd#BusinessCombinationTables"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/BusinessCombinationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/BusinessCombinationNarrativeDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#BusinessCombinationNarrativeDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/BusinessCombinationNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/BusinessCombinationNetCashFlowsDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#BusinessCombinationNetCashFlowsDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/BusinessCombinationNetCashFlowsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_93d9b69a-ca0f-427f-9c61-ed2b26c06927" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_b42b21c5-ca7f-43e0-802e-eb81d3c7c385" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_93d9b69a-ca0f-427f-9c61-ed2b26c06927" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_b42b21c5-ca7f-43e0-802e-eb81d3c7c385" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_93b47b3f-72d8-435d-9a96-26f505dc07f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_93d9b69a-ca0f-427f-9c61-ed2b26c06927" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_93b47b3f-72d8-435d-9a96-26f505dc07f9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_d0a5be19-f37b-41bf-89ea-7ccf6db31afd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_4e770b9c-0ab5-406c-944f-08aea47abafb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_d0a5be19-f37b-41bf-89ea-7ccf6db31afd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_4e770b9c-0ab5-406c-944f-08aea47abafb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAccountsReceivables_366c99e1-9cce-46f9-9a56-587a711207c0" xlink:href="fldm-20200930.xsd#fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAccountsReceivables"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_d0a5be19-f37b-41bf-89ea-7ccf6db31afd" xlink:to="loc_fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAccountsReceivables_366c99e1-9cce-46f9-9a56-587a711207c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherReceivables_e0550350-ff09-4ea1-b255-f3e9381a009e" xlink:href="fldm-20200930.xsd#fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherReceivables"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_d0a5be19-f37b-41bf-89ea-7ccf6db31afd" xlink:to="loc_fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherReceivables_e0550350-ff09-4ea1-b255-f3e9381a009e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_58f36205-0a05-4cd0-9495-ed8518c97885" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_d0a5be19-f37b-41bf-89ea-7ccf6db31afd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_58f36205-0a05-4cd0-9495-ed8518c97885" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_e80c0db1-2836-4291-bf5c-3a9a6909e3ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_d0a5be19-f37b-41bf-89ea-7ccf6db31afd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_e80c0db1-2836-4291-bf5c-3a9a6909e3ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_d2426d11-4545-47ab-89d1-95656dbb7fd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_d0a5be19-f37b-41bf-89ea-7ccf6db31afd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_d2426d11-4545-47ab-89d1-95656dbb7fd8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_964acc9b-e571-49f7-a86e-f4b054ca15e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_d0a5be19-f37b-41bf-89ea-7ccf6db31afd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_964acc9b-e571-49f7-a86e-f4b054ca15e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_1911b377-32e3-4ec8-a6d4-7442bdcefa49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_d0a5be19-f37b-41bf-89ea-7ccf6db31afd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_1911b377-32e3-4ec8-a6d4-7442bdcefa49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_cb4d3469-60fb-413f-90c8-d76da8c69409" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_8daab7d1-c473-42ad-a31c-ac7ca685224d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_cb4d3469-60fb-413f-90c8-d76da8c69409" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_8daab7d1-c473-42ad-a31c-ac7ca685224d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_9c89b621-0cdd-433a-b292-68c711950ed4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_cb4d3469-60fb-413f-90c8-d76da8c69409" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_9c89b621-0cdd-433a-b292-68c711950ed4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/RADxProgram" xlink:type="simple" xlink:href="fldm-20200930.xsd#RADxProgram"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/RADxProgram" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/RADxProgramTables" xlink:type="simple" xlink:href="fldm-20200930.xsd#RADxProgramTables"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/RADxProgramTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/RADxProgramDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#RADxProgramDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/RADxProgramDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DeferredGrantRevenueNoncurrent_a1933291-076d-4f3a-8b24-1177987a6b1a" xlink:href="fldm-20200930.xsd#fldm_DeferredGrantRevenueNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount_86f7b4d3-c95d-4608-b1b4-4113daaaa292" xlink:href="fldm-20200930.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_fldm_DeferredGrantRevenueNoncurrent_a1933291-076d-4f3a-8b24-1177987a6b1a" xlink:to="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount_86f7b4d3-c95d-4608-b1b4-4113daaaa292" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses_91340969-cb72-4eac-a7c0-b3636dce3156" xlink:href="fldm-20200930.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_fldm_DeferredGrantRevenueNoncurrent_a1933291-076d-4f3a-8b24-1177987a6b1a" xlink:to="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses_91340969-cb72-4eac-a7c0-b3636dce3156" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementReceivables_ec05e7d0-6ba5-4553-bfe1-012061ee8a12" xlink:href="fldm-20200930.xsd#fldm_ResearchAndDevelopmentArrangementReceivables"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount_ccea17bc-bbd9-4f0b-b463-6008fa7064bc" xlink:href="fldm-20200930.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_fldm_ResearchAndDevelopmentArrangementReceivables_ec05e7d0-6ba5-4553-bfe1-012061ee8a12" xlink:to="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount_ccea17bc-bbd9-4f0b-b463-6008fa7064bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersFundingReceived_c6d7cc6f-c08b-4e03-abe7-3a26acdf4936" xlink:href="fldm-20200930.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersFundingReceived"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_fldm_ResearchAndDevelopmentArrangementReceivables_ec05e7d0-6ba5-4553-bfe1-012061ee8a12" xlink:to="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersFundingReceived_c6d7cc6f-c08b-4e03-abe7-3a26acdf4936" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/Revenue" xlink:type="simple" xlink:href="fldm-20200930.xsd#Revenue"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/Revenue" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/RevenueTables" xlink:type="simple" xlink:href="fldm-20200930.xsd#RevenueTables"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/RevenueTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#RevenueScheduleofDisaggregationofRevenueDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#RevenueNarrativeDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/RevenueNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/RevenuePerformanceObligationsDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#RevenuePerformanceObligationsDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/RevenuePerformanceObligationsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/RevenuePerformanceObligationsDetails_1" xlink:type="simple" xlink:href="fldm-20200930.xsd#RevenuePerformanceObligationsDetails_1"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/RevenuePerformanceObligationsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnet" xlink:type="simple" xlink:href="fldm-20200930.xsd#GoodwillandIntangibleAssetsnet"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/GoodwillandIntangibleAssetsnet" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetTables" xlink:type="simple" xlink:href="fldm-20200930.xsd#GoodwillandIntangibleAssetsnetTables"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#GoodwillandIntangibleAssetsnetNarrativeDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0cefc465-03e1-4e00-b2a2-1341f81f645b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_569a0493-71ab-419a-ad5c-6ae3f62ae30f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0cefc465-03e1-4e00-b2a2-1341f81f645b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_569a0493-71ab-419a-ad5c-6ae3f62ae30f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_88f60879-99cb-4d53-aa1b-2000cd5cb786" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0cefc465-03e1-4e00-b2a2-1341f81f645b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_88f60879-99cb-4d53-aa1b-2000cd5cb786" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_bee94738-60ab-4735-8e42-35311fcf1475" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_59499d87-bca3-442c-8f5a-0d51f8836ce2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_bee94738-60ab-4735-8e42-35311fcf1475" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_59499d87-bca3-442c-8f5a-0d51f8836ce2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_35b434c8-d6ef-42b3-ac1c-4f62ef4c4bdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_bee94738-60ab-4735-8e42-35311fcf1475" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_35b434c8-d6ef-42b3-ac1c-4f62ef4c4bdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_12613519-ea7e-441a-9076-1976c5db0db1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_bee94738-60ab-4735-8e42-35311fcf1475" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_12613519-ea7e-441a-9076-1976c5db0db1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_76c47aeb-370f-4921-8f88-a42a3f44bf34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_bee94738-60ab-4735-8e42-35311fcf1475" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_76c47aeb-370f-4921-8f88-a42a3f44bf34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_6e7570ee-7a57-4209-b583-0637ebf69306" xlink:href="fldm-20200930.xsd#fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_bee94738-60ab-4735-8e42-35311fcf1475" xlink:to="loc_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_6e7570ee-7a57-4209-b583-0637ebf69306" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_f893be5e-3223-4faf-94ba-1b90d98c585f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_bee94738-60ab-4735-8e42-35311fcf1475" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_f893be5e-3223-4faf-94ba-1b90d98c585f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/BalanceSheetDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#BalanceSheetDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/BalanceSheetDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/BalanceSheetDetailsTables" xlink:type="simple" xlink:href="fldm-20200930.xsd#BalanceSheetDetailsTables"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/BalanceSheetDetailsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ce6c344a-6f18-4c7b-af5a-adb964a32016" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_21c34522-df83-4c78-a146-b039d919ee94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ce6c344a-6f18-4c7b-af5a-adb964a32016" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_21c34522-df83-4c78-a146-b039d919ee94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_9cd28408-6675-4f93-beb3-51efa98b895e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ce6c344a-6f18-4c7b-af5a-adb964a32016" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_9cd28408-6675-4f93-beb3-51efa98b895e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#BalanceSheetDetailsInventoriesDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_d05dc061-598b-4398-a898-f39a4e3dd769" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_e7dbce94-9a1e-43ed-957c-890c49ba2fdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_d05dc061-598b-4398-a898-f39a4e3dd769" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_e7dbce94-9a1e-43ed-957c-890c49ba2fdd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_37d5205a-79bd-4f85-b40e-1a60f3160d6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_d05dc061-598b-4398-a898-f39a4e3dd769" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_37d5205a-79bd-4f85-b40e-1a60f3160d6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_01bdeab8-4559-48f1-a9b0-840a7464e446" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_d05dc061-598b-4398-a898-f39a4e3dd769" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_01bdeab8-4559-48f1-a9b0-840a7464e446" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#BalanceSheetDetailsPropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f4cdb3ba-d1af-4935-9bf8-b4193c1b43f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_e8a40d67-54e0-477b-a336-47edea05554c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_f4cdb3ba-d1af-4935-9bf8-b4193c1b43f1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_e8a40d67-54e0-477b-a336-47edea05554c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_4dc3151b-0ff9-48cf-a803-49c125896281" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_f4cdb3ba-d1af-4935-9bf8-b4193c1b43f1" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_4dc3151b-0ff9-48cf-a803-49c125896281" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_1545ddb3-56a4-4755-8dda-f2fde1bcaaa5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_f4cdb3ba-d1af-4935-9bf8-b4193c1b43f1" xlink:to="loc_us-gaap_ConstructionInProgressGross_1545ddb3-56a4-4755-8dda-f2fde1bcaaa5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/BalanceSheetDetailsWarrantyAccrualDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#BalanceSheetDetailsWarrantyAccrualDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/BalanceSheetDetailsWarrantyAccrualDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/ConvertibleNotesandCreditFacility" xlink:type="simple" xlink:href="fldm-20200930.xsd#ConvertibleNotesandCreditFacility"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/ConvertibleNotesandCreditFacility" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/ConvertibleNotesandCreditFacilityTables" xlink:type="simple" xlink:href="fldm-20200930.xsd#ConvertibleNotesandCreditFacilityTables"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/ConvertibleNotesandCreditFacilityTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#ConvertibleNotesandCreditFacilityNarrativeDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#ConvertibleNotesandCreditFacilityScheduleofDebtDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_ee1a38cf-3a60-4d3a-ab29-a43ccc00b6a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_8656cb69-5256-4620-96ae-539cf4b8218d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_ee1a38cf-3a60-4d3a-ab29-a43ccc00b6a6" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_8656cb69-5256-4620-96ae-539cf4b8218d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_33f2c3bf-d254-43a3-bd99-71b43e779277" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_ee1a38cf-3a60-4d3a-ab29-a43ccc00b6a6" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_33f2c3bf-d254-43a3-bd99-71b43e779277" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_17c9bec2-ad1b-45af-b498-5710e711f692" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_ee1a38cf-3a60-4d3a-ab29-a43ccc00b6a6" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_17c9bec2-ad1b-45af-b498-5710e711f692" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/Leases" xlink:type="simple" xlink:href="fldm-20200930.xsd#Leases"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/Leases" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/LeasesTables" xlink:type="simple" xlink:href="fldm-20200930.xsd#LeasesTables"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/LeasesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#LeasesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/LeasesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#LeasesSupplementalBalancesheetDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_7c37f4cb-1a3a-4123-b6d4-51f7dbaf503d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_3c3d4a2c-a516-403e-9058-3ca181acb108" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_7c37f4cb-1a3a-4123-b6d4-51f7dbaf503d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_3c3d4a2c-a516-403e-9058-3ca181acb108" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e1808a54-6804-427a-b7be-9c2c687a8afa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_7c37f4cb-1a3a-4123-b6d4-51f7dbaf503d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e1808a54-6804-427a-b7be-9c2c687a8afa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_463781c5-73e5-4d3e-b48c-b7216f0878b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_OperatingLeaseRightOfUseAssetGross_74b45600-2a0a-4c2d-b30f-14fe9bd600a4" xlink:href="fldm-20200930.xsd#fldm_OperatingLeaseRightOfUseAssetGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset_463781c5-73e5-4d3e-b48c-b7216f0878b6" xlink:to="loc_fldm_OperatingLeaseRightOfUseAssetGross_74b45600-2a0a-4c2d-b30f-14fe9bd600a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization_8843f4f4-be07-4a13-a3b9-2fbb55615239" xlink:href="fldm-20200930.xsd#fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset_463781c5-73e5-4d3e-b48c-b7216f0878b6" xlink:to="loc_fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization_8843f4f4-be07-4a13-a3b9-2fbb55615239" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/LeasesScheduleofOperatingLeaseCostDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#LeasesScheduleofOperatingLeaseCostDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/LeasesScheduleofOperatingLeaseCostDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#LeasesOperatingLeaseMaturityDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_68e2e585-c1d5-47f7-87c9-a317b0ea4634" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_e8aa9d9f-cf1b-42de-8a26-9b83bf817861" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_68e2e585-c1d5-47f7-87c9-a317b0ea4634" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_e8aa9d9f-cf1b-42de-8a26-9b83bf817861" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_f29aee12-92d1-4fe9-be44-1eaf42efd560" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_68e2e585-c1d5-47f7-87c9-a317b0ea4634" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_f29aee12-92d1-4fe9-be44-1eaf42efd560" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c2a6a2d5-9393-44b0-8aef-1ac5ed042a7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_68e2e585-c1d5-47f7-87c9-a317b0ea4634" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c2a6a2d5-9393-44b0-8aef-1ac5ed042a7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_91cf71a7-73a1-47d0-b24a-b826fa7a7557" xlink:href="fldm-20200930.xsd#fldm_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_68e2e585-c1d5-47f7-87c9-a317b0ea4634" xlink:to="loc_fldm_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_91cf71a7-73a1-47d0-b24a-b826fa7a7557" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_50ebe363-6c58-403e-a9f9-6ccaaa6f24ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_68e2e585-c1d5-47f7-87c9-a317b0ea4634" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_50ebe363-6c58-403e-a9f9-6ccaaa6f24ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_70d64fe5-b83d-477d-b129-e7af27be3837" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_68e2e585-c1d5-47f7-87c9-a317b0ea4634" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_70d64fe5-b83d-477d-b129-e7af27be3837" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails_1" xlink:type="simple" xlink:href="fldm-20200930.xsd#LeasesOperatingLeaseMaturityDetails_1"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fa4293e5-fd84-4661-8809-d20002741cc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_09ccc4de-1363-4366-b7fe-76e396f10608" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fa4293e5-fd84-4661-8809-d20002741cc2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_09ccc4de-1363-4366-b7fe-76e396f10608" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_fbdb2949-1ce5-450f-999e-ce95f6bec60b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fa4293e5-fd84-4661-8809-d20002741cc2" xlink:to="loc_us-gaap_OperatingLeaseLiability_fbdb2949-1ce5-450f-999e-ce95f6bec60b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/FairValueofFinancialInstruments" xlink:type="simple" xlink:href="fldm-20200930.xsd#FairValueofFinancialInstruments"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/FairValueofFinancialInstruments" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/FairValueofFinancialInstrumentsTables" xlink:type="simple" xlink:href="fldm-20200930.xsd#FairValueofFinancialInstrumentsTables"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/FairValueofFinancialInstrumentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d56be788-13aa-44a5-a7f7-f4b4b16b5120" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_06e7e0e7-5bd5-423c-959b-b00b89e4f849" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d56be788-13aa-44a5-a7f7-f4b4b16b5120" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_06e7e0e7-5bd5-423c-959b-b00b89e4f849" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_e711591f-061b-41b6-a6b7-11d27480c8be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d56be788-13aa-44a5-a7f7-f4b4b16b5120" xlink:to="loc_us-gaap_ShortTermInvestments_e711591f-061b-41b6-a6b7-11d27480c8be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_0b6b6d50-7a8a-42a1-b41f-778e1d9cafcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d56be788-13aa-44a5-a7f7-f4b4b16b5120" xlink:to="loc_us-gaap_LongTermInvestments_0b6b6d50-7a8a-42a1-b41f-778e1d9cafcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CashCashEquivalentsAndShortTermInvestmentsAmortizedCost_7c0035c5-8ed4-4654-98be-902ee580201b" xlink:href="fldm-20200930.xsd#fldm_CashCashEquivalentsAndShortTermInvestmentsAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_dc44886c-5e08-4e27-9180-81b512c9ce5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_fldm_CashCashEquivalentsAndShortTermInvestmentsAmortizedCost_7c0035c5-8ed4-4654-98be-902ee580201b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_dc44886c-5e08-4e27-9180-81b512c9ce5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_441c8f5d-31cf-408c-aa92-ba48c8f29f92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_fldm_CashCashEquivalentsAndShortTermInvestmentsAmortizedCost_7c0035c5-8ed4-4654-98be-902ee580201b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_441c8f5d-31cf-408c-aa92-ba48c8f29f92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_ed81ddf9-7312-4e76-bf45-a2dccf689d6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_fldm_CashCashEquivalentsAndShortTermInvestmentsAmortizedCost_7c0035c5-8ed4-4654-98be-902ee580201b" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_ed81ddf9-7312-4e76-bf45-a2dccf689d6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_ab9f44b3-9fb1-48ad-bd58-83c860d5ba0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_469bd4c5-15c5-4fa4-b311-64a9c7b36a46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_ab9f44b3-9fb1-48ad-bd58-83c860d5ba0f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_469bd4c5-15c5-4fa4-b311-64a9c7b36a46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_994dc1e9-7779-46cd-aae2-4fdc6841e77f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_ab9f44b3-9fb1-48ad-bd58-83c860d5ba0f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_994dc1e9-7779-46cd-aae2-4fdc6841e77f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_bf023938-a8b5-4bf3-91a1-205c444f0cc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_ab9f44b3-9fb1-48ad-bd58-83c860d5ba0f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_bf023938-a8b5-4bf3-91a1-205c444f0cc3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_84595993-8467-410a-8483-7049b510c460" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_efe8d85e-c8bc-4d9e-8224-b602c3dc69c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_84595993-8467-410a-8483-7049b510c460" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_efe8d85e-c8bc-4d9e-8224-b602c3dc69c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_2ca94277-79d8-4caf-8a05-493080cab1b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_84595993-8467-410a-8483-7049b510c460" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_2ca94277-79d8-4caf-8a05-493080cab1b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_db0febf6-20eb-43e7-be71-d3bbd2760cfb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_08c36297-5ffc-44ff-8f03-393e23589307" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_db0febf6-20eb-43e7-be71-d3bbd2760cfb" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_08c36297-5ffc-44ff-8f03-393e23589307" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_2d3d3ed3-c594-4bbc-b00a-40c6118ef32b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_db0febf6-20eb-43e7-be71-d3bbd2760cfb" xlink:to="loc_us-gaap_ShortTermInvestments_2d3d3ed3-c594-4bbc-b00a-40c6118ef32b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_9af306d0-770e-4acc-89e7-ca235c72b30d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_db0febf6-20eb-43e7-be71-d3bbd2760cfb" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_9af306d0-770e-4acc-89e7-ca235c72b30d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#FairValueofFinancialInstrumentsScheduleofDebtDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="fldm-20200930.xsd#ShareholdersEquity"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/ShareholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/ShareholdersEquityTables" xlink:type="simple" xlink:href="fldm-20200930.xsd#ShareholdersEquityTables"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/ShareholdersEquityTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#ShareholdersEquityNarrativeDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#ShareholdersEquityScheduleofStockOptionsDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/StockBasedPlans" xlink:type="simple" xlink:href="fldm-20200930.xsd#StockBasedPlans"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/StockBasedPlans" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/StockBasedPlansTables" xlink:type="simple" xlink:href="fldm-20200930.xsd#StockBasedPlansTables"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/StockBasedPlansTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/StockBasedPlansNarrativeDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#StockBasedPlansNarrativeDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/StockBasedPlansNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#StockBasedPlansRestrictedandPerformanceStockUnitsDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#StockBasedPlansStockOptionActivityDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#StockBasedPlansStockBasedCompensationExpenseDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/IncomeTaxes" xlink:type="simple" xlink:href="fldm-20200930.xsd#IncomeTaxes"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/IncomeTaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#IncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/IncomeTaxesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/InformationAboutGeographicAreas" xlink:type="simple" xlink:href="fldm-20200930.xsd#InformationAboutGeographicAreas"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/InformationAboutGeographicAreas" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/InformationAboutGeographicAreasDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#InformationAboutGeographicAreasDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/InformationAboutGeographicAreasDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/DevelopmentAgreement" xlink:type="simple" xlink:href="fldm-20200930.xsd#DevelopmentAgreement"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/DevelopmentAgreement" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/DevelopmentAgreementDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#DevelopmentAgreementDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/DevelopmentAgreementDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="fldm-20200930.xsd#CommitmentsandContingencies"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/CommitmentsandContingencies" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>16
<FILENAME>fldm-20200930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:cc860809-a6b3-4939-9e89-fb60809a6371,g:7453d80d-f328-4339-bf18-c087f9945f8a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://fluidigm.com/role/Cover" xlink:type="simple" xlink:href="fldm-20200930.xsd#Cover"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/Cover" xlink:type="extended" id="i4ba248e3a3ec4517b4bb7563dfdd88c3_Cover"/>
  <link:roleRef roleURI="http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="fldm-20200930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended" id="i954ba733ee3142088d632498590fa215_CondensedConsolidatedBalanceSheets"/>
  <link:roleRef roleURI="http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="fldm-20200930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended" id="ia89f17f7ab7f42d090a588865966cdb5_CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:roleRef roleURI="http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="fldm-20200930.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended" id="i3b630c55968649a3a9ade66cba8ecee3_CondensedConsolidatedStatementsofOperations">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c5b18f5c-3257-492d-8eaa-9034e606f2ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_9d4d0e5b-d4c5-4bc6-b911-d8c83e6856b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c5b18f5c-3257-492d-8eaa-9034e606f2ef" xlink:to="loc_us-gaap_RevenuesAbstract_9d4d0e5b-d4c5-4bc6-b911-d8c83e6856b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b2ffe5c2-9014-4fbc-93ad-eccb7ecacfc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_9d4d0e5b-d4c5-4bc6-b911-d8c83e6856b1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b2ffe5c2-9014-4fbc-93ad-eccb7ecacfc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_c4ccf9cf-621a-4140-9871-3497ad42bf6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c5b18f5c-3257-492d-8eaa-9034e606f2ef" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_c4ccf9cf-621a-4140-9871-3497ad42bf6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_1f04cec9-5b4e-45b9-b213-21c2eeb2d27c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_c4ccf9cf-621a-4140-9871-3497ad42bf6d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_1f04cec9-5b4e-45b9-b213-21c2eeb2d27c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_d32d2ebd-12bf-4410-99da-12379438912d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_c4ccf9cf-621a-4140-9871-3497ad42bf6d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_d32d2ebd-12bf-4410-99da-12379438912d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_686e8ef8-79d6-4926-935a-2aadec76422d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_c4ccf9cf-621a-4140-9871-3497ad42bf6d" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_686e8ef8-79d6-4926-935a-2aadec76422d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_71b67855-46fc-4e93-b980-d7a390167d89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_c4ccf9cf-621a-4140-9871-3497ad42bf6d" xlink:to="loc_us-gaap_OperatingExpenses_71b67855-46fc-4e93-b980-d7a390167d89" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_bccd2c22-4600-4cf8-a7d4-db0bf8ee5a50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c5b18f5c-3257-492d-8eaa-9034e606f2ef" xlink:to="loc_us-gaap_OperatingIncomeLoss_bccd2c22-4600-4cf8-a7d4-db0bf8ee5a50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_d03da403-9d56-4136-998f-c9551f9b7ed4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c5b18f5c-3257-492d-8eaa-9034e606f2ef" xlink:to="loc_us-gaap_InterestExpense_d03da403-9d56-4136-998f-c9551f9b7ed4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_eb33a09c-e37e-419b-8a16-cccf50bf77b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c5b18f5c-3257-492d-8eaa-9034e606f2ef" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_eb33a09c-e37e-419b-8a16-cccf50bf77b1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_478f5555-8b3a-4997-bb4c-6d0a6a3d16a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c5b18f5c-3257-492d-8eaa-9034e606f2ef" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_478f5555-8b3a-4997-bb4c-6d0a6a3d16a5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ab7d82b8-4d23-4071-bd7f-eec601846184" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c5b18f5c-3257-492d-8eaa-9034e606f2ef" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ab7d82b8-4d23-4071-bd7f-eec601846184" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_42e2d8ae-e56e-4131-b4db-45bf91d2cf9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c5b18f5c-3257-492d-8eaa-9034e606f2ef" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_42e2d8ae-e56e-4131-b4db-45bf91d2cf9c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e4c3baa3-c8ca-459e-872c-06d48040924c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c5b18f5c-3257-492d-8eaa-9034e606f2ef" xlink:to="loc_us-gaap_NetIncomeLoss_e4c3baa3-c8ca-459e-872c-06d48040924c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_f3c6ecc3-a4d0-4388-b863-7f68959ff4ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c5b18f5c-3257-492d-8eaa-9034e606f2ef" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_f3c6ecc3-a4d0-4388-b863-7f68959ff4ea" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_f288a1cc-5b2d-4363-b863-dc882fd2aed4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c5b18f5c-3257-492d-8eaa-9034e606f2ef" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_f288a1cc-5b2d-4363-b863-dc882fd2aed4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_16974906-6a59-4678-a443-fb2f4db926b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_c5b18f5c-3257-492d-8eaa-9034e606f2ef" xlink:to="loc_us-gaap_StatementTable_16974906-6a59-4678-a443-fb2f4db926b6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9f5aa3d1-f887-4c61-b7dc-d9ef7beaf6f8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_16974906-6a59-4678-a443-fb2f4db926b6" xlink:to="loc_srt_ProductOrServiceAxis_9f5aa3d1-f887-4c61-b7dc-d9ef7beaf6f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9f5aa3d1-f887-4c61-b7dc-d9ef7beaf6f8_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_9f5aa3d1-f887-4c61-b7dc-d9ef7beaf6f8" xlink:to="loc_srt_ProductsAndServicesDomain_9f5aa3d1-f887-4c61-b7dc-d9ef7beaf6f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b2b3d833-c663-4ef2-9c2e-d63f7ce2a300" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_9f5aa3d1-f887-4c61-b7dc-d9ef7beaf6f8" xlink:to="loc_srt_ProductsAndServicesDomain_b2b3d833-c663-4ef2-9c2e-d63f7ce2a300" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_aa459245-cda2-4833-ae0a-a7c91db9a7ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b2b3d833-c663-4ef2-9c2e-d63f7ce2a300" xlink:to="loc_us-gaap_ProductMember_aa459245-cda2-4833-ae0a-a7c91db9a7ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_a9c005e4-7212-4e25-80cf-25cc7103df43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b2b3d833-c663-4ef2-9c2e-d63f7ce2a300" xlink:to="loc_us-gaap_ServiceMember_a9c005e4-7212-4e25-80cf-25cc7103df43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CollaborationRevenueMember_13eae3a1-a096-478c-a641-51d6e2dc987d" xlink:href="fldm-20200930.xsd#fldm_CollaborationRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b2b3d833-c663-4ef2-9c2e-d63f7ce2a300" xlink:to="loc_fldm_CollaborationRevenueMember_13eae3a1-a096-478c-a641-51d6e2dc987d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_6254f1a3-a4d3-4668-a0e3-2d361b03a85e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b2b3d833-c663-4ef2-9c2e-d63f7ce2a300" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_6254f1a3-a4d3-4668-a0e3-2d361b03a85e" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="fldm-20200930.xsd#CondensedConsolidatedStatementsofComprehensiveLoss"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="extended" id="i2708b2c9963446b1951245ad6b5c6aaf_CondensedConsolidatedStatementsofComprehensiveLoss"/>
  <link:roleRef roleURI="http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="fldm-20200930.xsd#CondensedConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="extended" id="i8cf2fd5d9d9e491490c3e3b134d17d52_CondensedConsolidatedStatementsofStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_706e9a87-2ac9-499c-b844-6cf74cfad1e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_706e9a87-2ac9-499c-b844-6cf74cfad1e4" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_025ee06e-5213-4348-be1e-33aa10159ebf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_025ee06e-5213-4348-be1e-33aa10159ebf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_63083a7a-8fe1-4c18-ad58-f125f563cc39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_StockholdersEquity_63083a7a-8fe1-4c18-ad58-f125f563cc39" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_cfd79ed0-4f5d-4ec7-971e-511ccf057e49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_cfd79ed0-4f5d-4ec7-971e-511ccf057e49" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_11091a2d-9aad-4e53-9c61-7767bf6cb941" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_11091a2d-9aad-4e53-9c61-7767bf6cb941" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_6788548b-0d34-4382-9b06-9e590be4f2fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_6788548b-0d34-4382-9b06-9e590be4f2fb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1bd1f568-a044-4843-a8c2-ca1d4dc2098f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1bd1f568-a044-4843-a8c2-ca1d4dc2098f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_7eb40abc-f182-43b8-b377-6ab1fb14b031" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_7eb40abc-f182-43b8-b377-6ab1fb14b031" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_daa39085-fd71-4882-a7bc-c7ee604f697c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_daa39085-fd71-4882-a7bc-c7ee604f697c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_7eb2aa3d-6070-401b-923f-f9d9578fe990" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_7eb2aa3d-6070-401b-923f-f9d9578fe990" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_8c556363-e742-4875-8f1d-25156645caef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_8c556363-e742-4875-8f1d-25156645caef" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_90bd77c9-8a52-41a9-84e3-5ca21963b745" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_90bd77c9-8a52-41a9-84e3-5ca21963b745" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_63092c88-2b47-4e93-8ffd-38fd9c1fa24b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_63092c88-2b47-4e93-8ffd-38fd9c1fa24b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_52b262e3-9ca3-48e6-9cb1-03687146c19c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_52b262e3-9ca3-48e6-9cb1-03687146c19c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_97d3713a-b8bf-4291-828a-c2cd0f8d4a03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_97d3713a-b8bf-4291-828a-c2cd0f8d4a03" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_ae682fac-3a9f-4d16-873a-4dfce66e10fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_ae682fac-3a9f-4d16-873a-4dfce66e10fa" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_e6006b88-1873-47a0-97fc-707652b95a7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_e6006b88-1873-47a0-97fc-707652b95a7f" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1d60e1b2-ae2f-41c9-a185-434e9a17d945" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_NetIncomeLoss_1d60e1b2-ae2f-41c9-a185-434e9a17d945" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_11db620d-01a8-454a-bd1b-d1a36d9777a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_11db620d-01a8-454a-bd1b-d1a36d9777a0" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_66b046ed-cffb-4eff-837e-fb55824bd905" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_81f78e5e-6722-4791-ac58-4df8915f9426" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_adfa12d7-60dc-4b46-a047-184d6447c6d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_706e9a87-2ac9-499c-b844-6cf74cfad1e4" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_adfa12d7-60dc-4b46-a047-184d6447c6d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_0ccec93e-2ba6-409d-a585-4b1b94762585" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_706e9a87-2ac9-499c-b844-6cf74cfad1e4" xlink:to="loc_us-gaap_StatementTable_0ccec93e-2ba6-409d-a585-4b1b94762585" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5fbdc633-425e-4ef6-8ff5-372a9cd318c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_0ccec93e-2ba6-409d-a585-4b1b94762585" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5fbdc633-425e-4ef6-8ff5-372a9cd318c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5fbdc633-425e-4ef6-8ff5-372a9cd318c8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5fbdc633-425e-4ef6-8ff5-372a9cd318c8" xlink:to="loc_us-gaap_EquityComponentDomain_5fbdc633-425e-4ef6-8ff5-372a9cd318c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9ad48a7a-fec7-4958-a826-16e935a4cc17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5fbdc633-425e-4ef6-8ff5-372a9cd318c8" xlink:to="loc_us-gaap_EquityComponentDomain_9ad48a7a-fec7-4958-a826-16e935a4cc17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_91811764-d527-4bb2-9248-daf88f9f0a62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9ad48a7a-fec7-4958-a826-16e935a4cc17" xlink:to="loc_us-gaap_CommonStockMember_91811764-d527-4bb2-9248-daf88f9f0a62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_4b800416-d5f5-4214-a5f1-9f6c622fd36e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9ad48a7a-fec7-4958-a826-16e935a4cc17" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_4b800416-d5f5-4214-a5f1-9f6c622fd36e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_6d8183b5-ebea-4f3d-af5b-3735800ddece" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9ad48a7a-fec7-4958-a826-16e935a4cc17" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_6d8183b5-ebea-4f3d-af5b-3735800ddece" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_bc87440b-5091-4a88-b446-47a760d0cf5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9ad48a7a-fec7-4958-a826-16e935a4cc17" xlink:to="loc_us-gaap_RetainedEarningsMember_bc87440b-5091-4a88-b446-47a760d0cf5e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_71ea0ed7-a71d-4cd8-9f41-c65fa4ea3677" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_0ccec93e-2ba6-409d-a585-4b1b94762585" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_71ea0ed7-a71d-4cd8-9f41-c65fa4ea3677" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_71ea0ed7-a71d-4cd8-9f41-c65fa4ea3677_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_71ea0ed7-a71d-4cd8-9f41-c65fa4ea3677" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_71ea0ed7-a71d-4cd8-9f41-c65fa4ea3677_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_7b6c89f4-1d48-45a8-8b0a-4064581e2a2c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_71ea0ed7-a71d-4cd8-9f41-c65fa4ea3677" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_7b6c89f4-1d48-45a8-8b0a-4064581e2a2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_740c44b7-e8a0-4b12-9fc8-3447be499798" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_7b6c89f4-1d48-45a8-8b0a-4064581e2a2c" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_740c44b7-e8a0-4b12-9fc8-3447be499798" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="fldm-20200930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended" id="i75f2bbd33bae4b1d97dfebd08669c485_CondensedConsolidatedStatementsofCashFlows"/>
  <link:roleRef roleURI="http://fluidigm.com/role/DescriptionofBusiness" xlink:type="simple" xlink:href="fldm-20200930.xsd#DescriptionofBusiness"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/DescriptionofBusiness" xlink:type="extended" id="i057c0cdf92d94c469a974bf78c81166f_DescriptionofBusiness"/>
  <link:roleRef roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="fldm-20200930.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended" id="i6e89713ff8d94ded9e2b49e1900e721c_SummaryofSignificantAccountingPolicies"/>
  <link:roleRef roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="fldm-20200930.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended" id="iacf8d10b351349e789d9172fec5b9573_SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:roleRef roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="fldm-20200930.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended" id="i154b2776a4d648a2b95d0588930026a1_SummaryofSignificantAccountingPoliciesTables"/>
  <link:roleRef roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="ia5e445ff78f345398aa036801de03c63_SummaryofSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:href="fldm-20200930.xsd#fldm_ScheduleOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_RevenueFromContractWithCustomerTermsOfPaymentPeriod_5e6a92b4-6b3b-4cf9-b9e0-8a2ab8fec12e" xlink:href="fldm-20200930.xsd#fldm_RevenueFromContractWithCustomerTermsOfPaymentPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_fldm_RevenueFromContractWithCustomerTermsOfPaymentPeriod_5e6a92b4-6b3b-4cf9-b9e0-8a2ab8fec12e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_RevenueFromContractWithCustomerPerformanceObligationPeriod_a73d3d88-7f86-48e8-97d3-67bafd3ebd6e" xlink:href="fldm-20200930.xsd#fldm_RevenueFromContractWithCustomerPerformanceObligationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_fldm_RevenueFromContractWithCustomerPerformanceObligationPeriod_a73d3d88-7f86-48e8-97d3-67bafd3ebd6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements_903b8c7a-58be-4528-8cc8-1932bf30c2f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_us-gaap_ProceedsFromLegalSettlements_903b8c7a-58be-4528-8cc8-1932bf30c2f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d8017a08-3678-4406-9cdd-80697f4e7acb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d8017a08-3678-4406-9cdd-80697f4e7acb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalFees_b5897d81-d7f5-4aa4-bee9-37f172f7d5c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LegalFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_us-gaap_LegalFees_b5897d81-d7f5-4aa4-bee9-37f172f7d5c6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ProductWarrantyTerm_4fc00bf7-9930-4a22-8fa2-f36382dac6cb" xlink:href="fldm-20200930.xsd#fldm_ProductWarrantyTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_fldm_ProductWarrantyTerm_4fc00bf7-9930-4a22-8fa2-f36382dac6cb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_d521ca68-b405-4c28-9e41-caa2b3a700ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_d521ca68-b405-4c28-9e41-caa2b3a700ab" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_66e8969d-8e85-44ae-96e7-08468d29f6e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_66e8969d-8e85-44ae-96e7-08468d29f6e8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue_0ff46820-2a61-4de3-8de1-8319b7080e04" xlink:href="fldm-20200930.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue_0ff46820-2a61-4de3-8de1-8319b7080e04" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_4ffc821f-6546-4602-8c03-4ea322ddd3c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_4ffc821f-6546-4602-8c03-4ea322ddd3c3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_89e7ffa1-beff-492c-8008-bd0c4dda89c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_89e7ffa1-beff-492c-8008-bd0c4dda89c9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_33f4a4d7-8a64-457b-bdad-eca64e362c41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_33f4a4d7-8a64-457b-bdad-eca64e362c41" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_26f15a18-bae3-4a53-992d-6d9480827228" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_26f15a18-bae3-4a53-992d-6d9480827228" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_143bcb7d-93dd-41a3-8151-3b7104675822" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_143bcb7d-93dd-41a3-8151-3b7104675822" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_5bd32944-3e7d-4c2c-ac3b-0d8ac40ae0f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_5bd32944-3e7d-4c2c-ac3b-0d8ac40ae0f0" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_900800f0-69b5-44d0-b92b-56f2464a29fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_900800f0-69b5-44d0-b92b-56f2464a29fb" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ce2c30a8-10aa-4899-95d6-e0ee0d372cf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_us-gaap_StockholdersEquity_ce2c30a8-10aa-4899-95d6-e0ee0d372cf8" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ScheduleOfSignificantAccountingPoliciesTable_dbbb109b-e8a0-49f9-9072-a1306729101a" xlink:href="fldm-20200930.xsd#fldm_ScheduleOfSignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_fldm_ScheduleOfSignificantAccountingPoliciesTable_dbbb109b-e8a0-49f9-9072-a1306729101a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5e24759d-db55-405b-88cd-40b3ab83efcb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesTable_dbbb109b-e8a0-49f9-9072-a1306729101a" xlink:to="loc_srt_ProductOrServiceAxis_5e24759d-db55-405b-88cd-40b3ab83efcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5e24759d-db55-405b-88cd-40b3ab83efcb_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_5e24759d-db55-405b-88cd-40b3ab83efcb" xlink:to="loc_srt_ProductsAndServicesDomain_5e24759d-db55-405b-88cd-40b3ab83efcb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a17cfaa2-3f36-46aa-8894-1e20cdce19f0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_5e24759d-db55-405b-88cd-40b3ab83efcb" xlink:to="loc_srt_ProductsAndServicesDomain_a17cfaa2-3f36-46aa-8894-1e20cdce19f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_5223c9b6-18e7-496a-a1be-8662a1ceccce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a17cfaa2-3f36-46aa-8894-1e20cdce19f0" xlink:to="loc_us-gaap_ProductMember_5223c9b6-18e7-496a-a1be-8662a1ceccce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_2c7aa887-91cf-43f4-b287-58d09b4125f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a17cfaa2-3f36-46aa-8894-1e20cdce19f0" xlink:to="loc_us-gaap_ServiceMember_2c7aa887-91cf-43f4-b287-58d09b4125f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember_a212c579-2a32-4cbe-9beb-2c16a84af8ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a17cfaa2-3f36-46aa-8894-1e20cdce19f0" xlink:to="loc_us-gaap_LicenseMember_a212c579-2a32-4cbe-9beb-2c16a84af8ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DevelopmentRevenueMember_e6c1c131-6b05-49f8-86cc-abe44ac05712" xlink:href="fldm-20200930.xsd#fldm_DevelopmentRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a17cfaa2-3f36-46aa-8894-1e20cdce19f0" xlink:to="loc_fldm_DevelopmentRevenueMember_e6c1c131-6b05-49f8-86cc-abe44ac05712" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cf99ba35-1aa9-4cf5-a959-5ea9d6175e84" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesTable_dbbb109b-e8a0-49f9-9072-a1306729101a" xlink:to="loc_srt_RangeAxis_cf99ba35-1aa9-4cf5-a959-5ea9d6175e84" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cf99ba35-1aa9-4cf5-a959-5ea9d6175e84_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_cf99ba35-1aa9-4cf5-a959-5ea9d6175e84" xlink:to="loc_srt_RangeMember_cf99ba35-1aa9-4cf5-a959-5ea9d6175e84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2c1fd013-bd09-4303-9e7f-193312e5c5c0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_cf99ba35-1aa9-4cf5-a959-5ea9d6175e84" xlink:to="loc_srt_RangeMember_2c1fd013-bd09-4303-9e7f-193312e5c5c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_40b40b0f-db80-44d4-872d-37125525f109" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2c1fd013-bd09-4303-9e7f-193312e5c5c0" xlink:to="loc_srt_MinimumMember_40b40b0f-db80-44d4-872d-37125525f109" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e53dd6a8-ef16-4e20-adf5-8d791c8a4d75" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2c1fd013-bd09-4303-9e7f-193312e5c5c0" xlink:to="loc_srt_MaximumMember_e53dd6a8-ef16-4e20-adf5-8d791c8a4d75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_4f7b4c0b-1ffb-4270-bfc4-92e3e45b89c2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesTable_dbbb109b-e8a0-49f9-9072-a1306729101a" xlink:to="loc_srt_LitigationCaseAxis_4f7b4c0b-1ffb-4270-bfc4-92e3e45b89c2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_4f7b4c0b-1ffb-4270-bfc4-92e3e45b89c2_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_4f7b4c0b-1ffb-4270-bfc4-92e3e45b89c2" xlink:to="loc_srt_LitigationCaseTypeDomain_4f7b4c0b-1ffb-4270-bfc4-92e3e45b89c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_c5c6926e-70a3-4611-8d52-014bc321969f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_4f7b4c0b-1ffb-4270-bfc4-92e3e45b89c2" xlink:to="loc_srt_LitigationCaseTypeDomain_c5c6926e-70a3-4611-8d52-014bc321969f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_IntellectualPropertyInfringementClaimsMember_e4d26138-9874-4501-aed1-6058489eab70" xlink:href="fldm-20200930.xsd#fldm_IntellectualPropertyInfringementClaimsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_c5c6926e-70a3-4611-8d52-014bc321969f" xlink:to="loc_fldm_IntellectualPropertyInfringementClaimsMember_e4d26138-9874-4501-aed1-6058489eab70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAxis_e0c380bc-9069-45f3-a6d7-06ea57976876" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesTable_dbbb109b-e8a0-49f9-9072-a1306729101a" xlink:to="loc_us-gaap_CapitalizedContractCostAxis_e0c380bc-9069-45f3-a6d7-06ea57976876" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain_e0c380bc-9069-45f3-a6d7-06ea57976876_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CapitalizedContractCostAxis_e0c380bc-9069-45f3-a6d7-06ea57976876" xlink:to="loc_us-gaap_CapitalizedContractCostDomain_e0c380bc-9069-45f3-a6d7-06ea57976876_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain_d05bdde4-7103-4ada-8fe5-7aefd7ad1119" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CapitalizedContractCostAxis_e0c380bc-9069-45f3-a6d7-06ea57976876" xlink:to="loc_us-gaap_CapitalizedContractCostDomain_d05bdde4-7103-4ada-8fe5-7aefd7ad1119" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CommissionCostsMember_82b7d485-27de-4a18-9118-7405209b9e8b" xlink:href="fldm-20200930.xsd#fldm_CommissionCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_d05bdde4-7103-4ada-8fe5-7aefd7ad1119" xlink:to="loc_fldm_CommissionCostsMember_82b7d485-27de-4a18-9118-7405209b9e8b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_024950ca-f01a-4f33-a1c2-68964370b60f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesTable_dbbb109b-e8a0-49f9-9072-a1306729101a" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_024950ca-f01a-4f33-a1c2-68964370b60f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_024950ca-f01a-4f33-a1c2-68964370b60f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_024950ca-f01a-4f33-a1c2-68964370b60f" xlink:to="loc_us-gaap_EquityComponentDomain_024950ca-f01a-4f33-a1c2-68964370b60f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d7cf9524-60f5-4542-9042-71e9d86af5d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_024950ca-f01a-4f33-a1c2-68964370b60f" xlink:to="loc_us-gaap_EquityComponentDomain_d7cf9524-60f5-4542-9042-71e9d86af5d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_25622f86-f9ac-4976-9ffc-22f0b385a5e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d7cf9524-60f5-4542-9042-71e9d86af5d4" xlink:to="loc_us-gaap_CommonStockMember_25622f86-f9ac-4976-9ffc-22f0b385a5e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_68c88987-92ea-4037-a40f-4cf77a70d573" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d7cf9524-60f5-4542-9042-71e9d86af5d4" xlink:to="loc_us-gaap_RetainedEarningsMember_68c88987-92ea-4037-a40f-4cf77a70d573" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6080bc6f-c167-4cfa-8833-2b40ec288c7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesTable_dbbb109b-e8a0-49f9-9072-a1306729101a" xlink:to="loc_us-gaap_DebtInstrumentAxis_6080bc6f-c167-4cfa-8833-2b40ec288c7e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6080bc6f-c167-4cfa-8833-2b40ec288c7e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_6080bc6f-c167-4cfa-8833-2b40ec288c7e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6080bc6f-c167-4cfa-8833-2b40ec288c7e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_400dba08-197e-41f6-a595-b8f541be0e04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_6080bc6f-c167-4cfa-8833-2b40ec288c7e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_400dba08-197e-41f6-a595-b8f541be0e04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeniorConvertibleNotesdue2034Member_9b82a44f-3905-4c1b-8c5a-9c78f774614b" xlink:href="fldm-20200930.xsd#fldm_SeniorConvertibleNotesdue2034Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_400dba08-197e-41f6-a595-b8f541be0e04" xlink:to="loc_fldm_SeniorConvertibleNotesdue2034Member_9b82a44f-3905-4c1b-8c5a-9c78f774614b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ExchangeConvertibleSeniorNotesDue2034Member_3b091de3-585d-412a-860d-51ac060f8560" xlink:href="fldm-20200930.xsd#fldm_ExchangeConvertibleSeniorNotesDue2034Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_400dba08-197e-41f6-a595-b8f541be0e04" xlink:to="loc_fldm_ExchangeConvertibleSeniorNotesDue2034Member_3b091de3-585d-412a-860d-51ac060f8560" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeniorConvertibleNotesDue2024Member_880cfcd7-c012-438e-bcd8-3a9917a0f7a6" xlink:href="fldm-20200930.xsd#fldm_SeniorConvertibleNotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_400dba08-197e-41f6-a595-b8f541be0e04" xlink:to="loc_fldm_SeniorConvertibleNotesDue2024Member_880cfcd7-c012-438e-bcd8-3a9917a0f7a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_942ab21e-bb6c-43d1-ba39-f82d9149b8bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesTable_dbbb109b-e8a0-49f9-9072-a1306729101a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_942ab21e-bb6c-43d1-ba39-f82d9149b8bd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_942ab21e-bb6c-43d1-ba39-f82d9149b8bd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_942ab21e-bb6c-43d1-ba39-f82d9149b8bd" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_942ab21e-bb6c-43d1-ba39-f82d9149b8bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fff063b9-444e-4794-a036-0d288a8adaf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_942ab21e-bb6c-43d1-ba39-f82d9149b8bd" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fff063b9-444e-4794-a036-0d288a8adaf1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_08609b50-2fc4-472c-9acd-fdcb595671e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fff063b9-444e-4794-a036-0d288a8adaf1" xlink:to="loc_us-gaap_ConvertibleDebtMember_08609b50-2fc4-472c-9acd-fdcb595671e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_73aa08bc-e8ec-4215-aa2f-586478bac328" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesTable_dbbb109b-e8a0-49f9-9072-a1306729101a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_73aa08bc-e8ec-4215-aa2f-586478bac328" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_73aa08bc-e8ec-4215-aa2f-586478bac328_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_73aa08bc-e8ec-4215-aa2f-586478bac328" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_73aa08bc-e8ec-4215-aa2f-586478bac328_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8039cc61-79ec-4edb-ac7b-987ef91e6d38" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_73aa08bc-e8ec-4215-aa2f-586478bac328" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8039cc61-79ec-4edb-ac7b-987ef91e6d38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_3abed56b-f418-454f-b8de-0f85a0fa98fa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8039cc61-79ec-4edb-ac7b-987ef91e6d38" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_3abed56b-f418-454f-b8de-0f85a0fa98fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_e46fa442-dce1-4728-b0d3-9e63b193fca5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesTable_dbbb109b-e8a0-49f9-9072-a1306729101a" xlink:to="loc_srt_MajorCustomersAxis_e46fa442-dce1-4728-b0d3-9e63b193fca5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_e46fa442-dce1-4728-b0d3-9e63b193fca5_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_e46fa442-dce1-4728-b0d3-9e63b193fca5" xlink:to="loc_srt_NameOfMajorCustomerDomain_e46fa442-dce1-4728-b0d3-9e63b193fca5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_f4be368c-1594-4b96-ba48-d859621e2f37" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_e46fa442-dce1-4728-b0d3-9e63b193fca5" xlink:to="loc_srt_NameOfMajorCustomerDomain_f4be368c-1594-4b96-ba48-d859621e2f37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_OneCustomerMember_ae8942a2-1d8d-4606-8cd2-6b7310b68d62" xlink:href="fldm-20200930.xsd#fldm_OneCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_f4be368c-1594-4b96-ba48-d859621e2f37" xlink:to="loc_fldm_OneCustomerMember_ae8942a2-1d8d-4606-8cd2-6b7310b68d62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_FiveLargestCustomersMember_1e17bcb7-b049-4de5-9191-5812009c9cb9" xlink:href="fldm-20200930.xsd#fldm_FiveLargestCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_f4be368c-1594-4b96-ba48-d859621e2f37" xlink:to="loc_fldm_FiveLargestCustomersMember_1e17bcb7-b049-4de5-9191-5812009c9cb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_84b37c8f-76a1-42ce-9f3a-400194c36349" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesTable_dbbb109b-e8a0-49f9-9072-a1306729101a" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_84b37c8f-76a1-42ce-9f3a-400194c36349" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_84b37c8f-76a1-42ce-9f3a-400194c36349_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_84b37c8f-76a1-42ce-9f3a-400194c36349" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_84b37c8f-76a1-42ce-9f3a-400194c36349_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_fc0f4248-bb1c-4b93-80c3-f8f00ccd9fb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_84b37c8f-76a1-42ce-9f3a-400194c36349" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_fc0f4248-bb1c-4b93-80c3-f8f00ccd9fb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_65885a84-35d5-4433-9faa-6fa34e14ba69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_fc0f4248-bb1c-4b93-80c3-f8f00ccd9fb8" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_65885a84-35d5-4433-9faa-6fa34e14ba69" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_4df6debe-4993-4ef7-a977-eb0696bd39b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesTable_dbbb109b-e8a0-49f9-9072-a1306729101a" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_4df6debe-4993-4ef7-a977-eb0696bd39b5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_4df6debe-4993-4ef7-a977-eb0696bd39b5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_4df6debe-4993-4ef7-a977-eb0696bd39b5" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_4df6debe-4993-4ef7-a977-eb0696bd39b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_aff754d8-9ffd-4fe6-ab03-e79442c9d4c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_4df6debe-4993-4ef7-a977-eb0696bd39b5" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_aff754d8-9ffd-4fe6-ab03-e79442c9d4c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_08d010bf-584d-4bba-9233-b5e9ae93a548" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_aff754d8-9ffd-4fe6-ab03-e79442c9d4c8" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_08d010bf-584d-4bba-9233-b5e9ae93a548" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails" xlink:type="extended" id="i218c96283b1b4eb8956e54833feb50ab_SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7b35da46-5f7e-4f20-b50f-3067eee8f265" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d948ee1b-d409-4459-835d-781a6908188d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7b35da46-5f7e-4f20-b50f-3067eee8f265" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d948ee1b-d409-4459-835d-781a6908188d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_15106370-aa89-46a9-a241-c86757d4ca55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d948ee1b-d409-4459-835d-781a6908188d" xlink:to="loc_us-gaap_StockholdersEquity_15106370-aa89-46a9-a241-c86757d4ca55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_8efb6d9e-32d2-47ad-b467-99c7b095d684" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d948ee1b-d409-4459-835d-781a6908188d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_8efb6d9e-32d2-47ad-b467-99c7b095d684" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_78004e2d-9684-44cd-a4f9-f7e657a46bf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c1702027-4340-457d-9117-361a7c7a81a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7b35da46-5f7e-4f20-b50f-3067eee8f265" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c1702027-4340-457d-9117-361a7c7a81a4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_84157348-1b84-49f4-b696-679888e32f27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c1702027-4340-457d-9117-361a7c7a81a4" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_84157348-1b84-49f4-b696-679888e32f27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_84157348-1b84-49f4-b696-679888e32f27_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_84157348-1b84-49f4-b696-679888e32f27" xlink:to="loc_us-gaap_EquityComponentDomain_84157348-1b84-49f4-b696-679888e32f27_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_963d47cc-6fc3-4156-ab86-213d78ec5bfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_84157348-1b84-49f4-b696-679888e32f27" xlink:to="loc_us-gaap_EquityComponentDomain_963d47cc-6fc3-4156-ab86-213d78ec5bfd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_94231429-642a-44f9-8c76-7dd5c16a7358" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_963d47cc-6fc3-4156-ab86-213d78ec5bfd" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_94231429-642a-44f9-8c76-7dd5c16a7358" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_a5d16fd5-e789-4da9-918d-654cce4b99de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_963d47cc-6fc3-4156-ab86-213d78ec5bfd" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_a5d16fd5-e789-4da9-918d-654cce4b99de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ae5db6d9-1f86-4959-85c7-07f908c93513" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_963d47cc-6fc3-4156-ab86-213d78ec5bfd" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ae5db6d9-1f86-4959-85c7-07f908c93513" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails" xlink:type="extended" id="i018ed8603468446a8152257bf1f2e6a4_SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_cc31b605-97c9-43b2-8f13-a36424535e75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7287bd81-c911-4ce6-b812-f7ecea1223e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_cc31b605-97c9-43b2-8f13-a36424535e75" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7287bd81-c911-4ce6-b812-f7ecea1223e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1a29fc8c-d703-49c5-99ae-b0c64c1e878b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_cc31b605-97c9-43b2-8f13-a36424535e75" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1a29fc8c-d703-49c5-99ae-b0c64c1e878b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_75960203-96eb-4122-bc33-48c75b597fc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1a29fc8c-d703-49c5-99ae-b0c64c1e878b" xlink:to="loc_us-gaap_DebtInstrumentAxis_75960203-96eb-4122-bc33-48c75b597fc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_75960203-96eb-4122-bc33-48c75b597fc8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_75960203-96eb-4122-bc33-48c75b597fc8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_75960203-96eb-4122-bc33-48c75b597fc8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_07dd9133-4de4-4cf1-ad37-b806f0f04d88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_75960203-96eb-4122-bc33-48c75b597fc8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_07dd9133-4de4-4cf1-ad37-b806f0f04d88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndNineteenConvertibleNotesMember_8d3e5ea1-8dc0-4fed-8f5a-f46cc3a241ff" xlink:href="fldm-20200930.xsd#fldm_TwoThousandAndNineteenConvertibleNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_07dd9133-4de4-4cf1-ad37-b806f0f04d88" xlink:to="loc_fldm_TwoThousandAndNineteenConvertibleNotesMember_8d3e5ea1-8dc0-4fed-8f5a-f46cc3a241ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember_e20e25a3-d21c-4060-9233-a1e02dc7c85b" xlink:href="fldm-20200930.xsd#fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_07dd9133-4de4-4cf1-ad37-b806f0f04d88" xlink:to="loc_fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember_e20e25a3-d21c-4060-9233-a1e02dc7c85b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndFourteenConvertibleNotesMember_c9daebe5-a8a5-4423-940b-f252edf07174" xlink:href="fldm-20200930.xsd#fldm_TwoThousandAndFourteenConvertibleNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_07dd9133-4de4-4cf1-ad37-b806f0f04d88" xlink:to="loc_fldm_TwoThousandAndFourteenConvertibleNotesMember_c9daebe5-a8a5-4423-940b-f252edf07174" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f935dc68-c6c1-4334-9fb7-52597ab0ca12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1a29fc8c-d703-49c5-99ae-b0c64c1e878b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f935dc68-c6c1-4334-9fb7-52597ab0ca12" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f935dc68-c6c1-4334-9fb7-52597ab0ca12_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f935dc68-c6c1-4334-9fb7-52597ab0ca12" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f935dc68-c6c1-4334-9fb7-52597ab0ca12_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_12335eff-7c1f-4c2e-8114-6d95305e3a96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f935dc68-c6c1-4334-9fb7-52597ab0ca12" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_12335eff-7c1f-4c2e-8114-6d95305e3a96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_9b18340e-0c79-4308-aa09-d01842611ebf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_12335eff-7c1f-4c2e-8114-6d95305e3a96" xlink:to="loc_us-gaap_EmployeeStockOptionMember_9b18340e-0c79-4308-aa09-d01842611ebf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_09d0df72-18c6-4359-8b41-8a20cff7b1f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_12335eff-7c1f-4c2e-8114-6d95305e3a96" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_09d0df72-18c6-4359-8b41-8a20cff7b1f8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/BusinessCombination" xlink:type="simple" xlink:href="fldm-20200930.xsd#BusinessCombination"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/BusinessCombination" xlink:type="extended" id="i82141c16c6154f9f96740ae884360d10_BusinessCombination"/>
  <link:roleRef roleURI="http://fluidigm.com/role/BusinessCombinationTables" xlink:type="simple" xlink:href="fldm-20200930.xsd#BusinessCombinationTables"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/BusinessCombinationTables" xlink:type="extended" id="i30292ce5176046ae8a12bd62b67f63d6_BusinessCombinationTables"/>
  <link:roleRef roleURI="http://fluidigm.com/role/BusinessCombinationNarrativeDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#BusinessCombinationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/BusinessCombinationNarrativeDetails" xlink:type="extended" id="i4ee79a4a16564102855c8821e3fbae96_BusinessCombinationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_4528469d-cc1c-4037-9bf3-1ee4f3d54c44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_b8748945-6044-488f-a0de-635063f2294d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4528469d-cc1c-4037-9bf3-1ee4f3d54c44" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_b8748945-6044-488f-a0de-635063f2294d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_ee69a780-aabc-4f4c-a15c-f31d5640be1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4528469d-cc1c-4037-9bf3-1ee4f3d54c44" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_ee69a780-aabc-4f4c-a15c-f31d5640be1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_ed43ca51-f8fc-4fa4-9ead-2867b8bd8904" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4528469d-cc1c-4037-9bf3-1ee4f3d54c44" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_ed43ca51-f8fc-4fa4-9ead-2867b8bd8904" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_c235a994-3f2f-4f48-aba3-f499f4f6b9e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4528469d-cc1c-4037-9bf3-1ee4f3d54c44" xlink:to="loc_us-gaap_SharePrice_c235a994-3f2f-4f48-aba3-f499f4f6b9e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c16ae27f-c545-4a06-aca2-87df05660800" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4528469d-cc1c-4037-9bf3-1ee4f3d54c44" xlink:to="loc_us-gaap_Goodwill_c16ae27f-c545-4a06-aca2-87df05660800" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e86b7837-696b-4116-b29d-c95a3311d338" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4528469d-cc1c-4037-9bf3-1ee4f3d54c44" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e86b7837-696b-4116-b29d-c95a3311d338" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f115e516-3156-4be5-a56d-a5ea1d574d06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e86b7837-696b-4116-b29d-c95a3311d338" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f115e516-3156-4be5-a56d-a5ea1d574d06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f115e516-3156-4be5-a56d-a5ea1d574d06_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f115e516-3156-4be5-a56d-a5ea1d574d06" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f115e516-3156-4be5-a56d-a5ea1d574d06_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fa643190-05ab-45f6-8a51-0dd0f2b5b197" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f115e516-3156-4be5-a56d-a5ea1d574d06" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fa643190-05ab-45f6-8a51-0dd0f2b5b197" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_InstruNorASMember_e53538ce-e03b-404d-a1e7-8c9f69760cc7" xlink:href="fldm-20200930.xsd#fldm_InstruNorASMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fa643190-05ab-45f6-8a51-0dd0f2b5b197" xlink:to="loc_fldm_InstruNorASMember_e53538ce-e03b-404d-a1e7-8c9f69760cc7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/BusinessCombinationNetCashFlowsDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#BusinessCombinationNetCashFlowsDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/BusinessCombinationNetCashFlowsDetails" xlink:type="extended" id="id133f59fa47942fd8a72cab20da621fc_BusinessCombinationNetCashFlowsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_6b5ecf0e-ae29-4e88-9ef3-028cb22d2413" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_9fb57a39-482d-43c3-bf82-42eccc4fd384" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6b5ecf0e-ae29-4e88-9ef3-028cb22d2413" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_9fb57a39-482d-43c3-bf82-42eccc4fd384" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_d1bb15ab-8eb7-4f5c-953f-c3afeea8b690" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6b5ecf0e-ae29-4e88-9ef3-028cb22d2413" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_d1bb15ab-8eb7-4f5c-953f-c3afeea8b690" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_27d41c9e-14b6-47dd-8bd9-638d9b9184ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6b5ecf0e-ae29-4e88-9ef3-028cb22d2413" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_27d41c9e-14b6-47dd-8bd9-638d9b9184ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_38fea189-7938-4d9c-a63a-89918dd4c8d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6b5ecf0e-ae29-4e88-9ef3-028cb22d2413" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_38fea189-7938-4d9c-a63a-89918dd4c8d6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_055c4906-8fa5-42fd-a4c5-8d174fd8b955" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_38fea189-7938-4d9c-a63a-89918dd4c8d6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_055c4906-8fa5-42fd-a4c5-8d174fd8b955" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_055c4906-8fa5-42fd-a4c5-8d174fd8b955_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_055c4906-8fa5-42fd-a4c5-8d174fd8b955" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_055c4906-8fa5-42fd-a4c5-8d174fd8b955_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_adfcf094-af8f-4868-9ce8-9e50cc4a9857" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_055c4906-8fa5-42fd-a4c5-8d174fd8b955" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_adfcf094-af8f-4868-9ce8-9e50cc4a9857" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_InstruNorASMember_55612504-fcdb-4a92-b762-ce4799829170" xlink:href="fldm-20200930.xsd#fldm_InstruNorASMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_adfcf094-af8f-4868-9ce8-9e50cc4a9857" xlink:to="loc_fldm_InstruNorASMember_55612504-fcdb-4a92-b762-ce4799829170" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails" xlink:type="extended" id="i9a45464f19eb4198a53090740738beee_BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b6c8c52f-4b61-44cd-9314-e312b09095c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_0bd51f27-959f-44e7-a56d-1314cb2bdfc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6c8c52f-4b61-44cd-9314-e312b09095c8" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_0bd51f27-959f-44e7-a56d-1314cb2bdfc2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_f41bee3d-3a15-4755-9642-e8cf7e6e6cea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_0bd51f27-959f-44e7-a56d-1314cb2bdfc2" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_f41bee3d-3a15-4755-9642-e8cf7e6e6cea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_a7ebb19a-c2ee-4b52-a052-94ee6aec888f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_0bd51f27-959f-44e7-a56d-1314cb2bdfc2" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_a7ebb19a-c2ee-4b52-a052-94ee6aec888f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_35e0dc28-acb4-45ef-827d-ad880d890bbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_0bd51f27-959f-44e7-a56d-1314cb2bdfc2" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_35e0dc28-acb4-45ef-827d-ad880d890bbf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_d926e524-0fdb-4f2f-9e0e-36f14179a087" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6c8c52f-4b61-44cd-9314-e312b09095c8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_d926e524-0fdb-4f2f-9e0e-36f14179a087" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_f15bff7f-ee9a-4f7c-a4cf-869d06fc65f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_d926e524-0fdb-4f2f-9e0e-36f14179a087" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_f15bff7f-ee9a-4f7c-a4cf-869d06fc65f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAccountsReceivables_62bc366b-3527-4c2f-915c-9c72e9e55c3a" xlink:href="fldm-20200930.xsd#fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAccountsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_d926e524-0fdb-4f2f-9e0e-36f14179a087" xlink:to="loc_fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAccountsReceivables_62bc366b-3527-4c2f-915c-9c72e9e55c3a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherReceivables_4da5be26-724e-40d0-a494-1060e386205c" xlink:href="fldm-20200930.xsd#fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_d926e524-0fdb-4f2f-9e0e-36f14179a087" xlink:to="loc_fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherReceivables_4da5be26-724e-40d0-a494-1060e386205c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_012ee29c-e3ec-4375-b78d-197c942b728a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_d926e524-0fdb-4f2f-9e0e-36f14179a087" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_012ee29c-e3ec-4375-b78d-197c942b728a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_d92c4b33-5e22-4245-97f1-0de2bb6db6c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_d926e524-0fdb-4f2f-9e0e-36f14179a087" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_d92c4b33-5e22-4245-97f1-0de2bb6db6c6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_f623c37f-95fa-4955-9082-6cbb330fff30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6c8c52f-4b61-44cd-9314-e312b09095c8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_f623c37f-95fa-4955-9082-6cbb330fff30" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_83fb55d0-de12-450c-9d55-6e4520340783" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_f623c37f-95fa-4955-9082-6cbb330fff30" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_83fb55d0-de12-450c-9d55-6e4520340783" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_002668cf-e9fb-4e61-8fd3-04b50ed45b1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_f623c37f-95fa-4955-9082-6cbb330fff30" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_002668cf-e9fb-4e61-8fd3-04b50ed45b1a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_18b8ba76-e608-4025-9ce3-a3101a52a54c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_f623c37f-95fa-4955-9082-6cbb330fff30" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_18b8ba76-e608-4025-9ce3-a3101a52a54c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_7fbb7f92-541a-4d81-b696-c687c56bde21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6c8c52f-4b61-44cd-9314-e312b09095c8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_7fbb7f92-541a-4d81-b696-c687c56bde21" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_82e61d9b-6a3a-4fc5-ad31-50abdffe791f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6c8c52f-4b61-44cd-9314-e312b09095c8" xlink:to="loc_us-gaap_Goodwill_82e61d9b-6a3a-4fc5-ad31-50abdffe791f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_43577e50-833b-447c-8823-398200dadafd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6c8c52f-4b61-44cd-9314-e312b09095c8" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_43577e50-833b-447c-8823-398200dadafd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2c2ef960-0224-40a6-ae30-195c4060ab5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_43577e50-833b-447c-8823-398200dadafd" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2c2ef960-0224-40a6-ae30-195c4060ab5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2c2ef960-0224-40a6-ae30-195c4060ab5a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2c2ef960-0224-40a6-ae30-195c4060ab5a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2c2ef960-0224-40a6-ae30-195c4060ab5a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91a5ba10-ac2c-4e63-aa23-e3f146b80688" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2c2ef960-0224-40a6-ae30-195c4060ab5a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91a5ba10-ac2c-4e63-aa23-e3f146b80688" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_InstruNorASMember_70947f5a-0eba-47dc-84a8-7547a5babcd9" xlink:href="fldm-20200930.xsd#fldm_InstruNorASMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91a5ba10-ac2c-4e63-aa23-e3f146b80688" xlink:to="loc_fldm_InstruNorASMember_70947f5a-0eba-47dc-84a8-7547a5babcd9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/RADxProgram" xlink:type="simple" xlink:href="fldm-20200930.xsd#RADxProgram"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/RADxProgram" xlink:type="extended" id="i531a8f7a917949beb9d85a6eca7ead60_RADxProgram"/>
  <link:roleRef roleURI="http://fluidigm.com/role/RADxProgramTables" xlink:type="simple" xlink:href="fldm-20200930.xsd#RADxProgramTables"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/RADxProgramTables" xlink:type="extended" id="i6e00d6c126fa48eabb111df1856039c1_RADxProgramTables"/>
  <link:roleRef roleURI="http://fluidigm.com/role/RADxProgramDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#RADxProgramDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/RADxProgramDetails" xlink:type="extended" id="ia6cfd2b15bdf40ac9cd4d19b8af7d0b8_RADxProgramDetails"/>
  <link:roleRef roleURI="http://fluidigm.com/role/Revenue" xlink:type="simple" xlink:href="fldm-20200930.xsd#Revenue"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/Revenue" xlink:type="extended" id="iaa9a937e96c4493ab2af62635c34e7f5_Revenue"/>
  <link:roleRef roleURI="http://fluidigm.com/role/RevenueTables" xlink:type="simple" xlink:href="fldm-20200930.xsd#RevenueTables"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/RevenueTables" xlink:type="extended" id="i2caa6f9c79dc4a84ae63289df18058d2_RevenueTables"/>
  <link:roleRef roleURI="http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#RevenueScheduleofDisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails" xlink:type="extended" id="i6eabcb58848842e6b113ab35ad788278_RevenueScheduleofDisaggregationofRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_3267c53c-3bb9-4e5b-b279-b033dfd25fbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_24cfb03d-7169-46a4-bc17-aadcd33b49b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3267c53c-3bb9-4e5b-b279-b033dfd25fbb" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_24cfb03d-7169-46a4-bc17-aadcd33b49b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_da15d609-2e8f-4155-aaf4-1514700a9811" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3267c53c-3bb9-4e5b-b279-b033dfd25fbb" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_da15d609-2e8f-4155-aaf4-1514700a9811" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_69789c78-f994-497c-a482-93e0f8bbf9d1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_da15d609-2e8f-4155-aaf4-1514700a9811" xlink:to="loc_srt_StatementGeographicalAxis_69789c78-f994-497c-a482-93e0f8bbf9d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_69789c78-f994-497c-a482-93e0f8bbf9d1_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_69789c78-f994-497c-a482-93e0f8bbf9d1" xlink:to="loc_srt_SegmentGeographicalDomain_69789c78-f994-497c-a482-93e0f8bbf9d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_45a77ebb-07bb-475c-89e1-041ef589f049" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_69789c78-f994-497c-a482-93e0f8bbf9d1" xlink:to="loc_srt_SegmentGeographicalDomain_45a77ebb-07bb-475c-89e1-041ef589f049" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_2de53187-1ba5-4b6e-8096-6cfd4c1fa9ca" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AmericasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_45a77ebb-07bb-475c-89e1-041ef589f049" xlink:to="loc_srt_AmericasMember_2de53187-1ba5-4b6e-8096-6cfd4c1fa9ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_eae68a3e-ebe5-4288-b936-4d8386654acf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EMEAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_45a77ebb-07bb-475c-89e1-041ef589f049" xlink:to="loc_us-gaap_EMEAMember_eae68a3e-ebe5-4288-b936-4d8386654acf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_06e02541-1e14-4295-8cc6-136a8261480c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_45a77ebb-07bb-475c-89e1-041ef589f049" xlink:to="loc_srt_AsiaPacificMember_06e02541-1e14-4295-8cc6-136a8261480c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_30be6bc7-6d25-49d6-a56a-64e37bf6c9ab" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_da15d609-2e8f-4155-aaf4-1514700a9811" xlink:to="loc_srt_ProductOrServiceAxis_30be6bc7-6d25-49d6-a56a-64e37bf6c9ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_30be6bc7-6d25-49d6-a56a-64e37bf6c9ab_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_30be6bc7-6d25-49d6-a56a-64e37bf6c9ab" xlink:to="loc_srt_ProductsAndServicesDomain_30be6bc7-6d25-49d6-a56a-64e37bf6c9ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_db7030fa-0c7a-4dc1-bcea-0b49f1bab4b9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_30be6bc7-6d25-49d6-a56a-64e37bf6c9ab" xlink:to="loc_srt_ProductsAndServicesDomain_db7030fa-0c7a-4dc1-bcea-0b49f1bab4b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_InstrumentsMember_82595fd0-4d2d-48bc-a9bb-02986b150ae6" xlink:href="fldm-20200930.xsd#fldm_InstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_db7030fa-0c7a-4dc1-bcea-0b49f1bab4b9" xlink:to="loc_fldm_InstrumentsMember_82595fd0-4d2d-48bc-a9bb-02986b150ae6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ConsumablesMember_86bf3271-b7c6-4a03-b2ed-aeb3c99ff338" xlink:href="fldm-20200930.xsd#fldm_ConsumablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_db7030fa-0c7a-4dc1-bcea-0b49f1bab4b9" xlink:to="loc_fldm_ConsumablesMember_86bf3271-b7c6-4a03-b2ed-aeb3c99ff338" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_92ef9574-5bc1-49e4-ba2b-6bf7756b385e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_db7030fa-0c7a-4dc1-bcea-0b49f1bab4b9" xlink:to="loc_us-gaap_ProductMember_92ef9574-5bc1-49e4-ba2b-6bf7756b385e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_500bc2a4-58a0-4e1b-b13f-32d7d0c48c7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_db7030fa-0c7a-4dc1-bcea-0b49f1bab4b9" xlink:to="loc_us-gaap_ServiceMember_500bc2a4-58a0-4e1b-b13f-32d7d0c48c7a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CollaborationRevenueMember_0ebf9f3f-a0fe-4286-b434-4c09c3a4187d" xlink:href="fldm-20200930.xsd#fldm_CollaborationRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_db7030fa-0c7a-4dc1-bcea-0b49f1bab4b9" xlink:to="loc_fldm_CollaborationRevenueMember_0ebf9f3f-a0fe-4286-b434-4c09c3a4187d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember_e2b432f1-4d73-4e9d-99cb-af965a3e3cd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_db7030fa-0c7a-4dc1-bcea-0b49f1bab4b9" xlink:to="loc_us-gaap_LicenseMember_e2b432f1-4d73-4e9d-99cb-af965a3e3cd5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrantMember_8c67734a-271c-43c3-b7a6-f6eff1a7fb44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_db7030fa-0c7a-4dc1-bcea-0b49f1bab4b9" xlink:to="loc_us-gaap_GrantMember_8c67734a-271c-43c3-b7a6-f6eff1a7fb44" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_2d57aa16-1df6-4e2d-85c0-87efd5ba311a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_db7030fa-0c7a-4dc1-bcea-0b49f1bab4b9" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_2d57aa16-1df6-4e2d-85c0-87efd5ba311a" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#RevenueNarrativeDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/RevenueNarrativeDetails" xlink:type="extended" id="id4f72094a68f4eef88b9033f45c3b611_RevenueNarrativeDetails"/>
  <link:roleRef roleURI="http://fluidigm.com/role/RevenuePerformanceObligationsDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#RevenuePerformanceObligationsDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/RevenuePerformanceObligationsDetails" xlink:type="extended" id="i125063ece53741c8af7ae6de122e5b64_RevenuePerformanceObligationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_e238f766-0998-43d7-9226-74f56e49f50f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_9d30e70d-291f-4ab4-8f51-529fb457a579" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_e238f766-0998-43d7-9226-74f56e49f50f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_9d30e70d-291f-4ab4-8f51-529fb457a579" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_18863d52-1fe4-43a6-940a-97b578214971" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_e238f766-0998-43d7-9226-74f56e49f50f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_18863d52-1fe4-43a6-940a-97b578214971" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d0120ac7-2507-495e-a254-da189441644e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_e238f766-0998-43d7-9226-74f56e49f50f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d0120ac7-2507-495e-a254-da189441644e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_45c15515-17f4-40f9-ab17-f830dc587532" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d0120ac7-2507-495e-a254-da189441644e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_45c15515-17f4-40f9-ab17-f830dc587532" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/RevenuePerformanceObligationsDetails_1" xlink:type="simple" xlink:href="fldm-20200930.xsd#RevenuePerformanceObligationsDetails_1"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/RevenuePerformanceObligationsDetails_1" xlink:type="extended" id="i40597fc609d743699bfa3dda11b5a9da_RevenuePerformanceObligationsDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_e238f766-0998-43d7-9226-74f56e49f50f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_9d30e70d-291f-4ab4-8f51-529fb457a579" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_e238f766-0998-43d7-9226-74f56e49f50f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_9d30e70d-291f-4ab4-8f51-529fb457a579" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_18863d52-1fe4-43a6-940a-97b578214971" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_e238f766-0998-43d7-9226-74f56e49f50f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_18863d52-1fe4-43a6-940a-97b578214971" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d0120ac7-2507-495e-a254-da189441644e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_e238f766-0998-43d7-9226-74f56e49f50f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d0120ac7-2507-495e-a254-da189441644e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnet" xlink:type="simple" xlink:href="fldm-20200930.xsd#GoodwillandIntangibleAssetsnet"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/GoodwillandIntangibleAssetsnet" xlink:type="extended" id="id3557173560444569f99254bd628c8be_GoodwillandIntangibleAssetsnet"/>
  <link:roleRef roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetTables" xlink:type="simple" xlink:href="fldm-20200930.xsd#GoodwillandIntangibleAssetsnetTables"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetTables" xlink:type="extended" id="if0dd0c85881a4fb5b3ea3eed0dc53f8c_GoodwillandIntangibleAssetsnetTables"/>
  <link:roleRef roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#GoodwillandIntangibleAssetsnetNarrativeDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails" xlink:type="extended" id="ic2ae97f8580d4580a9b1b484665c78c4_GoodwillandIntangibleAssetsnetNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a45b0b34-d429-4989-90a1-4b6d780c8c09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_20bc601e-b993-43f1-bae1-ac97ba988de3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a45b0b34-d429-4989-90a1-4b6d780c8c09" xlink:to="loc_us-gaap_Goodwill_20bc601e-b993-43f1-bae1-ac97ba988de3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_79b6fe5c-facd-4dc0-8c3b-258f0f492971" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a45b0b34-d429-4989-90a1-4b6d780c8c09" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_79b6fe5c-facd-4dc0-8c3b-258f0f492971" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_0cb47a84-eb7f-4bc2-87bc-772cb4b05895" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a45b0b34-d429-4989-90a1-4b6d780c8c09" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_0cb47a84-eb7f-4bc2-87bc-772cb4b05895" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_90fef025-d96e-4d79-85af-20c7a54c4ec6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a45b0b34-d429-4989-90a1-4b6d780c8c09" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_90fef025-d96e-4d79-85af-20c7a54c4ec6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9940b397-0f02-4b62-a1f4-20acdeed19a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a45b0b34-d429-4989-90a1-4b6d780c8c09" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9940b397-0f02-4b62-a1f4-20acdeed19a0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_42ca1ec7-ff15-419e-ae07-6c3a9c2f3734" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9940b397-0f02-4b62-a1f4-20acdeed19a0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_42ca1ec7-ff15-419e-ae07-6c3a9c2f3734" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_42ca1ec7-ff15-419e-ae07-6c3a9c2f3734_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_42ca1ec7-ff15-419e-ae07-6c3a9c2f3734" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_42ca1ec7-ff15-419e-ae07-6c3a9c2f3734_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_870f03c0-4c5e-40d4-a24d-3af61f2959aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_42ca1ec7-ff15-419e-ae07-6c3a9c2f3734" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_870f03c0-4c5e-40d4-a24d-3af61f2959aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_8892fad3-743e-4f29-b070-a6379ba0e70f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_870f03c0-4c5e-40d4-a24d-3af61f2959aa" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_8892fad3-743e-4f29-b070-a6379ba0e70f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_8db8b9d3-8a9c-4c22-8dc7-8fcb5ad4246a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9940b397-0f02-4b62-a1f4-20acdeed19a0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_8db8b9d3-8a9c-4c22-8dc7-8fcb5ad4246a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8db8b9d3-8a9c-4c22-8dc7-8fcb5ad4246a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8db8b9d3-8a9c-4c22-8dc7-8fcb5ad4246a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8db8b9d3-8a9c-4c22-8dc7-8fcb5ad4246a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c9ac88e8-db17-4945-8c2f-4c5f6ec1dc5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8db8b9d3-8a9c-4c22-8dc7-8fcb5ad4246a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c9ac88e8-db17-4945-8c2f-4c5f6ec1dc5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DVSSciencesInc.Member_318349c3-f4fa-4697-a7ca-e21c26dea7e8" xlink:href="fldm-20200930.xsd#fldm_DVSSciencesInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c9ac88e8-db17-4945-8c2f-4c5f6ec1dc5e" xlink:to="loc_fldm_DVSSciencesInc.Member_318349c3-f4fa-4697-a7ca-e21c26dea7e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_InstruNorASMember_709b3a1b-a38a-47c3-a37a-643a167ff434" xlink:href="fldm-20200930.xsd#fldm_InstruNorASMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c9ac88e8-db17-4945-8c2f-4c5f6ec1dc5e" xlink:to="loc_fldm_InstruNorASMember_709b3a1b-a38a-47c3-a37a-643a167ff434" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails" xlink:type="extended" id="i4e44055eefaf4f3aae775720ff1bc0cb_GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e644f76e-ca47-4d0d-899e-d355d0267718" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_7de506e9-c4a0-4405-94d0-e8cead2264fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e644f76e-ca47-4d0d-899e-d355d0267718" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_7de506e9-c4a0-4405-94d0-e8cead2264fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_be49da86-4df4-498c-9c11-73ea5061c09e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e644f76e-ca47-4d0d-899e-d355d0267718" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_be49da86-4df4-498c-9c11-73ea5061c09e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_11e2789d-40cb-4a67-a6ca-7ecb2a57f52e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e644f76e-ca47-4d0d-899e-d355d0267718" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_11e2789d-40cb-4a67-a6ca-7ecb2a57f52e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_4b2b1f7d-8800-4a35-9203-31f4d04570d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e644f76e-ca47-4d0d-899e-d355d0267718" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_4b2b1f7d-8800-4a35-9203-31f4d04570d9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6ff3d177-4c9d-41f9-8e4a-3303079e3d7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e644f76e-ca47-4d0d-899e-d355d0267718" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6ff3d177-4c9d-41f9-8e4a-3303079e3d7f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_aec6e9a0-5a23-4ecb-9514-135df200cc60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6ff3d177-4c9d-41f9-8e4a-3303079e3d7f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_aec6e9a0-5a23-4ecb-9514-135df200cc60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_aec6e9a0-5a23-4ecb-9514-135df200cc60_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_aec6e9a0-5a23-4ecb-9514-135df200cc60" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_aec6e9a0-5a23-4ecb-9514-135df200cc60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ba6a90fd-6a4e-47e3-841a-7c586d55a4bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_aec6e9a0-5a23-4ecb-9514-135df200cc60" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ba6a90fd-6a4e-47e3-841a-7c586d55a4bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_722ed731-0fd4-44e2-87d8-ccb5a0b674ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ba6a90fd-6a4e-47e3-841a-7c586d55a4bf" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_722ed731-0fd4-44e2-87d8-ccb5a0b674ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_PatentsandLicenseAgreementsMember_c3624774-0199-4ac2-a042-2bdd6f2d6d31" xlink:href="fldm-20200930.xsd#fldm_PatentsandLicenseAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ba6a90fd-6a4e-47e3-841a-7c586d55a4bf" xlink:to="loc_fldm_PatentsandLicenseAgreementsMember_c3624774-0199-4ac2-a042-2bdd6f2d6d31" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails" xlink:type="extended" id="i1cd34494bf814b26a58852e6c84d6500_GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f85c251c-fcab-49a1-b325-0cf45ff685d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_c3c49cb5-e5e0-461d-93ea-661dc1736713" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f85c251c-fcab-49a1-b325-0cf45ff685d5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_c3c49cb5-e5e0-461d-93ea-661dc1736713" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_4beb8049-cd64-410c-bdaf-a57e286bddf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f85c251c-fcab-49a1-b325-0cf45ff685d5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_4beb8049-cd64-410c-bdaf-a57e286bddf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_8166cc72-69fb-4021-b440-23df5997cd24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f85c251c-fcab-49a1-b325-0cf45ff685d5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_8166cc72-69fb-4021-b440-23df5997cd24" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c8ad79b0-9339-478d-b049-a1ae3f825a29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f85c251c-fcab-49a1-b325-0cf45ff685d5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c8ad79b0-9339-478d-b049-a1ae3f825a29" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0a407428-7f78-4f64-9ac5-71170e407799" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f85c251c-fcab-49a1-b325-0cf45ff685d5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0a407428-7f78-4f64-9ac5-71170e407799" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_4cbc3b87-10b1-480a-84c6-c79debb313ec" xlink:href="fldm-20200930.xsd#fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f85c251c-fcab-49a1-b325-0cf45ff685d5" xlink:to="loc_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_4cbc3b87-10b1-480a-84c6-c79debb313ec" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_60a9563b-5c46-4fb9-89f2-a92c96052504" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f85c251c-fcab-49a1-b325-0cf45ff685d5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_60a9563b-5c46-4fb9-89f2-a92c96052504" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_69f03874-c6b4-4fdf-8953-5974dd1a5d80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f85c251c-fcab-49a1-b325-0cf45ff685d5" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_69f03874-c6b4-4fdf-8953-5974dd1a5d80" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6a3fa240-f689-40b8-95b9-100426697b9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_69f03874-c6b4-4fdf-8953-5974dd1a5d80" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6a3fa240-f689-40b8-95b9-100426697b9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6a3fa240-f689-40b8-95b9-100426697b9e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6a3fa240-f689-40b8-95b9-100426697b9e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6a3fa240-f689-40b8-95b9-100426697b9e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cb2e61e-3fa4-4ce8-af88-9c52801b85fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6a3fa240-f689-40b8-95b9-100426697b9e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cb2e61e-3fa4-4ce8-af88-9c52801b85fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_0d2cbadf-d949-425d-b009-ff815c7d16d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cb2e61e-3fa4-4ce8-af88-9c52801b85fa" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_0d2cbadf-d949-425d-b009-ff815c7d16d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_PatentsandLicenseAgreementsMember_efe0ad57-a7f9-431d-b93b-ac647fa75532" xlink:href="fldm-20200930.xsd#fldm_PatentsandLicenseAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cb2e61e-3fa4-4ce8-af88-9c52801b85fa" xlink:to="loc_fldm_PatentsandLicenseAgreementsMember_efe0ad57-a7f9-431d-b93b-ac647fa75532" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/BalanceSheetDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#BalanceSheetDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/BalanceSheetDetails" xlink:type="extended" id="i711b85bb7f394ccca0e1396e653b2782_BalanceSheetDetails"/>
  <link:roleRef roleURI="http://fluidigm.com/role/BalanceSheetDetailsTables" xlink:type="simple" xlink:href="fldm-20200930.xsd#BalanceSheetDetailsTables"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/BalanceSheetDetailsTables" xlink:type="extended" id="ib4699380ca7c42dbbbb92160e98fc1c9_BalanceSheetDetailsTables"/>
  <link:roleRef roleURI="http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails" xlink:type="extended" id="i0131cc496a2f4ae49a3cb2505f2798e6_BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails"/>
  <link:roleRef roleURI="http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#BalanceSheetDetailsInventoriesDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails" xlink:type="extended" id="id6426a6486244900866270b4e42ddd9c_BalanceSheetDetailsInventoriesDetails"/>
  <link:roleRef roleURI="http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#BalanceSheetDetailsPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails" xlink:type="extended" id="i6c8ebef96c164f23becdcfdffc5b4056_BalanceSheetDetailsPropertyandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_dea957a9-94c1-43a7-bfdd-7639f21f9e8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_453d5a90-5029-492f-b05c-a2818ace9d02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_dea957a9-94c1-43a7-bfdd-7639f21f9e8a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_453d5a90-5029-492f-b05c-a2818ace9d02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_9897c1ee-c8c3-47b9-9fd3-0fed24513490" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_dea957a9-94c1-43a7-bfdd-7639f21f9e8a" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_9897c1ee-c8c3-47b9-9fd3-0fed24513490" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_93859ba0-451f-4207-a6e0-4fea757bd1f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_dea957a9-94c1-43a7-bfdd-7639f21f9e8a" xlink:to="loc_us-gaap_ConstructionInProgressGross_93859ba0-451f-4207-a6e0-4fea757bd1f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6b639cdd-8a4a-4787-b2fa-eeb2a93d6027" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_dea957a9-94c1-43a7-bfdd-7639f21f9e8a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6b639cdd-8a4a-4787-b2fa-eeb2a93d6027" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_262c8eed-757e-41e2-b9ee-3175fc0123ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_dea957a9-94c1-43a7-bfdd-7639f21f9e8a" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_262c8eed-757e-41e2-b9ee-3175fc0123ca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fb301dc7-922c-41b4-92b2-15eeb0294283" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_262c8eed-757e-41e2-b9ee-3175fc0123ca" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fb301dc7-922c-41b4-92b2-15eeb0294283" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_fb301dc7-922c-41b4-92b2-15eeb0294283_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fb301dc7-922c-41b4-92b2-15eeb0294283" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_fb301dc7-922c-41b4-92b2-15eeb0294283_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42d872ed-78d8-41bc-802e-00597649d4eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fb301dc7-922c-41b4-92b2-15eeb0294283" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42d872ed-78d8-41bc-802e-00597649d4eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ComputerEquipmentAndSoftwareMember_3f63e251-b55e-422c-b4b8-f34f4b9a7e2e" xlink:href="fldm-20200930.xsd#fldm_ComputerEquipmentAndSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42d872ed-78d8-41bc-802e-00597649d4eb" xlink:to="loc_fldm_ComputerEquipmentAndSoftwareMember_3f63e251-b55e-422c-b4b8-f34f4b9a7e2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LaboratoryAndManufacturingEquipmentMember_71d19431-e125-4385-96f0-0f17686d0819" xlink:href="fldm-20200930.xsd#fldm_LaboratoryAndManufacturingEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42d872ed-78d8-41bc-802e-00597649d4eb" xlink:to="loc_fldm_LaboratoryAndManufacturingEquipmentMember_71d19431-e125-4385-96f0-0f17686d0819" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_fd683b0f-3b31-4ea8-9baa-1e9b31606eaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42d872ed-78d8-41bc-802e-00597649d4eb" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_fd683b0f-3b31-4ea8-9baa-1e9b31606eaf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_97ab9250-5222-48c0-b8c8-fb2e29462555" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42d872ed-78d8-41bc-802e-00597649d4eb" xlink:to="loc_us-gaap_OfficeEquipmentMember_97ab9250-5222-48c0-b8c8-fb2e29462555" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/BalanceSheetDetailsWarrantyAccrualDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#BalanceSheetDetailsWarrantyAccrualDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/BalanceSheetDetailsWarrantyAccrualDetails" xlink:type="extended" id="i80eb2485657b4855815835303fd9797b_BalanceSheetDetailsWarrantyAccrualDetails"/>
  <link:roleRef roleURI="http://fluidigm.com/role/ConvertibleNotesandCreditFacility" xlink:type="simple" xlink:href="fldm-20200930.xsd#ConvertibleNotesandCreditFacility"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/ConvertibleNotesandCreditFacility" xlink:type="extended" id="i878de6525e24470385102fbf766fa1d1_ConvertibleNotesandCreditFacility"/>
  <link:roleRef roleURI="http://fluidigm.com/role/ConvertibleNotesandCreditFacilityTables" xlink:type="simple" xlink:href="fldm-20200930.xsd#ConvertibleNotesandCreditFacilityTables"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/ConvertibleNotesandCreditFacilityTables" xlink:type="extended" id="ife81d5fd9c874a4fa87f449a17111093_ConvertibleNotesandCreditFacilityTables"/>
  <link:roleRef roleURI="http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#ConvertibleNotesandCreditFacilityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" xlink:type="extended" id="ic5d74933ff6d44ea9cc4cd49073536ad_ConvertibleNotesandCreditFacilityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_45191e82-5f99-4852-bb21-d75be3280e8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_45191e82-5f99-4852-bb21-d75be3280e8f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_e7a6f169-42d0-49a3-baf8-291706c4ee5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_e7a6f169-42d0-49a3-baf8-291706c4ee5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_afdbf097-d80b-4550-98f5-c880dac15cdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_afdbf097-d80b-4550-98f5-c880dac15cdf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_f49366c1-feec-4829-adf8-7f15195b5c4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_f49366c1-feec-4829-adf8-7f15195b5c4d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_5a4d2e9b-7ab5-40da-abab-0687604f27e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_5a4d2e9b-7ab5-40da-abab-0687604f27e2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_2a173acc-618d-45c9-afe8-96ddca7e526b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_LongTermDebtFairValue_2a173acc-618d-45c9-afe8-96ddca7e526b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d30d89af-2a72-4416-a0f7-eb9d95107cd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d30d89af-2a72-4416-a0f7-eb9d95107cd0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_23ff6e9d-8dc2-4978-9806-91f20320a64b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_23ff6e9d-8dc2-4978-9806-91f20320a64b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_b351725e-153d-4d25-8b80-83b857d89765" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_b351725e-153d-4d25-8b80-83b857d89765" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_InitialConversionPriceOfStock_0a69095b-6b69-48db-8406-6292a8fedb0c" xlink:href="fldm-20200930.xsd#fldm_InitialConversionPriceOfStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_fldm_InitialConversionPriceOfStock_0a69095b-6b69-48db-8406-6292a8fedb0c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice_6cb222a7-c087-4c61-9be6-69dbf4824896" xlink:href="fldm-20200930.xsd#fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice_6cb222a7-c087-4c61-9be6-69dbf4824896" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtAndEquityOfferingCosts_84f9c7f5-8b9d-4556-92d1-fa63d0c436cf" xlink:href="fldm-20200930.xsd#fldm_DebtAndEquityOfferingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_fldm_DebtAndEquityOfferingCosts_84f9c7f5-8b9d-4556-92d1-fa63d0c436cf" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_1c55b56d-53f0-4ec4-a4a7-33791f29c3ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_1c55b56d-53f0-4ec4-a4a7-33791f29c3ae" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_c8d77f0e-0895-42a0-972a-a24149be4c73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_c8d77f0e-0895-42a0-972a-a24149be4c73" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_41c7168b-e88f-463e-9cee-6090d03190a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_41c7168b-e88f-463e-9cee-6090d03190a2" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_a1e92af8-1b71-4b69-affc-9b1f934702a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_a1e92af8-1b71-4b69-affc-9b1f934702a3" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_d5ae5dfe-764b-485a-8cb9-f58490b3baa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_d5ae5dfe-764b-485a-8cb9-f58490b3baa0" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_dc5a96a1-4598-4011-878c-494bc7d7d279" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_dc5a96a1-4598-4011-878c-494bc7d7d279" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_dc4fb0d5-0a1d-4fbb-8d21-915a79875e63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_dc4fb0d5-0a1d-4fbb-8d21-915a79875e63" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_6c67bda4-a00b-4cea-84a8-f67b75f97aab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_6c67bda4-a00b-4cea-84a8-f67b75f97aab" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables_6ffca6c0-e572-413c-bd6b-06d319b13070" xlink:href="fldm-20200930.xsd#fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables_6ffca6c0-e572-413c-bd6b-06d319b13070" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory_4331d6f5-803d-44c9-ab76-37c9acd49dd5" xlink:href="fldm-20200930.xsd#fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory_4331d6f5-803d-44c9-ab76-37c9acd49dd5" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_bac29acb-8d34-4afc-b69f-973afe1b802c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_LineOfCredit_bac29acb-8d34-4afc-b69f-973afe1b802c" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1e23a6a0-9c15-46ed-88ed-39c86cede540" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1e23a6a0-9c15-46ed-88ed-39c86cede540" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_dc23329f-8bf7-42b4-80fd-7765307893af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_dc23329f-8bf7-42b4-80fd-7765307893af" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtInstrumentEarlyRedemptionCostPercentOfMaximumBorrowingCapacity_8ba4e11d-08bd-417d-af6a-395ea39b058c" xlink:href="fldm-20200930.xsd#fldm_DebtInstrumentEarlyRedemptionCostPercentOfMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_fldm_DebtInstrumentEarlyRedemptionCostPercentOfMaximumBorrowingCapacity_8ba4e11d-08bd-417d-af6a-395ea39b058c" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LineOfCreditFacilityPercentageOfInterestOnObligationUponDefault_c2257e60-6d2e-42c5-9ded-e9836422dabe" xlink:href="fldm-20200930.xsd#fldm_LineOfCreditFacilityPercentageOfInterestOnObligationUponDefault"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_fldm_LineOfCreditFacilityPercentageOfInterestOnObligationUponDefault_c2257e60-6d2e-42c5-9ded-e9836422dabe" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_126e694c-65b8-4301-9c74-3afde4a04842" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_DebtInstrumentTable_126e694c-65b8-4301-9c74-3afde4a04842" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_71ad913b-7321-4245-9776-97516bb02f0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_126e694c-65b8-4301-9c74-3afde4a04842" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_71ad913b-7321-4245-9776-97516bb02f0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_71ad913b-7321-4245-9776-97516bb02f0b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_71ad913b-7321-4245-9776-97516bb02f0b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_71ad913b-7321-4245-9776-97516bb02f0b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e3b1f383-214a-476a-9a6c-783a55677540" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_71ad913b-7321-4245-9776-97516bb02f0b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e3b1f383-214a-476a-9a6c-783a55677540" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_fb5b0646-cd86-4465-8da0-9ce0155ecb29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e3b1f383-214a-476a-9a6c-783a55677540" xlink:to="loc_us-gaap_ConvertibleDebtMember_fb5b0646-cd86-4465-8da0-9ce0155ecb29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d5b206d2-aec6-43a8-8442-6252bc7641c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_126e694c-65b8-4301-9c74-3afde4a04842" xlink:to="loc_us-gaap_DebtInstrumentAxis_d5b206d2-aec6-43a8-8442-6252bc7641c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d5b206d2-aec6-43a8-8442-6252bc7641c0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_d5b206d2-aec6-43a8-8442-6252bc7641c0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d5b206d2-aec6-43a8-8442-6252bc7641c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_69c08ae3-6165-4fba-bf98-14e95556f14c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_d5b206d2-aec6-43a8-8442-6252bc7641c0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_69c08ae3-6165-4fba-bf98-14e95556f14c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeniorConvertibleNotesdue2034Member_a10f1bf1-c9fa-4211-8a16-636611df4f8e" xlink:href="fldm-20200930.xsd#fldm_SeniorConvertibleNotesdue2034Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69c08ae3-6165-4fba-bf98-14e95556f14c" xlink:to="loc_fldm_SeniorConvertibleNotesdue2034Member_a10f1bf1-c9fa-4211-8a16-636611df4f8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ExchangeConvertibleSeniorNotesDue2034Member_1fdcf835-a2a9-4311-9acb-f642fea6b451" xlink:href="fldm-20200930.xsd#fldm_ExchangeConvertibleSeniorNotesDue2034Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69c08ae3-6165-4fba-bf98-14e95556f14c" xlink:to="loc_fldm_ExchangeConvertibleSeniorNotesDue2034Member_1fdcf835-a2a9-4311-9acb-f642fea6b451" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeniorConvertibleNotesDue2024Member_3b4bc02f-47cd-42f7-85bf-0d300fe9ea68" xlink:href="fldm-20200930.xsd#fldm_SeniorConvertibleNotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69c08ae3-6165-4fba-bf98-14e95556f14c" xlink:to="loc_fldm_SeniorConvertibleNotesDue2024Member_3b4bc02f-47cd-42f7-85bf-0d300fe9ea68" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_e6e0f11e-a4d4-4242-8aa6-b71a5a1bbfd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_126e694c-65b8-4301-9c74-3afde4a04842" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_e6e0f11e-a4d4-4242-8aa6-b71a5a1bbfd9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_e6e0f11e-a4d4-4242-8aa6-b71a5a1bbfd9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_e6e0f11e-a4d4-4242-8aa6-b71a5a1bbfd9" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_e6e0f11e-a4d4-4242-8aa6-b71a5a1bbfd9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_b0c083e5-4023-484b-a32d-7a8f9a1a3cac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_e6e0f11e-a4d4-4242-8aa6-b71a5a1bbfd9" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_b0c083e5-4023-484b-a32d-7a8f9a1a3cac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TrusteeMember_22544785-2d46-4cac-87e7-707681af7c62" xlink:href="fldm-20200930.xsd#fldm_TrusteeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_b0c083e5-4023-484b-a32d-7a8f9a1a3cac" xlink:to="loc_fldm_TrusteeMember_22544785-2d46-4cac-87e7-707681af7c62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_72d87890-5d07-43e7-a3a2-b18d8a66d4c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_126e694c-65b8-4301-9c74-3afde4a04842" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_72d87890-5d07-43e7-a3a2-b18d8a66d4c2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_72d87890-5d07-43e7-a3a2-b18d8a66d4c2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_72d87890-5d07-43e7-a3a2-b18d8a66d4c2" xlink:to="loc_us-gaap_EquityComponentDomain_72d87890-5d07-43e7-a3a2-b18d8a66d4c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_fc27d484-ace7-4071-b1a5-8cf65bc83983" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_72d87890-5d07-43e7-a3a2-b18d8a66d4c2" xlink:to="loc_us-gaap_EquityComponentDomain_fc27d484-ace7-4071-b1a5-8cf65bc83983" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_8d59077d-81c9-483d-99b6-e927c67515d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_fc27d484-ace7-4071-b1a5-8cf65bc83983" xlink:to="loc_us-gaap_CommonStockMember_8d59077d-81c9-483d-99b6-e927c67515d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_a0bb20df-0f5e-4f08-9ecd-46cecddfc6d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_126e694c-65b8-4301-9c74-3afde4a04842" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_a0bb20df-0f5e-4f08-9ecd-46cecddfc6d8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_a0bb20df-0f5e-4f08-9ecd-46cecddfc6d8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_a0bb20df-0f5e-4f08-9ecd-46cecddfc6d8" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_a0bb20df-0f5e-4f08-9ecd-46cecddfc6d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_a7d291bd-0a23-45ed-891b-d2597b21124f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_a0bb20df-0f5e-4f08-9ecd-46cecddfc6d8" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_a7d291bd-0a23-45ed-891b-d2597b21124f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_1bf24c11-0686-4b7e-a772-89e4f587a031" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_a7d291bd-0a23-45ed-891b-d2597b21124f" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_1bf24c11-0686-4b7e-a772-89e4f587a031" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_3e0545cc-88b6-43c9-a658-a1515c7cf95f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_a7d291bd-0a23-45ed-891b-d2597b21124f" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_3e0545cc-88b6-43c9-a658-a1515c7cf95f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_4ba35660-0e13-4841-b461-31925023893e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_126e694c-65b8-4301-9c74-3afde4a04842" xlink:to="loc_us-gaap_CreditFacilityAxis_4ba35660-0e13-4841-b461-31925023893e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_4ba35660-0e13-4841-b461-31925023893e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_4ba35660-0e13-4841-b461-31925023893e" xlink:to="loc_us-gaap_CreditFacilityDomain_4ba35660-0e13-4841-b461-31925023893e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_cff55e8f-66c0-42cc-976f-d7cce3aab99c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_4ba35660-0e13-4841-b461-31925023893e" xlink:to="loc_us-gaap_CreditFacilityDomain_cff55e8f-66c0-42cc-976f-d7cce3aab99c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_e108a97f-3551-4922-a772-fa3cf7f0c138" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_cff55e8f-66c0-42cc-976f-d7cce3aab99c" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_e108a97f-3551-4922-a772-fa3cf7f0c138" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3132d494-1b8e-4a89-8ffb-92dccc77c90d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_126e694c-65b8-4301-9c74-3afde4a04842" xlink:to="loc_srt_RangeAxis_3132d494-1b8e-4a89-8ffb-92dccc77c90d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3132d494-1b8e-4a89-8ffb-92dccc77c90d_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_3132d494-1b8e-4a89-8ffb-92dccc77c90d" xlink:to="loc_srt_RangeMember_3132d494-1b8e-4a89-8ffb-92dccc77c90d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d0b466b5-0e72-4e1f-8805-c0469fb3770e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_3132d494-1b8e-4a89-8ffb-92dccc77c90d" xlink:to="loc_srt_RangeMember_d0b466b5-0e72-4e1f-8805-c0469fb3770e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3ce01833-6521-4774-bfa0-024694e0f6a9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d0b466b5-0e72-4e1f-8805-c0469fb3770e" xlink:to="loc_srt_MinimumMember_3ce01833-6521-4774-bfa0-024694e0f6a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ec0458ec-249b-4c69-bde7-625b7f96d3b3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d0b466b5-0e72-4e1f-8805-c0469fb3770e" xlink:to="loc_srt_MaximumMember_ec0458ec-249b-4c69-bde7-625b7f96d3b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_4c3794a6-0ce0-4dca-a988-23f6a3f37201" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_126e694c-65b8-4301-9c74-3afde4a04842" xlink:to="loc_us-gaap_VariableRateAxis_4c3794a6-0ce0-4dca-a988-23f6a3f37201" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_4c3794a6-0ce0-4dca-a988-23f6a3f37201_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_4c3794a6-0ce0-4dca-a988-23f6a3f37201" xlink:to="loc_us-gaap_VariableRateDomain_4c3794a6-0ce0-4dca-a988-23f6a3f37201_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_6035fa78-0855-4e80-a22d-32b81712aca8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_4c3794a6-0ce0-4dca-a988-23f6a3f37201" xlink:to="loc_us-gaap_VariableRateDomain_6035fa78-0855-4e80-a22d-32b81712aca8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember_52dd8640-04d4-4cfd-be34-101ba5d63587" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrimeRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_6035fa78-0855-4e80-a22d-32b81712aca8" xlink:to="loc_us-gaap_PrimeRateMember_52dd8640-04d4-4cfd-be34-101ba5d63587" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#ConvertibleNotesandCreditFacilityScheduleofDebtDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails" xlink:type="extended" id="i6c5ca847d4aa4ef3a7097240ea6611c1_ConvertibleNotesandCreditFacilityScheduleofDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f67776d3-97f5-4e5e-8f61-d3ad81bafcc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a70af316-a680-4c3c-be5c-f48eeded0bd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f67776d3-97f5-4e5e-8f61-d3ad81bafcc1" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a70af316-a680-4c3c-be5c-f48eeded0bd2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_bacfc7b5-e1d0-4c3c-b657-e2e5e4811d45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f67776d3-97f5-4e5e-8f61-d3ad81bafcc1" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_bacfc7b5-e1d0-4c3c-b657-e2e5e4811d45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_79bc989d-8dd5-4829-ba69-9d06195f6654" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f67776d3-97f5-4e5e-8f61-d3ad81bafcc1" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_79bc989d-8dd5-4829-ba69-9d06195f6654" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_f0bfb89d-3617-41da-b6aa-3af1d6c9897e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f67776d3-97f5-4e5e-8f61-d3ad81bafcc1" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_f0bfb89d-3617-41da-b6aa-3af1d6c9897e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_7eee510c-af6e-41b5-81d9-e04cf5d2509e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f67776d3-97f5-4e5e-8f61-d3ad81bafcc1" xlink:to="loc_us-gaap_LongTermDebt_7eee510c-af6e-41b5-81d9-e04cf5d2509e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_06d7a199-1242-4033-b4ac-8d957791b3f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f67776d3-97f5-4e5e-8f61-d3ad81bafcc1" xlink:to="loc_us-gaap_DebtInstrumentTable_06d7a199-1242-4033-b4ac-8d957791b3f5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cd797c55-3b87-4612-b4ba-1259f0f98d34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_06d7a199-1242-4033-b4ac-8d957791b3f5" xlink:to="loc_us-gaap_DebtInstrumentAxis_cd797c55-3b87-4612-b4ba-1259f0f98d34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cd797c55-3b87-4612-b4ba-1259f0f98d34_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_cd797c55-3b87-4612-b4ba-1259f0f98d34" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cd797c55-3b87-4612-b4ba-1259f0f98d34_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_41e8f597-0aab-4c00-aebb-0b9f4f9e850b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_cd797c55-3b87-4612-b4ba-1259f0f98d34" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_41e8f597-0aab-4c00-aebb-0b9f4f9e850b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeniorConvertibleNotesdue2034Member_f97ba959-b47e-49b5-9a60-dcd110b72376" xlink:href="fldm-20200930.xsd#fldm_SeniorConvertibleNotesdue2034Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_41e8f597-0aab-4c00-aebb-0b9f4f9e850b" xlink:to="loc_fldm_SeniorConvertibleNotesdue2034Member_f97ba959-b47e-49b5-9a60-dcd110b72376" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeniorConvertibleNotesDue2024Member_7e67acd5-e443-4f40-a335-8038fedeefa1" xlink:href="fldm-20200930.xsd#fldm_SeniorConvertibleNotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_41e8f597-0aab-4c00-aebb-0b9f4f9e850b" xlink:to="loc_fldm_SeniorConvertibleNotesDue2024Member_7e67acd5-e443-4f40-a335-8038fedeefa1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b949497b-2149-4eba-a0fc-3cfba6320b7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_06d7a199-1242-4033-b4ac-8d957791b3f5" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b949497b-2149-4eba-a0fc-3cfba6320b7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b949497b-2149-4eba-a0fc-3cfba6320b7a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b949497b-2149-4eba-a0fc-3cfba6320b7a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b949497b-2149-4eba-a0fc-3cfba6320b7a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_99518c32-f01c-4d72-8358-00c72c937481" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b949497b-2149-4eba-a0fc-3cfba6320b7a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_99518c32-f01c-4d72-8358-00c72c937481" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_016c0645-dd22-4f01-8f80-a8d21e8c9fe2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_99518c32-f01c-4d72-8358-00c72c937481" xlink:to="loc_us-gaap_ConvertibleDebtMember_016c0645-dd22-4f01-8f80-a8d21e8c9fe2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/Leases" xlink:type="simple" xlink:href="fldm-20200930.xsd#Leases"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/Leases" xlink:type="extended" id="i87af0f78f42c47fabc1c773a32354fb9_Leases"/>
  <link:roleRef roleURI="http://fluidigm.com/role/LeasesTables" xlink:type="simple" xlink:href="fldm-20200930.xsd#LeasesTables"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/LeasesTables" xlink:type="extended" id="i10ea18ddad70462c9dee64c24cb0a4b2_LeasesTables"/>
  <link:roleRef roleURI="http://fluidigm.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/LeasesNarrativeDetails" xlink:type="extended" id="id8b90413046a4bd08c1afa32c2ef8898_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_fb3052d1-1972-4e6f-b9d8-4575759aee5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LesseeOperatingLeaseRemainingTermOfContract_a92793b1-d8c5-4e2f-8f0a-5cfa73f50362" xlink:href="fldm-20200930.xsd#fldm_LesseeOperatingLeaseRemainingTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_fb3052d1-1972-4e6f-b9d8-4575759aee5b" xlink:to="loc_fldm_LesseeOperatingLeaseRemainingTermOfContract_a92793b1-d8c5-4e2f-8f0a-5cfa73f50362" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_5c32eb23-c995-4863-b3ea-2aea413b0a24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_fb3052d1-1972-4e6f-b9d8-4575759aee5b" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_5c32eb23-c995-4863-b3ea-2aea413b0a24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_9777b257-9124-4bef-8d22-5c115f4d3003" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_fb3052d1-1972-4e6f-b9d8-4575759aee5b" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_9777b257-9124-4bef-8d22-5c115f4d3003" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_b47de43c-6037-48f8-9ebb-8882da0767b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_fb3052d1-1972-4e6f-b9d8-4575759aee5b" xlink:to="loc_us-gaap_OperatingLeaseLiability_b47de43c-6037-48f8-9ebb-8882da0767b5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_7d053ee2-9ec1-4f35-b289-2a242b85ca7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_fb3052d1-1972-4e6f-b9d8-4575759aee5b" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_7d053ee2-9ec1-4f35-b289-2a242b85ca7a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseDiscountRate_5a625158-3b0f-43e5-abe5-1c38b2b0e172" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_fb3052d1-1972-4e6f-b9d8-4575759aee5b" xlink:to="loc_us-gaap_LesseeOperatingLeaseDiscountRate_5a625158-3b0f-43e5-abe5-1c38b2b0e172" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_d83a1a89-5f21-4ec3-bb69-4577b567aa3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_fb3052d1-1972-4e6f-b9d8-4575759aee5b" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_d83a1a89-5f21-4ec3-bb69-4577b567aa3e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d8565335-235c-4e13-ac96-374143275d10" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_d83a1a89-5f21-4ec3-bb69-4577b567aa3e" xlink:to="loc_srt_RangeAxis_d8565335-235c-4e13-ac96-374143275d10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d8565335-235c-4e13-ac96-374143275d10_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d8565335-235c-4e13-ac96-374143275d10" xlink:to="loc_srt_RangeMember_d8565335-235c-4e13-ac96-374143275d10_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_68dd19c8-65ab-46ac-af8d-c6825c45c03f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d8565335-235c-4e13-ac96-374143275d10" xlink:to="loc_srt_RangeMember_68dd19c8-65ab-46ac-af8d-c6825c45c03f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f3ea9d90-01bf-41bd-91c6-c5218434f2ee" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_68dd19c8-65ab-46ac-af8d-c6825c45c03f" xlink:to="loc_srt_MinimumMember_f3ea9d90-01bf-41bd-91c6-c5218434f2ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_678114fc-11ac-411e-bde6-a2e51f723daa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_68dd19c8-65ab-46ac-af8d-c6825c45c03f" xlink:to="loc_srt_MaximumMember_678114fc-11ac-411e-bde6-a2e51f723daa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_241b6e5a-ad0a-476e-ae8d-5cccba265d8d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_d83a1a89-5f21-4ec3-bb69-4577b567aa3e" xlink:to="loc_srt_StatementGeographicalAxis_241b6e5a-ad0a-476e-ae8d-5cccba265d8d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_241b6e5a-ad0a-476e-ae8d-5cccba265d8d_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_241b6e5a-ad0a-476e-ae8d-5cccba265d8d" xlink:to="loc_srt_SegmentGeographicalDomain_241b6e5a-ad0a-476e-ae8d-5cccba265d8d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_763f754b-e34f-4c12-a1d1-630a98069cb5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_241b6e5a-ad0a-476e-ae8d-5cccba265d8d" xlink:to="loc_srt_SegmentGeographicalDomain_763f754b-e34f-4c12-a1d1-630a98069cb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_bbf37e67-62f4-4e18-b13c-5382574f555b" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_763f754b-e34f-4c12-a1d1-630a98069cb5" xlink:to="loc_stpr_CA_bbf37e67-62f4-4e18-b13c-5382574f555b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#LeasesSupplementalBalancesheetDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails" xlink:type="extended" id="i826860119ab64bd688e52377293b2182_LeasesSupplementalBalancesheetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_25ac8547-12f9-4f5f-bf52-348c91839103" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_OperatingLeaseRightOfUseAssetGross_c68837df-d04a-41db-8a7d-4bce00f41257" xlink:href="fldm-20200930.xsd#fldm_OperatingLeaseRightOfUseAssetGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_25ac8547-12f9-4f5f-bf52-348c91839103" xlink:to="loc_fldm_OperatingLeaseRightOfUseAssetGross_c68837df-d04a-41db-8a7d-4bce00f41257" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization_082b9e3d-8811-4107-8c7d-267592021246" xlink:href="fldm-20200930.xsd#fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_25ac8547-12f9-4f5f-bf52-348c91839103" xlink:to="loc_fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization_082b9e3d-8811-4107-8c7d-267592021246" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_ee8a8553-eff4-4a47-84d4-cd4442a198cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_25ac8547-12f9-4f5f-bf52-348c91839103" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_ee8a8553-eff4-4a47-84d4-cd4442a198cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_651d535a-7d32-49c6-b711-f3f8d2b56638" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_25ac8547-12f9-4f5f-bf52-348c91839103" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_651d535a-7d32-49c6-b711-f3f8d2b56638" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9361381a-f9cf-43ea-a3c9-a107ec81ddcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_25ac8547-12f9-4f5f-bf52-348c91839103" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9361381a-f9cf-43ea-a3c9-a107ec81ddcd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_b81ead43-1c88-4fb2-88b0-4aacd93fc7e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_25ac8547-12f9-4f5f-bf52-348c91839103" xlink:to="loc_us-gaap_OperatingLeaseLiability_b81ead43-1c88-4fb2-88b0-4aacd93fc7e1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_43665b66-9f24-4eb3-8c36-b369a88c3b42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_25ac8547-12f9-4f5f-bf52-348c91839103" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_43665b66-9f24-4eb3-8c36-b369a88c3b42" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_c39daa86-0146-402b-b803-5eb864bb3085" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_25ac8547-12f9-4f5f-bf52-348c91839103" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_c39daa86-0146-402b-b803-5eb864bb3085" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_d4136feb-66c4-46ac-a6c0-6b5dadbb9c1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_25ac8547-12f9-4f5f-bf52-348c91839103" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_d4136feb-66c4-46ac-a6c0-6b5dadbb9c1f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bab4ae7b-19b8-480a-b6b7-dac93910b867" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_d4136feb-66c4-46ac-a6c0-6b5dadbb9c1f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bab4ae7b-19b8-480a-b6b7-dac93910b867" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bab4ae7b-19b8-480a-b6b7-dac93910b867_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bab4ae7b-19b8-480a-b6b7-dac93910b867" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bab4ae7b-19b8-480a-b6b7-dac93910b867_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a90ccad6-3488-466a-bb60-87f1a74e1bb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bab4ae7b-19b8-480a-b6b7-dac93910b867" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a90ccad6-3488-466a-bb60-87f1a74e1bb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_dad0a47f-a09d-4fb8-8561-d3a9e71ce6e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a90ccad6-3488-466a-bb60-87f1a74e1bb7" xlink:to="loc_us-gaap_BuildingMember_dad0a47f-a09d-4fb8-8561-d3a9e71ce6e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_417ad508-70a0-41ec-ab5f-127e51f08035" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a90ccad6-3488-466a-bb60-87f1a74e1bb7" xlink:to="loc_us-gaap_EquipmentMember_417ad508-70a0-41ec-ab5f-127e51f08035" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_493be0a1-f26e-473b-a6e9-06de173c2884" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VehiclesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a90ccad6-3488-466a-bb60-87f1a74e1bb7" xlink:to="loc_us-gaap_VehiclesMember_493be0a1-f26e-473b-a6e9-06de173c2884" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/LeasesScheduleofOperatingLeaseCostDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#LeasesScheduleofOperatingLeaseCostDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/LeasesScheduleofOperatingLeaseCostDetails" xlink:type="extended" id="i15c031d3bacd414aad47abd61dbb4e68_LeasesScheduleofOperatingLeaseCostDetails"/>
  <link:roleRef roleURI="http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#LeasesOperatingLeaseMaturityDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails" xlink:type="extended" id="i516263e41aff41dc996e3279d1333c63_LeasesOperatingLeaseMaturityDetails"/>
  <link:roleRef roleURI="http://fluidigm.com/role/FairValueofFinancialInstruments" xlink:type="simple" xlink:href="fldm-20200930.xsd#FairValueofFinancialInstruments"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/FairValueofFinancialInstruments" xlink:type="extended" id="if80f8c99605642c9a237e0bd22886f84_FairValueofFinancialInstruments"/>
  <link:roleRef roleURI="http://fluidigm.com/role/FairValueofFinancialInstrumentsTables" xlink:type="simple" xlink:href="fldm-20200930.xsd#FairValueofFinancialInstrumentsTables"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/FairValueofFinancialInstrumentsTables" xlink:type="extended" id="ia590864829b64cfa9b9c5ed043c867a3_FairValueofFinancialInstrumentsTables"/>
  <link:roleRef roleURI="http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" xlink:type="extended" id="i71b202fd5ab249b893f26b841d3781bb_FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3afbdbd2-c330-4a77-b6e0-645b9d1719b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_4a986aa6-a630-40bc-8ccc-ec3134033636" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3afbdbd2-c330-4a77-b6e0-645b9d1719b9" xlink:to="loc_us-gaap_AssetsAbstract_4a986aa6-a630-40bc-8ccc-ec3134033636" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8609eecf-772d-4bd4-855a-cd3985c332e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_4a986aa6-a630-40bc-8ccc-ec3134033636" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8609eecf-772d-4bd4-855a-cd3985c332e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_9c6f1ac6-b14d-4f1d-866f-e1518533691f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_4a986aa6-a630-40bc-8ccc-ec3134033636" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_9c6f1ac6-b14d-4f1d-866f-e1518533691f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_443e371c-8eb3-4398-a2b3-8eb19cc03088" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_4a986aa6-a630-40bc-8ccc-ec3134033636" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_443e371c-8eb3-4398-a2b3-8eb19cc03088" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_9c3a03cc-65c2-402d-a16c-2f304ae43a58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3afbdbd2-c330-4a77-b6e0-645b9d1719b9" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_9c3a03cc-65c2-402d-a16c-2f304ae43a58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CashCashEquivalentsAndShortTermInvestmentsAmortizedCost_cdbc45ed-ed39-4a36-bf34-611dac36284f" xlink:href="fldm-20200930.xsd#fldm_CashCashEquivalentsAndShortTermInvestmentsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3afbdbd2-c330-4a77-b6e0-645b9d1719b9" xlink:to="loc_fldm_CashCashEquivalentsAndShortTermInvestmentsAmortizedCost_cdbc45ed-ed39-4a36-bf34-611dac36284f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a9f9cbe3-a3db-417a-b6e3-bed5c3c34f0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3afbdbd2-c330-4a77-b6e0-645b9d1719b9" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a9f9cbe3-a3db-417a-b6e3-bed5c3c34f0f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_ae765121-79e6-4bc6-a565-e37a3ed779a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3afbdbd2-c330-4a77-b6e0-645b9d1719b9" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_ae765121-79e6-4bc6-a565-e37a3ed779a7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_550cc4fd-5b4f-45c0-971a-256e7e449454" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3afbdbd2-c330-4a77-b6e0-645b9d1719b9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_550cc4fd-5b4f-45c0-971a-256e7e449454" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_d3ff467c-e982-4293-a270-e4f04b59ef39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3afbdbd2-c330-4a77-b6e0-645b9d1719b9" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_d3ff467c-e982-4293-a270-e4f04b59ef39" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_47c29e3a-b5b8-43fe-a83e-6194c8feac6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3afbdbd2-c330-4a77-b6e0-645b9d1719b9" xlink:to="loc_us-gaap_ShortTermInvestments_47c29e3a-b5b8-43fe-a83e-6194c8feac6a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_01222730-3a41-4f45-8cc2-6d232b5efc59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3afbdbd2-c330-4a77-b6e0-645b9d1719b9" xlink:to="loc_us-gaap_LongTermInvestments_01222730-3a41-4f45-8cc2-6d232b5efc59" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_bb48890d-fcb1-42b1-9f66-01200b59ff2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3afbdbd2-c330-4a77-b6e0-645b9d1719b9" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_bb48890d-fcb1-42b1-9f66-01200b59ff2a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_45dead50-4b9c-4e97-800e-6dc732a9fd94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3afbdbd2-c330-4a77-b6e0-645b9d1719b9" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_45dead50-4b9c-4e97-800e-6dc732a9fd94" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_fbd8c1b5-720c-460e-b903-0551bbd72dce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_45dead50-4b9c-4e97-800e-6dc732a9fd94" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_fbd8c1b5-720c-460e-b903-0551bbd72dce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_fbd8c1b5-720c-460e-b903-0551bbd72dce_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_fbd8c1b5-720c-460e-b903-0551bbd72dce" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_fbd8c1b5-720c-460e-b903-0551bbd72dce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_607c5494-1c04-409a-b11f-792ada94514d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_fbd8c1b5-720c-460e-b903-0551bbd72dce" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_607c5494-1c04-409a-b11f-792ada94514d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_e3fcc70f-439c-4dc7-890e-bf1e6fb743c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_607c5494-1c04-409a-b11f-792ada94514d" xlink:to="loc_us-gaap_CashMember_e3fcc70f-439c-4dc7-890e-bf1e6fb743c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_a193804b-dd98-4072-b2b3-2ca28cb4988c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashMember_e3fcc70f-439c-4dc7-890e-bf1e6fb743c4" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_a193804b-dd98-4072-b2b3-2ca28cb4988c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_RestrictedCashAndCashEquivalentsMember_ac232c6a-e199-49e7-adcd-88a438e3ff3c" xlink:href="fldm-20200930.xsd#fldm_RestrictedCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashMember_e3fcc70f-439c-4dc7-890e-bf1e6fb743c4" xlink:to="loc_fldm_RestrictedCashAndCashEquivalentsMember_ac232c6a-e199-49e7-adcd-88a438e3ff3c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_637a919c-1f2c-4982-9510-02275bbe0e45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_45dead50-4b9c-4e97-800e-6dc732a9fd94" xlink:to="loc_us-gaap_FinancialInstrumentAxis_637a919c-1f2c-4982-9510-02275bbe0e45" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_637a919c-1f2c-4982-9510-02275bbe0e45_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_637a919c-1f2c-4982-9510-02275bbe0e45" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_637a919c-1f2c-4982-9510-02275bbe0e45_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d66a82c4-aae2-4f9c-b9ba-29a7acfc9c8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_637a919c-1f2c-4982-9510-02275bbe0e45" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d66a82c4-aae2-4f9c-b9ba-29a7acfc9c8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_f6b32bdd-309e-477e-973e-7e124b8b51f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d66a82c4-aae2-4f9c-b9ba-29a7acfc9c8d" xlink:to="loc_us-gaap_MoneyMarketFundsMember_f6b32bdd-309e-477e-973e-7e124b8b51f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_6a0186ac-52e7-41fb-93fb-165bbe66132a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d66a82c4-aae2-4f9c-b9ba-29a7acfc9c8d" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_6a0186ac-52e7-41fb-93fb-165bbe66132a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d9c0a69b-c05f-4996-9841-5715043c9f45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_45dead50-4b9c-4e97-800e-6dc732a9fd94" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d9c0a69b-c05f-4996-9841-5715043c9f45" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d9c0a69b-c05f-4996-9841-5715043c9f45_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d9c0a69b-c05f-4996-9841-5715043c9f45" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d9c0a69b-c05f-4996-9841-5715043c9f45_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1652a8eb-587e-4ce4-8abf-06a4fbd0f14c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d9c0a69b-c05f-4996-9841-5715043c9f45" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1652a8eb-587e-4ce4-8abf-06a4fbd0f14c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_c22e11bb-dfe2-4d70-ab61-29c739e915cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1652a8eb-587e-4ce4-8abf-06a4fbd0f14c" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_c22e11bb-dfe2-4d70-ab61-29c739e915cd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#FairValueofFinancialInstrumentsScheduleofDebtDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails" xlink:type="extended" id="i9995efa4a8fd434996fcc433a57dd126_FairValueofFinancialInstrumentsScheduleofDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5e5cfa4d-69bb-421d-950f-143f9cf062db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_4b0a6fcb-fe85-40b2-a14e-9061cde9b1cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5e5cfa4d-69bb-421d-950f-143f9cf062db" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_4b0a6fcb-fe85-40b2-a14e-9061cde9b1cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_db663ef4-9466-4872-a061-55fc5786266b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5e5cfa4d-69bb-421d-950f-143f9cf062db" xlink:to="loc_us-gaap_DebtInstrumentFairValue_db663ef4-9466-4872-a061-55fc5786266b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_fd87dd11-9896-4acd-8502-04fa70ab96fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5e5cfa4d-69bb-421d-950f-143f9cf062db" xlink:to="loc_us-gaap_DebtInstrumentTable_fd87dd11-9896-4acd-8502-04fa70ab96fe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6478cd17-1cd7-4d91-840d-a03afa0f4821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_fd87dd11-9896-4acd-8502-04fa70ab96fe" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6478cd17-1cd7-4d91-840d-a03afa0f4821" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6478cd17-1cd7-4d91-840d-a03afa0f4821_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6478cd17-1cd7-4d91-840d-a03afa0f4821" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6478cd17-1cd7-4d91-840d-a03afa0f4821_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_acf70ba3-fc8a-49c4-8cf7-90ce54a7d0fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6478cd17-1cd7-4d91-840d-a03afa0f4821" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_acf70ba3-fc8a-49c4-8cf7-90ce54a7d0fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_702bbe99-6ad7-4243-9fbb-0e7151b19a51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_acf70ba3-fc8a-49c4-8cf7-90ce54a7d0fc" xlink:to="loc_us-gaap_ConvertibleDebtMember_702bbe99-6ad7-4243-9fbb-0e7151b19a51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6fa308eb-5fc9-4dfe-95c4-bd4edcfabeb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_fd87dd11-9896-4acd-8502-04fa70ab96fe" xlink:to="loc_us-gaap_DebtInstrumentAxis_6fa308eb-5fc9-4dfe-95c4-bd4edcfabeb8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6fa308eb-5fc9-4dfe-95c4-bd4edcfabeb8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_6fa308eb-5fc9-4dfe-95c4-bd4edcfabeb8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6fa308eb-5fc9-4dfe-95c4-bd4edcfabeb8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0556671e-baa1-47a0-8eff-8f9b18f35281" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_6fa308eb-5fc9-4dfe-95c4-bd4edcfabeb8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0556671e-baa1-47a0-8eff-8f9b18f35281" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeniorConvertibleNotesdue2034Member_8e370da4-dd27-47d5-9bdf-d0a67c897cc1" xlink:href="fldm-20200930.xsd#fldm_SeniorConvertibleNotesdue2034Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0556671e-baa1-47a0-8eff-8f9b18f35281" xlink:to="loc_fldm_SeniorConvertibleNotesdue2034Member_8e370da4-dd27-47d5-9bdf-d0a67c897cc1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeniorConvertibleNotesDue2024Member_146fbaf5-9e26-4097-a4bc-3f50659b796e" xlink:href="fldm-20200930.xsd#fldm_SeniorConvertibleNotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0556671e-baa1-47a0-8eff-8f9b18f35281" xlink:to="loc_fldm_SeniorConvertibleNotesDue2024Member_146fbaf5-9e26-4097-a4bc-3f50659b796e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_adb24f1d-c779-4204-b65e-135b102b7dd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_fd87dd11-9896-4acd-8502-04fa70ab96fe" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_adb24f1d-c779-4204-b65e-135b102b7dd0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_adb24f1d-c779-4204-b65e-135b102b7dd0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_adb24f1d-c779-4204-b65e-135b102b7dd0" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_adb24f1d-c779-4204-b65e-135b102b7dd0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6697daca-ffbe-4ae5-9c53-d5e3e7ebd36d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_adb24f1d-c779-4204-b65e-135b102b7dd0" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6697daca-ffbe-4ae5-9c53-d5e3e7ebd36d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_257a74df-4155-40ec-bad1-bb01a5cc5055" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6697daca-ffbe-4ae5-9c53-d5e3e7ebd36d" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_257a74df-4155-40ec-bad1-bb01a5cc5055" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_e81cceac-e0ad-4841-96ef-34aa9b406c7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6697daca-ffbe-4ae5-9c53-d5e3e7ebd36d" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_e81cceac-e0ad-4841-96ef-34aa9b406c7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_e7b00dcc-9065-4a14-bf7e-f4b0c5abd2d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6697daca-ffbe-4ae5-9c53-d5e3e7ebd36d" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_e7b00dcc-9065-4a14-bf7e-f4b0c5abd2d3" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="fldm-20200930.xsd#ShareholdersEquity"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/ShareholdersEquity" xlink:type="extended" id="i0503865352c2427f8c3821f20a83a19d_ShareholdersEquity"/>
  <link:roleRef roleURI="http://fluidigm.com/role/ShareholdersEquityTables" xlink:type="simple" xlink:href="fldm-20200930.xsd#ShareholdersEquityTables"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/ShareholdersEquityTables" xlink:type="extended" id="i574fa09a84114f2086d9d7458ba39675_ShareholdersEquityTables"/>
  <link:roleRef roleURI="http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#ShareholdersEquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" xlink:type="extended" id="i1a7cb4779dee4c35a52964a2eb3eda81_ShareholdersEquityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareholdersEquityLineItems_9b45b297-a0fd-4679-a286-c2d0eb40abe0" xlink:href="fldm-20200930.xsd#fldm_ShareholdersEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SaleOfStockConsiderationReceivableOnTransaction_1665c6a8-124a-42a6-b7d4-1e86280c64b7" xlink:href="fldm-20200930.xsd#fldm_SaleOfStockConsiderationReceivableOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fldm_ShareholdersEquityLineItems_9b45b297-a0fd-4679-a286-c2d0eb40abe0" xlink:to="loc_fldm_SaleOfStockConsiderationReceivableOnTransaction_1665c6a8-124a-42a6-b7d4-1e86280c64b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_d7f841f0-dcf7-4a38-90b2-b591d0ca1001" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fldm_ShareholdersEquityLineItems_9b45b297-a0fd-4679-a286-c2d0eb40abe0" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_d7f841f0-dcf7-4a38-90b2-b591d0ca1001" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ProceedsFromIssuanceOfCommonStockIncludingRelatedExpenses_7e5ab342-25be-41ee-9794-cecbb3037797" xlink:href="fldm-20200930.xsd#fldm_ProceedsFromIssuanceOfCommonStockIncludingRelatedExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fldm_ShareholdersEquityLineItems_9b45b297-a0fd-4679-a286-c2d0eb40abe0" xlink:to="loc_fldm_ProceedsFromIssuanceOfCommonStockIncludingRelatedExpenses_7e5ab342-25be-41ee-9794-cecbb3037797" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_49266e8d-7ed3-4e09-96df-d71b10829aa4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fldm_ShareholdersEquityLineItems_9b45b297-a0fd-4679-a286-c2d0eb40abe0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_49266e8d-7ed3-4e09-96df-d71b10829aa4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesCommissionsAndFees_58664116-d06b-44b9-9031-f62a6f711030" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesCommissionsAndFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fldm_ShareholdersEquityLineItems_9b45b297-a0fd-4679-a286-c2d0eb40abe0" xlink:to="loc_us-gaap_SalesCommissionsAndFees_58664116-d06b-44b9-9031-f62a6f711030" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_85dd399e-5328-47f5-a004-fd57114ca4cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fldm_ShareholdersEquityLineItems_9b45b297-a0fd-4679-a286-c2d0eb40abe0" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_85dd399e-5328-47f5-a004-fd57114ca4cd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_b2a5aaa5-062a-43f1-8381-e19dbac22cce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fldm_ShareholdersEquityLineItems_9b45b297-a0fd-4679-a286-c2d0eb40abe0" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_b2a5aaa5-062a-43f1-8381-e19dbac22cce" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_10933f3e-fe05-4945-8d54-ef8cd91539e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fldm_ShareholdersEquityLineItems_9b45b297-a0fd-4679-a286-c2d0eb40abe0" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_10933f3e-fe05-4945-8d54-ef8cd91539e7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_0e4ddef0-9d2f-49c5-a32e-e4c5f14f05b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fldm_ShareholdersEquityLineItems_9b45b297-a0fd-4679-a286-c2d0eb40abe0" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_0e4ddef0-9d2f-49c5-a32e-e4c5f14f05b5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e69f829c-ba0c-4035-9a4a-2774d8373315" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fldm_ShareholdersEquityLineItems_9b45b297-a0fd-4679-a286-c2d0eb40abe0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e69f829c-ba0c-4035-9a4a-2774d8373315" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareholdersEquityTable_09663f8e-a0ee-484d-8320-4f678c0e2720" xlink:href="fldm-20200930.xsd#fldm_ShareholdersEquityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_fldm_ShareholdersEquityLineItems_9b45b297-a0fd-4679-a286-c2d0eb40abe0" xlink:to="loc_fldm_ShareholdersEquityTable_09663f8e-a0ee-484d-8320-4f678c0e2720" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_33f6f789-64b7-4376-ab17-006d1cfde572" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_fldm_ShareholdersEquityTable_09663f8e-a0ee-484d-8320-4f678c0e2720" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_33f6f789-64b7-4376-ab17-006d1cfde572" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_33f6f789-64b7-4376-ab17-006d1cfde572_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_33f6f789-64b7-4376-ab17-006d1cfde572" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_33f6f789-64b7-4376-ab17-006d1cfde572_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69461013-9ad3-4d9d-9e94-ed11f0a8ea43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_33f6f789-64b7-4376-ab17-006d1cfde572" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69461013-9ad3-4d9d-9e94-ed11f0a8ea43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_InstruNorASMember_99c48d57-bebe-42f2-bcc9-10bcd01bc47a" xlink:href="fldm-20200930.xsd#fldm_InstruNorASMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69461013-9ad3-4d9d-9e94-ed11f0a8ea43" xlink:to="loc_fldm_InstruNorASMember_99c48d57-bebe-42f2-bcc9-10bcd01bc47a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_cd8028f9-95cd-4c55-ba75-f71cb56fb9c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_fldm_ShareholdersEquityTable_09663f8e-a0ee-484d-8320-4f678c0e2720" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_cd8028f9-95cd-4c55-ba75-f71cb56fb9c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_cd8028f9-95cd-4c55-ba75-f71cb56fb9c9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cd8028f9-95cd-4c55-ba75-f71cb56fb9c9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_cd8028f9-95cd-4c55-ba75-f71cb56fb9c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4b0f8fe8-2bb6-4b59-af4a-eac188f8f23f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cd8028f9-95cd-4c55-ba75-f71cb56fb9c9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4b0f8fe8-2bb6-4b59-af4a-eac188f8f23f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_845b33b5-4e86-4fdc-b496-c4412919d1dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4b0f8fe8-2bb6-4b59-af4a-eac188f8f23f" xlink:to="loc_us-gaap_ConvertibleDebtMember_845b33b5-4e86-4fdc-b496-c4412919d1dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b7d0845e-1354-4358-bc5f-cec23ef031fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_fldm_ShareholdersEquityTable_09663f8e-a0ee-484d-8320-4f678c0e2720" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b7d0845e-1354-4358-bc5f-cec23ef031fc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b7d0845e-1354-4358-bc5f-cec23ef031fc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b7d0845e-1354-4358-bc5f-cec23ef031fc" xlink:to="loc_us-gaap_EquityComponentDomain_b7d0845e-1354-4358-bc5f-cec23ef031fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0483b61b-31fa-4be8-a8a8-1c1eedc4a0b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b7d0845e-1354-4358-bc5f-cec23ef031fc" xlink:to="loc_us-gaap_EquityComponentDomain_0483b61b-31fa-4be8-a8a8-1c1eedc4a0b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_84e1c67f-3806-4baa-ae79-4c78590fa9e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0483b61b-31fa-4be8-a8a8-1c1eedc4a0b3" xlink:to="loc_us-gaap_CommonStockMember_84e1c67f-3806-4baa-ae79-4c78590fa9e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_efd6c4ff-8dce-4080-a216-688f8836e772" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_fldm_ShareholdersEquityTable_09663f8e-a0ee-484d-8320-4f678c0e2720" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_efd6c4ff-8dce-4080-a216-688f8836e772" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_efd6c4ff-8dce-4080-a216-688f8836e772_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_efd6c4ff-8dce-4080-a216-688f8836e772" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_efd6c4ff-8dce-4080-a216-688f8836e772_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e2ce6c88-30a9-4ccf-94fe-5c5906f071e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_efd6c4ff-8dce-4080-a216-688f8836e772" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e2ce6c88-30a9-4ccf-94fe-5c5906f071e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndTwentyAtTheMarketEquityOfferingProgramMember_c9e00510-44d9-4135-9949-c42c4c204bc5" xlink:href="fldm-20200930.xsd#fldm_TwoThousandAndTwentyAtTheMarketEquityOfferingProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e2ce6c88-30a9-4ccf-94fe-5c5906f071e8" xlink:to="loc_fldm_TwoThousandAndTwentyAtTheMarketEquityOfferingProgramMember_c9e00510-44d9-4135-9949-c42c4c204bc5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#ShareholdersEquityScheduleofStockOptionsDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails" xlink:type="extended" id="i59405f113b764e2fb9e15b394430ea89_ShareholdersEquityScheduleofStockOptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_97428064-852a-4a7e-8cca-b9c68ef9538f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_528ecb71-3d26-4b58-b0c6-d561d32a658c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_97428064-852a-4a7e-8cca-b9c68ef9538f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_528ecb71-3d26-4b58-b0c6-d561d32a658c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_1203f0ad-ee85-4c4a-9d5e-775c713e4d9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_97428064-852a-4a7e-8cca-b9c68ef9538f" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_1203f0ad-ee85-4c4a-9d5e-775c713e4d9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_e8f99049-64b0-4e3b-a59e-6e362700f44a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_97428064-852a-4a7e-8cca-b9c68ef9538f" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_e8f99049-64b0-4e3b-a59e-6e362700f44a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_589ad24f-dac3-4bac-bb75-a84bb4d96c98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_e8f99049-64b0-4e3b-a59e-6e362700f44a" xlink:to="loc_us-gaap_AwardTypeAxis_589ad24f-dac3-4bac-bb75-a84bb4d96c98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_589ad24f-dac3-4bac-bb75-a84bb4d96c98_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_589ad24f-dac3-4bac-bb75-a84bb4d96c98" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_589ad24f-dac3-4bac-bb75-a84bb4d96c98_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_37888b70-093a-4277-a74b-56d87ad99487" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_589ad24f-dac3-4bac-bb75-a84bb4d96c98" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_37888b70-093a-4277-a74b-56d87ad99487" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a1bc7229-c1b0-4a44-b3d6-4c15ec522479" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_37888b70-093a-4277-a74b-56d87ad99487" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a1bc7229-c1b0-4a44-b3d6-4c15ec522479" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_RestrictedStockAndPerformanceShareUnitsMember_c697de4d-7e1d-4545-a2fc-86417d2e8208" xlink:href="fldm-20200930.xsd#fldm_RestrictedStockAndPerformanceShareUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_37888b70-093a-4277-a74b-56d87ad99487" xlink:to="loc_fldm_RestrictedStockAndPerformanceShareUnitsMember_c697de4d-7e1d-4545-a2fc-86417d2e8208" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_ed1f7718-c6e7-41d4-8809-1945540abefc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_e8f99049-64b0-4e3b-a59e-6e362700f44a" xlink:to="loc_us-gaap_PlanNameAxis_ed1f7718-c6e7-41d4-8809-1945540abefc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_ed1f7718-c6e7-41d4-8809-1945540abefc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_ed1f7718-c6e7-41d4-8809-1945540abefc" xlink:to="loc_us-gaap_PlanNameDomain_ed1f7718-c6e7-41d4-8809-1945540abefc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_f49e7c41-50cd-4a0a-9758-4b718bd1434e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_ed1f7718-c6e7-41d4-8809-1945540abefc" xlink:to="loc_us-gaap_PlanNameDomain_f49e7c41-50cd-4a0a-9758-4b718bd1434e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndNineEquityIncentivePlanMember_7669c4c1-29f5-48e7-bed8-0aa0ad3d1f4f" xlink:href="fldm-20200930.xsd#fldm_TwoThousandAndNineEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_f49e7c41-50cd-4a0a-9758-4b718bd1434e" xlink:to="loc_fldm_TwoThousandAndNineEquityIncentivePlanMember_7669c4c1-29f5-48e7-bed8-0aa0ad3d1f4f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndElevenEquityIncentivePlanMember_3cb35240-bb4b-470f-b71b-0151da093a95" xlink:href="fldm-20200930.xsd#fldm_TwoThousandAndElevenEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_f49e7c41-50cd-4a0a-9758-4b718bd1434e" xlink:to="loc_fldm_TwoThousandAndElevenEquityIncentivePlanMember_3cb35240-bb4b-470f-b71b-0151da093a95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndTenEquityIncentivePlanMember_f495788d-2aeb-4bb2-b516-1f4fcbf921a1" xlink:href="fldm-20200930.xsd#fldm_TwoThousandAndTenEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_f49e7c41-50cd-4a0a-9758-4b718bd1434e" xlink:to="loc_fldm_TwoThousandAndTenEquityIncentivePlanMember_f495788d-2aeb-4bb2-b516-1f4fcbf921a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndSeventeenInducementAwardPlanMember_1d7d7b70-170b-44d9-b00e-6dee9e43fbeb" xlink:href="fldm-20200930.xsd#fldm_TwoThousandAndSeventeenInducementAwardPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_f49e7c41-50cd-4a0a-9758-4b718bd1434e" xlink:to="loc_fldm_TwoThousandAndSeventeenInducementAwardPlanMember_1d7d7b70-170b-44d9-b00e-6dee9e43fbeb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember_7fa70389-2ac9-4f23-a9fb-13eeddaad6b8" xlink:href="fldm-20200930.xsd#fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_f49e7c41-50cd-4a0a-9758-4b718bd1434e" xlink:to="loc_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember_7fa70389-2ac9-4f23-a9fb-13eeddaad6b8" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/StockBasedPlans" xlink:type="simple" xlink:href="fldm-20200930.xsd#StockBasedPlans"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/StockBasedPlans" xlink:type="extended" id="i4e0f49aa6340421cb23f3c5caf20acc5_StockBasedPlans"/>
  <link:roleRef roleURI="http://fluidigm.com/role/StockBasedPlansTables" xlink:type="simple" xlink:href="fldm-20200930.xsd#StockBasedPlansTables"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/StockBasedPlansTables" xlink:type="extended" id="i6e1c1794fbb64180bfd603bbfaecbae2_StockBasedPlansTables"/>
  <link:roleRef roleURI="http://fluidigm.com/role/StockBasedPlansNarrativeDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#StockBasedPlansNarrativeDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/StockBasedPlansNarrativeDetails" xlink:type="extended" id="iefe3ca2dc7284615b5457a5df955aaa1_StockBasedPlansNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_5af0422c-2dae-4381-937a-fde17e83a9cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_5af0422c-2dae-4381-937a-fde17e83a9cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_PortionOfStockOptionsVestOnFirstAnniversary_732987ac-e3dd-4ed7-84a6-4cd769715c35" xlink:href="fldm-20200930.xsd#fldm_PortionOfStockOptionsVestOnFirstAnniversary"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_fldm_PortionOfStockOptionsVestOnFirstAnniversary_732987ac-e3dd-4ed7-84a6-4cd769715c35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_a843f383-b26f-4152-97fb-61ff60673cca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_a843f383-b26f-4152-97fb-61ff60673cca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_7df333c9-7e47-4dce-a9e3-a2f53a25ae62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_7df333c9-7e47-4dce-a9e3-a2f53a25ae62" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_7576429b-eee3-482b-8249-a0845ab3a54f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_7576429b-eee3-482b-8249-a0845ab3a54f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue_87fb70d4-70a8-4a94-8d6f-a6dc8319ee54" xlink:href="fldm-20200930.xsd#fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue_87fb70d4-70a8-4a94-8d6f-a6dc8319ee54" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SharebasedCompensationArrangementbySharebasedPaymentAwardVestingRestrictionsOwnershipPercentageofVotingStock_69ef41d9-8649-480f-ba82-cb191927c971" xlink:href="fldm-20200930.xsd#fldm_SharebasedCompensationArrangementbySharebasedPaymentAwardVestingRestrictionsOwnershipPercentageofVotingStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_fldm_SharebasedCompensationArrangementbySharebasedPaymentAwardVestingRestrictionsOwnershipPercentageofVotingStock_69ef41d9-8649-480f-ba82-cb191927c971" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement_e15353bf-7ce0-4bb7-8b56-25056c191e1d" xlink:href="fldm-20200930.xsd#fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement_e15353bf-7ce0-4bb7-8b56-25056c191e1d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_d522c57c-54a5-4fad-b74e-dc95d9adeff5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_d522c57c-54a5-4fad-b74e-dc95d9adeff5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_81f05e15-9d25-4568-a89d-4d5ae222fb44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_81f05e15-9d25-4568-a89d-4d5ae222fb44" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest_14d20b04-d7fb-4034-84e8-bb1b2ef12277" xlink:href="fldm-20200930.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest_14d20b04-d7fb-4034-84e8-bb1b2ef12277" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_EmployeeStockPurchasePlanOfferingPeriod_8069a4f8-57cd-407f-b9fa-8b2e6e52e040" xlink:href="fldm-20200930.xsd#fldm_EmployeeStockPurchasePlanOfferingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_fldm_EmployeeStockPurchasePlanOfferingPeriod_8069a4f8-57cd-407f-b9fa-8b2e6e52e040" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_16b99434-5669-4f1f-93d5-2bfa4b39fc72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_16b99434-5669-4f1f-93d5-2bfa4b39fc72" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_69c23a88-c9b3-4fa1-a379-a3cd3b05e27e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_69c23a88-c9b3-4fa1-a379-a3cd3b05e27e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_EmployeeStockPurchasePlanNumberOfSixMonthOfferingPeriods_3fcf84a6-aa30-4539-a7dd-cdb18387a8d1" xlink:href="fldm-20200930.xsd#fldm_EmployeeStockPurchasePlanNumberOfSixMonthOfferingPeriods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_fldm_EmployeeStockPurchasePlanNumberOfSixMonthOfferingPeriods_3fcf84a6-aa30-4539-a7dd-cdb18387a8d1" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount_f73a1a2d-063d-4dd3-b6e1-0c6a4131a94d" xlink:href="fldm-20200930.xsd#fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount_f73a1a2d-063d-4dd3-b6e1-0c6a4131a94d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_561abd9d-11f4-4f4f-985d-c378f9a74474" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_561abd9d-11f4-4f4f-985d-c378f9a74474" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_daebe773-eec4-4196-8942-041486135f90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_daebe773-eec4-4196-8942-041486135f90" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9dfc30da-66f7-44f0-a5f2-322ce8c54ee3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9dfc30da-66f7-44f0-a5f2-322ce8c54ee3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c8ccbc34-c1a8-46df-8263-1cc7587f4db1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9dfc30da-66f7-44f0-a5f2-322ce8c54ee3" xlink:to="loc_us-gaap_AwardTypeAxis_c8ccbc34-c1a8-46df-8263-1cc7587f4db1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c8ccbc34-c1a8-46df-8263-1cc7587f4db1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_c8ccbc34-c1a8-46df-8263-1cc7587f4db1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c8ccbc34-c1a8-46df-8263-1cc7587f4db1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ddf5accb-bdb5-4ed9-a5bc-08bb02f10f41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_c8ccbc34-c1a8-46df-8263-1cc7587f4db1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ddf5accb-bdb5-4ed9-a5bc-08bb02f10f41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_17311837-46df-4e40-b3ac-34c91f58e10a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ddf5accb-bdb5-4ed9-a5bc-08bb02f10f41" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_17311837-46df-4e40-b3ac-34c91f58e10a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_6d5e7cdd-3344-438a-a90f-7d26fc73e6f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ddf5accb-bdb5-4ed9-a5bc-08bb02f10f41" xlink:to="loc_us-gaap_StockCompensationPlanMember_6d5e7cdd-3344-438a-a90f-7d26fc73e6f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_AwardsHeldByOwnersOfMoreThan10OfCommonStockMember_482a7cd4-e596-467e-bee3-aa84eb0a6110" xlink:href="fldm-20200930.xsd#fldm_AwardsHeldByOwnersOfMoreThan10OfCommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ddf5accb-bdb5-4ed9-a5bc-08bb02f10f41" xlink:to="loc_fldm_AwardsHeldByOwnersOfMoreThan10OfCommonStockMember_482a7cd4-e596-467e-bee3-aa84eb0a6110" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_c7b5ac49-c612-43ea-a0c5-4b2e67388c83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ddf5accb-bdb5-4ed9-a5bc-08bb02f10f41" xlink:to="loc_us-gaap_PerformanceSharesMember_c7b5ac49-c612-43ea-a0c5-4b2e67388c83" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_fb47cb10-e62a-442b-b57c-de8b6839aa07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ddf5accb-bdb5-4ed9-a5bc-08bb02f10f41" xlink:to="loc_us-gaap_EmployeeStockMember_fb47cb10-e62a-442b-b57c-de8b6839aa07" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_62e89570-682c-49d6-b49e-602bdca32594" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9dfc30da-66f7-44f0-a5f2-322ce8c54ee3" xlink:to="loc_us-gaap_VestingAxis_62e89570-682c-49d6-b49e-602bdca32594" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_62e89570-682c-49d6-b49e-602bdca32594_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_62e89570-682c-49d6-b49e-602bdca32594" xlink:to="loc_us-gaap_VestingDomain_62e89570-682c-49d6-b49e-602bdca32594_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_0473f710-fdec-4983-856c-ee994f646f81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_62e89570-682c-49d6-b49e-602bdca32594" xlink:to="loc_us-gaap_VestingDomain_0473f710-fdec-4983-856c-ee994f646f81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_71a322f4-77f5-45b8-894f-250a24b1f611" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_0473f710-fdec-4983-856c-ee994f646f81" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_71a322f4-77f5-45b8-894f-250a24b1f611" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_aa6921c8-e3e8-4617-a4bf-44a2dcb514fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_0473f710-fdec-4983-856c-ee994f646f81" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_aa6921c8-e3e8-4617-a4bf-44a2dcb514fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_24b1056b-16ff-4045-bd7d-0a51e5cf809a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9dfc30da-66f7-44f0-a5f2-322ce8c54ee3" xlink:to="loc_us-gaap_PlanNameAxis_24b1056b-16ff-4045-bd7d-0a51e5cf809a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_24b1056b-16ff-4045-bd7d-0a51e5cf809a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_24b1056b-16ff-4045-bd7d-0a51e5cf809a" xlink:to="loc_us-gaap_PlanNameDomain_24b1056b-16ff-4045-bd7d-0a51e5cf809a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_9a1b42a2-7619-48cd-9e1c-0d4be4a3f4b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_24b1056b-16ff-4045-bd7d-0a51e5cf809a" xlink:to="loc_us-gaap_PlanNameDomain_9a1b42a2-7619-48cd-9e1c-0d4be4a3f4b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_EquityIncentivePlanTwentyElevenMember_4c9886b1-d558-4cc3-aef9-5e11bb1bd0ef" xlink:href="fldm-20200930.xsd#fldm_EquityIncentivePlanTwentyElevenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_9a1b42a2-7619-48cd-9e1c-0d4be4a3f4b2" xlink:to="loc_fldm_EquityIncentivePlanTwentyElevenMember_4c9886b1-d558-4cc3-aef9-5e11bb1bd0ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_A2017InducementAwardPlanMember_099331a6-765f-4155-a98b-e3abd0ccb602" xlink:href="fldm-20200930.xsd#fldm_A2017InducementAwardPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_9a1b42a2-7619-48cd-9e1c-0d4be4a3f4b2" xlink:to="loc_fldm_A2017InducementAwardPlanMember_099331a6-765f-4155-a98b-e3abd0ccb602" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_EquityIncentivePlanMember_9fc83682-968b-418e-b7eb-4f3d9de34c4e" xlink:href="fldm-20200930.xsd#fldm_EquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_9a1b42a2-7619-48cd-9e1c-0d4be4a3f4b2" xlink:to="loc_fldm_EquityIncentivePlanMember_9fc83682-968b-418e-b7eb-4f3d9de34c4e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember_2cb203d7-5f1c-4faa-835f-c322594032fb" xlink:href="fldm-20200930.xsd#fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_9a1b42a2-7619-48cd-9e1c-0d4be4a3f4b2" xlink:to="loc_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember_2cb203d7-5f1c-4faa-835f-c322594032fb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9121fd25-521b-4e1c-a92b-df1530551ff6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9dfc30da-66f7-44f0-a5f2-322ce8c54ee3" xlink:to="loc_srt_RangeAxis_9121fd25-521b-4e1c-a92b-df1530551ff6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9121fd25-521b-4e1c-a92b-df1530551ff6_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_9121fd25-521b-4e1c-a92b-df1530551ff6" xlink:to="loc_srt_RangeMember_9121fd25-521b-4e1c-a92b-df1530551ff6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_38c7dede-9f16-474e-b80d-1f945296ba43" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_9121fd25-521b-4e1c-a92b-df1530551ff6" xlink:to="loc_srt_RangeMember_38c7dede-9f16-474e-b80d-1f945296ba43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_aed0047f-1288-43b7-a1ee-c02197d457aa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_38c7dede-9f16-474e-b80d-1f945296ba43" xlink:to="loc_srt_MinimumMember_aed0047f-1288-43b7-a1ee-c02197d457aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_66d3f233-c7af-4da5-adbf-3ef2807e3177" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_38c7dede-9f16-474e-b80d-1f945296ba43" xlink:to="loc_srt_MaximumMember_66d3f233-c7af-4da5-adbf-3ef2807e3177" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#StockBasedPlansRestrictedandPerformanceStockUnitsDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails" xlink:type="extended" id="i9e401139bcaa42af8a5fb527cd510d33_StockBasedPlansRestrictedandPerformanceStockUnitsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_71c8d4f4-b6a3-42cb-aeb0-e43b937ba83f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9f716577-daa4-4748-b23c-a9c4eb15e564" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_71c8d4f4-b6a3-42cb-aeb0-e43b937ba83f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9f716577-daa4-4748-b23c-a9c4eb15e564" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2eb35812-c804-494f-a9b3-5fbd03ec19cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9f716577-daa4-4748-b23c-a9c4eb15e564" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2eb35812-c804-494f-a9b3-5fbd03ec19cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1f7a2677-43d3-4839-bb40-cb9a5788739c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9f716577-daa4-4748-b23c-a9c4eb15e564" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1f7a2677-43d3-4839-bb40-cb9a5788739c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_fa1c046d-b312-4aa4-b2e3-17f3ab74d61b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9f716577-daa4-4748-b23c-a9c4eb15e564" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_fa1c046d-b312-4aa4-b2e3-17f3ab74d61b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_4d6e4388-4b27-4dfb-9439-578e91a1b21e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9f716577-daa4-4748-b23c-a9c4eb15e564" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_4d6e4388-4b27-4dfb-9439-578e91a1b21e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c77f9fd2-ab9c-4807-9b76-c41ee9733712" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_b40b02f5-40d2-45f6-afe9-864ec97f41b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_71c8d4f4-b6a3-42cb-aeb0-e43b937ba83f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_b40b02f5-40d2-45f6-afe9-864ec97f41b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1d826a94-6bfc-4cdd-9961-f9990395eff3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_b40b02f5-40d2-45f6-afe9-864ec97f41b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1d826a94-6bfc-4cdd-9961-f9990395eff3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_73b7875e-606c-477f-a8de-74eac3f647b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_b40b02f5-40d2-45f6-afe9-864ec97f41b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_73b7875e-606c-477f-a8de-74eac3f647b5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_7f7e5cf5-9cb0-41f9-aa47-f6a44aeba4b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_b40b02f5-40d2-45f6-afe9-864ec97f41b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_7f7e5cf5-9cb0-41f9-aa47-f6a44aeba4b0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_e9db56af-260a-46df-ae08-a15d3fd39e10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_b40b02f5-40d2-45f6-afe9-864ec97f41b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_e9db56af-260a-46df-ae08-a15d3fd39e10" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b78d0057-26ca-4fc0-a65b-a79a21b066d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd67c52d-08e9-48f2-a4e5-31d99af83eff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_71c8d4f4-b6a3-42cb-aeb0-e43b937ba83f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd67c52d-08e9-48f2-a4e5-31d99af83eff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_84144932-a2de-4f61-a626-0ccea721b275" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd67c52d-08e9-48f2-a4e5-31d99af83eff" xlink:to="loc_srt_TitleOfIndividualAxis_84144932-a2de-4f61-a626-0ccea721b275" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_84144932-a2de-4f61-a626-0ccea721b275_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_84144932-a2de-4f61-a626-0ccea721b275" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_84144932-a2de-4f61-a626-0ccea721b275_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_320695fa-9c65-4c43-b208-edfdc88f6958" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_84144932-a2de-4f61-a626-0ccea721b275" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_320695fa-9c65-4c43-b208-edfdc88f6958" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CertainEmployeeMember_4b298e00-ef0d-464d-b969-46280c6e14d5" xlink:href="fldm-20200930.xsd#fldm_CertainEmployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_320695fa-9c65-4c43-b208-edfdc88f6958" xlink:to="loc_fldm_CertainEmployeeMember_4b298e00-ef0d-464d-b969-46280c6e14d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b9fd91c0-be18-4a34-bc10-c45931bc6773" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd67c52d-08e9-48f2-a4e5-31d99af83eff" xlink:to="loc_us-gaap_AwardTypeAxis_b9fd91c0-be18-4a34-bc10-c45931bc6773" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b9fd91c0-be18-4a34-bc10-c45931bc6773_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_b9fd91c0-be18-4a34-bc10-c45931bc6773" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b9fd91c0-be18-4a34-bc10-c45931bc6773_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e73fc26f-1283-482d-92d7-f3ee2ce7e6bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_b9fd91c0-be18-4a34-bc10-c45931bc6773" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e73fc26f-1283-482d-92d7-f3ee2ce7e6bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_b9d3bd19-1a73-4f2a-ab6a-c4400dba7ef7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e73fc26f-1283-482d-92d7-f3ee2ce7e6bc" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_b9d3bd19-1a73-4f2a-ab6a-c4400dba7ef7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_7242fb8a-74c1-4682-afaf-d5c1974d6545" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e73fc26f-1283-482d-92d7-f3ee2ce7e6bc" xlink:to="loc_us-gaap_PerformanceSharesMember_7242fb8a-74c1-4682-afaf-d5c1974d6545" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#StockBasedPlansStockOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" xlink:type="extended" id="ifd0a800d0ea9432081736bf958b1dba7_StockBasedPlansStockOptionActivityDetails"/>
  <link:roleRef roleURI="http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#StockBasedPlansStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails" xlink:type="extended" id="i109bd1916b35423c8fcdcc556145f517_StockBasedPlansStockBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c89f414f-532b-4d6a-8aa1-283bddf49e01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_602a4706-b84f-4505-b83f-a8842e6c447e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c89f414f-532b-4d6a-8aa1-283bddf49e01" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_602a4706-b84f-4505-b83f-a8842e6c447e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cc092664-41df-4cd9-a9bb-efef3dec4847" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c89f414f-532b-4d6a-8aa1-283bddf49e01" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cc092664-41df-4cd9-a9bb-efef3dec4847" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_2d5798cd-759b-4b5c-ab51-f4ae1d334457" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cc092664-41df-4cd9-a9bb-efef3dec4847" xlink:to="loc_us-gaap_PlanNameAxis_2d5798cd-759b-4b5c-ab51-f4ae1d334457" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_2d5798cd-759b-4b5c-ab51-f4ae1d334457_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_2d5798cd-759b-4b5c-ab51-f4ae1d334457" xlink:to="loc_us-gaap_PlanNameDomain_2d5798cd-759b-4b5c-ab51-f4ae1d334457_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_4427a52e-553b-4694-be10-f3f3a638dcda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_2d5798cd-759b-4b5c-ab51-f4ae1d334457" xlink:to="loc_us-gaap_PlanNameDomain_4427a52e-553b-4694-be10-f3f3a638dcda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember_fe19e0a5-cdf9-45f2-8a54-2349b4fe66c3" xlink:href="fldm-20200930.xsd#fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_4427a52e-553b-4694-be10-f3f3a638dcda" xlink:to="loc_fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember_fe19e0a5-cdf9-45f2-8a54-2349b4fe66c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_85b63550-fd38-4836-bacb-e894e6d76072" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cc092664-41df-4cd9-a9bb-efef3dec4847" xlink:to="loc_us-gaap_AwardTypeAxis_85b63550-fd38-4836-bacb-e894e6d76072" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_85b63550-fd38-4836-bacb-e894e6d76072_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_85b63550-fd38-4836-bacb-e894e6d76072" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_85b63550-fd38-4836-bacb-e894e6d76072_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_04909388-e05a-4ef9-bc82-4777ecbe5aff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_85b63550-fd38-4836-bacb-e894e6d76072" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_04909388-e05a-4ef9-bc82-4777ecbe5aff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_a691ca13-5aa5-4966-961a-401d06448102" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_04909388-e05a-4ef9-bc82-4777ecbe5aff" xlink:to="loc_us-gaap_EmployeeStockMember_a691ca13-5aa5-4966-961a-401d06448102" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/IncomeTaxes" xlink:type="simple" xlink:href="fldm-20200930.xsd#IncomeTaxes"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/IncomeTaxes" xlink:type="extended" id="id3f3225678a84ebc9ef1d54dd7f3feea_IncomeTaxes"/>
  <link:roleRef roleURI="http://fluidigm.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#IncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/IncomeTaxesDetails" xlink:type="extended" id="i403788e9d86147739f35de143b5215d1_IncomeTaxesDetails"/>
  <link:roleRef roleURI="http://fluidigm.com/role/InformationAboutGeographicAreas" xlink:type="simple" xlink:href="fldm-20200930.xsd#InformationAboutGeographicAreas"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/InformationAboutGeographicAreas" xlink:type="extended" id="i0ba48c16b1aa467b826c11f3ecf0ea59_InformationAboutGeographicAreas"/>
  <link:roleRef roleURI="http://fluidigm.com/role/InformationAboutGeographicAreasDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#InformationAboutGeographicAreasDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/InformationAboutGeographicAreasDetails" xlink:type="extended" id="i694784aede904e8abc24dc61accdab65_InformationAboutGeographicAreasDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_bdfeffa2-c019-494f-a79d-c60d3d49e669" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_09fa64b2-fff9-4f74-8ead-a01398de508c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_bdfeffa2-c019-494f-a79d-c60d3d49e669" xlink:to="loc_us-gaap_NumberOfReportableSegments_09fa64b2-fff9-4f74-8ead-a01398de508c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ff248994-d938-45bb-a325-fbb9604d6de3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_bdfeffa2-c019-494f-a79d-c60d3d49e669" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ff248994-d938-45bb-a325-fbb9604d6de3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_8506a0f4-8678-441f-b295-3a384fdeeefd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_bdfeffa2-c019-494f-a79d-c60d3d49e669" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_8506a0f4-8678-441f-b295-3a384fdeeefd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_bbfc62ec-2147-4e04-931c-9c5a08e895bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductInformationLineItems_bdfeffa2-c019-494f-a79d-c60d3d49e669" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_bbfc62ec-2147-4e04-931c-9c5a08e895bf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_eb1d5763-8a3d-47d2-a41d-6f4042c20b72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_bbfc62ec-2147-4e04-931c-9c5a08e895bf" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_eb1d5763-8a3d-47d2-a41d-6f4042c20b72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_eb1d5763-8a3d-47d2-a41d-6f4042c20b72_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_eb1d5763-8a3d-47d2-a41d-6f4042c20b72" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_eb1d5763-8a3d-47d2-a41d-6f4042c20b72_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_c5336051-de43-4298-aa70-602ca470aaec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_eb1d5763-8a3d-47d2-a41d-6f4042c20b72" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_c5336051-de43-4298-aa70-602ca470aaec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_b09621f4-d771-4720-9f12-98c9e4c8c26b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_c5336051-de43-4298-aa70-602ca470aaec" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_b09621f4-d771-4720-9f12-98c9e4c8c26b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f59c5d11-0433-48b5-bc05-603d10530ebc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_bbfc62ec-2147-4e04-931c-9c5a08e895bf" xlink:to="loc_srt_StatementGeographicalAxis_f59c5d11-0433-48b5-bc05-603d10530ebc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f59c5d11-0433-48b5-bc05-603d10530ebc_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_f59c5d11-0433-48b5-bc05-603d10530ebc" xlink:to="loc_srt_SegmentGeographicalDomain_f59c5d11-0433-48b5-bc05-603d10530ebc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_85870a6a-bc87-4af2-95b5-d5ef641cc037" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_f59c5d11-0433-48b5-bc05-603d10530ebc" xlink:to="loc_srt_SegmentGeographicalDomain_85870a6a-bc87-4af2-95b5-d5ef641cc037" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_9fc75b20-7266-48f9-a67e-22a76f052ce1" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_85870a6a-bc87-4af2-95b5-d5ef641cc037" xlink:to="loc_country_US_9fc75b20-7266-48f9-a67e-22a76f052ce1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_2e944eb2-860e-4ffa-b7e2-f3f8a9d4b539" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_85870a6a-bc87-4af2-95b5-d5ef641cc037" xlink:to="loc_country_CN_2e944eb2-860e-4ffa-b7e2-f3f8a9d4b539" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_bd969e94-d73d-436a-9a1b-5337bd10a2c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_bbfc62ec-2147-4e04-931c-9c5a08e895bf" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_bd969e94-d73d-436a-9a1b-5337bd10a2c0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_bd969e94-d73d-436a-9a1b-5337bd10a2c0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_bd969e94-d73d-436a-9a1b-5337bd10a2c0" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_bd969e94-d73d-436a-9a1b-5337bd10a2c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2c6f2121-74c4-4817-9e0b-26e311a3dcad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_bd969e94-d73d-436a-9a1b-5337bd10a2c0" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2c6f2121-74c4-4817-9e0b-26e311a3dcad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_6b81cead-d013-4b7f-9620-2afc5b680a24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2c6f2121-74c4-4817-9e0b-26e311a3dcad" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_6b81cead-d013-4b7f-9620-2afc5b680a24" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/DevelopmentAgreement" xlink:type="simple" xlink:href="fldm-20200930.xsd#DevelopmentAgreement"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/DevelopmentAgreement" xlink:type="extended" id="ib257cf36cedd464d8ffa8d18befdcbb8_DevelopmentAgreement"/>
  <link:roleRef roleURI="http://fluidigm.com/role/DevelopmentAgreementDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#DevelopmentAgreementDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/DevelopmentAgreementDetails" xlink:type="extended" id="if64e89b8e48d494d8b669f571b22761b_DevelopmentAgreementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f35d2e8a-c658-4a94-adf9-be10990953c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_UpFrontAndMilestonePaymentsMaximum_e207a9c9-f4c4-4c05-b94a-bd8cf8450298" xlink:href="fldm-20200930.xsd#fldm_UpFrontAndMilestonePaymentsMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f35d2e8a-c658-4a94-adf9-be10990953c4" xlink:to="loc_fldm_UpFrontAndMilestonePaymentsMaximum_e207a9c9-f4c4-4c05-b94a-bd8cf8450298" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CollaborativeArrangementTerm_14a0b190-f1c4-41a8-81b0-2477b8e9a0b3" xlink:href="fldm-20200930.xsd#fldm_CollaborativeArrangementTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f35d2e8a-c658-4a94-adf9-be10990953c4" xlink:to="loc_fldm_CollaborativeArrangementTerm_14a0b190-f1c4-41a8-81b0-2477b8e9a0b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_06336e16-f092-475b-b64a-b3c0e54d8de5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f35d2e8a-c658-4a94-adf9-be10990953c4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_06336e16-f092-475b-b64a-b3c0e54d8de5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_d2638f4d-e8e8-4b1e-b7bc-f24585e37bd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f35d2e8a-c658-4a94-adf9-be10990953c4" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_d2638f4d-e8e8-4b1e-b7bc-f24585e37bd9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6f9fe9c3-b7d3-4454-b4b8-db72e9637d5f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_d2638f4d-e8e8-4b1e-b7bc-f24585e37bd9" xlink:to="loc_srt_ProductOrServiceAxis_6f9fe9c3-b7d3-4454-b4b8-db72e9637d5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6f9fe9c3-b7d3-4454-b4b8-db72e9637d5f_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_6f9fe9c3-b7d3-4454-b4b8-db72e9637d5f" xlink:to="loc_srt_ProductsAndServicesDomain_6f9fe9c3-b7d3-4454-b4b8-db72e9637d5f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_cc8ec76c-fe2b-4c1f-9ca9-740700baab54" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_6f9fe9c3-b7d3-4454-b4b8-db72e9637d5f" xlink:to="loc_srt_ProductsAndServicesDomain_cc8ec76c-fe2b-4c1f-9ca9-740700baab54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CollaborationRevenueMember_fdd7cf4c-dad9-4566-a736-2b26c5c5a437" xlink:href="fldm-20200930.xsd#fldm_CollaborationRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_cc8ec76c-fe2b-4c1f-9ca9-740700baab54" xlink:to="loc_fldm_CollaborationRevenueMember_fdd7cf4c-dad9-4566-a736-2b26c5c5a437" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="fldm-20200930.xsd#CommitmentsandContingencies"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/CommitmentsandContingencies" xlink:type="extended" id="ib1a2b2226bdf4f4fa2e286cd79264c5f_CommitmentsandContingencies"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>17
<FILENAME>fldm-20200930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:cc860809-a6b3-4939-9e89-fb60809a6371,g:7453d80d-f328-4339-bf18-c087f9945f8a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_fldm_CertainEmployeeMember_0f69c301-64f4-4f60-8818-6b819723590d_terseLabel_en-US" xlink:label="lab_fldm_CertainEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certain Employee</link:label>
    <link:label id="lab_fldm_CertainEmployeeMember_label_en-US" xlink:label="lab_fldm_CertainEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certain Employee [Member]</link:label>
    <link:label id="lab_fldm_CertainEmployeeMember_documentation_en-US" xlink:label="lab_fldm_CertainEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certain Employee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CertainEmployeeMember" xlink:href="fldm-20200930.xsd#fldm_CertainEmployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_CertainEmployeeMember" xlink:to="lab_fldm_CertainEmployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_699f80c7-16c0-4580-836c-7ee89e777f9b_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_4988df12-0787-43fe-ad4e-caf20b60997e_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_7ed3a560-9a98-4e8c-aafe-e6a5a0a63443_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_3de399a2-f452-4f9c-8c2b-d2b3377e0870_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_ec0fae9a-d0d5-4650-b09e-22152d560432_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of activity of warranty accrual</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Warranty Liability [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2e7d73f3-2b8a-4dc7-8dc3-059881da09af_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductInformationLineItems_0e887133-63bd-41f2-8a78-b8eb72164528_terseLabel_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_ProductInformationLineItems_label_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductInformationLineItems" xlink:to="lab_us-gaap_ProductInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLegalSettlements_478ddb57-f945-467b-a13f-4740e3f2f05c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from legal settlements</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLegalSettlements_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLegalSettlements" xlink:to="lab_us-gaap_ProceedsFromLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_6c6bb732-375d-4d66-9622-15855f7b079f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_8918ea3b-a26f-4763-b4ae-ace8d86ab79d_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service revenue</link:label>
    <link:label id="lab_us-gaap_ServiceMember_268dfc45-dff3-4368-9a71-04c55729e2e2_verboseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service revenue</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_a72fcb23-6305-40aa-877e-d8fb66862773_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Released (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_6507dd3a-05fc-4960-8c02-114c8a2db7f9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CN_cb757b9a-0094-4c05-a054-831ecc2e3870_terseLabel_en-US" xlink:label="lab_country_CN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">China</link:label>
    <link:label id="lab_country_CN_label_en-US" xlink:label="lab_country_CN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CHINA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CN" xlink:to="lab_country_CN" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue_6c84e747-16d2-44f6-a944-7bbb5eb3c22e_terseLabel_en-US" xlink:label="lab_fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option grants exercise price minimum percentage on fair market value</link:label>
    <link:label id="lab_fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue_label_en-US" xlink:label="lab_fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option Grants Exercise Price Minimum Percentage On Fair Market Value</link:label>
    <link:label id="lab_fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue_documentation_en-US" xlink:label="lab_fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option Grants Exercise Price Minimum Percentage On Fair Market Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue" xlink:href="fldm-20200930.xsd#fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue" xlink:to="lab_fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_9a27600a-2197-478c-ae63-a38c427cd412_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional awards authorized for issuance (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ConsumablesMember_4d71cb59-78ab-4336-9770-8961a90792a5_terseLabel_en-US" xlink:label="lab_fldm_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables</link:label>
    <link:label id="lab_fldm_ConsumablesMember_label_en-US" xlink:label="lab_fldm_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables [Member]</link:label>
    <link:label id="lab_fldm_ConsumablesMember_documentation_en-US" xlink:label="lab_fldm_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ConsumablesMember" xlink:href="fldm-20200930.xsd#fldm_ConsumablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ConsumablesMember" xlink:to="lab_fldm_ConsumablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_8602647a-ad7f-448e-ad69-5fe5540a3c1a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_6ca37a4a-595f-4a85-b1e5-50f87accffd3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering related costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_InstruNorASMember_e11930de-204a-4696-a1ca-45c712aa4431_terseLabel_en-US" xlink:label="lab_fldm_InstruNorASMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">InstruNor AS</link:label>
    <link:label id="lab_fldm_InstruNorASMember_label_en-US" xlink:label="lab_fldm_InstruNorASMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">InstruNor AS [Member]</link:label>
    <link:label id="lab_fldm_InstruNorASMember_documentation_en-US" xlink:label="lab_fldm_InstruNorASMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">InstruNor AS [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_InstruNorASMember" xlink:href="fldm-20200930.xsd#fldm_InstruNorASMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_InstruNorASMember" xlink:to="lab_fldm_InstruNorASMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_82b14ab0-7aef-4b1c-8664-5684e13365dc_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a2a40736-7c55-4bb4-9554-6c6183df2550_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e98a3fce-48ca-4a0e-aac3-73551761f095_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ProductWarrantyTerm_b8f861ee-fb9b-4f4f-b9c6-379390b2c301_terseLabel_en-US" xlink:label="lab_fldm_ProductWarrantyTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product warranty term</link:label>
    <link:label id="lab_fldm_ProductWarrantyTerm_label_en-US" xlink:label="lab_fldm_ProductWarrantyTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Term</link:label>
    <link:label id="lab_fldm_ProductWarrantyTerm_documentation_en-US" xlink:label="lab_fldm_ProductWarrantyTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ProductWarrantyTerm" xlink:href="fldm-20200930.xsd#fldm_ProductWarrantyTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ProductWarrantyTerm" xlink:to="lab_fldm_ProductWarrantyTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_DeferredGrantRevenueNoncurrent_adacc4ff-c1b6-461b-bcba-f86d4c3904e6_terseLabel_en-US" xlink:label="lab_fldm_DeferredGrantRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred grant income, non-current</link:label>
    <link:label id="lab_fldm_DeferredGrantRevenueNoncurrent_f7b1d4d7-f186-4fb6-a274-7af46c0ac5d5_totalLabel_en-US" xlink:label="lab_fldm_DeferredGrantRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred grant income</link:label>
    <link:label id="lab_fldm_DeferredGrantRevenueNoncurrent_label_en-US" xlink:label="lab_fldm_DeferredGrantRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Grant Revenue, Noncurrent</link:label>
    <link:label id="lab_fldm_DeferredGrantRevenueNoncurrent_documentation_en-US" xlink:label="lab_fldm_DeferredGrantRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Grant Revenue, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DeferredGrantRevenueNoncurrent" xlink:href="fldm-20200930.xsd#fldm_DeferredGrantRevenueNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_DeferredGrantRevenueNoncurrent" xlink:to="lab_fldm_DeferredGrantRevenueNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_ef488eb4-7a7b-419c-b842-955d900f02cc_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_9531f97d-cb16-42eb-8758-478f67f44d7c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from debt issuance</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_fb006284-7dfc-42be-9ac7-8f3f19dc6b81_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_ea71a3ad-294d-40ba-bfb5-83aa5de3e2ec_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_53315500-7044-4ce2-85fe-813211b6a034_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from convertible debt issuance</link:label>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:to="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_7ac7d7ee-63a1-46b5-8942-954fb6e6db73_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_InstrumentsMember_96a1195c-d91b-4372-ad9e-6d3027f02775_terseLabel_en-US" xlink:label="lab_fldm_InstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments</link:label>
    <link:label id="lab_fldm_InstrumentsMember_label_en-US" xlink:label="lab_fldm_InstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments [Member]</link:label>
    <link:label id="lab_fldm_InstrumentsMember_documentation_en-US" xlink:label="lab_fldm_InstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_InstrumentsMember" xlink:href="fldm-20200930.xsd#fldm_InstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_InstrumentsMember" xlink:to="lab_fldm_InstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_e2b4910d-a1d1-4ea8-bac7-78c828b5c7ce_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_dc856b5a-b1f8-41be-ac8d-c1428aca469b_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesTerm_e16a02b7-88af-4bcd-8d98-99bbb30ccb63_terseLabel_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period due to pay liquidation damages</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesTerm_label_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Liquidated Damages, Term</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesTerm_documentation_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Liquidated Damages, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesTerm" xlink:href="fldm-20200930.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesTerm" xlink:to="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5dea381a-74cf-4117-9b6c-5fb989554abc_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0578f203-1536-4e8e-b1de-b791442fdda2_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_459bef80-a4ce-4c3b-885f-75a3dd8c14c6_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_5952f1c1-ec83-40aa-8d64-3a30aad79c75_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_268a4b8b-9cfc-48b8-b69d-c2e56dd46bc8_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f09224f6-1a01-4cee-ab5b-77213e0a3b73_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_c4ab8c09-3794-4356-a27c-06927cbe8e9b_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_78656c43-b472-4f7a-b2c2-0750de41a202_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of restricted stock, net of shares withheld for taxes, and other</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_4e7523d0-d59e-48ba-9588-810436c02b82_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tranche Two</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_c759447c-7adf-4808-9f80-072a07eb2d15_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_e429bcd1-f251-40c6-92cc-14adbb46d5b9_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_RestrictedCashAndCashEquivalentsMember_00b40b72-9cfc-4ff4-86b7-cd20fdd64914_terseLabel_en-US" xlink:label="lab_fldm_RestrictedCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash-restricted</link:label>
    <link:label id="lab_fldm_RestrictedCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_fldm_RestrictedCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash And Cash Equivalents [Member]</link:label>
    <link:label id="lab_fldm_RestrictedCashAndCashEquivalentsMember_documentation_en-US" xlink:label="lab_fldm_RestrictedCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash And Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_RestrictedCashAndCashEquivalentsMember" xlink:href="fldm-20200930.xsd#fldm_RestrictedCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_RestrictedCashAndCashEquivalentsMember" xlink:to="lab_fldm_RestrictedCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_547482db-0bac-4990-9dcf-e6fd55a912f0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_2995d999-41f4-421f-b380-7f3148cee683_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_b1924e2c-c939-4cda-ad39-bbfb31a34208_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: cash and cash equivalents acquired</link:label>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_label_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAcquiredFromAcquisition" xlink:to="lab_us-gaap_CashAcquiredFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_c5c61a41-bf05-404e-b1b1-bc619a4bc803_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleLongTermNotesPayable_023ccf32-cc50-4d15-bc9d-0a702172aaf5_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleLongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes, net</link:label>
    <link:label id="lab_us-gaap_ConvertibleLongTermNotesPayable_label_en-US" xlink:label="lab_us-gaap_ConvertibleLongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleLongTermNotesPayable" xlink:to="lab_us-gaap_ConvertibleLongTermNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_e28a7e22-1f5c-4a73-8d12-35c8f20e16ac_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_fb28c2ee-e695-4588-93a1-2c8329ce8ce6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Released (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_6da8b8c2-bf4b-4e3c-b101-120b2ca2eed7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_8838dca3-b0aa-4910-ab7d-8fce6d5a2d8b_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember_dd9e7c89-dfc1-45a1-83b5-a4471979fa8f_terseLabel_en-US" xlink:label="lab_fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Convertible Notes potential make-whole shares</link:label>
    <link:label id="lab_fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember_label_en-US" xlink:label="lab_fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Nineteen Convertible Notes Potential Make Whole Shares [Member]</link:label>
    <link:label id="lab_fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember_documentation_en-US" xlink:label="lab_fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Nineteen Convertible Notes Potential Make Whole Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember" xlink:href="fldm-20200930.xsd#fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember" xlink:to="lab_fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_EmployeeStockPurchasePlanOfferingPeriod_57a0726b-2303-4317-bdec-da9bd00414f8_terseLabel_en-US" xlink:label="lab_fldm_EmployeeStockPurchasePlanOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP, offering period</link:label>
    <link:label id="lab_fldm_EmployeeStockPurchasePlanOfferingPeriod_label_en-US" xlink:label="lab_fldm_EmployeeStockPurchasePlanOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan, Offering Period</link:label>
    <link:label id="lab_fldm_EmployeeStockPurchasePlanOfferingPeriod_documentation_en-US" xlink:label="lab_fldm_EmployeeStockPurchasePlanOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan, Offering Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_EmployeeStockPurchasePlanOfferingPeriod" xlink:href="fldm-20200930.xsd#fldm_EmployeeStockPurchasePlanOfferingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_EmployeeStockPurchasePlanOfferingPeriod" xlink:to="lab_fldm_EmployeeStockPurchasePlanOfferingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_b98f38dd-9fea-4747-bb2c-156a3615e0f8_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_e5c0f4ca-afb2-4427-b94a-1bc260757102_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use asset, net</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_c20acca2-206f-41d6-a1a9-8bf480a2ae6d_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_2f772723-e61f-4497-a498-fcf643162b32_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease right-of-use assets, net</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_bc6f4b66-ef7e-4e46-9691-5f705ccf7452_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized debt discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_431337ac-0747-437e-89bb-6f0566a52532_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_ccb8a035-891b-457e-855f-0bd0af50f3b7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_db642c7c-a798-4e79-86fb-2b980833eef3_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired finite-lived intangible assets, useful life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_TwoThousandAndFourteenConvertibleNotesMember_acff3483-7f02-473f-803c-07544478cf2b_terseLabel_en-US" xlink:label="lab_fldm_TwoThousandAndFourteenConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2014 Convertible Notes</link:label>
    <link:label id="lab_fldm_TwoThousandAndFourteenConvertibleNotesMember_label_en-US" xlink:label="lab_fldm_TwoThousandAndFourteenConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Fourteen Convertible Notes [Member]</link:label>
    <link:label id="lab_fldm_TwoThousandAndFourteenConvertibleNotesMember_documentation_en-US" xlink:label="lab_fldm_TwoThousandAndFourteenConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Fourteen Convertible Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndFourteenConvertibleNotesMember" xlink:href="fldm-20200930.xsd#fldm_TwoThousandAndFourteenConvertibleNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_TwoThousandAndFourteenConvertibleNotesMember" xlink:to="lab_fldm_TwoThousandAndFourteenConvertibleNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_4395a2be-feaa-4842-985a-4c2ee4801947_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice_97f403fb-a2b5-4aaf-87fe-0c36593b8e77_terseLabel_en-US" xlink:label="lab_fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt redemption conditioned upon common stock value exceeding a percentage of the conversion price</link:label>
    <link:label id="lab_fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice_label_en-US" xlink:label="lab_fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Condition, Stock Value Exceeding Percentage of Conversion Price</link:label>
    <link:label id="lab_fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice_documentation_en-US" xlink:label="lab_fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Condition, Stock Value Exceeding Percentage of Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice" xlink:href="fldm-20200930.xsd#fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice" xlink:to="lab_fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b65f1489-1e11-40d1-96ff-5d18d8d4ef08_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a0b736d6-958d-4a26-bea8-69346c9772a9_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_312d49f6-ee87-4387-ab28-ef1781155c42_verboseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_ba7faeea-ee6e-465b-adfb-9b853103b132_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total unrecognized compensation cost related to stock-based compensation arrangements</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_1abb48a9-5cd9-40ff-97e3-3ec77844f18d_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_f20bc81f-9049-4b3e-a8eb-8571f24b553f_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_LesseeOperatingLeaseRemainingTermOfContract_4145f440-2876-4114-adcc-218d98758a3e_terseLabel_en-US" xlink:label="lab_fldm_LesseeOperatingLeaseRemainingTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease term</link:label>
    <link:label id="lab_fldm_LesseeOperatingLeaseRemainingTermOfContract_label_en-US" xlink:label="lab_fldm_LesseeOperatingLeaseRemainingTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Remaining Term Of Contract</link:label>
    <link:label id="lab_fldm_LesseeOperatingLeaseRemainingTermOfContract_documentation_en-US" xlink:label="lab_fldm_LesseeOperatingLeaseRemainingTermOfContract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Remaining Term Of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LesseeOperatingLeaseRemainingTermOfContract" xlink:href="fldm-20200930.xsd#fldm_LesseeOperatingLeaseRemainingTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_LesseeOperatingLeaseRemainingTermOfContract" xlink:to="lab_fldm_LesseeOperatingLeaseRemainingTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_09632889-70dd-4e3b-ad86-ed6a84f9467c_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.001 par value, 10,000 shares authorized, no shares issued and outstanding at either September&#160;30, 2020 or December&#160;31, 2019</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_53e11d99-f8e7-4755-93f2-7157bdbecde6_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total costs and expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_6d4b073b-424f-4b32-8286-ecaeea305a0b_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use buildings</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9f31d3d0-61ca-4310-b6d5-88146e740a4c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_8e143e3a-59e7-4eaf-84d3-6f637ad67956_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_ebb9b466-c6d0-4f10-aa05-fcf1875221de_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_908dc723-962f-4935-9afb-238f05d531fd_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_cad33de8-ff9a-4879-893c-848f89924e43_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7d7e2eaf-5e8c-4484-b4da-9abddcc78655_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of foreign exchange rate fluctuations on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_af5c1d7a-2370-4334-8d11-ca9b5696a405_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction-in-progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressGross" xlink:to="lab_us-gaap_ConstructionInProgressGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_cdf508ab-26a1-4694-8b42-b675189a8061_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_f527955c-e1d3-4715-b59d-1c637e62a756_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_586cb515-0638-4cb3-8386-6c06ba099724_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8149e3d2-357a-4395-9f9f-bb30779ba6dc_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales to customers</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_8f3f6cad-40bd-41f7-bf79-9ca2bdb5d9c3_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_29a16fd4-78e8-4e26-9edf-9fc05b9c37cb_verboseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share price (usd per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_c99f8739-4c57-4588-b875-cd127ac2bd28_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_AssetsAndLiabilitiesLesseeTableTextBlock_6d9b79af-ae8a-4261-82f2-bb5f557f6418_terseLabel_en-US" xlink:label="lab_fldm_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of balance sheet information</link:label>
    <link:label id="lab_fldm_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_fldm_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_fldm_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_fldm_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="fldm-20200930.xsd#fldm_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_fldm_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_fd245129-9781-4e77-ae0c-5f748811d22f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_4a98adc1-22ac-42cf-a5be-3901c9d6ac3c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_a77ee13b-c354-48b2-8e3a-e3f8b185e81b_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_9b5ccfee-5631-4ea4-aa80-6a1e0f585b30_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_29cf8061-0602-4b2b-bad7-7cb0075603be_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion rate of notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest_dcbc679a-b557-4541-b861-2da9f9609317_terseLabel_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of performance period</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest_label_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Percentage Of Performance Units Expected To Vest</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest_documentation_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Percentage Of Performance Units Expected To Vest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest" xlink:href="fldm-20200930.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest" xlink:to="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_2d16cd9b-c686-4d63-ae4c-6230498218dc_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_b8bb6e5d-7d39-4f7f-a562-5dc71efc1a61_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of InstruNor AS (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_4036265d-8a9e-4eba-9a7a-af956db8aaaa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of potential common shares excluded from computations of net loss per share attributed to common stockholders</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_ac4bea6b-5ee5-450c-aa20-c252b3d39161_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_2e2a912c-bd82-4581-92f6-29e870496be5_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (shares)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_b4ee7ad5-c716-4724-966c-66bc94c0eaaa_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_SeniorConvertibleNotesdue2034Member_3e00b490-d986-4910-bea1-181c92878076_terseLabel_en-US" xlink:label="lab_fldm_SeniorConvertibleNotesdue2034Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Convertible Notes due 2034</link:label>
    <link:label id="lab_fldm_SeniorConvertibleNotesdue2034Member_97a3ac1e-0ae5-48e3-a35c-f079a464c6df_verboseLabel_en-US" xlink:label="lab_fldm_SeniorConvertibleNotesdue2034Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.75% 2014 Notes due 2034</link:label>
    <link:label id="lab_fldm_SeniorConvertibleNotesdue2034Member_531241f2-fb30-4ac2-9eae-46b7d70ef3cf_netLabel_en-US" xlink:label="lab_fldm_SeniorConvertibleNotesdue2034Member" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2014 Notes</link:label>
    <link:label id="lab_fldm_SeniorConvertibleNotesdue2034Member_label_en-US" xlink:label="lab_fldm_SeniorConvertibleNotesdue2034Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Convertible Notes due 2034 [Member]</link:label>
    <link:label id="lab_fldm_SeniorConvertibleNotesdue2034Member_documentation_en-US" xlink:label="lab_fldm_SeniorConvertibleNotesdue2034Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Convertible Notes due 2034 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeniorConvertibleNotesdue2034Member" xlink:href="fldm-20200930.xsd#fldm_SeniorConvertibleNotesdue2034Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_SeniorConvertibleNotesdue2034Member" xlink:to="lab_fldm_SeniorConvertibleNotesdue2034Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_7862978c-f1ec-42f4-ae30-011bfe48e7f5_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtSecuritiesMember_b71c2412-fdd3-4938-bbac-98f082affb10_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtSecuritiesMember" xlink:to="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalFees_35865372-437e-4215-9691-fa52179427c7_terseLabel_en-US" xlink:label="lab_us-gaap_LegalFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal fees</link:label>
    <link:label id="lab_us-gaap_LegalFees_label_en-US" xlink:label="lab_us-gaap_LegalFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalFees" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LegalFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalFees" xlink:to="lab_us-gaap_LegalFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_fafd0a17-6124-4084-a447-40e97018bf83_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_ff72ac3b-4c80-4f13-a3a0-ca8f45187ad1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease amortization</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_acb084da-a4e2-4ec6-b394-d8d86780a864_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9fee5e5d-53a7-439d-b415-4486f101b7db_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities assumed:</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_d7f28459-27b3-47a0-ad2f-e5567389918e_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_RevenueFromContractWithCustomerPerformanceObligationPeriod_096e5a95-98ed-473f-9633-9ee24d225bf1_terseLabel_en-US" xlink:label="lab_fldm_RevenueFromContractWithCustomerPerformanceObligationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance obligation period</link:label>
    <link:label id="lab_fldm_RevenueFromContractWithCustomerPerformanceObligationPeriod_label_en-US" xlink:label="lab_fldm_RevenueFromContractWithCustomerPerformanceObligationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer, Performance Obligation Period</link:label>
    <link:label id="lab_fldm_RevenueFromContractWithCustomerPerformanceObligationPeriod_documentation_en-US" xlink:label="lab_fldm_RevenueFromContractWithCustomerPerformanceObligationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer, Performance Obligation Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_RevenueFromContractWithCustomerPerformanceObligationPeriod" xlink:href="fldm-20200930.xsd#fldm_RevenueFromContractWithCustomerPerformanceObligationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_RevenueFromContractWithCustomerPerformanceObligationPeriod" xlink:to="lab_fldm_RevenueFromContractWithCustomerPerformanceObligationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_31acf3f8-8fac-47be-9db2-c0b542c28cc3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDiluted_0c0106bf-9ab9-4366-ab9b-a010cc798560_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share, basic and diluted (usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_f0fb9250-316e-42a8-befb-b444430629f7_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_DVSSciencesInc.Member_f6b8fbf1-797d-4a12-823d-625da81699f9_terseLabel_en-US" xlink:label="lab_fldm_DVSSciencesInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DVS Sciences, Inc.</link:label>
    <link:label id="lab_fldm_DVSSciencesInc.Member_label_en-US" xlink:label="lab_fldm_DVSSciencesInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DVS Sciences, Inc. [Member]</link:label>
    <link:label id="lab_fldm_DVSSciencesInc.Member_documentation_en-US" xlink:label="lab_fldm_DVSSciencesInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DVS Sciences, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DVSSciencesInc.Member" xlink:href="fldm-20200930.xsd#fldm_DVSSciencesInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_DVSSciencesInc.Member" xlink:to="lab_fldm_DVSSciencesInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_UpFrontAndMilestonePaymentsMaximum_36ab0f29-5b0e-4c03-857f-e293961ae49a_terseLabel_en-US" xlink:label="lab_fldm_UpFrontAndMilestonePaymentsMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration agreement, up-front and periodic milestone payments, up to</link:label>
    <link:label id="lab_fldm_UpFrontAndMilestonePaymentsMaximum_label_en-US" xlink:label="lab_fldm_UpFrontAndMilestonePaymentsMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Up-Front And Milestone Payments, Maximum</link:label>
    <link:label id="lab_fldm_UpFrontAndMilestonePaymentsMaximum_documentation_en-US" xlink:label="lab_fldm_UpFrontAndMilestonePaymentsMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Up-Front And Milestone Payments, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_UpFrontAndMilestonePaymentsMaximum" xlink:href="fldm-20200930.xsd#fldm_UpFrontAndMilestonePaymentsMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_UpFrontAndMilestonePaymentsMaximum" xlink:to="lab_fldm_UpFrontAndMilestonePaymentsMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_28dfff74-94e1-45fb-8052-31e3f9d10a4a_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Lease Payments for Operating Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_85682928-c4aa-43a5-bd05-d970c2fd594c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_EquityIncentivePlanMember_e52a3d6c-ab6d-4f32-b34c-4a4d4365fbc9_terseLabel_en-US" xlink:label="lab_fldm_EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plan</link:label>
    <link:label id="lab_fldm_EquityIncentivePlanMember_label_en-US" xlink:label="lab_fldm_EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_fldm_EquityIncentivePlanMember_documentation_en-US" xlink:label="lab_fldm_EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_EquityIncentivePlanMember" xlink:href="fldm-20200930.xsd#fldm_EquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_EquityIncentivePlanMember" xlink:to="lab_fldm_EquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_083ff44b-fdb5-4083-ad0e-ecdf1280a7cc_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares sold (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bc0b8cf6-4da5-4e6d-a12f-9efef800bde4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_df9b68bf-3efa-459d-bf86-31225878186c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock from at-the-market offering, net of commissions</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_331f324a-c2c8-4e18-8253-2c35677ee034_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption, Period One</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_8f6061f0-600a-4fc4-80bf-b6fc32bdb135_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ScheduleOfSignificantAccountingPoliciesTable_e08a306b-b888-48e4-b266-0f44c1d37973_terseLabel_en-US" xlink:label="lab_fldm_ScheduleOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_fldm_ScheduleOfSignificantAccountingPoliciesTable_label_en-US" xlink:label="lab_fldm_ScheduleOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_fldm_ScheduleOfSignificantAccountingPoliciesTable_documentation_en-US" xlink:label="lab_fldm_ScheduleOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ScheduleOfSignificantAccountingPoliciesTable" xlink:href="fldm-20200930.xsd#fldm_ScheduleOfSignificantAccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesTable" xlink:to="lab_fldm_ScheduleOfSignificantAccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_1d365116-81de-43e3-b9b7-32adb9bc91cc_verboseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of common stock reserved for future issuance</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_918507ff-22c7-41df-8570-8cb2002ee461_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount_86e5deab-74e9-4bd9-b2c3-c79808440d5d_terseLabel_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total value of milestones reasonably assured</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount_label_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Amount</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount_documentation_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount" xlink:href="fldm-20200930.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount" xlink:to="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d041b14a-d73e-4edc-af53-f18f1f6b3333_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_57a3b2af-82f4-4fe5-b063-9e0fee737925_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities to be issued (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1b7f590a-85cc-42bc-9df3-80bda7ad91c8_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards authorized for issuance (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b8b0cdbd-7953-4de6-8091-a857faa5bd71_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_e38ba2c6-3628-49ee-b72f-68d36a9e2137_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of consideration transferred and assets acquired and liabilities assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_3b247a74-16aa-48c6-9494-698c5ebe4b00_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_A2017InducementAwardPlanMember_7b3b4a74-d9ab-40ee-af13-a973e65a7606_terseLabel_en-US" xlink:label="lab_fldm_A2017InducementAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Inducement Award Plan</link:label>
    <link:label id="lab_fldm_A2017InducementAwardPlanMember_label_en-US" xlink:label="lab_fldm_A2017InducementAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Inducement Award Plan [Member]</link:label>
    <link:label id="lab_fldm_A2017InducementAwardPlanMember_documentation_en-US" xlink:label="lab_fldm_A2017InducementAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Inducement Award Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_A2017InducementAwardPlanMember" xlink:href="fldm-20200930.xsd#fldm_A2017InducementAwardPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_A2017InducementAwardPlanMember" xlink:to="lab_fldm_A2017InducementAwardPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_482f52fd-0d03-4dfe-8893-4047481c09f1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_b5900742-f582-4533-9b87-5965469bd80b_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Details</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount_145befa7-afa6-4b46-b96f-2d52f69592ee_terseLabel_en-US" xlink:label="lab_fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum employee purchase amount</link:label>
    <link:label id="lab_fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount_label_en-US" xlink:label="lab_fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Maximum Employee Purchase Amount</link:label>
    <link:label id="lab_fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount_documentation_en-US" xlink:label="lab_fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Maximum Employee Purchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount" xlink:href="fldm-20200930.xsd#fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount" xlink:to="lab_fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_36b67a19-3769-4676-b1b6-2b7f7f63b5db_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_71cfac7a-8503-4176-85ad-3a52e6becfc0_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts_8eab5595-b0bd-4e26-90f1-20ee94a65168_terseLabel_en-US" xlink:label="lab_fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional advance payments received</link:label>
    <link:label id="lab_fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts_label_en-US" xlink:label="lab_fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Increase From Cash Receipts</link:label>
    <link:label id="lab_fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts_documentation_en-US" xlink:label="lab_fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Increase From Cash Receipts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts" xlink:href="fldm-20200930.xsd#fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts" xlink:to="lab_fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_683144fc-35a1-4a9e-9163-e2da65cf68f4_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4904d76c-2c27-4048-b920-b38134e02363_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_4da08f4d-b18d-4fe9-8ce1-77e3c8d10e96_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_0e005ef7-50a2-412a-9a77-22f9824eb075_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of finite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_8a47cdb3-228c-4fbe-a858-1e078e937246_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d15c7e84-bcbf-4cd2-8509-929390803c8d_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale, amortized cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_07a6f4d1-4ba9-4836-92ca-f86f22221b0b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renewal term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e3e0ab48-121f-4d1b-a5a5-ae95c3baee0b_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gain</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_d6f933b4-56d7-4a4b-b166-b9398edac76c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_cc0df8de-4ff1-4e97-bf36-8f56170f80c8_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant Date Fair Value per Unit</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0d0fa8f2-3a37-461e-a371-9901389fdbb1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_bddcdd08-68a4-4206-bc8d-84b3dce3206d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_f4bb11ff-34f4-40f1-880c-3a252770190a_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_TwoThousandAndNineEquityIncentivePlanMember_dadc5a0b-24ca-4ebd-8e01-f8eaae982d32_terseLabel_en-US" xlink:label="lab_fldm_TwoThousandAndNineEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2009 Equity Incentive Plan</link:label>
    <link:label id="lab_fldm_TwoThousandAndNineEquityIncentivePlanMember_label_en-US" xlink:label="lab_fldm_TwoThousandAndNineEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Nine Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_fldm_TwoThousandAndNineEquityIncentivePlanMember_documentation_en-US" xlink:label="lab_fldm_TwoThousandAndNineEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Nine Equity Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndNineEquityIncentivePlanMember" xlink:href="fldm-20200930.xsd#fldm_TwoThousandAndNineEquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_TwoThousandAndNineEquityIncentivePlanMember" xlink:to="lab_fldm_TwoThousandAndNineEquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_8ca5d565-82c7-4cb4-b770-fb2c34bba46b_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowances</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_eb432020-98e9-4497-ae16-ac13e08f2eca_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of InstruNor AS</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_91cb8044-6807-4fa2-8fd8-768a4fc00449_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding (shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashMember_a60d7560-d342-48f0-882d-899bc61364e9_terseLabel_en-US" xlink:label="lab_us-gaap_CashMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash</link:label>
    <link:label id="lab_us-gaap_CashMember_label_en-US" xlink:label="lab_us-gaap_CashMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashMember" xlink:to="lab_us-gaap_CashMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_f7d950b6-729e-4170-95bf-ec9e21ea1e3c_verboseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_755c7509-3128-4121-917a-9a5b24b9a22b_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_5cd14ec9-1a84-4069-914a-2c48e30e4010_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_9ef4fad4-148a-4630-93f9-92e1f80d9040_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization_95b3a1b2-e992-4cfc-82b7-cb24f70b9793_negatedTerseLabel_en-US" xlink:label="lab_fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization</link:label>
    <link:label id="lab_fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization_label_en-US" xlink:label="lab_fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-Of-Use Asset, Accumulated Amortization</link:label>
    <link:label id="lab_fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization_documentation_en-US" xlink:label="lab_fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-Of-Use Asset, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization" xlink:href="fldm-20200930.xsd#fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization" xlink:to="lab_fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_49178525-8271-4774-8cd3-cab6d4db4d85_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of developed technology</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_8e59bf1d-297a-457f-b565-214da25a60eb_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangibles</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_84d394bc-bf07-4faf-b6eb-fc86eda6c702_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of lease expense</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_49fa03a7-16da-46ad-aa94-f35744e8eb53_verboseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostDomain_7b5224ae-e024-4bc6-aad6-05377581540d_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost [Domain]</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostDomain_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostDomain" xlink:to="lab_us-gaap_CapitalizedContractCostDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_00006ee3-9c07-453e-ac8e-2d1a0caad890_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_44265e46-0094-431f-928b-e9d3ca8d2a04_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_61f9d7c3-cea4-4c83-86b8-3aae4a5a313d_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information About Geographic Areas</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_ee3e575a-62aa-45f8-abe9-93fa537489da_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock from at-the-market offering, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_1a1f47d1-d20a-40e1-9e1e-1caf3242d5b8_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of restricted stock, net of shares withheld for taxes, and other (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber_f2eb8ec9-95d0-4656-9614-a79e2f4b68d5_terseLabel_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested awards (shares)</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Number</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber_documentation_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber" xlink:href="fldm-20200930.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber" xlink:to="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_b943b3c9-8d35-4317-91b4-1d3ec4307e69_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_2f2f0c33-f4e1-4c08-9254-c16cda8f9c4c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_aa839622-d7b0-48b3-982d-c03ff14e1db9_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ae372414-1323-4d03-836c-0eb7914ce3b4_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_acc6a020-c8f3-4b5d-8406-8d3bff39758b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_6d46a120-05d2-4100-88f3-e33df1cd654a_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_1c95ac28-c8e5-4094-9082-924eeb221892_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3afeac18-182c-4cf9-8d9e-8d4c18d37a65_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in unrealized gain (loss) on investments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_97b6612b-bca0-4c1f-8ae1-4ebc1c1f4ca7_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_7422ee38-93f5-4342-a080-27cf62d3a169_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business</link:label>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_277b6399-50ed-4b55-a5f9-74ec7c7d2f88_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentrations of Business and Credit Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_8f305859-688a-43c4-b8b5-687b3a98c397_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_9ac139b0-0393-40ac-93f9-3d3eae1d4f86_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_c0648db4-6050-4344-ad0d-ec62c875e8d8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_ffe7308e-1ffc-4c78-b40a-8c09cec01ffe_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_765e3283-a720-4d1c-978e-8dfac576fa92_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_OneCustomerMember_5eee0c3f-0b22-4c25-86f6-40c1a2befc33_terseLabel_en-US" xlink:label="lab_fldm_OneCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Customer</link:label>
    <link:label id="lab_fldm_OneCustomerMember_label_en-US" xlink:label="lab_fldm_OneCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Customer [Member]</link:label>
    <link:label id="lab_fldm_OneCustomerMember_documentation_en-US" xlink:label="lab_fldm_OneCustomerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Customer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_OneCustomerMember" xlink:href="fldm-20200930.xsd#fldm_OneCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_OneCustomerMember" xlink:to="lab_fldm_OneCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_854481a2-4ad1-45d8-a946-09e702c75db7_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_CommissionCostsMember_077f9867-4b19-4c59-a677-8a8c08949f40_terseLabel_en-US" xlink:label="lab_fldm_CommissionCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission Costs</link:label>
    <link:label id="lab_fldm_CommissionCostsMember_label_en-US" xlink:label="lab_fldm_CommissionCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission Costs [Member]</link:label>
    <link:label id="lab_fldm_CommissionCostsMember_documentation_en-US" xlink:label="lab_fldm_CommissionCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CommissionCostsMember" xlink:href="fldm-20200930.xsd#fldm_CommissionCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_CommissionCostsMember" xlink:to="lab_fldm_CommissionCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_bef692a7-3bad-4ae4-a4ac-2b59a633f104_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_7b2ba7dc-fcf5-4540-9d0b-90c2c99f54a7_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1f3a2b1e-a4a5-4265-84f6-fa2ee7396619_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne_a6c0a39b-1191-41c0-8d92-c59a371457d3_verboseLabel_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne_label_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Remaining Contractual Term One</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne_documentation_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Remaining Contractual Term One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne" xlink:href="fldm-20200930.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne" xlink:to="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_7ed9d1e6-9d5f-460a-b717-2a94a6cd4e7d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from stock issuance from ESPP</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_2b1e1d54-a09b-41ac-a3e5-dd52e78aa2e4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level I:</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue_78efa3f1-e733-41db-a2e7-fa95807dc79e_terseLabel_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum contract value</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue_label_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Maximum Contract Value</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue_documentation_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Maximum Contract Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue" xlink:href="fldm-20200930.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue" xlink:to="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_4b4106cf-dc7b-482a-bef1-b880365a5edd_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_7b9c654d-b93b-4a42-a2a9-5543e93e00c1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_1e08ac2d-9a7f-4fcd-a665-396174648a97_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RADx Program</link:label>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research, Development, and Computer Software Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:to="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ShareholdersEquityLineItems_cb54be8f-cb7c-4f42-bfc3-35d2ef991cb8_terseLabel_en-US" xlink:label="lab_fldm_ShareholdersEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity [Line Items]</link:label>
    <link:label id="lab_fldm_ShareholdersEquityLineItems_label_en-US" xlink:label="lab_fldm_ShareholdersEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity [Line Items]</link:label>
    <link:label id="lab_fldm_ShareholdersEquityLineItems_documentation_en-US" xlink:label="lab_fldm_ShareholdersEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Shareholders' Equity [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareholdersEquityLineItems" xlink:href="fldm-20200930.xsd#fldm_ShareholdersEquityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ShareholdersEquityLineItems" xlink:to="lab_fldm_ShareholdersEquityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_81f519f1-a6ff-4133-be7b-a9cb2cdad017_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fb8e2a65-59a2-45b8-ad2d-ec799cf6c1e5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Nonvested and Outstanding Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_8ba04855-37b4-4122-9b87-ba88cf7495c1_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses_b2eeaf2d-8a41-4085-819b-96e8f26a67d0_terseLabel_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts applied against research and development expenses</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses_label_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Expenses</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses_documentation_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses" xlink:href="fldm-20200930.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses" xlink:to="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ShareholdersEquityTable_f2313ced-9a5c-417f-911b-5e6a0832760a_terseLabel_en-US" xlink:label="lab_fldm_ShareholdersEquityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity [Table]</link:label>
    <link:label id="lab_fldm_ShareholdersEquityTable_label_en-US" xlink:label="lab_fldm_ShareholdersEquityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity [Table]</link:label>
    <link:label id="lab_fldm_ShareholdersEquityTable_documentation_en-US" xlink:label="lab_fldm_ShareholdersEquityTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareholdersEquityTable" xlink:href="fldm-20200930.xsd#fldm_ShareholdersEquityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ShareholdersEquityTable" xlink:to="lab_fldm_ShareholdersEquityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_7eec0091-b849-4164-9312-cf4b845346e5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_eaea220e-7f6f-491e-92e9-6a8d0cbc7008_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_7eaf7531-c7f5-471b-afb5-bff433b5dfbd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of consideration transferred</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue_0408859b-5135-4a1c-9ae4-bc7c5d8d3a51_terseLabel_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested awards</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Aggregate Intrinsic Value</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue_documentation_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Options, Expected To Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="fldm-20200930.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_3b4e2413-36cd-409c-acd7-0e5e87a363a7_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_30973f18-5756-4c74-a90b-b5fa792a5e06_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash items</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_747b6d88-b116-4688-839d-67312695b013_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostAxis_326565a4-66e3-4400-9e0c-ea6a7f468174_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost [Axis]</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostAxis_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostAxis" xlink:to="lab_us-gaap_CapitalizedContractCostAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_5394ca42-dcf4-4d61-89f6-78f44297e7ba_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1_46bbfc4b-617f-4d6e-924f-2f9e3517ad23_terseLabel_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested awards</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Remaining Contractual Term 1</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1_documentation_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expected to Vest, Weighted Average Remaining Contractual Term 1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1" xlink:href="fldm-20200930.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1" xlink:to="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c5991721-7cef-4b4f-911c-a943b2dfe6c2_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_659ae1d3-d481-453d-9b68-86dd16b9e7fc_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_d1d66a70-991f-460c-b0b2-03c436faa833_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_3b25a460-0269-4dd6-9a79-d55032eb7ab2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_369c9e03-a028-48fa-b908-9b6b4ef18c55_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_167d40ed-58ff-4638-9777-2bde9f72f0c1_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_a159e8e3-0680-4125-b914-e32dcdac6d3b_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_ea469327-d9ee-4b24-b53d-0e1af51f7223_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_4bda83a8-82a5-4eb3-8f35-3bf0d9009a3c_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable costs including non-lease component</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_90f6ff08-ff07-4d60-9d77-1aa0fc374f46_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_5897ae57-b788-4c36-8182-6008dbe84853_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_24d570f4-5856-4059-bdd3-d81fa9906d8e_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2d27fa61-e029-454d-847b-61f4216e5442_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_70f29c73-4a77-49c6-b5b0-920341a04aab_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_5ca41c91-7672-4219-86e7-abeea2906b09_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b770360d-6568-4b93-98ca-75091068fb0b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_f776a727-2687-4c9f-9fc4-a274cbc4178b_totalLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of InstruNor, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_46e69d6d-03c7-4065-a988-18d0a392320b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_42c45e82-4e9a-4d42-86d0-4352d91992d7_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_54b38f5f-dffc-419e-9416-fc63de33e55c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_14de5273-923d-45c4-9eaa-291ece32dbe6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_8ad62bb2-39eb-4c64-bc2f-6f869f3c395f_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_dbfae693-cbc6-456b-9742-168f3ad313a6_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_7abf8763-94cd-4866-9235-30baffa06ab5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_939a8dad-f0d8-430b-b889-b4ac28b07e2e_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d08395a3-5e09-4268-8743-e579e09a295d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_c5621099-ea6c-4d8f-a297-92f9a7355e36_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, non-current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_16dcf219-e51b-434d-a9e7-0fc69eaa5244_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, non-current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_87ffffd3-bc1d-4086-97df-d1baadd0381b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e08934a2-81c1-4397-b398-8042fb7b0487_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments_3f468d18-fcf6-4335-9406-5bba7e3b5599_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturities of investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Other Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice_c48b5079-5f88-484f-9f1f-7b3c213fd84b_terseLabel_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested awards (usd per share)</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice_label_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Exercise Price</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice" xlink:href="fldm-20200930.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice" xlink:to="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_2d6dbeee-5a45-4098-b11f-8de1d6a124dc_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_b7e8efa9-d61f-4f1c-ae5f-98f739312754_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_1a4391f3-5139-41f2-9ffe-dcf7cb781076_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_DebtInstrumentEarlyRedemptionCostPercentOfMaximumBorrowingCapacity_130f9c6a-6626-40fc-8f0a-fb454884ca8b_terseLabel_en-US" xlink:label="lab_fldm_DebtInstrumentEarlyRedemptionCostPercentOfMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayment fee, percentage</link:label>
    <link:label id="lab_fldm_DebtInstrumentEarlyRedemptionCostPercentOfMaximumBorrowingCapacity_label_en-US" xlink:label="lab_fldm_DebtInstrumentEarlyRedemptionCostPercentOfMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Early Redemption Cost, Percent Of Maximum Borrowing Capacity</link:label>
    <link:label id="lab_fldm_DebtInstrumentEarlyRedemptionCostPercentOfMaximumBorrowingCapacity_documentation_en-US" xlink:label="lab_fldm_DebtInstrumentEarlyRedemptionCostPercentOfMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Early Redemption Cost, Percent Of Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtInstrumentEarlyRedemptionCostPercentOfMaximumBorrowingCapacity" xlink:href="fldm-20200930.xsd#fldm_DebtInstrumentEarlyRedemptionCostPercentOfMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_DebtInstrumentEarlyRedemptionCostPercentOfMaximumBorrowingCapacity" xlink:to="lab_fldm_DebtInstrumentEarlyRedemptionCostPercentOfMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_851b838e-c65e-46b0-b413-70db4a33323e_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (usd per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicenseMember_62d4d88f-71df-44e2-81a0-1a689633e4c6_terseLabel_en-US" xlink:label="lab_us-gaap_LicenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenue</link:label>
    <link:label id="lab_us-gaap_LicenseMember_70b85d04-4370-4dbb-a3b7-dc22fe13765d_verboseLabel_en-US" xlink:label="lab_us-gaap_LicenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License and royalty revenue</link:label>
    <link:label id="lab_us-gaap_LicenseMember_label_en-US" xlink:label="lab_us-gaap_LicenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicenseMember" xlink:to="lab_us-gaap_LicenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_PatentsandLicenseAgreementsMember_1f313ce0-9f88-48cc-89ac-adfb81b2cb7b_terseLabel_en-US" xlink:label="lab_fldm_PatentsandLicenseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents and licenses</link:label>
    <link:label id="lab_fldm_PatentsandLicenseAgreementsMember_e0645fb9-12c4-4456-b8ab-ee1603df7f87_verboseLabel_en-US" xlink:label="lab_fldm_PatentsandLicenseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents and Licenses Amortization Expense</link:label>
    <link:label id="lab_fldm_PatentsandLicenseAgreementsMember_label_en-US" xlink:label="lab_fldm_PatentsandLicenseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents and License Agreements [Member]</link:label>
    <link:label id="lab_fldm_PatentsandLicenseAgreementsMember_documentation_en-US" xlink:label="lab_fldm_PatentsandLicenseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents and License Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_PatentsandLicenseAgreementsMember" xlink:href="fldm-20200930.xsd#fldm_PatentsandLicenseAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_PatentsandLicenseAgreementsMember" xlink:to="lab_fldm_PatentsandLicenseAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_968d8b5d-9a23-411d-84f1-76dee2483131_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of nonvested performance-based units activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Performance-based Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_a3a0ac2f-23df-41b7-8885-267a677e7a7e_verboseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia-Pacific</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1dc8ed5a-a5ea-491f-a519-b178f3b7971e_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_c39c57d1-75fd-4ac2-9587-c240af89f8de_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_FiveLargestCustomersMember_dbddeb39-e85e-4b95-84aa-8a3555f8641c_terseLabel_en-US" xlink:label="lab_fldm_FiveLargestCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5 Largest Customers</link:label>
    <link:label id="lab_fldm_FiveLargestCustomersMember_label_en-US" xlink:label="lab_fldm_FiveLargestCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Largest Customers [Member]</link:label>
    <link:label id="lab_fldm_FiveLargestCustomersMember_documentation_en-US" xlink:label="lab_fldm_FiveLargestCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Largest Customers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_FiveLargestCustomersMember" xlink:href="fldm-20200930.xsd#fldm_FiveLargestCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_FiveLargestCustomersMember" xlink:to="lab_fldm_FiveLargestCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_efde98dc-0f39-46ee-a08d-e2f35f811794_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_fbb01818-652e-4ae0-ba57-5bb9b710ffbb_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes and Credit Facility</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_43653674-8792-43f7-a234-67bc97f7d0d7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of remaining securities available for future issuance (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_CashCashEquivalentsAndShortTermInvestmentsAmortizedCost_702807d8-3b53-4dc9-94ad-93ffb0d596dd_totalLabel_en-US" xlink:label="lab_fldm_CashCashEquivalentsAndShortTermInvestmentsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_fldm_CashCashEquivalentsAndShortTermInvestmentsAmortizedCost_label_en-US" xlink:label="lab_fldm_CashCashEquivalentsAndShortTermInvestmentsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, And Short Term Investments, Amortized Cost</link:label>
    <link:label id="lab_fldm_CashCashEquivalentsAndShortTermInvestmentsAmortizedCost_documentation_en-US" xlink:label="lab_fldm_CashCashEquivalentsAndShortTermInvestmentsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, And Short Term Investments, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CashCashEquivalentsAndShortTermInvestmentsAmortizedCost" xlink:href="fldm-20200930.xsd#fldm_CashCashEquivalentsAndShortTermInvestmentsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_CashCashEquivalentsAndShortTermInvestmentsAmortizedCost" xlink:to="lab_fldm_CashCashEquivalentsAndShortTermInvestmentsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_CashPaidForOperatingLeaseLiabilitiesAbstract_b8118da7-2871-4d13-9cd7-361a21f12694_terseLabel_en-US" xlink:label="lab_fldm_CashPaidForOperatingLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurement of operating lease liabilities (included in net cash used in operating activities in thousands):</link:label>
    <link:label id="lab_fldm_CashPaidForOperatingLeaseLiabilitiesAbstract_label_en-US" xlink:label="lab_fldm_CashPaidForOperatingLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid For Operating Lease Liabilities [Abstract]</link:label>
    <link:label id="lab_fldm_CashPaidForOperatingLeaseLiabilitiesAbstract_documentation_en-US" xlink:label="lab_fldm_CashPaidForOperatingLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid For Operating Lease Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CashPaidForOperatingLeaseLiabilitiesAbstract" xlink:href="fldm-20200930.xsd#fldm_CashPaidForOperatingLeaseLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_CashPaidForOperatingLeaseLiabilitiesAbstract" xlink:to="lab_fldm_CashPaidForOperatingLeaseLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ComputerEquipmentAndSoftwareMember_921ac52a-d26d-4810-834f-e085d7c17fee_terseLabel_en-US" xlink:label="lab_fldm_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer equipment and software</link:label>
    <link:label id="lab_fldm_ComputerEquipmentAndSoftwareMember_label_en-US" xlink:label="lab_fldm_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment And Software [Member]</link:label>
    <link:label id="lab_fldm_ComputerEquipmentAndSoftwareMember_documentation_en-US" xlink:label="lab_fldm_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment And Software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ComputerEquipmentAndSoftwareMember" xlink:href="fldm-20200930.xsd#fldm_ComputerEquipmentAndSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ComputerEquipmentAndSoftwareMember" xlink:to="lab_fldm_ComputerEquipmentAndSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_e01f197f-aadd-4acb-a93d-03d035952be2_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of disaggregation of revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_fcc6c425-dd5f-49da-bef3-16bdec65d811_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_74b5bde2-d88d-4940-8c2e-11bbcc478381_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_ab71c7fe-2706-4744-adc0-3ceb862356ac_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard Product Warranty Accrual [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard Product Warranty Accrual [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:to="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_1c442af9-71f0-49d9-b6fe-6b397dac524c_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_b3ce8b9e-56cd-4eac-bd92-1fb704d25972_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_dc87dc04-2734-435b-9d74-04d55589b8ce_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_49b50ffc-5f98-4e4a-8196-fa1892f35601_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember_c6049336-6eff-4cdc-8ebd-8d45998c299b_verboseLabel_en-US" xlink:label="lab_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Employee Stock Purchase Plan</link:label>
    <link:label id="lab_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember_58e923af-a398-454a-824f-e1b04ac85584_terseLabel_en-US" xlink:label="lab_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Employee Stock Purchase Plan</link:label>
    <link:label id="lab_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Seventeen Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Seventeen Employee Stock Purchase Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember" xlink:href="fldm-20200930.xsd#fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember" xlink:to="lab_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_288a4a5c-f972-440f-aa23-40cefc7b9526_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for taxes related to net share settlement of equity awards and other</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_847d9ee3-27a0-4e37-86e1-ba6af6a5a5d9_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_3b3b71f6-ba61-4e0f-9cde-b43720c46184_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of cash and available-for-sale securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_67fc8d63-d18c-4680-929e-815cf4bfc75c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_TwoThousandAndSeventeenInducementAwardPlanMember_ff334f14-cb13-44bc-a281-5670ef11c571_verboseLabel_en-US" xlink:label="lab_fldm_TwoThousandAndSeventeenInducementAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Inducement Award Plan</link:label>
    <link:label id="lab_fldm_TwoThousandAndSeventeenInducementAwardPlanMember_label_en-US" xlink:label="lab_fldm_TwoThousandAndSeventeenInducementAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Seventeen Inducement Award Plan [Member]</link:label>
    <link:label id="lab_fldm_TwoThousandAndSeventeenInducementAwardPlanMember_documentation_en-US" xlink:label="lab_fldm_TwoThousandAndSeventeenInducementAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Seventeen Inducement Award Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndSeventeenInducementAwardPlanMember" xlink:href="fldm-20200930.xsd#fldm_TwoThousandAndSeventeenInducementAwardPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_TwoThousandAndSeventeenInducementAwardPlanMember" xlink:to="lab_fldm_TwoThousandAndSeventeenInducementAwardPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_aa74fdab-7e9b-468c-a7ed-3faae1abb670_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice_6ca92f83-37b4-4e7b-9c92-d578ab5cbc1c_terseLabel_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (usd per share)</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice_label_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Exercise Price</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice" xlink:href="fldm-20200930.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice" xlink:to="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_3e6f20b0-3d93-4558-931f-8a5504b9b4e7_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_d99e95e5-8d97-4673-ae49-edd1ef3224f4_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, total</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_5512e33a-77d7-4c22-a965-8ad23ebb1c76_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_38907059-8f30-4fb2-a936-665c95b699b2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_2103794d-c17f-4629-bf16-4ccfcd408943_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_357566d6-1c8a-4b12-a112-0d96c43f4ba7_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash-restricted</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_ec9ad310-18bf-4c37-9a1b-8e4618c53e8f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_8dcefab7-dced-4fbd-886f-41f6e5a746ad_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b881d7f2-42d1-462e-890c-4b502cb8883d_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale, fair value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_CA_b8eaeef6-f1e4-46f1-abf7-387a638dd1b0_terseLabel_en-US" xlink:label="lab_stpr_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CALIFORNIA</link:label>
    <link:label id="lab_stpr_CA_label_en-US" xlink:label="lab_stpr_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CALIFORNIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_CA" xlink:to="lab_stpr_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_e060fb11-5e35-4f0f-9e03-5c0b4e3fb013_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPayments_142ed487-efc2-4680-8a5c-c84187f2a8c3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty costs incurred</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Decrease for Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualPayments" xlink:to="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_13d48308-39d2-4ccb-8ba7-8f796ecba8d4_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_73143029-2858-4eb6-82d3-9f6c32a18f21_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_7c5f5ce6-6b35-433f-8aee-56c4d8bb5f10_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_61fab677-4640-4929-b879-8f7860e67b86_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_1de3193c-78eb-4655-8d91-757d43bfbdb3_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_79fd9dfc-20d2-495f-8b31-bd70a6c90c42_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_d45e7673-059a-431c-832f-165ea4e93913_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_9909efe7-9533-462c-9751-b0cd6e72a1cb_periodStartLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_8664d981-1921-4afb-b2e2-7ba19d013c06_periodEndLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrual" xlink:to="lab_us-gaap_ProductWarrantyAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory_4f37d371-af7a-472f-8b4c-abca16cda49a_terseLabel_en-US" xlink:label="lab_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of eligible inventory</link:label>
    <link:label id="lab_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory_label_en-US" xlink:label="lab_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Inventory</link:label>
    <link:label id="lab_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory_documentation_en-US" xlink:label="lab_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory" xlink:href="fldm-20200930.xsd#fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory" xlink:to="lab_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_3702208e-7499-4352-b165-25ffeb14fa28_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_ce21463e-6086-46c6-9fe3-ed15a40b3d01_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_7bb3b67e-6fc7-4af0-9305-1526481d17f2_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_73ea2f6b-1385-4b28-9a27-8d5ab38289a9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_2e24ca23-addc-4669-a4f8-fc40f39272d4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of restricted cash</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_be10ddd2-6420-4f6d-ad23-fe07fe5dd338_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_b4a34dae-843d-44e5-8c09-da3a665f028a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ed5d4189-643f-4aa8-aae1-21394710faf6_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_3fadcff6-4124-4acb-914d-ab52ac1fcbfb_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_6bbb1e3e-eec0-41aa-95df-361987d5a025_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Activity under stock options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_bb696b9e-b013-4ed8-ab8f-f0abe8a3a75b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Amortization Period</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_346a2eba-c164-4915-8108-3f0027bfd023_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 (remainder of the year)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_a939b588-2277-4a93-ac6a-92e59deecdd4_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_47f71301-bab1-4c9c-aecf-1f3467f88a9e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:to="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_ea827e42-dfdf-4b68-9219-f2db448c131f_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersFundingReceived_c828419f-a7d9-46ce-bc32-d06d3e3b4eaa_terseLabel_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersFundingReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funding received</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersFundingReceived_label_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersFundingReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Funding Received</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersFundingReceived_documentation_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersFundingReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Funding Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersFundingReceived" xlink:href="fldm-20200930.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersFundingReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersFundingReceived" xlink:to="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersFundingReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAmortizationAndAccretionNet_06095920-6c25-4366-8a48-8a4ce2115fa2_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAmortizationAndAccretionNet_label_en-US" xlink:label="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Amortization and Accretion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:to="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_9947bd4f-8630-4c6f-9ea1-2ce800193a26_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_940b80c1-b017-4262-8252-7d80a32982a3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_11e453d0-c2fc-4d85-951f-23818c5cb134_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_dde6db00-89c1-438b-8f68-5ef675427b14_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate per annum</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_84c3a327-a7f0-49ee-b6b2-d7b239714250_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_RevenueFromContractWithCustomerTermsOfPaymentPeriod_319445b4-1925-4897-81ea-ad8628b8eb7e_terseLabel_en-US" xlink:label="lab_fldm_RevenueFromContractWithCustomerTermsOfPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Terms of payment period</link:label>
    <link:label id="lab_fldm_RevenueFromContractWithCustomerTermsOfPaymentPeriod_label_en-US" xlink:label="lab_fldm_RevenueFromContractWithCustomerTermsOfPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer, Terms Of Payment Period</link:label>
    <link:label id="lab_fldm_RevenueFromContractWithCustomerTermsOfPaymentPeriod_documentation_en-US" xlink:label="lab_fldm_RevenueFromContractWithCustomerTermsOfPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer, Terms Of Payment Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_RevenueFromContractWithCustomerTermsOfPaymentPeriod" xlink:href="fldm-20200930.xsd#fldm_RevenueFromContractWithCustomerTermsOfPaymentPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_RevenueFromContractWithCustomerTermsOfPaymentPeriod" xlink:to="lab_fldm_RevenueFromContractWithCustomerTermsOfPaymentPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrantMember_f84b1fdd-c76a-49b8-b299-f446a43e7d27_terseLabel_en-US" xlink:label="lab_us-gaap_GrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant revenue</link:label>
    <link:label id="lab_us-gaap_GrantMember_label_en-US" xlink:label="lab_us-gaap_GrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrantMember" xlink:to="lab_us-gaap_GrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_a0d90783-9b33-4771-a9a3-bd5efb8b0bf0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_73fd3f1b-a86b-4bc2-a30e-4be8dc70161e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized debt issuance cost</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f4a259c6-1f79-474e-8fc1-6a82572eabcf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price per Option</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_9d9b1e2e-b914-43a0-9dc4-d80d6348c419_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reporting segment</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued_c0d3dd6f-f304-4c48-be09-a052dcf8854e_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for current period warranties</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Increase for Warranties Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualWarrantiesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:to="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesCommissionsAndFees_06f4fff2-92d8-4537-82d0-ad760e6e1a4b_terseLabel_en-US" xlink:label="lab_us-gaap_SalesCommissionsAndFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission expense</link:label>
    <link:label id="lab_us-gaap_SalesCommissionsAndFees_label_en-US" xlink:label="lab_us-gaap_SalesCommissionsAndFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Commissions and Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesCommissionsAndFees" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesCommissionsAndFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesCommissionsAndFees" xlink:to="lab_us-gaap_SalesCommissionsAndFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VehiclesMember_7dbc7229-adf8-4f51-9e0c-2619e191b840_terseLabel_en-US" xlink:label="lab_us-gaap_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use vehicles</link:label>
    <link:label id="lab_us-gaap_VehiclesMember_label_en-US" xlink:label="lab_us-gaap_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vehicles [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VehiclesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VehiclesMember" xlink:to="lab_us-gaap_VehiclesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_c191cca5-0999-487c-93c6-2a8906118292_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_94f4c149-ce2d-41ba-982d-6a449de20647_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock on bond conversion</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_044f9326-b3a4-4710-ba38-e1e80a4c5bf0_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_dd61a605-e1f7-4dc1-b0b0-95a1d30e6dd7_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_959c7ba5-f2a5-460d-825f-aac4fe709026_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable (net of allowances of $324 and $6, at September 30, 2020 and December&#160;31, 2019, respectively)</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0298e92f-0a6c-4440-93de-4988e94fa0af_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future minimum payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentAbstract_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract" xlink:to="lab_us-gaap_ResearchAndDevelopmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_64fe8f62-2a9a-41e1-8298-11d09fdb4780_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_144e2297-963e-434e-b12f-54fe3e5f2099_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_86642c8e-7f8d-46be-8cc4-a74cc1b76059_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_28b3cff4-bc04-4914-b636-a2106a0d96a1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Loss</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_aecbf886-8295-4b59-b8a9-fc788c88b35f_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_f2e632fa-8cc8-4a6b-a055-9238533deb00_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_13d2cadf-1478-4533-8814-48aebc1a0715_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_TwoThousandAndNineteenConvertibleNotesMember_057eb761-1f88-4e86-a0de-26ffab6adbb4_terseLabel_en-US" xlink:label="lab_fldm_TwoThousandAndNineteenConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Convertible Notes</link:label>
    <link:label id="lab_fldm_TwoThousandAndNineteenConvertibleNotesMember_label_en-US" xlink:label="lab_fldm_TwoThousandAndNineteenConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Nineteen Convertible Notes [Member]</link:label>
    <link:label id="lab_fldm_TwoThousandAndNineteenConvertibleNotesMember_documentation_en-US" xlink:label="lab_fldm_TwoThousandAndNineteenConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Nineteen Convertible Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndNineteenConvertibleNotesMember" xlink:href="fldm-20200930.xsd#fldm_TwoThousandAndNineteenConvertibleNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_TwoThousandAndNineteenConvertibleNotesMember" xlink:to="lab_fldm_TwoThousandAndNineteenConvertibleNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_e1bae22d-982a-4041-8d47-82f2dc1a8fb6_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in computing net loss per share, basic and diluted (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_4c21569b-eb0e-4f9f-a517-65df3b6086ce_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption, Period Two</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_248dc8e6-5130-47f6-9aa7-1421b2bf916b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price of common stock, percent</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_0a5208ec-9959-4848-9067-aa5195b33211_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_cf951ce6-2e8b-42cb-8d1a-4b340cb326ba_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquired on acquisition</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_d81e8e2d-b448-4246-9036-c82fa4dbb6f1_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a483465d-86b0-48cb-a5e7-23016b4c160b_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3c233197-3607-4463-bc9f-95d10bec0d20_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_e8752d53-41e8-47f2-a178-a7e640f09846_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_1ec71950-2803-4017-9f95-deededf90268_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_b203d735-516b-47a2-9ef8-7af4e8a1c09d_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_6fb8d076-0281-4525-8f99-974057790954_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_d18fd86b-0892-4012-ac3a-224eb9d7df4c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Par Value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_53380d8e-4ef9-49a4-b3f3-1529fece1b82_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_1ff70c34-077d-4973-a369-0c562c0d8c55_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_f493c34e-c0a6-4a71-b6cb-ca514b3be834_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_e243f9d4-9551-4f15-92de-7e50fd450ce4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options forfeited (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_47abde46-16bd-4f43-9132-0c4b71c6c551_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EMEAMember_822ceddb-ce0e-43ea-bada-7890d9f68051_terseLabel_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA</link:label>
    <link:label id="lab_us-gaap_EMEAMember_label_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EMEAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EMEAMember" xlink:to="lab_us-gaap_EMEAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_83cab999-1eab-4ac9-8106-a06de926c5cb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity issuance costs</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_6f87a2bf-0417-403f-b0ca-bac3e5e1abbe_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity issuance costs</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_729271b3-102c-495c-bb83-bf3aa616df12_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_f76db519-832a-4fa7-911f-e94d89d00195_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, current</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_2659ecf8-2865-41cb-ad90-756a1564912b_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7b75081b-6d73-4d6b-86d1-15b6857d8bae_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_e020a508-299b-4bf8-b96e-bc34d57af635_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_7be72b47-e2d7-4c98-b69f-12a28045b079_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_627ab33c-3f35-4ce4-a8f1-6fd32154389c_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_7a988696-fe3c-4d6e-9c29-b87559bc17cf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated future intangible asset amortization expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_a53df9c4-a518-45ef-82aa-7222aa25bc4d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_c00929d5-aabc-4cee-9dbe-7711a7fec699_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_EquityIncentivePlanTwentyElevenMember_a31b3050-c647-45aa-bcd4-b1cfb47916aa_terseLabel_en-US" xlink:label="lab_fldm_EquityIncentivePlanTwentyElevenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2011 Equity Incentive Plan</link:label>
    <link:label id="lab_fldm_EquityIncentivePlanTwentyElevenMember_label_en-US" xlink:label="lab_fldm_EquityIncentivePlanTwentyElevenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plan Twenty Eleven [Member]</link:label>
    <link:label id="lab_fldm_EquityIncentivePlanTwentyElevenMember_documentation_en-US" xlink:label="lab_fldm_EquityIncentivePlanTwentyElevenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plan Twenty Eleven [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_EquityIncentivePlanTwentyElevenMember" xlink:href="fldm-20200930.xsd#fldm_EquityIncentivePlanTwentyElevenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_EquityIncentivePlanTwentyElevenMember" xlink:to="lab_fldm_EquityIncentivePlanTwentyElevenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_AwardsHeldByOwnersOfMoreThan10OfCommonStockMember_6d1c77ad-0abe-444c-8b9d-c73dbf3e2ebf_terseLabel_en-US" xlink:label="lab_fldm_AwardsHeldByOwnersOfMoreThan10OfCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options held by owners of more than 10% of common stock</link:label>
    <link:label id="lab_fldm_AwardsHeldByOwnersOfMoreThan10OfCommonStockMember_label_en-US" xlink:label="lab_fldm_AwardsHeldByOwnersOfMoreThan10OfCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Held By Owners Of More Than 10% Of Common Stock [Member]</link:label>
    <link:label id="lab_fldm_AwardsHeldByOwnersOfMoreThan10OfCommonStockMember_documentation_en-US" xlink:label="lab_fldm_AwardsHeldByOwnersOfMoreThan10OfCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Held By Owners Of More Than 10% Of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_AwardsHeldByOwnersOfMoreThan10OfCommonStockMember" xlink:href="fldm-20200930.xsd#fldm_AwardsHeldByOwnersOfMoreThan10OfCommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_AwardsHeldByOwnersOfMoreThan10OfCommonStockMember" xlink:to="lab_fldm_AwardsHeldByOwnersOfMoreThan10OfCommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_ed9bb28e-195f-4200-99f9-1400a13f15ba_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a392fdc0-e3e1-4273-82c1-d42f5976469a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_fe927bc7-bff8-4c5e-80b2-23203b5f11f9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_527eb452-d4a0-4250-8f22-6799c3708669_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_89b316d5-d50e-4a96-ad92-45bea60b2db8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets acquired:</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_53ab15fa-6148-4b39-8f54-513229a6361b_terseLabel_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:to="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_5b837bb4-a8e8-4c97-8ab6-4a22f0ea889f_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt discounts, premiums and issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_b840062b-6d68-482a-9ceb-d4424ff6bbc4_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_0b3a0b1e-61cc-42b5-82a9-86527b78fd96_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining performance obligation, expected revenue</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_d64225c7-c53b-46b8-b3ae-1b6a48769dc5_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_56782dd7-c233-4140-bb4c-128ae247adbb_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_9d8d020b-2638-4d8b-9737-5ee8c9e5d197_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under ESPP</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermInvestments_67f0f3ca-3f77-4c92-b604-72078f6cf6f8_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale, cash-restricted</link:label>
    <link:label id="lab_us-gaap_LongTermInvestments_label_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermInvestments" xlink:to="lab_us-gaap_LongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_6cca08c8-9724-4759-9816-b7b6bd231a08_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock: $0.001 par value, 200,000 shares authorized at September&#160;30, 2020 and December&#160;31, 2019; 74,115 and 69,956 shares issued and outstanding at September&#160;30, 2020 and December&#160;31, 2019, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementReceivables_839a4134-5ec9-4726-8226-4ae09f207bbf_verboseLabel_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementReceivables" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant receivable</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementReceivables_7a6ff554-7eaf-487d-a10e-2bffb5f725dd_totalLabel_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementReceivables" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant receivable from RADx</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementReceivables_label_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Receivables</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementReceivables_documentation_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementReceivables" xlink:href="fldm-20200930.xsd#fldm_ResearchAndDevelopmentArrangementReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ResearchAndDevelopmentArrangementReceivables" xlink:to="lab_fldm_ResearchAndDevelopmentArrangementReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e5812d66-96c8-48ff-8f41-ec2b5cd24052_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_a2507561-d787-4733-a77e-cfe43589cea9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_a572b8e0-2edd-4b4e-b043-5229f1cfd0b4_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_04cf3c01-a651-4ab4-9fe1-74e7387f2866_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_EmployeeStockPurchasePlanNumberOfSixMonthOfferingPeriods_618ecd5f-0ccd-426e-a077-02f932021ff2_terseLabel_en-US" xlink:label="lab_fldm_EmployeeStockPurchasePlanNumberOfSixMonthOfferingPeriods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP, number of six-month offering periods</link:label>
    <link:label id="lab_fldm_EmployeeStockPurchasePlanNumberOfSixMonthOfferingPeriods_label_en-US" xlink:label="lab_fldm_EmployeeStockPurchasePlanNumberOfSixMonthOfferingPeriods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan, Number Of Six Month Offering Periods</link:label>
    <link:label id="lab_fldm_EmployeeStockPurchasePlanNumberOfSixMonthOfferingPeriods_documentation_en-US" xlink:label="lab_fldm_EmployeeStockPurchasePlanNumberOfSixMonthOfferingPeriods" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan, Number Of Six Month Offering Periods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_EmployeeStockPurchasePlanNumberOfSixMonthOfferingPeriods" xlink:href="fldm-20200930.xsd#fldm_EmployeeStockPurchasePlanNumberOfSixMonthOfferingPeriods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_EmployeeStockPurchasePlanNumberOfSixMonthOfferingPeriods" xlink:to="lab_fldm_EmployeeStockPurchasePlanNumberOfSixMonthOfferingPeriods" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue_61d6240d-e8c2-4bc1-b0e5-53dbeb8b92aa_terseLabel_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue_label_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Vested Aggregate Intrinsic Value</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue_documentation_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award, Options, Vested, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue" xlink:href="fldm-20200930.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue" xlink:to="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_ea84fe9d-d0c4-49ee-ba31-d5de7040a361_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_14c5e24b-3d9a-4bae-b029-1ed364580f46_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_483c40b3-2c1c-4b66-8cdc-e19fa29a5f86_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_8b3a9806-16fa-451b-8277-588d4ed82328_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_5474a2de-dd5f-4b87-b5d3-b6fd076d5bc4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_fafdeece-651c-4108-be3a-032bdf484c25_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_5540a4ab-0d11-4a3d-a9a3-898727e061d0_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of identifiable net assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_5388baf1-d350-4414-a5be-c12427f76f4c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_63f829b8-8fcd-4c5f-8146-9e3787699974_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting percentage</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_8744794a-0a43-4e93-88fe-48e335dfea47_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development Agreement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_6821b631-b7ef-4815-96a0-701f63662d79_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f1cbe816-05d2-4fc2-a2d8-46d618bdba26_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_4c6c0479-1c35-4c03-b9aa-6dfebeeb0142_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_5fc66885-ad6e-4a2d-8e67-ae9c69c0da43_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_44af1b68-dbfb-491c-a22b-cca68581d6b8_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_aadb37e4-84c5-408c-b990-bf28982c5443_netLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement_7a808fdc-eef5-4a19-9298-bca0c6718456_terseLabel_en-US" xlink:label="lab_fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of months over which options vest ratably</link:label>
    <link:label id="lab_fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement_label_en-US" xlink:label="lab_fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Months To Vest Ratably After First Anniversary Of Vesting Commencement</link:label>
    <link:label id="lab_fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement_documentation_en-US" xlink:label="lab_fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Months To Vest Ratably After First Anniversary Of Vesting Commencement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement" xlink:href="fldm-20200930.xsd#fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement" xlink:to="lab_fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_a04ae64b-86fe-425b-8672-f185e04b0424_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable" xlink:to="lab_us-gaap_ScheduleOfProductInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtPolicyTextBlock_ad998b63-6802-4cb0-b8e2-bc18c1951973_terseLabel_en-US" xlink:label="lab_us-gaap_DebtPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes</link:label>
    <link:label id="lab_us-gaap_DebtPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtPolicyTextBlock" xlink:to="lab_us-gaap_DebtPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfOtherInvestments_36328048-32c7-4c12-b4ce-5b6e68a0feda_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfOtherInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Other Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfOtherInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfOtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfOtherInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfOtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherReceivables_0ceb40fe-b156-4857-b063-a84ce32e2be7_terseLabel_en-US" xlink:label="lab_fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherReceivables_label_en-US" xlink:label="lab_fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Receivables</link:label>
    <link:label id="lab_fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherReceivables_documentation_en-US" xlink:label="lab_fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherReceivables" xlink:href="fldm-20200930.xsd#fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherReceivables" xlink:to="lab_fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_6f53d9ce-cbe2-4376-8acf-cb6e19f5a291_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_fde22d43-3e76-4dfd-a35e-14ee451c8b17_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_b71ce3e5-713b-48cd-a9d5-7e031c800600_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_596fbc0c-a70d-4817-b235-627f524bbb0d_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguished</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_8f0d7ce6-d84c-40df-995e-d73ee2342f9c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_7c16be2f-29b4-4d97-afc7-5e61327d1c0e_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_ad959d01-4412-4262-b105-9b783de6407f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a99bddf7-79b2-4da9-b491-d55cde54e4fb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_0ea20452-d27e-471c-b01e-b4641f83ae9f_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_7a6cb2c2-b102-492c-b5c6-6b0907a2b5e6_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_0855b6ce-b6d0-449a-9d7d-5acf933bf1bb_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_d6f9476e-9851-4b20-8fa6-27c3cf3543f3_negatedLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative-effect of new accounting standard for Topic 326 Credit Losses</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_6b96ccae-6561-4209-b6d4-ad52fc11e377_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_0011acf3-0d19-4fea-ac0f-7040affb9466_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_26b98df6-2985-447b-b26a-961231747782_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_71b076e3-3fa3-4cde-93ec-8de51663a988_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_b612bbd7-82c1-4fca-b4d7-899a67f8d7cf_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price (shares)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_dc522a06-af26-43af-9840-1a3711ebd904_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment fee amount</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f994b228-a238-4865-b924-42a69810b007_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_27e673a2-e8dd-4888-9691-43fb0c4fea8a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock_a92d8635-d049-4751-a2cc-c72ca585dce3_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Research and Development Activity Under NIH Contract</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_3d24b5cc-fa28-4f8e-ad73-3e4d26944f6f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_8d5b04f2-cf4e-458c-83a6-741fe13b7443_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_9236bc19-4e0a-4518-a24d-27c4ff3c3cfe_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental compensation cost</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Plan Modification, Incremental Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_8922fdfd-7cb7-4acc-96f5-4e1d11ed153a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and related benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_6f7d0ebf-8a57-48d8-b6ce-b7aeb164aca8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_bd1fb992-574a-4004-86d7-4d185edd09a7_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_6d4746ad-be06-4a9a-862c-0753057aaa06_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost (including variable costs)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_84698e49-e86f-4816-b651-e4859ca1dfcf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum employee subscription rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_a5f4453b-ab7b-4515-bcd0-f1583dfc58fa_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e797d970-a899-448b-9b80-1048283c2140_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive securities excluded from computations of net loss per share (shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_2b0925e0-d39c-48b5-8fd7-3fbac3fc9f04_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product revenue</link:label>
    <link:label id="lab_us-gaap_ProductMember_8850458a-6114-4954-885d-07b9a6224cbb_verboseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product revenue</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_76fe00fc-1d04-4229-bd84-ef6e55f5d100_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on disposal of property and equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_52ac5288-3045-4156-b645-b4f38b7c3434_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_b9a94646-d1e6-4795-b3c7-9d197455497c_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_3c93b077-8548-4cf3-938a-151bbb78834d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_dfbaac52-bc02-405c-a799-27d065044486_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_3e3cacbe-b412-4b3b-9562-01a2f56af692_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_f7b566e6-0389-4a5b-8f53-d637aa22fd6c_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_b8676a96-52d7-4f8d-a1cf-8da52a77dca5_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_RestrictedStockAndPerformanceShareUnitsMember_853ac490-6a52-43b7-b2d5-db9929952544_terseLabel_en-US" xlink:label="lab_fldm_RestrictedStockAndPerformanceShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units</link:label>
    <link:label id="lab_fldm_RestrictedStockAndPerformanceShareUnitsMember_label_en-US" xlink:label="lab_fldm_RestrictedStockAndPerformanceShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock And Performance Share Units [Member]</link:label>
    <link:label id="lab_fldm_RestrictedStockAndPerformanceShareUnitsMember_documentation_en-US" xlink:label="lab_fldm_RestrictedStockAndPerformanceShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock And Performance Share Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_RestrictedStockAndPerformanceShareUnitsMember" xlink:href="fldm-20200930.xsd#fldm_RestrictedStockAndPerformanceShareUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_RestrictedStockAndPerformanceShareUnitsMember" xlink:to="lab_fldm_RestrictedStockAndPerformanceShareUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_5f62647b-45b4-4181-a62b-9987078c87eb_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Plans</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_61c3e10d-6e5e-4f0d-aba6-128f94796271_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_43a266af-6ee5-49e8-8f54-679dc0ce2975_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_baf7fffd-262f-44dd-afe7-6ddd3a0ee3c8_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_efa2348d-444a-4538-beb0-097d68d09d57_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 (remainder of year)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_f4f8a82f-b900-4e85-95f3-654a1c65edae_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_baad4117-31a5-42a0-98be-0f3289160d3d_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_0f295812-03c1-4ddb-9695-bff9c78d57c1_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_57657d77-cc24-4397-b391-7af5f1a12847_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_1647b71c-b646-43c0-a7fd-77b652a8cba7_terseLabel_en-US" xlink:label="lab_fldm_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_fldm_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_label_en-US" xlink:label="lab_fldm_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, To Be Paid, After Year Four</link:label>
    <link:label id="lab_fldm_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_documentation_en-US" xlink:label="lab_fldm_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, To Be Paid, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:href="fldm-20200930.xsd#fldm_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:to="lab_fldm_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3abd80df-3db4-4460-92b1-01b195749602_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_AssetRetirementObligationsIncurredButNotYetPaid_750d08ad-f376-4c01-84c7-726d56733d71_terseLabel_en-US" xlink:label="lab_fldm_AssetRetirementObligationsIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset retirement obligations</link:label>
    <link:label id="lab_fldm_AssetRetirementObligationsIncurredButNotYetPaid_label_en-US" xlink:label="lab_fldm_AssetRetirementObligationsIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Retirement Obligations Incurred But Not Yet Paid</link:label>
    <link:label id="lab_fldm_AssetRetirementObligationsIncurredButNotYetPaid_documentation_en-US" xlink:label="lab_fldm_AssetRetirementObligationsIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Retirement Obligations Incurred But Not Yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_AssetRetirementObligationsIncurredButNotYetPaid" xlink:href="fldm-20200930.xsd#fldm_AssetRetirementObligationsIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_AssetRetirementObligationsIncurredButNotYetPaid" xlink:to="lab_fldm_AssetRetirementObligationsIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_d68325b8-4a4f-4e9d-80f8-e282f424dc41_terseLabel_en-US" xlink:label="lab_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_label_en-US" xlink:label="lab_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, After Year Four</link:label>
    <link:label id="lab_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_documentation_en-US" xlink:label="lab_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:href="fldm-20200930.xsd#fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:to="lab_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_13d13a51-bb60-4d61-997a-1bf24427e728_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_dbc2099d-ce64-45a6-b6b5-382e38ce2448_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_df3ff145-b451-48cb-a59b-e2aaa5ba3521_verboseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Amortization Expense</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b526dfab-ae82-44be-a4d7-4993c0a12f24_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_850199ec-4a88-45c7-bc77-44b1a9c36e73_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Options (000s)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_0369712d-04b0-457a-824e-3aacfa30914a_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_46f91fd6-5323-4d22-ba19-7c603b34f53b_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, non-current</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_17ab643d-544c-4d98-832c-c1523b5912a0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_9adf9d5a-8c4d-467d-ac86-d27d2e2f1b14_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosures of cash flow information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_InitialConversionPriceOfStock_997571f9-a9d2-41a4-8f08-992b19787d55_terseLabel_en-US" xlink:label="lab_fldm_InitialConversionPriceOfStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion price of stock (usd per share)</link:label>
    <link:label id="lab_fldm_InitialConversionPriceOfStock_label_en-US" xlink:label="lab_fldm_InitialConversionPriceOfStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Conversion Price Of Stock</link:label>
    <link:label id="lab_fldm_InitialConversionPriceOfStock_documentation_en-US" xlink:label="lab_fldm_InitialConversionPriceOfStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Conversion Price Of Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_InitialConversionPriceOfStock" xlink:href="fldm-20200930.xsd#fldm_InitialConversionPriceOfStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_InitialConversionPriceOfStock" xlink:to="lab_fldm_InitialConversionPriceOfStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_130c2007-3c94-4371-be22-20941411c82d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_3661d82f-ff1d-4f55-8915-a07dec89631f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under ESPP (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_5b7bbc7e-311e-4ca5-97b3-f32f6169141f_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_a3b5f88c-99c8-45d3-8224-ff0340a553f2_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_1acc7151-30da-48e1-b946-f763cd34a73e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_20828440-51f6-40b9-a788-a2fd929c8990_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustment</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_fe5876be-5bd2-4cfa-ae9c-8698ca6949eb_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_8487aea9-d438-4f30-908a-e8cd0701d6d0_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseDiscountRate_c224b8ca-dca1-4e71-a2b7-d0e4cef67c9d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseDiscountRate_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:to="lab_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_4c7c93a9-5e30-408b-b84b-84ed5bbb945c_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_c6c29420-7a0e-4461-8323-e3635865a48d_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_f0093024-a934-42a0-9def-37475f7fdc27_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Concentration Risk</link:label>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicConcentrationRiskMember" xlink:to="lab_us-gaap_GeographicConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_28b7eca7-6090-40bc-825c-a48b50cc48b4_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_LaboratoryAndManufacturingEquipmentMember_6c47c4ed-383d-46ed-bb4a-602cb71319c1_terseLabel_en-US" xlink:label="lab_fldm_LaboratoryAndManufacturingEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory and manufacturing equipment</link:label>
    <link:label id="lab_fldm_LaboratoryAndManufacturingEquipmentMember_label_en-US" xlink:label="lab_fldm_LaboratoryAndManufacturingEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory And Manufacturing Equipment [Member]</link:label>
    <link:label id="lab_fldm_LaboratoryAndManufacturingEquipmentMember_documentation_en-US" xlink:label="lab_fldm_LaboratoryAndManufacturingEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory And Manufacturing Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LaboratoryAndManufacturingEquipmentMember" xlink:href="fldm-20200930.xsd#fldm_LaboratoryAndManufacturingEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_LaboratoryAndManufacturingEquipmentMember" xlink:to="lab_fldm_LaboratoryAndManufacturingEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_ea7cf2a8-300d-4084-9ce0-9812a54460c0_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US treasury securities</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables_bf3c77f7-b7a8-486b-94f4-01766d4afe47_terseLabel_en-US" xlink:label="lab_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of eligible receivables</link:label>
    <link:label id="lab_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables_label_en-US" xlink:label="lab_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Receivables</link:label>
    <link:label id="lab_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables_documentation_en-US" xlink:label="lab_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables" xlink:href="fldm-20200930.xsd#fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables" xlink:to="lab_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_82a43e6b-5d35-4e56-ac14-39b4dc65bc59_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock from at-the-market offering, net of issuance costs (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_c4eec72c-5671-4fa5-ad7a-3cac52b20e4c_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_639dd1d3-5af7-4258-a6c9-e3bd6cd4c658_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_SeniorConvertibleNotesDue2024Member_0516ab73-9dbb-4907-b6a9-dfa2eec5480f_terseLabel_en-US" xlink:label="lab_fldm_SeniorConvertibleNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Convertible Notes Due 2024</link:label>
    <link:label id="lab_fldm_SeniorConvertibleNotesDue2024Member_fdd387fd-c6d9-4e6a-b32f-6998c9a7ee19_verboseLabel_en-US" xlink:label="lab_fldm_SeniorConvertibleNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.25% 2019 Notes due 2024</link:label>
    <link:label id="lab_fldm_SeniorConvertibleNotesDue2024Member_07e00cb5-fd90-412b-a05f-4f208dbb7fb0_netLabel_en-US" xlink:label="lab_fldm_SeniorConvertibleNotesDue2024Member" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Notes</link:label>
    <link:label id="lab_fldm_SeniorConvertibleNotesDue2024Member_label_en-US" xlink:label="lab_fldm_SeniorConvertibleNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Convertible Notes Due 2024 [Member]</link:label>
    <link:label id="lab_fldm_SeniorConvertibleNotesDue2024Member_documentation_en-US" xlink:label="lab_fldm_SeniorConvertibleNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Convertible Notes Due 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeniorConvertibleNotesDue2024Member" xlink:href="fldm-20200930.xsd#fldm_SeniorConvertibleNotesDue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_SeniorConvertibleNotesDue2024Member" xlink:to="lab_fldm_SeniorConvertibleNotesDue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_5b06fb22-8a3a-470d-a426-4f5ccae340cf_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_4a265d11-fc29-40cc-80cd-b8cb1f50ec1e_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_CollaborativeArrangementTerm_612150b0-d4bb-4298-8f7b-c672562d4b9e_terseLabel_en-US" xlink:label="lab_fldm_CollaborativeArrangementTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration agreement, term</link:label>
    <link:label id="lab_fldm_CollaborativeArrangementTerm_label_en-US" xlink:label="lab_fldm_CollaborativeArrangementTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Term</link:label>
    <link:label id="lab_fldm_CollaborativeArrangementTerm_documentation_en-US" xlink:label="lab_fldm_CollaborativeArrangementTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CollaborativeArrangementTerm" xlink:href="fldm-20200930.xsd#fldm_CollaborativeArrangementTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_CollaborativeArrangementTerm" xlink:to="lab_fldm_CollaborativeArrangementTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_f5dd689e-db7d-4781-8a4f-a0f155906812_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate on notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_7308b242-587c-42f6-a91e-d8a0ca6b38f5_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock on bond conversion (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_d8e801a2-ada4-40c4-b806-96568043975c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of debt into common stock (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_8c96e289-a87d-4b88-9b3b-99906b4de0d7_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_666702a9-b390-41b9-940b-632522f97392_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining performance obligation, expected timing of satisfaction</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_1648d0cb-858a-4635-a986-5147fa68b35d_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_69386f8b-a31d-4282-a890-3c8f9e2e1c25_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_9b7b85e0-ff14-4906-822d-ebe06aec223f_terseLabel_en-US" xlink:label="lab_fldm_ScheduleOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_label_en-US" xlink:label="lab_fldm_ScheduleOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_documentation_en-US" xlink:label="lab_fldm_ScheduleOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Significant Accounting Policies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems" xlink:href="fldm-20200930.xsd#fldm_ScheduleOfSignificantAccountingPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems" xlink:to="lab_fldm_ScheduleOfSignificantAccountingPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_7d2a393f-269f-490f-b0df-500bbde7001b_terseLabel_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenue</link:label>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductAndServiceOtherMember" xlink:to="lab_us-gaap_ProductAndServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_97f6b7af-6bd6-4ae6-9a18-84bf2e3a3d1f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock from option exercises (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d1bdae36-862b-4941-9553-6c1629114b7a_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option exercised (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b70772d6-81a4-4d3f-9892-1120c3fc36f5_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_SaleOfStockConsiderationReceivableOnTransaction_55b94c09-30c1-45a8-93c5-78dd49fd9fb6_terseLabel_en-US" xlink:label="lab_fldm_SaleOfStockConsiderationReceivableOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum aggregate sale proceeds</link:label>
    <link:label id="lab_fldm_SaleOfStockConsiderationReceivableOnTransaction_label_en-US" xlink:label="lab_fldm_SaleOfStockConsiderationReceivableOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Consideration Receivable On Transaction</link:label>
    <link:label id="lab_fldm_SaleOfStockConsiderationReceivableOnTransaction_documentation_en-US" xlink:label="lab_fldm_SaleOfStockConsiderationReceivableOnTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Consideration Receivable On Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SaleOfStockConsiderationReceivableOnTransaction" xlink:href="fldm-20200930.xsd#fldm_SaleOfStockConsiderationReceivableOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_SaleOfStockConsiderationReceivableOnTransaction" xlink:to="lab_fldm_SaleOfStockConsiderationReceivableOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_dc7ec651-fd83-470c-9fa5-3650f2f41acb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_5e85fcf9-3b95-4fab-9fd2-43e87dbfaffc_verboseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of future minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_a544057d-74e4-414d-995d-e85ec37531d3_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options, restricted stock units and performance awards</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_aecb3516-975d-443f-b385-43c90297b9ec_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities To Be Issued Upon Exercise Of Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ec5afc96-3e46-4286-86af-812208b8d121_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Consolidation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_SharebasedCompensationArrangementbySharebasedPaymentAwardVestingRestrictionsOwnershipPercentageofVotingStock_7a845631-2dcd-47e9-9380-1b72e4ff2616_terseLabel_en-US" xlink:label="lab_fldm_SharebasedCompensationArrangementbySharebasedPaymentAwardVestingRestrictionsOwnershipPercentageofVotingStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of voting power which impacts the term of equity incentive plan</link:label>
    <link:label id="lab_fldm_SharebasedCompensationArrangementbySharebasedPaymentAwardVestingRestrictionsOwnershipPercentageofVotingStock_label_en-US" xlink:label="lab_fldm_SharebasedCompensationArrangementbySharebasedPaymentAwardVestingRestrictionsOwnershipPercentageofVotingStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Vesting Restrictions, Ownership Percentage of Voting Stock</link:label>
    <link:label id="lab_fldm_SharebasedCompensationArrangementbySharebasedPaymentAwardVestingRestrictionsOwnershipPercentageofVotingStock_documentation_en-US" xlink:label="lab_fldm_SharebasedCompensationArrangementbySharebasedPaymentAwardVestingRestrictionsOwnershipPercentageofVotingStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Vesting Restrictions, Ownership Percentage of Voting Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SharebasedCompensationArrangementbySharebasedPaymentAwardVestingRestrictionsOwnershipPercentageofVotingStock" xlink:href="fldm-20200930.xsd#fldm_SharebasedCompensationArrangementbySharebasedPaymentAwardVestingRestrictionsOwnershipPercentageofVotingStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_SharebasedCompensationArrangementbySharebasedPaymentAwardVestingRestrictionsOwnershipPercentageofVotingStock" xlink:to="lab_fldm_SharebasedCompensationArrangementbySharebasedPaymentAwardVestingRestrictionsOwnershipPercentageofVotingStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_3844dab2-699e-49d7-a9cf-40346865170b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_e0581c1d-391e-40db-a948-e0cabcee26ee_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_8440c23e-cdda-47de-a049-8a0095b0812a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options forfeited (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_99feb26e-a83f-422b-84f0-659075a8526f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of investment in unrealized loss positions</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_b8645aa4-f9b5-45eb-a2f9-18cd7c0b3b4f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_fbbfc440-ce94-4cc3-914b-b7ce58a55cd5_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash-unrestricted</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_DebtAndEquityOfferingCosts_186a5c68-c47e-4c9c-892d-d93a8bd57851_terseLabel_en-US" xlink:label="lab_fldm_DebtAndEquityOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and equity offering costs</link:label>
    <link:label id="lab_fldm_DebtAndEquityOfferingCosts_label_en-US" xlink:label="lab_fldm_DebtAndEquityOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt And Equity Offering Costs</link:label>
    <link:label id="lab_fldm_DebtAndEquityOfferingCosts_documentation_en-US" xlink:label="lab_fldm_DebtAndEquityOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt And Equity Offering Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtAndEquityOfferingCosts" xlink:href="fldm-20200930.xsd#fldm_DebtAndEquityOfferingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_DebtAndEquityOfferingCosts" xlink:to="lab_fldm_DebtAndEquityOfferingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_8fa66d49-4a3c-4866-96fb-d356ffc85c7f_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_PortionOfStockOptionsVestOnFirstAnniversary_2310aa73-962d-4032-907b-27caf232c02b_terseLabel_en-US" xlink:label="lab_fldm_PortionOfStockOptionsVestOnFirstAnniversary" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate at which outstanding options vest on the first anniversary of the option grant date</link:label>
    <link:label id="lab_fldm_PortionOfStockOptionsVestOnFirstAnniversary_label_en-US" xlink:label="lab_fldm_PortionOfStockOptionsVestOnFirstAnniversary" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion Of Stock Options Vest On First Anniversary</link:label>
    <link:label id="lab_fldm_PortionOfStockOptionsVestOnFirstAnniversary_documentation_en-US" xlink:label="lab_fldm_PortionOfStockOptionsVestOnFirstAnniversary" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion Of Stock Options Vest On First Anniversary</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_PortionOfStockOptionsVestOnFirstAnniversary" xlink:href="fldm-20200930.xsd#fldm_PortionOfStockOptionsVestOnFirstAnniversary"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_PortionOfStockOptionsVestOnFirstAnniversary" xlink:to="lab_fldm_PortionOfStockOptionsVestOnFirstAnniversary" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_5e023eaa-9227-472e-b626-b95f620fce90_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_5adf0a39-64dc-4b29-a197-e780e8008478_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_4fb6881d-b474-41a8-bbf5-c3ff0ba9044d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_c08c9ac5-dd7a-4bf0-b68c-10f4d995110d_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_LineOfCreditFacilityPercentageOfInterestOnObligationUponDefault_425f8ead-874a-4d98-a366-af2c8671fc15_terseLabel_en-US" xlink:label="lab_fldm_LineOfCreditFacilityPercentageOfInterestOnObligationUponDefault" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of interest on obligation upon default</link:label>
    <link:label id="lab_fldm_LineOfCreditFacilityPercentageOfInterestOnObligationUponDefault_label_en-US" xlink:label="lab_fldm_LineOfCreditFacilityPercentageOfInterestOnObligationUponDefault" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Percentage Of Interest On Obligation Upon Default</link:label>
    <link:label id="lab_fldm_LineOfCreditFacilityPercentageOfInterestOnObligationUponDefault_documentation_en-US" xlink:label="lab_fldm_LineOfCreditFacilityPercentageOfInterestOnObligationUponDefault" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Percentage Of Interest On Obligation Upon Default</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LineOfCreditFacilityPercentageOfInterestOnObligationUponDefault" xlink:href="fldm-20200930.xsd#fldm_LineOfCreditFacilityPercentageOfInterestOnObligationUponDefault"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_LineOfCreditFacilityPercentageOfInterestOnObligationUponDefault" xlink:to="lab_fldm_LineOfCreditFacilityPercentageOfInterestOnObligationUponDefault" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_e15801e5-8bd4-4f64-801c-93059e68e828_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_0b5a8ad2-4540-4f14-9c64-287bc5a6d74c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value of debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_12e808dc-776b-4e24-8842-884e0ce49ebe_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_f0a38d0b-8ffa-49cb-a83b-3670b24a1a59_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_72ef5ca0-01f3-4563-b14e-88dd4956254c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for income taxes, net of refunds</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_eac1bcbc-0bbf-40dc-a84c-2a478b5090df_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Activity under restricted stock units</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5e160c19-c1ed-4dbe-baf0-3ef3babf57d7_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9c34e20f-6724-4185-baf6-1b781417a3c1_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_70bdc35d-a13c-40d2-8f00-9786489aa562_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_DevelopmentRevenueMember_9504d97b-3665-484e-81fb-7de192891800_terseLabel_en-US" xlink:label="lab_fldm_DevelopmentRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development revenue</link:label>
    <link:label id="lab_fldm_DevelopmentRevenueMember_label_en-US" xlink:label="lab_fldm_DevelopmentRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development Revenue [Member]</link:label>
    <link:label id="lab_fldm_DevelopmentRevenueMember_documentation_en-US" xlink:label="lab_fldm_DevelopmentRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DevelopmentRevenueMember" xlink:href="fldm-20200930.xsd#fldm_DevelopmentRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_DevelopmentRevenueMember" xlink:to="lab_fldm_DevelopmentRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_813db949-0276-4ac8-81ac-94b841ed9cef_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_71365438-a42d-485a-99f1-42b77b45116d_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember_d7817718-7f0d-407f-b1b7-1dd4ecffca0e_terseLabel_en-US" xlink:label="lab_fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units, stock options and performance share units</link:label>
    <link:label id="lab_fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember_label_en-US" xlink:label="lab_fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Performance Share Units And Restricted Stock Units [Member]</link:label>
    <link:label id="lab_fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember_documentation_en-US" xlink:label="lab_fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Performance Share Units And Restricted Stock Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember" xlink:href="fldm-20200930.xsd#fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember" xlink:to="lab_fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ExchangeConvertibleSeniorNotesDue2034Member_19f2e108-d0a3-4bf4-8d1f-45cfbab579f6_terseLabel_en-US" xlink:label="lab_fldm_ExchangeConvertibleSeniorNotesDue2034Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange Convertible Senior Notes due 2034</link:label>
    <link:label id="lab_fldm_ExchangeConvertibleSeniorNotesDue2034Member_label_en-US" xlink:label="lab_fldm_ExchangeConvertibleSeniorNotesDue2034Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange Convertible Senior Notes Due 2034 [Member]</link:label>
    <link:label id="lab_fldm_ExchangeConvertibleSeniorNotesDue2034Member_documentation_en-US" xlink:label="lab_fldm_ExchangeConvertibleSeniorNotesDue2034Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange Convertible Senior Notes Due 2034 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ExchangeConvertibleSeniorNotesDue2034Member" xlink:href="fldm-20200930.xsd#fldm_ExchangeConvertibleSeniorNotesDue2034Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ExchangeConvertibleSeniorNotesDue2034Member" xlink:to="lab_fldm_ExchangeConvertibleSeniorNotesDue2034Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_8e3bf984-ef08-4dc9-baba-8b51a1473125_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_7258808d-d01a-4ad6-a282-5f87a14ff824_netLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash consideration paid to former equity holders</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_1bf7ec99-d34d-44d7-a02a-11a3eb9b0a2f_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash consideration paid on closing to former equity holders</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AmericasMember_e0bbe89b-e356-461c-96e8-4f4f93de9d27_terseLabel_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas</link:label>
    <link:label id="lab_srt_AmericasMember_label_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AmericasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AmericasMember" xlink:to="lab_srt_AmericasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_d8587ed2-7052-4d72-bd4e-7caba3cc94f1_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_706b0e56-e968-4588-82c5-6411b70409b2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tranche One</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_3bbf6ec6-2322-4929-835c-44df65183cdf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_e35a7b39-8374-4bbb-806b-c283e5accc94_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash consideration common shares</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_f15db675-e614-449a-a25d-64d1b8f99c5d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_e03ddf82-64f3-4d67-9d9c-481d7ab63fc3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_c8125bcc-d92a-4cc2-9945-e9ac32927c9a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Intangible Assets and Other Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredAbstract_a5d8565a-19fa-4f3f-97b3-a8c0345e3cd7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price:</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_45c6c8e9-a903-45df-9d45-fe07a03856ea_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_88a8c58b-197a-40ea-8667-04f8009d3555_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_bee8a5c6-2c2a-413c-ab48-d60ac031e653_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrimeRateMember_e1be59bd-b48a-4650-bf77-5111676d3546_terseLabel_en-US" xlink:label="lab_us-gaap_PrimeRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prime Rate</link:label>
    <link:label id="lab_us-gaap_PrimeRateMember_label_en-US" xlink:label="lab_us-gaap_PrimeRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prime Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrimeRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrimeRateMember" xlink:to="lab_us-gaap_PrimeRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_4a8d82f0-d4c9-4458-aa11-53dc70401150_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_2ac78957-36a8-4d85-9692-71d240c7ab99_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_71dd4513-a5d6-403c-8063-3facdc3390b9_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_e06d3506-55ce-4a31-9f73-770673e92227_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock from option exercises</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a277cc4c-fba0-4190-ac95-b65280e0355b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_IntellectualPropertyInfringementClaimsMember_a04d2630-cde0-4c56-9595-ea10e17a5308_terseLabel_en-US" xlink:label="lab_fldm_IntellectualPropertyInfringementClaimsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intellectual Property Infringement Claims</link:label>
    <link:label id="lab_fldm_IntellectualPropertyInfringementClaimsMember_label_en-US" xlink:label="lab_fldm_IntellectualPropertyInfringementClaimsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intellectual Property Infringement Claims [Member]</link:label>
    <link:label id="lab_fldm_IntellectualPropertyInfringementClaimsMember_documentation_en-US" xlink:label="lab_fldm_IntellectualPropertyInfringementClaimsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intellectual Property Infringement Claims [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_IntellectualPropertyInfringementClaimsMember" xlink:href="fldm-20200930.xsd#fldm_IntellectualPropertyInfringementClaimsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_IntellectualPropertyInfringementClaimsMember" xlink:to="lab_fldm_IntellectualPropertyInfringementClaimsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_4b9174e4-d1e7-4634-98ae-713e7b27e839_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum ability to borrow under line of credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_02249bd2-0591-44d6-80a9-54b0b5c96566_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1b5e1fcc-0be6-49e0-80c6-1ef7b8e05748_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization and Translation</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_OperatingLeaseRightOfUseAssetGross_0a2d7466-f4dc-4950-959d-c6d0083ed6f2_terseLabel_en-US" xlink:label="lab_fldm_OperatingLeaseRightOfUseAssetGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease right-of-use assets, gross</link:label>
    <link:label id="lab_fldm_OperatingLeaseRightOfUseAssetGross_label_en-US" xlink:label="lab_fldm_OperatingLeaseRightOfUseAssetGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-Of-Use Asset, Gross</link:label>
    <link:label id="lab_fldm_OperatingLeaseRightOfUseAssetGross_documentation_en-US" xlink:label="lab_fldm_OperatingLeaseRightOfUseAssetGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-Of-Use Asset, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_OperatingLeaseRightOfUseAssetGross" xlink:href="fldm-20200930.xsd#fldm_OperatingLeaseRightOfUseAssetGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_OperatingLeaseRightOfUseAssetGross" xlink:to="lab_fldm_OperatingLeaseRightOfUseAssetGross" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_30c22bcf-fdbf-4e27-a2e0-fc64851ff443_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_1d6f9cea-c095-4998-84b5-9dffebb40e35_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_96ce7984-6183-42ea-ad3e-a08f0120acfd_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_TwoThousandAndTwentyAtTheMarketEquityOfferingProgramMember_3986cc84-0693-4f18-9a69-0acb5a5cdedc_terseLabel_en-US" xlink:label="lab_fldm_TwoThousandAndTwentyAtTheMarketEquityOfferingProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 At-the-Market Offering</link:label>
    <link:label id="lab_fldm_TwoThousandAndTwentyAtTheMarketEquityOfferingProgramMember_label_en-US" xlink:label="lab_fldm_TwoThousandAndTwentyAtTheMarketEquityOfferingProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Twenty At The Market Equity Offering Program [Member]</link:label>
    <link:label id="lab_fldm_TwoThousandAndTwentyAtTheMarketEquityOfferingProgramMember_documentation_en-US" xlink:label="lab_fldm_TwoThousandAndTwentyAtTheMarketEquityOfferingProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Twenty At The Market Equity Offering Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndTwentyAtTheMarketEquityOfferingProgramMember" xlink:href="fldm-20200930.xsd#fldm_TwoThousandAndTwentyAtTheMarketEquityOfferingProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_TwoThousandAndTwentyAtTheMarketEquityOfferingProgramMember" xlink:to="lab_fldm_TwoThousandAndTwentyAtTheMarketEquityOfferingProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_fdfd2416-29bf-4b77-b3b8-7987553ca5f7_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_a11eba95-ced4-4336-9425-7363f48a097c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_b8063dec-88ee-4c6f-9133-fb0ca20f8f9c_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_b771eec3-3ccf-472f-975c-7f6ac3f68d44_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_7bbecfa0-45b3-4215-a6c0-974ee9609957_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_52c03b55-230b-477b-b496-625361fc36b7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Remaining Contractual Life (in Years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f1f30bbb-88ee-48be-a0e2-a0a962d3736f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ba129f7c-a9fc-4ce0-b032-132260d75d7f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ProceedsFromIssuanceOfCommonStockIncludingRelatedExpenses_f938a4f5-b88d-4d9e-aff2-8ae238ba5af9_terseLabel_en-US" xlink:label="lab_fldm_ProceedsFromIssuanceOfCommonStockIncludingRelatedExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross proceeds from issuance of common stock through at-the-market offering</link:label>
    <link:label id="lab_fldm_ProceedsFromIssuanceOfCommonStockIncludingRelatedExpenses_label_en-US" xlink:label="lab_fldm_ProceedsFromIssuanceOfCommonStockIncludingRelatedExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Issuance Of Common Stock Including Related Expenses</link:label>
    <link:label id="lab_fldm_ProceedsFromIssuanceOfCommonStockIncludingRelatedExpenses_documentation_en-US" xlink:label="lab_fldm_ProceedsFromIssuanceOfCommonStockIncludingRelatedExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Issuance Of Common Stock Including Related Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ProceedsFromIssuanceOfCommonStockIncludingRelatedExpenses" xlink:href="fldm-20200930.xsd#fldm_ProceedsFromIssuanceOfCommonStockIncludingRelatedExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ProceedsFromIssuanceOfCommonStockIncludingRelatedExpenses" xlink:to="lab_fldm_ProceedsFromIssuanceOfCommonStockIncludingRelatedExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_6fd28685-76e0-45e3-b3a6-fa6ffc723d52_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_TwoThousandAndTenEquityIncentivePlanMember_426e3827-cd5f-4b7d-82d6-ac6a422db077_verboseLabel_en-US" xlink:label="lab_fldm_TwoThousandAndTenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DVS Sciences Inc. 2010 Equity Incentive Plan</link:label>
    <link:label id="lab_fldm_TwoThousandAndTenEquityIncentivePlanMember_label_en-US" xlink:label="lab_fldm_TwoThousandAndTenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Ten Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_fldm_TwoThousandAndTenEquityIncentivePlanMember_documentation_en-US" xlink:label="lab_fldm_TwoThousandAndTenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Ten Equity Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndTenEquityIncentivePlanMember" xlink:href="fldm-20200930.xsd#fldm_TwoThousandAndTenEquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_TwoThousandAndTenEquityIncentivePlanMember" xlink:to="lab_fldm_TwoThousandAndTenEquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ProceedsFromResearchAndDevelopmentGrant_0bda4a00-aa22-4f7a-ae8c-3f6f072b8261_terseLabel_en-US" xlink:label="lab_fldm_ProceedsFromResearchAndDevelopmentGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from RADx grant</link:label>
    <link:label id="lab_fldm_ProceedsFromResearchAndDevelopmentGrant_label_en-US" xlink:label="lab_fldm_ProceedsFromResearchAndDevelopmentGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Research and Development Grant</link:label>
    <link:label id="lab_fldm_ProceedsFromResearchAndDevelopmentGrant_documentation_en-US" xlink:label="lab_fldm_ProceedsFromResearchAndDevelopmentGrant" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Research and Development Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ProceedsFromResearchAndDevelopmentGrant" xlink:href="fldm-20200930.xsd#fldm_ProceedsFromResearchAndDevelopmentGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ProceedsFromResearchAndDevelopmentGrant" xlink:to="lab_fldm_ProceedsFromResearchAndDevelopmentGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ef234476-e251-4ae3-94e7-855f7b08445f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_TrusteeMember_0e3b232c-dc93-4cf0-9946-b68477ddc639_terseLabel_en-US" xlink:label="lab_fldm_TrusteeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trustee</link:label>
    <link:label id="lab_fldm_TrusteeMember_label_en-US" xlink:label="lab_fldm_TrusteeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trustee [Member]</link:label>
    <link:label id="lab_fldm_TrusteeMember_documentation_en-US" xlink:label="lab_fldm_TrusteeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trustee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TrusteeMember" xlink:href="fldm-20200930.xsd#fldm_TrusteeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_TrusteeMember" xlink:to="lab_fldm_TrusteeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_CollaborationRevenueMember_fa77b435-93ce-4413-a2f5-2858da7de1ee_terseLabel_en-US" xlink:label="lab_fldm_CollaborationRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development revenue</link:label>
    <link:label id="lab_fldm_CollaborationRevenueMember_label_en-US" xlink:label="lab_fldm_CollaborationRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Revenue [Member]</link:label>
    <link:label id="lab_fldm_CollaborationRevenueMember_documentation_en-US" xlink:label="lab_fldm_CollaborationRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CollaborationRevenueMember" xlink:href="fldm-20200930.xsd#fldm_CollaborationRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_CollaborationRevenueMember" xlink:to="lab_fldm_CollaborationRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_6714e575-390f-4261-a1c0-bf6092a96b35_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual terms</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_56a4d2e7-8679-434e-ad85-3a6fbc2dfcfb_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of expected timing of revenue recognition</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentOfFinancingAndStockIssuanceCosts_dba117c0-9c4d-45ed-bc1e-8c8434f3b35f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of debt and equity issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentOfFinancingAndStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of Financing and Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentOfFinancingAndStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OfficeEquipmentMember_511ab8be-b919-4b43-a5da-18d55298f0db_terseLabel_en-US" xlink:label="lab_us-gaap_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_OfficeEquipmentMember_label_en-US" xlink:label="lab_us-gaap_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OfficeEquipmentMember" xlink:to="lab_us-gaap_OfficeEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_26dc37eb-15ab-407e-9ff2-beaabd692b41_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_ad98f77f-55a5-4515-870c-293cdbc868fa_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAccountsReceivables_99c867d1-e311-4d35-adc4-f6384aeb56ee_terseLabel_en-US" xlink:label="lab_fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAccountsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAccountsReceivables_label_en-US" xlink:label="lab_fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAccountsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accounts Receivables</link:label>
    <link:label id="lab_fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAccountsReceivables_documentation_en-US" xlink:label="lab_fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAccountsReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accounts Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAccountsReceivables" xlink:href="fldm-20200930.xsd#fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAccountsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAccountsReceivables" xlink:to="lab_fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAccountsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_90342945-15f6-4727-9fe4-bdb5ab118398_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_d7e82489-6267-4d2f-ad73-eaedacb6c2d6_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesPercentage_d66d0ec6-2e73-47ab-902e-b3ab38882c9a_terseLabel_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of contractual amount to be paid on liquidated damages</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesPercentage_label_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Liquidated Damages, Percentage</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesPercentage_documentation_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Liquidated Damages, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesPercentage" xlink:href="fldm-20200930.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesPercentage" xlink:to="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryLIFOReservePeriodCharge_c985ccef-fdc2-4b74-b488-ccd95a92a48e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for excess and obsolete inventory</link:label>
    <link:label id="lab_us-gaap_InventoryLIFOReservePeriodCharge_label_en-US" xlink:label="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, LIFO Reserve, Period Charge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLIFOReservePeriodCharge" xlink:to="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0dda9fd6-d385-42de-b8fd-8eae4bd6c87e_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Changes and Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_f709542f-5cb2-41e1-877c-875290337a59_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_TwoThousandAndElevenEquityIncentivePlanMember_c79bf92a-133c-4cf9-8c9b-362ef5c8952e_verboseLabel_en-US" xlink:label="lab_fldm_TwoThousandAndElevenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2011 Equity Incentive Plan</link:label>
    <link:label id="lab_fldm_TwoThousandAndElevenEquityIncentivePlanMember_label_en-US" xlink:label="lab_fldm_TwoThousandAndElevenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Eleven Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_fldm_TwoThousandAndElevenEquityIncentivePlanMember_documentation_en-US" xlink:label="lab_fldm_TwoThousandAndElevenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Eleven Equity Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndElevenEquityIncentivePlanMember" xlink:href="fldm-20200930.xsd#fldm_TwoThousandAndElevenEquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_TwoThousandAndElevenEquityIncentivePlanMember" xlink:to="lab_fldm_TwoThousandAndElevenEquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_f8232f87-97d7-48ef-9017-b2c47bf295ed_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_b9d1eebe-5fb1-4a8d-8fd0-018cd973d758_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Marketable Securities</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>18
<FILENAME>fldm-20200930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:cc860809-a6b3-4939-9e89-fb60809a6371,g:7453d80d-f328-4339-bf18-c087f9945f8a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://fluidigm.com/role/Cover" xlink:type="simple" xlink:href="fldm-20200930.xsd#Cover"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_34caaca3-1ab2-41b4-83e0-0ce51e279b1c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_e6df99fb-22d3-4159-9e13-1dcec3b772bc" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_34caaca3-1ab2-41b4-83e0-0ce51e279b1c" xlink:to="loc_dei_DocumentType_e6df99fb-22d3-4159-9e13-1dcec3b772bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_62eaefe8-bdd7-4871-9fc0-f9b2b74f6380" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_34caaca3-1ab2-41b4-83e0-0ce51e279b1c" xlink:to="loc_dei_DocumentQuarterlyReport_62eaefe8-bdd7-4871-9fc0-f9b2b74f6380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_60215c19-737a-431b-9c01-8df9f410e3f0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_34caaca3-1ab2-41b4-83e0-0ce51e279b1c" xlink:to="loc_dei_DocumentPeriodEndDate_60215c19-737a-431b-9c01-8df9f410e3f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_d9eb8eb3-c942-4ec5-8441-c882ecba602c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_34caaca3-1ab2-41b4-83e0-0ce51e279b1c" xlink:to="loc_dei_DocumentTransitionReport_d9eb8eb3-c942-4ec5-8441-c882ecba602c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_e6bbbcf4-d80f-494d-b087-20cd11069574" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_34caaca3-1ab2-41b4-83e0-0ce51e279b1c" xlink:to="loc_dei_EntityFileNumber_e6bbbcf4-d80f-494d-b087-20cd11069574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_07845eb0-c6c1-40af-b78c-8d2e4a7e4ed8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_34caaca3-1ab2-41b4-83e0-0ce51e279b1c" xlink:to="loc_dei_EntityRegistrantName_07845eb0-c6c1-40af-b78c-8d2e4a7e4ed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_7770ee1a-8765-4507-9bdd-ff4ff19f0fe9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_34caaca3-1ab2-41b4-83e0-0ce51e279b1c" xlink:to="loc_dei_EntityIncorporationStateCountryCode_7770ee1a-8765-4507-9bdd-ff4ff19f0fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_5a6775c9-bb30-4091-89a4-38658e450554" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_34caaca3-1ab2-41b4-83e0-0ce51e279b1c" xlink:to="loc_dei_EntityTaxIdentificationNumber_5a6775c9-bb30-4091-89a4-38658e450554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_382746d8-07ce-4f9d-8b94-2430f18c6f6b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_34caaca3-1ab2-41b4-83e0-0ce51e279b1c" xlink:to="loc_dei_EntityAddressAddressLine1_382746d8-07ce-4f9d-8b94-2430f18c6f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_46e9a617-a5f2-4afd-821a-08c81e7cd047" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_34caaca3-1ab2-41b4-83e0-0ce51e279b1c" xlink:to="loc_dei_EntityAddressCityOrTown_46e9a617-a5f2-4afd-821a-08c81e7cd047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_fb626c6a-a855-4e1d-b134-1388fdbdf2a0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_34caaca3-1ab2-41b4-83e0-0ce51e279b1c" xlink:to="loc_dei_EntityAddressStateOrProvince_fb626c6a-a855-4e1d-b134-1388fdbdf2a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_0692c651-c35b-4830-8243-a4429780c4cc" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_34caaca3-1ab2-41b4-83e0-0ce51e279b1c" xlink:to="loc_dei_EntityAddressPostalZipCode_0692c651-c35b-4830-8243-a4429780c4cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_427cd8c1-84c5-4d16-9ebb-e27027596ccd" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_34caaca3-1ab2-41b4-83e0-0ce51e279b1c" xlink:to="loc_dei_CityAreaCode_427cd8c1-84c5-4d16-9ebb-e27027596ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_af56dbb3-8c3d-420a-8838-097a72a46585" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_34caaca3-1ab2-41b4-83e0-0ce51e279b1c" xlink:to="loc_dei_LocalPhoneNumber_af56dbb3-8c3d-420a-8838-097a72a46585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_10bcc088-dbea-4cbf-a6a6-d9e97f15e897" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_34caaca3-1ab2-41b4-83e0-0ce51e279b1c" xlink:to="loc_dei_Security12bTitle_10bcc088-dbea-4cbf-a6a6-d9e97f15e897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_ff06b7ab-85ab-489e-8859-89ec7b1d181e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_34caaca3-1ab2-41b4-83e0-0ce51e279b1c" xlink:to="loc_dei_TradingSymbol_ff06b7ab-85ab-489e-8859-89ec7b1d181e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_2fe5e0e9-cdba-4258-9cc1-d8ce81427cc9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_34caaca3-1ab2-41b4-83e0-0ce51e279b1c" xlink:to="loc_dei_SecurityExchangeName_2fe5e0e9-cdba-4258-9cc1-d8ce81427cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_72017253-02de-4aaa-aa80-8a4c84b9840e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_34caaca3-1ab2-41b4-83e0-0ce51e279b1c" xlink:to="loc_dei_EntityCurrentReportingStatus_72017253-02de-4aaa-aa80-8a4c84b9840e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_d05b1bfd-48ca-42a8-8729-5c0156ab98e3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_34caaca3-1ab2-41b4-83e0-0ce51e279b1c" xlink:to="loc_dei_EntityInteractiveDataCurrent_d05b1bfd-48ca-42a8-8729-5c0156ab98e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_b4429759-508b-4f65-b55e-b6e7b0d30c47" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_34caaca3-1ab2-41b4-83e0-0ce51e279b1c" xlink:to="loc_dei_EntityFilerCategory_b4429759-508b-4f65-b55e-b6e7b0d30c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_9b913eaf-6a2a-4980-b748-e825b70582b6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_34caaca3-1ab2-41b4-83e0-0ce51e279b1c" xlink:to="loc_dei_EntitySmallBusiness_9b913eaf-6a2a-4980-b748-e825b70582b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_15324c4e-531f-45a3-9b3e-a9c430d5b994" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_34caaca3-1ab2-41b4-83e0-0ce51e279b1c" xlink:to="loc_dei_EntityEmergingGrowthCompany_15324c4e-531f-45a3-9b3e-a9c430d5b994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_5823257c-3005-4cc2-ae36-b0fe39dc82cb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_34caaca3-1ab2-41b4-83e0-0ce51e279b1c" xlink:to="loc_dei_EntityShellCompany_5823257c-3005-4cc2-ae36-b0fe39dc82cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_d06cc838-b997-44cd-98e6-31eca562e5ee" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_34caaca3-1ab2-41b4-83e0-0ce51e279b1c" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_d06cc838-b997-44cd-98e6-31eca562e5ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_6b513a38-1422-430c-9c94-b38abb6d63d4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_34caaca3-1ab2-41b4-83e0-0ce51e279b1c" xlink:to="loc_dei_AmendmentFlag_6b513a38-1422-430c-9c94-b38abb6d63d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_3f934436-7c7b-44b0-8742-6554a7adda76" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_34caaca3-1ab2-41b4-83e0-0ce51e279b1c" xlink:to="loc_dei_DocumentFiscalYearFocus_3f934436-7c7b-44b0-8742-6554a7adda76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_7866918b-f56b-4403-9a98-e0e562a7d52b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_34caaca3-1ab2-41b4-83e0-0ce51e279b1c" xlink:to="loc_dei_DocumentFiscalPeriodFocus_7866918b-f56b-4403-9a98-e0e562a7d52b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_910cf7f7-f822-457e-b78f-2f552b451f4e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_34caaca3-1ab2-41b4-83e0-0ce51e279b1c" xlink:to="loc_dei_EntityCentralIndexKey_910cf7f7-f822-457e-b78f-2f552b451f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_a3cd6a5c-efe0-491b-86f3-9b1c7d0a1a5e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_34caaca3-1ab2-41b4-83e0-0ce51e279b1c" xlink:to="loc_dei_CurrentFiscalYearEndDate_a3cd6a5c-efe0-491b-86f3-9b1c7d0a1a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="fldm-20200930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_e77d824b-e547-4a55-8f25-c432e15a51c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_642c073d-dd86-4bc2-ab9e-70dde56c2420" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e77d824b-e547-4a55-8f25-c432e15a51c9" xlink:to="loc_us-gaap_AssetsAbstract_642c073d-dd86-4bc2-ab9e-70dde56c2420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_cbcc6ce6-7a45-4c96-b708-a42353717f22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_642c073d-dd86-4bc2-ab9e-70dde56c2420" xlink:to="loc_us-gaap_AssetsCurrentAbstract_cbcc6ce6-7a45-4c96-b708-a42353717f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_34601a2c-0658-44c1-b312-f13336c62fd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cbcc6ce6-7a45-4c96-b708-a42353717f22" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_34601a2c-0658-44c1-b312-f13336c62fd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_0853ac86-2a9a-4685-8b14-818a3db832e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cbcc6ce6-7a45-4c96-b708-a42353717f22" xlink:to="loc_us-gaap_ShortTermInvestments_0853ac86-2a9a-4685-8b14-818a3db832e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_f3814a47-5ddb-4a16-868b-1fd3ac728370" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cbcc6ce6-7a45-4c96-b708-a42353717f22" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_f3814a47-5ddb-4a16-868b-1fd3ac728370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementReceivables_82417fee-3de8-4f11-ac82-db74eb09ea7b" xlink:href="fldm-20200930.xsd#fldm_ResearchAndDevelopmentArrangementReceivables"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cbcc6ce6-7a45-4c96-b708-a42353717f22" xlink:to="loc_fldm_ResearchAndDevelopmentArrangementReceivables_82417fee-3de8-4f11-ac82-db74eb09ea7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_e782eff0-2aaf-4862-9973-4262318959f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cbcc6ce6-7a45-4c96-b708-a42353717f22" xlink:to="loc_us-gaap_InventoryNet_e782eff0-2aaf-4862-9973-4262318959f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_16ad8cef-b750-45b1-8923-b93751a803e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cbcc6ce6-7a45-4c96-b708-a42353717f22" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_16ad8cef-b750-45b1-8923-b93751a803e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_cb978994-36d0-463a-84e8-c420cd971cf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cbcc6ce6-7a45-4c96-b708-a42353717f22" xlink:to="loc_us-gaap_AssetsCurrent_cb978994-36d0-463a-84e8-c420cd971cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_35f7c73d-acc8-4553-955b-c45db6418d97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_642c073d-dd86-4bc2-ab9e-70dde56c2420" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_35f7c73d-acc8-4553-955b-c45db6418d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_2754e4a2-0621-45af-91dc-61b8de651188" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_642c073d-dd86-4bc2-ab9e-70dde56c2420" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_2754e4a2-0621-45af-91dc-61b8de651188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_713e2238-68d1-412e-86b5-e9b2cfaa6288" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_642c073d-dd86-4bc2-ab9e-70dde56c2420" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_713e2238-68d1-412e-86b5-e9b2cfaa6288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_95f5d6b6-fe39-4532-a995-bd32cc53b022" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_642c073d-dd86-4bc2-ab9e-70dde56c2420" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_95f5d6b6-fe39-4532-a995-bd32cc53b022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_502d69f5-f61d-4b9a-827e-001e63037c97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_642c073d-dd86-4bc2-ab9e-70dde56c2420" xlink:to="loc_us-gaap_Goodwill_502d69f5-f61d-4b9a-827e-001e63037c97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_56fe6689-24b1-416f-94fd-f1b9c7e4be25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_642c073d-dd86-4bc2-ab9e-70dde56c2420" xlink:to="loc_us-gaap_Assets_56fe6689-24b1-416f-94fd-f1b9c7e4be25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0ddbf4c5-db82-40ba-b795-67430f5e834e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e77d824b-e547-4a55-8f25-c432e15a51c9" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0ddbf4c5-db82-40ba-b795-67430f5e834e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_79aa1caf-544c-4f77-9572-a762e9ad36bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0ddbf4c5-db82-40ba-b795-67430f5e834e" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_79aa1caf-544c-4f77-9572-a762e9ad36bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_18cf2f98-9e8b-49f5-be4d-887495f15880" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_79aa1caf-544c-4f77-9572-a762e9ad36bb" xlink:to="loc_us-gaap_AccountsPayableCurrent_18cf2f98-9e8b-49f5-be4d-887495f15880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_1d18ff66-6e95-480b-ac7a-2435fad7b63f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_79aa1caf-544c-4f77-9572-a762e9ad36bb" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_1d18ff66-6e95-480b-ac7a-2435fad7b63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_8081a1f3-4635-422f-857a-d8c9fba1d66b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_79aa1caf-544c-4f77-9572-a762e9ad36bb" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_8081a1f3-4635-422f-857a-d8c9fba1d66b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_91f978d7-08ee-4efd-9e5f-278e63d1736e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_79aa1caf-544c-4f77-9572-a762e9ad36bb" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_91f978d7-08ee-4efd-9e5f-278e63d1736e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_80d06a07-f920-46c9-b66b-842eba541c73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_79aa1caf-544c-4f77-9572-a762e9ad36bb" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_80d06a07-f920-46c9-b66b-842eba541c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_3d4e8a8b-ddde-4e17-b270-2d4d2a4fdefc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_79aa1caf-544c-4f77-9572-a762e9ad36bb" xlink:to="loc_us-gaap_LiabilitiesCurrent_3d4e8a8b-ddde-4e17-b270-2d4d2a4fdefc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable_cedcea43-fb44-40c9-b01c-12d2cdbac75f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0ddbf4c5-db82-40ba-b795-67430f5e834e" xlink:to="loc_us-gaap_ConvertibleLongTermNotesPayable_cedcea43-fb44-40c9-b01c-12d2cdbac75f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_11e5a1a0-f503-4df6-8623-76157a4002d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0ddbf4c5-db82-40ba-b795-67430f5e834e" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_11e5a1a0-f503-4df6-8623-76157a4002d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1805dbb8-3278-4423-9b13-76b5dd3fd246" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0ddbf4c5-db82-40ba-b795-67430f5e834e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1805dbb8-3278-4423-9b13-76b5dd3fd246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_efe3c6ff-7b90-42fb-97ff-ae828ecdfd7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0ddbf4c5-db82-40ba-b795-67430f5e834e" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_efe3c6ff-7b90-42fb-97ff-ae828ecdfd7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DeferredGrantRevenueNoncurrent_aec46cbf-b7d3-455c-acd9-a86b0812ba43" xlink:href="fldm-20200930.xsd#fldm_DeferredGrantRevenueNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0ddbf4c5-db82-40ba-b795-67430f5e834e" xlink:to="loc_fldm_DeferredGrantRevenueNoncurrent_aec46cbf-b7d3-455c-acd9-a86b0812ba43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_98165d7f-8fb4-4b72-9b4c-a515fca88ef2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0ddbf4c5-db82-40ba-b795-67430f5e834e" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_98165d7f-8fb4-4b72-9b4c-a515fca88ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_563ceb7a-2e5a-423f-8934-18f0d50069b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0ddbf4c5-db82-40ba-b795-67430f5e834e" xlink:to="loc_us-gaap_Liabilities_563ceb7a-2e5a-423f-8934-18f0d50069b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_715029e3-168d-4957-bf66-6867348b706d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0ddbf4c5-db82-40ba-b795-67430f5e834e" xlink:to="loc_us-gaap_CommitmentsAndContingencies_715029e3-168d-4957-bf66-6867348b706d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_dad4ec43-ae30-4dcd-9cc2-061a8abd3594" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0ddbf4c5-db82-40ba-b795-67430f5e834e" xlink:to="loc_us-gaap_StockholdersEquityAbstract_dad4ec43-ae30-4dcd-9cc2-061a8abd3594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_6feff4a1-b16b-4d3e-894d-7648975be3bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_dad4ec43-ae30-4dcd-9cc2-061a8abd3594" xlink:to="loc_us-gaap_PreferredStockValue_6feff4a1-b16b-4d3e-894d-7648975be3bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_2ec1cc9f-bef9-4b86-9c72-d08ee6a4cc5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_dad4ec43-ae30-4dcd-9cc2-061a8abd3594" xlink:to="loc_us-gaap_CommonStockValue_2ec1cc9f-bef9-4b86-9c72-d08ee6a4cc5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_5fe48dab-2389-4c3d-9945-32ad0b5551f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_dad4ec43-ae30-4dcd-9cc2-061a8abd3594" xlink:to="loc_us-gaap_AdditionalPaidInCapital_5fe48dab-2389-4c3d-9945-32ad0b5551f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0a179472-360a-41ba-9c12-4c2b5be1e76b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_dad4ec43-ae30-4dcd-9cc2-061a8abd3594" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0a179472-360a-41ba-9c12-4c2b5be1e76b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_743486cd-a46a-4ceb-8996-d98cec3660b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_dad4ec43-ae30-4dcd-9cc2-061a8abd3594" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_743486cd-a46a-4ceb-8996-d98cec3660b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_baac15ec-18cc-4328-a87b-03c71e73db43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_dad4ec43-ae30-4dcd-9cc2-061a8abd3594" xlink:to="loc_us-gaap_StockholdersEquity_baac15ec-18cc-4328-a87b-03c71e73db43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_b7f85720-eef8-4532-beda-425dd1e57281" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0ddbf4c5-db82-40ba-b795-67430f5e834e" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_b7f85720-eef8-4532-beda-425dd1e57281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="fldm-20200930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_d73b7981-fe90-4e51-96b9-04da4e474151" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_f0935057-b177-462d-9951-b36830e0daaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d73b7981-fe90-4e51-96b9-04da4e474151" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_f0935057-b177-462d-9951-b36830e0daaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f75fe94e-2504-45ed-9bb1-e8b6c3cc05c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d73b7981-fe90-4e51-96b9-04da4e474151" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f75fe94e-2504-45ed-9bb1-e8b6c3cc05c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_d4669d31-090f-4656-b0b1-9f977d2a57e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d73b7981-fe90-4e51-96b9-04da4e474151" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_d4669d31-090f-4656-b0b1-9f977d2a57e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_e0e6fd15-9bc7-4ce4-a433-2a36dea5a2be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d73b7981-fe90-4e51-96b9-04da4e474151" xlink:to="loc_us-gaap_PreferredStockSharesIssued_e0e6fd15-9bc7-4ce4-a433-2a36dea5a2be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_7aeda6e8-39ea-4467-b718-a1dc305754e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d73b7981-fe90-4e51-96b9-04da4e474151" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_7aeda6e8-39ea-4467-b718-a1dc305754e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_9a9e65f6-c501-44f4-9d4d-b5d47f3c49ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d73b7981-fe90-4e51-96b9-04da4e474151" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_9a9e65f6-c501-44f4-9d4d-b5d47f3c49ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_50823cf6-d5fe-4bbf-a5e9-d8ef33a0b530" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d73b7981-fe90-4e51-96b9-04da4e474151" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_50823cf6-d5fe-4bbf-a5e9-d8ef33a0b530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_253b669a-5007-4d9d-85bd-454e153e6120" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d73b7981-fe90-4e51-96b9-04da4e474151" xlink:to="loc_us-gaap_CommonStockSharesIssued_253b669a-5007-4d9d-85bd-454e153e6120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_7e876362-1b9a-4ab8-87a4-afdce6beba34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d73b7981-fe90-4e51-96b9-04da4e474151" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_7e876362-1b9a-4ab8-87a4-afdce6beba34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="fldm-20200930.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_fe05137f-ecd7-4aaf-ba37-1313a3d3f40f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_16974906-6a59-4678-a443-fb2f4db926b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fe05137f-ecd7-4aaf-ba37-1313a3d3f40f" xlink:to="loc_us-gaap_StatementTable_16974906-6a59-4678-a443-fb2f4db926b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9f5aa3d1-f887-4c61-b7dc-d9ef7beaf6f8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_16974906-6a59-4678-a443-fb2f4db926b6" xlink:to="loc_srt_ProductOrServiceAxis_9f5aa3d1-f887-4c61-b7dc-d9ef7beaf6f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b2b3d833-c663-4ef2-9c2e-d63f7ce2a300" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_9f5aa3d1-f887-4c61-b7dc-d9ef7beaf6f8" xlink:to="loc_srt_ProductsAndServicesDomain_b2b3d833-c663-4ef2-9c2e-d63f7ce2a300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_aa459245-cda2-4833-ae0a-a7c91db9a7ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b2b3d833-c663-4ef2-9c2e-d63f7ce2a300" xlink:to="loc_us-gaap_ProductMember_aa459245-cda2-4833-ae0a-a7c91db9a7ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_a9c005e4-7212-4e25-80cf-25cc7103df43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b2b3d833-c663-4ef2-9c2e-d63f7ce2a300" xlink:to="loc_us-gaap_ServiceMember_a9c005e4-7212-4e25-80cf-25cc7103df43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CollaborationRevenueMember_13eae3a1-a096-478c-a641-51d6e2dc987d" xlink:href="fldm-20200930.xsd#fldm_CollaborationRevenueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b2b3d833-c663-4ef2-9c2e-d63f7ce2a300" xlink:to="loc_fldm_CollaborationRevenueMember_13eae3a1-a096-478c-a641-51d6e2dc987d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_6254f1a3-a4d3-4668-a0e3-2d361b03a85e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b2b3d833-c663-4ef2-9c2e-d63f7ce2a300" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_6254f1a3-a4d3-4668-a0e3-2d361b03a85e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c5b18f5c-3257-492d-8eaa-9034e606f2ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_16974906-6a59-4678-a443-fb2f4db926b6" xlink:to="loc_us-gaap_StatementLineItems_c5b18f5c-3257-492d-8eaa-9034e606f2ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_9d4d0e5b-d4c5-4bc6-b911-d8c83e6856b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c5b18f5c-3257-492d-8eaa-9034e606f2ef" xlink:to="loc_us-gaap_RevenuesAbstract_9d4d0e5b-d4c5-4bc6-b911-d8c83e6856b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b2ffe5c2-9014-4fbc-93ad-eccb7ecacfc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_9d4d0e5b-d4c5-4bc6-b911-d8c83e6856b1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b2ffe5c2-9014-4fbc-93ad-eccb7ecacfc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_c4ccf9cf-621a-4140-9871-3497ad42bf6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c5b18f5c-3257-492d-8eaa-9034e606f2ef" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_c4ccf9cf-621a-4140-9871-3497ad42bf6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_1f04cec9-5b4e-45b9-b213-21c2eeb2d27c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_c4ccf9cf-621a-4140-9871-3497ad42bf6d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_1f04cec9-5b4e-45b9-b213-21c2eeb2d27c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_d32d2ebd-12bf-4410-99da-12379438912d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_c4ccf9cf-621a-4140-9871-3497ad42bf6d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_d32d2ebd-12bf-4410-99da-12379438912d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_686e8ef8-79d6-4926-935a-2aadec76422d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_c4ccf9cf-621a-4140-9871-3497ad42bf6d" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_686e8ef8-79d6-4926-935a-2aadec76422d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_71b67855-46fc-4e93-b980-d7a390167d89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_c4ccf9cf-621a-4140-9871-3497ad42bf6d" xlink:to="loc_us-gaap_OperatingExpenses_71b67855-46fc-4e93-b980-d7a390167d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_bccd2c22-4600-4cf8-a7d4-db0bf8ee5a50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c5b18f5c-3257-492d-8eaa-9034e606f2ef" xlink:to="loc_us-gaap_OperatingIncomeLoss_bccd2c22-4600-4cf8-a7d4-db0bf8ee5a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_d03da403-9d56-4136-998f-c9551f9b7ed4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c5b18f5c-3257-492d-8eaa-9034e606f2ef" xlink:to="loc_us-gaap_InterestExpense_d03da403-9d56-4136-998f-c9551f9b7ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_eb33a09c-e37e-419b-8a16-cccf50bf77b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c5b18f5c-3257-492d-8eaa-9034e606f2ef" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_eb33a09c-e37e-419b-8a16-cccf50bf77b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_478f5555-8b3a-4997-bb4c-6d0a6a3d16a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c5b18f5c-3257-492d-8eaa-9034e606f2ef" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_478f5555-8b3a-4997-bb4c-6d0a6a3d16a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ab7d82b8-4d23-4071-bd7f-eec601846184" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c5b18f5c-3257-492d-8eaa-9034e606f2ef" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ab7d82b8-4d23-4071-bd7f-eec601846184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_42e2d8ae-e56e-4131-b4db-45bf91d2cf9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c5b18f5c-3257-492d-8eaa-9034e606f2ef" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_42e2d8ae-e56e-4131-b4db-45bf91d2cf9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e4c3baa3-c8ca-459e-872c-06d48040924c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c5b18f5c-3257-492d-8eaa-9034e606f2ef" xlink:to="loc_us-gaap_NetIncomeLoss_e4c3baa3-c8ca-459e-872c-06d48040924c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_f3c6ecc3-a4d0-4388-b863-7f68959ff4ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c5b18f5c-3257-492d-8eaa-9034e606f2ef" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_f3c6ecc3-a4d0-4388-b863-7f68959ff4ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_f288a1cc-5b2d-4363-b863-dc882fd2aed4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c5b18f5c-3257-492d-8eaa-9034e606f2ef" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_f288a1cc-5b2d-4363-b863-dc882fd2aed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="fldm-20200930.xsd#CondensedConsolidatedStatementsofComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b426b786-5ad0-4389-948a-389d8bf94a22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c888b43f-f2eb-4dae-9621-91b9cff0416a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b426b786-5ad0-4389-948a-389d8bf94a22" xlink:to="loc_us-gaap_NetIncomeLoss_c888b43f-f2eb-4dae-9621-91b9cff0416a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b384a080-5b06-49dc-9817-81a24a4ac513" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b426b786-5ad0-4389-948a-389d8bf94a22" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b384a080-5b06-49dc-9817-81a24a4ac513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_227c7a61-a851-490f-a7f0-60de58843b3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b384a080-5b06-49dc-9817-81a24a4ac513" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_227c7a61-a851-490f-a7f0-60de58843b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_0d3bac16-a22f-4b42-830e-2909bf3bddfb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b384a080-5b06-49dc-9817-81a24a4ac513" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_0d3bac16-a22f-4b42-830e-2909bf3bddfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_680e3869-c35a-40a5-a686-86300a9a9b59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b384a080-5b06-49dc-9817-81a24a4ac513" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_680e3869-c35a-40a5-a686-86300a9a9b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_eaa167be-ab60-4f4f-b15e-2fece62d5d29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b426b786-5ad0-4389-948a-389d8bf94a22" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_eaa167be-ab60-4f4f-b15e-2fece62d5d29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="fldm-20200930.xsd#CondensedConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_45efafb6-8553-4de9-8658-3a2bb17dc457" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_0ccec93e-2ba6-409d-a585-4b1b94762585" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_45efafb6-8553-4de9-8658-3a2bb17dc457" xlink:to="loc_us-gaap_StatementTable_0ccec93e-2ba6-409d-a585-4b1b94762585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5fbdc633-425e-4ef6-8ff5-372a9cd318c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0ccec93e-2ba6-409d-a585-4b1b94762585" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5fbdc633-425e-4ef6-8ff5-372a9cd318c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9ad48a7a-fec7-4958-a826-16e935a4cc17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5fbdc633-425e-4ef6-8ff5-372a9cd318c8" xlink:to="loc_us-gaap_EquityComponentDomain_9ad48a7a-fec7-4958-a826-16e935a4cc17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_91811764-d527-4bb2-9248-daf88f9f0a62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9ad48a7a-fec7-4958-a826-16e935a4cc17" xlink:to="loc_us-gaap_CommonStockMember_91811764-d527-4bb2-9248-daf88f9f0a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_4b800416-d5f5-4214-a5f1-9f6c622fd36e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9ad48a7a-fec7-4958-a826-16e935a4cc17" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_4b800416-d5f5-4214-a5f1-9f6c622fd36e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_6d8183b5-ebea-4f3d-af5b-3735800ddece" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9ad48a7a-fec7-4958-a826-16e935a4cc17" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_6d8183b5-ebea-4f3d-af5b-3735800ddece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_bc87440b-5091-4a88-b446-47a760d0cf5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9ad48a7a-fec7-4958-a826-16e935a4cc17" xlink:to="loc_us-gaap_RetainedEarningsMember_bc87440b-5091-4a88-b446-47a760d0cf5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_71ea0ed7-a71d-4cd8-9f41-c65fa4ea3677" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0ccec93e-2ba6-409d-a585-4b1b94762585" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_71ea0ed7-a71d-4cd8-9f41-c65fa4ea3677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_7b6c89f4-1d48-45a8-8b0a-4064581e2a2c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_71ea0ed7-a71d-4cd8-9f41-c65fa4ea3677" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_7b6c89f4-1d48-45a8-8b0a-4064581e2a2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_740c44b7-e8a0-4b12-9fc8-3447be499798" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_7b6c89f4-1d48-45a8-8b0a-4064581e2a2c" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_740c44b7-e8a0-4b12-9fc8-3447be499798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_706e9a87-2ac9-499c-b844-6cf74cfad1e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0ccec93e-2ba6-409d-a585-4b1b94762585" xlink:to="loc_us-gaap_StatementLineItems_706e9a87-2ac9-499c-b844-6cf74cfad1e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_706e9a87-2ac9-499c-b844-6cf74cfad1e4" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_025ee06e-5213-4348-be1e-33aa10159ebf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_025ee06e-5213-4348-be1e-33aa10159ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_63083a7a-8fe1-4c18-ad58-f125f563cc39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_StockholdersEquity_63083a7a-8fe1-4c18-ad58-f125f563cc39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_cfd79ed0-4f5d-4ec7-971e-511ccf057e49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_cfd79ed0-4f5d-4ec7-971e-511ccf057e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_11091a2d-9aad-4e53-9c61-7767bf6cb941" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_11091a2d-9aad-4e53-9c61-7767bf6cb941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_6788548b-0d34-4382-9b06-9e590be4f2fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_6788548b-0d34-4382-9b06-9e590be4f2fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1bd1f568-a044-4843-a8c2-ca1d4dc2098f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1bd1f568-a044-4843-a8c2-ca1d4dc2098f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_7eb40abc-f182-43b8-b377-6ab1fb14b031" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_7eb40abc-f182-43b8-b377-6ab1fb14b031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_daa39085-fd71-4882-a7bc-c7ee604f697c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_daa39085-fd71-4882-a7bc-c7ee604f697c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_7eb2aa3d-6070-401b-923f-f9d9578fe990" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_7eb2aa3d-6070-401b-923f-f9d9578fe990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_8c556363-e742-4875-8f1d-25156645caef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_8c556363-e742-4875-8f1d-25156645caef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_90bd77c9-8a52-41a9-84e3-5ca21963b745" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_90bd77c9-8a52-41a9-84e3-5ca21963b745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_63092c88-2b47-4e93-8ffd-38fd9c1fa24b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_63092c88-2b47-4e93-8ffd-38fd9c1fa24b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_52b262e3-9ca3-48e6-9cb1-03687146c19c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_52b262e3-9ca3-48e6-9cb1-03687146c19c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_97d3713a-b8bf-4291-828a-c2cd0f8d4a03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_97d3713a-b8bf-4291-828a-c2cd0f8d4a03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_ae682fac-3a9f-4d16-873a-4dfce66e10fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_ae682fac-3a9f-4d16-873a-4dfce66e10fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_e6006b88-1873-47a0-97fc-707652b95a7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_e6006b88-1873-47a0-97fc-707652b95a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1d60e1b2-ae2f-41c9-a185-434e9a17d945" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_NetIncomeLoss_1d60e1b2-ae2f-41c9-a185-434e9a17d945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_11db620d-01a8-454a-bd1b-d1a36d9777a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_11db620d-01a8-454a-bd1b-d1a36d9777a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_66b046ed-cffb-4eff-837e-fb55824bd905" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_66b046ed-cffb-4eff-837e-fb55824bd905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_81f78e5e-6722-4791-ac58-4df8915f9426" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_742dea2f-ad8d-4424-9fa6-c447e960ecfe" xlink:to="loc_us-gaap_StockholdersEquity_81f78e5e-6722-4791-ac58-4df8915f9426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_adfa12d7-60dc-4b46-a047-184d6447c6d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_706e9a87-2ac9-499c-b844-6cf74cfad1e4" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_adfa12d7-60dc-4b46-a047-184d6447c6d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="fldm-20200930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_1e61d5fe-4802-45e5-ab1f-f05ff7e50c32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_34b09299-e14b-4353-ba30-9524b149196d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1e61d5fe-4802-45e5-ab1f-f05ff7e50c32" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_34b09299-e14b-4353-ba30-9524b149196d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fb2335e7-a1c7-4a91-a0ff-1a064ad5e441" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_34b09299-e14b-4353-ba30-9524b149196d" xlink:to="loc_us-gaap_NetIncomeLoss_fb2335e7-a1c7-4a91-a0ff-1a064ad5e441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7b7da7c2-4640-4372-b758-ec1ef662a24e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_34b09299-e14b-4353-ba30-9524b149196d" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7b7da7c2-4640-4372-b758-ec1ef662a24e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_bd036824-a7ae-4fc1-a81e-d1e22afc2aec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7b7da7c2-4640-4372-b758-ec1ef662a24e" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_bd036824-a7ae-4fc1-a81e-d1e22afc2aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_121a13e9-661c-4c32-a396-d0084b9011c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7b7da7c2-4640-4372-b758-ec1ef662a24e" xlink:to="loc_us-gaap_ShareBasedCompensation_121a13e9-661c-4c32-a396-d0084b9011c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_2b0b130d-53c5-4cce-8f0f-2227e493c3d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7b7da7c2-4640-4372-b758-ec1ef662a24e" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_2b0b130d-53c5-4cce-8f0f-2227e493c3d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_58c4c3cd-9c89-41ba-9c89-32ed7944b04d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7b7da7c2-4640-4372-b758-ec1ef662a24e" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_58c4c3cd-9c89-41ba-9c89-32ed7944b04d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_d473d50f-ef43-44de-a877-77c5e769282a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7b7da7c2-4640-4372-b758-ec1ef662a24e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_d473d50f-ef43-44de-a877-77c5e769282a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_343dd04d-2f6a-4903-93dc-3ac2c22dee81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7b7da7c2-4640-4372-b758-ec1ef662a24e" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_343dd04d-2f6a-4903-93dc-3ac2c22dee81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_e1f9c54d-ac53-487b-83dd-374d48987896" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7b7da7c2-4640-4372-b758-ec1ef662a24e" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_e1f9c54d-ac53-487b-83dd-374d48987896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_851fd957-5e04-475b-8a7b-fb6d50d98c28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7b7da7c2-4640-4372-b758-ec1ef662a24e" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_851fd957-5e04-475b-8a7b-fb6d50d98c28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_ee9140a0-3f13-4f51-8598-76472ae12a95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7b7da7c2-4640-4372-b758-ec1ef662a24e" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_ee9140a0-3f13-4f51-8598-76472ae12a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2a04f0c0-1bb6-4463-b6a8-85993a5105ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7b7da7c2-4640-4372-b758-ec1ef662a24e" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2a04f0c0-1bb6-4463-b6a8-85993a5105ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_d95bebfa-8938-4229-ad9e-5ce8154fdd18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2a04f0c0-1bb6-4463-b6a8-85993a5105ee" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_d95bebfa-8938-4229-ad9e-5ce8154fdd18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_7448161b-b72c-470d-9656-c2d363cfcd95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2a04f0c0-1bb6-4463-b6a8-85993a5105ee" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_7448161b-b72c-470d-9656-c2d363cfcd95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ed1d482c-b72f-45c5-a787-b7cfea95e050" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2a04f0c0-1bb6-4463-b6a8-85993a5105ee" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ed1d482c-b72f-45c5-a787-b7cfea95e050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_831df0b1-537f-49ad-96f2-672b24289eef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2a04f0c0-1bb6-4463-b6a8-85993a5105ee" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_831df0b1-537f-49ad-96f2-672b24289eef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_c4ce2b75-6cba-4127-abe0-7ed424cce235" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2a04f0c0-1bb6-4463-b6a8-85993a5105ee" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_c4ce2b75-6cba-4127-abe0-7ed424cce235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_a73d09c2-26aa-44dc-a004-3d5ffaec7c94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2a04f0c0-1bb6-4463-b6a8-85993a5105ee" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_a73d09c2-26aa-44dc-a004-3d5ffaec7c94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b9c97578-e484-4f40-ad24-198d43f9801a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_34b09299-e14b-4353-ba30-9524b149196d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b9c97578-e484-4f40-ad24-198d43f9801a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5bea1f85-b19d-4e14-b62d-7a5deaa77359" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1e61d5fe-4802-45e5-ab1f-f05ff7e50c32" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5bea1f85-b19d-4e14-b62d-7a5deaa77359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_6ce363ca-761c-4f04-a1c7-1741b8266119" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5bea1f85-b19d-4e14-b62d-7a5deaa77359" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_6ce363ca-761c-4f04-a1c7-1741b8266119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_54aae7d6-438d-47b0-9429-94faa714a868" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5bea1f85-b19d-4e14-b62d-7a5deaa77359" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_54aae7d6-438d-47b0-9429-94faa714a868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ProceedsFromResearchAndDevelopmentGrant_1c5181c2-3ee6-43f4-9b49-0cd525fd9c99" xlink:href="fldm-20200930.xsd#fldm_ProceedsFromResearchAndDevelopmentGrant"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5bea1f85-b19d-4e14-b62d-7a5deaa77359" xlink:to="loc_fldm_ProceedsFromResearchAndDevelopmentGrant_1c5181c2-3ee6-43f4-9b49-0cd525fd9c99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfOtherInvestments_e833e2cf-216c-46e9-a335-51551790c108" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfOtherInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5bea1f85-b19d-4e14-b62d-7a5deaa77359" xlink:to="loc_us-gaap_ProceedsFromSaleOfOtherInvestments_e833e2cf-216c-46e9-a335-51551790c108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments_55cc8664-ae89-46d7-b228-f04075a0a8f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5bea1f85-b19d-4e14-b62d-7a5deaa77359" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments_55cc8664-ae89-46d7-b228-f04075a0a8f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_cfec4c4e-de87-44ef-b880-05503fbdab83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5bea1f85-b19d-4e14-b62d-7a5deaa77359" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_cfec4c4e-de87-44ef-b880-05503fbdab83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a6fab76f-3be4-4979-96a6-fbc922466644" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5bea1f85-b19d-4e14-b62d-7a5deaa77359" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a6fab76f-3be4-4979-96a6-fbc922466644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_52ac3066-430a-4a98-ba11-6b76ff1096e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1e61d5fe-4802-45e5-ab1f-f05ff7e50c32" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_52ac3066-430a-4a98-ba11-6b76ff1096e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_f30df67f-8985-43f4-b5bc-24eac68a6d3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_52ac3066-430a-4a98-ba11-6b76ff1096e3" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_f30df67f-8985-43f4-b5bc-24eac68a6d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentOfFinancingAndStockIssuanceCosts_d3cbf706-5e0f-4651-9a2f-a407eb86d9bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentOfFinancingAndStockIssuanceCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_52ac3066-430a-4a98-ba11-6b76ff1096e3" xlink:to="loc_us-gaap_PaymentOfFinancingAndStockIssuanceCosts_d3cbf706-5e0f-4651-9a2f-a407eb86d9bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_497ea932-9a7b-467d-897b-9d7461432461" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_52ac3066-430a-4a98-ba11-6b76ff1096e3" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_497ea932-9a7b-467d-897b-9d7461432461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_993033c9-69de-4491-a9ed-272981303628" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_52ac3066-430a-4a98-ba11-6b76ff1096e3" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_993033c9-69de-4491-a9ed-272981303628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_40536289-15b1-463b-9c3e-bdb2cc4f4826" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_52ac3066-430a-4a98-ba11-6b76ff1096e3" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_40536289-15b1-463b-9c3e-bdb2cc4f4826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_270b46f4-da13-4365-8172-e1977c0634d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_52ac3066-430a-4a98-ba11-6b76ff1096e3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_270b46f4-da13-4365-8172-e1977c0634d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8167c158-f48e-4ef6-be8d-e761c8229ebe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1e61d5fe-4802-45e5-ab1f-f05ff7e50c32" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8167c158-f48e-4ef6-be8d-e761c8229ebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_af2b5bfc-1c99-4ac4-9d80-9e17203c829f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1e61d5fe-4802-45e5-ab1f-f05ff7e50c32" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_af2b5bfc-1c99-4ac4-9d80-9e17203c829f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_aaf67544-5ecc-4de7-a594-897d0a3cfe42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1e61d5fe-4802-45e5-ab1f-f05ff7e50c32" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_aaf67544-5ecc-4de7-a594-897d0a3cfe42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7e2a1519-16ac-421f-86a0-19ef84fd2232" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1e61d5fe-4802-45e5-ab1f-f05ff7e50c32" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7e2a1519-16ac-421f-86a0-19ef84fd2232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_cc1b138c-e591-424e-9bd8-801d3c872d32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1e61d5fe-4802-45e5-ab1f-f05ff7e50c32" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_cc1b138c-e591-424e-9bd8-801d3c872d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_0cbf504b-da9e-4660-8ad1-ef6eea17d04f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_cc1b138c-e591-424e-9bd8-801d3c872d32" xlink:to="loc_us-gaap_InterestPaidNet_0cbf504b-da9e-4660-8ad1-ef6eea17d04f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_bf334613-ad8b-4a4c-a724-7a7b4ec1b00c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_cc1b138c-e591-424e-9bd8-801d3c872d32" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_bf334613-ad8b-4a4c-a724-7a7b4ec1b00c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_AssetRetirementObligationsIncurredButNotYetPaid_aabdce05-c413-4d74-be13-44a0349453f9" xlink:href="fldm-20200930.xsd#fldm_AssetRetirementObligationsIncurredButNotYetPaid"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_cc1b138c-e591-424e-9bd8-801d3c872d32" xlink:to="loc_fldm_AssetRetirementObligationsIncurredButNotYetPaid_aabdce05-c413-4d74-be13-44a0349453f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/DescriptionofBusiness" xlink:type="simple" xlink:href="fldm-20200930.xsd#DescriptionofBusiness"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/DescriptionofBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7da8ce17-6677-45b0-aacd-1276985b01ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_3b4d5e32-b398-4e37-8eb6-cc36935ca862" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7da8ce17-6677-45b0-aacd-1276985b01ac" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_3b4d5e32-b398-4e37-8eb6-cc36935ca862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="fldm-20200930.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1b8784f0-91e5-4679-aabd-b5336847e8ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_c836cfb6-a5ca-4b8d-ba56-f6ed3d9400d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1b8784f0-91e5-4679-aabd-b5336847e8ff" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_c836cfb6-a5ca-4b8d-ba56-f6ed3d9400d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="fldm-20200930.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e95df3a6-fd6f-476f-94e4-375293cc5dc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_bf1c1e3f-6293-43a0-8616-866bad5ffa60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e95df3a6-fd6f-476f-94e4-375293cc5dc5" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_bf1c1e3f-6293-43a0-8616-866bad5ffa60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_57627526-6c65-4406-ad02-5533b28c2d07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e95df3a6-fd6f-476f-94e4-375293cc5dc5" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_57627526-6c65-4406-ad02-5533b28c2d07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_bd8de56a-fce2-40ed-aaa3-a7e63a062b93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e95df3a6-fd6f-476f-94e4-375293cc5dc5" xlink:to="loc_us-gaap_UseOfEstimates_bd8de56a-fce2-40ed-aaa3-a7e63a062b93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_35399d90-2b38-4f94-980e-68019cdd7678" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e95df3a6-fd6f-476f-94e4-375293cc5dc5" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_35399d90-2b38-4f94-980e-68019cdd7678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_84d06bf5-b305-4644-9eae-52e367ca50ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e95df3a6-fd6f-476f-94e4-375293cc5dc5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_84d06bf5-b305-4644-9eae-52e367ca50ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_de59e6eb-1881-4af9-ae33-270224a52baa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e95df3a6-fd6f-476f-94e4-375293cc5dc5" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_de59e6eb-1881-4af9-ae33-270224a52baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_7a91545c-39ba-4ef0-b1ba-31dec4e9d6c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e95df3a6-fd6f-476f-94e4-375293cc5dc5" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_7a91545c-39ba-4ef0-b1ba-31dec4e9d6c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_08310499-4e81-4b26-b545-af7d96efdb9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e95df3a6-fd6f-476f-94e4-375293cc5dc5" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_08310499-4e81-4b26-b545-af7d96efdb9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_cde218b2-4930-4dc7-a865-6223b327b038" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e95df3a6-fd6f-476f-94e4-375293cc5dc5" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_cde218b2-4930-4dc7-a865-6223b327b038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtPolicyTextBlock_222b65b4-67b4-4769-a1b8-8583f72d8768" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e95df3a6-fd6f-476f-94e4-375293cc5dc5" xlink:to="loc_us-gaap_DebtPolicyTextBlock_222b65b4-67b4-4769-a1b8-8583f72d8768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_c5255ca2-fb83-4684-9b60-a9693a4c2520" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e95df3a6-fd6f-476f-94e4-375293cc5dc5" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_c5255ca2-fb83-4684-9b60-a9693a4c2520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_16aa30e4-a000-43d1-baf0-32cda184c33e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e95df3a6-fd6f-476f-94e4-375293cc5dc5" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_16aa30e4-a000-43d1-baf0-32cda184c33e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_e2ec008e-e1ab-4796-96c3-13db87eda11c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e95df3a6-fd6f-476f-94e4-375293cc5dc5" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_e2ec008e-e1ab-4796-96c3-13db87eda11c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="fldm-20200930.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c6170f0f-9ffe-429a-9557-0a757a745b1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_2f3b9045-e8c9-4908-a546-fe676d2570e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c6170f0f-9ffe-429a-9557-0a757a745b1b" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_2f3b9045-e8c9-4908-a546-fe676d2570e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_468fcf21-c358-478f-8d4d-ec55fe4a6224" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c6170f0f-9ffe-429a-9557-0a757a745b1b" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_468fcf21-c358-478f-8d4d-ec55fe4a6224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5e335e3c-1a35-4525-89ca-af9cd7ced7fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ScheduleOfSignificantAccountingPoliciesTable_dbbb109b-e8a0-49f9-9072-a1306729101a" xlink:href="fldm-20200930.xsd#fldm_ScheduleOfSignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5e335e3c-1a35-4525-89ca-af9cd7ced7fd" xlink:to="loc_fldm_ScheduleOfSignificantAccountingPoliciesTable_dbbb109b-e8a0-49f9-9072-a1306729101a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5e24759d-db55-405b-88cd-40b3ab83efcb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesTable_dbbb109b-e8a0-49f9-9072-a1306729101a" xlink:to="loc_srt_ProductOrServiceAxis_5e24759d-db55-405b-88cd-40b3ab83efcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a17cfaa2-3f36-46aa-8894-1e20cdce19f0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_5e24759d-db55-405b-88cd-40b3ab83efcb" xlink:to="loc_srt_ProductsAndServicesDomain_a17cfaa2-3f36-46aa-8894-1e20cdce19f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_5223c9b6-18e7-496a-a1be-8662a1ceccce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a17cfaa2-3f36-46aa-8894-1e20cdce19f0" xlink:to="loc_us-gaap_ProductMember_5223c9b6-18e7-496a-a1be-8662a1ceccce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_2c7aa887-91cf-43f4-b287-58d09b4125f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a17cfaa2-3f36-46aa-8894-1e20cdce19f0" xlink:to="loc_us-gaap_ServiceMember_2c7aa887-91cf-43f4-b287-58d09b4125f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember_a212c579-2a32-4cbe-9beb-2c16a84af8ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a17cfaa2-3f36-46aa-8894-1e20cdce19f0" xlink:to="loc_us-gaap_LicenseMember_a212c579-2a32-4cbe-9beb-2c16a84af8ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DevelopmentRevenueMember_e6c1c131-6b05-49f8-86cc-abe44ac05712" xlink:href="fldm-20200930.xsd#fldm_DevelopmentRevenueMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a17cfaa2-3f36-46aa-8894-1e20cdce19f0" xlink:to="loc_fldm_DevelopmentRevenueMember_e6c1c131-6b05-49f8-86cc-abe44ac05712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cf99ba35-1aa9-4cf5-a959-5ea9d6175e84" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesTable_dbbb109b-e8a0-49f9-9072-a1306729101a" xlink:to="loc_srt_RangeAxis_cf99ba35-1aa9-4cf5-a959-5ea9d6175e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2c1fd013-bd09-4303-9e7f-193312e5c5c0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_cf99ba35-1aa9-4cf5-a959-5ea9d6175e84" xlink:to="loc_srt_RangeMember_2c1fd013-bd09-4303-9e7f-193312e5c5c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_40b40b0f-db80-44d4-872d-37125525f109" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2c1fd013-bd09-4303-9e7f-193312e5c5c0" xlink:to="loc_srt_MinimumMember_40b40b0f-db80-44d4-872d-37125525f109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e53dd6a8-ef16-4e20-adf5-8d791c8a4d75" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2c1fd013-bd09-4303-9e7f-193312e5c5c0" xlink:to="loc_srt_MaximumMember_e53dd6a8-ef16-4e20-adf5-8d791c8a4d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_4f7b4c0b-1ffb-4270-bfc4-92e3e45b89c2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesTable_dbbb109b-e8a0-49f9-9072-a1306729101a" xlink:to="loc_srt_LitigationCaseAxis_4f7b4c0b-1ffb-4270-bfc4-92e3e45b89c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_c5c6926e-70a3-4611-8d52-014bc321969f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_4f7b4c0b-1ffb-4270-bfc4-92e3e45b89c2" xlink:to="loc_srt_LitigationCaseTypeDomain_c5c6926e-70a3-4611-8d52-014bc321969f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_IntellectualPropertyInfringementClaimsMember_e4d26138-9874-4501-aed1-6058489eab70" xlink:href="fldm-20200930.xsd#fldm_IntellectualPropertyInfringementClaimsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_c5c6926e-70a3-4611-8d52-014bc321969f" xlink:to="loc_fldm_IntellectualPropertyInfringementClaimsMember_e4d26138-9874-4501-aed1-6058489eab70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAxis_e0c380bc-9069-45f3-a6d7-06ea57976876" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesTable_dbbb109b-e8a0-49f9-9072-a1306729101a" xlink:to="loc_us-gaap_CapitalizedContractCostAxis_e0c380bc-9069-45f3-a6d7-06ea57976876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain_d05bdde4-7103-4ada-8fe5-7aefd7ad1119" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostAxis_e0c380bc-9069-45f3-a6d7-06ea57976876" xlink:to="loc_us-gaap_CapitalizedContractCostDomain_d05bdde4-7103-4ada-8fe5-7aefd7ad1119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CommissionCostsMember_82b7d485-27de-4a18-9118-7405209b9e8b" xlink:href="fldm-20200930.xsd#fldm_CommissionCostsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_d05bdde4-7103-4ada-8fe5-7aefd7ad1119" xlink:to="loc_fldm_CommissionCostsMember_82b7d485-27de-4a18-9118-7405209b9e8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_024950ca-f01a-4f33-a1c2-68964370b60f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesTable_dbbb109b-e8a0-49f9-9072-a1306729101a" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_024950ca-f01a-4f33-a1c2-68964370b60f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d7cf9524-60f5-4542-9042-71e9d86af5d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_024950ca-f01a-4f33-a1c2-68964370b60f" xlink:to="loc_us-gaap_EquityComponentDomain_d7cf9524-60f5-4542-9042-71e9d86af5d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_25622f86-f9ac-4976-9ffc-22f0b385a5e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d7cf9524-60f5-4542-9042-71e9d86af5d4" xlink:to="loc_us-gaap_CommonStockMember_25622f86-f9ac-4976-9ffc-22f0b385a5e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_68c88987-92ea-4037-a40f-4cf77a70d573" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d7cf9524-60f5-4542-9042-71e9d86af5d4" xlink:to="loc_us-gaap_RetainedEarningsMember_68c88987-92ea-4037-a40f-4cf77a70d573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6080bc6f-c167-4cfa-8833-2b40ec288c7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesTable_dbbb109b-e8a0-49f9-9072-a1306729101a" xlink:to="loc_us-gaap_DebtInstrumentAxis_6080bc6f-c167-4cfa-8833-2b40ec288c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_400dba08-197e-41f6-a595-b8f541be0e04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_6080bc6f-c167-4cfa-8833-2b40ec288c7e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_400dba08-197e-41f6-a595-b8f541be0e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeniorConvertibleNotesdue2034Member_9b82a44f-3905-4c1b-8c5a-9c78f774614b" xlink:href="fldm-20200930.xsd#fldm_SeniorConvertibleNotesdue2034Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_400dba08-197e-41f6-a595-b8f541be0e04" xlink:to="loc_fldm_SeniorConvertibleNotesdue2034Member_9b82a44f-3905-4c1b-8c5a-9c78f774614b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ExchangeConvertibleSeniorNotesDue2034Member_3b091de3-585d-412a-860d-51ac060f8560" xlink:href="fldm-20200930.xsd#fldm_ExchangeConvertibleSeniorNotesDue2034Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_400dba08-197e-41f6-a595-b8f541be0e04" xlink:to="loc_fldm_ExchangeConvertibleSeniorNotesDue2034Member_3b091de3-585d-412a-860d-51ac060f8560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeniorConvertibleNotesDue2024Member_880cfcd7-c012-438e-bcd8-3a9917a0f7a6" xlink:href="fldm-20200930.xsd#fldm_SeniorConvertibleNotesDue2024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_400dba08-197e-41f6-a595-b8f541be0e04" xlink:to="loc_fldm_SeniorConvertibleNotesDue2024Member_880cfcd7-c012-438e-bcd8-3a9917a0f7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_942ab21e-bb6c-43d1-ba39-f82d9149b8bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesTable_dbbb109b-e8a0-49f9-9072-a1306729101a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_942ab21e-bb6c-43d1-ba39-f82d9149b8bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fff063b9-444e-4794-a036-0d288a8adaf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_942ab21e-bb6c-43d1-ba39-f82d9149b8bd" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fff063b9-444e-4794-a036-0d288a8adaf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_08609b50-2fc4-472c-9acd-fdcb595671e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fff063b9-444e-4794-a036-0d288a8adaf1" xlink:to="loc_us-gaap_ConvertibleDebtMember_08609b50-2fc4-472c-9acd-fdcb595671e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_73aa08bc-e8ec-4215-aa2f-586478bac328" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesTable_dbbb109b-e8a0-49f9-9072-a1306729101a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_73aa08bc-e8ec-4215-aa2f-586478bac328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8039cc61-79ec-4edb-ac7b-987ef91e6d38" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_73aa08bc-e8ec-4215-aa2f-586478bac328" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8039cc61-79ec-4edb-ac7b-987ef91e6d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_3abed56b-f418-454f-b8de-0f85a0fa98fa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8039cc61-79ec-4edb-ac7b-987ef91e6d38" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_3abed56b-f418-454f-b8de-0f85a0fa98fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_e46fa442-dce1-4728-b0d3-9e63b193fca5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesTable_dbbb109b-e8a0-49f9-9072-a1306729101a" xlink:to="loc_srt_MajorCustomersAxis_e46fa442-dce1-4728-b0d3-9e63b193fca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_f4be368c-1594-4b96-ba48-d859621e2f37" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_e46fa442-dce1-4728-b0d3-9e63b193fca5" xlink:to="loc_srt_NameOfMajorCustomerDomain_f4be368c-1594-4b96-ba48-d859621e2f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_OneCustomerMember_ae8942a2-1d8d-4606-8cd2-6b7310b68d62" xlink:href="fldm-20200930.xsd#fldm_OneCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_f4be368c-1594-4b96-ba48-d859621e2f37" xlink:to="loc_fldm_OneCustomerMember_ae8942a2-1d8d-4606-8cd2-6b7310b68d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_FiveLargestCustomersMember_1e17bcb7-b049-4de5-9191-5812009c9cb9" xlink:href="fldm-20200930.xsd#fldm_FiveLargestCustomersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_f4be368c-1594-4b96-ba48-d859621e2f37" xlink:to="loc_fldm_FiveLargestCustomersMember_1e17bcb7-b049-4de5-9191-5812009c9cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_84b37c8f-76a1-42ce-9f3a-400194c36349" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesTable_dbbb109b-e8a0-49f9-9072-a1306729101a" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_84b37c8f-76a1-42ce-9f3a-400194c36349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_fc0f4248-bb1c-4b93-80c3-f8f00ccd9fb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_84b37c8f-76a1-42ce-9f3a-400194c36349" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_fc0f4248-bb1c-4b93-80c3-f8f00ccd9fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_65885a84-35d5-4433-9faa-6fa34e14ba69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_fc0f4248-bb1c-4b93-80c3-f8f00ccd9fb8" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_65885a84-35d5-4433-9faa-6fa34e14ba69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_4df6debe-4993-4ef7-a977-eb0696bd39b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesTable_dbbb109b-e8a0-49f9-9072-a1306729101a" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_4df6debe-4993-4ef7-a977-eb0696bd39b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_aff754d8-9ffd-4fe6-ab03-e79442c9d4c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_4df6debe-4993-4ef7-a977-eb0696bd39b5" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_aff754d8-9ffd-4fe6-ab03-e79442c9d4c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_08d010bf-584d-4bba-9233-b5e9ae93a548" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_aff754d8-9ffd-4fe6-ab03-e79442c9d4c8" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_08d010bf-584d-4bba-9233-b5e9ae93a548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:href="fldm-20200930.xsd#fldm_ScheduleOfSignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesTable_dbbb109b-e8a0-49f9-9072-a1306729101a" xlink:to="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_RevenueFromContractWithCustomerTermsOfPaymentPeriod_5e6a92b4-6b3b-4cf9-b9e0-8a2ab8fec12e" xlink:href="fldm-20200930.xsd#fldm_RevenueFromContractWithCustomerTermsOfPaymentPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_fldm_RevenueFromContractWithCustomerTermsOfPaymentPeriod_5e6a92b4-6b3b-4cf9-b9e0-8a2ab8fec12e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_RevenueFromContractWithCustomerPerformanceObligationPeriod_a73d3d88-7f86-48e8-97d3-67bafd3ebd6e" xlink:href="fldm-20200930.xsd#fldm_RevenueFromContractWithCustomerPerformanceObligationPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_fldm_RevenueFromContractWithCustomerPerformanceObligationPeriod_a73d3d88-7f86-48e8-97d3-67bafd3ebd6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements_903b8c7a-58be-4528-8cc8-1932bf30c2f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_us-gaap_ProceedsFromLegalSettlements_903b8c7a-58be-4528-8cc8-1932bf30c2f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d8017a08-3678-4406-9cdd-80697f4e7acb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d8017a08-3678-4406-9cdd-80697f4e7acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalFees_b5897d81-d7f5-4aa4-bee9-37f172f7d5c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LegalFees"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_us-gaap_LegalFees_b5897d81-d7f5-4aa4-bee9-37f172f7d5c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ProductWarrantyTerm_4fc00bf7-9930-4a22-8fa2-f36382dac6cb" xlink:href="fldm-20200930.xsd#fldm_ProductWarrantyTerm"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_fldm_ProductWarrantyTerm_4fc00bf7-9930-4a22-8fa2-f36382dac6cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_d521ca68-b405-4c28-9e41-caa2b3a700ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_d521ca68-b405-4c28-9e41-caa2b3a700ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_66e8969d-8e85-44ae-96e7-08468d29f6e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_66e8969d-8e85-44ae-96e7-08468d29f6e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue_0ff46820-2a61-4de3-8de1-8319b7080e04" xlink:href="fldm-20200930.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue_0ff46820-2a61-4de3-8de1-8319b7080e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_4ffc821f-6546-4602-8c03-4ea322ddd3c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_4ffc821f-6546-4602-8c03-4ea322ddd3c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_89e7ffa1-beff-492c-8008-bd0c4dda89c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_89e7ffa1-beff-492c-8008-bd0c4dda89c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_33f4a4d7-8a64-457b-bdad-eca64e362c41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_33f4a4d7-8a64-457b-bdad-eca64e362c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_26f15a18-bae3-4a53-992d-6d9480827228" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_26f15a18-bae3-4a53-992d-6d9480827228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_143bcb7d-93dd-41a3-8151-3b7104675822" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_143bcb7d-93dd-41a3-8151-3b7104675822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_5bd32944-3e7d-4c2c-ac3b-0d8ac40ae0f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_5bd32944-3e7d-4c2c-ac3b-0d8ac40ae0f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_900800f0-69b5-44d0-b92b-56f2464a29fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_900800f0-69b5-44d0-b92b-56f2464a29fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ce2c30a8-10aa-4899-95d6-e0ee0d372cf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ScheduleOfSignificantAccountingPoliciesLineItems_125b8ecc-e149-4ec6-a47e-7d1fc1a9ce39" xlink:to="loc_us-gaap_StockholdersEquity_ce2c30a8-10aa-4899-95d6-e0ee0d372cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d37303e0-ae77-4052-ae77-a201a003088e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c1702027-4340-457d-9117-361a7c7a81a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d37303e0-ae77-4052-ae77-a201a003088e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c1702027-4340-457d-9117-361a7c7a81a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_84157348-1b84-49f4-b696-679888e32f27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c1702027-4340-457d-9117-361a7c7a81a4" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_84157348-1b84-49f4-b696-679888e32f27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_963d47cc-6fc3-4156-ab86-213d78ec5bfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_84157348-1b84-49f4-b696-679888e32f27" xlink:to="loc_us-gaap_EquityComponentDomain_963d47cc-6fc3-4156-ab86-213d78ec5bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_94231429-642a-44f9-8c76-7dd5c16a7358" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_963d47cc-6fc3-4156-ab86-213d78ec5bfd" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_94231429-642a-44f9-8c76-7dd5c16a7358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_a5d16fd5-e789-4da9-918d-654cce4b99de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_963d47cc-6fc3-4156-ab86-213d78ec5bfd" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_a5d16fd5-e789-4da9-918d-654cce4b99de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ae5db6d9-1f86-4959-85c7-07f908c93513" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_963d47cc-6fc3-4156-ab86-213d78ec5bfd" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ae5db6d9-1f86-4959-85c7-07f908c93513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7b35da46-5f7e-4f20-b50f-3067eee8f265" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c1702027-4340-457d-9117-361a7c7a81a4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7b35da46-5f7e-4f20-b50f-3067eee8f265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d948ee1b-d409-4459-835d-781a6908188d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7b35da46-5f7e-4f20-b50f-3067eee8f265" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d948ee1b-d409-4459-835d-781a6908188d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_15106370-aa89-46a9-a241-c86757d4ca55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d948ee1b-d409-4459-835d-781a6908188d" xlink:to="loc_us-gaap_StockholdersEquity_15106370-aa89-46a9-a241-c86757d4ca55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_8efb6d9e-32d2-47ad-b467-99c7b095d684" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d948ee1b-d409-4459-835d-781a6908188d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_8efb6d9e-32d2-47ad-b467-99c7b095d684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_78004e2d-9684-44cd-a4f9-f7e657a46bf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d948ee1b-d409-4459-835d-781a6908188d" xlink:to="loc_us-gaap_StockholdersEquity_78004e2d-9684-44cd-a4f9-f7e657a46bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_294f6335-4920-4bc0-863e-bb6cba8002f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1a29fc8c-d703-49c5-99ae-b0c64c1e878b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_294f6335-4920-4bc0-863e-bb6cba8002f5" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1a29fc8c-d703-49c5-99ae-b0c64c1e878b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_75960203-96eb-4122-bc33-48c75b597fc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1a29fc8c-d703-49c5-99ae-b0c64c1e878b" xlink:to="loc_us-gaap_DebtInstrumentAxis_75960203-96eb-4122-bc33-48c75b597fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_07dd9133-4de4-4cf1-ad37-b806f0f04d88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_75960203-96eb-4122-bc33-48c75b597fc8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_07dd9133-4de4-4cf1-ad37-b806f0f04d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndNineteenConvertibleNotesMember_8d3e5ea1-8dc0-4fed-8f5a-f46cc3a241ff" xlink:href="fldm-20200930.xsd#fldm_TwoThousandAndNineteenConvertibleNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_07dd9133-4de4-4cf1-ad37-b806f0f04d88" xlink:to="loc_fldm_TwoThousandAndNineteenConvertibleNotesMember_8d3e5ea1-8dc0-4fed-8f5a-f46cc3a241ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember_e20e25a3-d21c-4060-9233-a1e02dc7c85b" xlink:href="fldm-20200930.xsd#fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_07dd9133-4de4-4cf1-ad37-b806f0f04d88" xlink:to="loc_fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember_e20e25a3-d21c-4060-9233-a1e02dc7c85b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndFourteenConvertibleNotesMember_c9daebe5-a8a5-4423-940b-f252edf07174" xlink:href="fldm-20200930.xsd#fldm_TwoThousandAndFourteenConvertibleNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_07dd9133-4de4-4cf1-ad37-b806f0f04d88" xlink:to="loc_fldm_TwoThousandAndFourteenConvertibleNotesMember_c9daebe5-a8a5-4423-940b-f252edf07174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f935dc68-c6c1-4334-9fb7-52597ab0ca12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1a29fc8c-d703-49c5-99ae-b0c64c1e878b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f935dc68-c6c1-4334-9fb7-52597ab0ca12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_12335eff-7c1f-4c2e-8114-6d95305e3a96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f935dc68-c6c1-4334-9fb7-52597ab0ca12" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_12335eff-7c1f-4c2e-8114-6d95305e3a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_9b18340e-0c79-4308-aa09-d01842611ebf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_12335eff-7c1f-4c2e-8114-6d95305e3a96" xlink:to="loc_us-gaap_EmployeeStockOptionMember_9b18340e-0c79-4308-aa09-d01842611ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_09d0df72-18c6-4359-8b41-8a20cff7b1f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_12335eff-7c1f-4c2e-8114-6d95305e3a96" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_09d0df72-18c6-4359-8b41-8a20cff7b1f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_cc31b605-97c9-43b2-8f13-a36424535e75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1a29fc8c-d703-49c5-99ae-b0c64c1e878b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_cc31b605-97c9-43b2-8f13-a36424535e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7287bd81-c911-4ce6-b812-f7ecea1223e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_cc31b605-97c9-43b2-8f13-a36424535e75" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7287bd81-c911-4ce6-b812-f7ecea1223e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/BusinessCombination" xlink:type="simple" xlink:href="fldm-20200930.xsd#BusinessCombination"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/BusinessCombination" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_35e78a76-cd12-4fa1-866d-cc223b631995" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_4ea8a9ab-8fb1-4f5e-92df-e487d8869bf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_35e78a76-cd12-4fa1-866d-cc223b631995" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_4ea8a9ab-8fb1-4f5e-92df-e487d8869bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/BusinessCombinationTables" xlink:type="simple" xlink:href="fldm-20200930.xsd#BusinessCombinationTables"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/BusinessCombinationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_d613a823-5d6a-4b0d-9783-95bf8834da75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_a7b49905-4174-418e-9ef7-672063b0c4d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_d613a823-5d6a-4b0d-9783-95bf8834da75" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_a7b49905-4174-418e-9ef7-672063b0c4d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_fcab9e07-86d8-4b89-9417-bec440229005" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_d613a823-5d6a-4b0d-9783-95bf8834da75" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_fcab9e07-86d8-4b89-9417-bec440229005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/BusinessCombinationNarrativeDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#BusinessCombinationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/BusinessCombinationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_66f7a1ef-dbb2-431a-9d77-c874565bbc33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e86b7837-696b-4116-b29d-c95a3311d338" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_66f7a1ef-dbb2-431a-9d77-c874565bbc33" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e86b7837-696b-4116-b29d-c95a3311d338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f115e516-3156-4be5-a56d-a5ea1d574d06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e86b7837-696b-4116-b29d-c95a3311d338" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f115e516-3156-4be5-a56d-a5ea1d574d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fa643190-05ab-45f6-8a51-0dd0f2b5b197" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f115e516-3156-4be5-a56d-a5ea1d574d06" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fa643190-05ab-45f6-8a51-0dd0f2b5b197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_InstruNorASMember_e53538ce-e03b-404d-a1e7-8c9f69760cc7" xlink:href="fldm-20200930.xsd#fldm_InstruNorASMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fa643190-05ab-45f6-8a51-0dd0f2b5b197" xlink:to="loc_fldm_InstruNorASMember_e53538ce-e03b-404d-a1e7-8c9f69760cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_4528469d-cc1c-4037-9bf3-1ee4f3d54c44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e86b7837-696b-4116-b29d-c95a3311d338" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_4528469d-cc1c-4037-9bf3-1ee4f3d54c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_b8748945-6044-488f-a0de-635063f2294d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4528469d-cc1c-4037-9bf3-1ee4f3d54c44" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_b8748945-6044-488f-a0de-635063f2294d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_ee69a780-aabc-4f4c-a15c-f31d5640be1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4528469d-cc1c-4037-9bf3-1ee4f3d54c44" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_ee69a780-aabc-4f4c-a15c-f31d5640be1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_ed43ca51-f8fc-4fa4-9ead-2867b8bd8904" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4528469d-cc1c-4037-9bf3-1ee4f3d54c44" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_ed43ca51-f8fc-4fa4-9ead-2867b8bd8904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_c235a994-3f2f-4f48-aba3-f499f4f6b9e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4528469d-cc1c-4037-9bf3-1ee4f3d54c44" xlink:to="loc_us-gaap_SharePrice_c235a994-3f2f-4f48-aba3-f499f4f6b9e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c16ae27f-c545-4a06-aca2-87df05660800" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4528469d-cc1c-4037-9bf3-1ee4f3d54c44" xlink:to="loc_us-gaap_Goodwill_c16ae27f-c545-4a06-aca2-87df05660800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/BusinessCombinationNetCashFlowsDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#BusinessCombinationNetCashFlowsDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/BusinessCombinationNetCashFlowsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_7308157f-dac5-44c8-8f3a-0610780c6107" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_38fea189-7938-4d9c-a63a-89918dd4c8d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_7308157f-dac5-44c8-8f3a-0610780c6107" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_38fea189-7938-4d9c-a63a-89918dd4c8d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_055c4906-8fa5-42fd-a4c5-8d174fd8b955" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_38fea189-7938-4d9c-a63a-89918dd4c8d6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_055c4906-8fa5-42fd-a4c5-8d174fd8b955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_adfcf094-af8f-4868-9ce8-9e50cc4a9857" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_055c4906-8fa5-42fd-a4c5-8d174fd8b955" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_adfcf094-af8f-4868-9ce8-9e50cc4a9857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_InstruNorASMember_55612504-fcdb-4a92-b762-ce4799829170" xlink:href="fldm-20200930.xsd#fldm_InstruNorASMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_adfcf094-af8f-4868-9ce8-9e50cc4a9857" xlink:to="loc_fldm_InstruNorASMember_55612504-fcdb-4a92-b762-ce4799829170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_6b5ecf0e-ae29-4e88-9ef3-028cb22d2413" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_38fea189-7938-4d9c-a63a-89918dd4c8d6" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_6b5ecf0e-ae29-4e88-9ef3-028cb22d2413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_9fb57a39-482d-43c3-bf82-42eccc4fd384" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6b5ecf0e-ae29-4e88-9ef3-028cb22d2413" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_9fb57a39-482d-43c3-bf82-42eccc4fd384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_d1bb15ab-8eb7-4f5c-953f-c3afeea8b690" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6b5ecf0e-ae29-4e88-9ef3-028cb22d2413" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_d1bb15ab-8eb7-4f5c-953f-c3afeea8b690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_27d41c9e-14b6-47dd-8bd9-638d9b9184ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6b5ecf0e-ae29-4e88-9ef3-028cb22d2413" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_27d41c9e-14b6-47dd-8bd9-638d9b9184ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_0972bee0-02ce-42d5-bfcc-f9da9e0e8bcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_43577e50-833b-447c-8823-398200dadafd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_0972bee0-02ce-42d5-bfcc-f9da9e0e8bcf" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_43577e50-833b-447c-8823-398200dadafd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2c2ef960-0224-40a6-ae30-195c4060ab5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_43577e50-833b-447c-8823-398200dadafd" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2c2ef960-0224-40a6-ae30-195c4060ab5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91a5ba10-ac2c-4e63-aa23-e3f146b80688" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2c2ef960-0224-40a6-ae30-195c4060ab5a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91a5ba10-ac2c-4e63-aa23-e3f146b80688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_InstruNorASMember_70947f5a-0eba-47dc-84a8-7547a5babcd9" xlink:href="fldm-20200930.xsd#fldm_InstruNorASMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91a5ba10-ac2c-4e63-aa23-e3f146b80688" xlink:to="loc_fldm_InstruNorASMember_70947f5a-0eba-47dc-84a8-7547a5babcd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b6c8c52f-4b61-44cd-9314-e312b09095c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_43577e50-833b-447c-8823-398200dadafd" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_b6c8c52f-4b61-44cd-9314-e312b09095c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_0bd51f27-959f-44e7-a56d-1314cb2bdfc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6c8c52f-4b61-44cd-9314-e312b09095c8" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_0bd51f27-959f-44e7-a56d-1314cb2bdfc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_f41bee3d-3a15-4755-9642-e8cf7e6e6cea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_0bd51f27-959f-44e7-a56d-1314cb2bdfc2" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_f41bee3d-3a15-4755-9642-e8cf7e6e6cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_a7ebb19a-c2ee-4b52-a052-94ee6aec888f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_0bd51f27-959f-44e7-a56d-1314cb2bdfc2" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_a7ebb19a-c2ee-4b52-a052-94ee6aec888f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_35e0dc28-acb4-45ef-827d-ad880d890bbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_0bd51f27-959f-44e7-a56d-1314cb2bdfc2" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_35e0dc28-acb4-45ef-827d-ad880d890bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_d926e524-0fdb-4f2f-9e0e-36f14179a087" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6c8c52f-4b61-44cd-9314-e312b09095c8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_d926e524-0fdb-4f2f-9e0e-36f14179a087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_f15bff7f-ee9a-4f7c-a4cf-869d06fc65f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_d926e524-0fdb-4f2f-9e0e-36f14179a087" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_f15bff7f-ee9a-4f7c-a4cf-869d06fc65f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAccountsReceivables_62bc366b-3527-4c2f-915c-9c72e9e55c3a" xlink:href="fldm-20200930.xsd#fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAccountsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_d926e524-0fdb-4f2f-9e0e-36f14179a087" xlink:to="loc_fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAccountsReceivables_62bc366b-3527-4c2f-915c-9c72e9e55c3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherReceivables_4da5be26-724e-40d0-a494-1060e386205c" xlink:href="fldm-20200930.xsd#fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherReceivables"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_d926e524-0fdb-4f2f-9e0e-36f14179a087" xlink:to="loc_fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherReceivables_4da5be26-724e-40d0-a494-1060e386205c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_012ee29c-e3ec-4375-b78d-197c942b728a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_d926e524-0fdb-4f2f-9e0e-36f14179a087" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_012ee29c-e3ec-4375-b78d-197c942b728a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_d92c4b33-5e22-4245-97f1-0de2bb6db6c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_d926e524-0fdb-4f2f-9e0e-36f14179a087" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_d92c4b33-5e22-4245-97f1-0de2bb6db6c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_f623c37f-95fa-4955-9082-6cbb330fff30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6c8c52f-4b61-44cd-9314-e312b09095c8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_f623c37f-95fa-4955-9082-6cbb330fff30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_83fb55d0-de12-450c-9d55-6e4520340783" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_f623c37f-95fa-4955-9082-6cbb330fff30" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_83fb55d0-de12-450c-9d55-6e4520340783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_002668cf-e9fb-4e61-8fd3-04b50ed45b1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_f623c37f-95fa-4955-9082-6cbb330fff30" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_002668cf-e9fb-4e61-8fd3-04b50ed45b1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_18b8ba76-e608-4025-9ce3-a3101a52a54c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_f623c37f-95fa-4955-9082-6cbb330fff30" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_18b8ba76-e608-4025-9ce3-a3101a52a54c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_7fbb7f92-541a-4d81-b696-c687c56bde21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6c8c52f-4b61-44cd-9314-e312b09095c8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_7fbb7f92-541a-4d81-b696-c687c56bde21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_82e61d9b-6a3a-4fc5-ad31-50abdffe791f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6c8c52f-4b61-44cd-9314-e312b09095c8" xlink:to="loc_us-gaap_Goodwill_82e61d9b-6a3a-4fc5-ad31-50abdffe791f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/RADxProgram" xlink:type="simple" xlink:href="fldm-20200930.xsd#RADxProgram"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/RADxProgram" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_8701caa5-3ef2-48b8-bb87-55477f3c4887" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_e0877592-f29c-4288-93e1-b96b61cdcf47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_8701caa5-3ef2-48b8-bb87-55477f3c4887" xlink:to="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_e0877592-f29c-4288-93e1-b96b61cdcf47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/RADxProgramTables" xlink:type="simple" xlink:href="fldm-20200930.xsd#RADxProgramTables"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/RADxProgramTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_85c0f2de-e6b5-4edf-974a-5e9f12a2f8d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock_475f0f8c-163f-4295-bf03-58aeed97305c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_85c0f2de-e6b5-4edf-974a-5e9f12a2f8d0" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock_475f0f8c-163f-4295-bf03-58aeed97305c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/RADxProgramDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#RADxProgramDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/RADxProgramDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_bc23e338-4b96-4527-91f0-c4f4efda83d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue_0b58917d-ad24-4c12-9d42-613b80a551fa" xlink:href="fldm-20200930.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_bc23e338-4b96-4527-91f0-c4f4efda83d5" xlink:to="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue_0b58917d-ad24-4c12-9d42-613b80a551fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesPercentage_914aac3d-a54b-43ff-9c61-fb3252bb17f1" xlink:href="fldm-20200930.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_bc23e338-4b96-4527-91f0-c4f4efda83d5" xlink:to="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesPercentage_914aac3d-a54b-43ff-9c61-fb3252bb17f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesTerm_04732884-6674-4a92-9809-d198685a5824" xlink:href="fldm-20200930.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_bc23e338-4b96-4527-91f0-c4f4efda83d5" xlink:to="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesTerm_04732884-6674-4a92-9809-d198685a5824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount_ff9d9b2b-bd68-473f-bdae-2987a4c97b59" xlink:href="fldm-20200930.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_bc23e338-4b96-4527-91f0-c4f4efda83d5" xlink:to="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount_ff9d9b2b-bd68-473f-bdae-2987a4c97b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses_65d6d7e5-5c49-40a3-87b7-e3145e960a6c" xlink:href="fldm-20200930.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_bc23e338-4b96-4527-91f0-c4f4efda83d5" xlink:to="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses_65d6d7e5-5c49-40a3-87b7-e3145e960a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DeferredGrantRevenueNoncurrent_720b0ba8-8c8d-4917-8df1-2c8303860e4c" xlink:href="fldm-20200930.xsd#fldm_DeferredGrantRevenueNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_bc23e338-4b96-4527-91f0-c4f4efda83d5" xlink:to="loc_fldm_DeferredGrantRevenueNoncurrent_720b0ba8-8c8d-4917-8df1-2c8303860e4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersFundingReceived_8b50629f-27eb-45b3-b198-59893b5b6431" xlink:href="fldm-20200930.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersFundingReceived"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_bc23e338-4b96-4527-91f0-c4f4efda83d5" xlink:to="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersFundingReceived_8b50629f-27eb-45b3-b198-59893b5b6431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementReceivables_e6cc89ae-fe60-4ab1-a394-007960571b82" xlink:href="fldm-20200930.xsd#fldm_ResearchAndDevelopmentArrangementReceivables"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_bc23e338-4b96-4527-91f0-c4f4efda83d5" xlink:to="loc_fldm_ResearchAndDevelopmentArrangementReceivables_e6cc89ae-fe60-4ab1-a394-007960571b82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/Revenue" xlink:type="simple" xlink:href="fldm-20200930.xsd#Revenue"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/Revenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_97ed335a-4bdd-4a66-b616-ad321b201325" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_f1308d5c-3776-4d5b-8118-9a593d74a734" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_97ed335a-4bdd-4a66-b616-ad321b201325" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_f1308d5c-3776-4d5b-8118-9a593d74a734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/RevenueTables" xlink:type="simple" xlink:href="fldm-20200930.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f02867e7-541b-42f9-bdaa-eb8af4a6c291" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_4052c8aa-0a3e-4a4f-8f1c-682f387e4d9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f02867e7-541b-42f9-bdaa-eb8af4a6c291" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_4052c8aa-0a3e-4a4f-8f1c-682f387e4d9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_8be26543-5200-4c61-afa9-9a8f13ac0383" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f02867e7-541b-42f9-bdaa-eb8af4a6c291" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_8be26543-5200-4c61-afa9-9a8f13ac0383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#RevenueScheduleofDisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_499fe673-e5de-4334-8f55-e778b0c959e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_da15d609-2e8f-4155-aaf4-1514700a9811" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_499fe673-e5de-4334-8f55-e778b0c959e5" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_da15d609-2e8f-4155-aaf4-1514700a9811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_69789c78-f994-497c-a482-93e0f8bbf9d1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_da15d609-2e8f-4155-aaf4-1514700a9811" xlink:to="loc_srt_StatementGeographicalAxis_69789c78-f994-497c-a482-93e0f8bbf9d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_45a77ebb-07bb-475c-89e1-041ef589f049" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_69789c78-f994-497c-a482-93e0f8bbf9d1" xlink:to="loc_srt_SegmentGeographicalDomain_45a77ebb-07bb-475c-89e1-041ef589f049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_2de53187-1ba5-4b6e-8096-6cfd4c1fa9ca" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AmericasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_45a77ebb-07bb-475c-89e1-041ef589f049" xlink:to="loc_srt_AmericasMember_2de53187-1ba5-4b6e-8096-6cfd4c1fa9ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_eae68a3e-ebe5-4288-b936-4d8386654acf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EMEAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_45a77ebb-07bb-475c-89e1-041ef589f049" xlink:to="loc_us-gaap_EMEAMember_eae68a3e-ebe5-4288-b936-4d8386654acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_06e02541-1e14-4295-8cc6-136a8261480c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_45a77ebb-07bb-475c-89e1-041ef589f049" xlink:to="loc_srt_AsiaPacificMember_06e02541-1e14-4295-8cc6-136a8261480c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_30be6bc7-6d25-49d6-a56a-64e37bf6c9ab" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_da15d609-2e8f-4155-aaf4-1514700a9811" xlink:to="loc_srt_ProductOrServiceAxis_30be6bc7-6d25-49d6-a56a-64e37bf6c9ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_db7030fa-0c7a-4dc1-bcea-0b49f1bab4b9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_30be6bc7-6d25-49d6-a56a-64e37bf6c9ab" xlink:to="loc_srt_ProductsAndServicesDomain_db7030fa-0c7a-4dc1-bcea-0b49f1bab4b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_InstrumentsMember_82595fd0-4d2d-48bc-a9bb-02986b150ae6" xlink:href="fldm-20200930.xsd#fldm_InstrumentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_db7030fa-0c7a-4dc1-bcea-0b49f1bab4b9" xlink:to="loc_fldm_InstrumentsMember_82595fd0-4d2d-48bc-a9bb-02986b150ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ConsumablesMember_86bf3271-b7c6-4a03-b2ed-aeb3c99ff338" xlink:href="fldm-20200930.xsd#fldm_ConsumablesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_db7030fa-0c7a-4dc1-bcea-0b49f1bab4b9" xlink:to="loc_fldm_ConsumablesMember_86bf3271-b7c6-4a03-b2ed-aeb3c99ff338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_92ef9574-5bc1-49e4-ba2b-6bf7756b385e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_db7030fa-0c7a-4dc1-bcea-0b49f1bab4b9" xlink:to="loc_us-gaap_ProductMember_92ef9574-5bc1-49e4-ba2b-6bf7756b385e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_500bc2a4-58a0-4e1b-b13f-32d7d0c48c7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_db7030fa-0c7a-4dc1-bcea-0b49f1bab4b9" xlink:to="loc_us-gaap_ServiceMember_500bc2a4-58a0-4e1b-b13f-32d7d0c48c7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CollaborationRevenueMember_0ebf9f3f-a0fe-4286-b434-4c09c3a4187d" xlink:href="fldm-20200930.xsd#fldm_CollaborationRevenueMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_db7030fa-0c7a-4dc1-bcea-0b49f1bab4b9" xlink:to="loc_fldm_CollaborationRevenueMember_0ebf9f3f-a0fe-4286-b434-4c09c3a4187d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember_e2b432f1-4d73-4e9d-99cb-af965a3e3cd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicenseMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_db7030fa-0c7a-4dc1-bcea-0b49f1bab4b9" xlink:to="loc_us-gaap_LicenseMember_e2b432f1-4d73-4e9d-99cb-af965a3e3cd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrantMember_8c67734a-271c-43c3-b7a6-f6eff1a7fb44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrantMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_db7030fa-0c7a-4dc1-bcea-0b49f1bab4b9" xlink:to="loc_us-gaap_GrantMember_8c67734a-271c-43c3-b7a6-f6eff1a7fb44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_2d57aa16-1df6-4e2d-85c0-87efd5ba311a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_db7030fa-0c7a-4dc1-bcea-0b49f1bab4b9" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_2d57aa16-1df6-4e2d-85c0-87efd5ba311a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_3267c53c-3bb9-4e5b-b279-b033dfd25fbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_da15d609-2e8f-4155-aaf4-1514700a9811" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_3267c53c-3bb9-4e5b-b279-b033dfd25fbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_24cfb03d-7169-46a4-bc17-aadcd33b49b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3267c53c-3bb9-4e5b-b279-b033dfd25fbb" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_24cfb03d-7169-46a4-bc17-aadcd33b49b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#RevenueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/RevenueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_12a6825d-473e-4ad9-bdd1-552cc6f3ec26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_bbdc0abf-9f81-45e1-ba01-9440cece93ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_12a6825d-473e-4ad9-bdd1-552cc6f3ec26" xlink:to="loc_us-gaap_ContractWithCustomerLiability_bbdc0abf-9f81-45e1-ba01-9440cece93ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_8103c324-f102-4775-a546-b22084ea7d51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_12a6825d-473e-4ad9-bdd1-552cc6f3ec26" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_8103c324-f102-4775-a546-b22084ea7d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts_86cbe29a-f8cd-43c4-a6bc-e5cebbce3da7" xlink:href="fldm-20200930.xsd#fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_12a6825d-473e-4ad9-bdd1-552cc6f3ec26" xlink:to="loc_fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts_86cbe29a-f8cd-43c4-a6bc-e5cebbce3da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/RevenuePerformanceObligationsDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#RevenuePerformanceObligationsDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/RevenuePerformanceObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_acb2c0e1-68b1-4b1e-96e8-64e24c3591df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d0120ac7-2507-495e-a254-da189441644e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_acb2c0e1-68b1-4b1e-96e8-64e24c3591df" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d0120ac7-2507-495e-a254-da189441644e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_45c15515-17f4-40f9-ab17-f830dc587532" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d0120ac7-2507-495e-a254-da189441644e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_45c15515-17f4-40f9-ab17-f830dc587532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_e238f766-0998-43d7-9226-74f56e49f50f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d0120ac7-2507-495e-a254-da189441644e" xlink:to="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_e238f766-0998-43d7-9226-74f56e49f50f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_9d30e70d-291f-4ab4-8f51-529fb457a579" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_e238f766-0998-43d7-9226-74f56e49f50f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_9d30e70d-291f-4ab4-8f51-529fb457a579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_18863d52-1fe4-43a6-940a-97b578214971" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_e238f766-0998-43d7-9226-74f56e49f50f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_18863d52-1fe4-43a6-940a-97b578214971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/RevenuePerformanceObligationsDetails_1" xlink:type="simple" xlink:href="fldm-20200930.xsd#RevenuePerformanceObligationsDetails_1"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/RevenuePerformanceObligationsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnet" xlink:type="simple" xlink:href="fldm-20200930.xsd#GoodwillandIntangibleAssetsnet"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/GoodwillandIntangibleAssetsnet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_95dffd53-96b4-41cb-98c8-60a91055f2bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_c8a1b5fd-a530-4032-968b-e8f8ca47d97b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_95dffd53-96b4-41cb-98c8-60a91055f2bc" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_c8a1b5fd-a530-4032-968b-e8f8ca47d97b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetTables" xlink:type="simple" xlink:href="fldm-20200930.xsd#GoodwillandIntangibleAssetsnetTables"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a2a560d4-f201-41ce-9608-23ea1f1bf806" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_d42263ae-dd47-4aed-ae5c-8b19f3240be5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a2a560d4-f201-41ce-9608-23ea1f1bf806" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_d42263ae-dd47-4aed-ae5c-8b19f3240be5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_17576e1b-a880-47ca-bc94-d0d500a0a526" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a2a560d4-f201-41ce-9608-23ea1f1bf806" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_17576e1b-a880-47ca-bc94-d0d500a0a526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#GoodwillandIntangibleAssetsnetNarrativeDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_46bc54ea-657f-48c1-b33c-f27c207c8fca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9940b397-0f02-4b62-a1f4-20acdeed19a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_46bc54ea-657f-48c1-b33c-f27c207c8fca" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9940b397-0f02-4b62-a1f4-20acdeed19a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_42ca1ec7-ff15-419e-ae07-6c3a9c2f3734" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9940b397-0f02-4b62-a1f4-20acdeed19a0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_42ca1ec7-ff15-419e-ae07-6c3a9c2f3734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_870f03c0-4c5e-40d4-a24d-3af61f2959aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_42ca1ec7-ff15-419e-ae07-6c3a9c2f3734" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_870f03c0-4c5e-40d4-a24d-3af61f2959aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_8892fad3-743e-4f29-b070-a6379ba0e70f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_870f03c0-4c5e-40d4-a24d-3af61f2959aa" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_8892fad3-743e-4f29-b070-a6379ba0e70f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_8db8b9d3-8a9c-4c22-8dc7-8fcb5ad4246a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9940b397-0f02-4b62-a1f4-20acdeed19a0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_8db8b9d3-8a9c-4c22-8dc7-8fcb5ad4246a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c9ac88e8-db17-4945-8c2f-4c5f6ec1dc5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8db8b9d3-8a9c-4c22-8dc7-8fcb5ad4246a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c9ac88e8-db17-4945-8c2f-4c5f6ec1dc5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DVSSciencesInc.Member_318349c3-f4fa-4697-a7ca-e21c26dea7e8" xlink:href="fldm-20200930.xsd#fldm_DVSSciencesInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c9ac88e8-db17-4945-8c2f-4c5f6ec1dc5e" xlink:to="loc_fldm_DVSSciencesInc.Member_318349c3-f4fa-4697-a7ca-e21c26dea7e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_InstruNorASMember_709b3a1b-a38a-47c3-a37a-643a167ff434" xlink:href="fldm-20200930.xsd#fldm_InstruNorASMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c9ac88e8-db17-4945-8c2f-4c5f6ec1dc5e" xlink:to="loc_fldm_InstruNorASMember_709b3a1b-a38a-47c3-a37a-643a167ff434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a45b0b34-d429-4989-90a1-4b6d780c8c09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9940b397-0f02-4b62-a1f4-20acdeed19a0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a45b0b34-d429-4989-90a1-4b6d780c8c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_20bc601e-b993-43f1-bae1-ac97ba988de3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a45b0b34-d429-4989-90a1-4b6d780c8c09" xlink:to="loc_us-gaap_Goodwill_20bc601e-b993-43f1-bae1-ac97ba988de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_79b6fe5c-facd-4dc0-8c3b-258f0f492971" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a45b0b34-d429-4989-90a1-4b6d780c8c09" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_79b6fe5c-facd-4dc0-8c3b-258f0f492971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_0cb47a84-eb7f-4bc2-87bc-772cb4b05895" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a45b0b34-d429-4989-90a1-4b6d780c8c09" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_0cb47a84-eb7f-4bc2-87bc-772cb4b05895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_90fef025-d96e-4d79-85af-20c7a54c4ec6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a45b0b34-d429-4989-90a1-4b6d780c8c09" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_90fef025-d96e-4d79-85af-20c7a54c4ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8d2e85bf-e38b-47a8-8553-d2d2ad7bccf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6ff3d177-4c9d-41f9-8e4a-3303079e3d7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8d2e85bf-e38b-47a8-8553-d2d2ad7bccf7" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6ff3d177-4c9d-41f9-8e4a-3303079e3d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_aec6e9a0-5a23-4ecb-9514-135df200cc60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6ff3d177-4c9d-41f9-8e4a-3303079e3d7f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_aec6e9a0-5a23-4ecb-9514-135df200cc60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ba6a90fd-6a4e-47e3-841a-7c586d55a4bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_aec6e9a0-5a23-4ecb-9514-135df200cc60" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ba6a90fd-6a4e-47e3-841a-7c586d55a4bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_722ed731-0fd4-44e2-87d8-ccb5a0b674ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ba6a90fd-6a4e-47e3-841a-7c586d55a4bf" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_722ed731-0fd4-44e2-87d8-ccb5a0b674ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_PatentsandLicenseAgreementsMember_c3624774-0199-4ac2-a042-2bdd6f2d6d31" xlink:href="fldm-20200930.xsd#fldm_PatentsandLicenseAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ba6a90fd-6a4e-47e3-841a-7c586d55a4bf" xlink:to="loc_fldm_PatentsandLicenseAgreementsMember_c3624774-0199-4ac2-a042-2bdd6f2d6d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e644f76e-ca47-4d0d-899e-d355d0267718" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6ff3d177-4c9d-41f9-8e4a-3303079e3d7f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e644f76e-ca47-4d0d-899e-d355d0267718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_7de506e9-c4a0-4405-94d0-e8cead2264fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e644f76e-ca47-4d0d-899e-d355d0267718" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_7de506e9-c4a0-4405-94d0-e8cead2264fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_be49da86-4df4-498c-9c11-73ea5061c09e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e644f76e-ca47-4d0d-899e-d355d0267718" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_be49da86-4df4-498c-9c11-73ea5061c09e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_11e2789d-40cb-4a67-a6ca-7ecb2a57f52e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e644f76e-ca47-4d0d-899e-d355d0267718" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_11e2789d-40cb-4a67-a6ca-7ecb2a57f52e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_4b2b1f7d-8800-4a35-9203-31f4d04570d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e644f76e-ca47-4d0d-899e-d355d0267718" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_4b2b1f7d-8800-4a35-9203-31f4d04570d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cb4ce9d8-1403-4fa4-bf6d-37802a86511a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_69f03874-c6b4-4fdf-8953-5974dd1a5d80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cb4ce9d8-1403-4fa4-bf6d-37802a86511a" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_69f03874-c6b4-4fdf-8953-5974dd1a5d80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6a3fa240-f689-40b8-95b9-100426697b9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_69f03874-c6b4-4fdf-8953-5974dd1a5d80" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6a3fa240-f689-40b8-95b9-100426697b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cb2e61e-3fa4-4ce8-af88-9c52801b85fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6a3fa240-f689-40b8-95b9-100426697b9e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cb2e61e-3fa4-4ce8-af88-9c52801b85fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_0d2cbadf-d949-425d-b009-ff815c7d16d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cb2e61e-3fa4-4ce8-af88-9c52801b85fa" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_0d2cbadf-d949-425d-b009-ff815c7d16d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_PatentsandLicenseAgreementsMember_efe0ad57-a7f9-431d-b93b-ac647fa75532" xlink:href="fldm-20200930.xsd#fldm_PatentsandLicenseAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cb2e61e-3fa4-4ce8-af88-9c52801b85fa" xlink:to="loc_fldm_PatentsandLicenseAgreementsMember_efe0ad57-a7f9-431d-b93b-ac647fa75532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f85c251c-fcab-49a1-b325-0cf45ff685d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_69f03874-c6b4-4fdf-8953-5974dd1a5d80" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f85c251c-fcab-49a1-b325-0cf45ff685d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_c3c49cb5-e5e0-461d-93ea-661dc1736713" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f85c251c-fcab-49a1-b325-0cf45ff685d5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_c3c49cb5-e5e0-461d-93ea-661dc1736713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_4beb8049-cd64-410c-bdaf-a57e286bddf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f85c251c-fcab-49a1-b325-0cf45ff685d5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_4beb8049-cd64-410c-bdaf-a57e286bddf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_8166cc72-69fb-4021-b440-23df5997cd24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f85c251c-fcab-49a1-b325-0cf45ff685d5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_8166cc72-69fb-4021-b440-23df5997cd24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c8ad79b0-9339-478d-b049-a1ae3f825a29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f85c251c-fcab-49a1-b325-0cf45ff685d5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c8ad79b0-9339-478d-b049-a1ae3f825a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0a407428-7f78-4f64-9ac5-71170e407799" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f85c251c-fcab-49a1-b325-0cf45ff685d5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0a407428-7f78-4f64-9ac5-71170e407799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_4cbc3b87-10b1-480a-84c6-c79debb313ec" xlink:href="fldm-20200930.xsd#fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f85c251c-fcab-49a1-b325-0cf45ff685d5" xlink:to="loc_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_4cbc3b87-10b1-480a-84c6-c79debb313ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_60a9563b-5c46-4fb9-89f2-a92c96052504" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f85c251c-fcab-49a1-b325-0cf45ff685d5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_60a9563b-5c46-4fb9-89f2-a92c96052504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/BalanceSheetDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#BalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/BalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_5818c528-8ef1-49e7-876d-73286e9d7f19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_a66097f8-222c-4f5d-a219-1f0e6cc04a86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_5818c528-8ef1-49e7-876d-73286e9d7f19" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_a66097f8-222c-4f5d-a219-1f0e6cc04a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/BalanceSheetDetailsTables" xlink:type="simple" xlink:href="fldm-20200930.xsd#BalanceSheetDetailsTables"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/BalanceSheetDetailsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_881b4c25-0eeb-4d71-aa3f-44819617828b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_5b0dbbf1-7ed3-4e51-9e1b-f7477cf65344" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_881b4c25-0eeb-4d71-aa3f-44819617828b" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_5b0dbbf1-7ed3-4e51-9e1b-f7477cf65344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_0f346b95-8478-4760-a82e-6fa0c02a6d74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_881b4c25-0eeb-4d71-aa3f-44819617828b" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_0f346b95-8478-4760-a82e-6fa0c02a6d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_625db317-b1dc-4ba2-8832-fe6733b21fbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_881b4c25-0eeb-4d71-aa3f-44819617828b" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_625db317-b1dc-4ba2-8832-fe6733b21fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_c39e923c-185c-40d4-908f-996fb90f1cae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_881b4c25-0eeb-4d71-aa3f-44819617828b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_c39e923c-185c-40d4-908f-996fb90f1cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_d6c3116e-08b7-40b1-89d3-ffe6f399145e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_881b4c25-0eeb-4d71-aa3f-44819617828b" xlink:to="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_d6c3116e-08b7-40b1-89d3-ffe6f399145e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_ee7d55d4-f623-4ef0-84b8-b46491644718" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9373b93c-e578-4768-9258-fbe3f1f9d2e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_ee7d55d4-f623-4ef0-84b8-b46491644718" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9373b93c-e578-4768-9258-fbe3f1f9d2e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_7ef0b591-d445-4cc2-980f-ca5c1750079d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_ee7d55d4-f623-4ef0-84b8-b46491644718" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_7ef0b591-d445-4cc2-980f-ca5c1750079d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a58058f6-d15e-40d2-b479-faf9f79e9799" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_ee7d55d4-f623-4ef0-84b8-b46491644718" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a58058f6-d15e-40d2-b479-faf9f79e9799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_ac09ba1a-c44b-4325-a298-69277f9c6d1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_ee7d55d4-f623-4ef0-84b8-b46491644718" xlink:to="loc_us-gaap_RestrictedCashCurrent_ac09ba1a-c44b-4325-a298-69277f9c6d1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_62c7e940-cfc7-4825-9b34-2ab0044844f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_ee7d55d4-f623-4ef0-84b8-b46491644718" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_62c7e940-cfc7-4825-9b34-2ab0044844f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#BalanceSheetDetailsInventoriesDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_3ce26686-72de-43de-906e-866f45506cfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_7db673e0-dd8f-486d-b3f9-1d019d833a7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_3ce26686-72de-43de-906e-866f45506cfd" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_7db673e0-dd8f-486d-b3f9-1d019d833a7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_eb4c03db-3748-4be2-8903-f4af74df40a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_3ce26686-72de-43de-906e-866f45506cfd" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_eb4c03db-3748-4be2-8903-f4af74df40a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_f0696344-3f87-415e-9556-325a3412cb9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_3ce26686-72de-43de-906e-866f45506cfd" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_f0696344-3f87-415e-9556-325a3412cb9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_ca2a4534-7e82-4008-9f49-9b9442738ba2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_3ce26686-72de-43de-906e-866f45506cfd" xlink:to="loc_us-gaap_InventoryNet_ca2a4534-7e82-4008-9f49-9b9442738ba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#BalanceSheetDetailsPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_20a7dc5a-1dcd-4e5e-857c-53c3010d72c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_262c8eed-757e-41e2-b9ee-3175fc0123ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_20a7dc5a-1dcd-4e5e-857c-53c3010d72c4" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_262c8eed-757e-41e2-b9ee-3175fc0123ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fb301dc7-922c-41b4-92b2-15eeb0294283" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_262c8eed-757e-41e2-b9ee-3175fc0123ca" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fb301dc7-922c-41b4-92b2-15eeb0294283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42d872ed-78d8-41bc-802e-00597649d4eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fb301dc7-922c-41b4-92b2-15eeb0294283" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42d872ed-78d8-41bc-802e-00597649d4eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ComputerEquipmentAndSoftwareMember_3f63e251-b55e-422c-b4b8-f34f4b9a7e2e" xlink:href="fldm-20200930.xsd#fldm_ComputerEquipmentAndSoftwareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42d872ed-78d8-41bc-802e-00597649d4eb" xlink:to="loc_fldm_ComputerEquipmentAndSoftwareMember_3f63e251-b55e-422c-b4b8-f34f4b9a7e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LaboratoryAndManufacturingEquipmentMember_71d19431-e125-4385-96f0-0f17686d0819" xlink:href="fldm-20200930.xsd#fldm_LaboratoryAndManufacturingEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42d872ed-78d8-41bc-802e-00597649d4eb" xlink:to="loc_fldm_LaboratoryAndManufacturingEquipmentMember_71d19431-e125-4385-96f0-0f17686d0819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_fd683b0f-3b31-4ea8-9baa-1e9b31606eaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42d872ed-78d8-41bc-802e-00597649d4eb" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_fd683b0f-3b31-4ea8-9baa-1e9b31606eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_97ab9250-5222-48c0-b8c8-fb2e29462555" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42d872ed-78d8-41bc-802e-00597649d4eb" xlink:to="loc_us-gaap_OfficeEquipmentMember_97ab9250-5222-48c0-b8c8-fb2e29462555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_dea957a9-94c1-43a7-bfdd-7639f21f9e8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_262c8eed-757e-41e2-b9ee-3175fc0123ca" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_dea957a9-94c1-43a7-bfdd-7639f21f9e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_453d5a90-5029-492f-b05c-a2818ace9d02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_dea957a9-94c1-43a7-bfdd-7639f21f9e8a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_453d5a90-5029-492f-b05c-a2818ace9d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_9897c1ee-c8c3-47b9-9fd3-0fed24513490" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_dea957a9-94c1-43a7-bfdd-7639f21f9e8a" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_9897c1ee-c8c3-47b9-9fd3-0fed24513490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_93859ba0-451f-4207-a6e0-4fea757bd1f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_dea957a9-94c1-43a7-bfdd-7639f21f9e8a" xlink:to="loc_us-gaap_ConstructionInProgressGross_93859ba0-451f-4207-a6e0-4fea757bd1f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6b639cdd-8a4a-4787-b2fa-eeb2a93d6027" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_dea957a9-94c1-43a7-bfdd-7639f21f9e8a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6b639cdd-8a4a-4787-b2fa-eeb2a93d6027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/BalanceSheetDetailsWarrantyAccrualDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#BalanceSheetDetailsWarrantyAccrualDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/BalanceSheetDetailsWarrantyAccrualDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_18640210-0ed8-44df-8a91-61a5579aeff0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_6c7a7927-c703-423b-8dd7-3aab387c0b59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_18640210-0ed8-44df-8a91-61a5579aeff0" xlink:to="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_6c7a7927-c703-423b-8dd7-3aab387c0b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual_51f7eccf-749f-4b98-8346-dee546ca5576" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_6c7a7927-c703-423b-8dd7-3aab387c0b59" xlink:to="loc_us-gaap_ProductWarrantyAccrual_51f7eccf-749f-4b98-8346-dee546ca5576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued_ff4fae02-f988-461e-9e31-b5c0c9a0be76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualWarrantiesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_6c7a7927-c703-423b-8dd7-3aab387c0b59" xlink:to="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued_ff4fae02-f988-461e-9e31-b5c0c9a0be76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments_fb3755a2-2d28-42a1-81a0-8e18fb84a650" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_6c7a7927-c703-423b-8dd7-3aab387c0b59" xlink:to="loc_us-gaap_ProductWarrantyAccrualPayments_fb3755a2-2d28-42a1-81a0-8e18fb84a650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual_218d3736-ee63-4b71-97f5-822436c6752b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_6c7a7927-c703-423b-8dd7-3aab387c0b59" xlink:to="loc_us-gaap_ProductWarrantyAccrual_218d3736-ee63-4b71-97f5-822436c6752b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/ConvertibleNotesandCreditFacility" xlink:type="simple" xlink:href="fldm-20200930.xsd#ConvertibleNotesandCreditFacility"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/ConvertibleNotesandCreditFacility" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_24f1f903-68d1-444a-9a62-f3e2e299e3a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_65af91a1-ce81-4f18-b607-01e8206d532d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_24f1f903-68d1-444a-9a62-f3e2e299e3a2" xlink:to="loc_us-gaap_LongTermDebtTextBlock_65af91a1-ce81-4f18-b607-01e8206d532d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/ConvertibleNotesandCreditFacilityTables" xlink:type="simple" xlink:href="fldm-20200930.xsd#ConvertibleNotesandCreditFacilityTables"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/ConvertibleNotesandCreditFacilityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0dbdaf94-10ce-48c6-baff-24273af02895" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_bc78be80-92bd-4560-a8e2-f60d6fee53ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0dbdaf94-10ce-48c6-baff-24273af02895" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_bc78be80-92bd-4560-a8e2-f60d6fee53ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#ConvertibleNotesandCreditFacilityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_cebed16c-fc49-40cd-b463-68860c207d86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_126e694c-65b8-4301-9c74-3afde4a04842" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cebed16c-fc49-40cd-b463-68860c207d86" xlink:to="loc_us-gaap_DebtInstrumentTable_126e694c-65b8-4301-9c74-3afde4a04842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_71ad913b-7321-4245-9776-97516bb02f0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_126e694c-65b8-4301-9c74-3afde4a04842" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_71ad913b-7321-4245-9776-97516bb02f0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e3b1f383-214a-476a-9a6c-783a55677540" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_71ad913b-7321-4245-9776-97516bb02f0b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e3b1f383-214a-476a-9a6c-783a55677540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_fb5b0646-cd86-4465-8da0-9ce0155ecb29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e3b1f383-214a-476a-9a6c-783a55677540" xlink:to="loc_us-gaap_ConvertibleDebtMember_fb5b0646-cd86-4465-8da0-9ce0155ecb29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d5b206d2-aec6-43a8-8442-6252bc7641c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_126e694c-65b8-4301-9c74-3afde4a04842" xlink:to="loc_us-gaap_DebtInstrumentAxis_d5b206d2-aec6-43a8-8442-6252bc7641c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_69c08ae3-6165-4fba-bf98-14e95556f14c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_d5b206d2-aec6-43a8-8442-6252bc7641c0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_69c08ae3-6165-4fba-bf98-14e95556f14c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeniorConvertibleNotesdue2034Member_a10f1bf1-c9fa-4211-8a16-636611df4f8e" xlink:href="fldm-20200930.xsd#fldm_SeniorConvertibleNotesdue2034Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69c08ae3-6165-4fba-bf98-14e95556f14c" xlink:to="loc_fldm_SeniorConvertibleNotesdue2034Member_a10f1bf1-c9fa-4211-8a16-636611df4f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ExchangeConvertibleSeniorNotesDue2034Member_1fdcf835-a2a9-4311-9acb-f642fea6b451" xlink:href="fldm-20200930.xsd#fldm_ExchangeConvertibleSeniorNotesDue2034Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69c08ae3-6165-4fba-bf98-14e95556f14c" xlink:to="loc_fldm_ExchangeConvertibleSeniorNotesDue2034Member_1fdcf835-a2a9-4311-9acb-f642fea6b451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeniorConvertibleNotesDue2024Member_3b4bc02f-47cd-42f7-85bf-0d300fe9ea68" xlink:href="fldm-20200930.xsd#fldm_SeniorConvertibleNotesDue2024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69c08ae3-6165-4fba-bf98-14e95556f14c" xlink:to="loc_fldm_SeniorConvertibleNotesDue2024Member_3b4bc02f-47cd-42f7-85bf-0d300fe9ea68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_e6e0f11e-a4d4-4242-8aa6-b71a5a1bbfd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_126e694c-65b8-4301-9c74-3afde4a04842" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_e6e0f11e-a4d4-4242-8aa6-b71a5a1bbfd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_b0c083e5-4023-484b-a32d-7a8f9a1a3cac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_e6e0f11e-a4d4-4242-8aa6-b71a5a1bbfd9" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_b0c083e5-4023-484b-a32d-7a8f9a1a3cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TrusteeMember_22544785-2d46-4cac-87e7-707681af7c62" xlink:href="fldm-20200930.xsd#fldm_TrusteeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_b0c083e5-4023-484b-a32d-7a8f9a1a3cac" xlink:to="loc_fldm_TrusteeMember_22544785-2d46-4cac-87e7-707681af7c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_72d87890-5d07-43e7-a3a2-b18d8a66d4c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_126e694c-65b8-4301-9c74-3afde4a04842" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_72d87890-5d07-43e7-a3a2-b18d8a66d4c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_fc27d484-ace7-4071-b1a5-8cf65bc83983" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_72d87890-5d07-43e7-a3a2-b18d8a66d4c2" xlink:to="loc_us-gaap_EquityComponentDomain_fc27d484-ace7-4071-b1a5-8cf65bc83983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_8d59077d-81c9-483d-99b6-e927c67515d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_fc27d484-ace7-4071-b1a5-8cf65bc83983" xlink:to="loc_us-gaap_CommonStockMember_8d59077d-81c9-483d-99b6-e927c67515d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_a0bb20df-0f5e-4f08-9ecd-46cecddfc6d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_126e694c-65b8-4301-9c74-3afde4a04842" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_a0bb20df-0f5e-4f08-9ecd-46cecddfc6d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_a7d291bd-0a23-45ed-891b-d2597b21124f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_a0bb20df-0f5e-4f08-9ecd-46cecddfc6d8" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_a7d291bd-0a23-45ed-891b-d2597b21124f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_1bf24c11-0686-4b7e-a772-89e4f587a031" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_a7d291bd-0a23-45ed-891b-d2597b21124f" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_1bf24c11-0686-4b7e-a772-89e4f587a031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_3e0545cc-88b6-43c9-a658-a1515c7cf95f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_a7d291bd-0a23-45ed-891b-d2597b21124f" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_3e0545cc-88b6-43c9-a658-a1515c7cf95f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_4ba35660-0e13-4841-b461-31925023893e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_126e694c-65b8-4301-9c74-3afde4a04842" xlink:to="loc_us-gaap_CreditFacilityAxis_4ba35660-0e13-4841-b461-31925023893e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_cff55e8f-66c0-42cc-976f-d7cce3aab99c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_4ba35660-0e13-4841-b461-31925023893e" xlink:to="loc_us-gaap_CreditFacilityDomain_cff55e8f-66c0-42cc-976f-d7cce3aab99c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_e108a97f-3551-4922-a772-fa3cf7f0c138" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_cff55e8f-66c0-42cc-976f-d7cce3aab99c" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_e108a97f-3551-4922-a772-fa3cf7f0c138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3132d494-1b8e-4a89-8ffb-92dccc77c90d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_126e694c-65b8-4301-9c74-3afde4a04842" xlink:to="loc_srt_RangeAxis_3132d494-1b8e-4a89-8ffb-92dccc77c90d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d0b466b5-0e72-4e1f-8805-c0469fb3770e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3132d494-1b8e-4a89-8ffb-92dccc77c90d" xlink:to="loc_srt_RangeMember_d0b466b5-0e72-4e1f-8805-c0469fb3770e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3ce01833-6521-4774-bfa0-024694e0f6a9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d0b466b5-0e72-4e1f-8805-c0469fb3770e" xlink:to="loc_srt_MinimumMember_3ce01833-6521-4774-bfa0-024694e0f6a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ec0458ec-249b-4c69-bde7-625b7f96d3b3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d0b466b5-0e72-4e1f-8805-c0469fb3770e" xlink:to="loc_srt_MaximumMember_ec0458ec-249b-4c69-bde7-625b7f96d3b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_4c3794a6-0ce0-4dca-a988-23f6a3f37201" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_126e694c-65b8-4301-9c74-3afde4a04842" xlink:to="loc_us-gaap_VariableRateAxis_4c3794a6-0ce0-4dca-a988-23f6a3f37201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_6035fa78-0855-4e80-a22d-32b81712aca8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_4c3794a6-0ce0-4dca-a988-23f6a3f37201" xlink:to="loc_us-gaap_VariableRateDomain_6035fa78-0855-4e80-a22d-32b81712aca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember_52dd8640-04d4-4cfd-be34-101ba5d63587" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrimeRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_6035fa78-0855-4e80-a22d-32b81712aca8" xlink:to="loc_us-gaap_PrimeRateMember_52dd8640-04d4-4cfd-be34-101ba5d63587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_126e694c-65b8-4301-9c74-3afde4a04842" xlink:to="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_45191e82-5f99-4852-bb21-d75be3280e8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_45191e82-5f99-4852-bb21-d75be3280e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_e7a6f169-42d0-49a3-baf8-291706c4ee5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_e7a6f169-42d0-49a3-baf8-291706c4ee5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_afdbf097-d80b-4550-98f5-c880dac15cdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_afdbf097-d80b-4550-98f5-c880dac15cdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_f49366c1-feec-4829-adf8-7f15195b5c4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_f49366c1-feec-4829-adf8-7f15195b5c4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_5a4d2e9b-7ab5-40da-abab-0687604f27e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_5a4d2e9b-7ab5-40da-abab-0687604f27e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_2a173acc-618d-45c9-afe8-96ddca7e526b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_LongTermDebtFairValue_2a173acc-618d-45c9-afe8-96ddca7e526b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d30d89af-2a72-4416-a0f7-eb9d95107cd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d30d89af-2a72-4416-a0f7-eb9d95107cd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_23ff6e9d-8dc2-4978-9806-91f20320a64b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_23ff6e9d-8dc2-4978-9806-91f20320a64b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_b351725e-153d-4d25-8b80-83b857d89765" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_b351725e-153d-4d25-8b80-83b857d89765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_InitialConversionPriceOfStock_0a69095b-6b69-48db-8406-6292a8fedb0c" xlink:href="fldm-20200930.xsd#fldm_InitialConversionPriceOfStock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_fldm_InitialConversionPriceOfStock_0a69095b-6b69-48db-8406-6292a8fedb0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice_6cb222a7-c087-4c61-9be6-69dbf4824896" xlink:href="fldm-20200930.xsd#fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice_6cb222a7-c087-4c61-9be6-69dbf4824896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtAndEquityOfferingCosts_84f9c7f5-8b9d-4556-92d1-fa63d0c436cf" xlink:href="fldm-20200930.xsd#fldm_DebtAndEquityOfferingCosts"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_fldm_DebtAndEquityOfferingCosts_84f9c7f5-8b9d-4556-92d1-fa63d0c436cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_1c55b56d-53f0-4ec4-a4a7-33791f29c3ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_1c55b56d-53f0-4ec4-a4a7-33791f29c3ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_c8d77f0e-0895-42a0-972a-a24149be4c73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_c8d77f0e-0895-42a0-972a-a24149be4c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_41c7168b-e88f-463e-9cee-6090d03190a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_41c7168b-e88f-463e-9cee-6090d03190a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_a1e92af8-1b71-4b69-affc-9b1f934702a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_a1e92af8-1b71-4b69-affc-9b1f934702a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_d5ae5dfe-764b-485a-8cb9-f58490b3baa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_d5ae5dfe-764b-485a-8cb9-f58490b3baa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_dc5a96a1-4598-4011-878c-494bc7d7d279" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_dc5a96a1-4598-4011-878c-494bc7d7d279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_dc4fb0d5-0a1d-4fbb-8d21-915a79875e63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_dc4fb0d5-0a1d-4fbb-8d21-915a79875e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_6c67bda4-a00b-4cea-84a8-f67b75f97aab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_6c67bda4-a00b-4cea-84a8-f67b75f97aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables_6ffca6c0-e572-413c-bd6b-06d319b13070" xlink:href="fldm-20200930.xsd#fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables_6ffca6c0-e572-413c-bd6b-06d319b13070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory_4331d6f5-803d-44c9-ab76-37c9acd49dd5" xlink:href="fldm-20200930.xsd#fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory_4331d6f5-803d-44c9-ab76-37c9acd49dd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_bac29acb-8d34-4afc-b69f-973afe1b802c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_LineOfCredit_bac29acb-8d34-4afc-b69f-973afe1b802c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1e23a6a0-9c15-46ed-88ed-39c86cede540" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1e23a6a0-9c15-46ed-88ed-39c86cede540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_dc23329f-8bf7-42b4-80fd-7765307893af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_dc23329f-8bf7-42b4-80fd-7765307893af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtInstrumentEarlyRedemptionCostPercentOfMaximumBorrowingCapacity_8ba4e11d-08bd-417d-af6a-395ea39b058c" xlink:href="fldm-20200930.xsd#fldm_DebtInstrumentEarlyRedemptionCostPercentOfMaximumBorrowingCapacity"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_fldm_DebtInstrumentEarlyRedemptionCostPercentOfMaximumBorrowingCapacity_8ba4e11d-08bd-417d-af6a-395ea39b058c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LineOfCreditFacilityPercentageOfInterestOnObligationUponDefault_c2257e60-6d2e-42c5-9ded-e9836422dabe" xlink:href="fldm-20200930.xsd#fldm_LineOfCreditFacilityPercentageOfInterestOnObligationUponDefault"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1ffba2cb-41f6-493b-a779-196e1cdceb45" xlink:to="loc_fldm_LineOfCreditFacilityPercentageOfInterestOnObligationUponDefault_c2257e60-6d2e-42c5-9ded-e9836422dabe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#ConvertibleNotesandCreditFacilityScheduleofDebtDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_da24525e-9e47-4a8d-81e7-a503b10e40d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_06d7a199-1242-4033-b4ac-8d957791b3f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_da24525e-9e47-4a8d-81e7-a503b10e40d1" xlink:to="loc_us-gaap_DebtInstrumentTable_06d7a199-1242-4033-b4ac-8d957791b3f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cd797c55-3b87-4612-b4ba-1259f0f98d34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_06d7a199-1242-4033-b4ac-8d957791b3f5" xlink:to="loc_us-gaap_DebtInstrumentAxis_cd797c55-3b87-4612-b4ba-1259f0f98d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_41e8f597-0aab-4c00-aebb-0b9f4f9e850b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_cd797c55-3b87-4612-b4ba-1259f0f98d34" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_41e8f597-0aab-4c00-aebb-0b9f4f9e850b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeniorConvertibleNotesdue2034Member_f97ba959-b47e-49b5-9a60-dcd110b72376" xlink:href="fldm-20200930.xsd#fldm_SeniorConvertibleNotesdue2034Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_41e8f597-0aab-4c00-aebb-0b9f4f9e850b" xlink:to="loc_fldm_SeniorConvertibleNotesdue2034Member_f97ba959-b47e-49b5-9a60-dcd110b72376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeniorConvertibleNotesDue2024Member_7e67acd5-e443-4f40-a335-8038fedeefa1" xlink:href="fldm-20200930.xsd#fldm_SeniorConvertibleNotesDue2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_41e8f597-0aab-4c00-aebb-0b9f4f9e850b" xlink:to="loc_fldm_SeniorConvertibleNotesDue2024Member_7e67acd5-e443-4f40-a335-8038fedeefa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b949497b-2149-4eba-a0fc-3cfba6320b7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_06d7a199-1242-4033-b4ac-8d957791b3f5" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b949497b-2149-4eba-a0fc-3cfba6320b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_99518c32-f01c-4d72-8358-00c72c937481" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b949497b-2149-4eba-a0fc-3cfba6320b7a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_99518c32-f01c-4d72-8358-00c72c937481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_016c0645-dd22-4f01-8f80-a8d21e8c9fe2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_99518c32-f01c-4d72-8358-00c72c937481" xlink:to="loc_us-gaap_ConvertibleDebtMember_016c0645-dd22-4f01-8f80-a8d21e8c9fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f67776d3-97f5-4e5e-8f61-d3ad81bafcc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_06d7a199-1242-4033-b4ac-8d957791b3f5" xlink:to="loc_us-gaap_DebtInstrumentLineItems_f67776d3-97f5-4e5e-8f61-d3ad81bafcc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a70af316-a680-4c3c-be5c-f48eeded0bd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f67776d3-97f5-4e5e-8f61-d3ad81bafcc1" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a70af316-a680-4c3c-be5c-f48eeded0bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_bacfc7b5-e1d0-4c3c-b657-e2e5e4811d45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f67776d3-97f5-4e5e-8f61-d3ad81bafcc1" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_bacfc7b5-e1d0-4c3c-b657-e2e5e4811d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_79bc989d-8dd5-4829-ba69-9d06195f6654" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f67776d3-97f5-4e5e-8f61-d3ad81bafcc1" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_79bc989d-8dd5-4829-ba69-9d06195f6654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_f0bfb89d-3617-41da-b6aa-3af1d6c9897e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f67776d3-97f5-4e5e-8f61-d3ad81bafcc1" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_f0bfb89d-3617-41da-b6aa-3af1d6c9897e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_7eee510c-af6e-41b5-81d9-e04cf5d2509e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f67776d3-97f5-4e5e-8f61-d3ad81bafcc1" xlink:to="loc_us-gaap_LongTermDebt_7eee510c-af6e-41b5-81d9-e04cf5d2509e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/Leases" xlink:type="simple" xlink:href="fldm-20200930.xsd#Leases"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_dad939aa-936e-4597-b78d-60bf25c5a2f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_17eeb72f-8554-4417-8cdf-29ba3cde0ede" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_dad939aa-936e-4597-b78d-60bf25c5a2f5" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_17eeb72f-8554-4417-8cdf-29ba3cde0ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/LeasesTables" xlink:type="simple" xlink:href="fldm-20200930.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_b0a1c837-b883-4938-8264-5f9b567e37da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_AssetsAndLiabilitiesLesseeTableTextBlock_40832143-4572-497a-b81b-7c2c4a95f9f7" xlink:href="fldm-20200930.xsd#fldm_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b0a1c837-b883-4938-8264-5f9b567e37da" xlink:to="loc_fldm_AssetsAndLiabilitiesLesseeTableTextBlock_40832143-4572-497a-b81b-7c2c4a95f9f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_2d3f5a64-fd1f-49c3-a663-af831dc585be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b0a1c837-b883-4938-8264-5f9b567e37da" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_2d3f5a64-fd1f-49c3-a663-af831dc585be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_ebaa11c0-fbf2-40ff-afb9-f9a6bf194933" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b0a1c837-b883-4938-8264-5f9b567e37da" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_ebaa11c0-fbf2-40ff-afb9-f9a6bf194933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_170d6b91-064d-4a84-9749-f5e8d27d5a96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_d83a1a89-5f21-4ec3-bb69-4577b567aa3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_170d6b91-064d-4a84-9749-f5e8d27d5a96" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_d83a1a89-5f21-4ec3-bb69-4577b567aa3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d8565335-235c-4e13-ac96-374143275d10" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_d83a1a89-5f21-4ec3-bb69-4577b567aa3e" xlink:to="loc_srt_RangeAxis_d8565335-235c-4e13-ac96-374143275d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_68dd19c8-65ab-46ac-af8d-c6825c45c03f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d8565335-235c-4e13-ac96-374143275d10" xlink:to="loc_srt_RangeMember_68dd19c8-65ab-46ac-af8d-c6825c45c03f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f3ea9d90-01bf-41bd-91c6-c5218434f2ee" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_68dd19c8-65ab-46ac-af8d-c6825c45c03f" xlink:to="loc_srt_MinimumMember_f3ea9d90-01bf-41bd-91c6-c5218434f2ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_678114fc-11ac-411e-bde6-a2e51f723daa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_68dd19c8-65ab-46ac-af8d-c6825c45c03f" xlink:to="loc_srt_MaximumMember_678114fc-11ac-411e-bde6-a2e51f723daa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_241b6e5a-ad0a-476e-ae8d-5cccba265d8d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_d83a1a89-5f21-4ec3-bb69-4577b567aa3e" xlink:to="loc_srt_StatementGeographicalAxis_241b6e5a-ad0a-476e-ae8d-5cccba265d8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_763f754b-e34f-4c12-a1d1-630a98069cb5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_241b6e5a-ad0a-476e-ae8d-5cccba265d8d" xlink:to="loc_srt_SegmentGeographicalDomain_763f754b-e34f-4c12-a1d1-630a98069cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_bbf37e67-62f4-4e18-b13c-5382574f555b" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_763f754b-e34f-4c12-a1d1-630a98069cb5" xlink:to="loc_stpr_CA_bbf37e67-62f4-4e18-b13c-5382574f555b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_fb3052d1-1972-4e6f-b9d8-4575759aee5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_d83a1a89-5f21-4ec3-bb69-4577b567aa3e" xlink:to="loc_us-gaap_OperatingLeasedAssetsLineItems_fb3052d1-1972-4e6f-b9d8-4575759aee5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LesseeOperatingLeaseRemainingTermOfContract_a92793b1-d8c5-4e2f-8f0a-5cfa73f50362" xlink:href="fldm-20200930.xsd#fldm_LesseeOperatingLeaseRemainingTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_fb3052d1-1972-4e6f-b9d8-4575759aee5b" xlink:to="loc_fldm_LesseeOperatingLeaseRemainingTermOfContract_a92793b1-d8c5-4e2f-8f0a-5cfa73f50362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_5c32eb23-c995-4863-b3ea-2aea413b0a24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_fb3052d1-1972-4e6f-b9d8-4575759aee5b" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_5c32eb23-c995-4863-b3ea-2aea413b0a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_9777b257-9124-4bef-8d22-5c115f4d3003" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_fb3052d1-1972-4e6f-b9d8-4575759aee5b" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_9777b257-9124-4bef-8d22-5c115f4d3003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_b47de43c-6037-48f8-9ebb-8882da0767b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_fb3052d1-1972-4e6f-b9d8-4575759aee5b" xlink:to="loc_us-gaap_OperatingLeaseLiability_b47de43c-6037-48f8-9ebb-8882da0767b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_7d053ee2-9ec1-4f35-b289-2a242b85ca7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_fb3052d1-1972-4e6f-b9d8-4575759aee5b" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_7d053ee2-9ec1-4f35-b289-2a242b85ca7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseDiscountRate_5a625158-3b0f-43e5-abe5-1c38b2b0e172" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_fb3052d1-1972-4e6f-b9d8-4575759aee5b" xlink:to="loc_us-gaap_LesseeOperatingLeaseDiscountRate_5a625158-3b0f-43e5-abe5-1c38b2b0e172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#LeasesSupplementalBalancesheetDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_54f160c7-b049-4a21-b498-92f611d4a145" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_d4136feb-66c4-46ac-a6c0-6b5dadbb9c1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_54f160c7-b049-4a21-b498-92f611d4a145" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_d4136feb-66c4-46ac-a6c0-6b5dadbb9c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bab4ae7b-19b8-480a-b6b7-dac93910b867" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_d4136feb-66c4-46ac-a6c0-6b5dadbb9c1f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bab4ae7b-19b8-480a-b6b7-dac93910b867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a90ccad6-3488-466a-bb60-87f1a74e1bb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bab4ae7b-19b8-480a-b6b7-dac93910b867" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a90ccad6-3488-466a-bb60-87f1a74e1bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_dad0a47f-a09d-4fb8-8561-d3a9e71ce6e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a90ccad6-3488-466a-bb60-87f1a74e1bb7" xlink:to="loc_us-gaap_BuildingMember_dad0a47f-a09d-4fb8-8561-d3a9e71ce6e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_417ad508-70a0-41ec-ab5f-127e51f08035" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a90ccad6-3488-466a-bb60-87f1a74e1bb7" xlink:to="loc_us-gaap_EquipmentMember_417ad508-70a0-41ec-ab5f-127e51f08035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_493be0a1-f26e-473b-a6e9-06de173c2884" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VehiclesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a90ccad6-3488-466a-bb60-87f1a74e1bb7" xlink:to="loc_us-gaap_VehiclesMember_493be0a1-f26e-473b-a6e9-06de173c2884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_25ac8547-12f9-4f5f-bf52-348c91839103" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_d4136feb-66c4-46ac-a6c0-6b5dadbb9c1f" xlink:to="loc_us-gaap_OperatingLeasedAssetsLineItems_25ac8547-12f9-4f5f-bf52-348c91839103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_OperatingLeaseRightOfUseAssetGross_c68837df-d04a-41db-8a7d-4bce00f41257" xlink:href="fldm-20200930.xsd#fldm_OperatingLeaseRightOfUseAssetGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_25ac8547-12f9-4f5f-bf52-348c91839103" xlink:to="loc_fldm_OperatingLeaseRightOfUseAssetGross_c68837df-d04a-41db-8a7d-4bce00f41257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization_082b9e3d-8811-4107-8c7d-267592021246" xlink:href="fldm-20200930.xsd#fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_25ac8547-12f9-4f5f-bf52-348c91839103" xlink:to="loc_fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization_082b9e3d-8811-4107-8c7d-267592021246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_ee8a8553-eff4-4a47-84d4-cd4442a198cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_25ac8547-12f9-4f5f-bf52-348c91839103" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_ee8a8553-eff4-4a47-84d4-cd4442a198cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_651d535a-7d32-49c6-b711-f3f8d2b56638" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_25ac8547-12f9-4f5f-bf52-348c91839103" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_651d535a-7d32-49c6-b711-f3f8d2b56638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9361381a-f9cf-43ea-a3c9-a107ec81ddcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_25ac8547-12f9-4f5f-bf52-348c91839103" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9361381a-f9cf-43ea-a3c9-a107ec81ddcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_b81ead43-1c88-4fb2-88b0-4aacd93fc7e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_25ac8547-12f9-4f5f-bf52-348c91839103" xlink:to="loc_us-gaap_OperatingLeaseLiability_b81ead43-1c88-4fb2-88b0-4aacd93fc7e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_43665b66-9f24-4eb3-8c36-b369a88c3b42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_25ac8547-12f9-4f5f-bf52-348c91839103" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_43665b66-9f24-4eb3-8c36-b369a88c3b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_c39daa86-0146-402b-b803-5eb864bb3085" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_25ac8547-12f9-4f5f-bf52-348c91839103" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_c39daa86-0146-402b-b803-5eb864bb3085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/LeasesScheduleofOperatingLeaseCostDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#LeasesScheduleofOperatingLeaseCostDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/LeasesScheduleofOperatingLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_4af1b668-87eb-43c1-ada8-9d7f8a62287a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_e4026ac1-c19d-423a-8882-202a7dab3d7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4af1b668-87eb-43c1-ada8-9d7f8a62287a" xlink:to="loc_us-gaap_OperatingLeaseCost_e4026ac1-c19d-423a-8882-202a7dab3d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_7fcee983-a76c-4b00-8d16-41fe15ed8fce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4af1b668-87eb-43c1-ada8-9d7f8a62287a" xlink:to="loc_us-gaap_VariableLeaseCost_7fcee983-a76c-4b00-8d16-41fe15ed8fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CashPaidForOperatingLeaseLiabilitiesAbstract_e2a69372-27f1-4347-9ddc-fc4121414183" xlink:href="fldm-20200930.xsd#fldm_CashPaidForOperatingLeaseLiabilitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4af1b668-87eb-43c1-ada8-9d7f8a62287a" xlink:to="loc_fldm_CashPaidForOperatingLeaseLiabilitiesAbstract_e2a69372-27f1-4347-9ddc-fc4121414183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_39d7ddc4-778b-4ac8-a56e-a3c2d97a8667" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_CashPaidForOperatingLeaseLiabilitiesAbstract_e2a69372-27f1-4347-9ddc-fc4121414183" xlink:to="loc_us-gaap_OperatingLeasePayments_39d7ddc4-778b-4ac8-a56e-a3c2d97a8667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#LeasesOperatingLeaseMaturityDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_3014d282-b7cf-49a7-a7be-27c6e19240a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_236bb7d6-8888-41b2-8a22-a88a5fe52b80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3014d282-b7cf-49a7-a7be-27c6e19240a3" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_236bb7d6-8888-41b2-8a22-a88a5fe52b80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_b70c4bf1-7b2c-4c33-ab27-f4071dd144ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_236bb7d6-8888-41b2-8a22-a88a5fe52b80" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_b70c4bf1-7b2c-4c33-ab27-f4071dd144ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_7dd0f99d-d115-48f0-bdb7-044779c83743" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_236bb7d6-8888-41b2-8a22-a88a5fe52b80" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_7dd0f99d-d115-48f0-bdb7-044779c83743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_9c6d0501-a687-4616-a757-57de0859d35f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_236bb7d6-8888-41b2-8a22-a88a5fe52b80" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_9c6d0501-a687-4616-a757-57de0859d35f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_b85166c0-c20c-4bcf-bd14-8bfa8dab1103" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_236bb7d6-8888-41b2-8a22-a88a5fe52b80" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_b85166c0-c20c-4bcf-bd14-8bfa8dab1103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_3761bd80-03d4-478d-84c6-a39b9c1e4513" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_236bb7d6-8888-41b2-8a22-a88a5fe52b80" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_3761bd80-03d4-478d-84c6-a39b9c1e4513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_6429e3a3-befb-4498-b8e6-e6f4da455c98" xlink:href="fldm-20200930.xsd#fldm_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_236bb7d6-8888-41b2-8a22-a88a5fe52b80" xlink:to="loc_fldm_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_6429e3a3-befb-4498-b8e6-e6f4da455c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1fa2b765-ea2c-486f-9e3d-9b99b366c702" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_236bb7d6-8888-41b2-8a22-a88a5fe52b80" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1fa2b765-ea2c-486f-9e3d-9b99b366c702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_40698892-47eb-4023-9725-15a36e152769" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_236bb7d6-8888-41b2-8a22-a88a5fe52b80" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_40698892-47eb-4023-9725-15a36e152769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_aae757e6-d54d-4da4-abdf-9c4da9f30d16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_236bb7d6-8888-41b2-8a22-a88a5fe52b80" xlink:to="loc_us-gaap_OperatingLeaseLiability_aae757e6-d54d-4da4-abdf-9c4da9f30d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails_1" xlink:type="simple" xlink:href="fldm-20200930.xsd#LeasesOperatingLeaseMaturityDetails_1"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/FairValueofFinancialInstruments" xlink:type="simple" xlink:href="fldm-20200930.xsd#FairValueofFinancialInstruments"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/FairValueofFinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_dc3fda0a-0748-4aa0-b26a-fc9e230061e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_49ac1621-13e7-4524-9b36-5f3f0b9dba8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_dc3fda0a-0748-4aa0-b26a-fc9e230061e8" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_49ac1621-13e7-4524-9b36-5f3f0b9dba8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/FairValueofFinancialInstrumentsTables" xlink:type="simple" xlink:href="fldm-20200930.xsd#FairValueofFinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/FairValueofFinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_538bf50e-41d9-4859-9c84-c0301df14264" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_ace4268e-23db-433c-9e52-38f812a9d594" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_538bf50e-41d9-4859-9c84-c0301df14264" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_ace4268e-23db-433c-9e52-38f812a9d594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_dd50fd21-59ce-41c3-929b-8647a60b3645" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_538bf50e-41d9-4859-9c84-c0301df14264" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_dd50fd21-59ce-41c3-929b-8647a60b3645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_26af22b7-1f99-4e9a-9a4f-c1aa324ea8ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_45dead50-4b9c-4e97-800e-6dc732a9fd94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_26af22b7-1f99-4e9a-9a4f-c1aa324ea8ba" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_45dead50-4b9c-4e97-800e-6dc732a9fd94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_fbd8c1b5-720c-460e-b903-0551bbd72dce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_45dead50-4b9c-4e97-800e-6dc732a9fd94" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_fbd8c1b5-720c-460e-b903-0551bbd72dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_607c5494-1c04-409a-b11f-792ada94514d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_fbd8c1b5-720c-460e-b903-0551bbd72dce" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_607c5494-1c04-409a-b11f-792ada94514d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_e3fcc70f-439c-4dc7-890e-bf1e6fb743c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_607c5494-1c04-409a-b11f-792ada94514d" xlink:to="loc_us-gaap_CashMember_e3fcc70f-439c-4dc7-890e-bf1e6fb743c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_a193804b-dd98-4072-b2b3-2ca28cb4988c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashMember_e3fcc70f-439c-4dc7-890e-bf1e6fb743c4" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_a193804b-dd98-4072-b2b3-2ca28cb4988c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_RestrictedCashAndCashEquivalentsMember_ac232c6a-e199-49e7-adcd-88a438e3ff3c" xlink:href="fldm-20200930.xsd#fldm_RestrictedCashAndCashEquivalentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashMember_e3fcc70f-439c-4dc7-890e-bf1e6fb743c4" xlink:to="loc_fldm_RestrictedCashAndCashEquivalentsMember_ac232c6a-e199-49e7-adcd-88a438e3ff3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_637a919c-1f2c-4982-9510-02275bbe0e45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_45dead50-4b9c-4e97-800e-6dc732a9fd94" xlink:to="loc_us-gaap_FinancialInstrumentAxis_637a919c-1f2c-4982-9510-02275bbe0e45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d66a82c4-aae2-4f9c-b9ba-29a7acfc9c8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_637a919c-1f2c-4982-9510-02275bbe0e45" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d66a82c4-aae2-4f9c-b9ba-29a7acfc9c8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_f6b32bdd-309e-477e-973e-7e124b8b51f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d66a82c4-aae2-4f9c-b9ba-29a7acfc9c8d" xlink:to="loc_us-gaap_MoneyMarketFundsMember_f6b32bdd-309e-477e-973e-7e124b8b51f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_6a0186ac-52e7-41fb-93fb-165bbe66132a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d66a82c4-aae2-4f9c-b9ba-29a7acfc9c8d" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_6a0186ac-52e7-41fb-93fb-165bbe66132a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d9c0a69b-c05f-4996-9841-5715043c9f45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_45dead50-4b9c-4e97-800e-6dc732a9fd94" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d9c0a69b-c05f-4996-9841-5715043c9f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1652a8eb-587e-4ce4-8abf-06a4fbd0f14c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d9c0a69b-c05f-4996-9841-5715043c9f45" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1652a8eb-587e-4ce4-8abf-06a4fbd0f14c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_c22e11bb-dfe2-4d70-ab61-29c739e915cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1652a8eb-587e-4ce4-8abf-06a4fbd0f14c" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_c22e11bb-dfe2-4d70-ab61-29c739e915cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3afbdbd2-c330-4a77-b6e0-645b9d1719b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_45dead50-4b9c-4e97-800e-6dc732a9fd94" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3afbdbd2-c330-4a77-b6e0-645b9d1719b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_4a986aa6-a630-40bc-8ccc-ec3134033636" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3afbdbd2-c330-4a77-b6e0-645b9d1719b9" xlink:to="loc_us-gaap_AssetsAbstract_4a986aa6-a630-40bc-8ccc-ec3134033636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8609eecf-772d-4bd4-855a-cd3985c332e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4a986aa6-a630-40bc-8ccc-ec3134033636" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8609eecf-772d-4bd4-855a-cd3985c332e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_9c6f1ac6-b14d-4f1d-866f-e1518533691f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4a986aa6-a630-40bc-8ccc-ec3134033636" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_9c6f1ac6-b14d-4f1d-866f-e1518533691f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_443e371c-8eb3-4398-a2b3-8eb19cc03088" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4a986aa6-a630-40bc-8ccc-ec3134033636" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_443e371c-8eb3-4398-a2b3-8eb19cc03088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_9c3a03cc-65c2-402d-a16c-2f304ae43a58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3afbdbd2-c330-4a77-b6e0-645b9d1719b9" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_9c3a03cc-65c2-402d-a16c-2f304ae43a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CashCashEquivalentsAndShortTermInvestmentsAmortizedCost_cdbc45ed-ed39-4a36-bf34-611dac36284f" xlink:href="fldm-20200930.xsd#fldm_CashCashEquivalentsAndShortTermInvestmentsAmortizedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3afbdbd2-c330-4a77-b6e0-645b9d1719b9" xlink:to="loc_fldm_CashCashEquivalentsAndShortTermInvestmentsAmortizedCost_cdbc45ed-ed39-4a36-bf34-611dac36284f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a9f9cbe3-a3db-417a-b6e3-bed5c3c34f0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3afbdbd2-c330-4a77-b6e0-645b9d1719b9" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a9f9cbe3-a3db-417a-b6e3-bed5c3c34f0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_ae765121-79e6-4bc6-a565-e37a3ed779a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3afbdbd2-c330-4a77-b6e0-645b9d1719b9" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_ae765121-79e6-4bc6-a565-e37a3ed779a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_550cc4fd-5b4f-45c0-971a-256e7e449454" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3afbdbd2-c330-4a77-b6e0-645b9d1719b9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_550cc4fd-5b4f-45c0-971a-256e7e449454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_d3ff467c-e982-4293-a270-e4f04b59ef39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3afbdbd2-c330-4a77-b6e0-645b9d1719b9" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_d3ff467c-e982-4293-a270-e4f04b59ef39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_47c29e3a-b5b8-43fe-a83e-6194c8feac6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3afbdbd2-c330-4a77-b6e0-645b9d1719b9" xlink:to="loc_us-gaap_ShortTermInvestments_47c29e3a-b5b8-43fe-a83e-6194c8feac6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_01222730-3a41-4f45-8cc2-6d232b5efc59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3afbdbd2-c330-4a77-b6e0-645b9d1719b9" xlink:to="loc_us-gaap_LongTermInvestments_01222730-3a41-4f45-8cc2-6d232b5efc59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_bb48890d-fcb1-42b1-9f66-01200b59ff2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_3afbdbd2-c330-4a77-b6e0-645b9d1719b9" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_bb48890d-fcb1-42b1-9f66-01200b59ff2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#FairValueofFinancialInstrumentsScheduleofDebtDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_76f59e39-d616-4dfd-9cf8-2a021beb1753" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_fd87dd11-9896-4acd-8502-04fa70ab96fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_76f59e39-d616-4dfd-9cf8-2a021beb1753" xlink:to="loc_us-gaap_DebtInstrumentTable_fd87dd11-9896-4acd-8502-04fa70ab96fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6478cd17-1cd7-4d91-840d-a03afa0f4821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_fd87dd11-9896-4acd-8502-04fa70ab96fe" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6478cd17-1cd7-4d91-840d-a03afa0f4821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_acf70ba3-fc8a-49c4-8cf7-90ce54a7d0fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6478cd17-1cd7-4d91-840d-a03afa0f4821" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_acf70ba3-fc8a-49c4-8cf7-90ce54a7d0fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_702bbe99-6ad7-4243-9fbb-0e7151b19a51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_acf70ba3-fc8a-49c4-8cf7-90ce54a7d0fc" xlink:to="loc_us-gaap_ConvertibleDebtMember_702bbe99-6ad7-4243-9fbb-0e7151b19a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6fa308eb-5fc9-4dfe-95c4-bd4edcfabeb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_fd87dd11-9896-4acd-8502-04fa70ab96fe" xlink:to="loc_us-gaap_DebtInstrumentAxis_6fa308eb-5fc9-4dfe-95c4-bd4edcfabeb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0556671e-baa1-47a0-8eff-8f9b18f35281" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_6fa308eb-5fc9-4dfe-95c4-bd4edcfabeb8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0556671e-baa1-47a0-8eff-8f9b18f35281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeniorConvertibleNotesdue2034Member_8e370da4-dd27-47d5-9bdf-d0a67c897cc1" xlink:href="fldm-20200930.xsd#fldm_SeniorConvertibleNotesdue2034Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0556671e-baa1-47a0-8eff-8f9b18f35281" xlink:to="loc_fldm_SeniorConvertibleNotesdue2034Member_8e370da4-dd27-47d5-9bdf-d0a67c897cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeniorConvertibleNotesDue2024Member_146fbaf5-9e26-4097-a4bc-3f50659b796e" xlink:href="fldm-20200930.xsd#fldm_SeniorConvertibleNotesDue2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0556671e-baa1-47a0-8eff-8f9b18f35281" xlink:to="loc_fldm_SeniorConvertibleNotesDue2024Member_146fbaf5-9e26-4097-a4bc-3f50659b796e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_adb24f1d-c779-4204-b65e-135b102b7dd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_fd87dd11-9896-4acd-8502-04fa70ab96fe" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_adb24f1d-c779-4204-b65e-135b102b7dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6697daca-ffbe-4ae5-9c53-d5e3e7ebd36d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_adb24f1d-c779-4204-b65e-135b102b7dd0" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6697daca-ffbe-4ae5-9c53-d5e3e7ebd36d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_257a74df-4155-40ec-bad1-bb01a5cc5055" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6697daca-ffbe-4ae5-9c53-d5e3e7ebd36d" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_257a74df-4155-40ec-bad1-bb01a5cc5055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_e81cceac-e0ad-4841-96ef-34aa9b406c7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6697daca-ffbe-4ae5-9c53-d5e3e7ebd36d" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_e81cceac-e0ad-4841-96ef-34aa9b406c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_e7b00dcc-9065-4a14-bf7e-f4b0c5abd2d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_6697daca-ffbe-4ae5-9c53-d5e3e7ebd36d" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_e7b00dcc-9065-4a14-bf7e-f4b0c5abd2d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5e5cfa4d-69bb-421d-950f-143f9cf062db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_fd87dd11-9896-4acd-8502-04fa70ab96fe" xlink:to="loc_us-gaap_DebtInstrumentLineItems_5e5cfa4d-69bb-421d-950f-143f9cf062db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_4b0a6fcb-fe85-40b2-a14e-9061cde9b1cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5e5cfa4d-69bb-421d-950f-143f9cf062db" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_4b0a6fcb-fe85-40b2-a14e-9061cde9b1cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_db663ef4-9466-4872-a061-55fc5786266b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5e5cfa4d-69bb-421d-950f-143f9cf062db" xlink:to="loc_us-gaap_DebtInstrumentFairValue_db663ef4-9466-4872-a061-55fc5786266b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="fldm-20200930.xsd#ShareholdersEquity"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/ShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_a2de97c2-c6d7-461c-9523-aa52ec71a5a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_6a3a6100-0e06-47e6-a858-db81a1921033" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a2de97c2-c6d7-461c-9523-aa52ec71a5a0" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_6a3a6100-0e06-47e6-a858-db81a1921033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/ShareholdersEquityTables" xlink:type="simple" xlink:href="fldm-20200930.xsd#ShareholdersEquityTables"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/ShareholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_911b1a86-8a1e-4e46-b447-61424e52f711" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_b5a51f10-c244-4598-9bdb-2e29e05cf247" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_911b1a86-8a1e-4e46-b447-61424e52f711" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_b5a51f10-c244-4598-9bdb-2e29e05cf247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#ShareholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_ab1caab5-6a43-4287-8cad-65ae00a02421" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareholdersEquityTable_09663f8e-a0ee-484d-8320-4f678c0e2720" xlink:href="fldm-20200930.xsd#fldm_ShareholdersEquityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ab1caab5-6a43-4287-8cad-65ae00a02421" xlink:to="loc_fldm_ShareholdersEquityTable_09663f8e-a0ee-484d-8320-4f678c0e2720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_33f6f789-64b7-4376-ab17-006d1cfde572" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ShareholdersEquityTable_09663f8e-a0ee-484d-8320-4f678c0e2720" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_33f6f789-64b7-4376-ab17-006d1cfde572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69461013-9ad3-4d9d-9e94-ed11f0a8ea43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_33f6f789-64b7-4376-ab17-006d1cfde572" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69461013-9ad3-4d9d-9e94-ed11f0a8ea43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_InstruNorASMember_99c48d57-bebe-42f2-bcc9-10bcd01bc47a" xlink:href="fldm-20200930.xsd#fldm_InstruNorASMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69461013-9ad3-4d9d-9e94-ed11f0a8ea43" xlink:to="loc_fldm_InstruNorASMember_99c48d57-bebe-42f2-bcc9-10bcd01bc47a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_cd8028f9-95cd-4c55-ba75-f71cb56fb9c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ShareholdersEquityTable_09663f8e-a0ee-484d-8320-4f678c0e2720" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_cd8028f9-95cd-4c55-ba75-f71cb56fb9c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4b0f8fe8-2bb6-4b59-af4a-eac188f8f23f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cd8028f9-95cd-4c55-ba75-f71cb56fb9c9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4b0f8fe8-2bb6-4b59-af4a-eac188f8f23f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_845b33b5-4e86-4fdc-b496-c4412919d1dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4b0f8fe8-2bb6-4b59-af4a-eac188f8f23f" xlink:to="loc_us-gaap_ConvertibleDebtMember_845b33b5-4e86-4fdc-b496-c4412919d1dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b7d0845e-1354-4358-bc5f-cec23ef031fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ShareholdersEquityTable_09663f8e-a0ee-484d-8320-4f678c0e2720" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b7d0845e-1354-4358-bc5f-cec23ef031fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0483b61b-31fa-4be8-a8a8-1c1eedc4a0b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b7d0845e-1354-4358-bc5f-cec23ef031fc" xlink:to="loc_us-gaap_EquityComponentDomain_0483b61b-31fa-4be8-a8a8-1c1eedc4a0b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_84e1c67f-3806-4baa-ae79-4c78590fa9e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0483b61b-31fa-4be8-a8a8-1c1eedc4a0b3" xlink:to="loc_us-gaap_CommonStockMember_84e1c67f-3806-4baa-ae79-4c78590fa9e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_efd6c4ff-8dce-4080-a216-688f8836e772" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ShareholdersEquityTable_09663f8e-a0ee-484d-8320-4f678c0e2720" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_efd6c4ff-8dce-4080-a216-688f8836e772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e2ce6c88-30a9-4ccf-94fe-5c5906f071e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_efd6c4ff-8dce-4080-a216-688f8836e772" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e2ce6c88-30a9-4ccf-94fe-5c5906f071e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndTwentyAtTheMarketEquityOfferingProgramMember_c9e00510-44d9-4135-9949-c42c4c204bc5" xlink:href="fldm-20200930.xsd#fldm_TwoThousandAndTwentyAtTheMarketEquityOfferingProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e2ce6c88-30a9-4ccf-94fe-5c5906f071e8" xlink:to="loc_fldm_TwoThousandAndTwentyAtTheMarketEquityOfferingProgramMember_c9e00510-44d9-4135-9949-c42c4c204bc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareholdersEquityLineItems_9b45b297-a0fd-4679-a286-c2d0eb40abe0" xlink:href="fldm-20200930.xsd#fldm_ShareholdersEquityLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ShareholdersEquityTable_09663f8e-a0ee-484d-8320-4f678c0e2720" xlink:to="loc_fldm_ShareholdersEquityLineItems_9b45b297-a0fd-4679-a286-c2d0eb40abe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SaleOfStockConsiderationReceivableOnTransaction_1665c6a8-124a-42a6-b7d4-1e86280c64b7" xlink:href="fldm-20200930.xsd#fldm_SaleOfStockConsiderationReceivableOnTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ShareholdersEquityLineItems_9b45b297-a0fd-4679-a286-c2d0eb40abe0" xlink:to="loc_fldm_SaleOfStockConsiderationReceivableOnTransaction_1665c6a8-124a-42a6-b7d4-1e86280c64b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_d7f841f0-dcf7-4a38-90b2-b591d0ca1001" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ShareholdersEquityLineItems_9b45b297-a0fd-4679-a286-c2d0eb40abe0" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_d7f841f0-dcf7-4a38-90b2-b591d0ca1001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ProceedsFromIssuanceOfCommonStockIncludingRelatedExpenses_7e5ab342-25be-41ee-9794-cecbb3037797" xlink:href="fldm-20200930.xsd#fldm_ProceedsFromIssuanceOfCommonStockIncludingRelatedExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ShareholdersEquityLineItems_9b45b297-a0fd-4679-a286-c2d0eb40abe0" xlink:to="loc_fldm_ProceedsFromIssuanceOfCommonStockIncludingRelatedExpenses_7e5ab342-25be-41ee-9794-cecbb3037797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_49266e8d-7ed3-4e09-96df-d71b10829aa4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ShareholdersEquityLineItems_9b45b297-a0fd-4679-a286-c2d0eb40abe0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_49266e8d-7ed3-4e09-96df-d71b10829aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesCommissionsAndFees_58664116-d06b-44b9-9031-f62a6f711030" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesCommissionsAndFees"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ShareholdersEquityLineItems_9b45b297-a0fd-4679-a286-c2d0eb40abe0" xlink:to="loc_us-gaap_SalesCommissionsAndFees_58664116-d06b-44b9-9031-f62a6f711030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_85dd399e-5328-47f5-a004-fd57114ca4cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ShareholdersEquityLineItems_9b45b297-a0fd-4679-a286-c2d0eb40abe0" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_85dd399e-5328-47f5-a004-fd57114ca4cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_b2a5aaa5-062a-43f1-8381-e19dbac22cce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ShareholdersEquityLineItems_9b45b297-a0fd-4679-a286-c2d0eb40abe0" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_b2a5aaa5-062a-43f1-8381-e19dbac22cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_10933f3e-fe05-4945-8d54-ef8cd91539e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ShareholdersEquityLineItems_9b45b297-a0fd-4679-a286-c2d0eb40abe0" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_10933f3e-fe05-4945-8d54-ef8cd91539e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_0e4ddef0-9d2f-49c5-a32e-e4c5f14f05b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ShareholdersEquityLineItems_9b45b297-a0fd-4679-a286-c2d0eb40abe0" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_0e4ddef0-9d2f-49c5-a32e-e4c5f14f05b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e69f829c-ba0c-4035-9a4a-2774d8373315" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ShareholdersEquityLineItems_9b45b297-a0fd-4679-a286-c2d0eb40abe0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e69f829c-ba0c-4035-9a4a-2774d8373315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#ShareholdersEquityScheduleofStockOptionsDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_350a245b-a4eb-4a58-9f23-d846fa02f347" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_e8f99049-64b0-4e3b-a59e-6e362700f44a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_350a245b-a4eb-4a58-9f23-d846fa02f347" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_e8f99049-64b0-4e3b-a59e-6e362700f44a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_589ad24f-dac3-4bac-bb75-a84bb4d96c98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_e8f99049-64b0-4e3b-a59e-6e362700f44a" xlink:to="loc_us-gaap_AwardTypeAxis_589ad24f-dac3-4bac-bb75-a84bb4d96c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_37888b70-093a-4277-a74b-56d87ad99487" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_589ad24f-dac3-4bac-bb75-a84bb4d96c98" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_37888b70-093a-4277-a74b-56d87ad99487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a1bc7229-c1b0-4a44-b3d6-4c15ec522479" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_37888b70-093a-4277-a74b-56d87ad99487" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a1bc7229-c1b0-4a44-b3d6-4c15ec522479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_RestrictedStockAndPerformanceShareUnitsMember_c697de4d-7e1d-4545-a2fc-86417d2e8208" xlink:href="fldm-20200930.xsd#fldm_RestrictedStockAndPerformanceShareUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_37888b70-093a-4277-a74b-56d87ad99487" xlink:to="loc_fldm_RestrictedStockAndPerformanceShareUnitsMember_c697de4d-7e1d-4545-a2fc-86417d2e8208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_ed1f7718-c6e7-41d4-8809-1945540abefc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_e8f99049-64b0-4e3b-a59e-6e362700f44a" xlink:to="loc_us-gaap_PlanNameAxis_ed1f7718-c6e7-41d4-8809-1945540abefc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_f49e7c41-50cd-4a0a-9758-4b718bd1434e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_ed1f7718-c6e7-41d4-8809-1945540abefc" xlink:to="loc_us-gaap_PlanNameDomain_f49e7c41-50cd-4a0a-9758-4b718bd1434e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndNineEquityIncentivePlanMember_7669c4c1-29f5-48e7-bed8-0aa0ad3d1f4f" xlink:href="fldm-20200930.xsd#fldm_TwoThousandAndNineEquityIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_f49e7c41-50cd-4a0a-9758-4b718bd1434e" xlink:to="loc_fldm_TwoThousandAndNineEquityIncentivePlanMember_7669c4c1-29f5-48e7-bed8-0aa0ad3d1f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndElevenEquityIncentivePlanMember_3cb35240-bb4b-470f-b71b-0151da093a95" xlink:href="fldm-20200930.xsd#fldm_TwoThousandAndElevenEquityIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_f49e7c41-50cd-4a0a-9758-4b718bd1434e" xlink:to="loc_fldm_TwoThousandAndElevenEquityIncentivePlanMember_3cb35240-bb4b-470f-b71b-0151da093a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndTenEquityIncentivePlanMember_f495788d-2aeb-4bb2-b516-1f4fcbf921a1" xlink:href="fldm-20200930.xsd#fldm_TwoThousandAndTenEquityIncentivePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_f49e7c41-50cd-4a0a-9758-4b718bd1434e" xlink:to="loc_fldm_TwoThousandAndTenEquityIncentivePlanMember_f495788d-2aeb-4bb2-b516-1f4fcbf921a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndSeventeenInducementAwardPlanMember_1d7d7b70-170b-44d9-b00e-6dee9e43fbeb" xlink:href="fldm-20200930.xsd#fldm_TwoThousandAndSeventeenInducementAwardPlanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_f49e7c41-50cd-4a0a-9758-4b718bd1434e" xlink:to="loc_fldm_TwoThousandAndSeventeenInducementAwardPlanMember_1d7d7b70-170b-44d9-b00e-6dee9e43fbeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember_7fa70389-2ac9-4f23-a9fb-13eeddaad6b8" xlink:href="fldm-20200930.xsd#fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_f49e7c41-50cd-4a0a-9758-4b718bd1434e" xlink:to="loc_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember_7fa70389-2ac9-4f23-a9fb-13eeddaad6b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_97428064-852a-4a7e-8cca-b9c68ef9538f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_e8f99049-64b0-4e3b-a59e-6e362700f44a" xlink:to="loc_us-gaap_ClassOfStockLineItems_97428064-852a-4a7e-8cca-b9c68ef9538f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_528ecb71-3d26-4b58-b0c6-d561d32a658c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_97428064-852a-4a7e-8cca-b9c68ef9538f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_528ecb71-3d26-4b58-b0c6-d561d32a658c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_1203f0ad-ee85-4c4a-9d5e-775c713e4d9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_97428064-852a-4a7e-8cca-b9c68ef9538f" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_1203f0ad-ee85-4c4a-9d5e-775c713e4d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/StockBasedPlans" xlink:type="simple" xlink:href="fldm-20200930.xsd#StockBasedPlans"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/StockBasedPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_47f61f4b-b1b9-4c6d-b02f-1df41d846982" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_a769112a-ee08-46cb-93c6-6c4ba0a17f79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_47f61f4b-b1b9-4c6d-b02f-1df41d846982" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_a769112a-ee08-46cb-93c6-6c4ba0a17f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/StockBasedPlansTables" xlink:type="simple" xlink:href="fldm-20200930.xsd#StockBasedPlansTables"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/StockBasedPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_84a03d80-2af4-400b-8da8-5a85e23b3a20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_22178e9e-9855-4629-be5d-e273c30749cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_84a03d80-2af4-400b-8da8-5a85e23b3a20" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_22178e9e-9855-4629-be5d-e273c30749cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_69930eab-084b-4dc4-a0f9-191ff60da01a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_84a03d80-2af4-400b-8da8-5a85e23b3a20" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_69930eab-084b-4dc4-a0f9-191ff60da01a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_f5c61bcc-57e0-47a3-8dbc-a1e0ba632a80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_84a03d80-2af4-400b-8da8-5a85e23b3a20" xlink:to="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_f5c61bcc-57e0-47a3-8dbc-a1e0ba632a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_3fea6589-ef33-4788-a485-c457bad10b02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_84a03d80-2af4-400b-8da8-5a85e23b3a20" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_3fea6589-ef33-4788-a485-c457bad10b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/StockBasedPlansNarrativeDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#StockBasedPlansNarrativeDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/StockBasedPlansNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c9833328-1542-4178-8633-6224452bb7f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9dfc30da-66f7-44f0-a5f2-322ce8c54ee3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c9833328-1542-4178-8633-6224452bb7f1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9dfc30da-66f7-44f0-a5f2-322ce8c54ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c8ccbc34-c1a8-46df-8263-1cc7587f4db1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9dfc30da-66f7-44f0-a5f2-322ce8c54ee3" xlink:to="loc_us-gaap_AwardTypeAxis_c8ccbc34-c1a8-46df-8263-1cc7587f4db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ddf5accb-bdb5-4ed9-a5bc-08bb02f10f41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_c8ccbc34-c1a8-46df-8263-1cc7587f4db1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ddf5accb-bdb5-4ed9-a5bc-08bb02f10f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_17311837-46df-4e40-b3ac-34c91f58e10a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ddf5accb-bdb5-4ed9-a5bc-08bb02f10f41" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_17311837-46df-4e40-b3ac-34c91f58e10a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_6d5e7cdd-3344-438a-a90f-7d26fc73e6f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ddf5accb-bdb5-4ed9-a5bc-08bb02f10f41" xlink:to="loc_us-gaap_StockCompensationPlanMember_6d5e7cdd-3344-438a-a90f-7d26fc73e6f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_AwardsHeldByOwnersOfMoreThan10OfCommonStockMember_482a7cd4-e596-467e-bee3-aa84eb0a6110" xlink:href="fldm-20200930.xsd#fldm_AwardsHeldByOwnersOfMoreThan10OfCommonStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ddf5accb-bdb5-4ed9-a5bc-08bb02f10f41" xlink:to="loc_fldm_AwardsHeldByOwnersOfMoreThan10OfCommonStockMember_482a7cd4-e596-467e-bee3-aa84eb0a6110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_c7b5ac49-c612-43ea-a0c5-4b2e67388c83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ddf5accb-bdb5-4ed9-a5bc-08bb02f10f41" xlink:to="loc_us-gaap_PerformanceSharesMember_c7b5ac49-c612-43ea-a0c5-4b2e67388c83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_fb47cb10-e62a-442b-b57c-de8b6839aa07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ddf5accb-bdb5-4ed9-a5bc-08bb02f10f41" xlink:to="loc_us-gaap_EmployeeStockMember_fb47cb10-e62a-442b-b57c-de8b6839aa07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_62e89570-682c-49d6-b49e-602bdca32594" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9dfc30da-66f7-44f0-a5f2-322ce8c54ee3" xlink:to="loc_us-gaap_VestingAxis_62e89570-682c-49d6-b49e-602bdca32594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_0473f710-fdec-4983-856c-ee994f646f81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_62e89570-682c-49d6-b49e-602bdca32594" xlink:to="loc_us-gaap_VestingDomain_0473f710-fdec-4983-856c-ee994f646f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_71a322f4-77f5-45b8-894f-250a24b1f611" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_0473f710-fdec-4983-856c-ee994f646f81" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_71a322f4-77f5-45b8-894f-250a24b1f611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_aa6921c8-e3e8-4617-a4bf-44a2dcb514fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_0473f710-fdec-4983-856c-ee994f646f81" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_aa6921c8-e3e8-4617-a4bf-44a2dcb514fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_24b1056b-16ff-4045-bd7d-0a51e5cf809a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9dfc30da-66f7-44f0-a5f2-322ce8c54ee3" xlink:to="loc_us-gaap_PlanNameAxis_24b1056b-16ff-4045-bd7d-0a51e5cf809a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_9a1b42a2-7619-48cd-9e1c-0d4be4a3f4b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_24b1056b-16ff-4045-bd7d-0a51e5cf809a" xlink:to="loc_us-gaap_PlanNameDomain_9a1b42a2-7619-48cd-9e1c-0d4be4a3f4b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_EquityIncentivePlanTwentyElevenMember_4c9886b1-d558-4cc3-aef9-5e11bb1bd0ef" xlink:href="fldm-20200930.xsd#fldm_EquityIncentivePlanTwentyElevenMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_9a1b42a2-7619-48cd-9e1c-0d4be4a3f4b2" xlink:to="loc_fldm_EquityIncentivePlanTwentyElevenMember_4c9886b1-d558-4cc3-aef9-5e11bb1bd0ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_A2017InducementAwardPlanMember_099331a6-765f-4155-a98b-e3abd0ccb602" xlink:href="fldm-20200930.xsd#fldm_A2017InducementAwardPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_9a1b42a2-7619-48cd-9e1c-0d4be4a3f4b2" xlink:to="loc_fldm_A2017InducementAwardPlanMember_099331a6-765f-4155-a98b-e3abd0ccb602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_EquityIncentivePlanMember_9fc83682-968b-418e-b7eb-4f3d9de34c4e" xlink:href="fldm-20200930.xsd#fldm_EquityIncentivePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_9a1b42a2-7619-48cd-9e1c-0d4be4a3f4b2" xlink:to="loc_fldm_EquityIncentivePlanMember_9fc83682-968b-418e-b7eb-4f3d9de34c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember_2cb203d7-5f1c-4faa-835f-c322594032fb" xlink:href="fldm-20200930.xsd#fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_9a1b42a2-7619-48cd-9e1c-0d4be4a3f4b2" xlink:to="loc_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember_2cb203d7-5f1c-4faa-835f-c322594032fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9121fd25-521b-4e1c-a92b-df1530551ff6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9dfc30da-66f7-44f0-a5f2-322ce8c54ee3" xlink:to="loc_srt_RangeAxis_9121fd25-521b-4e1c-a92b-df1530551ff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_38c7dede-9f16-474e-b80d-1f945296ba43" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_9121fd25-521b-4e1c-a92b-df1530551ff6" xlink:to="loc_srt_RangeMember_38c7dede-9f16-474e-b80d-1f945296ba43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_aed0047f-1288-43b7-a1ee-c02197d457aa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_38c7dede-9f16-474e-b80d-1f945296ba43" xlink:to="loc_srt_MinimumMember_aed0047f-1288-43b7-a1ee-c02197d457aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_66d3f233-c7af-4da5-adbf-3ef2807e3177" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_38c7dede-9f16-474e-b80d-1f945296ba43" xlink:to="loc_srt_MaximumMember_66d3f233-c7af-4da5-adbf-3ef2807e3177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9dfc30da-66f7-44f0-a5f2-322ce8c54ee3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_5af0422c-2dae-4381-937a-fde17e83a9cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_5af0422c-2dae-4381-937a-fde17e83a9cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_PortionOfStockOptionsVestOnFirstAnniversary_732987ac-e3dd-4ed7-84a6-4cd769715c35" xlink:href="fldm-20200930.xsd#fldm_PortionOfStockOptionsVestOnFirstAnniversary"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_fldm_PortionOfStockOptionsVestOnFirstAnniversary_732987ac-e3dd-4ed7-84a6-4cd769715c35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_a843f383-b26f-4152-97fb-61ff60673cca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_a843f383-b26f-4152-97fb-61ff60673cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_7df333c9-7e47-4dce-a9e3-a2f53a25ae62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_7df333c9-7e47-4dce-a9e3-a2f53a25ae62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_7576429b-eee3-482b-8249-a0845ab3a54f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_7576429b-eee3-482b-8249-a0845ab3a54f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue_87fb70d4-70a8-4a94-8d6f-a6dc8319ee54" xlink:href="fldm-20200930.xsd#fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue_87fb70d4-70a8-4a94-8d6f-a6dc8319ee54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SharebasedCompensationArrangementbySharebasedPaymentAwardVestingRestrictionsOwnershipPercentageofVotingStock_69ef41d9-8649-480f-ba82-cb191927c971" xlink:href="fldm-20200930.xsd#fldm_SharebasedCompensationArrangementbySharebasedPaymentAwardVestingRestrictionsOwnershipPercentageofVotingStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_fldm_SharebasedCompensationArrangementbySharebasedPaymentAwardVestingRestrictionsOwnershipPercentageofVotingStock_69ef41d9-8649-480f-ba82-cb191927c971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement_e15353bf-7ce0-4bb7-8b56-25056c191e1d" xlink:href="fldm-20200930.xsd#fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement_e15353bf-7ce0-4bb7-8b56-25056c191e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_d522c57c-54a5-4fad-b74e-dc95d9adeff5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_d522c57c-54a5-4fad-b74e-dc95d9adeff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_81f05e15-9d25-4568-a89d-4d5ae222fb44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_81f05e15-9d25-4568-a89d-4d5ae222fb44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest_14d20b04-d7fb-4034-84e8-bb1b2ef12277" xlink:href="fldm-20200930.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest_14d20b04-d7fb-4034-84e8-bb1b2ef12277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_EmployeeStockPurchasePlanOfferingPeriod_8069a4f8-57cd-407f-b9fa-8b2e6e52e040" xlink:href="fldm-20200930.xsd#fldm_EmployeeStockPurchasePlanOfferingPeriod"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_fldm_EmployeeStockPurchasePlanOfferingPeriod_8069a4f8-57cd-407f-b9fa-8b2e6e52e040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_16b99434-5669-4f1f-93d5-2bfa4b39fc72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_16b99434-5669-4f1f-93d5-2bfa4b39fc72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_69c23a88-c9b3-4fa1-a379-a3cd3b05e27e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_69c23a88-c9b3-4fa1-a379-a3cd3b05e27e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_EmployeeStockPurchasePlanNumberOfSixMonthOfferingPeriods_3fcf84a6-aa30-4539-a7dd-cdb18387a8d1" xlink:href="fldm-20200930.xsd#fldm_EmployeeStockPurchasePlanNumberOfSixMonthOfferingPeriods"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_fldm_EmployeeStockPurchasePlanNumberOfSixMonthOfferingPeriods_3fcf84a6-aa30-4539-a7dd-cdb18387a8d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount_f73a1a2d-063d-4dd3-b6e1-0c6a4131a94d" xlink:href="fldm-20200930.xsd#fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount_f73a1a2d-063d-4dd3-b6e1-0c6a4131a94d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_561abd9d-11f4-4f4f-985d-c378f9a74474" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_561abd9d-11f4-4f4f-985d-c378f9a74474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_daebe773-eec4-4196-8942-041486135f90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8dd1a7ea-d3cc-4371-9894-bdfe458a5ef2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_daebe773-eec4-4196-8942-041486135f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#StockBasedPlansRestrictedandPerformanceStockUnitsDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8556d746-0089-4c4c-811d-9ac9a154fbd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd67c52d-08e9-48f2-a4e5-31d99af83eff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8556d746-0089-4c4c-811d-9ac9a154fbd4" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd67c52d-08e9-48f2-a4e5-31d99af83eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_84144932-a2de-4f61-a626-0ccea721b275" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd67c52d-08e9-48f2-a4e5-31d99af83eff" xlink:to="loc_srt_TitleOfIndividualAxis_84144932-a2de-4f61-a626-0ccea721b275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_320695fa-9c65-4c43-b208-edfdc88f6958" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_84144932-a2de-4f61-a626-0ccea721b275" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_320695fa-9c65-4c43-b208-edfdc88f6958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CertainEmployeeMember_4b298e00-ef0d-464d-b969-46280c6e14d5" xlink:href="fldm-20200930.xsd#fldm_CertainEmployeeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_320695fa-9c65-4c43-b208-edfdc88f6958" xlink:to="loc_fldm_CertainEmployeeMember_4b298e00-ef0d-464d-b969-46280c6e14d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b9fd91c0-be18-4a34-bc10-c45931bc6773" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd67c52d-08e9-48f2-a4e5-31d99af83eff" xlink:to="loc_us-gaap_AwardTypeAxis_b9fd91c0-be18-4a34-bc10-c45931bc6773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e73fc26f-1283-482d-92d7-f3ee2ce7e6bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_b9fd91c0-be18-4a34-bc10-c45931bc6773" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e73fc26f-1283-482d-92d7-f3ee2ce7e6bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_b9d3bd19-1a73-4f2a-ab6a-c4400dba7ef7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e73fc26f-1283-482d-92d7-f3ee2ce7e6bc" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_b9d3bd19-1a73-4f2a-ab6a-c4400dba7ef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_7242fb8a-74c1-4682-afaf-d5c1974d6545" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e73fc26f-1283-482d-92d7-f3ee2ce7e6bc" xlink:to="loc_us-gaap_PerformanceSharesMember_7242fb8a-74c1-4682-afaf-d5c1974d6545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_71c8d4f4-b6a3-42cb-aeb0-e43b937ba83f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd67c52d-08e9-48f2-a4e5-31d99af83eff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_71c8d4f4-b6a3-42cb-aeb0-e43b937ba83f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9f716577-daa4-4748-b23c-a9c4eb15e564" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_71c8d4f4-b6a3-42cb-aeb0-e43b937ba83f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9f716577-daa4-4748-b23c-a9c4eb15e564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2eb35812-c804-494f-a9b3-5fbd03ec19cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9f716577-daa4-4748-b23c-a9c4eb15e564" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2eb35812-c804-494f-a9b3-5fbd03ec19cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1f7a2677-43d3-4839-bb40-cb9a5788739c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9f716577-daa4-4748-b23c-a9c4eb15e564" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1f7a2677-43d3-4839-bb40-cb9a5788739c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_fa1c046d-b312-4aa4-b2e3-17f3ab74d61b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9f716577-daa4-4748-b23c-a9c4eb15e564" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_fa1c046d-b312-4aa4-b2e3-17f3ab74d61b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_4d6e4388-4b27-4dfb-9439-578e91a1b21e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9f716577-daa4-4748-b23c-a9c4eb15e564" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_4d6e4388-4b27-4dfb-9439-578e91a1b21e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c77f9fd2-ab9c-4807-9b76-c41ee9733712" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9f716577-daa4-4748-b23c-a9c4eb15e564" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c77f9fd2-ab9c-4807-9b76-c41ee9733712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_b40b02f5-40d2-45f6-afe9-864ec97f41b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_71c8d4f4-b6a3-42cb-aeb0-e43b937ba83f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_b40b02f5-40d2-45f6-afe9-864ec97f41b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1d826a94-6bfc-4cdd-9961-f9990395eff3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_b40b02f5-40d2-45f6-afe9-864ec97f41b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1d826a94-6bfc-4cdd-9961-f9990395eff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_73b7875e-606c-477f-a8de-74eac3f647b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_b40b02f5-40d2-45f6-afe9-864ec97f41b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_73b7875e-606c-477f-a8de-74eac3f647b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_7f7e5cf5-9cb0-41f9-aa47-f6a44aeba4b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_b40b02f5-40d2-45f6-afe9-864ec97f41b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_7f7e5cf5-9cb0-41f9-aa47-f6a44aeba4b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_e9db56af-260a-46df-ae08-a15d3fd39e10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_b40b02f5-40d2-45f6-afe9-864ec97f41b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_e9db56af-260a-46df-ae08-a15d3fd39e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b78d0057-26ca-4fc0-a65b-a79a21b066d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_b40b02f5-40d2-45f6-afe9-864ec97f41b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b78d0057-26ca-4fc0-a65b-a79a21b066d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#StockBasedPlansStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_131ef441-b6c3-4937-b911-bfce9024fb6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_97b5786d-5d5a-4d11-955c-ddb3345ae444" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_131ef441-b6c3-4937-b911-bfce9024fb6c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_97b5786d-5d5a-4d11-955c-ddb3345ae444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6507b0f8-06e8-441f-8f30-dc7f4fa45049" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_97b5786d-5d5a-4d11-955c-ddb3345ae444" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6507b0f8-06e8-441f-8f30-dc7f4fa45049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_76591ea6-9803-4cda-9d16-15cb033b47f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_97b5786d-5d5a-4d11-955c-ddb3345ae444" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_76591ea6-9803-4cda-9d16-15cb033b47f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_06d8cbd3-47ed-4fde-a66a-892262696c81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_97b5786d-5d5a-4d11-955c-ddb3345ae444" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_06d8cbd3-47ed-4fde-a66a-892262696c81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4f1e3667-12a1-44db-b542-e4e769a1b5d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_97b5786d-5d5a-4d11-955c-ddb3345ae444" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4f1e3667-12a1-44db-b542-e4e769a1b5d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6a9d5301-bc1f-4567-aa6a-f521ef0647ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_97b5786d-5d5a-4d11-955c-ddb3345ae444" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6a9d5301-bc1f-4567-aa6a-f521ef0647ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_d26fe659-85eb-4804-b7ef-7938b303981b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_131ef441-b6c3-4937-b911-bfce9024fb6c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_d26fe659-85eb-4804-b7ef-7938b303981b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber_2363d0ca-0c4e-4bc0-911a-1a7d6901193c" xlink:href="fldm-20200930.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_131ef441-b6c3-4937-b911-bfce9024fb6c" xlink:to="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber_2363d0ca-0c4e-4bc0-911a-1a7d6901193c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_986b29bf-6e98-4d55-ad78-089ed378807c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_131ef441-b6c3-4937-b911-bfce9024fb6c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_986b29bf-6e98-4d55-ad78-089ed378807c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2bece193-7d7f-4e20-8a7a-c90b047e51c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_986b29bf-6e98-4d55-ad78-089ed378807c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2bece193-7d7f-4e20-8a7a-c90b047e51c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_247cf007-bf06-4cb5-a069-0c52afb028c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_986b29bf-6e98-4d55-ad78-089ed378807c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_247cf007-bf06-4cb5-a069-0c52afb028c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_19deb0f4-73e5-4367-81c3-26a52bcfad1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_986b29bf-6e98-4d55-ad78-089ed378807c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_19deb0f4-73e5-4367-81c3-26a52bcfad1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_33208c54-ed70-4492-822c-3c5c121c909d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_986b29bf-6e98-4d55-ad78-089ed378807c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_33208c54-ed70-4492-822c-3c5c121c909d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_05542c0a-808e-477a-9474-97b51b4a5d1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_986b29bf-6e98-4d55-ad78-089ed378807c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_05542c0a-808e-477a-9474-97b51b4a5d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice_cf1bdb7d-c2fe-4da6-ad46-a969048b6862" xlink:href="fldm-20200930.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_131ef441-b6c3-4937-b911-bfce9024fb6c" xlink:to="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice_cf1bdb7d-c2fe-4da6-ad46-a969048b6862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice_0ba13f0f-2228-477c-b7b7-69937001af28" xlink:href="fldm-20200930.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_131ef441-b6c3-4937-b911-bfce9024fb6c" xlink:to="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice_0ba13f0f-2228-477c-b7b7-69937001af28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ba4eeb27-b23c-4fda-b704-670968422136" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_131ef441-b6c3-4937-b911-bfce9024fb6c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ba4eeb27-b23c-4fda-b704-670968422136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_a739b135-478b-4904-bc3e-1d56ea71c6c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ba4eeb27-b23c-4fda-b704-670968422136" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_a739b135-478b-4904-bc3e-1d56ea71c6c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne_3f6e3905-f682-4837-a7c4-fbbdf38b32c8" xlink:href="fldm-20200930.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ba4eeb27-b23c-4fda-b704-670968422136" xlink:to="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne_3f6e3905-f682-4837-a7c4-fbbdf38b32c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1_6721cd98-7f41-49d2-9206-dd410bab402e" xlink:href="fldm-20200930.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ba4eeb27-b23c-4fda-b704-670968422136" xlink:to="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1_6721cd98-7f41-49d2-9206-dd410bab402e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_ee5d8689-db65-4b2d-9958-bc626873e3c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_131ef441-b6c3-4937-b911-bfce9024fb6c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_ee5d8689-db65-4b2d-9958-bc626873e3c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_e905303b-fd0e-4a83-828a-f4a135c0bf75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_ee5d8689-db65-4b2d-9958-bc626873e3c0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_e905303b-fd0e-4a83-828a-f4a135c0bf75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_b11cc0e0-e9a6-4e96-9f0c-13a941e23200" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_ee5d8689-db65-4b2d-9958-bc626873e3c0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_b11cc0e0-e9a6-4e96-9f0c-13a941e23200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue_e3519340-8a27-40c9-95b1-ae1c77322e0d" xlink:href="fldm-20200930.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_ee5d8689-db65-4b2d-9958-bc626873e3c0" xlink:to="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue_e3519340-8a27-40c9-95b1-ae1c77322e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue_b93b35bf-192b-466a-a590-18b1286e76d1" xlink:href="fldm-20200930.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_ee5d8689-db65-4b2d-9958-bc626873e3c0" xlink:to="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue_b93b35bf-192b-466a-a590-18b1286e76d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_baaaf696-713e-4560-a90c-d3dd290a806d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_131ef441-b6c3-4937-b911-bfce9024fb6c" xlink:to="loc_us-gaap_SharePrice_baaaf696-713e-4560-a90c-d3dd290a806d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#StockBasedPlansStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_67086914-8938-48d9-8cea-9d015767ce13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cc092664-41df-4cd9-a9bb-efef3dec4847" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_67086914-8938-48d9-8cea-9d015767ce13" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cc092664-41df-4cd9-a9bb-efef3dec4847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_2d5798cd-759b-4b5c-ab51-f4ae1d334457" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cc092664-41df-4cd9-a9bb-efef3dec4847" xlink:to="loc_us-gaap_PlanNameAxis_2d5798cd-759b-4b5c-ab51-f4ae1d334457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_4427a52e-553b-4694-be10-f3f3a638dcda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_2d5798cd-759b-4b5c-ab51-f4ae1d334457" xlink:to="loc_us-gaap_PlanNameDomain_4427a52e-553b-4694-be10-f3f3a638dcda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember_fe19e0a5-cdf9-45f2-8a54-2349b4fe66c3" xlink:href="fldm-20200930.xsd#fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_4427a52e-553b-4694-be10-f3f3a638dcda" xlink:to="loc_fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember_fe19e0a5-cdf9-45f2-8a54-2349b4fe66c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_85b63550-fd38-4836-bacb-e894e6d76072" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cc092664-41df-4cd9-a9bb-efef3dec4847" xlink:to="loc_us-gaap_AwardTypeAxis_85b63550-fd38-4836-bacb-e894e6d76072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_04909388-e05a-4ef9-bc82-4777ecbe5aff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_85b63550-fd38-4836-bacb-e894e6d76072" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_04909388-e05a-4ef9-bc82-4777ecbe5aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_a691ca13-5aa5-4966-961a-401d06448102" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_04909388-e05a-4ef9-bc82-4777ecbe5aff" xlink:to="loc_us-gaap_EmployeeStockMember_a691ca13-5aa5-4966-961a-401d06448102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c89f414f-532b-4d6a-8aa1-283bddf49e01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cc092664-41df-4cd9-a9bb-efef3dec4847" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c89f414f-532b-4d6a-8aa1-283bddf49e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_602a4706-b84f-4505-b83f-a8842e6c447e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c89f414f-532b-4d6a-8aa1-283bddf49e01" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_602a4706-b84f-4505-b83f-a8842e6c447e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/IncomeTaxes" xlink:type="simple" xlink:href="fldm-20200930.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_33e989f0-39b3-4dd5-9ce5-c2fdef2baab4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_4ca1aa8d-5d39-417f-a8d1-7758a63c14cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_33e989f0-39b3-4dd5-9ce5-c2fdef2baab4" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_4ca1aa8d-5d39-417f-a8d1-7758a63c14cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d7d48ad3-b701-4ffb-b72a-a66e463336fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2888d869-2ddb-4d12-9a6d-f7b4c987912c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d7d48ad3-b701-4ffb-b72a-a66e463336fa" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_2888d869-2ddb-4d12-9a6d-f7b4c987912c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/InformationAboutGeographicAreas" xlink:type="simple" xlink:href="fldm-20200930.xsd#InformationAboutGeographicAreas"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/InformationAboutGeographicAreas" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_adb8d87c-c4e0-41b7-83b3-e1372b7782cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_045bc0c7-a005-4ba6-915f-6e3ccdba00a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_adb8d87c-c4e0-41b7-83b3-e1372b7782cb" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_045bc0c7-a005-4ba6-915f-6e3ccdba00a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/InformationAboutGeographicAreasDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#InformationAboutGeographicAreasDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/InformationAboutGeographicAreasDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_d0909057-a440-4bfd-9685-ccd71c100b52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_bbfc62ec-2147-4e04-931c-9c5a08e895bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d0909057-a440-4bfd-9685-ccd71c100b52" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_bbfc62ec-2147-4e04-931c-9c5a08e895bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_eb1d5763-8a3d-47d2-a41d-6f4042c20b72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_bbfc62ec-2147-4e04-931c-9c5a08e895bf" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_eb1d5763-8a3d-47d2-a41d-6f4042c20b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_c5336051-de43-4298-aa70-602ca470aaec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_eb1d5763-8a3d-47d2-a41d-6f4042c20b72" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_c5336051-de43-4298-aa70-602ca470aaec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_b09621f4-d771-4720-9f12-98c9e4c8c26b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_c5336051-de43-4298-aa70-602ca470aaec" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_b09621f4-d771-4720-9f12-98c9e4c8c26b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f59c5d11-0433-48b5-bc05-603d10530ebc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_bbfc62ec-2147-4e04-931c-9c5a08e895bf" xlink:to="loc_srt_StatementGeographicalAxis_f59c5d11-0433-48b5-bc05-603d10530ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_85870a6a-bc87-4af2-95b5-d5ef641cc037" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_f59c5d11-0433-48b5-bc05-603d10530ebc" xlink:to="loc_srt_SegmentGeographicalDomain_85870a6a-bc87-4af2-95b5-d5ef641cc037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_9fc75b20-7266-48f9-a67e-22a76f052ce1" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_85870a6a-bc87-4af2-95b5-d5ef641cc037" xlink:to="loc_country_US_9fc75b20-7266-48f9-a67e-22a76f052ce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_2e944eb2-860e-4ffa-b7e2-f3f8a9d4b539" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CN"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_85870a6a-bc87-4af2-95b5-d5ef641cc037" xlink:to="loc_country_CN_2e944eb2-860e-4ffa-b7e2-f3f8a9d4b539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_bd969e94-d73d-436a-9a1b-5337bd10a2c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_bbfc62ec-2147-4e04-931c-9c5a08e895bf" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_bd969e94-d73d-436a-9a1b-5337bd10a2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2c6f2121-74c4-4817-9e0b-26e311a3dcad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_bd969e94-d73d-436a-9a1b-5337bd10a2c0" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2c6f2121-74c4-4817-9e0b-26e311a3dcad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_6b81cead-d013-4b7f-9620-2afc5b680a24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2c6f2121-74c4-4817-9e0b-26e311a3dcad" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_6b81cead-d013-4b7f-9620-2afc5b680a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_bdfeffa2-c019-494f-a79d-c60d3d49e669" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_bbfc62ec-2147-4e04-931c-9c5a08e895bf" xlink:to="loc_us-gaap_ProductInformationLineItems_bdfeffa2-c019-494f-a79d-c60d3d49e669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_09fa64b2-fff9-4f74-8ead-a01398de508c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_bdfeffa2-c019-494f-a79d-c60d3d49e669" xlink:to="loc_us-gaap_NumberOfReportableSegments_09fa64b2-fff9-4f74-8ead-a01398de508c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ff248994-d938-45bb-a325-fbb9604d6de3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_bdfeffa2-c019-494f-a79d-c60d3d49e669" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ff248994-d938-45bb-a325-fbb9604d6de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_8506a0f4-8678-441f-b295-3a384fdeeefd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_bdfeffa2-c019-494f-a79d-c60d3d49e669" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_8506a0f4-8678-441f-b295-3a384fdeeefd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/DevelopmentAgreement" xlink:type="simple" xlink:href="fldm-20200930.xsd#DevelopmentAgreement"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/DevelopmentAgreement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ba37fc48-8f6a-4ae8-858a-bd518be1f015" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_0077dfa2-c0be-4b43-837f-9167a8039b2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ba37fc48-8f6a-4ae8-858a-bd518be1f015" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_0077dfa2-c0be-4b43-837f-9167a8039b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/DevelopmentAgreementDetails" xlink:type="simple" xlink:href="fldm-20200930.xsd#DevelopmentAgreementDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/DevelopmentAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f0deca98-7aae-47d9-a52c-f627127522ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_d2638f4d-e8e8-4b1e-b7bc-f24585e37bd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f0deca98-7aae-47d9-a52c-f627127522ab" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_d2638f4d-e8e8-4b1e-b7bc-f24585e37bd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6f9fe9c3-b7d3-4454-b4b8-db72e9637d5f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_d2638f4d-e8e8-4b1e-b7bc-f24585e37bd9" xlink:to="loc_srt_ProductOrServiceAxis_6f9fe9c3-b7d3-4454-b4b8-db72e9637d5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_cc8ec76c-fe2b-4c1f-9ca9-740700baab54" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_6f9fe9c3-b7d3-4454-b4b8-db72e9637d5f" xlink:to="loc_srt_ProductsAndServicesDomain_cc8ec76c-fe2b-4c1f-9ca9-740700baab54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CollaborationRevenueMember_fdd7cf4c-dad9-4566-a736-2b26c5c5a437" xlink:href="fldm-20200930.xsd#fldm_CollaborationRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_cc8ec76c-fe2b-4c1f-9ca9-740700baab54" xlink:to="loc_fldm_CollaborationRevenueMember_fdd7cf4c-dad9-4566-a736-2b26c5c5a437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f35d2e8a-c658-4a94-adf9-be10990953c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_d2638f4d-e8e8-4b1e-b7bc-f24585e37bd9" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f35d2e8a-c658-4a94-adf9-be10990953c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_UpFrontAndMilestonePaymentsMaximum_e207a9c9-f4c4-4c05-b94a-bd8cf8450298" xlink:href="fldm-20200930.xsd#fldm_UpFrontAndMilestonePaymentsMaximum"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f35d2e8a-c658-4a94-adf9-be10990953c4" xlink:to="loc_fldm_UpFrontAndMilestonePaymentsMaximum_e207a9c9-f4c4-4c05-b94a-bd8cf8450298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CollaborativeArrangementTerm_14a0b190-f1c4-41a8-81b0-2477b8e9a0b3" xlink:href="fldm-20200930.xsd#fldm_CollaborativeArrangementTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f35d2e8a-c658-4a94-adf9-be10990953c4" xlink:to="loc_fldm_CollaborativeArrangementTerm_14a0b190-f1c4-41a8-81b0-2477b8e9a0b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_06336e16-f092-475b-b64a-b3c0e54d8de5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f35d2e8a-c658-4a94-adf9-be10990953c4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_06336e16-f092-475b-b64a-b3c0e54d8de5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="fldm-20200930.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_568e14d6-5638-484d-a392-b87b52c2be59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_50987e71-73df-4f21-9cdc-3904b564a786" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_568e14d6-5638-484d-a392-b87b52c2be59" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_50987e71-73df-4f21-9cdc-3904b564a786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>fldm-20200930_g1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fldm-20200930_g1.jpg
M_]C_X0O&17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    F    <@$R  (    4
M    F(=I  0    !    K    -@ +<;    G$  MQL   "<0061O8F4@4&AO
M=&]S:&]P($-#(#(P,34N-2 H36%C:6YT;W-H*0 R,#$V.C$Q.C S(#$Q.C$R
M.C(Q   #H $  P    $  0  H ( !     $   DZH , !     $   ,&
M      8! P #     0 &   !&@ %     0   28!&P %     0   2X!*  #
M     0 "   " 0 $     0   38" @ $     0  "H@         2     $
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M4__9_^T3Z%!H;W1O<VAO<" S+C  .$))300$       P' %:  ,;)4<< @
M @  ' (% !QF;'5I9%]L;V=O7V]R86YG95]B;&%C:U]#35E+.$))300E
M   00VA=E(]:<HLW&^FV!JK7T#A"24T$.@      [0   !     !       +
M<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0    !)
M;G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I;G1E
M<DYA;65415A4    !0!9 $\ 1 !!       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0'+            *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! !+
M  $  0$L     0 !.$))300F       .             #^    X0DE-! T
M      0    >.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M  0     .$))300:      -G    !@             #!@  "3H    9 &8
M; !U &D 9 !? &P ;P!G &\ 7P!P &D ;@!K %\ 8@!L &$ 8P!K %\ 4@!'
M $(    !                          $             "3H   ,&
M                  $                         $     $       !N
M=6QL     @    9B;W5N9'-/8FIC     0       %)C=#$    $     %1O
M<"!L;VYG          !,969T;&]N9P          0G1O;6QO;F<   ,&
M %)G:'1L;VYG   ).@    9S;&EC97-6;$QS     4]B:F,    !       %
M<VQI8V4    2    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P
M       &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R
M871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U
M;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M3&5F=&QO;F<          $)T;VUL;VYG   #!@    !29VAT;&]N9P  "3H
M   #=7)L5$585     $       !N=6QL5$585     $       !-<V=E5$58
M5     $       9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,
M8F]O; $    (8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T
M   /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU
M;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP
M965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S
M971L;VYG          IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T
M<V5T;&]N9P         +<FEG:'1/=71S971L;VYG       X0DE-!"@
M  P    "/_         X0DE-!!0       0    #.$))300,      JD
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MTW7C\T:4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H
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M,]E37V?SCV_F+<O_ ,8&#GXSZOJI5;UGJ3_94QE-K*:W'Z-V9?DLQZZZ&?\
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M2^54DE/U4DOE5))3]5)+Y5224__9.$))300A      !A     0$    / $$
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M0B!865H@!\X  @ )  8 ,0  86-S<$U31E0     245#('-21T(
M         /;6  $     TRU(4" @
M                               18W!R=    5     S9&5S8P   80
M  !L=W1P=    ?     48FMP=    @0    4<EA96@   A@    49UA96@
M BP    48EA96@   D     49&UN9    E0   !P9&UD9    L0   "(=G5E
M9    TP   "&=FEE=P   ]0    D;'5M:0   _@    4;65A<P  ! P    D
M=&5C:   !#     ,<E120P  !#P   @,9U120P  !#P   @,8E120P  !#P
M  @,=&5X=     !#;W!Y<FEG:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D
M($-O;7!A;GD  &1E<V,         $G-21T(@245#-C$Y-C8M,BXQ
M       2<U)'0B!)14,V,3DV-BTR+C$
M                                     %A96B        #S40 !
M 1;,6%E:(                     !865H@        ;Z(  #CU   #D%A9
M6B        !BF0  MX4  !C:6%E:(        "2@   /A   ML]D97-C
M     !9)14,@:'1T<#HO+W=W=RYI96,N8V@              !9)14,@:'1T
M<#HO+W=W=RYI96,N8V@
M                    9&5S8P         N245#(#8Q.38V+3(N,2!$969A
M=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="               N245#(#8Q
M.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="
M                     &1E<V,         +%)E9F5R96YC92!6:65W:6YG
M($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$              "Q2969E<F5N
M8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ
M                      !V:65W       3I/X %%\N !#/%  #[<P !!,+
M  -<G@    %865H@      !,"58 4    %<?YVUE87,          0
M                  */     G-I9R      0U)4(&-U<G8        $
M  4 "@ / !0 &0 > ", *  M #( -P [ $  10!* $\ 5 !9 %X 8P!H &T
M<@!W 'P @0"& (L D "5 )H GP"D *D K@"R +< O #! ,8 RP#0 -4 VP#@
M .4 ZP#P /8 ^P$! 0<!#0$3 1D!'P$E 2L!,@$X 3X!10%, 5(!60%@ 6<!
M;@%U 7P!@P&+ 9(!F@&A :D!L0&Y <$!R0'1 =D!X0'I ?(!^@(# @P"% (=
M B8"+P(X D$"2P)4 ET"9P)Q GH"A *. I@"H@*L K8"P0++ M4"X +K O4#
M  ,+ Q8#(0,M S@#0P-/ UH#9@-R WX#B@.6 Z(#K@.Z \<#TP/@ ^P#^00&
M!!,$( 0M!#L$2 15!&,$<01^!(P$F@2H!+8$Q 33!.$$\ 3^!0T%' 4K!3H%
M2058!6<%=P6&!98%I@6U!<4%U07E!?8&!@86!B<&-P9(!ED&:@9[!HP&G0:O
M!L &T0;C!O4'!P<9!RL'/0=/!V$'= >&!YD'K >_!]('Y0?X" L('P@R"$8(
M6@AN"(((E@BJ"+X(T@CG"/L)$ DE"3H)3PED"7D)CPFD";H)SPGE"?L*$0HG
M"CT*5 IJ"H$*F JN"L4*W KS"PL+(@LY"U$+:0N "Y@+L O("^$+^0P2#"H,
M0PQ<#'4,C@RG#, ,V0SS#0T-)@U #5H-= V.#:D-PPW>#?@.$PXN#DD.9 Y_
M#IL.M@[2#NX/"0\E#T$/7@]Z#Y8/LP_/#^P0"1 F$$,081!^$)L0N1#7$/41
M$Q$Q$4\1;1&,$:H1R1'H$@<2)A)%$F02A!*C$L,2XQ,#$R,30Q-C$X,3I!/%
M$^44!A0G%$D4:A2+%*T4SA3P%1(5-!56%7@5FQ6]%> 6 Q8F%DD6;!:/%K(6
MUA;Z%QT701=E%XD7KA?2%_<8&QA &&48BABO&-48^AD@&449:QF1&;<9W1H$
M&BH:41IW&IX:Q1KL&Q0;.QMC&XH;LAO:' (<*AQ2''L<HQS,'/4='AU''7 =
MF1W#'>P>%AY 'FH>E!Z^'ND?$Q\^'VD?E!^_'^H@%2!!(&P@F"#$(/ A'"%(
M(74AH2'.(?LB)R)5(H(BKR+=(PHC."-F(Y0CPB/P)!\D321\)*LDVB4))3@E
M:"67)<<E]R8G)E<FAR:W)N@G&"=))WHGJR?<* TH/RAQ**(HU"D&*3@I:RF=
M*= J BHU*F@JFRK/*P(K-BMI*YTKT2P%+#DL;BRB+-<M#"U!+78MJRWA+A8N
M3"Z"+K<N[B\D+UHOD2_'+_XP-3!L,*0PVS$2,4HQ@C&Z,?(R*C)C,ILRU#,-
M,T8S?S.X,_$T*S1E-)XTV#43-4TUAS7"-?TV-S9R-JXVZ3<D-V WG#?7.!0X
M4#B,.,@Y!3E".7\YO#GY.C8Z=#JR.N\[+3MK.ZH[Z#PG/&4\I#SC/2(]83VA
M/> ^(#Y@/J ^X#\A/V$_HC_B0"- 9$"F0.=!*4%J0:Q![D(P0G)"M4+W0SI#
M?4/ 1 -$1T2*1,Y%$D5519I%WD8B1F=&JT;P1S5'>T? 2 5(2TB12-=)'4EC
M2:E)\$HW2GU*Q$L,2U-+FDOB3"I,<DRZ30)-2DV33=Q.)4YN3K=/ $])3Y-/
MW5 G4'%0NU$&45!1FU'F4C%2?%+'4Q-37U.J4_940E2/5-M5*%5U5<)6#U9<
M5JE6]U=$5Y)7X%@O6'U8RUD:66E9N%H'6E9:IEKU6T5;E5OE7#5<AES672==
M>%W)7AI>;%Z]7P]?85^S8 5@5V"J8/QA3V&B8?5B26*<8O!C0V.78^MD0&24
M9.EE/6629>=F/6:29NAG/6>39^EH/VB6:.QI0VF::?%J2&J?:O=K3VNG:_]L
M5VRO;0AM8&VY;A)N:V[$;QYO>&_1<"MPAG#@<3IQE7'P<DMRIG,!<UUSN'04
M='!TS'4H=85UX78^=IMV^'=6=[-X$7AN>,QY*GF)>>=Z1GJE>P1[8WO"?"%\
M@7SA?4%]H7X!?F)^PG\C?X1_Y8!'@*B!"H%K@<V",(*2@O2#5X.ZA!V$@(3C
MA4>%JX8.AG*&UX<[AY^(!(AIB,Z),XF9B?Z*9(K*BS"+EHO\C&.,RHTQC9B-
M_XYFCLZ/-H^>D :0;I#6D3^1J)(1DGJ2XY--D[:4()2*E/257Y7)EC26GY<*
MEW67X)A,F+B9))F0F?R::)K5FT*;KYP<G(F<]YUDG=*>0)ZNGQV?BY_ZH&F@
MV*%'H;:B)J*6HP:C=J/FI%:DQZ4XI:FF&J:+IOVG;J?@J%*HQ*DWJ:FJ'*J/
MJP*K=:OIK%RLT*U$K;BN+:ZAKQ:OB[  L'6PZK%@L=:R2[+"LSBSKK0EM)RU
M$[6*M@&V>;;PMVBWX+A9N-&Y2KG"NCNZM;LNNZ>\(;R;O16]C[X*OH2^_[]Z
MO_7 <,#LP6?!X\)?PMO#6,/4Q%'$SL5+Q<C&1L;#QT''O\@]R+S).LFYRCC*
MM\LVR[;,-<RUS37-M<XVSK;/-\^XT#G0NM$\T;[2/]+!TT33QM1)U,O53M71
MUE76V-=<U^#89-CHV6S9\=IVVOO;@-P%W(K=$-V6WAS>HM\IWZ_@-N"]X43A
MS.)3XMOC8^/KY'/D_.6$Y@WFEN<?YZGH,NB\Z4;IT.I;ZN7K<.O[[(;M$>V<
M[BCNM.] [\SP6/#E\7+Q__*,\QGSI_0T],+U4/7>]FWV^_>*^!GXJ/DX^<?Z
M5_KG^W?\!_R8_2G]NOY+_MS_;?___^X #D%D;V)E &1      ?_; (0  0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0(! 0$! 0$" @(" @(" @(" @("
M @,# P,# P,# P,# P,# P$! 0$! 0$" 0$" P(" @,# P,# P,# P,# P,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#_\  $0@#!@DZ
M P$1  (1 0,1 ?_=  0!*/_$ :(    & @,!              <(!@4$"0,*
M @$ "P$   8# 0$!            !@4$ P<"" $)  H+$  " 0,$ 0,# @,#
M P(&"74! @,$$042!B$'$R( "#$403(C%0E10A9A)#,74G&!&&*1)4.AL? F
M-'(*&<'1-2?A4S:"\9*B1%1S148W1V,H5597&K+"TN+R9(-TDX1EH[/#T^,I
M.&;S=2HY.DA)2EA96F=H:6IV=WAY>H6&AXB)BI25EI>8F9JDI::GJ*FJM+6V
MM[BYNL3%QL?(R<K4U=;7V-G:Y.7FY^CIZO3U]O?X^?H1  (! P($! ,%! 0$
M!@8%;0$" Q$$(1(%,08 (A-!40<R811Q"$*!(Y$54J%B%C,)L23!T4-R\!?A
M@C0EDE,88T3QHK(F-1E4-D5D)PIS@Y-&=,+2XO)59756-X2%H[/#T^/S*1J4
MI+3$U.3TE:6UQ=7E]2A'5V8X=H:6IK;&UN;V9W>'EZ>WQ]?G]TA8:'B(F*BX
MR-CH^#E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZRMKJ^O_:  P# 0 "$0,1 #\
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MS9L#*\4>4WME\KO;)V/"U4%'BAAZ:&0?4)+]R@/UU#CV*+/VZLTHU]</(?1
M$'V5.HG^7647*/\ =T\FV6F;G??KJ_84)CM(H[2/_2EI/JI'7U*^$Q\M/5>?
M9G\P/YB=L?<1;F[VWGCL=4*\3X?9-13; QAIG_52SP[,CHGJ(R#8BJDE+#AB
M1[%-GRQL-E0PVR$CS?O/V]]:?E3K*/E'[L7L1R5I?:.6[665:$2W:M>R:A^(
M&Z:4(WIX80#R Z3O\O7^:3N'X=_)'=.T.TLQE]P?''LW<E!%O:*HEJ\M7[ W
M0N/I\0.R\)"QDED $2QYJEB!>HIT61%DJ*:&.1[FCDV+?MH2>R4+=PJ=' !U
MJ3X9_;V$\#@T!)!M]Z'[FVU^^_M-9;YR;!%:\U[1 YM"H6-+VWUO+]!*>U5^
M(M:2-18I6*,5BED==W7"9O#[EPV)W%M[*8_.8#/8VAS.$S6)JX*_%Y?$Y.F6
MMQV2QU=2LT<T$\+I+%+&Q5U8,I((]X\21R0R-%*I5E)!!%"",$$>1!X]?/)N
M&WW^TW\^U;I"]O<VTCQ2Q2*4DBDC8H\<B, RNC JRL 5(((KTZ>Z=(^O>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K_]#?
MX]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T&O8'<
MO4O5%,:OLSLS8NPHO"9XUW9NG"X.IJ8Q_P J5'D)DFG8VLJ0HS,> "?:NUL+
MZ].FTA>7_2J3^T@4'Y]"WECD+G?G6;P.4=HO-R:M#]-;RS*I_ILBE4'J7( &
M20.J_.S/YP?PZV)YZ?;69WEVMD8E=5BV1M:II,:*D<+'-F-Y/BXS'?ZRTJSB
MW*ACQ[$]GR)OUS0S*L _IM4_L75^PTZR=Y1^XI[[\R:9=VM[798C3-W<*TFG
MU$5J+AJ^BR&,UXTX]5Y]F?SR^S\IYZ7J3IK9NSX&5XH\IO?,97>N2L>%JH:'
M$C$4\,@'(21JA ?KJ''L4V?MS9I0WUPTA]$ 0?94ZB?Y=91\H_W=/)]GIFYW
MW^ZOV%"8[2*.TC_TI>3ZIW'J5$34X4.>J\>S?Y@?S$[8^XBW-WMO+&XZH5XG
MP^R:FGV!BS3/PU)/#LV.B>HC(-B*J24L.&)]BFSY8V&RH8;9"1YOWG[>^M/R
MIUE)RC]V+V(Y*TOM'+=K+*M");M6O9-0_$#=-*$;T\-4 \@.B?5=75U]3-65
MU545M94R-+4557-)45,\K?JDFGF)9F/Y+$GV>JJJ-*B@'D.ITA@AMHE@MT6.
M-!154!54>@ H /D.H_O?3O7O?NO=>]^Z]U7;N.L_B&X,[7WN*S,9*J4_C3/6
M/(H'^%B+>Q9$NB)5] !_+K*K:8/I=KMK;AX<4:_L4#K8A_DI?S3CTSF<+\1O
MD)N/1U%N3)"DZCWQF:JT'6.Y<K4EAM/,UE0;18#)5#DP3,P2@JG)>U+/))2Q
M7[A<F?O"-M\VM/UT%94 _M%'X@/XU'$?B7AW !N6?]X+]S/^OUA<>^/M=:5W
MRTCU;G:1+W;A!&O^Y,2J.Z\@04= -5S"H"UFC1)MR'W O7!?KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z__1W^/?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW0:]@]R]2=3TQJ^S>S-B;"B\)GC7=FZ<+@ZF
MIC%_^ 5'D)DFG8VLJ0HS,> "?:NUV^^O3ILX7E_TJD_M(%!^?0LY8Y#YVYTF
M\#E':+S<FK0_36\LRJ?Z;(I5!ZEB .)/5??9G\X7X<[$\]/MK-;R[7R,2NJQ
M;(VM4TF-%2.%CGS&\GQ<9CO]9:59Q;E0QX]BBSY#WZYH9E6 ?TVJ?V)J_8:=
M9.<H_<7]]N9-,N[06NRQ&F;NX5I-/J(K47# ^BR&,UXD<>J\^S/YYG9^4\]+
MU)TULW9\#*\4>4WOF,KO7)6/"U4%#B1B*>&0#D1R&I4'ZZAQ[%%I[<V:4:^N
M&D/H@"#[*G43_+K*/E#^[JY/M-,W.^_W5\PH3':11VD?^E+R?4NX]2HB:G"A
MSU7IV9_,&^8O:_GAW+WMO+&8Z=7B;$;(GINO\::9_P!5+/'LV.BDJ(R"0152
M2DCAB1[%-GROL-E0PVRDCS?O/_&JT_*G64G*/W8/8CDK2^T\MVLTJT/BW:M>
MR:A^(&Z:54/IX:H <@#HGM765>0J9JVOJJFNK*F0RU%75SRU-342M^J2:>8L
M[L?R6)/L]554:5% /(=3M!!!:PK;VR+'&@HJJ JJ/0 4 'R ZC>]].]>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW3=F*S^'8C*Y"]OL<=75E_Z?;4S37_ .3?=XUU
MR*OJ0/Y]*["#ZJ^AM?\ ?DB+_O3 ?Y>JY?8MZRNZ][]U[K< _DE?S3O])6-P
M'PX^0^X]78F$H4QW2._<U5_N[[P6/@M#U[GJVH-WS-#"EL94.UZVF7PO_E<*
M-603[A\F?2.V_;4GZ3&LR ? 3^-1_"3\0_"<_">WA9_>%?<S_JE=W/OS[6VE
M-JN'+[M9Q+BSF=LWL**,6LSG_&$ I;RMXB_H2,(-EOW$?7(_KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO_]+?X]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW0;=
M@]R=2]3TOWG9O9FQ-@PF%IXANW=6%P4]3&M_^ 5)D9HY9V-B%2%&9CPH)X]K
M+7;[Z^;39PO+_I5+?M(%!^?0JY:Y&YTYRF\#E/:;O<FK0_36\LP4_P!)D4J@
M]2Q  R2!U7QV;_.'^&^P_N*?;6;WCVQDHE=5AV-M:JI<:*E;A(Y\SO)L7$8R
M;7FI5G%N5#'CV*;/D'F"YH9E2 ?TVJ?V)J_8:=9+\I?<>]\^8],NZV]MLT1(
MJ;NX5GT^9$5J+AJ^BR&,UXD<>J[^S/YZ':&4\]+U'TSLW9\#*\4>4WOF,KO;
M)6-PM7!0XD8>GAD Y$<AJ4!^NH<>Q59^VUFE#?7#R'T0!!]E3J)_EUE#RE_=
MX\H6FF;G;?KJ^84)CM(H[6/_ $I>3ZEV'J5$1(X4.>J\^S/YA/S&[8\\6Y>]
M]Y8W'5"O$V(V//3=?XTTTGZJ6>/9D=%)41D$@BJDE)'#$CV*;3E;8+&AAMD)
M'F_>?M[ZT_*G64/*/W9?8KDS3)M7+EK-*M#XMV&O9-0_$#=-*J'_ )IJ@!R
M.B>U=95Y"IFK:^JJ:ZLJ9&EJ*NKGEJ:FHE;]4DT\Q9W8_DL2?9ZJJ@TJ* >0
MZG:"""VA6WMD6.-!154!5 ] !0 ?(#J.#[WT^#Z]<@?>NG >N8/NM.G W7?O
M75NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7ND'V=6?8["W+->QDH!1C^I_B
M%0E"0/\ 82'VJLUU72#YU_9GH3<G6_U/,UI'Z/K_ -X4O_S[T1#V)NLD^O>_
M=>ZG8S)Y+"9+'YG#9"MQ.7Q%=29/%97&U4]#D<9DJ"H6JH<A05M,RR0SPRHL
MD4L;!D8!E((!]T=$D0QR ,K @@BH(.""/,'S'2>\L[3<+26POXDG@G1HY(Y%
M#I)&ZE71T8%61U)5E8$,"000>MZG^4/_ #.\;\T>ODZJ[6R=%0_)KKK#Q-F0
M_@HX^U=K482E3?V&I4TH*V,F./.4<2A4E9:F%5@G\--CASSR>_+]U];9 FSE
M.//PV.=!/I_ 3Y8.14_.)]^7[G]W[ <T'G3DN%Y.4-UE/A4JQVZX>K&RE8U)
MB:A:TE8U9 89"9(_$END]Q_US_Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z_]/?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]T&O8/<O4G4U+]YV=V9L38,)A:>(;MW5A<#/4QK?_@%29&:.6=C8A4A
M1F8\*">/:RTV^_OFTV4+R_Z52U/M(%!^?0IY;Y'YRYQF\#E3:KO<6K0_3V\L
MH4_TF12J#U+$ #)-.J]^SOYQ7PUV%YZ?;><WEVQD8E=5AV+M6JI<<M2MPD<V
M8WF^*B:,FUYJ43BW*ACQ[%5GR!S!=4,RI /Z; G]B:OV&G62?*GW)/?'F+3+
MNEO;;/$:9N[A6?3ZB*V%PP/]&3PS7C3CU7;V;_/5[.RGGI>HNE]F[/A97BCR
MN^LSE=ZY$AKA:J&@PXP]/!(!8B.1ZE ?KJ''L66?MI9I1K^X>3Y( @^RIUD_
MRZR:Y3_N^>4K33+SKOMS>M@F.TBCM4_TI>3ZEV'S41&G"ASU7AV;_,-^9/;/
MGAW)WOO'%8Z=7B;#[&GI>OL=]M)?52S+LV.BEJ(R"0152RDCAB1[%5GRIR_8
MT,-LC$>;U<_\;K3\J=9.\I?=H]C>3M+[5R[;32K0^)=AKQ]0_$/JFE5#Y_IJ
M@!X =$ZK*ZLR-5/6Y"KJ:ZMJ9#+4U=9/+5551*WZI)ZB<L[L?R6)/L_551=*
M"@'D.IUMX8+:%;>V18T0455 50/0 4 'R ZC^]]/\.N0/O1'5U;KD#[KTX#Z
M=<P?>B.G W7+WKIP&O7=_>NM@TZY ^]=. ^G7('WHCIP-UR]ZZOQZ][UU[KW
MOW7NO>_=>Z][]U[KWOW7N@9[UK/M]E1TX/-?F:&G*_DI%%+6$_ZP,2_[<>S'
M;5K<5] ?\W4@>V\'B\PF7_?43M^9*K_@8]$Z]G_4\]>]^Z]U[W[KW2]ZN[/W
MWTQV#M+M/K+<=?M/?>Q\S39W;>?QKA:BBKJ>ZLDL;@QS4\\;/3U5-,K13PO)
M#*CQNRE+>6=MN%J]E>('CD%&4^8_R$<01D&A&1T&N<>3^6^?^5[[DWF^T2^V
MW<8FAGAD':Z-Y@BA1T8!XY%(>.15D1E=01]!'^7'\_\ 8GSVZ6I]U4/V&WNW
M-GQ4&)[?Z\AG)?!YR:(BGW!A(IV:63#93QR34,K%C&RRTLCO+ SOC!S9RQ<\
ML[@86J\$E3$_J/X3Y:UX'UPPP>OF%^];]V/F3[M/N VS7&NZV._+R;9?$8FA
M!&J"8@!5NK?4JS*  X*3(JI(%6PWV%NL6^O>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[K__U-_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T&O8?<W4G4M)][
MV?V;L3K^!H6GA_O=NK"X&>JC2]_L:3(S1RU#$BRI"C,QX )X]K+3;K^_;390
MO*?Z"EJ?:0*#\^A/RYR3SCSA-X'*NUW>XM6A^G@EE"D_Q,BE4'J6( &2:=5Y
M]G?SCOAGL+ST^VLYO+MG(Q*ZK#L7:E52XU:E;A8YLSO-\5$T9-KS4HG%N5#'
MCV+++V^YANJ&94@']-@3^Q-1_(TZR0Y5^Y3[W<PZ9=SM[;9XC3-U<*SZ?41V
MPG8'^C(8S7C3CU79V=_/:[/RGGI>H>EMF[/@97BCRN^LSE=[9(AKA:N''X<8
M>G@D L1'(]2@(YU#CV+;+VQLDHU_<O(?1 $'V5.LG^762W*GW .5+33+SGOE
MS>M@F.UBCM4_TI>3ZEV'S41&G"ASU79V;_,0^9?;/GAW+WSO+%8V=7B;#[%G
MI>O<=]M)?52S+LR.BEJ(R"0152RDCAB1[%EGRGR]8T,-JC$>;UD/V]]:?D!U
MDQRI]VSV0Y.TOMG+UM-*M#XET&O'U#\0^I:54/G^FJ '( Z)S65U9D:J>NR%
M74U];4R-+4UE9/+5551*WZI)ZB<L[L?RS$GV?JBHNE!0#R&!U.5O#!;0K;VR
M+'&HHJJ J@>@ H /L'6 'WOI2#UW[UU;KL'WJG5@WKUS!]ZITZ&]>N0/O75P
M?7KE[UU;KL'WJG5PW7,'WKIP'KD#[K3IP-URO[UTX#7KOWKJW7('WKJP/7('
MWJG3@;KG?WKIP&O7O>NM]>]^Z]U[W[KW7O?NO=%N^0M9:';&/!_7+DZR1?Z>
M)(8(3_L=<G^V]F^U+EW^P?X>I:]K8*R7ET?(1J/S+$_X%Z++[.>I?Z][]U[K
MWOW7NO>_=>Z,;\4_E%VE\/NZ=K]V=3Y/[;-8.7[3-8.JDF_@6]-JU<J-FMH;
MDIHB/+25:HI!'KAF2*IA*3PQNI3O6S66^[>^W7HJK9!'Q(PX,OH1_,5!P3U%
M/O3[.<F^^WM_>>WO.L.NWN1JBF4#QK2Y4'PKJ!C\,L9)Q\,B,\4@:.1U/T-O
MB3\K.K?F3TIMGNOJK(:\;ED^PW'MRKFA?/;&W=20H^9VCN*&+]-13,ZM'( $
MJ('BJ8KQ2H3BUOFRWFP;@^WWHRN58?"ZG@R_(_R-0<CKY;_>_P!EN<O83W!N
M_;[G2*DL!UP3J"(;RV8D17,!/%) "&6NJ*17B>CHPZ,Q[*.HBZ][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[K_]7?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW0:]A=R]2=34GWO9_9NP^OZ<PM/%
M_>_=>$P$U5&M_P#@%2Y*:.6=B00J0HS,>%!/'M9:;=?W[:;*%Y3_ $%9J?:0
M*#\^A-R[R7S?S=-X'*^UW6X-6A^G@EE"G^DR*54>I8@ 9)IU7EV?_.0^&&P?
M/3[;SV\NV<E$KJ(-A[3JJ?'K4KPD<V9WH^)A:,FQ::D^X '*AB-/L767MYS'
M=4,R);K_ $V!/[$U'\C3K(OE;[F/O7S#IDW*WMMHB-,W4ZE]/F1';"=@?Z,G
MAFO&@SU75V=_/>[-RGGI>G^E-F[0A*O%'E=^9K+;UR#!N%JH<=AAAZ>"0#]*
M225* BYU#T^Q=9>U]DE&W"Y>3Y( @^RIUD_\9ZR2Y5^X-RM;:9><M\N;QL$Q
MVL4=LG^E+R?4.P^:B(TX4.>JZNSOYBOS/[9\\.Y.^=XXC&SJ\1P^PYJ7KS'_
M &TGZZ2;^YD=%-41D$@BKFE)'#$CCV+;+E'EVPH8;5&(\WK(:^O>2!^0'62?
M*OW;_9/E#2^V<OVTTJT/B78:\?4/Q#ZEI50^GAJ@!R #T32LKJW)54]?D:RJ
MKZZJD,M565M1+5551*WZI)ZB<L[L?RS$GV(5144(@  X 8'4WV\,%K"L%JBQ
MQH**J@*H'H%% !]@ZC@^]TZ4ANN7NO3@->N[^_=;!IUR!]ZZ<!].N8/NI'3B
MMUR!]ZZ<!].N7O75P:]=W]^ZV#3KD#[K3IP-US!]ZZ<!Z[]ZZOQZ[!]ZZL#3
MKF#[U3IP-UR!]ZZ<!ZY@^ZTZ<#==^]=6Z[!]^ZL#Z]<P?=>G ?7KD#[UTX#Z
M]=^]=6Z][]U[KWOW7NBB=]5GGW;0TBFZT6$IPP_I-4U4TK_[=/'[/ML6D!;U
M/^0=3I[9P>'L<DYXR3-^Q54#^>KH#_9EU(O7O?NO=>]^Z]U[W[KW7O?NO='_
M /Y=OSWW]\"N[*7>N'%=N#J_=3T.'[>Z[CJ0D&YMNQ3'Q9;%1S,(HLSC/)+/
MC:ABH.J2FD=8*B7V&.:N6;7F7;S;R469*F)_X6]#YZ&X,/L(R!UC)]Z?[M'+
M/WEO;Y^7[[1:[Q9!Y=LOBM3;SD"L<A U-:W&E4G05I1)54R1)U]!CJ;M?8'>
M/7.T>V.KMQT.[-A[XP]/FMO9N@8^.HIIB8YJ:J@>TE/54TJR4U92S*LL$\<D
M,JK(C*,7KZRNMNNY+*\0I+&:,#_JR",@C!!!&.OF YVY*YF]NN:[[DGG&T>R
MW+;I6BGA?BK#(92,/'(I62*124DC970E6!(B>TO06Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z__UM_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=(GL+LGKWJ;:V1WQVAO?:G7FSL2FO([GWGG\9MO!TA*EHXY<EEI8HO(]B(
MX@Q=SZ44GCVIM+*[OYQ:V,332-P5%+,?R )_/RZ.^7N6^8>;-UCV/E>QGW&\
ME^"&WB>:5O4A(U9J#S:E%&20.M>_Y;?\*-^@.MOXGM;XJ;+R/?6ZX?-31[ZW
M*F1V7U30U*W1:BDIJA(\WF C@AXEIZ")U(>&L=3[EO8/9W=KS3/OL@M(_P"!
M:/*?M([$^VKD>:CKH1[2?W<G/_,GA;I[K7J;#:-0FUA*7-\R^C,";:WJ.#%[
MAU-0\*GJDR?^;M\TOD=E<OAM_P#>&X-I?Q&6IGQ.WNKY3UOMW^&RC5-@4&W&
MBK:E8EU%?XA6U,DD=P[MI]4E#V_Y<V:-9;2U62E*M+^HU?XNZH%?Z*J > ZS
M=C^Z'[*^W%I#>\O['%=^& ))KT?63:QPE_6#1H6Q7PHXU5J%5%<!#6U];DJN
M>OR5959"NJI#+4UM;42U5742M^J6>HG+.['\LQ)]KE144*@  X 8'0SMX8+6
M);>W18XT%%50%51Z "@ ^P=8 ?>Z=*@W7('W6G3@;KF#[UTX#7KOWKJW78/O
M75@>N8/O5.G W7('WKIP&O7?O75N'7('WKJP/7('WJG3@;KF#[KTZ#UR!]ZZ
MN#7KOW[JW#KL'WHCJZMUS!]UZ<!].N5_>NK@UZ[]^ZL#3KD#[K3JX;KD#[UT
MZ#Z=<P?>B.G%;KE[UU?CUV#[UUL&G7('WKIP'TZY ^ZTZ<#=<O>NK]>]^Z]T
M1GMBL^]W_N!P;I!-2T:#_4_:4,4,@'_(88^Q+8KIM4^>?VGK(_DF#Z?EBU4\
M6#,?]L[$?R(Z#KVKZ%77O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U<E_*0_F;97X2
M]C#KCLS(5^2^,W8^8@.YZ4">MFZSW+5!*.+L3 TD>IV@TK'%FJ.%2\T"K-$K
MST\<4P!YXY03F&T^KLP!>1#M/#Q%&=#'U_@)X'!H"2,"OOP?="LOO"\J?ULY
M1B2+F_:8C].V$%_ M6-C,QH ]26M)7.F.0M&Y6*5GCWN,/F,3N'$XO/X')T&
M:P>;QU%E\-F,55P5^,RN*R-,M9C\ECJZE9HIH)XG26*6-BKJP9200?>-TD;Q
M.T4H*LI(((H01@@CR(/$=?-Y?V%[M=]-MFY0O;W-N[Q2Q2*4DCDC8J\;HP#(
MZ,"K*P!4@@BHZ<?=.DG7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__U]_CW[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]T7/Y$?+?XW_%#;G]YOD#V_L_K>DEIY:C&XO*U
MYJ]UY](;AUVULW$K497(D$:6^RHY I_65'/LXV?E_>=_F\#:+=YCYD"BK_IG
M-%7\R.I$]O?:;W&]U=Q_=G(&T7&XN" [HNF"*O#QKB0I!#ZCQ)%KY5ZUH?EO
M_P *5,K6?Q/:GPPZK3$0'S4L?;?<=/#69-AS&:S;?6^*F:FA((\E/492OG#*
M0)L>C K[FKE_V71=-QS)/J/'PH<#[&D(J?F%4?)SUTH]I?[MVTB\+=?>7=?&
M;#&PV\E4]=,UXZAV]'2"*.A'9<$9ZUM.]/DMWW\FMTMO/OKM?>?:&>#S-1R;
MERTDV+PT=0VN:EVWMVE$6.Q=.Q%S38ZEABOSHO[F;:]EVK9(/IMJMT@3STC)
M^;,:LQ^;$GKI+R)[;\A^V>UC9N0MJM]LM\:A#& \A'!IIFU33./XY7=J>=.@
M1!]F5.AV&ZDTM54451!5TDTE/4TTL<]//$Q22&:)@\<B,.000"#[HRA@585!
MZW(D<T;12@,C @@\"#@@]'QZTW[3[XPBR2M'%FZ!8X<M2K907(M'70)_QSEL
M3;^RVI?H 2%+VT:UEH/A/ _Y/RZ@OF38I-DO2J5,$E3&WR\U/])?YBA]0!(O
M[0]!T&G7('WJG3@;KD#[UTX#US!]UITZ&ZY>]=6Z[O[]U8'UZY ^]=. ]<@?
M=:=.!NN7O75NNP??NK ^O7('W6G3@;UZY@^]4Z=#>O7('WKJX/KUW[UU;KD#
M[U3JX;KD#[UTX#URO[KTX#Z]<O?NM]=@^]4ZN&ZY@^Z]. ]<@?>J=.!NN0/O
M73@->N_>NK TZY ^]=7!].N8/O5.G W7*_O73@->J[MR5O\ $=Q9ZNO<5F8R
M52I_&B:L=T _P ( ]BN)=$2KZ ?X.LJ-H@^EVJVMN!CBC7\PH!_GTR^W.C'K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K9&_DG_ ,T[_1'E\'\0/D-N/3U7
MN'(K1=.;ZS-5:'K?<63J;ILK-UE0;1X+(SN31SLP6AJG*O\ Y).STD2^X7)G
MUR-ONUI^L@K*@']HH_&!_&HXC\0_I"C<G?[P?[F?]>+&Y]]/:ZTKO5JFO=+.
M)<W\$:YNX44=UY @_50"MS"M5_7C"S[BON!^N#W7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U__T-_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5>?RU_FD_"[X9ID,;VGVO09OL&A2
M0+U+UN*?>O8SU*+J%'DL70RI2XAV'*-G*VB1A^EF-@1?R_R+S+S(0]A;E83_
M *+)V1T]02*O_M W4_>U/W9/>/W@:.XY8VMH+!Z?X]=UM[2G\2.REYP/,6T<
MQ'F!UJ]_+C_A13\H.X/XGM?XV[?Q?QNV34>:F3<0>EWEVUD:1KQ&3^/9" 8W
M%>5/5HH*!ZF!C^WD&(#>YRY?]G=CV[3/O3F]E&=.4B!_TH.IJ?TF"GS3KII[
M3?W?'MEREX6Y^XUP_,5ZM#X/=;V*-QIX2-XT^DXK+*(W'Q0"I'5 ^[]Z[P["
MW'D]X;]W7N/>V[,U.:K,;GW;F\EN+<&5J6%C/D<QEY9JB9[<:I)";<>Y8M[6
MWM(5M[2-8HUP%10J@?(  #K/;9]HVCE_;XMHV*UALK6$:8X8(TAB0>B1QJJ*
M/D .DX#[=Z-P>N8/O5.KANN0/O73H/7('W6G3@;I3;4W/D=HYNDS6-;]R!M%
M13LQ$5;2.1YZ2:W]E@.#;TL PY ]L7$"7$1B?S_D?7I#NFVV^[V3V5QP;(/F
MK#@P^S^8J.!ZL!V]G\=N;$4>9Q<ODI:R/5I-O+!,O$U-.HOI>-KJP_V(N""0
MA-"\$AC?B/\ 57J!-PL;C;;Q[*Z%'0_D1Y,/4$9'^?I[]M=).'7('W4CJZMU
MS!]ZZ<!].N0/O5.G W7+W7IP&O7=_?NM@TZY ^]=. ^G7,'W4CIQ6ZY>]=7X
M]>!]^ZV#3KF#[UTX#UR!]UITX&ZY ^]=. ]<O>NK\>NP?>NM@TZY@^]4Z=#=
M<@?>NG >N_>NK==@^]=6!IUS!]ZITX&ZY ^]4Z<#=<P?=:=. ^O7?O75NN0/
MOW5P>H&6K?X=BLG7DV%#CZVL)/X%-3--<_\ )/O:+KD5?4@?M/2VPB^JO8;;
M_?CHO^],!_EZKEO?Z_4_G^OL64ZRP!\NN0/O73@/KUW[]UOKWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[K<,_DF_S3O]*N+P7P]^0VX]?9N!QZT/2^_,U57F
M[#V_C:>\>Q<[6U!N^;Q\"?Y!.YU5U*AC?_*X-=9 _N%R9]$[;]M:?HL:RH!\
M#'\8'\#'B/PG/PGMX2?WA/W,_P"I=[<^^WM;:4V>Y?7NMG$N+&>1LWD**,6D
MSG]9 *6\S:E_0DTP;)_N)>N2_7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_T=_CW[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW4>KJZ
M3'TM37U]53T5#10355965<T=-2TE+3QF6>IJ:B8JD<:*"SNQ  !)('O:JSL$
M05)P ,DGT'3D44L\JP0*7=R%55!+,2:  #)). !DGJEGY=?SX?A)\:/XGMW8
MVX*CY*]E47F@7;G4U;1S;,HJZ.X6//\ :<XDQB1E@R.<0F2FC86D@6]_<E\O
M>U7,^]Z9KI/HH3^*4'61_1BPW^]Z ?(]9A>U/W(?>3W&\+<-Z@'+NW/0^-?*
MPN&4^<5D*3$TH1XYMT895SUJZ_+G^=Y\XOE3_$]OX[>J]!]95WF@_N+TW45^
M!R%=02700;E[ 9SF:TO&3'4Q4]12T<P)#48' G+E_P!L>5]ATS/%]7./QS48
M _T8_@'R)#,/XNNF'M1]S+V6]L?"O[BR_?NY)0_4[@%E56'G#:T^GCH<HSI+
M*A&)NJ@WE>5WEE=Y9)':2221F>221SJ=W=KDDDW)/)]R%0 4'66R:54*HH!@
M >0].O ^_ ].@]9 ?>^G WKUR!]ZZ<!ZY ^]4Z<#=<P?>J=.!NN0/NM.G0WK
MUS!]ZZN#Z]"QU5V%)LS+_;5TCMM[*2(E?'RPHYOT19*)!^5X$H7]2?@LJCV7
M7]F+F/4OQKP^?R_S=!GFG8%WJS\2$ 7$0)0_Q#S0_;Q7T;T!/1YHI8YHXY8G
M26*5%DBEC8/')&ZZD='7@@@@@CZCV%2"#0]0D0R,4<4(-"#@@CR/63WKKW78
M/O5.KANN8/NO3@/7('WJG3@;KF#[UTX#7KOWKJW#KL'WKJP/7,'WJG3@;KE?
MWKIP&O7?O75@:=<@?>NK@^G7('WHCIQ6ZY@^Z]. ^G7*_O75P:]=^_=6!IUR
M!]ZIU<-UR!]UZ=!].N7O75P:]=W]^ZV#3KD#[K3IP-US!]ZZ<!].N0/NM.G
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M4:LK*3'TE57U]534-#14\U765M9/%34E)2T\9FJ*FJJ9BJ1QH@+.[L H!)(
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MA%ZWWW4['S:5#&2;#UQC@R](O):$'T5<*GCRPW++_J@66XU7"&]M%NHJ<&'
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MDWD#;AM7)NVP;?#C4(D >2G RRFLLK?TI7=OGT!H/LTZ&0/IUR!]ZITX&ZY
M^Z]. ^G7,'WJG3@;KD#[UTX#Z=<P?=2.G W7('WKIP'TZY@^]4Z=#=<@?=>G
M ?3KF#[U3IP-UR!]UZ<!ZY@^]4Z<#=<@?>NG >N8/NM.G W7('WKIP'KF#[K
M3IT-UR!]ZZ<!ZY ^]4Z<#=<P?=:=.!NN0/O5.G W7,'WJG3@;UZY ^Z]. ^O
M7,'WL'IP'KF#[]TX#UR!]ZITX&ZY@_[?W7IP&O'HZ'3?8W]YL>-OYB>^>QD
M\$TK>O*T$8"K*6/ZIHA99?RPL_)UV#.Y67@/XT8[&_D?\Q\OV=1!S?R_^[;C
MZ^T7]"4Y X(Q\ODK<5\@:KC%1R]E70*ZY ^]4ZN&ZY ^Z]. ]<@?>NG :]=^
M_=6ZY ^]4ZN&ZY@^Z]. ^G7('WJG3@;KE[UTX#7KN_O76P:=<@?>NK@^G7('
MWJG3@;KE[KTX#7KN_OW6P:=<@?>NG >N8/NM.G W7('WKIP'TZY>]=7!KU R
MM8,=B\E7DV%#05E82?H!34[3$_\ )ONR+K=4]2!^WI590FXO(K8?Z(ZK_O3
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M^63_ #"_^\,OD7_Z*W='_P!3^]?UXY/_ .CG;_\ .5?\_3@^\5[%>?-NU_\
M99#_ -!=<A_+*_F%?]X9?(O_ -%;NG_ZG]Z_KOR?_P!'*W_YRK_GZL/O%^Q/
M_36[7_V60_\ 077(?RROYA7_ 'AE\B__ $5NZ/\ ZG]Z_KOR?_T<K?\ YRK_
M )^G!]XSV(\^;MJ_[+(?^@NN0_EE_P PK_O#/Y%_^BMW1_UX]Z_KOR?_ -'*
MW_YRK_GZN/O&^Q'GS=M7_99#_P!!=<O^&R_YA/\ WAG\BO\ T5VZ/^O'NO\
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MR_\ \IL'_.5/\_6Q[Y^S0_YVG:_^RZW_ .MG7+_9)OF#_P!XQ=Z_^BPW?_\
M4GO7]8^7_P#E-@_YRI_GZN/?3V9'_.T[7_V76_\ ULZY#X3_ #!_[QB[U_\
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M9S&/RB:/JK('W('4_ ]<O>NK\>NP??NK TZY ^ZTZ<#=<P?>NG >N0/NM.G
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MX&-(/:A_IL//^B,^NGCT;S;NVL+M:A7'X6BCI8?299/UU-5(!;S550WJ=O\
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M!O\ PH9Z[7<7Q&ZZ["@@,E=UOW1B8*B8+<4^WMZ;;R&+R!+#D:J^GQ2_T/\
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M4:9(Z$#7BZ%_J-2N/WY!_5AH!^BD@-[(+K<GDJD/:OKYG_-_AZB3F#GNZO\
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M  G _P"/+^5__AS]2?\ NJS_ +Q[][O]RMN_TLW^&/KGO]]\UW3EW_FE>?\
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M@/\ T8.'_P"C_?OZB<X_]&VX_P"<;=>_X''WX_Z9/<_^R63_ #==_P##HO\
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M#U(5@?H01_4&_P#O7NA'5@?7KE[UUOKL'W[JX/KUR!]UIU<-US!]ZITZ&ZY
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M"[]_[P&Z?_\ 1T;T_P#K-[]U[KW_ $'!=^_]X#=/_P#HZ-Z?_6;W[KW5R/\
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M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KXPO\
M/W_[?)?S"?\ Q8#,?^Z.@]^Z]U4#[]U[KWOW7NMVS_A$5_V5Y\T__%;]G_\
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MS_A%+_V\Z^1'_BA_8/\ \$%UK[]U[KZ=GOW7NO>_=>Z][]U[KWOW7NOD*?\
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M_P!YC_%__P \7:__ -;/?NO=>_Z C_FC_P!YC_%__P \7:__ -;/?NO=>_Z
MC_FC_P!YC_%__P \7:__ -;/?NO=>_Z C_FC_P!YC_%__P \7:__ -;/?NO=
M>_Z C_FC_P!YC_%__P \7:__ -;/?NO=>_Z C_FC_P!YC_%__P \7:__ -;/
M?NO=>_Z C_FC_P!YC_%__P \7:__ -;/?NO=>_Z C_FC_P!YC_%__P \7:__
M -;/?NO=>_Z C_FC_P!YC_%__P \7:__ -;/?NO=>_Z C_FC_P!YC_%__P \
M7:__ -;/?NO=>_Z C_FC_P!YC_%__P \7:__ -;/?NO=>_Z C_FC_P!YC_%_
M_P \7:__ -;/?NO=>_Z C_FC_P!YC_%__P \7:__ -;/?NO=>_Z C_FC_P!Y
MC_%__P \7:__ -;/?NO=>_Z C_FC_P!YC_%__P \7:__ -;/?NO=>_Z C_FC
M_P!YC_%__P \7:__ -;/?NO=7A_R#_\ A._\@?Y1ORU[/^0_;'??3G:FW]]_
M'3<W2]#@.O,;O6CS%%F,YV7M3?$&7JY=R4=/ :9(-OU$+JCE]<L9 TAB/=>Z
MVV??NO=>]^Z]U[W[KW7O?NO=?(4_X5,_]OS_ )H_]0'QJ_\ @3]C^_=>ZU\O
M?NO=>]^Z]UMN_P#",+_MZ]VA_P"*0=N?^_@Z]]^Z]U]1OW[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]UJX_P#"O_\ [<[9[_Q9#HW_ *WY3W[KW7RE
M??NO=>]^Z]U[W[KW7W>/B;_V2Q\:/_%?^FO_ 'W6-]^Z]T8#W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=?&%_G[_\ ;Y+^83_XL!F/_='0>_=>ZJ!]^Z]U
M[W[KW6[9_P (BO\ LKSYI_\ BM^S_P#WYU/[]U[KZ1GOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z^?G_PN8_XNO\L?_M7_ #&_]R>KO?NO=:"?OW7NO>_=>ZL._E&?
M]O5?Y:__ (OA\2__ '^V"]^Z]U]NKW[KW7O?NO=>]^Z]U[W[KW7O?NO=!_VS
M_P RK[+_ /$?[R_]YRI]^Z]U\$?W[KW7O?NO=>]^Z]UL:?RK/^$WWR)_FM_&
M3(?)[JWY!=+=8[9Q_:.ZNK)-M[_QF^:O.R93:F'Q>8JLFDNW:.>G^WE3*Q)&
M"^NZ-< 6O[KW5E'_ $!'_-'_ +S'^+__ )XNU_\ ZV>_=>Z]_P! 1_S1_P"\
MQ_B__P">+M?_ .MGOW7NO?\ 0$?\T?\ O,?XO_\ GB[7_P#K9[]U[KW_ $!'
M_-'_ +S'^+__ )XNU_\ ZV>_=>Z]_P! 1_S1_P"\Q_B__P">+M?_ .MGOW7N
MO?\ 0$?\T?\ O,?XO_\ GB[7_P#K9[]U[J)5?\(DOG B_P"1?+[XJ5#:&(%5
MC^W:-=?]E=4.$GX/Y-N/Z'W[KW06[H_X18_S/L5'-4;:[T^$6ZXXP3'2?Z0N
MZ\%E:@CE1%#7[ :E%_\ :ZU;&WXN1[KW1,NSO^$IW\ZSKN*:IQ'QQV7VQ14X
M=IJGK'O3J6IE$:?[LAQ.]LK@Z^:_X2"D=^?T_6WNO=51=\_RWOG[\7X:ZN[_
M /AK\DNK,'C=?W>[-T=0;VAV,HCYD:'?E+1RX:55 NS0US "Q)L1[]U[HE7O
MW7NO>_=>Z][]U[KWOW7NO>_=>Z&CX_?(OO/XJ=J;:[M^.G:6\>GNU-I3^;";
MRV3EI<9D8X7=6JL7D8?53U^/J@@CK<97PS4E5'>*HAEC)4^Z]U]*/^2)_P *
MBNIOG!4;1^,GS@?:O1'RQKS18#9V_P""1,)TSW]EGTTU%144E:Y3;>YZQK(N
M(J)315TY"XZ>.>>'%I[KW6W;[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KX>W\TS_MYQ_,9_\ %[_EY_\ ! [A]^Z]T1#W[KW7
MO?NO=?0+_P"$,_\ Q:_YG/\ U'_#C_W'[2]^Z]UOV^_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NM0?\ X4#?\*3]M?!6/=7P^^$>9P&^
M/F+-35&'[#[("46?V7\9A50E):,4T@DI<MO1%;5%C90])C&TR9%)IE./;W7N
MOF5;ZWWO7M#>6YNQ.Q]V;BWWOW>F:K]Q[NWENW,5^X-S;ESV4G-3D<OF\UDW
MEJ*FHFD8M)++(S$_GW[KW24]^Z]U[W[KW7O?NO=*79VR]X]B;GPVRNO]I[EW
MSO+<=:F.V]M+9V"RFYMSY[(2@F.@PV!PL4]553, 2L4$3,;&P]^Z]ULK?#'_
M (28_P TWY/T^(W/VUM[97PWZ^R4<-7][WGE)ZOLRHQTPYDQ_4&SUJ\A35*G
MAJ+<=3AY  3_ *D-[KW6R_\ ''_A%Q\ .O8,=7_)#OCY!?(W<5,(S78[;T^W
M.C^N<@WUE5]OX>+,Y]!?A3%NI+"]P205]U[JXOJK_A/C_)FZ=@IH=K_ 'I3/
M-3:6^X[57=G=D]1(OZI*D]P9/.*VH\E- 0?14"V ]U[HZ&W?Y>/P VA"*;:?
MP:^'NV*<*$$&WOC-TMA8=*\JOCQN$C%A8<6]^Z]TJJGX5_#>M3Q5GQ+^,U7'
M9AXZGH?JR=+.-+C1+BB.1P?Z^_=>Z!?>/\I_^6!OZ&6+=G\O'X5Y.2?4'KXO
MC-T]B\P-7ZO'G,1B(*Q+_4Z)QSS]0/?NO=$*[;_X3$_R4^VHZN5_A_3];9BI
M5UCSO4G:?;>R)*(N/U4FW(,W-@;@V(\F(>UK?0D'W7NJ;?D3_P (D?C=N"&L
MKOBK\R>XNL,A:6>FV_WCL_:/<.$GF-V2@BSFS!L^LHH+V"S2T]=(H'J64\^_
M=>ZUQ_EW_P )8/YN/Q9I\IG]M=1;;^5>Q\;YIFW!\9=Q3;QW$M(+M3^3JS<5
M+B=T3U#*/W(<3B:Y$8%1*PTLWNO=:]&[-H[LV%N/+[.WSMC<6R]W;?K),=GM
MK;LPN2VYN/"9"*QEH<OA,Q%#4TTRW&J*:)6'Y'OW7ND][]U[KWOW7NO>_=>Z
M][]U[JT[^5Y_-^^7W\J/M'^]_0>Z_P"/=8;CR=)4]K?'S>-76U?5W95'$$@F
MJI:"-BV)S:0*$HL_C@E3%I2.855'Y:.7W7NOJ^_RO/YJGQB_FO=$2=P_'W*5
M^*W)M5\/B.Y.GMT>*/?746Z\O2RU%'C,SX (*W'UHIJJ3$9FC)@K(XI 1!50
M55)3^Z]U9;[]U[KWOW7NO>_=>Z][]U[KWOW7NJH/YZ?_ &Y^_F(_^*P=A_\
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M\YH\!W'L6ACGIE6WAI:;)[=J2Q*^?(H TA]U[K2U^9/\OCYE?R_][KL/Y;]
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M[Q'<4]-+N>G2>DQN'W=CFCKY*-JK1BMPI4TCAY\C43)[KW2*_P"%"ORAW/\
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MKWOW7NO>_=>Z][]U[K3D_P"%4W_'W_"G_P -OO?_ -V>T_>2_P!W[_<;=/\
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M[>O?S(__ !>#Y._^_BR_OW7NJX??NO=>]^Z]UOF?\(</^/\ _P"8_P#^&?\
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MZY ^]=.@]<P?=:=.!NN0/O73@/7,'WJG3@;KD#[KTX#US!]ZITX&ZY ^Z].
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M_<#>I:B!8XA\E+']K$C_ (STN<?UKL3&:?MMKXMRMK-6Q/DV!']K5D6E-_\
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M\3CZ<$4]#C,;NJKHJ"C@#$D)%$B(H)/ 'OW7N@R]^Z]U[W[KW7TF_P#A$?\
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M?^M^4]^Z]U\I7W[KW7O?NO=>]^Z]U]WCXF_]DL?&C_Q7_IK_ -]UC??NO=&
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MKW7O?NO=; /_  G2_E1?\.??.#&OV3@YZWXK?&X83L[OV66%_P"&[PF>O?\
MN!TRU0OT;<E72U#UZ@J?X51Y'1)%.U.Q]U[KZ]])24M!2TU#0TU/1T5'3PTE
M'1TD,=/2TE+3QB&GIJ:GA 2..- %1% "@   #W[KW4CW[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW54'\]/_MS]_,1_P#%8.P__<)/?NO=?%F]^Z]U[W[KW7O?NO=?;Y_E._\
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M)+/"==-E=UO'4X;%LHUQ4:9*J5H)TH9']U[KY>'OW7NO>_=>Z][]U[KZ,/\
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M?('_ .%&_P#*^A_EI_/[<</7>!&)^,_R4ARW<G0L5'3F'$;56JR8C[$ZDHR
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M]U[KWOW7NO>_=>Z)C_,#^</47\NKXF]L?+#N:J#[>Z[PK+MW:U/5PTF;[&[
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MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NOC"_S]_P#M\E_,)_\
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M +><?S&?_%[_ )>?_! [A]^Z]T1#W[KW7O?NO=?0+_X0S_\ %K_F<_\ 4?\
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M!?SRNNSOK^7OV!F(XO/5=7;UZZ[$I8PI:3C<"[&R$L?]/%1YRIE<_P"H5O\
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MN/(]VX]. ^G75OR/]M[]]O3JMUL]_P#">3_CUOE/_P"'!U)_[KMP^X$]Z?\
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M7$C\CWL'IP'KJ_\ 7WOIP-Z]<@?>J=.!O7KE>_U]UZ=#==$6][KTX#UL]?\
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M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7R%/\
MA4S_ -OS_FC_ -0'QJ_^!/V/[]U[K7R]^Z]U[W[KW6V[_P (PO\ MZ]VA_XI
M!VY_[^#KWW[KW7U&_?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6KC
M_P *_P#_ +<[9[_Q9#HW_K?E/?NO=?*5]^Z]U[W[KW7O?NO=?=X^)O\ V2Q\
M:/\ Q7_IK_WW6-]^Z]T8#W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?&%_
MG[_]ODOYA/\ XL!F/_='0>_=>ZJ!]^Z]U[W[KW6[9_PB*_[*\^:?_BM^S_\
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MG&92D+L8*N":(DZ+GW7NC >_=>Z][]U[KB[I&C22,J(BL[N[!41%&IF9FX
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MZV>?^$\W_'K?*>W_ #O^I/\ W7;A]P)[S_[D;?\ Z6;_  Q]8>?>I-;S9/\
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MS5O^?,_!#_T5'>O_ -LOW[KW7O\ H-)_FK?\^9^"'_HJ.]?_ +9?OW7NO?\
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MBK(GG;VNY/T <S;DF3_N.I' <#*1\^"?*K>:D93^QGMYX2KSMO,?<P/TB,.
M.#.0?,C$7RJXK5"-;8'W.%.LH0W7,'W7IP'KE]?K[UTX&ZXD6]W#5P>G >O?
M7_7]WZ<5J==>_=/!J]>M_3_;>_=/*_KU[Z^_=/ UZX$$?ZWNU:].!NNP?>NG
M ?3K9[_X3R_\>M\I_P#M?]2?^Z[</N _>C_<C;_]+-_ACZP^^],:WFR_Z2Z_
MX]!UL>>X1ZQ.Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NOE-
M_*$_\Y,_(G_Q.O;G_O?Y#WG_ +$/]T=E_P T(?\ JVO7TA>W3?\ ( V+_I7V
M7_:-'T!@/LTZ&H/7,'W6G3@;KD#[UTZ#Z=<P?=:=.!NN0/O73@/7,'WJG3@;
MKD#[KTX#Z=<P?>J=.!NN0/O73@/IUR!]UITX&ZY@^]=. ]<@?=:=.ANN8/O7
M3@/IUR!]ZITX&ZY@^]5ITX#US!][X]7#=<P?>NG >N0/O5.G0W7('WKIP'HQ
MWQB^*7>_S [(H^KNA=BY'>&?D\$^9R(!HMK[/Q$LOB?/[RW%,/M\?1I9M+2L
M9)F'BIXYIV2)B7?-^VKEVS-]NLHC3R'%G/\ "B\6/V8'$D"IZC_W+]U^1?:'
MEQ^9^?+Y+2W%1&GQ3W$@%?"MX1WRR'%0!I0'7(R("PWC/Y<?\FWHCX.TN)[!
MW>N.[F^2 @2:;L/+8X?W=V)52QVJ*'JW UH;[4I<Q-F:D&NF&HQFCAE>E&,'
M./N-NO,[-:6];:R_WV#W./65AQ]= [1YZB W7$3[QGWQ^>_>^27E[:"^S<MU
M(%I&_P"M=*#AKV5::Z_$+=*0(::O&=%EZN0]QUUASU[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7Q)?YPW_;U[^9'_ .+P?)W_ -_%E_?N
MO=5P^_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZW+/\ A$Y_
MV\0^4/\ XI?G/_?X[+]^Z]U],SW[KW7O?NO=>]^Z]U[W[KW7O?NO=?(4_P"%
M3/\ V_/^:/\ U ?&K_X$_8_OW7NM?+W[KW7O?NO=;;O_  C"_P"WKW:'_BD'
M;G_OX.O??NO=?4;]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=:N/_
M  K_ /\ MSMGO_%D.C?^M^4]^Z]U\I7W[KW7O?NO=>]^Z]U]WCXF_P#9+'QH
M_P#%?^FO_?=8WW[KW1@/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U\87^?
MO_V^2_F$_P#BP&8_]T=![]U[JH'W[KW7O?NO=;MG_"(K_LKSYI_^*W[/_P#?
MG4_OW7NOI&>_=>Z][]U[KWOW7NO>_=>Z][]U[KY^?_"YC_BZ_P L?_M7_,;_
M -R>KO?NO=:"?OW7NO>_=>ZL._E&?]O5?Y:__B^'Q+_]_M@O?NO=?;J]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW0?]L_\RK[+_P#$?[R_]YRI]^Z]U\$?W[KW7O?N
MO=>]^Z]U]3K_ (1M_P#;I#<O_BX'<G_O#[/]^Z]UM?>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NM:C_A6FT(_DL=U"52SMVS\?EIB+^B;_2?1,S'
MG_CF)!^?K_L??NO=?)>]^Z]U[W[KW7O?NO=?9%_X3DPS0?R4/@*D[,[MUIO*
M92X92(:CN+<E13J WX6-E"GZ$ $<>_=>ZNS]^Z]U[W[KW7O?NO=>]^Z]U\/;
M^:9_V\X_F,_^+W_+S_X('</OW7NB(>_=>Z][]U[KZ!?_  AG_P"+7_,Y_P"H
M_P"''_N/VE[]U[K?M]^Z]U[W[KW7O?NO=>]^Z]U\RG_A; LP_F.?&9VU?;M\
M)=L+$-0*^9>]M]FHLE[@Z3'<VYX^MN/=>ZTW??NO=>]^Z]T<O^7++'!_,)^"
M$\K:8H?F7\8)9&LS:8X^[L&[MI4$FP!X O[]U[K[EOOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M^'-_,U_[>1_S!O\ Q=_Y7_\ O^<_[]U[HD'OW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>ZW7/\ A$?_ -EH_,?_ ,5?P7_OU\9[]U[KZ3GOW7NO
M>_=>Z][]U[KWOW7NJH/YZ?\ VY^_F(_^*P=A_P#N$GOW7NOBS>_=>Z][]U[K
MWOW7NOM\_P IW_MUE_+3_P#% /AO_P# Z[<]^Z]T?_W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=?.\_P"%='\G/^Y&YIOYJ'QXVKHVCO7)XO _+_;.$H]%/MS?&0EC
MQ&U.\TI:<:$I<[(8,3N&0! ,D:.K82S9*KEC]U[K1*]^Z]U[W[KW7..22&1)
M8G>*6)UDCDC9DDCD1M2.CK8@@@$$&X/OW7NOK1_\)J/YP$?\R?XD1]2]P[E2
MM^8/Q=Q&%VQV7)D:I3F.UNNPHQFQ^Z85E.NHJ)EC&,W*ZERN1C6JE\29.EB]
M^Z]U;_\ S"/G)U%_+G^)G:_RO[EJE? ]?X9HML[4@JXJ3-=D=AY96I=D]<[<
M\@<FKRE9I1Y1&ZTM,M16S**>FF9?=>Z^+!\L/E!VY\T/D5VS\G^],^VX>SNX
M-VUNZ-P5*>9<=BX'5:/!;6V_2SO(U/B\/014N+Q=,7;Q4L$499BI8^Z]T7GW
M[KW7O?NO=;/'_"9/^3LW\Q;Y3?[,!W9M@U_P]^+>X,3F-V4F4I"^'[A[=A6/
M,[.ZB03CQ5-!3#PYC=$?[B_9_;4,R*N525/=>Z^K^JJBJB*JHJA550%55465
M54<  ?0>_=>Z[]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7P9OD)_S/SO#_P 2_P!E
M_P#O9UOOW7N@@]^Z]U[W[KW7TF_^$1__ &1?\R/_ !9_ _\ OJ<;[]U[K==]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_4W^/?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW58/\T#YWT/PZZ>;"[/KZ2;OCLVBKL;U_07BJ)-JXRQI<KV+DZ1[@1T98Q8Y
M)E*SUA7T2PP52J/.0^4GYEW+Q;D$6D!!D/#6>(C!]6XM3@OF"5ZE/VLY!?G/
M>?'O5(V^U(:8\/$;BL*GU;BY&52N0S)724KZZNR==69/)5E5D<CD:NHK\AD*
MZHEJZVNK:N9JBKK*RJG+/+++(S/)([%F8DDDGWE,B(B"- %"@  8  P !Y >
M0ZSHA$<4:Q1*%10  !0 #   P !@#RZAD ^[<.GP?3KCR/K[MQZ<#=<@?>J=
M.ANN0/NO3@/7B/R/=@U,'IP'KK_ ^[_,=7#4ZZ^G^M_7WOI]6!X]>^O_ !7W
M[IU6(X]>_P!?W[I\-7KB1^1[V#Z]. ];/?\ PGD_X];Y3_\ AP=2?^Z[</N!
M/>G_ ')V_P#TLW^&/K$#[TAK>[+_ *2Y_P"/0=;'GN$.L4>O>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KY3'RB/\ SDS\B?\ Q.O;G_O?Y#WT
M V+_ )(=E_S0A_ZMKU]'WMV?^0!L5?\ HWV7_:-'T!@/LTZ&@/KUS!]ZZ<!]
M>N0/O5.G W7,'W6G3@;KD#[U3IP-US!]UZ=!ZY ^]4ZN&ZY@^]=.@]<@?=:=
M.!NN0/O73@/7,'WJG3@;KD#[KTX#US!]ZITX&ZY ^Z].@^G7,'WJG3@;KD#[
MUPZ<!ZY@^]\>KANN8/OW3@/IU=S_ "W/Y*O=WS2DPG9_:/\ %^D_C9.\-9%N
MFNH5CWQV30A@[0=:X/(H56EE7T_QZNC-*NH-315Y26-(PYT]R]LY:#6-C2YO
M1C2#V1G_ (8P\Q_OM>[^(I4$X8_>+^^?R5[,K-RURQX>]<QK53 K5MK-N%;R
M5#4NIS]-&?%-*2- "K'=^^.GQGZ1^*/6^-ZJZ(V%B-B[3H-$U6**,SYG<>5\
M0AGS^Z\]4ZJK(U\H4!ZBJD8JH6*,)"D<:XQ;QO>Y[_>M?[K*99#PKP4?PHHP
MJCT ^9J23UQ0]P_<KG7W4YCDYIYZOY+Z[DPNHTCA2M1%!$*)#$M<(@ )JS:G
M9F(\>RKH"]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7Q)?YPW_;U[^9'_XO!\G?_?Q9?W[KW5</OW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NMRS_A$Y_V\0^4/_BE^<_\ ?X[+]^Z]U],SW[KW
M7O?NO=>]^Z]U[W[KW7O?NO=?(4_X5,_]OS_FC_U ?&K_ .!/V/[]U[K7R]^Z
M]U[W[KW6V[_PC"_[>O=H?^*0=N?^_@Z]]^Z]U]1OW[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]UJX_\*__ /MSMGO_ !9#HW_K?E/?NO=?*5]^Z]U[
MW[KW7O?NO=?=X^)O_9+'QH_\5_Z:_P#?=8WW[KW1@/?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U\87^?O_ -ODOYA/_BP&8_\ ='0>_=>ZJ!]^Z]U[W[KW
M6[9_PB*_[*\^:?\ XK?L_P#]^=3^_=>Z^D9[]U[KWOW7NO>_=>Z][]U[KWOW
M7NOGY_\ "YC_ (NO\L?_ +5_S&_]R>KO?NO=:"?OW7NO>_=>ZL._E&?]O5?Y
M:_\ XOA\2_\ W^V"]^Z]U]NKW[KW7O?NO=>]^Z]U[W[KW7O?NO=!_P!L_P#,
MJ^R__$?[R_\ ><J??NO=?!']^Z]U[W[KW7O?NO=?4Z_X1M_]ND-R_P#BX'<G
M_O#[/]^Z]UM?>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NM5W_A8?
MNJ+;W\H%L1),L;[Z^4G2>U8$8V-1+1XO<&]S"@_)"89Y/]93[]U[KY5/OW7N
MO>_=>Z][]U[K[17\AO;3;4_D[?R\L6RLAJOC?M#<H#7N5WG/4;P1N?PPK@P_
MP/OW7NK;O?NO=>]^Z]U[W[KW7O?NO=?#V_FF?]O./YC/_B]_R\_^"!W#[]U[
MHB'OW7NO>_=>Z^@7_P (9_\ BU_S.?\ J/\ AQ_[C]I>_=>ZW[??NO=>]^Z]
MU[W[KW7O?NO=?->_X6WX!Z;YK_#S=)6T>9^+67P"/I U/MKMG+9&1==KFPRR
MFU^+_P")]^Z]UI4>_=>Z][]U[HPGQ(W,FROE9\9-Y2S"GCVE\A.E]S23L=*P
MI@>Q\;E7F+?@*(KW_P /?NO=?=T]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7PYOYFO_;R/^8-_
MXN_\K_\ W_.?]^Z]T2#W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=;KG_"(_\ [+1^8_\ XJ_@O_?KXSW[KW7TG/?NO=>]^Z]U[W[KW7O?NO=5
M0?ST_P#MS]_,1_\ %8.P_P#W"3W[KW7Q9O?NO=>]^Z]U[W[KW7V^?Y3O_;K+
M^6G_ .* ?#?_ .!UVY[]U[H__OW7NO>_=>Z][]U[KWOW7NO>_=>Z0_9O6NQ.
MY>N]\=3=H;7Q6]>N>R=JYW9&^-I9R#[G$[CVMN7&R8G-XBOB!!\<]/*Z%D96
M4D,C*P!'NO=?&C_G,_RO=]_RIOFCO+HG*+E<WT]NG[K?WQS[%KH=2;TZJR=>
MZ4-!D:V)5B;-X*75B<W$JH3-$E6D24M;2E_=>ZJ;]^Z]U[W[KW1U_P"7G\Y^
MW/Y<GRVZG^6'3M2\N:V!F!!NK:4U9+1X;LGKG,,M)O?KK<)C#@TN3H]2Q3-%
M(:6J2FK8E^XI867W7NK4O^%#7\Z]OYLG>NR=M]-ONC;WP^Z3P]'5==;8W%3M
MA\SO#LG<F&AEWOV)O'"Q221I4TA=L#B(6DE$%-!/41.C9.HC]^Z]UKK>_=>Z
M][]U[HT7PO\ B)W#\[ODUU+\5NB\/_%.P.V-S08:GK*B.<X;:F!IT:OW5OG<
M\].K-#B\+CHJG(UTBJ7,<1CB229XXW]U[K[3WP5^&'3_ /+\^+/4WQ2Z0QWV
M^S>L-OQT=;G*JG@ASN^]X5[??;P["W3)!<29',5[S5<P#%(59*: )300QI[K
MW1N/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7P9OD)_S/SO#_P 2_P!E_P#O
M9UOOW7N@@]^Z]U[W[KW7TF_^$1__ &1?\R/_ !9_ _\ OJ<;[]U[K==]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_5W^/?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T"?R([\V#
M\9NH=W]R=D5_VNW]JT!>GH(7C&3W)G*F\6%VQ@X9#^Y65L^F*,?I1=<TI2&*
M1U--EVB\WW<HMLLA5Y#Q\E4?$S>@49/KP%20.COEW8+_ )FW>'9MM6LDIR?P
MHH^)V]%49/F< 5) .A5\C_D#O[Y0=P[O[E[&K!-G=SUO^18R"21L7MC;]*3%
MA-K82*3]%)10VC0D:I'USREII9';+K9-GM-@VV/;+(=D8R?-F/Q.WS8_L% ,
M #K/CEG8=OY6V>'9MM%(XADGXG<_$[>K,<^@%%%   !OT]FW0C5NNK?D?[;W
MZOKT\K=>^OOW3H/IUP((_P!;WNM>G W78/OU.G0W7,'WKIP'TZ]:_P#K^_ D
M=. ]=?3CVX"#U<'TZ];^G^V][Z=5^NO?NG@U.'7OI_K>_=/J]>MGK_A/-_QZ
MWRG_ /#@ZD_]UVX/<">]'^Y.W_Z6;_#'UB)]Z+_<S9O])<_\>AZV._<(]8I]
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7RE?E$?^<F?D5_XG
M7MS_ -^!D/?0+8?^2'9?\T(?^K:]?1S[>'_D ;'_ -*^R_[1H^@,!]FE.AH&
MZY ^]=. ^G7,'W6G3@;KD#[UTX#US!]ZITX&ZY ^Z]. ]<P?>J=.!NN0/O73
M@/7,'W6G3H;KD#[UTX#US!]UITX&ZY ^]4Z<#=<P?>J=.!NN0/NO3@/KUR!]
MZZ<!]>N8/NM.G W2WZZZYW[VYO3;_776.T-P;[WSNFN3'8#:^V,;4Y7,9.J<
M%V$-+2JQ$<:!I9YGTQQ1JTDC)&K,$MY>6FWVSWE](L448JS,: #[3^P#B3@9
MZ*]_YCV+E39Y^8.9;N*QLK52\LTSA(T7YL3Q)H%459F(506(!W)/Y:W\@;8_
M3O\  .YOFI2X/LWM*'[;*8+IF)X,QUEL2J%IX7WA*-4.X\E$;*U/8XR%]8"U
M_P"U4)CGSI[LW6XZ]MY:+009#3<)'']#SC4^OQG'P9!Y$?>,^_AO?-WC\G^S
M;R;;MAJDNX&L=Y<KP(@&&M(6\FQ<N*9@[HVV6HHHX(XX88TAAA1(HHHD6..*
M.-="1QHE@JJ   !8#W"I))J>N<3,SL7<DDFI)R23Q)/KUS]ZZKU[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U\27^<-_P!O
M7OYD?_B\'R=_]_%E_?NO=5P^_=>Z][]U[K:4_P"$RG\I+XB?S5MU_,/#_+"A
M[%K:/I/;W262V0.O][/LR2.IWYDMT4N?.4=*:I^X4IB:3PBRZ"'^NKCW7NMM
M;_H$ _D[?\Z'Y(?^CRG_ /K7[]U[KW_0(!_)V_YT/R0_]'E/_P#6OW[KW7O^
M@0#^3M_SH?DA_P"CRG_^M?OW7NO?] @'\G;_ )T/R0_]'E/_ /6OW[KW7O\
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MKZ!?_"&?_BU_S.?^H_X<?^X_:7OW7NM^WW[KW7O?NO=>]^Z]U[W[KW7S_/\
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MNO=>]^Z]U[W[KW7P9OD)_P S\[P_\2_V7_[V=;[]U[H(/?NO=>]^Z]U])O\
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MS(__ !>#Y._^_BR_OW7NJX??NO=>]^Z]UOF?\(</^/\ _P"8_P#^&?\ %_\
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MCBZ[_P"@@ONK_O'_ *N_]"'=G_1WO7^LQM7_ "FR_P"\IU<?=.Y:/_+6N?\
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M\!U?_P"A#NO_ *.]^_UF=K_Y3)?]Y3K8^Z!RQ_T=[K_G'%_FZ[_Z"".Z?^?
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M8NF\!FZ+5CNV?D!B/'D*/,B"H!%1A]FEH*Z5K".?+-1PJ\J4>0@'NO=?3?\
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M!'6[O$1'C"T^)=V+Y6EC]U[KY_?OW7NO>_=>Z][]U[K?Q_X1L_RQ*EZ[?O\
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MRY0^LF',6XK^E&?T5(^-P?C_ -*A^'U?/X<S7[4\F?6W"\R[FGZ,1_04CXY
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MJ<C4TE.S(DC2)[KW7VD.C>E.M?CAT[UIT-T[MJDVAU?U'LS [#V1MVCNZ8[
M;>H$H*3[FI?UU%3-I,]95S%I:B=Y)Y6:61V/NO="K[]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z^'M_-,_P"WG'\QG_Q>_P"7G_P0.X??NO=$0]^Z]U[W[KW7
MT"_^$,__ !:_YG/_ %'_  X_]Q^TO?NO=;]OOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KY>?_"MC^5O4_%7Y=P?./JW;OVW0GS&S=95;U7&TOCQVQODM#1MD
M=X454(QIC3=U-%+N2E=G+35JYD:4CAB#>Z]UJ)^_=>Z][]U[KWOW7NOHX?\
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MI99#5G8EF8^I)R>N76[[QNN_[E-O.]W$EW=W#%Y9I79Y)&/$LS$DGRXX  &
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MO_XOA\2__?[8+W[KW7VZO?NO=>]^Z]U[W[KW7O?NO=>]^Z]T'_;/_,J^R_\
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M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=:W'_  HL_DEXS^:1\?X.V.E\3CJ#YL]
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MR>6IJZRKJ93-4U554S%GDDD=F=W=BS,2223[]U[J/[]U[KWOW7NMUS_A$?\
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M\/Y'/:OS,W.V^=Y[F;KCXMXG,R4DV^*>.GJ-\;^EH91_$=N[#PU2K0QO"?\
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M/UD*K5Z][]U?KN_]?>NK!NO6M_K>_=/*_KUZ]_K[]T\&Z]:W^M[]T\K>O71
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MJ3_['??NO=;N'_"3KY_?,+Y[=._,7<7R\[RW)W?FNNNR^K,+LNOW'C-K8R7
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M[+00'NGX3?(?8-2RI]U'U?OCK;MR")R!Y!!-NM]DLX'.DM&E_P V]^Z]T<#
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M_P"W/W\Q'_Q6#L/_ -PD]^Z]U\6;W[KW7O?NO=>]^Z]U]OG^4[_VZR_EI_\
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M/PJV _ ]FT<<<*Z8E"CY='T*QPKHB4*/D*=-GT]N<>E(;KUOZ>_=/J_KU[_
M^_=.AJ==?3_$>]]/J]>/7?\ K^]=.AJ==?3_ %OZ_P#%?>^GU:O'KWU_XK[]
MTZK4X]>O;Z^]@]/A@>O6_I[O7IU7]>MS_P#X2J_\RQ^8W_A^=0_^\_G/>,7W
M@?\ <_;/^:<W_'H^L.?O3FNY[/\ \TKC_C\76V/[QXZQ1Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[K37_P"%6/\ Q]_PF_\ #;[Y_P#=IM/WDU]W
MS_<;=?\ 36_^";K./[GII9;]_I[3_CMQUJ/_ $]Y'!J\>LTU:O#KOZ_Z_O?3
MRO3J11U=3CZNEKJ25H*NCJ(:JFF3AXIX)!+%(I_J& (]Z95=2C9!P>G&5)4,
M;BH8$$?(\>K(-E[FI]W[:Q>>I]*O50!*VG4W^UKX?VZRGL>;!P2E^2A5OS[!
M%U UM.T+>7 ^H\NHPO;=[&[>V?R.#Z@\#^SC\Z]*G@^T_#ID'KC8CW;CU<-U
MV#[UTX#Z=<@?>B.G W79%_I[]6G3H;KC].#[WTX#UU;\C_;>_?;TZK=>^OOW
M#IY6IU[Z>[@UZ>5O3KOWOJ]:]=W]^ZL#3KWU]ZZ=5_7KW^!][Z>5O3KW^]?[
MU[]T\K^O77OW3G78/O75@?7KF#[UTX#UR!]ZITX&Z[]ZZMUR!]ZZL#Z]+GK;
MKK>7;F_-J]:=?82JW%O/>F9I,%M_$4@&NIK:IN9)I6LD,$*!YZFHD(CAB1Y9
M&5$9@COKVUVVSDO[QPD42EF)\@/\)/  9)( R>B_>M[VWEW:;C?-YE$-M:H9
M)'/DH]!Q+,:*JBI9B% )('6]O\)?B+L[X:](83K/ ?:93=5=XLYV5O** I4;
MNWC/3JE741O*!(E!2 ?:XVG8#QPKK8&>6>23$?FKF2ZYGW5[^:JQCMB3R1/(
M?Z8\6/F<<  .3WNE[C;G[F<U2[[>5CMTK';0DXAA!P,8,C_%*WFQH.Q4 -[[
M#74<=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?$E_G#?]O7OYD?_ (O!\G?_ '\67]^Z
M]U7#[]U[KWOW7NM\S_A#A_Q__P#,?_\ #/\ B_\ ^[K??OW7NOH6>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z^0I_
MPJ9_[?G_ #1_Z@/C5_\  G[']^Z]UKY>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z^BW_PA]_YD'\^O_$O]+?\ O&9KW[KW6\[[]U[KWOW7
MNO>_=>Z][]U[KWOW7N@K[MZ/ZC^2/5F].DN]NOMM=H]4]A8>;![PV1NV@3(8
M?+T$K"6)K766"IIY5CJ:*MI9(ZBEG2.HIY8IXXY%]U[KYI_\YS_A*[WU\.ZS
M=OR"^!^/W7\COBW&U9G,SUO30RY[OGI'' M45<=1BJ&,2[JP-*O,>3QT1R%/
M#?[^D:*GER4WNO=:AC*R,R.K*ZL596!5E939E93R"#]1[]U[KKW[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW5XG\I;^0I\R_YK&Y,;N3;.$J.EOBW1Y1:?=_R6W]AJU=NU,--4^')XCJG
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MVWOWV]/*_KUX'W[IX'TZ];^G^V]^Z>5^NO>^GE:F1U[Z?XCWX'IY6KUN?_\
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MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NM-;_A5C_P ?A\)O_#:[Y_\
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M(42REV(N?=>Z!_\ Z Y_Y0__ "O_ "P_]'3MS_[&??NO=>_Z Y_Y0_\ RO\
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M_P!C/OW7NO?] <_\H?\ Y7_EA_Z.G;G_ -C/OW7NO?\ 0'/_ "A_^5_Y8?\
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MW5LK+[!WD^U\E#A]PK@LU&(JPX?*5$%2D$]AZ)&@<#_4GW[KW6N/_P! <_\
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MW3JM3KKZ>_=/JU>'6Y]_PE5_YEC\QO\ P_.H?_>?SGO&3W__ -S]M_YIS?\
M'H^L3?O*FNX[3_S3G_X]'UMC^\>^L8^O>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>ZTV/\ A5C_ ,??\)O_  V^^?\ W:;2]Y,_=\_W&W7_ $UO_@FZ
MS/\ NGFEGOG^GM?^.W'6I!?\>\C.LP%;TZZM;Z<CW[IY6Z]]??NGE:G77T]^
MX]/JW7OK[]T\K]#;T7O/^[>ZEQ%9+HQ6Y#%1/K:T<&35B,=4<\#46,+?\'4G
MA?95NUKX]OXJ_$F?M'F/\O1-O]E]59^,@J\6?M7\0_R_E\^CT$?T]A0,1QZ
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M*W7O\/>^GE;TZZM^1_MO?OMZ>5NA6Z>WE_=+=M.E5+X\1F_'C,EJ-HX6D?\
MR*M:_ \4ALS'Z(S^R_<[;ZBV)4=R9'^4?F/YTZ+MXM/K+,E!WIW#_*/S'\P.
MC]$$?ZWL'\>@"&Z[!]^(Z=#=<P?>NG ?3KQ%_P#7]^!(Z<!ZZ^GMP$'JX-.'
M7K?T_P!M[WT\K^O77OW3P:G7OI_K>_=/*]>NB+^]UITZ#UQY'!][Z<#=;@7\
MG[^7[_LO>PXOD'VOA!#W5V7AHSMS$9*GM6]:; R*+40T;P2B\&6RJZ)Z^_[D
M$'BI#XG-8CXT^Y7.7[ZO/W-MSUM8&[B.$L@Q7YHG!?(FK9&DC!;WV]T/ZT[D
M>5]DDKMUHWZC*<7$RX)KYQ1Y">3-5\CPR+MO<5=8\=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7__TM_CW[KW7O?NO=>]^Z]UH\_\
M*$?Y8G^A7?E7\W.D]O>#J;M'/)'W3@,32VI.ONT,U4?M;O2& 6AQ>Y9V/G8C
M1#E&92]J^FB3*+V@YY_>=H.6-S>MQ OZ+$YDB7\'S:,</,Q_Z1B9HY"YE^KA
M&S7K?JQ#],G\2#\/VH.'JO\ I2>M87_ ^YQZDT-7KUOZ>]]/*_KU[Z^_<.G@
MW77(]^X]/*W7K7_P/OW3RMUU?W[IY6Z[M?D?7W[IY6Z\#^/>P:=/*WIUZWY'
MNX->GE;KWU][Z=5J==?3W[I]6KPZ]_K?7^GOW3ROU[W[IX'S'7K?T_VWOW3J
MOU[_ 'UO?NG@WF.NOI]/I[WT^K]>^OOW3RM3AUU]/?NGE:O7K?T_VWOWV]/*
MU.O ^]UZ>#=;GW_"5:W^C'YC6_Y[SJ+_ -Y_.>\:/?XUOMM_YIS?\>3K&'[P
MAK?[9_S3F_X]'UMC>\>^L=NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>ZTV/\ A5C_ ,??\)O_  V^^?\ W:;3]Y+_ '?_ /<;=/\ 30?X)>LN_NP$
M"TWD?T[;_CL_6I!]?]?^OO(GK*U6IQZ]>W!][!Z?#5Z];^GN]>G5?R/7OKP?
M?NG@W77T_P"*_P#%?>^/3RMUW]?K[UT\&Z]R/^*^]\>GE?KWU_P/OW#IY6Z/
MSTYO+^]NTJ>.JEUY?!B/&9'4;R3(B?Y#6M^3Y8Q9F/U='/L'[G:_37)*_"^1
M_E'Y'^1'0$WBT^DO"5%$D[E_RC\C_(CH5R/R/9>#Z]%@/7@??J=.!NN0/O73
MH/7+@_7WK(X=.!NN-B/;@:N.K@^G7OK_ ('_ 'OW;IU7IUU[]T\&\QUZW]/]
MM[]]O3ROU>E_)S_E^_Z;]YTWR9[:P8GZBZ[S/^_%PF3I]5)V)O\ Q<P=:R6G
ME%I\3A90'GN/'45@2G/DC@K(O<2^YO.7[IM3L.VO2YF7]1@<QQGRKY.XX>:K
M4X)4]8\>^WN?_5[;SRCL<E+ZZ7]9U.8(6' $<))1@>:QU;!9&ZVX_>.'6$/7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7__3
MW^/?NO=>]^Z]U[W[KW2([*ZXV3W!U_O'J[LC;U!NO8>_=O9/:^Z]O9*,O293
M#9:F:EJX&9"'CD ;7#/$RR12*DL;)(BL%5E>W6W7<=_9.8Y86#(PXA@:C_9!
MP1@XZ>M[B:TG2YMV*NA!4CR(_P!7#SX'KYG/\RCX%[V_E]?)3<74>;^_S/7N
M:^XW3TSORI@"Q;PV!5U;)2)53Q*L0RN,?_(,O JKIF03H@IZFG9\V^2N;+;F
M_9$W&*BS+V31C\$@&:>>EOB0^F*ZE:F17+N^Q;YMZW24#CMD7^%O^@3Q7Y8X
M@]5^?3_BOL7="-6KUZWOW3RM3CU[_ ^]]/*W75K?ZW^]>_=/*_D>O<'Z_P"W
M]^X=/*W77(^O^W]^X]/!NN^#]?\ ;^_<.G@W77(^O^W][!].G@W7?U_U_P#>
M_=P>GE;R/7O\#[WTZK==6]^Z?5J\>O?7_BOOW3RM3KKZ>_=/!J]=_7_7_K[]
MTZK$=>^GOW3ZM7KJW]/K[]T\K^O7O>^G@W77T]^Z>5^O?7_7]^X=/*WIUN??
M\)5O^98_,;_P_.HO_>?SGO&?W]_W/VW_ )IS?\>3K&;[P)K?;9_S3F_X]'UM
MC>\?>L>>O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZTV?^%6'_ !]_
MPF_\-OOG_P!VFTO>2WW?_P#<;=/]-;_X)NLMONQFEKO'^GMO\$_6I!;^G^V]
MY$]95J_77O?3P:G#KWT_Q'O8/3RM7KOZ^[ ].JU/LZZ_P/O?3ZMUZW]/]M_Q
M3W[IY6]>O ^_4Z>#=>M_3Z>_=.JWKT)G4^\O[G;MHZBIET8G)Z<9EKFR1P3N
M/#6-^!X)-+DVOHU@?J]H=QM?J;8A?B7(_P WYC^=.D6ZVGUMF57XU[E^T<1^
M8Q]M.K!?Z&X(/T(^EOQ[!O0!#=>(O[V#3IP'KC]/K[WTX&ZY ^Z].@^O7._]
M?>NK@^O7$C^GNP;R/3@/7OK]?]O[O]G3BL1T=+X)?#C=OS1[PQ77V+^[Q6Q<
M']MG^T]Y0Q@Q[;VE'4:7IZ2616C.2R+*U)C82K7<O,R&"GG90OS=S/;<K[2U
MY)1IGJL2?Q/3B?Z*\6/I0<2.@1[A\]V7(?+S[G-1[F2J6\1_T22G$^>A/BD.
M,44'4R@[VNPMB;2ZPV7MGKW8F#HMM[/V?AJ+ [>PE A2FH,;00B*%-3$O)(U
MC)--(S22R,TDC-([,<2+R[N;^ZDO;MR\LK%F8\23_JP!@# QUSLW+<;W=[^;
M=-RD,L\[%W=N)8FI^0'D *      #I6^TW2+KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K__U-_CW[KW7O?NO=>]^Z]U[W[K
MW5=G\S?X![._F$_&K.]7Y 8_#]H;8^[W7TGOJJBL^U]\P4A1<=7U,2M+_",P
MBK0Y6)5<!#'5+&]124^D8\C\VW/)^]I?)5H)*),@_$E>('#6GQ(?M6H#'H_Y
M<WR;8MQ6Y6IC;MD7U7U'])>*_F.!/7S0^P=@;QZJWQNWK7L+;^0VIOC8VX,I
MM?=>W,K$(J_#YS#5;460HIU4E6TR(=$D;,CK9T9D96.;-G=VU_:QWMFXDBE4
M,C#@5(J#_L<1P.>LA[>XBN85N;=@R. 01P(/#I'?3Z?3^GM3TK5^O?7W[IY6
MIPZZ^GO?3RM7KUOR/?NGE:G7O\/?NGE;TZZM;D?3W[I]6Z[!]^Z=5NNK6^G(
M]^Z>5NN^#_Q7W<'IY6IUUR/=N/3RMUW;^GOW3ROZ]=?Z_OW3P:G7OI_K>_=/
M*]>/7O\ 7]^Z>#4Z]]/];^O_ !7W[IY7KUU]?^*^_=/*U.O?3Z^]]/!J]>M[
M]T\K^O6RS_(8_F =+_"3K_Y$T/;F![)RK]C;QV'5X";8F"V_EZ>--L87(0Y.
M/(OF\MC61[UT!C$:N"+W*V ,(^[/*&Y\T7ED^W/&O@I(&\1F'Q,M*:4;^$^G
M4*^[7*.Y\TWED^W/$O@I(&\1F'Q,M*:4;^$^G5_!_GU?#,?\P9\AO_0*V%_]
ME/N(_P#6EYF_WY;_ .]R?]:NHC'M)S,?]%M_][D_ZU=>_P"'ZOAE_P \9\AO
M_0*V%_\ 93[]_K2\S?[]M_\ >Y/^M75A[1<SG_1;;_>Y/^M77C_/J^&8_P"8
M,^0W_H%;"_\ LI]^_P!:7F7_ '[;_P"]R?\ 6KJP]H.:#_HMM_O<G_6KKW_#
M]7PR_P">,^0W_H%;"_\ LI]^_P!:3F;_ '[;_P"]R?\ 6KJW^L[S3_OVV_YR
M2?\ 6KKK_A^OX9#_ )@SY#_^@5L+_P"RGWO_ %I.9O\ ?MO_ +W)_P!:NMCV
M<YI/^BVW_.23_K3U[_A^OX9?\\7\A_\ T"MA?_93[]_K2<S?[]M_][D_ZU=6
M'LSS4?\ 1;;_ )R2?]:>NO\ A^SX9?\ /%_(?_T"MA?_ &4^_?ZT?,W^_;?_
M 'N3_K5U8>R_-9_T:U_YR2?]:>N_^'Z_AE_SQGR'_P#0*V%_]E/OW^M)S-_O
MVW_WN3_K5U;_ %E>;/\ ?UK_ ,Y)/^M/6N)_/M^;_4OS=R_QFSO46#[!Q./Z
MVQW:>)W!)OS#8+$-+6;LJ<#68I,<N$R>2#C1CJDR&0QD6&D-<VFKVCY6W'E:
M.^BW%XV,YB*^&S'""0&NI5_B'"O4_P#LCRCN?)T>XP[H\3-<&%E\-F;""0&N
MI$_C%*5ZUY_<R]3X&KPZ[^O^O[UT\KTZ][WT\K>8ZZM_3_;>_5Z>5_7KWU]V
M!Z>#>8Z]]/=NGE>O7K7^GU]^Z>5O3KU[>]]/*WIUZU_I[UTZK4Z/?TEO/^\^
MTXZ"KEUY;;HBQU5J:\DU'I/\-JS?DW13$Q/)9"Q_4/82W6U\"XUK\+Y'V^8_
MR_GT"-ZM/I;OQ$^"3(^1_$/VY^P]#';\C_;>RS[>BM6ZZX/OW#IT'TZX\CW;
MCTX&ZY ^]4Z<#=<@?=>G >EOUOUQO'MW?FU.M.O<)4[BWGO3,TF"V_AZ0 /5
M5M6W,DTKV2&"% \]342$1PPH\LC*B,P37E_;;;:27UXX2*)2S$^0'^$G@ ,D
MD 9Z2;GNMCLNW3;KN4@B@@4N['R ^7$DF@51EF( J2.M[WX1_$/9OPSZ/PG6
M6WQ293=5=XLYV7O.* I4;NWE/3JE741O*!(E!2#_ "7&T[ >.%=; SRSR28E
M<U<R77,^ZO?S56,=L2>2)Y#TU'BQ\SC@ !SRY^YUON>N8)-UN:I"M4@BKB.(
M' ]-;?$[>;&@[0H!O_8:Z!/7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=?_U=_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=:
MMW_"AC^6)_I8V;6_.CI+;WD[+ZYPD4/?.W\52WJ=[];X:G$=+O\ B@IQ>7([
M=@4)7,REI<6H8NHQT<<L[>S_ #S^[[D<K;H_Z$S?H,3A)#QC^2R'X?23_3DB
M1^1>8_I)AL]VWZ<A_3)_"Y_#]C>7HW^FZTD?I[R=ZF)6KUU;^G!]^Z>5_7KW
MOW3P;TZZ^GO?3ROU[@_Z_OW#IY6Z]R/?NGU:O7K7^G!_I[]]O3RMUT#[]T\K
M==V_I_MO?J^O3JOUX'_D7NP-.GE;TZ]].1]/=ZUZ>5J]>^OOW3RO3KKZ>_=/
M*WIUZW]/]M[]T\K]>!]^Z>!].O6_I_MO^*>_=/*_7O?NG@U,CKKZ?XCWOIY7
MKU8/U!A?X)U]@(F33/D(&S%1Q8LV2?[B L/ZB Q*;_T]A#<9?%NW/D,?LQ_A
MKT%MPE\6[<C@,#\O]FO0F ^T/20'KUOZ?[;_ (I[]TZK=>!]^Z>#=>M_3_??
MZWOW3JOZ]=?7WOIT'TZX\C_6][X].*W7OK_OO][]^X=/*_77T^OOW3P;H/>T
M]M_WHV1F:&./R5M+#_%,< -3FLQX,PCC'^JEC\D(_P"#^UNWS_3W:N>!P?L/
M^;CT9;9<_37B.3VGM/V'_,:'\NJ\/]?V,^A^&IUU]/\ BOO?3ZL#QZ[^OU]Z
MZ=5B.NOI_P 5][Z?5J]>_P!X/OW3JO3CUZ_X/NP/3P->O6_I[MT\K^O7N#[]
MPZ>#==<C_BOO?'IY6KT(?6.\&V;NR@R,KE<;5'^'Y=1?3]C4N-4^D?4PN%E'
M%R%*C]1]H;^V^IMR@^(9'VC_ #\.DFYVOUMHT:_&,K]H\OSX?GU8>K*RJZ,K
MHX#(ZD,KJPNK*PX((^GL&4\NH_#9H<'KE:_TX/OW3JMUU_@??NG@U>N)%N1[
MW7JX/7@??B.G5;K< _D__P O[_9?-AQ?(/M?""'NKLO#1G;F(R5/:MZTV!D4
M6HAHW@E%X,MEET3UY/[D$'BI#XG-8CXV^Y/./[YNSLVWO6U@;N8'$L@Q7YHG
M!?(FK9&DC"_WJ]Q_ZR[@>6]GDK86K=[*<3S+@FHXQQY">3-5\C01=M[BSJ!N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[K__6W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]UBG@AJ89J:IABJ*>HBD
M@G@GC26&>&5#'+#-%("K*RDJRL""#8^]@E3J7!'6P2#4=?/*_G=_RRYO@UWK
M_I,ZOPDL7QB[OR^0K]EK20LU#UIO617R.=ZMJ9$NL5.%\E;@"^DO1B2G7R/0
M3RMF#[8<[CFG:OHKYO\ 'K4 /7C(G!91ZG\,GHU#@.!U./*',/[WL_I[EO\
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M^RS=I?#M-(XN0/\ +_DZ1;G,4M2HXL0/\O\ DZ/+]/\ BOL+]!U6KQZ]]?\
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MO?7W[IX-YCKKZ>]]/*]>O?7_ %_?NGE;KU[>_=/*W7K?D?[;W[[>GE;KP/\
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M^]@]/!@>EAL3=,VS=T8W.1EVIXI/M\C"GUJ,;4$)5QV_+ 6D0'C6JG\>V;N
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M?5J]>M[WT\K4P>O?X'W[IX-URCBDFECAA0R22R)'$B\L\DC:451_4D@#WHD
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MTJQH?^#>T>X2^%9NPXD4'YX_P=4NIM%NQ'GC]O5AA%^1[!]>B('KC_@?>^G
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M_ /\O2+<),+&/M_S?Y>C8 ^P_3HO#=<N#_K^_<.G W7#D>]\>G ?3KUOR/\
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M31*LLLM(L4O^U/._[@W#]R;D]+.Z8:23B*4X#?)'PK^0.EL -45<L[Q]#/\
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M+\KNF-O?;]!]T[AF.\L)B:73C^JNV,HSUM73QT\(TT^'S["6KH+?M4]6*BD
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M';>Z]IYK)[<W+M_+TTE%E<)G<+6OCLKBLC23 -'/3SQO%*C"X92/>:$$\-U
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M[NJWYT?X>X$]^KG1M%A9U_M)G?\ YQII_P"LG4)^]]SIVJQM/XY7?_>$T_\
M63K=A]XP]8W]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__0W^/?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW4+)8W'9G'9##Y>@H\KB<K156-
MRF,R--#6X_)8ZN@:EK:"NHZE6CFAFB=HY8I%*LI*L""1[LCO&XDC)5E(((-"
M",@@C((/ ];!*D,IH1P/6O1W'_PGXZPJ!7U?QL[7RO7%.9JVKQ>P=]8E-T;7
MH/NZIZI,1B]R8IJ7(4='#KT0FIILA,% #R.Q+>Y>VWW;OEHN]6XF. 9$.EC0
M4J5-5)/G0H/0#H56_-,PH+M _JRFA^VG G]G53/<_P#*;^</3!JZJ7J:?LW
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2_=>Z][]U[KWOW7NO>_=>Z__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>fldm-20200930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:fldm="http://fluidigm.com/20200930"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="fldm-20200930.xsd" xlink:type="simple"/>
    <context id="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie22f33a35cf745b0a81fe1558fdc9dbd_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="icc600eac6fe343ec8d22cf6dea665c5b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i63dac85b57b74b8ea053ca16f3171b97_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if32b1e8a019b42fea7b915507e3650c8_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iedd975972ec54477b7d1edc9dcd0e9ae_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id978df8be0b2445ca43d804b18f99d88_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iea38c8e677cb447a95163f4ee5133194_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i38d8014ca50e40ea95a3204f7d46b5a7_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie4c104320701492cab8cff2d9393f868_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i64595cdf77c94fb899f02002ee32e32b_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ied63bbfdfbdd4d17b689fb84bd615a22_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:CollaborationRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i33305dd63fcd4c7b827cced58c13da0a_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:CollaborationRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib7451c9afcd847cda97b00adbdae3f05_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:CollaborationRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i86ecea94f14744c580bbf02abb8493f8_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:CollaborationRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id1eb2e1b7d5c4eeaa06d2bbb0f149ea2_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i507e1652ea0c4fb1b2d67aeec5653728_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6cb05eac3b154d7798dda674fcc015dd_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6188317019ad466c8b5326b1720b484d_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="idbea30ceb41f4d23b750317c34a1821d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idb6dc60b8a3d4ad7aad987d15b284ba8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iacf13335933a47178e0765e3e574fd1e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3689cf18c31b470096fb83d4554d4782_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifc0e648162d14d4a989f9ef273403334_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic59bca928d1a49b4afeb85ec17e11c85_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i36c4cb3e31604770b06e9f2af6bc483e_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i903ebee619a74d21ad02859fe06eab6b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8a2616563d5a4bf89c8fd60f83692c9c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibc5ef7f40aa14d038c66e7a001196cf4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i825a8299b5f54c08a2883e0433b958bd_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="id422164ca6d94e2e8c2996678b723f51_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1d2d48c8e5c3470aab6bb7cb60d28da5_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i670b6d125a2743c08d4f1fb8430f5363_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="if10319fa5a0a46069beb6a1617e9f6da_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ibfb2229b05674790ae2d1f3af5d1a49f_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i97dd927c2f794a548af4aa13566b425b_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i7e3fc5b723344c56acd377344374f431_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i9523a3afd1ad4cae8e97ae81c5b0ed5b_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ibc7d24911d4349cd97850e4e2f548bc4_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ifa0257e64d8943b3aaf914e3e8b12824_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie18fac1bb2c44c8b98f020e75b62badd_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3d8ba5cd36dd447cba44d5143adbb7ff_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i9edab7afab564a09b7d72cd4c082b2f5_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="idc294b4f830b49dd8ecde477cdb866de_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i3871bafb7b75405199d644b44fa3429b_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i8f326510b71a4deaa593f4283e018c5a_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i2c632cc5576242fab0816f314eb6446f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iae5604185464427688d8d6538b0064b8_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i95bfaeccfec4464a937794e5c3340391_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i914a38e1ce8241ef9a128a191d3a503c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i21d4b3ca64494bd286868cbca12d4736_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0d88028473ce421e97253b37a085c9e7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1c27fe0a0d9a44659e8415f944fc0c03_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if25548e8d7ec4e77ab7481b4e6c75c64_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i15f7cdd5345a4dc1b08684ff2ea04b58_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="if7e2f1181ae54e4b90452df5f1cf9b06_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i4be4fa2cf5014c1bb4baf526bd96dec8_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i5bd1ce88d5fa454a8d4dad452aa7cf9c_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i4f51ec45ffb24e5f9fd56e8ed689edf8_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i72b360b54d1e4205854b7f3e6a0724de_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i006e76de3dab42169ad0c46b3b037dab_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i4fa0d20dd1f44516b4524fc6b0a6ad86_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ic90d17da59fa4e799e7084567efe5328_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="if46fa428977348b594b019217c905309_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i67c00423ce714ae287a3c1d8bec497ad_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i762d0930982d49b1b7f455398759b828_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i28fa2add73b04911a549411241057bc3_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i1627ca022cf54d98a6481fda43a44841_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i83369a9b2fda4053aa441b96d2bb50e2_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="iab67de1396ff47ea8462d8bc17240232_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i8f25eadecc464dbcaa3a44c5bca043bf_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i10aed62e1a344f72932514716243a2f3_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i0de2145a374c410095bc37bc5d98afc0_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i01c50ded41e34c848e04a247fa124bd3_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ia605d1ab95f846f0a9f63de67c948fd4_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ic3b58d4f02e844cb988b744432f0e0f9_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i43b1f7df8afe4a64be00a01331b55b55_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i69bd8f22916f463b9f97b4855c9980e9_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i813b7fdc72d64db19cd209236a971747_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i632b1c03d2644d748bb6a03e0f90c982_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i8d08643e37974cfba86f788447c6f6e2_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iaf04055382af45aca35807748405a7fa_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iab02e207f49f4cb8bf2279f9e687111f_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2d98876aa25d4522b3599841a5fc587e_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="if4c2400e4e364dc9b526d08b10e59300_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i14df96aacd544435a5bd5f0a00f0fa84_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="id976dd8bd6b34f3b9a6b24612ef2d5bc_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="ic00370e08713445eacc3076d8d3e2ced_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i4101cc4ce01446f6b62b021b3dbb5704_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4329505554d74bb8bd0456959ea7b9d9_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia193ed94f89f408ab31b7ae2e68ec878_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0f2c6e8ac0b0407b9dcbc0fb91830d02_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifb7c86dd6e67421cbc4e92e76dcf85bd_D20200301-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">fldm:IntellectualPropertyInfringementClaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i7fc39d91e80e413683ccff3b0727279b_D20200301-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i51f17d522ac148c68bc6b818c1014f68_D20200301-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i57729bb7112d4134be2670ea3e309064_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">fldm:CommissionCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i261b1732f7d64d5ca4da0ff8446c81ce_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">fldm:CommissionCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4c26186ae0bf4d6799d6b7bcd5a15cd7_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">fldm:OneCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:DevelopmentRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ieaa80a8a61d943508698a74efef90b12_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">fldm:OneCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:DevelopmentRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i761f7b389ced4f93be18b27ca86ce004_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">fldm:FiveLargestCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i40175ade607f4de5b40b93529bd75aa1_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">fldm:FiveLargestCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib9ec2d4a080349c7820e11d6b38ab5d3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">fldm:FiveLargestCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic252519a5f1b45f3853a2e0071c6dcc7_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">fldm:FiveLargestCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9ad72ef114054c68ba1d7499333b66b9_I20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <instant>2020-09-28</instant>
        </period>
    </context>
    <context id="ifa53719e19cc4a179c2e811a860e7411_I20140228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-02-28</instant>
        </period>
    </context>
    <context id="i426efa56430840c1b19eac7bd8d458cc_I20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-31</instant>
        </period>
    </context>
    <context id="i3111d806397142758e8cb5ee0d0eb9e6_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i3ac00b245134442884f3defdcfc7fae1_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i9b34d835daa64fc59dd63f13ee337947_I20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-30</instant>
        </period>
    </context>
    <context id="i48e1ed537f2e4db1b0713b2e240b93fb_D20191101-20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2019-11-30</endDate>
        </period>
    </context>
    <context id="i23b95cce717045feba062bba6e018b4e_I20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-30</instant>
        </period>
    </context>
    <context id="i32b55c5ab8514931aa3c38ad7314012a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i522074f70914431c93eb1fb60866c897_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4664c6ae00ef4abf82e3edabaf2c670a_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ie36983d4e5c64db793c5d3166fe61fa4_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i69ebb284db184ca8bdf4d66d0dff3121_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ifa27eb06261444ae9b065f2110889263_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i1ae09a39637843f6a26b4e4e0127ab7d_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i527a5548d615414180d912a5102a2912_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib06456778615411fbbea453bd61bcfdc_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i82ce3762aa614b6ebe557f7b073bebe4_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i80cf78799b76440ea86f5da1c2493062_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id07a1b059c244e2399380a15a12a57c5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i00a783530ec64310a75d4833347282a5_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i377c087ac7164a9897550043dca2a0e6_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i83297b8f97a34354a79b62e5e754b631_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i59a12e7ed1b243b496ec5f9736293ba2_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i76daca0d7ecf4e55b49f9ef61b74d961_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:TwoThousandAndNineteenConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i547f784eb6974c818432924005a65edd_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:TwoThousandAndNineteenConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="if0007477bb8545a8afa0513c08a9049c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i75455403764249069c09679d89b70c29_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i537a3353f9d94a15afb6333fd0f64d0c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:TwoThousandAndFourteenConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i634dc22add2d4eb0a343c30ed934f69b_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:TwoThousandAndFourteenConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ibccd6f048dc74a6c953e619b2a9e9ea6_D20200117-20200117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">fldm:InstruNorASMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-17</startDate>
            <endDate>2020-01-17</endDate>
        </period>
    </context>
    <context id="i879547fef02c413ab97b1073b8418853_I20200117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <instant>2020-01-17</instant>
        </period>
    </context>
    <context id="ic833fc7e7ff14f309dbabe622e99c8de_I20200117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">fldm:InstruNorASMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-17</instant>
        </period>
    </context>
    <context id="ic1f96d93c1f9456eadce09f1a0df997c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="idc94006eea6b434ca69524643dc9911e_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2d0a47c0cefc4e1db4ee8e02eca066a9_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia24e4dab3a1e4846aed1d65d31ca64e9_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i856788a23f0e421e9c4f6bfcd2937c25_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie818350e13f1407c8991ea709abe673f_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i36a9b9de3bfd42a795635e6c4734733a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iceddf551be474cbfa9d1febcb7e64631_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2c769151da2142868115a7ca0373be74_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8c7ed6ed420047e1b49b17f97ea91343_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ibb3c7d9e2c814e0e8399d92211de70ff_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if0b62a4024244e348817dc10a1f4ca62_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9557da47acfa4592bd8a6eb4d01dbcac_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:InstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i10f3f219918f49f0a4aaeea16520869b_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:InstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ifcec3908df424a9b994b171239c3ad23_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:InstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i65e54d66980042b78f398dff2722c68c_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:InstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i1295e00055ed464589bdacaa5e07480f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3749711354f04142930ba804e3127822_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="idd2f4f0a6d4b4ccbb836a1200a172bdb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i997fea8ff4474842a30928a2e82a8b6e_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i826fe1457ec74796bbc8e35e49f0de7a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3b9fcc905d1e46f5ad329420385ba4f7_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i48f7db29c2964b2fab7a487953e7132a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i05f132757b684062b8a1afe7a0434252_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i27c25df473b54c1d8ffbd994b10b9e7c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id0c099e000eb4fe285d40608c7ab5954_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i611ead10ea7746c88a251afc99eef27e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id6eb5cddfd9a4a429b59d0409dc55f67_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5b8ca235d25d4be7b24f48e1d7b063c2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2020-10-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ibee58402214d46c9b90764b31cb5bb82_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2021-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie8df7afdb66042e49508527a5cb31fa1_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i6080b667adf249898c3e460f95952085_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i4597ae00a444403dacaf5086f59bacac_I20140228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">fldm:DVSSciencesInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-02-28</instant>
        </period>
    </context>
    <context id="ic6b361716cf04338b59854e72cf943b0_D20140201-20140228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">fldm:DVSSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-02-01</startDate>
            <endDate>2014-02-28</endDate>
        </period>
    </context>
    <context id="i0baca80d39e748b7bcbaf3ac214f583b_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">fldm:InstruNorASMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i62aeb047eea249e8a505e86f7dbd1080_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">fldm:InstruNorASMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="id93cbf33dc99482fbdd7c3492d9fd706_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i448598bde68f45d1ba361f740dd9f13e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic4d4f73bdbe84c6cb586dc7a3922ccec_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">fldm:PatentsandLicenseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2f1a0048873a41439f03f292dfd42431_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">fldm:PatentsandLicenseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4a2e644816c049b1a4a674aba901cf89_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifb41af4444ce4ac891cf86ca937bc359_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3f4c794c8ce04cb098b7c1033bc0c119_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">fldm:PatentsandLicenseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i863d909053654a5097e30eaeb582a60f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">fldm:PatentsandLicenseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8bbffea3402e4561b1e8ab6fc7c2bc4d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i62ab5d72d0304d8f95c3a6e3503aa15d_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i4662072a04b84dfea208dcc931393b9d_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iff7244c4435948719187b0a6db553efc_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">fldm:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7ecee074f6a34af38aebd80a676157ca_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">fldm:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i01205e4ce2b043afa5ff5d22df71e7af_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">fldm:LaboratoryAndManufacturingEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i91971e3a302e4ce4a2fa240ccce4fd9f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">fldm:LaboratoryAndManufacturingEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8b83a6bdbb5d4e1b9fb3f33d02641612_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i419524240cb046929a4263a9eb516164_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib48332e9db7f4b1cae5ea5950a5b520a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib0266b792ecf4882bcc51181909743f4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i266ba35bf50e46ca809c2c0afea3c12e_D20140201-20140228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-02-01</startDate>
            <endDate>2014-02-28</endDate>
        </period>
    </context>
    <context id="i901752533bd34a9a91d8a9858d1558a3_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7cf57a0407f34c83945d84ded692dd5e_I20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-31</instant>
        </period>
    </context>
    <context id="i70f4e685daae494d9cca4f8a847b35fe_I20180312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-12</instant>
        </period>
    </context>
    <context id="i153e522b034a4cdcbce58b6ee2e543f6_D20180301-20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-03-01</startDate>
            <endDate>2018-03-31</endDate>
        </period>
    </context>
    <context id="i4e7aaefc048a42149aea7d5215e3344e_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">fldm:TrusteeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i2cad803f6a554d6c9a8a592ef9a317bb_I20190228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">fldm:TrusteeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-28</instant>
        </period>
    </context>
    <context id="ib5cf93a475bc40c383848b0c6ddce383_I20190228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-28</instant>
        </period>
    </context>
    <context id="i9568f571b19e40a9ae266303330ceee6_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="icd70bc4d28f3483ba710eda050328360_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">fldm:TrusteeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i5c04b2fe57fb44e19f764085727f7dfc_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ic24a6649e6b74cc5ac3591a7f4087baa_D20191101-20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2019-11-30</endDate>
        </period>
    </context>
    <context id="i283104e8693b4a0798cde8043a32a819_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i52d079e3857749d3ae194474f9fd3966_I20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-30</instant>
        </period>
    </context>
    <context id="i929bb4c9acdd42b2a23fb169207c1a68_D20191101-20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2019-11-30</endDate>
        </period>
    </context>
    <context id="i9bc0b6e687014f408106f0f70ddbb047_D20191101-20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2019-11-30</endDate>
        </period>
    </context>
    <context id="i0880c31bdb2349949c55fad2b57d1d5c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id881c17013fa4c2ba5f1f0618b5dcb03_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i6106e4be78de4e3d82d9ce346c18dd6d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3c17219e8d044f0c861d706caf153722_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2c6c4c342964442b8318f2e869e57561_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i989719e68b6f4b5e9cfa93a8c07dd96e_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="i17eada3644a34f059d1bcbfd779f95b7_D20180801-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i1bdc25d355644c6f9172d331aa5efd27_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i53d97ec6192a48d09c54804db8566219_D20180801-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="iafb598ed96e949659e7f73e00e9c6bbb_D20180801-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i3876be73e4a0486f968bd16f58652b42_D20200421-20200421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <startDate>2020-04-21</startDate>
            <endDate>2020-04-21</endDate>
        </period>
    </context>
    <context id="i9ad788af389e495fbf8a9625e4693669_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i90329f25a47f4987b6c5028226f49c7f_D20191101-20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2019-11-30</endDate>
        </period>
    </context>
    <context id="iae5da18636984c8688424ae820893260_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2b70060a9d624550994ac1dfff5b7ef1_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i151e8307ce6242f184098e1f36b5547f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i38ab737fcaf84f2aa05da79a61e26690_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6737de729bd64f70bd4ad7bbc31e49bd_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="idcdd71a5639445c98dc5fca10293c9ee_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5e18a8db5c42483eb2fc3227bf81e1bc_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i280bb003acb74672b814ebca8eb8d86c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6162a93a7603404baafc5676dff7d019_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="id5eff83c101c4f12b196d0f171c521dc_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i4fcc88cfdd4a41b8a7adcab32fd08549_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">fldm:RestrictedCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i37f15e5bdea442009df048b62f08f96a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i29ac583d810f4a91a7b25c3ca9dff3f8_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic036c6e4072e4f078642894c02e6a2b2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i183046f58bdf41d8884897ea6e6cf0af_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">fldm:RestrictedCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5f7f6ee0988a4bdba5cf8633c5e65b6e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i681f2afaf9324c6a97f01c2538888b09_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibc62fa7bd73e4eae81ee6e9258a1d986_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ief09788b1d7b41ddad84a806425db48f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie61b59be16e3451fbb4832bb215eaefa_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i34fa6e2b348a44feba0389d8f9e424b4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i807edf5453ef492d89797af2d92ce323_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i06f63608f6e14bd49a545fbfd1a0bb51_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i84de06c926844e43876c040386be167d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ia3c3d82adad646dbb37ebc978e243f31_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia6b4b841ac1e4d6eb459e46913612d7a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i53a339bce2b7419593141ef24bbc8bed_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ibe0d0e9dffbd495fae18e77547f3d88c_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if34280ce49a6438a9aba047d76278cbc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9ef442f5f71545048e77e64914ccc44a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9ef4d07044c44fb9900a21ed9c2b3e8a_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fldm:TwoThousandAndTwentyAtTheMarketEquityOfferingProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ic4d47fe556de4b5a85e774b65e566c18_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fldm:TwoThousandAndTwentyAtTheMarketEquityOfferingProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iff9fa89f0d3e4906b1a6686b38fead1e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndNineEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i98ff5d8d443c4c78babb4c655a8e6efa_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">fldm:RestrictedStockAndPerformanceShareUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndNineEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ia3da57b8f28d46aa9eb2676696423f21_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndNineEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9bd22d380b1a4d6ea4fd44b27e0141f4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndElevenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i638e57cbaa7d456f8b185da5205acb2f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">fldm:RestrictedStockAndPerformanceShareUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndElevenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i4ea312f66de54b4e9c6d400430165a3f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndElevenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5fabe06699de401a840160fc6badcdb3_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndTenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id13d013dd44e44adb532dfeeae35dbb5_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">fldm:RestrictedStockAndPerformanceShareUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndTenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iafad09c62b1d4a0c9f23fde9d0b1485c_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndTenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib0b9e4ec81a9465d991e4f00f8bdb0ce_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndSeventeenInducementAwardPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1d7a0bcaab4e48bea67be674fa9e6cdc_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">fldm:RestrictedStockAndPerformanceShareUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndSeventeenInducementAwardPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="idb080589897242f4a5db6a13881cbb4a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndSeventeenInducementAwardPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i8d050d829f6246668dee88b2edbb05f9_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ied741f884347441db18e2bd390ba3411_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">fldm:RestrictedStockAndPerformanceShareUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i241d9546e6e84c83986e1cc5b11f3c0f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7de5c3aaabc04d038a06ae0f7741f31f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iefea4fc822cc4bf48772c4ff54bacc58_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">fldm:RestrictedStockAndPerformanceShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i52a11bc3f5e44d13bf15a18be4a29d8f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i263f694376794abc814fc456f821bbd2_I20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="i3b04e9f77df54a0b9e2eb4b34d0fc115_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifa1dea2f8c814e519c099b477d05617b_D20200501-20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <context id="ibce292aab63145e2bc9d3e50b05a5089_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1284d595ff29438b8ddea2c07841e004_D20200501-20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <context id="ibfd04ed28b304350bca273167b0b25b1_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8149995fd4334ebd8d795406a38a6aa0_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">fldm:AwardsHeldByOwnersOfMoreThan10OfCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i86d0a118c5b6489788d92ddc7d23fbd6_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib3e373d05502431a8c7dc9abf1ab0362_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:EquityIncentivePlanTwentyElevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i8fa5a801a597442f88adb537d10639f1_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:EquityIncentivePlanTwentyElevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i2a6bf5ef9a12484b86b93a4e3f7508a8_I20170131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:A2017InducementAwardPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-01-31</instant>
        </period>
    </context>
    <context id="if3575d83de144e808258ee710b5e28d6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib711ac2faf28446d9e3400f0d3bd6600_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if5379688acd14de7b8f11138da8190d7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i43caef91ebc84c58affb994dda276bd2_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic5115d69f217430288b67bde40c9b1dc_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i61c3102478484d46b94add36424eda3f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i32afb092bbb44b9b9f083571429c2990_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie07832375f9440358e7271a1d7a2f6c2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icae4702ca6dc445a8b04b4ce1f0e0fd9_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i44e0332a734548d5b4a5b0f2a9cd04b5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">fldm:CertainEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i76eddca721de44d59d30a86ae6150eae_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">fldm:CertainEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if76795b7980f4cf1b2d2d91e17de5300_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">fldm:CertainEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9dad88f3165a4f0eae5db5d9dc24638f_D20190531-20190531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <startDate>2019-05-31</startDate>
            <endDate>2019-05-31</endDate>
        </period>
    </context>
    <context id="id735d6be492745c7b536c828704a562f_I20190531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-31</instant>
        </period>
    </context>
    <context id="i2e63e5ad862548fb846d042a7966af01_D20190601-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <startDate>2019-06-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i5cf64713f36146589fe70c417cb48244_I20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="iec50ef8ea8764ccc81da85f1d3289c10_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ic6bc844ecc89460581bfb369e1d5f54c_D20190601-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i12094595ba954861a1470caab2024faa_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if87552129e8440cebc8cf50867ede516_D20200601-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i28c40c94918f4477a5ef78ff4d1aaa6a_D20200601-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic4e3f90a457a4d718ca93f052c881c93_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ia4856057ff874e7e95190bbf158b2cc5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0b89a3284da34463afa07821cc02ca87_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i73d9e7c6273e4f8d91c0d44a383a2ca2_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i478d956acce94a509514c698c820bfdc_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i0ce4b9d2150942418669ac5b5403bf4e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1826be0f06d44338b008edc9592cb9bf_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iefccdb36374e4d188b0f54d8e13766ac_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6205bf705fb745b9b232a8a68ddc2049_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iaff11e46a2f34810b12b962e4ab4033d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i028e85ad01cf4114b46ee8d96cd7d003_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie397e48475d94899ad01bc3593897a72_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i37d450f4eec141f1aa6f1972f269f72d_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9aa3f12a222e452b988bb807b5313e33_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3d3e63bab0634cd1b9e1748d9bddf3cb_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="investment">
        <measure>fldm:investment</measure>
    </unit>
    <unit id="offering_period">
        <measure>fldm:offering_period</measure>
    </unit>
    <unit id="segment">
        <measure>fldm:segment</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80L2ZyYWc6NTRmMzg0M2E4MDFhNGZlOTk1YTUwZGZiY2IwNzA5ZmUvdGFibGU6NTNjOWY0Yjc0NWM0NDUzNGJjM2I1YTljNGRlYzYwY2YvdGFibGVyYW5nZTo1M2M5ZjRiNzQ1YzQ0NTM0YmMzYjVhOWM0ZGVjNjBjZl8zLTEtMS0xLTA_4ee4539c-3694-4a59-aa75-35675e9ef609">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80L2ZyYWc6NTRmMzg0M2E4MDFhNGZlOTk1YTUwZGZiY2IwNzA5ZmUvdGFibGU6NTNjOWY0Yjc0NWM0NDUzNGJjM2I1YTljNGRlYzYwY2YvdGFibGVyYW5nZTo1M2M5ZjRiNzQ1YzQ0NTM0YmMzYjVhOWM0ZGVjNjBjZl80LTEtMS0xLTA_fc252636-0632-4e5a-8e09-70794dd52c95">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80L2ZyYWc6NTRmMzg0M2E4MDFhNGZlOTk1YTUwZGZiY2IwNzA5ZmUvdGFibGU6NTNjOWY0Yjc0NWM0NDUzNGJjM2I1YTljNGRlYzYwY2YvdGFibGVyYW5nZTo1M2M5ZjRiNzQ1YzQ0NTM0YmMzYjVhOWM0ZGVjNjBjZl81LTEtMS0xLTA_d30bef38-d30b-472e-8850-1c337364d4fe">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80L2ZyYWc6NTRmMzg0M2E4MDFhNGZlOTk1YTUwZGZiY2IwNzA5ZmUvdGFibGU6NTNjOWY0Yjc0NWM0NDUzNGJjM2I1YTljNGRlYzYwY2YvdGFibGVyYW5nZTo1M2M5ZjRiNzQ1YzQ0NTM0YmMzYjVhOWM0ZGVjNjBjZl82LTEtMS0xLTA_da690765-059d-4c64-bc74-0bed7e77bff1">0001162194</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80L2ZyYWc6NTRmMzg0M2E4MDFhNGZlOTk1YTUwZGZiY2IwNzA5ZmUvdGFibGU6NTNjOWY0Yjc0NWM0NDUzNGJjM2I1YTljNGRlYzYwY2YvdGFibGVyYW5nZTo1M2M5ZjRiNzQ1YzQ0NTM0YmMzYjVhOWM0ZGVjNjBjZl83LTEtMS0xLTA_18333c99-a698-488a-933f-f0b459c31661">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i903ebee619a74d21ad02859fe06eab6b_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNS0wLTEtMS0wL3RleHRyZWdpb246YzE1Y2EwOTY4NmU1NGM2MTg4YzNlY2I4ZmUxN2NiNGJfNTM_94103613-d465-4432-851c-cde5b3c8b940">us-gaap:AccountingStandardsUpdate201613Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <fldm:RevenueFromContractWithCustomerPerformanceObligationPeriod
      contextRef="ia193ed94f89f408ab31b7ae2e68ec878_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfNTUwMg_166c41b6-37fc-4b8a-8206-665c77cdd303">P1Y</fldm:RevenueFromContractWithCustomerPerformanceObligationPeriod>
    <fldm:RevenueFromContractWithCustomerPerformanceObligationPeriod
      contextRef="i57729bb7112d4134be2670ea3e309064_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfOTE2Nw_1c099c37-d651-4eff-8b5d-06284641991e">P1Y</fldm:RevenueFromContractWithCustomerPerformanceObligationPeriod>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQzNjc_09dd10ab-4bd6-4959-a108-786ca8b4f9e5">us-gaap:AccountingStandardsUpdate201613Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i5b8ca235d25d4be7b24f48e1d7b063c2_I20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80Ni9mcmFnOjRjMDgyZTc3ZmY5ODRmNGQ4ZTQzOTg0ZmJlZjhlYThkL3RhYmxlOmMwNDljM2IyZTE2MTQ5MTJiNDM5N2JmMTQxZjIxMTc2L3RhYmxlcmFuZ2U6YzA0OWMzYjJlMTYxNDkxMmI0Mzk3YmYxNDFmMjExNzZfMS0xLTEtMS0w_d6026a91-897d-41df-bee8-7d32a2915055">P3M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="ibee58402214d46c9b90764b31cb5bb82_I20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80Ni9mcmFnOjRjMDgyZTc3ZmY5ODRmNGQ4ZTQzOTg0ZmJlZjhlYThkL3RhYmxlOmMwNDljM2IyZTE2MTQ5MTJiNDM5N2JmMTQxZjIxMTc2L3RhYmxlcmFuZ2U6YzA0OWMzYjJlMTYxNDkxMmI0Mzk3YmYxNDFmMjExNzZfMi0xLTEtMS0w_b68ad4ae-3fed-40ba-90e8-5938583ac332">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="ie8df7afdb66042e49508527a5cb31fa1_I20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80Ni9mcmFnOjRjMDgyZTc3ZmY5ODRmNGQ4ZTQzOTg0ZmJlZjhlYThkL3RhYmxlOmMwNDljM2IyZTE2MTQ5MTJiNDM5N2JmMTQxZjIxMTc2L3RhYmxlcmFuZ2U6YzA0OWMzYjJlMTYxNDkxMmI0Mzk3YmYxNDFmMjExNzZfMy0xLTEtMS0w_16f09007-01eb-49ac-b54f-d9f5d19ccc64">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i6080b667adf249898c3e460f95952085_I20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80Ni9mcmFnOjRjMDgyZTc3ZmY5ODRmNGQ4ZTQzOTg0ZmJlZjhlYThkL3RhYmxlOmMwNDljM2IyZTE2MTQ5MTJiNDM5N2JmMTQxZjIxMTc2L3RhYmxlcmFuZ2U6YzA0OWMzYjJlMTYxNDkxMmI0Mzk3YmYxNDFmMjExNzZfNC0xLTEtMS0w_05608b36-faeb-40fa-80f0-47275eb32444"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i153e522b034a4cdcbce58b6ee2e543f6_D20180301-20180331"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81OC9mcmFnOjg0YmJjY2IxMmIxZTQ1NTNhYzc5MjZlNThiMGEzNDRkL3RhYmxlOjYwMGFkZmUzYmVlOTQ2ZmVhNDMzNDIzNWVjOTAzY2JjL3RhYmxlcmFuZ2U6NjAwYWRmZTNiZWU5NDZmZWE0MzM0MjM1ZWM5MDNjYmNfMS0yLTEtMS0w_59db6e0b-d30a-4209-be6a-32799c2ece31"
      unitRef="number">0.1269438</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i90329f25a47f4987b6c5028226f49c7f_D20191101-20191130"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81OC9mcmFnOjg0YmJjY2IxMmIxZTQ1NTNhYzc5MjZlNThiMGEzNDRkL3RhYmxlOjYwMGFkZmUzYmVlOTQ2ZmVhNDMzNDIzNWVjOTAzY2JjL3RhYmxlcmFuZ2U6NjAwYWRmZTNiZWU5NDZmZWE0MzM0MjM1ZWM5MDNjYmNfMy0yLTEtMS0w_5b71d29b-32c0-4889-9067-e6b79111cd46"
      unitRef="number">0.3448276</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <dei:DocumentType
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGV4dHJlZ2lvbjphMTM5MTUzZjU3Njc0MjJhOGIwMmU4NGU0NDFhZWNmZF8yMjk2_a09faebc-128d-4b08-aeff-a2bcb6633f0d">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGV4dHJlZ2lvbjphMTM5MTUzZjU3Njc0MjJhOGIwMmU4NGU0NDFhZWNmZF8yMjk3_5eae5e00-2183-4f5d-9855-ff0248b073a7">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGV4dHJlZ2lvbjphMTM5MTUzZjU3Njc0MjJhOGIwMmU4NGU0NDFhZWNmZF8yNjA_180257f6-72d6-472c-9f82-ffd065e7a127">2020-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGV4dHJlZ2lvbjphMTM5MTUzZjU3Njc0MjJhOGIwMmU4NGU0NDFhZWNmZF8yMjkx_c37bd71d-0b94-46ff-abbc-e172eda92115">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGV4dHJlZ2lvbjphMTM5MTUzZjU3Njc0MjJhOGIwMmU4NGU0NDFhZWNmZF8yMjky_25bbc18f-04b6-4bfe-a67b-6da88cd85bc5">001-34180</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGV4dHJlZ2lvbjphMTM5MTUzZjU3Njc0MjJhOGIwMmU4NGU0NDFhZWNmZF8yMjkz_d2632aff-f0d8-4c53-afd8-8249ab021900">FLUIDIGM CORP</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGFibGU6ZWIxM2M2MjU5OWU5NDU5OTkyZDIyNWNjZTFjMGUxMDQvdGFibGVyYW5nZTplYjEzYzYyNTk5ZTk0NTk5OTJkMjI1Y2NlMWMwZTEwNF8wLTAtMS0xLTA_cf0a68d1-66be-4b43-b09d-711c240ca2d1">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGFibGU6ZWIxM2M2MjU5OWU5NDU5OTkyZDIyNWNjZTFjMGUxMDQvdGFibGVyYW5nZTplYjEzYzYyNTk5ZTk0NTk5OTJkMjI1Y2NlMWMwZTEwNF8wLTQtMS0xLTA_d9d88aac-f81d-44fb-998b-70a00649c01c">77-0513190</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGFibGU6ZWIxM2M2MjU5OWU5NDU5OTkyZDIyNWNjZTFjMGUxMDQvdGFibGVyYW5nZTplYjEzYzYyNTk5ZTk0NTk5OTJkMjI1Y2NlMWMwZTEwNF8zLTAtMS0xLTA_0a0368a6-f216-4513-b60e-0a7a72281f36">2 Tower Place, Ste 2000</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGFibGU6ZWIxM2M2MjU5OWU5NDU5OTkyZDIyNWNjZTFjMGUxMDQvdGFibGVyYW5nZTplYjEzYzYyNTk5ZTk0NTk5OTJkMjI1Y2NlMWMwZTEwNF8zLTEtMS0xLTA_8de501f2-a794-4862-832e-4ed443b621d0">South San Francisco,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGFibGU6ZWIxM2M2MjU5OWU5NDU5OTkyZDIyNWNjZTFjMGUxMDQvdGFibGVyYW5nZTplYjEzYzYyNTk5ZTk0NTk5OTJkMjI1Y2NlMWMwZTEwNF8zLTItMS0xLTA_033278c4-99d2-4898-bf9e-1c3914af403c">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGFibGU6ZWIxM2M2MjU5OWU5NDU5OTkyZDIyNWNjZTFjMGUxMDQvdGFibGVyYW5nZTplYjEzYzYyNTk5ZTk0NTk5OTJkMjI1Y2NlMWMwZTEwNF8zLTQtMS0xLTA_c748a2fd-02ba-4423-b78e-6d2de5471166">94080</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGV4dHJlZ2lvbjphMTM5MTUzZjU3Njc0MjJhOGIwMmU4NGU0NDFhZWNmZF8yMjk0_75a0e412-5086-4e07-97e1-7f17cd7e8cc2">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGV4dHJlZ2lvbjphMTM5MTUzZjU3Njc0MjJhOGIwMmU4NGU0NDFhZWNmZF8yMjk4_ea6c1c75-a68d-4a7d-b8d0-7ec7154bd723">266-6000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGFibGU6ZjczYThmNjRlNDIwNDEyZGIxMDA5MGJkNWMyMWE0NGIvdGFibGVyYW5nZTpmNzNhOGY2NGU0MjA0MTJkYjEwMDkwYmQ1YzIxYTQ0Yl8xLTAtMS0xLTA_8fb6a1bc-439c-4f3b-8d02-49ebbed49f03">Common Stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGFibGU6ZjczYThmNjRlNDIwNDEyZGIxMDA5MGJkNWMyMWE0NGIvdGFibGVyYW5nZTpmNzNhOGY2NGU0MjA0MTJkYjEwMDkwYmQ1YzIxYTQ0Yl8xLTEtMS0xLTA_e47eed16-9f7a-47cb-9df6-6c30cd2b11d8">FLDM</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGFibGU6ZjczYThmNjRlNDIwNDEyZGIxMDA5MGJkNWMyMWE0NGIvdGFibGVyYW5nZTpmNzNhOGY2NGU0MjA0MTJkYjEwMDkwYmQ1YzIxYTQ0Yl8xLTItMS0xLTA_8ab5580d-815d-4627-b298-59582b9f2463">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGV4dHJlZ2lvbjphMTM5MTUzZjU3Njc0MjJhOGIwMmU4NGU0NDFhZWNmZF8yMjk5_0509e21c-c77d-49d4-8743-afbd6f0fb01b">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGV4dHJlZ2lvbjphMTM5MTUzZjU3Njc0MjJhOGIwMmU4NGU0NDFhZWNmZF8yMzAw_55d89257-7d42-4c8d-9670-0c38f15eb515">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGFibGU6OGNkYzI4NTM2Nzk1NDU2M2JlNjQzZTUxZGYyMDUwODMvdGFibGVyYW5nZTo4Y2RjMjg1MzY3OTU0NTYzYmU2NDNlNTFkZjIwNTA4M18wLTAtMS0xLTA_5e09b192-9aa2-4077-ae60-19f2e6de237d">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGFibGU6OGNkYzI4NTM2Nzk1NDU2M2JlNjQzZTUxZGYyMDUwODMvdGFibGVyYW5nZTo4Y2RjMjg1MzY3OTU0NTYzYmU2NDNlNTFkZjIwNTA4M18xLTctMS0xLTA_3b35f813-9271-4d66-9138-583ad08725b2">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGFibGU6OGNkYzI4NTM2Nzk1NDU2M2JlNjQzZTUxZGYyMDUwODMvdGFibGVyYW5nZTo4Y2RjMjg1MzY3OTU0NTYzYmU2NDNlNTFkZjIwNTA4M18yLTctMS0xLTA_9993b8ac-bd9f-413f-a8d6-c4b02cbbd694">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGV4dHJlZ2lvbjphMTM5MTUzZjU3Njc0MjJhOGIwMmU4NGU0NDFhZWNmZF8yMjk1_043ef5ae-922b-4fb8-a3da-7a328f324873">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ie22f33a35cf745b0a81fe1558fdc9dbd_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xL2ZyYWc6YTEzOTE1M2Y1NzY3NDIyYThiMDJlODRlNDQxYWVjZmQvdGV4dHJlZ2lvbjphMTM5MTUzZjU3Njc0MjJhOGIwMmU4NGU0NDFhZWNmZF8xODE0MTk0MTg2MDgyNQ_eb8e81ce-af82-4db4-8470-4db32cefbe91"
      unitRef="shares">74119005</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfNC0yLTEtMS0w_3e703f8f-3ed5-4616-a13e-f9d807299684"
      unitRef="usd">72345000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfNC00LTEtMS0w_0a05644b-ff3b-4e49-bf5c-cb3ad3dc5062"
      unitRef="usd">21661000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfNS0yLTEtMS0w_b3651c9f-6c99-4304-b309-51b2eb531291"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfNS00LTEtMS0w_95df2f64-f2f5-4419-8752-337dbe40af14"
      unitRef="usd">36978000</us-gaap:ShortTermInvestments>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfNi0wLTEtMS0wL3RleHRyZWdpb246N2FhNDVkNjJkNDAwNGNjYWEzNjJjZmI5OTAwODQ5OWNfNDY_57173bc7-4c4f-4a38-bad8-506f7df88f9b"
      unitRef="usd">324000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfNi0wLTEtMS0wL3RleHRyZWdpb246N2FhNDVkNjJkNDAwNGNjYWEzNjJjZmI5OTAwODQ5OWNfNTM_54aebddc-a120-47ec-9f6c-5ab7d07af3b4"
      unitRef="usd">6000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfNi0yLTEtMS0w_56c76a00-1326-406d-a341-6a47e4810581"
      unitRef="usd">17613000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfNi00LTEtMS0w_f3fa093e-8dc9-4abd-87dd-981ca9653291"
      unitRef="usd">18981000</us-gaap:AccountsReceivableNetCurrent>
    <fldm:ResearchAndDevelopmentArrangementReceivables
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfNy0yLTEtMS0xNTc5_60127cda-a3ad-4e6a-acfb-59e35c9bed70"
      unitRef="usd">7456000</fldm:ResearchAndDevelopmentArrangementReceivables>
    <fldm:ResearchAndDevelopmentArrangementReceivables
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfNy00LTEtMS0xNTc5_c95e0f19-7b03-4177-9894-a8eee60ed817"
      unitRef="usd">0</fldm:ResearchAndDevelopmentArrangementReceivables>
    <us-gaap:InventoryNet
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfNy0yLTEtMS0w_a4859f24-3a0f-409a-836b-a4d5d14f504d"
      unitRef="usd">19560000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfNy00LTEtMS0w_f9db4628-6b10-4d43-b57b-612ed19acf09"
      unitRef="usd">13884000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfOC0yLTEtMS0w_da007e80-5dcf-4f40-8c0f-6420e6a97090"
      unitRef="usd">5689000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfOC00LTEtMS0w_96adfc7b-1a76-41a4-9f5a-f6feb261de8b"
      unitRef="usd">4592000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfOS0yLTEtMS0w_067bdf01-5a8a-486e-b82b-cb35c9c1726f"
      unitRef="usd">122663000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfOS00LTEtMS0w_ec9546b3-5ce0-471b-b04c-b5fe5273cc2c"
      unitRef="usd">96096000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMTEtMi0xLTEtMA_ed88dd9e-e696-4585-bb4d-e2b2d587ef54"
      unitRef="usd">7531000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMTEtNC0xLTEtMA_bd048b7d-afdd-4c70-a192-5b7e8d7c7e9c"
      unitRef="usd">8056000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMTItMi0xLTEtMA_4ff98fad-1d67-4922-804d-76d944622893"
      unitRef="usd">38469000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMTItNC0xLTEtMA_86cad029-bb63-4cb8-aeaa-d0001dc3099c"
      unitRef="usd">4860000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMTMtMi0xLTEtMA_08ecc6ef-f2ea-460f-82e2-d1ab3947f851"
      unitRef="usd">4904000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMTMtNC0xLTEtMA_166a1840-a396-4e6a-837c-099bed06e160"
      unitRef="usd">5492000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMTQtMi0xLTEtMA_efe0ebfe-93bc-4c9b-89ea-3fcc20ea3313"
      unitRef="usd">42955000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMTQtNC0xLTEtMA_2a3e98c5-c8a0-4c93-b358-b798ed2dd401"
      unitRef="usd">46200000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMTUtMi0xLTEtMA_7e1c97d3-1d8d-4c98-a79c-b0edadec53c5"
      unitRef="usd">106455000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMTUtNC0xLTEtMA_5811655a-e644-4595-9941-6315e1589234"
      unitRef="usd">104108000</us-gaap:Goodwill>
    <us-gaap:Assets
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMTYtMi0xLTEtMA_c2c90d71-68dd-49fa-8580-ce130e2cf55f"
      unitRef="usd">322977000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMTYtNC0xLTEtMA_5c1ff7c5-05cc-4e42-9fcb-87d0f4a37d78"
      unitRef="usd">264812000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMTktMi0xLTEtMA_0e1682e3-0f29-4f04-bf72-a69cfa77f811"
      unitRef="usd">10971000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMTktNC0xLTEtMA_9c872ecf-0aec-4a7b-a098-4c3a19a8a359"
      unitRef="usd">6510000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjAtMi0xLTEtMA_45511d8f-1f11-44f2-81b4-fe9e0beb31bc"
      unitRef="usd">9122000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjAtNC0xLTEtMA_d8bcc6eb-7e45-4253-9952-4884808f1c41"
      unitRef="usd">5160000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjEtMi0xLTEtMA_e0fc3101-e1b9-4bac-8434-24e41ffb4c0a"
      unitRef="usd">2697000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjEtNC0xLTEtMA_d1fddfa5-0dd4-418f-88f3-390fdbc5fd1a"
      unitRef="usd">1833000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjItMi0xLTEtMA_bd7e603e-a558-4eec-89fa-e9e488a9d28d"
      unitRef="usd">6565000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjItNC0xLTEtMA_9580a3f7-4ac7-452f-ad11-81874552d83d"
      unitRef="usd">7515000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjMtMi0xLTEtMA_49fd3277-ee1a-430d-9ba1-0e67d565a4fe"
      unitRef="usd">13436000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjMtNC0xLTEtMA_ad0e9bf3-45f5-4fab-9dfc-ca60fdfeb98e"
      unitRef="usd">11803000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjQtMi0xLTEtMA_5dcbdeea-45a2-4c91-8eb2-5077fb859722"
      unitRef="usd">42791000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjQtNC0xLTEtMA_46c17213-2c2c-4010-a9c6-98461cd27692"
      unitRef="usd">32821000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ConvertibleLongTermNotesPayable
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjUtMi0xLTEtMA_041eda7a-b7e5-4c82-8fc3-dc8c7fd3f695"
      unitRef="usd">54121000</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:ConvertibleLongTermNotesPayable
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjUtNC0xLTEtMA_07a2e686-3e64-405c-8eea-2f944f2efa8f"
      unitRef="usd">53821000</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjYtMi0xLTEtMA_c54f6d18-5626-4cff-b64c-f2b0976e633a"
      unitRef="usd">9041000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjYtNC0xLTEtMA_d1a7e6af-e946-4b01-95bb-bb6c3da8305a"
      unitRef="usd">11494000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjctMi0xLTEtMA_0eb3c40a-44ea-429b-b071-e9db587bbf97"
      unitRef="usd">38607000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjctNC0xLTEtMA_4748955d-3c65-4d6d-aa1e-c691b8cd8426"
      unitRef="usd">4323000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjgtMi0xLTEtMA_a5e17ce4-907b-4ac8-aea0-b3f6eea1552d"
      unitRef="usd">7684000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjgtNC0xLTEtMA_2f2a3a73-c13f-4b82-a641-973cc7226a6d"
      unitRef="usd">8168000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <fldm:DeferredGrantRevenueNoncurrent
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzAtMi0xLTEtMTUwMg_08277549-370f-4ed2-829f-946b8c85e78e"
      unitRef="usd">18224000</fldm:DeferredGrantRevenueNoncurrent>
    <fldm:DeferredGrantRevenueNoncurrent
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzAtNC0xLTEtMTQ5Nw_cd4570ce-c574-4f24-a84e-1d57b463f34f"
      unitRef="usd">0</fldm:DeferredGrantRevenueNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjktMi0xLTEtMA_52e398a4-cf13-4578-af1a-2960563e55d5"
      unitRef="usd">536000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMjktNC0xLTEtMA_f10104a6-3995-4ee7-bbae-570473ad4d9b"
      unitRef="usd">573000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzAtMi0xLTEtMA_30ae78f1-23a6-4386-9121-a6fe57cbafe4"
      unitRef="usd">171004000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzAtNC0xLTEtMA_b14723fc-afe0-4e53-971b-a161e23a1b31"
      unitRef="usd">111200000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzEtMi0xLTEtMA_76cc9e51-e605-4b91-a443-15269f987dd3"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzEtNC0xLTEtMA_94226603-062e-4c11-a9ac-633366bc10ca"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjQ3NTAwYmYwYjNmMzQ4MjdiNzhjNTI1OGJiYjNjNzMzXzIx_0636529a-9894-4321-bdf4-16bc6e9a6bd2"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjQ3NTAwYmYwYjNmMzQ4MjdiNzhjNTI1OGJiYjNjNzMzXzIx_eac5f643-3718-4f62-9523-22708ccf2b52"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjQ3NTAwYmYwYjNmMzQ4MjdiNzhjNTI1OGJiYjNjNzMzXzM1_96b75cdd-4a70-4cad-9244-9e1a8e735d67"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjQ3NTAwYmYwYjNmMzQ4MjdiNzhjNTI1OGJiYjNjNzMzXzM1_ac1e0c2e-a180-4527-884a-ebb3278e5181"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjQ3NTAwYmYwYjNmMzQ4MjdiNzhjNTI1OGJiYjNjNzMzXzU3_51c750aa-ee00-4336-89a7-ac53c6911097"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjQ3NTAwYmYwYjNmMzQ4MjdiNzhjNTI1OGJiYjNjNzMzXzU3_5654cf09-a98e-4edf-a254-72409388effe"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjQ3NTAwYmYwYjNmMzQ4MjdiNzhjNTI1OGJiYjNjNzMzXzU3_719c26ad-862b-4345-a355-36a24c7718a9"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjQ3NTAwYmYwYjNmMzQ4MjdiNzhjNTI1OGJiYjNjNzMzXzU3_bc0492ad-b6e6-4f8e-a3a7-ed1bc5840368"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzMtMi0xLTEtMA_b46801cb-510d-41af-93ed-d491649994dc"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzMtNC0xLTEtMA_f8446df5-448f-4837-9334-05b448180a5e"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmI5NTY3YzRiY2JlMzQ2ZDJiZTVjZDkwNmY5MGJiOGIwXzE4_8556c5de-debf-4225-9c04-8b0af47bf6fd"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmI5NTY3YzRiY2JlMzQ2ZDJiZTVjZDkwNmY5MGJiOGIwXzE4_fd510e3f-84e8-426f-ad58-91343dab39dd"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmI5NTY3YzRiY2JlMzQ2ZDJiZTVjZDkwNmY5MGJiOGIwXzMy_ec5db666-2c26-4fb6-8a0a-42023c765fa7"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmI5NTY3YzRiY2JlMzQ2ZDJiZTVjZDkwNmY5MGJiOGIwXzMy_f21a58d1-b63b-4463-8df1-2202bb37fed6"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmI5NTY3YzRiY2JlMzQ2ZDJiZTVjZDkwNmY5MGJiOGIwXzkz_a879b1de-a656-41cc-8c68-47fb8b7850ff"
      unitRef="shares">74115000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmI5NTY3YzRiY2JlMzQ2ZDJiZTVjZDkwNmY5MGJiOGIwXzkz_b83fa9df-0814-4d81-91c0-6e35223f0470"
      unitRef="shares">74115000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmI5NTY3YzRiY2JlMzQ2ZDJiZTVjZDkwNmY5MGJiOGIwXzEwMA_7dec243e-069f-46a4-9472-53aa0297262d"
      unitRef="shares">69956000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmI5NTY3YzRiY2JlMzQ2ZDJiZTVjZDkwNmY5MGJiOGIwXzEwMA_d33b4411-9c6b-4e47-8b11-27c653f3d6d4"
      unitRef="shares">69956000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzQtMi0xLTEtMA_9aa1b43f-0970-4280-8be7-d308e3ce0ec3"
      unitRef="usd">74000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzQtNC0xLTEtMA_40d4ce61-636c-4567-a114-375a10d1b6a0"
      unitRef="usd">70000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzUtMi0xLTEtMA_7e7392de-7b14-4814-a439-810ddef009ab"
      unitRef="usd">810923000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzUtNC0xLTEtMA_e153aed2-9f2e-4ec7-a354-aebb78071e08"
      unitRef="usd">777765000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzYtMi0xLTEtMA_150a35d5-512e-4d33-8a0c-3d89257b5f84"
      unitRef="usd">-289000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzYtNC0xLTEtMA_0c35a9ce-2237-4af4-afae-b0ab139871f2"
      unitRef="usd">-582000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzctMi0xLTEtMA_f5ead3b3-6fcd-403d-830e-3a043a5c3ad0"
      unitRef="usd">-658735000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzctNC0xLTEtMA_83a79733-343f-48b0-9da3-5d81fbeb5382"
      unitRef="usd">-623641000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzgtMi0xLTEtMA_43e18a59-f2b1-4c0f-a018-aa4a13f2aa1b"
      unitRef="usd">151973000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzgtNC0xLTEtMA_85385c09-7c81-47b7-8a3e-1a1dac18247b"
      unitRef="usd">153612000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzktMi0xLTEtMA_3e06a9db-4bba-4238-b4d6-4fda04a98fe2"
      unitRef="usd">322977000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xNi9mcmFnOjM0ZDlkNGE2MTY4YzRhOTFiNjZlYWZjOWRiYWQ4YmM0L3RhYmxlOmE1YzRlODExMzEwNjQ2OWU5Zjk5NWJjM2Y3NzBjNDZiL3RhYmxlcmFuZ2U6YTVjNGU4MTEzMTA2NDY5ZTlmOTk1YmMzZjc3MGM0NmJfMzktNC0xLTEtMA_10e55d42-809b-4b04-84f8-80aef7da2cf0"
      unitRef="usd">264812000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i63dac85b57b74b8ea053ca16f3171b97_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMy0yLTEtMS0w_04df5bf3-f03c-429d-82a9-ff9bd1b90fc9"
      unitRef="usd">29210000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if32b1e8a019b42fea7b915507e3650c8_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMy00LTEtMS0w_b9434857-51ae-4f08-8a98-4b758700b6a9"
      unitRef="usd">20666000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iedd975972ec54477b7d1edc9dcd0e9ae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMy02LTEtMS0w_22a52076-27de-44d4-9b05-30e673bad39d"
      unitRef="usd">65596000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id978df8be0b2445ca43d804b18f99d88_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMy04LTEtMS0w_b0afbf50-5979-4936-a4e3-1ef160398d18"
      unitRef="usd">68728000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iea38c8e677cb447a95163f4ee5133194_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfNC0yLTEtMS0w_7f7401e4-6312-4fe5-affc-41e1b2ede8d8"
      unitRef="usd">6131000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i38d8014ca50e40ea95a3204f7d46b5a7_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfNC00LTEtMS0w_2612f0de-16ce-42b4-8a79-7939d0b7f9d3"
      unitRef="usd">5630000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie4c104320701492cab8cff2d9393f868_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfNC02LTEtMS0w_3bc420fb-3cc6-4432-9da7-da79060854ca"
      unitRef="usd">16457000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i64595cdf77c94fb899f02002ee32e32b_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfNC04LTEtMS0w_c8bb141f-4780-4aab-9f90-d5a673a83c35"
      unitRef="usd">15875000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ied63bbfdfbdd4d17b689fb84bd615a22_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfNS0yLTEtMS0w_d9ba2b05-8ece-4ffb-8480-b20827e885cf"
      unitRef="usd">3180000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i33305dd63fcd4c7b827cced58c13da0a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfNS00LTEtMS0w_de5c8caa-0978-4eaa-bdd5-d45accc9ed02"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib7451c9afcd847cda97b00adbdae3f05_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfNS02LTEtMS0w_604299e7-85ac-4ee4-b69d-dbf72aa1b973"
      unitRef="usd">6180000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i86ecea94f14744c580bbf02abb8493f8_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfNS04LTEtMS0w_f7e1322e-8af7-43b1-af97-841c4e2867ff"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id1eb2e1b7d5c4eeaa06d2bbb0f149ea2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfNi0yLTEtMS0w_0d9dd1f1-210c-421e-ac44-90a8062058bd"
      unitRef="usd">1340000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i507e1652ea0c4fb1b2d67aeec5653728_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfNi00LTEtMS0w_03150dc0-f313-4d00-94a9-15c3922f6630"
      unitRef="usd">200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6cb05eac3b154d7798dda674fcc015dd_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfNi02LTEtMS0w_fd7e6db8-8a59-4120-89db-5450df70d50a"
      unitRef="usd">5303000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6188317019ad466c8b5326b1720b484d_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfNi04LTEtMS0w_b13b49e4-fb32-43ad-abc5-d6986f57bc28"
      unitRef="usd">200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfNy0yLTEtMS0w_828f9c19-b8ba-46a4-8c1c-e4617483a772"
      unitRef="usd">39861000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfNy00LTEtMS0w_51e57782-5619-4dc5-aa66-3c5edf69ca9e"
      unitRef="usd">26496000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfNy02LTEtMS0w_41be0c49-4f28-4c79-9cd1-a980c147120a"
      unitRef="usd">93536000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfNy04LTEtMS0w_02dd85f8-9ee8-4af0-9a1d-94ff4bbec46c"
      unitRef="usd">84803000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i63dac85b57b74b8ea053ca16f3171b97_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfOS0yLTEtMS0w_5519c42c-ea51-4db5-bb35-380b66a1cac3"
      unitRef="usd">12773000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="if32b1e8a019b42fea7b915507e3650c8_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfOS00LTEtMS0w_cc75e57b-b559-4b85-bbb8-d0c83080ffe5"
      unitRef="usd">10520000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="iedd975972ec54477b7d1edc9dcd0e9ae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfOS02LTEtMS0w_b6acb7cf-0403-4e33-adcd-4a9cc75d7e5c"
      unitRef="usd">31896000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="id978df8be0b2445ca43d804b18f99d88_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfOS04LTEtMS0w_96ab897f-7a45-47a5-975e-881270f85246"
      unitRef="usd">33009000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="iea38c8e677cb447a95163f4ee5133194_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTAtMi0xLTEtMA_038550f4-bbdc-4c4a-9b48-513bf4bf622f"
      unitRef="usd">1769000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i38d8014ca50e40ea95a3204f7d46b5a7_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTAtNC0xLTEtMA_cc930b41-4651-4782-b8e2-d510df1be928"
      unitRef="usd">1938000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ie4c104320701492cab8cff2d9393f868_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTAtNi0xLTEtMA_5e0490bb-2f7d-4889-821a-870e95f27451"
      unitRef="usd">4531000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i64595cdf77c94fb899f02002ee32e32b_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTAtOC0xLTEtMA_f3f74869-0ecc-47d8-bc5c-58fca0896960"
      unitRef="usd">5403000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTEtMi0xLTEtMA_17f646c5-b210-4482-a801-c40ab67ac551"
      unitRef="usd">8128000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTEtNC0xLTEtMA_0fb26a99-3aed-467e-b01f-3334393debf9"
      unitRef="usd">7125000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTEtNi0xLTEtMA_28713343-22d8-4b7c-85a2-eae6cbaacca7"
      unitRef="usd">25275000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTEtOC0xLTEtMA_f7dbb20b-ebd3-45f8-8941-14d5c1bc594f"
      unitRef="usd">23362000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTItMi0xLTEtMA_4d5fe8aa-8897-4e08-9830-365ba8963f23"
      unitRef="usd">22655000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTItNC0xLTEtMA_64af4d29-b74f-44f5-847b-45591a7a9122"
      unitRef="usd">20729000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTItNi0xLTEtMA_1b017ae2-0453-4b47-84a0-654952b08e7c"
      unitRef="usd">65966000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTItOC0xLTEtMA_06556c39-79d5-4d57-b2e7-73e8e5dc3493"
      unitRef="usd">65687000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTYtMi0xLTEtMA_423a1ed1-c7bb-49e3-b8b2-bd59820875ea"
      unitRef="usd">45325000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTYtNC0xLTEtMA_1984e8b1-3e83-4ac5-b387-02947803dcff"
      unitRef="usd">40312000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTYtNi0xLTEtMA_5a492115-63d5-4210-8524-159972d7d383"
      unitRef="usd">127668000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTYtOC0xLTEtMA_bdf36140-464d-4d08-a645-24e5617ded08"
      unitRef="usd">127461000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTctMi0xLTEtMA_e78a2bd3-a1a2-4c13-bbe7-c1d0dfded447"
      unitRef="usd">-5464000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTctNC0xLTEtMA_629e0a80-2743-4d19-8b71-67aa4ad9122c"
      unitRef="usd">-13816000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTctNi0xLTEtMA_89877270-3786-4d64-973e-d6fc6d89038c"
      unitRef="usd">-34132000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTctOC0xLTEtMA_8e3ff703-644c-4011-8ec8-e86eb6b35661"
      unitRef="usd">-42658000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTgtMi0xLTEtMA_27ef672b-9180-4996-8443-dbb2f23c2166"
      unitRef="usd">885000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTgtNC0xLTEtMA_41f37fc5-55bc-4eef-b8f7-e5c74ba829c0"
      unitRef="usd">444000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTgtNi0xLTEtMA_ef6b2890-4ade-423b-9e3c-aedd31931135"
      unitRef="usd">2682000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTgtOC0xLTEtMA_faa90d4a-19f3-475f-8278-c455725e8c3a"
      unitRef="usd">3636000</us-gaap:InterestExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTktMi0xLTEtMA_4372ce27-2fd8-492e-b792-17524ac56384"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTktNC0xLTEtMA_ff37b67f-2b46-45b3-929b-71f7e519733d"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTktNi0xLTEtMA_2a9bf802-0c60-4863-8714-7d1f437a6e52"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMTktOC0xLTEtMA_14942160-8df5-4d02-af24-4bb2c9d5de71"
      unitRef="usd">-9000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjAtMi0xLTEtMA_870b569b-5e20-4641-9ef6-454703f33dc2"
      unitRef="usd">107000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjAtNC0xLTEtMA_bed83828-9605-4ad4-840a-4094349283f7"
      unitRef="usd">205000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjAtNi0xLTEtMA_204d5955-4c6e-4a55-961d-e51459d95121"
      unitRef="usd">-248000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjAtOC0xLTEtMA_1fa042bb-e939-4636-9ced-fae1fa1f2435"
      unitRef="usd">920000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjEtMi0xLTEtMA_4faf1b20-3dd3-48ec-ba14-2137e2ca295e"
      unitRef="usd">-6242000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjEtNC0xLTEtMA_a32996ae-dd33-4917-81bf-c3db3c97324e"
      unitRef="usd">-14055000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjEtNi0xLTEtMA_aa239465-4c41-42b8-bee2-d1ec9b392e00"
      unitRef="usd">-37062000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjEtOC0xLTEtMA_98a3e8af-6053-42b4-9971-02b4190710c6"
      unitRef="usd">-54374000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjItMi0xLTEtMA_c07f5f1f-9773-46cd-a2d2-19d55d63b252"
      unitRef="usd">-243000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjItNC0xLTEtMA_69368de2-598a-494f-91a8-705e86ec9a9b"
      unitRef="usd">-1168000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjItNi0xLTEtMA_edf205cd-0d71-4f44-b566-a394a8f92cc0"
      unitRef="usd">-2068000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjItOC0xLTEtMA_8a797e31-cc6d-4635-9fe2-a001a7a515b5"
      unitRef="usd">-2269000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjMtMi0xLTEtMA_60542476-6ec7-4823-977a-cf8db5034740"
      unitRef="usd">-5999000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjMtNC0xLTEtMA_71353883-8225-41d8-8101-fbad1198a3ab"
      unitRef="usd">-12887000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjMtNi0xLTEtMA_004a9259-77af-4c31-934e-1f1134767638"
      unitRef="usd">-34994000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjMtOC0xLTEtMA_c8b58fc3-6514-485b-b3f3-a571288fe228"
      unitRef="usd">-52105000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjQtMi0xLTEtMA_d098b834-fd49-45ad-a863-a25240c1a53d"
      unitRef="usdPerShare">-0.08</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjQtNC0xLTEtMA_fbabd511-df5d-410a-a11a-df8850082e78"
      unitRef="usdPerShare">-0.19</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjQtNi0xLTEtMA_ab9b0727-85d1-4e16-bf1a-e4873326befc"
      unitRef="usdPerShare">-0.49</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjQtOC0xLTEtMA_8c4e5b04-53f2-4c9b-b58a-cff2ac3e473c"
      unitRef="usdPerShare">-0.79</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjUtMi0xLTEtMA_65b0ad35-f8b1-4eab-8eb8-16a0147d7a26"
      unitRef="shares">72486000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjUtNC0xLTEtMA_92e48c9d-d37d-4ece-ba43-c79e30946915"
      unitRef="shares">69469000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjUtNi0xLTEtMA_0669c046-186c-42ad-b769-53ff8f4d4648"
      unitRef="shares">71294000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xOS9mcmFnOjY5MjQzNDM4YTVjMjQ1MWViNjY4MzY2NjllMzI4N2M0L3RhYmxlOjI4NWJjNWVlYWVmNDRiNGE4NDZmZjk0NzkxY2NkNWQxL3RhYmxlcmFuZ2U6Mjg1YmM1ZWVhZWY0NGI0YTg0NmZmOTQ3OTFjY2Q1ZDFfMjUtOC0xLTEtMA_f83b2935-bd7e-451b-b66b-685532deaf32"
      unitRef="shares">65792000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:NetIncomeLoss
      contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfMi0yLTEtMS0w_60542476-6ec7-4823-977a-cf8db5034740"
      unitRef="usd">-5999000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfMi00LTEtMS0w_0ee30f21-df76-4c24-ab51-a9a4851ab465"
      unitRef="usd">-12887000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfMi02LTEtMS0w_7f2d42d9-bc29-4fc8-b3d6-88723494db9f"
      unitRef="usd">-34994000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfMi02LTEtMS0w_944f1989-8792-4656-9689-4fabd5f0837f"
      unitRef="usd">-34994000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfMi05LTEtMS0w_c8b58fc3-6514-485b-b3f3-a571288fe228"
      unitRef="usd">-52105000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfNC0yLTEtMS0w_2d8bd5b4-5a53-4414-ab42-a390e02da086"
      unitRef="usd">523000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfNC00LTEtMS0w_228d98c5-c655-46cb-a151-14d77741e1b1"
      unitRef="usd">-121000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfNC02LTEtMS0w_7ef5f3d0-ce94-4e01-9db8-d63128686a41"
      unitRef="usd">329000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfNC05LTEtMS0w_1bb351b3-2414-4bfe-9995-21525fa2d9eb"
      unitRef="usd">-122000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfNS0yLTEtMS0w_2a29002f-9175-4a3f-be47-91766f425f35"
      unitRef="usd">-3000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfNS00LTEtMS0w_704b2e33-ecaf-4636-972c-4d2d7d0fb145"
      unitRef="usd">-14000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfNS02LTEtMS0w_b224372b-1834-470a-b1b4-a103961fef82"
      unitRef="usd">-36000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfNS05LTEtMS0w_bf72656c-e3ff-4b8c-b3a1-2dff9b82f98e"
      unitRef="usd">51000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfNi0yLTEtMS0w_1d9dc43b-57d0-46e1-98a5-2820e4a0fd4d"
      unitRef="usd">520000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfNi00LTEtMS0w_6b52747e-e6c1-4503-9380-fc849955773f"
      unitRef="usd">-135000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfNi02LTEtMS0w_bd949f94-7851-4cf2-885a-7b28659cd42f"
      unitRef="usd">293000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfNi05LTEtMS0w_cbde3e25-457d-46c5-8c6b-8a6c8ed50a4a"
      unitRef="usd">-71000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfNy0yLTEtMS0w_32843186-6a90-42b0-9cfc-4c3d5b0d83d7"
      unitRef="usd">-5479000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfNy00LTEtMS0w_f15c54fd-0f82-479b-9409-993133147e03"
      unitRef="usd">-13022000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfNy02LTEtMS0w_62fce817-e859-4218-bdb1-dc7c48b88b05"
      unitRef="usd">-34701000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yMi9mcmFnOmVkNTJkMGI4YzVjMDRjNGZhMzNhYWYwZGEwODJhOGI5L3RhYmxlOjViMmEwYjRhNDkxNTQ0NTBiY2M4ZTdjZDk1YTEyMzE2L3RhYmxlcmFuZ2U6NWIyYTBiNGE0OTE1NDQ1MGJjYzhlN2NkOTVhMTIzMTZfNy05LTEtMS0w_3baafdfe-94b8-4613-a87f-3a4121221da3"
      unitRef="usd">-52176000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="idbea30ceb41f4d23b750317c34a1821d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMi0yLTEtMS0w_f78ffd4d-f5cc-46e7-a76b-2ae013be5d5e"
      unitRef="shares">69956000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="idbea30ceb41f4d23b750317c34a1821d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMi00LTEtMS0w_92f6bda4-887b-4896-82c5-1436252712ce"
      unitRef="usd">70000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idb6dc60b8a3d4ad7aad987d15b284ba8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMi02LTEtMS0w_41336a81-ea3a-4207-95f9-76ef08cc402e"
      unitRef="usd">777765000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iacf13335933a47178e0765e3e574fd1e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMi04LTEtMS0w_6f98b1b5-f8e3-459c-9967-0790d8ed510d"
      unitRef="usd">-582000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3689cf18c31b470096fb83d4554d4782_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMi0xMC0xLTEtMA_cea9cc45-b814-44a9-9859-f8775fe82b7e"
      unitRef="usd">-623641000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMi0xMi0xLTEtMA_a7c83789-2b5d-4f7c-a711-67fb265f8521"
      unitRef="usd">153612000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="ifc0e648162d14d4a989f9ef273403334_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMy0yLTEtMS0w_7f1ecbae-a386-4307-aab8-65f698621bec"
      unitRef="shares">255000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="ic59bca928d1a49b4afeb85ec17e11c85_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMy02LTEtMS0w_b7e29ad7-9e1f-4277-aca0-b247abdecf69"
      unitRef="usd">-146000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i36c4cb3e31604770b06e9f2af6bc483e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMy0xMi0xLTEtMA_ee5480af-559b-42f7-8617-9a915fbc2cd3"
      unitRef="usd">-146000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockholdersEquity
      contextRef="i8a2616563d5a4bf89c8fd60f83692c9c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNS0xMC0xLTEtMA_1de0b24e-0859-4f24-a06c-c05d91e56fd7"
      unitRef="usd">-100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibc5ef7f40aa14d038c66e7a001196cf4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNS0xMi0xLTEtMA_aae285a6-990e-4c63-896b-30c4ae5fca75"
      unitRef="usd">-100000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic59bca928d1a49b4afeb85ec17e11c85_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNi02LTEtMS0w_7193a5f7-f63d-47ef-96a2-25330af3dd8c"
      unitRef="usd">2364000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i36c4cb3e31604770b06e9f2af6bc483e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNi0xMi0xLTEtMA_bf6445e2-1d93-4faf-a507-293fbab40660"
      unitRef="usd">2364000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="ifc0e648162d14d4a989f9ef273403334_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNy0yLTEtMS0w_66a1e15a-d703-47a8-a1d4-0ba47162f368"
      unitRef="shares">485000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="ifc0e648162d14d4a989f9ef273403334_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNy00LTEtMS0w_cda4e265-0d67-4a0e-bbd9-c102f9d0da8f"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="ic59bca928d1a49b4afeb85ec17e11c85_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNy02LTEtMS0w_bd4aefb9-cae1-4818-885b-b8fb287e3482"
      unitRef="usd">2048000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i36c4cb3e31604770b06e9f2af6bc483e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNy0xMi0xLTEtMA_91783757-619b-495e-a7df-c587c0a3147a"
      unitRef="usd">2049000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:NetIncomeLoss
      contextRef="i825a8299b5f54c08a2883e0433b958bd_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfOC0xMC0xLTEtMA_fde7bed6-2ddf-4619-887c-693fdb117c64"
      unitRef="usd">-15980000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i36c4cb3e31604770b06e9f2af6bc483e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfOC0xMi0xLTEtMA_96530458-aeb3-432d-aea5-a40acbc00262"
      unitRef="usd">-15980000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="id422164ca6d94e2e8c2996678b723f51_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfOS04LTEtMS0w_75a61f61-f27e-4b3f-a178-01c47aa25020"
      unitRef="usd">-303000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i36c4cb3e31604770b06e9f2af6bc483e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfOS0xMi0xLTEtMA_43760a64-d989-4552-b03e-a71594eae9fb"
      unitRef="usd">-303000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i1d2d48c8e5c3470aab6bb7cb60d28da5_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTAtMi0xLTEtMA_aa094476-ff3e-4097-9cbe-84f342b6f286"
      unitRef="shares">70696000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i1d2d48c8e5c3470aab6bb7cb60d28da5_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTAtNC0xLTEtMA_5b7b6c88-159d-4fd5-a278-ad77270c1e91"
      unitRef="usd">71000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i670b6d125a2743c08d4f1fb8430f5363_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTAtNi0xLTEtMA_17b2218d-7c0c-4b45-a93d-0d80597ec259"
      unitRef="usd">782031000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if10319fa5a0a46069beb6a1617e9f6da_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTAtOC0xLTEtMA_b98de119-cb91-4b04-8981-00f04cf90afb"
      unitRef="usd">-885000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibfb2229b05674790ae2d1f3af5d1a49f_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTAtMTAtMS0xLTA_4ba9f6fc-43b8-49a4-aebf-9b463f6dbff4"
      unitRef="usd">-639721000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i97dd927c2f794a548af4aa13566b425b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTAtMTItMS0xLTA_35bd4875-be7e-47df-8b6c-350622fa96fd"
      unitRef="usd">141496000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i7e3fc5b723344c56acd377344374f431_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTEtMi0xLTEtMA_c3a8e341-3b6b-4f01-a6a0-b96285394652"
      unitRef="shares">286000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i9523a3afd1ad4cae8e97ae81c5b0ed5b_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTEtNi0xLTEtMA_b2d2d8cb-e8e3-48fe-b568-5e1af959c559"
      unitRef="usd">-116000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="ibc7d24911d4349cd97850e4e2f548bc4_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTEtMTItMS0xLTA_e3304047-1209-48f0-bb62-4c85117a9b8d"
      unitRef="usd">-116000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i7e3fc5b723344c56acd377344374f431_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTItMi0xLTEtMA_03468c2d-ebc6-4cab-8bbe-55ede6fc8745"
      unitRef="shares">301000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i9523a3afd1ad4cae8e97ae81c5b0ed5b_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTItNi0xLTEtMA_209bc94b-8366-4b4f-ad09-7961d22c3388"
      unitRef="usd">645000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ibc7d24911d4349cd97850e4e2f548bc4_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTItMTItMS0xLTA_6dd71020-4dbb-4d36-92c3-d504a77411f9"
      unitRef="usd">645000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i9523a3afd1ad4cae8e97ae81c5b0ed5b_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTMtNi0xLTEtMA_0fdce3a5-b0bd-4d8b-ac27-24a505df1b3d"
      unitRef="usd">3633000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ibc7d24911d4349cd97850e4e2f548bc4_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTMtMTItMS0xLTA_79ae9da2-4496-4150-a199-6a6c0e91c745"
      unitRef="usd">3633000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="ifa0257e64d8943b3aaf914e3e8b12824_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTUtMTAtMS0xLTA_62823a49-0c10-4b43-887c-ac1013ae03d0"
      unitRef="usd">-13015000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibc7d24911d4349cd97850e4e2f548bc4_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTUtMTItMS0xLTA_d85b7616-f0bb-477c-aa04-cfd4f5ce2a9d"
      unitRef="usd">-13015000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ie18fac1bb2c44c8b98f020e75b62badd_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTYtOC0xLTEtMA_a6e344dd-ebae-4c89-9401-722b83af44a8"
      unitRef="usd">76000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ibc7d24911d4349cd97850e4e2f548bc4_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTYtMTItMS0xLTA_87582339-5844-4ca8-82ed-dfa43f607f27"
      unitRef="usd">76000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i3d8ba5cd36dd447cba44d5143adbb7ff_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTctMi0xLTEtMA_7e449b9b-742a-4681-b38b-25c914da07f1"
      unitRef="shares">71283000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i3d8ba5cd36dd447cba44d5143adbb7ff_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTctNC0xLTEtMA_7d76c686-b095-4800-83a9-bdab39404285"
      unitRef="usd">71000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9edab7afab564a09b7d72cd4c082b2f5_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTctNi0xLTEtMA_8e163e36-9d8c-4385-8b2f-ac5f39d1cbaa"
      unitRef="usd">786193000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idc294b4f830b49dd8ecde477cdb866de_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTctOC0xLTEtMA_d223eeee-9e54-4846-98ed-3aef04e51790"
      unitRef="usd">-809000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3871bafb7b75405199d644b44fa3429b_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTctMTAtMS0xLTA_ecc730b4-9461-4565-a26b-c019c8119122"
      unitRef="usd">-652736000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8f326510b71a4deaa593f4283e018c5a_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTctMTItMS0xLTA_52758a83-1be5-45ed-9f03-08e2016d794c"
      unitRef="usd">132719000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i2c632cc5576242fab0816f314eb6446f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTgtMi0xLTEtMTk1_859faef4-0940-4f00-9fc2-62d5f6b4d420"
      unitRef="shares">258000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i2c632cc5576242fab0816f314eb6446f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTgtNC0xLTEtMjEy_aac222a2-4312-41a8-ba13-33cb4f90e3af"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="iae5604185464427688d8d6538b0064b8_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTgtNi0xLTEtMTk3_b2df8e63-8084-4277-8175-8a0ce94b46dc"
      unitRef="usd">-124000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTgtMTItMS0xLTIwMg_d3eecf76-cdfc-4e4c-adc3-273d93f27495"
      unitRef="usd">-123000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i2c632cc5576242fab0816f314eb6446f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTktMi0xLTEtMTk1_5d2124a8-9c75-48dd-8d7d-4a31d2a25ad1"
      unitRef="shares">94000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iae5604185464427688d8d6538b0064b8_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTktNi0xLTEtMTk3_8aea024b-b344-4fb4-8fff-ca54958be896"
      unitRef="usd">450000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMTktMTItMS0xLTIwMg_be5ea545-7ed6-4c58-aee5-c84311f1c194"
      unitRef="usd">450000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i2c632cc5576242fab0816f314eb6446f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjAtMi0xLTEtMjIyNQ_7c3f6e66-6212-4ae8-a618-f19a6293d490"
      unitRef="shares">2480000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i2c632cc5576242fab0816f314eb6446f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjAtNC0xLTEtMjIyNQ_7a34d4f3-4031-475e-91d5-579477c3724b"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="iae5604185464427688d8d6538b0064b8_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjAtNi0xLTEtMjIyNQ_4a46cfc1-311b-4ee7-a948-59bfb2235ea8"
      unitRef="usd">20226000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjAtMTItMS0xLTIyMjU_17be8b3e-ae41-4e6f-b3be-894b02878573"
      unitRef="usd">20228000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="iae5604185464427688d8d6538b0064b8_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjEtNi0xLTEtMzQwNw_85a05ee0-eab9-4baa-9775-1c7c1ceeb5e2"
      unitRef="usd">180000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjEtMTItMS0xLTM0MDM_aa69c941-e349-41ff-99f5-b0a44ff38f93"
      unitRef="usd">180000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iae5604185464427688d8d6538b0064b8_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjAtNi0xLTEtMTk3_04435f5f-5754-4da1-b078-21b14864d9f1"
      unitRef="usd">4358000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjAtMTItMS0xLTIwMg_a65684aa-d3a3-4f6f-95c6-059ad378337c"
      unitRef="usd">4358000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="i95bfaeccfec4464a937794e5c3340391_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjEtMTAtMS0xLTMyOA_1ecbefbc-b5a4-4759-803d-fc19a5129375"
      unitRef="usd">-5999000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjEtMTItMS0xLTIwMg_a1cb4131-1756-402a-b674-21d3f0b305f9"
      unitRef="usd">-5999000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i914a38e1ce8241ef9a128a191d3a503c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjItOC0xLTEtMjE1_f38fcba7-4f12-4860-9a45-a6ba47abfd22"
      unitRef="usd">520000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjItMTItMS0xLTIwMg_52e1629f-995e-498c-a2c6-d70b4afc189a"
      unitRef="usd">520000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i21d4b3ca64494bd286868cbca12d4736_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjQtMi0xLTEtMjA1_225d8160-99b5-411f-ad42-d4c988ce6f78"
      unitRef="shares">74115000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i21d4b3ca64494bd286868cbca12d4736_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjQtNC0xLTEtMjA1_d198af46-90a7-4a55-9058-adf37c82d2d2"
      unitRef="usd">74000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0d88028473ce421e97253b37a085c9e7_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjQtNi0xLTEtMjA1_b8cb673a-ebdb-4758-88a0-3da1204847e3"
      unitRef="usd">810923000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1c27fe0a0d9a44659e8415f944fc0c03_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjQtOC0xLTEtMjA1_4cdac42d-cfaa-42b1-868b-6d275d22a3e2"
      unitRef="usd">-289000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if25548e8d7ec4e77ab7481b4e6c75c64_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjQtMTAtMS0xLTIwNQ_ae9312a8-f424-407a-8552-5f9f51ff88e4"
      unitRef="usd">-658735000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjQtMTItMS0xLTIwNQ_a8bf6f36-7b3c-481e-a959-0fa2c6a63807"
      unitRef="usd">151973000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i15f7cdd5345a4dc1b08684ff2ea04b58_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjEtMi0xLTEtMA_35a9561b-c3c1-4018-94e1-0fe1476c6bc4"
      unitRef="shares">49338000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i15f7cdd5345a4dc1b08684ff2ea04b58_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjEtNC0xLTEtMA_8af26e8b-9f76-4af3-840a-8320e17615cd"
      unitRef="usd">49000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if7e2f1181ae54e4b90452df5f1cf9b06_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjEtNi0xLTEtMA_9a65f5e5-5371-416d-b2c7-56218c531a41"
      unitRef="usd">631605000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4be4fa2cf5014c1bb4baf526bd96dec8_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjEtOC0xLTEtMA_50b5952a-3475-4c4a-96fc-b91e6088a126"
      unitRef="usd">-687000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5bd1ce88d5fa454a8d4dad452aa7cf9c_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjEtMTAtMS0xLTA_93f39301-e8ec-4baa-8109-a04a3b91d3c8"
      unitRef="usd">-558851000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4f51ec45ffb24e5f9fd56e8ed689edf8_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjEtMTItMS0xLTA_6ea4940b-d5af-489f-98e6-e7edd390af57"
      unitRef="usd">72116000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i72b360b54d1e4205854b7f3e6a0724de_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjItMi0xLTEtMA_fcd71bb0-29e0-4019-9395-ebe21e795f5f"
      unitRef="shares">19460000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i72b360b54d1e4205854b7f3e6a0724de_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjItNC0xLTEtMA_75e64e0d-9a3a-405a-942d-78bf3aa28a9f"
      unitRef="usd">19000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i006e76de3dab42169ad0c46b3b037dab_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjItNi0xLTEtMA_31b741be-5692-4f0b-b03e-d762a6e0fd39"
      unitRef="usd">133279000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i4fa0d20dd1f44516b4524fc6b0a6ad86_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjItMTItMS0xLTA_9cfcd7a8-98f2-43ff-829a-7a028572ce34"
      unitRef="usd">133298000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i72b360b54d1e4205854b7f3e6a0724de_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjMtMi0xLTEtMA_0b2dd36b-5d59-4648-87d6-fda644ab417a"
      unitRef="shares">140000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i72b360b54d1e4205854b7f3e6a0724de_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjMtNC0xLTEtMA_84a0584b-70dd-4cd0-92f3-b570905c25fe"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i006e76de3dab42169ad0c46b3b037dab_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjMtNi0xLTEtMA_553edf76-3ca9-4f37-aaf2-e77b0532a645"
      unitRef="usd">-177000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i4fa0d20dd1f44516b4524fc6b0a6ad86_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjMtMTItMS0xLTA_e943eb88-c6f8-446b-b166-e20e2ca294cd"
      unitRef="usd">-176000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i72b360b54d1e4205854b7f3e6a0724de_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjQtMi0xLTEtMA_747f72f9-3cbf-412c-b2dc-b91afd404ec4"
      unitRef="shares">53000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i006e76de3dab42169ad0c46b3b037dab_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjQtNi0xLTEtMA_bc7445e5-9f35-4195-8e7c-abb5dbcafc28"
      unitRef="usd">255000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i4fa0d20dd1f44516b4524fc6b0a6ad86_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjQtMTItMS0xLTA_385a6880-9f6a-44ab-8f60-169af0daa2a4"
      unitRef="usd">255000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i006e76de3dab42169ad0c46b3b037dab_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjUtNi0xLTEtMA_f14725f3-4016-440d-afb6-2ceaf1bf7f1f"
      unitRef="usd">2207000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i4fa0d20dd1f44516b4524fc6b0a6ad86_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjUtMTItMS0xLTA_b22ecb35-fc63-4eca-8b2d-bbe43f6843d4"
      unitRef="usd">2207000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="ic90d17da59fa4e799e7084567efe5328_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjYtMTAtMS0xLTA_382140fd-8b7b-4eb8-8e09-219bd2f8284d"
      unitRef="usd">-25465000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i4fa0d20dd1f44516b4524fc6b0a6ad86_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjYtMTItMS0xLTA_36a82fa0-e38b-4db1-ac6c-ace761248ef4"
      unitRef="usd">-25465000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if46fa428977348b594b019217c905309_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjctOC0xLTEtMA_cf7b4eed-9d4d-4e79-8875-3fb4f9580ce9"
      unitRef="usd">10000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i4fa0d20dd1f44516b4524fc6b0a6ad86_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjctMTItMS0xLTA_02e6aa18-e0e6-40d0-a0fb-064ebda03572"
      unitRef="usd">10000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i67c00423ce714ae287a3c1d8bec497ad_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjgtMi0xLTEtMA_e44d2a49-36e3-42f8-8421-101e16cb8686"
      unitRef="shares">68991000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i67c00423ce714ae287a3c1d8bec497ad_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjgtNC0xLTEtMA_491db82b-c27f-4662-80fb-c8777968092b"
      unitRef="usd">69000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i762d0930982d49b1b7f455398759b828_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjgtNi0xLTEtMA_faa9f99c-c02b-4e20-83c9-9fe069e8dea5"
      unitRef="usd">767169000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i28fa2add73b04911a549411241057bc3_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjgtOC0xLTEtMA_cdcc3fcb-a109-4f6a-a538-5bfac54ce8ad"
      unitRef="usd">-677000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1627ca022cf54d98a6481fda43a44841_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjgtMTAtMS0xLTA_2d3b5eff-91a1-49f1-bfb0-52a9910dc1cd"
      unitRef="usd">-584316000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i83369a9b2fda4053aa441b96d2bb50e2_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjgtMTItMS0xLTA_115c1973-e627-4672-8f4f-21b6ef8259bd"
      unitRef="usd">182245000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="iab67de1396ff47ea8462d8bc17240232_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjktMi0xLTEtMA_008bdc1b-d93a-4a87-aad5-8062b7df4f63"
      unitRef="shares">183000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i8f25eadecc464dbcaa3a44c5bca043bf_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjktNi0xLTEtMA_779e6b82-c588-49f9-aab1-ff8a350482c3"
      unitRef="usd">-325000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i10aed62e1a344f72932514716243a2f3_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMjktMTItMS0xLTA_4351adaf-baf5-44df-9aa5-a13fcad8e5c9"
      unitRef="usd">-325000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="iab67de1396ff47ea8462d8bc17240232_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzAtMi0xLTEtMA_18838cf2-e959-487d-a16f-e42dad9b8456"
      unitRef="shares">130000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i8f25eadecc464dbcaa3a44c5bca043bf_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzAtNi0xLTEtMA_1cc488bd-573f-48bd-9800-3f1b4a457148"
      unitRef="usd">793000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i10aed62e1a344f72932514716243a2f3_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzAtMTItMS0xLTA_19962c90-c232-4fc0-9789-d94b239b0df3"
      unitRef="usd">793000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="iab67de1396ff47ea8462d8bc17240232_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzEtMi0xLTEtMA_b5b6f209-2b0f-4e09-a2d4-fba69b0d7d2c"
      unitRef="shares">96000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i8f25eadecc464dbcaa3a44c5bca043bf_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzEtNi0xLTEtMA_f6ae7a59-0d97-4adf-9003-dcc94bf85d58"
      unitRef="usd">641000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i10aed62e1a344f72932514716243a2f3_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzEtMTItMS0xLTA_8ac9b310-012c-42e3-a7d3-3751280dc463"
      unitRef="usd">641000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i8f25eadecc464dbcaa3a44c5bca043bf_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzItNi0xLTEtMA_4c5f36bf-faac-4998-8123-b9ccf0a0720e"
      unitRef="usd">2985000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i10aed62e1a344f72932514716243a2f3_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzItMTItMS0xLTA_3c8a9e77-1be6-46dc-9739-f90f80e56a36"
      unitRef="usd">2985000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="i0de2145a374c410095bc37bc5d98afc0_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzMtMTAtMS0xLTA_5b3d3b49-5e3f-4bc8-b28a-c9fc50bd0840"
      unitRef="usd">-13753000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i10aed62e1a344f72932514716243a2f3_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzMtMTItMS0xLTA_5bac0ca5-ef11-45de-bfbb-3fb5a52cb0aa"
      unitRef="usd">-13753000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i01c50ded41e34c848e04a247fa124bd3_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzQtOC0xLTEtMA_5d505467-17b0-4a23-80a3-dd2648dcac4c"
      unitRef="usd">54000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i10aed62e1a344f72932514716243a2f3_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzQtMTItMS0xLTA_dc95c57a-f47e-419b-99cf-fd0d9375ad23"
      unitRef="usd">54000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ia605d1ab95f846f0a9f63de67c948fd4_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzUtMi0xLTEtMA_4d0ebcfb-8134-46c8-9953-6d84a09dd81c"
      unitRef="shares">69400000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ia605d1ab95f846f0a9f63de67c948fd4_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzUtNC0xLTEtMA_a3373014-ac62-4a36-a5fd-2835497bcc08"
      unitRef="usd">69000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic3b58d4f02e844cb988b744432f0e0f9_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzUtNi0xLTEtMA_288321c3-db0a-4e42-89c7-3881d28f0068"
      unitRef="usd">771263000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i43b1f7df8afe4a64be00a01331b55b55_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzUtOC0xLTEtMA_8ad786e1-984d-46e7-9b3f-b8747ea57958"
      unitRef="usd">-623000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i69bd8f22916f463b9f97b4855c9980e9_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzUtMTAtMS0xLTA_25b360ea-6989-480d-89dd-d916907caa22"
      unitRef="usd">-598069000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i813b7fdc72d64db19cd209236a971747_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfMzUtMTItMS0xLTA_863329e2-bb29-4433-81b1-87ffb30f1f27"
      unitRef="usd">172640000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i632b1c03d2644d748bb6a03e0f90c982_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjItMi0xLTEtMjE4_b4d2cfa0-9612-45cc-b27e-810acf436ab8"
      unitRef="shares">149000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i632b1c03d2644d748bb6a03e0f90c982_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjItNC0xLTEtMjE5_16ae2a92-8d87-4cea-97be-dd5fd303ff51"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i8d08643e37974cfba86f788447c6f6e2_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjItNi0xLTEtMjE5_4ed988a4-ca49-4096-8940-e1e3c4736e15"
      unitRef="usd">-70000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjItMTItMS0xLTIyNA_6b3b5cc3-23df-436a-b88f-d994f9726254"
      unitRef="usd">-69000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i632b1c03d2644d748bb6a03e0f90c982_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjMtMi0xLTEtMjE4_97495a07-d4dd-4bff-bf04-5449b11f9987"
      unitRef="shares">1000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i8d08643e37974cfba86f788447c6f6e2_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjMtNi0xLTEtMjE5_cb306925-c084-4efa-bac3-154e4074d818"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjMtMTItMS0xLTIyNA_ed47eec5-eff1-47f8-9d69-28affbb7f508"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i8d08643e37974cfba86f788447c6f6e2_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjQtNi0xLTEtMjE5_fd0fbeaf-40c6-4746-91f4-70358e6ed71d"
      unitRef="usd">3055000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjQtMTItMS0xLTIyNA_4a7a3584-1565-4ba8-9d51-78e779268f4e"
      unitRef="usd">3055000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="iaf04055382af45aca35807748405a7fa_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjUtMTAtMS0xLTIyMQ_a7a5e577-a9b2-433e-82dc-c36a5d6dec4b"
      unitRef="usd">-12887000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjUtMTItMS0xLTIyNA_c60aaab1-49b6-46e2-be3b-de3b3229b7aa"
      unitRef="usd">-12887000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iab02e207f49f4cb8bf2279f9e687111f_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjYtOC0xLTEtMjIx_e14e177b-0856-495b-abee-5b768612f353"
      unitRef="usd">-135000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjYtMTItMS0xLTIyNA_3f043e79-6a15-4b0c-af1d-bcb0ff590748"
      unitRef="usd">-135000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i2d98876aa25d4522b3599841a5fc587e_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjctMi0xLTEtMjI5_295e023d-30cb-402e-969e-e02b7ffa6ea3"
      unitRef="shares">69550000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i2d98876aa25d4522b3599841a5fc587e_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjctNC0xLTEtMjI3_8bac111f-1580-4e83-8cf2-83d62f969775"
      unitRef="usd">70000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if4c2400e4e364dc9b526d08b10e59300_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjctNi0xLTEtMjM0_1dc0591a-73df-4ba2-89c9-f460fffb5be6"
      unitRef="usd">774249000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i14df96aacd544435a5bd5f0a00f0fa84_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjctOC0xLTEtMjIx_3f5d4751-6bab-4235-b34c-caeb9748fd32"
      unitRef="usd">-758000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id976dd8bd6b34f3b9a6b24612ef2d5bc_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjctMTAtMS0xLTIyMQ_fcc4d57f-9de4-4562-b104-3402fe1019f8"
      unitRef="usd">-610956000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic00370e08713445eacc3076d8d3e2ced_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yNS9mcmFnOmVlNWY2YmNkN2EwYjQwODdiMDU2NDU5ZjFlZTEzMTI4L3RhYmxlOjA5ZGYxODFhYTAwNjRjOGZiM2E2NzNlMzBjZTJiNjQ2L3RhYmxlcmFuZ2U6MDlkZjE4MWFhMDA2NGM4ZmIzYTY3M2UzMGNlMmI2NDZfNjctMTItMS0xLTIyNA_c4a73686-5f30-495c-91cf-e0e7ea850c7b"
      unitRef="usd">162605000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMy0yLTEtMS0w_7f2d42d9-bc29-4fc8-b3d6-88723494db9f"
      unitRef="usd">-34994000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMy0yLTEtMS0w_944f1989-8792-4656-9689-4fabd5f0837f"
      unitRef="usd">-34994000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMy00LTEtMS0w_1c78e136-8d7f-4eaf-b69e-74e250ebef22"
      unitRef="usd">-52105000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNS0yLTEtMS0w_c23dbefc-639d-49a6-ac1b-f6c920fc4f60"
      unitRef="usd">2988000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNS00LTEtMS0w_c89d2909-06ec-4903-a8f9-678601cb7c32"
      unitRef="usd">3484000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:ShareBasedCompensation
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNi0yLTEtMS0w_1dcd3302-db71-464f-9a9d-735b4a7cd60f"
      unitRef="usd">10358000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNi00LTEtMS0w_b9e41adc-faf8-44a3-ac42-8420d0cca578"
      unitRef="usd">8292000</us-gaap:ShareBasedCompensation>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNy0yLTEtMS0w_9c8ca640-b0ef-4d83-a3ce-3a2da7927c7e"
      unitRef="usd">8929000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNy00LTEtMS0w_98641d25-310a-47c7-88ce-c91315256979"
      unitRef="usd">8400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfOC0yLTEtMS0w_c95c3e10-01fe-4ce4-b438-080552c020c3"
      unitRef="usd">415000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfOC00LTEtMS0w_32bb2705-0366-4e3e-afee-becf49f49b86"
      unitRef="usd">2130000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTAtMi0xLTEtMA_0f941aa4-d429-4d1e-baf5-bb0ab2fea383"
      unitRef="usd">1863000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTAtNC0xLTEtMA_c3998f84-01c5-4a00-8b39-b5f4cdf603ef"
      unitRef="usd">-371000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTEtMi0xLTEtMA_096b8e9a-3f64-4808-bc97-8dd0fbf3f86c"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTEtNC0xLTEtMA_316334b9-b3cc-444a-ba10-7d8c53abe3e6"
      unitRef="usd">-9000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTItMi0xLTEtMA_f8832aec-016d-40fd-be27-edfc38a97199"
      unitRef="usd">680000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTItNC0xLTEtMA_6167f2e4-5dd2-45ae-baa4-b0d10d8c5f67"
      unitRef="usd">1356000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTMtMi0xLTEtMA_496e3b2f-a785-4140-a72e-7d8ce9c48102"
      unitRef="usd">-191000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTMtNC0xLTEtMA_c048a36f-9af5-4c7b-9cfd-d58e2abb92bc"
      unitRef="usd">-52000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTQtMi0xLTEtMA_609ca232-1277-465a-bd7b-074ea3f5eef9"
      unitRef="usd">13000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTQtNC0xLTEtMA_8093a691-40e7-4005-ba26-c8dfc54c01e2"
      unitRef="usd">195000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTYtMi0xLTEtMA_900ea0c4-af65-48f0-a841-e0dcdfaab1d9"
      unitRef="usd">-967000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTYtNC0xLTEtMA_c410918a-cdda-4e12-a37c-fe85118e34aa"
      unitRef="usd">-3195000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTctMi0xLTEtMA_e426e31e-cd48-474e-b376-d4aec72879ad"
      unitRef="usd">6773000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTctNC0xLTEtMA_935f3b28-2fe1-4f29-bcd7-436a08fcaed6"
      unitRef="usd">3672000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTgtMi0xLTEtMA_e2146c0d-c128-40ab-b814-cd30e734403a"
      unitRef="usd">2395000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTgtNC0xLTEtMA_11c512cb-2e3b-4dff-a4cb-62176e6220b1"
      unitRef="usd">1338000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTktMi0xLTEtMA_e9991169-042b-4308-b71e-ffc1714c0988"
      unitRef="usd">4996000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMTktNC0xLTEtMA_f3490f26-65f0-49b1-87f8-6a9db1db3111"
      unitRef="usd">605000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjAtMi0xLTEtMA_67ab2ce2-0178-4ed5-863b-e9268851d257"
      unitRef="usd">1258000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjAtNC0xLTEtMA_06b61884-137c-4dda-bdce-75861cb378c0"
      unitRef="usd">1592000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjEtMi0xLTEtMA_4a3f8b11-cfa5-44f4-b5df-216246bf4fd9"
      unitRef="usd">-180000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjEtNC0xLTEtMA_46cb53b5-666b-48ea-8c77-1fe494288135"
      unitRef="usd">-10506000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjItMi0xLTEtMA_e7cff63c-61c6-451c-84f2-1dda1bed2d00"
      unitRef="usd">-11684000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjItNC0xLTEtMA_a7633ef2-6db8-4ba9-8bde-799e63a4f6aa"
      unitRef="usd">-29691000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjQtMi0xLTEtMA_d3c77004-1b3a-4cc1-a6c9-db479a9eeab7"
      unitRef="usd">5154000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjQtNC0xLTEtMA_0033b516-12d7-4570-a48e-d35ab43fb4bf"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjUtMi0xLTEtMA_1e56ee54-d274-4494-ad22-7d665cf03f7a"
      unitRef="usd">0</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjUtNC0xLTEtMA_c63c5ede-1240-4e9a-82c4-17f8691c2061"
      unitRef="usd">52719000</us-gaap:PaymentsToAcquireInvestments>
    <fldm:ProceedsFromResearchAndDevelopmentGrant
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjYtMi0xLTEtMzQ3Mg_574d0aba-ee76-49c1-b9d7-bc4be7e0382c"
      unitRef="usd">11151000</fldm:ProceedsFromResearchAndDevelopmentGrant>
    <fldm:ProceedsFromResearchAndDevelopmentGrant
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjYtNC0xLTEtMzQ3Mg_d3865658-91d4-47bd-8f90-c8ba517817ef"
      unitRef="usd">0</fldm:ProceedsFromResearchAndDevelopmentGrant>
    <us-gaap:ProceedsFromSaleOfOtherInvestments
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjYtMi0xLTEtMA_b4e35756-ffda-40c5-82bf-44e3ed4ff807"
      unitRef="usd">5010000</us-gaap:ProceedsFromSaleOfOtherInvestments>
    <us-gaap:ProceedsFromSaleOfOtherInvestments
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjYtNC0xLTEtMA_d1c40705-630e-4c6c-a8a2-b1698b9156ae"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfOtherInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjctMi0xLTEtMA_d80b359d-6726-4289-9983-b243fa44dfb8"
      unitRef="usd">31800000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjctNC0xLTEtMA_1085f281-24bb-41b5-941c-f71322856b46"
      unitRef="usd">16000000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjktMi0xLTEtMA_c0fef6d5-c0b1-4a52-94b2-0d154b593ba0"
      unitRef="usd">2010000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMjktNC0xLTEtMA_c53d4923-95e6-4466-ab60-449fcb7516d6"
      unitRef="usd">2031000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMzAtMi0xLTEtMA_dd588b45-4c9f-4783-b0cb-8d20c787b9e7"
      unitRef="usd">40797000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMzAtNC0xLTEtMA_35123194-0ca7-4133-802c-464fb532f65f"
      unitRef="usd">-38750000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMzYtMi0xLTEtMjM0OQ_016d9fef-cfed-42fb-984d-a244091d2852"
      unitRef="usd">20226000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMzYtNC0xLTEtMjM0OQ_9d26e0a6-7a80-4814-89e6-55f2db9fab1b"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentOfFinancingAndStockIssuanceCosts
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMzUtMi0xLTEtMA_9a1ab7a0-cbe6-44f1-aa42-f6e2691dd261"
      unitRef="usd">509000</us-gaap:PaymentOfFinancingAndStockIssuanceCosts>
    <us-gaap:PaymentOfFinancingAndStockIssuanceCosts
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMzUtNC0xLTEtMA_937f5d90-d52d-4265-863f-5fcc64685ae3"
      unitRef="usd">128000</us-gaap:PaymentOfFinancingAndStockIssuanceCosts>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMzYtMi0xLTEtMA_910573b5-9688-4213-a7c4-c45cde715e20"
      unitRef="usd">450000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMzYtNC0xLTEtMA_3a69fdeb-8035-4ed2-be79-fc62abd16353"
      unitRef="usd">1049000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMzctMi0xLTEtMA_ac818eb7-87dc-4e8a-8717-6befdd20d53d"
      unitRef="usd">645000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMzctNC0xLTEtMA_974e81ad-65b2-48e8-9706-b7e20f03bcc2"
      unitRef="usd">641000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMzgtMi0xLTEtMA_881b332c-0b58-4bfe-8c54-d687423396d3"
      unitRef="usd">387000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfMzgtNC0xLTEtMA_bc973d8f-cbe4-4e1e-8b0d-ed03beba3d1b"
      unitRef="usd">556000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNDEtMi0xLTEtMA_3ae59e16-db5f-4b3f-9bce-02392ea52e89"
      unitRef="usd">20425000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNDEtNC0xLTEtMA_a6819b2f-3ad7-4c70-bbc8-f548a9956caa"
      unitRef="usd">1006000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNDItMi0xLTEtMA_a8d2baa1-6d32-42ed-a1b4-42c5b611e2aa"
      unitRef="usd">86000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNDItNC0xLTEtMA_99ff7bb1-73c7-49dd-91b5-4ccef9c4055b"
      unitRef="usd">-5000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNDMtMi0xLTEtMA_8708ef1a-5877-4bde-91b6-dba85ea4e208"
      unitRef="usd">49624000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNDMtNC0xLTEtMA_c004a943-4e14-4ae6-aac9-f47e337581ce"
      unitRef="usd">-67440000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNDQtMi0xLTEtMA_defe38d0-6e91-4171-9143-2e64cbd23ba2"
      unitRef="usd">23736000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4f51ec45ffb24e5f9fd56e8ed689edf8_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNDQtNC0xLTEtMA_f1d02549-f672-4317-87ef-17419b81e33f"
      unitRef="usd">95401000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNDUtMi0xLTEtMA_c8b7cd76-62db-427f-9da2-a6dfcd8f65ef"
      unitRef="usd">73360000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic00370e08713445eacc3076d8d3e2ced_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNDUtNC0xLTEtMA_b6e75ae5-8191-4847-9868-f0572aeef885"
      unitRef="usd">27961000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNDctMi0xLTEtMA_4033449b-53d2-4422-b0ae-eb6c3bc108c9"
      unitRef="usd">86000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNDctNC0xLTEtMA_c955d7bd-8706-49d2-a8aa-107f7a70e17a"
      unitRef="usd">3513000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNDgtMi0xLTEtMA_21aa24e4-82ba-4988-8d94-ede0a81725bf"
      unitRef="usd">386000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNDgtNC0xLTEtMA_29a655d3-c624-44f6-ab3a-c18d7d3cd939"
      unitRef="usd">128000</us-gaap:IncomeTaxesPaidNet>
    <fldm:AssetRetirementObligationsIncurredButNotYetPaid
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNTAtMi0xLTEtMA_38a5951d-4ca7-44b1-a86e-a8da3d08bd61"
      unitRef="usd">319000</fldm:AssetRetirementObligationsIncurredButNotYetPaid>
    <fldm:AssetRetirementObligationsIncurredButNotYetPaid
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8yOC9mcmFnOmNhNTA4ZDM3MjU4ZjQ2M2U5ZjU5YTA0MmYwNDEwOWY3L3RhYmxlOmUzY2UzMzg5OTY1ZDQ1ZjViZjljMGM1YzIxMWQwZTExL3RhYmxlcmFuZ2U6ZTNjZTMzODk5NjVkNDVmNWJmOWMwYzVjMjExZDBlMTFfNTAtNC0xLTEtMA_7d2dbe86-8f50-44e3-b574-80af3c4b09c5"
      unitRef="usd">311000</fldm:AssetRetirementObligationsIncurredButNotYetPaid>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNC9mcmFnOmE3Mzg5NGZkMzE4NzQ0NTlhYTA4ZTZlMDU1NWUzYjY2L3RleHRyZWdpb246YTczODk0ZmQzMTg3NDQ1OWFhMDhlNmUwNTU1ZTNiNjZfOTYy_12a9ad5e-fd10-4d57-91da-f7e830983d42">Description of BusinessFluidigm Corporation (the Company, Fluidigm, we, our or us) creates, manufactures, and markets technologies and tools for life sciences research, including preparatory and analytical instruments for Mass Cytometry, PCR, Library Prep, Single Cell Genomics, and consumables, including integrated fluidic circuits (IFC), assays, and reagents. Our focus is on the most pressing needs in translational and clinical research, including infectious disease, cancer, immunology and immunotherapy. We sell our instruments, consumables and services to academic institutions, clinical laboratories, and contract research organizations, as well as biopharmaceutical, biotechnology, and agricultural biotechnology companies. The Company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was founded in 1999 and is headquartered in South San Francisco, California.</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQ0MDY_75f2f5b4-5eb8-40ae-a209-6576188e50bc">Summary of Significant Accounting Policies&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation and Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (U.S. GAAP) and include the accounts of our wholly owned subsidiaries. As of September&#160;30, 2020, we had wholly owned subsidiaries in Singapore, Canada, the Netherlands, Japan, France, the United Kingdom, China, Germany and Norway. All subsidiaries, except for Singapore, use their local currency as their functional currency. The Singapore subsidiary uses the U.S. dollar as its functional currency. All intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain prior period amounts in the condensed consolidated statements of income and condensed consolidated statements of cash flows were reclassified to conform with the current period presentation. These reclassifications were immaterial and did not affect prior period total assets, total liabilities, stockholders&#x2019; equity, total revenue, total costs and expenses, loss from operations or net loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Unaudited Interim Financial Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying interim condensed consolidated financial statements and related disclosures are unaudited, have been prepared on the same basis as the annual financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for a fair statement of the results of operations for the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The year-end condensed consolidated balance sheet was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP.  The condensed consolidated results of operations for the nine months ended September 30, 2020 are not necessarily indicative of the results to be expected for the full year or for any other year or interim period. The accompanying condensed consolidated financial statements should be read in conjunction with the audited financial statements and the related notes for the year ended December 31, 2019 included in our annual report on Form 10-K, filed with the SEC on February 27, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in accordance with U.S.&#160;GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions believed to be reasonable, which together form the basis for making judgments about the carrying values of assets and liabilities. The full extent to which the COVID-19 pandemic impacts our business, results of operations and financial condition will depend on numerous evolving factors including, but not limited to, the magnitude and duration of the pandemic, the extent to which it will impact worldwide macroeconomic conditions, including the speed of recovery, and governmental and business reactions to the pandemic. We assessed certain accounting matters that generally require consideration of forecasted financial information in the context of information available to us and the unknown impact of COVID-19 as of September 30, 2020. These accounting matters included, but were not limited to, our allowance for doubtful accounts and credit losses, inventory and related reserves and the carrying value of goodwill and other long-lived assets. Actual results could differ materially from these estimates and could have a material adverse effect on our condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currency&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities of non-U.S. subsidiaries that use the local currency as their functional currency are translated into U.S. dollars at exchange rates in effect on the balance sheet date. The adjustments resulting from the foreign currency translations are recorded in accumulated other comprehensive loss, a separate component of stockholders&#x2019; equity. Income and expense accounts are translated at monthly average exchange rates during the year. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generate revenue primarily from the sale of our products and services. Product revenue is derived from the sale of instruments and consumables, including IFCs, assays and reagents. Service revenue is derived from the sale of instrument service contracts, repairs, installation, training and other specialized product support services. We also generate revenue from development agreements, license and royalty agreements and grants. Revenue is reported net of any sales, use and value-added taxes we collect from customers as required by government authorities. Research and development cost includes costs associated with development and grant revenue. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue based on the amount of consideration we expect to receive in exchange for the goods and services we transfer to the customer. Our commercial arrangements typically include multiple distinct products and services, and we allocate revenue to these performance obligations based on their relative standalone selling prices. Standalone selling prices (SSP) are generally determined using observable data from recent transactions. In cases where sufficient data is not available, we estimate a product&#x2019;s SSP using a cost plus a margin approach or by applying a discount to the product&#x2019;s list price.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Product Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize product revenue at the point in time when control of the goods passes to the customer and we have an enforceable right to payment. This generally occurs either when the product is shipped from one of our facilities or when it arrives at the customer&#x2019;s facility, based on the contractual terms. Customers generally do not have a unilateral right to return products after delivery. Invoices are generally issued at shipment and generally become due in 30 to 60 days.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We sometimes perform shipping and handling activities after control of the product passes to the customer. We have made an accounting policy election to account for these activities as product fulfillment activities rather than as separate performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Service Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue from repairs, maintenance, installation, training and other specialized product support services at the point in time the work is completed. Installation and training services are generally billed in advance of service. Repairs and other services are generally billed at the point the work is completed. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue associated with instrument service contracts is recognized on a straight-line basis over the life of the agreement, which is generally &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfNTUwMg_166c41b6-37fc-4b8a-8206-665c77cdd303"&gt;one&lt;/span&gt; to three years. We believe this time-elapsed approach is appropriate for service contracts because we provide services on demand throughout the term of the agreement. Invoices are generally issued in advance of service on a monthly, quarterly, annual or multi-year basis. Payments made in advance of service are reported on our condensed consolidated balance sheet as deferred revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Development Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has entered and may continue to enter into development agreements with third parties that provide for up-front and periodic milestone payments. Our development agreements may include more than one performance obligation. At the inception of the contract, we assess whether each obligation represents a separate performance obligation or whether such obligations should be combined as a single performance obligation. The transaction price for each development agreement is determined based on the amount of consideration we expect to be entitled to for satisfying all performance obligations within the agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. In arrangements where we satisfy performance obligation(s) over time, we recognize development revenue typically using an input method based on our costs incurred relative to the total expected cost which determines the extent of our progress toward completion. As part of the accounting for these arrangements, we must develop estimates and assumptions that require judgment to determine the transaction price and progress towards completion. We review our estimate of the transaction price and progress toward completion based on the best information available to recognize the cumulative progress toward completion as of the end of each reporting period, and make revisions to such estimates as necessary. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may also generate revenue from development or collaboration agreements that do not include upfront or milestone-based payments and generally recognize revenue on these types of agreements based on the timing of development activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other revenue consists of license and royalty revenue and grant revenue. We recognize revenue from license agreements when the license is transferred to the customer and the customer is able to use and benefit from the license. For contracts that include sales-based royalties, we recognize revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, we entered into an agreement to settle intellectual property infringement claims, in which we received a $3.5 million payment in exchange for a perpetual license under certain Fluidigm intellectual property. The settlement is considered a multiple-element arrangement with each element accounted for individually. Accordingly, $3.1 million of the proceeds was recognized as license revenue and $0.4 million was offset against legal costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We receive grants from various entities to perform research and development activities over contractually defined periods. Revenue is generally recognized provided that the conditions under which the grants were provided have been met and any remaining performance obligations are perfunctory. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Incremental sales commission costs incurred to obtain instrument service contracts are capitalized and amortized to selling, general and administrative expense over the life of the contract, which is generally &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfOTE2Nw_1c099c37-d651-4eff-8b5d-06284641991e"&gt;one&lt;/span&gt; to three years. As a practical expedient, we expense sales commissions associated with product support services that are delivered in less than one year as they are incurred. Sales commissions associated with the sale of products are expensed as they are incurred. To date, capitalized contract costs have been immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Product Warranties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generally provide a one-year warranty on our instruments. We accrue for estimated warranty obligations at the time of product shipment. We periodically review our warranty liability and record adjustments based on the terms of warranties provided to customers, and historical and anticipated warranty claim experience. This expense is recorded as a component of cost of product revenue in the condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Judgments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Applying the revenue recognition practices discussed above often requires significant judgment. Judgment is required when identifying performance obligations, estimating SSP and allocating purchasing consideration in multi-element arrangements, determining the transaction price and progress towards completion on development arrangements and estimating the future amount of our warranty obligations. Moreover, significant judgment is required when interpreting commercial terms and determining when control of goods and services passes to the customer. Any material changes created by errors in judgment could have a material effect on our operating results and overall financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade accounts receivable are recorded at net invoice value. We review our exposure to accounts receivable and provide allowances of specific amounts if collectability is no longer reasonably assured based on historical experience and specific customer collection issues. We evaluate such allowances on a regular basis and adjust them as needed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Concentrations of Business and Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject us to credit risk consist of cash, cash equivalents, investments, and accounts receivable. Our cash, cash equivalents, and investments may consist of deposits held with banks, money market funds, and other highly liquid investments that may at times exceed federally insured limits. Cash equivalents and investments are financial instruments that potentially subject us to concentrations of risk. Under our investment policy, we invest primarily in securities issued by the U.S. government. The goals of our investment policy, in order of priority, are as follows: preserve capital, meet liquidity needs, and optimize returns. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generally do not require collateral to support credit sales. To reduce credit risk, we perform credit evaluations of our customers. One customer from whom we derived development revenue exceeded 10% of revenue for the three and nine months ended September&#160;30, 2020. No other customer represented more than 10% of total revenue for the three and nine months ended September&#160;30, 2020 or 2019. Including the development revenue, revenues from our five largest customers were 31% and 25% &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of total revenue for the three months ended September&#160;30, 2020 and 2019, respectively. Revenues from our five largest customers were 23% and 20% of total revenue for the nine months ended September&#160;30, 2020 and 2019, respectively. There was no single customer that represented more than 10% of total accounts receivable at September&#160;30, 2020, or December&#160;31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our products include components that are currently procured from a single source or a limited number of sources. We believe that other vendors would be able to provide similar components; however, the qualification of such vendors may require start-up time. In order to mitigate any adverse impacts from a disruption of supply, we attempt to maintain an adequate supply of critical limited-source components.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine if an arrangement is a lease, or contains a lease, at inception. Operating leases are included in operating lease right-of-use (ROU) assets and current and non-current operating lease liabilities in our condensed consolidated balance sheets. ROU assets represent our right-to-use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we generally use our incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. Significant judgment is required in determining the incremental collateralized borrowing rate. Lease expense for lease payments is recognized on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We elected the short-term lease recognition exemption for all leases that qualify. For those leases that qualify, we will not recognize ROU assets or lease liabilities for leases with an initial lease term of one year or less. We also elected not to separate lease and nonlease components for our building leases. The nonlease components are generally variable in nature and are expected to represent most of our variable lease costs. Variable costs are expensed as incurred. We have taken a portfolio approach for our vehicle leases by country. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Goodwill, Intangible Assets and Other Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill, which has an indefinite useful life, represents the excess of cost over fair value of net assets acquired. Our intangible assets include developed technology, patents and licenses. The cost of identifiable intangible assets with finite lives is generally amortized on a straight-line basis over the assets&#x2019; respective estimated useful lives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and intangible assets with indefinite lives are not subject to amortization but are tested for impairment on an annual basis during the fourth quarter or whenever events or changes in circumstances indicate the carrying amount of these assets may not be recoverable. Events or changes in circumstances that could affect the likelihood that we will be required to recognize an impairment charge include, but are not limited to, declines in our stock price or market capitalization, economic downturns and other macroeconomic events, including the current COVID-19 pandemic, declines in our market share or revenues, and an increase in our losses, rapid changes in technology, failure to achieve the benefits of capacity increases and utilization, significant litigation arising out of an acquisition, or other matters. Any impairment charges could have a material adverse effect on our operating results and net asset value in the quarter in which we recognize the impairment charge.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In evaluating our goodwill and intangible assets with indefinite lives for indications of impairment, we first conduct an assessment of qualitative factors to determine whether it is more likely than not that the fair value of our reporting unit is less than its carrying amount. If we determine that it is more likely than not that the fair value of our reporting unit is less than its carrying amount, we compare the fair value of our reporting unit to its carrying value. If the fair value of our reporting unit exceeds its carrying value, goodwill is not considered impaired and no further analysis is required. If the carrying value of the reporting unit exceeds its fair value, then an impairment loss equal to the difference would be recorded to goodwill. We did not recognize any impairment of goodwill for any of the periods presented herein.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate our long-lived assets, including finite-lived intangibles, for indicators of possible impairment when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. If any indicator of impairment exists, we assess the recoverability of the affected long-lived assets by determining whether the carrying value of the asset can be recovered through undiscounted future operating cash flows. If impairment is indicated, we estimate the asset&#x2019;s fair value using future discounted cash flows associated with the use of the asset and adjust the carrying value of the asset accordingly. We did not recognize any impairment of intangibles for any of the periods presented herein.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Deferred Grant Income &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2020, we executed a definitive contract with the National Institutes of Health (NIH) for a project under the NIH Rapid Acceleration of Diagnostics (RADx) program. The definitive contract, which amended the letter contract we entered &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;into with the NIH in July 2020 (collectively, the NIH Contract), has a total value of up to $34.0&#160;million upon the achievement of certain conditional milestones. Proceeds from the NIH Contract will be used primarily to expand production capacity and product throughput capabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounting for the NIH Contract does not fall under ASC 606, Revenue from Contracts with Customers, as the NIH will not benefit directly from our expansion or product development.  As there is no authoritative guidance under U.S. GAAP on accounting for government assistance to for-profit business entities, we applied International Accounting Standards (IAS) 20, Accounting for Government Grants and Disclosure of Government Assistance, by analogy when accounting for the NIH Contract payments to Fluidigm. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The NIH Contract proceeds meet the definition of grants related to assets as the primary condition for the payments is to fund the purchase and construction of longer-term assets to scale up production capacity. Under IAS 20, government grants related to assets are presented in the statement of financial position either by setting up the grant as deferred income or by deducting the grant in arriving at the carrying amount of the asset. Either of these two methods of presentation of grants related to assets in financial statements are regarded as acceptable alternatives under IAS 20. We have elected to record the grants received as deferred income using the first method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under IAS 20, grant proceeds are recognized when there is reasonable assurance the conditions of the grant will be met and the grant will be received.  With the NIH Contract, this occurs when either each milestone has been accepted by NIH or management concludes the conditions of the grant have been substantially met.  We record the NIH Contract proceeds as deferred income.  Proceeds used for capital expenditures will be amortized over the period of depreciation for the assets as a reduction of depreciation expense.  Any portion of the proceeds used to reimburse research and development expense are recorded as a reduction of those expenses incurred to date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Convertible Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2014, we closed an underwritten public offering of $201.3 million aggregate principal amount of our 2.75% Senior Convertible Notes due 2034 (2014 Notes). In March 2018, we entered into separate privately negotiated transactions with certain holders of our 2014 Notes to exchange $150.0 million in aggregate principal amount of the 2014 Notes for our 2.75% Exchange Convertible Senior Notes due 2034 (2018 Notes). As the 2018 Notes were convertible, at our election, into cash, shares of our common stock, or a combination of cash and shares of our common stock, we accounted for the 2018 Notes under the cash conversion guidance in ASC 470, whereby the embedded conversion option in the 2018 Notes was separated and accounted for in equity. In the first quarter of 2019, the 2018 Notes were converted into 19.5 million shares of our common stock and the 2018 Notes were retired. We recorded a loss of $9.0 million on the retirement of the 2018 Notes. We determined the fair value of the 2018 Notes&#160;using valuation techniques that required us to make assumptions related to the implied discount rate.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2019, we closed a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of $55.0 million aggregate principal amount of our 5.25% Senior Convertible Notes due 2024 (2019 Notes). Most of the issuance proceeds were used to retire approximately $50.2 million of aggregate principal amount of our 2014 Notes, leaving approximately $1.1 million of aggregate principal amount of our 2014 Notes outstanding. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As the 2019 Notes do not provide for a cash conversion feature, the 2019 Notes are recorded as debt in their entirety in accordance with ASC 470. For the 2014, 2018 and 2019 Notes, offering-related costs, including underwriting costs, were capitalized as debt issuance costs, recorded as an offset to the carrying value of the related Notes, and are amortized over the expected term of the related Notes using the effective interest method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 8 for a detailed discussion of the accounting treatment of the transactions and additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Comprehensive Loss &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive loss is comprised of net loss and other comprehensive income (loss). Other comprehensive income (loss) consists of unrealized gains and losses on our investments and foreign currency translation adjustments. Total comprehensive loss for all periods presented has been disclosed in the condensed consolidated statements of comprehensive loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of accumulated other comprehensive loss, net of tax, for the three and nine months ended September&#160;30, 2020 are as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gain (Loss) on Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(618)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(303)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(303)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance at March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(921)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(812)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(809)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(289)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(289)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Immaterial amounts of unrealized gains and losses have been reclassified into the condensed consolidated statement of operations for the three and nine months ended September&#160;30, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net Loss per Share &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our basic and diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding for the period. Restricted stock units, performance share units, and stock options to purchase our common stock are considered to be potentially dilutive common shares but have been excluded from the calculation of diluted net loss per share as their effect is anti-dilutive for all periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following potentially dilutive common shares were excluded from the computations of diluted net loss per share for the periods presented because including them would have been anti-dilutive (in thousands):  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options, restricted stock units and performance awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Convertible Notes potential make-whole shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2014 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:15pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recent Accounting Changes and Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Adoption of New Accounting Guidance &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the U.S.-based Financial&#160;Accounting Standards&#160;Board (FASB) issued Accounting Standards Update (ASU) 2018-15-Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40), which establishes new guidance on the accounting for costs incurred to implement a cloud computing arrangement that is considered a service arrangement. The new guidance requires the capitalization of such costs, aligning it with the accounting for costs associated with developing or obtaining internal-use software. The new guidance is effective for fiscal years beginning after December 15, 2019. The adoption of the new guidance did not have a significant impact on our financial results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2017, the FASB issued ASU 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The ASU eliminates the requirement for an entity to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, an entity performs its annual, or interim, goodwill impairment testing by comparing the fair value of a reporting unit with its carrying amount and recording an impairment charge for the amount by which the carrying amount exceeds the fair value. The ASU is effective for annual and interim goodwill impairment testing performed for our fiscal year beginning January 1, 2020. The adoption of the new guidance did not have a significant impact on our financial results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The FASB issued two ASUs related to financial instruments &#x2013; credit losses. The ASUs issued were: (1) in June 2016, &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQzNjc_09dd10ab-4bd6-4959-a108-786ca8b4f9e5"&gt;ASU 2016-13, Financial Instruments-Credit Losses (Topic 326)&lt;/span&gt;: Measurement of Credit Losses on Financial Instruments, and (2) in November 2018, ASU 2018-19-Codification Improvements to Topic 326, Financial Instruments-Credit Losses. ASU 2016-13 is intended to improve financial reporting by requiring more timely recording of credit losses on loans and other financial &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;instruments held by financial institutions and other organizations. ASU 2018-19 clarifies that receivables arising from operating leases are not within the scope of the credit losses standard, but rather, should be accounted for in accordance with the lease standard. These ASUs are effective for fiscal years beginning after December 15, 2019, and interim periods within those years, with early adoption permitted. The modified retrospective method is required upon adoption. The adoption of the new guidance resulted in an adjustment of approximately $0.1 million to reduce the accumulated deficit component of stockholders&#x2019; equity and decrease current assets by the same amount in our condensed consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06 Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity. The amendment to this ASU reduces the number of accounting models for convertible instruments and allows more contracts to qualify for equity classification, which is expected to result in more convertible instruments being accounted for as a single unit, rather than being bifurcated between debt and equity. The new guidance is effective for fiscal years beginning after December 15, 2021. We are currently evaluating the impact of adoption on our condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2019, the FASB issued ASU 2019-12-Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The amendments in this update improve consistent application of and simplify U.S. GAAP for Topic 740 by clarifying and amending existing guidance for, among other items, intra-period allocation, reporting tax law changes and losses in interim periods, state and local taxes not fully based on income and recognition of deferred tax liability related to certain transactions. There is also new guidance related to consolidated group reporting and tax impacts resulting from business combinations. The new guidance is effective for fiscal years beginning after December 15, 2020. We are currently evaluating the impact of adoption on our condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQzNDg_a3a82197-f067-4c95-92d5-64073827fed6">The accompanying consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (U.S. GAAP) and include the accounts of our wholly owned subsidiaries. As of September&#160;30, 2020, we had wholly owned subsidiaries in Singapore, Canada, the Netherlands, Japan, France, the United Kingdom, China, Germany and Norway. All subsidiaries, except for Singapore, use their local currency as their functional currency. The Singapore subsidiary uses the U.S. dollar as its functional currency. All intercompany transactions and balances have been eliminated in consolidation.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQzNDk_bbec414f-c659-4757-b19d-eec278a30dc2">Certain prior period amounts in the condensed consolidated statements of income and condensed consolidated statements of cash flows were reclassified to conform with the current period presentation. These reclassifications were immaterial and did not affect prior period total assets, total liabilities, stockholders&#x2019; equity, total revenue, total costs and expenses, loss from operations or net loss.</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:UseOfEstimates
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQzMjY_92c83558-b7f8-468f-8aa9-edb93178da65">&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in accordance with U.S.&#160;GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions believed to be reasonable, which together form the basis for making judgments about the carrying values of assets and liabilities. The full extent to which the COVID-19 pandemic impacts our business, results of operations and financial condition will depend on numerous evolving factors including, but not limited to, the magnitude and duration of the pandemic, the extent to which it will impact worldwide macroeconomic conditions, including the speed of recovery, and governmental and business reactions to the pandemic. We assessed certain accounting matters that generally require consideration of forecasted financial information in the context of information available to us and the unknown impact of COVID-19 as of September 30, 2020. These accounting matters included, but were not limited to, our allowance for doubtful accounts and credit losses, inventory and related reserves and the carrying value of goodwill and other long-lived assets. Actual results could differ materially from these estimates and could have a material adverse effect on our condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQzNjA_d9871560-21d1-4c71-b019-6319e2839545">Foreign CurrencyAssets and liabilities of non-U.S. subsidiaries that use the local currency as their functional currency are translated into U.S. dollars at exchange rates in effect on the balance sheet date. The adjustments resulting from the foreign currency translations are recorded in accumulated other comprehensive loss, a separate component of stockholders&#x2019; equity. Income and expense accounts are translated at monthly average exchange rates during the year.</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQzNDY_043ccfa5-3269-49d4-978f-f3cf7dff4e65">&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generate revenue primarily from the sale of our products and services. Product revenue is derived from the sale of instruments and consumables, including IFCs, assays and reagents. Service revenue is derived from the sale of instrument service contracts, repairs, installation, training and other specialized product support services. We also generate revenue from development agreements, license and royalty agreements and grants. Revenue is reported net of any sales, use and value-added taxes we collect from customers as required by government authorities. Research and development cost includes costs associated with development and grant revenue. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue based on the amount of consideration we expect to receive in exchange for the goods and services we transfer to the customer. Our commercial arrangements typically include multiple distinct products and services, and we allocate revenue to these performance obligations based on their relative standalone selling prices. Standalone selling prices (SSP) are generally determined using observable data from recent transactions. In cases where sufficient data is not available, we estimate a product&#x2019;s SSP using a cost plus a margin approach or by applying a discount to the product&#x2019;s list price.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Product Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize product revenue at the point in time when control of the goods passes to the customer and we have an enforceable right to payment. This generally occurs either when the product is shipped from one of our facilities or when it arrives at the customer&#x2019;s facility, based on the contractual terms. Customers generally do not have a unilateral right to return products after delivery. Invoices are generally issued at shipment and generally become due in 30 to 60 days.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We sometimes perform shipping and handling activities after control of the product passes to the customer. We have made an accounting policy election to account for these activities as product fulfillment activities rather than as separate performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Service Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue from repairs, maintenance, installation, training and other specialized product support services at the point in time the work is completed. Installation and training services are generally billed in advance of service. Repairs and other services are generally billed at the point the work is completed. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue associated with instrument service contracts is recognized on a straight-line basis over the life of the agreement, which is generally &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfNTUwMg_166c41b6-37fc-4b8a-8206-665c77cdd303"&gt;one&lt;/span&gt; to three years. We believe this time-elapsed approach is appropriate for service contracts because we provide services on demand throughout the term of the agreement. Invoices are generally issued in advance of service on a monthly, quarterly, annual or multi-year basis. Payments made in advance of service are reported on our condensed consolidated balance sheet as deferred revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Development Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has entered and may continue to enter into development agreements with third parties that provide for up-front and periodic milestone payments. Our development agreements may include more than one performance obligation. At the inception of the contract, we assess whether each obligation represents a separate performance obligation or whether such obligations should be combined as a single performance obligation. The transaction price for each development agreement is determined based on the amount of consideration we expect to be entitled to for satisfying all performance obligations within the agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. In arrangements where we satisfy performance obligation(s) over time, we recognize development revenue typically using an input method based on our costs incurred relative to the total expected cost which determines the extent of our progress toward completion. As part of the accounting for these arrangements, we must develop estimates and assumptions that require judgment to determine the transaction price and progress towards completion. We review our estimate of the transaction price and progress toward completion based on the best information available to recognize the cumulative progress toward completion as of the end of each reporting period, and make revisions to such estimates as necessary. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may also generate revenue from development or collaboration agreements that do not include upfront or milestone-based payments and generally recognize revenue on these types of agreements based on the timing of development activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other revenue consists of license and royalty revenue and grant revenue. We recognize revenue from license agreements when the license is transferred to the customer and the customer is able to use and benefit from the license. For contracts that include sales-based royalties, we recognize revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, we entered into an agreement to settle intellectual property infringement claims, in which we received a $3.5 million payment in exchange for a perpetual license under certain Fluidigm intellectual property. The settlement is considered a multiple-element arrangement with each element accounted for individually. Accordingly, $3.1 million of the proceeds was recognized as license revenue and $0.4 million was offset against legal costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We receive grants from various entities to perform research and development activities over contractually defined periods. Revenue is generally recognized provided that the conditions under which the grants were provided have been met and any remaining performance obligations are perfunctory. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Incremental sales commission costs incurred to obtain instrument service contracts are capitalized and amortized to selling, general and administrative expense over the life of the contract, which is generally &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfOTE2Nw_1c099c37-d651-4eff-8b5d-06284641991e"&gt;one&lt;/span&gt; to three years. As a practical expedient, we expense sales commissions associated with product support services that are delivered in less than one year as they are incurred. Sales commissions associated with the sale of products are expensed as they are incurred. To date, capitalized contract costs have been immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Product Warranties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generally provide a one-year warranty on our instruments. We accrue for estimated warranty obligations at the time of product shipment. We periodically review our warranty liability and record adjustments based on the terms of warranties provided to customers, and historical and anticipated warranty claim experience. This expense is recorded as a component of cost of product revenue in the condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Judgments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Applying the revenue recognition practices discussed above often requires significant judgment. Judgment is required when identifying performance obligations, estimating SSP and allocating purchasing consideration in multi-element arrangements, determining the transaction price and progress towards completion on development arrangements and estimating the future amount of our warranty obligations. Moreover, significant judgment is required when interpreting commercial terms and determining when control of goods and services passes to the customer. Any material changes created by errors in judgment could have a material effect on our operating results and overall financial condition.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <fldm:RevenueFromContractWithCustomerTermsOfPaymentPeriod
      contextRef="i4101cc4ce01446f6b62b021b3dbb5704_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfNDc0Mg_273bcddf-9c5b-49c9-9cb2-06825716f467">P30D</fldm:RevenueFromContractWithCustomerTermsOfPaymentPeriod>
    <fldm:RevenueFromContractWithCustomerTermsOfPaymentPeriod
      contextRef="i4329505554d74bb8bd0456959ea7b9d9_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfNDc0OA_df750076-1b23-45f4-b0e8-69b3c9d49e49">P60D</fldm:RevenueFromContractWithCustomerTermsOfPaymentPeriod>
    <fldm:RevenueFromContractWithCustomerPerformanceObligationPeriod
      contextRef="i0f2c6e8ac0b0407b9dcbc0fb91830d02_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfNTUwOA_8e1a7686-f6a4-486e-a955-e90029460ba2">P3Y</fldm:RevenueFromContractWithCustomerPerformanceObligationPeriod>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="ifb7c86dd6e67421cbc4e92e76dcf85bd_D20200301-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfODM0MQ_1fd135e1-1395-47fd-878b-6d9d49e3a69f"
      unitRef="usd">3500000</us-gaap:ProceedsFromLegalSettlements>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7fc39d91e80e413683ccff3b0727279b_D20200301-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfODU1NA_b78672a0-6358-49c2-ba2f-f5ffaa56b090"
      unitRef="usd">3100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:LegalFees
      contextRef="i51f17d522ac148c68bc6b818c1014f68_D20200301-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfODYxMQ_818be27e-fc4d-4934-8f94-963b248de434"
      unitRef="usd">400000</us-gaap:LegalFees>
    <fldm:RevenueFromContractWithCustomerPerformanceObligationPeriod
      contextRef="i261b1732f7d64d5ca4da0ff8446c81ce_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfOTE3Mw_c178f414-19dc-428c-94bd-44a5c17022f1">P3Y</fldm:RevenueFromContractWithCustomerPerformanceObligationPeriod>
    <fldm:ProductWarrantyTerm
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTgxNDE5NDE4ODMwNDk_a7267724-efc2-4f5f-a612-fec8e8b7ee6b">P1Y</fldm:ProductWarrantyTerm>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQzODI_2a01f6eb-e52f-47ea-804f-4e336c54738b">&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade accounts receivable are recorded at net invoice value. We review our exposure to accounts receivable and provide allowances of specific amounts if collectability is no longer reasonably assured based on historical experience and specific customer collection issues. We evaluate such allowances on a regular basis and adjust them as needed.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQzNzU_404f7076-daf9-408e-91d4-67b0e5c905bf">&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Concentrations of Business and Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject us to credit risk consist of cash, cash equivalents, investments, and accounts receivable. Our cash, cash equivalents, and investments may consist of deposits held with banks, money market funds, and other highly liquid investments that may at times exceed federally insured limits. Cash equivalents and investments are financial instruments that potentially subject us to concentrations of risk. Under our investment policy, we invest primarily in securities issued by the U.S. government. The goals of our investment policy, in order of priority, are as follows: preserve capital, meet liquidity needs, and optimize returns. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generally do not require collateral to support credit sales. To reduce credit risk, we perform credit evaluations of our customers. One customer from whom we derived development revenue exceeded 10% of revenue for the three and nine months ended September&#160;30, 2020. No other customer represented more than 10% of total revenue for the three and nine months ended September&#160;30, 2020 or 2019. Including the development revenue, revenues from our five largest customers were 31% and 25% &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of total revenue for the three months ended September&#160;30, 2020 and 2019, respectively. Revenues from our five largest customers were 23% and 20% of total revenue for the nine months ended September&#160;30, 2020 and 2019, respectively. There was no single customer that represented more than 10% of total accounts receivable at September&#160;30, 2020, or December&#160;31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our products include components that are currently procured from a single source or a limited number of sources. We believe that other vendors would be able to provide similar components; however, the qualification of such vendors may require start-up time. In order to mitigate any adverse impacts from a disruption of supply, we attempt to maintain an adequate supply of critical limited-source components.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i4c26186ae0bf4d6799d6b7bcd5a15cd7_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTY0OTI2NzQ2NjEyOQ_4357c101-ab7c-4e3f-9b6d-8673384997d1"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ieaa80a8a61d943508698a74efef90b12_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTY0OTI2NzQ2NjEyOQ_6452375f-5e91-4b4c-b0e6-4a4ae19936f5"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i761f7b389ced4f93be18b27ca86ce004_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTIxNTI_20baa655-409b-400c-9e3a-641aab023cbf"
      unitRef="number">0.31</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i40175ade607f4de5b40b93529bd75aa1_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTIxNTk_43ca4926-4c18-4d33-b7b4-835791d76e28"
      unitRef="number">0.25</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib9ec2d4a080349c7820e11d6b38ab5d3_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTIyNjE_7879dbda-2b88-421a-a4e2-9e5ce049b6f6"
      unitRef="number">0.23</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic252519a5f1b45f3853a2e0071c6dcc7_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTIyNjg_1820e6e0-22df-48eb-b6d9-ac7d059eace8"
      unitRef="number">0.20</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQzMTk_9b24637e-ac8e-4f10-b3d8-5063c1cd8a24">&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine if an arrangement is a lease, or contains a lease, at inception. Operating leases are included in operating lease right-of-use (ROU) assets and current and non-current operating lease liabilities in our condensed consolidated balance sheets. ROU assets represent our right-to-use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we generally use our incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. Significant judgment is required in determining the incremental collateralized borrowing rate. Lease expense for lease payments is recognized on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;We elected the short-term lease recognition exemption for all leases that qualify. For those leases that qualify, we will not recognize ROU assets or lease liabilities for leases with an initial lease term of one year or less. We also elected not to separate lease and nonlease components for our building leases. The nonlease components are generally variable in nature and are expected to represent most of our variable lease costs. Variable costs are expensed as incurred. We have taken a portfolio approach for our vehicle leases by country.</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQzOTM_e7708a7d-02f7-4659-8be9-89c5b9a78b45">&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Goodwill, Intangible Assets and Other Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill, which has an indefinite useful life, represents the excess of cost over fair value of net assets acquired. Our intangible assets include developed technology, patents and licenses. The cost of identifiable intangible assets with finite lives is generally amortized on a straight-line basis over the assets&#x2019; respective estimated useful lives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and intangible assets with indefinite lives are not subject to amortization but are tested for impairment on an annual basis during the fourth quarter or whenever events or changes in circumstances indicate the carrying amount of these assets may not be recoverable. Events or changes in circumstances that could affect the likelihood that we will be required to recognize an impairment charge include, but are not limited to, declines in our stock price or market capitalization, economic downturns and other macroeconomic events, including the current COVID-19 pandemic, declines in our market share or revenues, and an increase in our losses, rapid changes in technology, failure to achieve the benefits of capacity increases and utilization, significant litigation arising out of an acquisition, or other matters. Any impairment charges could have a material adverse effect on our operating results and net asset value in the quarter in which we recognize the impairment charge.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In evaluating our goodwill and intangible assets with indefinite lives for indications of impairment, we first conduct an assessment of qualitative factors to determine whether it is more likely than not that the fair value of our reporting unit is less than its carrying amount. If we determine that it is more likely than not that the fair value of our reporting unit is less than its carrying amount, we compare the fair value of our reporting unit to its carrying value. If the fair value of our reporting unit exceeds its carrying value, goodwill is not considered impaired and no further analysis is required. If the carrying value of the reporting unit exceeds its fair value, then an impairment loss equal to the difference would be recorded to goodwill. We did not recognize any impairment of goodwill for any of the periods presented herein.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate our long-lived assets, including finite-lived intangibles, for indicators of possible impairment when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. If any indicator of impairment exists, we assess the recoverability of the affected long-lived assets by determining whether the carrying value of the asset can be recovered through undiscounted future operating cash flows. If impairment is indicated, we estimate the asset&#x2019;s fair value using future discounted cash flows associated with the use of the asset and adjust the carrying value of the asset accordingly. We did not recognize any impairment of intangibles for any of the periods presented herein.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Deferred Grant Income &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2020, we executed a definitive contract with the National Institutes of Health (NIH) for a project under the NIH Rapid Acceleration of Diagnostics (RADx) program. The definitive contract, which amended the letter contract we entered &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;into with the NIH in July 2020 (collectively, the NIH Contract), has a total value of up to $34.0&#160;million upon the achievement of certain conditional milestones. Proceeds from the NIH Contract will be used primarily to expand production capacity and product throughput capabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounting for the NIH Contract does not fall under ASC 606, Revenue from Contracts with Customers, as the NIH will not benefit directly from our expansion or product development.  As there is no authoritative guidance under U.S. GAAP on accounting for government assistance to for-profit business entities, we applied International Accounting Standards (IAS) 20, Accounting for Government Grants and Disclosure of Government Assistance, by analogy when accounting for the NIH Contract payments to Fluidigm. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The NIH Contract proceeds meet the definition of grants related to assets as the primary condition for the payments is to fund the purchase and construction of longer-term assets to scale up production capacity. Under IAS 20, government grants related to assets are presented in the statement of financial position either by setting up the grant as deferred income or by deducting the grant in arriving at the carrying amount of the asset. Either of these two methods of presentation of grants related to assets in financial statements are regarded as acceptable alternatives under IAS 20. We have elected to record the grants received as deferred income using the first method.&lt;/span&gt;&lt;/div&gt;Under IAS 20, grant proceeds are recognized when there is reasonable assurance the conditions of the grant will be met and the grant will be received.  With the NIH Contract, this occurs when either each milestone has been accepted by NIH or management concludes the conditions of the grant have been substantially met.  We record the NIH Contract proceeds as deferred income.  Proceeds used for capital expenditures will be amortized over the period of depreciation for the assets as a reduction of depreciation expense.  Any portion of the proceeds used to reimburse research and development expense are recorded as a reduction of those expenses incurred to date.</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTY1NTk_7e82e624-5799-42d9-8cb8-8f197f7c1e39"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTY1NTk_8f94e07a-9aa2-41dc-9829-f64be6ce579f"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTY1NTk_d7bf317a-4801-4a54-92a4-49d1e5fcd804"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTY1NTk_f63ae66e-1a26-43cf-9990-c20fd6aa5ca7"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue
      contextRef="i9ad72ef114054c68ba1d7499333b66b9_I20200928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTgxNDE5NDE5MDIyODM_a389ee4f-30be-483d-ba1f-7f4111f9a2f2"
      unitRef="usd">34000000.0</fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue>
    <us-gaap:DebtPolicyTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQ0MDQ_bb93323a-e7a3-49e3-a19f-173c3588f283">&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Convertible Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2014, we closed an underwritten public offering of $201.3 million aggregate principal amount of our 2.75% Senior Convertible Notes due 2034 (2014 Notes). In March 2018, we entered into separate privately negotiated transactions with certain holders of our 2014 Notes to exchange $150.0 million in aggregate principal amount of the 2014 Notes for our 2.75% Exchange Convertible Senior Notes due 2034 (2018 Notes). As the 2018 Notes were convertible, at our election, into cash, shares of our common stock, or a combination of cash and shares of our common stock, we accounted for the 2018 Notes under the cash conversion guidance in ASC 470, whereby the embedded conversion option in the 2018 Notes was separated and accounted for in equity. In the first quarter of 2019, the 2018 Notes were converted into 19.5 million shares of our common stock and the 2018 Notes were retired. We recorded a loss of $9.0 million on the retirement of the 2018 Notes. We determined the fair value of the 2018 Notes&#160;using valuation techniques that required us to make assumptions related to the implied discount rate.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2019, we closed a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of $55.0 million aggregate principal amount of our 5.25% Senior Convertible Notes due 2024 (2019 Notes). Most of the issuance proceeds were used to retire approximately $50.2 million of aggregate principal amount of our 2014 Notes, leaving approximately $1.1 million of aggregate principal amount of our 2014 Notes outstanding. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As the 2019 Notes do not provide for a cash conversion feature, the 2019 Notes are recorded as debt in their entirety in accordance with ASC 470. For the 2014, 2018 and 2019 Notes, offering-related costs, including underwriting costs, were capitalized as debt issuance costs, recorded as an offset to the carrying value of the related Notes, and are amortized over the expected term of the related Notes using the effective interest method.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtPolicyTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ifa53719e19cc4a179c2e811a860e7411_I20140228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTc0NDM_8ff288a5-f56d-451a-bc92-02dbdaeab8f2"
      unitRef="usd">201300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ifa53719e19cc4a179c2e811a860e7411_I20140228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTc0ODA_45e74032-d3c3-4669-bd3e-b494285db957"
      unitRef="number">0.0275</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i426efa56430840c1b19eac7bd8d458cc_I20180331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTc2NTY_db591804-a62f-4790-b886-9a4923a13e80"
      unitRef="usd">150000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i426efa56430840c1b19eac7bd8d458cc_I20180331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTc3MTU_df977f09-19b9-4945-afaa-4002f7b10cba"
      unitRef="number">0.0275</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i3111d806397142758e8cb5ee0d0eb9e6_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTgxNjg_6a44fc48-f0f4-435d-b6d3-527a0c6c2b5b"
      unitRef="shares">19500000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i3ac00b245134442884f3defdcfc7fae1_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTgyNTM_9e6174ac-b33d-49e1-ac67-9374b0d792bd"
      unitRef="usd">-9000000.0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i9b34d835daa64fc59dd63f13ee337947_I20191130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTg1NzU_80fb45b7-8b14-4ae3-ac5d-01a00d826e69"
      unitRef="usd">55000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9b34d835daa64fc59dd63f13ee337947_I20191130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTg2MTI_3f5ab17b-7654-41ee-8e7d-40e3f2dd60fd"
      unitRef="number">0.0525</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i48e1ed537f2e4db1b0713b2e240b93fb_D20191101-20191130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTg3Mjc_d4c22c19-fd3b-4c04-9c9b-4e853fca23b2"
      unitRef="usd">50200000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i23b95cce717045feba062bba6e018b4e_I20191130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMTg4MDE_58f77703-a6b3-4ea4-977e-df4666d08bcd"
      unitRef="usd">1100000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQ0MTA_2b5c91c3-8cb7-4d26-a922-4c4f4f67f843">&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Comprehensive Loss &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive loss is comprised of net loss and other comprehensive income (loss). Other comprehensive income (loss) consists of unrealized gains and losses on our investments and foreign currency translation adjustments. Total comprehensive loss for all periods presented has been disclosed in the condensed consolidated statements of comprehensive loss.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQzNjE_61918113-31b1-4a83-a84c-15596aed9988">&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of accumulated other comprehensive loss, net of tax, for the three and nine months ended September&#160;30, 2020 are as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gain (Loss) on Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(618)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(303)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(303)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance at March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(921)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(812)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(809)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(289)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(289)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="i32b55c5ab8514931aa3c38ad7314012a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfMS0yLTEtMS0w_185ea4b7-9db2-4267-80d4-d29bcb1dbd8d"
      unitRef="usd">-618000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i522074f70914431c93eb1fb60866c897_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfMS00LTEtMS0w_b720fad9-48cc-43c3-b7fd-0ab9d79b4bd7"
      unitRef="usd">36000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iacf13335933a47178e0765e3e574fd1e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfMS02LTEtMS0w_641e50d3-a810-49f4-988c-8c3f9dbc4bcb"
      unitRef="usd">-582000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i4664c6ae00ef4abf82e3edabaf2c670a_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfMi0yLTEtMS0w_7f5110b8-a191-4d87-a6d8-340b1ec38999"
      unitRef="usd">-303000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ie36983d4e5c64db793c5d3166fe61fa4_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfMi00LTEtMS0w_b4041d00-6c20-4358-8c90-9a0b11c1924c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i36c4cb3e31604770b06e9f2af6bc483e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfMi02LTEtMS0w_803b9d80-2998-49af-8a0d-dd1faa453178"
      unitRef="usd">-303000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="i69ebb284db184ca8bdf4d66d0dff3121_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfMy0yLTEtMS0w_47a22e27-dbac-4314-88d3-f13e5252448a"
      unitRef="usd">-921000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifa27eb06261444ae9b065f2110889263_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfMy00LTEtMS0w_3364a100-3e71-4c7a-88d6-3cc650824c98"
      unitRef="usd">36000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if10319fa5a0a46069beb6a1617e9f6da_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfMy02LTEtMS0w_a98cc016-93e7-4dd3-beae-671538a53ba7"
      unitRef="usd">-885000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i1ae09a39637843f6a26b4e4e0127ab7d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfNC0yLTEtMS00MjA_fdee21ba-d90d-4925-813b-450773e1f003"
      unitRef="usd">109000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i527a5548d615414180d912a5102a2912_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfNC00LTEtMS00MjA_a2d49e08-2fe8-42d8-a917-3d93c33ae7b2"
      unitRef="usd">-33000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ibc7d24911d4349cd97850e4e2f548bc4_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfNC02LTEtMS00MjA_4cf8e3e9-3abe-489d-96b7-e06372d061de"
      unitRef="usd">76000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="ib06456778615411fbbea453bd61bcfdc_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfNS0yLTEtMS00MjA_78cd0875-609e-4e72-99b9-95c8c4362c19"
      unitRef="usd">-812000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i82ce3762aa614b6ebe557f7b073bebe4_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfNS00LTEtMS00MjA_62336abe-38ac-4484-b632-24d7114e34e4"
      unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idc294b4f830b49dd8ecde477cdb866de_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfNS02LTEtMS00MjA_965c8fa8-4223-45a2-a2fa-df5f858bb21c"
      unitRef="usd">-809000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i80cf78799b76440ea86f5da1c2493062_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfNC0yLTEtMS0w_b2ecea33-63b5-4baa-b036-fe43f855e0c9"
      unitRef="usd">523000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="id07a1b059c244e2399380a15a12a57c5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfNC00LTEtMS0w_b7e7045a-cd44-45b3-8a01-3a7020cd0dfd"
      unitRef="usd">-3000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfNC02LTEtMS0w_75d21101-5942-425d-8fbe-40ac7fd3e531"
      unitRef="usd">520000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="i00a783530ec64310a75d4833347282a5_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfNS0yLTEtMS0w_1e01c4b2-e896-489c-9336-306333436bf5"
      unitRef="usd">-289000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i377c087ac7164a9897550043dca2a0e6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfNS00LTEtMS0w_d2ac990f-d1c5-441f-b270-937494b079d5"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1c27fe0a0d9a44659e8415f944fc0c03_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOmVkN2MyNzM2MjhhYTQ1ZGZhODE5YzQ3MDk1N2ViYTk3L3RhYmxlcmFuZ2U6ZWQ3YzI3MzYyOGFhNDVkZmE4MTljNDcwOTU3ZWJhOTdfNS02LTEtMS0w_3a27a8d3-cedf-45d5-bb8c-114ab4bd41e7"
      unitRef="usd">-289000</us-gaap:StockholdersEquity>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQzNTU_267b9941-7ddf-4523-ba73-916aacda809b">&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net Loss per Share &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our basic and diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding for the period. Restricted stock units, performance share units, and stock options to purchase our common stock are considered to be potentially dilutive common shares but have been excluded from the calculation of diluted net loss per share as their effect is anti-dilutive for all periods presented.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQzMTQ_9e3effeb-db96-41ab-bec6-febf2594873c">&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following potentially dilutive common shares were excluded from the computations of diluted net loss per share for the periods presented because including them would have been anti-dilutive (in thousands):  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options, restricted stock units and performance awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Convertible Notes potential make-whole shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2014 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i83297b8f97a34354a79b62e5e754b631_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOjM5NjM1Njk1MTZkNDQ2Y2Q4ZmIzNDZkYjViNThjMmVjL3RhYmxlcmFuZ2U6Mzk2MzU2OTUxNmQ0NDZjZDhmYjM0NmRiNWI1OGMyZWNfMi0yLTEtMS0w_74227dd7-15ca-458a-8556-3888f46f27c9"
      unitRef="shares">7652000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i59a12e7ed1b243b496ec5f9736293ba2_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOjM5NjM1Njk1MTZkNDQ2Y2Q4ZmIzNDZkYjViNThjMmVjL3RhYmxlcmFuZ2U6Mzk2MzU2OTUxNmQ0NDZjZDhmYjM0NmRiNWI1OGMyZWNfMi00LTEtMS0w_40887d8d-5645-4fd4-b593-bd135eed6dd0"
      unitRef="shares">5342000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i76daca0d7ecf4e55b49f9ef61b74d961_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOjM5NjM1Njk1MTZkNDQ2Y2Q4ZmIzNDZkYjViNThjMmVjL3RhYmxlcmFuZ2U6Mzk2MzU2OTUxNmQ0NDZjZDhmYjM0NmRiNWI1OGMyZWNfMy0yLTEtMS0w_dde88f98-90b3-4dd5-93db-eb0dee40a2a5"
      unitRef="shares">18966000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i547f784eb6974c818432924005a65edd_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOjM5NjM1Njk1MTZkNDQ2Y2Q4ZmIzNDZkYjViNThjMmVjL3RhYmxlcmFuZ2U6Mzk2MzU2OTUxNmQ0NDZjZDhmYjM0NmRiNWI1OGMyZWNfMy00LTEtMS0w_961a612e-d882-4393-b540-fd812f80c802"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if0007477bb8545a8afa0513c08a9049c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOjM5NjM1Njk1MTZkNDQ2Y2Q4ZmIzNDZkYjViNThjMmVjL3RhYmxlcmFuZ2U6Mzk2MzU2OTUxNmQ0NDZjZDhmYjM0NmRiNWI1OGMyZWNfNC0yLTEtMS0w_0e749f06-a14e-4f1a-8157-9ab4104f8df4"
      unitRef="shares">826000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i75455403764249069c09679d89b70c29_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOjM5NjM1Njk1MTZkNDQ2Y2Q4ZmIzNDZkYjViNThjMmVjL3RhYmxlcmFuZ2U6Mzk2MzU2OTUxNmQ0NDZjZDhmYjM0NmRiNWI1OGMyZWNfNC00LTEtMS0w_1a7863ab-0a1e-4bf8-9f98-1787cc02328f"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i537a3353f9d94a15afb6333fd0f64d0c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOjM5NjM1Njk1MTZkNDQ2Y2Q4ZmIzNDZkYjViNThjMmVjL3RhYmxlcmFuZ2U6Mzk2MzU2OTUxNmQ0NDZjZDhmYjM0NmRiNWI1OGMyZWNfNS0yLTEtMS0w_4ffc18fa-a4b1-4cd4-865e-02efa2792741"
      unitRef="shares">19000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i634dc22add2d4eb0a343c30ed934f69b_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOjM5NjM1Njk1MTZkNDQ2Y2Q4ZmIzNDZkYjViNThjMmVjL3RhYmxlcmFuZ2U6Mzk2MzU2OTUxNmQ0NDZjZDhmYjM0NmRiNWI1OGMyZWNfNS00LTEtMS0w_ca11aa39-aaf5-4bf0-ad7b-c8446ef67c9f"
      unitRef="shares">916000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOjM5NjM1Njk1MTZkNDQ2Y2Q4ZmIzNDZkYjViNThjMmVjL3RhYmxlcmFuZ2U6Mzk2MzU2OTUxNmQ0NDZjZDhmYjM0NmRiNWI1OGMyZWNfNi0yLTEtMS0w_dff15097-97bd-414d-824b-14f1196a9150"
      unitRef="shares">27463000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RhYmxlOjM5NjM1Njk1MTZkNDQ2Y2Q4ZmIzNDZkYjViNThjMmVjL3RhYmxlcmFuZ2U6Mzk2MzU2OTUxNmQ0NDZjZDhmYjM0NmRiNWI1OGMyZWNfNi00LTEtMS0w_4c565870-6559-468c-819a-408622840338"
      unitRef="shares">6258000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQzNDI_205661ce-f643-4285-a47f-ac3c2ad928c1">&lt;div style="margin-top:15pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recent Accounting Changes and Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Adoption of New Accounting Guidance &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the U.S.-based Financial&#160;Accounting Standards&#160;Board (FASB) issued Accounting Standards Update (ASU) 2018-15-Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40), which establishes new guidance on the accounting for costs incurred to implement a cloud computing arrangement that is considered a service arrangement. The new guidance requires the capitalization of such costs, aligning it with the accounting for costs associated with developing or obtaining internal-use software. The new guidance is effective for fiscal years beginning after December 15, 2019. The adoption of the new guidance did not have a significant impact on our financial results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2017, the FASB issued ASU 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The ASU eliminates the requirement for an entity to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, an entity performs its annual, or interim, goodwill impairment testing by comparing the fair value of a reporting unit with its carrying amount and recording an impairment charge for the amount by which the carrying amount exceeds the fair value. The ASU is effective for annual and interim goodwill impairment testing performed for our fiscal year beginning January 1, 2020. The adoption of the new guidance did not have a significant impact on our financial results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The FASB issued two ASUs related to financial instruments &#x2013; credit losses. The ASUs issued were: (1) in June 2016, &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQzNjc_09dd10ab-4bd6-4959-a108-786ca8b4f9e5"&gt;ASU 2016-13, Financial Instruments-Credit Losses (Topic 326)&lt;/span&gt;: Measurement of Credit Losses on Financial Instruments, and (2) in November 2018, ASU 2018-19-Codification Improvements to Topic 326, Financial Instruments-Credit Losses. ASU 2016-13 is intended to improve financial reporting by requiring more timely recording of credit losses on loans and other financial &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;instruments held by financial institutions and other organizations. ASU 2018-19 clarifies that receivables arising from operating leases are not within the scope of the credit losses standard, but rather, should be accounted for in accordance with the lease standard. These ASUs are effective for fiscal years beginning after December 15, 2019, and interim periods within those years, with early adoption permitted. The modified retrospective method is required upon adoption. The adoption of the new guidance resulted in an adjustment of approximately $0.1 million to reduce the accumulated deficit component of stockholders&#x2019; equity and decrease current assets by the same amount in our condensed consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06 Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity. The amendment to this ASU reduces the number of accounting models for convertible instruments and allows more contracts to qualify for equity classification, which is expected to result in more convertible instruments being accounted for as a single unit, rather than being bifurcated between debt and equity. The new guidance is effective for fiscal years beginning after December 15, 2021. We are currently evaluating the impact of adoption on our condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2019, the FASB issued ASU 2019-12-Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The amendments in this update improve consistent application of and simplify U.S. GAAP for Topic 740 by clarifying and amending existing guidance for, among other items, intra-period allocation, reporting tax law changes and losses in interim periods, state and local taxes not fully based on income and recognition of deferred tax liability related to certain transactions. There is also new guidance related to consolidated group reporting and tax impacts resulting from business combinations. The new guidance is effective for fiscal years beginning after December 15, 2020. We are currently evaluating the impact of adoption on our condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="i8a2616563d5a4bf89c8fd60f83692c9c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjMzMTk_c4961740-5cfb-4798-8945-844e445960f0"
      unitRef="usd">-100000</us-gaap:StockholdersEquity>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RleHRyZWdpb246ZDAyMDAxYzMzZjk0NGIyNmJhN2NkODA4OTVlMzI3YjJfMTI4NA_01109acc-cd68-4618-b2b0-4a6b3bfd0ffe">Business Combination&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 17, 2020, we completed the acquisition of all of the outstanding shares of InstruNor AS, a privately held Norwegian company (InstruNor). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;InstruNor is a provider of the only fully integrated sample preparation system for flow and mass cytometry. The acquisition of InstruNor supports our entry into the sample preparation market for cytometry analysis and expands our capabilities to include fully automated sample preparation for flow and mass cytometry. The value of this technology is reflected in the intangible asset for developed technology. The developed technology was valued using a discounted cash flow model for which the most sensitive assumption was revenue growth rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The purchase price of $7.2 million included approximately $5.2 million in cash and 485,451 shares of our common stock valued at the closing price on the effective date of $4.22. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the net cash flows is summarized below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 17, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash consideration paid to former equity holders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: cash and cash equivalents acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition of InstruNor, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The acquisition was accounted for in accordance with ASC 805, Business Combinations. The assets acquired and liabilities assumed were recorded at their estimated fair values at the InstruNor acquisition date. Goodwill of $2.2 million was calculated as the purchase price less the fair value of the net assets acquired as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:14pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 17, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase price:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash consideration paid on closing to former equity holders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash consideration common shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets acquired:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities assumed:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of identifiable net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired on acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ibccd6f048dc74a6c953e619b2a9e9ea6_D20200117-20200117"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RleHRyZWdpb246ZDAyMDAxYzMzZjk0NGIyNmJhN2NkODA4OTVlMzI3YjJfNzQ2_4fad0d36-d5c0-43b4-99a5-2a689e2e8c46"
      unitRef="usd">7200000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ibccd6f048dc74a6c953e619b2a9e9ea6_D20200117-20200117"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RleHRyZWdpb246ZDAyMDAxYzMzZjk0NGIyNmJhN2NkODA4OTVlMzI3YjJfNzcy_9d4bfe43-ccb6-4b44-972e-f2732a1035a0"
      unitRef="usd">5200000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="ibccd6f048dc74a6c953e619b2a9e9ea6_D20200117-20200117"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RleHRyZWdpb246ZDAyMDAxYzMzZjk0NGIyNmJhN2NkODA4OTVlMzI3YjJfNzg3_45dace8b-1a27-415a-8901-ee96a88e982a"
      unitRef="shares">485451</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:SharePrice
      contextRef="i879547fef02c413ab97b1073b8418853_I20200117"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RleHRyZWdpb246ZDAyMDAxYzMzZjk0NGIyNmJhN2NkODA4OTVlMzI3YjJfODcw_03a160eb-6fbb-4128-b350-60f0669440b0"
      unitRef="usdPerShare">4.22</us-gaap:SharePrice>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RleHRyZWdpb246ZDAyMDAxYzMzZjk0NGIyNmJhN2NkODA4OTVlMzI3YjJfMTI4NQ_bc3b5628-cd8a-416d-8825-d7752d1b6693">&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the net cash flows is summarized below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 17, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash consideration paid to former equity holders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: cash and cash equivalents acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition of InstruNor, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ibccd6f048dc74a6c953e619b2a9e9ea6_D20200117-20200117"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RhYmxlOmZiNTYzYjk5ZmFhMTQwY2ZhYThjNDFkOTIwOGNmZGRmL3RhYmxlcmFuZ2U6ZmI1NjNiOTlmYWExNDBjZmFhOGM0MWQ5MjA4Y2ZkZGZfMS0yLTEtMS0w_7c71d391-ea15-4033-b06a-a96016500a0f"
      unitRef="usd">5165000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="ibccd6f048dc74a6c953e619b2a9e9ea6_D20200117-20200117"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RhYmxlOmZiNTYzYjk5ZmFhMTQwY2ZhYThjNDFkOTIwOGNmZGRmL3RhYmxlcmFuZ2U6ZmI1NjNiOTlmYWExNDBjZmFhOGM0MWQ5MjA4Y2ZkZGZfMi0yLTEtMS0w_41f2c685-e04c-48d7-9085-2b80a4aa516e"
      unitRef="usd">11000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ibccd6f048dc74a6c953e619b2a9e9ea6_D20200117-20200117"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RhYmxlOmZiNTYzYjk5ZmFhMTQwY2ZhYThjNDFkOTIwOGNmZGRmL3RhYmxlcmFuZ2U6ZmI1NjNiOTlmYWExNDBjZmFhOGM0MWQ5MjA4Y2ZkZGZfMy0yLTEtMS0w_a6ce0671-16d9-41b2-95ef-92f1ba1d7a3b"
      unitRef="usd">5154000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RleHRyZWdpb246ZDAyMDAxYzMzZjk0NGIyNmJhN2NkODA4OTVlMzI3YjJfMTI4Ng_aeadb006-6770-481f-9821-cf4558328e0c">Goodwill of $2.2 million was calculated as the purchase price less the fair value of the net assets acquired as follows (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 17, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase price:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash consideration paid on closing to former equity holders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash consideration common shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets acquired:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities assumed:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of identifiable net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired on acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:Goodwill
      contextRef="ic833fc7e7ff14f309dbabe622e99c8de_I20200117"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RleHRyZWdpb246ZDAyMDAxYzMzZjk0NGIyNmJhN2NkODA4OTVlMzI3YjJfMTE2OA_50b48298-099a-49ae-9296-4a1185270cd6"
      unitRef="usd">2200000</us-gaap:Goodwill>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ibccd6f048dc74a6c953e619b2a9e9ea6_D20200117-20200117"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RhYmxlOjgyMjYyMDhhYTM4MzQzMjQ4NDU1MmNmZGY4MmQ0OTMzL3RhYmxlcmFuZ2U6ODIyNjIwOGFhMzgzNDMyNDg0NTUyY2ZkZjgyZDQ5MzNfMi0yLTEtMS0w_21ea50fa-64b1-48ba-8329-a4579e1414d0"
      unitRef="usd">5165000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="ibccd6f048dc74a6c953e619b2a9e9ea6_D20200117-20200117"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RhYmxlOjgyMjYyMDhhYTM4MzQzMjQ4NDU1MmNmZGY4MmQ0OTMzL3RhYmxlcmFuZ2U6ODIyNjIwOGFhMzgzNDMyNDg0NTUyY2ZkZjgyZDQ5MzNfMy0yLTEtMS0w_579e216e-a026-4abb-a753-dda218908ceb"
      unitRef="usd">2049000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ibccd6f048dc74a6c953e619b2a9e9ea6_D20200117-20200117"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RhYmxlOjgyMjYyMDhhYTM4MzQzMjQ4NDU1MmNmZGY4MmQ0OTMzL3RhYmxlcmFuZ2U6ODIyNjIwOGFhMzgzNDMyNDg0NTUyY2ZkZjgyZDQ5MzNfNC0yLTEtMS0w_3a04f574-fd89-4495-9e58-b5efe10129ed"
      unitRef="usd">7214000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="ic833fc7e7ff14f309dbabe622e99c8de_I20200117"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RhYmxlOjgyMjYyMDhhYTM4MzQzMjQ4NDU1MmNmZGY4MmQ0OTMzL3RhYmxlcmFuZ2U6ODIyNjIwOGFhMzgzNDMyNDg0NTUyY2ZkZjgyZDQ5MzNfNy0yLTEtMS0w_9b1c1df4-0879-4e01-b3d7-05097c21f253"
      unitRef="usd">11000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <fldm:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAccountsReceivables
      contextRef="ic833fc7e7ff14f309dbabe622e99c8de_I20200117"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RhYmxlOjgyMjYyMDhhYTM4MzQzMjQ4NDU1MmNmZGY4MmQ0OTMzL3RhYmxlcmFuZ2U6ODIyNjIwOGFhMzgzNDMyNDg0NTUyY2ZkZjgyZDQ5MzNfOC0yLTEtMS0w_feacc58d-7b37-4cc3-9c9a-4cfde85ebe71"
      unitRef="usd">32000</fldm:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAccountsReceivables>
    <fldm:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherReceivables
      contextRef="ic833fc7e7ff14f309dbabe622e99c8de_I20200117"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RhYmxlOjgyMjYyMDhhYTM4MzQzMjQ4NDU1MmNmZGY4MmQ0OTMzL3RhYmxlcmFuZ2U6ODIyNjIwOGFhMzgzNDMyNDg0NTUyY2ZkZjgyZDQ5MzNfOS0yLTEtMS0w_b9d0b12d-eafb-438a-b735-c5ba4f15bcbc"
      unitRef="usd">13000</fldm:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="ic833fc7e7ff14f309dbabe622e99c8de_I20200117"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RhYmxlOjgyMjYyMDhhYTM4MzQzMjQ4NDU1MmNmZGY4MmQ0OTMzL3RhYmxlcmFuZ2U6ODIyNjIwOGFhMzgzNDMyNDg0NTUyY2ZkZjgyZDQ5MzNfMTAtMi0xLTEtMA_ba456d18-3014-4dd9-8df0-20f2120d3d54"
      unitRef="usd">153000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="ic833fc7e7ff14f309dbabe622e99c8de_I20200117"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RhYmxlOjgyMjYyMDhhYTM4MzQzMjQ4NDU1MmNmZGY4MmQ0OTMzL3RhYmxlcmFuZ2U6ODIyNjIwOGFhMzgzNDMyNDg0NTUyY2ZkZjgyZDQ5MzNfMTEtMi0xLTEtMA_bf56a26e-9ed7-45c1-bd67-c94b90952ce5"
      unitRef="usd">5380000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="ic833fc7e7ff14f309dbabe622e99c8de_I20200117"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RhYmxlOjgyMjYyMDhhYTM4MzQzMjQ4NDU1MmNmZGY4MmQ0OTMzL3RhYmxlcmFuZ2U6ODIyNjIwOGFhMzgzNDMyNDg0NTUyY2ZkZjgyZDQ5MzNfMTMtMi0xLTEtMA_50713667-e924-4484-8d8f-d6968535fb8f"
      unitRef="usd">14000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="ic833fc7e7ff14f309dbabe622e99c8de_I20200117"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RhYmxlOjgyMjYyMDhhYTM4MzQzMjQ4NDU1MmNmZGY4MmQ0OTMzL3RhYmxlcmFuZ2U6ODIyNjIwOGFhMzgzNDMyNDg0NTUyY2ZkZjgyZDQ5MzNfMTQtMi0xLTEtMA_7ff8272c-74f3-40aa-92ac-703ce6c9b4ec"
      unitRef="usd">15000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="ic833fc7e7ff14f309dbabe622e99c8de_I20200117"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RhYmxlOjgyMjYyMDhhYTM4MzQzMjQ4NDU1MmNmZGY4MmQ0OTMzL3RhYmxlcmFuZ2U6ODIyNjIwOGFhMzgzNDMyNDg0NTUyY2ZkZjgyZDQ5MzNfMTUtMi0xLTEtMA_42ccda72-8747-4beb-b36d-34c7f006e52a"
      unitRef="usd">566000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="ic833fc7e7ff14f309dbabe622e99c8de_I20200117"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RhYmxlOjgyMjYyMDhhYTM4MzQzMjQ4NDU1MmNmZGY4MmQ0OTMzL3RhYmxlcmFuZ2U6ODIyNjIwOGFhMzgzNDMyNDg0NTUyY2ZkZjgyZDQ5MzNfMTYtMi0xLTEtMA_4fad9352-37bf-4254-a822-74531544d8be"
      unitRef="usd">4994000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="ic833fc7e7ff14f309dbabe622e99c8de_I20200117"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80MC9mcmFnOmQwMjAwMWMzM2Y5NDRiMjZiYTdjZDgwODk1ZTMyN2IyL3RhYmxlOjgyMjYyMDhhYTM4MzQzMjQ4NDU1MmNmZGY4MmQ0OTMzL3RhYmxlcmFuZ2U6ODIyNjIwOGFhMzgzNDMyNDg0NTUyY2ZkZjgyZDQ5MzNfMTctMi0xLTEtMA_5721873a-2854-4b55-9d77-60a75f1fbd2b"
      unitRef="usd">2220000</us-gaap:Goodwill>
    <us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xMTU5L2ZyYWc6OTU2NjliMmNjMjdjNGJlMWI0MTA1ZmE3M2QxMjVmMjUvdGV4dHJlZ2lvbjo5NTY2OWIyY2MyN2M0YmUxYjQxMDVmYTczZDEyNWYyNV8xODE0MTk0MTg2MjE1OQ_f453c58a-11df-4595-b1fd-21dc56c2b055">RADx Program&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%"&gt;In July 2020, we entered into a letter contract with the National Institutes of Health (NIH) for a project under the NIH Rapid Acceleration of Diagnostics (RADx) program. The RADx program provides grants to support a range of new lab-based and point-of-care tests that could significantly increase the number, type and availability of COVID-19 tests. On September 28, 2020, we executed a definitive contract with the NIH as an amendment to the letter contract (collectively, the NIH Contract). The NIH Contract has a total value of up to $34.0&#160;million upon the achievement of certain conditional milestones. Proceeds from the NIH Contract will be used primarily to expand production capacity and product throughput capabilities for COVID-19 testing with Fluidigm microfluidics technology. We expect to complete the NIH Contract by the end of 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%"&gt;The NIH has the right to terminate the NIH Contract for convenience.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%"&gt;In the event of termination for convenience, Fluidigm will be paid a percentage of the NIH Contract price reflecting the percentage of the work performed prior to the notice of termination, plus reasonable charges. In the event of termination for cause due to our default, NIH is not liable for supplies or services not accepted. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%"&gt;If we fail to deliver within the time specified in the NIH Contract and the delay is due to Fluidigm&#x2019;s fault or negligence, we are required to pay liquidated damages in the amount of 33% of the amount(s) already disbursed to date under the NIH Contract within six months from the date of termination.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity under the NIH Contract through September&#160;30, 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:15pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total value of milestones reasonably assured&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts applied against research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred grant income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total value of milestones reasonably assured &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funding received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant receivable from RADx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock>
    <fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue
      contextRef="i9ad72ef114054c68ba1d7499333b66b9_I20200928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xMTU5L2ZyYWc6OTU2NjliMmNjMjdjNGJlMWI0MTA1ZmE3M2QxMjVmMjUvdGV4dHJlZ2lvbjo5NTY2OWIyY2MyN2M0YmUxYjQxMDVmYTczZDEyNWYyNV8xODE0MTk0MTg4NTg0NQ_0a3745f0-621e-437c-bc62-b402b54cb979"
      unitRef="usd">34000000.0</fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue>
    <fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesPercentage
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xMTU5L2ZyYWc6OTU2NjliMmNjMjdjNGJlMWI0MTA1ZmE3M2QxMjVmMjUvdGV4dHJlZ2lvbjo5NTY2OWIyY2MyN2M0YmUxYjQxMDVmYTczZDEyNWYyNV8xODE0MTk0MTg4NTg2MA_604300a8-2d38-4080-9b4f-d6df9e4cd672"
      unitRef="number">0.33</fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesPercentage>
    <fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesTerm
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xMTU5L2ZyYWc6OTU2NjliMmNjMjdjNGJlMWI0MTA1ZmE3M2QxMjVmMjUvdGV4dHJlZ2lvbjo5NTY2OWIyY2MyN2M0YmUxYjQxMDVmYTczZDEyNWYyNV8xODE0MTk0MTg4NTg2NA_5a4246ba-af5c-4ffe-b315-924128aa47a3">P6M</fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesTerm>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xMTU5L2ZyYWc6OTU2NjliMmNjMjdjNGJlMWI0MTA1ZmE3M2QxMjVmMjUvdGV4dHJlZ2lvbjo5NTY2OWIyY2MyN2M0YmUxYjQxMDVmYTczZDEyNWYyNV8xNjQ5MjY3NDQyNTYzMQ_f90a9cc9-35c5-40f2-8644-76c09e04acaf">&lt;div style="margin-bottom:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity under the NIH Contract through September&#160;30, 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:15pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total value of milestones reasonably assured&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts applied against research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred grant income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total value of milestones reasonably assured &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funding received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant receivable from RADx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock>
    <fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAmount
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xMTU5L2ZyYWc6OTU2NjliMmNjMjdjNGJlMWI0MTA1ZmE3M2QxMjVmMjUvdGFibGU6MzM0NTI3NjgwMDk5NDYzZGE0MDcxODE2ZmU0MzI2N2EvdGFibGVyYW5nZTozMzQ1Mjc2ODAwOTk0NjNkYTQwNzE4MTZmZTQzMjY3YV8yLTItMS0xLTE4MzU_f5f1d3ac-0821-4e3d-a181-dc207971d8ce"
      unitRef="usd">18607000</fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAmount>
    <fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xMTU5L2ZyYWc6OTU2NjliMmNjMjdjNGJlMWI0MTA1ZmE3M2QxMjVmMjUvdGFibGU6MzM0NTI3NjgwMDk5NDYzZGE0MDcxODE2ZmU0MzI2N2EvdGFibGVyYW5nZTozMzQ1Mjc2ODAwOTk0NjNkYTQwNzE4MTZmZTQzMjY3YV8zLTItMS0xLTE4MzU_c283054a-ccd6-4421-b88c-e0f0ea9aa968"
      unitRef="usd">383000</fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses>
    <fldm:DeferredGrantRevenueNoncurrent
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xMTU5L2ZyYWc6OTU2NjliMmNjMjdjNGJlMWI0MTA1ZmE3M2QxMjVmMjUvdGFibGU6MzM0NTI3NjgwMDk5NDYzZGE0MDcxODE2ZmU0MzI2N2EvdGFibGVyYW5nZTozMzQ1Mjc2ODAwOTk0NjNkYTQwNzE4MTZmZTQzMjY3YV80LTItMS0xLTE4MzU_f0156ef7-479e-4911-9499-f86d7c838894"
      unitRef="usd">18224000</fldm:DeferredGrantRevenueNoncurrent>
    <fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAmount
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xMTU5L2ZyYWc6OTU2NjliMmNjMjdjNGJlMWI0MTA1ZmE3M2QxMjVmMjUvdGFibGU6MzM0NTI3NjgwMDk5NDYzZGE0MDcxODE2ZmU0MzI2N2EvdGFibGVyYW5nZTozMzQ1Mjc2ODAwOTk0NjNkYTQwNzE4MTZmZTQzMjY3YV82LTItMS0xLTE4MzU_3ccbb070-b7a1-436e-9c62-949c6f144bc5"
      unitRef="usd">18607000</fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAmount>
    <fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersFundingReceived
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xMTU5L2ZyYWc6OTU2NjliMmNjMjdjNGJlMWI0MTA1ZmE3M2QxMjVmMjUvdGFibGU6MzM0NTI3NjgwMDk5NDYzZGE0MDcxODE2ZmU0MzI2N2EvdGFibGVyYW5nZTozMzQ1Mjc2ODAwOTk0NjNkYTQwNzE4MTZmZTQzMjY3YV83LTItMS0xLTE4MzU_c76677aa-6170-4c74-998e-d4de8e798d0f"
      unitRef="usd">11151000</fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersFundingReceived>
    <fldm:ResearchAndDevelopmentArrangementReceivables
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8xMTU5L2ZyYWc6OTU2NjliMmNjMjdjNGJlMWI0MTA1ZmE3M2QxMjVmMjUvdGFibGU6MzM0NTI3NjgwMDk5NDYzZGE0MDcxODE2ZmU0MzI2N2EvdGFibGVyYW5nZTozMzQ1Mjc2ODAwOTk0NjNkYTQwNzE4MTZmZTQzMjY3YV84LTItMS0xLTE4MzU_815efcb6-6dfa-4b74-9b2c-beb8467cad13"
      unitRef="usd">7456000</fldm:ResearchAndDevelopmentArrangementReceivables>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RleHRyZWdpb246MzhkOTM1NDdiYTZhNGNjNDkwMTc1YWYwZTUzYTU5MGNfMTMxNA_a4c7beca-3919-46f8-922f-3515dbad2dc0">Revenue&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents our revenue for the three and nine months ended September&#160;30, 2020 and 2019, respectively, based on geographic area and by source (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.169%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.039%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Geographic Markets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EMEA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Source:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consumables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Development revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;License and royalty revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Grant revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Total other revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We reported $20.0 million of deferred revenue in our December&#160;31, 2019 consolidated balance sheet. During the nine months ended September&#160;30, 2020, $8.8 million of the opening balance was recognized as revenue and $9.9 million of net additional advance payments were received from customers, primarily associated with instrument service contracts. At September&#160;30, 2020, we reported $21.1 million of deferred revenue. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the expected timing of revenue recognition for unfulfilled performance obligations associated with instrument service contracts that were partially completed at September&#160;30, 2020 (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.798%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.165%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Expected Revenue &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020 (remainder of the year)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected revenue includes both billed amounts included in deferred revenue and unbilled amounts that are not reflected in our condensed consolidated financial statements and are subject to change if our customers decide to cancel or modify their contracts. Purchase orders for instrument service contracts can generally be canceled before the service period begins without penalty.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We apply the practical expedient that permits us not to disclose information about unsatisfied performance obligations for service contracts with an expected term of one year or less.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RleHRyZWdpb246MzhkOTM1NDdiYTZhNGNjNDkwMTc1YWYwZTUzYTU5MGNfMTMxNg_73a5b67a-977e-4865-8023-2a9d3ed70e57">&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents our revenue for the three and nine months ended September&#160;30, 2020 and 2019, respectively, based on geographic area and by source (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.169%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.039%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Geographic Markets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EMEA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Source:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consumables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Development revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;License and royalty revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Grant revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Total other revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic1f96d93c1f9456eadce09f1a0df997c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOmFkZGFhMjdkNjVhZjQzN2M4OGIwMGJjY2VjOGQzMDI2L3RhYmxlcmFuZ2U6YWRkYWEyN2Q2NWFmNDM3Yzg4YjAwYmNjZWM4ZDMwMjZfMy0xLTEtMS0w_167ac689-77ed-4900-bf9d-85c8c73c6878"
      unitRef="usd">23653000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idc94006eea6b434ca69524643dc9911e_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOmFkZGFhMjdkNjVhZjQzN2M4OGIwMGJjY2VjOGQzMDI2L3RhYmxlcmFuZ2U6YWRkYWEyN2Q2NWFmNDM3Yzg4YjAwYmNjZWM4ZDMwMjZfMy0zLTEtMS0w_5ca73a8a-b93a-493b-8dc0-6e61d6ae9118"
      unitRef="usd">11112000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2d0a47c0cefc4e1db4ee8e02eca066a9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOmFkZGFhMjdkNjVhZjQzN2M4OGIwMGJjY2VjOGQzMDI2L3RhYmxlcmFuZ2U6YWRkYWEyN2Q2NWFmNDM3Yzg4YjAwYmNjZWM4ZDMwMjZfMy01LTEtMS0w_5644ef19-e0e1-42a2-ac24-6c3a61c1f1ed"
      unitRef="usd">52437000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia24e4dab3a1e4846aed1d65d31ca64e9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOmFkZGFhMjdkNjVhZjQzN2M4OGIwMGJjY2VjOGQzMDI2L3RhYmxlcmFuZ2U6YWRkYWEyN2Q2NWFmNDM3Yzg4YjAwYmNjZWM4ZDMwMjZfMy03LTEtMS0w_30b374a9-73d8-458c-be88-5292c8b48934"
      unitRef="usd">35203000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i856788a23f0e421e9c4f6bfcd2937c25_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOmFkZGFhMjdkNjVhZjQzN2M4OGIwMGJjY2VjOGQzMDI2L3RhYmxlcmFuZ2U6YWRkYWEyN2Q2NWFmNDM3Yzg4YjAwYmNjZWM4ZDMwMjZfNC0xLTEtMS0w_1cc0bf96-5814-4abe-9734-a04a4d1833f4"
      unitRef="usd">8837000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie818350e13f1407c8991ea709abe673f_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOmFkZGFhMjdkNjVhZjQzN2M4OGIwMGJjY2VjOGQzMDI2L3RhYmxlcmFuZ2U6YWRkYWEyN2Q2NWFmNDM3Yzg4YjAwYmNjZWM4ZDMwMjZfNC0zLTEtMS0w_f70259ce-4df9-46b1-b82a-d5cd1ce09b44"
      unitRef="usd">9092000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i36a9b9de3bfd42a795635e6c4734733a_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOmFkZGFhMjdkNjVhZjQzN2M4OGIwMGJjY2VjOGQzMDI2L3RhYmxlcmFuZ2U6YWRkYWEyN2Q2NWFmNDM3Yzg4YjAwYmNjZWM4ZDMwMjZfNC01LTEtMS0w_c580e6d8-a737-47d0-95f6-27a9d19769e1"
      unitRef="usd">23490000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iceddf551be474cbfa9d1febcb7e64631_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOmFkZGFhMjdkNjVhZjQzN2M4OGIwMGJjY2VjOGQzMDI2L3RhYmxlcmFuZ2U6YWRkYWEyN2Q2NWFmNDM3Yzg4YjAwYmNjZWM4ZDMwMjZfNC03LTEtMS0w_03100666-191e-4385-a786-b40009885299"
      unitRef="usd">28465000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2c769151da2142868115a7ca0373be74_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOmFkZGFhMjdkNjVhZjQzN2M4OGIwMGJjY2VjOGQzMDI2L3RhYmxlcmFuZ2U6YWRkYWEyN2Q2NWFmNDM3Yzg4YjAwYmNjZWM4ZDMwMjZfNS0xLTEtMS0w_865118cf-274c-4b2f-a23b-1f1494dfc061"
      unitRef="usd">7371000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8c7ed6ed420047e1b49b17f97ea91343_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOmFkZGFhMjdkNjVhZjQzN2M4OGIwMGJjY2VjOGQzMDI2L3RhYmxlcmFuZ2U6YWRkYWEyN2Q2NWFmNDM3Yzg4YjAwYmNjZWM4ZDMwMjZfNS0zLTEtMS0w_146923d0-5759-4725-85f8-3b45d10974dc"
      unitRef="usd">6292000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibb3c7d9e2c814e0e8399d92211de70ff_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOmFkZGFhMjdkNjVhZjQzN2M4OGIwMGJjY2VjOGQzMDI2L3RhYmxlcmFuZ2U6YWRkYWEyN2Q2NWFmNDM3Yzg4YjAwYmNjZWM4ZDMwMjZfNS01LTEtMS0w_67e13e75-66ca-49d6-b665-c60ba641d44f"
      unitRef="usd">17609000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if0b62a4024244e348817dc10a1f4ca62_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOmFkZGFhMjdkNjVhZjQzN2M4OGIwMGJjY2VjOGQzMDI2L3RhYmxlcmFuZ2U6YWRkYWEyN2Q2NWFmNDM3Yzg4YjAwYmNjZWM4ZDMwMjZfNS03LTEtMS0w_d2c7e096-c540-46fb-a270-7b272768a550"
      unitRef="usd">21135000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOmFkZGFhMjdkNjVhZjQzN2M4OGIwMGJjY2VjOGQzMDI2L3RhYmxlcmFuZ2U6YWRkYWEyN2Q2NWFmNDM3Yzg4YjAwYmNjZWM4ZDMwMjZfNi0xLTEtMS0w_25b522d2-78f3-4489-aa01-68657fca5a5f"
      unitRef="usd">39861000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOmFkZGFhMjdkNjVhZjQzN2M4OGIwMGJjY2VjOGQzMDI2L3RhYmxlcmFuZ2U6YWRkYWEyN2Q2NWFmNDM3Yzg4YjAwYmNjZWM4ZDMwMjZfNi0zLTEtMS0w_ebac154a-d323-4cdb-ae7e-a91fb3ea06c4"
      unitRef="usd">26496000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOmFkZGFhMjdkNjVhZjQzN2M4OGIwMGJjY2VjOGQzMDI2L3RhYmxlcmFuZ2U6YWRkYWEyN2Q2NWFmNDM3Yzg4YjAwYmNjZWM4ZDMwMjZfNi01LTEtMS0w_2d159664-e119-4e78-86f8-16c36b6baecd"
      unitRef="usd">93536000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOmFkZGFhMjdkNjVhZjQzN2M4OGIwMGJjY2VjOGQzMDI2L3RhYmxlcmFuZ2U6YWRkYWEyN2Q2NWFmNDM3Yzg4YjAwYmNjZWM4ZDMwMjZfNi03LTEtMS0w_7b936dab-790a-4072-9d1d-9e70cf6c7c09"
      unitRef="usd">84803000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9557da47acfa4592bd8a6eb4d01dbcac_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfNC0xLTEtMS0w_a3c4730f-89ef-48f0-8ecd-e63d7c2ee175"
      unitRef="usd">12624000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i10f3f219918f49f0a4aaeea16520869b_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfNC0zLTEtMS0w_e7dfe2b0-d0b1-44a8-8122-bebb383eeb7a"
      unitRef="usd">9159000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifcec3908df424a9b994b171239c3ad23_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfNC01LTEtMS0w_849561d4-8206-4045-9a25-5ee1dacb4ecf"
      unitRef="usd">30672000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i65e54d66980042b78f398dff2722c68c_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfNC03LTEtMS0w_a956505e-f483-4973-bd08-2f2b547bb25f"
      unitRef="usd">34200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1295e00055ed464589bdacaa5e07480f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfNS0xLTEtMS0w_ab66c31f-5521-44c1-88b4-43ff22b941df"
      unitRef="usd">16586000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3749711354f04142930ba804e3127822_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfNS0zLTEtMS0w_a7601c8d-9b37-447d-a339-64b85a37a6e3"
      unitRef="usd">11507000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idd2f4f0a6d4b4ccbb836a1200a172bdb_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfNS01LTEtMS0w_9429b60e-2ced-4178-8070-e53d86c8709b"
      unitRef="usd">34924000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i997fea8ff4474842a30928a2e82a8b6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfNS03LTEtMS0w_d2a048d1-1e96-420b-b720-2ff226f2271f"
      unitRef="usd">34528000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i63dac85b57b74b8ea053ca16f3171b97_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfNi0xLTEtMS0w_b8ded64f-e3bd-4d79-bf0d-7d110248fda5"
      unitRef="usd">29210000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if32b1e8a019b42fea7b915507e3650c8_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfNi0zLTEtMS0w_dc443e22-fd27-4360-b2b3-b5617067acd7"
      unitRef="usd">20666000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iedd975972ec54477b7d1edc9dcd0e9ae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfNi01LTEtMS0w_a6530c62-95f0-47cb-a55f-4ac9dec5d575"
      unitRef="usd">65596000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id978df8be0b2445ca43d804b18f99d88_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfNi03LTEtMS0w_d7621103-5c78-4048-a6d0-875e8a8130a3"
      unitRef="usd">68728000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iea38c8e677cb447a95163f4ee5133194_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfNy0xLTEtMS0w_f49c98e8-9319-415e-8c78-2938f5174b4f"
      unitRef="usd">6131000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i38d8014ca50e40ea95a3204f7d46b5a7_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfNy0zLTEtMS0w_8bb2cfaa-2683-4ea1-91d7-a021ce002190"
      unitRef="usd">5630000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie4c104320701492cab8cff2d9393f868_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfNy01LTEtMS0w_d997bad2-a624-4b26-9148-c16549d3c7ae"
      unitRef="usd">16457000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i64595cdf77c94fb899f02002ee32e32b_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfNy03LTEtMS0w_51608bf6-3afe-4095-973c-8dbae3a4ecb8"
      unitRef="usd">15875000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ied63bbfdfbdd4d17b689fb84bd615a22_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfOC0xLTEtMS0w_dc1067e5-c9bd-48e5-83db-5a3c02c02d4c"
      unitRef="usd">3180000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i33305dd63fcd4c7b827cced58c13da0a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfOC0zLTEtMS0w_7b729491-950f-44ea-8e30-457a80022805"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib7451c9afcd847cda97b00adbdae3f05_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfOC01LTEtMS0w_6ef14f46-6410-4d5c-8117-229356a7ca53"
      unitRef="usd">6180000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i86ecea94f14744c580bbf02abb8493f8_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfOC03LTEtMS0w_142c1b30-d5c8-4909-9d17-dbdd9c225d29"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i826fe1457ec74796bbc8e35e49f0de7a_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfMTAtMS0xLTEtMA_4d5b0adf-4dca-409e-bafb-df51afdb2ab3"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3b9fcc905d1e46f5ad329420385ba4f7_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfMTAtMy0xLTEtMA_ba90c730-3bfd-41aa-bcfd-bbaff44e6f6f"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i48f7db29c2964b2fab7a487953e7132a_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfMTAtNS0xLTEtMA_0ef1f9d1-0885-4f32-b2ad-2e40d6df45f1"
      unitRef="usd">3163000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i05f132757b684062b8a1afe7a0434252_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfMTAtNy0xLTEtMA_0f38dfc5-f7e9-453f-80b4-8440d124ac31"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i27c25df473b54c1d8ffbd994b10b9e7c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfMTEtMS0xLTEtMA_ce356976-0f43-4171-9dd2-891469b50ae9"
      unitRef="usd">1340000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id0c099e000eb4fe285d40608c7ab5954_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfMTEtMy0xLTEtMA_cabb1bdd-505d-4660-99be-05c7c53ad49e"
      unitRef="usd">200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i611ead10ea7746c88a251afc99eef27e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfMTEtNS0xLTEtMA_f1f81c1b-1638-4f27-802a-edd2cce491b6"
      unitRef="usd">2140000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id6eb5cddfd9a4a429b59d0409dc55f67_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfMTEtNy0xLTEtMA_7ff39215-f608-4c5e-a8c8-325e841e079a"
      unitRef="usd">200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id1eb2e1b7d5c4eeaa06d2bbb0f149ea2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfMTItMS0xLTEtMA_25b164c8-fb09-4f3b-a5d5-177aba507626"
      unitRef="usd">1340000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i507e1652ea0c4fb1b2d67aeec5653728_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfMTItMy0xLTEtMA_f922be90-a5e1-4b40-a088-1548197dd9bf"
      unitRef="usd">200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6cb05eac3b154d7798dda674fcc015dd_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfMTItNS0xLTEtMA_2940631b-9c49-41a9-b137-0e827e6a5004"
      unitRef="usd">5303000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6188317019ad466c8b5326b1720b484d_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfMTItNy0xLTEtMA_b5cee7b1-2384-4e3c-bd0a-44209aa0ba24"
      unitRef="usd">200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfMTMtMS0xLTEtMA_13b28616-f69f-4607-ac21-d8ffb064d8b5"
      unitRef="usd">39861000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfMTMtMy0xLTEtMA_ac884f2c-368f-4a58-9ddc-1f4a0207ca73"
      unitRef="usd">26496000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfMTMtNS0xLTEtMA_3b792285-df76-4c0e-bdfa-0a6a97d1afe8"
      unitRef="usd">93536000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjM4ZGVmMjBhZjA0MjQ1ZWFhNzI2ZTM4MDkzOTY4MmY1L3RhYmxlcmFuZ2U6MzhkZWYyMGFmMDQyNDVlYWE3MjZlMzgwOTM5NjgyZjVfMTMtNy0xLTEtMA_3c4b64d3-1f68-419b-847c-8e8c3751fa4c"
      unitRef="usd">84803000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RleHRyZWdpb246MzhkOTM1NDdiYTZhNGNjNDkwMTc1YWYwZTUzYTU5MGNfMjE2_852daf35-678d-4592-ba71-5bbdb5e4347d"
      unitRef="usd">20000000.0</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RleHRyZWdpb246MzhkOTM1NDdiYTZhNGNjNDkwMTc1YWYwZTUzYTU5MGNfMjk1_e015f844-b65c-4553-a558-a94bc7e696c4"
      unitRef="usd">8800000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <fldm:ContractWithCustomerLiabilityIncreaseFromCashReceipts
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RleHRyZWdpb246MzhkOTM1NDdiYTZhNGNjNDkwMTc1YWYwZTUzYTU5MGNfMzUx_b0ae0383-39ba-4a36-9054-584c0da66f38"
      unitRef="usd">9900000</fldm:ContractWithCustomerLiabilityIncreaseFromCashReceipts>
    <us-gaap:ContractWithCustomerLiability
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RleHRyZWdpb246MzhkOTM1NDdiYTZhNGNjNDkwMTc1YWYwZTUzYTU5MGNfNDk0_67da0d5d-6998-446b-8f1b-d442ed8fd8a5"
      unitRef="usd">21100000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RleHRyZWdpb246MzhkOTM1NDdiYTZhNGNjNDkwMTc1YWYwZTUzYTU5MGNfMTMxMg_c5c7aee7-aead-4ca5-a607-e6e1890a673c">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the expected timing of revenue recognition for unfulfilled performance obligations associated with instrument service contracts that were partially completed at September&#160;30, 2020 (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.798%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.165%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Expected Revenue &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020 (remainder of the year)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected revenue includes both billed amounts included in deferred revenue and unbilled amounts that are not reflected in our condensed consolidated financial statements and are subject to change if our customers decide to cancel or modify their contracts. Purchase orders for instrument service contracts can generally be canceled before the service period begins without penalty.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i5b8ca235d25d4be7b24f48e1d7b063c2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjQ2MzJkYmI2ZTExNjQ5YWRhNTI3OTYxMGE2OWI3NmQ4L3RhYmxlcmFuZ2U6NDYzMmRiYjZlMTE2NDlhZGE1Mjc5NjEwYTY5Yjc2ZDhfMS0yLTEtMS0w_4b9929db-4db2-44c5-ad29-25b2ade38fcc"
      unitRef="usd">3873000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ibee58402214d46c9b90764b31cb5bb82_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjQ2MzJkYmI2ZTExNjQ5YWRhNTI3OTYxMGE2OWI3NmQ4L3RhYmxlcmFuZ2U6NDYzMmRiYjZlMTE2NDlhZGE1Mjc5NjEwYTY5Yjc2ZDhfMi0yLTEtMS0w_c3a32b4c-04b4-40a1-aa2d-3e6f4b53342b"
      unitRef="usd">10385000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ie8df7afdb66042e49508527a5cb31fa1_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjQ2MzJkYmI2ZTExNjQ5YWRhNTI3OTYxMGE2OWI3NmQ4L3RhYmxlcmFuZ2U6NDYzMmRiYjZlMTE2NDlhZGE1Mjc5NjEwYTY5Yjc2ZDhfMy0yLTEtMS0w_c68f87d7-cf3d-4451-8442-205722d4c5b7"
      unitRef="usd">5775000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i6080b667adf249898c3e460f95952085_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjQ2MzJkYmI2ZTExNjQ5YWRhNTI3OTYxMGE2OWI3NmQ4L3RhYmxlcmFuZ2U6NDYzMmRiYjZlMTE2NDlhZGE1Mjc5NjEwYTY5Yjc2ZDhfNC0yLTEtMS0w_997e98a7-44a7-4292-b5fe-580b1d4956bd"
      unitRef="usd">4079000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80My9mcmFnOjM4ZDkzNTQ3YmE2YTRjYzQ5MDE3NWFmMGU1M2E1OTBjL3RhYmxlOjQ2MzJkYmI2ZTExNjQ5YWRhNTI3OTYxMGE2OWI3NmQ4L3RhYmxlcmFuZ2U6NDYzMmRiYjZlMTE2NDlhZGE1Mjc5NjEwYTY5Yjc2ZDhfNS0yLTEtMS0w_c86800d7-95b5-49ac-844c-f231b227c88d"
      unitRef="usd">24112000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RleHRyZWdpb246YmI4NWM0ZDFjODFmNDczMDkyNWEzYTY0YzdkNGZmNTNfMjMzOQ_4ed8fdc6-2654-461f-868f-db79bc66b1e4">Goodwill and Intangible Assets, net&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with our acquisition of DVS Sciences, Inc. in February 2014, we recognized goodwill of $104.1 million and $112.0 million of developed technology. In the first quarter of 2020, we recognized $2.2 million (Euro 2.0 million) of goodwill from the InstruNor acquisition and $5.4 million (Euro 4.9 million) of developed technology (see Note 3). As the goodwill and developed technology from the InstruNor acquisition are recorded in the functional currency of our European operations, which is the Euro, these balances are revalued each period and the U.S. dollar value of these assets will fluctuate as foreign exchange rates change. We are amortizing InstruNor developed technology over 8.0 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and intangible assets with indefinite lives are not subject to amortization but are tested for impairment on an annual basis during the fourth quarter or whenever events or changes in circumstances indicate the carrying amount of these assets may not be recoverable. Qualitative assessment includes assessing significant events and circumstances such as our current results, assumptions regarding future performance, strategic initiatives and overall economic factors, including the ongoing global COVID-19 pandemic and macroeconomic developments to determine the existence of potential indicators of impairment and assess if it is more likely than not that the fair value of our reporting unit or intangible assets is less than their carrying value. If indicators of impairment are identified, a quantitative impairment test is performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of fiscal 2020, the Company assessed whether the current and potential future impact of the COVID-19 pandemic represented an event which necessitated an impairment review.&#160;This assessment included an update of the qualitative and quantitative factors affecting our business. As a result of this assessment, we determined that a triggering event had occurred and a quantitative impairment test was performed. As a result of this quantitative analysis, we determined that the fair values of our goodwill and developed technology intangibles were not less than their carrying values and no impairment was recognized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets also include other patents and licenses, which are included in other non-current assets. Intangible assets, net, were as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.020%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization and Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Amortization Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74,425)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,030)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.020%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization and Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Amortization Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,342)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total amortization expense for the three months ended September&#160;30, 2020 and 2019 was $3.2 million and $3.0 million, respectively. Amortization of intangibles was $9.6 million and $9.2 million for the nine months ended September&#160;30, 2020 and 2019, respectively.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on the carrying value of intangible assets, net,&#160;as of&#160;September&#160;30, 2020, the amortization expense is expected to be as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.782%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Developed Technology Amortization Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Patents and Licenses Amortization Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020 (remainder of the year)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:Goodwill
      contextRef="i4597ae00a444403dacaf5086f59bacac_I20140228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RleHRyZWdpb246YmI4NWM0ZDFjODFmNDczMDkyNWEzYTY0YzdkNGZmNTNfMTQ1_07823a71-e7ed-4ed5-9c92-bcf7dae87aec"
      unitRef="usd">104100000</us-gaap:Goodwill>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="ic6b361716cf04338b59854e72cf943b0_D20140201-20140228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RleHRyZWdpb246YmI4NWM0ZDFjODFmNDczMDkyNWEzYTY0YzdkNGZmNTNfMTUy_e246dda6-e2e3-4236-862d-7013eedda849"
      unitRef="usd">112000000.0</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:Goodwill
      contextRef="i0baca80d39e748b7bcbaf3ac214f583b_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RleHRyZWdpb246YmI4NWM0ZDFjODFmNDczMDkyNWEzYTY0YzdkNGZmNTNfMjI0_5ca0c1cf-423e-4140-8524-11ac5e7e5816"
      unitRef="usd">2200000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i0baca80d39e748b7bcbaf3ac214f583b_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RleHRyZWdpb246YmI4NWM0ZDFjODFmNDczMDkyNWEzYTY0YzdkNGZmNTNfMTA5OTUxMTYzMDEyMw_30168479-eb13-4ff4-bd64-987e4c858679"
      unitRef="eur">2000000.0</us-gaap:Goodwill>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i62aeb047eea249e8a505e86f7dbd1080_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RleHRyZWdpb246YmI4NWM0ZDFjODFmNDczMDkyNWEzYTY0YzdkNGZmNTNfMjc0_96d7559e-e240-4131-92b3-ab752d9967d5"
      unitRef="usd">5400000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i62aeb047eea249e8a505e86f7dbd1080_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RleHRyZWdpb246YmI4NWM0ZDFjODFmNDczMDkyNWEzYTY0YzdkNGZmNTNfMTA5OTUxMTYzMDEzNw_641e27a2-88b5-432c-bf62-5e316b590ff7"
      unitRef="eur">4900000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i62aeb047eea249e8a505e86f7dbd1080_D20200101-20200331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RleHRyZWdpb246YmI4NWM0ZDFjODFmNDczMDkyNWEzYTY0YzdkNGZmNTNfMzY5_cabda0b9-cd3e-4479-a752-9d6b8ae9575f">P8Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RleHRyZWdpb246YmI4NWM0ZDFjODFmNDczMDkyNWEzYTY0YzdkNGZmNTNfMjMzMw_6d822dee-c1fa-4848-ad4b-58bb3e8ffe9b">Intangible assets, net, were as follows (in thousands): &lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.020%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization and Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Amortization Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74,425)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,030)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.020%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization and Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Amortization Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,342)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id93cbf33dc99482fbdd7c3492d9fd706_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjI0MWRlNzY4ODcxNDQwM2I4ODliZmI3NTYxNjE4YjBkL3RhYmxlcmFuZ2U6MjQxZGU3Njg4NzE0NDAzYjg4OWJmYjc1NjE2MThiMGRfMi0yLTEtMS0w_1fbbacd5-8c67-4213-bf09-63db56b4bbaf"
      unitRef="usd">117380000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id93cbf33dc99482fbdd7c3492d9fd706_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjI0MWRlNzY4ODcxNDQwM2I4ODliZmI3NTYxNjE4YjBkL3RhYmxlcmFuZ2U6MjQxZGU3Njg4NzE0NDAzYjg4OWJmYjc1NjE2MThiMGRfMi00LTEtMS0w_7f17405f-539f-4c3d-8073-6b7d30009d16"
      unitRef="usd">74425000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id93cbf33dc99482fbdd7c3492d9fd706_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjI0MWRlNzY4ODcxNDQwM2I4ODliZmI3NTYxNjE4YjBkL3RhYmxlcmFuZ2U6MjQxZGU3Njg4NzE0NDAzYjg4OWJmYjc1NjE2MThiMGRfMi02LTEtMS0w_4398d779-7c5e-4437-905c-32a3968e222b"
      unitRef="usd">42955000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i448598bde68f45d1ba361f740dd9f13e_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjI0MWRlNzY4ODcxNDQwM2I4ODliZmI3NTYxNjE4YjBkL3RhYmxlcmFuZ2U6MjQxZGU3Njg4NzE0NDAzYjg4OWJmYjc1NjE2MThiMGRfMi04LTEtMS0w_28c11635-ed6d-4511-a1b9-e2efb1bc1fc1">P9Y10M24D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic4d4f73bdbe84c6cb586dc7a3922ccec_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjI0MWRlNzY4ODcxNDQwM2I4ODliZmI3NTYxNjE4YjBkL3RhYmxlcmFuZ2U6MjQxZGU3Njg4NzE0NDAzYjg4OWJmYjc1NjE2MThiMGRfMy0yLTEtMS0w_f64414fd-14e3-49a4-935a-c1e5d9928424"
      unitRef="usd">11274000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic4d4f73bdbe84c6cb586dc7a3922ccec_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjI0MWRlNzY4ODcxNDQwM2I4ODliZmI3NTYxNjE4YjBkL3RhYmxlcmFuZ2U6MjQxZGU3Njg4NzE0NDAzYjg4OWJmYjc1NjE2MThiMGRfMy00LTEtMS0w_a25a454f-31f1-4b0f-8872-4d5809e190e2"
      unitRef="usd">9030000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic4d4f73bdbe84c6cb586dc7a3922ccec_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjI0MWRlNzY4ODcxNDQwM2I4ODliZmI3NTYxNjE4YjBkL3RhYmxlcmFuZ2U6MjQxZGU3Njg4NzE0NDAzYjg4OWJmYjc1NjE2MThiMGRfMy02LTEtMS0w_4649a681-fbf2-46f3-b6d3-261f35740caf"
      unitRef="usd">2244000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i2f1a0048873a41439f03f292dfd42431_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjI0MWRlNzY4ODcxNDQwM2I4ODliZmI3NTYxNjE4YjBkL3RhYmxlcmFuZ2U6MjQxZGU3Njg4NzE0NDAzYjg4OWJmYjc1NjE2MThiMGRfMy04LTEtMS0w_99c312dd-65b7-4afd-a4a4-e2c676b7a22d">P7Y9M18D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4a2e644816c049b1a4a674aba901cf89_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjRiYmM2YzNkZWRlZTQyMjE5Yjc2MDkzMWM0OGM1MzZjL3RhYmxlcmFuZ2U6NGJiYzZjM2RlZGVlNDIyMTliNzYwOTMxYzQ4YzUzNmNfMy0yLTEtMS0w_ff9617bc-a542-466e-9090-98184a522f2f"
      unitRef="usd">112000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4a2e644816c049b1a4a674aba901cf89_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjRiYmM2YzNkZWRlZTQyMjE5Yjc2MDkzMWM0OGM1MzZjL3RhYmxlcmFuZ2U6NGJiYzZjM2RlZGVlNDIyMTliNzYwOTMxYzQ4YzUzNmNfMy00LTEtMS0w_65d52e8e-c2cf-420f-87f5-0a12fd63a908"
      unitRef="usd">65800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i4a2e644816c049b1a4a674aba901cf89_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjRiYmM2YzNkZWRlZTQyMjE5Yjc2MDkzMWM0OGM1MzZjL3RhYmxlcmFuZ2U6NGJiYzZjM2RlZGVlNDIyMTliNzYwOTMxYzQ4YzUzNmNfMy02LTEtMS0w_76543d5f-5eff-4573-8e98-1cb1f14dd141"
      unitRef="usd">46200000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="ifb41af4444ce4ac891cf86ca937bc359_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjRiYmM2YzNkZWRlZTQyMjE5Yjc2MDkzMWM0OGM1MzZjL3RhYmxlcmFuZ2U6NGJiYzZjM2RlZGVlNDIyMTliNzYwOTMxYzQ4YzUzNmNfMy04LTEtMS0w_0a75a44f-f6d3-496b-baec-63abe508737d">P10Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3f4c794c8ce04cb098b7c1033bc0c119_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjRiYmM2YzNkZWRlZTQyMjE5Yjc2MDkzMWM0OGM1MzZjL3RhYmxlcmFuZ2U6NGJiYzZjM2RlZGVlNDIyMTliNzYwOTMxYzQ4YzUzNmNfNC0yLTEtMS0w_bb455575-0a13-4362-8fc1-0c597d0afb72"
      unitRef="usd">11274000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3f4c794c8ce04cb098b7c1033bc0c119_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjRiYmM2YzNkZWRlZTQyMjE5Yjc2MDkzMWM0OGM1MzZjL3RhYmxlcmFuZ2U6NGJiYzZjM2RlZGVlNDIyMTliNzYwOTMxYzQ4YzUzNmNfNC00LTEtMS0w_c4642aba-05fd-4ad4-9be4-6d8113697962"
      unitRef="usd">8342000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i3f4c794c8ce04cb098b7c1033bc0c119_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjRiYmM2YzNkZWRlZTQyMjE5Yjc2MDkzMWM0OGM1MzZjL3RhYmxlcmFuZ2U6NGJiYzZjM2RlZGVlNDIyMTliNzYwOTMxYzQ4YzUzNmNfNC02LTEtMS0w_1d68f3ef-dfc5-444d-8ad8-778e5524e83e"
      unitRef="usd">2932000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i863d909053654a5097e30eaeb582a60f_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjRiYmM2YzNkZWRlZTQyMjE5Yjc2MDkzMWM0OGM1MzZjL3RhYmxlcmFuZ2U6NGJiYzZjM2RlZGVlNDIyMTliNzYwOTMxYzQ4YzUzNmNfNC04LTEtMS0w_1b5e740c-44cb-4fef-ae9b-fcc0c0076200">P7Y9M18D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i8bbffea3402e4561b1e8ab6fc7c2bc4d_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RleHRyZWdpb246YmI4NWM0ZDFjODFmNDczMDkyNWEzYTY0YzdkNGZmNTNfMjA4NQ_6161fd6a-9c19-4c6e-9e75-7046f2f2f7b7"
      unitRef="usd">3200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i62ab5d72d0304d8f95c3a6e3503aa15d_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RleHRyZWdpb246YmI4NWM0ZDFjODFmNDczMDkyNWEzYTY0YzdkNGZmNTNfMjA5Mg_81ec035b-2bc8-4fa7-80b4-c677be85fb72"
      unitRef="usd">3000000.0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i448598bde68f45d1ba361f740dd9f13e_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RleHRyZWdpb246YmI4NWM0ZDFjODFmNDczMDkyNWEzYTY0YzdkNGZmNTNfMjE0Mg_f2be5d7a-71fb-4cf7-9236-b44cd20a9c5f"
      unitRef="usd">9600000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i4662072a04b84dfea208dcc931393b9d_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RleHRyZWdpb246YmI4NWM0ZDFjODFmNDczMDkyNWEzYTY0YzdkNGZmNTNfMjE0OQ_05494c20-0ad1-43f0-870b-554fb34267e9"
      unitRef="usd">9200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RleHRyZWdpb246YmI4NWM0ZDFjODFmNDczMDkyNWEzYTY0YzdkNGZmNTNfMjMzNg_ccde4dda-fa44-4e16-9e70-0b2bcb0d2925">&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on the carrying value of intangible assets, net,&#160;as of&#160;September&#160;30, 2020, the amortization expense is expected to be as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.782%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Developed Technology Amortization Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Patents and Licenses Amortization Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020 (remainder of the year)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="id93cbf33dc99482fbdd7c3492d9fd706_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfMS0xLTEtMS0w_f6c08721-ed24-4b4c-b622-0bb9cd866660"
      unitRef="usd">2978000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="ic4d4f73bdbe84c6cb586dc7a3922ccec_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfMS0zLTEtMS0w_b55cdabf-6148-44c4-a0fa-cf1216f7c70d"
      unitRef="usd">229000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfMS01LTEtMS0w_d6528f01-76da-4c51-a755-f8a842f60b4c"
      unitRef="usd">3207000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="id93cbf33dc99482fbdd7c3492d9fd706_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfMi0xLTEtMS0w_461489f5-05f8-459a-bc02-57f9c43b6bf2"
      unitRef="usd">11911000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ic4d4f73bdbe84c6cb586dc7a3922ccec_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfMi0zLTEtMS0w_da58ecb2-8415-4954-9bb0-c7b76d7feb1d"
      unitRef="usd">760000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfMi01LTEtMS0w_40553e8e-91e1-4754-ba1a-68bed8dfa1a0"
      unitRef="usd">12671000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="id93cbf33dc99482fbdd7c3492d9fd706_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfMy0xLTEtMS0w_0426865c-7f28-40f2-918b-7ee2c1c41c37"
      unitRef="usd">11911000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ic4d4f73bdbe84c6cb586dc7a3922ccec_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfMy0zLTEtMS0w_204b21e7-6a01-4e5a-8510-508e9f74e796"
      unitRef="usd">677000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfMy01LTEtMS0w_5ca8e437-17e6-4108-a716-3e9fedb14ee6"
      unitRef="usd">12588000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="id93cbf33dc99482fbdd7c3492d9fd706_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfNC0xLTEtMS0w_738d7063-2ce5-49b5-98ed-4e9c67c8d94d"
      unitRef="usd">11911000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ic4d4f73bdbe84c6cb586dc7a3922ccec_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfNC0zLTEtMS0w_928778ef-d9f7-4b09-8fa5-a057d33d4e1f"
      unitRef="usd">571000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfNC01LTEtMS0w_9d792812-96a4-4cf9-92e6-61cb9d83fb8a"
      unitRef="usd">12482000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="id93cbf33dc99482fbdd7c3492d9fd706_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfNS0xLTEtMS0w_dd2eb8f4-db28-46ba-ac36-23d66e5ad400"
      unitRef="usd">2111000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ic4d4f73bdbe84c6cb586dc7a3922ccec_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfNS0zLTEtMS0w_67d19802-5ed2-410b-b9cb-d9699a17633b"
      unitRef="usd">7000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfNS01LTEtMS0w_c1119f1b-36c5-454b-8364-320f3e51f5b5"
      unitRef="usd">2118000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <fldm:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
      contextRef="id93cbf33dc99482fbdd7c3492d9fd706_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfNi0xLTEtMS0w_def7dec5-a4dc-42be-a0ea-8159dc31af61"
      unitRef="usd">2133000</fldm:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour>
    <fldm:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
      contextRef="ic4d4f73bdbe84c6cb586dc7a3922ccec_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfNi0zLTEtMS0w_dd6d3920-cb28-477f-b987-03e00a73db4f"
      unitRef="usd">0</fldm:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour>
    <fldm:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfNi01LTEtMS0w_aebdb540-e1d8-413f-b4fd-7c36d673a764"
      unitRef="usd">2133000</fldm:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id93cbf33dc99482fbdd7c3492d9fd706_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfNy0xLTEtMS0w_1fda8275-27ed-4813-aa1e-1d051fe80c79"
      unitRef="usd">42955000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic4d4f73bdbe84c6cb586dc7a3922ccec_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfNy0zLTEtMS0w_59223eb5-cdf5-41df-ba8c-3d8a4b74fc1d"
      unitRef="usd">2244000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF80OS9mcmFnOmJiODVjNGQxYzgxZjQ3MzA5MjVhM2E2NGM3ZDRmZjUzL3RhYmxlOjVmZWYxZDA2MmNmZTRkMDNhYzZmZjk5YWU3ZmNkNDg1L3RhYmxlcmFuZ2U6NWZlZjFkMDYyY2ZlNGQwM2FjNmZmOTlhZTdmY2Q0ODVfNy01LTEtMS0w_15d03388-fff6-415d-a258-94b9b1a9d820"
      unitRef="usd">45199000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RleHRyZWdpb246ZjExYjc3MTg4NWFiNDZjZWE4ZWE4YTVlNTVhNGY1NmRfNzkz_c0310ba3-361d-4d14-83b3-f497d8ae9424">Balance Sheet Details&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents and Restricted Cash &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash, cash equivalents and restricted cash consisted of the following as of September&#160;30, 2020 and December&#160;31, 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.973%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term restricted cash of approximately $15 thousand is included in prepaid expenses and other current assets and $1.0 million of non-current restricted cash is included in other non-current assets in the condensed consolidated balance sheet as of September&#160;30, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consisted of the following as of September&#160;30, 2020 and December&#160;31, 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.973%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property and Equipment, net &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment consisted of the following as of September&#160;30, 2020 and December&#160;31, 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.973%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory and manufacturing equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26,262)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,954)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction-in-progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Warranties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity for our warranty accrual for the nine months ended September&#160;30, 2020&#160;and 2019, which is included in other accrued liabilities, is summarized below (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.973%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrual for current period warranties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warranty costs incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(387)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(668)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RleHRyZWdpb246ZjExYjc3MTg4NWFiNDZjZWE4ZWE4YTVlNTVhNGY1NmRfNzc1_89830358-c5de-472e-9739-96487950b9ff">&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash, cash equivalents and restricted cash consisted of the following as of September&#160;30, 2020 and December&#160;31, 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.973%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RleHRyZWdpb246ZjExYjc3MTg4NWFiNDZjZWE4ZWE4YTVlNTVhNGY1NmRfNzk2_ece15dd8-e205-453b-b48b-90c76ad037a2">&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash, cash equivalents and restricted cash consisted of the following as of September&#160;30, 2020 and December&#160;31, 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.973%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOjRlOTM2NWU4Mzg1ODQwNTc5OGE5OTRmNGExY2FkYjJjL3RhYmxlcmFuZ2U6NGU5MzY1ZTgzODU4NDA1Nzk4YTk5NGY0YTFjYWRiMmNfMS0yLTEtMS0w_13793c5b-5933-482e-bd7c-5e29604924a9"
      unitRef="usd">72345000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOjRlOTM2NWU4Mzg1ODQwNTc5OGE5OTRmNGExY2FkYjJjL3RhYmxlcmFuZ2U6NGU5MzY1ZTgzODU4NDA1Nzk4YTk5NGY0YTFjYWRiMmNfMS00LTEtMS0w_02e6c295-989b-4931-8446-243e1ce97d15"
      unitRef="usd">21661000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOjRlOTM2NWU4Mzg1ODQwNTc5OGE5OTRmNGExY2FkYjJjL3RhYmxlcmFuZ2U6NGU5MzY1ZTgzODU4NDA1Nzk4YTk5NGY0YTFjYWRiMmNfMi0yLTEtMS0w_6d260fd9-60b4-43ab-9384-f0623ce02fd2"
      unitRef="usd">1015000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOjRlOTM2NWU4Mzg1ODQwNTc5OGE5OTRmNGExY2FkYjJjL3RhYmxlcmFuZ2U6NGU5MzY1ZTgzODU4NDA1Nzk4YTk5NGY0YTFjYWRiMmNfMi00LTEtMS0w_9c6e6748-ac6c-4e85-8156-75aea6ea803b"
      unitRef="usd">2075000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOjRlOTM2NWU4Mzg1ODQwNTc5OGE5OTRmNGExY2FkYjJjL3RhYmxlcmFuZ2U6NGU5MzY1ZTgzODU4NDA1Nzk4YTk5NGY0YTFjYWRiMmNfMy0yLTEtMS0w_c62a2f33-e57f-4bce-9e12-3d96485545bd"
      unitRef="usd">73360000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOjRlOTM2NWU4Mzg1ODQwNTc5OGE5OTRmNGExY2FkYjJjL3RhYmxlcmFuZ2U6NGU5MzY1ZTgzODU4NDA1Nzk4YTk5NGY0YTFjYWRiMmNfMy00LTEtMS0w_80014639-dfa0-40e1-af92-a3e661d0bc3e"
      unitRef="usd">23736000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:RestrictedCashCurrent
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RleHRyZWdpb246ZjExYjc3MTg4NWFiNDZjZWE4ZWE4YTVlNTVhNGY1NmRfMjIy_01b67ceb-d386-4ab1-8cc1-be41af0edd4a"
      unitRef="usd">15000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RleHRyZWdpb246ZjExYjc3MTg4NWFiNDZjZWE4ZWE4YTVlNTVhNGY1NmRfMjg2_b6ca6fcb-00d6-4556-a323-9cfead8da771"
      unitRef="usd">1000000.0</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RleHRyZWdpb246ZjExYjc3MTg4NWFiNDZjZWE4ZWE4YTVlNTVhNGY1NmRfNzkw_7dc5ebde-bc01-4ad7-9724-c4f6c3358b2c">&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consisted of the following as of September&#160;30, 2020 and December&#160;31, 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.973%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmI5MDk3ZjdjOTE3MjRhNzRiZDdmZmQ3OWUyYmIxYjhhL3RhYmxlcmFuZ2U6YjkwOTdmN2M5MTcyNGE3NGJkN2ZmZDc5ZTJiYjFiOGFfMS0yLTEtMS0w_fa9e4435-09fe-4c00-8f5f-f02afec31178"
      unitRef="usd">8768000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmI5MDk3ZjdjOTE3MjRhNzRiZDdmZmQ3OWUyYmIxYjhhL3RhYmxlcmFuZ2U6YjkwOTdmN2M5MTcyNGE3NGJkN2ZmZDc5ZTJiYjFiOGFfMS00LTEtMS0w_75f1cb5c-fcb3-4a69-8713-9239b4d37a3c"
      unitRef="usd">6133000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmI5MDk3ZjdjOTE3MjRhNzRiZDdmZmQ3OWUyYmIxYjhhL3RhYmxlcmFuZ2U6YjkwOTdmN2M5MTcyNGE3NGJkN2ZmZDc5ZTJiYjFiOGFfMi0yLTEtMS0w_83091e25-f5da-4209-8f59-1bcd04c145da"
      unitRef="usd">920000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmI5MDk3ZjdjOTE3MjRhNzRiZDdmZmQ3OWUyYmIxYjhhL3RhYmxlcmFuZ2U6YjkwOTdmN2M5MTcyNGE3NGJkN2ZmZDc5ZTJiYjFiOGFfMi00LTEtMS0w_7f06b4ff-72ad-435b-8fa1-b07605df9439"
      unitRef="usd">659000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmI5MDk3ZjdjOTE3MjRhNzRiZDdmZmQ3OWUyYmIxYjhhL3RhYmxlcmFuZ2U6YjkwOTdmN2M5MTcyNGE3NGJkN2ZmZDc5ZTJiYjFiOGFfMy0yLTEtMS0w_0fa3adaf-9bba-4074-bfbb-c930cfe17e11"
      unitRef="usd">9872000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmI5MDk3ZjdjOTE3MjRhNzRiZDdmZmQ3OWUyYmIxYjhhL3RhYmxlcmFuZ2U6YjkwOTdmN2M5MTcyNGE3NGJkN2ZmZDc5ZTJiYjFiOGFfMy00LTEtMS0w_51ba002c-2a28-4b92-a600-f2dd10c37493"
      unitRef="usd">7092000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmI5MDk3ZjdjOTE3MjRhNzRiZDdmZmQ3OWUyYmIxYjhhL3RhYmxlcmFuZ2U6YjkwOTdmN2M5MTcyNGE3NGJkN2ZmZDc5ZTJiYjFiOGFfNC0yLTEtMS0w_ac20cf7d-21ac-4700-939a-535982d82fb3"
      unitRef="usd">19560000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmI5MDk3ZjdjOTE3MjRhNzRiZDdmZmQ3OWUyYmIxYjhhL3RhYmxlcmFuZ2U6YjkwOTdmN2M5MTcyNGE3NGJkN2ZmZDc5ZTJiYjFiOGFfNC00LTEtMS0w_f18c814a-4973-4f59-b42b-db5d5403d2cc"
      unitRef="usd">13884000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RleHRyZWdpb246ZjExYjc3MTg4NWFiNDZjZWE4ZWE4YTVlNTVhNGY1NmRfNzg4_9759c0d7-cc2a-4d95-a5d9-cd16c1426cbb">&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment consisted of the following as of September&#160;30, 2020 and December&#160;31, 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.973%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory and manufacturing equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26,262)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,954)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction-in-progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iff7244c4435948719187b0a6db553efc_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmE2ZDViMWQyZjc3MTQyODRhMDI1MWUyYmMzYTkzYWVkL3RhYmxlcmFuZ2U6YTZkNWIxZDJmNzcxNDI4NGEwMjUxZTJiYzNhOTNhZWRfMS0yLTEtMS0w_4fafbbd6-b481-4974-ac3b-96547ec3bea5"
      unitRef="usd">4363000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i7ecee074f6a34af38aebd80a676157ca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmE2ZDViMWQyZjc3MTQyODRhMDI1MWUyYmMzYTkzYWVkL3RhYmxlcmFuZ2U6YTZkNWIxZDJmNzcxNDI4NGEwMjUxZTJiYzNhOTNhZWRfMS00LTEtMS0w_14ae8910-a3c7-49c1-8bdf-12c431d1606d"
      unitRef="usd">3997000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i01205e4ce2b043afa5ff5d22df71e7af_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmE2ZDViMWQyZjc3MTQyODRhMDI1MWUyYmMzYTkzYWVkL3RhYmxlcmFuZ2U6YTZkNWIxZDJmNzcxNDI4NGEwMjUxZTJiYzNhOTNhZWRfMi0yLTEtMS0w_3eccbe54-adde-4566-9a97-89a1b81aac11"
      unitRef="usd">18988000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i91971e3a302e4ce4a2fa240ccce4fd9f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmE2ZDViMWQyZjc3MTQyODRhMDI1MWUyYmMzYTkzYWVkL3RhYmxlcmFuZ2U6YTZkNWIxZDJmNzcxNDI4NGEwMjUxZTJiYzNhOTNhZWRfMi00LTEtMS0w_1d40371e-9ce2-42a2-b46c-77aca8fa5f61"
      unitRef="usd">19325000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i8b83a6bdbb5d4e1b9fb3f33d02641612_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmE2ZDViMWQyZjc3MTQyODRhMDI1MWUyYmMzYTkzYWVkL3RhYmxlcmFuZ2U6YTZkNWIxZDJmNzcxNDI4NGEwMjUxZTJiYzNhOTNhZWRfMy0yLTEtMS0w_37c2e06d-898b-4138-9448-21ff3b310010"
      unitRef="usd">8118000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i419524240cb046929a4263a9eb516164_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmE2ZDViMWQyZjc3MTQyODRhMDI1MWUyYmMzYTkzYWVkL3RhYmxlcmFuZ2U6YTZkNWIxZDJmNzcxNDI4NGEwMjUxZTJiYzNhOTNhZWRfMy00LTEtMS0w_47c92522-c9d3-4433-88c1-74e20ef9cb93"
      unitRef="usd">7788000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ib48332e9db7f4b1cae5ea5950a5b520a_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmE2ZDViMWQyZjc3MTQyODRhMDI1MWUyYmMzYTkzYWVkL3RhYmxlcmFuZ2U6YTZkNWIxZDJmNzcxNDI4NGEwMjUxZTJiYzNhOTNhZWRfNC0yLTEtMS0w_af228f05-fc22-47d5-8b60-fca2ca230d5a"
      unitRef="usd">2211000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ib0266b792ecf4882bcc51181909743f4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmE2ZDViMWQyZjc3MTQyODRhMDI1MWUyYmMzYTkzYWVkL3RhYmxlcmFuZ2U6YTZkNWIxZDJmNzcxNDI4NGEwMjUxZTJiYzNhOTNhZWRfNC00LTEtMS0w_d4633351-9eeb-40ec-8028-949101bb679f"
      unitRef="usd">1824000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmE2ZDViMWQyZjc3MTQyODRhMDI1MWUyYmMzYTkzYWVkL3RhYmxlcmFuZ2U6YTZkNWIxZDJmNzcxNDI4NGEwMjUxZTJiYzNhOTNhZWRfNS0yLTEtMS0w_42ee16e0-0906-4367-b671-4f8b333adfc6"
      unitRef="usd">33680000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmE2ZDViMWQyZjc3MTQyODRhMDI1MWUyYmMzYTkzYWVkL3RhYmxlcmFuZ2U6YTZkNWIxZDJmNzcxNDI4NGEwMjUxZTJiYzNhOTNhZWRfNS00LTEtMS0w_699b889e-fbeb-4fea-a67b-3db4750e7280"
      unitRef="usd">32934000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmE2ZDViMWQyZjc3MTQyODRhMDI1MWUyYmMzYTkzYWVkL3RhYmxlcmFuZ2U6YTZkNWIxZDJmNzcxNDI4NGEwMjUxZTJiYzNhOTNhZWRfNi0yLTEtMS0w_16652c19-5977-416b-9395-93cb75b2b0ee"
      unitRef="usd">26262000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmE2ZDViMWQyZjc3MTQyODRhMDI1MWUyYmMzYTkzYWVkL3RhYmxlcmFuZ2U6YTZkNWIxZDJmNzcxNDI4NGEwMjUxZTJiYzNhOTNhZWRfNi00LTEtMS0w_2b768a2f-23fc-44d3-bfbd-6d86382182bb"
      unitRef="usd">24954000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:ConstructionInProgressGross
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmE2ZDViMWQyZjc3MTQyODRhMDI1MWUyYmMzYTkzYWVkL3RhYmxlcmFuZ2U6YTZkNWIxZDJmNzcxNDI4NGEwMjUxZTJiYzNhOTNhZWRfNy0yLTEtMS0w_8e172422-aa94-47d1-99c6-ebdcf814fc8d"
      unitRef="usd">113000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmE2ZDViMWQyZjc3MTQyODRhMDI1MWUyYmMzYTkzYWVkL3RhYmxlcmFuZ2U6YTZkNWIxZDJmNzcxNDI4NGEwMjUxZTJiYzNhOTNhZWRfNy00LTEtMS0w_3942e8b4-4a7a-41d3-837c-45b4414c9c25"
      unitRef="usd">76000</us-gaap:ConstructionInProgressGross>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmE2ZDViMWQyZjc3MTQyODRhMDI1MWUyYmMzYTkzYWVkL3RhYmxlcmFuZ2U6YTZkNWIxZDJmNzcxNDI4NGEwMjUxZTJiYzNhOTNhZWRfOC0yLTEtMS0w_8e5b000f-30cd-4ed3-b4a4-52107f43ee65"
      unitRef="usd">7531000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOmE2ZDViMWQyZjc3MTQyODRhMDI1MWUyYmMzYTkzYWVkL3RhYmxlcmFuZ2U6YTZkNWIxZDJmNzcxNDI4NGEwMjUxZTJiYzNhOTNhZWRfOC00LTEtMS0w_e1a90b4d-4000-4952-bb00-b7c3f606813b"
      unitRef="usd">8056000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RleHRyZWdpb246ZjExYjc3MTg4NWFiNDZjZWE4ZWE4YTVlNTVhNGY1NmRfNzcy_32ec292b-84cc-4fb6-9180-6cca992a9b90">&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity for our warranty accrual for the nine months ended September&#160;30, 2020&#160;and 2019, which is included in other accrued liabilities, is summarized below (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.973%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrual for current period warranties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warranty costs incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(387)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(668)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock>
    <us-gaap:ProductWarrantyAccrual
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOjg1ZWQ1MGFiOTQ1YTQ1NTZhM2E3YjE1ZmFhZTljOGRmL3RhYmxlcmFuZ2U6ODVlZDUwYWI5NDVhNDU1NmEzYTdiMTVmYWFlOWM4ZGZfMi0yLTEtMS0w_373afc4e-1df7-4fd8-abe5-0e089edc60fe"
      unitRef="usd">1390000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrual
      contextRef="i4f51ec45ffb24e5f9fd56e8ed689edf8_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOjg1ZWQ1MGFiOTQ1YTQ1NTZhM2E3YjE1ZmFhZTljOGRmL3RhYmxlcmFuZ2U6ODVlZDUwYWI5NDVhNDU1NmEzYTdiMTVmYWFlOWM4ZGZfMi00LTEtMS0w_650865ec-8752-4d0b-8b6f-103e41ea052c"
      unitRef="usd">863000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrualWarrantiesIssued
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOjg1ZWQ1MGFiOTQ1YTQ1NTZhM2E3YjE1ZmFhZTljOGRmL3RhYmxlcmFuZ2U6ODVlZDUwYWI5NDVhNDU1NmEzYTdiMTVmYWFlOWM4ZGZfMy0yLTEtMS0w_931d1298-af2b-4bf0-b948-de2850876921"
      unitRef="usd">677000</us-gaap:ProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:ProductWarrantyAccrualWarrantiesIssued
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOjg1ZWQ1MGFiOTQ1YTQ1NTZhM2E3YjE1ZmFhZTljOGRmL3RhYmxlcmFuZ2U6ODVlZDUwYWI5NDVhNDU1NmEzYTdiMTVmYWFlOWM4ZGZfMy00LTEtMS0w_06bc62a1-960f-407d-ba9c-7531f8811bab"
      unitRef="usd">912000</us-gaap:ProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:ProductWarrantyAccrualPayments
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOjg1ZWQ1MGFiOTQ1YTQ1NTZhM2E3YjE1ZmFhZTljOGRmL3RhYmxlcmFuZ2U6ODVlZDUwYWI5NDVhNDU1NmEzYTdiMTVmYWFlOWM4ZGZfNC0yLTEtMS0w_25eb8865-8e11-4ac8-a924-85bcb3a5df1a"
      unitRef="usd">387000</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:ProductWarrantyAccrualPayments
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOjg1ZWQ1MGFiOTQ1YTQ1NTZhM2E3YjE1ZmFhZTljOGRmL3RhYmxlcmFuZ2U6ODVlZDUwYWI5NDVhNDU1NmEzYTdiMTVmYWFlOWM4ZGZfNC00LTEtMS0w_7ed2d209-8bc3-4040-9f05-5b29f167da0f"
      unitRef="usd">668000</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:ProductWarrantyAccrual
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOjg1ZWQ1MGFiOTQ1YTQ1NTZhM2E3YjE1ZmFhZTljOGRmL3RhYmxlcmFuZ2U6ODVlZDUwYWI5NDVhNDU1NmEzYTdiMTVmYWFlOWM4ZGZfNS0yLTEtMS0w_b69176cc-5071-4716-88f9-4b84c0bb279f"
      unitRef="usd">1680000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrual
      contextRef="ic00370e08713445eacc3076d8d3e2ced_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81Mi9mcmFnOmYxMWI3NzE4ODVhYjQ2Y2VhOGVhOGE1ZTU1YTRmNTZkL3RhYmxlOjg1ZWQ1MGFiOTQ1YTQ1NTZhM2E3YjE1ZmFhZTljOGRmL3RhYmxlcmFuZ2U6ODVlZDUwYWI5NDVhNDU1NmEzYTdiMTVmYWFlOWM4ZGZfNS00LTEtMS0w_16e8c16c-3ee9-4fd0-90a1-4a0b9f94715f"
      unitRef="usd">1107000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:LongTermDebtTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMTEyODE_8e308591-a544-4d5d-9569-d777c3a23270">Convertible Notes and Credit Facility&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2014 Senior Convertible Notes (2014 Notes)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2014, we closed an underwritten public offering of $201.3 million aggregate principal amount of our 2014 Notes. We received $195.2 million, net of underwriting discounts, from the issuance of the 2014 Notes and incurred approximately $1.1 million in offering-related expenses. The underwriting discount and offering-related expenses are being amortized to interest expense using the effective-interest rate method. The effective interest rate on the 2014 Notes, reflecting the impact of debt discounts and issuance costs, is 3.0%. The 2014 Notes will mature on February 1, 2034, unless earlier converted, redeemed, or repurchased in accordance with the terms of the 2014 Notes. We have retired the majority of the 2014 Notes through the issuance of the 2018 Notes and 2019 Notes, as discussed below. As of September&#160;30, 2020, there is $1.1 million aggregate principal of the 2014 Notes outstanding. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2018 Senior Convertible Notes (2018 Notes)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2018, we entered into separate privately negotiated transactions with certain holders of our 2014 Notes to exchange $150.0 million in aggregate principal amount of the 2014 Notes for 2018 Notes, leaving $51.3 million of the aggregate principal amount of the 2014 Notes outstanding. As of the closing of the 2018 Notes on March 12, 2018, the estimated fair value was $145.5 million. The difference between the $150.0 million aggregate principal amount of the 2018 Notes and its fair value was being amortized over the expected term of the 2018 Notes using the effective interest method through the first note holder put date of February 6, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2018 Notes accrued interest at a rate of 2.75% payable semi-annually in arrears on February 1 and August 1 of each year. The 2018 Notes were set to mature on February 1, 2034, unless earlier converted, redeemed, or repurchased in accordance with the terms of the indenture governing the 2018 Notes. The initial conversion rate of the 2018 Notes was 126.9438 shares of our common stock, par value $0.001 per share, per $1,000 principal amount of the 2018 Notes (which is equivalent to an initial conversion price of approximately $7.88 per share). The conversion rate was subject to adjustment upon the occurrence of certain specified events. Those certain specified events included holders who converted their 2018 Notes voluntarily prior to our exercise of the issuer&#x2019;s conversion option described below or in connection with a make-whole fundamental change prior to February 6, 2023, entitling the holders, under certain circumstances, to a make-whole premium in the form of an increase in the conversion rate determined by reference to a make-whole table set forth in the indenture governing the 2018 Notes. Any time &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;prior to the maturity of the 2018 Notes, we could convert the 2018 Notes, in whole but not in part, into cash, shares of our common stock, or combination thereof, if the closing price of our common stock equaled or exceeded 110% of the conversion price then in effect for a specified number of days. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Offering-related costs for the 2018 Notes were approximately $2.8 million. Offering-related costs of $2.2 million were capitalized as debt issuance costs, recorded as an offset to the carrying value of the 2018 Notes, and were being amortized over the expected term of the 2018 Notes using the effective interest method through the first note holder put date of February 6, 2023. The effective interest rate on the 2018 Notes was 12.3%. Offering-related costs of $0.6 million were accounted for as equity issuance costs, recorded as an offset to additional paid-in capital, and were not subject to amortization. Offering-related costs were allocated between debt and equity in the same proportion as the allocation of the 2018 Notes between debt and equity. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2019, we received notices from holders of the 2018 Notes electing to voluntarily convert approximately $138.1 million in aggregate principal amount of the 2018 Notes. In February 2019, we notified the trustee, U.S. Bank National Association, of our intention to exercise our issuer&#x2019;s conversion option with respect to the remaining approximately $11.9 million in aggregate principal amount of the 2018 Notes. In total, $150.0 million of the 2018 Notes were converted into 19.5 million shares of our common stock and the bonds were retired. We recognized a loss of $9.0 million on the retirement of the 2018 Notes, which represented the difference between the fair value of the bonds retired and their carrying costs. The net impact on equity was $133.3 million and represented the fair value of the bonds retired.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2019 Senior Convertible Notes (2019 Notes)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2019, we issued $55.0 million aggregate principal amount of 2019 Notes. Net proceeds of the offering of the 2019 Notes issuance were $52.7 million, after deductions for commissions and other debt issuance costs of approximately $2.3 million. $51.8 million of the proceeds of the 2019 Notes were used to retire $50.2 million aggregate principal amount of our 2014 Notes, leaving $1.1 million of aggregate principal value of  2014 Notes outstanding. We accounted for the transaction as an extinguishment of debt due to the significance of the change in value of the embedded conversion option, resulting in a $3.0 million loss in the fourth quarter of 2019. The loss on extinguishment of debt was calculated as the difference between the reacquisition price (i.e., the fair value of the principal amount of 2019 Notes) and the net carrying value of the 2014 Notes exchanged. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2019 Notes bear interest at 5.25% per annum, payable semiannually in arrears on June 1 and December 1 of each year, beginning on June 1, 2020. The Notes will mature on December 1, 2024, unless earlier repurchased or converted pursuant to their terms. The 2019 Notes will be convertible at the option of the holder at any point prior to the close of business on the second scheduled trading day preceding the maturity date. The initial conversion rate of the Notes is 344.8276 shares of the Company&#x2019;s common stock per $1,000 principal amount of 2019 Notes (which is equivalent to an initial conversion price of approximately $2.90 per share). The conversion rate is subject to adjustment upon the occurrence of certain specified events. Those certain specified events include voluntary conversion of the 2019 Notes prior to our exercise of the Issuer&#x2019;s Conversion Option or in connection with a make-whole fundamental change, entitling the holders, under certain circumstances, to a make-whole premium in the form of an increase in the conversion rate determined by reference to a make-whole table set forth in the indenture governing the 2019 Notes. The conversion rate will not be adjusted for any accrued and unpaid interest. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2019 Notes will also be convertible at our option upon certain conditions in accordance with the terms of the indenture governing the 2019 Notes. On or after December 1, 2021 to December 1, 2022, if the price of the Company&#x2019;s common stock has equaled or exceeded 150% of the conversion price then in effect for a specified number of days (Issuer&#x2019;s Conversion Option), we may, at our option, elect to convert the 2019 Notes in whole but not in part into shares of the Company, determined in accordance with the terms of the indenture. On or after December 1, 2022, if the price of the Company&#x2019;s common stock has equaled or exceeded 130% of the conversion price then in effect for a specified number of days, we may, at our option, elect to convert the 2019 Notes in whole but not in part into shares of the Company, determined in accordance with the terms of the indenture. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Offering-related costs for the 2019 Notes were capitalized as debt issuance costs and are recorded as an offset to the carrying value of the 2019 Notes. The debt issuance costs are being amortized over the expected term of the 2019 Notes using the effective interest method through the maturity date of December 1, 2024. The effective interest rate on the 2019 Notes is 6.2%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying values of the components of the 2014 Notes and the 2019 Notes are as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.973%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&#160;&#160;2.75% 2014 Notes due 2034   &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt issuance cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&#160;&#160;&#160;5.25% 2019 Notes due 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal amount &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt issuance cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,937)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Net carrying value of all Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2018 Revolving Credit Facility &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, we entered into a revolving credit facility with Silicon Valley Bank (as amended, the Revolving Credit Facility) in an aggregate principal amount of up to the lesser of (i) $15.0 million (Maximum Amount) or (ii) the sum of (a) 85% of our eligible receivables and (b) 50% of our eligible inventory, in each case, subject to certain limitations (Borrowing Base), provided that the amount of eligible inventory that may be counted towards the Borrowing Base shall be subject to a cap as set forth in the Revolving Credit Facility. Subject to the level of this Borrowing Base, we may make and repay borrowings from time to time until the maturity of the Revolving Credit Facility. The Borrowing Base as of September&#160;30, 2020 under the Revolving Credit Facility was $15.0 million. There were no borrowings outstanding under the Revolving Credit Facility at September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Revolving Credit Facility is collateralized by substantially all our property, other than intellectual property. Until an amendment in April 2020, the Revolving Credit Facility was set to mature on August 2, 2020. The interest rate on outstanding loans under the Revolving Credit Facility was the greater of (i) prime rate plus 0.50% or (ii) 5.50%. Interest on any outstanding loans is due and payable monthly and the principal balance is due at maturity, though loans can be prepaid at any time without penalty. Effective April 21, 2020, the Revolving Credit Facility was amended to extend the maturity date to August 2, 2022. In addition, the interest rate on outstanding loans under the Revolving Credit Facility was reduced by 0.25%. The quarterly unused line fee, which was previously based on the Maximum Amount, will now be based on the Borrowing Base. The annual commitment fee of $112,500 is unchanged.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Revolving Credit Facility contains customary affirmative and negative covenants that, unless waived by the bank, limit our ability to, among other things, incur additional indebtedness, grant liens, make investments, repurchase stock, pay dividends, transfer assets, enter into affiliate transactions, undergo a change of control, or engage in merger and acquisition activity, including merging or consolidating with a third party. The Revolving Credit Facility also contains customary events of default, subject to customary cure periods for certain defaults, that include, among other things, non-payment defaults, covenant defaults, material judgment defaults, bankruptcy and insolvency defaults, cross-defaults to certain other material indebtedness, and defaults due to inaccuracy of representation and warranties. Upon an event of default, the lender may declare all or a portion of the outstanding obligations payable by us to be immediately due and payable and exercise other rights and remedies provided for under the Revolving Credit Facility. During the existence of an event of default, interest on the obligations under the Revolving Credit Facility could be increased to&#160;5.0% above the otherwise applicable rate of interest. We were in compliance with all the terms and conditions of the Revolving Credit Facility at September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ifa53719e19cc4a179c2e811a860e7411_I20140228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMTUy_172134a7-ee0c-40ce-b509-816858fb7445"
      unitRef="usd">201300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i266ba35bf50e46ca809c2c0afea3c12e_D20140201-20140228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMjEz_a24e14f2-0eec-4b2a-8fc0-141f57a4f5ef"
      unitRef="usd">195200000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="ifa53719e19cc4a179c2e811a860e7411_I20140228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMzEx_e3d89b4d-887d-451f-b07a-23263e4bd742"
      unitRef="usd">1100000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="ifa53719e19cc4a179c2e811a860e7411_I20140228"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNzAw_87a1747f-c073-4b21-a8e7-1743f273c632"
      unitRef="number">0.030</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i901752533bd34a9a91d8a9858d1558a3_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfOTky_20f50b11-c49a-496b-bc0e-54cceea53efd"
      unitRef="usd">1100000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i426efa56430840c1b19eac7bd8d458cc_I20180331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMTIxNQ_a2a0dac7-9efd-445e-a97f-3a1d65b200d8"
      unitRef="usd">150000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i7cf57a0407f34c83945d84ded692dd5e_I20180331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMTI5MA_8383a9c6-b5ae-4743-8036-92441b42d329"
      unitRef="usd">51300000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebtFairValue
      contextRef="i70f4e685daae494d9cca4f8a847b35fe_I20180312"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMTQzOA_59a1d512-78e5-4297-9983-3a38857b1cef"
      unitRef="usd">145500000</us-gaap:LongTermDebtFairValue>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i426efa56430840c1b19eac7bd8d458cc_I20180331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMTQ2OQ_2e732fb7-1cdd-409b-9ffc-5fab999705df"
      unitRef="usd">150000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7cf57a0407f34c83945d84ded692dd5e_I20180331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMTczOQ_e3dcd174-8958-4e31-8dbf-341cbcf78f12"
      unitRef="number">0.0275</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i426efa56430840c1b19eac7bd8d458cc_I20180331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMjA4NQ_7eceb47d-bc9d-4470-8b11-e793106b7d62"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <fldm:InitialConversionPriceOfStock
      contextRef="i426efa56430840c1b19eac7bd8d458cc_I20180331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMjIxNA_e9763867-93b4-4e10-9869-46cd3275a46b"
      unitRef="usdPerShare">7.88</fldm:InitialConversionPriceOfStock>
    <fldm:DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice
      contextRef="i153e522b034a4cdcbce58b6ee2e543f6_D20180301-20180331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMzAyNg_2e8c477a-5262-44e9-87ba-287f9f0bffb9"
      unitRef="number">1.10</fldm:DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice>
    <fldm:DebtAndEquityOfferingCosts
      contextRef="i426efa56430840c1b19eac7bd8d458cc_I20180331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMzE2Mg_efb72f7a-eba5-4a90-98e8-50a2cb5e1ae8"
      unitRef="usd">2800000</fldm:DebtAndEquityOfferingCosts>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i426efa56430840c1b19eac7bd8d458cc_I20180331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMzE5Mg_c4f898fb-7d3c-4721-a5ac-3222977386f8"
      unitRef="usd">2200000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i426efa56430840c1b19eac7bd8d458cc_I20180331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMzUxMQ_08c92323-da06-450a-b1b3-2d656e7c5dff"
      unitRef="number">0.123</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="i153e522b034a4cdcbce58b6ee2e543f6_D20180301-20180331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMzU0MQ_0ed3fef7-50cb-49b0-9076-0c7d447cf724"
      unitRef="usd">600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i4e7aaefc048a42149aea7d5215e3344e_I20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMzk1NA_5038ea3e-9ac5-4e14-865c-17e845e5b582"
      unitRef="usd">138100000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i2cad803f6a554d6c9a8a592ef9a317bb_I20190228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNDE4NQ_d5cc216a-1306-4763-ae5c-423ea51c43b4"
      unitRef="usd">11900000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ib5cf93a475bc40c383848b0c6ddce383_I20190228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNDI0Mw_bc4bbdbb-2932-46ef-baac-5c09ce0c32d6"
      unitRef="usd">150000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i9568f571b19e40a9ae266303330ceee6_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNDI4NA_beebafdb-abfb-47cb-bcfc-040cc8f93c53"
      unitRef="shares">19500000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="icd70bc4d28f3483ba710eda050328360_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNDM2Ng_96a0efa2-9059-48e0-bee0-26ec1710ab18"
      unitRef="usd">-9000000.0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i5c04b2fe57fb44e19f764085727f7dfc_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNDUzOA_3fc16d2f-046a-417c-9149-49534fe18203"
      unitRef="usd">133300000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i9b34d835daa64fc59dd63f13ee337947_I20191130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNDY2NQ_80fb45b7-8b14-4ae3-ac5d-01a00d826e69"
      unitRef="usd">55000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i48e1ed537f2e4db1b0713b2e240b93fb_D20191101-20191130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNDc3MQ_0d52a3ed-8c0f-4b35-99a9-4a68d5b1279a"
      unitRef="usd">52700000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i9b34d835daa64fc59dd63f13ee337947_I20191130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNDg1NQ_f1488900-0979-403c-976f-2548ad90a35c"
      unitRef="usd">2300000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="ic24a6649e6b74cc5ac3591a7f4087baa_D20191101-20191130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNDg1OQ_fd21374e-425b-48a0-9dda-006c0701bfd6"
      unitRef="usd">51800000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i48e1ed537f2e4db1b0713b2e240b93fb_D20191101-20191130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNDkxNg_d4c22c19-fd3b-4c04-9c9b-4e853fca23b2"
      unitRef="usd">50200000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i901752533bd34a9a91d8a9858d1558a3_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNDk3Mw_20f50b11-c49a-496b-bc0e-54cceea53efd"
      unitRef="usd">1100000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i283104e8693b4a0798cde8043a32a819_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNTE5MQ_15e64182-9ed4-4b77-a027-0e0f4ac2e93d"
      unitRef="usd">-3000000.0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9b34d835daa64fc59dd63f13ee337947_I20191130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNTQ4MA_3f5ab17b-7654-41ee-8e7d-40e3f2dd60fd"
      unitRef="number">0.0525</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <fldm:InitialConversionPriceOfStock
      contextRef="i52d079e3857749d3ae194474f9fd3966_I20191130"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNjA2Nw_870be699-172e-4034-bd95-d2bbd159328c"
      unitRef="usdPerShare">2.90</fldm:InitialConversionPriceOfStock>
    <fldm:DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice
      contextRef="i929bb4c9acdd42b2a23fb169207c1a68_D20191101-20191130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNjkzNg_2d16f8a7-829a-4169-8a2d-c252e9388c06"
      unitRef="number">1.50</fldm:DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice>
    <fldm:DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice
      contextRef="i9bc0b6e687014f408106f0f70ddbb047_D20191101-20191130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNzMwMg_c4e2237c-cd20-4cfb-bc5a-8d9377ecd91e"
      unitRef="number">1.30</fldm:DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i9b34d835daa64fc59dd63f13ee337947_I20191130"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfNzkxMw_53b5ec91-5963-494e-a285-04e2a2022d51"
      unitRef="number">0.062</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMTEyODQ_053a85e4-e954-4b49-a45e-b3c46b18704f">&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying values of the components of the 2014 Notes and the 2019 Notes are as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.973%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&#160;&#160;2.75% 2014 Notes due 2034   &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt issuance cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&#160;&#160;&#160;5.25% 2019 Notes due 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal amount &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt issuance cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,937)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Net carrying value of all Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the par value, carrying value and the estimated fair value of the 2014 and 2019 Notes at September&#160;30, 2020 and December&#160;31, 2019, respectively (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.680%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Par Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Par Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2014 Notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7cf57a0407f34c83945d84ded692dd5e_I20180331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfMi0wLTEtMS0wL3RleHRyZWdpb246ZjQ0N2I1NmIwMGRmNGU0MDlhNTAwM2M0MTk4Zjk3ZWFfNw_e3dcd174-8958-4e31-8dbf-341cbcf78f12"
      unitRef="number">0.0275</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i901752533bd34a9a91d8a9858d1558a3_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfMy0yLTEtMS0w_d9022a40-f322-49b1-8637-195437a7c766"
      unitRef="usd">1079000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i0880c31bdb2349949c55fad2b57d1d5c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfMy00LTEtMS0w_76f08312-750f-411d-9b7f-3236e58559c4"
      unitRef="usd">1079000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i901752533bd34a9a91d8a9858d1558a3_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfNC0yLTEtMS0w_2b16bfea-efae-4606-b7a0-1a81dede3386"
      unitRef="usd">17000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i0880c31bdb2349949c55fad2b57d1d5c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfNC00LTEtMS0w_816d47e3-e434-429e-90bb-8de320ed079d"
      unitRef="usd">18000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i901752533bd34a9a91d8a9858d1558a3_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfNS0yLTEtMS0w_c84d0cda-01c8-4413-b843-67b35c792d72"
      unitRef="usd">4000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i0880c31bdb2349949c55fad2b57d1d5c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfNS00LTEtMS0w_950298fb-844f-43b7-8d48-cd5317970bcc"
      unitRef="usd">4000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="i901752533bd34a9a91d8a9858d1558a3_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfNi0yLTEtMS0w_e6abad12-593e-438f-991f-951d0937c7c8"
      unitRef="usd">1058000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i0880c31bdb2349949c55fad2b57d1d5c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfNi00LTEtMS0w_1fe08753-c31a-47df-98bc-bf563e33e7c9"
      unitRef="usd">1057000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9b34d835daa64fc59dd63f13ee337947_I20191130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfMTQtMC0xLTEtMC90ZXh0cmVnaW9uOmY3YjQ1MDM2YmI0MzRiYTI4OWI4MmE4ZmYxZDAxN2EzXzg_3f5ab17b-7654-41ee-8e7d-40e3f2dd60fd"
      unitRef="number">0.0525</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id881c17013fa4c2ba5f1f0618b5dcb03_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfMTUtMi0xLTEtMA_be6d7d54-000e-40f0-99f3-087e1602c43f"
      unitRef="usd">55000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6106e4be78de4e3d82d9ce346c18dd6d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfMTUtNC0xLTEtMA_868b3239-81fa-45cf-ac8d-99770bf6e979"
      unitRef="usd">55000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="id881c17013fa4c2ba5f1f0618b5dcb03_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfMTgtMi0xLTEtMA_1c8403b7-3f41-4b4c-b80a-7212ccb793fd"
      unitRef="usd">1937000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i6106e4be78de4e3d82d9ce346c18dd6d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfMTgtNC0xLTEtMA_f35dfcab-cd52-415a-a1ac-e9e32c009dea"
      unitRef="usd">2236000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="id881c17013fa4c2ba5f1f0618b5dcb03_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfMTktMi0xLTEtMA_6ed7c8c1-2b76-4c3f-b5b6-d22c57a363d4"
      unitRef="usd">53063000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i6106e4be78de4e3d82d9ce346c18dd6d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfMTktNC0xLTEtMA_5afcbb73-e98c-4e9c-a15a-2e4e21233b69"
      unitRef="usd">52764000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i3c17219e8d044f0c861d706caf153722_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfMjAtMi0xLTEtMA_8028ea3b-c8ca-4a3d-954e-75a930f1d334"
      unitRef="usd">54121000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i2c6c4c342964442b8318f2e869e57561_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RhYmxlOjY0OWFhZjIwNWE3MDRlMzRhNzY2YjFiN2RiODU2NWQ5L3RhYmxlcmFuZ2U6NjQ5YWFmMjA1YTcwNGUzNGE3NjZiMWI3ZGI4NTY1ZDlfMjAtNC0xLTEtMA_9ea054aa-1ffc-45a6-95c7-fcde5c422e89"
      unitRef="usd">53821000</us-gaap:LongTermDebt>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i989719e68b6f4b5e9cfa93a8c07dd96e_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfODI0OA_a8fcd218-9015-42bb-aeac-4d28b61f0831"
      unitRef="usd">15000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <fldm:LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables
      contextRef="i17eada3644a34f059d1bcbfd779f95b7_D20180801-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfODI5MQ_cd9aad2a-20ae-4300-8f99-fff83db03a13"
      unitRef="number">0.85</fldm:LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables>
    <fldm:LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory
      contextRef="i17eada3644a34f059d1bcbfd779f95b7_D20180801-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfODMzMA_5820f24c-be9c-420e-af57-952f2df15c3b"
      unitRef="number">0.50</fldm:LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i1bdc25d355644c6f9172d331aa5efd27_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfODgwNw_9573cd09-a75d-45b0-9520-a69f09182d75"
      unitRef="usd">15000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCredit
      contextRef="i1bdc25d355644c6f9172d331aa5efd27_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfODgyMg_b2c07d85-3152-4efd-9be6-a960a6b59328"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i53d97ec6192a48d09c54804db8566219_D20180801-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfOTIyMw_4a7c12c0-f4b1-4757-a753-50a69ea135b7"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="iafb598ed96e949659e7f73e00e9c6bbb_D20180801-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfOTIzNA_cf2762ea-5401-4453-99d3-40e99207e68b"
      unitRef="number">0.0550</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <fldm:DebtInstrumentEarlyRedemptionCostPercentOfMaximumBorrowingCapacity
      contextRef="i3876be73e4a0486f968bd16f58652b42_D20200421-20200421"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfOTc3MA_2f06a1f7-89f5-4e64-82b7-2d021a3254bf"
      unitRef="number">0.0025</fldm:DebtInstrumentEarlyRedemptionCostPercentOfMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityCommitmentFeeAmount
      contextRef="i3876be73e4a0486f968bd16f58652b42_D20200421-20200421"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfOTkyNQ_2f09cb41-ec2a-4cf7-b356-20800498c87c"
      unitRef="usd">112500</us-gaap:LineOfCreditFacilityCommitmentFeeAmount>
    <fldm:LineOfCreditFacilityPercentageOfInterestOnObligationUponDefault
      contextRef="i9ad788af389e495fbf8a9625e4693669_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF81NS9mcmFnOjQzMDc1ZDljOTE1MzRlN2FiMzIyZTNiN2I4OTZiYzc4L3RleHRyZWdpb246NDMwNzVkOWM5MTUzNGU3YWIzMjJlM2I3Yjg5NmJjNzhfMTExMzE_a3c74cf3-5f8c-4bbd-b565-79f2f6edda5a"
      unitRef="number">0.050</fldm:LineOfCreditFacilityPercentageOfInterestOnObligationUponDefault>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RleHRyZWdpb246N2EzZWFhY2RlOTI3NDQ1M2JjYWJkY2Q0ZTc0ODBjYmNfMTA5Mw_a86e719d-0d45-4b6d-835d-cf99cca98284">Leases&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have operating leases for buildings, equipment and vehicles. Existing leases have remaining terms of less than one year to ten years. Some leases contain options to extend the lease, usually for up to five years, and termination options.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows as of September&#160;30, 2020 and December&#160;31, 2019 (in thousands, except for discount rate and lease term):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,723&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,234&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;583&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease right-of-use assets, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,392&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,658&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,923)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,798)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease right-of-use assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,469&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,860&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,697&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,833&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,607&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,323&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,304&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,156&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate per annum&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A new operating lease for our corporate headquarters in South San Francisco, California commenced in March 2020.  We recorded a ROU asset of $35.7 million at the inception of the lease and an operating lease liability of $35.3 million. The lease term is approximately ten years. Future minimum lease payments over the life of the lease were discounted at a rate of 12.6%, which was our estimated incremental collateralized borrowing rate for the term of the lease at the inception of the lease. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of lease expense for the three and nine months ended September&#160;30, 2020 and 2019, respectively (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost (including variable costs)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable costs including non-lease component&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Supplemental Cash Flow Information:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of operating lease liabilities (included in net cash used in operating activities in thousands):&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 0.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under commenced non-cancelable operating leases, which are as of September&#160;30, 2020 as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.328%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Minimum Lease Payments for Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020 (remainder of year)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future minimum payments &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,256)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <fldm:LesseeOperatingLeaseRemainingTermOfContract
      contextRef="iae5da18636984c8688424ae820893260_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RleHRyZWdpb246N2EzZWFhY2RlOTI3NDQ1M2JjYWJkY2Q0ZTc0ODBjYmNfMTI5_cd489d5d-2941-4e30-afab-e54b43a28d8f">P1Y</fldm:LesseeOperatingLeaseRemainingTermOfContract>
    <fldm:LesseeOperatingLeaseRemainingTermOfContract
      contextRef="i2b70060a9d624550994ac1dfff5b7ef1_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RleHRyZWdpb246N2EzZWFhY2RlOTI3NDQ1M2JjYWJkY2Q0ZTc0ODBjYmNfMTM1_74637165-5a44-4aaa-88f3-29efef2e3880">P10Y</fldm:LesseeOperatingLeaseRemainingTermOfContract>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RleHRyZWdpb246N2EzZWFhY2RlOTI3NDQ1M2JjYWJkY2Q0ZTc0ODBjYmNfMjA2_34a767fa-8d27-4a30-a8b9-e86e1505eed8">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <fldm:AssetsAndLiabilitiesLesseeTableTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RleHRyZWdpb246N2EzZWFhY2RlOTI3NDQ1M2JjYWJkY2Q0ZTc0ODBjYmNfMTA5NQ_bb6a0c9e-3587-42e1-a261-1ed3c7bd3329">&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows as of September&#160;30, 2020 and December&#160;31, 2019 (in thousands, except for discount rate and lease term):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,723&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,234&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;583&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease right-of-use assets, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,392&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,658&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,923)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,798)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease right-of-use assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,469&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,860&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,697&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,833&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,607&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,323&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,304&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,156&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate per annum&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</fldm:AssetsAndLiabilitiesLesseeTableTextBlock>
    <fldm:OperatingLeaseRightOfUseAssetGross
      contextRef="i151e8307ce6242f184098e1f36b5547f_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfMS0yLTEtMS0w_da7782bb-4b84-4aa2-b675-3407a645c128"
      unitRef="usd">40723000</fldm:OperatingLeaseRightOfUseAssetGross>
    <fldm:OperatingLeaseRightOfUseAssetGross
      contextRef="i38ab737fcaf84f2aa05da79a61e26690_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfMS00LTEtMS0w_cf8171cc-5316-4ccd-9c6b-555cade1ecf5"
      unitRef="usd">6234000</fldm:OperatingLeaseRightOfUseAssetGross>
    <fldm:OperatingLeaseRightOfUseAssetGross
      contextRef="i6737de729bd64f70bd4ad7bbc31e49bd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfMi0yLTEtMS0w_0b530d63-bc91-45d0-a41b-0f3c337c38b9"
      unitRef="usd">86000</fldm:OperatingLeaseRightOfUseAssetGross>
    <fldm:OperatingLeaseRightOfUseAssetGross
      contextRef="idcdd71a5639445c98dc5fca10293c9ee_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfMi00LTEtMS0w_e36af2be-1ab6-4687-bf9a-42c55724a0b2"
      unitRef="usd">69000</fldm:OperatingLeaseRightOfUseAssetGross>
    <fldm:OperatingLeaseRightOfUseAssetGross
      contextRef="i5e18a8db5c42483eb2fc3227bf81e1bc_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfMy0yLTEtMS0w_88f28404-a1e9-4b37-9233-54f639efd22b"
      unitRef="usd">583000</fldm:OperatingLeaseRightOfUseAssetGross>
    <fldm:OperatingLeaseRightOfUseAssetGross
      contextRef="i280bb003acb74672b814ebca8eb8d86c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfMy00LTEtMS0w_40f45cfc-4e50-437b-b802-835f4cb3fd54"
      unitRef="usd">355000</fldm:OperatingLeaseRightOfUseAssetGross>
    <fldm:OperatingLeaseRightOfUseAssetGross
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfNC0yLTEtMS0w_f0b5d268-0d7b-4fa7-b6cc-8bf061adcc5a"
      unitRef="usd">41392000</fldm:OperatingLeaseRightOfUseAssetGross>
    <fldm:OperatingLeaseRightOfUseAssetGross
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfNC00LTEtMS0w_6b511c68-7023-4632-b053-b804e394b84f"
      unitRef="usd">6658000</fldm:OperatingLeaseRightOfUseAssetGross>
    <fldm:OperatingLeaseRightOfUseAssetAccumulatedAmortization
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfNS0yLTEtMS0w_b325255b-c7ed-4865-8f18-9783112136ab"
      unitRef="usd">2923000</fldm:OperatingLeaseRightOfUseAssetAccumulatedAmortization>
    <fldm:OperatingLeaseRightOfUseAssetAccumulatedAmortization
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfNS00LTEtMS0w_98ff5be2-1b43-40e9-9a9d-f819deb2f96c"
      unitRef="usd">1798000</fldm:OperatingLeaseRightOfUseAssetAccumulatedAmortization>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfNi0yLTEtMS0w_5faf5c50-7fc2-4e2b-9d88-9b6de5081213"
      unitRef="usd">38469000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfNi00LTEtMS0w_3d41e90f-bc91-4ca6-966b-fdb57307e9f4"
      unitRef="usd">4860000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfOC0yLTEtMS0w_a5ada6f6-d80b-408c-a328-5cd7680959c9"
      unitRef="usd">2697000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfOC00LTEtMS0w_304b78a7-2278-4e46-989e-90daf8190281"
      unitRef="usd">1833000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfOS0yLTEtMS0w_053f5d0d-f36a-4bd0-b547-1617935f02e6"
      unitRef="usd">38607000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfOS00LTEtMS0w_1a2c9fdc-5380-4f58-aa7a-d1bf0a883b18"
      unitRef="usd">4323000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfMTAtMi0xLTEtMA_2b9af410-4da2-4c26-89e4-82891c9c5d95"
      unitRef="usd">41304000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfMTAtNC0xLTEtMA_475f3a6f-4a03-4782-bf4b-f02cba091af6"
      unitRef="usd">6156000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfMTItMi0xLTEtMA_49190cd1-699a-415d-a7a7-e7f5508e428d">P8Y10M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfMTItNC0xLTEtMA_0b944d40-10cc-4c31-9168-44d39a2afaca">P4Y8M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfMTMtMi0xLTEtMA_8d94ff77-0c39-4fc8-9b57-d583dcf07870"
      unitRef="number">0.119</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOmQwOWRlOTE2M2I4ZDRmODdiNjhjNTFkZmY0MDU0YjU2L3RhYmxlcmFuZ2U6ZDA5ZGU5MTYzYjhkNGY4N2I2OGM1MWRmZjQwNTRiNTZfMTMtNC0xLTEtMA_dc7f6d4c-4d0e-44b2-b5cb-d77d8831efb4"
      unitRef="number">0.050</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i6162a93a7603404baafc5676dff7d019_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RleHRyZWdpb246N2EzZWFhY2RlOTI3NDQ1M2JjYWJkY2Q0ZTc0ODBjYmNfNTIz_a34335f1-7931-4815-9a5c-5a18bc825ef2"
      unitRef="usd">35700000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="i6162a93a7603404baafc5676dff7d019_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RleHRyZWdpb246N2EzZWFhY2RlOTI3NDQ1M2JjYWJkY2Q0ZTc0ODBjYmNfNTky_7294495c-ff2a-443e-8a72-901905da64ef"
      unitRef="usd">35300000</us-gaap:OperatingLeaseLiability>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i6162a93a7603404baafc5676dff7d019_I20200331"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RleHRyZWdpb246N2EzZWFhY2RlOTI3NDQ1M2JjYWJkY2Q0ZTc0ODBjYmNfNjI4_1540f724-9f01-4f08-9d3b-e8c9d86fc776">P10Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseDiscountRate
      contextRef="i6162a93a7603404baafc5676dff7d019_I20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RleHRyZWdpb246N2EzZWFhY2RlOTI3NDQ1M2JjYWJkY2Q0ZTc0ODBjYmNfNzE4_03f16a85-6318-4ed3-80b1-e49d79e6f09d"
      unitRef="number">0.126</us-gaap:LesseeOperatingLeaseDiscountRate>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RleHRyZWdpb246N2EzZWFhY2RlOTI3NDQ1M2JjYWJkY2Q0ZTc0ODBjYmNfMTA4OQ_b35f932c-4fa7-4e9b-abd3-f61c74c2298e">&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of lease expense for the three and nine months ended September&#160;30, 2020 and 2019, respectively (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost (including variable costs)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable costs including non-lease component&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Supplemental Cash Flow Information:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of operating lease liabilities (included in net cash used in operating activities in thousands):&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 0.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjEzYzljMDdlNjJiZTRiNmFhMmVkZmNlMGUxYmI3NjUyL3RhYmxlcmFuZ2U6MTNjOWMwN2U2MmJlNGI2YWEyZWRmY2UwZTFiYjc2NTJfMi0yLTEtMS0w_960ebed8-9770-4fa9-a491-42b4f137de0e"
      unitRef="usd">2501000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjEzYzljMDdlNjJiZTRiNmFhMmVkZmNlMGUxYmI3NjUyL3RhYmxlcmFuZ2U6MTNjOWMwN2U2MmJlNGI2YWEyZWRmY2UwZTFiYjc2NTJfMi00LTEtMS0w_c5bebcb6-de7c-40c9-8110-c35eec5f24af"
      unitRef="usd">1604000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjEzYzljMDdlNjJiZTRiNmFhMmVkZmNlMGUxYmI3NjUyL3RhYmxlcmFuZ2U6MTNjOWMwN2U2MmJlNGI2YWEyZWRmY2UwZTFiYjc2NTJfMi02LTEtMS0w_8699d84e-0ac8-4e66-8c4f-e2a00ff5e8b2"
      unitRef="usd">7012000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjEzYzljMDdlNjJiZTRiNmFhMmVkZmNlMGUxYmI3NjUyL3RhYmxlcmFuZ2U6MTNjOWMwN2U2MmJlNGI2YWEyZWRmY2UwZTFiYjc2NTJfMi04LTEtMS0w_5b18952a-13ff-4b2d-be17-03989e5d2d2b"
      unitRef="usd">4660000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjEzYzljMDdlNjJiZTRiNmFhMmVkZmNlMGUxYmI3NjUyL3RhYmxlcmFuZ2U6MTNjOWMwN2U2MmJlNGI2YWEyZWRmY2UwZTFiYjc2NTJfMy0yLTEtMS0w_f802bb12-42f7-4f3b-8133-1f9d5ab7e36d"
      unitRef="usd">407000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjEzYzljMDdlNjJiZTRiNmFhMmVkZmNlMGUxYmI3NjUyL3RhYmxlcmFuZ2U6MTNjOWMwN2U2MmJlNGI2YWEyZWRmY2UwZTFiYjc2NTJfMy00LTEtMS0w_2a14fd73-f7db-4354-9783-a408ed6aa824"
      unitRef="usd">748000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjEzYzljMDdlNjJiZTRiNmFhMmVkZmNlMGUxYmI3NjUyL3RhYmxlcmFuZ2U6MTNjOWMwN2U2MmJlNGI2YWEyZWRmY2UwZTFiYjc2NTJfMy02LTEtMS0w_fefd02bb-b124-4f91-80a9-723463c4e724"
      unitRef="usd">1576000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjEzYzljMDdlNjJiZTRiNmFhMmVkZmNlMGUxYmI3NjUyL3RhYmxlcmFuZ2U6MTNjOWMwN2U2MmJlNGI2YWEyZWRmY2UwZTFiYjc2NTJfMy04LTEtMS0w_736b5e92-148d-4c23-9583-e5eab08e00aa"
      unitRef="usd">2051000</us-gaap:VariableLeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjEzYzljMDdlNjJiZTRiNmFhMmVkZmNlMGUxYmI3NjUyL3RhYmxlcmFuZ2U6MTNjOWMwN2U2MmJlNGI2YWEyZWRmY2UwZTFiYjc2NTJfOS02LTEtMS0w_d5af868d-d2f3-4346-bee3-fd12ce027289"
      unitRef="usd">3443000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjEzYzljMDdlNjJiZTRiNmFhMmVkZmNlMGUxYmI3NjUyL3RhYmxlcmFuZ2U6MTNjOWMwN2U2MmJlNGI2YWEyZWRmY2UwZTFiYjc2NTJfOS04LTEtMS0w_5375020c-68ec-4716-99a5-6f04424518a0"
      unitRef="usd">3068000</us-gaap:OperatingLeasePayments>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RleHRyZWdpb246N2EzZWFhY2RlOTI3NDQ1M2JjYWJkY2Q0ZTc0ODBjYmNfMTA5Mg_12caee32-acde-41ea-bb40-14e9e374cd1b">&lt;div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under commenced non-cancelable operating leases, which are as of September&#160;30, 2020 as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.328%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Minimum Lease Payments for Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020 (remainder of year)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future minimum payments &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,256)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjZiNDQyZmIxYjExMDQyYWE5N2E3MDBkZDhlNWM3MTkwL3RhYmxlcmFuZ2U6NmI0NDJmYjFiMTEwNDJhYTk3YTcwMGRkOGU1YzcxOTBfMS0yLTEtMS0w_d5dc74e6-a746-464a-9432-7efc038ff6d8"
      unitRef="usd">1802000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjZiNDQyZmIxYjExMDQyYWE5N2E3MDBkZDhlNWM3MTkwL3RhYmxlcmFuZ2U6NmI0NDJmYjFiMTEwNDJhYTk3YTcwMGRkOGU1YzcxOTBfMi0yLTEtMS0w_20e21bd3-b28b-4721-b696-f1de7511e450"
      unitRef="usd">7362000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjZiNDQyZmIxYjExMDQyYWE5N2E3MDBkZDhlNWM3MTkwL3RhYmxlcmFuZ2U6NmI0NDJmYjFiMTEwNDJhYTk3YTcwMGRkOGU1YzcxOTBfMy0yLTEtMS0w_9c8fd3ab-99f9-4f0c-bcc7-4b3109c8816f"
      unitRef="usd">7040000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjZiNDQyZmIxYjExMDQyYWE5N2E3MDBkZDhlNWM3MTkwL3RhYmxlcmFuZ2U6NmI0NDJmYjFiMTEwNDJhYTk3YTcwMGRkOGU1YzcxOTBfNC0yLTEtMS0w_e8720a90-a808-4a75-90f9-8c7db3ef4385"
      unitRef="usd">6950000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjZiNDQyZmIxYjExMDQyYWE5N2E3MDBkZDhlNWM3MTkwL3RhYmxlcmFuZ2U6NmI0NDJmYjFiMTEwNDJhYTk3YTcwMGRkOGU1YzcxOTBfNS0yLTEtMS0w_1f15ecca-76a7-4c77-95a7-a11f0a4be4d6"
      unitRef="usd">7152000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <fldm:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjZiNDQyZmIxYjExMDQyYWE5N2E3MDBkZDhlNWM3MTkwL3RhYmxlcmFuZ2U6NmI0NDJmYjFiMTEwNDJhYTk3YTcwMGRkOGU1YzcxOTBfNi0yLTEtMS0w_ac42d291-f308-41a3-a1f4-10954b237185"
      unitRef="usd">39254000</fldm:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjZiNDQyZmIxYjExMDQyYWE5N2E3MDBkZDhlNWM3MTkwL3RhYmxlcmFuZ2U6NmI0NDJmYjFiMTEwNDJhYTk3YTcwMGRkOGU1YzcxOTBfNy0yLTEtMS0w_6650265b-049a-411a-b073-2244a82d9512"
      unitRef="usd">69560000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjZiNDQyZmIxYjExMDQyYWE5N2E3MDBkZDhlNWM3MTkwL3RhYmxlcmFuZ2U6NmI0NDJmYjFiMTEwNDJhYTk3YTcwMGRkOGU1YzcxOTBfOC0yLTEtMS0w_77041f9a-fb05-4a4b-bf35-b76898232fe6"
      unitRef="usd">28256000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82MS9mcmFnOjdhM2VhYWNkZTkyNzQ0NTNiY2FiZGNkNGU3NDgwY2JjL3RhYmxlOjZiNDQyZmIxYjExMDQyYWE5N2E3MDBkZDhlNWM3MTkwL3RhYmxlcmFuZ2U6NmI0NDJmYjFiMTEwNDJhYTk3YTcwMGRkOGU1YzcxOTBfOS0yLTEtMS0w_d76f649d-ca3f-4dbb-a373-073c8702ef5f"
      unitRef="usd">41304000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RleHRyZWdpb246MzgwM2U3ZjU4NDA1NGFiYmFiY2YyOWNjN2MzMzExNzdfMTQ2NQ_a9c6c40c-52af-494f-90c8-944233415098">Fair Value of Financial Instruments&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize our cash and available-for-sale securities that were measured at fair value by significant investment category within the fair value hierarchy (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-Term Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash- Restricted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash-unrestricted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash-restricted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Total cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Level I:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-Term Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash- Restricted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash-unrestricted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash-restricted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Total cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Level I:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;US treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no transfers between Level I and Level II measurements, and no changes in the valuation techniques used, during the nine months ended&#160;September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on an evaluation of securities that were in a loss position, we did not recognize any other-than-temporary impairment charges for the nine months ended September&#160;30, 2020 and 2019. None of our investments have been in a continuous loss position for more than 12 months. We concluded that the declines in market value of our available-for-sale securities investment portfolio were temporary in nature and did not consider any of our investments to be other-than-temporarily impaired. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Convertible Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2019, we significantly reduced the amount of our outstanding debt. As a result, our convertible notes are not regularly traded and it is difficult to estimate a reliable and accurate market price for these securities. The estimated fair values for these securities represent Level III valuations since a fair value for these securities cannot be determined by using readily observable inputs or measures, such as market prices. Fair values were estimated using pricing models and risk-adjusted value ranges. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the par value, carrying value and the estimated fair value of the 2014 and 2019 Notes at September&#160;30, 2020 and December&#160;31, 2019, respectively (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.680%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Par Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Par Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2014 Notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RleHRyZWdpb246MzgwM2U3ZjU4NDA1NGFiYmFiY2YyOWNjN2MzMzExNzdfMTQ1NQ_5e44fe45-4326-4714-aef2-85a135568293">&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize our cash and available-for-sale securities that were measured at fair value by significant investment category within the fair value hierarchy (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-Term Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash- Restricted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash-unrestricted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash-restricted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Total cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Level I:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-Term Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash- Restricted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash-unrestricted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash-restricted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Total cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Level I:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;US treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="id5eff83c101c4f12b196d0f171c521dc_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMy0xLTEtMS0w_a61d3b35-1021-47d4-9d82-2c1860a82c51"
      unitRef="usd">49144000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="id5eff83c101c4f12b196d0f171c521dc_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMy03LTEtMS0w_d4a159b2-a06d-44c2-bc4b-ff1aa125c6c0"
      unitRef="usd">49144000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="id5eff83c101c4f12b196d0f171c521dc_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMy05LTEtMS0w_742ca9a0-7523-4799-9a80-3d3226c412de"
      unitRef="usd">49144000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i4fcc88cfdd4a41b8a7adcab32fd08549_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfNC0xLTEtMS0w_7a9149f9-8b09-40ab-9db7-19931e82a4ba"
      unitRef="usd">1015000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i4fcc88cfdd4a41b8a7adcab32fd08549_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfNC03LTEtMS0w_1b036fd1-ea9b-401e-a11a-7609c8226d93"
      unitRef="usd">1015000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i4fcc88cfdd4a41b8a7adcab32fd08549_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfNC0xMy0xLTEtMA_95056540-0c24-44da-b377-743f83a8cd25"
      unitRef="usd">1015000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i37f15e5bdea442009df048b62f08f96a_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfNS0xLTEtMS0w_802e8771-f6b8-4f8e-94dd-802370736098"
      unitRef="usd">50159000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i37f15e5bdea442009df048b62f08f96a_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfNS03LTEtMS0w_6d3fd01f-4c52-4a4e-bbd3-3f958ef7cfca"
      unitRef="usd">50159000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i37f15e5bdea442009df048b62f08f96a_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfNS05LTEtMS0w_09e2d6b2-3d9a-4a05-9cef-57e30a3bc8b0"
      unitRef="usd">49144000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i37f15e5bdea442009df048b62f08f96a_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfNS0xMy0xLTEtMA_4bde2044-d1ff-4a9b-9781-ff8f3622cb72"
      unitRef="usd">1015000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i29ac583d810f4a91a7b25c3ca9dff3f8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfOC0xLTEtMS0w_48b8d761-117e-4732-bab0-b82a7537fb3b"
      unitRef="usd">23201000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i29ac583d810f4a91a7b25c3ca9dff3f8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfOC0zLTEtMS0w_ddb74ba0-2969-49eb-b617-536a957e46f8"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i29ac583d810f4a91a7b25c3ca9dff3f8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfOC01LTEtMS0w_02f6057c-7064-4bf7-b2e3-6f8385c2af82"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i29ac583d810f4a91a7b25c3ca9dff3f8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfOC03LTEtMS0w_2da96089-905e-4cb3-acc3-3196f29bac52"
      unitRef="usd">23201000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i29ac583d810f4a91a7b25c3ca9dff3f8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfOC05LTEtMS0w_feaa7b46-b301-4584-9b73-8291e17c138c"
      unitRef="usd">23201000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="i29ac583d810f4a91a7b25c3ca9dff3f8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfOC0xMS0xLTEtMA_d90aeaaf-0ad6-45d3-a68a-0cb4cf5754ad"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i29ac583d810f4a91a7b25c3ca9dff3f8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfOC0xMy0xLTEtMA_3ba30c43-193a-47ad-be2a-0f901b331d01"
      unitRef="usd">0</us-gaap:LongTermInvestments>
    <fldm:CashCashEquivalentsAndShortTermInvestmentsAmortizedCost
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMTEtMS0xLTEtMA_53de43f9-cd30-408e-8e05-23a98fc1b0f5"
      unitRef="usd">73360000</fldm:CashCashEquivalentsAndShortTermInvestmentsAmortizedCost>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMTEtMy0xLTEtMA_f5f2e8e1-ce05-42c3-9d46-e197515d9972"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMTEtNS0xLTEtMA_c30001a1-91e7-4770-95a4-9b02f99f08b4"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMTEtNy0xLTEtMA_455e512c-dc9d-413b-8e5b-6b51f68f3da1"
      unitRef="usd">73360000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMTEtOS0xLTEtMA_5c0acb31-1bb5-47d9-b0cb-f9e772eaf4fb"
      unitRef="usd">72345000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMTEtMTEtMS0xLTA_7e79e9a5-ae35-42b7-af0d-b5d521bc9743"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMTEtMTMtMS0xLTA_0c49862a-c9e7-4121-a1a6-dab711aa9d2a"
      unitRef="usd">1015000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic036c6e4072e4f078642894c02e6a2b2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMTYtMS0xLTEtMA_5430842f-762f-4d09-9e63-5146be2aaefb"
      unitRef="usd">16614000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic036c6e4072e4f078642894c02e6a2b2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMTYtNy0xLTEtMA_4fbc0611-e093-4ff8-a4db-a4cf711b655d"
      unitRef="usd">16614000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic036c6e4072e4f078642894c02e6a2b2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMTYtOS0xLTEtMA_a52383a5-7c38-4ad5-884e-e0f3c6840729"
      unitRef="usd">16614000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i183046f58bdf41d8884897ea6e6cf0af_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMTctMS0xLTEtMA_84faf1a3-f9f4-455f-8b3a-9de3162cdcf4"
      unitRef="usd">2075000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i183046f58bdf41d8884897ea6e6cf0af_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMTctNy0xLTEtMA_11a1c5d1-6458-4e7e-b7ec-368e1343c2d6"
      unitRef="usd">2075000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i183046f58bdf41d8884897ea6e6cf0af_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMTctMTMtMS0xLTA_6c14c31d-4e55-4a97-ba84-be2f05913351"
      unitRef="usd">2075000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5f7f6ee0988a4bdba5cf8633c5e65b6e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMTgtMS0xLTEtMA_5eafaa3e-0fe0-457b-b249-c9b49c06182d"
      unitRef="usd">18689000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5f7f6ee0988a4bdba5cf8633c5e65b6e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMTgtNy0xLTEtMA_7b26a743-3e45-409d-89bc-4e2e6c6d1763"
      unitRef="usd">18689000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i5f7f6ee0988a4bdba5cf8633c5e65b6e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMTgtOS0xLTEtMA_051ee4d9-ee94-46f2-be22-b2fbe90e27a2"
      unitRef="usd">16614000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i5f7f6ee0988a4bdba5cf8633c5e65b6e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMTgtMTMtMS0xLTA_cd7da99c-d50c-4e4a-ac54-37a51f42c108"
      unitRef="usd">2075000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i681f2afaf9324c6a97f01c2538888b09_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjEtMS0xLTEtMA_8a7d0b2d-c5f6-4434-86ef-507064ffe43e"
      unitRef="usd">5047000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i681f2afaf9324c6a97f01c2538888b09_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjEtMy0xLTEtMA_15c44264-32fa-4822-87b3-edd8bbb96432"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i681f2afaf9324c6a97f01c2538888b09_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjEtNS0xLTEtMA_590d5100-ac3c-461a-90d7-941192052013"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i681f2afaf9324c6a97f01c2538888b09_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjEtNy0xLTEtMA_d5baf33b-7ce8-49e7-9670-f8ef4a853653"
      unitRef="usd">5047000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i681f2afaf9324c6a97f01c2538888b09_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjEtOS0xLTEtMA_55d5ac4f-c484-455b-88bb-3a8b4f2a44ac"
      unitRef="usd">5047000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="i681f2afaf9324c6a97f01c2538888b09_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjEtMTEtMS0xLTA_65b0ede0-a0d6-4361-a395-347656d45022"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i681f2afaf9324c6a97f01c2538888b09_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjEtMTMtMS0xLTA_2a09452c-99df-4919-9a4f-7eee2c393e85"
      unitRef="usd">0</us-gaap:LongTermInvestments>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ibc62fa7bd73e4eae81ee6e9258a1d986_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjItMS0xLTEtMA_71b203bb-b169-4ee9-b0bb-9e0af20c587d"
      unitRef="usd">36942000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ibc62fa7bd73e4eae81ee6e9258a1d986_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjItMy0xLTEtMA_71aab9af-6b58-46ab-a817-4675b22c145e"
      unitRef="usd">36000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ibc62fa7bd73e4eae81ee6e9258a1d986_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjItNS0xLTEtMA_86c6c3b6-2ae2-40ee-b7b6-502274a0c222"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibc62fa7bd73e4eae81ee6e9258a1d986_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjItNy0xLTEtMA_0a73d3db-b582-424d-8231-818af1a7d1c3"
      unitRef="usd">36978000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ibc62fa7bd73e4eae81ee6e9258a1d986_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjItOS0xLTEtMA_19cb96de-b0f2-4f4d-a1c1-afe18d5c0016"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="ibc62fa7bd73e4eae81ee6e9258a1d986_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjItMTEtMS0xLTA_a382ad45-2f04-4a68-9226-273e48978367"
      unitRef="usd">36978000</us-gaap:ShortTermInvestments>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ief09788b1d7b41ddad84a806425db48f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjMtMS0xLTEtMA_45dc01e5-10ae-44f1-ac95-5b4959e9ccca"
      unitRef="usd">41989000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ief09788b1d7b41ddad84a806425db48f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjMtMy0xLTEtMA_6bb55f78-1ce6-4b51-a87c-44de2392fadf"
      unitRef="usd">36000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ief09788b1d7b41ddad84a806425db48f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjMtNS0xLTEtMA_d6108bd1-e0ee-4b99-b8a7-561e579cd01e"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ief09788b1d7b41ddad84a806425db48f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjMtNy0xLTEtMA_83b37b09-5b5d-48c3-9f64-2a6280aebc6d"
      unitRef="usd">42025000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ief09788b1d7b41ddad84a806425db48f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjMtOS0xLTEtMA_232b8822-de96-4deb-b122-709faec6fc88"
      unitRef="usd">5047000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="ief09788b1d7b41ddad84a806425db48f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjMtMTEtMS0xLTA_70f24e83-4db7-4a83-9991-21f2231ca3b2"
      unitRef="usd">36978000</us-gaap:ShortTermInvestments>
    <fldm:CashCashEquivalentsAndShortTermInvestmentsAmortizedCost
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjQtMS0xLTEtMA_cce6cf86-293b-4292-96bd-c8ed6506ac18"
      unitRef="usd">60678000</fldm:CashCashEquivalentsAndShortTermInvestmentsAmortizedCost>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjQtMy0xLTEtMA_0d152f1d-0add-4814-9261-d43db4185afa"
      unitRef="usd">36000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjQtNS0xLTEtMA_d2b65213-8644-4df4-9b51-a50e8954db9b"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjQtNy0xLTEtMA_5d7f5267-4319-4546-bf01-441898288ea1"
      unitRef="usd">60714000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjQtOS0xLTEtMA_49780a85-704f-4a67-9d8b-5f05422de080"
      unitRef="usd">21661000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjQtMTEtMS0xLTA_23cf08af-e347-4166-a014-0e1dc0265595"
      unitRef="usd">36978000</us-gaap:ShortTermInvestments>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjQ1OTYyMjMyNTA5MzRiMTBiZTA0MDg5MmM2ZGUyNmYxL3RhYmxlcmFuZ2U6NDU5NjIyMzI1MDkzNGIxMGJlMDQwODkyYzZkZTI2ZjFfMjQtMTMtMS0xLTA_2f54d4a3-72db-4add-8433-c89bc906f774"
      unitRef="usd">2075000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RleHRyZWdpb246MzgwM2U3ZjU4NDA1NGFiYmFiY2YyOWNjN2MzMzExNzdfNTI2_1d7f46d7-aefb-4f09-a712-625cd2eff12c"
      unitRef="investment">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i901752533bd34a9a91d8a9858d1558a3_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfMi0xLTEtMS0w_825b786d-218e-43fe-b01a-f01f8bbee5df"
      unitRef="usd">1079000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ie61b59be16e3451fbb4832bb215eaefa_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfMi0zLTEtMS0w_9ad8fbcc-32ec-4b74-844d-281140471fd1"
      unitRef="usd">1058000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i34fa6e2b348a44feba0389d8f9e424b4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfMi01LTEtMS0w_c9f7f9b0-40b8-40b2-8059-8308aa6163ee"
      unitRef="usd">1122000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i0880c31bdb2349949c55fad2b57d1d5c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfMi03LTEtMS0w_3c701e7f-25e5-4aa1-9334-e3b70fef14f5"
      unitRef="usd">1079000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i807edf5453ef492d89797af2d92ce323_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfMi05LTEtMS0w_5d19aa60-9b67-45f1-9b4b-b419bce50b8e"
      unitRef="usd">1057000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i06f63608f6e14bd49a545fbfd1a0bb51_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfMi0xMS0xLTEtMA_443cbae9-8066-4390-b978-5a7531b272f9"
      unitRef="usd">1122000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id881c17013fa4c2ba5f1f0618b5dcb03_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfMy0xLTEtMS0w_0f1c2527-f07e-42ec-b0ee-e05b10f146c1"
      unitRef="usd">55000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebt
      contextRef="id881c17013fa4c2ba5f1f0618b5dcb03_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfMy0zLTEtMS0w_6ed7c8c1-2b76-4c3f-b5b6-d22c57a363d4"
      unitRef="usd">53063000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i84de06c926844e43876c040386be167d_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfMy01LTEtMS0w_57e82029-07da-4ec4-a1a0-a3231ecca902"
      unitRef="usd">143039000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i6106e4be78de4e3d82d9ce346c18dd6d_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfMy03LTEtMS0w_436e2b98-14a1-4dfc-8f8b-93484c90c25f"
      unitRef="usd">55000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ia3c3d82adad646dbb37ebc978e243f31_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfMy05LTEtMS0w_6ca50c30-d767-4c54-b088-19179c7dbf7f"
      unitRef="usd">52764000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ia6b4b841ac1e4d6eb459e46913612d7a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfMy0xMS0xLTEtMA_25f06345-2944-4c9a-bbc1-136a92865de6"
      unitRef="usd">73975000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i3c17219e8d044f0c861d706caf153722_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfNC0xLTEtMS0w_2a2e5de2-247c-402d-9224-698dca67c604"
      unitRef="usd">56079000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i53a339bce2b7419593141ef24bbc8bed_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfNC0zLTEtMS0w_a24182bb-fe10-4a86-aee1-1e337ffd54a8"
      unitRef="usd">54121000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ibe0d0e9dffbd495fae18e77547f3d88c_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfNC01LTEtMS0w_379f2d61-7eba-4bf8-92c1-043435cfd3df"
      unitRef="usd">144161000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i2c6c4c342964442b8318f2e869e57561_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfNC03LTEtMS0w_6da95041-62ff-4700-958f-90fd6674d49e"
      unitRef="usd">56079000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFairValue
      contextRef="if34280ce49a6438a9aba047d76278cbc_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfNC05LTEtMS0w_ca4dc1a6-eca7-456b-8069-c0ee2ea38857"
      unitRef="usd">53821000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i9ef442f5f71545048e77e64914ccc44a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82NC9mcmFnOjM4MDNlN2Y1ODQwNTRhYmJhYmNmMjljYzdjMzMxMTc3L3RhYmxlOjRiZjQ5OGVlYzRhODQ2NjhhOTkwOWE5N2JlNjkwOTA3L3RhYmxlcmFuZ2U6NGJmNDk4ZWVjNGE4NDY2OGE5OTA5YTk3YmU2OTA5MDdfNC0xMS0xLTEtMA_986bde50-1b44-4b78-a608-e523a631403c"
      unitRef="usd">75097000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RleHRyZWdpb246MjY5NDhlYmQ1NGNkNDRkYmI4ODBlNTJiODkzYTU1MWNfNjgx_df1cd33f-2fcb-413d-ad20-863b48e877f8">Shareholders&#x2019; Equity&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2020 At-the-Market Offering &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, we entered into an Open Market Sale Agreement (Sale Agreement) with Jefferies LLC (Jefferies) to sell shares of our common stock having aggregate sales proceeds of up to $50,000,000, from time to time, through an &#x201c;at-the-market&#x201d; equity offering program under which Jefferies acts as sales agent. During the third quarter of 2020, we sold 2.5 million shares of our common stock pursuant to the Sale Agreement, for aggregate gross proceeds of $20.9 million. Our net proceeds from the sale of such shares of common stock were approximately $20.1 million, after deducting related expenses, including commissions of approximately $0.6 million and issuance costs of approximately $0.2 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;InstruNor Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, we completed the acquisition of all of the outstanding shares of InstruNor (see Note 3). The purchase price was approximately $7.2 million, consisting of $5.2 million in cash and 485,451 shares of our common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Conversion of 2018 Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2019, we issued 19,460,260 shares of our common stock in connection with the conversion of our 2018 Notes (see Note 8). As a result of this issuance of our common stock, we recorded a total of $133.3 million of equity, which was equivalent to the fair value of the bonds retired.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2020, we had reserved shares of common stock for future issuance under equity compensation plans as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in 000's)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Securities To Be Issued Upon Exercise Of Options &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number Of Remaining Securities Available For Future Issuance &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2009 Equity Incentive Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2011 Equity Incentive Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DVS Sciences Inc. 2010 Equity Incentive Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2017 Inducement Award Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2017 Employee Stock Purchase Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <fldm:SaleOfStockConsiderationReceivableOnTransaction
      contextRef="i9ef4d07044c44fb9900a21ed9c2b3e8a_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RleHRyZWdpb246MjY5NDhlYmQ1NGNkNDRkYmI4ODBlNTJiODkzYTU1MWNfMTgxNDE5NDE4NjE5MDQ_8b46653f-e6d1-45b9-bc76-21863e5bce7e"
      unitRef="usd">50000000</fldm:SaleOfStockConsiderationReceivableOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="ic4d47fe556de4b5a85e774b65e566c18_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RleHRyZWdpb246MjY5NDhlYmQ1NGNkNDRkYmI4ODBlNTJiODkzYTU1MWNfMTA5OTUxMTYzMDgwOA_7ea3d9bc-907a-4e05-bf0d-19f8f239c078"
      unitRef="shares">2500000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <fldm:ProceedsFromIssuanceOfCommonStockIncludingRelatedExpenses
      contextRef="ic4d47fe556de4b5a85e774b65e566c18_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RleHRyZWdpb246MjY5NDhlYmQ1NGNkNDRkYmI4ODBlNTJiODkzYTU1MWNfMTA5OTUxMTYzMDg0Ng_66ad8c73-aab3-4b7a-9cb9-c6aa352afda4"
      unitRef="usd">20900000</fldm:ProceedsFromIssuanceOfCommonStockIncludingRelatedExpenses>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="ic4d47fe556de4b5a85e774b65e566c18_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RleHRyZWdpb246MjY5NDhlYmQ1NGNkNDRkYmI4ODBlNTJiODkzYTU1MWNfMTA5OTUxMTYzMDg2Ng_633c6f9c-9bf2-494a-883d-aef089e5fcbe"
      unitRef="usd">20100000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SalesCommissionsAndFees
      contextRef="ic4d47fe556de4b5a85e774b65e566c18_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RleHRyZWdpb246MjY5NDhlYmQ1NGNkNDRkYmI4ODBlNTJiODkzYTU1MWNfMTA5OTUxMTYzMDg4NQ_d00c9d69-e804-4cc7-bb65-ce957b99ea9e"
      unitRef="usd">600000</us-gaap:SalesCommissionsAndFees>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="ic4d47fe556de4b5a85e774b65e566c18_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RleHRyZWdpb246MjY5NDhlYmQ1NGNkNDRkYmI4ODBlNTJiODkzYTU1MWNfMTA5OTUxMTYzMDkwNQ_a3cc4181-186d-4364-ba72-2aabe212baea"
      unitRef="usd">200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ibccd6f048dc74a6c953e619b2a9e9ea6_D20200117-20200117"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RleHRyZWdpb246MjY5NDhlYmQ1NGNkNDRkYmI4ODBlNTJiODkzYTU1MWNfMTk1_4fad0d36-d5c0-43b4-99a5-2a689e2e8c46"
      unitRef="usd">7200000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ibccd6f048dc74a6c953e619b2a9e9ea6_D20200117-20200117"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RleHRyZWdpb246MjY5NDhlYmQ1NGNkNDRkYmI4ODBlNTJiODkzYTU1MWNfMjEz_9d4bfe43-ccb6-4b44-972e-f2732a1035a0"
      unitRef="usd">5200000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="ibccd6f048dc74a6c953e619b2a9e9ea6_D20200117-20200117"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RleHRyZWdpb246MjY5NDhlYmQ1NGNkNDRkYmI4ODBlNTJiODkzYTU1MWNfMjI4_45dace8b-1a27-415a-8901-ee96a88e982a"
      unitRef="shares">485451</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i5c04b2fe57fb44e19f764085727f7dfc_D20190101-20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RleHRyZWdpb246MjY5NDhlYmQ1NGNkNDRkYmI4ODBlNTJiODkzYTU1MWNfMzI0_7e09a2e7-41ee-4140-9d60-22d6287215f8"
      unitRef="shares">19460260</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i5c04b2fe57fb44e19f764085727f7dfc_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RleHRyZWdpb246MjY5NDhlYmQ1NGNkNDRkYmI4ODBlNTJiODkzYTU1MWNfNDkz_3fc16d2f-046a-417c-9149-49534fe18203"
      unitRef="usd">133300000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RleHRyZWdpb246MjY5NDhlYmQ1NGNkNDRkYmI4ODBlNTJiODkzYTU1MWNfNjgy_fe58ece4-92fa-4743-ba38-b62acf6b266c">&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2020, we had reserved shares of common stock for future issuance under equity compensation plans as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in 000's)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Securities To Be Issued Upon Exercise Of Options &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number Of Remaining Securities Available For Future Issuance &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2009 Equity Incentive Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2011 Equity Incentive Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DVS Sciences Inc. 2010 Equity Incentive Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2017 Inducement Award Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2017 Employee Stock Purchase Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total stock-based compensation expense recognized was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units, stock options and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="iff9fa89f0d3e4906b1a6686b38fead1e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfMS0yLTEtMS0w_b65686a9-52e6-4540-89a7-cf0c9e361169"
      unitRef="shares">19000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i98ff5d8d443c4c78babb4c655a8e6efa_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfMS00LTEtMS0w_955c6bb8-4ca3-429a-8d8f-ca50eae0206d"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ia3da57b8f28d46aa9eb2676696423f21_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfMS02LTEtMS0w_a3fcb50b-79c9-436e-8886-b58939eb4812"
      unitRef="shares">0</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i9bd22d380b1a4d6ea4fd44b27e0141f4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfMi0yLTEtMS0w_047af4be-b9cf-473b-8aec-4d228a9725e1"
      unitRef="shares">1387000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i638e57cbaa7d456f8b185da5205acb2f_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfMi00LTEtMS0w_613cbfcf-de4d-4ed0-9cfd-cc353b282799"
      unitRef="shares">5810000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i4ea312f66de54b4e9c6d400430165a3f_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfMi02LTEtMS0w_1b65f43d-9c6c-4328-90dd-0e3deccdfd5d"
      unitRef="shares">3057000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i5fabe06699de401a840160fc6badcdb3_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfMy0yLTEtMS0w_4e1ed34a-aa97-432e-8476-809020cbe92e"
      unitRef="shares">13000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="id13d013dd44e44adb532dfeeae35dbb5_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfMy00LTEtMS0w_dffc5497-5db5-455c-ad40-4150ef31b164"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="iafad09c62b1d4a0c9f23fde9d0b1485c_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfMy02LTEtMS0w_0546efae-df1f-43e7-8ea2-ba34e136834a"
      unitRef="shares">0</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ib0b9e4ec81a9465d991e4f00f8bdb0ce_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfNC0yLTEtMS0w_7cee65f9-5091-4f55-939b-cdde1d1fdb77"
      unitRef="shares">207000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i1d7a0bcaab4e48bea67be674fa9e6cdc_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfNC00LTEtMS0w_d6b4b25e-8280-425e-ab87-2f654742cdca"
      unitRef="shares">216000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="idb080589897242f4a5db6a13881cbb4a_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfNC02LTEtMS0w_ade76e35-a465-4771-8b5b-79c606d80e4f"
      unitRef="shares">0</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i8d050d829f6246668dee88b2edbb05f9_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfNS0yLTEtMS0w_2e8c9b3b-f03e-411e-a581-0c4093a1a729"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ied741f884347441db18e2bd390ba3411_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfNS00LTEtMS0w_63cba810-e8e8-45d0-9603-70ebb9e8c457"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i241d9546e6e84c83986e1cc5b11f3c0f_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfNS02LTEtMS0w_83d4aa01-aa04-4b5b-8e51-316e6adaaf82"
      unitRef="shares">3100000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i7de5c3aaabc04d038a06ae0f7741f31f_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfNi0yLTEtMS0w_6515d821-2b97-4afc-8f5f-276a2366f804"
      unitRef="shares">1626000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="iefea4fc822cc4bf48772c4ff54bacc58_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfNi00LTEtMS0w_4e6f7d4b-7826-43e9-99a4-41dbd4dbd05f"
      unitRef="shares">6026000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF82Ny9mcmFnOjI2OTQ4ZWJkNTRjZDQ0ZGJiODgwZTUyYjg5M2E1NTFjL3RhYmxlOjZjMDY2MDRhMmRkNTQwZWM4NmQ1NmY3Mjg3ZmIyZTBiL3RhYmxlcmFuZ2U6NmMwNjYwNGEyZGQ1NDBlYzg2ZDU2ZjcyODdmYjJlMGJfNi02LTEtMS0w_1099c6cd-0313-47c8-af32-60f6cef63893"
      unitRef="shares">6157000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTA5NDA_8b6f488c-9041-4dd0-9026-72a6191cfbd1">Stock-Based Plans&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our board of directors sets the terms, conditions, and restrictions related to our 2017 Employee Stock Purchase Plan (ESPP) and the grant of stock options, restricted stock units (RSUs) and performance-based awards under our equity incentive plans. Our board of directors determines the number of awards to grant and also sets vesting criteria. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In general, RSUs vest on a quarterly basis over a period of four years from the date of grant at a rate of either 25% on the first anniversary of the grant date and ratably each quarter over the remaining 12 quarters, or ratably each quarter over 16 quarters, subject to the employees&#x2019; continued employment. In May 2020, we granted 1.8 million retention RSUs that vest over three years, with 50% of the RSUs vesting after one year and 25% of the RSUs vesting each year thereafter. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Incentive stock options and non-statutory stock options granted under our 2011 Equity Incentive Plan (2011 Plan) have a term of no more than ten years from the date of grant and an exercise price of at least 100% of the fair market value of the underlying common stock on the date of grant. If a participant owns stock representing more than 10% of the voting power of all classes of our stock on the grant date, an incentive stock option awarded to the participant will have a term of no more than five years from the date of grant and an exercise price of at least 110% of the fair market value of the underlying common stock on the date of grant. Generally, options vest at a rate of either 25% on the first anniversary of the option grant date and ratably each month over the remaining period of 36 months, or ratably each month over 48 months. We may grant options with different vesting terms from time to time. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For performance-based share awards, our board of directors sets the performance objectives and other vesting provisions in determining the number of shares or value of performance units and performance shares that will be paid out. Such payout will be a function of the extent to which performance objectives or other vesting provisions have been achieved.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2011 Equity Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January&#160;2011, our board of directors adopted the 2011 Plan under which incentive stock options, non-statutory stock options, RSUs, stock appreciation rights, performance stock units (PSUs), and performance shares may be granted to our employees, directors, and consultants. In April 2019, our board of directors authorized, and in June 2019, our stockholders approved an amendment and restatement of the 2011 Plan to make various changes, including increasing the number of shares reserved for issuance by approximately 5.0 million shares and extending the term of the 2011 Plan until April 2029. In May 2020, our board of directors authorized, and in June 2020, our stockholders approved an increase in the number of shares reserved for issuance under the 2011 Plan of 1.4 million shares. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2009 Equity Incentive Plan and 2017 Inducement Award Plan &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our 2009 Equity Incentive Plan (the 2009 Plan) terminated on the date the 2011 Plan was adopted. Options granted, or shares issued under the 2009 Plan that were outstanding on the date the 2011 Plan became effective, remained subject to the terms of the 2009 Plan. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2017, we adopted the Fluidigm Corporation 2017 Inducement Award Plan (Inducement Plan) and reserved 2 million shares of our common stock for issuance pursuant to equity awards granted under the Inducement Plan. The Inducement Plan provided for the grant of equity-based awards on terms substantially similar to the 2011 Plan. In accordance with Rule 5635(c)(4) of the Nasdaq Listing Rules, awards under the Inducement Plan were only be made to individuals not previously our &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;employees or non-employee members of our board of directors (or following such individual&#x2019;s bona fide period of non-employment), as an inducement material to the individual&#x2019;s entry into employment with us or in connection with a merger or acquisition, to the extent permitted by Rule 5635(c)(3) of the Nasdaq Listing Rules. In June 2019, concurrently with the increase in shares available for grant under the 2011 Plan, the Inducement Plan was terminated such that no further grants could be made thereunder. Options granted and shares issued under the Inducement Plan that were outstanding when the Inducement Plan was terminated remain outstanding subject to their terms and the terms of the Inducement Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Valuation and Expense Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use the Black-Scholes option-pricing model to estimate the fair value of stock options granted under our equity incentive plans. We grant stock options at exercise prices not less than the fair value of our common stock at the date of grant. The fair value of RSUs granted to employees was estimated on the date of grant by multiplying the number of shares granted by the fair market value of our common stock on the grant date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity under the various plans was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Units&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.423%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Units (in 000s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant Date Fair Value per Unit&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSU granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSU released&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(872)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSU forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(305)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2020, the unrecognized compensation costs related to outstanding unvested RSUs under our equity incentive plans were $22.0 million. We expect to recognize those costs over a weighted average period of 2.8 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of &lt;br/&gt;Options (000s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Exercise Price&lt;br/&gt;per Option&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average Remaining Contractual Life (in Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Intrinsic &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Value &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt; in (000s)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Awards expected to vest at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Aggregate intrinsic value as of September&#160;30, 2020 was calculated as the difference between the closing price per share of our common stock on the last trading day of September&#160;30, 2020, which was $7.43, and the exercise price of the options, multiplied by the number of in-the-money options. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2020, the unrecognized compensation costs related to outstanding unvested options under our equity incentive plans were $1.1 million. We expect to recognize those costs over a weighted average period of 1.4 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Performance-based Awards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Performance Stock Units with Market Conditions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have granted PSU awards to certain executive officers and senior level employees. The number of PSUs ultimately earned under these awards is calculated based on the Total Shareholder Return (TSR) of our common stock as compared to the TSR of a defined group of peer companies during the applicable three-year performance period. The percentage of PSUs that vest will depend on our relative position at the end of the performance period and can range from 0% to 200% of the number of units granted. Under FASB ASC Topic 718, the provisions of the PSU awards related to TSR are considered a market &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;condition, and the effects of that market condition are reflected in the grant date fair value of the awards. We used a Monte Carlo simulation pricing model to incorporate the market condition effects at our grant date. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity under the TSR-based PSUs is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.423%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Units (in 000s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant Date Fair Value per Unit&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/&gt;&lt;td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSU granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSU released&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/&gt;&lt;td style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSU forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/&gt;&lt;td style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of&#160;September&#160;30, 2020, the unrecognized compensation costs related to these awards were $4.6 million. We expect to recognize those costs over a weighted average period of 1.7 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Performance Stock Units with Performance Conditions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2019, we also granted a PSU award under which the number of PSUs that ultimately vest is dependent on achieving certain discrete operational milestones between September 30, 2019 and December 31, 2020. Activity to date under this PSU award is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.423%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Units (in 000s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant Date Fair Value per Unit&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSU granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSU released&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSU forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2017 Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2017, our stockholders approved our ESPP at the annual meeting of stockholders. Our ESPP offers U.S. and some non-U.S. employees the right to purchase shares of our common stock. Our first ESPP offering period began on October 1, 2017 with a shorter offering period ending on November 30, 2017. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to June 2019, our ESPP program had a six-month offering period, with a new period commencing on the first trading day on or after May 31 and November 30 of each year. Employees were eligible to participate through payroll deductions of up to 10% of their compensation. The purchase price at which shares were sold under the ESPP was 85% of the lower of the fair market value of a share of our common stock on the first day of the offering period or the last day of the offering period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective in June 2019, our ESPP program was amended to offer a twelve-month offering period with two six-month purchase periods beginning on each of May 31 and November 30. Employees were eligible under the amended program to participate through payroll deductions of up to 15% of their compensation. Employees may not purchase more than $25 thousand of stock for any calendar year. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the updated ESPP program, the purchase price at which shares are sold for the first purchase period is 85% of the lower of the fair market value of a share of our common stock on the first day of the offering period or the last day of the first purchase period. For the second purchase period, the purchase price at which shares are sold is 85% of the lower of the fair market value of the common stock on the first day of the offering period and the last day of the offering period. In the event the fair market value of the common stock at the beginning of the second purchase period is less than the fair market value on the beginning of the offering period, the purchase price for the second offering period is reset to 85% of the lower of the fair value of the common stock at the beginning of the second purchase period and the last day of the offering period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The offering period of June 1, 2019 to May 31, 2020 had two purchase periods, with one period ending November 30, 2019 and the other period ending May 31, 2020. As the fair market value of the common stock at November 30, 2019 was lower than the fair value of the common stock at the beginning of the offering period, the purchase price for the second purchase period was reset based on the lower of the November 30, 2019 price and the May 31, 2020 price. The resetting of the purchase price is considered to be a modification of the original terms of the award. Under ASC 718, the incremental fair value based on the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;difference between the fair value of the modified award and the fair value of the original award immediately before it was modified was approximately $0.3 million. This amount was amortized over the remaining offering period which ended May 31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2020, our board of directors authorized, and in June 2020, our stockholders approved, an amendment and restatement of the ESPP that increased the number of shares reserved for issuance by an additional 3.0 million shares and made various other changes. Effective June 2020, our ESPP program was amended to offer a six-month offering period, with a new offering and purchase period commencing on the first trading day on or after May 31 and November 30 of each year. Employees are eligible under the amended program to participate through payroll deductions of up to 10% of their compensation. Employees may not purchase more than $25 thousand of stock for any calendar year. The purchase price of the shares sold under the ESPP is 85% of the lower of fair market value of a share of our common stock on the first day of the offering period or the last day of the offering period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total stock-based compensation expense recognized was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units, stock options and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i52a11bc3f5e44d13bf15a18be4a29d8f_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNDMz_40aa4e58-69d6-48e6-85d3-91c8c41e266e">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <fldm:PortionOfStockOptionsVestOnFirstAnniversary
      contextRef="i52a11bc3f5e44d13bf15a18be4a29d8f_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNDc5_5f91ec7a-189b-4a93-9d17-0b001474265f"
      unitRef="number">0.25</fldm:PortionOfStockOptionsVestOnFirstAnniversary>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i263f694376794abc814fc456f821bbd2_I20200531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNjk2_6d43d239-b9a9-44ed-949d-68189629fb8c"
      unitRef="shares">1800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i3b04e9f77df54a0b9e2eb4b34d0fc115_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNzI5_9d93c41c-cddd-4d83-800b-c8b1bcafa7e6">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="ifa1dea2f8c814e519c099b477d05617b_D20200501-20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNzM4_56a156f4-a201-42ae-aca1-35e2c56efa39"
      unitRef="number">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ibce292aab63145e2bc9d3e50b05a5089_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNzY3_2722215b-e34a-454e-ad45-091b250bb51c">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i1284d595ff29438b8ddea2c07841e004_D20200501-20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNzc0_5eae0c7b-2048-476b-9af3-598add42a5d5"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="ibfd04ed28b304350bca273167b0b25b1_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfOTYx_439ea952-69ed-4c67-9cc9-71041b5875cd">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <fldm:StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue
      contextRef="ibfd04ed28b304350bca273167b0b25b1_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTAyMQ_a2f0030a-c52f-418d-8fc2-a16e28bd5734"
      unitRef="number">1</fldm:StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue>
    <fldm:SharebasedCompensationArrangementbySharebasedPaymentAwardVestingRestrictionsOwnershipPercentageofVotingStock
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTE1Mw_999a9b11-3b1a-46dd-930e-9bc064c08352"
      unitRef="number">0.10</fldm:SharebasedCompensationArrangementbySharebasedPaymentAwardVestingRestrictionsOwnershipPercentageofVotingStock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i8149995fd4334ebd8d795406a38a6aa0_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTMwOQ_823815fa-49c3-473e-a766-abdc968fc6f6">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <fldm:StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue
      contextRef="i8149995fd4334ebd8d795406a38a6aa0_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTM2OQ_209ac1af-ff8b-46b1-846d-ab108a9c74a8"
      unitRef="number">1.10</fldm:StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue>
    <fldm:PortionOfStockOptionsVestOnFirstAnniversary
      contextRef="i86d0a118c5b6489788d92ddc7d23fbd6_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTQ5NA_d783a02f-1ccb-437b-af63-b9ff32512adb"
      unitRef="number">0.25</fldm:PortionOfStockOptionsVestOnFirstAnniversary>
    <fldm:NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement
      contextRef="i3b04e9f77df54a0b9e2eb4b34d0fc115_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTU5OQ_1c9bab01-dcf0-499d-a091-bd1a38a1f2e6">P36M</fldm:NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement>
    <fldm:NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement
      contextRef="ibce292aab63145e2bc9d3e50b05a5089_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTYzMA_8125e9ae-35dc-496f-bb0b-aefb7f1f0753">P48M</fldm:NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ib3e373d05502431a8c7dc9abf1ab0362_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMjYxMQ_52667091-0a58-4b7e-89f3-244049d7165c"
      unitRef="shares">5000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i8fa5a801a597442f88adb537d10639f1_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMjg1Mg_0bb70178-8172-42b5-ac6d-4b96598c1c0b"
      unitRef="shares">1400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i2a6bf5ef9a12484b86b93a4e3f7508a8_I20170131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMzMwMQ_2e3af203-e83b-4546-9eb2-553d87ac2024"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTA5MzA_2b848e1a-0ab3-487a-9018-706c13222668">&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity under the various plans was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Units&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.423%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Units (in 000s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant Date Fair Value per Unit&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSU granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSU released&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(872)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSU forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(305)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="if3575d83de144e808258ee710b5e28d6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjdkYmE2ZGJmN2Y0MDRlNDRiNWE2MTJlMzA4MTk5YTdkL3RhYmxlcmFuZ2U6N2RiYTZkYmY3ZjQwNGU0NGI1YTYxMmUzMDgxOTlhN2RfMS0yLTEtMS0w_73dce71a-0df6-4812-88d9-a76868bf558b"
      unitRef="shares">2551000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="if3575d83de144e808258ee710b5e28d6_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjdkYmE2ZGJmN2Y0MDRlNDRiNWE2MTJlMzA4MTk5YTdkL3RhYmxlcmFuZ2U6N2RiYTZkYmY3ZjQwNGU0NGI1YTYxMmUzMDgxOTlhN2RfMS00LTEtMS0w_b2f873ad-d289-4226-a682-cdb1a7e4a23f"
      unitRef="usdPerShare">7.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i52a11bc3f5e44d13bf15a18be4a29d8f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjdkYmE2ZGJmN2Y0MDRlNDRiNWE2MTJlMzA4MTk5YTdkL3RhYmxlcmFuZ2U6N2RiYTZkYmY3ZjQwNGU0NGI1YTYxMmUzMDgxOTlhN2RfMi0yLTEtMS0w_f5077c71-74a7-4fa2-be49-bcc39dd9f392"
      unitRef="shares">3642000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i52a11bc3f5e44d13bf15a18be4a29d8f_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjdkYmE2ZGJmN2Y0MDRlNDRiNWE2MTJlMzA4MTk5YTdkL3RhYmxlcmFuZ2U6N2RiYTZkYmY3ZjQwNGU0NGI1YTYxMmUzMDgxOTlhN2RfMi00LTEtMS0w_7ac492c5-b939-4bdd-aa08-7add76553c52"
      unitRef="usdPerShare">3.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i52a11bc3f5e44d13bf15a18be4a29d8f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjdkYmE2ZGJmN2Y0MDRlNDRiNWE2MTJlMzA4MTk5YTdkL3RhYmxlcmFuZ2U6N2RiYTZkYmY3ZjQwNGU0NGI1YTYxMmUzMDgxOTlhN2RfMy0yLTEtMS0w_194a610d-a668-4d2c-a805-dbf2e50513ff"
      unitRef="shares">872000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i52a11bc3f5e44d13bf15a18be4a29d8f_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjdkYmE2ZGJmN2Y0MDRlNDRiNWE2MTJlMzA4MTk5YTdkL3RhYmxlcmFuZ2U6N2RiYTZkYmY3ZjQwNGU0NGI1YTYxMmUzMDgxOTlhN2RfMy00LTEtMS0w_4735ac81-1420-4bc6-9632-36c24698e844"
      unitRef="usdPerShare">7.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i52a11bc3f5e44d13bf15a18be4a29d8f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjdkYmE2ZGJmN2Y0MDRlNDRiNWE2MTJlMzA4MTk5YTdkL3RhYmxlcmFuZ2U6N2RiYTZkYmY3ZjQwNGU0NGI1YTYxMmUzMDgxOTlhN2RfNC0yLTEtMS0w_81324663-2e61-4ee1-8c68-a387519e8d4c"
      unitRef="shares">305000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i52a11bc3f5e44d13bf15a18be4a29d8f_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjdkYmE2ZGJmN2Y0MDRlNDRiNWE2MTJlMzA4MTk5YTdkL3RhYmxlcmFuZ2U6N2RiYTZkYmY3ZjQwNGU0NGI1YTYxMmUzMDgxOTlhN2RfNC00LTEtMS0w_1fb61f93-7ecf-45aa-a5ac-fe29629953cc"
      unitRef="usdPerShare">6.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ib711ac2faf28446d9e3400f0d3bd6600_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjdkYmE2ZGJmN2Y0MDRlNDRiNWE2MTJlMzA4MTk5YTdkL3RhYmxlcmFuZ2U6N2RiYTZkYmY3ZjQwNGU0NGI1YTYxMmUzMDgxOTlhN2RfNS0yLTEtMS0w_25b8a454-1426-436f-b63c-f6e9cd2e77fa"
      unitRef="shares">5016000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ib711ac2faf28446d9e3400f0d3bd6600_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjdkYmE2ZGJmN2Y0MDRlNDRiNWE2MTJlMzA4MTk5YTdkL3RhYmxlcmFuZ2U6N2RiYTZkYmY3ZjQwNGU0NGI1YTYxMmUzMDgxOTlhN2RfNS00LTEtMS0w_439f2673-bbb3-494e-b749-198545ba84aa"
      unitRef="usdPerShare">4.99</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="ib711ac2faf28446d9e3400f0d3bd6600_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNTA4MA_1a657db8-d49e-422f-b054-96bf6f748366"
      unitRef="usd">22000000.0</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="i52a11bc3f5e44d13bf15a18be4a29d8f_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNTE1Mw_8438478b-7450-4a74-bcd9-91d0b53fd754">P2Y9M18D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTA5Mzc_3c648454-9c1e-4934-92c6-fcba4144dfb5">&lt;div style="margin-top:15pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of &lt;br/&gt;Options (000s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Exercise Price&lt;br/&gt;per Option&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average Remaining Contractual Life (in Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Intrinsic &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Value &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt; in (000s)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Awards expected to vest at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______&lt;/span&gt;&lt;/div&gt;(1)Aggregate intrinsic value as of September&#160;30, 2020 was calculated as the difference between the closing price per share of our common stock on the last trading day of September&#160;30, 2020, which was $7.43, and the exercise price of the options, multiplied by the number of in-the-money options.</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfMS0yLTEtMS0w_b1644bc1-4bbb-4345-98af-c4a81166a82c"
      unitRef="shares">2027000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfMS00LTEtMS0w_344061b9-c225-4227-906f-18ed28ac9a10"
      unitRef="usdPerShare">7.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i903ebee619a74d21ad02859fe06eab6b_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfMS02LTEtMS0w_850cffa8-7a96-42b4-a708-efde4906a9ac">P6Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="ia85757d6f56b40de9d8d04f4618b8bc8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfMS04LTEtMS0w_ef2bfc16-2269-4023-8f98-585fd4a9a3b7"
      unitRef="usd">81000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfMi0yLTEtMS0w_fa610fc4-211e-4a03-928a-8e92ae59dd07"
      unitRef="shares">105000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfMi00LTEtMS0w_950217e3-438f-454f-b6c4-16fab8871164"
      unitRef="usdPerShare">3.74</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfMy0yLTEtMS0w_b23edcd9-7ebb-48d4-912b-d8d379a4f67b"
      unitRef="shares">98000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfMy00LTEtMS0w_a63d3a67-0171-4aaa-99b3-16a0b69e1d0e"
      unitRef="usdPerShare">4.90</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfMy04LTEtMS0w_e994fcf9-c1d2-41bd-8188-6b0c9b119bdd"
      unitRef="usd">352000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfNC0yLTEtMS0w_11255244-36ea-449f-bef2-ae5574111d78"
      unitRef="shares">408000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfNC00LTEtMS0w_a6d9f6e2-c68f-4116-ad09-b7c37957a499"
      unitRef="usdPerShare">9.20</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfNS0yLTEtMS0w_75210807-4807-490a-8d79-fee4eb69a498"
      unitRef="shares">1626000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfNS00LTEtMS0w_99d20a29-395a-4d1e-8b21-8ea4e55c214e"
      unitRef="usdPerShare">7.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfNS02LTEtMS0w_fa439971-6251-4bff-bba0-21dbff5aac7b">P6Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfNS04LTEtMS0w_d3fcf0f2-36e5-4b34-8f95-8739f011c05e"
      unitRef="usd">2514000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfNi0yLTEtMS0w_7c7e29d2-769d-49cc-b2fd-e09d8e9dfd64"
      unitRef="shares">1259000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfNi00LTEtMS0w_b0828059-2ff2-4c85-994c-b905cd40c7d7"
      unitRef="usdPerShare">7.86</fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice>
    <fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfNi02LTEtMS0w_51c3ed16-fd76-411a-8e1c-fae8016ee94c">P6Y</fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne>
    <fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfNi04LTEtMS0w_a4244b94-befd-4f87-bf1a-36d8a9a4e522"
      unitRef="usd">1799000</fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue>
    <fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfNy0yLTEtMS0w_534aa547-aa13-4ee5-90b4-cc24fd6117c8"
      unitRef="shares">367000</fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber>
    <fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfNy00LTEtMS0w_fcb97fae-1d5c-41c2-b853-7015d3ed5d7e"
      unitRef="usdPerShare">5.56</fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice>
    <fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfNy02LTEtMS0w_9f6a84b3-e5c0-468e-9076-680da2386c57">P7Y10M24D</fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1>
    <fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmIzMTVhMzFkOWY2NzQ4ODQ5ZTFiOGI5NzIxOWMzYTE4L3RhYmxlcmFuZ2U6YjMxNWEzMWQ5ZjY3NDg4NDllMWI4Yjk3MjE5YzNhMThfNy04LTEtMS0w_2dbc152a-5dba-4812-9c22-5dd22c321f11"
      unitRef="usd">715000</fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:SharePrice
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNTM0Mw_3d175043-4b04-4481-8e4a-0caad87d1e75"
      unitRef="usdPerShare">7.43</us-gaap:SharePrice>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="if5379688acd14de7b8f11138da8190d7_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNTU2MQ_da263161-67cc-4351-b0de-c22fbca0c78e"
      unitRef="usd">1100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="i43caef91ebc84c58affb994dda276bd2_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNTYzNA_d6160c4f-cada-4fd7-bc7c-3643c89c34a2">P1Y4M24D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ic5115d69f217430288b67bde40c9b1dc_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTA5Mzg_963b64ed-a457-4c34-a603-4fd93fca63d5">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest
      contextRef="i61c3102478484d46b94add36424eda3f_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNjE2Ng_96d64ef5-2cc8-4661-8a08-d87fe8da26b7"
      unitRef="number">0</fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest>
    <fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest
      contextRef="i32afb092bbb44b9b9f083571429c2990_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNjE3Mg_c09ccea7-0a07-41b7-a05a-7d90d3fd9a2e"
      unitRef="number">2</fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest>
    <us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTA5NDc_24e202b4-4ee2-4abf-8aa9-546b8342f450">&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity under the TSR-based PSUs is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.423%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Units (in 000s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant Date Fair Value per Unit&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/&gt;&lt;td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSU granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSU released&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/&gt;&lt;td style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSU forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/&gt;&lt;td style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Activity to date under this PSU award is as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.423%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Units (in 000s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant Date Fair Value per Unit&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSU granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSU released&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSU forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ie07832375f9440358e7271a1d7a2f6c2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmY4NzRlZDIxMmQwNjQ2NmFhM2VkYmNjOTY0YWY0YjQ3L3RhYmxlcmFuZ2U6Zjg3NGVkMjEyZDA2NDY2YWEzZWRiY2M5NjRhZjRiNDdfMS0yLTEtMS0w_3112c02a-f31b-45dd-aed8-a7d0b58fa521"
      unitRef="shares">547000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ie07832375f9440358e7271a1d7a2f6c2_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmY4NzRlZDIxMmQwNjQ2NmFhM2VkYmNjOTY0YWY0YjQ3L3RhYmxlcmFuZ2U6Zjg3NGVkMjEyZDA2NDY2YWEzZWRiY2M5NjRhZjRiNDdfMS00LTEtMS0w_5c4d87b8-f7cc-4d66-bff0-37fd430ad3af"
      unitRef="usdPerShare">15.09</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ic5115d69f217430288b67bde40c9b1dc_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmY4NzRlZDIxMmQwNjQ2NmFhM2VkYmNjOTY0YWY0YjQ3L3RhYmxlcmFuZ2U6Zjg3NGVkMjEyZDA2NDY2YWEzZWRiY2M5NjRhZjRiNDdfMi0yLTEtMS0w_39ce1fbd-a663-4d48-8005-1c8f37dd62d1"
      unitRef="shares">509000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ic5115d69f217430288b67bde40c9b1dc_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmY4NzRlZDIxMmQwNjQ2NmFhM2VkYmNjOTY0YWY0YjQ3L3RhYmxlcmFuZ2U6Zjg3NGVkMjEyZDA2NDY2YWEzZWRiY2M5NjRhZjRiNDdfMi00LTEtMS0w_83cab8a8-4ecb-403d-bb3c-3c7881266815"
      unitRef="usdPerShare">4.82</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ic5115d69f217430288b67bde40c9b1dc_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmY4NzRlZDIxMmQwNjQ2NmFhM2VkYmNjOTY0YWY0YjQ3L3RhYmxlcmFuZ2U6Zjg3NGVkMjEyZDA2NDY2YWEzZWRiY2M5NjRhZjRiNDdfMy0yLTEtMS0w_1be210df-9689-46af-8570-646cd321b3d6"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ic5115d69f217430288b67bde40c9b1dc_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmY4NzRlZDIxMmQwNjQ2NmFhM2VkYmNjOTY0YWY0YjQ3L3RhYmxlcmFuZ2U6Zjg3NGVkMjEyZDA2NDY2YWEzZWRiY2M5NjRhZjRiNDdfMy00LTEtMS0w_4a0228cd-46ea-46cc-8199-ff1121f45977"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ic5115d69f217430288b67bde40c9b1dc_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmY4NzRlZDIxMmQwNjQ2NmFhM2VkYmNjOTY0YWY0YjQ3L3RhYmxlcmFuZ2U6Zjg3NGVkMjEyZDA2NDY2YWEzZWRiY2M5NjRhZjRiNDdfNC0yLTEtMS0w_473d321e-f69a-4f5c-bb92-e5d34f910f96"
      unitRef="shares">94000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ic5115d69f217430288b67bde40c9b1dc_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmY4NzRlZDIxMmQwNjQ2NmFhM2VkYmNjOTY0YWY0YjQ3L3RhYmxlcmFuZ2U6Zjg3NGVkMjEyZDA2NDY2YWEzZWRiY2M5NjRhZjRiNDdfNC00LTEtMS0w_28341029-cce1-4cc3-94b8-a34f2e24a9b4"
      unitRef="usdPerShare">14.26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="icae4702ca6dc445a8b04b4ce1f0e0fd9_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmY4NzRlZDIxMmQwNjQ2NmFhM2VkYmNjOTY0YWY0YjQ3L3RhYmxlcmFuZ2U6Zjg3NGVkMjEyZDA2NDY2YWEzZWRiY2M5NjRhZjRiNDdfNS0yLTEtMS0w_aa87f8ef-5c65-4fea-a914-38bf9efd316c"
      unitRef="shares">962000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="icae4702ca6dc445a8b04b4ce1f0e0fd9_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOmY4NzRlZDIxMmQwNjQ2NmFhM2VkYmNjOTY0YWY0YjQ3L3RhYmxlcmFuZ2U6Zjg3NGVkMjEyZDA2NDY2YWEzZWRiY2M5NjRhZjRiNDdfNS00LTEtMS0w_3e6e486f-a163-4c3b-ac0c-e86b91c8ec15"
      unitRef="usdPerShare">9.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="icae4702ca6dc445a8b04b4ce1f0e0fd9_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNjY1NA_dcf4d28b-8e91-4a4a-9078-249fe6f4fad6"
      unitRef="usd">4600000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="ic5115d69f217430288b67bde40c9b1dc_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNjcyNw_ba7b7633-31fb-45c9-abb2-1d6a505f8bb8">P1Y8M12D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i44e0332a734548d5b4a5b0f2a9cd04b5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjU0Mzk5NzQ3NTY0NjRhYzJiZjM5ZDUyMjNiMmUwYjkyL3RhYmxlcmFuZ2U6NTQzOTk3NDc1NjQ2NGFjMmJmMzlkNTIyM2IyZTBiOTJfMS0yLTEtMS0w_5afdedd2-aca4-4184-97ef-af0a56bf4aa9"
      unitRef="shares">64000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i44e0332a734548d5b4a5b0f2a9cd04b5_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjU0Mzk5NzQ3NTY0NjRhYzJiZjM5ZDUyMjNiMmUwYjkyL3RhYmxlcmFuZ2U6NTQzOTk3NDc1NjQ2NGFjMmJmMzlkNTIyM2IyZTBiOTJfMS00LTEtMS0w_3960d1b5-0532-437e-a55d-37a20e248446"
      unitRef="usdPerShare">7.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i76eddca721de44d59d30a86ae6150eae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjU0Mzk5NzQ3NTY0NjRhYzJiZjM5ZDUyMjNiMmUwYjkyL3RhYmxlcmFuZ2U6NTQzOTk3NDc1NjQ2NGFjMmJmMzlkNTIyM2IyZTBiOTJfMi0yLTEtMS0w_0909e9c4-ae1a-4d81-ad7a-2b965c9aee1d"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i76eddca721de44d59d30a86ae6150eae_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjU0Mzk5NzQ3NTY0NjRhYzJiZjM5ZDUyMjNiMmUwYjkyL3RhYmxlcmFuZ2U6NTQzOTk3NDc1NjQ2NGFjMmJmMzlkNTIyM2IyZTBiOTJfMi00LTEtMS0w_d05648cc-58f8-4b57-997e-d527cfaad13b"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i76eddca721de44d59d30a86ae6150eae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjU0Mzk5NzQ3NTY0NjRhYzJiZjM5ZDUyMjNiMmUwYjkyL3RhYmxlcmFuZ2U6NTQzOTk3NDc1NjQ2NGFjMmJmMzlkNTIyM2IyZTBiOTJfMy0yLTEtMS0w_4906b7df-e22a-4676-a630-3ac2ab13ea85"
      unitRef="shares">4000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i76eddca721de44d59d30a86ae6150eae_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjU0Mzk5NzQ3NTY0NjRhYzJiZjM5ZDUyMjNiMmUwYjkyL3RhYmxlcmFuZ2U6NTQzOTk3NDc1NjQ2NGFjMmJmMzlkNTIyM2IyZTBiOTJfMy00LTEtMS0w_f25e6e4f-10da-4b57-9972-89f9378ee074"
      unitRef="usdPerShare">7.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i76eddca721de44d59d30a86ae6150eae_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjU0Mzk5NzQ3NTY0NjRhYzJiZjM5ZDUyMjNiMmUwYjkyL3RhYmxlcmFuZ2U6NTQzOTk3NDc1NjQ2NGFjMmJmMzlkNTIyM2IyZTBiOTJfNC0yLTEtMS0w_a2eec850-0159-4136-a646-526e29ef1004"
      unitRef="shares">12000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i76eddca721de44d59d30a86ae6150eae_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjU0Mzk5NzQ3NTY0NjRhYzJiZjM5ZDUyMjNiMmUwYjkyL3RhYmxlcmFuZ2U6NTQzOTk3NDc1NjQ2NGFjMmJmMzlkNTIyM2IyZTBiOTJfNC00LTEtMS0w_792c73bb-4bdd-4735-b27d-c6ac8cd5068a"
      unitRef="usdPerShare">7.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="if76795b7980f4cf1b2d2d91e17de5300_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjU0Mzk5NzQ3NTY0NjRhYzJiZjM5ZDUyMjNiMmUwYjkyL3RhYmxlcmFuZ2U6NTQzOTk3NDc1NjQ2NGFjMmJmMzlkNTIyM2IyZTBiOTJfNS0yLTEtMS0w_a5c51cbc-b06c-45f2-831e-5b641ac93c7e"
      unitRef="shares">48000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="if76795b7980f4cf1b2d2d91e17de5300_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjU0Mzk5NzQ3NTY0NjRhYzJiZjM5ZDUyMjNiMmUwYjkyL3RhYmxlcmFuZ2U6NTQzOTk3NDc1NjQ2NGFjMmJmMzlkNTIyM2IyZTBiOTJfNS00LTEtMS0w_ba2fb413-9b98-4cec-b939-97559394b4dd"
      unitRef="usdPerShare">7.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <fldm:EmployeeStockPurchasePlanOfferingPeriod
      contextRef="i9dad88f3165a4f0eae5db5d9dc24638f_D20190531-20190531"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTA5NDE_46f78a15-fd8a-41b2-b8b4-df357711c995">P6M</fldm:EmployeeStockPurchasePlanOfferingPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
      contextRef="id735d6be492745c7b536c828704a562f_I20190531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNzYzNQ_91d5c760-786d-459e-a1f7-f22dfb0e5ec3"
      unitRef="number">0.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i9dad88f3165a4f0eae5db5d9dc24638f_D20190531-20190531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNzcyNQ_e2a21d8f-3917-4c73-8dfb-3b74f2a8d401"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <fldm:EmployeeStockPurchasePlanOfferingPeriod
      contextRef="i2e63e5ad862548fb846d042a7966af01_D20190601-20190630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTA5NDI_3a3d7494-b921-415b-914a-ecda26cf2a90">P12M</fldm:EmployeeStockPurchasePlanOfferingPeriod>
    <fldm:EmployeeStockPurchasePlanNumberOfSixMonthOfferingPeriods
      contextRef="i5cf64713f36146589fe70c417cb48244_I20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfNzk3Mg_3254ecb2-26c6-4d25-a5e0-ce196adc1723"
      unitRef="offering_period">2</fldm:EmployeeStockPurchasePlanNumberOfSixMonthOfferingPeriods>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
      contextRef="iec50ef8ea8764ccc81da85f1d3289c10_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfODE0OA_476db68d-4662-4b52-a7bf-14ba7dfb8349"
      unitRef="number">0.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate>
    <fldm:SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount
      contextRef="ic6bc844ecc89460581bfb369e1d5f54c_D20190601-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfODIxMQ_b589f5f0-248c-4565-a600-95fad93dd207"
      unitRef="usd">25000</fldm:SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i9dad88f3165a4f0eae5db5d9dc24638f_D20190531-20190531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfODM1Ng_e2a21d8f-3917-4c73-8dfb-3b74f2a8d401"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i9dad88f3165a4f0eae5db5d9dc24638f_D20190531-20190531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfODU5Mw_e2a21d8f-3917-4c73-8dfb-3b74f2a8d401"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i9dad88f3165a4f0eae5db5d9dc24638f_D20190531-20190531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfODk3NQ_e2a21d8f-3917-4c73-8dfb-3b74f2a8d401"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <fldm:EmployeeStockPurchasePlanNumberOfSixMonthOfferingPeriods
      contextRef="i5cf64713f36146589fe70c417cb48244_I20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfOTE3Mw_3254ecb2-26c6-4d25-a5e0-ce196adc1723"
      unitRef="offering_period">2</fldm:EmployeeStockPurchasePlanNumberOfSixMonthOfferingPeriods>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
      contextRef="i12094595ba954861a1470caab2024faa_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfOTg4NA_1290cb41-cd8a-4656-a8a1-2c9198a7bc86"
      unitRef="usd">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="if87552129e8440cebc8cf50867ede516_D20200601-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTAxODc_4340d34a-f747-4320-a34a-a332d4831caf"
      unitRef="shares">3000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <fldm:EmployeeStockPurchasePlanOfferingPeriod
      contextRef="i28c40c94918f4477a5ef78ff4d1aaa6a_D20200601-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTA5MzE_0f0bbaad-ed37-4c00-817a-c30ff8d96ba9">P6M</fldm:EmployeeStockPurchasePlanOfferingPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
      contextRef="ic4e3f90a457a4d718ca93f052c881c93_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTA1NDE_a5155984-d4ce-40ca-9983-7476c7588298"
      unitRef="number">0.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate>
    <fldm:SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount
      contextRef="ic6bc844ecc89460581bfb369e1d5f54c_D20190601-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTA2MDQ_b589f5f0-248c-4565-a600-95fad93dd207"
      unitRef="usd">25000</fldm:SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i28c40c94918f4477a5ef78ff4d1aaa6a_D20200601-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RleHRyZWdpb246MTNmNTUyM2NhZDcwNDc4MjkyNzE1YjI1NmI1M2E3YTlfMTA2OTU_032b6d4e-ec5d-41ac-b239-d6bddc995cd5"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia4856057ff874e7e95190bbf158b2cc5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjI4M2FjZDU2ZjFiZjQyYzFhZjFkMGFkYzU4ZTM5OTg5L3RhYmxlcmFuZ2U6MjgzYWNkNTZmMWJmNDJjMWFmMWQwYWRjNThlMzk5ODlfMi0yLTEtMS0w_c60293be-0b60-4047-8bc7-68a2039b1820"
      unitRef="usd">4114000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0b89a3284da34463afa07821cc02ca87_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjI4M2FjZDU2ZjFiZjQyYzFhZjFkMGFkYzU4ZTM5OTg5L3RhYmxlcmFuZ2U6MjgzYWNkNTZmMWJmNDJjMWFmMWQwYWRjNThlMzk5ODlfMi00LTEtMS0w_7b93611a-d985-4348-a199-4db6d2424d36"
      unitRef="usd">2738000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i73d9e7c6273e4f8d91c0d44a383a2ca2_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjI4M2FjZDU2ZjFiZjQyYzFhZjFkMGFkYzU4ZTM5OTg5L3RhYmxlcmFuZ2U6MjgzYWNkNTZmMWJmNDJjMWFmMWQwYWRjNThlMzk5ODlfMi02LTEtMS0w_65bc2ce8-e38a-44d6-b360-1bb994ff85b8"
      unitRef="usd">9558000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i478d956acce94a509514c698c820bfdc_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjI4M2FjZDU2ZjFiZjQyYzFhZjFkMGFkYzU4ZTM5OTg5L3RhYmxlcmFuZ2U6MjgzYWNkNTZmMWJmNDJjMWFmMWQwYWRjNThlMzk5ODlfMi04LTEtMS0w_8675e1b8-2e8b-4fb6-b9f4-1457b416ddd1"
      unitRef="usd">7731000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0ce4b9d2150942418669ac5b5403bf4e_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjI4M2FjZDU2ZjFiZjQyYzFhZjFkMGFkYzU4ZTM5OTg5L3RhYmxlcmFuZ2U6MjgzYWNkNTZmMWJmNDJjMWFmMWQwYWRjNThlMzk5ODlfMy0yLTEtMS0w_142cca3c-1454-49cc-9592-e03c29bc10ae"
      unitRef="usd">243000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1826be0f06d44338b008edc9592cb9bf_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjI4M2FjZDU2ZjFiZjQyYzFhZjFkMGFkYzU4ZTM5OTg5L3RhYmxlcmFuZ2U6MjgzYWNkNTZmMWJmNDJjMWFmMWQwYWRjNThlMzk5ODlfMy00LTEtMS0w_a15eb970-99d3-463d-81f9-d0bdf10e53b4"
      unitRef="usd">291000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iefccdb36374e4d188b0f54d8e13766ac_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjI4M2FjZDU2ZjFiZjQyYzFhZjFkMGFkYzU4ZTM5OTg5L3RhYmxlcmFuZ2U6MjgzYWNkNTZmMWJmNDJjMWFmMWQwYWRjNThlMzk5ODlfMy02LTEtMS0w_7b5cd2d7-ac2f-469c-9e94-b7d4940f7338"
      unitRef="usd">800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6205bf705fb745b9b232a8a68ddc2049_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjI4M2FjZDU2ZjFiZjQyYzFhZjFkMGFkYzU4ZTM5OTg5L3RhYmxlcmFuZ2U6MjgzYWNkNTZmMWJmNDJjMWFmMWQwYWRjNThlMzk5ODlfMy04LTEtMS0w_aa7716ba-99ad-4c25-8eff-772e6b92e068"
      unitRef="usd">561000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjI4M2FjZDU2ZjFiZjQyYzFhZjFkMGFkYzU4ZTM5OTg5L3RhYmxlcmFuZ2U6MjgzYWNkNTZmMWJmNDJjMWFmMWQwYWRjNThlMzk5ODlfNC0yLTEtMS0w_1a74b370-0383-42fc-80ff-028a0c4e0f98"
      unitRef="usd">4357000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjI4M2FjZDU2ZjFiZjQyYzFhZjFkMGFkYzU4ZTM5OTg5L3RhYmxlcmFuZ2U6MjgzYWNkNTZmMWJmNDJjMWFmMWQwYWRjNThlMzk5ODlfNC00LTEtMS0w_d4727a5e-c198-4e5e-b56a-b316a652ab0d"
      unitRef="usd">3029000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjI4M2FjZDU2ZjFiZjQyYzFhZjFkMGFkYzU4ZTM5OTg5L3RhYmxlcmFuZ2U6MjgzYWNkNTZmMWJmNDJjMWFmMWQwYWRjNThlMzk5ODlfNC02LTEtMS0w_f5f3a44e-adaa-4063-8250-f6b72cd3c82f"
      unitRef="usd">10358000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83MC9mcmFnOjEzZjU1MjNjYWQ3MDQ3ODI5MjcxNWIyNTZiNTNhN2E5L3RhYmxlOjI4M2FjZDU2ZjFiZjQyYzFhZjFkMGFkYzU4ZTM5OTg5L3RhYmxlcmFuZ2U6MjgzYWNkNTZmMWJmNDJjMWFmMWQwYWRjNThlMzk5ODlfNC04LTEtMS0w_16743c44-d4a3-494d-adc1-fc9ab0851fff"
      unitRef="usd">8292000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83My9mcmFnOjk3NjBjYjIwODE5ODQ1ZWRiYjNlZGYyMzg1OTg1YTM0L3RleHRyZWdpb246OTc2MGNiMjA4MTk4NDVlZGJiM2VkZjIzODU5ODVhMzRfMzA4Mw_f36d0e64-fd70-4c20-a1b4-af28406867e4">Income Taxes&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our quarterly provision for income taxes is based on an estimated effective annual income tax rate. Our quarterly provision for income taxes also includes the tax impact of certain unusual or infrequently occurring items, if any, including changes in judgment about valuation allowances and effects of changes in tax laws or rates, in the interim period in which they occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded a tax benefit of $0.2 million and $2.1 million for the three and nine months ended September&#160;30, 2020, respectively. We recorded a tax benefit of $1.2 million and $2.3 million for the three and nine months ended September&#160;30, 2019, respectively. The benefits for all periods were primarily attributable to the tax benefit from the amortization of our acquisition-related deferred tax liabilities partially offset by tax provisions for our foreign operations and state minimum income taxes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our tax benefit for income taxes for the periods presented differ from the 21% U.S. Federal statutory rate for the nine months ended September&#160;30, 2020 and 2019, respectively, primarily due to maintaining a valuation allowance for most of our deferred tax assets, which primarily consist of net operating loss carryforwards. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our tax positions are subject to audits by multiple tax jurisdictions. We believe that we have provided adequate reserves for uncertain tax positions for all tax years still open for assessment. For the three and nine months ended September&#160;30, 2020,&#160;and 2019, respectively, we did&#160;not recognize any material interest or penalties related to uncertain tax positions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Recording deferred tax assets is appropriate when realization of these assets is more likely than not. Assessing the realizability of deferred tax assets is dependent upon several factors including historical financial results and future expected financial results. The deferred tax assets have been offset by valuation allowances. In the future we may release valuation allowances and recognize deferred tax assets in certain of our foreign subsidiaries depending on the achievement of future profitability in the relevant jurisdictions. Any release of valuation allowances could have the effect of decreasing the income tax provision in the period the valuation allowance is released. We continue to monitor the likelihood that we will be able to recover our deferred tax assets, including those for which a valuation allowance is recorded. There can be no assurance that we will generate profits in the future periods enabling us to fully realize our deferred tax assets. The timing of recording a valuation allowance or the reversal of such valuation allowance is subject to objective and subjective factors that cannot be readily predicted in advance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 27, 2020, the Coronavirus Aid, Relief and Economic Security (CARES) Act was signed into law. The CARES Act includes provisions relating to refundable payroll tax credits, net operating loss carryback periods, alternative minimum tax credit refunds, modifications to the net interest deduction limitations and technical corrections to the tax deprecation methods for qualified improvement property. We are currently analyzing the impact of these changes and therefore, an estimate of the impact on income taxes, if any, is not yet available.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if34d6cb92429486486b628a7b0f777e5_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83My9mcmFnOjk3NjBjYjIwODE5ODQ1ZWRiYjNlZGYyMzg1OTg1YTM0L3RleHRyZWdpb246OTc2MGNiMjA4MTk4NDVlZGJiM2VkZjIzODU5ODVhMzRfMTA5OTUxMTYzMTE2Ng_3936d724-5323-4a32-9b99-89df3b1ef0a2"
      unitRef="usd">-200000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83My9mcmFnOjk3NjBjYjIwODE5ODQ1ZWRiYjNlZGYyMzg1OTg1YTM0L3RleHRyZWdpb246OTc2MGNiMjA4MTk4NDVlZGJiM2VkZjIzODU5ODVhMzRfMTA5OTUxMTYzMTE3Mg_72ae63fa-22b2-4457-ae99-30ef8ac769d4"
      unitRef="usd">-2100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2bb234831ad34b26a42c89b19ba5a72e_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83My9mcmFnOjk3NjBjYjIwODE5ODQ1ZWRiYjNlZGYyMzg1OTg1YTM0L3RleHRyZWdpb246OTc2MGNiMjA4MTk4NDVlZGJiM2VkZjIzODU5ODVhMzRfMTA5OTUxMTYzMTE2Mw_110094f5-bbf5-47d8-8243-2605e7b842f4"
      unitRef="usd">-1200000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if2e10183386b4aea8d51d735e38907f6_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83My9mcmFnOjk3NjBjYjIwODE5ODQ1ZWRiYjNlZGYyMzg1OTg1YTM0L3RleHRyZWdpb246OTc2MGNiMjA4MTk4NDVlZGJiM2VkZjIzODU5ODVhMzRfMTA5OTUxMTYzMTE3NQ_eb946e20-7e1f-4b19-bdbe-7dd9d4b64d17"
      unitRef="usd">-2300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83Ni9mcmFnOjI0Mjg3MjExYTQ4ZDQ4YmFiNzY2Njg0NGE5ZDYwMjhhL3RleHRyZWdpb246MjQyODcyMTFhNDhkNDhiYWI3NjY2ODQ0YTlkNjAyOGFfMTY4NQ_6d564ceb-aef8-4c5c-8f44-e01ded259ce8">Information About Geographic Areas&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We operate in one reporting segment that develops, manufacturers and commercializes tools for life sciences research. Our chief executive officer manages our operations and evaluates our financial performance on a consolidated basis. For purposes of allocating resources and evaluating regional financial performance, our chief executive officer reviews separate sales information for the different regions of the world. Our general and administrative expenses and our research and development expenses are not allocated to any specific region. Most of our principal operations, other than manufacturing, and our decision-making functions are located at our corporate headquarters in the United States.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary table of our total revenue by geographic areas of our customers and by product and services for the three and nine months ended September&#160;30, 2020 and 2019 is included in Note 5 to the condensed consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales to customers in the United States represented $23.3 million, or 58% of total revenues, and $50.7 million, or 54% of total revenues, for the three and nine months ended September&#160;30, 2020, respectively. Sales to customers in the United States represented $10.5 million, or 40% of total revenues, and $32.9 million, or 39% of total revenues, for the three and nine months ended September&#160;30, 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No foreign country or jurisdiction had sales in excess of 10% of total revenues for the three months ended September&#160;30, 2020 and 2019, except for China, which had total revenues of $3.9 million, or 15% of total revenues for the three months ended September&#160;30, 2019. There was no foreign country or jurisdiction with sales in excess of 10% of our total revenues for the nine months ended September&#160;30, 2020 or 2019, except for China, which had sales of $11.4 million, or 13% of total revenues, for the nine months ended September&#160;30, 2019.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83Ni9mcmFnOjI0Mjg3MjExYTQ4ZDQ4YmFiNzY2Njg0NGE5ZDYwMjhhL3RleHRyZWdpb246MjQyODcyMTFhNDhkNDhiYWI3NjY2ODQ0YTlkNjAyOGFfNTg_d45f1df8-3c6a-44e8-b2ef-1dcf286d4d81"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaff11e46a2f34810b12b962e4ab4033d_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83Ni9mcmFnOjI0Mjg3MjExYTQ4ZDQ4YmFiNzY2Njg0NGE5ZDYwMjhhL3RleHRyZWdpb246MjQyODcyMTFhNDhkNDhiYWI3NjY2ODQ0YTlkNjAyOGFfOTk3_5fd23c56-d8fa-45dd-9ce4-89e66aaa9829"
      unitRef="usd">23300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iaff11e46a2f34810b12b962e4ab4033d_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83Ni9mcmFnOjI0Mjg3MjExYTQ4ZDQ4YmFiNzY2Njg0NGE5ZDYwMjhhL3RleHRyZWdpb246MjQyODcyMTFhNDhkNDhiYWI3NjY2ODQ0YTlkNjAyOGFfMTAwNA_6fc41a51-89f6-4b05-896b-d391537794f6"
      unitRef="number">0.58</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i028e85ad01cf4114b46ee8d96cd7d003_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83Ni9mcmFnOjI0Mjg3MjExYTQ4ZDQ4YmFiNzY2Njg0NGE5ZDYwMjhhL3RleHRyZWdpb246MjQyODcyMTFhNDhkNDhiYWI3NjY2ODQ0YTlkNjAyOGFfMTAzMA_726a5846-23f9-4f48-b811-5e4d5833a5be"
      unitRef="usd">50700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i028e85ad01cf4114b46ee8d96cd7d003_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83Ni9mcmFnOjI0Mjg3MjExYTQ4ZDQ4YmFiNzY2Njg0NGE5ZDYwMjhhL3RleHRyZWdpb246MjQyODcyMTFhNDhkNDhiYWI3NjY2ODQ0YTlkNjAyOGFfMTAzNw_f9ed6067-94b4-4dcd-8e69-51107a7b21d2"
      unitRef="number">0.54</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie397e48475d94899ad01bc3593897a72_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83Ni9mcmFnOjI0Mjg3MjExYTQ4ZDQ4YmFiNzY2Njg0NGE5ZDYwMjhhL3RleHRyZWdpb246MjQyODcyMTFhNDhkNDhiYWI3NjY2ODQ0YTlkNjAyOGFfMTEzOQ_728b8cb4-bec5-4b9b-9b88-45c6e3e996a5"
      unitRef="usd">10500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie397e48475d94899ad01bc3593897a72_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83Ni9mcmFnOjI0Mjg3MjExYTQ4ZDQ4YmFiNzY2Njg0NGE5ZDYwMjhhL3RleHRyZWdpb246MjQyODcyMTFhNDhkNDhiYWI3NjY2ODQ0YTlkNjAyOGFfMTE0Ng_aa1775ef-10ad-403c-9eb3-a27af349eb00"
      unitRef="number">0.40</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i37d450f4eec141f1aa6f1972f269f72d_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83Ni9mcmFnOjI0Mjg3MjExYTQ4ZDQ4YmFiNzY2Njg0NGE5ZDYwMjhhL3RleHRyZWdpb246MjQyODcyMTFhNDhkNDhiYWI3NjY2ODQ0YTlkNjAyOGFfMTE3Mg_3e7b4309-5903-4252-91cc-f8d9fd0c589d"
      unitRef="usd">32900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i37d450f4eec141f1aa6f1972f269f72d_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83Ni9mcmFnOjI0Mjg3MjExYTQ4ZDQ4YmFiNzY2Njg0NGE5ZDYwMjhhL3RleHRyZWdpb246MjQyODcyMTFhNDhkNDhiYWI3NjY2ODQ0YTlkNjAyOGFfMTE3OQ_fba683f8-4032-4b76-b99d-f4c1298531f5"
      unitRef="number">0.39</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9aa3f12a222e452b988bb807b5313e33_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83Ni9mcmFnOjI0Mjg3MjExYTQ4ZDQ4YmFiNzY2Njg0NGE5ZDYwMjhhL3RleHRyZWdpb246MjQyODcyMTFhNDhkNDhiYWI3NjY2ODQ0YTlkNjAyOGFfMTQyMA_6eeda073-0a70-459b-9d80-97f73a63064d"
      unitRef="usd">3900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i9aa3f12a222e452b988bb807b5313e33_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83Ni9mcmFnOjI0Mjg3MjExYTQ4ZDQ4YmFiNzY2Njg0NGE5ZDYwMjhhL3RleHRyZWdpb246MjQyODcyMTFhNDhkNDhiYWI3NjY2ODQ0YTlkNjAyOGFfMTQyNw_91bc5917-f2a6-4d87-9ef6-517b3c04b766"
      unitRef="number">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3d3e63bab0634cd1b9e1748d9bddf3cb_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83Ni9mcmFnOjI0Mjg3MjExYTQ4ZDQ4YmFiNzY2Njg0NGE5ZDYwMjhhL3RleHRyZWdpb246MjQyODcyMTFhNDhkNDhiYWI3NjY2ODQ0YTlkNjAyOGFfMTYxNg_a5014f6c-6ef1-4667-9f82-97a65fd0f47d"
      unitRef="usd">11400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i3d3e63bab0634cd1b9e1748d9bddf3cb_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83Ni9mcmFnOjI0Mjg3MjExYTQ4ZDQ4YmFiNzY2Njg0NGE5ZDYwMjhhL3RleHRyZWdpb246MjQyODcyMTFhNDhkNDhiYWI3NjY2ODQ0YTlkNjAyOGFfMTYyMw_151ffc18-4fdd-4480-bfc2-9066a8673235"
      unitRef="number">0.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83OS9mcmFnOmRkYzcyZThhYjBhMjRhNmM5MWMwMDc3MDEzYjBkYmM5L3RleHRyZWdpb246ZGRjNzJlOGFiMGEyNGE2YzkxYzAwNzcwMTNiMGRiYzlfNTgy_a8179f8c-0481-4ee4-8514-1a4bfa6bd7a1">Development Agreement &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective March 31, 2020, we signed an OEM Supply and Development Agreement (Development Agreement) with a customer. Under the Development Agreement, Fluidigm will develop products based on our microfluidics technology. The Development Agreement provides up-front and periodic milestone payments of up to $11.7&#160;million during the development stage. The development stage is expected to last approximately one year from the date of the agreement. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognized $3.2 million and $6.2&#160;million of development revenue from this agreement in the three and nine months ended September&#160;30, 2020, respectively.&lt;/span&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <fldm:UpFrontAndMilestonePaymentsMaximum
      contextRef="icc600eac6fe343ec8d22cf6dea665c5b_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83OS9mcmFnOmRkYzcyZThhYjBhMjRhNmM5MWMwMDc3MDEzYjBkYmM5L3RleHRyZWdpb246ZGRjNzJlOGFiMGEyNGE2YzkxYzAwNzcwMTNiMGRiYzlfMzM3_ca4fe1c0-816e-4fc5-9f09-c185346cadb8"
      unitRef="usd">11700000</fldm:UpFrontAndMilestonePaymentsMaximum>
    <fldm:CollaborativeArrangementTerm
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83OS9mcmFnOmRkYzcyZThhYjBhMjRhNmM5MWMwMDc3MDEzYjBkYmM5L3RleHRyZWdpb246ZGRjNzJlOGFiMGEyNGE2YzkxYzAwNzcwMTNiMGRiYzlfNDI2_375fbaa8-34e7-4a24-8d77-677bc9fe59c8">P1Y</fldm:CollaborativeArrangementTerm>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ied63bbfdfbdd4d17b689fb84bd615a22_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83OS9mcmFnOmRkYzcyZThhYjBhMjRhNmM5MWMwMDc3MDEzYjBkYmM5L3RleHRyZWdpb246ZGRjNzJlOGFiMGEyNGE2YzkxYzAwNzcwMTNiMGRiYzlfMTY0OTI2NzQ0MjI1Nw_b07523f0-9efc-45c2-8d72-208528d5a95c"
      unitRef="usd">3200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib7451c9afcd847cda97b00adbdae3f05_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF83OS9mcmFnOmRkYzcyZThhYjBhMjRhNmM5MWMwMDc3MDEzYjBkYmM5L3RleHRyZWdpb246ZGRjNzJlOGFiMGEyNGE2YzkxYzAwNzcwMTNiMGRiYzlfMTA5OTUxMTYyODYxMA_86c803d0-e108-495c-80e7-1fd3935b86c2"
      unitRef="usd">6200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF84Mi9mcmFnOjBmNmU3NWJmZGZkNjRmZjQ5Y2QwNjE2ZTMxYzk0YjUwL3RleHRyZWdpb246MGY2ZTc1YmZkZmQ2NGZmNDljZDA2MTZlMzFjOTRiNTBfMjE3Mg_8a992f8e-073c-4677-99eb-4d8722ec71de">Commitments and Contingencies&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Indemnification&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, we have entered into indemnification provisions under certain of our agreements in the ordinary course of business, typically with business partners, customers, and suppliers. Pursuant to these agreements, we may indemnify, hold harmless, and agree to reimburse the indemnified parties on a case-by-case basis for losses suffered or incurred by the indemnified parties in connection with any patent or other intellectual property infringement claim by any third party with respect to our products. The term of these indemnification provisions is generally perpetual from the time of the execution of the agreement. The maximum potential amount of future payments we could be required to make under these indemnification provisions is typically not limited to a specific amount. In addition, we have entered into indemnification agreements with our officers, directors, and certain other employees. With certain exceptions, these agreements provide for indemnification for related expenses including, among others, attorneys&#x2019; fees, judgments, fines and settlement amounts incurred by any of these individuals in any action or proceeding. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2020, a putative class action complaint alleging violations of the federal securities laws was filed against the Company (also naming our Chief Executive Officer and Chief Financial Officer as defendants) in the U.S. District Court for the Northern District of California. The complaint seeks unspecified damages on behalf of a purported class of persons and entities who acquired our common stock between February 7, 2019 and November 5, 2019. The litigation is in its early stages and the lead plaintiff has not yet been determined. We believe the claims alleged in the complaint lack merit and we intend to defend ourselves vigorously.&lt;/span&gt;&lt;/div&gt;From time to time, we may be subject to various legal proceedings and claims arising in the ordinary course of business. These include disputes and lawsuits related to intellectual property, mergers and acquisitions, licensing, contract law, tax, regulatory, distribution arrangements, employee relations and other matters. Periodically, we review the status of each matter and assess its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and a range of possible losses can be estimated, we accrue a liability for the estimated loss. Legal proceedings are subject to uncertainties, and the outcomes are difficult to predict. Because of such uncertainties, accruals are based only on the best information available at the time. As additional information becomes available, we continue to reassess the potential liability related to pending claims and litigation and may revise estimates.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978852726632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-34180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">FLUIDIGM CORP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">77-0513190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2 Tower Place, Ste 2000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">South San Francisco,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">266-6000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">FLDM<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,119,005<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001162194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978852138296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 72,345<span></span>
</td>
<td class="nump">$ 21,661<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">36,978<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable (net of allowances of $324 and $6, at September 30, 2020 and December&#160;31, 2019, respectively)</a></td>
<td class="nump">17,613<span></span>
</td>
<td class="nump">18,981<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ResearchAndDevelopmentArrangementReceivables', window );">Grant receivable</a></td>
<td class="nump">7,456<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">19,560<span></span>
</td>
<td class="nump">13,884<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">5,689<span></span>
</td>
<td class="nump">4,592<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">122,663<span></span>
</td>
<td class="nump">96,096<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">7,531<span></span>
</td>
<td class="nump">8,056<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset, net</a></td>
<td class="nump">38,469<span></span>
</td>
<td class="nump">4,860<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">4,904<span></span>
</td>
<td class="nump">5,492<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Developed technology, net</a></td>
<td class="nump">42,955<span></span>
</td>
<td class="nump">46,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">106,455<span></span>
</td>
<td class="nump">104,108<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">322,977<span></span>
</td>
<td class="nump">264,812<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">10,971<span></span>
</td>
<td class="nump">6,510<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and related benefits</a></td>
<td class="nump">9,122<span></span>
</td>
<td class="nump">5,160<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current</a></td>
<td class="nump">2,697<span></span>
</td>
<td class="nump">1,833<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">6,565<span></span>
</td>
<td class="nump">7,515<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue, current</a></td>
<td class="nump">13,436<span></span>
</td>
<td class="nump">11,803<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">42,791<span></span>
</td>
<td class="nump">32,821<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleLongTermNotesPayable', window );">Convertible notes, net</a></td>
<td class="nump">54,121<span></span>
</td>
<td class="nump">53,821<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability</a></td>
<td class="nump">9,041<span></span>
</td>
<td class="nump">11,494<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, non-current</a></td>
<td class="nump">38,607<span></span>
</td>
<td class="nump">4,323<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue, non-current</a></td>
<td class="nump">7,684<span></span>
</td>
<td class="nump">8,168<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_DeferredGrantRevenueNoncurrent', window );">Deferred grant income, non-current</a></td>
<td class="nump">18,224<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">536<span></span>
</td>
<td class="nump">573<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">171,004<span></span>
</td>
<td class="nump">111,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value, 10,000 shares authorized, no shares issued and outstanding at either September&#160;30, 2020 or December&#160;31, 2019</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock: $0.001 par value, 200,000 shares authorized at September&#160;30, 2020 and December&#160;31, 2019; 74,115 and 69,956 shares issued and outstanding at September&#160;30, 2020 and December&#160;31, 2019, respectively</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">70<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">810,923<span></span>
</td>
<td class="nump">777,765<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(289)<span></span>
</td>
<td class="num">(582)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(658,735)<span></span>
</td>
<td class="num">(623,641)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">151,973<span></span>
</td>
<td class="nump">153,612<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 322,977<span></span>
</td>
<td class="nump">$ 264,812<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_DeferredGrantRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Grant Revenue, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_DeferredGrantRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ResearchAndDevelopmentArrangementReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research and Development Arrangement, Receivables</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ResearchAndDevelopmentArrangementReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleLongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleLongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978852676680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, net of allowances</a></td>
<td class="nump">$ 324<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (shares)</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (shares)</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (shares)</a></td>
<td class="nump">74,115,000<span></span>
</td>
<td class="nump">69,956,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (shares)</a></td>
<td class="nump">74,115,000<span></span>
</td>
<td class="nump">69,956,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978932038264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 39,861<span></span>
</td>
<td class="nump">$ 26,496<span></span>
</td>
<td class="nump">$ 93,536<span></span>
</td>
<td class="nump">$ 84,803<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">8,128<span></span>
</td>
<td class="nump">7,125<span></span>
</td>
<td class="nump">25,275<span></span>
</td>
<td class="nump">23,362<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">22,655<span></span>
</td>
<td class="nump">20,729<span></span>
</td>
<td class="nump">65,966<span></span>
</td>
<td class="nump">65,687<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total costs and expenses</a></td>
<td class="nump">45,325<span></span>
</td>
<td class="nump">40,312<span></span>
</td>
<td class="nump">127,668<span></span>
</td>
<td class="nump">127,461<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(5,464)<span></span>
</td>
<td class="num">(13,816)<span></span>
</td>
<td class="num">(34,132)<span></span>
</td>
<td class="num">(42,658)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(885)<span></span>
</td>
<td class="num">(444)<span></span>
</td>
<td class="num">(2,682)<span></span>
</td>
<td class="num">(3,636)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss from extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(9,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">205<span></span>
</td>
<td class="num">(248)<span></span>
</td>
<td class="nump">920<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Loss before income taxes</a></td>
<td class="num">(6,242)<span></span>
</td>
<td class="num">(14,055)<span></span>
</td>
<td class="num">(37,062)<span></span>
</td>
<td class="num">(54,374)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="nump">243<span></span>
</td>
<td class="nump">1,168<span></span>
</td>
<td class="nump">2,068<span></span>
</td>
<td class="nump">2,269<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (5,999)<span></span>
</td>
<td class="num">$ (12,887)<span></span>
</td>
<td class="num">$ (34,994)<span></span>
</td>
<td class="num">$ (52,105)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share, basic and diluted (usd per share)</a></td>
<td class="num">$ (0.08)<span></span>
</td>
<td class="num">$ (0.19)<span></span>
</td>
<td class="num">$ (0.49)<span></span>
</td>
<td class="num">$ (0.79)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Shares used in computing net loss per share, basic and diluted (shares)</a></td>
<td class="nump">72,486<span></span>
</td>
<td class="nump">69,469<span></span>
</td>
<td class="nump">71,294<span></span>
</td>
<td class="nump">65,792<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 29,210<span></span>
</td>
<td class="nump">$ 20,666<span></span>
</td>
<td class="nump">$ 65,596<span></span>
</td>
<td class="nump">$ 68,728<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenue</a></td>
<td class="nump">12,773<span></span>
</td>
<td class="nump">10,520<span></span>
</td>
<td class="nump">31,896<span></span>
</td>
<td class="nump">33,009<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">6,131<span></span>
</td>
<td class="nump">5,630<span></span>
</td>
<td class="nump">16,457<span></span>
</td>
<td class="nump">15,875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenue</a></td>
<td class="nump">1,769<span></span>
</td>
<td class="nump">1,938<span></span>
</td>
<td class="nump">4,531<span></span>
</td>
<td class="nump">5,403<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=fldm_CollaborationRevenueMember', window );">Development revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">3,180<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,180<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 1,340<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 5,303<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=fldm_CollaborationRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=fldm_CollaborationRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978932061544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (5,999)<span></span>
</td>
<td class="num">$ (12,887)<span></span>
</td>
<td class="num">$ (34,994)<span></span>
</td>
<td class="num">$ (52,105)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">523<span></span>
</td>
<td class="num">(121)<span></span>
</td>
<td class="nump">329<span></span>
</td>
<td class="num">(122)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Net change in unrealized gain (loss) on investments</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">520<span></span>
</td>
<td class="num">(135)<span></span>
</td>
<td class="nump">293<span></span>
</td>
<td class="num">(71)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (5,479)<span></span>
</td>
<td class="num">$ (13,022)<span></span>
</td>
<td class="num">$ (34,701)<span></span>
</td>
<td class="num">$ (52,176)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978842775528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders' Equity - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th">
<div>Accumulated Deficit </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning Balance (shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,338<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Dec. 31, 2018</a></td>
<td class="nump">$ 72,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
<td class="nump">$ 631,605<span></span>
</td>
<td class="num">$ (687)<span></span>
</td>
<td class="num">$ (558,851)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Issuance of common stock on bond conversion (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of common stock on bond conversion</a></td>
<td class="nump">133,298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">133,279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of shares withheld for taxes, and other (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of shares withheld for taxes, and other</a></td>
<td class="num">(176)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">(177)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock from option exercises (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock from option exercises</a></td>
<td class="nump">255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">2,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(25,465)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25,465)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance (shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Mar. 31, 2019</a></td>
<td class="nump">182,245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
<td class="nump">767,169<span></span>
</td>
<td class="num">(677)<span></span>
</td>
<td class="num">(584,316)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning Balance (shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,338<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Dec. 31, 2018</a></td>
<td class="nump">72,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
<td class="nump">631,605<span></span>
</td>
<td class="num">(687)<span></span>
</td>
<td class="num">(558,851)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(52,105)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income, net of tax</a></td>
<td class="num">(71)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance (shares) at Sep. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Sep. 30, 2019</a></td>
<td class="nump">162,605<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70<span></span>
</td>
<td class="nump">774,249<span></span>
</td>
<td class="num">(758)<span></span>
</td>
<td class="num">(610,956)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning Balance (shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,338<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Dec. 31, 2018</a></td>
<td class="nump">$ 72,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
<td class="nump">631,605<span></span>
</td>
<td class="num">(687)<span></span>
</td>
<td class="num">(558,851)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance (shares) at Dec. 31, 2019</a></td>
<td class="nump">69,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Dec. 31, 2019</a></td>
<td class="nump">$ 153,612<span></span>
</td>
<td class="num">$ (100)<span></span>
</td>
<td class="nump">$ 70<span></span>
</td>
<td class="nump">777,765<span></span>
</td>
<td class="num">(582)<span></span>
</td>
<td class="num">(623,641)<span></span>
</td>
<td class="num">$ (100)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="text">us-gaap:AccountingStandardsUpdate201613Member<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning Balance (shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Mar. 31, 2019</a></td>
<td class="nump">$ 182,245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
<td class="nump">767,169<span></span>
</td>
<td class="num">(677)<span></span>
</td>
<td class="num">(584,316)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of shares withheld for taxes, and other (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of shares withheld for taxes, and other</a></td>
<td class="num">(325)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(325)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock from option exercises (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock from option exercises</a></td>
<td class="nump">793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under ESPP (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under ESPP</a></td>
<td class="nump">641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">2,985<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,985<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(13,753)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,753)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance (shares) at Jun. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Jun. 30, 2019</a></td>
<td class="nump">172,640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
<td class="nump">771,263<span></span>
</td>
<td class="num">(623)<span></span>
</td>
<td class="num">(598,069)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of shares withheld for taxes, and other (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of shares withheld for taxes, and other</a></td>
<td class="num">(69)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">(70)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock from option exercises (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock from option exercises</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">3,055<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,055<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(12,887)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,887)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income, net of tax</a></td>
<td class="num">(135)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(135)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance (shares) at Sep. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Sep. 30, 2019</a></td>
<td class="nump">$ 162,605<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70<span></span>
</td>
<td class="nump">774,249<span></span>
</td>
<td class="num">(758)<span></span>
</td>
<td class="num">(610,956)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning Balance (shares) at Dec. 31, 2019</a></td>
<td class="nump">69,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Dec. 31, 2019</a></td>
<td class="nump">$ 153,612<span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="nump">$ 70<span></span>
</td>
<td class="nump">777,765<span></span>
</td>
<td class="num">(582)<span></span>
</td>
<td class="num">(623,641)<span></span>
</td>
<td class="num">(100)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of shares withheld for taxes, and other (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of shares withheld for taxes, and other</a></td>
<td class="num">(146)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(146)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">2,364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Acquisition of InstruNor AS (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Acquisition of InstruNor AS</a></td>
<td class="nump">2,049<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">2,048<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(15,980)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,980)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income, net of tax</a></td>
<td class="num">(303)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(303)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance (shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Mar. 31, 2020</a></td>
<td class="nump">$ 141,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">782,031<span></span>
</td>
<td class="num">(885)<span></span>
</td>
<td class="num">(639,721)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning Balance (shares) at Dec. 31, 2019</a></td>
<td class="nump">69,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Dec. 31, 2019</a></td>
<td class="nump">$ 153,612<span></span>
</td>
<td class="num">$ (100)<span></span>
</td>
<td class="nump">$ 70<span></span>
</td>
<td class="nump">777,765<span></span>
</td>
<td class="num">(582)<span></span>
</td>
<td class="num">(623,641)<span></span>
</td>
<td class="num">$ (100)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock from option exercises (shares)</a></td>
<td class="nump">98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (34,994)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">$ 293<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance (shares) at Sep. 30, 2020</a></td>
<td class="nump">74,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Sep. 30, 2020</a></td>
<td class="nump">$ 151,973<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
<td class="nump">810,923<span></span>
</td>
<td class="num">(289)<span></span>
</td>
<td class="num">(658,735)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="text">us-gaap:AccountingStandardsUpdate201613Member<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning Balance (shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Mar. 31, 2020</a></td>
<td class="nump">$ 141,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">782,031<span></span>
</td>
<td class="num">(885)<span></span>
</td>
<td class="num">(639,721)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of shares withheld for taxes, and other (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of shares withheld for taxes, and other</a></td>
<td class="num">(116)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(116)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under ESPP (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under ESPP</a></td>
<td class="nump">645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">3,633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(13,015)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,015)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance (shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Jun. 30, 2020</a></td>
<td class="nump">132,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">786,193<span></span>
</td>
<td class="num">(809)<span></span>
</td>
<td class="num">(652,736)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of shares withheld for taxes, and other (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of shares withheld for taxes, and other</a></td>
<td class="num">(123)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">(124)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock from option exercises (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock from option exercises</a></td>
<td class="nump">450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock from at-the-market offering, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock from at-the-market offering, net of issuance costs</a></td>
<td class="nump">20,228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">20,226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Equity issuance costs</a></td>
<td class="num">(180)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(180)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">4,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(5,999)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,999)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">$ 520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance (shares) at Sep. 30, 2020</a></td>
<td class="nump">74,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Sep. 30, 2020</a></td>
<td class="nump">$ 151,973<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
<td class="nump">$ 810,923<span></span>
</td>
<td class="num">$ (289)<span></span>
</td>
<td class="num">$ (658,735)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 24: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978961876984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (34,994)<span></span>
</td>
<td class="num">$ (52,105)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">2,988<span></span>
</td>
<td class="nump">3,484<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">10,358<span></span>
</td>
<td class="nump">8,292<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of developed technology</a></td>
<td class="nump">8,929<span></span>
</td>
<td class="nump">8,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discounts, premiums and issuance costs</a></td>
<td class="nump">415<span></span>
</td>
<td class="nump">2,130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Lease amortization</a></td>
<td class="nump">1,863<span></span>
</td>
<td class="num">(371)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReservePeriodCharge', window );">Provision for excess and obsolete inventory</a></td>
<td class="nump">680<span></span>
</td>
<td class="nump">1,356<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on disposal of property and equipment</a></td>
<td class="nump">191<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other non-cash items</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">195<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="nump">967<span></span>
</td>
<td class="nump">3,195<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(6,773)<span></span>
</td>
<td class="num">(3,672)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(2,395)<span></span>
</td>
<td class="num">(1,338)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">4,996<span></span>
</td>
<td class="nump">605<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">1,258<span></span>
</td>
<td class="nump">1,592<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="num">(180)<span></span>
</td>
<td class="num">(10,506)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(11,684)<span></span>
</td>
<td class="num">(29,691)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition, net of cash acquired</a></td>
<td class="num">(5,154)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(52,719)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ProceedsFromResearchAndDevelopmentGrant', window );">Proceeds from RADx grant</a></td>
<td class="nump">11,151<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfOtherInvestments', window );">Proceeds from sale of investments</a></td>
<td class="nump">5,010<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments', window );">Proceeds from maturities of investments</a></td>
<td class="nump">31,800<span></span>
</td>
<td class="nump">16,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(2,010)<span></span>
</td>
<td class="num">(2,031)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">40,797<span></span>
</td>
<td class="num">(38,750)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock from at-the-market offering, net of commissions</a></td>
<td class="nump">20,226<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentOfFinancingAndStockIssuanceCosts', window );">Payment of debt and equity issuance costs</a></td>
<td class="num">(509)<span></span>
</td>
<td class="num">(128)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">450<span></span>
</td>
<td class="nump">1,049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans', window );">Proceeds from stock issuance from ESPP</a></td>
<td class="nump">645<span></span>
</td>
<td class="nump">641<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments for taxes related to net share settlement of equity awards and other</a></td>
<td class="num">(387)<span></span>
</td>
<td class="num">(556)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">20,425<span></span>
</td>
<td class="nump">1,006<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of foreign exchange rate fluctuations on cash and cash equivalents</a></td>
<td class="nump">86<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="nump">49,624<span></span>
</td>
<td class="num">(67,440)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">23,736<span></span>
</td>
<td class="nump">95,401<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">73,360<span></span>
</td>
<td class="nump">27,961<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">86<span></span>
</td>
<td class="nump">3,513<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes, net of refunds</a></td>
<td class="nump">386<span></span>
</td>
<td class="nump">128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_AssetRetirementObligationsIncurredButNotYetPaid', window );">Asset retirement obligations</a></td>
<td class="nump">$ 319<span></span>
</td>
<td class="nump">$ 311<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_AssetRetirementObligationsIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Retirement Obligations Incurred But Not Yet Paid</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_AssetRetirementObligationsIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ProceedsFromResearchAndDevelopmentGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Research and Development Grant</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ProceedsFromResearchAndDevelopmentGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAmortizationAndAccretionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAmortizationAndAccretionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReservePeriodCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e99989-122729<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReservePeriodCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentOfFinancingAndStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of the cash outflow during the period which has been paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt and the cost incurred directly for the issuance of equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentOfFinancingAndStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the maturity (principal being due), prepayment and call (request of early payment) of other investments not otherwise defined in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the sale of investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978939803128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Description of Business</a></td>
<td class="text">Description of BusinessFluidigm Corporation (the Company, Fluidigm, we, our or us) creates, manufactures, and markets technologies and tools for life sciences research, including preparatory and analytical instruments for Mass Cytometry, PCR, Library Prep, Single Cell Genomics, and consumables, including integrated fluidic circuits (IFC), assays, and reagents. Our focus is on the most pressing needs in translational and clinical research, including infectious disease, cancer, immunology and immunotherapy. We sell our instruments, consumables and services to academic institutions, clinical laboratories, and contract research organizations, as well as biopharmaceutical, biotechnology, and agricultural biotechnology companies. The Company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was founded in 1999 and is headquartered in South San Francisco, California.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978846591848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation and Consolidation</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (U.S. GAAP) and include the accounts of our wholly owned subsidiaries. As of September&#160;30, 2020, we had wholly owned subsidiaries in Singapore, Canada, the Netherlands, Japan, France, the United Kingdom, China, Germany and Norway. All subsidiaries, except for Singapore, use their local currency as their functional currency. The Singapore subsidiary uses the U.S. dollar as its functional currency. All intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period amounts in the condensed consolidated statements of income and condensed consolidated statements of cash flows were reclassified to conform with the current period presentation. These reclassifications were immaterial and did not affect prior period total assets, total liabilities, stockholders&#8217; equity, total revenue, total costs and expenses, loss from operations or net loss.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unaudited Interim Financial Information</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim condensed consolidated financial statements and related disclosures are unaudited, have been prepared on the same basis as the annual financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for a fair statement of the results of operations for the periods presented.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The year-end condensed consolidated balance sheet was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP.  The condensed consolidated results of operations for the nine months ended September 30, 2020 are not necessarily indicative of the results to be expected for the full year or for any other year or interim period. The accompanying condensed consolidated financial statements should be read in conjunction with the audited financial statements and the related notes for the year ended December 31, 2019 included in our annual report on Form 10-K, filed with the SEC on February 27, 2020.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with U.S.&#160;GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions believed to be reasonable, which together form the basis for making judgments about the carrying values of assets and liabilities. The full extent to which the COVID-19 pandemic impacts our business, results of operations and financial condition will depend on numerous evolving factors including, but not limited to, the magnitude and duration of the pandemic, the extent to which it will impact worldwide macroeconomic conditions, including the speed of recovery, and governmental and business reactions to the pandemic. We assessed certain accounting matters that generally require consideration of forecasted financial information in the context of information available to us and the unknown impact of COVID-19 as of September 30, 2020. These accounting matters included, but were not limited to, our allowance for doubtful accounts and credit losses, inventory and related reserves and the carrying value of goodwill and other long-lived assets. Actual results could differ materially from these estimates and could have a material adverse effect on our condensed consolidated financial statements.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities of non-U.S. subsidiaries that use the local currency as their functional currency are translated into U.S. dollars at exchange rates in effect on the balance sheet date. The adjustments resulting from the foreign currency translations are recorded in accumulated other comprehensive loss, a separate component of stockholders&#8217; equity. Income and expense accounts are translated at monthly average exchange rates during the year. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenue primarily from the sale of our products and services. Product revenue is derived from the sale of instruments and consumables, including IFCs, assays and reagents. Service revenue is derived from the sale of instrument service contracts, repairs, installation, training and other specialized product support services. We also generate revenue from development agreements, license and royalty agreements and grants. Revenue is reported net of any sales, use and value-added taxes we collect from customers as required by government authorities. Research and development cost includes costs associated with development and grant revenue. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue based on the amount of consideration we expect to receive in exchange for the goods and services we transfer to the customer. Our commercial arrangements typically include multiple distinct products and services, and we allocate revenue to these performance obligations based on their relative standalone selling prices. Standalone selling prices (SSP) are generally determined using observable data from recent transactions. In cases where sufficient data is not available, we estimate a product&#8217;s SSP using a cost plus a margin approach or by applying a discount to the product&#8217;s list price.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Revenue</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize product revenue at the point in time when control of the goods passes to the customer and we have an enforceable right to payment. This generally occurs either when the product is shipped from one of our facilities or when it arrives at the customer&#8217;s facility, based on the contractual terms. Customers generally do not have a unilateral right to return products after delivery. Invoices are generally issued at shipment and generally become due in 30 to 60 days.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sometimes perform shipping and handling activities after control of the product passes to the customer. We have made an accounting policy election to account for these activities as product fulfillment activities rather than as separate performance obligations.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service Revenue</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue from repairs, maintenance, installation, training and other specialized product support services at the point in time the work is completed. Installation and training services are generally billed in advance of service. Repairs and other services are generally billed at the point the work is completed. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue associated with instrument service contracts is recognized on a straight-line basis over the life of the agreement, which is generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfNTUwMg_166c41b6-37fc-4b8a-8206-665c77cdd303">one</span> to three years. We believe this time-elapsed approach is appropriate for service contracts because we provide services on demand throughout the term of the agreement. Invoices are generally issued in advance of service on a monthly, quarterly, annual or multi-year basis. Payments made in advance of service are reported on our condensed consolidated balance sheet as deferred revenue.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Development Revenue</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered and may continue to enter into development agreements with third parties that provide for up-front and periodic milestone payments. Our development agreements may include more than one performance obligation. At the inception of the contract, we assess whether each obligation represents a separate performance obligation or whether such obligations should be combined as a single performance obligation. The transaction price for each development agreement is determined based on the amount of consideration we expect to be entitled to for satisfying all performance obligations within the agreement. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. In arrangements where we satisfy performance obligation(s) over time, we recognize development revenue typically using an input method based on our costs incurred relative to the total expected cost which determines the extent of our progress toward completion. As part of the accounting for these arrangements, we must develop estimates and assumptions that require judgment to determine the transaction price and progress towards completion. We review our estimate of the transaction price and progress toward completion based on the best information available to recognize the cumulative progress toward completion as of the end of each reporting period, and make revisions to such estimates as necessary. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also generate revenue from development or collaboration agreements that do not include upfront or milestone-based payments and generally recognize revenue on these types of agreements based on the timing of development activities.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Revenue</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other revenue consists of license and royalty revenue and grant revenue. We recognize revenue from license agreements when the license is transferred to the customer and the customer is able to use and benefit from the license. For contracts that include sales-based royalties, we recognize revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, we entered into an agreement to settle intellectual property infringement claims, in which we received a $3.5 million payment in exchange for a perpetual license under certain Fluidigm intellectual property. The settlement is considered a multiple-element arrangement with each element accounted for individually. Accordingly, $3.1 million of the proceeds was recognized as license revenue and $0.4 million was offset against legal costs.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive grants from various entities to perform research and development activities over contractually defined periods. Revenue is generally recognized provided that the conditions under which the grants were provided have been met and any remaining performance obligations are perfunctory. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Costs</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incremental sales commission costs incurred to obtain instrument service contracts are capitalized and amortized to selling, general and administrative expense over the life of the contract, which is generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfOTE2Nw_1c099c37-d651-4eff-8b5d-06284641991e">one</span> to three years. As a practical expedient, we expense sales commissions associated with product support services that are delivered in less than one year as they are incurred. Sales commissions associated with the sale of products are expensed as they are incurred. To date, capitalized contract costs have been immaterial.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Warranties</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally provide a one-year warranty on our instruments. We accrue for estimated warranty obligations at the time of product shipment. We periodically review our warranty liability and record adjustments based on the terms of warranties provided to customers, and historical and anticipated warranty claim experience. This expense is recorded as a component of cost of product revenue in the condensed consolidated statements of operations.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Judgments</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Applying the revenue recognition practices discussed above often requires significant judgment. Judgment is required when identifying performance obligations, estimating SSP and allocating purchasing consideration in multi-element arrangements, determining the transaction price and progress towards completion on development arrangements and estimating the future amount of our warranty obligations. Moreover, significant judgment is required when interpreting commercial terms and determining when control of goods and services passes to the customer. Any material changes created by errors in judgment could have a material effect on our operating results and overall financial condition.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade accounts receivable are recorded at net invoice value. We review our exposure to accounts receivable and provide allowances of specific amounts if collectability is no longer reasonably assured based on historical experience and specific customer collection issues. We evaluate such allowances on a regular basis and adjust them as needed.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentrations of Business and Credit Risk</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to credit risk consist of cash, cash equivalents, investments, and accounts receivable. Our cash, cash equivalents, and investments may consist of deposits held with banks, money market funds, and other highly liquid investments that may at times exceed federally insured limits. Cash equivalents and investments are financial instruments that potentially subject us to concentrations of risk. Under our investment policy, we invest primarily in securities issued by the U.S. government. The goals of our investment policy, in order of priority, are as follows: preserve capital, meet liquidity needs, and optimize returns. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally do not require collateral to support credit sales. To reduce credit risk, we perform credit evaluations of our customers. One customer from whom we derived development revenue exceeded 10% of revenue for the three and nine months ended September&#160;30, 2020. No other customer represented more than 10% of total revenue for the three and nine months ended September&#160;30, 2020 or 2019. Including the development revenue, revenues from our five largest customers were 31% and 25% </span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of total revenue for the three months ended September&#160;30, 2020 and 2019, respectively. Revenues from our five largest customers were 23% and 20% of total revenue for the nine months ended September&#160;30, 2020 and 2019, respectively. There was no single customer that represented more than 10% of total accounts receivable at September&#160;30, 2020, or December&#160;31, 2019.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products include components that are currently procured from a single source or a limited number of sources. We believe that other vendors would be able to provide similar components; however, the qualification of such vendors may require start-up time. In order to mitigate any adverse impacts from a disruption of supply, we attempt to maintain an adequate supply of critical limited-source components.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if an arrangement is a lease, or contains a lease, at inception. Operating leases are included in operating lease right-of-use (ROU) assets and current and non-current operating lease liabilities in our condensed consolidated balance sheets. ROU assets represent our right-to-use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we generally use our incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. Significant judgment is required in determining the incremental collateralized borrowing rate. Lease expense for lease payments is recognized on a straight-line basis over the lease term.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We elected the short-term lease recognition exemption for all leases that qualify. For those leases that qualify, we will not recognize ROU assets or lease liabilities for leases with an initial lease term of one year or less. We also elected not to separate lease and nonlease components for our building leases. The nonlease components are generally variable in nature and are expected to represent most of our variable lease costs. Variable costs are expensed as incurred. We have taken a portfolio approach for our vehicle leases by country. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill, Intangible Assets and Other Long-Lived Assets</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill, which has an indefinite useful life, represents the excess of cost over fair value of net assets acquired. Our intangible assets include developed technology, patents and licenses. The cost of identifiable intangible assets with finite lives is generally amortized on a straight-line basis over the assets&#8217; respective estimated useful lives.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and intangible assets with indefinite lives are not subject to amortization but are tested for impairment on an annual basis during the fourth quarter or whenever events or changes in circumstances indicate the carrying amount of these assets may not be recoverable. Events or changes in circumstances that could affect the likelihood that we will be required to recognize an impairment charge include, but are not limited to, declines in our stock price or market capitalization, economic downturns and other macroeconomic events, including the current COVID-19 pandemic, declines in our market share or revenues, and an increase in our losses, rapid changes in technology, failure to achieve the benefits of capacity increases and utilization, significant litigation arising out of an acquisition, or other matters. Any impairment charges could have a material adverse effect on our operating results and net asset value in the quarter in which we recognize the impairment charge.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In evaluating our goodwill and intangible assets with indefinite lives for indications of impairment, we first conduct an assessment of qualitative factors to determine whether it is more likely than not that the fair value of our reporting unit is less than its carrying amount. If we determine that it is more likely than not that the fair value of our reporting unit is less than its carrying amount, we compare the fair value of our reporting unit to its carrying value. If the fair value of our reporting unit exceeds its carrying value, goodwill is not considered impaired and no further analysis is required. If the carrying value of the reporting unit exceeds its fair value, then an impairment loss equal to the difference would be recorded to goodwill. We did not recognize any impairment of goodwill for any of the periods presented herein.</span></div><div style="margin-bottom:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate our long-lived assets, including finite-lived intangibles, for indicators of possible impairment when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. If any indicator of impairment exists, we assess the recoverability of the affected long-lived assets by determining whether the carrying value of the asset can be recovered through undiscounted future operating cash flows. If impairment is indicated, we estimate the asset&#8217;s fair value using future discounted cash flows associated with the use of the asset and adjust the carrying value of the asset accordingly. We did not recognize any impairment of intangibles for any of the periods presented herein.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deferred Grant Income </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, we executed a definitive contract with the National Institutes of Health (NIH) for a project under the NIH Rapid Acceleration of Diagnostics (RADx) program. The definitive contract, which amended the letter contract we entered </span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">into with the NIH in July 2020 (collectively, the NIH Contract), has a total value of up to $34.0&#160;million upon the achievement of certain conditional milestones. Proceeds from the NIH Contract will be used primarily to expand production capacity and product throughput capabilities.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting for the NIH Contract does not fall under ASC 606, Revenue from Contracts with Customers, as the NIH will not benefit directly from our expansion or product development.  As there is no authoritative guidance under U.S. GAAP on accounting for government assistance to for-profit business entities, we applied International Accounting Standards (IAS) 20, Accounting for Government Grants and Disclosure of Government Assistance, by analogy when accounting for the NIH Contract payments to Fluidigm. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The NIH Contract proceeds meet the definition of grants related to assets as the primary condition for the payments is to fund the purchase and construction of longer-term assets to scale up production capacity. Under IAS 20, government grants related to assets are presented in the statement of financial position either by setting up the grant as deferred income or by deducting the grant in arriving at the carrying amount of the asset. Either of these two methods of presentation of grants related to assets in financial statements are regarded as acceptable alternatives under IAS 20. We have elected to record the grants received as deferred income using the first method.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under IAS 20, grant proceeds are recognized when there is reasonable assurance the conditions of the grant will be met and the grant will be received.  With the NIH Contract, this occurs when either each milestone has been accepted by NIH or management concludes the conditions of the grant have been substantially met.  We record the NIH Contract proceeds as deferred income.  Proceeds used for capital expenditures will be amortized over the period of depreciation for the assets as a reduction of depreciation expense.  Any portion of the proceeds used to reimburse research and development expense are recorded as a reduction of those expenses incurred to date. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Convertible Notes</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2014, we closed an underwritten public offering of $201.3 million aggregate principal amount of our 2.75% Senior Convertible Notes due 2034 (2014 Notes). In March 2018, we entered into separate privately negotiated transactions with certain holders of our 2014 Notes to exchange $150.0 million in aggregate principal amount of the 2014 Notes for our 2.75% Exchange Convertible Senior Notes due 2034 (2018 Notes). As the 2018 Notes were convertible, at our election, into cash, shares of our common stock, or a combination of cash and shares of our common stock, we accounted for the 2018 Notes under the cash conversion guidance in ASC 470, whereby the embedded conversion option in the 2018 Notes was separated and accounted for in equity. In the first quarter of 2019, the 2018 Notes were converted into 19.5 million shares of our common stock and the 2018 Notes were retired. We recorded a loss of $9.0 million on the retirement of the 2018 Notes. We determined the fair value of the 2018 Notes&#160;using valuation techniques that required us to make assumptions related to the implied discount rate.&#160;</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, we closed a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of $55.0 million aggregate principal amount of our 5.25% Senior Convertible Notes due 2024 (2019 Notes). Most of the issuance proceeds were used to retire approximately $50.2 million of aggregate principal amount of our 2014 Notes, leaving approximately $1.1 million of aggregate principal amount of our 2014 Notes outstanding. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the 2019 Notes do not provide for a cash conversion feature, the 2019 Notes are recorded as debt in their entirety in accordance with ASC 470. For the 2014, 2018 and 2019 Notes, offering-related costs, including underwriting costs, were capitalized as debt issuance costs, recorded as an offset to the carrying value of the related Notes, and are amortized over the expected term of the related Notes using the effective interest method.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 8 for a detailed discussion of the accounting treatment of the transactions and additional information.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comprehensive Loss </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive loss is comprised of net loss and other comprehensive income (loss). Other comprehensive income (loss) consists of unrealized gains and losses on our investments and foreign currency translation adjustments. Total comprehensive loss for all periods presented has been disclosed in the condensed consolidated statements of comprehensive loss.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of accumulated other comprehensive loss, net of tax, for the three and nine months ended September&#160;30, 2020 are as follows (in thousands): </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Investments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(618)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(582)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance at March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(921)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(885)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance at June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(812)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(809)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(289)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(289)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immaterial amounts of unrealized gains and losses have been reclassified into the condensed consolidated statement of operations for the three and nine months ended September&#160;30, 2020 and 2019.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Loss per Share </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our basic and diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding for the period. Restricted stock units, performance share units, and stock options to purchase our common stock are considered to be potentially dilutive common shares but have been excluded from the calculation of diluted net loss per share as their effect is anti-dilutive for all periods presented.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following potentially dilutive common shares were excluded from the computations of diluted net loss per share for the periods presented because including them would have been anti-dilutive (in thousands):  </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options, restricted stock units and performance awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,652&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,342&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Convertible Notes potential make-whole shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2014 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">916&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,463&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,258&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Changes and Accounting Pronouncements</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adoption of New Accounting Guidance </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the U.S.-based Financial&#160;Accounting Standards&#160;Board (FASB) issued Accounting Standards Update (ASU) 2018-15-Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40), which establishes new guidance on the accounting for costs incurred to implement a cloud computing arrangement that is considered a service arrangement. The new guidance requires the capitalization of such costs, aligning it with the accounting for costs associated with developing or obtaining internal-use software. The new guidance is effective for fiscal years beginning after December 15, 2019. The adoption of the new guidance did not have a significant impact on our financial results.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2017, the FASB issued ASU 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The ASU eliminates the requirement for an entity to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, an entity performs its annual, or interim, goodwill impairment testing by comparing the fair value of a reporting unit with its carrying amount and recording an impairment charge for the amount by which the carrying amount exceeds the fair value. The ASU is effective for annual and interim goodwill impairment testing performed for our fiscal year beginning January 1, 2020. The adoption of the new guidance did not have a significant impact on our financial results.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FASB issued two ASUs related to financial instruments &#8211; credit losses. The ASUs issued were: (1) in June 2016, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQzNjc_09dd10ab-4bd6-4959-a108-786ca8b4f9e5">ASU 2016-13, Financial Instruments-Credit Losses (Topic 326)</span>: Measurement of Credit Losses on Financial Instruments, and (2) in November 2018, ASU 2018-19-Codification Improvements to Topic 326, Financial Instruments-Credit Losses. ASU 2016-13 is intended to improve financial reporting by requiring more timely recording of credit losses on loans and other financial </span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">instruments held by financial institutions and other organizations. ASU 2018-19 clarifies that receivables arising from operating leases are not within the scope of the credit losses standard, but rather, should be accounted for in accordance with the lease standard. These ASUs are effective for fiscal years beginning after December 15, 2019, and interim periods within those years, with early adoption permitted. The modified retrospective method is required upon adoption. The adoption of the new guidance resulted in an adjustment of approximately $0.1 million to reduce the accumulated deficit component of stockholders&#8217; equity and decrease current assets by the same amount in our condensed consolidated balance sheet.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06 Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity. The amendment to this ASU reduces the number of accounting models for convertible instruments and allows more contracts to qualify for equity classification, which is expected to result in more convertible instruments being accounted for as a single unit, rather than being bifurcated between debt and equity. The new guidance is effective for fiscal years beginning after December 15, 2021. We are currently evaluating the impact of adoption on our condensed consolidated financial statements.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, the FASB issued ASU 2019-12-Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The amendments in this update improve consistent application of and simplify U.S. GAAP for Topic 740 by clarifying and amending existing guidance for, among other items, intra-period allocation, reporting tax law changes and losses in interim periods, state and local taxes not fully based on income and recognition of deferred tax liability related to certain transactions. There is also new guidance related to consolidated group reporting and tax impacts resulting from business combinations. The new guidance is effective for fiscal years beginning after December 15, 2020. We are currently evaluating the impact of adoption on our condensed consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978846633912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combination</a></td>
<td class="text">Business Combination<div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 17, 2020, we completed the acquisition of all of the outstanding shares of InstruNor AS, a privately held Norwegian company (InstruNor). </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">InstruNor is a provider of the only fully integrated sample preparation system for flow and mass cytometry. The acquisition of InstruNor supports our entry into the sample preparation market for cytometry analysis and expands our capabilities to include fully automated sample preparation for flow and mass cytometry. The value of this technology is reflected in the intangible asset for developed technology. The developed technology was valued using a discounted cash flow model for which the most sensitive assumption was revenue growth rate.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purchase price of $7.2 million included approximately $5.2 million in cash and 485,451 shares of our common stock valued at the closing price on the effective date of $4.22. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the net cash flows is summarized below (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:85.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 17, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash consideration paid to former equity holders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,165&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: cash and cash equivalents acquired</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition of InstruNor, net of cash acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,154&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition was accounted for in accordance with ASC 805, Business Combinations. The assets acquired and liabilities assumed were recorded at their estimated fair values at the InstruNor acquisition date. Goodwill of $2.2 million was calculated as the purchase price less the fair value of the net assets acquired as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:85.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 17, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase price:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash consideration paid on closing to former equity holders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash consideration common shares </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,214&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets acquired:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of identifiable net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,994&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired on acquisition</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,220&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978848089672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RADx Program<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock', window );">RADx Program</a></td>
<td class="text">RADx Program<div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">In July 2020, we entered into a letter contract with the National Institutes of Health (NIH) for a project under the NIH Rapid Acceleration of Diagnostics (RADx) program. The RADx program provides grants to support a range of new lab-based and point-of-care tests that could significantly increase the number, type and availability of COVID-19 tests. On September 28, 2020, we executed a definitive contract with the NIH as an amendment to the letter contract (collectively, the NIH Contract). The NIH Contract has a total value of up to $34.0&#160;million upon the achievement of certain conditional milestones. Proceeds from the NIH Contract will be used primarily to expand production capacity and product throughput capabilities for COVID-19 testing with Fluidigm microfluidics technology. We expect to complete the NIH Contract by the end of 2021.</span></div><div style="margin-bottom:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">The NIH has the right to terminate the NIH Contract for convenience.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">In the event of termination for convenience, Fluidigm will be paid a percentage of the NIH Contract price reflecting the percentage of the work performed prior to the notice of termination, plus reasonable charges. In the event of termination for cause due to our default, NIH is not liable for supplies or services not accepted. </span></div><div style="margin-bottom:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">If we fail to deliver within the time specified in the NIH Contract and the delay is due to Fluidigm&#8217;s fault or negligence, we are required to pay liquidated damages in the amount of 33% of the amount(s) already disbursed to date under the NIH Contract within six months from the date of termination.</span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity under the NIH Contract through September&#160;30, 2020 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:15pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.993%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total value of milestones reasonably assured</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts applied against research and development expenses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred grant income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,224&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total value of milestones reasonably assured </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funding received</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,151&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant receivable from RADx</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,456&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 730<br> -URI http://asc.fasb.org/subtopic&amp;trid=2197926<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978846633336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue</a></td>
<td class="text">Revenue<div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our revenue for the three and nine months ended September&#160;30, 2020 and 2019, respectively, based on geographic area and by source (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.169%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.039%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographic Markets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,653&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,609&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,861&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,496&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,536&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,803&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.040%"/><td style="width:0.1%"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Source:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,210&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,666&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,596&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,728&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;License and royalty revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Grant revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Total other revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,340&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,303&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,861&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,496&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,536&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,803&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Performance Obligations</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We reported $20.0 million of deferred revenue in our December&#160;31, 2019 consolidated balance sheet. During the nine months ended September&#160;30, 2020, $8.8 million of the opening balance was recognized as revenue and $9.9 million of net additional advance payments were received from customers, primarily associated with instrument service contracts. At September&#160;30, 2020, we reported $21.1 million of deferred revenue. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the expected timing of revenue recognition for unfulfilled performance obligations associated with instrument service contracts that were partially completed at September&#160;30, 2020 (in thousands): </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.798%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.165%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expected Revenue </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 (remainder of the year)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,873&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,385&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,079&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,112&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______</span></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected revenue includes both billed amounts included in deferred revenue and unbilled amounts that are not reflected in our condensed consolidated financial statements and are subject to change if our customers decide to cancel or modify their contracts. Purchase orders for instrument service contracts can generally be canceled before the service period begins without penalty.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply the practical expedient that permits us not to disclose information about unsatisfied performance obligations for service contracts with an expected term of one year or less.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978846704776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, net<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets, net</a></td>
<td class="text">Goodwill and Intangible Assets, net<div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our acquisition of DVS Sciences, Inc. in February 2014, we recognized goodwill of $104.1 million and $112.0 million of developed technology. In the first quarter of 2020, we recognized $2.2 million (Euro 2.0 million) of goodwill from the InstruNor acquisition and $5.4 million (Euro 4.9 million) of developed technology (see Note 3). As the goodwill and developed technology from the InstruNor acquisition are recorded in the functional currency of our European operations, which is the Euro, these balances are revalued each period and the U.S. dollar value of these assets will fluctuate as foreign exchange rates change. We are amortizing InstruNor developed technology over 8.0 years. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and intangible assets with indefinite lives are not subject to amortization but are tested for impairment on an annual basis during the fourth quarter or whenever events or changes in circumstances indicate the carrying amount of these assets may not be recoverable. Qualitative assessment includes assessing significant events and circumstances such as our current results, assumptions regarding future performance, strategic initiatives and overall economic factors, including the ongoing global COVID-19 pandemic and macroeconomic developments to determine the existence of potential indicators of impairment and assess if it is more likely than not that the fair value of our reporting unit or intangible assets is less than their carrying value. If indicators of impairment are identified, a quantitative impairment test is performed.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of fiscal 2020, the Company assessed whether the current and potential future impact of the COVID-19 pandemic represented an event which necessitated an impairment review.&#160;This assessment included an update of the qualitative and quantitative factors affecting our business. As a result of this assessment, we determined that a triggering event had occurred and a quantitative impairment test was performed. As a result of this quantitative analysis, we determined that the fair values of our goodwill and developed technology intangibles were not less than their carrying values and no impairment was recognized.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets also include other patents and licenses, which are included in other non-current assets. Intangible assets, net, were as follows (in thousands): </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.020%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization and Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Amortization Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,380&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,425)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,955&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and licenses</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,274&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,030)</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,244&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8 years</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.020%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization and Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Amortization Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,800)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and licenses</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,274&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,342)</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,932&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8 years</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total amortization expense for the three months ended September&#160;30, 2020 and 2019 was $3.2 million and $3.0 million, respectively. Amortization of intangibles was $9.6 million and $9.2 million for the nine months ended September&#160;30, 2020 and 2019, respectively.  </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the carrying value of intangible assets, net,&#160;as of&#160;September&#160;30, 2020, the amortization expense is expected to be as follows (in thousands): </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.971%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Technology Amortization Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Patents and Licenses Amortization Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 (remainder of the year)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,978&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,207&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,671&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,482&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,955&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,244&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,199&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978848110024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Balance Sheet Details</a></td>
<td class="text">Balance Sheet Details<div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash, Cash Equivalents and Restricted Cash </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents and restricted cash consisted of the following as of September&#160;30, 2020 and December&#160;31, 2019 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.329%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.973%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.976%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,345&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,075&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,360&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,736&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term restricted cash of approximately $15 thousand is included in prepaid expenses and other current assets and $1.0 million of non-current restricted cash is included in other non-current assets in the condensed consolidated balance sheet as of September&#160;30, 2020. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consisted of the following as of September&#160;30, 2020 and December&#160;31, 2019 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.329%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.973%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.976%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,768&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,133&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,560&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,884&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment, net </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following as of September&#160;30, 2020 and December&#160;31, 2019 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.329%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.973%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.976%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,363&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,997&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory and manufacturing equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,988&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,788&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,680&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,934&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,262)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,954)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction-in-progress</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,531&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,056&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Warranties</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity for our warranty accrual for the nine months ended September&#160;30, 2020&#160;and 2019, which is included in other accrued liabilities, is summarized below (in thousands): </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.329%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.973%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.976%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,390&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrual for current period warranties</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty costs incurred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(387)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(668)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,680&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,107&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI http://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978846321512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Notes and Credit Facility<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Convertible Notes and Credit Facility</a></td>
<td class="text">Convertible Notes and Credit Facility<div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2014 Senior Convertible Notes (2014 Notes)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2014, we closed an underwritten public offering of $201.3 million aggregate principal amount of our 2014 Notes. We received $195.2 million, net of underwriting discounts, from the issuance of the 2014 Notes and incurred approximately $1.1 million in offering-related expenses. The underwriting discount and offering-related expenses are being amortized to interest expense using the effective-interest rate method. The effective interest rate on the 2014 Notes, reflecting the impact of debt discounts and issuance costs, is 3.0%. The 2014 Notes will mature on February 1, 2034, unless earlier converted, redeemed, or repurchased in accordance with the terms of the 2014 Notes. We have retired the majority of the 2014 Notes through the issuance of the 2018 Notes and 2019 Notes, as discussed below. As of September&#160;30, 2020, there is $1.1 million aggregate principal of the 2014 Notes outstanding. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2018 Senior Convertible Notes (2018 Notes)</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2018, we entered into separate privately negotiated transactions with certain holders of our 2014 Notes to exchange $150.0 million in aggregate principal amount of the 2014 Notes for 2018 Notes, leaving $51.3 million of the aggregate principal amount of the 2014 Notes outstanding. As of the closing of the 2018 Notes on March 12, 2018, the estimated fair value was $145.5 million. The difference between the $150.0 million aggregate principal amount of the 2018 Notes and its fair value was being amortized over the expected term of the 2018 Notes using the effective interest method through the first note holder put date of February 6, 2023. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Notes accrued interest at a rate of 2.75% payable semi-annually in arrears on February 1 and August 1 of each year. The 2018 Notes were set to mature on February 1, 2034, unless earlier converted, redeemed, or repurchased in accordance with the terms of the indenture governing the 2018 Notes. The initial conversion rate of the 2018 Notes was 126.9438 shares of our common stock, par value $0.001 per share, per $1,000 principal amount of the 2018 Notes (which is equivalent to an initial conversion price of approximately $7.88 per share). The conversion rate was subject to adjustment upon the occurrence of certain specified events. Those certain specified events included holders who converted their 2018 Notes voluntarily prior to our exercise of the issuer&#8217;s conversion option described below or in connection with a make-whole fundamental change prior to February 6, 2023, entitling the holders, under certain circumstances, to a make-whole premium in the form of an increase in the conversion rate determined by reference to a make-whole table set forth in the indenture governing the 2018 Notes. Any time </span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prior to the maturity of the 2018 Notes, we could convert the 2018 Notes, in whole but not in part, into cash, shares of our common stock, or combination thereof, if the closing price of our common stock equaled or exceeded 110% of the conversion price then in effect for a specified number of days. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Offering-related costs for the 2018 Notes were approximately $2.8 million. Offering-related costs of $2.2 million were capitalized as debt issuance costs, recorded as an offset to the carrying value of the 2018 Notes, and were being amortized over the expected term of the 2018 Notes using the effective interest method through the first note holder put date of February 6, 2023. The effective interest rate on the 2018 Notes was 12.3%. Offering-related costs of $0.6 million were accounted for as equity issuance costs, recorded as an offset to additional paid-in capital, and were not subject to amortization. Offering-related costs were allocated between debt and equity in the same proportion as the allocation of the 2018 Notes between debt and equity. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2019, we received notices from holders of the 2018 Notes electing to voluntarily convert approximately $138.1 million in aggregate principal amount of the 2018 Notes. In February 2019, we notified the trustee, U.S. Bank National Association, of our intention to exercise our issuer&#8217;s conversion option with respect to the remaining approximately $11.9 million in aggregate principal amount of the 2018 Notes. In total, $150.0 million of the 2018 Notes were converted into 19.5 million shares of our common stock and the bonds were retired. We recognized a loss of $9.0 million on the retirement of the 2018 Notes, which represented the difference between the fair value of the bonds retired and their carrying costs. The net impact on equity was $133.3 million and represented the fair value of the bonds retired.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2019 Senior Convertible Notes (2019 Notes)</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, we issued $55.0 million aggregate principal amount of 2019 Notes. Net proceeds of the offering of the 2019 Notes issuance were $52.7 million, after deductions for commissions and other debt issuance costs of approximately $2.3 million. $51.8 million of the proceeds of the 2019 Notes were used to retire $50.2 million aggregate principal amount of our 2014 Notes, leaving $1.1 million of aggregate principal value of  2014 Notes outstanding. We accounted for the transaction as an extinguishment of debt due to the significance of the change in value of the embedded conversion option, resulting in a $3.0 million loss in the fourth quarter of 2019. The loss on extinguishment of debt was calculated as the difference between the reacquisition price (i.e., the fair value of the principal amount of 2019 Notes) and the net carrying value of the 2014 Notes exchanged. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2019 Notes bear interest at 5.25% per annum, payable semiannually in arrears on June 1 and December 1 of each year, beginning on June 1, 2020. The Notes will mature on December 1, 2024, unless earlier repurchased or converted pursuant to their terms. The 2019 Notes will be convertible at the option of the holder at any point prior to the close of business on the second scheduled trading day preceding the maturity date. The initial conversion rate of the Notes is 344.8276 shares of the Company&#8217;s common stock per $1,000 principal amount of 2019 Notes (which is equivalent to an initial conversion price of approximately $2.90 per share). The conversion rate is subject to adjustment upon the occurrence of certain specified events. Those certain specified events include voluntary conversion of the 2019 Notes prior to our exercise of the Issuer&#8217;s Conversion Option or in connection with a make-whole fundamental change, entitling the holders, under certain circumstances, to a make-whole premium in the form of an increase in the conversion rate determined by reference to a make-whole table set forth in the indenture governing the 2019 Notes. The conversion rate will not be adjusted for any accrued and unpaid interest. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2019 Notes will also be convertible at our option upon certain conditions in accordance with the terms of the indenture governing the 2019 Notes. On or after December 1, 2021 to December 1, 2022, if the price of the Company&#8217;s common stock has equaled or exceeded 150% of the conversion price then in effect for a specified number of days (Issuer&#8217;s Conversion Option), we may, at our option, elect to convert the 2019 Notes in whole but not in part into shares of the Company, determined in accordance with the terms of the indenture. On or after December 1, 2022, if the price of the Company&#8217;s common stock has equaled or exceeded 130% of the conversion price then in effect for a specified number of days, we may, at our option, elect to convert the 2019 Notes in whole but not in part into shares of the Company, determined in accordance with the terms of the indenture. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Offering-related costs for the 2019 Notes were capitalized as debt issuance costs and are recorded as an offset to the carrying value of the 2019 Notes. The debt issuance costs are being amortized over the expected term of the 2019 Notes using the effective interest method through the maturity date of December 1, 2024. The effective interest rate on the 2019 Notes is 6.2%.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of the components of the 2014 Notes and the 2019 Notes are as follows (in thousands): </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.329%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.973%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.976%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;2.75% 2014 Notes due 2034   </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,079&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,079&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt discount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,058&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,057&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;5.25% 2019 Notes due 2024</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,937)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,236)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,063&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,764&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Net carrying value of all Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,121&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,821&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2018 Revolving Credit Facility </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, we entered into a revolving credit facility with Silicon Valley Bank (as amended, the Revolving Credit Facility) in an aggregate principal amount of up to the lesser of (i) $15.0 million (Maximum Amount) or (ii) the sum of (a) 85% of our eligible receivables and (b) 50% of our eligible inventory, in each case, subject to certain limitations (Borrowing Base), provided that the amount of eligible inventory that may be counted towards the Borrowing Base shall be subject to a cap as set forth in the Revolving Credit Facility. Subject to the level of this Borrowing Base, we may make and repay borrowings from time to time until the maturity of the Revolving Credit Facility. The Borrowing Base as of September&#160;30, 2020 under the Revolving Credit Facility was $15.0 million. There were no borrowings outstanding under the Revolving Credit Facility at September&#160;30, 2020.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Credit Facility is collateralized by substantially all our property, other than intellectual property. Until an amendment in April 2020, the Revolving Credit Facility was set to mature on August 2, 2020. The interest rate on outstanding loans under the Revolving Credit Facility was the greater of (i) prime rate plus 0.50% or (ii) 5.50%. Interest on any outstanding loans is due and payable monthly and the principal balance is due at maturity, though loans can be prepaid at any time without penalty. Effective April 21, 2020, the Revolving Credit Facility was amended to extend the maturity date to August 2, 2022. In addition, the interest rate on outstanding loans under the Revolving Credit Facility was reduced by 0.25%. The quarterly unused line fee, which was previously based on the Maximum Amount, will now be based on the Borrowing Base. The annual commitment fee of $112,500 is unchanged.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Credit Facility contains customary affirmative and negative covenants that, unless waived by the bank, limit our ability to, among other things, incur additional indebtedness, grant liens, make investments, repurchase stock, pay dividends, transfer assets, enter into affiliate transactions, undergo a change of control, or engage in merger and acquisition activity, including merging or consolidating with a third party. The Revolving Credit Facility also contains customary events of default, subject to customary cure periods for certain defaults, that include, among other things, non-payment defaults, covenant defaults, material judgment defaults, bankruptcy and insolvency defaults, cross-defaults to certain other material indebtedness, and defaults due to inaccuracy of representation and warranties. Upon an event of default, the lender may declare all or a portion of the outstanding obligations payable by us to be immediately due and payable and exercise other rights and remedies provided for under the Revolving Credit Facility. During the existence of an event of default, interest on the obligations under the Revolving Credit Facility could be increased to&#160;5.0% above the otherwise applicable rate of interest. We were in compliance with all the terms and conditions of the Revolving Credit Facility at September&#160;30, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978848659864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have operating leases for buildings, equipment and vehicles. Existing leases have remaining terms of less than one year to ten years. Some leases contain options to extend the lease, usually for up to five years, and termination options.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows as of September&#160;30, 2020 and December&#160;31, 2019 (in thousands, except for discount rate and lease term):</span></div><div style="margin-bottom:5pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use buildings</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,723</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,234</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use equipment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use vehicles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease right-of-use assets, gross</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,392</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,658</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,923)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,798)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease right-of-use assets, net</span></td><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,469</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,860</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,697</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,833</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, non-current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,607</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,323</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,304</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,156</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate per annum</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A new operating lease for our corporate headquarters in South San Francisco, California commenced in March 2020.  We recorded a ROU asset of $35.7 million at the inception of the lease and an operating lease liability of $35.3 million. The lease term is approximately ten years. Future minimum lease payments over the life of the lease were discounted at a rate of 12.6%, which was our estimated incremental collateralized borrowing rate for the term of the lease at the inception of the lease. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of lease expense for the three and nine months ended September&#160;30, 2020 and 2019, respectively (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost (including variable costs)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,501&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,604&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,012&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,660&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable costs including non-lease component</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,576&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,051&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental Cash Flow Information:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of operating lease liabilities (included in net cash used in operating activities in thousands):</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 0.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,443&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,068&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under commenced non-cancelable operating leases, which are as of September&#160;30, 2020 as follows (in thousands): </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.328%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Minimum Lease Payments for Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 (remainder of year)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,802&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,362&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,950&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,254&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum payments </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,256)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978846624056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value of Financial Instruments</a></td>
<td class="text">Fair Value of Financial Instruments<div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize our cash and available-for-sale securities that were measured at fair value by significant investment category within the fair value hierarchy (in thousands): </span></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.828%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gain</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-Term Marketable Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash- Restricted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash-unrestricted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash-restricted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Total cash</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,159&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,159&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,144&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,015&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Level I:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,360&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,360&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,345&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,015&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gain</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-Term Marketable Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash- Restricted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash-unrestricted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash-restricted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Total cash</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,689&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,689&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,614&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,075&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Level I:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,047&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,047&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,047&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;US treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,942&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,978&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,978&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subtotal</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,989&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,025&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,047&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,978&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,678&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,714&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,661&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,978&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,075&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers between Level I and Level II measurements, and no changes in the valuation techniques used, during the nine months ended&#160;September&#160;30, 2020.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on an evaluation of securities that were in a loss position, we did not recognize any other-than-temporary impairment charges for the nine months ended September&#160;30, 2020 and 2019. None of our investments have been in a continuous loss position for more than 12 months. We concluded that the declines in market value of our available-for-sale securities investment portfolio were temporary in nature and did not consider any of our investments to be other-than-temporarily impaired. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Notes</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, we significantly reduced the amount of our outstanding debt. As a result, our convertible notes are not regularly traded and it is difficult to estimate a reliable and accurate market price for these securities. The estimated fair values for these securities represent Level III valuations since a fair value for these securities cannot be determined by using readily observable inputs or measures, such as market prices. Fair values were estimated using pricing models and risk-adjusted value ranges. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the par value, carrying value and the estimated fair value of the 2014 and 2019 Notes at September&#160;30, 2020 and December&#160;31, 2019, respectively (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.680%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2014 Notes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,079&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,058&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,079&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,057&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,039&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,079&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,121&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,161&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,079&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,821&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,097&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978848448712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Shareholders' Equity</a></td>
<td class="text">Shareholders&#8217; Equity<div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2020 At-the-Market Offering </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, we entered into an Open Market Sale Agreement (Sale Agreement) with Jefferies LLC (Jefferies) to sell shares of our common stock having aggregate sales proceeds of up to $50,000,000, from time to time, through an &#8220;at-the-market&#8221; equity offering program under which Jefferies acts as sales agent. During the third quarter of 2020, we sold 2.5 million shares of our common stock pursuant to the Sale Agreement, for aggregate gross proceeds of $20.9 million. Our net proceeds from the sale of such shares of common stock were approximately $20.1 million, after deducting related expenses, including commissions of approximately $0.6 million and issuance costs of approximately $0.2 million. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">InstruNor Acquisition</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, we completed the acquisition of all of the outstanding shares of InstruNor (see Note 3). The purchase price was approximately $7.2 million, consisting of $5.2 million in cash and 485,451 shares of our common stock.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conversion of 2018 Notes</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2019, we issued 19,460,260 shares of our common stock in connection with the conversion of our 2018 Notes (see Note 8). As a result of this issuance of our common stock, we recorded a total of $133.3 million of equity, which was equivalent to the fair value of the bonds retired.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020, we had reserved shares of common stock for future issuance under equity compensation plans as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in 000's)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Securities To Be Issued Upon Exercise Of Options </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number Of Remaining Securities Available For Future Issuance </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2009 Equity Incentive Plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2011 Equity Incentive Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DVS Sciences Inc. 2010 Equity Incentive Plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2017 Inducement Award Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2017 Employee Stock Purchase Plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,626&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,026&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,157&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978848063992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Plans<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Plans</a></td>
<td class="text">Stock-Based Plans<div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors sets the terms, conditions, and restrictions related to our 2017 Employee Stock Purchase Plan (ESPP) and the grant of stock options, restricted stock units (RSUs) and performance-based awards under our equity incentive plans. Our board of directors determines the number of awards to grant and also sets vesting criteria. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, RSUs vest on a quarterly basis over a period of four years from the date of grant at a rate of either 25% on the first anniversary of the grant date and ratably each quarter over the remaining 12 quarters, or ratably each quarter over 16 quarters, subject to the employees&#8217; continued employment. In May 2020, we granted 1.8 million retention RSUs that vest over three years, with 50% of the RSUs vesting after one year and 25% of the RSUs vesting each year thereafter. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incentive stock options and non-statutory stock options granted under our 2011 Equity Incentive Plan (2011 Plan) have a term of no more than ten years from the date of grant and an exercise price of at least 100% of the fair market value of the underlying common stock on the date of grant. If a participant owns stock representing more than 10% of the voting power of all classes of our stock on the grant date, an incentive stock option awarded to the participant will have a term of no more than five years from the date of grant and an exercise price of at least 110% of the fair market value of the underlying common stock on the date of grant. Generally, options vest at a rate of either 25% on the first anniversary of the option grant date and ratably each month over the remaining period of 36 months, or ratably each month over 48 months. We may grant options with different vesting terms from time to time. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For performance-based share awards, our board of directors sets the performance objectives and other vesting provisions in determining the number of shares or value of performance units and performance shares that will be paid out. Such payout will be a function of the extent to which performance objectives or other vesting provisions have been achieved.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2011 Equity Incentive Plan</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January&#160;2011, our board of directors adopted the 2011 Plan under which incentive stock options, non-statutory stock options, RSUs, stock appreciation rights, performance stock units (PSUs), and performance shares may be granted to our employees, directors, and consultants. In April 2019, our board of directors authorized, and in June 2019, our stockholders approved an amendment and restatement of the 2011 Plan to make various changes, including increasing the number of shares reserved for issuance by approximately 5.0 million shares and extending the term of the 2011 Plan until April 2029. In May 2020, our board of directors authorized, and in June 2020, our stockholders approved an increase in the number of shares reserved for issuance under the 2011 Plan of 1.4 million shares. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2009 Equity Incentive Plan and 2017 Inducement Award Plan </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our 2009 Equity Incentive Plan (the 2009 Plan) terminated on the date the 2011 Plan was adopted. Options granted, or shares issued under the 2009 Plan that were outstanding on the date the 2011 Plan became effective, remained subject to the terms of the 2009 Plan. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2017, we adopted the Fluidigm Corporation 2017 Inducement Award Plan (Inducement Plan) and reserved 2 million shares of our common stock for issuance pursuant to equity awards granted under the Inducement Plan. The Inducement Plan provided for the grant of equity-based awards on terms substantially similar to the 2011 Plan. In accordance with Rule 5635(c)(4) of the Nasdaq Listing Rules, awards under the Inducement Plan were only be made to individuals not previously our </span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">employees or non-employee members of our board of directors (or following such individual&#8217;s bona fide period of non-employment), as an inducement material to the individual&#8217;s entry into employment with us or in connection with a merger or acquisition, to the extent permitted by Rule 5635(c)(3) of the Nasdaq Listing Rules. In June 2019, concurrently with the increase in shares available for grant under the 2011 Plan, the Inducement Plan was terminated such that no further grants could be made thereunder. Options granted and shares issued under the Inducement Plan that were outstanding when the Inducement Plan was terminated remain outstanding subject to their terms and the terms of the Inducement Plan.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Valuation and Expense Information</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the Black-Scholes option-pricing model to estimate the fair value of stock options granted under our equity incentive plans. We grant stock options at exercise prices not less than the fair value of our common stock at the date of grant. The fair value of RSUs granted to employees was estimated on the date of grant by multiplying the number of shares granted by the fair market value of our common stock on the grant date. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity under the various plans was as follows:</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.397%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.423%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Units (in 000s)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant Date Fair Value per Unit</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,551&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU released</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(872)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(305)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,016&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, the unrecognized compensation costs related to outstanding unvested RSUs under our equity incentive plans were $22.0 million. We expect to recognize those costs over a weighted average period of 2.8 years.</span></div><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">: </span></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of <br/>Options (000s)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Exercise Price<br/>per Option</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average Remaining Contractual Life (in Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intrinsic </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> in (000s)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,027&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.78&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(408)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,626&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,259&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Awards expected to vest at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______</span></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Aggregate intrinsic value as of September&#160;30, 2020 was calculated as the difference between the closing price per share of our common stock on the last trading day of September&#160;30, 2020, which was $7.43, and the exercise price of the options, multiplied by the number of in-the-money options. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, the unrecognized compensation costs related to outstanding unvested options under our equity incentive plans were $1.1 million. We expect to recognize those costs over a weighted average period of 1.4 years. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance-based Awards</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance Stock Units with Market Conditions</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have granted PSU awards to certain executive officers and senior level employees. The number of PSUs ultimately earned under these awards is calculated based on the Total Shareholder Return (TSR) of our common stock as compared to the TSR of a defined group of peer companies during the applicable three-year performance period. The percentage of PSUs that vest will depend on our relative position at the end of the performance period and can range from 0% to 200% of the number of units granted. Under FASB ASC Topic 718, the provisions of the PSU awards related to TSR are considered a market </span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">condition, and the effects of that market condition are reflected in the grant date fair value of the awards. We used a Monte Carlo simulation pricing model to incorporate the market condition effects at our grant date. </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity under the TSR-based PSUs is as follows: </span></div><div style="margin-bottom:5pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.397%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.423%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Units (in 000s)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant Date Fair Value per Unit</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.09&#160;</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU released</span></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bfe4ff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">962&#160;</span></td><td style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bfe4ff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.74&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of&#160;September&#160;30, 2020, the unrecognized compensation costs related to these awards were $4.6 million. We expect to recognize those costs over a weighted average period of 1.7 years.</span></div><div style="margin-bottom:8pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance Stock Units with Performance Conditions</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2019, we also granted a PSU award under which the number of PSUs that ultimately vest is dependent on achieving certain discrete operational milestones between September 30, 2019 and December 31, 2020. Activity to date under this PSU award is as follows:</span></div><div style="margin-bottom:5pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.397%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.423%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Units (in 000s)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant Date Fair Value per Unit</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.05&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU released</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2017 Employee Stock Purchase Plan</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2017, our stockholders approved our ESPP at the annual meeting of stockholders. Our ESPP offers U.S. and some non-U.S. employees the right to purchase shares of our common stock. Our first ESPP offering period began on October 1, 2017 with a shorter offering period ending on November 30, 2017. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to June 2019, our ESPP program had a six-month offering period, with a new period commencing on the first trading day on or after May 31 and November 30 of each year. Employees were eligible to participate through payroll deductions of up to 10% of their compensation. The purchase price at which shares were sold under the ESPP was 85% of the lower of the fair market value of a share of our common stock on the first day of the offering period or the last day of the offering period. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective in June 2019, our ESPP program was amended to offer a twelve-month offering period with two six-month purchase periods beginning on each of May 31 and November 30. Employees were eligible under the amended program to participate through payroll deductions of up to 15% of their compensation. Employees may not purchase more than $25 thousand of stock for any calendar year. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the updated ESPP program, the purchase price at which shares are sold for the first purchase period is 85% of the lower of the fair market value of a share of our common stock on the first day of the offering period or the last day of the first purchase period. For the second purchase period, the purchase price at which shares are sold is 85% of the lower of the fair market value of the common stock on the first day of the offering period and the last day of the offering period. In the event the fair market value of the common stock at the beginning of the second purchase period is less than the fair market value on the beginning of the offering period, the purchase price for the second offering period is reset to 85% of the lower of the fair value of the common stock at the beginning of the second purchase period and the last day of the offering period.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The offering period of June 1, 2019 to May 31, 2020 had two purchase periods, with one period ending November 30, 2019 and the other period ending May 31, 2020. As the fair market value of the common stock at November 30, 2019 was lower than the fair value of the common stock at the beginning of the offering period, the purchase price for the second purchase period was reset based on the lower of the November 30, 2019 price and the May 31, 2020 price. The resetting of the purchase price is considered to be a modification of the original terms of the award. Under ASC 718, the incremental fair value based on the </span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">difference between the fair value of the modified award and the fair value of the original award immediately before it was modified was approximately $0.3 million. This amount was amortized over the remaining offering period which ended May 31, 2020. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, our board of directors authorized, and in June 2020, our stockholders approved, an amendment and restatement of the ESPP that increased the number of shares reserved for issuance by an additional 3.0 million shares and made various other changes. Effective June 2020, our ESPP program was amended to offer a six-month offering period, with a new offering and purchase period commencing on the first trading day on or after May 31 and November 30 of each year. Employees are eligible under the amended program to participate through payroll deductions of up to 10% of their compensation. Employees may not purchase more than $25 thousand of stock for any calendar year. The purchase price of the shares sold under the ESPP is 85% of the lower of fair market value of a share of our common stock on the first day of the offering period or the last day of the offering period.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense recognized was as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.655%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.202%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units, stock options and performance share units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,738&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,558&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,731&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,357&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,029&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,358&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,292&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978846596856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our quarterly provision for income taxes is based on an estimated effective annual income tax rate. Our quarterly provision for income taxes also includes the tax impact of certain unusual or infrequently occurring items, if any, including changes in judgment about valuation allowances and effects of changes in tax laws or rates, in the interim period in which they occur.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded a tax benefit of $0.2 million and $2.1 million for the three and nine months ended September&#160;30, 2020, respectively. We recorded a tax benefit of $1.2 million and $2.3 million for the three and nine months ended September&#160;30, 2019, respectively. The benefits for all periods were primarily attributable to the tax benefit from the amortization of our acquisition-related deferred tax liabilities partially offset by tax provisions for our foreign operations and state minimum income taxes. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our tax benefit for income taxes for the periods presented differ from the 21% U.S. Federal statutory rate for the nine months ended September&#160;30, 2020 and 2019, respectively, primarily due to maintaining a valuation allowance for most of our deferred tax assets, which primarily consist of net operating loss carryforwards. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our tax positions are subject to audits by multiple tax jurisdictions. We believe that we have provided adequate reserves for uncertain tax positions for all tax years still open for assessment. For the three and nine months ended September&#160;30, 2020,&#160;and 2019, respectively, we did&#160;not recognize any material interest or penalties related to uncertain tax positions.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recording deferred tax assets is appropriate when realization of these assets is more likely than not. Assessing the realizability of deferred tax assets is dependent upon several factors including historical financial results and future expected financial results. The deferred tax assets have been offset by valuation allowances. In the future we may release valuation allowances and recognize deferred tax assets in certain of our foreign subsidiaries depending on the achievement of future profitability in the relevant jurisdictions. Any release of valuation allowances could have the effect of decreasing the income tax provision in the period the valuation allowance is released. We continue to monitor the likelihood that we will be able to recover our deferred tax assets, including those for which a valuation allowance is recorded. There can be no assurance that we will generate profits in the future periods enabling us to fully realize our deferred tax assets. The timing of recording a valuation allowance or the reversal of such valuation allowance is subject to objective and subjective factors that cannot be readily predicted in advance.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the Coronavirus Aid, Relief and Economic Security (CARES) Act was signed into law. The CARES Act includes provisions relating to refundable payroll tax credits, net operating loss carryback periods, alternative minimum tax credit refunds, modifications to the net interest deduction limitations and technical corrections to the tax deprecation methods for qualified improvement property. We are currently analyzing the impact of these changes and therefore, an estimate of the impact on income taxes, if any, is not yet available.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978846579976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Information About Geographic Areas<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Information About Geographic Areas</a></td>
<td class="text">Information About Geographic Areas<div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in one reporting segment that develops, manufacturers and commercializes tools for life sciences research. Our chief executive officer manages our operations and evaluates our financial performance on a consolidated basis. For purposes of allocating resources and evaluating regional financial performance, our chief executive officer reviews separate sales information for the different regions of the world. Our general and administrative expenses and our research and development expenses are not allocated to any specific region. Most of our principal operations, other than manufacturing, and our decision-making functions are located at our corporate headquarters in the United States.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary table of our total revenue by geographic areas of our customers and by product and services for the three and nine months ended September&#160;30, 2020 and 2019 is included in Note 5 to the condensed consolidated financial statements. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales to customers in the United States represented $23.3 million, or 58% of total revenues, and $50.7 million, or 54% of total revenues, for the three and nine months ended September&#160;30, 2020, respectively. Sales to customers in the United States represented $10.5 million, or 40% of total revenues, and $32.9 million, or 39% of total revenues, for the three and nine months ended September&#160;30, 2019, respectively. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No foreign country or jurisdiction had sales in excess of 10% of total revenues for the three months ended September&#160;30, 2020 and 2019, except for China, which had total revenues of $3.9 million, or 15% of total revenues for the three months ended September&#160;30, 2019. There was no foreign country or jurisdiction with sales in excess of 10% of our total revenues for the nine months ended September&#160;30, 2020 or 2019, except for China, which had sales of $11.4 million, or 13% of total revenues, for the nine months ended September&#160;30, 2019.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978848068136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Development Agreement<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Development Agreement</a></td>
<td class="text">Development Agreement <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective March 31, 2020, we signed an OEM Supply and Development Agreement (Development Agreement) with a customer. Under the Development Agreement, Fluidigm will develop products based on our microfluidics technology. The Development Agreement provides up-front and periodic milestone payments of up to $11.7&#160;million during the development stage. The development stage is expected to last approximately one year from the date of the agreement. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized $3.2 million and $6.2&#160;million of development revenue from this agreement in the three and nine months ended September&#160;30, 2020, respectively.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -URI http://asc.fasb.org/topic&amp;trid=5833765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978846431368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Indemnification</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we have entered into indemnification provisions under certain of our agreements in the ordinary course of business, typically with business partners, customers, and suppliers. Pursuant to these agreements, we may indemnify, hold harmless, and agree to reimburse the indemnified parties on a case-by-case basis for losses suffered or incurred by the indemnified parties in connection with any patent or other intellectual property infringement claim by any third party with respect to our products. The term of these indemnification provisions is generally perpetual from the time of the execution of the agreement. The maximum potential amount of future payments we could be required to make under these indemnification provisions is typically not limited to a specific amount. In addition, we have entered into indemnification agreements with our officers, directors, and certain other employees. With certain exceptions, these agreements provide for indemnification for related expenses including, among others, attorneys&#8217; fees, judgments, fines and settlement amounts incurred by any of these individuals in any action or proceeding. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, a putative class action complaint alleging violations of the federal securities laws was filed against the Company (also naming our Chief Executive Officer and Chief Financial Officer as defendants) in the U.S. District Court for the Northern District of California. The complaint seeks unspecified damages on behalf of a purported class of persons and entities who acquired our common stock between February 7, 2019 and November 5, 2019. The litigation is in its early stages and the lead plaintiff has not yet been determined. We believe the claims alleged in the complaint lack merit and we intend to defend ourselves vigorously.</span></div>From time to time, we may be subject to various legal proceedings and claims arising in the ordinary course of business. These include disputes and lawsuits related to intellectual property, mergers and acquisitions, licensing, contract law, tax, regulatory, distribution arrangements, employee relations and other matters. Periodically, we review the status of each matter and assess its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and a range of possible losses can be estimated, we accrue a liability for the estimated loss. Legal proceedings are subject to uncertainties, and the outcomes are difficult to predict. Because of such uncertainties, accruals are based only on the best information available at the time. As additional information becomes available, we continue to reassess the potential liability related to pending claims and litigation and may revise estimates.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978852465992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation and Consolidation</a></td>
<td class="text">The accompanying consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (U.S. GAAP) and include the accounts of our wholly owned subsidiaries. As of September&#160;30, 2020, we had wholly owned subsidiaries in Singapore, Canada, the Netherlands, Japan, France, the United Kingdom, China, Germany and Norway. All subsidiaries, except for Singapore, use their local currency as their functional currency. The Singapore subsidiary uses the U.S. dollar as its functional currency. All intercompany transactions and balances have been eliminated in consolidation.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text">Certain prior period amounts in the condensed consolidated statements of income and condensed consolidated statements of cash flows were reclassified to conform with the current period presentation. These reclassifications were immaterial and did not affect prior period total assets, total liabilities, stockholders&#8217; equity, total revenue, total costs and expenses, loss from operations or net loss.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with U.S.&#160;GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions believed to be reasonable, which together form the basis for making judgments about the carrying values of assets and liabilities. The full extent to which the COVID-19 pandemic impacts our business, results of operations and financial condition will depend on numerous evolving factors including, but not limited to, the magnitude and duration of the pandemic, the extent to which it will impact worldwide macroeconomic conditions, including the speed of recovery, and governmental and business reactions to the pandemic. We assessed certain accounting matters that generally require consideration of forecasted financial information in the context of information available to us and the unknown impact of COVID-19 as of September 30, 2020. These accounting matters included, but were not limited to, our allowance for doubtful accounts and credit losses, inventory and related reserves and the carrying value of goodwill and other long-lived assets. Actual results could differ materially from these estimates and could have a material adverse effect on our condensed consolidated financial statements.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency</a></td>
<td class="text">Foreign CurrencyAssets and liabilities of non-U.S. subsidiaries that use the local currency as their functional currency are translated into U.S. dollars at exchange rates in effect on the balance sheet date. The adjustments resulting from the foreign currency translations are recorded in accumulated other comprehensive loss, a separate component of stockholders&#8217; equity. Income and expense accounts are translated at monthly average exchange rates during the year.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenue primarily from the sale of our products and services. Product revenue is derived from the sale of instruments and consumables, including IFCs, assays and reagents. Service revenue is derived from the sale of instrument service contracts, repairs, installation, training and other specialized product support services. We also generate revenue from development agreements, license and royalty agreements and grants. Revenue is reported net of any sales, use and value-added taxes we collect from customers as required by government authorities. Research and development cost includes costs associated with development and grant revenue. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue based on the amount of consideration we expect to receive in exchange for the goods and services we transfer to the customer. Our commercial arrangements typically include multiple distinct products and services, and we allocate revenue to these performance obligations based on their relative standalone selling prices. Standalone selling prices (SSP) are generally determined using observable data from recent transactions. In cases where sufficient data is not available, we estimate a product&#8217;s SSP using a cost plus a margin approach or by applying a discount to the product&#8217;s list price.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Revenue</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize product revenue at the point in time when control of the goods passes to the customer and we have an enforceable right to payment. This generally occurs either when the product is shipped from one of our facilities or when it arrives at the customer&#8217;s facility, based on the contractual terms. Customers generally do not have a unilateral right to return products after delivery. Invoices are generally issued at shipment and generally become due in 30 to 60 days.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sometimes perform shipping and handling activities after control of the product passes to the customer. We have made an accounting policy election to account for these activities as product fulfillment activities rather than as separate performance obligations.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service Revenue</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue from repairs, maintenance, installation, training and other specialized product support services at the point in time the work is completed. Installation and training services are generally billed in advance of service. Repairs and other services are generally billed at the point the work is completed. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue associated with instrument service contracts is recognized on a straight-line basis over the life of the agreement, which is generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfNTUwMg_166c41b6-37fc-4b8a-8206-665c77cdd303">one</span> to three years. We believe this time-elapsed approach is appropriate for service contracts because we provide services on demand throughout the term of the agreement. Invoices are generally issued in advance of service on a monthly, quarterly, annual or multi-year basis. Payments made in advance of service are reported on our condensed consolidated balance sheet as deferred revenue.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Development Revenue</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered and may continue to enter into development agreements with third parties that provide for up-front and periodic milestone payments. Our development agreements may include more than one performance obligation. At the inception of the contract, we assess whether each obligation represents a separate performance obligation or whether such obligations should be combined as a single performance obligation. The transaction price for each development agreement is determined based on the amount of consideration we expect to be entitled to for satisfying all performance obligations within the agreement. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. In arrangements where we satisfy performance obligation(s) over time, we recognize development revenue typically using an input method based on our costs incurred relative to the total expected cost which determines the extent of our progress toward completion. As part of the accounting for these arrangements, we must develop estimates and assumptions that require judgment to determine the transaction price and progress towards completion. We review our estimate of the transaction price and progress toward completion based on the best information available to recognize the cumulative progress toward completion as of the end of each reporting period, and make revisions to such estimates as necessary. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also generate revenue from development or collaboration agreements that do not include upfront or milestone-based payments and generally recognize revenue on these types of agreements based on the timing of development activities.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Revenue</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other revenue consists of license and royalty revenue and grant revenue. We recognize revenue from license agreements when the license is transferred to the customer and the customer is able to use and benefit from the license. For contracts that include sales-based royalties, we recognize revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, we entered into an agreement to settle intellectual property infringement claims, in which we received a $3.5 million payment in exchange for a perpetual license under certain Fluidigm intellectual property. The settlement is considered a multiple-element arrangement with each element accounted for individually. Accordingly, $3.1 million of the proceeds was recognized as license revenue and $0.4 million was offset against legal costs.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive grants from various entities to perform research and development activities over contractually defined periods. Revenue is generally recognized provided that the conditions under which the grants were provided have been met and any remaining performance obligations are perfunctory. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Costs</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incremental sales commission costs incurred to obtain instrument service contracts are capitalized and amortized to selling, general and administrative expense over the life of the contract, which is generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfOTE2Nw_1c099c37-d651-4eff-8b5d-06284641991e">one</span> to three years. As a practical expedient, we expense sales commissions associated with product support services that are delivered in less than one year as they are incurred. Sales commissions associated with the sale of products are expensed as they are incurred. To date, capitalized contract costs have been immaterial.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Warranties</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally provide a one-year warranty on our instruments. We accrue for estimated warranty obligations at the time of product shipment. We periodically review our warranty liability and record adjustments based on the terms of warranties provided to customers, and historical and anticipated warranty claim experience. This expense is recorded as a component of cost of product revenue in the condensed consolidated statements of operations.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Judgments</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Applying the revenue recognition practices discussed above often requires significant judgment. Judgment is required when identifying performance obligations, estimating SSP and allocating purchasing consideration in multi-element arrangements, determining the transaction price and progress towards completion on development arrangements and estimating the future amount of our warranty obligations. Moreover, significant judgment is required when interpreting commercial terms and determining when control of goods and services passes to the customer. Any material changes created by errors in judgment could have a material effect on our operating results and overall financial condition.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade accounts receivable are recorded at net invoice value. We review our exposure to accounts receivable and provide allowances of specific amounts if collectability is no longer reasonably assured based on historical experience and specific customer collection issues. We evaluate such allowances on a regular basis and adjust them as needed.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Business and Credit Risk</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentrations of Business and Credit Risk</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to credit risk consist of cash, cash equivalents, investments, and accounts receivable. Our cash, cash equivalents, and investments may consist of deposits held with banks, money market funds, and other highly liquid investments that may at times exceed federally insured limits. Cash equivalents and investments are financial instruments that potentially subject us to concentrations of risk. Under our investment policy, we invest primarily in securities issued by the U.S. government. The goals of our investment policy, in order of priority, are as follows: preserve capital, meet liquidity needs, and optimize returns. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally do not require collateral to support credit sales. To reduce credit risk, we perform credit evaluations of our customers. One customer from whom we derived development revenue exceeded 10% of revenue for the three and nine months ended September&#160;30, 2020. No other customer represented more than 10% of total revenue for the three and nine months ended September&#160;30, 2020 or 2019. Including the development revenue, revenues from our five largest customers were 31% and 25% </span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of total revenue for the three months ended September&#160;30, 2020 and 2019, respectively. Revenues from our five largest customers were 23% and 20% of total revenue for the nine months ended September&#160;30, 2020 and 2019, respectively. There was no single customer that represented more than 10% of total accounts receivable at September&#160;30, 2020, or December&#160;31, 2019.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products include components that are currently procured from a single source or a limited number of sources. We believe that other vendors would be able to provide similar components; however, the qualification of such vendors may require start-up time. In order to mitigate any adverse impacts from a disruption of supply, we attempt to maintain an adequate supply of critical limited-source components.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if an arrangement is a lease, or contains a lease, at inception. Operating leases are included in operating lease right-of-use (ROU) assets and current and non-current operating lease liabilities in our condensed consolidated balance sheets. ROU assets represent our right-to-use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we generally use our incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. Significant judgment is required in determining the incremental collateralized borrowing rate. Lease expense for lease payments is recognized on a straight-line basis over the lease term.</span></div>We elected the short-term lease recognition exemption for all leases that qualify. For those leases that qualify, we will not recognize ROU assets or lease liabilities for leases with an initial lease term of one year or less. We also elected not to separate lease and nonlease components for our building leases. The nonlease components are generally variable in nature and are expected to represent most of our variable lease costs. Variable costs are expensed as incurred. We have taken a portfolio approach for our vehicle leases by country.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill, Intangible Assets and Other Long-Lived Assets</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill, Intangible Assets and Other Long-Lived Assets</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill, which has an indefinite useful life, represents the excess of cost over fair value of net assets acquired. Our intangible assets include developed technology, patents and licenses. The cost of identifiable intangible assets with finite lives is generally amortized on a straight-line basis over the assets&#8217; respective estimated useful lives.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and intangible assets with indefinite lives are not subject to amortization but are tested for impairment on an annual basis during the fourth quarter or whenever events or changes in circumstances indicate the carrying amount of these assets may not be recoverable. Events or changes in circumstances that could affect the likelihood that we will be required to recognize an impairment charge include, but are not limited to, declines in our stock price or market capitalization, economic downturns and other macroeconomic events, including the current COVID-19 pandemic, declines in our market share or revenues, and an increase in our losses, rapid changes in technology, failure to achieve the benefits of capacity increases and utilization, significant litigation arising out of an acquisition, or other matters. Any impairment charges could have a material adverse effect on our operating results and net asset value in the quarter in which we recognize the impairment charge.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In evaluating our goodwill and intangible assets with indefinite lives for indications of impairment, we first conduct an assessment of qualitative factors to determine whether it is more likely than not that the fair value of our reporting unit is less than its carrying amount. If we determine that it is more likely than not that the fair value of our reporting unit is less than its carrying amount, we compare the fair value of our reporting unit to its carrying value. If the fair value of our reporting unit exceeds its carrying value, goodwill is not considered impaired and no further analysis is required. If the carrying value of the reporting unit exceeds its fair value, then an impairment loss equal to the difference would be recorded to goodwill. We did not recognize any impairment of goodwill for any of the periods presented herein.</span></div><div style="margin-bottom:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate our long-lived assets, including finite-lived intangibles, for indicators of possible impairment when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. If any indicator of impairment exists, we assess the recoverability of the affected long-lived assets by determining whether the carrying value of the asset can be recovered through undiscounted future operating cash flows. If impairment is indicated, we estimate the asset&#8217;s fair value using future discounted cash flows associated with the use of the asset and adjust the carrying value of the asset accordingly. We did not recognize any impairment of intangibles for any of the periods presented herein.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deferred Grant Income </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, we executed a definitive contract with the National Institutes of Health (NIH) for a project under the NIH Rapid Acceleration of Diagnostics (RADx) program. The definitive contract, which amended the letter contract we entered </span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">into with the NIH in July 2020 (collectively, the NIH Contract), has a total value of up to $34.0&#160;million upon the achievement of certain conditional milestones. Proceeds from the NIH Contract will be used primarily to expand production capacity and product throughput capabilities.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting for the NIH Contract does not fall under ASC 606, Revenue from Contracts with Customers, as the NIH will not benefit directly from our expansion or product development.  As there is no authoritative guidance under U.S. GAAP on accounting for government assistance to for-profit business entities, we applied International Accounting Standards (IAS) 20, Accounting for Government Grants and Disclosure of Government Assistance, by analogy when accounting for the NIH Contract payments to Fluidigm. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The NIH Contract proceeds meet the definition of grants related to assets as the primary condition for the payments is to fund the purchase and construction of longer-term assets to scale up production capacity. Under IAS 20, government grants related to assets are presented in the statement of financial position either by setting up the grant as deferred income or by deducting the grant in arriving at the carrying amount of the asset. Either of these two methods of presentation of grants related to assets in financial statements are regarded as acceptable alternatives under IAS 20. We have elected to record the grants received as deferred income using the first method.</span></div>Under IAS 20, grant proceeds are recognized when there is reasonable assurance the conditions of the grant will be met and the grant will be received.  With the NIH Contract, this occurs when either each milestone has been accepted by NIH or management concludes the conditions of the grant have been substantially met.  We record the NIH Contract proceeds as deferred income.  Proceeds used for capital expenditures will be amortized over the period of depreciation for the assets as a reduction of depreciation expense.  Any portion of the proceeds used to reimburse research and development expense are recorded as a reduction of those expenses incurred to date.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtPolicyTextBlock', window );">Convertible Notes</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Convertible Notes</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2014, we closed an underwritten public offering of $201.3 million aggregate principal amount of our 2.75% Senior Convertible Notes due 2034 (2014 Notes). In March 2018, we entered into separate privately negotiated transactions with certain holders of our 2014 Notes to exchange $150.0 million in aggregate principal amount of the 2014 Notes for our 2.75% Exchange Convertible Senior Notes due 2034 (2018 Notes). As the 2018 Notes were convertible, at our election, into cash, shares of our common stock, or a combination of cash and shares of our common stock, we accounted for the 2018 Notes under the cash conversion guidance in ASC 470, whereby the embedded conversion option in the 2018 Notes was separated and accounted for in equity. In the first quarter of 2019, the 2018 Notes were converted into 19.5 million shares of our common stock and the 2018 Notes were retired. We recorded a loss of $9.0 million on the retirement of the 2018 Notes. We determined the fair value of the 2018 Notes&#160;using valuation techniques that required us to make assumptions related to the implied discount rate.&#160;</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, we closed a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of $55.0 million aggregate principal amount of our 5.25% Senior Convertible Notes due 2024 (2019 Notes). Most of the issuance proceeds were used to retire approximately $50.2 million of aggregate principal amount of our 2014 Notes, leaving approximately $1.1 million of aggregate principal amount of our 2014 Notes outstanding. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the 2019 Notes do not provide for a cash conversion feature, the 2019 Notes are recorded as debt in their entirety in accordance with ASC 470. For the 2014, 2018 and 2019 Notes, offering-related costs, including underwriting costs, were capitalized as debt issuance costs, recorded as an offset to the carrying value of the related Notes, and are amortized over the expected term of the related Notes using the effective interest method.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Loss</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comprehensive Loss </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive loss is comprised of net loss and other comprehensive income (loss). Other comprehensive income (loss) consists of unrealized gains and losses on our investments and foreign currency translation adjustments. Total comprehensive loss for all periods presented has been disclosed in the condensed consolidated statements of comprehensive loss.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss per Share</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Loss per Share </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our basic and diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding for the period. Restricted stock units, performance share units, and stock options to purchase our common stock are considered to be potentially dilutive common shares but have been excluded from the calculation of diluted net loss per share as their effect is anti-dilutive for all periods presented.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Changes and Accounting Pronouncements</a></td>
<td class="text"><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Changes and Accounting Pronouncements</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adoption of New Accounting Guidance </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the U.S.-based Financial&#160;Accounting Standards&#160;Board (FASB) issued Accounting Standards Update (ASU) 2018-15-Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40), which establishes new guidance on the accounting for costs incurred to implement a cloud computing arrangement that is considered a service arrangement. The new guidance requires the capitalization of such costs, aligning it with the accounting for costs associated with developing or obtaining internal-use software. The new guidance is effective for fiscal years beginning after December 15, 2019. The adoption of the new guidance did not have a significant impact on our financial results.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2017, the FASB issued ASU 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The ASU eliminates the requirement for an entity to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, an entity performs its annual, or interim, goodwill impairment testing by comparing the fair value of a reporting unit with its carrying amount and recording an impairment charge for the amount by which the carrying amount exceeds the fair value. The ASU is effective for annual and interim goodwill impairment testing performed for our fiscal year beginning January 1, 2020. The adoption of the new guidance did not have a significant impact on our financial results.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FASB issued two ASUs related to financial instruments &#8211; credit losses. The ASUs issued were: (1) in June 2016, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjUxMGI2MGJjNWExYTQ3NDhiM2U2NGE2ZWYxOTY2ZmNkL3NlYzo1MTBiNjBiYzVhMWE0NzQ4YjNlNjRhNmVmMTk2NmZjZF8zNy9mcmFnOjcwOGI4NGQyNDUzZjRhNzI4NWVmMzI2MDIzMGFjYTBmL3RleHRyZWdpb246NzA4Yjg0ZDI0NTNmNGE3Mjg1ZWYzMjYwMjMwYWNhMGZfMjQzNjc_09dd10ab-4bd6-4959-a108-786ca8b4f9e5">ASU 2016-13, Financial Instruments-Credit Losses (Topic 326)</span>: Measurement of Credit Losses on Financial Instruments, and (2) in November 2018, ASU 2018-19-Codification Improvements to Topic 326, Financial Instruments-Credit Losses. ASU 2016-13 is intended to improve financial reporting by requiring more timely recording of credit losses on loans and other financial </span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">instruments held by financial institutions and other organizations. ASU 2018-19 clarifies that receivables arising from operating leases are not within the scope of the credit losses standard, but rather, should be accounted for in accordance with the lease standard. These ASUs are effective for fiscal years beginning after December 15, 2019, and interim periods within those years, with early adoption permitted. The modified retrospective method is required upon adoption. The adoption of the new guidance resulted in an adjustment of approximately $0.1 million to reduce the accumulated deficit component of stockholders&#8217; equity and decrease current assets by the same amount in our condensed consolidated balance sheet.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06 Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity. The amendment to this ASU reduces the number of accounting models for convertible instruments and allows more contracts to qualify for equity classification, which is expected to result in more convertible instruments being accounted for as a single unit, rather than being bifurcated between debt and equity. The new guidance is effective for fiscal years beginning after December 15, 2021. We are currently evaluating the impact of adoption on our condensed consolidated financial statements.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, the FASB issued ASU 2019-12-Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The amendments in this update improve consistent application of and simplify U.S. GAAP for Topic 740 by clarifying and amending existing guidance for, among other items, intra-period allocation, reporting tax law changes and losses in interim periods, state and local taxes not fully based on income and recognition of deferred tax liability related to certain transactions. There is also new guidance related to consolidated group reporting and tax impacts resulting from business combinations. The new guidance is effective for fiscal years beginning after December 15, 2020. We are currently evaluating the impact of adoption on our condensed consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108315417&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5033-111524<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978846557960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Components of accumulated other comprehensive loss</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of accumulated other comprehensive loss, net of tax, for the three and nine months ended September&#160;30, 2020 are as follows (in thousands): </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Investments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(618)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(582)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance at March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(921)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(885)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance at June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(812)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(809)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(289)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(289)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Summary of potential common shares excluded from computations of net loss per share attributed to common stockholders</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following potentially dilutive common shares were excluded from the computations of diluted net loss per share for the periods presented because including them would have been anti-dilutive (in thousands):  </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options, restricted stock units and performance awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,652&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,342&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Convertible Notes potential make-whole shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2014 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">916&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,463&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,258&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978848122584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of consideration transferred</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the net cash flows is summarized below (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:85.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 17, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash consideration paid to former equity holders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,165&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: cash and cash equivalents acquired</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition of InstruNor, net of cash acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,154&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of consideration transferred and assets acquired and liabilities assumed</a></td>
<td class="text">Goodwill of $2.2 million was calculated as the purchase price less the fair value of the net assets acquired as follows (in thousands):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:85.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 17, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase price:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash consideration paid on closing to former equity holders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash consideration common shares </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,214&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets acquired:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of identifiable net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,994&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired on acquisition</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,220&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978847846104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RADx Program (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock', window );">Summary of Research and Development Activity Under NIH Contract</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity under the NIH Contract through September&#160;30, 2020 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:15pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.993%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total value of milestones reasonably assured</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts applied against research and development expenses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred grant income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,224&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total value of milestones reasonably assured </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funding received</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,151&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant receivable from RADx</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,456&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others (including royalty arrangements, purchase provisions, license agreements, and commitments to provide additional funding), aggregated by similar arrangements or individually if necessary to understand the effects on the financial statements. Include also the amount of costs incurred under a research and development arrangement accounted for as a contract to perform research and development for others. Aggregation of similar arrangements by type may be appropriate. Include also the amount of compensation earned (contract income) under a research and development arrangement accounted for as a contract to perform research and development for others. Aggregation of similar arrangements by type may be appropriate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420387&amp;loc=d3e23199-108380<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6420387&amp;loc=d3e23221-108380<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978846675608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Summary of disaggregation of revenue</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our revenue for the three and nine months ended September&#160;30, 2020 and 2019, respectively, based on geographic area and by source (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.169%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.039%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographic Markets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,653&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,609&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,861&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,496&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,536&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,803&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.040%"/><td style="width:0.1%"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Source:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,210&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,666&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,596&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,728&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;License and royalty revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Grant revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Total other revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,340&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,303&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,861&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,496&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,536&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,803&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock', window );">Summary of expected timing of revenue recognition</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the expected timing of revenue recognition for unfulfilled performance obligations associated with instrument service contracts that were partially completed at September&#160;30, 2020 (in thousands): </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.798%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.165%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expected Revenue </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 (remainder of the year)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,873&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,385&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,079&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,112&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______</span></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected revenue includes both billed amounts included in deferred revenue and unbilled amounts that are not reflected in our condensed consolidated financial statements and are subject to change if our customers decide to cancel or modify their contracts. Purchase orders for instrument service contracts can generally be canceled before the service period begins without penalty.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of expected timing for satisfying remaining performance obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978846482216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of finite-lived intangible assets</a></td>
<td class="text">Intangible assets, net, were as follows (in thousands): <div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.020%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization and Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Amortization Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,380&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,425)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,955&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and licenses</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,274&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,030)</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,244&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8 years</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.020%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization and Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Amortization Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,800)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and licenses</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,274&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,342)</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,932&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8 years</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Estimated future intangible asset amortization expense</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the carrying value of intangible assets, net,&#160;as of&#160;September&#160;30, 2020, the amortization expense is expected to be as follows (in thousands): </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.971%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Technology Amortization Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Patents and Licenses Amortization Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 (remainder of the year)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,978&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,207&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,671&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,482&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,955&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,244&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,199&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978852655272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Summary of cash and cash equivalents</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents and restricted cash consisted of the following as of September&#160;30, 2020 and December&#160;31, 2019 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.329%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.973%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.976%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,345&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,075&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,360&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,736&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock', window );">Schedule of restricted cash</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents and restricted cash consisted of the following as of September&#160;30, 2020 and December&#160;31, 2019 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.329%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.973%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.976%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,345&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,075&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,360&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,736&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of inventories</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consisted of the following as of September&#160;30, 2020 and December&#160;31, 2019 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.329%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.973%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.976%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,768&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,133&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,560&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,884&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of property and equipment</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following as of September&#160;30, 2020 and December&#160;31, 2019 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.329%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.973%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.976%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,363&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,997&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory and manufacturing equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,988&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,788&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,680&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,934&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,262)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,954)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction-in-progress</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,531&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,056&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock', window );">Schedule of activity of warranty accrual</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity for our warranty accrual for the nine months ended September&#160;30, 2020&#160;and 2019, which is included in other accrued liabilities, is summarized below (in thousands): </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.329%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.973%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.976%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,390&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrual for current period warranties</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty costs incurred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(387)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(668)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,680&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,107&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978846355256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Notes and Credit Facility (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of debt</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of the components of the 2014 Notes and the 2019 Notes are as follows (in thousands): </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.329%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.973%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.976%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;2.75% 2014 Notes due 2034   </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,079&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,079&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt discount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,058&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,057&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;5.25% 2019 Notes due 2024</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,937)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,236)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,063&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,764&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Net carrying value of all Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,121&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,821&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the par value, carrying value and the estimated fair value of the 2014 and 2019 Notes at September&#160;30, 2020 and December&#160;31, 2019, respectively (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.680%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2014 Notes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,079&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,058&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,079&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,057&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,039&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,079&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,121&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,161&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,079&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,821&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,097&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978852385992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Schedule of balance sheet information</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows as of September&#160;30, 2020 and December&#160;31, 2019 (in thousands, except for discount rate and lease term):</span></div><div style="margin-bottom:5pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use buildings</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,723</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,234</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use equipment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use vehicles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease right-of-use assets, gross</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,392</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,658</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,923)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,798)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease right-of-use assets, net</span></td><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,469</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,860</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,697</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,833</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, non-current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,607</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,323</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,304</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,156</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate per annum</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of lease expense</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of lease expense for the three and nine months ended September&#160;30, 2020 and 2019, respectively (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost (including variable costs)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,501&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,604&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,012&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,660&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable costs including non-lease component</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,576&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,051&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental Cash Flow Information:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of operating lease liabilities (included in net cash used in operating activities in thousands):</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 0.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,443&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,068&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of future minimum lease payments</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under commenced non-cancelable operating leases, which are as of September&#160;30, 2020 as follows (in thousands): </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.328%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Minimum Lease Payments for Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 (remainder of year)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,802&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,362&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,950&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,254&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum payments </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,256)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets And Liabilities, Lessee [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978847840792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of cash and available-for-sale securities</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize our cash and available-for-sale securities that were measured at fair value by significant investment category within the fair value hierarchy (in thousands): </span></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.828%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gain</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-Term Marketable Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash- Restricted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash-unrestricted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash-restricted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Total cash</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,159&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,159&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,144&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,015&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Level I:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,360&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,360&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,345&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,015&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gain</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-Term Marketable Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash- Restricted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash-unrestricted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash-restricted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Total cash</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,689&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,689&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,614&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,075&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Level I:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,047&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,047&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,047&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;US treasury securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,942&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,978&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,978&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subtotal</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,989&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,025&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,047&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,978&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,678&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,714&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,661&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,978&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,075&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of debt</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of the components of the 2014 Notes and the 2019 Notes are as follows (in thousands): </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.329%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.973%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.976%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;2.75% 2014 Notes due 2034   </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,079&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,079&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt discount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,058&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,057&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;5.25% 2019 Notes due 2024</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,937)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,236)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,063&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,764&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Net carrying value of all Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,121&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,821&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the par value, carrying value and the estimated fair value of the 2014 and 2019 Notes at September&#160;30, 2020 and December&#160;31, 2019, respectively (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.680%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2014 Notes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,079&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,058&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,079&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,057&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,039&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,079&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,121&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,161&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,079&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,821&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,097&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978847857592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Schedule of common stock reserved for future issuance</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020, we had reserved shares of common stock for future issuance under equity compensation plans as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in 000's)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Securities To Be Issued Upon Exercise Of Options </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number Of Remaining Securities Available For Future Issuance </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2009 Equity Incentive Plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2011 Equity Incentive Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DVS Sciences Inc. 2010 Equity Incentive Plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2017 Inducement Award Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2017 Employee Stock Purchase Plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,626&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,026&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,157&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense recognized was as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.655%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.202%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units, stock options and performance share units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,738&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,558&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,731&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,357&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,029&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,358&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,292&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978851976008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Activity under restricted stock units</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity under the various plans was as follows:</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.397%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.423%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Units (in 000s)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant Date Fair Value per Unit</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,551&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU released</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(872)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(305)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,016&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Activity under stock options</a></td>
<td class="text"><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">: </span></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of <br/>Options (000s)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Exercise Price<br/>per Option</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average Remaining Contractual Life (in Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intrinsic </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> in (000s)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,027&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.78&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(408)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,626&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,259&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Awards expected to vest at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______</span></div>(1)Aggregate intrinsic value as of September&#160;30, 2020 was calculated as the difference between the closing price per share of our common stock on the last trading day of September&#160;30, 2020, which was $7.43, and the exercise price of the options, multiplied by the number of in-the-money options.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock', window );">Schedule of nonvested performance-based units activity</a></td>
<td class="text"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity under the TSR-based PSUs is as follows: </span></div><div style="margin-bottom:5pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.397%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.423%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Units (in 000s)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant Date Fair Value per Unit</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.09&#160;</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU released</span></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bfe4ff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">962&#160;</span></td><td style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bfe4ff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.74&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Activity to date under this PSU award is as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.397%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.423%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Units (in 000s)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant Date Fair Value per Unit</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.05&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU released</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Schedule of stock-based compensation expense</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020, we had reserved shares of common stock for future issuance under equity compensation plans as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in 000's)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Securities To Be Issued Upon Exercise Of Options </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number Of Remaining Securities Available For Future Issuance </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2009 Equity Incentive Plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2011 Equity Incentive Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DVS Sciences Inc. 2010 Equity Incentive Plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2017 Inducement Award Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2017 Employee Stock Purchase Plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,626&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,026&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,157&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense recognized was as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.655%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.202%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units, stock options and performance share units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,738&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,558&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,731&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,357&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,029&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,358&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,292&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested performance-based units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978838758728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Narrative (Details) - USD ($)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Nov. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Feb. 28, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ScheduleOfSignificantAccountingPoliciesLineItems', window );"><strong>Schedule Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,861,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,496,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 93,536,000<span></span>
</td>
<td class="nump">$ 84,803,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Legal fees</a></td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ProductWarrantyTerm', window );">Product warranty term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment of goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue', window );">Maximum contract value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">us-gaap:AccountingStandardsUpdate201613Member<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">us-gaap:AccountingStandardsUpdate201613Member<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Cumulative-effect of new accounting standard for Topic 326 Credit Losses</a></td>
<td class="num">(141,496,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (151,973,000)<span></span>
</td>
<td class="num">$ (153,612,000)<span></span>
</td>
<td class="num">$ (162,605,000)<span></span>
</td>
<td class="num">$ (182,245,000)<span></span>
</td>
<td class="num">$ (151,973,000)<span></span>
</td>
<td class="num">$ (162,605,000)<span></span>
</td>
<td class="num">$ (153,612,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (132,719,000)<span></span>
</td>
<td class="num">$ (172,640,000)<span></span>
</td>
<td class="num">$ (72,116,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=fldm_FiveLargestCustomersMember', window );">5 Largest Customers | Revenue from Contract with Customer | Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ScheduleOfSignificantAccountingPoliciesLineItems', window );"><strong>Schedule Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ScheduleOfSignificantAccountingPoliciesLineItems', window );"><strong>Schedule Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Cumulative-effect of new accounting standard for Topic 326 Credit Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ScheduleOfSignificantAccountingPoliciesLineItems', window );"><strong>Schedule Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56,079,000<span></span>
</td>
<td class="nump">56,079,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56,079,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,079,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesdue2034Member', window );">Senior Convertible Notes due 2034 | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ScheduleOfSignificantAccountingPoliciesLineItems', window );"><strong>Schedule Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,079,000<span></span>
</td>
<td class="nump">1,079,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,079,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,079,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 201,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="nump">1,079,000<span></span>
</td>
<td class="nump">1,079,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,079,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,079,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=fldm_ExchangeConvertibleSeniorNotesDue2034Member', window );">Exchange Convertible Senior Notes due 2034 | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ScheduleOfSignificantAccountingPoliciesLineItems', window );"><strong>Schedule Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesDue2024Member', window );">Senior Convertible Notes Due 2024 | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ScheduleOfSignificantAccountingPoliciesLineItems', window );"><strong>Schedule Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,000,000.0<span></span>
</td>
<td class="nump">55,000,000<span></span>
</td>
<td class="nump">55,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,000,000<span></span>
</td>
<td class="nump">55,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ScheduleOfSignificantAccountingPoliciesLineItems', window );"><strong>Schedule Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of debt into common stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Cumulative-effect of new accounting standard for Topic 326 Credit Losses</a></td>
<td class="num">(71,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(74,000)<span></span>
</td>
<td class="num">(70,000)<span></span>
</td>
<td class="num">$ (70,000)<span></span>
</td>
<td class="num">$ (69,000)<span></span>
</td>
<td class="num">(74,000)<span></span>
</td>
<td class="num">$ (70,000)<span></span>
</td>
<td class="num">(70,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(71,000)<span></span>
</td>
<td class="num">(69,000)<span></span>
</td>
<td class="num">(49,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | Senior Convertible Notes due 2034 | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ScheduleOfSignificantAccountingPoliciesLineItems', window );"><strong>Schedule Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of debt into common stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | Exchange Convertible Senior Notes due 2034 | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ScheduleOfSignificantAccountingPoliciesLineItems', window );"><strong>Schedule Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of debt into common stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Accumulated Deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ScheduleOfSignificantAccountingPoliciesLineItems', window );"><strong>Schedule Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Cumulative-effect of new accounting standard for Topic 326 Credit Losses</a></td>
<td class="nump">639,721,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">658,735,000<span></span>
</td>
<td class="nump">623,641,000<span></span>
</td>
<td class="nump">610,956,000<span></span>
</td>
<td class="nump">$ 584,316,000<span></span>
</td>
<td class="nump">$ 658,735,000<span></span>
</td>
<td class="nump">610,956,000<span></span>
</td>
<td class="nump">623,641,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 652,736,000<span></span>
</td>
<td class="nump">$ 598,069,000<span></span>
</td>
<td class="nump">$ 558,851,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Accumulated Deficit | Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ScheduleOfSignificantAccountingPoliciesLineItems', window );"><strong>Schedule Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Cumulative-effect of new accounting standard for Topic 326 Credit Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=fldm_IntellectualPropertyInfringementClaimsMember', window );">Intellectual Property Infringement Claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ScheduleOfSignificantAccountingPoliciesLineItems', window );"><strong>Schedule Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLegalSettlements', window );">Proceeds from legal settlements</a></td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Commission Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ScheduleOfSignificantAccountingPoliciesLineItems', window );"><strong>Schedule Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_RevenueFromContractWithCustomerPerformanceObligationPeriod', window );">Performance obligation period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Commission Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ScheduleOfSignificantAccountingPoliciesLineItems', window );"><strong>Schedule Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_RevenueFromContractWithCustomerPerformanceObligationPeriod', window );">Performance obligation period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ScheduleOfSignificantAccountingPoliciesLineItems', window );"><strong>Schedule Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,210,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,666,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65,596,000<span></span>
</td>
<td class="nump">68,728,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product revenue | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ScheduleOfSignificantAccountingPoliciesLineItems', window );"><strong>Schedule Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_RevenueFromContractWithCustomerTermsOfPaymentPeriod', window );">Terms of payment period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product revenue | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ScheduleOfSignificantAccountingPoliciesLineItems', window );"><strong>Schedule Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_RevenueFromContractWithCustomerTermsOfPaymentPeriod', window );">Terms of payment period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ScheduleOfSignificantAccountingPoliciesLineItems', window );"><strong>Schedule Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,131,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,630,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,457,000<span></span>
</td>
<td class="nump">15,875,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ScheduleOfSignificantAccountingPoliciesLineItems', window );"><strong>Schedule Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_RevenueFromContractWithCustomerPerformanceObligationPeriod', window );">Performance obligation period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ScheduleOfSignificantAccountingPoliciesLineItems', window );"><strong>Schedule Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_RevenueFromContractWithCustomerPerformanceObligationPeriod', window );">Performance obligation period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_LicenseMember', window );">Other revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ScheduleOfSignificantAccountingPoliciesLineItems', window );"><strong>Schedule Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 3,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,163,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=fldm_DevelopmentRevenueMember', window );">Development revenue | One Customer | Revenue from Contract with Customer | Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ScheduleOfSignificantAccountingPoliciesLineItems', window );"><strong>Schedule Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ProductWarrantyTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product Warranty Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ProductWarrantyTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Maximum Contract Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_RevenueFromContractWithCustomerPerformanceObligationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue From Contract With Customer, Performance Obligation Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_RevenueFromContractWithCustomerPerformanceObligationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_RevenueFromContractWithCustomerTermsOfPaymentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue From Contract With Customer, Terms Of Payment Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_RevenueFromContractWithCustomerTermsOfPaymentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ScheduleOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Significant Accounting Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ScheduleOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 24: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received for the settlement of litigation during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=fldm_FiveLargestCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=fldm_FiveLargestCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesdue2034Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesdue2034Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=fldm_ExchangeConvertibleSeniorNotesDue2034Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=fldm_ExchangeConvertibleSeniorNotesDue2034Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=fldm_IntellectualPropertyInfringementClaimsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=fldm_IntellectualPropertyInfringementClaimsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAxis=fldm_CommissionCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAxis=fldm_CommissionCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=fldm_DevelopmentRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=fldm_DevelopmentRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=fldm_OneCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=fldm_OneCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978849097192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Accumulated Other Comprehensive Loss (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance</a></td>
<td class="nump">$ 132,719<span></span>
</td>
<td class="nump">$ 141,496<span></span>
</td>
<td class="nump">$ 153,612<span></span>
</td>
<td class="nump">$ 172,640<span></span>
</td>
<td class="nump">$ 182,245<span></span>
</td>
<td class="nump">$ 72,116<span></span>
</td>
<td class="nump">$ 153,612<span></span>
</td>
<td class="nump">$ 72,116<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">520<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="num">(303)<span></span>
</td>
<td class="num">(135)<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">293<span></span>
</td>
<td class="num">(71)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance</a></td>
<td class="nump">151,973<span></span>
</td>
<td class="nump">132,719<span></span>
</td>
<td class="nump">141,496<span></span>
</td>
<td class="nump">162,605<span></span>
</td>
<td class="nump">172,640<span></span>
</td>
<td class="nump">182,245<span></span>
</td>
<td class="nump">151,973<span></span>
</td>
<td class="nump">162,605<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance</a></td>
<td class="num">(812)<span></span>
</td>
<td class="num">(921)<span></span>
</td>
<td class="num">(618)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(618)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">523<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="num">(303)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance</a></td>
<td class="num">(289)<span></span>
</td>
<td class="num">(812)<span></span>
</td>
<td class="num">(921)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(289)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Unrealized Gain (Loss) on Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance</a></td>
<td class="num">(809)<span></span>
</td>
<td class="num">(885)<span></span>
</td>
<td class="num">(582)<span></span>
</td>
<td class="num">(623)<span></span>
</td>
<td class="num">(677)<span></span>
</td>
<td class="num">(687)<span></span>
</td>
<td class="num">(582)<span></span>
</td>
<td class="num">(687)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">520<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="num">(303)<span></span>
</td>
<td class="num">(135)<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance</a></td>
<td class="num">$ (289)<span></span>
</td>
<td class="num">$ (809)<span></span>
</td>
<td class="num">$ (885)<span></span>
</td>
<td class="num">$ (758)<span></span>
</td>
<td class="num">$ (623)<span></span>
</td>
<td class="num">$ (677)<span></span>
</td>
<td class="num">$ (289)<span></span>
</td>
<td class="num">$ (758)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978851802520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Potential Common Shares Excluded from Computations of Diluted Net Loss Per Share (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computations of net loss per share (shares)</a></td>
<td class="nump">27,463<span></span>
</td>
<td class="nump">6,258<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options, restricted stock units and performance awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computations of net loss per share (shares)</a></td>
<td class="nump">7,652<span></span>
</td>
<td class="nump">5,342<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=fldm_TwoThousandAndNineteenConvertibleNotesMember', window );">2019 Convertible Notes | Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computations of net loss per share (shares)</a></td>
<td class="nump">18,966<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember', window );">2019 Convertible Notes potential make-whole shares | Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computations of net loss per share (shares)</a></td>
<td class="nump">826<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=fldm_TwoThousandAndFourteenConvertibleNotesMember', window );">2014 Convertible Notes | Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computations of net loss per share (shares)</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">916<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=fldm_TwoThousandAndNineteenConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=fldm_TwoThousandAndNineteenConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=fldm_TwoThousandAndFourteenConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=fldm_TwoThousandAndFourteenConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978851093320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combination - Narrative (Details)<br> $ / shares in Units, $ in Thousands, &#8364; in Millions</strong></div></th>
<th class="th">
<div>Jan. 17, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (usd per share) | $ / shares</a></td>
<td class="nump">$ 4.22<span></span>
</td>
<td class="nump">$ 7.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 106,455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 104,108<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=fldm_InstruNorASMember', window );">InstruNor AS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="nump">$ 7,214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash consideration paid to former equity holders</a></td>
<td class="nump">$ 5,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Purchase price (shares) | shares</a></td>
<td class="nump">485,451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 2,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,200<span></span>
</td>
<td class="nump">&#8364; 2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=fldm_InstruNorASMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=fldm_InstruNorASMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978938135624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination - Net Cash Flows (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 17, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition of InstruNor, net of cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,154<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=fldm_InstruNorASMember', window );">InstruNor AS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash consideration paid to former equity holders</a></td>
<td class="nump">$ 5,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Less: cash and cash equivalents acquired</a></td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition of InstruNor, net of cash acquired</a></td>
<td class="nump">$ 5,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=fldm_InstruNorASMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=fldm_InstruNorASMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978854874344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combination - Schedule of Consideration Transferred and Identifiable Assets and Liabilities (Details)<br> $ in Thousands, &#8364; in Millions</strong></div></th>
<th class="th">
<div>Jan. 17, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities assumed:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill acquired on acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 106,455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 104,108<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=fldm_InstruNorASMember', window );">InstruNor AS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredAbstract', window );"><strong>Purchase price:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash consideration paid on closing to former equity holders</a></td>
<td class="nump">$ 5,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Non-cash consideration common shares</a></td>
<td class="nump">2,049<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="nump">7,214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Assets acquired:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAccountsReceivables', window );">Accounts receivable</a></td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherReceivables', window );">Other receivables</a></td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories, net</a></td>
<td class="nump">153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Developed technology</a></td>
<td class="nump">5,380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities assumed:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Other current liabilities</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability, net</a></td>
<td class="nump">566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Fair value of identifiable net assets acquired</a></td>
<td class="nump">4,994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill acquired on acquisition</a></td>
<td class="nump">$ 2,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,200<span></span>
</td>
<td class="nump">&#8364; 2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAccountsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accounts Receivables</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAccountsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Receivables</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=fldm_InstruNorASMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=fldm_InstruNorASMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978932225528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RADx Program (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 28, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue', window );">Maximum contract value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesPercentage', window );">Percentage of contractual amount to be paid on liquidated damages</a></td>
<td class="nump">33.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesTerm', window );">Period due to pay liquidation damages</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount', window );">Total value of milestones reasonably assured</a></td>
<td class="nump">$ 18,607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses', window );">Amounts applied against research and development expenses</a></td>
<td class="nump">383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_DeferredGrantRevenueNoncurrent', window );">Deferred grant income</a></td>
<td class="nump">18,224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersFundingReceived', window );">Funding received</a></td>
<td class="nump">11,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ResearchAndDevelopmentArrangementReceivables', window );">Grant receivable from RADx</a></td>
<td class="nump">$ 7,456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_DeferredGrantRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Grant Revenue, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_DeferredGrantRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersFundingReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Funding Received</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersFundingReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Liquidated Damages, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Liquidated Damages, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Maximum Contract Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ResearchAndDevelopmentArrangementReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research and Development Arrangement, Receivables</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ResearchAndDevelopmentArrangementReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978850467128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Schedule of Disaggregation of Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,861<span></span>
</td>
<td class="nump">$ 26,496<span></span>
</td>
<td class="nump">$ 93,536<span></span>
</td>
<td class="nump">$ 84,803<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=fldm_InstrumentsMember', window );">Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,624<span></span>
</td>
<td class="nump">9,159<span></span>
</td>
<td class="nump">30,672<span></span>
</td>
<td class="nump">34,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=fldm_ConsumablesMember', window );">Consumables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,586<span></span>
</td>
<td class="nump">11,507<span></span>
</td>
<td class="nump">34,924<span></span>
</td>
<td class="nump">34,528<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,210<span></span>
</td>
<td class="nump">20,666<span></span>
</td>
<td class="nump">65,596<span></span>
</td>
<td class="nump">68,728<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,131<span></span>
</td>
<td class="nump">5,630<span></span>
</td>
<td class="nump">16,457<span></span>
</td>
<td class="nump">15,875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=fldm_CollaborationRevenueMember', window );">Development revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,180<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,180<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_LicenseMember', window );">License and royalty revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 3,100<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,163<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_GrantMember', window );">Grant revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,340<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">2,140<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,340<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">5,303<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AmericasMember', window );">Americas</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,653<span></span>
</td>
<td class="nump">11,112<span></span>
</td>
<td class="nump">52,437<span></span>
</td>
<td class="nump">35,203<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember', window );">EMEA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,837<span></span>
</td>
<td class="nump">9,092<span></span>
</td>
<td class="nump">23,490<span></span>
</td>
<td class="nump">28,465<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia-Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,371<span></span>
</td>
<td class="nump">$ 6,292<span></span>
</td>
<td class="nump">$ 17,609<span></span>
</td>
<td class="nump">$ 21,135<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=fldm_InstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=fldm_InstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=fldm_ConsumablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=fldm_ConsumablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=fldm_CollaborationRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=fldm_CollaborationRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_GrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_GrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_EMEAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978848084840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">$ 21.1<span></span>
</td>
<td class="nump">$ 20.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="nump">8.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts', window );">Additional advance payments received</a></td>
<td class="nump">$ 9.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Increase From Cash Receipts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978851329096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue - Performance Obligations (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligation, expected revenue</a></td>
<td class="nump">$ 24,112<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-10-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-10-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligation, expected revenue</a></td>
<td class="nump">$ 3,873<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligation, expected timing of satisfaction</a></td>
<td class="text">3 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligation, expected revenue</a></td>
<td class="nump">$ 10,385<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligation, expected timing of satisfaction</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligation, expected revenue</a></td>
<td class="nump">$ 5,775<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligation, expected timing of satisfaction</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligation, expected revenue</a></td>
<td class="nump">$ 4,079<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligation, expected timing of satisfaction</a></td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-10-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-10-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978850457048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, net - Narrative (Details)<br> $ in Thousands, &#8364; in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 28, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jan. 17, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 106,455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 106,455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 104,108<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,929<span></span>
</td>
<td class="nump">$ 8,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=fldm_DVSSciencesInc.Member', window );">DVS Sciences, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 104,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=fldm_InstruNorASMember', window );">InstruNor AS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2.0<span></span>
</td>
<td class="nump">$ 2,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="nump">$ 9,600<span></span>
</td>
<td class="nump">$ 9,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology | DVS Sciences, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived intangible assets acquired</a></td>
<td class="nump">$ 112,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology | InstruNor AS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,400<span></span>
</td>
<td class="nump">&#8364; 4.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired finite-lived intangible assets, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=fldm_DVSSciencesInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=fldm_DVSSciencesInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=fldm_InstruNorASMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=fldm_InstruNorASMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978851426104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, net - Schedule of Finite-lived Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 45,199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Amount</a></td>
<td class="nump">117,380<span></span>
</td>
<td class="nump">$ 112,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization and Translation</a></td>
<td class="num">(74,425)<span></span>
</td>
<td class="num">(65,800)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 42,955<span></span>
</td>
<td class="nump">$ 46,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted-Average Amortization Period</a></td>
<td class="text">9 years 10 months 24 days<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=fldm_PatentsandLicenseAgreementsMember', window );">Patents and licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Amount</a></td>
<td class="nump">$ 11,274<span></span>
</td>
<td class="nump">$ 11,274<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization and Translation</a></td>
<td class="num">(9,030)<span></span>
</td>
<td class="num">(8,342)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 2,244<span></span>
</td>
<td class="nump">$ 2,932<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted-Average Amortization Period</a></td>
<td class="text">7 years 9 months 18 days<span></span>
</td>
<td class="text">7 years 9 months 18 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=fldm_PatentsandLicenseAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=fldm_PatentsandLicenseAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978850967848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, net - Future Amortization Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">2020 (remainder of the year)</a></td>
<td class="nump">$ 3,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2021</a></td>
<td class="nump">12,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2022</a></td>
<td class="nump">12,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2023</a></td>
<td class="nump">12,482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2024</a></td>
<td class="nump">2,118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour', window );">Thereafter</a></td>
<td class="nump">2,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">45,199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed Technology Amortization Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">2020 (remainder of the year)</a></td>
<td class="nump">2,978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2021</a></td>
<td class="nump">11,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2022</a></td>
<td class="nump">11,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2023</a></td>
<td class="nump">11,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2024</a></td>
<td class="nump">2,111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour', window );">Thereafter</a></td>
<td class="nump">2,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">42,955<span></span>
</td>
<td class="nump">$ 46,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=fldm_PatentsandLicenseAgreementsMember', window );">Patents and Licenses Amortization Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">2020 (remainder of the year)</a></td>
<td class="nump">229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2021</a></td>
<td class="nump">760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2022</a></td>
<td class="nump">677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2023</a></td>
<td class="nump">571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2024</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 2,244<span></span>
</td>
<td class="nump">$ 2,932<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Asset, Expected Amortization, After Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=fldm_PatentsandLicenseAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=fldm_PatentsandLicenseAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978851065608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Summary of Cash and Cash Equivalents (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 72,345<span></span>
</td>
<td class="nump">$ 21,661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash</a></td>
<td class="nump">1,015<span></span>
</td>
<td class="nump">2,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash</a></td>
<td class="nump">73,360<span></span>
</td>
<td class="nump">$ 23,736<span></span>
</td>
<td class="nump">$ 27,961<span></span>
</td>
<td class="nump">$ 95,401<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Short-term restricted cash</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Non-current restricted cash</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978846447208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 8,768<span></span>
</td>
<td class="nump">$ 6,133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">920<span></span>
</td>
<td class="nump">659<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">9,872<span></span>
</td>
<td class="nump">7,092<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories</a></td>
<td class="nump">$ 19,560<span></span>
</td>
<td class="nump">$ 13,884<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978851406824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 33,680<span></span>
</td>
<td class="nump">$ 32,934<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation and amortization</a></td>
<td class="num">(26,262)<span></span>
</td>
<td class="num">(24,954)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction-in-progress</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">7,531<span></span>
</td>
<td class="nump">8,056<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=fldm_ComputerEquipmentAndSoftwareMember', window );">Computer equipment and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">4,363<span></span>
</td>
<td class="nump">3,997<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=fldm_LaboratoryAndManufacturingEquipmentMember', window );">Laboratory and manufacturing equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">18,988<span></span>
</td>
<td class="nump">19,325<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">8,118<span></span>
</td>
<td class="nump">7,788<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 2,211<span></span>
</td>
<td class="nump">$ 1,824<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=fldm_ComputerEquipmentAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=fldm_ComputerEquipmentAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=fldm_LaboratoryAndManufacturingEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=fldm_LaboratoryAndManufacturingEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978849071480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details - Warranty Accrual (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInStandardProductWarrantyAccrualRollForward', window );"><strong>Movement in Standard Product Warranty Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrual', window );">Beginning balance</a></td>
<td class="nump">$ 1,390<span></span>
</td>
<td class="nump">$ 863<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualWarrantiesIssued', window );">Accrual for current period warranties</a></td>
<td class="nump">677<span></span>
</td>
<td class="nump">912<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualPayments', window );">Warranty costs incurred</a></td>
<td class="num">(387)<span></span>
</td>
<td class="num">(668)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrual', window );">Ending balance</a></td>
<td class="nump">$ 1,680<span></span>
</td>
<td class="nump">$ 1,107<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInStandardProductWarrantyAccrualRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInStandardProductWarrantyAccrualRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualWarrantiesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in the standard and extended product warranty accrual from warranties issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualWarrantiesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978839650264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Notes and Credit Facility - Narrative (Details)<br> $ / shares in Units, shares in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 21, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2019 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Aug. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2018 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Feb. 28, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 28, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 12, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Equity issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 180,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock from at-the-market offering, net of commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,226,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeeAmount', window );">Commitment fee amount</a></td>
<td class="nump">$ 112,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_DebtInstrumentEarlyRedemptionCostPercentOfMaximumBorrowingCapacity', window );">Prepayment fee, percentage</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum ability to borrow under line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables', window );">Percentage of eligible receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory', window );">Percentage of eligible inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_LineOfCreditFacilityPercentageOfInterestOnObligationUponDefault', window );">Percentage of interest on obligation upon default</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Minimum | Prime Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Additional interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Maximum | Prime Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Additional interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of debt into common stock (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,079,000<span></span>
</td>
<td class="nump">$ 56,079,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56,079,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock from at-the-market offering, net of commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 133,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | Senior Convertible Notes due 2034</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 201,300,000<span></span>
</td>
<td class="nump">1,079,000<span></span>
</td>
<td class="nump">1,079,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,079,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible debt issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,079,000<span></span>
</td>
<td class="nump">1,079,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,079,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from debt issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | Senior Convertible Notes due 2034 | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of debt into common stock (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | Exchange Convertible Senior Notes due 2034</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Estimated fair value of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 145,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Initial conversion rate of notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3448276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1269438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_InitialConversionPriceOfStock', window );">Initial conversion price of stock (usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice', window );">Debt redemption conditioned upon common stock value exceeding a percentage of the conversion price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_DebtAndEquityOfferingCosts', window );">Debt and equity offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Offering related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Equity issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum ability to borrow under line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | Exchange Convertible Senior Notes due 2034 | Redemption, Period One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice', window );">Debt redemption conditioned upon common stock value exceeding a percentage of the conversion price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | Exchange Convertible Senior Notes due 2034 | Redemption, Period Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice', window );">Debt redemption conditioned upon common stock value exceeding a percentage of the conversion price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | Exchange Convertible Senior Notes due 2034 | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of debt into common stock (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | Exchange Convertible Senior Notes due 2034 | Trustee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum ability to borrow under line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 138,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | Senior Convertible Notes Due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,000,000<span></span>
</td>
<td class="nump">55,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,937,000<span></span>
</td>
<td class="nump">2,236,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,937,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,000,000<span></span>
</td>
<td class="nump">$ 55,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Offering related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_DebtAndEquityOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt And Equity Offering Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_DebtAndEquityOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_DebtInstrumentEarlyRedemptionCostPercentOfMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Early Redemption Cost, Percent Of Maximum Borrowing Capacity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_DebtInstrumentEarlyRedemptionCostPercentOfMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Redemption Condition, Stock Value Exceeding Percentage of Conversion Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_InitialConversionPriceOfStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Initial Conversion Price Of Stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_InitialConversionPriceOfStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Inventory</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Receivables</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_LineOfCreditFacilityPercentageOfInterestOnObligationUponDefault">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Percentage Of Interest On Obligation Upon Default</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_LineOfCreditFacilityPercentageOfInterestOnObligationUponDefault</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_PrimeRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesdue2034Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesdue2034Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=fldm_ExchangeConvertibleSeniorNotesDue2034Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=fldm_ExchangeConvertibleSeniorNotesDue2034Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=fldm_TrusteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=fldm_TrusteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978838685608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Convertible Notes and Credit Facility - Schedule of Debt (Details) - Convertible Debt - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Nov. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Feb. 28, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt, total</a></td>
<td class="nump">$ 54,121<span></span>
</td>
<td class="nump">$ 53,821<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesdue2034Member', window );">2.75% 2014 Notes due 2034</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal amount</a></td>
<td class="nump">1,079<span></span>
</td>
<td class="nump">1,079<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="nump">$ 51,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized debt discount</a></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Unamortized debt issuance cost</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,100)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt, total</a></td>
<td class="nump">1,058<span></span>
</td>
<td class="nump">1,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesDue2024Member', window );">5.25% 2019 Notes due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal amount</a></td>
<td class="nump">55,000<span></span>
</td>
<td class="nump">55,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Unamortized debt issuance cost</a></td>
<td class="num">(1,937)<span></span>
</td>
<td class="num">(2,236)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt, total</a></td>
<td class="nump">$ 53,063<span></span>
</td>
<td class="nump">$ 52,764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesdue2034Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesdue2034Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978850821832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Renewal term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use asset</a></td>
<td class="nump">$ 38,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,860<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="nump">$ 41,304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,156<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_CA', window );">CALIFORNIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDiscountRate', window );">Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_LesseeOperatingLeaseRemainingTermOfContract', window );">Remaining lease term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_LesseeOperatingLeaseRemainingTermOfContract', window );">Remaining lease term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_LesseeOperatingLeaseRemainingTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Remaining Term Of Contract</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_LesseeOperatingLeaseRemainingTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount rate used by lessee to determine present value of operating lease payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978851747848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Supplemental Balance sheet (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_OperatingLeaseRightOfUseAssetGross', window );">Total operating lease right-of-use assets, gross</a></td>
<td class="nump">$ 41,392<span></span>
</td>
<td class="nump">$ 6,658<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(2,923)<span></span>
</td>
<td class="num">(1,798)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Total operating lease right-of-use assets, net</a></td>
<td class="nump">38,469<span></span>
</td>
<td class="nump">4,860<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current</a></td>
<td class="nump">2,697<span></span>
</td>
<td class="nump">1,833<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, non-current</a></td>
<td class="nump">38,607<span></span>
</td>
<td class="nump">4,323<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 41,304<span></span>
</td>
<td class="nump">$ 6,156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (in years)</a></td>
<td class="text">8 years 10 months 24 days<span></span>
</td>
<td class="text">4 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate per annum</a></td>
<td class="nump">11.90%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Operating lease right-of-use buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_OperatingLeaseRightOfUseAssetGross', window );">Total operating lease right-of-use assets, gross</a></td>
<td class="nump">$ 40,723<span></span>
</td>
<td class="nump">$ 6,234<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Operating lease right-of-use equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_OperatingLeaseRightOfUseAssetGross', window );">Total operating lease right-of-use assets, gross</a></td>
<td class="nump">86<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Operating lease right-of-use vehicles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_OperatingLeaseRightOfUseAssetGross', window );">Total operating lease right-of-use assets, gross</a></td>
<td class="nump">$ 583<span></span>
</td>
<td class="nump">$ 355<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Right-Of-Use Asset, Accumulated Amortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_OperatingLeaseRightOfUseAssetGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Right-Of-Use Asset, Gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_OperatingLeaseRightOfUseAssetGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978847855928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Operating Lease Cost (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost (including variable costs)</a></td>
<td class="nump">$ 2,501<span></span>
</td>
<td class="nump">$ 1,604<span></span>
</td>
<td class="nump">$ 7,012<span></span>
</td>
<td class="nump">$ 4,660<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable costs including non-lease component</a></td>
<td class="nump">$ 407<span></span>
</td>
<td class="nump">$ 748<span></span>
</td>
<td class="nump">1,576<span></span>
</td>
<td class="nump">2,051<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_CashPaidForOperatingLeaseLiabilitiesAbstract', window );"><strong>Cash paid for amounts included in the measurement of operating lease liabilities (included in net cash used in operating activities in thousands):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,443<span></span>
</td>
<td class="nump">$ 3,068<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_CashPaidForOperatingLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Paid For Operating Lease Liabilities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_CashPaidForOperatingLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978851547400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Operating Lease Maturity (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Minimum Lease Payments for Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2020 (remainder of year)</a></td>
<td class="nump">$ 1,802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">7,362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">7,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">6,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">7,152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour', window );">Thereafter</a></td>
<td class="nump">39,254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future minimum payments</a></td>
<td class="nump">69,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(28,256)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total</a></td>
<td class="nump">$ 41,304<span></span>
</td>
<td class="nump">$ 6,156<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, To Be Paid, After Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978849169384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value of Financial Instruments - Summary of Investments and Cash Equivalents (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>investment</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">$ 72,345<span></span>
</td>
<td class="nump">$ 21,661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Cash-restricted</a></td>
<td class="nump">1,015<span></span>
</td>
<td class="nump">2,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash</a></td>
<td class="nump">73,360<span></span>
</td>
<td class="nump">23,736<span></span>
</td>
<td class="nump">$ 27,961<span></span>
</td>
<td class="nump">$ 95,401<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_CashCashEquivalentsAndShortTermInvestmentsAmortizedCost', window );">Amortized Cost</a></td>
<td class="nump">73,360<span></span>
</td>
<td class="nump">60,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Fair Value</a></td>
<td class="nump">73,360<span></span>
</td>
<td class="nump">60,714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-Term Marketable Securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">36,978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of investment in unrealized loss positions | investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level I:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale, amortized cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-Term Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds | Level I:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">$ 23,201<span></span>
</td>
<td class="nump">5,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale, amortized cost</a></td>
<td class="nump">23,201<span></span>
</td>
<td class="nump">5,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale, fair value</a></td>
<td class="nump">23,201<span></span>
</td>
<td class="nump">5,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-Term Marketable Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Available-for-sale, cash-restricted</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">US treasury securities | Level I:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale, amortized cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,942<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-Term Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember', window );">Total cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">49,144<span></span>
</td>
<td class="nump">16,614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Cash-restricted</a></td>
<td class="nump">1,015<span></span>
</td>
<td class="nump">2,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash</a></td>
<td class="nump">50,159<span></span>
</td>
<td class="nump">18,689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash-unrestricted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">49,144<span></span>
</td>
<td class="nump">16,614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=fldm_RestrictedCashAndCashEquivalentsMember', window );">Cash-restricted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Cash-restricted</a></td>
<td class="nump">$ 1,015<span></span>
</td>
<td class="nump">$ 2,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_CashCashEquivalentsAndShortTermInvestmentsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents, And Short Term Investments, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_CashCashEquivalentsAndShortTermInvestmentsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=fldm_RestrictedCashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=fldm_RestrictedCashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978850930920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value of Financial Instruments - Schedule of Debt (Details) - Convertible Debt - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Nov. 30, 2019</div></th>
<th class="th"><div>Feb. 28, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 56,079,000<span></span>
</td>
<td class="nump">$ 56,079,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt</a></td>
<td class="nump">54,121,000<span></span>
</td>
<td class="nump">53,821,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt</a></td>
<td class="nump">144,161,000<span></span>
</td>
<td class="nump">75,097,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">2014 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">1,079,000<span></span>
</td>
<td class="nump">1,079,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 201,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">2014 Notes | Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt</a></td>
<td class="nump">1,058,000<span></span>
</td>
<td class="nump">1,057,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">2014 Notes | Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt</a></td>
<td class="nump">1,122,000<span></span>
</td>
<td class="nump">1,122,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">2019 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">55,000,000<span></span>
</td>
<td class="nump">55,000,000<span></span>
</td>
<td class="nump">$ 55,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">2019 Notes | Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,764,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">2019 Notes | Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt</a></td>
<td class="nump">$ 143,039,000<span></span>
</td>
<td class="nump">$ 73,975,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesdue2034Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesdue2034Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978849672904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 17, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ShareholdersEquityLineItems', window );"><strong>Shareholders' Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock from at-the-market offering, net of commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,226,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Equity issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 180,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ShareholdersEquityLineItems', window );"><strong>Shareholders' Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,480,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | 2020 At-the-Market Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ShareholdersEquityLineItems', window );"><strong>Shareholders' Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_SaleOfStockConsiderationReceivableOnTransaction', window );">Maximum aggregate sale proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares sold (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ProceedsFromIssuanceOfCommonStockIncludingRelatedExpenses', window );">Gross proceeds from issuance of common stock through at-the-market offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock from at-the-market offering, net of commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesCommissionsAndFees', window );">Commission expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Equity issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ShareholdersEquityLineItems', window );"><strong>Shareholders' Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock from at-the-market offering, net of commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 133,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,460,260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=fldm_InstruNorASMember', window );">InstruNor AS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ShareholdersEquityLineItems', window );"><strong>Shareholders' Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="nump">$ 7,214,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash consideration paid to former equity holders</a></td>
<td class="nump">$ 5,165,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Purchase price (shares)</a></td>
<td class="nump">485,451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ProceedsFromIssuanceOfCommonStockIncludingRelatedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Issuance Of Common Stock Including Related Expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ProceedsFromIssuanceOfCommonStockIncludingRelatedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_SaleOfStockConsiderationReceivableOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Consideration Receivable On Transaction</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_SaleOfStockConsiderationReceivableOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ShareholdersEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Shareholders' Equity [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ShareholdersEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesCommissionsAndFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesCommissionsAndFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=fldm_TwoThousandAndTwentyAtTheMarketEquityOfferingProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=fldm_TwoThousandAndTwentyAtTheMarketEquityOfferingProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=fldm_InstruNorASMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=fldm_InstruNorASMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978850908488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Shareholders' Equity - Schedule of Stock Options (Details)<br> shares in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of remaining securities available for future issuance (shares)</a></td>
<td class="nump">6,157<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=fldm_TwoThousandAndNineEquityIncentivePlanMember', window );">2009 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of remaining securities available for future issuance (shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=fldm_TwoThousandAndElevenEquityIncentivePlanMember', window );">2011 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of remaining securities available for future issuance (shares)</a></td>
<td class="nump">3,057<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=fldm_TwoThousandAndTenEquityIncentivePlanMember', window );">DVS Sciences Inc. 2010 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of remaining securities available for future issuance (shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=fldm_TwoThousandAndSeventeenInducementAwardPlanMember', window );">2017 Inducement Award Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of remaining securities available for future issuance (shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember', window );">2017 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of remaining securities available for future issuance (shares)</a></td>
<td class="nump">3,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Securities To Be Issued Upon Exercise Of Options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Securities to be issued (shares)</a></td>
<td class="nump">1,626<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Securities To Be Issued Upon Exercise Of Options | 2009 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Securities to be issued (shares)</a></td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Securities To Be Issued Upon Exercise Of Options | 2011 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Securities to be issued (shares)</a></td>
<td class="nump">1,387<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Securities To Be Issued Upon Exercise Of Options | DVS Sciences Inc. 2010 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Securities to be issued (shares)</a></td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Securities To Be Issued Upon Exercise Of Options | 2017 Inducement Award Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Securities to be issued (shares)</a></td>
<td class="nump">207<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Securities To Be Issued Upon Exercise Of Options | 2017 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Securities to be issued (shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=fldm_RestrictedStockAndPerformanceShareUnitsMember', window );">Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Securities to be issued (shares)</a></td>
<td class="nump">6,026<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=fldm_RestrictedStockAndPerformanceShareUnitsMember', window );">Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units | 2009 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Securities to be issued (shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=fldm_RestrictedStockAndPerformanceShareUnitsMember', window );">Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units | 2011 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Securities to be issued (shares)</a></td>
<td class="nump">5,810<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=fldm_RestrictedStockAndPerformanceShareUnitsMember', window );">Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units | DVS Sciences Inc. 2010 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Securities to be issued (shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=fldm_RestrictedStockAndPerformanceShareUnitsMember', window );">Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units | 2017 Inducement Award Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Securities to be issued (shares)</a></td>
<td class="nump">216<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=fldm_RestrictedStockAndPerformanceShareUnitsMember', window );">Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units | 2017 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Securities to be issued (shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=fldm_TwoThousandAndNineEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=fldm_TwoThousandAndNineEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=fldm_TwoThousandAndElevenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=fldm_TwoThousandAndElevenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=fldm_TwoThousandAndTenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=fldm_TwoThousandAndTenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=fldm_TwoThousandAndSeventeenInducementAwardPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=fldm_TwoThousandAndSeventeenInducementAwardPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=fldm_RestrictedStockAndPerformanceShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=fldm_RestrictedStockAndPerformanceShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978851678056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Plans - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 31, 2019</div></th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>May 31, 2020 </div>
<div>offering_period </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2017 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_SharebasedCompensationArrangementbySharebasedPaymentAwardVestingRestrictionsOwnershipPercentageofVotingStock', window );">Percentage of voting power which impacts the term of equity incentive plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_EmployeeStockPurchasePlanOfferingPeriod', window );">ESPP, offering period</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase price of common stock, percent</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_EmployeeStockPurchasePlanNumberOfSixMonthOfferingPeriods', window );">ESPP, number of six-month offering periods | offering_period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=fldm_EquityIncentivePlanTwentyElevenMember', window );">2011 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Awards authorized for issuance (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=fldm_A2017InducementAwardPlanMember', window );">2017 Inducement Award Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Awards authorized for issuance (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=fldm_EquityIncentivePlanMember', window );">Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total unrecognized compensation cost related to stock-based compensation arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted average remaining contractual terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember', window );">2017 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost', window );">Incremental compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Additional awards authorized for issuance (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember', window );">Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement', window );">Number of months over which options vest ratably</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember', window );">Tranche Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement', window );">Number of months over which options vest ratably</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">48 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_PortionOfStockOptionsVestOnFirstAnniversary', window );">Rate at which outstanding options vest on the first anniversary of the option grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Awards authorized for issuance (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total unrecognized compensation cost related to stock-based compensation arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted average remaining contractual terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_PortionOfStockOptionsVestOnFirstAnniversary', window );">Rate at which outstanding options vest on the first anniversary of the option grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue', window );">Stock option grants exercise price minimum percentage on fair market value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=fldm_AwardsHeldByOwnersOfMoreThan10OfCommonStockMember', window );">Stock options held by owners of more than 10% of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue', window );">Stock option grants exercise price minimum percentage on fair market value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total unrecognized compensation cost related to stock-based compensation arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted average remaining contractual terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest', window );">Percentage of performance period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest', window );">Percentage of performance period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee Stock | 2017 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate', window );">Maximum employee subscription rate</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount', window );">Maximum employee purchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_EmployeeStockPurchasePlanNumberOfSixMonthOfferingPeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee Stock Purchase Plan, Number Of Six Month Offering Periods</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_EmployeeStockPurchasePlanNumberOfSixMonthOfferingPeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_EmployeeStockPurchasePlanOfferingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee Stock Purchase Plan, Offering Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_EmployeeStockPurchasePlanOfferingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Months To Vest Ratably After First Anniversary Of Vesting Commencement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_PortionOfStockOptionsVestOnFirstAnniversary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Portion Of Stock Options Vest On First Anniversary</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_PortionOfStockOptionsVestOnFirstAnniversary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Percentage Of Performance Units Expected To Vest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement By Share-based Payment Award, Maximum Employee Purchase Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_SharebasedCompensationArrangementbySharebasedPaymentAwardVestingRestrictionsOwnershipPercentageofVotingStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Vesting Restrictions, Ownership Percentage of Voting Stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_SharebasedCompensationArrangementbySharebasedPaymentAwardVestingRestrictionsOwnershipPercentageofVotingStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Option Grants Exercise Price Minimum Percentage On Fair Market Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>An excess of the fair value of the modified award over the fair value of the award immediately before the modification.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=fldm_EquityIncentivePlanTwentyElevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=fldm_EquityIncentivePlanTwentyElevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=fldm_A2017InducementAwardPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=fldm_A2017InducementAwardPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=fldm_EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=fldm_EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=fldm_AwardsHeldByOwnersOfMoreThan10OfCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=fldm_AwardsHeldByOwnersOfMoreThan10OfCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978849093080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Plans - Restricted and Performance Stock Units (Details)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Nonvested and Outstanding Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning Balance (shares) | shares</a></td>
<td class="nump">2,551<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (shares) | shares</a></td>
<td class="nump">3,642<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Released (shares) | shares</a></td>
<td class="num">(872)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (shares) | shares</a></td>
<td class="num">(305)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending Balance (shares) | shares</a></td>
<td class="nump">5,016<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract', window );"><strong>Weighted-Average Grant Date Fair Value per Unit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning Balance (usd per share) | $ / shares</a></td>
<td class="nump">$ 7.43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (usd per share) | $ / shares</a></td>
<td class="nump">3.95<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Released (usd per share) | $ / shares</a></td>
<td class="nump">7.30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (usd per share) | $ / shares</a></td>
<td class="nump">6.39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending Balance (usd per share) | $ / shares</a></td>
<td class="nump">$ 4.99<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Nonvested and Outstanding Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning Balance (shares) | shares</a></td>
<td class="nump">547<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (shares) | shares</a></td>
<td class="nump">509<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Released (shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (shares) | shares</a></td>
<td class="num">(94)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending Balance (shares) | shares</a></td>
<td class="nump">962<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract', window );"><strong>Weighted-Average Grant Date Fair Value per Unit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning Balance (usd per share) | $ / shares</a></td>
<td class="nump">$ 15.09<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (usd per share) | $ / shares</a></td>
<td class="nump">4.82<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Released (usd per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (usd per share) | $ / shares</a></td>
<td class="nump">14.26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending Balance (usd per share) | $ / shares</a></td>
<td class="nump">$ 9.74<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=fldm_CertainEmployeeMember', window );">Certain Employee | Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Nonvested and Outstanding Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning Balance (shares) | shares</a></td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Released (shares) | shares</a></td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (shares) | shares</a></td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending Balance (shares) | shares</a></td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract', window );"><strong>Weighted-Average Grant Date Fair Value per Unit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning Balance (usd per share) | $ / shares</a></td>
<td class="nump">$ 7.05<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (usd per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Released (usd per share) | $ / shares</a></td>
<td class="nump">7.05<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (usd per share) | $ / shares</a></td>
<td class="nump">7.05<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending Balance (usd per share) | $ / shares</a></td>
<td class="nump">$ 7.05<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=fldm_CertainEmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=fldm_CertainEmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978851374296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Plans - Stock Option Activity (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jan. 17, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Options (000s)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning Balance (shares)</a></td>
<td class="nump">2,027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Options granted (shares)</a></td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Option exercised (shares)</a></td>
<td class="num">(98)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options forfeited (shares)</a></td>
<td class="num">(408)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending Balance (shares)</a></td>
<td class="nump">1,626<span></span>
</td>
<td class="nump">2,027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Vested (shares)</a></td>
<td class="nump">1,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber', window );">Unvested awards (shares)</a></td>
<td class="nump">367<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise Price per Option</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning Balance (usd per share)</a></td>
<td class="nump">$ 7.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted (usd per share)</a></td>
<td class="nump">3.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised (usd per share)</a></td>
<td class="nump">4.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Options forfeited (usd per share)</a></td>
<td class="nump">9.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending Balance (usd per share)</a></td>
<td class="nump">7.34<span></span>
</td>
<td class="nump">$ 7.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice', window );">Vested (usd per share)</a></td>
<td class="nump">7.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice', window );">Unvested awards (usd per share)</a></td>
<td class="nump">$ 5.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted- Average Remaining Contractual Life (in Years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Contractual term</a></td>
<td class="text">6 years 4 months 24 days<span></span>
</td>
<td class="text">6 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne', window );">Vested</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1', window );">Unvested awards</a></td>
<td class="text">7 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding</a></td>
<td class="nump">$ 2,514<span></span>
</td>
<td class="nump">$ 81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Options exercised</a></td>
<td class="nump">352<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue', window );">Vested</a></td>
<td class="nump">1,799<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue', window );">Unvested awards</a></td>
<td class="nump">$ 715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (usd per share)</a></td>
<td class="nump">$ 7.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.22<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award, Options, Expected To Vest, Outstanding, Aggregate Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expected to Vest, Weighted Average Remaining Contractual Term 1</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement by Share Based Payment Award, Options, Vested, Aggregate Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Remaining Contractual Term One</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978961870392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Plans - Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">$ 4,357<span></span>
</td>
<td class="nump">$ 3,029<span></span>
</td>
<td class="nump">$ 10,358<span></span>
</td>
<td class="nump">$ 8,292<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">243<span></span>
</td>
<td class="nump">291<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="nump">561<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember', window );">Restricted stock units, stock options and performance share units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">$ 4,114<span></span>
</td>
<td class="nump">$ 2,738<span></span>
</td>
<td class="nump">$ 9,558<span></span>
</td>
<td class="nump">$ 7,731<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978851779608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="nump">$ 243<span></span>
</td>
<td class="nump">$ 1,168<span></span>
</td>
<td class="nump">$ 2,068<span></span>
</td>
<td class="nump">$ 2,269<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978851055480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Information About Geographic Areas (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reporting segment | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 39,861<span></span>
</td>
<td class="nump">$ 26,496<span></span>
</td>
<td class="nump">$ 93,536<span></span>
</td>
<td class="nump">$ 84,803<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember', window );">Geographic Concentration Risk | United States | Revenue from Contract with Customer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 23,300<span></span>
</td>
<td class="nump">$ 10,500<span></span>
</td>
<td class="nump">$ 50,700<span></span>
</td>
<td class="nump">$ 32,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">58.00%<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="nump">54.00%<span></span>
</td>
<td class="nump">39.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember', window );">Geographic Concentration Risk | China | Revenue from Contract with Customer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139978848672952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Development Agreement (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_UpFrontAndMilestonePaymentsMaximum', window );">Collaboration agreement, up-front and periodic milestone payments, up to</a></td>
<td class="nump">$ 11,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_CollaborativeArrangementTerm', window );">Collaboration agreement, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">39,861,000<span></span>
</td>
<td class="nump">$ 26,496,000<span></span>
</td>
<td class="nump">$ 93,536,000<span></span>
</td>
<td class="nump">$ 84,803,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=fldm_CollaborationRevenueMember', window );">Development revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 3,180,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 6,180,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_CollaborativeArrangementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_CollaborativeArrangementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_UpFrontAndMilestonePaymentsMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Up-Front And Milestone Payments, Maximum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_UpFrontAndMilestonePaymentsMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=fldm_CollaborationRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=fldm_CollaborationRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>90
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MXW@X=;O?$1;]DD6_'8N)E!F/R(-(E#9U=' <HS.!T!F4= ;MZ"R$#E5@RXE
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M1J3H/O)T@5YDM7U[ ^+/C]W^>V:5+[!6OC"71NAB36;[-GZ@6LL,1VQ@5ED
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MSQD^BH0\B%QG + @CDY4*-I5*!K^RJ#N<CSMS_&7!+6?-DGDYN )A$J8V]$
M*#/5$M>(/BK@IU[@T"Y/T_X\/>W>KUP2U%VNIN_.U:S+U>R=N9KY,YS)"FZJ
M!E!N1 .0T%,TZU5TS+'+T*Q_7&PFI_,N8%UN9O3=+CAX.=J?^,Z[@'F5BS#N
MN<!'4>PYP0<%##/7"?VJ&I[#@X\':U$]UU]ME&G;MJ5N7@VW3]LO0Y_K[R'.
M\WMR.R' \RFYG37??3KUS6>HKVGUG)<*%6)IEC*]IPF7JOFRT]QHN:D_73Q)
MK>6ZOER)-!.5!9C_+Z74^QN[0/M];?P?4$L#!!0    ( -.39E%R</4H9 ,
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MWO?$\)OZ\+4]_YB];2$<UL$-35A)T/>K1R$YO/ _.MP%C;M NPN.N/L$G;&
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MNR2Y?VL^9_LQZT_1<<41^9@N;MS\W1Z1P3\.XS^\?79J?^PKA(#V)T8@D+!
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M,-^??.JDH_]]G3H1!L7B*2CN%%("N*W;+J2$8:P8P-A.+24 QD):"K#SM)0
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MEB9:US4&^N^W15%_?]-\?=KV.P*/_P=02P,$%     @ TY-F4<=3OOH'"
MUR   !@   !X;"]W;W)K<VAE971S+W-H965T-RYX;6R5FFUSVS82Q[\*1],7
MZ4P4$0!)B1G;,XZ=S'7FVGKB:_L:(B$)%Y)0 <@/]^EO =*B1#S(?1-3U +Z
M8['8WP+(U;.0/]2.,9V\M$VGKF<[K?>?%PM5[5A+U2>Q9QU\LQ&RI1H^RNU"
M[26CM6W4-@N<IL6BI;R;W5S9=P_RYDH<=,,[]B 3=6A;*E^_L$8\7\_0[.W%
M=[[=:?-B<7.UIUOVR/0?^P<)GQ;'7FK>LDYQT262;:YGM^CS79:;!M;B3\Z>
MU<ES8H:R%N*'^?!+?3U+C2+6L$J;+BC\>6)WK&E,3Z#C[Z'3V?$W3</3Y[?>
MO]G!PV#65+$[T?S%:[V[GJUF2<TV]-#H[^+Y7VP8D!58B4;9?Y/GP3:=)=5!
M:=$.C4%!R[O^+WT9'''2 /KQ-\!# SQMD 4:D*$!L0/ME=EAW5--;ZZD>$ZD
ML8;>S(/UC6T-H^&=F<9'+>%;#NWTS9WH:I@45B?PI$3#:ZKAPZ.&/S!;6B5B
MD]Q1M4N^P8RK9)[\\7B??/CIY^2GA'?)?W;BH&A7JZN%!C6FST4U_/*7_I=Q
MX)?+Y%?1Z9U*OH*"^KS] D9Q' I^&\H7'.WPD>T_)23]F. 4IQX]=^]NCLJ(
M''+T++']D4!_O^^9I)IWVSY4N>9,1;K-CMUFMMLLT.UOL+0;H;P.[UL6MJ59
MOT\W<Y*597:U>#KU@\<LQRC-CV9GPO*CL#PZWMOZOQ"N?<QH 4N\$EW%&Y9T
M@V+SUCQ7)IH.)N0@@(3'2Y\C;BJ.:HJHF^X99+6*TSY7='5"6R$U_Y]]X?-=
MWUU^XA1<KE83S[E&)%ME?K\MCTJ74:6/6E0_YB85U4DE6LC/JE?-7LPS\XE=
M.CI02O*I6M=JA4OL5[LZJEU%U=Z>N-&DAIH] 0KVH%VS:M>)1FQ??8I7KI82
MEQ/!'J,L3?V"RZ/@\A\*7NNDYJH2!XC4CPF$2<L/K;)!PI4ZT*YB,!%*>Y=8
MZ4C,4#X9AFN#$0D, Z5CHDZC _DW@Q"Y&,9#)V>AL2K(1*'':DZ6*"#QA"4H
M+M&L<ANY9D4?N-J9=/#F=:]<Y A)IUI=DS(-107"HU8<U?H@Q1.WQ0C40J"X
M8JJ/ ;$&##+-(#L]@7HAO?$\]'ZJJE@YTETC1/(B('T$"R+O<C-$\5XHVA@'
M[Z7)I/K5#H']?>![XWJO<N***M%4N6N4!S('&LF%XNCZ7>^83#K1S2T".%08
M_KHA\[AM*M!C4P8(AD:$H3C#[G:TVS)EP$258KJ/B(;3-6\NH@F-;$)Q.-U6
M??8QD&3\B:X;]M&@T>L,ESEEL9QZPP.FL#M&,J$XFGX95H!3N0S27,#,B^72
MF2J/&2F6H7 :283B*'J0;$]Y_<;)8?7:&.LGSZO99<P<DW*:PGUFB)!50/,(
M(W2!1F\SOZ>O9MJ]$CV,*<MBJM"U*D(E'!XA@^.0N6<;)B707 +7NX-7'_8@
M!CO%A\\J#U4?>$0,CB.FSR$G*]*KT$7&'#G9V6N5YFD@/^,1+3B.EM_>4^1Z
M=;N\F"-4K*8%O,\.ET49 #@>R8+C>Q:SX-7[]RQX3/TXGOIO*T"2XJ9JL9G.
M(,NZB)HOY'3_-[C#S?'S'.6.-URS0'6 1Q#@/)Y;#K+:49-40"BW7K$[&Z_,
M_&(-XS&!+=<2E0&=(TEPG"10Q52,U2K92-$FWV_O7Y*MI'[P8Q<2"*%\BGZ/
M6<B=(TAP'"3G,J%D8>_QJ\N-/$6.:UVKD-R1+/@264[EME0?I%T*[Q'M@H-
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MTAC ]QLA]-L'\P/'_\MP\W]02P,$%     @ TY-F495*=5?3 P  ,@@  !@
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M8L#GC>=R'!82X/1OPN(?4$L#!!0    ( -.39E%OU8&DDR4  +AT   8
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MQO?M2^R0L;V3_F>CO2669I*'\/UG5<_3P;ORM]H *CV;,K8(,?$U!P#96FW
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M<-9N(F5G.0GE#3!'$]QT]<B+6[?3T+U#8@#2/)P0RRC) QYB)Y#9Q0N >MA
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ML:2+/%H^0/M+8_SVA0&Z?PVN_P%02P,$%     @ TY-F49TC^-5C!0  X@L
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M]:[PJCKI1R#*>C];65^TUJ-GK%_36V=C&>@WFW/^V+Z/2#;AC-;A7(Q>!/S
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M3!?)A)G^D=]/G&[]PQH4Q8G[X0;?1=*0 /9+K=TX(0?[+ZVS_P!02P,$%
M  @ TY-F4<?I'U)Q!P  BA(  !D   !X;"]W;W)K<VAE971S+W-H965T,3,N
M>&ULQ5AA;]LX$OTKA"\XI( J6[(<V[TD0-*TNP%NN]E-M\7A<!]HB;)YE4B5
MI.)X?_V](65%3KWIXG#  4$L49R9-S-O9BB=;[7Y8C="./985\I>C#;.-6_&
M8YMO1,UMK!NA\*34IN8.MV8]MHT1O/!"=35.)Y.S<<VE&EV>^[4[<WFN6U=)
M)>X,LVU=<[.[%I7>7HR2T7[A5[G>.%H87YXW?"WNA?NMN3.X&_=:"ED+9:56
MS(CR8G25O+G.:+_?\$F*K1U<,_)DI?47NKDM+D83 B0JD3O2P/'S(-Z*JB)%
M@/&UTSGJ39+@\'JO_;WW';ZLN!5O=?59%FYS,5J,6"%*WE;N5[W]473^S$A?
MKBOK_[-MV#N;CEC>6J?K3A@(:JG"+W_LXC 06$S^0"#M!%*/.QCR*&^XXY?G
M1F^9H=W01A?>52\-<%)14NZ=P5,).7?Y@];%5E85XZI@M\IQM9:K2K K:X6S
M$5/"G8\=#-'V<=XIO0Y*TS]0NF0_:>4VEKU3A2@.Y<< V*-,]RBOTQ<5WHLF
M9M-)Q-)).GE!W[3W>NKU3?\KK]F-M'FE;6L$^^?5RCH#[OSK!;-9;S;S9K/_
M;;!?5$I5^\8V/!<7(Y2E%>9!C/Z,)2RS7"O5E<=6N@W3K4&=?&VEE7Y1E^SF
MTSV[SZ50N8#<K<IC)A5[+U:F11$C(4D6L:U @>9ZK>3OHF#KO7&(GR23+$[
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MMG/]]-=O@EW&B6MJ \UO<;F@@1D=$]#]S-JPV;" [0A^_A]02P,$%     @
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M@\OKA::L>XOEK%84+@>_IVH@JU",-B"W69G6['22[N*2N#49M".MABP0$;X
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MVAJ&&#[D;.M!G/.H[/AY47%A0D6>W$)I/P_+4Z[O>-L08@@S!]$[B:_:/'>
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MYW1%1;GS%KL:<O[BG4)([FS@H8M6!OE:[JJ5BU^0FXCWIO)+)_ZH9FJV+S^
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MU'):("R:#Q06G4/9:K U1SE?ZU0/N(^Y':M+J]H"H"N1I'8J*YK*+Y$C,5:
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MT27ZUQQM.6NW -\SA2SM!FZ#=:-__A]02P,$%     @ TY-F4>8A;E 6$
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MMKL>N!OTZQVDU\(A4@3A!:33\\I2KD%;0OPQ59XUYH$%%AVS!TODG(=@:9>
M?G#:+%7Q-?0R,'66=B$*TG;VM-#(Z$#6GFO_"ED?HQ'.?_UEK0J'T[@IBL\A
M]ZT<(^;+7*:?SF]3"%/H R2$<ZPCN%#*%%D@)FJK +)41]2IY4/EYJ&^R&\!
M7G;JV7*GG&&O!>*<KSWW*-A#2=BCIV[YL+>0RNY6CM5@ 6HH\)SUUD'H&"M(
MN?2:"Z?>,![VAKD'"[ ]ZO?JRTA<8PA#*38F&!(JDB8'6.?!R#T5[YN.%O?%
M/E+6^52\JTGD)Z=@>,/AT)V!/C!E5=GY-11*<@&6(7,":I#FCRHE,!2C>$">
M+9+!9!*+)^(J&H]0CC6KH\'E.(&!432;T(!56(G"R.GT*CFC):,AC8 ]SJ%.
MQ*'1<()#E]%HUIQ+%GZK(.#RV;['*B:#87P)L\?1;":N#\P:^,H6L-HL"LS2
M4,KH"NP"J7'E3D>Q<;^JP-($GI.%/&3+[/E/DJ3)0,F\%7@>^W!-!!!EP+#Y
M<-^.VWC! P:RX)LPD413;@!$7HT!I-J*W%-<_4!<+Q96+=!LWT"LT(73*:&#
M$J?Q&:+O*>O^ 54/DRO2V]44-#2%C]-X#R[CX82T?C6NAX(?@WYGTS-6V! G
M39)Z3LL&QD.:-(M Q0_:0#RX3"[9F,9 U!@^@DG&8_$K*PXXZ5V53&:T:GH)
MJY"8>'"%5L2I!6N,[2'T-'JV&5VB/";1Y!)VHOWBB?@7_T>2;>2N:[FSPQ]D
M"#TXE7E:L4%*[@V$5@06/*K<*!]0TMPX+IRQWP/VXEL.1^ DQVY0:279=R:W
MA[R&JV&DY@GZ]J"..?M-IJ9Y \F9QT+=H%V#AKHXAP?G0)/:AA71'^RY(9Y\
MI?/&4?S(OHM5F??=F[T.D;>WUD 'IRE3>LN!XE5](X)T47\D^-P-@&AS79 J
M6V(> 8I**V+0S.>@*LMY@U.%AM0J5_<0TNM(QV&Q4=4- 5Y>AJH:&"C:J8\+
M?2U(BMKVRFQY6_M@2DA<Z2*+JU^(1V5E 6X^W+X_ZP_9CI0,*^I>*<RE5B9>
M6U+=MK"F6G,W2UF>7FB(LEEE0P2&(CO7*>61U)L_ISYZN\'""F*VX3/: NHM
ML-XT^*G-E2FP.^(+*2:;(\LQG#:'3(/FS/>Z>=X8J$$#F0O=X7$7<?@#<IFT
M>N"-"KA!Y'4<@46@ '^ZOGTIKF]?@6S7 "97\93=I-4Z\QNUC*+E(RA,1 AL
M%$$I@F*6(16I[]Q:SDYEL]]3EGLS:2^KYCG#I=Y-6782+5(-T13YW!./QXM8
M)5Y)FQNL&M&2<.N]Y!,\UE?8G'_N$1.H!4)130]D3B"*<+V*&M?=S.FQ$J3)
M&&-$/(FPG]#*CR;#&47":4*/Z^R(JKKD+S 6/MUT4Z39&*-C/(X@[K5.[@DE
ML\N$XBB$XD?#V([K,V2.H\M'A\RK'LC<1\;V8 L>?V0<X,H3FS5X:UJ7<XUC
M=/J^Y3[\D<6W,)#@0#L/!M3F#.UINC+QN)MIE^)U(80>Q=T@ $$0$*PV>,T;
M OBN-L!8T.UV3"@9MHP79$I>%8P8B&FX^8,,^'),B1*D=6WS[3?3)L<?G[57
MM<PW3NJ1X]8[GH9Y#]_O8Z>[6E2@'N[0'6ZZX@B^#! 06Q9%A>I1BIH7H8[U
MZ_C6GN8;3,"<^!C=1AQ&S4I1^X:>-!4CW4NA?%%9ZT#EX58>'\&78LU!K3NM
M.T@@"[2T7]+2H(18,5>AC^.6AF_#=]:INC/Z#CAOV]D5N)7%'  HW&GU$P4@
M*E#S"G(,=!>GOYS[F[/N"8- 0:$VX5#D#++45DN6.>LDG 4UG>@B')OKHY@$
MVJ*2.HWA]CNJ5>\!1^5ZH2FRF^8>E4("Y 4+NIZRAF)V5OD71C":KG%^<PNJ
M;0?I?"(0],6Y+39S"!R\^NAX!Z;1BB(D,4R3I\TU?A[NC@\6^_+A1)T%YS-T
M2K%W%.Q[LY30'YX&X@NM[YZKG8Z^J7F 5SH^G<:-\$YZH_)[U6\#OI>W,2TS
M:81(4Q#P%KHHO$V07H'4?LT?5G8C\4!B(/M[S&!RT R:\_'NC1K%@9_F1OY)
M,L&05CG)"5_3E)?%%M-AH%!:;[X?:\JK=49QM"UUG[X=-SP9["XTY-DX=B2-
M$>#_Q0I[">1[<AQV"K.VW?%OD\6W<DL%\_>P&)+A!SWM#6\(E551?@,=/A2U
MW&1^1$C(=T\7M'M*T;_C'H+WR'O>5=&N,#1?2E)X.RK^1^/WJ\7_H<\\YPQY
M(9L!JAEY?):!,0[A:Q>T?'##%[6Z\70WF,YJ^OA=AN[L]EG4Z?@FJ]@_"R&:
M17V@!_[5POX.4]A5#!+#MM"I^CNFL,^"]VHOM(XR:(CU2/N6+7IW2,.N0U/"
M@E;I110H%?4<ZO[VRR@&LC&-*7CGLH12YH#-6$_7E31=2N$M"BQIR;;#XH%V
MW+XJF*!P5UISO3^QIM+G\I!&99K+CCLUQ\"C2Q)XO2-%Z\Z;#T^&T:BIQ#Y@
M=2!7IBI*']DA3Z0*K^?]J;VP3HC+<;9KPZV72A[_G8C!5[U50N&3BK-P@9CU
M7[L<?F,$3LFX7 21C_K?&*&;P7"]PL[MWUIIYU0[;'U-0O5U&74])GM<[P_.
ML^4?EWD=3L ?/_/J2>E#J&$U]^7R!]**_WD:S\U4VMNWK3J=&N6O=UN=G.YE
M(#4 @NC<V5.0#KZTW/X5Q$X9_DX71\<)L_EJJ/[TOO<5^L'NY6[?VVZ^X?E$
MC =QS!<Y5R-L LP&DPDU ^![W#0">,M&O]@(2,8CD<QB,1T.Q>0R?DAH>-9H
M@@VZT6"88$,N'L(#NMH:)+-$]/VTXJ+UNQ5ZB0)_G4-O%!0E_X2E?EK_ .B:
M?_?23.=?#[V5%E ?\[DY+!U&5Y,3;AZ$+Z59TZ]@[DQ9FA5]7"K )8L38'QN
M3!F^X 'USZ)>_!=02P,$%     @ TY-F41W$G:7.!@  $1$  !D   !X;"]W
M;W)K<VAE971S+W-H965T,C N>&ULI5A1;]LV$/XKA+$!&Y#9CM-MW9 $2+L.
MZ\.PHEFWAV$/E'2RV%*D2E)VW5^_[XZ2K+1V5VPOL421=Q^_^^Z.S/7>AS>Q
M(4KJ76M=O%DT*74_KE:Q;*C5<>D[<OA2^]#JA->P7<4ND*YD46M7F_7ZNU6K
MC5O<7LO8BW![[?MDC:,70<6^;74X/"'K]S>+R\4X\-)LF\0#J]OK3F_IGM*K
M[D7 VVJR4IF67#3>J4#US>+N\L<GCWB^3/C#T#[.GA7OI/#^#;\\KVX6:P9$
MELK$%C1^=O24K&5#@/%VL+F87/+"^?-H_6?9._92Z$A/O?W35*FY63Q>J(IJ
MW=OTTN]_H6$_W[*]TMLH?]4^S[VZ6JBRC\FWPV(@:(W+O_K=P,-LP>/UF06;
M8<%&<&='@O(GG?3M=?![%7@VK/&#;%56 YQQ')3[%/#58%VZ?>Y*WY+Z7;^C
M>+U*L,CCJW)8_22OWIQ9_8/ZU;O41/7,550]7+\"D@G.9H3S9/-)@_?4+=75
M^D)MUIOU)^Q=3=N[$GM7_[H]]9.)I?6Q#Z3^NBMB"A#$WY]P\6AR\4A<//J/
M#'[^:O5;']3;7H=$P1Y4%_S.B/B1>\KDB4DFFBA2K!3KVBF*R4"@>*>Z)M$Y
MAEVO[6R9"IBQ_'P?VD;/([:O\)::;,2T'7A3OE8EA82D5[WK(WN2]76@MSVY
M!-.^+/L0C-LJDZB-%\K4 '6X&&SRA[+1;LO;<>IU7VV1ZTGI J5#[;3M=4Y;
MB[JA7<F(W+C!* ".JQF9U?O(('B;[,T)9N.P4=.J#G]]Q:/[QI0-?QL@+M6?
MA/)2^@ )*RVV"G)4&]GF%^OE!HEGK8 !@B\VR\MI@%D3:II ))\= JS:G!7$
M6:&@:1!04)B$?0%_L<N!LH=_ W#Y,8"K_P7@\H</ ?P."X/+*";!^D!95'M"
MRG0@40>#N.J4@BGZI L+MWY2Q@BY#KZ50=WZD,S['$9LQ$-YNGS;0V\\]$T@
M*YI%#:40\"!1-+HP%A,0V XJ-4""0-5U1(,J#C)G$FW&RG;QB_H+-P M#K-:
M8H('+INF[=L'\LZ)\ #WAPDP4COR@*87H5!&;*#"<-SIYO)+]6IYOU0_4P7_
M5OSVR8>#J'&R]#G:$-P?Q^AB%H&J%^*YY7(&<B;I4QDC?EL?T\C^ Z9U!*5(
ME)P/1^LER#-YC0/G Z/P@>(95:E#.,#N7H=J1F+G<U!!.\02^^(U@#-(C4R'
MIA"Y%GW2=#:+Y74?3*R,=.8H"5"0-;1C(>L$R:E&[RA'6K*B0EUA*CD&83=$
MIW=C$7J(850PCQY(AXB (%]X+SEC>.\Q<KU!S/YC"I^+$[!7!D9\DJ3>.O.>
MS8( S:5(:C(>B"D.$)?35M0^I@-(.[.OI7HI58*#<2*4W!5T!\H02Z9JWQ"?
MF[2=Y2 V&FDV'RE*R+DW0,[,.X:]5'="#[MA8@83DI:<BN=\5]0Q6ZCA?0=O
M$='D7*C1+WR(L[+?0%X^F)(_&@>E,BD@! +):5OWB=LTO6-:X>>C6;EBG<(A
MLBF(W*QFG&HF2_4\-XC!%Z+6Z@,'@=!8S_>?8TA/LN"FMCBDW%B8D!+15 8I
M1B-33(7/('39L/BE 6+A@ FA1&$:B1\:&B/<:<S[((7NW!$]3)S<0.E[6V6*
MV%3NI3FB):(\17QV:#@>$ ;_0R/EQU,EQ\01125IC6J"XC$4+.],&K)--&<:
M+Z9RQN\Y10N0,306IAH2.E^YCHI*C8^YW.5J=KH<"K;<9D5 H+B$Y.'2>3;:
M!YGV ,\6W4%J> Y&'&D80S3T!F1Q81E)'QEZW7/7RHE#YS:018R3FPBA'K"=
MK^8#<X'S*O*!JX:JL-DS6YT582]/^518C1_X=<Q-V3*XX*)52,971DZ'Q (C
M.3?I:L>F4?.=^E4'.-Y\/]9"QO74!^_TS@10<&>J"Q0K5/1:7#Z##'QK2A12
MG+A8S5\]O7OY[/YK=0>$>PVT2!+Q [@XR65N9(Y,F<ZAL]XO!5.BSUJI>U>)
M<CI]"'XH_B5O@*5RKI,5NGPS!A$EW:(P.RW4C(>&HYG!">:U'B< U*_<;88S
M$+N8*CLDUN=KIT5\T^Q(DJALG-0^1#ODNVF<GZ-0'#"< ]H2E%WEAH;^9^&5
M26J9A5PMN-RCXN1#)/=>/G3G [A&9SF\GW)Z.KCG'C">G@43YP)7JHOY;6*8
M.ZUT#XY'L_-\E&9WP/[U3AO+45B>NEBM9M?4EL)6+N-2E5S*-]9I=+KOW^5K
M[G%Z_F<!!+@UX,U2C:7KY???+E3(%_#\DGPGE][")URAY;&!JBGP!'ROO4_C
M"SN8_@MR^P]02P,$%     @ TY-F4<1P_,I[!   [PL  !D   !X;"]W;W)K
M<VAE971S+W-H965T,C$N>&ULK59-<]LV$/TK.QKWIE+?K96Q/6.[7SDD]=A-
M<^CT )%+$34(, !HV?WU?0M2LNS:CB?)12*!Q>[;MV^7.-HX?QTJYDBWM;'A
M>%#%V+P9C4)><:U"YAJVV"F=KU7$JU^/0N-9%>E0;4;3\?B'4:VT'9P<I;4+
M?W+DVFBTY0M/H:UKY>_.V+C-\6 RV"Y<ZG4596%T<M2H-5]Q_-!<>+R-=EX*
M7;,-VEGR7!X/3B=OSN9BGPS^U+P)>\\DF:R<NY:7M\7Q8"R V' >Q8/"WPV?
MLS'B"# ^]3X'NY!R</]YZ_V7E#MR6:G Y\Y\U$6LC@>' RJX5*V)EV[S&_?Y
M+,1?[DQ(O[3I;&>+ >5MB*[N#P-!K6WWKVY['O8.'(Z?.3#M#TP3[BY00OF3
MBNKDR+L->;&&-WE(J:;3 *>M%.4J>NQJG(LG;VU76&'H=(6JT:_LUEXUE<[I
M%&4.1Z.(.&(]RGN?9YW/Z3,^E_3.V5@%^MD67#P\/P*^'<CI%N39]$6'5]QD
M-!L/:3J>CE_P-]LE/4O^9L_Z6T-7D2ZY<3YJNZ:_3E<A>DCD[Q?<SW?NY\G]
M_)MR^K4^Z2,3>M6KR*0M.<MHFFU^H<\X5BI"M#=HQB8,(23;ELBZ]>P#*5M0
M[NJ:?:Z5T?]RH.B@+T)H,KID"KEFFV/=<V#E\RJCWUM/>:6Y)+[EO)4>(U>6
M.F<O[M'8@1QL.FB W\7A&V5:0.TV2VV5E: $JY0HHI T+0#9X(PN8%M(_^F0
M$?J1FM8W+LCYDI0Q+E<I40"#0X&X%Z7;6",X(CP9:YA@/)>'YQN9!F"Q48G?
MH PBZ+V:"$6Q8BIT6;(7JKN "9]L8#B9HJ-KS19<F(10%6AJ+=I+$?D6TS;T
MZ 72ENBTT!<N5?+>TC-9%[<D@*7H8'U'H>%<(X$>28:N#%'@B-_&:Y#0 ,5]
M84 "D$H>RNY) ^P-=W@*^)2!_'VMKH76LK5Y7U7@V"* R!*?#C5*A%7X7GQJ
ME8^B,ZA3&/E@M=A>19%!1J?;#P-%M3*\!1I=!$A4@&W+M+H#>SO=JZ3[WK ;
MEEL=P[#QKFCSF%X#^QLMJMC6*5:>.6U9=!K5W<!B&5B$<1.Y7H&)[<Q)AM/Q
M9$E:X.>F%3OD\=XAN84P+DZAU4**4CQ4[;WB@N0JY4.^5TE#.'D/_"EBI(E%
M!%:6#J:S;(;/@#&@'.7RM#C\+BELGZ70E>M@,<Y^?&@\?]+XRS@9BC8;3E]5
M<_>%^4S&V>(!Q/GX^7QFTVSYP'BV_&;Y3):/\WGOQ!&^ZA;5;&V$,.'W'_1#
M*'1WI:A4L1L%:$CH*ZEQ\E0.CU"]5G##Y+>)Z?AY!24-:0/M5RGXHQ (>C![
MQ-%D\95@)LN,_L!8P A#L]G/L[+1L7J!EO\U]3V:5[4B;#]/3!=>^)A,LOE#
M0F8OBN8U4LF>NB2,]BYA4/\Z735#QU)W']NM[FZSI]TE[MZ\NPJ_4WZM,5(-
MESB*+L;ET7?7R^XENB9=Z58NHM72HTQ8]F* _=)A+O4O$F!WQS_Y#U!+ P04
M    " #3DV91=I$S-A0#  #I!@  &0   'AL+W=O<FMS:&5E=',O<VAE970R
M,BYX;6RE5=]OVC 0_E=.41\VB240:+M5@ 3]H>VA*BKK^C#MP227Q*IC>[93
M8'_]S@YD3*/5M+V ?;[[[KOSY\MXK<R3K1 =;&HA[22JG-,726*S"FMF8Z51
MTDFA3,T<;4V96&V0Y2&H%DG:[Y\E->,RFHZ#;6&F8]4XP24N#-BFKIG9SE&H
M]20:1'O#/2\KYPW)=*Q9B4MT#WIA:)=T*#FO45JN)!@L)M%L<#$?>?_@\(7C
MVAZLP5>R4NK);S[EDZCO":' S'D$1G_/>(E">""B\7V'&74I?>#A>H]^$VJG
M6E;,XJ42CSQWU21Z'T&.!6N$NU?KC[BKY]3C94K8\ OKG6\_@JRQ3M6[8&)0
M<]G^L\VN#W\3D.X"TL"[31187C''IF.CUF"\-Z'Y12@U1!,Y+OVE+)VA4TYQ
M;GJ%SW0QFMKL8%8:1+\:)XZ@O4.2[6#F+4SZ LP'N%7251:N98[Y[_$)4>IX
MI7M>\_15P"7J&(;]'J3]M/\*WK"K<QCPAB_@W9F22?Z#>2GTX%))JP3/6:L,
MF</"H*7*6X,JX(9+)C/.!"S)&+IBX>ML99TA(7U[A=&H8S0*C$;_V_E_@('K
MHL"@=[AE)JM@.&@[V8,U@N6EQ)S*AKOK6U@V6HMM:,)QK#='S6])J*X"MA,I
MFA@>Z.X-N J/ _7@1C0\YV5-H4+0VPE.H(W*FXS:ZU]7#K[_C2&M9T85(2"S
MX#"KI!*JW,;P^:4$'NF9YVBAT>\*0X(,56DT7!$*00HDKA)!LVU[HW33C0:G
MX&0PB,^]A_ "R!O#91E*R0\R64=SJB7PAQFX!=QHZCK50(""64JOB=*&T_!
M:K'/O$5F@+C5+3@=> Y^S?9EQ/"(-.\R59)@">QD&*<=,U_0R=F!@:(/N1A:
MRP;W*8A4APM<AD2N(D, DJ0EJ-N'B_[A CT[$ON*KG'_]GH$:74K)K&-CPD_
M.1@_)(0R#%D+F6JD:R=19^WF^*P=7[_<VX\ J;7DTH+ @D+[\?EI!*8=K.W&
M*1V&V4HY4EU85O0M0N,=Z+Q0RNTW/D'W=9O^!%!+ P04    " #3DV91WC%Y
MXD %  "_"P  &0   'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6RM5MMN&S<0
M_96!"A0MX$BR;#>7V@9L)4;RD-2(F^:AZ .U.ZMES<N&Y$K6W_<,N5H[:6,$
M;5^D79)SYLS,F5F>;GVXC2USHCMK7#R;M"EU+V:S6+5L59SZCAUV&A^L2G@-
MZUGL JLZ&UDS6\SG/\VLTFYR?IK7KL/YJ>^3T8ZO \7>6A5VEVS\]FQR.-DO
MO-?K-LG"[/RT4VN^X?2ANPYXFXTHM;;LHO:. C=GDXO#%Y?'<CX?^$WS-CYX
M)HEDY?VMO+RISR9S(<2&JR0("G\;7K(Q @0:GP;,R>A2#!\^[]&O<NR(9:4B
M+[WYJ.O4GDV>3:CF1O4FO??;USS$<R)XE3<Q_]*VG#U93*CJ8_)V, 8#JUWY
M5W=#'AX8/)M_Q6 Q&"PR[^(HLWRIDCH_#7Y+04X#31YRJ-D:Y+23HMRD@%T-
MNW2^]-;JA"RG2,K5M/0N:;=F5VF.I[,$%W)P5@UPEP5N\16XY_06 &VD5Z[F
M^G/[&:B-_!9[?I>+1P%ON)O2T?R %O/%_!&\HS'>HXQW]&_BI9<Z5L;'/C#]
M?K&**4 T?SSB]7CT>IR]'O]?6?X/</0&J;=.-[I26?A7P5M*Z"1*/O\?T):I
M51LF('#@FK3#EO["K@M^HZ7Y(O78"E1Q2&AS\@WY/I!:!^9" HNI9?*AU@ZM
M317V(\O!51]!/L8#2KL.R,;LH/#4CAO4J9 <!YPH<L^/$E7LN\YHO$[I&G"]
M<BE'T#*@[YWG:*S:C?QW!]1Z4R/"8$UV+6C90.P#:[O*](3R&#2R($PD@3(L
MJ$*K/UGMGLB_]+V.A!%(4$?$D=@W3<X<EK2K^B#/J]U7(9&@RCLWC**< .5V
MV$X(04 \+ 4J83[A5*^,Y+]#QB6P)DAY)5RJC-)67(E]:G4H3H:L!HX=S"5.
M*1$@ZK["U*9?00RUME*3DL%'RHU8(28.N5K@T'$FU&0A"9"(J0 1WW'59X!A
M8:Q,<8I9I6UOJ?,2J@:,LKZ7H!MJ^B2MUJE=D1$*">6@="M&))]Z+5E%*%;=
M\J#!;^%^KS3G$QF-7BDXBB0[8C:0F*)92-6U%I1O;(L'LL\IESS[!MM9N#4X
M5\GO-3RV3"XOV\[X'3/J\5%,][M\5W$GX-(F7\B[Q%9S5M^77&0ML%$2']_A
M0QVSUBK3HQ'7!Q*E6Q?G0BB!F.-=_/Z[9XO#IS]3 RH']&=?KX=.:J0E2_-Q
M2J8HKJ0J?J9S$=]#)6E0A$2RT&5/%:'[+,&*6>A,_S:G"-,]L5TA-3+>P9"Z
M/BGY3HO.,1P&G,HC<\@4R* ]UL"@C?8F)R'NA==P+9(%=?#4N>V,VJ)*"JVK
M#<L, $9,^31F:"=,?P!K3TY9 95:+EO-#;TJL@:17TIMRZ#->U<8<@@!KL:]
M*#<!=C5F5/QQ/PX_3&^F\DE)0:,EEP!/N6*R]\X'J8J[WT<42V4T#CBM2N_<
MAQV9;V4,#_I%++6RN#3E8;7B5IE& "1_H0,T#I0$8A$-'"5-$H"T8,[,MD4[
M5$.+2=CP!;$0)G!U"\2T9<:G@U>AEX'^5#[ A\\SQCN_*34[*8N%JP'NNJA2
M9QEH2(950!?&E)F*K81N<'>D$I=N&G1<S'VZPPUT)4YKED$%)=9H$\Q>QD=@
M4Z9U'GZQB"#W9UD=TV04R.,+HE/VMN4\45UN_E(@RE\FLP&?C5[[X/MH=M-_
M^L3/'ERJ +G.5\<H \JE<K\:5\?;Z46YE-T?+U?;MRI LY C-S"=3Y^>3"B4
MZV)Y2;[+5[251XO:_-@B2QSD /8;C^DYO(B#\<Y^_A=02P,$%     @ TY-F
M41^[[9AG(@  K6P  !D   !X;"]W;W)K<VAE971S+W-H965T,C0N>&ULO5U;
M<]M&LOXK*&]V2ZHB95*6?,FM2I9CQ]G$25GVYN'4>0"!(3EK$$!P$:W]]:>_
M[NF9 0G2TI[LOM@2"<ST]/3EZ\N,OMU6S:=V;4R7?-X49?O=HW77U5\_?MQF
M:[-)V[.J-B5]LZR:3=K1K\WJ<5LW)LWYI4WQ^'PV>_IXD]KRT???\F>_-=]_
M6_5=84OS6Y.T_6:3-G<O35%MOWLT?Z0?O+>K=8</'G__;9VNS(WI/M:_-?3;
M8S]*;C>F;&U5)HU9?O?H:O[UR_E3O,!/_,.:;1O]G& IBZKZA%_>YM\]FH$B
M4YBLPQ I_7=KKDU18"2BXP\WZ",_)UZ,?];17_/B:3&+M#775?&[S;OU=X^>
M/TIRLTS[HGM?;7\T;D&7&"^KBI;_3;;R[.731TG6MUVU<2\3!1M;RO_I9\>(
MZ(7GLP,OG+L7SIENF8BI?)5VZ???-M4V:? TC88?>*G\-A%G2^S*3=?0MY;>
MZ[Z_D=U(JF5R8U>E7=HL+;OD*LNJONQLN4I^JPJ;6=,F)_K3Z;>/.YH: SS.
MW#0O99KS ].\2'ZIRF[=)C^4N<F'[S\FDCW=YTKWR_.C ]Z8^BQY,ILDY[/S
MV9'QGG@^/.'QGAP8;VS!_W.U:+N&Y.9_CTQPX2>XX DN#DSP,FUM"S;_UIC6
ME%TJ0EGFR755MC1ESI^,L?;XP!_6AF0[JS9U6MZ!_LR/9_)D:<NTS&Q:)"U-
M:4B?NC99I[<F61A3)J3)==K0<[;$>]!RV]V1#';KY./9S5FR,J5ITJ*XPQRF
MQI!I8%7=6!J\+B =_/B;JZO?3GE5]$71YR;I''D])J;E5WV3;-<51JRV)0W7
M]HO6YC9MB.5GR14_=(.9-@O3_.TO\Z>S;W2?)\G6$/'YX0&PCANB+*VKQDR2
MZ[1,\W3"1+PS]&]3$&WM)/DI)6Y-DM<-,<?(]Q]+B]7]G=[.JPV]NR;639(W
MAG2_O.,UO:N:;7I'1!;%8-9)8CZ#.0GQ+YZ^;WG]MDF**J,MR/JF,65&@[7N
M\V5?LG6*OCQ+L*-^E##1'<9KA5;P.B<>I W&LL3:T9% J"T[TSCQ2$B<RS;E
M!UM>TB(MP()8)DQAR="P](A4!.D\.Z((EUX1+H_*ZWN3%6G;LJ5A.L9$_O@0
MUZ;IR.% _(CAM:'_2"PW(F/T.5A$=.?D/&@1 WV(M(#DC(2TVAAFQ+V>S])V
MG2S)D[4DB;0WC5\+/=I5JD*B/TP%;T6G--:1[O,^M_$8CA\RM"6[3!L'S05Y
MN<V3LNJ2=+DD?S9<>5=U>*IM34>B*+\5-EW8PG8LG>1%LD^D,KEIVK_]Y?GY
M_-DWB?FC)TW7QQMS:\K>Z*]9U78B'^9S#:[0($75DI0UU28A2- X4HF(DJ #
MOCLF&T^];#P]NK$?B1_$YA_:SF+UHZ+QL!%8F<3*B<6E+T=MHBW93#4YU"$R
M@+!HQ![B%NT=>=Z2L K>P'9OTD\F,7XJ\(MVH=_4PIQNG?H-8S/H))2HJ1JG
M7DY4OV"P>>38QI,HP%K^;AB2L%$-=- JUY;VO+$P.MA!,E)8%8:A+V_):%4]
M/0>#.*!X0;I/DL"RO(!HIBU9E$5!@K%=VXQDNEJQ&4U8S$'\@OT:#!]Q Z3]
ML\]7CNH%P4!98=HT3/=M6O2&54G$E4F*9%6,W[(O0'?GV.RFIB^N?_W'VU?3
M^8N$^)";C<U(36HR9RUS8-&W) TMR2IM%:$R\3=!6#%78"\4WK)(;"U-EQL2
M=&9/V6], _Z8VZJX!=5+FJ)J6N?3Z),)S=6Q/L)6=LPP\2*;E$!4!\?'6ML'
MJ<.W2K8\N[M"VPDILB; V2(G-(A!LZ8R1'"%)7O"::&>(AZPK0V10G.13:EN
M34/J#2I6^+G$GCACHHS"!CM?0$3$!+)H88M:MHC.WD:>GR2-K).3\0 2G**P
M2!/ED<Z1*R/K.91P6TI8@6>"+G3$%S'.X=OT-K4%!!&$]K*5>+PO/Y6$ I1E
M])87D72()#Q85+L[LAB'67+97C;#NWL,.:.55ELV$Q#[O.H7'4EL0#GL3@A4
M63&,AO>)["O)D."(QA2LZ_ &S:T)RQGJ">A?557.0L&ZRZI75.5J6EBHJ2@1
M^?FLZ]F*B]@3'05<!ID>J*6X$=H=MMX=KWYHM>0%A@!I$OQ.3G*#9\6$82-I
M]0<<Y9C=.N82GGF7\.RH0:?8BR*K,KEVH&;,)3QLA*M1RP-FEU4Y9:,_@)0L
MX@[*/03()02L!7 5#DR1[$;(C4CH !S7:;DB6\N;05H0N"WFE?%9(B$Z6"TF
M,LW_2<&AV%G9=C94;H-9W;!F3XO2(890H LY.W%")+G]IA<J1<;@:AJS1O1]
M:UB*R90DK;A1PU]7)8P7<>TPNCA+W@: Y9!$I"9#]A S-H@1$6J0W)&;W64.
M65.U='<F;8Y)UW,O7<^_ $89]R0$2BL8[@,1V(,'@?D4J]@9!5< ;11KVT@1
MDS8MC$9%=5/E?>8D$X;!9G"(O\G'?A3RML1I5O^]86Q) 6L?, ,TM-_ ;@Y\
MQ=O7U]C/MDWO6F>0B-U06+*7/.\#9U-RV7PC8F8?7*>VX7G)(A0B>Q/LN"U!
M1#!HY+9@..R_3*Y,( VL 9(B/L A%6VUSU:F*Z=?BJIF8M)58\0 $6JEEUGJ
ML,KJ+BTHN@W?BWLD&<32WX<E>X0&< NP0J$35MU*3(>WV$)/TQPJU*6?#6 [
M+;] NDE(DNP-_$K:JF,DWWL7^>,D[;LUX32!/N_),*<- 0&&#M&" ,?5.;4*
MSMNV(JZ!2 :K P;HJI1'S+U&Q/-?@7/ CKE:&D&G'.4,G/?6L.IF#%1H# .+
M #NER@DGB '@JH;"BW=9P^&'',)0KIPEO[(SV=#/[#;(]6$XV9?NK@9X)571
M/,(&)JXFP<L)VM*'W;B^".+9&G;262PF,C_M'@%"!A8PJ]6BL"MG%6-ND$5G
M)XVUDO26>4I>EWXT1>'R'BR3-X>^2DYN;I (:4P$CG)#CI5":YH% &Q%LX-L
MAC5DV5,1&[ 8J#"*U&%'$7N"HVO#.8'E$CFJLI,7260Y.%24Q(D2=?%DN!VK
MG'5N$R+.D9"*<-4%0!6Y_F8%?U#3"RD)(NTLR2O]6MS)P\1\MMX>+^X,7-BV
M$Q8$PZ5Z-1#!>L>JI1(HU!5Y2<:"EMP&+;84DU(5"J%%RFK&IKLRI7LO0(9$
M% @R,\S@!NE9O%"G=Y QN%%B6]B=BIP@Z:JQ;)-XZFB%8'&[MG6MAA![[@PW
MA0<>1+@W"?J1/%O&=MV 1L\J]Q9A]($:J@4%GH.XT.9?>T,2R5+%.^X@6U]:
M.-$&&%#7V9BN;\I(2Y;T ,D@D&/#KOFV8E$="JFE<%"\,98;S(E_8&'8I><]
M6X$G,\SU=$9R>"=&NJ5OL7NM*IKP34T^V8R<%87S\<(U(6UGHY7QXUO-4_'J
M-RD'6X.T)#*X=XE/_=.[[ELU5HQ#PORMGXV _)+@MJP[/$&V$%)!4+#$TQX(
M'; EP8^."O_ <WD_B1H*!822D?Q3G.:X5N$3E$H@T@!R!9FE'/(09I2 1"<-
MPPTDA9!SX?!C?BL<6.JS<&:\K)CBH\,,2#U HC)SU_<= R+BSAWG6<L(QV)I
MI"93(#F7P8!/%H1OET9ET",%S7\,+0:]_"IRNTH>\/FU2[BN25H,,K!8(K%B
MD]XQ;=:Y)/Y.0H-Q"*.Y1-O0/J=-YR,2VO1;) <@T7T])5ERJBI909LE&TN(
MI0.5SN:UXG0/3 32O+=%YIFEG5\?E7(*.V6GZ"53QVD.93Z[(<DBP"RR%!CV
M*WX0B+\D1=LXP!B?T9E7D:9^, ZL,P>Q"XY.%NQE4QZ31+@XO 9L5N1KQ7DQ
M4YG245X)*O;._.$PBHBD86Q72*H-L[7T6+L4-TOA_B&0 FEPJ1)/3I2LX2_*
ME"R_"9OAN'& IRQY;BV>N_=Y$1Z1B4;R6]0'YH76@K3GCM$AP22CM@S/20J,
MD0:Q''M.;F-=<?IJ8])68CWZEE;92H*Q[INZ:B545Y7&0Q[D$DH:H$@!2UNC
MS#VPDI/V-*9K&YOJ>/\]DO3@U&$H9*_JOM,5>'F0=$G+V66.Q/. *IT_DWR[
M2 :G5 @_B:GQF]+&R<(0*PI?NFJ;-KD:2='*E@V%MV'!+T;.+V(3KWA#?E47
M^Z64MB;Y--,[%*%N5*'8, V);@=4LX.\11D_3F;K(NXU8#3>4"<7AN.G ^G$
ML-D",#@3@BTZ,KPD%WE?2A99-A82-K+<L@V>.)/_2=;6:J:5;5?$9$+O!/HI
M' <N^]VP);YGK%LU''2FB\K9F<B@\V8YH*B&O:_%42!?K^YA*LQ2)[&#]_9A
MBW"U945PR?PPZ8#Q'2J)*SPQL*,>5Y$_8G.CGE-^TWG8@+:2QA^+XWWL<,]P
MEYGG!XH\K&)]_8XLFX:MC5CHO2AC\(%%K4-STT+/@OBWM%U(FKBQSY+751.A
M$]XCW1Q.,;C=D$5R^6X[MAB'EQCV@T$G]C0L1!/,/*!$-A-L^8F-GSKL$,0"
M <FS.2\\*%?6 ]9PL5C#[#Q\Y)T"&^1?.*/AJ_>*A1CQI)&XLEZ8CEPB5ZPY
MCX(8"/[!-!V@R1(N01[.BM1N.+?D:!4>&<F*)U\].;N$?!=L+T2N]W(6*1A0
M&YY%=[XO<T0BKM[QNNAM;E>;<8H$.PC-B@K4YS,5FK*8&O= 9'4%UK'5\-^*
MH4: 60$2YJ0D>0\=/.-^G :YNX+B15K=W*\N1$N9,613M^D [Z:M7UNL+E_-
MSB[\$%NV9DM:"6U'"C"=%&:E96!5)L[[2*Y,I%K+B(QDK(1H&O(UAU)944S%
M+C<*=SE#LE3$0>9SF),;L4BY@N!<]$CK_E(=<YL9JH>.>*[K^!=#W\/&"'X&
M;&_,Q@4_AX 8@AA\A[Q_!;M][59"/\!FO2VSQKB:FZ@A<ET478/C.Z" &%<M
M6.*.1C*8,DMKV[FPCXG=P./\2P9Q.:B)\DJ>R,D&6X0\[-0T#3\:[T3 ?3S<
MT9S.[RS*O(V_Q\&<!B4IGIXB2T_2Q8_>*2"*<M0"7+.LZ1WB=BXQCUZ*6=ZI
M4V&"?=3K\A0\F@8_3E \H/ #:LE'*W'0JT$U9>C D('!9-NPX"!S5<CQBJN/
MRNXB29W-;#U<$9NNJ"KO$E&Z+RY<Y=(,QR^#6@OCPVCM/DW_@*:74!$_&_3\
M_>0+]U>:\!-?(E,T476CAI!P+(^$8,]%8H(@M]@7@JFA7Z*-QE>X>.9GDL6Z
MQ+CDS7)8$PF##FC>1,4$SR"1R9P6-\2O]61WTE8[X4($1CQBBSQFCFE41;"Z
M[@=C6,C,P-3%H0A7P +=7*/K.4P+ >- 3@?9I%\H'(?"3D89.L)&>%F*JSOA
M@L^QBSB+30ZKW4VSCB3R#R7AKLA6^GJQ^-86M6\6N\5=0@!*&B<"L>.UYF&-
MV8DHQW92TN8TTBU;F;$>CF.UP!>^%OCB:!GO2@N3[]G9 =&-U0(?/$CRH>$4
MI7[3A&\&A5@R;R@W6<G+2H%I+R[Z3!$PI":D-(<#EGFPP=JFP%K/^4(2G- G
MM]1RE1I$KB)P>P&#<-?[<\<!8!/G.0YW%_E9/#9V<TC"H.U=)<]@=0AL.!2*
M*45^KC&K'JV-DID3)P8##>';2+ADB&/'-GT^"PW0L^/-A%6)@HOO:%LF+[4]
MAKMSI9'CO6T_C;8]_UF#)Z^CMIA0Q9547X787WHXVG[Q3VA*S]KHVDP:#.#"
M)>U3G$BW(NP",5ML'-I0G)^;^*:R'1ERA;D#(TAKKQ]%\YDZ<4X1<(MVU+4I
M7')VD9:?D-TF'P9;T7PRR+)S%V[(#:_M"H7_PM)<PPF8 1P0=XF4%=!K"Y!L
M<BU9E"*?W*>#>LD.U7M$0^V6_Q:[][83G#]+/C+2%'2CT[@J!$<]\FG4 $ &
ML36$_@0)NYH+V4O?W!MJQ!)FK*JT\/W3(Y-8)$=S"06Y.90K2UAHBN09%*S]
M6OI/FUL/(VE;T%8B;(<)@&+IQM2(WCGB1"%)]':O !4:O@JM0'&"0PH13CP9
M_](ZD&LAV&)BL67^:-C@/G?607G,:30%6B2>911Z<R2R7>,?XSL5QI)V(C7T
MY7SV5TD@NJ2 JUYW:PI$>>$ELE@;.:Y@<%QAM(GL7:6M,DJ*SV33&R%_[J8;
MM-G^FY,B%C^?S5]P6TW4]C>RW(G^H"V[*%-R*T_:K""*H3F!PZ$G\[\R&>>7
M7Z3V2T3R,$0E=V$BK4G3(H1]_R""SI\X@HZQ[UY,.T3/!TD.I^ST7)' [Z7+
M<WYQ0T=]<#="!J=?7M%#\NE\XG;RU[CQ1_- 'O)K#W'C.\DEQLK8WC$C?8&C
M)99FDJ_Q'8MES]/!_?.WKF58NGQE;!%BXFL.H+;5&HKFLQ1,M#0B7'(@[9MD
M76T-@U+LQ1\4P?L>=IX1GEW'A0%74T'12---^YK-.>>(Q'*AH9KLX8I;%G#B
MPK4?:HNO6RY%'$U?AUD0JTBAJ2.>UZXQFQ P=ZRB.$GS"M3 H^P>87<S3OLP
MGZ:.=V%Q1Z%%=+9J?M3[_VS0LS$*&^[S(O8JY-7MDE<3I9" C9("CTX2EU1$
M]B9\**E%J<V1J'E07<CP$"MM>64',GQ 6@FFU7**I.;)^U\_GL9=VWJT@:U7
M54[U]]U1XAY+>[2%=-#KB.3/KQ]U0J^*_+X0UE53R;9*HL>UJ.!Y;R"$ G!0
MVCWW"!J..TR"<MY>7@FI<7)9@T9+_GZ/MS'INWVFBODU0:=I*PK2:/$;U].S
MTYRE5/J^X!VZ0C;'KY@+01N7+\#JW*X[Q^VC!&Z>QHFWCMLL696"F^_=Z0(;
MI;,6%45U6X[.]@@-*9S&E6\X%H6%7VJM@F$"+SZ,Q M(O9GA+7-)J=TMZ/:9
M-4QDC,;%MMR+\.,U'22LX>%9(7V.!BO9H>K!709AGXZ9FO-@:LZ/6HPWKD]\
M0O:T(PMA8;^C3F>IK/R,UO&?&2/)=Z.VZ3\R4Q+>D]PBZ@5<.>6D+YEAR!KZ
MZ)&0G,1] 5+^1($LI,# QV5JFZ 1B)U5Y3+9='&O-I#IOE<_ZX 34GDF6Y=5
M4:W(E2!?5WK%Y=RY.Y>BV3>7I;+L)/>'Y[#'K:G@'K!!'C6D;+\L)C*B=E4'
M !/IF>?:+<A\$Y\7.$!:Q'(A+W4''33807)!B!1CB-,0W*UM6E^>V*"]1TJ0
MXF;+$L41H3_JU%Z2]: YR04W7*F2!CG@A@1HKN.>.<T<X;RA;;)^@Y[+C#]
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MG*["4;[6CBX&X;&@FQ@:;T#?-YH":!>>H+O;+?X%4$L#!!0    ( -.39E%
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MWR@DG4+B>;>&/,O7S++Y5*LM:"=-:&[A7?7:1(Y+EY0'J^F6DYZ=+QM#)\;
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M;]I $/XK(RN'1$*Q,9!0!$B0-$T.J5 >[:'J8;'']BK[<'?70/KK.[L&2J7
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M>/2:/UE_GT8T"D/<W7DT(\-QI&2M%296'-,T#T@<T2*>H6(<8F79-FUW25>
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M&/^%0^>;%P&4K;&J[H.)0<UEU[+O_3Z<!$SC5P+2/B#UO+M$GN4MLVPYU^H
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M$QH/G*M.FHR3%5_*)ZMI5Y*<G7] <LG R;U8%&A.+\:60'EKG'4 URU ^ +
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MG*F)'[A,35TB33P_"%VZIY3NGY^=AQT09^U611=!5RXXZ2?QU $FD]0I\),
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MD>T+J=UHL;2ODIG0^,:QRP(?E2 - >+G MW1;8P"]TR=_@M02P,$%     @
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M>4Z@C\*AE[SHE=I,Q(AJ=#= @6#@D!"I_6&20$<F@S:3P?_)I$T?KW15.9K
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MQK%D;[!G?L% H*BGQSY%U(UXY0LT]#O?>?$%6/KZ\O'HJ!OLF4LL7V"IKT?
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M\3)9:O<+IW9NDGB0-=I(T8%)@>!5^\_.G1$7 (HS#(@Z0/02,+D"B#M _*N
M20>8.&?:5)P/*3-LO53R!,K.IFCVP9GIT)0^K^RZ/QI%7SGAS/IADYYAJ^1!
M,0%O4S2,E_H=_ &?'U-X^^8=O %>P:="-II5N5[ZAD@MU,\Z@MN6(+I"L(![
M69E"PY]5COG/>)_$]HJC9\6WT6C 1ZQO( Y^ARB(@@$]=[\ C^97X>DX/,6,
MV$,+#Q<CV<2]_[&+%U_S'S4RE15 [D**1SJ(-1TK _]L=MHH.A;_CK!,>I:)
M8YE<8;EG9RX: 1DMA8T)1U8V.&1>&R=Q<6S-.*[C21"04<<!^FE//QVEWZ+*
M*">J(R#WO8B&E<"$;"A9(V&'4#.> ]6"DG]O>,X,YI S0:C!;3=.&<<W0?#;
MB'5)KSWY/^U<DI &K<J:/?7R;-D:T3<>-@'ACL6(PEFO<#8:ZI,TY*1;46NO
MX"52V:A04UUF6E9L5SX!T[I1+\]?*W3V:LG#>1+,AI=\WHN:CXK:N(75P.JZ
MY+20[$ ]2!N2=+'?\XO]CF=J97K8RI9J>KDIY_&POD6O;S&J+\4]*C($J/ 1
M.Z\R*88.Q.WB%7<XCZ))S]X6C<4K#Z\<F3#X49B#484?FBKGU8$<RY!:X^#2
M=2%^4A>&T_ *]T53"$>Y_W*FM,RT?1#V2@JPO6)01?@J^]EDFKRP:&#62X_\
MBSXF4!W<?4!3P:"MU+:T_FU_Y]BX3NO_F-Y>6.Z9.M"&@Q+W! UN9N21:N\
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MC,Y960/D]07GXOVD[J#[.C/X!5!+ P04    " #3DV91]+O/^X0"   /!@
M&0   'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6R%54UOVS ,_2N"T4,+;)'M
M?*PI' -ILF$[9"@:=#L,.R@V'0N5)4]2DG:_?I3L>&Z79CG$$LWW^$B)=')0
M^M&4 )8\54*:65!:6]]0:K(2*F8&J@:);PJE*V9QJ[?4U!I8[D&5H'$83FC%
MN S2Q-ON=)JHG15<PITF9E=53#_?@E"'61 %1\,]WY;6&6B:U&P+:[ /]9W&
M'>U8<EZ!-%Q)HJ&8!?/H9C%Q_M[A&X>#Z:V)RV2CU*/;?,EG0>@$@8#,.@:&
MCSTL0 A'A#)^M9Q!%](!^^LC^R>?.^:R80862GSGN2UGP75 <BC83MA[=?@,
M;3YCQY<I8?P_.32^XU% LIVQJFK!J*#BLGFRI[8./0#RG ;$+2!^#7@KPK %
M#'VBC3*?UI)9EB9:'8AVWLCF%KXV'HW9<.E.<6TUON6(L^D][$'N@+PG7YG6
MS-647"[!,B[,%5H?UDMR>7%%+@B79,6%P-J;A%H,[0AHUH:Y;<+$;X29DI62
MMC3DH\PA?XFG*+G3'1]UW\9G"==0#\@P?$?B, Y/Z%F<AR\A0WCDX-'TC)QA
M5\:AYQO^IXR%5A598*H:[R<>I2W)PA\B:/)COC'>_O-,P%$7<.0#CMY,H "M
M(<=.\I%/'4G#$(6>PK7S/HVC0930?;]0C=>D[Q1V+B^TC3MMX[/:CL70D*FM
MY+]?'WBCKN&(HE[@Z\%UV/]%IW5,.AV3LSKF><[=K&""L'S/9 :D9L\X@JQQ
MV@#O^DEEDW_K-AU,7VFAO9[#T]WZ461(IG;2-NW76;MI-_=-3O^Z-Z-RQ?26
M2T,$% @-!Q^P-+H9/\W&JMIW\$99O$I^6>+$!NT<\'VAE#UN7(#N&Y#^ 5!+
M P04    " #3DV91/FO@4AL#  #U#0  &0   'AL+W=O<FMS:&5E=',O<VAE
M970T-2YX;6S%5TUOHS 0_2L6ZJ&5TH(A"4F4(/5C5UMI5QLU[>ZAZL$A0[ *
MF+6=C_[[M1T*K)K I9M<@HT]\][,O'CP>,/XJX@!)-JF228F5BQE/K)M$<:0
M$G'%<LC42L1X2J2:\J4M<@YD88S2Q'8=IV^GA&96,#;OICP8LY5,: 93CL0J
M30E_NX&$;286MMY?/-!E+/4+.QCG9 DSD$_YE*N977I9T!0R05F&.$03ZQJ/
M;O!0&Y@=ORAL1&V,="ASQE[UY'XQL1S-"!((I79!U&,-MY DVI/B\:=P:I68
MVK ^?O?^U02O@ID3 ;<L^4T7,IY8 PLM("*K1#ZPS3<H NII?R%+A/E%FV*O
M8Z%P)21+"V/%(*79[DFV12)J!BX^8. 6!J[AO0,R+.^(),&8LPWB>K?RI@<F
M5&.MR-%,5V4FN5JERDX&#["&; 7H$DV!FR)G(:"?\X0NB4Z;0.=W( E-Q 4Z
M0S1#CS%;"9(MQ-B6"E][L<,"ZV:'Y1[ FD%^A3RG@US'=9YF=^C\[.)?+[9B
M7X;@EB&XQJW7$D+$68J^;"7PC"3HUN0..'K^KO:C>PFI>&E \THTSZ!U#Z)I
MK=-LB?):PEB9L Z";:XD!PLE6D-L7Z)V&'V#H?\XZ\#M8NR.[?4>:MV26K>%
MFL'KH(KC_J)V5)H*CH\TU?M8A&9J240DW&V82<(E4I("]'R]I>)E9*IVB9U+
M!S>DL5=R[1VA:/T2K7^$HO4_%,T;^-[^FODE,_^SF,FR5*)6JGU$FR$]E+),
MQJ(AKX.2_>#$BL-*;LV*&Y9<AT=0'':J@]4Y@N8*D+KHL.,->OM5AVO'/CZ^
M[EHP,7H#PIN26QWYV#VQ\-Q6X>&J96#O&-*K^@!N:P2?(KWN!^GU?/^0\JJ#
M'_=.H+QFS';E59T$M[62_ZT\KUUY57?!_C&45_4#W-80/D5Y@P_*ZSK^\(#R
MJ@: AR=07B.FOE2-1$Y"F%CJUB2 K\$*T+Y<V[6/>'TA^D'XDJKO[P0BY=FY
M\I7$^>Z.L9M(EIOO^CF3JIIF&*M[&7"]0:U'C,GWB;XJE#>]X"]02P,$%
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ME>[04'Q;WXH>N-)WK/HQU]=@$&: ?K_F7+TTS$6KO5C/_P-02P,$%     @
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M?&U/WP57^BRWPT+?YR ,0+]?<J[>)^9 [_XAC/\"4$L#!!0    ( -.39E$
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MO&=-&L51=+8.0V9QX$\OK$0GW'1<N>\!#P][D6T)SU%*'L' 56-4=#I+)S^
M^4X7Z;@P_G?F^](74=HC?D @9R?+\QQMIY%T7"1_3U..YY6TD@7'?0\6=<J?
MS'B4_D[=Z.P'T-])'8U>F/ZH]W;W?7HN_ -6-/+/WZ'NR<G1'-M_8W+'"T4R
M2-'-NYGA\LGZ)%Q/M"CM8?)!:#R:VN$>OQY &@-\G@JACQ-S/FV_1Y;_ %!+
M P04    " #3DV91U$5Q_;8"   G!P  &0   'AL+W=O<FMS:&5E=',O<VAE
M970U,BYX;6R-55UOVC 4_2M6U(=66IN00 (5(!6Z:7NHA,JZ/DQ[<),+L>K8
MF>U ^^]W[82,0F![ 7_<<^ZY'[D>;Z5ZU3F (6\%%WKBY<:4M[ZOTQP*JF]D
M"0)O5E(5U.!6K7U=*J"9 Q7<#X,@]@O*A#<=N[.%FHYE93@3L%!$5T5!U?L,
MN-Q.O)ZW.WADZ]S8 W\Z+ND:EF">RH7"G=^R9*P H9D41,%JXMWU;N>)M7<&
M/QAL]=Z:V$A>I'RUFV_9Q NL(."0&LM \6\#<^#<$J&,WPVGU[JTP/WUCOV+
MBQUC>:$:YI(_L\SD$V_HD0Q6M.+F46Z_0A//P/*EDFOW2[:U;1)[)*VTD44#
M1@4%$_4_?6ORL = GFY V #"0T#_!"!J )$+M%;FPKJGAD['2FZ)LM;(9A<N
M-PZ-T3!AJ[@T"F\9XLQT1CD5*9"E:YE[,)1Q3:[),U6*"O-.[M)45923R^;N
M"B^?EO?D\N**7! FR/=<5IJ*3(]]@X(LK9\VSF>U\_"$\Q%YD,+DFGP6&60?
M\3X&TD83[J*9A6<)EU#>D"CX1,(@##KTS/\;WAN=D1.UR8T<7W2"[T%N #O>
MV#0M#>:(JHPLE,RJU!QG^.>CY)Q@<V[1[-<9]_W6?=^Y[Y^J+:R9$$RLL=%=
ME;LJ5%/$CL)^\IMI+QIA[C;[:3LV&L91:_-!W* 5-S@K;A<U#B+L<Z5LFDI0
M3&9D6V>&06=+U;2#/2UQDASH/;89]<)NO7&K-SZKMRU7*K716%$G.NM2&!]Y
MOXZ&AQ([C.)XV*TQ:34F9S7B9_2/:B?'U8Z'A]7N,.H%R8$T?V_F%*#6;A1K
MS$XE3/W!MJ?MM+]S0^[@?(:O0#VT_]+43\@#5=C FG!8(65PDV"V5#V6ZXV1
MI9ML+]+@G'3+'%\R4-8 [U=2FMW&.FC?QND?4$L#!!0    ( -.39E&R.Q0"
MH@D  .,X   9    >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;,5;6V_;.!;^
M*X0Q"[1 :HN4*,F#)$#K.#<GF2!I=Q\6^R#;="S4DCP2G:3 _/BA+C8EBSID
MIG&W#ZDOAX?G0G[?X:%\_)*DW[,E8QR]1JLX.^DM.5__/AADLR6+@JR?K%DL
MOEDD:11P\39]&F3KE 7S8E"T&A#+<@=1$,:]T^/BL_OT]#C9\%48L_L499LH
M"M(?7]@J>3GIX=[V@X?P:<GS#P:GQ^O@B3TR_FU]GXIW@YV6>1BQ. N3&*5L
M<=+[C'^_\TD^H)#X=\A>LMIKE+LR39+O^9NK^4G/RBUB*S;CN8I _/?,1FRU
MRC4)._ZLE/9V<^8#ZZ^WVL\+YX4STR!CHV3UGW#.ER<]OX?F;!%L5OPA>;ED
ME4,TUS=+5EGQ%[U4LE8/S3893Z)JL+ @"N/R_^"U"D1M ,$= T@U@.P-L+L&
MV-4 VW0&IQK@F,Y JP'4= :W&N":SN!5 SS3 7XUP#<U:5@-&.X/\+H29VTS
M9YD:A7?)-LXVWJ8;[^>[>\@VX=@XXWB;<ESD?% NWV+MGP4\.#U.DQ>4YO)"
M7_ZBV$#%>+'DPSC?ZX\\%=^&8AP_'27Q,TMY.%TQ=)=PEJ$@GJ-1RN8A1^?!
M+%R%_ ?ZA.Z"- WR;8D^G#$>A*OL(_H-#5"V#%(Q*(S1MSCDV5'M@Z_+9),)
M;=GQ@ M+\_D&L\JJ+Z55I,.JS^NTCP@^0L0BUK?',_3AMX\*+2-8RUWRW$>V
ME6O!PTJ+M%FA[TQCU>9)Z"NLPGZW56-8RVV0MK2 5IW#^L[95,3*+_0YW59=
MP%H>V7H;JUW$0:LN87UG;+;STBCV5\;V[?0IM%R;QWZKI=.BR3M'[.9=/+PU
M7PV ECN#.&$"K/2!P)D=V) =V)!"K=VY**8<7<493S>B7.#HOS=" %UQ%F7_
M ]3;._5VH=[IQ+(H$N6#0,W9]R.T#E+T'*PV K$VV1RM65JFYB/Z"X%YNBAG
M\8I9\EKI^=3J6Q8^'CS7U[^1U$0GU7#4V3GJ@(Z._]SDJ!QFV2:(9PS-DHPK
M/2G5N+79L6^)?^KIZ6YZ"DY_DV09$H%FKSR,GS9AMBRRF2Q$D37E*CM*?;0>
MA6:<KFC+TCV)B5;BIBTQM*QN=]V=NR[H[GV:S!B;9VB1)I$,NG!W5EMPY;<!
M_\27[),HF[^S/"(+EHH0':&X>%<,$ I$D:L$'+<5)H$MQ*U[4'KJ K%H^.CM
M?/2T6R?D11H7C*$@2C:Q*I-?O/:*PH1VA=C?3>]K0LS6P8_M]$?Y9IV)-^*P
MH;(!UF7U"?T7@";#G4U#4,\#>TY6SR)[^]40H!M;LNRR#@&%N%;784U(PW@6
MKH-5=S(O*A7U!8?IWI:IJ-! LFFHY 1,0$-O@]<PVHBM,RUK39Z@:9+F:C;Q
M7(!V+E_LG2(+RJJ-M!<E;)QD% Q3ROUN(>8FL%7X5%3**9NQ\#D0+]5E)*S4
MIX("H"6*)1%@F DZ[ M%41_S)/VAM Y622V==9(GL(8H&JE#R89G7!P(Q)Y2
MKD8M2TPP1 )-(R6Z8PV\-T(8QIR)LH#G_)9,13R#HB6Q68L_50M!62K"<V@3
M+G$:PT#=B4JBJKD-XV(G_87$YH\8>@@X@R:5Z(S]@X"5A%H,8^WGN7!%Q%F@
MU2X!:<OZ:OG"JJP^!4--)$03ZY^'N@(MPU 3"=L$'R+4I%:"PW#[EE!K5%%=
MJ"7,$J/*_3$OI""%$A>)<Y P2F@C,+25?9.BXUG5O7DXDV9)^*$\8^0GCL[3
MQC5IPQX>.FX'KA&):P3&G'IGYZQ5ES>52O@AWD'B*J&&Z"I!?=E2J:A'C+J6
M-VR5+9>5I*N5G)A(-EV2X$9@1-I/A%@-ANO=EEAE'Z2<M"4NV;IR\A<=@JXK
M0QK5G&W;0#EG2_"S8<12I.*1Q6&2HG8?=+YAB%BV X6OUIFP#Y(?"7BVIA#4
M[YMSN]T.(!:V%?7^127: "7E#C,5G!@(-EV74&S#4-Q<FK-:(DM8KM:J,B(J
M[*4$6FL2?VT8?\_JDW>V:,[M]ED>8V5*VMT!1Y$/$ZF)3JKILF0'&RY.QV*K
M%W=WVM+B7*/)UA3,MB04&R:4FR1^^B2,B8K5<(36^HTRLMMDH,S)6"%(.S94
MF[,Z-I2AX,1 L!DR25@V3%A7]>3E!Z$X!T3538=&$>E[^ZV8*OMO'M?LDTI>
M=. :OHD-.CP85=H:E07Q #AP)($Z,($6<" [IFRNG+_-?=2"X,B1U.>\/_69
M5RJ.9$+G($SHU'KC,!.^7V7N*"AKV-GK="1A.29GAT8JQJ^S91 _L48RJOP8
MER..Y";'/4@2)!,X,'X;E"-C1]%+KMIV72&6J._ J&_.1&.-)DSZ-DA%CL15
M!X:U?T!%XTKE&X)$)3A2&!S'&0\C$94Y6@3A]K*L^Q;GKE+7L,6A%+)%PB.%
MX=&<<S2*=-Q!)6)2&#&OXI"'(CDS"2BE<8M.XT:52FPW+OQLQ_&)Y^X5#VI9
M3-RA8_L=\90P2W_)7>B8OND"DTJ4IC!**X(KMD-YHJP@^FV6CJH)_?KIIC_<
MCWE;R.O[7=&N78C"B%[@:<KF+%H7[6+A5=EE$WNK:!TWR*?,!'O-*Y.\O1C4
M[KMR_\7AN14796Y@HT3)JJFBJ20,:G"8R9\,8N75\_90WWFN&=/VN8;X$%1(
M;J$PM_RQG3MEJP*]NFWPVA>J4#5%);]0#;\8WL"/:?N$X$(62#*A,)G\]+79
M+7TSM;B26ER86M[\B,"EVRZ];=55Y+7;9B'XFE]RD M3QT_594+X80< 1^A>
M+-%DCOZ(H6L!5W*1>Y G9US)%R[,%_\7!!MIC,+:NTA7$HYK<BQXU^1^?4D@
MTR1[N/0@R:T]P&* WK\^N;!1V-8F5U*"JWM\Y>>2:WC*=24_N >Y,74E_+LF
MEPKO<<JM)C(\Y7J2 CR8 GXV)U_33<89!)^>1';O(+>JGL1G[\ /L5Q[BH=8
M;%_5=;Q5B>(A0(&>I $/1MPW\_9UI="8CCV)V-Z;$;NS8W56K!L"=4<\B<?>
M0?#8DWCLZ9XHU/>@O7;]3)7/9EUX[6:^6O+26')B(METOO:D(8S59O<B%UZ[
M=L=#VU,XI2KR[?9#DQ,#C4V7)-I[[]5M&FDTN7T"4J(G"<)[]V;3A=<^$72M
M)%/)B8ED\YE1R3 ^S##&/:.11A'5/#+J2Z+QX2.$\=ETY+=;_02ZY/8E%_DP
M%QG=-/AM#J%8>3X?U'Y<E/_\[S9(G\(X0RNV$$.M?@ZF:?F+NO(-3];%[XVF
M">=)5+Q<LD"P8"X@OE\D(DW5F_PG3+O?-9[^#5!+ P04    " #3DV91#\K/
M(:D#  "^#0  &0   'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6RU5VVOVC84
M_BM6U$FM5$B<-T(%2"L4[4I==55VMP_3/ICD %83F]D.M/OULTUN2"#D4JG]
M G%\GL?/>?&Q,SER\47N !3Z6N1,3IV=4OMWKBO3'11$#OD>F)[9<%$0I8=B
MZ\J] ))94)&[ON?%;D$H<V83^^Y1S":\5#EE\"B0+(N"B&_O(>?'J8.=YQ>?
MZ7:GS MW-MF3+:Q />T?A1ZY-4M&"V"2<H8$;*;.K_C=$L<&8"W^I'"4C6=D
M7%ES_L4,'K*IXQE%D$.J# 71?P>80YX;)JWCWXK4J=<TP.;S,_O2.J^=61,)
M<Y[_13.UFSJ)@S+8D#)7G_GQ-Z@<B@Q?RG-I?]&QLO4<E)92\:(":P4%9:=_
M\K4*1 . PQL OP+X]P*""A#<"P@K0'@O(*H T;V N +89+JG8-E(+X@BLXG@
M1R2,M68S#S9=%JT#3)FIK)42>I9JG)K-.3N 4'2= _K$%4A$6(;F C*JT)*D
M-*?J&QJ@E2[IK-1&?(,6L%;H]0(4H;E\HR>;)'9R@)Y6"_3ZU1OT"E&&_MCQ
M4FI>.7&5UFQ6=M-*W_N3/O^&OA7LARCPWB+?\[T.^+P?OH!4P[&!XW$'?-$/
M_\0/SZMWPC_TPW\GHEX]Z8 O^^%+6 ^1GUAXV(:[.LUUKOTZU[[E"VX&0Z?F
M@4DE2MT;%/K[HS9 #PH*^4\/?5#3!Y8^O$'_D;/M0($H],Y>J[=(<47RKHR?
M:&)+8SK?81:%V,<3]]!,;(=5D#2L6AK#6F/8J]$?CJ)?;#RK:L]*T,.@+[Q1
MS1W]C/#&-7W<*_V!Z=B"5$@0I;<A0\PXT%64_3PV!%W%^-VPEANCVHU1+\^C
MH"RE>Y(C4O"2J:X".3%$C=1C;S2^J(][C!:CJR+"V//:1A^NC2(<-*Q:?B:U
MGTFOGT],^Z=[XG^0V?V ,BK36PXG5[X,\.C"WRZ;I%OCN-8X_CZ-5,J2L!10
MRF6GT/&UB/!"Y\LFR_%5P >MM+2<P=[Y*/-^3 .J>-JU$R47CG1;C6ZH;!RX
MN%=E-/1/+6C<:D%^7PO"YQ:/?TJ/Q^<FC_N[_-UM:/$"D8U#GZ1S3\?]3?V>
MEE)1-),91=YE*YB_:-:6>#X:</2#=UI%V-[OX^"R*W29^7X0WQ!\/FQP?[N_
M?R_%'>>T%P>7.CO,_%$<7NAT&S=9\V6C;U!;RB3*8:-QGCZ#'"1.'PNG@>)[
M>[E=<Z6ORO9QIS^P0!@#/;_ANCRK@;DOUY]LL_\!4$L#!!0    ( -.39E&W
MS(:3.0,  .X+   9    >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;+56;6_:
M,!#^*U:T2:VT-G$2 E2 1&'5D/JF=MT^3/O@D@.L)C:S36G__6PG)+0E9M+:
M+V []SSWW)U]NMZ:BP>Y %#H*<^8['L+I98GOB^G"\B)/.9+8/K+C(N<*+T5
M<U\N!9#4@O+,#X,@\7-"F3?HV;-K,>CQE<HH@VN!Y"K/B7@^A8RO^Q[V-@<W
M=+Y0YL ?])9D#K>@[I;70N_\BB6E.3!).4,"9GUOB$_&N&, UN('A;7<6B,3
MRCWG#V8S2?M>8!1!!E-E*(C^>X019)EATCK^E*1>Y=, M]<;]C,;O [FGD@8
M\>PG3=6B[W4\E,*,K#)UP]??H RH9?BF/)/V%ZT+VU;LH>E**IZ78*T@IZSX
M)T]E(K8 FF<W("P!X6M DX>H!$3_"HA+0&PS4X1B\S FB@QZ@J^1,-::S2QL
M,BU:AT^9J?NM$OHKU3@U. >=-(F.T"41@I@:H(,Q*$(S>:A/[V['Z.#3(?J$
M*$/?%WPE"4MESU?:M2'PIZ6;T\)-V."FBRXX4PN)OK(4TI=X7TNN=(<;W:>A
MD_ 6EL<H"KZ@, B#'7I&;O@%$1J.&^%C-WP,TPT<=QW11%45(LL7-?!=+<$D
MG\V1K4>*AE*"DNC7N39$$P6Y_.UP$U=N8NLF;G!S PS6)$,*1+ZKAFYT"ST#
M$=*AHU7I:+EUF,=XQ&='*PF(F%!WJ2DX$LMAVM?C(.K$B4[WXW:AWEK%G22H
MC%[H2RI]B5-?78[,E -EE-S3C*KG73*3MP)P%,2O9+ZU2G KV2VS7<EL.V6.
MAN>3LZN;R\G049-.1=;YR"O8K=QT_[_TH^[;TK?:04-5<5#WNN#=ZCHJN5Z*
MB!I%;#5<[!1AT]OT!$=[P#C8^PAQ6"L)G61C*J=\Q13228&=8MQX'!XGP6>7
ME+K_X<A)=4$9S5>YBZMN<CC^R)N,ZRZ&][0Q,(-5?9V:VNH>&FQ+ZE)4]RWL
M;EP7Y&E?&NOF@ML?FL:Z\>#.^Z313>-Z&O[6@)2#F-M!4R)[^XM9J3JMAMFA
M'>'\VKR8A/7D,*=,:JTS#0V.V[JXHA@NBXWB2SMNW7.EAS>[7.B!'(0QT-]G
MG*O-QCBH1OS!7U!+ P04    " #3DV91:2$_#-(#  "Q#@  &0   'AL+W=O
M<FMS:&5E=',O<VAE970U-BYX;6RUEVUOVCH4Q[^*A7:E5AHDSA/)!$@MU;1)
MG5:-[>[%M!<F,6#-L3/;@?5^^FLG-('$1.K4OH$X.0\_GV/[+\\.7/R2.XP5
M^)-3)N>CG5+%.\>1Z0[G2$YX@9G^LN$B1TH/Q=:1A< HJYQRZGBN&SDY(FRT
MF%7O'L1BQDM%"<,/ L@RSY%XO,64'^8C.'IZ\85L=\J\<!:S FWQ"JMOQ8/0
M(Z>)DI$<,TDX P)OYJ,;^&X)$^-06?Q+\$&>/ ,SE37GO\S@8S8?N88(4YPJ
M$P+IOSU>8DI-),WQ^QATU.0TCJ?/3]'?5Y/7DUDCB9><?B>9VLU'\0AD>(-*
MJK[PPP=\G%!HXJ6<RNH7'&K;J<Z8EE+Q_.BLQSEA]3_Z<RS$B8,777#PC@Y>
MUR&\X. ?'?QJHC59-:T[I-!B)O@!"&.MHYF'JC:5MYX-8::-*R7T5Z+]U.(>
MZQI(, :KLB@HU@U2B();1!%+,:A7TM4=5HA0>:W-OJWNP-6;:_ &$ :^[G@I
M$<ODS%&:Q41TTF/>VSJO=R'O"A<3X+MO@>=ZKL5].>Q^AU/M#HT[3,[='5V!
MI@Q>4P:OBN=?B/>YP (IPK:@*D@&;J3$2H(?]]H0?%0XES\'TOA-&K]*$UQ(
M\Y6;ZO(F&37)@#!+;<PWXU(/4)7X+=@*+JUUK3-$50:S2?>+ /J)-W/VI^7K
M6T51&#=&9_1!0Q\,TM^D:9F7%"E='Y1SH<A_R.Q%&V4=*3S)/_82S^]06JS@
M-+F &3:8X4L5F6%E@P][6'X<1$D'OF\5Q)%K9X\:]FB0_7.'FA*T)I0H@C5M
M6@JA]Z>-..JQ>%$R[0#WC6#L^W;@:0,\_7M@QMEX 'IJ*7/D=JG[5H'O7:".
M&^KX+Y;(";L--[9M/#?HX/:M(AA&=MRDP4T&<;]78F1VW5X3;_5BQD:A6W*%
M10ZN](G\B)&0US;ZX0QQ[0F@"W+.U$X"+P 9>K058CD<*CB&BI\B0<\2Z:P.
MT&W5RGU>)3(B4UXR!70G,= -!8BQ,K<*TG!H"">)^X]5BH8=PXG;]3N?W8D6
MPV=MIK,S:UT2FNEO@X5L]0Z^JN#!5O'@ZTL>M&B>.^VIB<4L\OS OO=@JWIP
M6/8&NX)_EZ3(>P?<>:I6N6#XJEUI908.Z\R+=*6O)W'4;4G?YD1'S^%;R8'/
MTYPS[#W>D91V3_#S3*U,P/A5^]$>\'#XT'R1?B2]Y1_&O3W2-_+#L-,1Y^0^
M82YSGY#8$B8UU49[N9.I[J>H[T?U0/&BNF*LN=(7ENIQI^^46!@#_7W#N7H:
MF%M+<TM=_ ]02P,$%     @ TY-F4?.%/:PF P  / D  !D   !X;"]W;W)K
M<VAE971S+W-H965T-3<N>&ULI5;?;]HP$/Y7K&@/15J;WTE; 5(+G39IU:JR
M=@_3'@PQQ*IC9[8#W7^_LQ-2""E"VPO8Y^^[\WV^^#S<"/FB<D(T>BT85R,G
MU[J\=EVUR$F!U84H"8>5I9 %UC"5*U>5DN#,D@KF!IZ7N 6FW!D/K>U!CH>B
MTHQR\B"1JHH"RS^WA(G-R/&=K>&1KG)M#.YX6.(5F1']5#Y(F+FMEXP6A"LJ
M.))D.7)N_.N[U. MX)F2C=H9(Y/)7(@7,_F2C1S/;(@PLM#& X:_-9D0QHPC
MV,;OQJ?3AC3$W?'6^R>;.^0RQXI,!/M!,YV/G$L'962)*Z8?Q>8S:?*)C;^%
M8,K^HDV#]1RTJ)0614.&'124U__XM=%AAP!^^@E!0PBZA.@=0M@0PE,C1 TA
M.C5"W!!LZFZ=NQ5NBC4>#Z78(&G0X,T,K/J6#7I1;NIDIB6L4N#I\5<"*BMT
MCF90@5G%"!)+]*TD$FO*5\@NHXE0&IU-B<:4J0& GV93=/9A@#X@RM'W7%0*
M\TP-70T[,G[=11/]MHX>O!,]1/>"ZURA.YZ1K(<_/<Z_.L)W08E6CF KQVUP
MU.&,E!<H]#ZBP N\GOU,3J;[5WWI_%_TNW^.OB=&V-9&:/V%QVOCY\U<:0E?
M]*\C/J/69V1]1N_X?"LM9DMK84N+\@6K,F-=8TGQG-4+:M!74G6 Q 8PU^!Z
M',2>/W37N^=T"/(3+]H'30]!J><'^Z"[0U"4)%X+VE,A;E6(CZKPO)<E>DN?
M"WZ^%:8H!2=<]TD0'^[)2SL*'&+2Z+(C0(V)=U6*TZ0CP"$H\&*_7X"D%2 Y
M6EH3K')48IHA:'4(%Z+BK0XD,[>*S@DJ0(E*$FA+VEQ+HE,[##2DC&H*17JV
MR^707Q<F0J5JPQO3-J::8H,T5]?@^DAMIVU2Z8FU;8,OH0<KM)2BZ.Z\[Z:<
MI@?G%491V#F+'I"77';.PMUI!P61*]N'%504B%Q__:VU;?4WML-U[+?^]<3O
ML4_A:5!W\C?W];OB'LL5Y0K27$(H[R*%LI%UKZXG6I2V&<V%AM9FASD\;X@T
M %A?"J&W$Q.@?3"-_P)02P,$%     @ TY-F4:02JJ?" @  (P@  !D   !X
M;"]W;W)K<VAE971S+W-H965T-3@N>&ULC99=;YLP%(;_BH5ZT4I;P7PE5 1I
M331M4JM%3;M=N^$0K )FMFF:?S_;4)H-2'83;./W/.>\B8\3[QE_$3F 1&]E
M48F%E4M9W]BVV.90$G'-:JC4FXSQDD@UY3M;U!Q(:D1E8;N.$]HEH965Q&9M
MS9.8-;*@%:PY$DU9$GZXA8+M%Q:VWA<>Z"Z7>L%.XIKL8 /RJ5YS-;/[*"DM
MH1*458A#MK"^X)LE-@*SXR>%O3@:(UW*,V,O>O(]75B.S@@*V$H=@JC'*RRA
M*'0DE<?O+JC5,[7P>/P>_:LI7A7S3 0L6?&+IC)?6',+I9"1II /;/\-NH("
M'6_+"F$^T;[=&T86VC9"LK(3JPQ*6K5/\M89<23 _H3 [03N_PJ\3N"90MO,
M3%DK(DD2<[9'7.]6T?3 >&/4JAI:Z:]Q([EZ2Y5.)G>@/!#H,_I1 R>25CMD
MEM ]D0VG\H N5R )+<25VO2T6:'+BRMT@6B%'G/6"%*E(K:ERD3'L[<=];:E
MNA/4#=37R',^(==QG1'Y\K1\!5LEQUJ.H[_EMJJ_-\'M37!-/&\BWCVM:-F4
M7>5K<E"_4RF0.B3_VB).T+R>YAF:/T'3-:-+#OJ0I< 1R] !"+\:L[&-%)I(
M^D2^)GCNN+'].L+W>[Y_CH_'6*TJ.&+-O'""%?2LX!S+'6,%0Y;C.^.LL&>%
MYUC>&"L<L,(HF&#->M;L',L?8\V&=>%@PL-YSYJ?9#WFH!IT)H&/$><#HA>Y
M@3^.C'ID=!K))"E0UJ@6 +KKF--1=^=B+(MHS.-PPF3L?#0GYV0>=R#$#:)E
MW4A(5<]1'H"0H_W&&63PV9V[03B1PE%_Q.>M&"7BP=GTL>=\.-]ULN&V$ _2
MLH\ZN+X^[PG?T4J@ C(E<ZYGJC#>WDCM1++:-/5G)M4588:YNL6!ZPWJ?<:8
M?)_H>Z+_7Y#\ 5!+ P04    " #3DV91?!C]HZX%   7'0  &0   'AL+W=O
M<FMS:&5E=',O<VAE970U.2YX;6RMF6UOFSH4Q[^*%>W%)JT#/P!)E49JTFVW
MTG8U+>WN:YHX#1K@#)MTN[H?_MJ$88B-0]J]24(X/OSM8__.L9D^L>([WU(J
MP,\LS?G5:"O$[M+S^&I+LYB_8SN:RSL;5F2QD)?%H\=W!8W75:,L]9#OAUX6
M)_EH-JW^^U+,IJP4:9+3+P7@99;%Q:\Y3=G3U0B.?O_Q-7G<"O6'-YONXD>Z
MI.)^]Z605U[C99UD-.<)RT%!-U>C:WCYGD2J067Q+:%/O/4;J*X\,/9=7=RN
MKT:^4D13NA+*12R_]G1!TU1YDCI^U$Y'S3-5P_;OW]X_5)V7G7F(.5VP])]D
M+;97H_$(K.DF+E/QE3W]1>L.!<K?BJ6\^@1/M:T_ JN2"Y;5C:6"+,D/W_'/
M>B!:#3#L:8#J!NBH >IK@.L&>&@#4C<@0QL$=8.JZ]ZA[]7 W<0BGDT+]@0*
M92V]J1_5Z%>MY7@EN9HH2U'(NXEL)V8?XJ0 W^*TI(!MP(<DC_-5$J?@-N>B
M*.6,$!Q<@.5A&BF3VWQ/N3C<B/,U6,1\"][_*)-]G%9_OKZA(DY2_@:\ DD.
M[K:LY-*03STA]:JG>JM:V_R@#?5H6]+=.X#]MP#YR+]?WH#7K]XDS>,M_A9N
M?S=T)?U!Y0].:G\6+S>#5;F\O!^N96SUXLE(-N%$33A1Y1;WN+WFG I^Z?"$
M&T^X\D1Z/%5QM078%L>#J[!RI="TGT4(DV#J[=O1,:T0#$/86'5TDD8G.:GS
MHI!SHDA6@JYMZ@X.@M9SH0^/Q9E&R(\"N[:@T18XM=TQ(9?22BI\6WT"VEHG
M:FRU[NJ^37Q@Z(HP#OTC]:85PA$.NU8W@1F :-(*P&'BFE:3@/@]80J;H0B=
M0W&=L4(D_\J.+ABWK=UY.*BCIE7HA]'8+BYJQ$5.<1\+QCFXSV6F32N-'V6&
MM6F,C*<?ZS,M6E'HB!LWXL;GB?LDKVWBQB?%N2PZVB:-MHE3F\X>-D&301$U
MK4(_@L0N#/HZK_E.:<NMG' 7=[3(P.>X^"YSTD-*P9*NRB(1";6G(]^8^L=J
M:Y-N@"=]$Q"VTC!TROV[S!YHH1*LSG J?98Z[JF:!SO&$U5A<? ?<.;">?W
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MC$(N] 1XON%</0_TB;'^EV/Z%5!+ P04    " #3DV91QN6$JLH$  #D'0
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MX@7]^XIS]7Q3=% ?\<__!U!+ P04    " #3DV914PFUN:T$  #9$@  &0
M 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6R56%UOHS@4_2M6U(=6F@(VWZ,T
M4M/,:F>ULULUVX[VT04G006<M4W2_OLUA@ )X#)]:,#Q.??<Z\O!\?Q(V1O?
M$2+ >Y;F_&ZV$V+_U31YM",9Y@;=DUQ^LZ$LPT+>LJW)]XS@6(&RU$26Y9D9
M3O+98J[&'MEB3@N1)CEY9( 768;9QY*D]'@W@[/3P%.RW8ERP%S,]WA+UD0\
M[Q^9O#,;ECC)2,X3F@-&-G>S>_AUA8(2H&:\).3(.]>@3.65TK?RYGM\-[-*
M120ED2@IL/PXD >2IB63U/%?33IK8I; [O6)_3>5O$SF%7/R0-.?22QV=[-@
M!F*RP44JGNCQ=U(GY)9\$4VY^@^.]5QK!J*""YK58*D@2_+J$[_7A>@ D#<"
M0#4 70+<$8!= ^P+ '1& $X-<%1EJE14'598X,6<T2-@Y6S)5EZH8BJT3#_)
MRW5?"R:_321.+-:"1F^W2UFY&#RF..?@%J@Q\/=>+<Q]N3")^ #7*R)PDO(;
M.>-YO0+75S?@"IB [S C'"0Y>,X3P;]T!O[9T8+C/):#5V?W<U-([:4",ZIU
M+BN=:$1G"'[07.PX^);')![ /^CQ$&D(3%FTIG+H5+DETC*NR=X MO4%( M9
M0X+T\!6))!R6<!@.P%=Z^!\X-P#TAZ*?96,W?6 K/GN$[Z\B>R4,T$V][AQ<
M6Y;%;S343D/M*&IGA'I)MDF>)_D6++'LL(B ZZI%;H;:H.)R%5=I6H>%S-"?
MFX<!!6ZCP-4J.*6T93@7LM%U\=U>?&BYP^&])KPW(3P@[X1%"?\DOM>+?QL&
MP_'])KX_*7WYEMB0Y+,"^'T!CC6B(&@4!%H%\IF;NOY!O_X>\IKPU:/5GS3>
M)&&C,=1J?"'\L]*$?6W(#8?#0JMU8$L;^#D_5*'Q$;.8:Q745%T)MC>2..R\
M Z#VX?^IWHXDOKT_$";?]N!;W:K@D25RO?;2&:HFTM@!1&TX]*N&4/!815&I
M#V=><0:=S'W#'^E+V-H>M'_-&B8HJ1BATUT$PW=&I+0V"?4^>9+2\8D)8IR^
M&,<8Z\G6,.$TQ^Q8Q@0M;E]+:,#P[&]$6>NE4&^FEU8R09;7E^4;MG/A*?6T
MB0W6>B_4F^_)5B;H](=T!MZ(@M9[H=Y\>_XR04K0JX5KN&-*6H>%X32? 2>C
M>2+E;Y-R01_D[HS)7P$%3L&?R4:NK-PP_DLPT^Y!4.NR2.^R77Y!6#:4]B<4
M'O@H]0 '9-56$CD@QA]#N]F'B53AB0H& U3GJ;9VCN"$EAM,4 ^L5>E$M":/
M]"9_T76#:O0,?ETC:&GK?:ZO-7ZDW_#>;[>,;+$@X+MLC$3^D(W "TX+HF-O
MO1Q]XN6%X (KJQK,O$)[W0V,"R\=:6!6 (>?0=0Z.YKF[,U;9E!??Q=LNV@D
M=&O=2&_=FK[L[WJA/_:N0*WW(KWW3NE!OU=C'X[L]U%KN4AON>O26<%>;9XF
MV"WJVZUO./9Y.ZP&9CD&NEP5LW,6D!&V56<J'$2TR$5U+-",-N<V]^JTPFRG
M5X<^/S"3&S4.4K*14,OPY?JPZARENA%TKTX67JD0-%.7.X)CPLH)\OL-I>)T
M4P9H3K,6_P-02P,$%     @ TY-F46LT&MLT P  V0H  !D   !X;"]W;W)K
M<VAE971S+W-H965T-C8N>&ULS59;;]HP&/TK5M2'5FJ;.Y<*D+A-F[1*J+3;
MP[0'DWR0J(F=V4XI_WZV$]( (:JV/O0%;.><\UV=?(,M9<\\ A#H-4T('QJ1
M$-F=:?(@@A3S6YH!D4_6E*58R"W;F#QC@$--2A/3L:R.F>*8&*.!/ENPT8#F
M(HD)+!CB>9IBMIM 0K=#PS;V!P_Q)A+JP!P-,KR!)8BG;,'DSJQ4PC@%PF-*
M$(/UT!C;=W/;4@2-^!'#EM?62(6RHO19;;Z%0\-2'D$"@5 26/Z]P!221"E)
M/_Z4HD9E4Q'KZ[WZ%QV\#&:%.4QI\C,.130T>@8*88WS1#S0[5<H _*57D 3
MKG_1ML1:!@IR+FA:DJ4':4R*?_Q:)J)&D#K-!*<D.,<$[PS!+0GN>RUX)<%[
MKP6_).C0S2)VG;@9%G@T8'2+F$)+-;70V==LF:^8J$99"B:?QI(G1DM!@^>;
MB4QUB!8))AS=H/K9E*:R)SG659V_JC6@RQD('"?\2H*?EC-T>7&%+E!,T&-$
M<XY)R >FD,XI$V90.C(I'''...*B>TI$Q-&<A! V\&?M_'X+WY1)J3+C[#,S
M<5H%EY#=(M>Z1H[E6 W^3-]-M_M-X?R?]?D_6S](AENUB:OUW'-Z$69PLSIM
MB3%CF&Q OCH$6NU0';? .WT\WF(6HE_?I23Z)B#EOUL<\BJ'/.V0=\:A1RIP
M@KCNU,)<4'.KJ?T*O8[64Z_/EY'G^MV!^5*OZ2G(M9S^(6AV"K(MU^\=HN:G
MJ)[3=RK00=1^%;7?&O4\S1*Z R@"1UG.@D@&CS)Y<UN2VJGD.Y^CRMW*H>X'
M5[G0\VM9=SSWJ,@-F+Y]5.-33,^RCBI\BO$[=G.!>U7 O=: 'X +%@="1EJ4
M.">QX-?EAF8J;([D&Q9EP/280 +9#:H>!;0EZ?W*A_[GZ +;>OM(61_<!Z7@
MP76W;>^H$QI03M<]NLFS!E3?/[GO#:ANUSWN![/VJ4Z!;?2,Q&4X.1'%Z[@Z
MK>:PL9X^CLXG]MW4;CB?J;E-CP9O\L70=X_9)I;=D\!:FK)NN[)S63%'%1M!
M,STHK*B08X=>1G+V!*8 \OF:4K'?* /5-#OZ"U!+ P04    " #3DV91[\;^
M&%\"  "#!@  &0   'AL+W=O<FMS:&5E=',O<VAE970V-RYX;6RE55U/VS 4
M_2M6Q -(6YTO.D!I)-IT&@](%87M8=J#F]PV%HZ=V0XM_WZVDV:%A0YM+XE]
M?<\Y/M?Q3;(5\E&5 !KM*L;5Q"NUKJ\P5GD)%5$C40,W*VLA*Z+-5&ZPJB60
MPH$JAD/?'^.*4.ZEB8LM9)J(1C/*82&1:JJ*R.<I,+&=>(&W#]S13:EM *=)
M33:P!/U0+Z29X9ZEH!5P105'$M83[SJXFL<VWR5\I;!5!V-DG:R$>+23FV+B
M^79#P"#7EH&8UQ/,@#%+9+;QL^/T>DD+/!SOV3\[[\;+BBB8"?:-%KJ<>!<>
M*F!-&J;OQ/8+='[.+5\NF')/M&US8Y.<-TJ+J@.;'524MV^RZ^IP # \PX"P
M X2O ?$;@*@#1.]5B#M _%Z%\P[@K./6NRM<1C1)$RFV2-ILPV8'KOH.;>I%
MN?U.EEJ:56IP.KWAN:@ W9,=*'2:@2:4J3/T$3TL,W1Z<H9.$.7HOA2-(KQ0
M"=9&U$)QW@E,6X'P#8$(W0JN2X7FO(!B )\=QU\>P6-CMG<<[AU/PZ.$2ZA'
M*/(_H- /_8']S-X-#RZ'[/R?^OR?U5\4(^J//W)\T5^/'V54Y4RH1@+Z?KU2
M6IH[_..(1-Q+Q$XB/BZAC<0*.*RI'OJ(6HZQX["][2D-XRC!3X<'\V=.$(PO
M7B9E T3^ZZ3Y0%(XONR36I_XX%95(#>NG2F4BX;KML)]M.^8UZY1O(I/@ZM9
M,!#/3(=M&^)O^K8]WQ*YH5PA!FLCY8\^F4LOVY;73K2HW9U>"6TZA!N6YB\!
MTB:8];40>C^Q OU_)_T%4$L#!!0    ( -.39E&94)IW@P,  -<,   9
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M2B]Q]9CJ+P\B#$"_WW&NG@?&0/LML_P/4$L#!!0    ( -.39E&%7QL$_0(
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M9Q*C*#>3&'7ZKCMR&"(<ACXOV"U3.5B(@JL 3FH7L,WG*(#>Z#T$%G<C(AS
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M\G@+PK)1ZC*,W>G/AE?[>XGW]T&?_PU02P,$%     @ TY-F49=W<N0L @
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MZS^.'Y]E9YO^+9^-_Q%<O !02P$"% ,4    " #3DV91!T%-8H$   "Q
M$               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (
M -.39E'XTWY*[0   "L"   1              "  :\   !D;V-0<F]P<R]C
M;W)E+GAM;%!+ 0(4 Q0    ( -.39E&97)PC$ 8  )PG   3
M  "  <L!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ TY-F4222
MH.4X!0  ;A4  !@              ("!# @  'AL+W=O<FMS:&5E=',O<VAE
M970Q+GAM;%!+ 0(4 Q0    ( -.39E'<33<>"@<  "L=   8
M  " @7H-  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " #3
MDV9144?1(A(#  !F"@  &               @(&Z%   >&PO=V]R:W-H965T
M<R]S:&5E=#,N>&UL4$L! A0#%     @ TY-F49EW\\,<!@  :QL  !@
M         ("! A@  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0
M   ( -.39E%R</4H9 ,   \+   8              " @50>  !X;"]W;W)K
M<VAE971S+W-H965T-2YX;6Q02P$"% ,4    " #3DV91+\ZE7P$,   O4
M&               @('N(0  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L!
M A0#%     @ TY-F4<=3OOH'"   UR   !@              ("!)2X  'AL
M+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( -.39E&52G57TP,
M #((   8              " @6(V  !X;"]W;W)K<VAE971S+W-H965T."YX
M;6Q02P$"% ,4    " #3DV91;]6!I),E  "X=   &               @(%K
M.@  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ TY-F4>W6
M*KL6!0  )@P  !D              ("!-&   'AL+W=O<FMS:&5E=',O<VAE
M970Q,"YX;6Q02P$"% ,4    " #3DV91G2/XU6,%  #B"P  &0
M    @(&!90  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    (
M -.39E$5AN\,VP4  '4-   9              " @1MK  !X;"]W;W)K<VAE
M971S+W-H965T,3(N>&UL4$L! A0#%     @ TY-F4<?I'U)Q!P  BA(  !D
M             ("!+7$  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"
M% ,4    " #3DV91"S>O3L8$  "."P  &0              @('5>   >&PO
M=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( -.39E&;97P7;0\
M )(R   9              " @=)]  !X;"]W;W)K<VAE971S+W-H965T,34N
M>&UL4$L! A0#%     @ TY-F41;,YJOR!0  5 X  !D              ("!
M=HT  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    " #3DV91
MODHR6% &  #N$   &0              @(&?DP  >&PO=V]R:W-H965T<R]S
M:&5E=#$W+GAM;%!+ 0(4 Q0    ( -.39E%DLJV85@4  /0+   9
M      " @2::  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%
M  @ TY-F4>8A;E 6$   (C4  !D              ("!LY\  'AL+W=O<FMS
M:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    " #3DV91'<2=I<X&   1$0
M&0              @($ L   >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+
M 0(4 Q0    ( -.39E'$</S*>P0  .\+   9              " @06W  !X
M;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ TY-F47:1,S84
M P  Z08  !D              ("!M[L  'AL+W=O<FMS:&5E=',O<VAE970R
M,BYX;6Q02P$"% ,4    " #3DV91WC%YXD %  "_"P  &0
M@($"OP  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( -.3
M9E$?N^V89R(  *UL   9              " @7G$  !X;"]W;W)K<VAE971S
M+W-H965T,C0N>&UL4$L! A0#%     @ TY-F48![BG<O!   YPD  !D
M         ("!%^<  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4
M    " #3DV910'X'U*D#  #-"   &0              @(%]ZP  >&PO=V]R
M:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( -.39E'^P/J6R (  /\%
M   9              " @5WO  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL
M4$L! A0#%     @ TY-F4=C@H8PF!0  P@L  !D              ("!7/(
M 'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4    " #3DV91L6-9
MHM$#   ;"0  &0              @(&Y]P  >&PO=V]R:W-H965T<R]S:&5E
M=#(Y+GAM;%!+ 0(4 Q0    ( -.39E&;=&='L@0  /L-   9
M  " @<'[  !X;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @
MTY-F45P)YW-S P  '0@  !D              ("!J@ ! 'AL+W=O<FMS:&5E
M=',O<VAE970S,2YX;6Q02P$"% ,4    " #3DV91HTS:E0(%  #6#   &0
M            @(%4! $ >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4
M Q0    ( -.39E'9 NY?$P4  +(.   9              " @8T) 0!X;"]W
M;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ TY-F40)S8A*Z P
M2@@  !D              ("!UPX! 'AL+W=O<FMS:&5E=',O<VAE970S-"YX
M;6Q02P$"% ,4    " #3DV911J8X7)(%  #C#@  &0              @('(
M$@$ >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( -.39E%J
M( 5?PPH   -#   9              " @9$8 0!X;"]W;W)K<VAE971S+W-H
M965T,S8N>&UL4$L! A0#%     @ TY-F46&ACW$F!0  CA@  !D
M     ("!BR,! 'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( -.39E&*7',-8P,  )4)   9              "
M@5@W 0!X;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ TY-F
M46WL$_0#!0  J1D  !D              ("!\CH! 'AL+W=O<FMS:&5E=',O
M<VAE970T,RYX;6Q02P$"% ,4    " #3DV91]+O/^X0"   /!@  &0
M        @($L0 $ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0
M   ( -.39E$^:^!2&P,  /4-   9              " @>=" 0!X;"]W;W)K
M<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @ TY-F48$$,DE'!   TQ(
M !D              ("!.48! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q0
M2P$"% ,4    " #3DV91;W8]@90#  ";#   &0              @(&W2@$
M>&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( -.39E$*3DY%
MRP,  &0/   9              " @8). 0!X;"]W;W)K<VAE971S+W-H965T
M-#@N>&UL4$L! A0#%     @ TY-F48KA<J;! @  +0@  !D
M ("!A%(! 'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    " #3
MDV91  I\8WD"  !1!@  &0              @(%\50$ >&PO=V]R:W-H965T
M<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    ( -.39E&RU'F->@,  )L,   9
M          " @2Q8 0!X;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#
M%     @ TY-F4=1%<?VV @  )P<  !D              ("!W5L! 'AL+W=O
M<FMS:&5E=',O<VAE970U,BYX;6Q02P$"% ,4    " #3DV91LCL4 J()  #C
M.   &0              @('*7@$ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM
M;%!+ 0(4 Q0    ( -.39E$/RL\AJ0,  +X-   9              " @:-H
M 0!X;"]W;W)K<VAE971S+W-H965T-30N>&UL4$L! A0#%     @ TY-F4;?,
MAI,Y P  [@L  !D              ("!@VP! 'AL+W=O<FMS:&5E=',O<VAE
M970U-2YX;6Q02P$"% ,4    " #3DV91:2$_#-(#  "Q#@  &0
M    @('S;P$ >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    (
M -.39E'SA3VL)@,  #P)   9              " @?QS 0!X;"]W;W)K<VAE
M971S+W-H965T-3<N>&UL4$L! A0#%     @ TY-F4:02JJ?" @  (P@  !D
M             ("!67<! 'AL+W=O<FMS:&5E=',O<VAE970U."YX;6Q02P$"
M% ,4    " #3DV91?!C]HZX%   7'0  &0              @(%2>@$ >&PO
M=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    ( -.39E$2_ FZGP,
M #$0   9              " @3>  0!X;"]W;W)K<VAE971S+W-H965T-C N
M>&UL4$L! A0#%     @ TY-F428],%HG!   \1   !D              ("!
M#80! 'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6Q02P$"% ,4    " #3DV91
MQN6$JLH$  #D'0  &0              @(%KB $ >&PO=V]R:W-H965T<R]S
M:&5E=#8R+GAM;%!+ 0(4 Q0    ( -.39E&.A7<69P<  #HJ   9
M      " @6R- 0!X;"]W;W)K<VAE971S+W-H965T-C,N>&UL4$L! A0#%
M  @ TY-F43S*2X>[!   [A<  !D              ("!"I4! 'AL+W=O<FMS
M:&5E=',O<VAE970V-"YX;6Q02P$"% ,4    " #3DV914PFUN:T$  #9$@
M&0              @('\F0$ >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+
M 0(4 Q0    ( -.39E%K-!K;- ,  -D*   9              " @>"> 0!X
M;"]W;W)K<VAE971S+W-H965T-C8N>&UL4$L! A0#%     @ TY-F4>_&_AA?
M @  @P8  !D              ("!2Z(! 'AL+W=O<FMS:&5E=',O<VAE970V
M-RYX;6Q02P$"% ,4    " #3DV91F5":=X,#  #7#   &0
M@('AI $ >&PO=V]R:W-H965T<R]S:&5E=#8X+GAM;%!+ 0(4 Q0    ( -.3
M9E&%7QL$_0(  /D)   9              " @9NH 0!X;"]W;W)K<VAE971S
M+W-H965T-CDN>&UL4$L! A0#%     @ TY-F49 G?&.% @  1@\   T
M         ( !SZL! 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #3DV91EXJ[
M',     3 @  "P              @ %_K@$ 7W)E;',O+G)E;'-02P$"% ,4
M    " #3DV91YD4+XE,%  "++0  #P              @ %HKP$ >&PO=V]R
M:V)O;VLN>&UL4$L! A0#%     @ TY-F49=W<N0L @  ]B@  !H
M     ( !Z+0! 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%
M  @ TY-F4=9((R[W 0  *R@  !,              ( !3+<! %M#;VYT96YT
A7U1Y<&5S72YX;6Q02P4&     $T 30 2%0  =+D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>321</ContextCount>
  <ElementCount>422</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>85</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Description of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/DescriptionofBusiness</Role>
      <ShortName>Description of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2102102 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2108103 - Disclosure - Business Combination</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/BusinessCombination</Role>
      <ShortName>Business Combination</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2113104 - Disclosure - RADx Program</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/RADxProgram</Role>
      <ShortName>RADx Program</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2116105 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2121106 - Disclosure - Goodwill and Intangible Assets, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/GoodwillandIntangibleAssetsnet</Role>
      <ShortName>Goodwill and Intangible Assets, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2126107 - Disclosure - Balance Sheet Details</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/BalanceSheetDetails</Role>
      <ShortName>Balance Sheet Details</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2132108 - Disclosure - Convertible Notes and Credit Facility</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://fluidigm.com/role/ConvertibleNotesandCreditFacility</Role>
      <ShortName>Convertible Notes and Credit Facility</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2136109 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2142110 - Disclosure - Fair Value of Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/FairValueofFinancialInstruments</Role>
      <ShortName>Fair Value of Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2146111 - Disclosure - Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/ShareholdersEquity</Role>
      <ShortName>Shareholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2150112 - Disclosure - Stock-Based Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/StockBasedPlans</Role>
      <ShortName>Stock-Based Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2156113 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2158114 - Disclosure - Information About Geographic Areas</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/InformationAboutGeographicAreas</Role>
      <ShortName>Information About Geographic Areas</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2160115 - Disclosure - Development Agreement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/DevelopmentAgreement</Role>
      <ShortName>Development Agreement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2162116 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2203201 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://fluidigm.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2304301 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fluidigm.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2309302 - Disclosure - Business Combination (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/BusinessCombinationTables</Role>
      <ShortName>Business Combination (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fluidigm.com/role/BusinessCombination</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2314303 - Disclosure - RADx Program (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/RADxProgramTables</Role>
      <ShortName>RADx Program (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fluidigm.com/role/RADxProgram</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2317304 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fluidigm.com/role/Revenue</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2322305 - Disclosure - Goodwill and Intangible Assets, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/GoodwillandIntangibleAssetsnetTables</Role>
      <ShortName>Goodwill and Intangible Assets, net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fluidigm.com/role/GoodwillandIntangibleAssetsnet</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2327306 - Disclosure - Balance Sheet Details (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/BalanceSheetDetailsTables</Role>
      <ShortName>Balance Sheet Details (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fluidigm.com/role/BalanceSheetDetails</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2333307 - Disclosure - Convertible Notes and Credit Facility (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://fluidigm.com/role/ConvertibleNotesandCreditFacilityTables</Role>
      <ShortName>Convertible Notes and Credit Facility (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fluidigm.com/role/ConvertibleNotesandCreditFacility</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2337308 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fluidigm.com/role/Leases</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2343309 - Disclosure - Fair Value of Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/FairValueofFinancialInstrumentsTables</Role>
      <ShortName>Fair Value of Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fluidigm.com/role/FairValueofFinancialInstruments</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2347310 - Disclosure - Shareholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/ShareholdersEquityTables</Role>
      <ShortName>Shareholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fluidigm.com/role/ShareholdersEquity</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2351311 - Disclosure - Stock-Based Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/StockBasedPlansTables</Role>
      <ShortName>Stock-Based Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fluidigm.com/role/StockBasedPlans</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2405401 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Summary of Significant Accounting Policies - Accumulated Other Comprehensive Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Accumulated Other Comprehensive Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Summary of Significant Accounting Policies - Potential Common Shares Excluded from Computations of Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Potential Common Shares Excluded from Computations of Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - Business Combination - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/BusinessCombinationNarrativeDetails</Role>
      <ShortName>Business Combination - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - Business Combination - Net Cash Flows (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/BusinessCombinationNetCashFlowsDetails</Role>
      <ShortName>Business Combination - Net Cash Flows (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2412406 - Disclosure - Business Combination - Schedule of Consideration Transferred and Identifiable Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails</Role>
      <ShortName>Business Combination - Schedule of Consideration Transferred and Identifiable Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2415407 - Disclosure - RADx Program (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/RADxProgramDetails</Role>
      <ShortName>RADx Program (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fluidigm.com/role/RADxProgramTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2418408 - Disclosure - Revenue - Schedule of Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails</Role>
      <ShortName>Revenue - Schedule of Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2419409 - Disclosure - Revenue - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/RevenueNarrativeDetails</Role>
      <ShortName>Revenue - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2420410 - Disclosure - Revenue - Performance Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/RevenuePerformanceObligationsDetails</Role>
      <ShortName>Revenue - Performance Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2423411 - Disclosure - Goodwill and Intangible Assets, net - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails</Role>
      <ShortName>Goodwill and Intangible Assets, net - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2424412 - Disclosure - Goodwill and Intangible Assets, net - Schedule of Finite-lived Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets, net - Schedule of Finite-lived Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2425413 - Disclosure - Goodwill and Intangible Assets, net - Future Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails</Role>
      <ShortName>Goodwill and Intangible Assets, net - Future Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2428414 - Disclosure - Balance Sheet Details - Summary of Cash and Cash Equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails</Role>
      <ShortName>Balance Sheet Details - Summary of Cash and Cash Equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2429415 - Disclosure - Balance Sheet Details - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails</Role>
      <ShortName>Balance Sheet Details - Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2430416 - Disclosure - Balance Sheet Details - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails</Role>
      <ShortName>Balance Sheet Details - Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2431417 - Disclosure - Balance Sheet Details - Warranty Accrual (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/BalanceSheetDetailsWarrantyAccrualDetails</Role>
      <ShortName>Balance Sheet Details - Warranty Accrual (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2434418 - Disclosure - Convertible Notes and Credit Facility - Narrative (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails</Role>
      <ShortName>Convertible Notes and Credit Facility - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2435419 - Disclosure - Convertible Notes and Credit Facility - Schedule of Debt (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails</Role>
      <ShortName>Convertible Notes and Credit Facility - Schedule of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2438420 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2439421 - Disclosure - Leases - Supplemental Balance sheet (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails</Role>
      <ShortName>Leases - Supplemental Balance sheet (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2440422 - Disclosure - Leases - Schedule of Operating Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/LeasesScheduleofOperatingLeaseCostDetails</Role>
      <ShortName>Leases - Schedule of Operating Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2441423 - Disclosure - Leases - Operating Lease Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails</Role>
      <ShortName>Leases - Operating Lease Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2444424 - Disclosure - Fair Value of Financial Instruments - Summary of Investments and Cash Equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails</Role>
      <ShortName>Fair Value of Financial Instruments - Summary of Investments and Cash Equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2445425 - Disclosure - Fair Value of Financial Instruments - Schedule of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails</Role>
      <ShortName>Fair Value of Financial Instruments - Schedule of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2448426 - Disclosure - Shareholders' Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/ShareholdersEquityNarrativeDetails</Role>
      <ShortName>Shareholders' Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2449427 - Disclosure - Shareholders' Equity - Schedule of Stock Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails</Role>
      <ShortName>Shareholders' Equity - Schedule of Stock Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2452428 - Disclosure - Stock-Based Plans - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/StockBasedPlansNarrativeDetails</Role>
      <ShortName>Stock-Based Plans - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2453429 - Disclosure - Stock-Based Plans - Restricted and Performance Stock Units (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails</Role>
      <ShortName>Stock-Based Plans - Restricted and Performance Stock Units (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2454430 - Disclosure - Stock-Based Plans - Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails</Role>
      <ShortName>Stock-Based Plans - Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2455431 - Disclosure - Stock-Based Plans - Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails</Role>
      <ShortName>Stock-Based Plans - Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2457432 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fluidigm.com/role/IncomeTaxes</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2459433 - Disclosure - Information About Geographic Areas (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/InformationAboutGeographicAreasDetails</Role>
      <ShortName>Information About Geographic Areas (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fluidigm.com/role/InformationAboutGeographicAreas</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="fldm-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2461434 - Disclosure - Development Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/DevelopmentAgreementDetails</Role>
      <ShortName>Development Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fluidigm.com/role/DevelopmentAgreement</ParentRole>
      <Position>69</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="fldm-20200930.htm">fldm-20200930.htm</File>
    <File>exhibit101to3q20orm.htm</File>
    <File>exhibit10210q3q2020.htm</File>
    <File>exhibit102a10q3q2020.htm</File>
    <File>exhibit10310q3q2020.htm</File>
    <File>exhibit103a10q3q2020.htm</File>
    <File>exhibit10410q3q2020.htm</File>
    <File>exhibit10510q3q2020.htm</File>
    <File>exhibit10610q3q2020.htm</File>
    <File>exhibit31110q3q2020ng.htm</File>
    <File>exhibit31210q3q2020ng.htm</File>
    <File>exhibit32110q3q2020ng.htm</File>
    <File>exhibit32210q3q2020ng.htm</File>
    <File>fldm-20200930.xsd</File>
    <File>fldm-20200930_cal.xml</File>
    <File>fldm-20200930_def.xml</File>
    <File>fldm-20200930_lab.xml</File>
    <File>fldm-20200930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>fldm-20200930_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/stpr/2018-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>96
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "fldm-20200930.htm": {
   "axisCustom": 0,
   "axisStandard": 30,
   "contextCount": 321,
   "dts": {
    "calculationLink": {
     "local": [
      "fldm-20200930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "fldm-20200930_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "fldm-20200930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "fldm-20200930_lab.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "fldm-20200930_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "fldm-20200930.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 582,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 8,
    "http://fluidigm.com/20200930": 2,
    "http://xbrl.sec.gov/dei/2020-01-31": 5,
    "total": 15
   },
   "keyCustom": 49,
   "keyStandard": 373,
   "memberCustom": 34,
   "memberStandard": 50,
   "nsprefix": "fldm",
   "nsuri": "http://fluidigm.com/20200930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://fluidigm.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108103 - Disclosure - Business Combination",
     "role": "http://fluidigm.com/role/BusinessCombination",
     "shortName": "Business Combination",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2113104 - Disclosure - RADx Program",
     "role": "http://fluidigm.com/role/RADxProgram",
     "shortName": "RADx Program",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2116105 - Disclosure - Revenue",
     "role": "http://fluidigm.com/role/Revenue",
     "shortName": "Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121106 - Disclosure - Goodwill and Intangible Assets, net",
     "role": "http://fluidigm.com/role/GoodwillandIntangibleAssetsnet",
     "shortName": "Goodwill and Intangible Assets, net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2126107 - Disclosure - Balance Sheet Details",
     "role": "http://fluidigm.com/role/BalanceSheetDetails",
     "shortName": "Balance Sheet Details",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2132108 - Disclosure - Convertible Notes and Credit Facility",
     "role": "http://fluidigm.com/role/ConvertibleNotesandCreditFacility",
     "shortName": "Convertible Notes and Credit Facility",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2136109 - Disclosure - Leases",
     "role": "http://fluidigm.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2142110 - Disclosure - Fair Value of Financial Instruments",
     "role": "http://fluidigm.com/role/FairValueofFinancialInstruments",
     "shortName": "Fair Value of Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2146111 - Disclosure - Shareholders' Equity",
     "role": "http://fluidigm.com/role/ShareholdersEquity",
     "shortName": "Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2150112 - Disclosure - Stock-Based Plans",
     "role": "http://fluidigm.com/role/StockBasedPlans",
     "shortName": "Stock-Based Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "icc600eac6fe343ec8d22cf6dea665c5b_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "icc600eac6fe343ec8d22cf6dea665c5b_I20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2156113 - Disclosure - Income Taxes",
     "role": "http://fluidigm.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2158114 - Disclosure - Information About Geographic Areas",
     "role": "http://fluidigm.com/role/InformationAboutGeographicAreas",
     "shortName": "Information About Geographic Areas",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2160115 - Disclosure - Development Agreement",
     "role": "http://fluidigm.com/role/DevelopmentAgreement",
     "shortName": "Development Agreement",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2162116 - Disclosure - Commitments and Contingencies",
     "role": "http://fluidigm.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2203201 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2304301 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "role": "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309302 - Disclosure - Business Combination (Tables)",
     "role": "http://fluidigm.com/role/BusinessCombinationTables",
     "shortName": "Business Combination (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2314303 - Disclosure - RADx Program (Tables)",
     "role": "http://fluidigm.com/role/RADxProgramTables",
     "shortName": "RADx Program (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2317304 - Disclosure - Revenue (Tables)",
     "role": "http://fluidigm.com/role/RevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2322305 - Disclosure - Goodwill and Intangible Assets, net (Tables)",
     "role": "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetTables",
     "shortName": "Goodwill and Intangible Assets, net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "icc600eac6fe343ec8d22cf6dea665c5b_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "icc600eac6fe343ec8d22cf6dea665c5b_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2327306 - Disclosure - Balance Sheet Details (Tables)",
     "role": "http://fluidigm.com/role/BalanceSheetDetailsTables",
     "shortName": "Balance Sheet Details (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2333307 - Disclosure - Convertible Notes and Credit Facility (Tables)",
     "role": "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityTables",
     "shortName": "Convertible Notes and Credit Facility (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "fldm:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2337308 - Disclosure - Leases (Tables)",
     "role": "http://fluidigm.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "fldm:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2343309 - Disclosure - Fair Value of Financial Instruments (Tables)",
     "role": "http://fluidigm.com/role/FairValueofFinancialInstrumentsTables",
     "shortName": "Fair Value of Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2347310 - Disclosure - Shareholders' Equity (Tables)",
     "role": "http://fluidigm.com/role/ShareholdersEquityTables",
     "shortName": "Shareholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2351311 - Disclosure - Stock-Based Plans (Tables)",
     "role": "http://fluidigm.com/role/StockBasedPlansTables",
     "shortName": "Stock-Based Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "if34d6cb92429486486b628a7b0f777e5_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405401 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)",
     "role": "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Summary of Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i51f17d522ac148c68bc6b818c1014f68_D20200301-20200331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:LegalFees",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i8f326510b71a4deaa593f4283e018c5a_I20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Summary of Significant Accounting Policies - Accumulated Other Comprehensive Loss (Details)",
     "role": "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails",
     "shortName": "Summary of Significant Accounting Policies - Accumulated Other Comprehensive Loss (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i80cf78799b76440ea86f5da1c2493062_D20200701-20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Summary of Significant Accounting Policies - Potential Common Shares Excluded from Computations of Diluted Net Loss Per Share (Details)",
     "role": "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails",
     "shortName": "Summary of Significant Accounting Policies - Potential Common Shares Excluded from Computations of Diluted Net Loss Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i879547fef02c413ab97b1073b8418853_I20200117",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410404 - Disclosure - Business Combination - Narrative (Details)",
     "role": "http://fluidigm.com/role/BusinessCombinationNarrativeDetails",
     "shortName": "Business Combination - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "if34d6cb92429486486b628a7b0f777e5_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Statements of Operations",
     "role": "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations",
     "shortName": "Condensed Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "if34d6cb92429486486b628a7b0f777e5_D20200701-20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - Business Combination - Net Cash Flows (Details)",
     "role": "http://fluidigm.com/role/BusinessCombinationNetCashFlowsDetails",
     "shortName": "Business Combination - Net Cash Flows (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "ibccd6f048dc74a6c953e619b2a9e9ea6_D20200117-20200117",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CashAcquiredFromAcquisition",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "icc600eac6fe343ec8d22cf6dea665c5b_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412406 - Disclosure - Business Combination - Schedule of Consideration Transferred and Identifiable Assets and Liabilities (Details)",
     "role": "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails",
     "shortName": "Business Combination - Schedule of Consideration Transferred and Identifiable Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "ibccd6f048dc74a6c953e619b2a9e9ea6_D20200117-20200117",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i9ad72ef114054c68ba1d7499333b66b9_I20200928",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415407 - Disclosure - RADx Program (Details)",
     "role": "http://fluidigm.com/role/RADxProgramDetails",
     "shortName": "RADx Program (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": "2",
      "lang": "en-US",
      "name": "fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "if34d6cb92429486486b628a7b0f777e5_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418408 - Disclosure - Revenue - Schedule of Disaggregation of Revenue (Details)",
     "role": "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails",
     "shortName": "Revenue - Schedule of Disaggregation of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i9557da47acfa4592bd8a6eb4d01dbcac_D20200701-20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "icc600eac6fe343ec8d22cf6dea665c5b_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419409 - Disclosure - Revenue - Narrative (Details)",
     "role": "http://fluidigm.com/role/RevenueNarrativeDetails",
     "shortName": "Revenue - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "icc600eac6fe343ec8d22cf6dea665c5b_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "icc600eac6fe343ec8d22cf6dea665c5b_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420410 - Disclosure - Revenue - Performance Obligations (Details)",
     "role": "http://fluidigm.com/role/RevenuePerformanceObligationsDetails",
     "shortName": "Revenue - Performance Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "icc600eac6fe343ec8d22cf6dea665c5b_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "icc600eac6fe343ec8d22cf6dea665c5b_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423411 - Disclosure - Goodwill and Intangible Assets, net - Narrative (Details)",
     "role": "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
     "shortName": "Goodwill and Intangible Assets, net - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i4597ae00a444403dacaf5086f59bacac_I20140228",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "icc600eac6fe343ec8d22cf6dea665c5b_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424412 - Disclosure - Goodwill and Intangible Assets, net - Schedule of Finite-lived Intangible Assets (Details)",
     "role": "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets, net - Schedule of Finite-lived Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "id93cbf33dc99482fbdd7c3492d9fd706_I20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "icc600eac6fe343ec8d22cf6dea665c5b_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425413 - Disclosure - Goodwill and Intangible Assets, net - Future Amortization Expense (Details)",
     "role": "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails",
     "shortName": "Goodwill and Intangible Assets, net - Future Amortization Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "icc600eac6fe343ec8d22cf6dea665c5b_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "icc600eac6fe343ec8d22cf6dea665c5b_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428414 - Disclosure - Balance Sheet Details - Summary of Cash and Cash Equivalents (Details)",
     "role": "http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails",
     "shortName": "Balance Sheet Details - Summary of Cash and Cash Equivalents (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "icc600eac6fe343ec8d22cf6dea665c5b_I20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "if34d6cb92429486486b628a7b0f777e5_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Statements of Comprehensive Loss",
     "role": "http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss",
     "shortName": "Condensed Consolidated Statements of Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "if34d6cb92429486486b628a7b0f777e5_D20200701-20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "icc600eac6fe343ec8d22cf6dea665c5b_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429415 - Disclosure - Balance Sheet Details - Inventories (Details)",
     "role": "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails",
     "shortName": "Balance Sheet Details - Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "icc600eac6fe343ec8d22cf6dea665c5b_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "icc600eac6fe343ec8d22cf6dea665c5b_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430416 - Disclosure - Balance Sheet Details - Property and Equipment (Details)",
     "role": "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails",
     "shortName": "Balance Sheet Details - Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "icc600eac6fe343ec8d22cf6dea665c5b_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "ia85757d6f56b40de9d8d04f4618b8bc8_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyAccrual",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431417 - Disclosure - Balance Sheet Details - Warranty Accrual (Details)",
     "role": "http://fluidigm.com/role/BalanceSheetDetailsWarrantyAccrualDetails",
     "shortName": "Balance Sheet Details - Warranty Accrual (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "ia85757d6f56b40de9d8d04f4618b8bc8_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyAccrual",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "icc600eac6fe343ec8d22cf6dea665c5b_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434418 - Disclosure - Convertible Notes and Credit Facility - Narrative (Details)",
     "role": "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails",
     "shortName": "Convertible Notes and Credit Facility - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3876be73e4a0486f968bd16f58652b42_D20200421-20200421",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityCommitmentFeeAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3c17219e8d044f0c861d706caf153722_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435419 - Disclosure - Convertible Notes and Credit Facility - Schedule of Debt (Details)",
     "role": "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails",
     "shortName": "Convertible Notes and Credit Facility - Schedule of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3c17219e8d044f0c861d706caf153722_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "icc600eac6fe343ec8d22cf6dea665c5b_I20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseRenewalTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438420 - Disclosure - Leases - Narrative (Details)",
     "role": "http://fluidigm.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "icc600eac6fe343ec8d22cf6dea665c5b_I20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseRenewalTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "fldm:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "icc600eac6fe343ec8d22cf6dea665c5b_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "fldm:OperatingLeaseRightOfUseAssetGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439421 - Disclosure - Leases - Supplemental Balance sheet (Details)",
     "role": "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails",
     "shortName": "Leases - Supplemental Balance sheet (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "fldm:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "icc600eac6fe343ec8d22cf6dea665c5b_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "fldm:OperatingLeaseRightOfUseAssetGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "if34d6cb92429486486b628a7b0f777e5_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440422 - Disclosure - Leases - Schedule of Operating Lease Cost (Details)",
     "role": "http://fluidigm.com/role/LeasesScheduleofOperatingLeaseCostDetails",
     "shortName": "Leases - Schedule of Operating Lease Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "if34d6cb92429486486b628a7b0f777e5_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "icc600eac6fe343ec8d22cf6dea665c5b_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441423 - Disclosure - Leases - Operating Lease Maturity (Details)",
     "role": "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails",
     "shortName": "Leases - Operating Lease Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "icc600eac6fe343ec8d22cf6dea665c5b_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "icc600eac6fe343ec8d22cf6dea665c5b_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444424 - Disclosure - Fair Value of Financial Instruments - Summary of Investments and Cash Equivalents (Details)",
     "role": "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails",
     "shortName": "Fair Value of Financial Instruments - Summary of Investments and Cash Equivalents (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "icc600eac6fe343ec8d22cf6dea665c5b_I20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i15f7cdd5345a4dc1b08684ff2ea04b58_I20181231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed Consolidated Statements of Stockholders' Equity",
     "role": "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
     "shortName": "Condensed Consolidated Statements of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i4fa0d20dd1f44516b4524fc6b0a6ad86_D20190101-20190331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3c17219e8d044f0c861d706caf153722_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445425 - Disclosure - Fair Value of Financial Instruments - Schedule of Debt (Details)",
     "role": "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails",
     "shortName": "Fair Value of Financial Instruments - Schedule of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i53a339bce2b7419593141ef24bbc8bed_I20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromIssuanceOfCommonStock",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448426 - Disclosure - Shareholders' Equity - Narrative (Details)",
     "role": "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails",
     "shortName": "Shareholders' Equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i9ef4d07044c44fb9900a21ed9c2b3e8a_I20200331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "fldm:SaleOfStockConsiderationReceivableOnTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "icc600eac6fe343ec8d22cf6dea665c5b_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449427 - Disclosure - Shareholders' Equity - Schedule of Stock Options (Details)",
     "role": "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails",
     "shortName": "Shareholders' Equity - Schedule of Stock Options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "icc600eac6fe343ec8d22cf6dea665c5b_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "icc600eac6fe343ec8d22cf6dea665c5b_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "fldm:SharebasedCompensationArrangementbySharebasedPaymentAwardVestingRestrictionsOwnershipPercentageofVotingStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452428 - Disclosure - Stock-Based Plans - Narrative (Details)",
     "role": "http://fluidigm.com/role/StockBasedPlansNarrativeDetails",
     "shortName": "Stock-Based Plans - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "icc600eac6fe343ec8d22cf6dea665c5b_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "fldm:SharebasedCompensationArrangementbySharebasedPaymentAwardVestingRestrictionsOwnershipPercentageofVotingStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "if3575d83de144e808258ee710b5e28d6_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453429 - Disclosure - Stock-Based Plans - Restricted and Performance Stock Units (Details)",
     "role": "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails",
     "shortName": "Stock-Based Plans - Restricted and Performance Stock Units (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "if3575d83de144e808258ee710b5e28d6_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "ia85757d6f56b40de9d8d04f4618b8bc8_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454430 - Disclosure - Stock-Based Plans - Stock Option Activity (Details)",
     "role": "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails",
     "shortName": "Stock-Based Plans - Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "if34d6cb92429486486b628a7b0f777e5_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455431 - Disclosure - Stock-Based Plans - Stock-Based Compensation Expense (Details)",
     "role": "http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails",
     "shortName": "Stock-Based Plans - Stock-Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "if34d6cb92429486486b628a7b0f777e5_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "if34d6cb92429486486b628a7b0f777e5_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2457432 - Disclosure - Income Taxes (Details)",
     "role": "http://fluidigm.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2459433 - Disclosure - Information About Geographic Areas (Details)",
     "role": "http://fluidigm.com/role/InformationAboutGeographicAreasDetails",
     "shortName": "Information About Geographic Areas (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "icc600eac6fe343ec8d22cf6dea665c5b_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "fldm:UpFrontAndMilestonePaymentsMaximum",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2461434 - Disclosure - Development Agreement (Details)",
     "role": "http://fluidigm.com/role/DevelopmentAgreementDetails",
     "shortName": "Development Agreement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "lang": "en-US",
      "name": "fldm:CollaborativeArrangementTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Condensed Consolidated Statements of Cash Flows",
     "role": "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationAmortizationAndAccretionNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Description of Business",
     "role": "http://fluidigm.com/role/DescriptionofBusiness",
     "shortName": "Description of Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2102102 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://fluidigm.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20200930.htm",
      "contextRef": "i3b52e4ea04eb4059bc525afadd48b679_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 85,
   "tag": {
    "country_CN": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "CHINA",
        "terseLabel": "China"
       }
      }
     },
     "localname": "CN",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/InformationAboutGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/InformationAboutGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r542"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r543"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r544"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding (shares)"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r544"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r544"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r545"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r544"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r544"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r544"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r544"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r541"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "fldm_A2017InducementAwardPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2017 Inducement Award Plan [Member]",
        "label": "2017 Inducement Award Plan [Member]",
        "terseLabel": "2017 Inducement Award Plan"
       }
      }
     },
     "localname": "A2017InducementAwardPlanMember",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_AssetRetirementObligationsIncurredButNotYetPaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Asset Retirement Obligations Incurred But Not Yet Paid",
        "label": "Asset Retirement Obligations Incurred But Not Yet Paid",
        "terseLabel": "Asset retirement obligations"
       }
      }
     },
     "localname": "AssetRetirementObligationsIncurredButNotYetPaid",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Assets And Liabilities, Lessee [Table Text Block]",
        "label": "Assets And Liabilities, Lessee [Table Text Block]",
        "terseLabel": "Schedule of balance sheet information"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "fldm_AwardsHeldByOwnersOfMoreThan10OfCommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Awards Held By Owners Of More Than 10% Of Common Stock",
        "label": "Awards Held By Owners Of More Than 10% Of Common Stock [Member]",
        "terseLabel": "Stock options held by owners of more than 10% of common stock"
       }
      }
     },
     "localname": "AwardsHeldByOwnersOfMoreThan10OfCommonStockMember",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAccountsReceivables": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accounts Receivables",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accounts Receivables",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAccountsReceivables",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherReceivables": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Receivables",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Receivables",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherReceivables",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_CashCashEquivalentsAndShortTermInvestmentsAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash, Cash Equivalents, And Short Term Investments, Amortized Cost",
        "label": "Cash, Cash Equivalents, And Short Term Investments, Amortized Cost",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "CashCashEquivalentsAndShortTermInvestmentsAmortizedCost",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_CashPaidForOperatingLeaseLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash Paid For Operating Lease Liabilities [Abstract]",
        "label": "Cash Paid For Operating Lease Liabilities [Abstract]",
        "terseLabel": "Cash paid for amounts included in the measurement of operating lease liabilities (included in net cash used in operating activities in thousands):"
       }
      }
     },
     "localname": "CashPaidForOperatingLeaseLiabilitiesAbstract",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/LeasesScheduleofOperatingLeaseCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "fldm_CertainEmployeeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Certain Employee [Member]",
        "label": "Certain Employee [Member]",
        "terseLabel": "Certain Employee"
       }
      }
     },
     "localname": "CertainEmployeeMember",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_CollaborationRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Collaboration Revenue",
        "label": "Collaboration Revenue [Member]",
        "terseLabel": "Development revenue"
       }
      }
     },
     "localname": "CollaborationRevenueMember",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations",
      "http://fluidigm.com/role/DevelopmentAgreementDetails",
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_CollaborativeArrangementTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Collaborative Arrangement, Term",
        "label": "Collaborative Arrangement, Term",
        "terseLabel": "Collaboration agreement, term"
       }
      }
     },
     "localname": "CollaborativeArrangementTerm",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/DevelopmentAgreementDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "fldm_CommissionCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission Costs [Member]",
        "label": "Commission Costs [Member]",
        "terseLabel": "Commission Costs"
       }
      }
     },
     "localname": "CommissionCostsMember",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_ComputerEquipmentAndSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Computer Equipment And Software [Member]",
        "label": "Computer Equipment And Software [Member]",
        "terseLabel": "Computer equipment and software"
       }
      }
     },
     "localname": "ComputerEquipmentAndSoftwareMember",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_ConsumablesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Consumables [Member]",
        "label": "Consumables [Member]",
        "terseLabel": "Consumables"
       }
      }
     },
     "localname": "ConsumablesMember",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contract With Customer, Liability, Increase From Cash Receipts",
        "label": "Contract With Customer, Liability, Increase From Cash Receipts",
        "terseLabel": "Additional advance payments received"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityIncreaseFromCashReceipts",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_DVSSciencesInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "DVS Sciences, Inc. [Member]",
        "label": "DVS Sciences, Inc. [Member]",
        "terseLabel": "DVS Sciences, Inc."
       }
      }
     },
     "localname": "DVSSciencesInc.Member",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_DebtAndEquityOfferingCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt And Equity Offering Costs",
        "label": "Debt And Equity Offering Costs",
        "terseLabel": "Debt and equity offering costs"
       }
      }
     },
     "localname": "DebtAndEquityOfferingCosts",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_DebtInstrumentEarlyRedemptionCostPercentOfMaximumBorrowingCapacity": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Early Redemption Cost, Percent Of Maximum Borrowing Capacity",
        "label": "Debt Instrument, Early Redemption Cost, Percent Of Maximum Borrowing Capacity",
        "terseLabel": "Prepayment fee, percentage"
       }
      }
     },
     "localname": "DebtInstrumentEarlyRedemptionCostPercentOfMaximumBorrowingCapacity",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Redemption Condition, Stock Value Exceeding Percentage of Conversion Price",
        "label": "Debt Instrument, Redemption Condition, Stock Value Exceeding Percentage of Conversion Price",
        "terseLabel": "Debt redemption conditioned upon common stock value exceeding a percentage of the conversion price"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "fldm_DeferredGrantRevenueNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://fluidigm.com/role/RADxProgramDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Deferred Grant Revenue, Noncurrent",
        "label": "Deferred Grant Revenue, Noncurrent",
        "terseLabel": "Deferred grant income, non-current",
        "totalLabel": "Deferred grant income"
       }
      }
     },
     "localname": "DeferredGrantRevenueNoncurrent",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets",
      "http://fluidigm.com/role/RADxProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_DevelopmentRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Development Revenue",
        "label": "Development Revenue [Member]",
        "terseLabel": "Development revenue"
       }
      }
     },
     "localname": "DevelopmentRevenueMember",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_EmployeeStockPurchasePlanNumberOfSixMonthOfferingPeriods": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Employee Stock Purchase Plan, Number Of Six Month Offering Periods",
        "label": "Employee Stock Purchase Plan, Number Of Six Month Offering Periods",
        "terseLabel": "ESPP, number of six-month offering periods"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanNumberOfSixMonthOfferingPeriods",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "fldm_EmployeeStockPurchasePlanOfferingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Employee Stock Purchase Plan, Offering Period",
        "label": "Employee Stock Purchase Plan, Offering Period",
        "terseLabel": "ESPP, offering period"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanOfferingPeriod",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "fldm_EquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Incentive Plan [Member]",
        "label": "Equity Incentive Plan [Member]",
        "terseLabel": "Equity Incentive Plan"
       }
      }
     },
     "localname": "EquityIncentivePlanMember",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_EquityIncentivePlanTwentyElevenMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Incentive Plan Twenty Eleven [Member]",
        "label": "Equity Incentive Plan Twenty Eleven [Member]",
        "terseLabel": "2011 Equity Incentive Plan"
       }
      }
     },
     "localname": "EquityIncentivePlanTwentyElevenMember",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_ExchangeConvertibleSeniorNotesDue2034Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Exchange Convertible Senior Notes Due 2034 [Member]",
        "label": "Exchange Convertible Senior Notes Due 2034 [Member]",
        "terseLabel": "Exchange Convertible Senior Notes due 2034"
       }
      }
     },
     "localname": "ExchangeConvertibleSeniorNotesDue2034Member",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Finite-Lived Intangible Asset, Expected Amortization, After Year Four",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_FiveLargestCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Five Largest Customers [Member]",
        "label": "Five Largest Customers [Member]",
        "terseLabel": "5 Largest Customers"
       }
      }
     },
     "localname": "FiveLargestCustomersMember",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_InitialConversionPriceOfStock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Initial Conversion Price Of Stock",
        "label": "Initial Conversion Price Of Stock",
        "terseLabel": "Initial conversion price of stock (usd per share)"
       }
      }
     },
     "localname": "InitialConversionPriceOfStock",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "fldm_InstruNorASMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "InstruNor AS [Member]",
        "label": "InstruNor AS [Member]",
        "terseLabel": "InstruNor AS"
       }
      }
     },
     "localname": "InstruNorASMember",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/BusinessCombinationNarrativeDetails",
      "http://fluidigm.com/role/BusinessCombinationNetCashFlowsDetails",
      "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails",
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
      "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_InstrumentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Instruments [Member]",
        "label": "Instruments [Member]",
        "terseLabel": "Instruments"
       }
      }
     },
     "localname": "InstrumentsMember",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_IntellectualPropertyInfringementClaimsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Intellectual Property Infringement Claims [Member]",
        "label": "Intellectual Property Infringement Claims [Member]",
        "terseLabel": "Intellectual Property Infringement Claims"
       }
      }
     },
     "localname": "IntellectualPropertyInfringementClaimsMember",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_LaboratoryAndManufacturingEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Laboratory And Manufacturing Equipment [Member]",
        "label": "Laboratory And Manufacturing Equipment [Member]",
        "terseLabel": "Laboratory and manufacturing equipment"
       }
      }
     },
     "localname": "LaboratoryAndManufacturingEquipmentMember",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, To Be Paid, After Year Four",
        "label": "Lessee, Operating Lease, Liability, To Be Paid, After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearFour",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_LesseeOperatingLeaseRemainingTermOfContract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee, Operating Lease, Remaining Term Of Contract",
        "label": "Lessee, Operating Lease, Remaining Term Of Contract",
        "terseLabel": "Remaining lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRemainingTermOfContract",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Inventory",
        "label": "Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Inventory",
        "terseLabel": "Percentage of eligible inventory"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Receivables",
        "label": "Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Receivables",
        "terseLabel": "Percentage of eligible receivables"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "fldm_LineOfCreditFacilityPercentageOfInterestOnObligationUponDefault": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line Of Credit Facility, Percentage Of Interest On Obligation Upon Default",
        "label": "Line Of Credit Facility, Percentage Of Interest On Obligation Upon Default",
        "terseLabel": "Percentage of interest on obligation upon default"
       }
      }
     },
     "localname": "LineOfCreditFacilityPercentageOfInterestOnObligationUponDefault",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number Of Months To Vest Ratably After First Anniversary Of Vesting Commencement",
        "label": "Number Of Months To Vest Ratably After First Anniversary Of Vesting Commencement",
        "terseLabel": "Number of months over which options vest ratably"
       }
      }
     },
     "localname": "NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "fldm_OneCustomerMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "One Customer",
        "label": "One Customer [Member]",
        "terseLabel": "One Customer"
       }
      }
     },
     "localname": "OneCustomerMember",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseRightOfUseAsset",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Operating Lease, Right-Of-Use Asset, Accumulated Amortization",
        "label": "Operating Lease, Right-Of-Use Asset, Accumulated Amortization",
        "negatedTerseLabel": "Accumulated amortization"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAccumulatedAmortization",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_OperatingLeaseRightOfUseAssetGross": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseRightOfUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Operating Lease, Right-Of-Use Asset, Gross",
        "label": "Operating Lease, Right-Of-Use Asset, Gross",
        "terseLabel": "Total operating lease right-of-use assets, gross"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetGross",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Options, Performance Share Units And Restricted Stock Units [Member]",
        "label": "Options, Performance Share Units And Restricted Stock Units [Member]",
        "terseLabel": "Restricted stock units, stock options and performance share units"
       }
      }
     },
     "localname": "OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_PatentsandLicenseAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Patents and License Agreements [Member]",
        "label": "Patents and License Agreements [Member]",
        "terseLabel": "Patents and licenses",
        "verboseLabel": "Patents and Licenses Amortization Expense"
       }
      }
     },
     "localname": "PatentsandLicenseAgreementsMember",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails",
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_PortionOfStockOptionsVestOnFirstAnniversary": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Portion Of Stock Options Vest On First Anniversary",
        "label": "Portion Of Stock Options Vest On First Anniversary",
        "terseLabel": "Rate at which outstanding options vest on the first anniversary of the option grant date"
       }
      }
     },
     "localname": "PortionOfStockOptionsVestOnFirstAnniversary",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "fldm_ProceedsFromIssuanceOfCommonStockIncludingRelatedExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Proceeds From Issuance Of Common Stock Including Related Expenses",
        "label": "Proceeds From Issuance Of Common Stock Including Related Expenses",
        "terseLabel": "Gross proceeds from issuance of common stock through at-the-market offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStockIncludingRelatedExpenses",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_ProceedsFromResearchAndDevelopmentGrant": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Proceeds from Research and Development Grant",
        "label": "Proceeds from Research and Development Grant",
        "terseLabel": "Proceeds from RADx grant"
       }
      }
     },
     "localname": "ProceedsFromResearchAndDevelopmentGrant",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_ProductWarrantyTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Product Warranty Term",
        "label": "Product Warranty Term",
        "terseLabel": "Product warranty term"
       }
      }
     },
     "localname": "ProductWarrantyTerm",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/RADxProgramDetails": {
       "order": 1.0,
       "parentTag": "fldm_ResearchAndDevelopmentArrangementReceivables",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Research And Development Arrangement, Contract To Perform For Others, Amount",
        "label": "Research And Development Arrangement, Contract To Perform For Others, Amount",
        "terseLabel": "Total value of milestones reasonably assured"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersAmount",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/RADxProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/RADxProgramDetails": {
       "order": 2.0,
       "parentTag": "fldm_DeferredGrantRevenueNoncurrent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Research And Development Arrangement, Contract To Perform For Others, Expenses",
        "label": "Research And Development Arrangement, Contract To Perform For Others, Expenses",
        "terseLabel": "Amounts applied against research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/RADxProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersFundingReceived": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/RADxProgramDetails": {
       "order": 2.0,
       "parentTag": "fldm_ResearchAndDevelopmentArrangementReceivables",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Research And Development Arrangement, Contract To Perform For Others, Funding Received",
        "label": "Research And Development Arrangement, Contract To Perform For Others, Funding Received",
        "terseLabel": "Funding received"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersFundingReceived",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/RADxProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesPercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Research And Development Arrangement, Contract To Perform For Others, Liquidated Damages, Percentage",
        "label": "Research And Development Arrangement, Contract To Perform For Others, Liquidated Damages, Percentage",
        "terseLabel": "Percentage of contractual amount to be paid on liquidated damages"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesPercentage",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/RADxProgramDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Research And Development Arrangement, Contract To Perform For Others, Liquidated Damages, Term",
        "label": "Research And Development Arrangement, Contract To Perform For Others, Liquidated Damages, Term",
        "terseLabel": "Period due to pay liquidation damages"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesTerm",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/RADxProgramDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Research And Development Arrangement, Contract To Perform For Others, Maximum Contract Value",
        "label": "Research And Development Arrangement, Contract To Perform For Others, Maximum Contract Value",
        "terseLabel": "Maximum contract value"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/RADxProgramDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_ResearchAndDevelopmentArrangementReceivables": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://fluidigm.com/role/RADxProgramDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Research and Development Arrangement, Receivables",
        "label": "Research and Development Arrangement, Receivables",
        "totalLabel": "Grant receivable from RADx",
        "verboseLabel": "Grant receivable"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementReceivables",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets",
      "http://fluidigm.com/role/RADxProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_RestrictedCashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Restricted Cash And Cash Equivalents [Member]",
        "label": "Restricted Cash And Cash Equivalents [Member]",
        "terseLabel": "Cash-restricted"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsMember",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_RestrictedStockAndPerformanceShareUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Restricted Stock And Performance Share Units [Member]",
        "label": "Restricted Stock And Performance Share Units [Member]",
        "terseLabel": "Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units"
       }
      }
     },
     "localname": "RestrictedStockAndPerformanceShareUnitsMember",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_RevenueFromContractWithCustomerPerformanceObligationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Revenue From Contract With Customer, Performance Obligation Period",
        "label": "Revenue From Contract With Customer, Performance Obligation Period",
        "terseLabel": "Performance obligation period"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPerformanceObligationPeriod",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "fldm_RevenueFromContractWithCustomerTermsOfPaymentPeriod": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Revenue From Contract With Customer, Terms Of Payment Period",
        "label": "Revenue From Contract With Customer, Terms Of Payment Period",
        "terseLabel": "Terms of payment period"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTermsOfPaymentPeriod",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "fldm_SaleOfStockConsiderationReceivableOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sale Of Stock, Consideration Receivable On Transaction",
        "label": "Sale Of Stock, Consideration Receivable On Transaction",
        "terseLabel": "Maximum aggregate sale proceeds"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivableOnTransaction",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_ScheduleOfSignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule Of Significant Accounting Policies [Line Items]",
        "label": "Schedule Of Significant Accounting Policies [Line Items]",
        "terseLabel": "Schedule Of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfSignificantAccountingPoliciesLineItems",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "fldm_ScheduleOfSignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule Of Significant Accounting Policies [Table]",
        "label": "Schedule Of Significant Accounting Policies [Table]",
        "terseLabel": "Schedule Of Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "ScheduleOfSignificantAccountingPoliciesTable",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "fldm_SeniorConvertibleNotesDue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Convertible Notes Due 2024 [Member]",
        "label": "Senior Convertible Notes Due 2024 [Member]",
        "netLabel": "2019 Notes",
        "terseLabel": "Senior Convertible Notes Due 2024",
        "verboseLabel": "5.25% 2019 Notes due 2024"
       }
      }
     },
     "localname": "SeniorConvertibleNotesDue2024Member",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails",
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_SeniorConvertibleNotesdue2034Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Convertible Notes due 2034 [Member]",
        "label": "Senior Convertible Notes due 2034 [Member]",
        "netLabel": "2014 Notes",
        "terseLabel": "Senior Convertible Notes due 2034",
        "verboseLabel": "2.75% 2014 Notes due 2034"
       }
      }
     },
     "localname": "SeniorConvertibleNotesdue2034Member",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails",
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Percentage Of Performance Units Expected To Vest",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Percentage Of Performance Units Expected To Vest",
        "terseLabel": "Percentage of performance period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award, Options, Expected To Vest, Outstanding, Aggregate Intrinsic Value",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Aggregate Intrinsic Value",
        "terseLabel": "Unvested awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Number",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Number",
        "terseLabel": "Unvested awards (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Exercise Price",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Exercise Price",
        "terseLabel": "Unvested awards (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expected to Vest, Weighted Average Remaining Contractual Term 1",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Remaining Contractual Term 1",
        "terseLabel": "Unvested awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share Based Compensation Arrangement by Share Based Payment Award, Options, Vested, Aggregate Intrinsic Value",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested Aggregate Intrinsic Value",
        "terseLabel": "Vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Exercise Price",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Exercise Price",
        "terseLabel": "Vested (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Remaining Contractual Term One",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Remaining Contractual Term One",
        "verboseLabel": "Vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Maximum Employee Purchase Amount",
        "label": "Share-based Compensation Arrangement By Share-based Payment Award, Maximum Employee Purchase Amount",
        "terseLabel": "Maximum employee purchase amount"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_SharebasedCompensationArrangementbySharebasedPaymentAwardVestingRestrictionsOwnershipPercentageofVotingStock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Vesting Restrictions, Ownership Percentage of Voting Stock",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Vesting Restrictions, Ownership Percentage of Voting Stock",
        "terseLabel": "Percentage of voting power which impacts the term of equity incentive plan"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardVestingRestrictionsOwnershipPercentageofVotingStock",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "fldm_ShareholdersEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Line Items] for Shareholders' Equity [Table]",
        "label": "Shareholders' Equity [Line Items]",
        "terseLabel": "Shareholders' Equity [Line Items]"
       }
      }
     },
     "localname": "ShareholdersEquityLineItems",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "fldm_ShareholdersEquityTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Shareholders' Equity [Table]",
        "label": "Shareholders' Equity [Table]",
        "terseLabel": "Shareholders' Equity [Table]"
       }
      }
     },
     "localname": "ShareholdersEquityTable",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock Option Grants Exercise Price Minimum Percentage On Fair Market Value",
        "label": "Stock Option Grants Exercise Price Minimum Percentage On Fair Market Value",
        "terseLabel": "Stock option grants exercise price minimum percentage on fair market value"
       }
      }
     },
     "localname": "StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "fldm_TrusteeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trustee [Member]",
        "label": "Trustee [Member]",
        "terseLabel": "Trustee"
       }
      }
     },
     "localname": "TrusteeMember",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_TwoThousandAndElevenEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two Thousand And Eleven Equity Incentive Plan [Member]",
        "label": "Two Thousand And Eleven Equity Incentive Plan [Member]",
        "verboseLabel": "2011 Equity Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandAndElevenEquityIncentivePlanMember",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_TwoThousandAndFourteenConvertibleNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two Thousand And Fourteen Convertible Notes [Member]",
        "label": "Two Thousand And Fourteen Convertible Notes [Member]",
        "terseLabel": "2014 Convertible Notes"
       }
      }
     },
     "localname": "TwoThousandAndFourteenConvertibleNotesMember",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_TwoThousandAndNineEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two Thousand And Nine Equity Incentive Plan [Member]",
        "label": "Two Thousand And Nine Equity Incentive Plan [Member]",
        "terseLabel": "2009 Equity Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandAndNineEquityIncentivePlanMember",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_TwoThousandAndNineteenConvertibleNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two Thousand And Nineteen Convertible Notes [Member]",
        "label": "Two Thousand And Nineteen Convertible Notes [Member]",
        "terseLabel": "2019 Convertible Notes"
       }
      }
     },
     "localname": "TwoThousandAndNineteenConvertibleNotesMember",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two Thousand And Nineteen Convertible Notes Potential Make Whole Shares [Member]",
        "label": "Two Thousand And Nineteen Convertible Notes Potential Make Whole Shares [Member]",
        "terseLabel": "2019 Convertible Notes potential make-whole shares"
       }
      }
     },
     "localname": "TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_TwoThousandAndSeventeenInducementAwardPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two Thousand And Seventeen Inducement Award Plan [Member]",
        "label": "Two Thousand And Seventeen Inducement Award Plan [Member]",
        "verboseLabel": "2017 Inducement Award Plan"
       }
      }
     },
     "localname": "TwoThousandAndSeventeenInducementAwardPlanMember",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_TwoThousandAndTenEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two Thousand And Ten Equity Incentive Plan [Member]",
        "label": "Two Thousand And Ten Equity Incentive Plan [Member]",
        "verboseLabel": "DVS Sciences Inc. 2010 Equity Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandAndTenEquityIncentivePlanMember",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_TwoThousandAndTwentyAtTheMarketEquityOfferingProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two Thousand And Twenty At The Market Equity Offering Program [Member]",
        "label": "Two Thousand And Twenty At The Market Equity Offering Program [Member]",
        "terseLabel": "2020 At-the-Market Offering"
       }
      }
     },
     "localname": "TwoThousandAndTwentyAtTheMarketEquityOfferingProgramMember",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two Thousand Seventeen Employee Stock Purchase Plan [Member]",
        "label": "Two Thousand Seventeen Employee Stock Purchase Plan [Member]",
        "terseLabel": "2017 Employee Stock Purchase Plan",
        "verboseLabel": "2017 Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "TwoThousandSeventeenEmployeeStockPurchasePlanMember",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails",
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_UpFrontAndMilestonePaymentsMaximum": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Up-Front And Milestone Payments, Maximum",
        "label": "Up-Front And Milestone Payments, Maximum",
        "terseLabel": "Collaboration agreement, up-front and periodic milestone payments, up to"
       }
      }
     },
     "localname": "UpFrontAndMilestonePaymentsMaximum",
     "nsuri": "http://fluidigm.com/20200930",
     "presentation": [
      "http://fluidigm.com/role/DevelopmentAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_AmericasMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Americas [Member]",
        "terseLabel": "Americas"
       }
      }
     },
     "localname": "AmericasMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Asia Pacific [Member]",
        "verboseLabel": "Asia-Pacific"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r116",
      "r123",
      "r198",
      "r350",
      "r351",
      "r352",
      "r367",
      "r368"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r116",
      "r123",
      "r198",
      "r350",
      "r351",
      "r352",
      "r367",
      "r368"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r116",
      "r123",
      "r198",
      "r350",
      "r351",
      "r352",
      "r367",
      "r368"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r174",
      "r292",
      "r298",
      "r512"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r314",
      "r316",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r473",
      "r509",
      "r513"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails",
      "http://fluidigm.com/role/LeasesNarrativeDetails",
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r314",
      "r316",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r473",
      "r509",
      "r513"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails",
      "http://fluidigm.com/role/LeasesNarrativeDetails",
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r174",
      "r292",
      "r298",
      "r512"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r170",
      "r292",
      "r296",
      "r474",
      "r508",
      "r510"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations",
      "http://fluidigm.com/role/DevelopmentAgreementDetails",
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r170",
      "r292",
      "r296",
      "r474",
      "r508",
      "r510"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations",
      "http://fluidigm.com/role/DevelopmentAgreementDetails",
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r304",
      "r314",
      "r316",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r473",
      "r509",
      "r513"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails",
      "http://fluidigm.com/role/LeasesNarrativeDetails",
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r304",
      "r314",
      "r316",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r473",
      "r509",
      "r513"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails",
      "http://fluidigm.com/role/LeasesNarrativeDetails",
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r171",
      "r172",
      "r292",
      "r297",
      "r511",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/InformationAboutGeographicAreasDetails",
      "http://fluidigm.com/role/LeasesNarrativeDetails",
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r171",
      "r172",
      "r292",
      "r297",
      "r511",
      "r527",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/InformationAboutGeographicAreasDetails",
      "http://fluidigm.com/role/LeasesNarrativeDetails",
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r176",
      "r442"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_CA": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "CALIFORNIA",
        "terseLabel": "CALIFORNIA"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://fluidigm.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r117",
      "r118",
      "r119",
      "r120",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r367",
      "r368",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible List]",
        "terseLabel": "Accounting Standards Update [Extensible List]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r5",
      "r20",
      "r177",
      "r178"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable (net of allowances of $324 and $6, at September 30, 2020 and December\u00a031, 2019, respectively)"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r39",
      "r237"
     ],
     "calculation": {
      "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "auth_ref": [
      "r63",
      "r64",
      "r65",
      "r69",
      "r70"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]",
        "terseLabel": "Unrealized Gain (Loss) on Investments"
       }
      }
     },
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r23",
      "r67",
      "r68",
      "r69",
      "r500",
      "r521",
      "r525"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r420"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r66",
      "r69",
      "r70",
      "r113",
      "r114",
      "r115",
      "r397",
      "r516",
      "r517"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)",
        "verboseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r62",
      "r69",
      "r70",
      "r397",
      "r415",
      "r416",
      "r417",
      "r418",
      "r420"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Translation Adjustment"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Acquired finite-lived intangible assets, useful life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r21",
      "r353"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r113",
      "r114",
      "r115",
      "r350",
      "r351",
      "r352"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r317",
      "r319",
      "r355",
      "r356"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "auth_ref": [
      "r261",
      "r269"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.",
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs",
        "negatedTerseLabel": "Equity issuance costs",
        "terseLabel": "Equity issuance costs"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails",
      "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r319",
      "r341",
      "r354"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Total stock-based compensation"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r27",
      "r180",
      "r201"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowances"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r99",
      "r425"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of debt discounts, premiums and issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r99",
      "r223",
      "r232"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of developed technology",
        "verboseLabel": "Amortization of intangibles"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive securities excluded from computations of net loss per share (shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r108",
      "r156",
      "r160",
      "r166",
      "r194",
      "r394",
      "r398",
      "r412",
      "r479",
      "r497"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS",
        "verboseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r59",
      "r108",
      "r194",
      "r394",
      "r398",
      "r412"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r188"
     ],
     "calculation": {
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gain"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r189"
     ],
     "calculation": {
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Gross Unrealized Loss"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r186",
      "r207"
     ],
     "calculation": {
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Available-for-sale, amortized cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r185",
      "r187",
      "r207",
      "r485"
     ],
     "calculation": {
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "totalLabel": "Available-for-sale, fair value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r320",
      "r344"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails",
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails",
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails",
      "http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Balance Sheet Related Disclosures [Abstract]",
        "terseLabel": "Balance Sheet Related Disclosures [Abstract]"
       }
      }
     },
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation and Consolidation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Operating lease right-of-use buildings"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r313",
      "r315"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BusinessCombinationNarrativeDetails",
      "http://fluidigm.com/role/BusinessCombinationNetCashFlowsDetails",
      "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails",
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
      "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r313",
      "r315",
      "r376",
      "r377"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BusinessCombinationNarrativeDetails",
      "http://fluidigm.com/role/BusinessCombinationNetCashFlowsDetails",
      "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails",
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
      "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "verboseLabel": "Purchase price (shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BusinessCombinationNarrativeDetails",
      "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BusinessCombinationNarrativeDetails",
      "http://fluidigm.com/role/BusinessCombinationNetCashFlowsDetails",
      "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r382",
      "r383",
      "r384"
     ],
     "calculation": {
      "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "totalLabel": "Total purchase price",
        "verboseLabel": "Total purchase price"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BusinessCombinationNarrativeDetails",
      "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails",
      "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Business Combination, Consideration Transferred [Abstract]",
        "terseLabel": "Purchase price:"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "auth_ref": [
      "r382",
      "r383"
     ],
     "calculation": {
      "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "terseLabel": "Non-cash consideration common shares"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Business Combination"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BusinessCombination"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]",
        "terseLabel": "Assets acquired:"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r379"
     ],
     "calculation": {
      "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r379"
     ],
     "calculation": {
      "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": {
     "auth_ref": [
      "r379"
     ],
     "calculation": {
      "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r379"
     ],
     "calculation": {
      "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "terseLabel": "Deferred tax liability, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": {
     "auth_ref": [
      "r379"
     ],
     "calculation": {
      "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets",
        "terseLabel": "Developed technology"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r378",
      "r379"
     ],
     "calculation": {
      "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventories, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]",
        "terseLabel": "Liabilities assumed:"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r378",
      "r379"
     ],
     "calculation": {
      "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "totalLabel": "Fair value of identifiable net assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r2",
      "r112",
      "r147"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "terseLabel": "Description of Business"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/DescriptionofBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalizedContractCostAxis": {
     "auth_ref": [
      "r215"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by cost capitalized in obtaining or fulfilling contract with customer.",
        "label": "Capitalized Contract Cost [Axis]",
        "terseLabel": "Capitalized Contract Cost [Axis]"
       }
      }
     },
     "localname": "CapitalizedContractCostAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalizedContractCostDomain": {
     "auth_ref": [
      "r215"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cost capitalized in obtaining and fulfilling contract with customer.",
        "label": "Capitalized Contract Cost [Domain]",
        "terseLabel": "Capitalized Contract Cost [Domain]"
       }
      }
     },
     "localname": "CapitalizedContractCostDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r408",
      "r409"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Carrying Value"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://fluidigm.com/role/BusinessCombinationNetCashFlowsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).",
        "label": "Cash Acquired from Acquisition",
        "negatedTerseLabel": "Less: cash and cash equivalents acquired"
       }
      }
     },
     "localname": "CashAcquiredFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BusinessCombinationNetCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r36",
      "r101"
     ],
     "calculation": {
      "http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      },
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsAndShortTermInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "netLabel": "Cash and Cash Equivalents",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails",
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of cash and cash equivalent balance.",
        "label": "Cash and Cash Equivalents [Axis]",
        "terseLabel": "Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash-unrestricted"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestments": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails": {
       "order": 3.0,
       "parentTag": "fldm_CashCashEquivalentsAndShortTermInvestmentsAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.",
        "label": "Cash, Cash Equivalents, and Short-term Investments",
        "totalLabel": "Fair Value"
       }
      }
     },
     "localname": "CashCashEquivalentsAndShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r94",
      "r101",
      "r103"
     ],
     "calculation": {
      "http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period",
        "totalLabel": "Total cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails",
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r94",
      "r413"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashMember": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits.",
        "label": "Cash [Member]",
        "terseLabel": "Total cash"
       }
      }
     },
     "localname": "CashMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "auth_ref": [
      "r388",
      "r389",
      "r391"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "terseLabel": "Development Agreement"
       }
      }
     },
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/DevelopmentAgreement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]"
       }
      }
     },
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/DevelopmentAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r50",
      "r242",
      "r487",
      "r504"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r239",
      "r240",
      "r241",
      "r243"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Number of remaining securities available for future issuance (shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r113",
      "r114"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails",
      "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (usd per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r19",
      "r261"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending Balance (shares)",
        "periodStartLabel": "Beginning Balance (shares)",
        "terseLabel": "Common stock, shares outstanding (shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock: $0.001 par value, 200,000 shares authorized at September\u00a030, 2020 and December\u00a031, 2019; 74,115 and 69,956 shares issued and outstanding at September\u00a030, 2020 and December\u00a031, 2019, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r73",
      "r75",
      "r76",
      "r79",
      "r489",
      "r506"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive Loss"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r142",
      "r143",
      "r174",
      "r410",
      "r411"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/InformationAboutGeographicAreasDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r142",
      "r143",
      "r174",
      "r410",
      "r411",
      "r526"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/InformationAboutGeographicAreasDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r142",
      "r143",
      "r174",
      "r410",
      "r411",
      "r526"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/InformationAboutGeographicAreasDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r137",
      "r494"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentrations of Business and Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r142",
      "r143",
      "r174",
      "r410",
      "r411"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk, percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/InformationAboutGeographicAreasDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r142",
      "r143",
      "r174",
      "r410",
      "r411"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/InformationAboutGeographicAreasDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConstructionInProgressGross": {
     "auth_ref": [
      "r236"
     ],
     "calculation": {
      "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress, Gross",
        "terseLabel": "Construction-in-progress"
       }
      }
     },
     "localname": "ConstructionInProgressGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r271",
      "r272",
      "r293"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r271",
      "r272",
      "r293"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue, current"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r271",
      "r272",
      "r293"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Deferred revenue, non-current"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r294"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Revenue recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtMember": {
     "auth_ref": [
      "r251"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt [Member]",
        "terseLabel": "Convertible Debt"
       }
      }
     },
     "localname": "ConvertibleDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails",
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails",
      "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtSecuritiesMember": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder.",
        "label": "Convertible Debt Securities [Member]",
        "terseLabel": "Convertible Notes"
       }
      }
     },
     "localname": "ConvertibleDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleLongTermNotesPayable": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.",
        "label": "Convertible Notes Payable, Noncurrent",
        "terseLabel": "Convertible notes, net"
       }
      }
     },
     "localname": "ConvertibleLongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r80",
      "r474"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "terseLabel": "Costs and expenses:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r140",
      "r174"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r14",
      "r16",
      "r17",
      "r480",
      "r481",
      "r495"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails",
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Additional interest rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r17",
      "r252",
      "r481",
      "r495"
     ],
     "calculation": {
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Principal amount",
        "verboseLabel": "Long-term debt, principal amount"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails",
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r47",
      "r262",
      "r265",
      "r267"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Initial conversion rate of notes"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r424",
      "r426"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Par Value",
        "verboseLabel": "Principal amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r407"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "verboseLabel": "Debt"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r46",
      "r254",
      "r424"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate on notes"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails",
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails",
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r48"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails",
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "terseLabel": "Redemption, Period One"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "terseLabel": "Redemption, Period Two"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r48",
      "r110",
      "r262",
      "r266",
      "r267",
      "r268",
      "r423",
      "r424",
      "r426",
      "r493"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails",
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r423",
      "r426"
     ],
     "calculation": {
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedTerseLabel": "Unamortized debt discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtPolicyTextBlock": {
     "auth_ref": [
      "r104",
      "r249"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.",
        "label": "Debt, Policy [Policy Text Block]",
        "terseLabel": "Convertible Notes"
       }
      }
     },
     "localname": "DebtPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r193"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table Text Block]",
        "terseLabel": "Schedule of cash and available-for-sale securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": {
     "auth_ref": [
      "r192",
      "r208"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions",
        "terseLabel": "Number of investment in unrealized loss positions"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r425"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "terseLabel": "Offering related costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r40",
      "r425"
     ],
     "calculation": {
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "negatedTerseLabel": "Unamortized debt issuance cost",
        "terseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails",
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r361",
      "r362"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liability"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAmortizationAndAccretionNet": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Depreciation, Amortization and Accretion, Net",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAmortizationAndAccretionNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Developed technology",
        "verboseLabel": "Developed Technology Amortization Expense"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails",
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r292",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Summary of disaggregation of revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-Based Plans"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "auth_ref": [
      "r320",
      "r344"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of share-based payment arrangement.",
        "label": "Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]",
        "terseLabel": "Schedule of stock-based compensation expense",
        "verboseLabel": "Schedule of common stock reserved for future issuance"
       }
      }
     },
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityTables",
      "http://fluidigm.com/role/StockBasedPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EMEAMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Regions of Europe, Middle East and Africa.",
        "label": "EMEA [Member]",
        "terseLabel": "EMEA"
       }
      }
     },
     "localname": "EMEAMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic and Diluted",
        "terseLabel": "Net loss per share, basic and diluted (usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r104",
      "r130",
      "r131"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Loss per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r413"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of foreign exchange rate fluctuations on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation and related benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r343"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Total unrecognized compensation cost related to stock-based compensation arrangements"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Employee Stock",
        "verboseLabel": "Employee stock purchase plan"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails",
      "http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options, restricted stock units and performance awards",
        "verboseLabel": "Securities To Be Issued Upon Exercise Of Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue from External Customer [Line Items]",
        "terseLabel": "Revenue from External Customer [Line Items]"
       }
      }
     },
     "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/RevenuePerformanceObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Operating lease right-of-use equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r113",
      "r114",
      "r115",
      "r118",
      "r125",
      "r127",
      "r132",
      "r198",
      "r261",
      "r269",
      "r350",
      "r351",
      "r352",
      "r367",
      "r368",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r420",
      "r516",
      "r517",
      "r518"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails",
      "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r407"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Gross amount of debt extinguished.",
        "label": "Extinguishment of Debt, Amount",
        "terseLabel": "Debt extinguished"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r402",
      "r404"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of assets using significant unobservable inputs (level 3). Such reconciliation, separately presenting changes during the period, at a minimum, may include, but is not limited to: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income, and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r401",
      "r446",
      "r447",
      "r448"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r400",
      "r405"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r305",
      "r306",
      "r311",
      "r312",
      "r401",
      "r446"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level I:"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r446",
      "r447",
      "r448"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r190",
      "r191",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r209",
      "r210",
      "r211",
      "r212",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r231"
     ],
     "calculation": {
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Accumulated Amortization and Translation"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r233"
     ],
     "calculation": {
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "2020 (remainder of the year)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r233"
     ],
     "calculation": {
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r233"
     ],
     "calculation": {
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r233"
     ],
     "calculation": {
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r224",
      "r227",
      "r231",
      "r234",
      "r475",
      "r476"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails",
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r231",
      "r476"
     ],
     "calculation": {
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "verboseLabel": "Gross Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails",
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r224",
      "r230"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails",
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r231",
      "r475"
     ],
     "calculation": {
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails",
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "auth_ref": [
      "r475"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "terseLabel": "Weighted-Average Amortization Period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinitelivedIntangibleAssetsAcquired1": {
     "auth_ref": [
      "r225"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.",
        "label": "Finite-lived Intangible Assets Acquired",
        "terseLabel": "Finite-lived intangible assets acquired"
       }
      }
     },
     "localname": "FinitelivedIntangibleAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r104",
      "r421"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedLabel": "Loss on disposal of property and equipment"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r99",
      "r255",
      "r256"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on extinguishment of debt",
        "terseLabel": "Loss from extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations",
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeographicConcentrationRiskMember": {
     "auth_ref": [
      "r141"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa).",
        "label": "Geographic Concentration Risk [Member]",
        "terseLabel": "Geographic Concentration Risk"
       }
      }
     },
     "localname": "GeographicConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/InformationAboutGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r216",
      "r218",
      "r478"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill acquired on acquisition"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BusinessCombinationNarrativeDetails",
      "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails",
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets",
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r104",
      "r220",
      "r228"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill, Intangible Assets and Other Long-Lived Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r99",
      "r217",
      "r219",
      "r221"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Impairment of goodwill"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrantMember": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Award of money not required to be repaid.",
        "label": "Grant [Member]",
        "terseLabel": "Grant revenue"
       }
      }
     },
     "localname": "GrantMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r111",
      "r156",
      "r159",
      "r162",
      "r165",
      "r168"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Loss before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r364",
      "r365",
      "r366",
      "r369",
      "r371",
      "r373",
      "r374",
      "r375"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r109",
      "r126",
      "r127",
      "r155",
      "r363",
      "r370",
      "r372",
      "r507"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax benefit"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations",
      "http://fluidigm.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r102"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Cash paid for income taxes, net of refunds"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r235"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Intangible Assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r222",
      "r229"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Developed technology, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r77",
      "r154",
      "r422",
      "r425",
      "r490"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r93",
      "r96",
      "r102"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r28",
      "r214"
     ],
     "calculation": {
      "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryLIFOReservePeriodCharge": {
     "auth_ref": [
      "r56",
      "r57",
      "r58",
      "r213"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.",
        "label": "Inventory, LIFO Reserve, Period Charge",
        "terseLabel": "Provision for excess and obsolete inventory"
       }
      }
     },
     "localname": "InventoryLIFOReservePeriodCharge",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r4",
      "r55"
     ],
     "calculation": {
      "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Total inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails",
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r30",
      "r214"
     ],
     "calculation": {
      "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r29",
      "r214"
     ],
     "calculation": {
      "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r438"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of lease expense"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LegalFees": {
     "auth_ref": [
      "r81"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.",
        "label": "Legal Fees",
        "terseLabel": "Legal fees"
       }
      }
     },
     "localname": "LegalFees",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseDiscountRate": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discount rate used by lessee to determine present value of operating lease payments.",
        "label": "Lessee, Operating Lease, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "LesseeOperatingLeaseDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r439"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "verboseLabel": "Schedule of future minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r439"
     ],
     "calculation": {
      "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total future minimum payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r439"
     ],
     "calculation": {
      "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r439"
     ],
     "calculation": {
      "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r439"
     ],
     "calculation": {
      "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r439"
     ],
     "calculation": {
      "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "verboseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r439"
     ],
     "calculation": {
      "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2020 (remainder of year)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r439"
     ],
     "calculation": {
      "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Renewal term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r441"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r43",
      "r108",
      "r161",
      "r194",
      "r395",
      "r398",
      "r399",
      "r412"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r26",
      "r108",
      "r194",
      "r412",
      "r482",
      "r502"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r45",
      "r108",
      "r194",
      "r395",
      "r398",
      "r399",
      "r412"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LicenseMember": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Right to use intangible asset. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark.",
        "label": "License [Member]",
        "terseLabel": "Other revenue",
        "verboseLabel": "License and royalty revenue"
       }
      }
     },
     "localname": "LicenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r17",
      "r481",
      "r495"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Line of credit outstanding"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "auth_ref": [
      "r42",
      "r110"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.",
        "label": "Lender Name [Axis]",
        "terseLabel": "Lender Name [Axis]"
       }
      }
     },
     "localname": "LineOfCreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeeAmount": {
     "auth_ref": [
      "r42"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the fee for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Commitment Fee Amount",
        "terseLabel": "Commitment fee amount"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeeAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.",
        "label": "Line of Credit Facility, Lender [Domain]",
        "terseLabel": "Line of Credit Facility, Lender [Domain]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLenderDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r42"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum ability to borrow under line of credit"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r17",
      "r253",
      "r481",
      "r498"
     ],
     "calculation": {
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Long-term debt, total"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-term Debt, Fair Value",
        "terseLabel": "Estimated fair value of debt"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-term Debt [Text Block]",
        "terseLabel": "Convertible Notes and Credit Facility"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacility"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermInvestments": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).",
        "label": "Long-term Investments",
        "terseLabel": "Available-for-sale, cash-restricted"
       }
      }
     },
     "localname": "LongTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r48"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails",
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails",
      "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r48",
      "r250"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails",
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails",
      "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MovementInStandardProductWarrantyAccrualRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Movement in Standard Product Warranty Accrual [Roll Forward]",
        "terseLabel": "Movement in Standard Product Warranty Accrual [Roll Forward]"
       }
      }
     },
     "localname": "MovementInStandardProductWarrantyAccrualRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsWarrantyAccrualDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r94",
      "r97",
      "r100"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r71",
      "r74",
      "r78",
      "r100",
      "r108",
      "r117",
      "r121",
      "r122",
      "r123",
      "r124",
      "r126",
      "r127",
      "r128",
      "r156",
      "r159",
      "r162",
      "r165",
      "r168",
      "r194",
      "r412",
      "r488",
      "r505"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss",
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations",
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Changes and Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reporting segment"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/InformationAboutGeographicAreasDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OfficeEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine.",
        "label": "Office Equipment [Member]",
        "terseLabel": "Office furniture and fixtures"
       }
      }
     },
     "localname": "OfficeEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total costs and expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r156",
      "r159",
      "r162",
      "r165",
      "r168"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r433",
      "r440"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost (including variable costs)"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/LeasesScheduleofOperatingLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
        "verboseLabel": "Minimum Lease Payments for Operating Leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r428"
     ],
     "calculation": {
      "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total",
        "totalLabel": "Total operating lease liabilities",
        "verboseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/LeasesNarrativeDetails",
      "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails",
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r428"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities, current",
        "verboseLabel": "Operating lease liabilities, current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets",
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r428"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities, non-current",
        "verboseLabel": "Operating lease liabilities, non-current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets",
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r429",
      "r435"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/LeasesScheduleofOperatingLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r427"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use asset, net",
        "totalLabel": "Total operating lease right-of-use assets, net",
        "verboseLabel": "Right-of-use asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets",
      "http://fluidigm.com/role/LeasesNarrativeDetails",
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "terseLabel": "Lease amortization"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r437",
      "r440"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "verboseLabel": "Weighted average discount rate per annum"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r436",
      "r440"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "verboseLabel": "Weighted average remaining lease term (in years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Leased Assets [Line Items]",
        "terseLabel": "Operating Leased Assets [Line Items]"
       }
      }
     },
     "localname": "OperatingLeasedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/LeasesNarrativeDetails",
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r72",
      "r75",
      "r392",
      "r393",
      "r396"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive income (loss)",
        "totalLabel": "Other comprehensive income (loss), net of tax",
        "verboseLabel": "Other comprehensive income, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss",
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r63",
      "r67"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Net change in unrealized gain (loss) on investments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other non-cash items"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentOfFinancingAndStockIssuanceCosts": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The total of the cash outflow during the period which has been paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt and the cost incurred directly for the issuance of equity securities.",
        "label": "Payment of Financing and Stock Issuance Costs",
        "negatedTerseLabel": "Payment of debt and equity issuance costs"
       }
      }
     },
     "localname": "PaymentOfFinancingAndStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Payments for taxes related to net share settlement of equity awards and other"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r86",
      "r385"
     ],
     "calculation": {
      "http://fluidigm.com/role/BusinessCombinationNetCashFlowsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
       "weight": 1.0
      },
      "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "netLabel": "Cash consideration paid to former equity holders",
        "terseLabel": "Cash consideration paid on closing to former equity holders"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BusinessCombinationNarrativeDetails",
      "http://fluidigm.com/role/BusinessCombinationNetCashFlowsDetails",
      "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails",
      "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://fluidigm.com/role/BusinessCombinationNetCashFlowsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Acquisition, net of cash acquired",
        "totalLabel": "Acquisition of InstruNor, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BusinessCombinationNetCashFlowsDetails",
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedLabel": "Purchases of investments"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Shares"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails",
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r320",
      "r344"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails",
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails",
      "http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails",
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails",
      "http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (usd per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.001 par value, 10,000 shares authorized, no shares issued and outstanding at either September\u00a030, 2020 or December\u00a031, 2019"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r6",
      "r34",
      "r35"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrimeRateMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.",
        "label": "Prime Rate [Member]",
        "terseLabel": "Prime Rate"
       }
      }
     },
     "localname": "PrimeRateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "auth_ref": [
      "r90"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Proceeds from Convertible Debt",
        "terseLabel": "Proceeds from convertible debt issuance"
       }
      }
     },
     "localname": "ProceedsFromConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from issuance of common stock from at-the-market offering, net of commissions"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails",
      "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r90"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from Issuance of Debt",
        "terseLabel": "Proceeds from debt issuance"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans": {
     "auth_ref": [
      "r89",
      "r345"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised",
        "terseLabel": "Proceeds from stock issuance from ESPP"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLegalSettlements": {
     "auth_ref": [
      "r95"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash received for the settlement of litigation during the current period.",
        "label": "Proceeds from Legal Settlements",
        "terseLabel": "Proceeds from legal settlements"
       }
      }
     },
     "localname": "ProceedsFromLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with the maturity (principal being due), prepayment and call (request of early payment) of other investments not otherwise defined in the taxonomy.",
        "label": "Proceeds from Maturities, Prepayments and Calls of Other Investments",
        "terseLabel": "Proceeds from maturities of investments"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfOtherInvestments": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow from the sale of investments classified as other.",
        "label": "Proceeds from Sale of Other Investments",
        "terseLabel": "Proceeds from sale of investments"
       }
      }
     },
     "localname": "ProceedsFromSaleOfOtherInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r89",
      "r345"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductAndServiceOtherMember": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other.",
        "label": "Product and Service, Other [Member]",
        "terseLabel": "Other revenue"
       }
      }
     },
     "localname": "ProductAndServiceOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations",
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Product Information [Line Items]",
        "terseLabel": "Product Information [Line Items]"
       }
      }
     },
     "localname": "ProductInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/InformationAboutGeographicAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Product revenue",
        "verboseLabel": "Product revenue"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations",
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductWarrantyAccrual": {
     "auth_ref": [
      "r246",
      "r247",
      "r486"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.",
        "label": "Standard and Extended Product Warranty Accrual",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "ProductWarrantyAccrual",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsWarrantyAccrualDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualPayments": {
     "auth_ref": [
      "r244"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.",
        "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments",
        "negatedTerseLabel": "Warranty costs incurred"
       }
      }
     },
     "localname": "ProductWarrantyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsWarrantyAccrualDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualWarrantiesIssued": {
     "auth_ref": [
      "r245"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in the standard and extended product warranty accrual from warranties issued.",
        "label": "Standard and Extended Product Warranty Accrual, Increase for Warranties Issued",
        "terseLabel": "Accrual for current period warranties"
       }
      }
     },
     "localname": "ProductWarrantyAccrualWarrantiesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsWarrantyAccrualDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r39",
      "r238"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails",
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r38",
      "r236"
     ],
     "calculation": {
      "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r11",
      "r12",
      "r238",
      "r503"
     ],
     "calculation": {
      "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails",
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r11",
      "r238"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r11",
      "r236"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails",
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r104",
      "r179",
      "r182",
      "r183",
      "r184"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Research and Development [Abstract]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock": {
     "auth_ref": [
      "r359",
      "r360"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others (including royalty arrangements, purchase provisions, license agreements, and commitments to provide additional funding), aggregated by similar arrangements or individually if necessary to understand the effects on the financial statements. Include also the amount of costs incurred under a research and development arrangement accounted for as a contract to perform research and development for others. Aggregation of similar arrangements by type may be appropriate. Include also the amount of compensation earned (contract income) under a research and development arrangement accounted for as a contract to perform research and development for others. Aggregation of similar arrangements by type may be appropriate.",
        "label": "Research and Development Arrangement, Contract to Perform for Others [Table Text Block]",
        "terseLabel": "Summary of Research and Development Activity Under NIH Contract"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/RADxProgramTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r358",
      "r538"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.",
        "label": "Research, Development, and Computer Software Disclosure [Text Block]",
        "verboseLabel": "RADx Program"
       }
      }
     },
     "localname": "ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/RADxProgram"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalents": {
     "auth_ref": [
      "r10",
      "r101",
      "r103",
      "r477",
      "r499"
     ],
     "calculation": {
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsAndShortTermInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents",
        "terseLabel": "Cash-restricted"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r10",
      "r101",
      "r103"
     ],
     "calculation": {
      "http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Current",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]",
        "terseLabel": "Cash and Cash Equivalents [Domain]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r3",
      "r10",
      "r103"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "terseLabel": "Short-term restricted cash"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r8",
      "r13",
      "r103",
      "r528"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Non-current restricted cash"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails",
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r22",
      "r269",
      "r353",
      "r501",
      "r520",
      "r525"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r113",
      "r114",
      "r115",
      "r118",
      "r125",
      "r127",
      "r198",
      "r350",
      "r351",
      "r352",
      "r367",
      "r368",
      "r516",
      "r518"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r152",
      "r153",
      "r158",
      "r163",
      "r164",
      "r170",
      "r171",
      "r174",
      "r291",
      "r292",
      "r474"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total revenue",
        "verboseLabel": "Sales to customers"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations",
      "http://fluidigm.com/role/DevelopmentAgreementDetails",
      "http://fluidigm.com/role/InformationAboutGeographicAreasDetails",
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "auth_ref": [
      "r142",
      "r174"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "terseLabel": "Revenue from Contract with Customer"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/InformationAboutGeographicAreasDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r105",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r303"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r281",
      "r282",
      "r295",
      "r303"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/Revenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r279"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Remaining performance obligation, expected revenue"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/RevenuePerformanceObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Remaining performance obligation, expected timing of satisfaction"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/RevenuePerformanceObligationsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in CCYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/RevenuePerformanceObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/RevenuePerformanceObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of expected timing for satisfying remaining performance obligation.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]",
        "terseLabel": "Summary of expected timing of revenue recognition"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenue:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Shares sold (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SalesCommissionsAndFees": {
     "auth_ref": [
      "r82"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller).",
        "label": "Sales Commissions and Fees",
        "terseLabel": "Commission expense"
       }
      }
     },
     "localname": "SalesCommissionsAndFees",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r69",
      "r419",
      "r420"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Components of accumulated other comprehensive loss"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Summary of potential common shares excluded from computations of net loss per share attributed to common stockholders"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r376",
      "r377"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BusinessCombinationNarrativeDetails",
      "http://fluidigm.com/role/BusinessCombinationNetCashFlowsDetails",
      "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r376",
      "r377"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of consideration transferred"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BusinessCombinationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash and cash equivalents.",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Summary of cash and cash equivalents"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/DevelopmentAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityTables",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r224",
      "r230",
      "r475"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails",
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r224",
      "r230"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of finite-lived intangible assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r9",
      "r31",
      "r32",
      "r33"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested performance-based units.",
        "label": "Schedule of Nonvested Performance-based Units Activity [Table Text Block]",
        "terseLabel": "Schedule of nonvested performance-based units activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "terseLabel": "Activity under restricted stock units"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOperatingLeasedAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of long-lived, depreciable assets that are subject to a operating lease agreements and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Schedule of Operating Leased Assets [Table]",
        "terseLabel": "Schedule of Operating Leased Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfOperatingLeasedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/LeasesNarrativeDetails",
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.",
        "label": "Schedule of Product Information [Table]",
        "terseLabel": "Schedule of Product Information [Table]"
       }
      }
     },
     "localname": "ScheduleOfProductInformationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/InformationAboutGeographicAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.",
        "label": "Schedule of Product Warranty Liability [Table Text Block]",
        "terseLabel": "Schedule of activity of warranty accrual"
       }
      }
     },
     "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r39",
      "r238"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of consideration transferred and assets acquired and liabilities assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BusinessCombinationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": {
     "auth_ref": [
      "r10",
      "r103",
      "r477",
      "r499"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.",
        "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Schedule of restricted cash"
       }
      }
     },
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r320",
      "r344"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails",
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails",
      "http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r325",
      "r336",
      "r338"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Activity under stock options"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r51",
      "r106",
      "r133",
      "r134",
      "r258",
      "r259",
      "r260",
      "r262",
      "r263",
      "r264",
      "r266",
      "r267",
      "r268",
      "r269"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Estimated future intangible asset amortization expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r148",
      "r150",
      "r151",
      "r156",
      "r157",
      "r162",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r173",
      "r174",
      "r175"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Information About Geographic Areas"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/InformationAboutGeographicAreas"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Service revenue",
        "verboseLabel": "Service revenue"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations",
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "verboseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "verboseLabel": "Granted (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Ending Balance (shares)",
        "periodStartLabel": "Beginning Balance (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number of Nonvested and Outstanding Units"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Ending Balance (usd per share)",
        "periodStartLabel": "Beginning Balance (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms",
        "terseLabel": "Weighted average remaining contractual terms"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Released (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Released (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails",
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails",
      "http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate",
        "terseLabel": "Maximum employee subscription rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Additional awards authorized for issuance (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r323"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Securities to be issued (shares)",
        "verboseLabel": "Awards authorized for issuance (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails",
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Weighted- Average Remaining Contractual Life (in Years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r337"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedTerseLabel": "Options forfeited (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Options granted (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r344"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r327",
      "r344"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Ending Balance (shares)",
        "periodStartLabel": "Beginning Balance (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Options (000s)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r326"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Ending Balance (usd per share)",
        "periodStartLabel": "Beginning Balance (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted-Average Exercise Price per Option"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost": {
     "auth_ref": [
      "r342"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "An excess of the fair value of the modified award over the fair value of the award immediately before the modification.",
        "label": "Share-based Payment Arrangement, Plan Modification, Incremental Cost",
        "terseLabel": "Incremental compensation cost"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r318",
      "r324"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails",
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails",
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails",
      "http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Options exercised (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Options forfeited (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Options granted (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche One [Member]",
        "terseLabel": "Tranche One"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche Two [Member]",
        "terseLabel": "Tranche Two"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "verboseLabel": "Share price (usd per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BusinessCombinationNarrativeDetails",
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Award vesting percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract]",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant Date Fair Value per Unit"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of options vested.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares",
        "terseLabel": "Vested (shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Purchase price of common stock, percent"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r15",
      "r483",
      "r484",
      "r496"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsAndShortTermInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-term Investments",
        "terseLabel": "Short-term investments",
        "verboseLabel": "Short-Term Marketable Securities"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r54",
      "r113",
      "r114",
      "r115",
      "r118",
      "r125",
      "r127",
      "r132",
      "r198",
      "r261",
      "r269",
      "r350",
      "r351",
      "r352",
      "r367",
      "r368",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r420",
      "r516",
      "r517",
      "r518"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails",
      "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations",
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r113",
      "r114",
      "r115",
      "r132",
      "r474"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations",
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockCompensationPlanMember": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.",
        "label": "Share-based Payment Arrangement [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "StockCompensationPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r18",
      "r19",
      "r269"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "terseLabel": "Acquisition of InstruNor AS (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r53",
      "r261",
      "r262",
      "r269"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "terseLabel": "Conversion of debt into common stock (shares)",
        "verboseLabel": "Issuance of common stock on bond conversion (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r18",
      "r19",
      "r261",
      "r269"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of common stock under ESPP (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r18",
      "r19",
      "r261",
      "r269"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of common stock from at-the-market offering, net of issuance costs (in shares)",
        "verboseLabel": "Shares issued (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r18",
      "r19",
      "r261",
      "r269"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Issuance of restricted stock, net of shares withheld for taxes, and other (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r18",
      "r19",
      "r261",
      "r269",
      "r329"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Option exercised (shares)",
        "terseLabel": "Issuance of common stock from option exercises (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r54",
      "r261",
      "r269"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Acquisition of InstruNor AS"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r54",
      "r261",
      "r269"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "terseLabel": "Issuance of common stock on bond conversion"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r18",
      "r19",
      "r261",
      "r269"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of common stock under ESPP"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r18",
      "r19",
      "r261",
      "r269"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of common stock from at-the-market offering, net of issuance costs"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r261",
      "r269"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Issuance of restricted stock, net of shares withheld for taxes, and other"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r54",
      "r261",
      "r269"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Issuance of common stock from option exercises"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r19",
      "r24",
      "r25",
      "r108",
      "r181",
      "r194",
      "r412"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "negatedLabel": "Cumulative-effect of new accounting standard for Topic 326 Credit Losses",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets",
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r107",
      "r269",
      "r270"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Shareholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r60"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "terseLabel": "Balance Sheet Details"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetails"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosures of cash flow information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r190",
      "r191",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r305",
      "r312",
      "r491"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "terseLabel": "US treasury securities"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r135",
      "r136",
      "r138",
      "r139",
      "r144",
      "r145",
      "r146"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r434",
      "r440"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable costs including non-lease component"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/LeasesScheduleofOperatingLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VehiclesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equipment used primarily for road transportation.",
        "label": "Vehicles [Member]",
        "terseLabel": "Operating lease right-of-use vehicles"
       }
      }
     },
     "localname": "VehiclesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted",
        "terseLabel": "Shares used in computing net loss per share, basic and diluted (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 8
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4647-111522"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5033-111524"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26610-111562"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.L)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e99989-122729"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68051541&loc=SL49131252-203054"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(2))",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(3))",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(5)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109126253&loc=d3e4852-112606"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130561-203045"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130564-203045"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "808",
   "URI": "http://asc.fasb.org/topic&trid=5833765"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=d3e13220-108610"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13467-108611"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13476-108611"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918666-209980"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62557-112803"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "730",
   "Topic": "985",
   "URI": "http://asc.fasb.org/subtopic&trid=2197926"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r541": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r542": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r543": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r544": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r545": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "http://asc.fasb.org/topic&trid=2122208"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>97
<FILENAME>0001162194-20-000107-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001162194-20-000107-xbrl.zip
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MLP*KT:Y#J./T6_^X:_=;34QU&[1_[XCQE,UNX^[6SP[LMX9W_4Z*<[9@Z>)
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M15789;_=NF+-UJ#1;_=HG]B\?L=^]9*25YJZ[J4![;FC9#8V1"R]X1X@(VO
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MSB<&K Q8Q(@#/M$U\+7Q -P$?F+Q,7==/$FX>L$=7"Y=X_!_+0V'SX'KN7@
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ML,A8YNH*U!F=>LX10TRD@RT[>3/XP3*._]AMY;#_KFI9M:1FX>#2@,>SPNA
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M/4!W1.U[1Y]G@TH[5]8B)5=#$78!5HPXIBC$ZC:H-BGA[ 7_]_ELELWL1_[
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M#MC\!C:;%?HBP/>J6<^R1K,!_]P.LJP^Z/6I2<MEO8_?^*&-)L>;^B*HR:?
M9KGL5K#V-#+D0I8N=(,%-\-. _BQE')"529CPK#@4L!5[BX P2<H5#]$=.-'
M^FI@7A%CGR(ZWA7HYB8%"$(OR%KR *:S&M.G(*],ZO*!-Q ^,H);B1S.%HC:
MA1\&=($'N,(*>6* ##+8 <\19E86<32J90K%8S6<M]+L)*KB"8>%4 ]%]XE
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M=Y-I@NI+=/M[<.1B:0.IQYVCQX>#>@%ZDL-%$GK8]Y6*O&8ZM=:1W@ WZ@U
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M>8?SV]A$[,UH9)QZ<TS@%Z6JJ/XE_H[=C<.F C1 SF]3%?2GBG6G>E;O%>)
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MLLT13.>->]/4<4]5E2KM^TY$+'P<C$O>ECZ>K857@N'5D001D*O)L0^<:VW
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M$F.+.=$_C3)\!W,L8 A"M(/E:!SP(M<_%K6PV4,?:XY6/*WF:&'V4B&6O43
M6DTT:W<:-W?-5A->L*N[FQLV;/WW</=M/S]^-]HZ[E@0>.O$C:2GK@U,I9'P
M5ZUFJP^PKS?^<=<>T$FP?NOWNQM1Y96!,[E@F6*5-:[@<*[KO6&KS]2+C0EF
MB0>1W,MP_]J R*^.0-4"5V5=%Y9\RD0T4=#GS71,JL<).W(RG)@6++H]894
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MKZ>J0VK[E5AD2DW(_"A@0@<]+!?-1FI!%TMG/-/%7#:+CT&[PTPC/_2WI3U
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MCQTJ''N^P/%;%K^W/4,G73BH2$M2D,DY0 4RU$P]:1'4>I>JS?R92QGU@D:
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M07I#4.+=PGQE F"IE&6WAF7,EW/V'<?!R_[D:XU."^62;-WN-R4_T_EOU3@
M,.^HIQO 58WQ#W;#]0>^$005GUFN12-DQ1-<<)Y B77%*N?*- ]P;I/3IO5S
MC%&9*]N>L*9M"6($(NO8UL*QIZ!I=IU[W9(I6?%V_Z?EA$A*X5$KM9.>#O6*
M3A2GZ(F<2$3#BG+,H32!L'[G%GD76C_A65; [+&5JP/6QTY.R[@+<-5G.;E
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M9+WR,DPOE,/2>!##?DCAST'<OW+^(RF'<:.5%):Z(B<FD1F!I;LXC(Q&],Q
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MK[PM:/EG>Y[KM-WP96?\&?<;S_4\7%V\8$_F#\)#3W 7/GBX<UU6F@!'_#4
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MR@_BE\#=6)^E9ZT!NB[M?N\&7 _P-T0NLO)F^AZ9H4YX;4N=Q*7(0A8,\L_
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MAZ* =MM8YK7O\2$K =#5@#4NIF6/75!9?P\<Q--O3TT^80/#I#Z(!PH3N6\
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M>S2A$CX(1_/9Y!Y^$.\LSAX=5+B0#BZK>@BX&+Z*I];E4VY[>*%98/EF'A[
M?H;W^01DB(_*#($RX8HS_0=G@U9_D&\[W_.E\+X@+,= 2J:_Z*9%O0?P84X.
M76L&]#1T6V-#>!S/<.8T5_/5<7^ A.%&@ \2V&"G":D3D= FB>31$UJ<[H,K
M>H'=&A,-<TPGP$_=RM%28DXZ_&IPSX-O@U0D*S!..9V]F/24\AOX(1V>3;?X
M.!_,(Q=?$O%)&VB2DAJ[M0)S;#Z#D(2]LH&KGNES7C"?([&$Z!2$>S4M"R4C
MOHT79W!MO%[/ADT26R"N9K"VZ1H!2-BKWFW[.MP87+;@%?P:;0Z\]I/IGJ>#
M. 4*6\X<(5"9M_ PE FW92XQF[[$;'*K-H4I4M<3;.R*.X)X*&E2KJ4SK%;3
M*>^HG]APF6338[%!V<^#$6:]R-&U71,#'[]KDA+%@E8@AL"S[3L^F 2WICN#
M?WX";S^Z&&>XNKU]!(ZFD!3Q9_*8;UG"P0@']_^W<B57*-9RA6KMS9Z-D UV
MX9W#=X<7M4+]7?U8#:U<KQ^B&:E<3-?%O<MERT#Y9O,0/>=ERK;ON76JHC4:
MI3VV3F5M./U^#&_7]&94D4$)N ^WN)\W-;Z9%NAFQ^:_.!UB >E?G1)@&NZ+
M!#N/F#\+"HD,USN2L6?.+^OMF>(O<U[.9_W'C &*L)"O/W-69$-0)NP[7@.>
MB;R__,?R3)^293;G5GYA67N8^I=/R3^E#(J<8ZZ_=9&YD<QMY;&: IZ#]?F+
MR5\O$O<B<2\2=\]$^=C HO-??Q8USM$%[ALSG2Z"]R)X+X)WST3YV&"E\U]_
MZR)Y_WUY^!3+'S_U^(?_N@CWBW"_"/>]$N5C<Z?.?_VM++H5;Y<@'$OJAT.[
M/#&T*RR6/(7XOTC_B_2_2/]]$F6'\5V?<OT7X;]-^+\QW8SE+UH@$UQ\T0)'
MTP)KNQ5C9/F4_+4#RM0O29\= F29H<_1XT<[H7(=-:CTP9Q!9K8T&W+T@+3Z
M)572QBYOU6I;/52O;=0/&^_X.* 5NMI4C=7R.->6.D7L8#;B+EN>C;4)W^0\
M_GW$ I+ZDLR)_7MI2\Y 6_*EM>?2VO..UIXE25T4'OS!_-,/ :)<[G(J7WD7
M4.+/;%+N@#7W*=>?Q4S<T;W$E&![VWVV=W7P9HCJV? ^+K'#,XH=?A!O;4]/
MD8&M6R]6A@A-D(TH739VZEA/<3Q)D)VT60Q:8N>AR1]!G-@KZ$EQ]R^=$AFF
MK+%6YWL+)[\_W7>Z_<&P==_IW?]V08K)&E),VYG-N&M@F(; UP>^[@<"=ET@
M1 EX6@^MP!=S++ 4$?U(Q0$=-PX7->83$[,'_^+C"%/&P'RUZ0>^0(]2]S/Q
M?NKZZ5%?/C5GC$[.&4VM2L+F[F[ 7([;@^AEL.&D.PA(["=NH(=P7:;CPF9S
MCT)\X! XHL49_@[\*;ZW$.%$N-"<&[X \(K!#>7P%8DLQK"3A$#%X .DCP@'
MS##@=]TVN+A2I8J@F.P1T=R*A6*.#8(10;NUJ!2N].6.ZQ9\KL\])W"1<1^3
M3]F*/>6 4+HVL]Y.++*=_3+);<;)N0WD4*V,Z_YJ_F^ .'(@-SKZ3'^.U3:&
M@"SY&]U#'"M]@1AK7GI:']DSZ4V6)>1$-RTO#GF'[R-$G85L"1^8<Q<#\>)U
M)7*1X>$(X&N^.8,WX RIL/WR.4+6#N]B!"[?\FTIP7]SX$EL@JO#;R^]Y'-W
M9MJZ3Z<_"03(7J>.Q?&QX7<Z?(@C1N'_W/+*O2F(A1Q]T-(-PAJ$-P(0_V.Q
MS3FX0HCL%[N_%3&$_"23JY'897"E<OG?%1B?>/'*NP8QA/"'E$88!:XG01KA
M0J&>XN%B-,9:]F+U7F/FO*Y5=;0<3&/,=7.\YJEMAUF8]H#7=9O5V R^.O54
MNH2+YR#X/T%=$$/P##MS\HZRYLC\/TS2C& 7,2&$V9\IJ&&59%JSQ:]3+C89
M#@JP!>SX6(TBB$X):0,34U(+1S(N;:@C4TUP;2?PZ?6)'E@^?M7FS^"=<%NP
MX-*NZM)P$2<+P9?;%B6SJB4-=$J^D@L_S8:P<T*3P$NBAL+++UE1'C(\Z*VY
M(U EEX]K2HU#@R(_E\89;],X![KK>OMF$!@(28K)QSA;K8,^=3GP*9@P(D4,
MO"-^B1A(_.V,,+LJ?D?^F,%?E&_5Y8M=X!%DP05[ MYJ"1/I7R+Y>M5]:EV+
MCREA(?ZZ=1Q"AI5#W-S@6?S6&H, ,0EAED9&X&M7MQV\2+7Y9:W<.DUY*#Z8
MX<P7+/!4V!B[UN!XH%7H(#L"W:E2@H<B%;R-?W+4:\(XA-T3%^) 5$M=<S8+
M;%/9<O!%TH%*TL(]"./V%("6<N<Z+;GO3_(7I=G?-T9L'T\6>G$1GR>9.>:L
M,3WNK<EG%T:,C\9\!#RL)1=T(LCGU6J.\Y*-_.36>%-KD&R\U4V7X&+IW*E0
M0&K4;!WM6@EVY0H$%@D 3:R#E@]7:MOS4?P2'#(SO7AUB+ 1Z%,!B K;%P4J
M/KJ=!A?XU3$)-PL\7X T2Y]3/@66@TPX,#OPL*6_D@-K>V@@@XDF+R:,9F#\
M +@=E+N+1L*$(\ W?&2"U)#W1GTNG%TPFL5?^#V0P_B X1,[(Y1>! 5._BU8
MI)[XGCG#(QA!A$N;]LDV4?IA](5[V@X&X?OM@\07"^F_=RET*WR60K?&4D#\
M4NB6S4*WCZBK@ZG;R<G55;&H-2EX-."@(C#8B!L >NM%!QL;=-.CZZ"E MLH
MHX*]&!=</=[UKL/)!&N''@C=!]\B&<U?*"ZRI'8X]SWIL8K0MU"+')B+1ANT
M,3@ E^\")_KDQ=X$'A9->*SE>8YA)B,3X8."BB*'Y-$!7AZ)QB^*7QH&1CK4
M2RV#(B'%9K/&KNYZCZW6]?H83$(WTIWPPZ"?GP,0W0XXV)X/U]?=L0>V'H5T
MX(-2/>%8/;S-K52D??$M,KRO:$@1QF6U6ZVOR=!LK9!3OY5$=$K^5=$8&PHC
M'WA84%1?(2NWGRD>X 4C(WR5(F4.T765AJ3#I7D;A=!BFZJN+I[&"XPIQHZ7
MKK[NNA2_<+G!49]CH MDH4\NBF2NJ=@S<X6YX)<1!^)/5,PANEMNZ6^Y2<*'
M9!Y<Q9O0&PN<+B%X0<:13&"XD7I./>2AD(QKWJ,ET'0.L'?@!> #3Y_ )L)V
M*W]KXV+DJ) -CT1V%X@[# MBF-U^SF$4AW9)<@]%-C'P%[G4X4;JSR[G%#H;
M<?^5<WLE-B,C/*NKTI9.)MW!"RC3@!$\E_VPG5<@II(.&$&2P@'UF3&EN*0N
M.V&0?\34837:A&3#&$S%I1.QPNN5#;NI6QZ8?^!"C27105N8$Q%4Q!$N+Z:>
M6"[>^&$R <YUX5@]7*NUKWF?@N/U+QX<Q3FF:4 BD+T)7^M?[Y#1V&KRG6V8
MZ?GTNJF@%46<"30_[EM']W5B9M@P8"298EWV8M2(&AER&L>%VEA=P1578%=<
M>]9R8'[8 1[,P*7#1VF%!49:33L7+]Y#;\6[SLDY1LA_=#>T96@\D&X%PI^)
M!MW \3.F)AROF3Q@,Y6+\7)B+A*>2-]Y13DB([7H<7FY:&:.&27O*(TH5D89
M'"$6XX%11L\UTQ?BL:9RU>2>.>Z8$A+B6D)\T"B@6/R]A?$U.6\I&JV4&,V#
M#S;F<\M9J$7%)C>U'[[W.OEB$VPSY=:2JR87)#U'#LZA<._ [\.U>U-SCE=2
MCN8$](ZGB=U5NT7WQ<4(V2 #XJ$-R)S ]\QQ&)Y>6IG&%"/1-6+)'77/YX@*
MW*9-4&.B\!Z!Y\4#:Z'X,/!A0-O*[&BXIT1C=6E=496\8IIL!7^2:6VL\!]>
MQG*>31$2X#_G6![D<:'VXZZW(COEB^'%Q+2J^+ LCP'+&#]PH)7'P'_T3/A0
M+N)@"T=;H3\3!R'$O)0-WCSLS(;5Y(01 ->\[;1RK-UIPS_?!CG6&CSV:53;
M3:N/[R@QW.%X4<4U'3Z!U7 YZVKE;N3*1Y03YWC.K6A.%;XL&5/DFC!Z E2!
MCX+[Q+TYYK'P'/RZ">KIR>6X2A?$9+3$83!YK$QF1?4;R/6DZH55MA"L&N8$
MX"4SO)2P[+O Y4)$+5N CH#9A'-GJ)Q3#ODVKB7$F5^V0Y#M8JGEN(@682PA
MWL4\LU"VKRN\P$\03RO^?U QKK#Z0YET4>#-TE_AF+F1MP!_!)9(>5.)!PC)
M/@@^'#T#<E(W7=(K9,_1_#LD%ZP,GD*:[3(*K9;HR1%6?!,IPQPA!NR$ZX1>
MO1,:IZ%)&J9V=1=,VV=Q)&.DU"F[JZQ%W1+!RY44,,BYHX3O,GE>S9.?UV))
MJ]?4"#30+QSWR87]>C'= )U5J>#!\P=&X3/0+QCT,3%]#(82[+K-7YFQ& %O
M*K_!-;T?X'(Y&%3V0^-='!_7D8KUV7)&H.34._>]F]X->HW.LPU+47) ?G\*
M3X_Z8 )'CH%-$[BAWB<E(#)C'B=+2/<%@U*9@X\NLXPQX%5 *<[ J7BAY-D,
MJ&F8#JQ3>K04D-)A)^! C?$%8%=RB<G7CYY'K!"5,.@<2RD\E[+L8+#X.( 2
M:00O>22>I+\8&P(98$0-ITB.N!)4 ?EA_M1U@F<2(%[LX"Z3BBP [P=^-_:P
M%%R7L1&0ERH3$&X-6 -$/'IB.1!3)W==]QPA$<7P1Z6!*7,E+L9MX F'#FTN
M$1F*)DE&NE_:T9Z4)'!+L<ZY9!NR7 =#-L J&P15(-M%7*]1*.2+]2(S=)OD
M"^ITC 7ZCF,QBB'I7B#,*K"9?BQMTL()MBW<PT"DR)[2&F-F()K? 1:CA-\*
M0SQHC7$PSNE;\KDF(!PIL?'&&9Y,]G^&27:-X;2(Q-)?:/WX*; !?'\N-"W9
M9/2/X;F&AMEO#99+K\PC>GOTPIC[E"J&7[TY_9#;0+^#BLF7Z+<)^!0GR8RS
M7[<*Y)]94!.U:MRNH[H>69$ES+K>J@V$E4&J)(A=6=?Q+X6&2&0*1$Z68X-,
M,['000338A[K^AK;L/INN<Z/(F(+476'$MJ9Y(0U Z+)PZJ\Q+V6XV/D\,1J
MSS:$BN,A*[ (YR122;CC+45,E:RQE4^+U @^86@33L2SB6)'J9.6PKHHZ"E#
MBO?8DOV\I!X_3>JQ>4D]?H;48^$4F<=!0*ZG\KU\JLA<#B5N$&VJ=%='O]C
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M%GV@<EK!A,MQ(/&!/M7FJAI1>NGCT8$3.LFEM4[RGP?8%][O#KKWPQ9"^HB
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MNDR57>#,H"-1XBSB+F6-/?9[WUK]?\#/A]_ZK6_L6^N^]5NW_VE-FT?7I,[
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MF8PTEAX8P/TMET,IL>8)"!,@S=7EPBZY<^?SY\X;E]SY^>7.3R'_),I0#D%
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M>6@<VHV(2KMD18J*H;2H6,V(2G&2X55:M9?EFUTVY= P&+:GFJ2=&)/H;1[
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M$:F]V% ]($W<6?(\@T/SM++&:\9COK%,JZ41.=:)1 /JV#1X#Z4PM[,>N_7
M)V2?+BYZN;,:>&;>@I>!@62>)R&9#11D;Y/@8TW3FB Y5;-' 5#624%"-*.O
M&U:7[H G%O /\;2(QC^+3,#*P,9$L%S"^2_>E<+5'?R\$W$3LN#NU3Q[$/(B
M$[J^?GVY*I*@L"B8?;TA<U$2A7QI&KH@[\"[_0KGB!Z["98Q?Y6K%(C8F?L
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MO-"$C4ZOR[U'W '=QQ7U07^*;F:,AF<E7V]H#B_A8@R+,A?B%CBY)3ZC.5A
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M">%2%Q,O?J/#N)4P#N?[+U*=SQ9BYKF]LUD;<EK753ZX%F*-G:>=>W,0G&$
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MVZ>N:+MO8:_S+72^A7;Z%E[GS#3138EC5HBKF1?+ET_ZSM5^<?*Y6N7H(>0
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MX?70UK%^C3W:\[0U<N>(?519<;XFM9;3 ?5=H/Y)?_?XZ&N ^@<'_8.3DS\
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MG4#N!/(&C 0$\J 3R)U [@1R)Y [@;P!(P&!O-<)Y$X@=P*Y$\B=0-Z D8!
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M#F!8P<0WYQ=?VV?MCY])LW/UI7/5Z+4[EU,2+C@HL&3L/@TD%CQT>0Q1$L0
M+M.LZNN(-B7K -P]Z8XBP;3L(*Q-A"J0;I1 C-:%%9Q#8.U"O!0MTE4K'Y8+
M-I*#!<;,5028I]D]@*@C&NNY!]15\NV;O<-'8YHMT]E&D5A%NO_:@Q7&%%"?
MW=$;O?0N<R.05 .B?AW":JE=,:F,DJ82(HVA8,RD%PO*F7T[56TV& !3(88%
MQ9ZDL8+1ZHSME$@[G;!3F#&U04SM8:%;K4@:OD^ XD!"1L- X_J),F&TQP;
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M& S 5;;[M(^)V+/9O2P:@7 U9IF_\=/(:PB1K%HUMT&[14.RD[[KSZTGB76
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M3;P-(<YS;O9M'4JN#KF?%26G4>34YUE\Y%(F)NC+XI!%#5S\!%T$,Q$9:%,
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M[A4YNS(_-V!_LF? !%KH<UAH3__&T,N;IE-YL5S'EB"W*MEY>.]P4Z_+?@D
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MX>7P].+LM^#S[Q>?/UT.+UGEHM,*VNKSZ16X"<'%Z-??KBY1*P5A%,9B)J,
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MV_:#W]-$*,6?WX+A'ZBYB"CBR(82FD<F1C,$,49113"GS/POO>SQLF?##^O
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MU6-*?C:6J=W&J/6IIC24*1%AP,HMW0 W-0)^L%H]PS)ULBFJ&K%>4+U5YM#
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MM8/R->J4?&U0F:(LK,+Z20TA+R8@'AE6 /^),K")@V]O$4*0^';(6(B-Z]B
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MT=FECR6R>BACQA&[#6Q<.2=4KB[R(>EN&:A965PRFQ,O"SB92YM#?(7+] W
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MW=#7S75K4G>Z5A<'!2'&%4)JOYE(M<+&YE:HEI[9-XIX$BWS??3!;O_H^+L
M*7=VUJ,']EIFDX7RUKA3.N9N@GJJF"8(#^6Y&Z#'U?J)KLL%M4@G<H,:&/+)
MZHF:6%!X'/868\Z#>@]4O'%9R 26)JZJB)J)>Y+OS118K843CJB^#,\ E.\4
M0<)@QS,D>(:$)^O0Z8TH;T1Y(VK#K8ZMJ%-&U"E;3E5?F8J#PCJ:,?)+Q%4\
M\O8:9"HV^]%&C^F'4UE?MF)W'*9?3 ['\4"I8]B"A F82M&UB+X@3.=6PNT*
M,);4A#@P@M]3NO$E>ODP/!0PN>H'9UD*"Z@T"P:H IA1&NCR/[("?^]?]LWO
MJV?.0O1Z"]TDT]XCQZ)%\56[P-I2JC]Z*U3:_ZYL*7P#?V;YEX!?B*ZG_@.?
M=5GD0A3!?V5EGH;)*],9C3HTWL(E^)PXK%K&&@.40QO]X#RSR]!#[74=IE/1
MPXV6<*TW/DWW/@5=-!7*?5OHNQME5VL<Y LCO2KRJJ@SLGLK[IPJ4E6@LR:W
M98HN ,M>D-P3] 4B4A[&W\=>R_,B(#FMV3'@VR2\Y939=7:+O<%[]O<S$+\F
M$(K.!3RO5,B28IZN25,,AMZ&"=#7QW:77IAZ8>J%:6>DSY;HE##]@#;M<A=-
MPY<*)G*H34?BSDB9_2?#VV"L$PQ1XF3:&O0/_DV7H6,O<J)DPMQ=\+]V#W9Z
M'*]$P8K1DVDN,';B!:.GYMGPTW'0/^C281^Q>PGGD/,98006$ >0>\%,P"$'
MPX>=2/S:-!0701K.J,FX_DYB-/6+V"[G>,2G82K_7\@WP4;D%'XM%DNYBS0K
M,'5A#"NX"?+.H8M['V4/67LT:B\SO,S8\$-VT#_LE,R8:/_(TCKJL-)$*AA?
M,,\2&5&$*@0[ @<-O\D-'T+/C9\166UKJ(Z"8B:>AZ$Z"AK2/?GZ0N)9<2-W
MR[$WB2Z=*G))42T<89:/P?H5Z9(HFLH;8071/,]F\X+$4R1<L53%(2EG?%UK
M3F[::6NWCR%+>59.=2)Y)I!O$D8Q$\5UAB%0CH+"2E)&*.6?&=8R^-;U."T5
MX@+9-V$'P S[P?M0)H81TWR,"^NXMT9:ZL<LC>).4<O<072]60U%:Y4Z,=NE
MQ8P%92&U3ZY7R,8=M6V)$TXRW##-E\AA81RXHQE"C")GTY1RV1@<YHBK L7"
MK,9V56)G]JQ_$"N6TM!;?U0M@6A=!D,DJEE/$3:%O)R]M8:E! 9>6TH4:DE)
MAW)5K[,#2'"N[/$6Q'6UBTQ+#J]V(HE",PFR,4B(D$%8+HZKB7%H8A4JK%;P
M!P;J<5CIPFY(/ <$,N" ]&U 3'Q& !!AM,Z,PGOFQ<0#/(-IZ9RH&7(M(H)K
M1.2NC0/0JV+;+<X(C#R--:H!3DJ2X>E4.FBM!T(2ANXK)A.8*"\>_BJ#;]I^
M'<$A8RK1L:A=A[2%=L2-]A*<Z;T.08!0SIAS(-5+H&VM5P+73*]"+QB7A253
M=4;1<R/R]%,67G8U1:PE5&*/#.@*/%(A4FRA/?!8Z.)&-A(:;3R<XV)X]@E.
MU?\9#C_[[D'>_MPP@^VP6]V#&L;&%R'F/<<RTT%\BLM7I3%8\IR9WR+?*SJQ
MJ+IS,(&VBFPJR#8AO:C*N4&,QUE4HNXA0?ZJG0$,<\.]&F&$5@'-KD8XQD8!
M(WVT5OW.JGLBF_H\ESB=I7+O)DY1"M4$R=NDO>X!89;$JJ!<Z/P):RIX,!A'
MVC9"7*-RB!U)$Z$A/-&$X77@/3[76A!HT29LPQI&(;X[,4<Z2/V%'8O'''X;
MYG#@,8<><^B[,GTW0Z%QFGQ7IA\U(QC>A#*A(Z(;EJ1X_I.J5^%U5H+BI+9,
MM187-]B@PD0 "+#_%<97Q71"IW2+C[*!R(4X2R?48.,?*!><V!'\7,P+PPY3
MA16,'PKR&YS1,J=6'J#';W %%CB'"MT05QZY8SZ,"%]!U5_8*JH:N,+[J1)'
M2-XJ2*Y:WY%#[#O2A/^YTR+U3_XUCEZ1?\Z6'MLJ;%-4#4'L9,<BD>+&.O2@
MT,2-'89 -NS(AB]=&XE-K5/<38EFQ1[]O5^UQT'SBVYJX"44)W'%/*Q$!3M1
MKF%5@Z'T'/ )!<=NI1)-& JMN/Z=^PR)FV<:YK$QO5:8>SY#TG7%\^(%YF&W
MVG7=*\S0<C,66*WQ5D.,<,"<FGZY'[-ECJ>>!1D[M)QS:173!%^N9+47"%X@
M;/8).NQ6!R0*K31LN7N%Q)@J#IH_$U_G6!EJ+0=B+Y &$>$\0EUGMR@&V)JI
M8C%@Z-$G3AH.;Z44=U\"*\M"N"R RU IW-EHCZ(UZ5)[09THC;!?7]8R3C!]
MX*X)94/A$4Z?-U7J;G;-#(NI ''C6&%,C[%/MS47FM\@6?2">5(JZ@:.66%.
M/,F8'J-+.W+=A.IAJ+9N)5LV/]OR[M/'X24,-S@]?Q>\_W0Q'/UZ;BJ?WX\^
MC,Y_I6\^GH[.X;/3\[.AS\AX];9)^N"H6QF9W^_I+[T$$,F%G(W+7(D:6<]$
M3KB236N?'2-I-;>,$RK16E Y\A\E.R%)8B>I+N9AKH&($T+*]#!UKO1(>^S
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MOI[^<=*^"Z]![(/#->I)O\<X^ \9S@*\XB.X7P&>@WM 3N'P#T#N>IC8OS[
M-)_,TD(*I[?+!LIM%AZ!G\LQAC*S@3;14R[:-'F%=XP*8[OXE3EQJL51J>F?
M/3V!@!NQT]&"?]_A71#F$0]'?&RV\CW I]\#7+ %^-C$GA]A7,FU.6O-K@JZ
MWK$F$30S3.WS@(Q4:'A(83ZX,Y0!S2;&?1_,1Q[Y(@D%:@34O@!*$&YG;>+<
M4,T-U=Q0_0&.*J_"4-U_#:&!AK-8%^P&P+AF?P*.WO (>@A8' 'HD0D;<K=#
M- GW%T"A#C$E"C<;!AK,53D !3RU'_,7=A%RI,Z1.D?J'^"HNHE(C<!CA*_
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MN%-BLZK8NG-VRABP2$,*S'>9HPC?T@)C\9B @\'TM =J/26E2PEQ!A.X.&6
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M48 )I\,O%)]1@!^I88^NMX8[K"]I=^]UJU6K93\006.N4!04*DW@K*X4V"L
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MC<:Y:H^#V=">29MA1".,L9(GDRK5S8'[N2 D/>$U=9/)%AK5@_X!RMXJPB)
ML01SD0*K;-8C N#O.&EO;S X4!00C[D-3(SO0S^DOTTD"%("[<(/X?:'U$P7
M_EY?+4O#:5W&A-2?TP16&O3=I5R0(IX6:4Q<5M6>G F%MAH99/,#S"-GH/TR
M0JC -TA;D7-YP'1M0D1S8M7>FP:C^$6JL"TP)9BF1!KWTX%*\@9BE5EWQ6?<
MIA@3B_'B,J"EZZ#*[+Z=RWVFG$RG@&"'#@CF@&".EG,+#=GC_O'IZ9.;G-_'
M/#XYZ)^>'#I#]L5;?CMAIPQ9E)^+(K?-QJ >M:5P1*V;(Q8#M=A!IJ1)(^-+
M(!VWY(J(NA2,Y:285>%TBGXFHY"!MGG6#>G^^ %',Y+4A1&<]'72MROB"E&P
M79H/6JGQ#.QV\H9+-(;5_K5G587"G'HJ$JQHLXS\)!0?QAJ0G8=ZKR_ PLU)
M*H)+'4JB3T;$=O *=)@+K[KPJ@NO=D:.[,A.B44$P451I3A$X\?LP)T!FC52
M4(9#6N.\YH9Q'TU$JW'5I@D\)AAIP30HR]<J@VBQEQM-\*9%2F \!;M#Z5^K
MIL@L))[]J4UEPD48*/*H3N/.LM*6O!U7"=6J:NKK@]%EC)GH$9=C81.;&A>&
M]M6IBG7KD',2>Q>C:^_J[,/HBGM93E:-UZ"&KO_=1W0E^A&Z29B,Y!+!*E5P
M7G67V(!' P4TP$:FD>)B%]WMU@1-Z4J%= FIHH<"_'802E7ZL*I6'0[-6!0N
M$N-7&)HOZZ\(67.+L'J[$BL2MSWO)KE%0JQ&()]V+@;#<NQ4CY5 J8I?BSC&
M?^JF\F:-<:%P89U6=UK=:?7.J,&=::>T^IE-MT,-($FA3$-L>P.R3,>5%/Q=
MJP3%M*7EN:V"J4%-ALQAJ')$):W*%RBAVVPL#+>8AUFF<FARJ24WY_G DTI2
M6U/TK/0@&@*-^V%Q+GQ!\!K*ZDZ8X1@YS!1Q&2MD;1; PAE%TK(0.,VO(;*@
MP0>&X"<ABP'+*2769WU5M9NP+#!Z4&\BRRS]9-W6 =>=:G"JH3NR=&?6*=5P
MG2B88=D9;2JQA3EZ2B@$T>LA^EDDE2@6: Z;<!FF(9C('IN+J2)RE)0-YGM-
MDE"K9:_Y9IPM1@55!RZ6_+B&G<+V1^$SRZ590P;'XMIB>@OJS=+:K@H*XW\N
M8(D3TA,:JH]ZIE&TVW(7IP-<D?V6"X+];E'<GJ$)RM61JB;'T'%7S_?/"8PY
M-L:KJL=96_Z(OUE;_YC*.<<O A,-0Q*:6RY\%(1)E"H(TUG*QG]N/;#L\M-O
M9Q^NQR/'U>AD\%8)K8-N<376K+N%L/UZ,!@1GYM*-#-I.VL#2D>OI](84UE!
M/7&K"$2X'UVGD+SP1XI(WOT*DE=%L>4WZ1=DB+;CP9V!YH3#EI^F@VZQ(.T(
M=4S',=?0H=-I5^=Q]33:4EHPV#078=SP'FORQ7+<,"W75@-2)LKJLJ62.2O9
MXJQ".J14M'W09Y @G4+['ZT=H4/[.[3_5J+]AW_D_&U"3UO5[G20MH6Q=F=2
MBF\RL)8F?B@\Q,1%S?IJ#-/5B6*Y8=925HE2V^DXZSFJ6C"1B[Y"BVC3)M>T
M^3DMM((P)F*[84CU;#S%/,D1$:!4!F@;4B)!(<VH%?D302.0R;-\3-G:IJ:#
M3':MIG^FI?YI0%BH#JU<*S5^/M.LS*B6KX'-4/2LC'/(:NRD]!),I)/37E;6
MJ]K$@L<!QS1/PTF1*X)9@XC S8  \7EB&EN8I6BRB[9$-@XHO; U>]U7>_TL
MJYDJFN)X'0_74]HHRA4BOBPL/LP3_VN%R%;HNL4:(Z3S7\!?..D/CH\>X[\<
M@?_R]$E&\(J.-H/%/PAM?]@_V=NL-, E&;?:.>H6V+Z.$:7^M988K.H^^%%:
MX@_/DSFH$>^J(>YV-(LD_5SQ0+X"(S+-"D6N5>F2)+QY@>8$*B;J"D)BAN][
M54R0'VM!0MW2_1K":$$&28=6]6"5]I 8?6-3OF57!-AV!Q'$1,1:&21^8:P1
M U;$[EF,^\0AWH"[*9DZ\AD]3B?SG<QW,M]56#V,$G&!&5@M]&Y%VNS9A$)U
M4\J,S=R%H_WG<Q>&REVP6OX)'Z6ZMO5999'W@%#SY)8;_!4P5OHL7LHL-REI
MC*102$9XRQ"&F"?$PFN ,(R CYE81OTR7I7>&7G+NK=5#%>9GZ@7PVU?=>RU
MO$X5NDG"5W(>1LRMX@.[07V<F+LEU/4YE_,%JS=1ZE-RBG+QE<KI:"/,U#<E
MY3'VWPKD!*XD2"?=#1MJTWJP0L;A:-<+=8**\.E9WNMBV@$5.Y_>"+ \YR[:
MJ^TB7.5I@3XDF"(I0UV+_"9)%=C5MCE4AQ[FOFF063?;2>(N)$/IL=[Y<R[4
M?LM"9<5T&OHA3O=KG-Q&,IA)U6L!45R2Z(!B==(4TQ'!>&.,7V0AC%.D%1&5
M)6B=,89,%[U+[&@C=/@CS+ZRB)O#$[A()*30CSG-\)!*FSH4#'BK:8A440Q"
MHR>(U+KEVEWMC#MGW#GC[D480V#<=<NZ&V&$&?LJ,R.:+,V\FI&C7600:<*+
MY$S&:V"W)><:*BU'H/;'->.Q2ZFZE*I+J:[O^/F,5JL*7F(O,!7O- +40@C;
M I9Z=.(6H$V3RAFR3J>F50N)7.D78'JB"7O&17K#T_U]:B4)WAYV4H&GE;^)
MQ*WJLBA7IMI\PMU"\:*R@CH'3RV;RE1E:<EWE&G&SIK.; IO07:V1#\O0M_-
M>,(RI$BFP?P(-7Z51LM,(R Z)[ ,"Q5,Y2+\JB:QR%WOFWH/;7;P66.*X6(S
MQXE5+G^>I(M$#X%N3FN<2E^&2VJ5X"6+,%9^,?KGX LWZA3K=^(<.!YK\( Y
M2XCGNC)A'C=-#D<;9IQE-HQ:G&TU+B!Y /80:0O@H8_"THG#;U7)#=G;E1>=
M]56$_.4Y> \_*C93 Y4FE9%_]()WBX7)*'PN4O]&J!:ZEP0Y@W?]/DRSW+N4
MTR(#45NZSJKQ$CS.>N,]Z@^^H,0[8Q ><VOT!0VA&D>!Z!10\R0FSTC0I[4S
M(^6F@]^K]DK8%]BZ$TT5<PK@@[[<+7#-B6\Y2U#0:"M2RX-4SI-EJ3^EO1>R
MJF&*DHL-TYY>5;4X>E4YT5(&S#03"#-.9RPL02\G\$\)6C+4[PONB=&X>O[I
M?L'T F,NXVFE5_(B#;GI "7<\!/+ <##>-]";20N-Q7S)L2"B;=$M='1^I++
MWSDR8Z<6>QL\1'.+E 35I@@=M 1U'V9[BUMIJ_@I/U#]VY[T^P0SDU>[!U2^
MN'O2 (MPHV[#+HT2@.HOBUB%_$@7X$RNM%QL,0K6:%J.9$W#B(FUS1ZO->6>
ME'W!*RV-S'I:CR^?B7%B#BCV;"8<3GIB>-E7'V0ZQXEWT#E.DK*+<#9;303(
MT<H$%-)&F2UL?6@N@?)PFT+\-9-OR]OB[2A9NQ21%@8T(Z3_5JE7+NY7+_/)
MHLP'IWBXGRM\&BZK\=.RK>%M#-.^"1=ZT6&1*DZ],A=-75MV0_Z(381?E8:5
M,#2Y+3$&-!BI1_4@90\L^/M+A(H%55BD+[BMK\4CU3CFU,V\41RS'IH^M6J=
MO?'%^:>/H[XWGK(3&&<E,JW9.!W[;-:;A$]@DT?:1:W<PQC".M=2X3Q41V2C
MCN=/ L1L@=(9""3"#1O+5((VVZ<5)YI*[":YQ<+P51,SJ7I*F/>2HLQ9)M$2
M/>EQK-<8WW-CA(_&:>HGW(VY1,E;G_/W]L\[%1\[<?$Q%Q_["\7'6F-@SZ@L
M*U(9O##VT DTSKU_F]*XMQ9)_W1)_^<T'Z0R'^[0=>V% J/+?\(EMCE0_:BA
MZ9$3(:0L.+FRJG0A9KVL%][6VX]2T'?;,<V16S8''G;2CY2V!SN1 CUI />E
M.E\3%L+//N-G!@,*P^9 C)HD.Z$:S/ET]11&3^LR9?.XA^IM[\\]"UMH.$^U
MX:QAKW[2UA%7KS0ZF,Q/AVM]/;J\'%]_NOR-7K0NP]#]P=2.;?9TYZIPC!F0
M\S=)EA86H_I*2H\'HP#*&U[S6W:M-=]JY41M,(/6FA#9NAPEQ6IY2@G:G)$O
M3#'X*3:$9, *(:%5^4^=JT[=L1-2=*RK8\*,A(7I%?:DKXO>%N^<J0A3W2<4
M(4&F*P</H\J@*$P<$>-F/M%*<?Q#"2T> <.&DI3Y9?4P(FS[D5*+47B$FA#L
M%I5P*9^)4]>V39Z*UC#C7QH_Y @-GAM"<M#?[Q(BYE-,<%QT6O);]%NJ4#^0
MR6?OWX\_C,^N1U=V')Q2/;Z5RR$(IR8>[5FEE2N+6QME B->JT0%^(%Y3M^[
M>U!E9$BAD7E(&SRS&8%RQ2A.WFSW 3WH%L/=1>(AOAX-7!%[_R7B0J0KWNU#
MX[/ 0&4<"-7B-8P#2HIB3"1*;N^K3JZB\M:P-;6UN@79\O>_'1R_Q>Q7L*2O
M,.ZJZ\/[WA61^',%O07L\%,9A%PR '=%2Z?@/K1E:3F6VW,X6N2UV5&:78U
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M8ZSM*",1JK:&G2^HRC6%C2)\%5.N8D?9FKAKI'G!)60NA*R@G 8^4,F.DKS
M6'(FUMZ:*%!!8OY&3U]E!V1I8#'X2\^=HMJE9;5NXCW/>EH=A48-%!ZRWAL\
MT.:-T!.KL!BTH<PH=T$(+MP+7!Y/ T&#UE33TUQ0,26WL9Y"T^AN'^RZZ!I.
MHOGFJVP<Y RT6N>T@&7R*\L*/ L8,"F3/!GG$,!>EJ6U+'O5L?HJQG'?<.O0
MX>I6OKM0 T0%/96Z3NFWKJ*+6<O=X"8(I,/WGU [C5V*HV2(,527R0JM!HR_
M\L#]_M#>#3D("O7Z*SD?Q?E13=*5:U?&/ 5S:%8ACX>PUB%#_MCUT4/K4;WK
M'\FL/N1EK'\1M7<P9 819UHXTV++=?%QY[BKC"CQ!>:_YPF&>*A\GE#8)@0\
MD91."4!]P;?1JLSCH['PP#3^6D593X7WF V^920JQ!-H4-OC<_SF 260FIFH
M6J>MDM0R:#-_B-@OXKR4C&<"N>;OL#60,BF01-T#"Z'6PX*7I'(92E4LMQ11
MP52D]*NZF&;QO1G:8!W>I5N8[^T'?8\OWE^.+WX>?81WX.#<3M%MDV8XZ1:<
M^]<:\AG=V)IECSJ ^ ?;L 4-+V(]$+SJMU5],<6/C[X:)3(( M?TWU3-) (3
M&+^LBXQ8GK>5;2L 8CE@S8BF.Z/<<3_R&2H5YSTJ76*M,4$?+22-/9&8'8%O
M;F&A^MY/$H&(E@61S.=8 DXE6H+;J]0AY_=,+6MGHO3A>9A;]C'X&<BT)))#
M "+HR,RF1]1(QX2R-R)2O'69[AZC: 9,U51H; %\$<8^N+UA$B28N H 9,]2
M>=XM>,B^@X<X>,B#X2%_EN4!+ZX_X)?W<-/CY.CXR4V/O?[QP=.W\,!F&R>;
M#589-+5#>LIOX$ZC8( FP0\;V0^/_6EWK*WU=1U'+V\Z9?37_QHGM^ 0SRB:
M"J:.ZK76'C=M0$+O":3:(']\?*8$'K(HV]9;S09CZT-!6FA4:\9#H5B09!-P
MR4W/9.L1,IUGIMJL,CIXH40?1%D4RU4G*N29:"5 CEMLL%AB3%=@L@4>(:(L
M(<,1//L(X[+A=$HU>;<QTX(W M:6.34OLER;B?>]!<X*AUDN5=B7*;/E#&6\
M;X(.Q*][]\U@Z7]/0BJ)%]:@*5/>?HD*DNA$"2^CJJ#O:;2QZM!PUY/-4GM,
M-5*:G)6RF I\&'LH@HE)-C$1+*%1B..707T&.B.2%4@ZG422$4_*P#1D4_ L
MGPFSLAR63$7&)ZDA.+)6,R_IJK0GH-Z%G@M>U3K=OG==83ZN)M3P&*6MP3#"
M(E&\;P86<5N-BV)CSBJ5L&;<$R)TIVS672_#6N:F2 AS5:>Z_@SJ8Q"2(;&4
M'!Q#MT; OLZIO9@I]H0WZ,N4DH%1F&O6:8.!(&I4GO**-E><J.W$XJ0D68<7
M1PL4A4(!+HB^C-\,DU[%TG)SJ.K,UZNT;B5P.^6&_AW9L5I\BJ=5N$T5\A@M
M^H#;;[V&>L=GTD#QRHW2JR;B:%LI!UN_1;HLD%,9!X)?);(596QDLVYI%<9:
M>-D/PXV3%(T0\95"Z&C<D))*WWVG.-.L:9IUJK!G1W2J.YN=P%)@#3BK.A!E
MQ:%$UNQ78?43Z=4Z!RR03B#/#6%AK\0#:G.&-"GW:>#8H<]%E)=48!FI5+P.
M(M40)<W[]&K5E_4R*](P9JYKM _),C60/S]0];)R#"?]P?'18QS]O?[IR<%W
M</1!\'\/1__D]- 59[QX0;<SZ93<;B8P+"^1"CF4<Z+$=SAM4,@B_4*"X,$0
MBRRH&8!VK$JQK[L$R(>GNO_22",G')UP?#G29,?OE'#<B#V+@=A9KHHZLJJ!
M6%)P8D.4I8AZ"O?#M.<E/SL(DC26*Q-UFU*,0IFE7*W6$NLID<MAJI*[&.5H
ML7=-RACC(29ZYN2O \!L^2$\Z59MVQ]RE"N5&8'$A@B<%T:\1*,MX1U]%<NB
ME)WLE=U#G:+H. CF^\=@&\+99< T2^N) M=!*S,54\[RLD$RS_ ADO#O?SL\
M?6N@ICWO)KG%'NT]]OA5/0?UAR!V8EV\QT._<]S$64@,BWK]:IVH'K9TU%@#
MX^&PUS LF5+?*"K%8!K%/[B$/*-L?4\&6H5:5LNH*7M,M=V4J^(?%7>AU916
M*]F6'EVT\^Q(",Q0;Y7*HS)5-(.O# =&)1O$//_P-Z,+JV+5D>M!K\>!AOX@
M:.C @88<:.@OQ"GC;%]G^SZK[=NI NH+T,(RSR.%UU:Y5._W(I@Q!%FW8E^"
M"HASD:[ 0,!N#;AQE8+0"5VRMA23*<D4DI+8R5,E<ADOT9*[M1'*FFJ&OR@-
M1[AI$5M4F7C3&QDYT@4G,[;]D)UTJS+R4OH)-@J4BB=2A>#8PR7SAKW)S/C0
M5=^G63#"K??489^&:4;'G8HLN-BDC/.5X34[XF>!F=@I0XE!Q=_,#6/\)88U
MRG@]/\P]CMO:4NV3_D'?.XN1GF&N^!;2NQ;*%$;"7U+&T'%[9/2L3]XZJ7:?
M5!OL/U:J#9\>-;[7/S[9_RY8],%FR1V7A=EFD=D]:)$5[0()'F&[KT6:3$.N
M7Z=_&TG:TO2$NM9;44VL(8]TL"@0<S%3'"-^4J1YV:R^QN^!;#HRU0CD5&9%
ME)? 8 O73)BC:H0.8U:EL&_M/(;1+:T;J']8Q!CP!@L[3[@"6[]G0-C!S(KV
M!8I0DA[!9"]5S-,]2U9.)*Q,0UT6F)YQ/ =\.LV0GES)6L&CG>YQNL?IGJX(
MZX[!H\Z8G/968'MMJV/N?2IH;5[#KH9BNI#U/W3ML)R$=!*R<Q*R6Q@IM,YO
MD_N(^ C^F8NOTL1N>[J@;<DD#VNJ-X],[><\"3@7AD8HWHFBO:JSL<JYMSV\
M/9MN"W G8%U0=\M/V4G_N&-"HPZ"4LPN\AN80B'EI[,VXIYZ"7%K>=^ZF&^E
MTDB!UINL/Y28RE,X*X;&UBH.3J4FN%6.L@ZZ$D,K!H ;S>]:*XC*ZM8M+"!R
MXLF)IX>)IY..B2>!-?@1DO(FZ:K,4.LJF,R L&,8  B#:BBNK$E6[ QR1JQ6
M\1*F%E !N^XYVD8584LI4^Y(-@\*FY*<@!Y3DA-H*=60:$\ND1HEDC&%'JNE
MD5:#2[Q4#;9+Y);C?VT]8N]Z=/EQ?'%V/?YTX7UZ[YW]?#ER-)=.@VR=R#WM
M%LWE=8V:LH@Y)T1Y)6(=PLH>S9R,EF,8]TSR94[HSUC1)<+%>1@Q887(##UQ
M*W%S@TN8$E?45X8)HBD/(R:@EI)8.CB3$PS;?I).[V!D>X'3L4T[(PUJ3+8.
MG>-JI%V-=&?C_YU#YY3T=HG4)27@JPI=B4C(%M,4G-.>(HRX\+%(%1@E3N)=
M?<%.61G(]5PK'>RSN:(Q]I\&U!"'/,]*ZN"P?[ C7[VB;\+8U7W]L;JOP[5#
M='5?KN[K:>J^_G2[X1",^[W'V T'_>'PNQCW1R>N?_?+5XEP[I X:6>_TGF6
MF\TQXC2GF*UJR8A\PVF8JZY!#5TX63D@D ,".2!0Y\1$QZ"2%4= 3D41$242
MYZ),FU0%!=*V>L:O=3CH[^_XK\@2H;\'KU3:G_R#2C?2,,Z*%(U^)PZ=.'3B
ML#/RHWNXR$9;2F1@0_F51$O*"O'G'"Q!PB?LL4$VG^Y?,)&QG(84^.!&Q ER
MZ<"75L,-X;&_QLF?B8B_IL4B]U?4U#F@6R']STQ@[P*0QGWOBAH>J^!S29B$
MA?3<;0#N&L[G\#SNM$D](G3@>A8NT5+5-?7*AK5@[4XL.['LQ')GY!B88EV:
MSIB(-.4W881?Z5^77)T,*D?\E@TE52A2?L?_!*F9W%*'1;)H4XG=CE4?8_K$
M<N!MDK2R.WQ^"U];Q3][IOA'$[;!+T!5>#O#/?7%'"9X@U>$2= K 00E"]X]
M8U&A/U/A&G!W'1B7"/ =*6 !%7F:<E*8XDT28]!]'F8(0W,BWHEX)^([(Q-W
M9-=$?"EOD18F7H;$K(*BS)O**"'>E(B[>*F2=GAJ,15^7J2RYQ58!(!6MHAD
M:P6^$X!. #H!V!F)L3/ME  <@86YR"L(4VS:64PR%73U=L2KGK<S><7<'SN^
MLBX5RW2X)I)+4 R94D9:M:-$(]7DD9M1WCJNC?FP]$TI;\UL>S)&V*L,0I7@
MAJ?!8_+5[A2#$3L'AX_-I.E'N2R:P[R^F -\VJU6=[4XJ!)*U$(6_YT1L(1+
MLV<I^-I,@A?FK4*D5VVI:GQV&QBF^L&6M^4'PV5U3S]94 R@1.(21%Z%8MD[
MUH%/BH+:45-=L6Z&QB3UAIJ^-FUNEPI"2S\36UGJI\8DQC!55@X;*]6QF P^
MR?(PQ^I7C N8.*MWS07TV.$VL']%#89W0B4R59 XEDC5E.8W)+:1HPIK";"5
MTQ*IV@UW>OD[B_N*RA54E9F6N2VR?2>L/G0IPH@D%+R8I$A]W?2UF$Y#/R3&
M5?I/"/]$BO@,.;?X-\RU@O5KL(DSAB6)E&YF4ZC8+:<R>"W9=+4FX5@=;M\[
MTTN0A=\0K'%4 6LP<2PNR5TOO/&.U=:N]@ZHA<K;B/YI(U![TQEW;:$+@\0O
M\#$J2%^N&G;<DG.8&W7/5=$::LJEV!XEI1#@%G08)KAR<+(6-UFY+:KOBS0_
M;:]&+,STK6&NW TX<FO5@:K5M?W.+"V-;TNW.]YPV:F;@FE<1N.SJ-KJB]IX
M27RXZ_L7'AKFY9N@1N#6O]6E/EE65&Q99FOBQ(M$KJF![D/_V%-K/TN/+9%$
M::R4PBYJ@#=[QV0E_-DR'W7YV&X/3A);OS"P1M0["YKOC.E8S9LK]\-&"_=8
MF<O"IB)Y[SH*FY^$[UUEV2V0\9$#&3N0\<MJ+N$\.^?9/<RSZU0SLVH'J77E
MC.#,*=1(#'= V^BT:AL%2R[B:1C*MLJW"!&]+S5?K*'X09?/L9&9ZA]QJ1I(
M75)BU/;JB)_#</-:S=/P"U3JBD8]T,76AD4LC)=)J-CFJP:O!OI8$!JX+9Y-
M%WMR$FK+C_1IMUK.5''&1_UASSOJ[^$?^SWO&/\)(AG_..PA\GB/_MRG/P]Z
M&H]\W!+OT'(F76*$VI)%72*XV7Y^FY]'%Z/+LP^.SL9)T6T2.R T.L5G8X(W
MNL+[5J0IP>)NI&>3FC7)&%5,):A5@!/J.<:^.(M49CK*F7FW-R+/$NH4JEI[
M(HN8C@%E?K(P?&?FSM4'$GY-X^&J7^E^8=\641+6FNV@M/?.WK\??QC#-83_
MN/KRD[$K=5LQQ3Y)T4L*&[%=F/7:NM/J93.35*T?0IW[]+[&R6TD@YG)IB((
MA2C%_3#UBWF6HVF<6?%W^0V9,-<'P>SF$JE4Z[WFW2A".H8)2@P#^)+LU+:1
MDP?/KQUFJU[(!%,N*HQFYM*K1OR(P1?IZ(C="'<5_"#,(Q5EM2OZ8_.F*P-U
M=K.3^%LN(=%X[*+$'_WK\^7HZNK#;]Z[\=7YA[/QQROO[.(W^/\[[^S#!V_\
M\?.'\>B=]^O9Y>79Q?5X=$5??3S[/_"WBT_Z>N_39=M//[WW/HXNSW^!?Y[]
M!)+W^C?\X?OQ]05>\Q[^CL_Z3/;HEP]GE][G+Y>?/UV-\,+K7T8U<8;/N("+
M/C+?X=67S_S GW[3LL@$"@C+=PX/&=%ES1X[YY\NKD<P8'@ W>#ZE_%529_H
M!-(] NF@?W@X?(Q .N@/#Y^>DPFY%0XVPQ5V2"!U"D6R(U3,D/^L!?Q",'3F
M<3A=]13Y+MD2-PFUIDKGQ+YHQ_S07O&+-%4%#Y@  4,I"%/I<Y'=#*EVB>=[
MDJ !.I?SB<0O\K3(<HE-7A),R--G8+0540[/QHB?K[(=V%T '@N6&GP =MQT
MVO/D'"S/%5V=Y47 AB/%(&?&Q@+K)TQU2WL,+H ABR4C-"S\CG_&">C,V\$C
MRK^,5MQ5 3.6>X.WXXMWHX\7X^O1Z(H^&;Y]U5,M,^F)7!&(QJ$?B7#> X-:
M3,(HQ(E@8\M>R8C.3=)H;0F#X,-/HB0C0[7$6F@;]FL8DTT9"\136VQ./6-&
M1^$\S%7LUF1.P2 $N93&<E4FA*6T 2'<;Q/_;>*P\,RR(>>K^G*HI3C'"6;E
M*DP$^@T(Z8'E3\.,S/D"+=F>Z4)\B[B3*DZ\FFPN2:J:L^)EI608+@IS*=LW
M@]V!#3_+-4>@NJ^V'%ZL?D!^!;Y^1J3+=(FQ<>RD1CAU6N<,M[E=J401;3P[
MU)N(W22#K6I'5;5X+Z47I4^79ADM4]_(/;K2C[3VC]XPN$EHY.I]:?,>I PQ
M@]&!@SO BT_#29%KA ]#D6:PLS3M]C+DUDIPP5<ZSO,0O,&8%A'NCVY$G/-A
ML[^9>F,>/)Y9I[9?EA^QUS_=?_J[GISV3S:T,1QN?ZM-@FXQJ(RPAU$IK52H
M".5:P%R)J,0:LKC"IV+1J8A7)2AQOD 96P?B*6W-M\6*4U^S""CC W_!6"<4
MQ];(&H-JTQ)LV#3!=\5<ZBH U@@8&,0G8;@/"V\S"2*\R N!K0D8U2E\ZL-0
M[YYG$L((A45.230W"!T9A1A!;+(3Z.H"85L=.;Q%"Z&G&XEKSDG3_:"V4E0I
MH0$NF.1-Y>]@#_@A=TI%$U/K]CQQ#)1_#!QV[,!A#AS6-0;*1Y=)'O>/3T]=
M0:,SC-IGI$(@5LN>LKE$%()WUS "2C=4.5^6MK_#PE I.K86L ;#?B*X<PR^
M!G^,X/U9<J]R5FZE'F:8MPQ09= PF<< ;_8^K1&7_CM!\M=/H-\ @G&<H;Q7
MKSTF8P(Y5O2F=U=WI8K=@J9!)&<BJJ0_E]*4688Q_".OA57JAAJUGN,D)E^S
MJ6'HW&!7ONZD?6>D?<>8\W["9GD<!F7]P>Z9=L+J<5$[+(I]^21>22Y<ZK-?
M!H>?@XM6M'3':N:NV?8618JUE"ANDXGN\IG*61%Q%T!=_Y.]JG Z8<DH?&FC
M17HED(3)]Y0G67Y?=8M[NFD?M?7#(+<=X^ZU$Z&6<_3@_J!P(DM)&I94@E7,
MD<Z*;6[N0X73_K>]'KQ(_#]6]6,TF\Q^>HCUG8CC DWTV0RA.#D/0G4]K!H*
M7*\*NTR%86D,,LCZWKLBI;<"+YO2(SE:_5G%M[[CM?[)JT7#D?^-D\;H.8P%
M(32TA#C!*M9;U5WV'KHBQ,&XX9@JM:74$:@LXVQ+(\!)AAW'U<C5,L])F@BB
MA)QSCULDO*D\5%]<J32V:JS;+(R6XLQZ<U^T#&4TW>7Y$PZ(VI>E>8GEFG,E
M:.;#4<7^:%21:C4" :<2)AJ"XJ:]D4H5[\]4B$JDLDJO]F][A^T[^)4J$#<C
MHE6&E9RE8L[5TU@#3K6>.A]AFXDXWLLP^^I]%+%0?8C?P_8(K'I5Z?TBTB4F
M#C^JE. XYOIL''(/_N7WE;$7IJJ;)WBU,"OJKXGQ+-A/X;R8F]-+W4_T:,V+
M4ALPJ)8C^E0<7' %.]R5SBTO<FL!<KD#ZA9]F&_XWIU-Z6Q*9U-VQ0CK&.WG
M0W@:)'ZE^(U47D-+7>( 08FK4*\F__ ('@C#P3$-ISF&3G>&A^T4%)B2P,='
MD<JK8'N0% R&6S913!C5![-N5MHP9MQL"H1MG;K8T,4P1"14QJ.B$F$:RI[6
M]!M&\ZA,"CVJ=0Z&I[1J,IFB?$8H6&P/C<K!DH]:N0(8U=*OY:YG&D2&KB5D
M$+1EBMT*IJ#@WSMD@%-?3GUU1]YWC-*TIEZ,4YL]P(N<R%6BG!?J!ZV<E?1N
MKATO(->]YG4J)D 4M!2-OP^OUK.A;_1%()<R2A:R@EOKU1^^>3SG#P9DVISE
M"D1 S;8$":@/4CE%OFWRLRHDBQYL05@OY<>RBQJB\E><.*;G0AF0:2JTE12I
M4TTO#+3VURQ^Z2:O11E40>1"G1 J%G/)V%.$8H>B5]J98I';T:!Y3]/J\S53
M79-7OR4F_F)$H',Y'-Z*5B4C]#1"N1)EP"I^:HS=Y)AMQ,":MGI)0)'_H)T.
MPUUE>2T.DO3'($DG#I+D($E/!DEZNH7](X=LR^!13K$_NV+O%!W,KP]1D)1.
M$AQ(HS+\GA?+4.6-*WY*K'OFX*-*%N.2\<!8^SE\E2F7 8T%332,I*@WF 4B
M<X)38[9/HS!.X'6 1P(_99K8)6@'\ 136"B^T/J@A]<S$$G9(9&XK10W]2A9
MME", 313RR4R0"7C.3%_0CM]*F58XUCY/B2.A0<NVPP+B3 ;E41A8%Q.;JR1
MFM4@@XB3@L1C#,O'KAY]R.P"\%R99Y@::^'A@96=A#&%*IFGF1L8M570M>.N
MRHHZR35E=L+/M;9S ON%"#@0V$==$MC7-UQMDL)Q-965 94=ZFRTRK=3LB(C
M0, ZMBZ0$ES66X(F028:9I7S9#Y/XELI(F9)_P@" 80B&(AY[J(P[NQO^UE!
MIKHNG?U:% :=,(VFIE(RE@&XE>D4HUQ0:#V4 GUOS'94Z,-'8(6PDT?V6)8G
M"3,$"-^P%JE8-B$.+;O$5PXHAJ"3@(J0&04D_1M&LX%=(_#68+K\KE S7V*B
ME[H"D841FI;A,0 +SII&C<EOQ$VJLYMW/\XN/L>U&/'%9P&"AJ@M $K&2^MQ
M2L95!_9.X@+I.K=S#K)+@A]E[:N*:"1#?87YWQDS7[$_3;@LPB,1VHCKSC6\
MLIR@7M)\M6!CJ[:6B%E2/T$3CKU^:LF9PG)8V78TL#'4CW*>ASHC:\X8]9G.
M?NBB :HPJ.^D/_2V[GM1E2>#!D*L5[0BZQ1NC'@V3[?[7(9)9'0:[8):6J-F
MCE<IRJYTJ8+UO#H7AJ'!.?]E_.'=Y>B"K_DXOBYI,D*;NE]77Y#1K.H.U&>*
MW2'Q?8%JEW4JC=K,PRE-IS2W7,F TCSII-)DH5A/W"8:\</@Y2:VO024:KEM
MM<;D]CWKNF+:OK+%K]666X5Q%'D8P;SXR8L4B;(UQS8&=8F1166XF_TWK2A%
ME"5: >1()SD#_2=35D5^@M21M49%&>IJ,TN062HN4HI[G7MAE;/"<$LJ;<I)
MO ,&APB>Y(2<$W);+A1 R)UV2<B=Q2N%[,M4 W.T^^*V@*O5-BL$HXJCK<KY
M1^-WY>VH4H22=$JS4+W2?0LR,6?9Q^'?FE!5!:T<Q>4(+<N\4M[-11BA#8L+
M2-8L?H U#$6*X$M?AHM< TMEP%?#L. &^@Y3\8U1)IIU%H<>LE&?,<TK9KQJ
MX%6,>F*JBAP:789+@=W*E88B)&-:#RS:3<,9]4[ *'(*VT*D*QIU3TM'U=N)
M :I3D W)+;DC09!BS0RKGBZTLIK:-<K56=7G4!GSX<&SC?GC"EM0@+OT#;RZ
M%%P5TFM;/^R]X;XWZGL_I[A%SY:RV4!KVT9\E13@1%Z)V'N/CB82CX%S=>:=
M'@Q.!EL_^K-<%5&]C%W]7GQ3HO?H</!J=T/+!A0ZW'V[I8N! 3WK:W@,/.<Y
MUNP3$6^2@W*-T19X[&Q%:NTZ%8%$]\'[0)8Z+->#=LE3\,7<?:<_':5TZE!*
M#J7TYQ(GH9 ]H-J#;=$<NACW2XR6.NS;U=8KNU^2:)5\E=XY+7_/NRK"7++L
M/=Y;SX:V+<,?[A\.JAE4-.CB0F[]R,_%?)*&U,;BXYDW )MT/="S*OF;AL5V
M&$O#8^5$'IP>[IX>'CUH/G<:3OM'SS:_GU2R057X*6 6^\6(4U+%D%Q@KYQ2
M,AFF!84R5?Q@O8MQ]UJTR+=G7(P+%0QI"464H9  (Z"!"I4HD!3UD#%7]3U]
MHTPU;IR*;QO<@((3Y<4JVG'_=6!"Y$HWJH]ES'5!F[Z6[Q>V!).B/V"SXJ%Q
MR\/^Z>%F580/BEL.^R<'FY'^=2AN.1QT*7!Y=4/&FL#4@DD?+XC*Q/N]2,,L
M"#G'R@WE*6>KBNL8W-36[XD"H*J54\\+(TK6]AI-G3C52S(3[XNQ.F5.ILCW
MGO$A%(N%Q*M#"S2%^$VP;(EE1+)X*:U4B_GE#-&:+(8-&*NG0;%$XF]:!60&
MU 'V,E@%IG2EUN]+/<[<KR2J+]$:J9PKLJ8[,6"*($;XF!7BAK-HC^<*8197
MP&2(&W%\\4Y&;K](01G9J5Z#XQ;\"<-O4$H1T)V9,*N-.SB%6S;8N$]LJNPV
MQAN8X!Q)R'OVZ5<B*F?B<?1A(JG!6?$4/&J0*7-"H&%7P?P6W7BL]<MDM)3$
M\67P8(;B2O7/0*11H)$VW*,:+2Z=N:&AUID[A\.>146N1U#RL^M1HYPK8DU<
M!69O L.Q4CPF,T830CF:)L4,";0FH4:.J?89/,8VB9D6D32@LK,YO&D?VR=:
MMSC+LL0/1<EGA8&YF&$%]J/,>*9D-&[$S]ZR&3"0@AM"*MYYN]:ZO)2L3JH0
MT!79AI2+*B0(YD0%[!(/2Z8:Q22FU+[ER2;^,A&I1<=JP1/Q=1?<J['<!(H#
MKG4I;F1$,_@)[&/4>54D,JVFN"4UV?+NK 6-58A(U4;TO5'=2Z+@0KFM^*ZT
M_FRAW A*@%9L$Z*<67$'3QN(K?E_^4I\SX8.7Y&IF>VMQ\^LNQYI(_Q&F2O<
MDD9DBOLFDZIS)[D8N$.P1"306#RX1,X2*I"M>X$]RZ[ 87$#&FNU>E17 L/5
M[9 H]VG=1.!A3(-=_I>AX/73),MV=4<&KM3EU9G0&\F9@H"NY3M1R\SRM&JP
MZ%SD.<^])I]4KU(0:7(I'+_:=S5%CD^_@RFR!^/YZYDBG6J"6:LU(U9%5!<R
M4\&*/$REAI0KB619 J5*1LK4BFPR0EJY1*PWE*G#)%5LT-C=D3V+M!:D6D8P
M9(QKH5IGDP+-F##FTD(M0K"D#J$E,37:PMF0?V6!8'",>"63F"!Z&K7%X[ ;
MIYU,HU'6YMHXFX$ELC%MQ8! TX$,#<)(Q%_[E.3YWLWI.\6JL+<>->'RE2Y?
M^33YRNUC7/C382<7WJ^JR_*OOXPN1Y_>]]JT 7$UTMMLX*@Y[,C=Z(W7$Z9>
M4*"6*4 _I3">H%YIW0SL/_$"G+XDJ_7TI#\X/GH4-GK8/QT\CE?Q[N^.3]8_
M]+&V\/Y>_^3DI0QV[[1_>K 9[%P9[C4%-3SD_7*G[3M R]=ZQHOYZ?=P5K;0
M#L&N]>-WV%P>V]F_'WWX\.G7JXU-U^/#+;)=/[TW;!;GGSY\&/T\JBG3)_/4
M>/Y/#DO\7C2F#S@"+V@!GH+-E??KGS.[#7WQC[^=?_HXNKX<_PMV\>7G3Y=G
MU^-/%TT?]8G%\=&3_?3Q@G,+W\;?_W9P_#:C/[W_2E:^]'Y*P0&V:@PZ=::<
M4.FF4+&W\<_B]R+S?DU2HC6H;^5[3J_R!P@EM\@]HKOR</QONV(054YYSWL7
MIA*;,F]]0&EML<#+-.;NK7#HEMQQ@G?397B4!&H7R<^7</F<RHQBDLZN>Z84
MWAXIPV/Z<_ =L)?;<*:<4.FF-:<V[_"D;?=^#P-NV\3G.Y%+=V3_VD>VFQO9
MM2=XJ*.P-W2)=)=(_PLETK?M )Y]_CRZ>#?^EW>V2;WTZ;/5#EY7Z'MP+R&,
MVOM\=HW9K\OQS[]<7]U-3+$A^NM9,%OZP#D0UD-TQ]Y6+]?#P80X[XTPB-NA
M&E]/DF %_[G)Y]$__C]02P,$%     @ U)-F40W,<:.(50  AEH# !<   !E
M>&AI8FET,3 U,3!Q,W$R,#(P+FAT;>V]:W?;.)HN^OW\"NZJF=[.'%GQ_9+T
M]%HJ1ZG2[,3.LIVNKD]G420DHT*1:H*4H_WKSWL!0)"B;"=QRC*#66NZ8DDD
M 1!XK\_[O'__7V\NSJ[_^# ,;HI9$GSX^,N[T5GPT_;+E[_OG[U\^>;Z3?#;
M]?MWP4%_9S>XSL-4R4)F:9B\?#D\_RGXZ:8HYJ]>OKR]O>W?[O>S?/KR^O(E
MWNK@99)E2O3C(O[I'W_'3^!_11C_X__Y^__:W@[>9%$Y$VD11+D("Q$'I9+I
M-/@]%NI3L+VM?W66S9>YG-X4P=[.WD[P>Y9_DHN0OR]DD8A_F/O\_27__?>7
M])"_C[-X^8^_QW(1R/B_?Y+19%\<GXXCL;MW<"#VHS":Q#OCO>/=O9.]\>YD
M___;A4&^A)_S-:I8)N*_?YK)=/M&X/-?'>_-B]>W,BYN7NWN[/SG3_2[?_Q]
MDL$4]*^C+,GR5S_OT/^]QF^V)^%,)LM7__M:SH0*SL5M<)G-PO1_]Q0LY+82
MN9SP#Y7\O^+5+CZ#_KS5#X7[)#(59A"[NX?PY#.1%Z%,86(P;SF1L'@RG63Y
M+,0W$\S"_!-\="N+F^!O/Y_NOOZO__HO^._^Z^ F5,%8B#00GZ.DC.%'DSR;
M!<6-5/#1C1S+ KZ/PE*) /X)GZ99 ?<K8)QA$H0IW#4KDQA^%$39;"Y@R>5"
M)$NX<SZ;E$D@)\&\'"<R@L]BJ:($=D#<#_[^$F=E%M@N\R,OWW%C]0Z:J[>'
M[^UO/^\>[;RNC\AYY87X7&R'B9RFKVCC_?38[WCGOG=,HQSRZ^#![N[T#]<.
M&%[W%+9ID<U?G<*MG?%'L#U$_D03.-@YVNF#*!F!W-@)?@OS19C'FSN)]KUR
M=K$]_-?9NX]7HW\. YC,\/QJ& Q^O1P.WP_/KS=P-G3'5[* IT4/F-\OHK@%
M>;"!$[ES;WW(A2+A1R+IK4B2[%8%V<1L,U ;22*F8G/GU?XZ!ND&GY#V5_%^
M"8I %+G\#(N>S[.<=-#FSJ)]X8>3B8A0E04A[:.+J,C&(M?2][ 'UL?.SG.;
MU*7XV\^')Z^K0Q&"6O^Y9A$\<$I/-(%1"E9&BB>==Q6^F>)&!+.R*,$<F8/M
M(A4\#H5 E"U$&J:%"I0H C"&P/@9"Y +/;ID'N:%A)_>B%P461!.<T'O>I*1
M[*"%>LAB[)YLT L>7%Z/SMX-@]%#C)DG'>F;X=O1^>AZ='%^M=E;;J# #R%[
MFJWB 6X4="]X&_%V03\%UG(&>^TF3!(P?D%PU+^>B3"%_Z[96)MD]_)8P%_*
M_W'?JQEG19'-7AW1VRG"<2+,#\99#H=T&V:2A',E7IE_O 8?8)Z$RU<RI0'1
M1:\7X+_(*$STSH0W7CE6_1UVK@H83A&;^^NO^_35RR)>_6Z_?WITN/;;G?[N
MVN_NNNOI?O]D_V&W?4DCYE'#]-4\3/_[I_V?S 7S,(YA0[S:FW\.=NLR)!&3
MHF5-GN $X$QW^[MV'^@Y/^?I#,X&;X;O1V?!Y?!J.+@\^RWX\/'RP\75\(J5
M([JZH%8^#*[!H \N1[_^=GV%ZB,(HS 6,QD%8&N*,(]N O@P@U.>HU.\#3_9
M!@4T 3=913=9$N;@\<Y+L(!0(]W>2+@@S$50IC%ZZY_ Z0[!7(5K4W,=W&\*
M6BM/4;Z /I.I G^Z)$U7W,"OXTRP!XZ#1/E2'R7)*(%J,"XCUH\Y..MI.0FC
MHLQI7OI+15-2(9Q8^"]=)7**&*01_0Y6=R$CP;\+@XD0_=HNH-W]DH[O]Y-C
M!X_AOWM9]2/)JKU.R:JW;T?O1G#&632%Z3+  %^QU/($C.$BA_GU,#*G_TC
M6!DO>WBLX4.2-AB:FV6I^04' D,R@9?PVR"[346N;N0<+S(_ AD $B<1H0+K
M64[@ER AT&8,M@YW_O,%'SIM?R^R FT<5631ITHJVMOV@X]I(I3BSV_!1 _4
M7$04J&0S"HTG$TX9@ARC8"086V;^5U[X>.&SZ:=UM[_?)>'S=C1\]R:XPR@"
MMSD6"W"IYSW7RNCAKT'^3"8@ XR5T0.#(DE8*LWFX(Q3NB!+!3KHZ*Y;NP2,
M&'[R"#__V\\'QZ_A(OW1J.X^K9<%[>>/9NXZ[_BW?B';N/JO]HZ?S-/44^0%
M_^*@S$'_<//F\J#);)+ONVEADMVU(W23D.!B4 KV52Z2$(.6*VG)2MO0.=BI
M+@G'*DO*8OTE]1,$<MMNJI80@?N_-WDE\J9B>YR+\--V.('%?!4FM^%2_>0S
MJW]=9O6^G=T>[WGL1?=Q*6]N/9ZY== E<^NWP>4_!Y=O6&,^-)_9XP"2CA^]
M#Y4*HQL0*0484@+LJ9"1.; P-A.'P6ETUL ^H_@..'GH@5W0GV2O78OH)H59
M3Y?T].L<XUX@Z()W\(L403F]X+<L66:?1'!&,J077)6R$'QPC_>.>\'N_N%.
M8SR#A4A+&/%9.!OG,L;!UW^PL[>[?^(=/2]Y-OVH[CK@FPY('AUW>1-\N+PX
M&U[92+B.)8.0P @VYE-SBBU5<2'PWX)_#MZ-W@1G[P:C]R9PPP:1CD;7?$9_
MNOWIWO3CL-L_ZNKI?O/Q[%H?;AMO>91SC7$=>\<9V OX@4TAP3<+&7,2/8S
M%HDIRT1>$_P.GHS9<;)O5F61%QE>9&SZ&=OM'W=09.BL4SN@#ST/UZO(\FF8
MPC-BG7)"$9&$[+2<P83 L4AE:)P/6:!4 +$BYV'BNB+@ @1#%$&_YNA[&)_A
M*BM!5ER%:? 6/H^DBC)P) ;!Z<'.R8Z7$%Y";/J1VNV?=$E"G ^O@ZOAY3]!
M4 2C\[.+]UI6U#\+*.E;29.3O=WCUW#,(T)KQC(7$0<X9*K_B#)%6$V+L>F9
M%--,!T-,0FC%N/!2P$N!33\VN_W3SDF!P3LW7A#.LA(/*AWQ9 GG.!)R@=D/
MG0A6/?(Q\+\6*%)@$>%$Y"L> /DK/1(C7YGX79,:/3FDSVAE0?B ;'FUO;>'
MGSU1HF]+OC"3^^L?7U^;W?W^#F6.HU*!2 KS);Z@&*RP?Y<AHX\0)A2J&TH[
MX?OF%#XB&4,PY1))Y9OC//L$[U2+?;PFG&*ZWWR H"2I%!B/JMHO(4:ZX6*\
M'X$DX;V?/E1XWI_>W\#WOD$O?J>_CPO!9UC!V9V',J:7G8M8%APDR.'T<N5%
M+OX4%F::BZ+,'_EM'>T_Y7N1+X( ,2XHUF"_H/VA8$7 W\$LK"IHD\/DYR78
M*5A)0WH:L7CI(D/3Q)%PL:Y))@G'>)@B_ S#3<1"\FT<VX:OJ4&!X0GY5.C8
M2JAP7!7,MV=NB7(4P37:0XM% K(WI_.*>6;"V> K'=-'\-"QN F3B2-VA_0&
M\9=?^19;A.V3OL8%OD7>LV14F85$?>2N3WWMJI 5+%5Q(_/8%@QQ;1$&R28(
MT"YSBF5A4(Q+X7N8F%_9*/W'6\XGA/58A0]R6F453I-*74*9,QZB"!9A4A)@
M#!&KJ!9(6]1+MZQE "MLD9\3#4;G_4R&0L^^'<23M1D(W5C;$:S6RMP0%Z*R
M),8CC_&6V5BF=H/BZ2>X;BA3JD""A5NY 6Y7#.=B)4"&)0 D6RKP72^H7BH7
M+R'@)$RB,@FUQ)^522'GR=(\8YIGX-9I2T\+N[CVZDQ=7MN Z4#!=LE#UAT#
MDGJ#__>7X!9K\8(!SIE,23B:8#'HQR%\$ <PSV5D[[\R6UHKY_"Y>PM7XI<'
MWER56-[16*H[9J7N?')<YF;M<@$2'ZRH(,^688*@ZG!)KNT<=DW6(B8\.F[]
M,/>>'AU7DQ[X.(^-\]BXOQX;]RP5'N<1Q0+%'Y6W68$YS:EP.P0YC"]1I$H(
MJM2FW$*/=H"V'Y21H+"E0BS4+4%:!U=$6E0/.U+T84V$P3YY%B[Y#N$<34#8
M;;0U-3@KV.*Z&U:4N"G'6-!GS<LE[?8;D<0O0-O&<L*Z+A83T-"F8+W2MT9E
MVBI!^-:H7E08K",DSY&L5S#[S5#@9J2EUD\5?CP66B?/V&NX8S#PMYX<WK5Z
M--RE4J&Y:QM\=V7EXZL^OOJEI<H[70JPMJ58J%PNPY@ G&/,A1*\\T&>%4;<
M1$Y75.D3+OO5,0BL\Z5*9OT]RE2L(E3K_ M"?JR"-FJ/YH1PR)6%8/6;^L/*
MKU[VM/%/LL>.#<4-"W4PS.$<PP('&6L-79 $NAX^FY1II(&N#QW?%CI4\SDH
M%SS5+XPH!A=6@N)/T29Q5@N?MD5C"\%APM^*S^%LCCXJC]O.52^G<J[>5A&Z
M1%,!^F(YISK)>FWU'*V6,!(E;3JR:-!OOO=]\.1U?@P&/)-1GDV24L8R@@'<
MR#D- ]:.?KZR-"_ZS7Q=I=>T:Q]4L4"]IR25D:8Z\$=OTM;#.R$L-VO7IG+7
MO!9X!3-PQD"M^W2>5S>;+IY!W72*&J,&Z6-M<XVQ$I:3!6=J*(9<<-VF"A*I
M"I8*@_D<Y*;\S.=CP,&25<(<D^")DE#.E(VUN,_@'\H4'0-Z9BQ4E,NQ3@O1
ME?!OC,X(F;(W@ (33J'D=)(N8Y=IJ4>M(S=?-1-^@"Y8CYR!XS-KC]F&@X_J
MK'56C50"F>6->Z*^8R $3B]#[P<S+.CY%IA$L,N@(9AKI[/^K2 "$XMU4[B?
M*A%W)6DT^+ YU>6R"FZ,C%7X_F'PL7_5/^OW[).D4J6V#7)A,D'X(4>%X;-)
M]8+HOZ!@0*'!MDNKU;=#KT\IRG+0+>"-Q?811=:C6]07$YD&8H>\@#D0C*OD
M58E7)9LN>D&5=(JYI(I*K#@O.G% B4@WN(  =-<G"+8T.N0FQ.QH10;BIBM?
M@"6ON4AL D+'C+C(;96SH/X0D/RW @0*_'=KW+@3!8Q!E"2F[JV>*-7!%A ^
M1GH1/S"IGT]I=KM]D]TZ=FYU!1QJ'=5BT(0)Z12F\$X*2B.C"8Y/'9<%&>6)
MG$FM&K:D'JN^$3H*< W""?AS>*="%9CY,?$Q^M9\;>,[^.E"?]B>QD.+']-W
M=Z?S"-]#JL.&[%CP;YF[R_7Q/AO+PP>8C BY6?\N$6\BF[R/Y@U1H)#5K7FJ
M>0GT!%NX %Y6+F:RG 6855^?L*0I\%-[[FXU7^F[]*NQVZ09JRHE44!S=AE9
M;3@U1]>N/E"[3S8Y/4;'#C&3?Y;Q%!?!JRZONC9=U(/JZA3O32V@;FBW4.I5
M"HC$#DD51^YH^:A=#2V%C&C'E)>YRE5Z;%A?<3B%#]5^?]<?>W_L-_V8P+'O
M%/_"]?#R<G1]<?D''_K?LSR)X>UYVDM_%C=^[\)9[!0C@5-[S*=12'(%K=<3
M<F"*=2X%H80-(9'AC_J6\_,B#3 A#YI6(#@E$G0&D(<N!2.<P;#H8$Y%&A$2
M%!-5)0?Q&%R"-_VSS*6*)6<],(B6+O]ZN= I\-:^!V]Y\-9? -[:#("6)R_;
M1(T]DW&<B,?>*,<$L[M?RS6V2@?T=IF&\[D($Z-BS=\@)&(147(./ZZBE*X>
MYT.O;I 3FI)6",A>R0KU#/4U78?P^'*L"JQ+H_HQ%F<(HZ!(;SV#I*])V6]7
MXM\E_!@OJMD/FJ)@GLLLQ^"C3C6M#L5[!E[.;/J)!,^@4VQ&UYHL7@683=G;
M>?V!+(7@77@;G!YM'^X>T^>[5,+6]IN3[:.]'?,;BW+"!- ,9 X#B>G$9\A2
M7X0%&) >C.1/^L:?##CIG2(A6CGI6&'5<KBQ=JMQGGODMV2ESIAJNX%I![@@
MKD$[0  ?^&D2ZD^Y-NU!Y[YQUC:W)]SF-X6[''[ IDSGUX/VQG"//*I3+V*]
MB/T2D;37K4YH)C<I%;?JH4BH4C HQE]@6*<6^^D9X&$=P/<PT%YJ88L/179Z
MJ\N+A$T_0WO=:CCFPA7"$FPH$P&A$(D&P@F#!_;4SOZT/JOMO=>M#EV. B<R
MK4*CBRA<F<%A76H49"Q"I7F<*(D6W&;Y)Z7)*U#Y%A:HI&Y,<H;:'E= 2[A2
MJ +NJQCBR"D:^&$J)LAZ@PI\+!(I%D*#+P5QZSCP1G#/4/'#\ZNG6*(=6PP-
M9L<<D9N%T\94HR]Y(O!59AY/K<8P?.,6-A!65)%I0@DLKK&FWV-U'Y@G'ECI
MI=7&'^^];C6XJ=I[HN1!IAQM]G/%+85=8PF#Y*2,KB"M>PS,"Y@%XYQ3-)I\
M!S[1N.JJS[(IGB)Y6*]#,]5-G#&R,'N7)LEM1X@CX(9V2B1<G$6^45CWCKQ(
M\2)ET\_@7B<[UY!(B862>592968V-IQHF +>)J2*0KO#8+5KI]H)35@0*'Y
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MT[ UKJ0C&3 +&Z$+ P2>):L5SA@(:Q*X<J^VA:@3F+;39#;30(UP'5==28<
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MUOD0=RV!OPFSNF=N1P^9&P?]-VMV%$[1$;YNOKENSNI'V(^C+K_ 56MQO19
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MY:VKY:QL-K5;36&:8I?S#WD&&QJ,)ZX8#6 31SE(>20S-E\1,Y^")VCBH5B
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M54X37KH2UEXB>(FPX4?HJ%MM>"B.T[#F[I428ZIQ:/Y,?)YCV:BU'8C=0!H
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MJIN(%:<JMN)9A$E/8\:8R;ZBW =)DJ=B:6.U$XIL:<.4BQU;(H05[%WF&A>
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M2>B>G.@8F++F)(A)6";$<<2I*MLT5V.%C!VO^+7N[O3WMZ(79(O0O^,7&A9
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M"#HQP_-Z&F=W-M?:(?O- V>WL^>TW?UIY%PS<H,1N9V]_<-[Z=73QQ>S><
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M3P;[9E._/8JE/H'Z2JCGL=0:OL\@#!*IN1Q.TP2<$G'#,<(":8WXW>L<E]\
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M!K]7F5=\49%W]2Z^NY #,1=3:Z5#A^ZO%U8K\D4<*<"'Z^>!EBV,5$!^^[S
M=$FV+ZKX/LK%\=$-AOUYE?9J/U,11>9D(5!5W^?N*$ 4*_.LL\%OO-I?R0Q[
MC*>Z7,>2L$D6;B!KS8W\]Q<%6=B3A2H(0;PJ&UZJ[3Y5+W.$*&6W"\!(688H
M,TQ 58(E #6:&G.(Y5@+8@^]<7\#$1N(6&^C>O^B(*):3Z >/G$D8GX_+R88
M9P"_'1JO)V];-$DHTW?I\\!4);6M4*;XH W;"1(0+T^=49-K+I/:.L12A61Q
M_D2.Z18XAWR?2%(O=ETMOR-#W'!EO*G)XK)DALPD;XVLXB! %^;6L/!M6R0)
M+LX#[N$'&@LA^/P2YH4TX2I6$^&YLH\*0G</5RH?RU()[BK>ET.NIL 6W2T0
MWU^9CZX:X]7>VJ);<%+&TK*C%Q=M7MVQWETI"R -[U@QM1 VJTUQ>G,76XYL
M0Y@;9:68A.0 DN -YW2;PI((=E8 ^L_KD<</!OW=0Z?CWO[UPQ].?'#XL%GG
M$GO@=%J+3;O>#R=>_Y/N[H<,X=G0Q0= 20#&VO)/O'5X'NX]N)JUOTO5OOVG
M5*G'$?Z"6O7ZU2[$ ^8O3 <A@"9OX>"H/$UQHV1W[WA^M)@4>ZK1@>$^0::.
M'P0O3U!AG7W$CFE C7P)SU?[[.3%J#Y52GAX@U+9W/*2GQO^T^+DZH[>4_N$
M1"W&GQVU4:N7HU8K@]PO7R^Z'\XO/EV1TT_GY-W%Y>7G[]WG@+J?WY'BIW[.
M/E]>7OQ^,>/):C^MC:P]ILUZ0.\TO+T0ZUXKSQKKD3_]&?*LMN]W^E>F\$<)
ML?;:UQ/!T<9&'BSD?XFAQ\A;B?>U;R+.M=^N+BQ/=29G=(N_ &6<"AY_5CU\
MN<[V C_T^!Q<[UM^B_*G5=CGH7SE3^H8A3N[^/P<5.T*?VSYMM^%VC@]#SIG
M*/Y8)/Z.S3GS'-)J3_Q:U<:*UW[CFBT3&+3:YG\3>[>Y>VXDV,7N V@_=J_\
M4J2U'G?R->P/WC="'4=O_@=02P,$%     @ U)-F4?8J5XV""   ]2@  !D
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M:2JF:#R@\89QNIC;#2O+:UC32V,VK'TE<&OO'=S&CV+S]LU1LW%XH@M %:R
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M0>Q46D<_S,-&M?#ASQ]]<UJ:Q]5#G(8!F=(9)YK/!)]#(;%38<CO&=6 =KF
M]ZG2EJB$7"H=DT:]\B^B(G(I,\'$)(82HT& 8E&#$)V\@! U]RY$[ZB!P$ (
MX@6Y2]1<<C;A91^I/#Y,@0F) CX (U"1$)HL2)98G7'P !B"(PL0.$IB>-*"
M2A+1$%YIHF)AB55>;DL@X2$WANH%BL3TCL.X:SH-O&-@# PI'=. ,5 @%!J8
M!8@ET!TL85R3^52$4V(R_%CUGW/-<R7H0"R,! J";&8N[!0<-"D/G8&H-P73
M% ,W9]"-D?%B?1I>" );_S\(Y"02"<08X;**:1G@!^+0K-?:11)!"G&I KZ'
M,F.@$W"S%L R8$Y@VDDA[(A81+*4*TCF:# /A@;4,T>LRRB121  '"H BQO.
M.'M":J8DDFIN"I!J/A'& BNWA.)+;S=865[#FBF,V;+VA< MV#NXC39B\_K5
M<;/1/C4YH')6@ E"19& 1Q>U :&:.WQ O,58<HPCX0#*L11FBN(H%D-RQ 2)
MSTR84"J303],FUI)#Y14JY S>&W( >""<0":#W[_/IS29,))%S+2329!PA'+
MPP/^QG5UG!*?_*- SIAX@*)^@FEK#;<>1VC+S@-%&P-%,!#Z^1#-((%E_>M9
M4Z-^O$<0I?L#T9-JO8WS<,$-; L@6JZ>?1Y*92RU(<W,[EVPYHTYP"(?R5=1
ME6E0 +EI)HS+>"#%$Z<'B?(J5Z[G6\TE=3C+R^@**^4\%V.C@+P)MA@E!7.G
M"B8;&^!Y5 MT0/AB[RI @IHR@P78+4OCJK7+C\IP,,A"/L9.*3!)$6:28EH'
MMYP1JT(./3PM6&<S\&W,41 R+_3G[.LS[7[A>+P_.,Y3[2:,=\Y76VC>/=/M
M#&I8"#/!$*O4J(1B2J<&<(Z4$@%,-2O !/ 6="RDL NL[8\-BTO+X<Y!RJ^*
M#=$U2NHJQWWN4)K!#L= %)"+A*'2S!G@R.F$)T Q)" ;6GB*2P9%@'A[],+2
M$BDD[Y>"WW!_\%ODX?Z,RLPE*XPNCR*@AV(&<3&/T+PEE=@A^?K'QYF?PRMT
MA,1I/+\<J\P^;<$NY8$NI3F2Y^CSVQTR+FBY6X+<ST2Q$\<!7@#DV/Y KDB9
M/IC;H, ]=T[;7,NCR/N"1(G57(5AIC'T:Z7S$:VQ,A;>XR$EZ#(A*,K/<,C!
M$UTBP#"DL ?2N>&P5^+NN !/$I)L:=<;;]64FB7/P.3G,,^9JPIN/O*,O2!2
MW'&9GQT\D"]_\Q1]&\[W:A-VN'<P_[I-F#M,9,4**:]2%&;,=92NLA7B[ N(
MQQ:#79I&@<5:I<VRUKL7H#*.A;6<_T$]&"M@$]C.!-CGE!P EB']&DSO\!>Y
M=+$ ^>^9 //=8LN2T!TQO/EKK_7=:GQ7 CT#NB@ :;B]Q8UR*#A (Z_3RSW/
MG-,[++R>KKG2ZXBF.^<LCH.^"'#Y]L0?+CR2UBB#CH8OL]J3X,SI*70!A &+
M+/OJ;Z#TFRP&?, L.6?R:O+HP=E+JNS[MQGJ0@&/-&2-,D2=NT0'N'&GTCG
MRK[^B62FY(QC$4SH)#]<UWENY'$JU8)#ZWRJ?$*D&_ %N#T+0ZAN@>"9I_)D
MISCZGQ\_!\BQLE;%';P$L 91-^UGUFWN<ODQK VN*V"\I*GAG>++*5255-)%
M1R3.!M?I=(:%" A,_BLMZ,SO&)RTJX>- *\96 W_6:$^OX%0=3<0:I9MM[7:
MU7;KZ>9ZM?%DVQ^I#:I!T'YVK8V@V@J:SZZV5:V?/+^QK:!Z?!SLI+;FHN8C
M!P@P*4W>EEJEHD.^?#O-])XT-F]7X(I^" L/OC\_S[E[+A>0.QPY($-8R?$8
M%O-1V=W(6:Z9?#:^W5' _W-[>;R3DP^2P+,Y]'TB]V-]^@Y!VA&*[Q:;+/4%
MN/3Z50!%TWVN71[9\'#'7%)'1TL[S<H7B+Y$G._@?E[%L<:#+'$_*9#"D[V8
MFQWQ]1>F]@93>^'^CK#I306/R.62M%_[4Y)M#-4<CWV$-S^X.9LJ?W6XXW_*
MF_&MN[2KI>>8=GW5A8YA_67VZ2Y/W7-\\F)N_NFO";L+R^?_ U!+ P04
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MZO< 4F@K=3L#*P8 -N;>R-1.F4S4R<< XL&3KV+(H/-%MJ@?:?0MO$(9-.4
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MAZ/IW-GY!-M*6D*MA<D,9TD9DHM>N90H&Y\DQ_@"&VT)%X3D8FQB=&!D"LA
M>G I8W!1",PQ(^DB3*-MX@)E<O[6T5M*[)-"D>  DO&"=:U0&%G#5O^FT=9Q
M@3(Y?SN9)45%,KIL$D>'B,)F%6,4#&T@;+:=O!;GKPWR^=?;DP,:K:*QK E2
M:8TB%(G=5AE5M@Z)DK%&.[52:=.YPKD8BVE3%(8PZ2@-9.>"SQFM@Y*2D.P4
M-=IB+EHZ%Q!42N^U9.$+F,':Y*/1RD;IE(C@(3?:;"Y:.N=O.XN&S!(:%*@
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ML\+':\W!58BJ8L+^!C(L,H9IQV\C2,T/GT6- $;K,DD=;"G@"#VP,? Q2:=
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M6==K;VO-P5ER*<MS,+$*=3U,#?GRWG(M3*(<,8L3XMA8I)ETR/(@ N%)8![
MMC)-(7&-;*L"V%KJ( 6PCZQK?'F?3'!<4HVD(QCQP!ER0CDD"8V!&+ ?L '
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MT'[:;7?^9V/8/XLW(\#?']Y6-SP;?W2%0NY!(=?:Y"OIO8F"H"@Q6#_.@*K
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MI[1EK*<.<6^3XDJTKT"RN]UG([D6-IN(S:[-)U=1,4-#1,IEGT9V;%C.#-)
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MW<T:G@A7G'NA,:CJF%H'"GKV14[HJ"B']\*@?>6C2"H21FE$VB:%.',$V60
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M6 0#C'E$=&0I*<R0Y-PCC@E!.GJ-HI;12<>$E+G+52[SN.D,K1\#K,/\\5V
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M;P_@3]OP8_?#*W@,O5 (\2&$>##N^[#48$P3,D2!+6190BYRE7^4,G$@129
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M,8F48QZ!.HK(&F$03CD":B736.WL$4%VC=H.RW,:&)V-8KJ;=<&MZV'OFZ'
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MV2J<.9)42-JFR*WD+F)L,6&,."'@?S?CVM>ZC%04NPN*M4(6V@:E923(:![
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MOR?!8V&(1:K4U7*V='0S*'$)1G-RPD69.[KQ77KWFM$5,BMD/@7(7,4=27@
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M-NC<;Y7O+:4Z5;Y_@'RW.! A7A#J':*1.<1#2LAR^*>D1,DH*<6.E!1R=K5
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MYP?[OW7>GL O#E\>G;S=^)=Z&\_'\<S%80/2#.]VLOER==RWW.E\YV;\F\)
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M+H&1DRT=HK3R'E-&=;KOHI+.JW,S38=W7IT?;]\Q91D3+)E@>*:'22[7H::
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M<UY\"E&+Z*(BSYZSBXDN79C@>\IG1>_<:AC0A02>%,:5]>\ [AL!KEWRZDS
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M,/;SW5=P[^W7YWO;?P_>_?.2[9Z\'^Q^.?JT?[ K]DZ.SM^?_+W,UF-99FS
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MX7Z\PNT4%\0;"[*MN?+!@M&)L0TN@ Z:L.C<!VLEX:VNW3$1GKA$DA.0ZR#
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M\BRNTUY_&$/M;RN@D=5""15D$H!&.$03=,"YL2'13CNO#W<R"!'*R"40$BN
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M)79L*R/JG*HZTU0__#R-'H@3U$FX9#?]"7\=I/)=]K)NO@=+^E>[Y[^_,3H
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M8E:'E//. D1[2@#!-9MXI-@]"EHKA#C9P8?"6^R)3YDR(N+ CD@+RA$AU@M
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M,=D$.:PD%B$9S@RH'.+>O>BJQ.>5^"RW7QP<QU [ZO7"H[C*;@54]YH!^%*
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MB@A7WE!!*?(F,,0Y8TAK3Y#BD>*8C'=E]8:ZORGQ\JHWGD\/V4VIY6,MC?K
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M0IQU&^_ +EXCKGT+;K()P<,+#H9%+"JK(:&JSWC4<K0G4CK^:\^+SK,5;*T
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M*C'N-3/96<9##-+0$$2LZ.;1Z$8TM@XUT\SF[LI.V(@X:&$(-ELB0SDGCM/
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M2;#S:M[<Y;&%;Y *!%"!YTD;G1Q2@7G$5<X@$M8C1BDU2H%EE HJN#X#LT0
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M!B_3,"KQ7,6[N T8AKT+VX U-YFCD>_'+YH3<8&X9/\$[.F+4\]M<> !VTP
M;:0FEQ:)#(.9L Y%P1UGENJ@T]KK;B<VSJ+M752PS+RO6UCJ (@EMB9(RH7
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MI_#[X?[>5[:_YT^;?[[_NOOG1[+_P\/8?D_@$Y]-!1:#5SQ*9!67B$MND>%
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MX"HY+! 'IQ>YQ 1R2FJC*:,I@@M,-?#/RS7=+B6'%>JY./4L#+,PS.?!,*\
M[0+.BX#S3(*<DDER ])K64(\.(<L T()I-)KA6E,(JV]YF2=/7RKLB43R@LG
MOIYK(;HK$YWO>U)N]DQ)/H<S]Q3)56>]\ITJ710$.XF=%Y98KKAV+$IN94S$
M2)E\.)!\[<8C+3_C%-"E=/_J%!#!&XT'/GKVUK9Z_]KV,&X!]6QW<VVK_JH<
M,MOY8XQH3=[<@N_0?;*[]>YT9R\C$*#,\<YQ\ZA]M/\C'#5_-+\W]SR[>,BL
M^>/+*;P/^WSTD>]L;9*=/]^V]H_A?W3_;/?3SM$.A2M_O/F^\R.DYMX[NO/N
MP!HO/<<>"6H!EPQ/R&"OD>&<,L:)P$;7Y@=D-X;-;#RH2=K1H#W!D;,@K<(&
M*R(X2X8Q<>E06I[V1C7O^2C"VU;'=GS+MAO;G3Y\H0I67-:8:1&?>Y#QYK>8
M?6L%WX>_,\.2Y]S <$%'F,"") FFE#WXP<>MZ 8?HL_G&UNQO_G-MJH3;&^[
MO0]@4U?JQ.,C"",!8121\Q0Y."^,RGS"FB,;$T4:((T)(34U;+$3CRMRPG'O
M,([.&N8S2Y6IZ#?ZPV-X8;A+HSOLU962;"<T[%@P$+ UU+?YZ."YU#0&AW;0
M.(V]\^)\<,&@D;*&?:LTS)TU^F W6@G,=F?0:'6^Q?Z@JN#G[2!^Z?;.&J>M
MP>&HPM_4A8<MH'P]?WAVC].0JW?8D=$-36YW?G"1VZH-4/\G<H12W7D&'N-=
MG\Z\R@W#[W;7G_^N>H,*^63>E9"G,J^@6[<\G3S?#QGC(-".N/@W[UV"\XF6
M*9TI2MJX98'*1Y[JFVM<SG'+5WL9-H^[\"X_@(+D)@7WJ1%ZI6_]W*?PSUZW
MWV]\[/0BO$N>R3]MJU-F<ADS^3?\N\SD7:I/G+OK9?KN,'U_C!VYZI<W_S-L
M@7]5QSC*;"YNZ@_!QJ"]V#MN-&WO:ZS=RTD8I4SJ'444-=['_J#7\H,8'IL]
M/8L=X,U^/P[ZM^GJL=PB*TL]%%)>LKQD><G5?LF?#,5/M+L-&G9Z5QJX10;[
MW/)FY@WQV:3&! &:IIDGF'B>"'7$R( 34<0+2H)?0FI,%J[-3LC_F2+WFX,_
M;*]W!C-:>4XKDRASQYV\4:+,.P+//FL>-<]V<DW2'^];^=F?]S9Q<^N+:!XW
MZ><_/Y[M'.]_OY0HL_51[!QMGS5_;)/FUM<?.W]NPSC_:C?AV;M;7\_V?WS^
M^GEOFWX^>IOK'GR?G**1)##'!"*8$L15X,@$31'U1$ML-?6"K+WF9IWP>R?*
MS(>V5>X]6X!IE<;V?_Z7IH3^5J2N2%V1NB)USUKJ"@E[]B2,3;*5N27".(HL
ME@%Q[BERGCN4$K&64.&EQX6$%6!:A;$58'KVP"0F9]PX]=98C)2@#+Q#8Y"Q
M&B,6&*72<T)#+,!4@&D5QE9X>I&Z(G5E_WB138NKMRS.A_WBZ_;QY+W6/@7P
M4CAQVBH;O'6,IH"UX&8)+&Z2&C&?SQ4"MP"!V_EC*KROK"$\5S36#AO$<2YP
M')Q"Q!A&HJ:6.YL;16 B5JA.W[)WBY^G#M_-])1E*LM4EJE8Q)=E$2>Q5N(P
MDRD0%*UQ8!%)S$5K<R';7.:?4AD,*Q;Q:>IP@=JR3&69BD4L%O$6/N)Y&MCF
M@1%82,$QPIYRQ'FPR#&ED.(L:6:U#U0\%9M8TG5OAM^\8O7/NH1S+H:Q:.SR
MQ1;"6WC\SP;EF<I='X0+T7*>X3PDG,OQT(1U,M(N:3_W K!? O[9/Q03<$<3
M\&$J3*@QC5HI@I)T&O&D(S(\! 1_9PHK)G-9JM<"KQ-AEK3/^^#E\G[2=ES!
MP>>!@_?:R"O"7(1YE09>A+D(\[,1YL)07RQ#G83M96 I8)(0]X+F:OL1N=Q=
MG"4C=$S*)V\+0RTX6'#P)^)@R;Q>,MY-,J^QB31(1Q$+N2.2Q0(9'Q,2*C)L
MF?/:+?M(2,&[@G>K-/#BQ!1A?C;"O%K&NVRF+CF2/K69RF'A*.8<!9+ 7<E9
M1D9I@E+2B4E*O5-T29NICXMUY8S!C37J+O46*/7JRDN6ERPO6>K5K4@"S/3/
MO^.WV&YLWPVC;^#YY1[E'N4>][I'X9MW!;;K?S9AELX:QU6Y[T:"&;A4Y?O>
MR<TK-U,+][U]GJ$&:JP7F@5-< )/E5CEJ/#,6Q-28DDO(=1PL?'>A;9\XYXF
MN:7)[[;?*J&'14(/N]-G?;EV.BA)$"$J(JX81<XZC)RF5@FFDF-N[35EZQ23
ME4_C7IAJ%XPJ&'4-1OV(O6ZP_<,%X<G[X?&P;0<Q5 UO)OUN<N.@WR,\(>[9
M[P6S%L.L'Y/*=\$I[BQ&U$B#N(D..4D4$DQ:(U3D,NGSG: "6@6T"FC= [1R
MCZX"6G<$+3+)S:!)8J$\4EARQ%U2R-'($& 5T\)3FS0MH%5 :R7&MMK>X 2U
M9C&L@--BX#1)E*7!&HFU008+\ *]8\AZSQ C1B9J0*0%+5Y@P:95&-MJ85/)
M:'T 8)IDM*9H8=&X1(YA@KC0'!FG&-+4D$B4)TS[ DP%F%9A;"OCZ57]6',[
MUNW.M]@?')?DO#M$R)L?SI/S@L$6<"@A;(,$$ K CJ2V"'O'?1)*<!N*ZU90
M:"7&MC(H]'>W\Z6 T#U!:)(AS)QEV'.&B&$6<64#<I$"""6#B6.,!$R>#@@]
M:%K&_6Y>OEF^602U?/-%??,E9/!69>M*Q;IRE.X&6NR]Q#A:+U-DG$6O Z4^
MR1"ME,(+=X^H86J'XWG%0#8[89[3/I/H5LCS(@W)Z@#BF#P+%B)GR2 ?&$8<
MZXATQ )19HU.GCB<Q-IKQ=:9Q$_[?%TY2UP <#4 L"3/K1083B()220:=23(
M9PCDU#-D I<H$J,$$<$8M;Q,E(*&!0T+&I:LO-5"PYT)-?0,)(U8@@R)"G&E
M,#+"YFUF3),Q"6O'"QH6-"QH^-#.\37%,J_PCPON+8I[4Q5GA(B"4(^"-P%Q
MPARXQ,(AZ01)4B<6+"DN<8&] GL_$?9*)N&R$6]W*@CHL?6.$42< []7!8,<
M]@XE$Y6BT2:>'" >76?\B1?9*HA7$&\U$*^D*#YD3.]\DV/S0$5EHK$"V<AR
M4,\I9!,.R(D@*''>*,Z*&UO0K:#;S^)SI5SJTN&N>0YWV'.C);7(FQRU(Y0@
M2ZQ$P3I%B+4F4%OJI8[3>L9?&6N+J.!Q_FT6J<\UF1(&@P[=H6O'NU0?+,\L
MSWR*SWS0G+N;W\-<^NX<>N+!UL3>S['3^H*95G/-]%;T\=C%7H.1]0;%Q-RB
M=.8CS_0\T;G1"JSV*ISGEC5R<MEMJI<NJQ[NLYG":DNV,=F3;>04E3*3RYC)
MO+U=9O(.,_G6MGJ-*E1<IN\.TY=]M(;M "CF7Z:\M3*;=YC-*LJ'<IBOT:PJ
MQ>9$E\8DO:5,ZAU%%#4FT87'9D_/H@CR9K\?!_W2:*.\9'G)\I*ET<8C0G%E
MWX;@"EQEX!89[#/=L7FFFS*822\CQXI&GK#2DE-MN,<T2DL=S9LRQ!#*2$FR
M6:&=F?V9DW:<8<UI0DK"#QZP029*A@3A,M>KL#$GV1"Y+LFR6M ^H9WF DVK
M-+9[]8HM4E>DKDA=D;HG(G6%ACU_&C9]NB,YCR4A*&+#$$])(\N#@Q\^*4*<
M%"(4&E:@:17&5J#I^4/3U#$,*RC3S JD/-.(VR"0UCP"4B7FI<YK:PHT%6A:
MA;$5KEZDKDA=V45>9.OBZHV+\V'3Q88]5R-73VP7X'%$,\QE$MJ%Q$G00 "T
M4='**'W"-BV!QY7C%TNE<'XZR*]YLHE8AI))''$A$M*.661"9$12'WSB:Z_I
M.E;W/GVQ>N7PG[D6W\WXE&4JRU26J=C$%V83IR*NA%CB12!(<J$1CRHBIZ)'
M3.I(&&>>!EELXM/4X@*V99G*,A6;6&SB;?S$J6/ZTA/N&0E@#X5 W!J%G-4\
M=RY*6!C"F"!/Q2B6S-V;\3>O6/VS:K;1\*!+I>/&0XW_V<"\2"K)&+'1VG(7
MG!4^:<F8%U$*)^.2MG4O(/LEY)_]0[$!=[4!7V82@J--UK*(<(H8<:$<<I0;
MY(WC)N>H:)HS4?2ZU.9IEVHI=:D*$BY_/Z\(<Q'F51IX$>8BS,]&F M'?;D<
M=2IVKQR55G&&6.0"<6P"TL9YQ".-TLM E&2%HQ8D+$CX$Y&P)&$O&_&FDK"Q
M(#'R8%",AB,N$\TQ6?A!DXL&1ZHL77(2=D&\@GBK-/#BR!1A?C;"O%KFN^RI
M+CN>/K6GZH,*UAB/@L#91>$662\X8LH*DCCU!.LE[:D^+MB5\P8W5JT;-P]%
MH)JH#RI5*MB5ERPO65ZR5+!;D3R8Z9]_QV^QW=B^&T;?0/3+/<H]RCWN=8_"
M-^\*;-?_;,(LG36.JP+@C00S<*GN][V3G%=NIFX?B)@WQ&<3:Y":)&J33891
M[J4U*F'BJ6 :_L]ALX18P[D/]+;;^P >T%9T@TF%^?,N)[G)R>^VWRJQAX5B
M#T=O9L[]6A6PHR"[(DG$.>-(RYB0P I+GE+D#/!0K&.N5CZ=>V&N74"J@-0=
M.MW>@$_>#X^';3N(H>J!,VF!DWL)_1[A"7'/?B^@M2AH31W,%)YS*CEB-%G$
M-:5(*\=0#$$[YXSDC"ZM,VZ!K0);+QJV<N.N EMWA:V=J7,3!@<!0H&L9QYQ
M22R"ORAD."&&8@&+N[R&W@6V"FP]*=A:R"6<X-8LBA5X6A2>)JPJ"&<38PXI
M'S7BN0NWD0JCI&/B5@LF!2NN8 &G%1C;:H%326U]"&2:2FT5(@CK>4*>ZZHX
MG4.P=@XQJQV'U>7<^H),!9E68&PKX^U5C5ISG];MSK?8'QS/).GA@D&WBSGM
MO9D4/A$.QQ#!>\-!(LXD0989@1A74LC !:8EZ%1@:#7&MC(P]'>W\Z6@T'U1
M:)(J3"TV7%"/C D)G#1BD+' C%2,D7IF6-3BZ:!023Q[F/R,CQ\:@UZT_6'O
MK-&_N3?[=47IYLS9\RM*Y[RDR2H7%(L\VJA)C#(:*K0EP6A9DAI6'26WIY,:
M%'$4,W 0'9$&\1@-<AC^:2*VB6(OM IKKYE<-YP^OWXT1:WOK]9EPW\%%'JJ
MF@.QUAF;D'2Y$K.T#EE-%/RFA*/4$RYB5NBBS$69R^;XTU'QJ<UQ+;WTS$E$
M;:2(XYB+K<,_<UA%<8L]76)XI>CY<]?SLIO\*/H\,=G8*A98  XN-.@SY0%I
M6#.DB<Z-AE0@GM4<7.FBSD6=[V:VR];K0ZCQU-8K,=X9&< 8XP1JG$"-+?$$
MV12)#L)C3&0QRT6/EV&6K]VR++I[2Z]Y:LO2,DUMX +1A#GB5FID* 6*G==0
M@^%E4A4;_$1UM[24?5%';J=_?ABZ06[&L>A&WHLM#;;P^%=;]1<PVS%A '?M
M2%".DQ!LT-QJ+#D5P7&]C'9+96?K04UZ<WIGBXO@,8D"$6PCXCP!$_=&(.&X
M$28:[[U=>\W)NKE_6>-%E6;%$Y0*^!7PNS7XE?V_%8"]23!1.B=$4AH1'R7B
M3@#L:>4! $.DS(!C&M(R]O\*Y!7(>ZF05W9)5Q4(IW9)@R18NT!0S!NDW!F#
MG+8*"0FD4!D?@!PN._VSH&%!PU4:^&I[OV4O>5FH-Z%_FCFF'#;@YHJ N/8,
MF20YHE92#8ZP\S* UTO7,5U6T^$">@7T5FG@JP5Z9=O](1!O:MN=,NITKFL5
MH@&'-\2<RP[_5-@D&[U,7NOEGG@N@%< ;Y4&OEJ 5U(3EA'0FTI-4#A1'C4#
M;',*P7(!I3.&($H2A87RECFZK-2$@G %X580X>Z6P/&XPEP.[-ZTJGL+)6:,
M!CA:S?K%7S%8LM =NG8\7]$7J_/+GZ#5!H4%:(_50@D59!+2<0R.0M !\\0E
MT4X[K^]!>U([',_K70T^WSPF-)/C46C10K3HW71Z!X"[S*W[$#7,(4X-148Z
M4 8=@Q186D_ [9-X72XM87-YFO7(Z9X%8PO&KA#&E@R2%4#6J>-H@0B:2$ 8
MY!1Q33@R5!(4. N.$RULLDL\05Y0M:!J0=6'9:XE2665L'8Z284Z*2AA2$O.
M$0\)L+9*V1,X:B-X<,8M^\Q@ =P"N 5P'R%4,+TE?+MH08'61:%U0F-%4$E0
MJ1!GQ" NN$0N88(X4%BCJ=;1DBI H @OR%J0M2#K\T#6DFRS;%"=2K;A1FD,
M"XD4K%P^)J\0+*-#(F'!*0T1:[SVFI)U*4D!U0*J!52?/J@68KJ,^.I40@]E
M/F%M$XJ, STE4B*+"4<XDN QE4(8L>1:(P5$"X@6$'U$$'T/R-EK^4$,\SEJ
M =2% 76JTT,2/'#+D*+! 2L- 6G.&/+:.&^P3$IQ8*7K6-W[S,N*X^D2DL[^
M,\@; O#?T/KV>CQ=.\-CT$+_^K_AC^,['-O>EU9G/ <:E'+TEVK0= R<K4X
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M3S%?Y-O#+)B51F29!0G)2E79"M#PKW%0F8LX?@4[7GH$-T9]6,YIQ9J\(+Q
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M[\-S3F ,62/&'&U[0L#Z,#T=GU]G<I_YMX'YRP-U64.!&  %@(>[,Z!M><(
M?D-6A*Z#%?M6#:O5.8$9;63MKRDAT,'^T!\V;']FE#"BMU-CJ)1U,KSZ]OF+
M^;_'W1#;_6K&>JT^<)1P-.SGK]4OWJM8YD4EG$LUA-16V6B=XC'7.''@ZH3
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MN80#(B;I1)GQ6&FP&!N7DW ;@.7M+ 378.')L-<?VD[5E#&+URS:KE<]$"=
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MJT+!X?_]0"2WH'<@0RO8(/(#PWA@)>1Q. ^6#^37VU)(;B3I ?=W?,ZWA4?
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MS(Q8;%P$Y^/1][P@*]_>J $]&OX!/++140>B6.1P0S3(.@,#O!9]RK,.T@8
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M_6%G=WHR+2983Q-UJ9UY@2]V.NK#L5=TQ/GY>/1=*_KF_:<__T3\3.W5A["
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M #I_)7$P/M_#[%/^HX?O.2L>Q;:[.^ZA@+_YO9.O/NQ,+0&V@E2$#E=>X(A
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MYW >1([0( H^]F$6,@H3A:F).XOI$I4HE!UO)L3IA8(Q1 JK@:&PTK,45@9
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M6;'<(!'"SY@G/,_3//#2)([3-':C%&3%U[[?8K:GVM!_78*Y"&::$F[D.Z[
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ML3T#C+S:'N4S0*;HCRX4)K!@M6NITVDO&.V&"&R B58V:P#)BZ@"DSQ ^;A
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M%H',AOV0P-=KY'5=/1/=SB\ ?5R&YK>%R^=H;>,/NLC6V&0.GEL8T[>NGD,
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M$>@4,L=P=6[:%[_FG5Q\HU=++O58=:T]*^UI"]=W"%ITRK>Y9G[,X?LT,[2
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MU[YUJVXJ+[*1\X6_'4?0R/G0.#CH#QLX^)-T<G\ 1D:=,;&G)0QTVL:U]+2
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M7I @"&JYEC3:Z<GVZF,*:*5I*8B_O[!H%V+?]7M]?^0V2O<6,=B&O@^PZXW
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M: &?<NI10/*\<8/['MODSP9@<&MI+;1S)_7"C4=JC#*^]YAAI=#I!?KF]W8
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M,WRZI.%A6[&)!I#+C[M!*4LV#>ESJW1@H.@=K!MRU4>E$CS/3<\,W#)G27J
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M9#5(%*!RCGK\QF3=9I(-.C;,R=\KRZ0H3598U&:?!1&[:>*$K3<\E$D4V*R
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M1KR"0Q((JP,RPZ/"0SC]S!"6WR 70<RY6"DUW%%:]F("^HJKR[48I+54>]\
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ME(^H<MO&:V6LSQJ5*55[UE<PI#&>ECJK[;K0D.V%UGQ.;\?D/[C1K$PF7^[
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MLF7Z >S69"XHDT6\/"TM5C[#!51KB"6E.:?).N(./.[@FR/NX/<92;8!K)L
MB@FN.D N+UA"=#.(#8>X6PT2/7)8(1P=%B:?/Y)TH;H9SB57>Z+=  <)!9LY
M;Z9@'@02,,N;B^(DQ! *!= =+[DQID)TIR#%D%3($N(I*-,GQ1FUFOBDM]O$
MZ#4Y$7SZXDO*HH!.[(;2P&=MST*I34#-C*D#/]@NY:MS;M3L;%LOML$.%-%
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MI]?0%I:6/@.?;,1@T+K%<WB ?WC[S.X ,\4+P]?>V&2BVQQE]\+7?0OBRAY
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M8BS2+DX\-,$GP<D1/COKSJEEZT$4:K[">:.&0WVLZ<XCK%>[L>-'23V$7&
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M2P>3ZNV(B>##EO4';$$Y+SY-5FG BDI\ZJ[ITTU GN<SP0>>1,\6"^)-?/F
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M[@"OE)W"&;-YI3RJ2ASW0;V24\(P?7/#:O+0'4Q:3!KO=&V/(\X/6-W+)P;
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M):VPKY)^7X.\PD\._A>[SM52IN^-)@\^Q;"4-WNI"';)"93JC!HW 8\(IOM
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MQ#\/3W$Y=\"=ZSGZ_,O_ 5!+ P04    " #4DV91=CF8&+TI  #3P@$ %0
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MG"W)1^\_35Y/?9C.IJLI+)_-T_O5(OYYLI@E5 ^__-^SZ>K;Q+)@!>Y,XK3
M[4JE)U9SW*[*<96RR2::Z^P[7V(/W.R7H4?O^7Q/"UN?PFRUO/A)SVA"V3F(
M_V-7PM8,K[+P2; V"2$,L082KM$"L=8:HD$;XQU-AM/&:[R^G"L(>M;%)XL.
MUXVZ^J<G7Z!HUG.UO2;(=_$:M&XKC?-//%V>G9[V8Y+I"DXO_K[H\(:86"WJ
M\'TM5US*4,%O6 ]P(7P6C 20C$C%$G'*<!1;]LYQ*5AN(O]MJ-X, _XCP&"@
M%*JAX?GB]'2Z*OY-623JWA7Z0>@/%7@JT%08A7;6@42"=$9X4D-"4EE*4$FI
MT (6]]"T"S[$CX"/6G*I!I1GRR7:X(E!< 9 :(+PG,AD*()4H][RVDHI:+0Y
MM<#$>OHZBWA^UG7(V F30: 'H4AR"?DHM$%)9=3&X)/0CDHIF^#[&A5C,GP'
MR/@F;@_G<#6DONT6GZ!;?7N+ON,*-T_9C9_*3OH=5I,@*$LA)B)$4;+:*F*Y
M4,3X#%)3'I+Q+61^'U%C,GH5(%"-_]40\0;I\46!O@8,&]\5-K[)?RRA7^PD
M"E#914\,ZFDBH]+$1I&)XHHY;[.Q0;6 Q+U4C<G05<!$/0G4 \7J!+KUTGY?
MS..YQO(VI8SN-T$;&A&?JIS3<$T<\!R4#-ZD)J[P1FIV 8%\1" 8S/%JPG\U
M7_GYQVF8P3D]L/KE:YR=E5/ 7Q>+]&4ZFTU\"D)J &*$P?",(7D(TDBXEMQ$
MZ9B1M@46=B%N%VBHQP.-ZO*HAI3+V3,+.2?/" 7TM67D G$JRFJ=$S)E*G@3
M;W$?B>O'(_&#^%I-JE=/8<H4(G!&(F2$54P8L/FDB8>LA R),G/<TZ\#;=F5
M\:ZH5YI]IE0%0I5!%]P;U*P<77"#CA;N&TI#F[.]NTD:4\1S* XVFK;A JAX
MK#-?=3ZN_C5=G3P_6ZX6I]_)^W:%.&F<2$*A.XY>%P9H*I=;)DX$=S8F'1SN
MS#9'/#O1-Z;(J!946HBF&FY>0 :</KV:1Z3K@_]Z%=/HJ?/(@Y0L$B.+IZZH
M)U:Z1!@U*D:,Z,$VB96VT#6F:*D63FJ*HJ9>^8RQ?7'47B_F'S] =_K[8@7+
MM_Z;QY]-DK"*"1U(,EDC:,&0 #P286G6EJ8H@FZD3^ZC:TR!5$4]4DT4+?RJ
MBS- 8Y0W%@,ZX#P3:9(@UB!8$R"!3F5PH<F)\6U2QA0SU4+!0(8/%GS)%;A4
M5;]V?KYZ!Y]A?@97+%G,TH*U0"08)"@&3BQ02;BRBH+Q(;(;1N-V!L(.\XPI
M0!HJWMIL;724NLEOL8QJ)BTGS/A4;J>0+)TE48G[G+T4S#2)D[=2M@L^S"/!
M1QMQM#0#W'G''$22?$3(>F9)B(A6"38(Z3C3JHEGL,T,''")&./B;+ZZ,+07
M"TQ&^*A3(D$*W(Y.,6(MNF?HOAMAK*!6-%G@9G)&&F0?@H9;5XS#^5\-Z+^<
M?IHMO@&\@UG)5]NP4O3 K,S"$"5""?]I1#<,]SE5S"HMI$^VB?NSE;*1QM8U
M$%)7*JUMYP5-2D<602:2)9Q?A%@,\HDW7D4=?:9:'-%P[@&3!PBM:\"DHCSJ
MI=G$V)UMA*SF)D) 2J*2'O4;T^CN1;3F7&-8Y[W5%AK9E\T4C32HKF1B*DCA
M.*>YE_8/K$NL7,;H<AF3)7J0BCH"40N*(4'RLLE!_R[$C33RK@&5ZK)IF>CK
MF0*G&27:(#$R((2=P+! ,/R-0&P#-+G1KI^^_K8[#X[[H?_+S\Y@DIT%%0,Z
M?\PAEZ7&U:E,B<C9^6P"!EFR36[7+5K&Y'X/Q,'M]*YAG*^:NKR87Z%"<L&C
M\I[8"(+(% SQT@?B8O+,>\&2=JWRE:\2,B;/NK+P!_&\GI.4TK2LW<_>^FEZ
M-7_N/TU7?C9QVB9KF"<\"#3.64AB<\K$,>%X H$6N@D [J!G3*YS91S4D$!-
MG_GL]*P/]?I[> 3IIPY.8+Z<?H;U]=GKQ;)<FKW)'_S72:*,1N$"D9&Q\D\F
M 7E 4H#$K8HT^R9/NO:D<TS^=6WX-)18-5B]@Y6?SB']XKLY!HG+*T2_@#R-
MT]7$X-S:)4,230AWKC$:H-(@ +RF1HO(%6^!I.VDC<GCK@R>RG*I_$+F\O1
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M%%"W1Q:)1"\"LHPRI&,[>CN0/88+DM&!<I!L'PB/9=^\7)QU$\8U$XHY MX
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MK(A6TZ2";]-,>U]"Q^'Y2.U"D@@=5O CLY<D",:(EMY%$X3V;:K)_CB>SU&
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M(8A/\AF9N0Y[.?Z$ERC)ST>/Q3,7LJWSHZ7%S "30(Y_<E;+-OKH!N]$A-*
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M!]<#Y_C:.R*A+>IE_D[67%2W$!>OIL\_5_N<CQ<?ZGOTJM3W:B1M$08$O2)
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MX^+W^6RQ&"': ,[76]F1#%%T8B!,8D6)3*\[CRBZ]&[86SMW 3LAO0S*08,
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M69[2AB)VY+/=^.@'X;CVL?UL,,.U+_*[;9<;ET]A\>&WR>RO/L5[.WYR@V.
MN_!OG 1DH50QH4#MN2Y+]N!D@BAY!BM%25M/ K8\H^%A@(T&4^'(*/H)3*/W
M+""YQESZ%*7,4K<I?M#R,.#.#<10HG&@:+Q>9J954BP6+YF6F%+2):LVM2D?
MV2;N/MK8>Q-W'PY:I%30.[9&MLI%NF* 418QBCH;>XR.Z6(2"T85EA041/#1
MAB;[*[=@.B%E#&7Y!M[J+:)=54B]"GTD7=8B!61"1W+)7,[,QQR853Z'&(37
MD(X\B=P >4*R:<9-B[WX??<+E"_DQ_O 7%">Z1P2 ZN ^5!+)M7&#[G)/LNC
MW,WKHZ*FS#STW3QN3-*AMLLM]0H+.:0,=#+,9^%HP?4QM"GD_MAW\_;20,?=
MO'VXN)=]F2X ?^SF'<;GWALTAY!Q+ZJ!7&AJ#II!\85<>TMS<\(Z01M.7CT$
M;W[LYC46RSX<M-_-,\8*:;AF)>7(Z.F216<E2ZA="%X&X3:"J<>\F[>7[6_?
MS=O'</>RFW>YCL[*KG0^F.87N=ZQ+N.ZD#XA9WU9;]N^I"_'DU7N_+#;@(-"
M&G[_L)W%-C8> VBCK2XB8-0B>#"*!^XT=\I'1-RV\3@HN(8[EM$FGTQ-P(E6
M7'3]"$IHADK(2*,,IDWAI@>2OOPD+E;-AD<\9B.*="R80,;0Z"Z.A 09@^*@
M2#-1DUO;!V!]$#/U80KJD<Q\$%/WD=-<M*!)066F0) [XHQAP6K)T*?:2@=M
MPN\LI[D9N_ONDN]#34.'OX,]MJ;,/J$58YTS.P*',8H +$E$>O6,9,#ICZ 1
M+6#RWC>YO3K@&$Y?D/=%>(--V+VNG2B#/"?I&:2HF398F)>.PK+L/:^IV['-
MU>K'<27H :IO/\H:9&-OP?H&T^S]=-44X8:;?'DT\>2:NTP_.S^C;U[\RJ4)
M<Y 6C=2,EQKYU63S@!R9LD5HX0)PWW039?@AG;8#>!^\'V>Q/WADJ].XZ6J-
M^ 23ZN*,BC"Q%%<8(JT)NKA4-[WHI;4A<UN2-44\=%7?'-:#F)3O18 -WXN>
MZAEZ4_/ H<%6BU_TC%C0!R -KMZO'UD9D[(V,F5JC\!4S5[O,X;D) 8T)JF-
M^&O'%FECH-^]UA^<&@9TFP<?VZK-S]6!Z0PFHK3,24WQ ,^<7N&@F>"6H_)6
M<I..+O--E#\T_J!T\, =]]K\;$J/^S+B@H)<&1+YD)B85LZPZ#R%/;5A@Y;1
M2=]D#ZW):+[[E^#A:*7!7=-A![56![X<?ZI?+F'Z?OSUWU;C)QV58@9ES>W5
MM8-)J;<;4,9H,T5B32\0'F&,/UZ6!ZZKFZ^0>4BOT-7O7-)0K%1)4;033(':
M Y&&Q[UD-D4:-"^EJ"89Z(W']6,;J(D"CK-Y?G@T?SZ?TS^X^H-UV/,:OJQ.
M"KPJT1CR S,*>IL-IV@GTX@M:B.YTMSYII>0CC+*Q[U.]-9HR^VB007VT'=6
M;PQV%6"-.)?6^E08AD(K-]*,YDM6C.MH.&9M8IO"9$<8VX\WYR&+Z8&O/L_P
MXL#P'7R^\L.1\-%'<):AY9YI+DU-U*P-%0478"08W>3V5ONA_7A;'K"4'OA^
MUI^X'+D2HRM!,J,%6;MVKHTV6):L=\G82!'6@S^GHW'\B#4&8;AE'3LO:6')
M(3(+JI[I)5,;-PEF.,1<"KH@FB3=/- Z=GTD<I!-'T(=.ZV,<V@X\ZK6+-$N
M,>^E8BIXR7F&#*5)+>9'>?.UCT*:,O/0;[[*)+$$2T*04M,2#98!*LX$6:QV
M]H-HF@9'C_7FZUX:Z'CS=1\N[N4.8Q> /VZ^'L;GWI<9#R'C7E03R-6/(#B#
M)%,-F2D  'I54!6A;>U%V:8#]..Z^=I6+/MPT/[FJ^-!N]J(F&.$6H2$)D\-
MGCFC7<494PZG<_-U+]O??O-U'\.UO_GZYLFSSZ_GL_=S.#ODENK5?][S1NE.
M)!NW/XT2X(N#(%S0(6(,V1NPF, A9,M'.S =9)/#&R3=_)#A[-.A(9)%\F!L
M$M(6T!XA1B%$+L(;RU5(8G0KOH-LU>.R\Y9/&<Y:7:X4@TTERR@,A9$T;Z>0
MLLXB1 _%91[]Z':$>]@+/^'T' \RTOJ?]K7,-@2;YH  03D,-FD=%$0)Q4JK
M3%(::?(:;<&RMPUZO%O7/F 8>W1XIV0"L"4D%W*B&5L#+0/2A_I6<>.S'.W$
MM;=MOEU7?S9>P/OW<WR_VAF;E?4O]'G9]GS$,/8];$0W9C5:'J/Q7M/_)%J:
MU$B<RD!V%+DY/]KW8?W\YNL?_NKRP[]M:2AI73(J,15C+>9E(HO2!1:Y4IDF
M'%-B;.$VWP6L;\"P_KR+-K?3U3G&/\?+#T_/%\O9&<XOVN".I^_KEBW]KYXI
MC*1.A<:=F1.6;&%!LYB$(S\JITP!.*WE3<J2'H#U^![HH$K:#"U:L]7@5O\.
M>USLVV00AAR]P"36,C3"&()5-!-&:,<Y!"^:G.'<!NI8.ZA-A3*8U>][QW0Q
M7X[>+F&Y^K3?L;IM'S^,$TQ68;H-SM,J[EFI[8YT6-VV\I(%A;SX&$O(7?1#
M#[FB'?IJ4S>WHKBO7=+A.)X-;>L!-RU6H"XT=!72.IKO FJ//=!N0MB%YKC[
MG0.R-6MEZJ/I0!MPM8P#XX[^T,XDY@,*QK7 8GPH7(='RO^.'<QCT[^/A0>F
M_0FY-H3DLG^YS&B4\(Z)6*L21HO,\V!9#?QU$@5"ZG)(UHGKZX\^GC<Y(!>S
M00S9P#-\_L?S)Y<=02@ ]Z"08>T8HZ7W+ 9E:\Z'\M8:#:E)AL4W"(^9VIX&
M'?IM78SA-:1Q&:<U&&Z12Z,%$RAH,I+!,)^294)9\-(*[7F7',9N+^SFTQ\S
ML?W-.6#2:P7S>C[+YVGY:OX6YY_&"5=KC>(1;4R.68I):*W)ME;2 68U*A>+
M30&Z;(UTHG<;@)/ROWM;N WCBR?3O$:T6 NZ"ZBA7>^=:([O>O<GZB;K UEY
MX E]-[@<'5>\ ./)U03-)%A,2%]&'0HY%5''P;SN(U-_B]=]).;W,6Z;)(%5
MR<?UHN.E":9D3D!J&R0?*: (=363P=LH#">'8X\D@2L??=P%>B![WTP,.-18
M SK6*S2U$-WYV>K<ZA*-C45)1\-QY"5HX(I%B9D!1I5"*.5&"^8=U-WXZ$=/
M73]CM>CL=#'&-9A0DY",T\Q$&I(.J%D$&1EA=,[8J+S!#O/K_@5OKZ)XS"3W
M-VN+KDL7X[HLG\]Y3!((C >:,%!$%H4J3,GL,D_:TVB;))9?17$*'!]NU@'O
MCJQGE0E]:S9?WX!91067L1O&$@KA %ZPQN661:THBDL\) 5:>)<[SL6[GO&8
MN1S2? UNC;RDX4T7EV!0TK-EH1DD.T42"YF%D"*#$JP!A2KE)FVJKJ%XS&SW
M-VN#DBF_SV%ZN5#X9)U3&A@Y!&G=^].!9<5B*0)<B;I)HL,5#*? [Z$FO<FN
M'<B_^C:^U3WRK_OAQ@$(RT0NY/LA^>[>),Z\PY)-!"7:E":X#=0I\#^8T6\*
MP@V=1'VQW/P)\[K\?!H@.>_&1PV3A'<[PLW^WKHXR8,&ZXM&+-['P)4JVB05
MK1"C#ECWMN%KG)?9_ RFQ'><C"]V2?OT4>KTN<-8=P_L&Z:NK;"LPH1&.2U2
MS3JF8+^6<Y%HHM6C3D_H>; V78Z77_XYSOABNGK(%4>JIHX])\CS*4PNT\9>
M?DTY0JE\<=8R'H*GV3D[%F2M@*F+L4AONN%MSN$.13Q0^N,;K)/<>/I^*RVC
MD!5'QS.3012F:;)COAC!C RT7M'\95R7?<Y#$QYO1W?\%,?CZ&M'[N. 5#4X
MT^X$\OGGCYB6F-^-S^A77I6W]-U%@51_1O]@/,MB)+RW*AO)1$&*;Q2Y2$%S
M8,%%X[P4.K@FF9%##>"'*AL2WF#CL?<XUL>>7$@.R3%:!ETM@8,,I-$LU[[$
M6@NK=9,=RV'@'ROU]Y%*=7^*[SM[>+"AOUW"?/D,EA>'?>0W"V.$8<*5>CNX
M! 91.%:\XCD9[XQJTM)PV&'<5][$?>APZ%?A<#WLG+N'CF%OC3!&HE4$-A+'
MB,$V\6]$89J;X$JR/&2GE0TA%E"9E"&B@9"A4Q1&S_@1A_V(PW[$83_BL!]Q
MV$FH\D<<]B,..P&IWG<<-IBG>ED-$J8W.F=,<7F(AWK')_;T3/?!NWD$HXQQ
MPBECN=;:V%!"(+9BMM(G'W'4'?E0]CV\:D>GSVUJZPXU/@K/F2=OO!>@2S11
M(2C$7",R57RZP^)]2G_<_LE#'"[N^82F7.QU%)DD((5F1 O/FOZ $$747EMK
MDO-)W\'*C6?U6VU_V]VZY]M<#]I$'A7-K%H&FFA]8(&#J!?FLO,DL<2;1!U=
MP U6XUCR2.&R0!9#4+2@%<$BH&"0R/&!X'W&)JU-[J_&\>#<[ZQUO(]M&\1"
M%P.=;!OH90EN,7(AVH(F,?(Q<LWOX,PG%<FY\(47'62C.*<+N!/4QN"<- A%
M+H'<8HQ_XOC]!_)2GWS".;S'?RRPG$]>C@N.>(K:@=<,HZMUH)-DWL7$G)/T
MD\B-#TV2(_N /D&='8W#!GGR3\YF\^7X?]:W*V^TU@N\8*E-+'*P6)-% _,&
M"@DCN=K*0F.;EHVWPSI%#0W'0X,N#=]JA=]BB(N(.01--@B.<<);ARX9B*)9
M#:,S108B0)-NA=TA'FOCH[EF&K'R4,Z3;QG4KU_^@/^>S9].8+&X.!R4"00F
MQTH1AFD1D %RQVQ2$)(LRJDF2>1[8+S_.O_#JF2KLS4\6PU\KEN@?@/Z)YQ=
M5K/N K=E#X ]\=Y/1X!F_'?7V6#D/0#->4?OH*)@1"=#"S[/FH'4F2DH5A09
M3( FUR0>A-;NZ"?P4*6V#V<-)/8,/^%D]A'S.TP?IK/)[/V7-S7J^'KKV@=9
M("OFM,+:SKM6N72<@544!$,]26Z2[W 'K@?ES/?G=;-&Z("D--BVVM6:P^?H
M8R!8GMX2&K>DJ#336^1+B@;(5]7V^^J1U-1W&H*%AIU7=_?YZ +P1W>DP_C<
MN^'-(63<2W>D%"!YCY[EFK^I@ZZUU6HCNV2*Q21R:E-QXW%U1VHKEGTX&+KP
MT;/_>OLVC7&:</%BFOZV7@F5\$J'I%C1M;&OI:D47 *&4B1I,X+#;A5TMG[\
M0^R2M!<'LT$-.'1!I*U]FZ("$1DH7_LVI=H#V=5:7?1=ZTK1FSLRC[GAU<%4
M]C-<^SSWVS,%OC4.N>6LK5D&QEY/;YJ=<;@=-G/J46MN#-(J36^Q D#GC).<
MHM>8>(IW9&[LA>,(61UHM2[.(DN@Z;7(/#,?* 2OB5J92^N<:-('\1A9';<\
MX_?Y;+$8N8R&6PPLZ5H=B7AE@4S T">$+*75;;H9WP7L007<AVEECYV:_;EH
MEAVR%=^3E,[/SB=0#X>OG &.(NJ0P==JTO6Z4_")A20$<PJ!AB(2#TV<Y/VA
M?E]Z&H*OX^XO_XG+D1 HG0^9:5I$F 9+OJ$EW]!ABA*,*T8>6TU_XO+[4LZ^
M/#38T;D%W==,^:NJOKROH:.,HCBR@^<T?8*BZ5-R16P7,H\VCF]VKVTNG]OP
M?E^Z&HRY^TT<L:6H+!P9)M7W0Y3 /&I@2G'%74"579/CB4>:.-)'3(U8>8R)
M(X")W$+R"4WM3ZUI&F;!",V$,KE0))J2;9*N=%J)(WNII$?BR#YL/8!#_"YP
M?R2.M.*_YVG^(>0] ,U%L!!XR<R"1J8=*N:U( \S&6^S,:!CDV7T06AMP,21
M8TIM'\[N(7'$28G9*<$((H6V&FN*>O8LU8,H'JW3T&0CZ]$GCNS%ZYZ)(_N0
M,O1ISVM8UD8<,,WKJM)/WL\1KS;G2,I*[9PF5D.@L"-)!EQ+)F/.MLALL]JX
MZ;3C].?.1YVF"AJ8^;[/BGX[7Y[/\6J,6J_?TZB:G0_=^<2F9T+[C7>SPFW*
M2NM RO""0G@+QGLCT2:OLS6<WW$.=.>SCW#V4[Q)THC$2H+(= #!HI*&\52T
M*<5ZTZ9R_SV?_6PQ^L4&#;UR-9):))C\?PCUW4TZT&3-T"!GVHI<&\<"L_2W
M))RR3C2Y##P ]@<UYQZFN'UV_%LP>N1#IIM#^)-FG'=_X>03_C&;+C\L1CIB
M]%P'EK(EAT+PQ&*&PL XE-[2BE*._;YV@/W=2[$7C\>-5[>@K^_-N[]F(R^L
M3<E)9D,A>W%)]M*:,ZD(;0@N97GL^UN[T7[WFCN$M>.>9NT"3=K!4?*078B<
M9F=%7K/SF<7ZPH  5,5+BOB/?9IU&]X?<CN(N0:G6?O#_FUV/A]QT-QIZ9DK
MSC-=:%H.D QS0CB.]#,7'HC>*MP?<CN$MP$;H:UB_]V0+XO6747^I"QQ_A6W
M3C&IZ!T3/ JF/0?F=;(LN9 Q1B44IKLBZ[X@3DA%1^6C0;.U.U)2+(=@K(K,
M)&U)Y3$P'XID$&0*EAMI^+%=KX>;&M1H%MJ7AP9-V_8Y[0V%*^\T2S92A%%R
M(:1&,1.<SEF R?Y'B8]A--.(E<>8J6%!%9 479#%R/?CT;-@Z"41G&MI;7#Q
MZ FQCS%38Q^5],C4V(>M!W!JW@7NCTR-5OSW/#X_A+R'H+D4)5J!C-#7[LKH
M&11/V).1GHOH3?E1XN.A26T/SNXA4X-GF2+0G)Z#)E-(4_='>&"E>&&2R\+F
M)@5&'WVFQEZ\[IFIL0\IQ\_4P((<LJEWA0NA4X+0!8I"(%GM"CASH\W6Z69J
M'**"!F9NGZGQ*TQJ)X2W'Q"7/=(OMGU,SYR*.Y%M)$HX46F)T145=$H). H5
M+%JCHG1>CN[ V,MFAQ?WW_UAP]NO0QG_J&T(RO,$+FF9(_U?D,)R#+XDD<(V
M*_:IW;_EX]Z>GYW!_,NL/(7%!WJ1ZG^>_]_S\2>8U-=H6)5V?-CP7!PRR@VN
MN% B)1TLR*(!=0!%TY;AID@7/-IM7.T_WEY<OIA^HH^=S<<X,&];/GAXCNY"
MO]ETQ)*7"59[*[4.G'MKI>-1([U(.8>TC8_;Q]'+]J_GY(K,EU^(Y<KPQ[H(
M#4O";4\8GHW.X]F@Q2:/$4NP25A=I(J8<BJYE&2BYF;K:W+;L_HY[I>?_)J>
MN7QRY>._;1-FA& <!$;KF*@]L1R+)6?FK I%BA+0-PD'[X;6-VK9^82+N_G:
MJ&P@<&;XJ@2R+.0?F\1 >N$A8<B\2:/7VV$=WUL=6".;8<J +#1(7KMRK?X9
M?IQC&J\.TNCO$UR9?7KM@&WG8$;!!Y<$(DL^*:8I^&>A9,5XP2RU$8KFZ!9J
M&FH )Z>[>V&VP=[+T]FJ5-.J.=R+"I-"O,6ZO CYSJ96ZV0$HU"(S^NU_IH#
M6I!".Q>S**Z%Z&[!='(Z&LK^#1+1=HY\=:X;:7")!NE!UWI>GL8L"S#$*"&H
M;+ELHHW;0)V<. 9CH&D-A)TH+\[FI)7DM"*-V#AD6J!D,=!\IX0S)7$A56KB
M 78%>*Q3]<9::<+'0SE1WSFD7[^\HX]8'9B4J+BHI42#E(G&%37]+4HF#+T1
MY/UIZ9O</.F [?Y/T(?41-=)ZD!N&C@YNT=/'[#>)>\"L>59>0>,]W,^/CB_
M7?73DYQ[TI&6V3M97R6??86:F.<2&><F.*M#UAA/2C]WG'D_!/GLP\G09:&?
MSLX^GB]Q_A4787P[*\N_8(Z7)8Z+52B-8-'43@S5!E%'SXK21<< #C?+V.TX
MK+S[60_(13Z4GUD[XPY]3OT2XFQ>?^$+X?H#IN>U"_OY?#Q]_Q7P9=T#D470
M2C 4TI#GYPT+MM![7H2SWF;N1>@D@<Z//#$EM#%U@S7D)<("/\PF^<79Q_GL
MT[7C])*M5Y$7IB+ATPB>4?P/3&"@;UAN$9I4N;D%T^G(9&@"&NRXO"IEG'!3
ML,%!#-)P9J243/O$6?2)9K HD=9&*XUI<H5Y*YK3TT-_H^_<76F9V?+/VLY^
MNOSR)*7Y.4R&/0S=\>'#GX-V&<7&$:CG&*7VQAH7Z3_&"^.545R5'%QP<=L1
MZ-WCZ<[%T]GT$^FQ)EW].5MB38]Z.L<\7OX&:3P9+[\<PL'=']K3]GNBWK0Y
MO5=HC30HM7:<UDS!98G%65N UM/17O@'M/7AN4I=/[JUW3OD,17T(AN2=_).
M@R[@7='UQHT30M" [K9^GZRF.S_\S_IR+<>?^I0\VO\AK7FY?50;#"63G0Y*
ME6*S)K<AI*13UH$[FIDLY+L9NO&XOBG5<7G1A.7Z#K,H)8*L1;I%L4RO<C6=
M"TP$BR+EA%$W\25VX.F?.7[U8\F6M3K4^70YTD8$@5XR4VH),6\DBU$*EIV)
MJ"2M(;Y15\CM@([O-@VA@)LYX0.8NT&:!;F("3$O?B,K7'G3*MP1.K!%V)JB
MGGF]IZA8A.*9#,)QFS1BF[9LMV Z#3$,9?0F%TH*SFEZ_6T\K9[@T]GBXC(R
ME!P+#XYESVG,AMS[X(MAR7N>(0F3<J-982N>T]#!$,9N$$M?'^J+Z1+GN%B^
M@24^+P5376I?XSS1S^ ]C@J-V=HD6$%,-(')P""76B-#T-1FHDFZ43'8/5">
MBEY:$=,@R^$ZV*?DI'VY:$E15ST#.DL,D3F(IG90!@81(N/6.\MUD0Z;I'C>
M!NH4-=+#[ ,6L/FZ?SB;OG^'\[.*\3<8S_\+)N<XDA2-*4B)6>$SS7:)=$IQ
M&PLVYP0.C;1-COVVHCD-$?0W=(.R,[MGK[?+F@QZ9>K*BF<?H# )3C*MA67
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MN5&(LE8+$^1C*<.B](%6,JEE]"9!H\/-O=">%4$&UD2#N)AM"&]#\VJ,[\B
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M")&!Y3IT0LJC\*Y2NOET<UV+L%RMRBI 5<*(>QD#JLP\^3L$F#OF$P&6UIE
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M5=(U2?!J-Z272?OSLV,+\8\+2=^Y(=T%"XS_7AY>/=R@YB-54EE&P  H3MZ
M(L N9Y9R%%YY!SYW.R<_%,&+H>#I]+2%74=>%QXZ:S8VB]L!7WV:WM",*4Z!
M )D9MZKZGUFQ:%$PGBQHH00$W>U$NPV^E\7,"]#Q%MX>?.-XM$B7&273/"[C
MM/PGOTW2;/D/OC_S'!DK(-9&BT(434N_)IO'&YJ<ROD2P&GM+NM8K\?@7LPL
MN%C&;)D6!]]'#A9\>)7SD@:WI3OOA2%FP(C.*8:8:&PB6$:REXQKH;T5RI3
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MQ6H7V]2BN10)_)BO9YNO+;GZA(^R.@BBN)JS85A(9 AI40(C_\ZQ8D%K,HY
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M#HN7:&7N\M>(R7*>+M^M4@_G\7<(!;MA"5[4!*GP=\@,_WKH-SR>F#_A)=@
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M$0HP100*J?R7/%3^>SS\J67Y#\J% A:)5%)THBX'7)B"L[."#,I944$&HZ
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M, .L #M@%X &7 $/@ 3X 'N!_< 1X"1P!H@ +@'1P T@$4@%,H <(!]X")0
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M--A_:/T;A?:N.B@CBRH4LOR[=]5!)*:+(:!;"S#20;_S=)B8&1GH6:"L=!"
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MO=@(5[T<M[H,-X%CZVZ>$_;W10%?H#?ZO@Q-X=2.MK8\Y:NZHV8".]\DL#Y
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MTGT^;Q TVO?&1W8P7J'EXP6VYA[\=(/\+@>,VU,O,U6E[AJJ>9CFT-*25Z]
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M?^P,93-G\?%IY7YVYN34U7M\,78G6#=$9#HMZ% JBFZYUB7$^^2? D^HIG]
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M>@V]ZI3!Z*G(7NO;5F_BND1W8TK>:@&C,AG;R5T?.^-V7HZL_#Y\1_&B;.H
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MJZFPF?C=-;P\7>%+72=&8#,TO)5X4([[;:Y!,$;]H>&A"OF]TZMO^D5[3+S
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M(R$@CMI&FJ[$SMEDPYI[ LT]'.&(N@4!(TF=$#"6AB!M3)9=N T!Q]#D$J$
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M>0.L.XD#IR1=<!!P\<, !-RNIUD4,D;D(_\R0&AI '9*@OQS0",8E@*61$+
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M7*5IKY*BU7<+U?:]D,N+4U"/"*H;1*0?OZ0/*BQ;[E]H]=A(;*WY>(H"G-9
M'NKL[/'Q(S@]8BLH#%>@HV2V6^)I96K2UO)*S9B+ZXJ+EN^#-,[1A?Z?4Z;V
MA[@CJ $3>=PL>@11DQWP!?O04Z=$/)9ECJUXV9"[.(^[N#2WC>K[(%T.QI^;
M,E]0M.RA&EPN==516',%38SH/ ,T2DCGY__*[,A%SVU@.!M2*;7-'NFI./F-
M;V1/TI I$X?%_0IDXBR=_>OE;LAW\YOH/2]CAW73XTG68AR!QEBYR987"- X
M/?F?82C')U/J=?BXEUV<7N\(_O2\Y:KK!#*KKKO;TM:)\JF&9.]DV#0M:[!'
MJT6S)9FJG7\8ZI]"E!AVP!!>FS[D47P$VQK%J* \*!N/MM!4;HZY,^BV%'.
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M#!0MNL[C&-E@SG!$?;.%"?J3R<OE!/LE:;G;-_-TCGM8#Z2]>W<HD-,P+"'
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ML:8%[)]ELZ[H1X+:PN1'[S-"&4L^AZ('H^H#:08T-L;R<QM(*1C]*(]% FT
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MW K.72]%WC#:XM6SXMF-'>F"2UOQ>]S^*Z4!R2%,X+@-U8TTSPORBWZ*'!/
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M6GEV:+ZFL^VY6;2/X?6@Y_RT?SS5K^@PX_ 71B6"P@2RK%$N+")CD<6?V)E
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M5>,3!\5SN,[-"38N'=]U">P.Q=[56D7)G,)J3(ZWGIK*R@\"((]?7J!JP^G
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M3HQPSW?-W6!H?#296_^D<H-*HQQ+?[" JA2'U>:4]0>0>E\)*U1B&.G +V_
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M/'0F$ES%>2U:W+8#W+CLT936D-:X???]JYU960'<6<&@78]IUTE+_JJ.?W@
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MVP^TH:TDHIDS;D5]P[B2(F9K-_(6TEC'6S::),96%%=>X3Y8['':N*JGN^V
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MY0(0+*4631[U0P#EQO^V7!3\P\2OY1J"'R5H0Y?[2H%A8[_6 /_RF)1"\6(
M?G]*$G@VM> !=&\K@J+.2>O>7,@$^0-\O(!FWQ&\&B+T.GE+V\H.&!41J2^X
M#>NQ9=GNU7Q'(MY;9B$AMEYK6AR"J?F?Z,78\")..YYL23IRF;EIV[WZ*J"^
MD\W\Y8%WDN1IHG,'1:ZX("1J=OVA"^>'^Z]VGHGQ?R44".&7.:BNO+NK,^DN
MI%7TM._/D8;^.B11[V^"$/T2:0CQFT_ =STC5! ?;"P*"Q4:JUKWLZ1=L08'
M"="N6&?-[ GP=M&D7;'6&<Z7^^T5:T^./ Z=K]C).?V/K%^^1&E7GY&<!0AO
M]3WW$,(  7[TSE,'NH4=A,HQ*L@BTE9_O(*Y_NJ!S.>Z1>M!>%>V,U%TM"O6
M]-M7K+$JHR%UD)"-V-[BK^^G#'S]^V+O^-Y>,WHE_+[55ASA+P49QD3/A/6X
M<Q-O/5X34LO3/'C\P7FY4?U[6&1KU]LK>O:8]&L-;MHCJN2+*0=2VAFB,SG6
MZB$^A&-QWE\G]M^(!5#C^O1B:1#[2Q[5X_RO.%018>= ,056CBVR*%.)G1[_
M@GOX_\>^?_^!H.VA$SQ.PX\\S<7D67R..1A=N\=;>P@UD>V@X\%5/W:)@PJR
M##O-PK"Q'=Z&I0R?6>"]'^O=UA$;U;CU;3H8/:O\OLW=>$GND81K6;9PL&(Y
MK/^"E0@'S9WE=.P'^<2*4(X*+(?1(Y;IQMNJ6["W9>ELG2N[%NA?*JE?E=L[
M/J-84Z;G9KR4%R;48\)?]BHX5SH/<E;OZD<9@,/"9/Z(A/22X,7TMO"[7N84
M9>A%)<CMN[:YE(Q!V.DB+QD5\-*-,F.N$=S;1<F2RJ_)0_G3()QTT)LP"0#U
MTT2F/\'^K] &AG=C&]/D>,K>6=$LK=0FV\.1J?/ZI7=BN"DD5$%/15^H]J6"
M_?=]H7LNR:ZQU>2]%KSGB7"V_YN>/2*1"OHR ?V&)P,;P1QL!: 1CAYE0+5U
M]_\PW<<%VJ&AG29%%V"WE6!&8(22[M,:M#[SM]K:#A^$KG"3KE!!1RG+5!#6
M,8,&@7?#?S9'-YYR%$D%V;X>0FT4LS0"RS&DC38=T'_ I)OV<[:-+\E;KQO%
MEM7?"!ADEK6X[TA*<9I7Q)B<FKV,&WQ[R"M:'VMWY74FS]GCG]YT*(BOR%6I
M,D7[;^<S&!4BST.C;<V)J>2UV03"N\R&JLXR.7AR6["88\F%-&N5NW/6S^:"
MOO8:I^7YG2^VFLAJ,SE:%78RZ\ZU!28.88+A3/(/BQQ./ V16&=H9GA=(;"$
MR)H"\,)',62>"\K )LUM/"SL!<)AG#WY_5=3Q7-OIQS:!4L./:."Y#+?16J=
MOQL*6&D(-@J3G%4) (-+C4?A.FJ%%[Y,'RX<8#$OVIW)J*5E7!1YXJQ<\_B9
M<[LC"MN8>]%*:Y').AQ&.K0[Y.V#?S[YWQZ.MJC%3_!GSLQT8\A;Y.6!OA#6
MGH6YA'B! :'NC[K</@,S35I9_43Q0LF=*Q,NY9G2=QXG#GYN4DX0 H9D:L@O
M1>;*+1Q+#2V3Y;!&G/6O96$YG.9D.G;$?3?M+\WFD9]#WU: 5RY2]#&2 ^Y#
M36.>U=G3ES:EQJ0%5SY$W_ 4,?J6F60PKO7LQ:62I;"[YN173_DEE)2N,7;G
MZV$\LQ/^_W/'_?K@$X!7GMM305S05<3'28I%(FL1,BI?M&"/E#_Q ?+J)X\L
M9(;&@V%=7CJ'5QZJ6;I;.4?N\'9_^-#V8O'KPO'K9HQ 931ABV]HF>%;M=VY
M5O8N;.408*P^(K;%1M/E>VT#M,2*?&X:B;L?$&]XFG14U:\_+2DWX@-[(F^W
M?7;3&_=]=$ KE/Z)$XE?F_RG7PW_O?017^397]RX$'/[U<70L4@=%K7KH]+=
MRW)S]X^#Y#GZ&#Q!X9+U.8_EDQHE+/W(?3Y>C<O(3ZB.1/WQL?"DS6P>S<-G
MK'3>JKF<6'INZ,M9F:XA:I+V4O'36P/M3_1\-[FM!JXOFP_.JU(0?=[. $,(
M&MJ156ZLS 8-O7YE)9ER)BYOO3G,CV\.56Z')KN,T=]<>GG=GW)[))78 :=7
MDO$,%7WSY)?<#C2IF2$=KM2-M<)N>I4PGZ"]AL_>3NL 5BY>AO82[GL4VU:L
M$>P]G'7C 3"+QFYZ"7DL8$N1!KA-$EJ+'H_.L5M#82L6,B+((8;#-.$9X7""
M%CY7%KV%0CE,#V,KG*0I">L, -!D'L0O>%]GSDF$CHCCEO!>&5000%)^B8;D
M/?%34OD\[84+#UT_P5.+J: 0J=YZGQ%(7L#OC%* S#R_,Y$MO&#B=;QU%"=M
M*'(06ZBJ_SI_=],</P>C'HGQO,60CT;HP@7(PA+ONEBY2E7,$/P2JJK78ZOE
M?C#><D+!W>>D)S\5=+JD;>"P;%N67)791>0),$ML?6668@2O)K_C0=D/NG(<
MR/51^X;1Q<\ACJEYY8R?5&J51!N:_4T*BSW=?3@$H9-@MFL0 U%'"72(!EU7
M;@X1O.T3[+$M9R #4]Q=#^$M,202.CUNM8;96LC8@0!&31&]Z/@:(3=>.\/
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M>?;7QL8.?8]>L&.EK=QE77>]4IU-Q_',:* E%23XI"9HB[U/W!=]=H.PLE"
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M'&)A,WV)G[AI96'>.BLQ'NSPNC_^>5%@[2WTR/+1*FW&$_M%>=\4S&0D6."
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MA#RF*:8>S[4N,SS\1GZS<4 WOEH#J0K-\CV5LXJ*,;U6$;+Y]FEB-<4[IJI
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MZO\[,,-?'_Q.@L:<%>C(8? 2S?O!3P61!2A7J*!YO#>-/D[I_*G>OK%+ &D
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M[4J8_T ONDT:O46_!T-T;L:6.A;B/WJ3<GR5_U8>G S]"GQV;X60V>+;UMK
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M,+"J(=ASV)<*[=SC"M@XI'_IW&QK+[8N.SM;/K8A<*2?88Y?,#0_F&"U,GY
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MUY"K2N#C(3^KLB"?BIE+2R70Y7W3>LS&C43BVH]86@]R,,#S$3,(H\&"](+
M'%2OY65!%#O6.SY]9D$^&V=!UP7 A</^OWKG/7-"\]'H9.*)&C]W<IOYQ\6E
MZG)1K_%*4M%:\8XB$D7PM(/5L?>WEZK,),UC4]-UT!<O1!1KL>DVW''E"!?9
M 3I7_7]9PC>YC79N(2Z->=L=;DEWHW$6%B8^[&+$/8SC?#?/MZ_SC,P!O;!/
M0T4GF2O;#02N%O98N?*T%1M<OQ+54!L'^BS"R DH/6J=!:&I47@B1]^TKMI^
M-*>]S-&-IFW5"I=4,T+EYPMB9M)28-LEW:]=R#453DD6WJ-LOJU;(BL3N)>T
MORQ3='<*D/*GT!+GH\_VD4-AQZK@:<>3LAQ<SSHF5I(,[DQD7X5$S474-,>'
M[3=6UT^S+L0%.H%M.,LTJ&#R]!S3RMQ![^(3VK8NI"!3VTK<ZHE]<2IW_%12
M?7-EK]8Q(]L[[?KET3=X?^#,.K!38^Q>*L$O)W :L&-FV/J9DEV"4U2=12'+
MKJ(,@EKW^DA>E>N/KP)'=^E4$JV+ S]%=::S(/)@ =/[]RS(AT;D<XO;(M%'
M'M'@I>9!L<'*./YK*3>:>24F[CGE1MU$<,4)KX$!+KV8Y/D"Y"A-:X?6-F1S
M=5C0ZMO4J1_WV!9@8HKX,H4GIMI J;<+^^F  <Q!2L](G6[$$P55K,FY87>U
M14^7KGE96TX@9] +0N0(W4*UM127ZH M= !AF9B3@&?VF[N9I^S(VY <1' H
MS/ZAVIT?5;5NX.89U*2^;'C]'N/IQ9('(C#ZYW9M&9F;P6E^(.F]-9EZ%;9T
MEY:@\[S64Z%5>KC <[]Q*P_!\?/5:^Y)W?8_U9HLG#LX&R&^Y&.JQO8HHWU<
MTO 1VRYI,/%S.TKC6.18S*"&M6>4ALCM10WA1-VY65>-XZ/)8 GBN]^?2N'D
M6A8D6$@$^@*.=(1'P ZL'K.8'^P/NIS=-I:]/R7:9F6\*_3-X5;XI_H!ET8I
M[S;579'^T8HEQ>J=7[ZHZIN<YUD$ P##3'UBB_%KY/.,1G7%Y-S]TB-?JVI=
M*I*H9.U8F8.<K5_-RB+83;TM,[@EK0H.=)R9'YIO5LI3/!^MN=33U7V]?0[3
MG??'IV=R,EW&BBF#;15B=@/'-I8BF@,>^Z]_*5/,X6+J)Z^NP,;0@/L[O "<
MZ,BR'>!;X(3^6Z:"G5',@IQ" YXTL'"RC D)\)6?5_O]1V[@/\+&B?2&@-T>
M,6HZ_D8T+8RO6VYVN:ZQ;Y>C-#:X]^5!/J\KKA&QP9(OY/BC]YKIC\8?E+A^
M9^_='T[>88M"X"M/)?_[G* ?%>AB.;2N3R$*M/6OV6G!WIY$0QQV^[<OM>7=
MC];P()BPK6!!DAXMW2=TMN\WICWQ?Y-F4B>96-C;QQE]-&2-:M/W],)"\J35
M'6%0QRG%K@][J@;F==/@XD"R!%-]M6O?EIX4P3:R3 ?QV:>B@-)8:=SS;"/V
MQ1\G0$;SW]3/V9 Y*F1!I&1'FY>,:3GP!XWN*DU*L(P"FOJD'_NHK:6!\3?%
M9%N)?;XSB.VJPJ<FW"3YQ5$_/=)XN^V;?5GJ6[?K220"0HT%B5%8M* ^I+_U
MG5HP/Q?D2"&L)^S;QGV7_FRP=WK_C,ZXQS%5(U[V0Q;JJTSBWI3F[=Q"1XPZ
M=^"O&W?52^A54HQF_W$3/CQ+QT%G)X3:;%D07NP8<+"Q<0UOU$W^\GC+ ,I^
M<)H%^8BFO6)!NI!U*$;C+!AD@_]M%=2_(A>I0I/CZ,=1-OX+S%7_,JI>1#_&
M<>EPG<%+(B* K%J^1AG%7#[YTC8S)QLI(,_KW;8MM4W]&DKX6+38K:@KS:K
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MY4>#3$T*2.SU<@ZH6>76VTXBZE'152Y3W4@+3"VHT#J@Z&.6#Z8QEJE.U6K
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M,O/.ZD]5Y?)XSMW#]?ZUPTRT1:KTAZ[>0;F*H5,9W7K<2T(OE*4":G#N+^0
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M!\PRO 9)L2MAC'80EG[7 E-R+LW.#L."9)2R(!$#'EG<> ;2A[<N%V.T3!H
M/1'[>5+/=VD+X"%@X,RJY.&-RL%),\6X&DG4/H_Q.!+S_%G+^X%3D31!!BY[
MT/P&TIB\;]!/,Z3&9.L=L?>--KSA5\H2(>M!T+0F(UAZOB8*-\/[S@PAUWQQ
M_A6ZUQ\K(Z!FEI?\>?",P[R"*^-1Z^+PYR< 5H9]/:P^!7&J'/5[=Q@PF;Y$
M'*.\RGUZ0RQ#;_N2P$8XPGT1XSOY=)W(E<B>?QZ%QBQ,O=_0RW 6K-@Z5P+\
MX*X&;HT"A*^[X ;R1]R4 _,R&X$,)\P&)-\DIAIGT%]AXZ;F9J= ;FG!;:<4
M4G43/^]/T1G=&KU5+ COB4B'8QG/3?UU]U]%*S=&I!0<.[>HMLW:XAO<K0)'
M,7S3ZXE/;R.MA7'=#J/Y)S9RRYF6_0181\00 \_,F\V(EN>S0WHFYTZ[P;=R
M02+VM)TX_T6Q9L<5@F,SF=_W_1_PB?\<^'/@SX'_J0-8%IY8+!S1.+:PTONJ
ME/.X'N_SU*Q&Z\(*CKL.8J<.K/4>C"\**8MZ?<:U3NI>9S-_EM$UPT VE*>:
M]X &GT3+1;:#NZY<9',^/*_L:!(9_.8-'YL+FT]$C1ORDRW-WEKE!WIPM$+A
MR9@HNOV<Z4R25[;K81T#KD_-.8P>9+9K#"KKP3O<X;C]2R?M0[>'D6)]?8M>
MQLR6*XG*SPKNZ^?.*]MRYY!<Q XQP?#:K'F,\Q;34;WC2Z?(98("M2P(7T@@
M"Y)V_A5W\K=E^ 6UZ\25H?4H17Y)#SR.*4D>\/6!X=$ % 63U]_!#&!)&,CW
M&S))I)Q^$MER#1SJ!S/BS@X;R6X0;V["2TGCS2\G&6< 'D<2Y\T(\,C>RJ2
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MF<  H1+-(; PDI]V:8 5A],2H3X</@0#1LL(LS(5*HT(798@ 8Z;<Q+<029
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MS;,J@;8P*=U\K):[75TNP##NK1P;XI!IJ=ZB>>Z:V(J "7"'_5M+$\4ATU#
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M3]X!OIND-[ C&8Y/Z*EO75RVHL9A@9 <ZK(X/YVK/[#B:L&A'KQ<5?T\,/_
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M[G[(KVV S6Q5<I'^5FJO+<0[Q,J2JNV;ET0@*^AF?"HF&+P?.:"E,KT*PT$
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M,U>VIQJ=E]7D[0[[)E^6KK9%ORG0:/VC(XIKP7OY-<=K)\5XSY[ATQ37%!>
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M+FCGSNP_*M;<N%$!\EGO;I2)]P!<K6CE6(U,P,MR.2/*F1M0E6W7$MSK.<6
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M@!0\<H.N*?5NWZZM/3)/>8(DTS3!]4E(/$,@7UW6&&WY*T$.J'13Y5@+117
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M0%8R5^4>ZCYV]5Z?EO*[GDJ>1]_V=+)73 <_I:S@K,4MT:SZT*W#)'KW#C@
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M\%4"F4H())P&3+!($.YT>GAJH*DM+!_E0J,'/NE+G.JBG 74CK?Z@&E@<G)
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M:UI_99592\!J$W5I;6VY%W79=<#TJ;T;8QX=G+XCS\Y()UW7A;V^?9G9&B>
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M#K@/[O16CUMJP#SH&ZO;+-GO)ULX7=GO]OQ,.)[GQ$7WY7K='O1YNGG>Z&G
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MW4=5<,Z1RA142B2&SAB#-)<:9@6BI)0Y2](\S-,=*M+4*&XC)7A<2'M8:Q4
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MV@K1R@>L@*"5T+U4^!%P_:1^+1Q#V^SN2'A5!3^G\A7EP(\>.5H=\'/*[!<
M/WO-R!6&-];IIM- ZRBT#/*\D*4].>N*T[*,IEJ*!*I,(?/EEQDDJ4!0XE3G
MM"QP0=F8E8?]57#ZH,:OG_7NI2H1![P$CK$+$YO3Z60474@HVN[=MP"T)T[M
M/N2PKK&2DZIJ'#YYDZAV'"#^M!**XL]+M.K(5X@0WDSL356+^;*V<1Z;"L!:
MT;3DHH1<:P*QR!4D"4]AFJ5)QG.-D/:*Z3\]S-3LV*:YTT[,X'+*9T!U6Q.N
MAVI@^@Y *:@!UGD08K>_.C'2Z,VOSFM[JO55S]5A/'#W7=G8_L77#\IPTD$&
MXV=E3\PVOS2FW@.:Y6FI.,Y38]:RQ%BY>0*)3E-8E)2*K$Q(45"_)GF^(OA\
M$N,TS]OF,K,NEWFUD1K,K=C D-@#^,78(D^*K7S-5^\I<N.;(6$?F(FVHH-&
MO!/)Y%OYVRN U2 >2X5"%Y._O&48E=E"$3KDO.#GO'P\:G?)Q@@@E&>HD#F4
MN:URSVAA"RVE$.=<L<+86)*3EPI#?2[JU*RS+B"1=1K\[>6"3@^FU(UGIS%1
M S/R0"&FW85#6)K#3\M4 TH/I/W+QI&>1GW(\-$S(X:M-6WRQ?Q4\L5&"&-M
M9XRC7#-8(&SVXSRCQMK.,<Q1EJ:4%5F!O,KSN0PZ-?[OLJ :H8]RUW;K@M^R
MX(2^&\''QG1@JGX&YU%2V9:4XS&M#SXQ.=-IW%'9SP>)0Q[SNC>P9NA>MM>=
M30YC"V&LZZ:^ON%#ZWNP-0#K6<Y)5G)N\_.5]1+2$A+&;3?=--6)8H10K^Q;
MUX&GQDS/$B^7&DCK(9,;:6_ ]Y5ZJ!X?ZL; N:K%B.O,N#'6$'@/S%J'4#?.
MR.=M01J4M[)'K"3JB5;44J*N8X];2]03D:-BHK[WA_'91[5^S>IOGU;+'Y54
M\M73[[4ES^UXMV)=_6CLNQDG.$F*U!8#+0RCD91!*A2'$N,4:UUP+O!LO5RS
MN1NCN0_MQ6E; 8;[T(SD0!C1#7FULML36;V1VUA;&\']&,QC+MPX;!B$!V8Q
M"ZZ5&GS: _<7*[DQ;'\%6^'![668O7G,'[&83.8Q^JA<YH_*(9L%/"&,SSZW
MC1*V;L]/:J67JP>[ M[Q>9?M-$MXQA*.E-DR"@%QRG.;[V[VC46>EKPD6M+"
MQSAS&G5JEMG.__]])RY8;N6]:<J<B/6N_80?G;E-A1N310=X8!+[O.G7L0-Y
M3V1PMP>R6>@?8[:?\((J)GNY#3PJ<7EA<<A9?C<';B?GS80J>3HJIJLG,I,%
M3M-<E%#D&8>XX 0:!E,0\8)A4A94"J]>.&[#3HVP[JUIUZ;.=)%O8D]HS]VB
M&_".>\7H< Y,3R>C!W<16#>;"DD1-XA>$$7='KJ-/.[FT N-HZVAW]W!S7':
M\KE*&N/M]\5*L7ES'+#XH=H&E'\WM/AA6===UE->E"25TG!4FF40(YQ SK&
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M!7F",YBG*=5(:)EP[%J9]<P84^.=C9B@E1-804$CJ7NAUG-P]K-*)) &)I$
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M.H.,QH;="(L$RWA*- Z8N751H.DYHR?S\,P/?#&7W<&[ ^1[7=Y"212)8I9
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MJA,51P3*B*6V80>"1,8:(BPT9QSG5&?.KR^/A:?VPFI%!QW902T\J*0'<JV
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M)IKDD.8RAX@H#6D4YY G N5<)Q0KZ=<P[7"1R5FC5D9HVY)5<<!&2M\.94?
MY%3&2G$%L>:VISJ1D&AI31HB),U3F6/B]C(-!><XK\T:4"LF^+T:A5GE8WY7
M8KVLDEL"0.MHQ%\)U]!&^_:+]]GAB]>C^]AI]<,V 3NRSLB]N$YK>M@2Z\QG
M3U%I=U.^F)_^SW]K?V/^9YO4_9__]O\#4$L#!!0    ( -239E':-(4[6[$
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MFWI]MDR_+)89EV0X+E\:ENF6CN^#]N(3OWX.2WH0I$_36;[\ZVI!AM#;>C&
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M6C0"<K0*(_,8[)VDW_VP;.^WCM,(9'CHM!7WP3CZ@LNX&,@L58LZIX]\H\5
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M))1#5K1AR]J7EMR[7-N,UC:US/#@0LQ2/]0+>HA./T<570T_!_.DV!I((1U
MZ]WE>S<L;;MHF(*EJ, A\MJ$,$LDTZLRQ:S*>:LCRMC$7CU R]A]E891\_WK
MET?)O /8W&A]O*5?8.(I>8H:L'CR[9PA>9"#E^NQI@DJ)=TH(7";D+%+/IL
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MIU5,Z^D7O.3*.(.N7NNS/IMJQPUMV#J ""%CLD:)-MC:C;QQ2_2;@*R!7CI
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MW21D5R^_XC)-5TCBQ:A8B(E" UJO2D8*/*6U8$+D)7(5F3REG_$$J>,V7^L
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MQ<P_3LGD;D?%W.4L913<18IWO&2@<K(0'(7)1@@9I;"1R3;#4'<F<>3QDFW
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ML5@(WEK R(PW,4L?FW1F>X*FD>8 C;YU'J23'N%UXZ@IE&*URJZ6BU, 4M!
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MF_<(/>-FRV=RN4/HHE-(U9\N\O7YBQZC<]E!JC5@RJLZ %*4>AR+R9&GV&8
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MZ7P1V?(I<&RIMP[BQLK-%D</.+[_&W?^Y@2U8]H5 XE?[5$4)%/KH6#QQ5(
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MK5=H@,4ZGC9%!*P3IX0DW,HBK6!-+N"V"=D+$Z[W:& 0,7<&D^NZ1R9U0>N
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MB%5;G_*DD(R,B1Q*SI%,K?" B0Z'+9R,L XZJB9S) ^BLJ<*]A:N;T@E=8?
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MU!H"6@V4 ,2@30D^-IM(<%3_V> 7Q,W\TLGR[A SFT.D BNN9 <BA#I>2WO
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M;VIYE"V&,L@ @8<Z+\,D,D&B $]%\5K0XUV3N4BGD3WDAI0GO_VN+5_>;LQ
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MR!:*1!0)+9IXR&$#)S.B=BML'6)$[3:,[@#L+P\XC3[+F+D''FS-78L (9I
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M7=[;7[FC#KRZ_A'=+E&V![Q.0,Z>%-I\G%^%LT<TB9RGQ) !^F! H3?@"TO
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MYY_/YO\@+@Z"Y1D0R+-*@4O0@0X"Y8T!;SAMAO',C%*.LR9J])FU=% 8,2I
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M;W)M+FAT;5!+ 0(4 Q0    ( -239E'F0OIN/$L  %%  @ 7
M  "  3+P  !E>&AI8FET,3 R,3!Q,W$R,#(P+FAT;5!+ 0(4 Q0    ( -23
M9E&LHKH/1@X  *#9   8              "  :,[ 0!E>&AI8FET,3 R83$P
M<3-Q,C R,"YH=&U02P$"% ,4    " #4DV91*W2,N5A5  "B/0, %P
M        @ $?2@$ 97AH:6)I=#$P,S$P<3-Q,C R,"YH=&U02P$"% ,4
M" #4DV91Q\Y0X2$3   GN@  &               @ &LGP$ 97AH:6)I=#$P
M,V$Q,'$S<3(P,C N:'1M4$L! A0#%     @ U)-F43H"^1K:50  ,$,# !<
M             ( ! [,! &5X:&EB:70Q,#0Q,'$S<3(P,C N:'1M4$L! A0#
M%     @ U)-F40W,<:.(50  AEH# !<              ( !$@D" &5X:&EB
M:70Q,#4Q,'$S<3(P,C N:'1M4$L! A0#%     @ U)-F49EV@42K#P  U7\
M !<              ( !SUX" &5X:&EB:70Q,#8Q,'$S<3(P,C N:'1M4$L!
M A0#%     @ U)-F4?8J5XV""   ]2@  !D              ( !KVX" &5X
M:&EB:70S,3$Q,'$S<3(P,C!N9RYH=&U02P$"% ,4    " #4DV91 8^M&HL(
M   ++0  &0              @ %H=P( 97AH:6)I=#,Q,C$P<3-Q,C R,&YG
M+FAT;5!+ 0(4 Q0    ( -239E%T3A'!^ 0  .,5   9              "
M 2J  @!E>&AI8FET,S(Q,3!Q,W$R,#(P;F<N:'1M4$L! A0#%     @ U)-F
M4;;:6W#9!   .Q4  !D              ( !684" &5X:&EB:70S,C(Q,'$S
M<3(P,C!N9RYH=&U02P$"% ,4    " #4DV91<6[P]/LM P""'R$ $0
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M2P$"% ,4    " #4DV91VC2%.UNQ  "!'0@ %0              @ &[@ D
K9FQD;2TR,#(P,#DS,%]P<F4N>&UL4$L%!@     3 !, $@4  $DR"@    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
